PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Douard, V; Suzuki, T; Sabbagh, Y; Lee, J; Shapses, S; Lin, S; Ferraris, RP				Douard, Veronique; Suzuki, Takuji; Sabbagh, Yves; Lee, Jacklyn; Shapses, Sue; Lin, Sheldon; Ferraris, Ronaldo P.			Dietary fructose inhibits lactation-induced adaptations in rat 1,25-(OH)(2)D-3 synthesis and calcium transport	FASEB JOURNAL			English	Article						bone; intestine; kidney; parathyroid hormone; vitamin D	VITAMIN-D-RECEPTOR; BONE-MINERAL DENSITY; KAPPA-B; MICE; INDUCTION; KNOCKOUT; GENES; IDENTIFICATION; CONSUMPTION; HOMEOSTASIS	We recently showed that excessive fructose consumption, already associated with numerous metabolic abnormalities, reduces rates of intestinal Ca2+ transport. Using a rat lactation model with increased Ca2+ requirements, we tested the hypothesis that mechanisms underlying these inhibitory effects of fructose involve reductions in renal synthesis of 1,25-(OH)(2)D-3. Pregnant and virgin (control) rats were fed isocaloric fructose or, as controls, glucose, and starch diets from d2 of gestation to the end of lactation. Compared to virgins, lactating dams fed glucose or starch had higher rates of intestinal transcellular Ca2+ transport, elevated intestinal and renal expression of Ca2+ channels, Ca2+-binding proteins, and CaATPases, as well as increased levels of 25-(OH)D-3 and 1,25-(OH)(2)D-3. Fructose consumption prevented almost all of these lactation-induced increases, and reduced vitamin D receptor binding to promoter regions of Ca2+ channels and binding proteins. Changes in 1,25-(OH)(2)D-3 level were tightly correlated with alterations in expression of 1 alpha-hydroxylase but not with levels of parathyroid hormone and of 24-hydroxylase. Bone mineral density, content, and mechanical strength each decreased with lactation, but then fructose exacerbated these effects. When Ca2+ requirements increase during lactation or similar physiologically challenging conditions, excessive fructose consumption may perturb Ca2+ homeostasis because of fructose-induced reductions in synthesis of 1,25-(OH)(2)D-3.-Douard, V., Suzuki, T., Sabbagh, Y., Lee, J., Shapses, S., Lin, S., Ferraris, R. P. Dietary fructose inhibits lactation-induced adaptations in rat 1,25-(OH)(2)D-3 synthesis and calcium transport. FASEB J. 26, 707-721 (2012). www.fasebj.org	[Douard, Veronique; Suzuki, Takuji; Lee, Jacklyn; Ferraris, Ronaldo P.] UMDNJ New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07101 USA; [Lin, Sheldon] UMDNJ New Jersey Med Sch, Dept Orthoped, Newark, NJ 07101 USA; [Suzuki, Takuji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Physiol, Shizuoka 4228526, Japan; [Sabbagh, Yves] Genzyme Corp, Renal & Endocrine Sci Grp, Framingham, MA 01701 USA; [Shapses, Sue] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Shizuoka; Sanofi-Aventis; Genzyme Corporation; Rutgers State University New Brunswick	Ferraris, RP (corresponding author), UMDNJ New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave,MSB H621, Newark, NJ 07101 USA.	ferraris@umdnj.edu	Sabbagh, Yves/I-9792-2019; Douard, veronique/AAU-6271-2020	Sabbagh, Yves/0000-0001-5339-6705; Shapses, Sue/0000-0002-3128-2325; Suzuki, Takuji/0000-0002-7257-6792	National Science Foundation [IOS-1121049]; U.S. National Institutes of Health [DK-075617, AG-12161]; Foundation of the University of Medicine and Dentistry of New Jersey (UMDNJ); Institut Benjamin Delessert; Japan Society for the Promotion of Science [20-11635]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG012161, R01AG012161] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of the University of Medicine and Dentistry of New Jersey (UMDNJ); Institut Benjamin Delessert; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Science Foundation (IOS-1121049 to R. P. F.), the U.S. National Institutes of Health (DK-075617 to R. P. F. and AG-12161 to S. A. S.), the Foundation of the University of Medicine and Dentistry of New Jersey (UMDNJ; to R. P. F.), and Institut Benjamin Delessert (to V. D.), and a Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (20-11635 to T. S.). This study was presented at the Annual Meeting of the Federation of American Societies for Experimental Biology (April 2010; Anaheim, CA, USA). The authors are grateful to Prof. Sylvia Christakos (UMDNJ) for the CaBP28k antibody and for valuable discussion, and to Dr. K. Mochizuki for technical advice, as well as to A. Asgerally, H. Ambia-Sobhan, Dr. J. D. Bogden, M. Chi, A. Hamzelou, F. Kemp, Dr. D. Lagunoff, and D. Paglia for technical help.	Abrams SA, 2007, AM J CLIN NUTR, V85, p604S, DOI 10.1093/ajcn/85.2.604S; Ajibade DV, 2010, ENDOCRINOLOGY, V151, P2974, DOI 10.1210/en.2010-0033; Al-Zube L, 2009, J ORTHOP RES, V27, P1074, DOI 10.1002/jor.20842; Benn BS, 2008, ENDOCRINOLOGY, V149, P3196, DOI 10.1210/en.2007-1655; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Boass A, 1996, J BONE MINER RES, V11, P1640; Bray GA, 2004, AM J CLIN NUTR, V79, P537; CONDRESCU M, 1995, J BIOL CHEM, V270, P9137, DOI 10.1074/jbc.270.16.9137; Douard V, 2008, J PHYSIOL-LONDON, V586, P3657, DOI 10.1113/jphysiol.2008.155226; Douard V, 2008, ENDOCRINOLOGY, V149, P409, DOI 10.1210/en.2007-0906; Douard V, 2010, J AM SOC NEPHROL, V21, P261, DOI 10.1681/ASN.2009080795; Ebert R, 2004, MOL ENDOCRINOL, V18, P2440, DOI 10.1210/me.2002-0441; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Gezmish O, 2010, REPROD SCI, V17, P168, DOI 10.1177/1933719109349536; Gkika D, 2006, J AM SOC NEPHROL, V17, P3020, DOI 10.1681/ASN.2006060676; Hache S, 2011, J CELL MOL MED, V15, P654, DOI 10.1111/j.1582-4934.2010.01039.x; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Horst RL, 2005, J MAMMARY GLAND BIOL, V10, P141, DOI 10.1007/s10911-005-5397-x; Johnson LE, 2001, J NUTR, V131, P1787, DOI 10.1093/jn/131.6.1787; Kawashima Y, 2009, BONE, V44, P648, DOI 10.1016/j.bone.2008.12.012; Kellett GL, 2011, NUTR REV, V69, P347, DOI 10.1111/j.1753-4887.2011.00395.x; Kirchner S, 2008, AM J CLIN NUTR, V87, P1028, DOI 10.1093/ajcn/87.4.1028; Lee GS, 2007, J BONE MINER RES, V22, P1968, DOI 10.1359/JBMR.070801; McGartland C, 2003, J BONE MINER RES, V18, P1563, DOI 10.1359/jbmr.2003.18.9.1563; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Mochizuki K, 2010, MOL NUTR FOOD RES, V54, P1445, DOI 10.1002/mnfr.200900467; Nakayama T, 2010, AM J PHYSIOL-RENAL, V298, pF712, DOI 10.1152/ajprenal.00433.2009; PATEL S, 1988, KIDNEY INT, V34, P224, DOI 10.1038/ki.1988.168; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Singh P, 2004, ASSAY DRUG DEV TECHN, V2, P161, DOI 10.1089/154065804323056503; Suzuki T, 2011, BIOCHEM J, V435, P43, DOI 10.1042/BJ20101987; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tjaderhane L, 1998, J NUTR, V128, P1807, DOI 10.1093/jn/128.10.1807; Tsai J, 2009, AM J PHYSIOL-GASTR L, V296, pG1287, DOI 10.1152/ajpgi.90540.2008; Tucker KL, 2006, AM J CLIN NUTR, V84, P936, DOI 10.1093/ajcn/84.4.936; Van Cromphaut SJ, 2003, J BONE MINER RES, V18, P1725, DOI 10.1359/jbmr.2003.18.10.1725; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Weiler H, 2005, CAN MED ASSOC J, V172, P757, DOI 10.1503/cmaj.1040508; Wuest M, 2011, NUCL MED BIOL, V38, P461, DOI 10.1016/j.nucmedbio.2010.11.004; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051; ZERNICKE RF, 1995, BONE, V16, P25, DOI 10.1016/S8756-3282(00)80007-1	44	18	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					707	721		10.1096/fj.11-190264	http://dx.doi.org/10.1096/fj.11-190264			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22038050	Green Published			2022-12-25	WOS:000300485700022
J	Ugleholdt, R; Pedersen, J; Bassi, MR; Fuchtbauer, EM; Jorgensen, SM; Kissow, HL; Nytofte, N; Poulsen, SS; Rosenkilde, MM; Seino, Y; Thams, P; Holst, PJ; Holst, JJ				Ugleholdt, Randi; Pedersen, Jens; Bassi, Maria Rosaria; Fuchtbauer, Ernst-Martin; Jorgensen, Signe Marie; Kissow, Hanne-Louise; Nytofte, Nikolaj; Poulsen, Steen Seier; Rosenkilde, Mette Marie; Seino, Yutaka; Thams, Peter; Holst, Peter Johannes; Holst, Jens Juul			Transgenic Rescue of Adipocyte Glucose-dependent Insulinotropic Polypeptide Receptor Expression Restores High Fat Diet-induced Body Weight Gain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; LIPOPROTEIN-LIPASE ACTIVITY; ADIPOSE-TISSUE; LIPID-METABOLISM; SOLUBILIZED MEMBRANES; ENTEROINSULAR AXIS; GIP; OBESITY; LIPOLYSIS	The glucose-dependent insulinotropic polypeptide receptor (GIPr) has been implicated in high fat diet-induced obesity and is proposed as an anti-obesity target despite an uncertainty regarding the mechanism of action. To independently investigate the contribution of the insulinotropic effects and the direct effects on adipose tissue, we generated transgenic mice with targeted expression of the human GIPr to white adipose tissue or beta-cells, respectively. These mice were then cross-bred with the GIPr knock-out strain. The central findings of the study are that mice with GIPr expression targeted to adipose tissue have a similar high fat diet -induced body weight gain as control mice, significantly greater than the weight gain in mice with a general ablation of the receptor. Surprisingly, this difference was due to an increase in total lean body mass rather than a gain in total fat mass that was similar between the groups. In contrast, glucose-dependent insulinotropic polypeptide-mediated insulin secretion does not seem to be important for regulation of body weight after high fat feeding. The study supports a role of the adipocyte GIPr in nutrient-dependent regulation of body weight and lean mass, but it does not support a direct and independent role for the adipocyte or beta-cell GIPr in promoting adipogenesis.	[Ugleholdt, Randi; Pedersen, Jens; Jorgensen, Signe Marie; Kissow, Hanne-Louise; Nytofte, Nikolaj; Poulsen, Steen Seier; Holst, Jens Juul] Univ Copenhagen, Ctr Basic Metab Res, Novo Nordisk Fdn, DK-2200 Copenhagen N, Denmark; [Ugleholdt, Randi; Pedersen, Jens; Jorgensen, Signe Marie; Kissow, Hanne-Louise; Nytofte, Nikolaj; Poulsen, Steen Seier; Thams, Peter; Holst, Jens Juul] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Bassi, Maria Rosaria; Holst, Peter Johannes] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, DK-1014 Copenhagen, Denmark; [Fuchtbauer, Ernst-Martin] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Rosenkilde, Mette Marie] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Seino, Yutaka] Kyoto Univ, Dept Diabet & Clin Nutr, Kyoto 6068507, Japan	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; University of Copenhagen; Kyoto University	Holst, JJ (corresponding author), Univ Copenhagen, Ctr Basic Metab Res, Novo Nordisk Fdn, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	jjholst@sund.ku.dk	Holst, Jens/AAA-8022-2022; Kissow, Hannelouise/AAW-2119-2020	Kissow, Hannelouise/0000-0001-9351-8885; Holst, Jens Juul/0000-0001-6853-3805; Bassi, Maria Rosaria/0000-0001-6736-6152; Poulsen, Steen Seier/0000-0003-4419-4911; Rosenkilde, Mette Marie/0000-0001-9600-3254; Holst, Peter Johannes/0000-0002-1279-304X	Danish Medical Research Council; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; Aase and Ejnar Danielsens Foundation; Augustinus Foundation; Becket Foundation; Fonden til Laegevidenskabens Fremme	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; Aase and Ejnar Danielsens Foundation; Augustinus Foundation; Becket Foundation; Fonden til Laegevidenskabens Fremme	This work was supported by the Danish Medical Research Council, the Novo Nordisk Foundation, Fabrikant Vilhelm Pedersen og Hustrus Mindelegat, the Aase and Ejnar Danielsens Foundation, the Augustinus Foundation, the Becket Foundation, and Fonden til Laegevidenskabens Fremme.	Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Asmar M, 2010, DIABETES, V59, P2160, DOI 10.2337/db10-0098; Asmar M, 2010, AM J PHYSIOL-ENDOC M, V298, pE614, DOI 10.1152/ajpendo.00639.2009; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barnes KM, 2009, CURR PROTEIN PEPT SC, V10, P96, DOI 10.2174/138920309787315239; BECK B, 1983, REGUL PEPTIDES, V7, P3, DOI 10.1016/0167-0115(83)90276-8; BECK B, 1987, CELL MOL BIOL, V33, P555; Bertin E, 2001, J CLIN ENDOCR METAB, V86, P1229, DOI 10.1210/jc.86.3.1229; Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968; Cammisotto PG, 2002, AM J PHYSIOL-CELL PH, V283, pC244, DOI 10.1152/ajpcell.00033.2002; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; CREUTZFELDT W, 1978, DIABETOLOGIA, V14, P15, DOI 10.1007/BF00429703; de Fonseca FR, 2000, METABOLISM, V49, P709, DOI 10.1053/meta.2000.6251; Deacon CF, 2000, J CLIN ENDOCR METAB, V85, P3575, DOI 10.1210/jc.85.10.3575; Ding KH, 2004, AM J PHYSIOL-ENDOC M, V286, pE773, DOI 10.1152/ajpendo.00507.2003; DUPRE J, 1976, METABOLISM, V25, P1197, DOI 10.1016/S0026-0495(76)80002-9; EBERT R, 1991, HORM METAB RES, V23, P517, DOI 10.1055/s-2007-1003745; ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141; FALKO JM, 1975, J CLIN ENDOCR METAB, V41, P260, DOI 10.1210/jcem-41-2-260; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Getty-Kaushik L, 2006, OBESITY, V14, P1124, DOI 10.1038/oby.2006.129; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; HAUNER H, 1988, ANN NUTR METAB, V32, P282, DOI 10.1159/000177467; HIGUCHI Y, 1992, J EXP MED, V176, P1719, DOI 10.1084/jem.176.6.1719; HOLST JJ, 1980, BIOCHEM J, V187, P337, DOI 10.1042/bj1870337; Isken F, 2008, AM J PHYSIOL-ENDOC M, V295, pE350, DOI 10.1152/ajpendo.00008.2008; Kim SJ, 2007, J BIOL CHEM, V282, P34139, DOI 10.1074/jbc.M704896200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; KNAPPER JME, 1995, J NUTR, V125, P183; Lewis JT, 2000, ENDOCRINOLOGY, V141, P3710, DOI 10.1210/en.141.10.3710; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; Marroqui L, 2011, DIABETOLOGIA, V54, P843, DOI 10.1007/s00125-010-2024-1; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; McIntosh CHS, 1999, ENDOCRINOLOGY, V140, P398, DOI 10.1210/en.140.1.398; Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244; MERIDA E, 1993, J CLIN ENDOCR METAB, V77, P1654, DOI 10.1210/jc.77.6.1654; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Naitoh R, 2008, BIOCHEM BIOPH RES CO, V376, P21, DOI 10.1016/j.bbrc.2008.08.052; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; OBEN J, 1991, J ENDOCRINOL, V130, P267, DOI 10.1677/joe.0.1300267; Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002; Pederson RA, 1996, METABOLISM, V45, P1335, DOI 10.1016/S0026-0495(96)90112-2; Perez C, 2004, DIABETES, V53, P347, DOI 10.2337/diabetes.53.2.347; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Ruclovich N, 2007, REGUL PEPTIDES, V142, P138, DOI 10.1016/j.regpep.2007.02.006; RUIZGRANDE C, 1992, PEPTIDES, V13, P13, DOI 10.1016/0196-9781(92)90134-O; Sancho V, 2005, J MOL ENDOCRINOL, V35, P27, DOI 10.1677/jme.1.01747; Sancho V, 2006, INT J MOL MED, V17, P1133; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Song Diane H, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P46, DOI 10.1097/MED.0b013e328011aa88; Tang-Christensen M, 2000, NAT MED, V6, P802, DOI 10.1038/77535; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Thams P, 2001, DIABETOLOGIA, V44, P738, DOI 10.1007/s001250051683; VALVERDE I, 1993, ENDOCRINOLOGY, V132, P75, DOI 10.1210/en.132.1.75; Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428; WASADA T, 1981, J CLIN INVEST, V68, P1106, DOI 10.1172/JCI110335; Yamada C, 2007, BIOCHEM BIOPH RES CO, V364, P175, DOI 10.1016/j.bbrc.2007.09.128; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zhou HY, 2005, BIOCHEM BIOPH RES CO, V335, P937, DOI 10.1016/j.bbrc.2005.07.164	64	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44632	44645		10.1074/jbc.M111.311779	http://dx.doi.org/10.1074/jbc.M111.311779			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22027838	hybrid, Green Published			2022-12-25	WOS:000298645500034
J	Lee, S; Kim, JH; Kim, JH; Seo, JW; Han, HS; Lee, WH; Mori, K; Nakao, K; Barasch, J; Suk, K				Lee, Shinrye; Kim, Jong-Heon; Kim, Jae-Hong; Seo, Jung-Wan; Han, Hyung-Soo; Lee, Won-Ha; Mori, Kiyoshi; Nakao, Kazuwa; Barasch, Jonathan; Suk, Kyoungho			Lipocalin-2 Is a Chemokine Inducer in the Central Nervous System ROLE OF CHEMOKINE LIGAND 10 (CXCL10) IN LIPOCALIN-2-INDUCED CELL MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; FIBRILLARY ACIDIC PROTEIN; ACUTE-PHASE PROTEIN; SPINAL-CORD-INJURY; GENE-EXPRESSION; GLIAL-CELLS; MULTIPLE-SCLEROSIS; SIGNALING PATHWAY; BREAST-CANCER; UP-REGULATION	The secreted protein lipocalin-2 (LCN2) has been implicated in diverse cellular processes, including cell morphology and migration. Little is known, however, about the role of LCN2 in the CNS. Here, we show that LCN2 promotes cell migration through up-regulation of chemokines in brain. Studies using cultured glial cells, microvascular endothelial cells, and neuronal cells suggest that LCN2 may act as a chemokine inducer on the multiple cell types in the CNS. In particular, up-regulation of CXCL10 by JAK2/STAT3 and IKK/NF-kappa B pathways in astrocytes played a pivotal role in LCN2-induced cell migration. The cell migration-promoting activity of LCN2 in the CNS was verified in vivo using mouse models. The expression of LCN2 was notably increased in brain following LPS injection or focal injury. Mice lacking LCN2 showed the impaired migration of astrocytes to injury sites with a reduced CXCL10 expression in the neuroinflammation or injury models. Thus, the LCN2 proteins, secreted under inflammatory conditions, may amplify neuroinflammation by inducing CNS cells to secrete chemokines such as CXCL10, which recruit additional inflammatory cells.	[Suk, Kyoungho] Kyungpook Natl Univ, Dept Pharmacol, Sch Med, Taegu 700422, South Korea; [Han, Hyung-Soo] Kyungpook Natl Univ, Dept Physiol, Sch Med, Brain Sci & Engn Inst,Cell & Matrix Res Inst, Taegu 700422, South Korea; [Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Sch Med, Taegu 700422, South Korea; [Mori, Kiyoshi; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan; [Barasch, Jonathan] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyoto University; Columbia University	Suk, K (corresponding author), Kyungpook Natl Univ, Dept Pharmacol, Sch Med, 101 Dong In, Taegu 700422, South Korea.	ksuk@knu.ac.kr	Mori, Kiyoshi/N-1267-2014	Mori, Kiyoshi/0000-0002-7285-8351	National Research Foundation [2009-0078941]; Ministry of Education, Science and Technology of Korean government; Ministry of Education, Science and Technology [2010-0029460]	National Research Foundation; Ministry of Education, Science and Technology of Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation Grant 2009-0078941 funded by the Ministry of Education, Science and Technology of Korean government. This work was also supported by the Basic Science Research Program through the National Research Foundation funded by Ministry of Education, Science and Technology Grant 2010-0029460.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Ambrosini E, 2004, NEUROCHEM RES, V29, P1017, DOI 10.1023/B:NERE.0000021246.96864.89; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Andjelkovic AV, 2002, J NEUROSCI RES, V70, P219, DOI 10.1002/jnr.10372; Araki W, 2000, ANN NY ACAD SCI, V920, P241; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Bertollini C, 2006, NEUROPHARMACOLOGY, V51, P816, DOI 10.1016/j.neuropharm.2006.05.027; Biber K, 2002, NEUROSCIENCE, V112, P487, DOI 10.1016/S0306-4522(02)00114-8; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Boran MS, 2007, J NEUROCHEM, V102, P216, DOI 10.1111/j.1471-4159.2007.04464.x; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Cattaneo E, 1999, TRENDS NEUROSCI, V22, P365, DOI 10.1016/S0166-2236(98)01378-2; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Chensue SW, 2001, CLIN MICROBIOL REV, V14, P821, DOI 10.1128/CMR.14.4.821-835.2001; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Chung RS, 2009, NEUROTOX RES, V15, P381, DOI 10.1007/s12640-009-9044-y; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Czapski GA, 2007, J NEUROSCI RES, V85, P1694, DOI 10.1002/jnr.21294; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; ENOKIDO Y, 1992, BRAIN RES, V599, P261, DOI 10.1016/0006-8993(92)90400-4; Erskine L, 2000, J NEUROSCI, V20, P4975; Fisher SN, 1995, BRAIN BEHAV IMMUN, V9, P331, DOI 10.1006/brbi.1995.1031; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goldberg SH, 2001, NEUROPATH APPL NEURO, V27, P127, DOI 10.1046/j.1365-2990.2001.00312.x; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Gwira JA, 2005, J BIOL CHEM, V280, P7875, DOI 10.1074/jbc.M413192200; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Hwang J, 2008, INT IMMUNOPHARMACOL, V8, P1686, DOI 10.1016/j.intimp.2008.08.004; Ivashkiv L B, 2000, Rev Immunogenet, V2, P220; Kalla R, 2003, GLIA, V41, P50, DOI 10.1002/glia.10176; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Lee HJ, 2006, INT J CANCER, V118, P2490, DOI 10.1002/ijc.21657; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lin HH, 2011, INT J BIOL SCI, V7, P74, DOI 10.7150/ijbs.7.74; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; Matejuk A, 2001, J NEUROSCI RES, V65, P529, DOI 10.1002/jnr.1183; Misse D, 2001, BLOOD, V98, P541, DOI 10.1182/blood.V98.3.541; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Na YJ, 2007, J NEUROCHEM, V103, P637, DOI 10.1111/j.1471-4159.2007.04769.x; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Niclou SP, 2000, J NEUROSCI, V20, P4962; Odemis V, 2002, J BIOL CHEM, V277, P39801, DOI 10.1074/jbc.M200472200; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Paglinawan R, 2003, GLIA, V44, P219, DOI 10.1002/glia.10286; Park C, 2006, GLIA, V53, P248, DOI 10.1002/glia.20278; Playford RJ, 2006, GASTROENTEROLOGY, V131, P809, DOI 10.1053/j.gastro.2006.05.051; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Simpson J, 2000, J NEUROIMMUNOL, V108, P192, DOI 10.1016/S0165-5728(00)00274-5; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Sun DM, 1997, J NEUROSCI RES, V48, P192; Sunil VR, 2007, EXP MOL PATHOL, V83, P177, DOI 10.1016/j.yexmp.2007.03.004; Takanaga H, 2004, J BIOL CHEM, V279, P15441, DOI 10.1074/jbc.M311844200; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; VANGURI P, 1995, J NEUROIMMUNOL, V56, P35, DOI 10.1016/0165-5728(94)00131-7; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang HH, 2007, J CLIN PATHOL, V60, P555, DOI 10.1136/jcp.2006.039297; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	100	107	108	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43855	43870		10.1074/jbc.M111.299248	http://dx.doi.org/10.1074/jbc.M111.299248			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22030398	Green Published, hybrid			2022-12-25	WOS:000298402300027
J	Lin, S; Yu, L; Yang, JH; Liu, Z; Karia, B; Bishop, AJR; Jackson, J; Lozano, G; Copland, JA; Mu, XX; Sun, BC; Sun, LZ				Lin, Shu; Yu, Lan; Yang, Junhua; Liu, Zhao; Karia, Bijal; Bishop, Alexander J. R.; Jackson, James; Lozano, Guillermina; Copland, John A.; Mu, Xiaoxin; Sun, Beicheng; Sun, Lu-Zhe			Mutant p53 Disrupts Role of ShcA Protein in Balancing Smad Protein-dependent and -independent Signaling Activity of Transforming Growth Factor-beta (TGF-beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-LINES; HUMAN PROSTATE CARCINOMA; RECEPTOR-TYPE-II; BREAST-CANCER; MAP KINASE; ADAPTER PROTEIN; MCF-7 CELLS; P66 SHC; INVASION; EXPRESSION	Biomarkers are lacking for identifying the switch of transforming growth factor-beta (TGF-beta) from tumor-suppressing to tumor-promoting. Mutated p53 (mp53) has been suggested to switch TGF-beta to a tumor promoter. However, we found that mp53 does not always promote the oncogenic role of TGF-beta. Here, we show that endogenous mp53 knockdown enhanced cell migration and phosphorylation of ERK in DU145 prostate cancer cells. Furthermore, ectopic expression of mp53 in p53-null PC-3 prostate cancer cells enhanced Smad-dependent signaling but inhibited TGF-beta -induced cell migration by down-regulating activated ERK. Reactivation of ERK by the expression of its activator, MEK-1, restored TGF-beta -induced cell migration. Because TGF-beta is known to activate the MAPK/ERK pathway through direct phosphorylation of the adaptor protein ShcA and MAPK/ERK signaling is pivotal to tumor progression, we investigated whether ShcA contributed to mp53-induced ERK inhibition and the conversion of the role of TGF-beta during carcinogenesis. We found that mp53 expression led to a decrease of phosphorylated p52ShcA/ERK levels and an increase of phosphorylated Smad levels in a panel of mp53-expressing cancer cell lines and in mammary glands and tumors from mp53 knock-in mice. By manipulating ShcA levels to regulate ERK and Smad signaling in human untransformed and cancer cell lines, we showed that the role of TGF-beta in regulating anchorage-dependent and -independent growth and migration can be shifted between growth suppression and migration promotion. Thus, our results for the first time suggest that mp53 disrupts the role of ShcA in balancing the Smad-dependent and -independent signaling activity of TGF-beta and that ShcA/ERK signaling is a major pathway regulating the tumor-promoting activity of TGF-beta	[Lin, Shu; Yu, Lan; Yang, Junhua; Liu, Zhao; Karia, Bijal; Bishop, Alexander J. R.; Mu, Xiaoxin; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Karia, Bijal; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Bishop, Alexander J. R.; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Jackson, James; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Copland, John A.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Mu, Xiaoxin; Sun, Beicheng] Nanjing Med Univ, Affiliated Hosp 1, Key Lab Living Donor Liver Transplantat, Nanjing 210009, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Nanjing Medical University	Sun, LZ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr,Mail Code 7762, San Antonio, TX 78229 USA.	sunl@uthscsa.edu	, LuZhe/AAW-4095-2021; Lin, Shu/C-3790-2013	Jackson, James Griffith/0000-0002-2640-6442	National Institutes of Health [R01CA075253, R01CA079683, R01CA104505, P30CA054174-17]; NCI cancer center; NATIONAL CANCER INSTITUTE [R01CA079683, R01CA075253, P30CA054174, R01CA104505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI cancer center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA075253 (to L.-Z. S.), R01CA079683 (to L.-Z. S.), R01CA104505 (to J. A. C.), and P30CA054174-17, an NCI cancer center support grant (to the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aubrecht J, 1999, CARCINOGENESIS, V20, P2229, DOI 10.1093/carcin/20.12.2229; Bandyopadhyay A, 2005, PROSTATE, V63, P81, DOI 10.1002/pros.20166; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; BARTEK J, 1990, ONCOGENE, V5, P893; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Buganim Y, 2010, CANCER RES, V70, P2274, DOI 10.1158/0008-5472.CAN-09-2661; Chen CG, 1997, J BIOL CHEM, V272, P12862, DOI 10.1074/jbc.272.19.12862; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Davol PA, 2003, CANCER RES, V63, P6772; Dong P, 2007, CLIN EXP METASTAS, V24, P471, DOI 10.1007/s10585-007-9084-8; Frackelton AR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1631; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; ISAACS WB, 1991, CANCER RES, V51, P4716; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Kalo E, 2007, MOL CELL BIOL, V27, P8228, DOI 10.1128/MCB.00374-07; Ko Y, 1998, INT J ONCOL, V12, P87; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Lei XF, 2007, EXP CELL RES, V313, P1687, DOI 10.1016/j.yexcr.2007.02.016; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Lotti LV, 1996, MOL CELL BIOL, V16, P1946; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Ma Z, 2010, ONCOGENE, V29, P5559, DOI 10.1038/onc.2010.326; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; OKADA S, 1995, J BIOL CHEM, V270, P20737, DOI 10.1074/jbc.270.35.20737; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Rajendran M, 2010, CANCER METAST REV, V29, P207, DOI 10.1007/s10555-010-9213-8; Ramachandra M, 2002, CANCER RES, V62, P6045; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Sun LZ, 2004, FRONT BIOSCI, V9, P1925, DOI 10.2741/1382; Ursini-Siegel J, 2008, CELL CYCLE, V7, P1936, DOI 10.4161/cc.7.13.6205; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	56	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44023	44034		10.1074/jbc.M111.265397	http://dx.doi.org/10.1074/jbc.M111.265397			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039050	Green Published, hybrid			2022-12-25	WOS:000298402300043
J	Asnani, MR; McCaw-Binns, AM; Reid, ME				Asnani, Monika R.; McCaw-Binns, Affette M.; Reid, Marvin E.			Excess Risk of Maternal Death from Sickle Cell Disease in Jamaica: 1998-2007	PLOS ONE			English	Article							PREGNANCY OUTCOMES; DEVELOPING-COUNTRY; PREVENT ECLAMPSIA; MORTALITY; BAHRAIN; STRATEGIES; EXPERIENCE; MANAGEMENT; MORBIDITY; CARE	Background: Decreases in direct maternal deaths in Jamaica have been negated by growing indirect deaths. With sickle cell disease (SCD) a consistent underlying cause, we describe the epidemiology of maternal deaths in this population. Methods: Demographic, service delivery and cause specific mortality rates were compared among women with (n = 42) and without SCD (n = 376), and between SCD women who died in 1998-2002 and 2003-7. Results: Women with SCD had fewer viable pregnancies (p: 0.02) despite greater access to high risk antenatal care (p: 0.001), and more often died in an intensive care unit (p: 0.002). In the most recent period (2003-7) SCD women achieved more pregnancies (median 2 vs. 3; p: 0.009), made more antenatal visits (mean 3.3 vs. 7.3; p: 0.01) and were more often admitted antenatally (p:<0.0001). The maternal mortality ratio for SCD decedents was 7-11 times higher than the general population, with 41% of deaths attributable to their disorder. Cause specific mortality was higher for cardiovascular complications, gestational hypertension and haemorrhage. Respiratory failure was the leading immediate cause of death. Conclusions: Women with SCD experience a significant excess risk of dying in pregnancy and childbirth [MMR: (SCD) 719/100,000, (non SCD) 78/100,000]. MDG5 cannot be realised without improving care for women with SCD. Tertiary services (e. g. ventilator support) are needed at regional centres to improve outcomes in this and other high risk populations. Universal SCD screening in pregnancy in populations of African and Mediterranean descent is needed as are guidelines for managing SCD pregnancies and educating families with SCD.	[Asnani, Monika R.; Reid, Marvin E.] Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica; [McCaw-Binns, Affette M.] Univ W Indies, Dept Community Hlth & Psychiat, Kingston 7, Jamaica	University West Indies Mona Jamaica; University West Indies Mona Jamaica	Asnani, MR (corresponding author), Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica.	monika.parshadasnani@uwimona.edu.jm	Reid, Marvin/J-2884-2014	Reid, Marvin/0000-0003-4005-9384				Afolabi BB, 2009, J OBSTET GYNAECOL, V29, P104, DOI 10.1080/01443610802667112; Al Arrayed S, 2005, COMMUNITY GENET, V8, P52, DOI 10.1159/000083340; Barfield WD, 2010, AM J PREV MED, V38, pS542, DOI 10.1016/j.amepre.2009.12.020; Chakravarty EF, 2008, OBSTET GYNECOL, V111, P927, DOI 10.1097/01.AOG.0000308710.86880.a6; Dauphin-McKenzie N, 2006, OBSTET GYNECOL SURV, V61, P343, DOI 10.1097/01.ogx.0000216976.15100.29; ELSHAFEI AM, 1988, AUST NZ J OBSTET GYN, V28, P41; Geelhoed DW, 2003, EUR J OBSTET GYN R B, V107, P135, DOI 10.1016/S0301-2115(02)00224-5; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; KAMPIKAHO A, 1991, E AFR MED J, V68, P624; Litos M, 2007, EUR J OBSTET GYN R B, V133, P169, DOI 10.1016/j.ejogrb.2006.08.009; MacGillivray I, 2004, INT J GYNECOL OBSTET, V87, P295, DOI 10.1016/j.ijgo.2004.07.009; McCaw-Binns A, 2008, INT J GYNECOL OBSTET, V100, P31, DOI 10.1016/j.ijgo.2007.06.054; McCaw-Binns A, 2007, INT J GYNECOL OBSTET, V96, P226, DOI 10.1016/j.ijgo.2006.12.002; McCaw-Binns AM, 2004, INT J GYNECOL OBSTET, V87, P286, DOI 10.1016/j.ijgo.2004.07.008; Okpala I, 2002, EUR J HAEMATOL, V68, P157, DOI 10.1034/j.1600-0609.2002.01523.x; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; Perez A, 2010, MEDICC REV, V12, P27, DOI 10.37757/MR2010.V12.N2.7; Rahimy MC, 2000, BLOOD, V96, P1685, DOI 10.1182/blood.V96.5.1685.h8001685_1685_1689; Rajab KE, 2006, INT J GYNECOL OBSTET, V93, P171, DOI 10.1016/j.ijgo.2006.02.007; Rajab KE, 2004, SAUDI MED J, V25, P265; Sandhu A. K., 2008, Eastern Mediterranean Health Journal, V14, P720; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Serjeant GR, 2005, BJOG-INT J OBSTET GY, V112, P1308, DOI 10.1111/j.1471-0528.2005.00678.x; Serjeant GR, 1997, LANCET, V350, P725, DOI 10.1016/S0140-6736(97)07330-3; Smith JA, 1996, OBSTET GYNECOL, V87, P199, DOI 10.1016/0029-7844(95)00367-3; *STAT I JAM, 2008, DEM STAT 2007; Sun PM, 2001, AM J OBSTET GYNECOL, V184, P1127, DOI 10.1067/mob.2001.115477; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Unuigbe J A, 1988, Trop J Obstet Gynaecol, V1, P13	30	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26281	10.1371/journal.pone.0026281	http://dx.doi.org/10.1371/journal.pone.0026281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039456	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200009
J	Huang, L; Ho, P; Yu, J; Zhu, L; Lee, KH; Chen, CH				Huang, Li; Ho, Phong; Yu, Jie; Zhu, Lei; Lee, Kuo-Hsiung; Chen, Chin-Ho			Picomolar Dichotomous Activity of Gnidimacrin Against HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-KINASE-C; ANTIRETROVIRAL THERAPY; BLOOD-LYMPHOCYTES; PKC-BETA; PROSTRATIN; EXPRESSION; INFECTION; INHIBITION; ACTIVATION	Highly active antiretroviral therapy (HAART) has offered a promising approach for controlling HIV-1 replication in infected individuals. However, with HARRT, HIV-1 is suppressed rather than eradicated due to persistence of HIV-1 in latent viral reservoirs. Thus, purging the virus from latent reservoirs is an important strategy toward eradicating HIV-1 infection. In this study, we discovered that the daphnane diterpene gnidimacrin, which was previously reported to have potent anti-cancer cell activity, activated HIV-1 replication and killed persistently-infected cells at picomolar concentrations. In addition to its potential to purge HIV-1 from latently infected cells, gnidimacrin potently inhibited a panel of HIV-1 R5 virus infection of peripheral blood mononuclear cells (PBMCs) at an average concentration lower than 10 pM. In contrast, gnidimacrin only partially inhibited HIV-164 virus infection of PBMCs. The strong anti-HIV-1 R5 virus activity of gnidimacrin was correlated with its effect on down-regulation of the HIV-1 coreceptor CCR5. The anti-R5 virus activity of gnidimacrin was completely abrogated by a selective protein kinase C beta inhibitor enzastaurin, which suggests that protein kinase C beta plays a key role in the potent anti-HIV-1 activity of gnidimacrin in PBMCs. In summary, these results suggest that gnidimacrin could activate latent HIV-1, specifically kill HIV-1 persistently infected cells, and inhibit R5 viruses at picomolar concentrations.	[Huang, Li; Ho, Phong; Yu, Jie; Zhu, Lei; Chen, Chin-Ho] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	Duke University; University of North Carolina; University of North Carolina Chapel Hill; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, L (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	chc@duke.edu		Huang, Li/0000-0001-5659-4053	National Institutes of Health National Institute of Allergy and Infectious Disease [AI065310, AI033066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033066] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health National Institute of Allergy and Infectious Disease [Grants AI065310] and the National Institutes of Health National Institute of Allergy and Infectious Disease [AI033066]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada Y, 2011, ORG LETT, V13, P2904, DOI 10.1021/ol200889s; Bedoya LM, 2009, BIOCHEM PHARMACOL, V77, P965, DOI 10.1016/j.bcp.2008.11.025; Biancotto A, 2004, J VIROL, V78, P10507, DOI 10.1128/JVI.78.19.10507-10515.2004; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; BORRIS RP, 1988, J ETHNOPHARMACOL, V24, P41, DOI 10.1016/0378-8741(88)90138-9; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Dau B, 2009, DRUGS, V69, P31, DOI 10.2165/00003495-200969010-00003; Faul MM, 2003, BIOORG MED CHEM LETT, V13, P1857, DOI 10.1016/S0960-894X(03)00286-5; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Fujiwara M, 1996, ANTIMICROB AGENTS CH, V40, P271, DOI 10.1128/AAC.40.1.271; GUSTAFSON KR, 1992, J MED CHEM, V35, P1978, DOI 10.1021/jm00089a006; HOLLINGER FB, 1992, J CLIN MICROBIOL, V30, P1787, DOI 10.1128/JCM.30.7.1787-1794.1992; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Marquez N, 2008, BIOCHEM PHARMACOL, V75, P1370, DOI 10.1016/j.bcp.2007.12.004; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Pereira CF, 2004, CURR PHARM DESIGN, V10, P4005, DOI 10.2174/1381612043382459; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Rullas J, 2004, ANTIVIR THER, V9, P545; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Warrilow D, 2006, AIDS RES HUM RETROV, V22, P854, DOI 10.1089/aid.2006.22.854; WENDER PA, 1986, P NATL ACAD SCI USA, V83, P4214, DOI 10.1073/pnas.83.12.4214; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yoshida M, 2003, INT J CANCER, V105, P601, DOI 10.1002/ijc.11157; Yoshida M, 1998, INT J CANCER, V77, P243, DOI 10.1002/(SICI)1097-0215(19980717)77:2<243::AID-IJC13>3.0.CO;2-C; YOSHIDA M, 1996, INT J CANCER, V66, P68; Zhang L, 2010, PHYTOCHEMISTRY, V71, P1879, DOI 10.1016/j.phytochem.2010.08.008; Zhang L, 2010, ORG LETT, V12, P152, DOI 10.1021/ol9025638	33	25	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26677	10.1371/journal.pone.0026677	http://dx.doi.org/10.1371/journal.pone.0026677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039528	gold, Green Published, Green Submitted			2022-12-25	WOS:000296515200040
J	Montero-Pedrazuela, A; Fernandez-Lamo, I; Alieva, M; Pereda-Perez, I; Venero, C; Guadano-Ferraz, A				Montero-Pedrazuela, Ana; Fernandez-Lamo, Ivan; Alieva, Maria; Pereda-Perez, Inmaculada; Venero, Cesar; Guadano-Ferraz, Ana			Adult-Onset Hypothyroidism Enhances Fear Memory and Upregulates Mineralocorticoid and Glucocorticoid Receptors in the Amygdala	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; THYROID-HORMONE ACTION; RAT-BRAIN; HIPPOCAMPAL NEUROGENESIS; CORTICOSTERONE SECRETION; BASOLATERAL AMYGDALA; NERVOUS-SYSTEM; DENTATE GYRUS; EXPRESSION; EXTINCTION	Hypothyroidism is the most common hormonal disease in adults, which is frequently accompanied by learning and memory impairments and emotional disorders. However, the deleterious effects of thyroid hormones deficiency on emotional memory are poorly understood and often underestimated. To evaluate the consequences of hypothyroidism on emotional learning and memory, we have performed a classical Pavlovian fear conditioning paradigm in euthyroid and adult-thyroidectomized Wistar rats. In this experimental model, learning acquisition was not impaired, fear memory was enhanced, memory extinction was delayed and spontaneous recovery of fear memory was exacerbated in hypothyroid rats. The potentiation of emotional memory under hypothyroidism was associated with an increase of corticosterone release after fear conditioning and with higher expression of glucocorticoid and mineralocorticoid receptors in the lateral and basolateral nuclei of the amygdala, nuclei that are critically involved in the circuitry of fear memory. Our results demonstrate for the first time that adult-onset hypothyroidism potentiates fear memory and also increases vulnerability to develop emotional memories. Furthermore, our findings suggest that enhanced corticosterone signaling in the amygdala is involved in the pathophysiological mechanisms of fear memory potentiation. Therefore, we recommend evaluating whether inappropriate regulation of fear in patients with post-traumatic stress and other mental disorders is associated with abnormal levels of thyroid hormones, especially those patients refractory to treatment.	[Montero-Pedrazuela, Ana; Fernandez-Lamo, Ivan; Alieva, Maria; Guadano-Ferraz, Ana] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Dept Nervous Syst & Endocrine Pathophysiol, Madrid, Spain; [Pereda-Perez, Inmaculada; Venero, Cesar] Univ Nacl Educ Distancia, Dept Psychobiol, E-28040 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad Nacional de Educacion a Distancia (UNED)	Montero-Pedrazuela, A (corresponding author), Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Dept Nervous Syst & Endocrine Pathophysiol, Madrid, Spain.	cvenero@psi.uned.es; aguadano@iib.uam.es	Guadaño-Ferraz, Ana/J-7870-2013; Venero, César/G-2789-2011; Montero-Pedrazuela, Ana/J-7723-2013; Alieva, Maria/ACQ-0401-2022; Venero, César/AAP-7263-2021	Guadaño-Ferraz, Ana/0000-0002-0666-935X; Montero-Pedrazuela, Ana/0000-0003-2308-0894; Venero, César/0000-0003-4879-3495; Alieva, Maria/0000-0002-1425-9908	Spanish Ministry of Science and Innovation [BFU2007-62979, BFU 2010-16498, SAF2009-09129]; Ministry of Science and Innovation, Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants BFU2007-62979 and BFU 2010-16498 (A.G.-F) and SAF2009-09129 (C.V.) from the Spanish Ministry of Science and Innovation. I.F.-L. was recipient of a fellowship and A.M.-P. of a contract both from the Ministry of Science and Innovation, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoubi KH, 2009, HIPPOCAMPUS, V19, P66, DOI 10.1002/hipo.20476; Ambrogini P, 2005, NEUROENDOCRINOLOGY, V81, P244, DOI 10.1159/000087648; ANNAU Z, 1961, J COMP PHYSIOL PSYCH, V54, P428, DOI 10.1037/h0042199; BAUER M, 1994, PSYCHIAT RES, V51, P61, DOI 10.1016/0165-1781(94)90047-7; Baumgartner A, 1998, J NEUROCHEM, V71, P817; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; Bernal J, 2002, HORMONES BRAIN BEHAV, P543; Bernal Juan, 2002, Methods Mol Biol, V202, P71; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Burmeister LA, 2001, THYROID, V11, P1177, DOI 10.1089/10507250152741037; Conrad C D, 2001, Stress, V4, P305; Constantinou C, 2005, MOL CELL BIOCHEM, V278, P93, DOI 10.1007/s11010-005-6934-z; Cordero MI, 1998, BEHAV NEUROSCI, V112, P885, DOI 10.1037/0735-7044.112.4.885; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890; Desouza LA, 2005, MOL CELL NEUROSCI, V29, P414, DOI 10.1016/j.mcn.2005.03.010; Diez D, 2008, ENDOCRINOLOGY, V149, P3989, DOI 10.1210/en.2008-0350; Dluhy RG, 2005, WERNERS INGBARS THYR, P602; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Duntas LH, 2007, EUR J ENDOCRINOL, V156, P13, DOI 10.1530/eje.1.02310; Etgen AM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1121; EYSENCK HJ, 1979, BEHAV RES THER, V17, P511, DOI 10.1016/0005-7967(79)90067-6; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1979, J COMP PHYSIOL PSYCH, V93, P736, DOI 10.1037/h0077609; Fernandez-Lamo I, 2009, EUR J NEUROSCI, V30, P679, DOI 10.1111/j.1460-9568.2009.06862.x; Gerges NZ, 2001, BRAIN RES, V922, P250, DOI 10.1016/S0006-8993(01)03181-X; GOLD MS, 1981, JAMA-J AM MED ASSOC, V245, P1919, DOI 10.1001/jama.245.19.1919; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Guadano-Ferraz A, 2003, MOL PSYCHIATR, V8, P30, DOI 10.1038/sj.mp.4001196; Guadano-Ferraz A, 1999, J NEUROSCI, V19, P3430; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Haviland MG, 2006, CHILD ABUSE NEGLECT, V30, P589, DOI 10.1016/j.chiabu.2005.11.011; Helmreich DL, 2011, HORM BEHAV, V60, P284, DOI 10.1016/j.yhbeh.2011.06.003; Hui GK, 2004, NEUROBIOL LEARN MEM, V81, P67, DOI 10.1016/j.nlm.2003.09.002; Iniguez MA, 1996, ENDOCRINOLOGY, V137, P1032, DOI 10.1210/en.137.3.1032; IRANMANESH A, 1990, J CLIN ENDOCR METAB, V70, P155, DOI 10.1210/jcem-70-1-155; Kamoi K, 2006, ENDOCR J, V53, P511, DOI 10.1507/endocrj.K06-022; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee E, 2008, J TOXICOL SCI, V33, P299, DOI 10.2131/jts.33.299; Lo MJ, 1998, J INVEST MED, V46, P444; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Miller KJ, 2007, J NEUROPSYCH CLIN N, V19, P132, DOI 10.1176/appi.neuropsych.19.2.132; Montero-Pedrazuela A, 2006, MOL PSYCHIATR, V11, P361, DOI 10.1038/sj.mp.4001802; Morte B, 2002, P NATL ACAD SCI USA, V99, P3985, DOI 10.1073/pnas.062413299; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; OBREGON MJ, 1981, ENDOCRINOLOGY, V109, P908, DOI 10.1210/endo-109-3-908; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Puymirat J, 1991, Thyroid, V1, P173, DOI 10.1089/thy.1991.1.173; Rescorla RA, 1997, Q J EXP PSYCHOL-B, V50, P238; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; RUIZMARCOS A, 1988, EXP BRAIN RES, V73, P583, DOI 10.1007/BF00406617; Sadow PM, 2003, MOL CELL ENDOCRINOL, V203, P65, DOI 10.1016/S0303-7207(03)00122-9; SANCHEZFRANCO F, 1989, HORM METAB RES, V21, P550, DOI 10.1055/s-2007-1009285; Sarabdjitsingh RA, 2010, BRAIN RES, V1331, P1, DOI 10.1016/j.brainres.2010.03.052; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; Sui L, 2006, BRAIN RES, V1096, P53, DOI 10.1016/j.brainres.2006.04.042; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Vanderpump MPJ, 2002, THYROID, V12, P839, DOI 10.1089/105072502761016458; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; Wang S, 1999, PSYCHOSOM MED, V61, P131, DOI 10.1097/00006842-199903000-00001; Whybrow PC, 2005, WERNER INGBARS THYRO, P842; World Health Organization, 1990, 43 WORLD HLTH ASS; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Yang YL, 2006, NEUROPSYCHOPHARMACOL, V31, P912, DOI 10.1038/sj.npp.1300899; YEHUDA R, 1993, BIOL PSYCHIAT, V33, P479, DOI 10.1016/0006-3223(93)90001-T; Zorawski M, 2002, NEUROBIOL LEARN MEM, V78, P458, DOI 10.1006/nlme.2002.4075	75	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26582	10.1371/journal.pone.0026582	http://dx.doi.org/10.1371/journal.pone.0026582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039511	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200028
J	D'Amore, DC; Moreno, K; McHenry, CR; Wroe, S				D'Amore, Domenic C.; Moreno, Karen; McHenry, Colin R.; Wroe, Stephen			The Effects of Biting and Pulling on the Forces Generated during Feeding in the Komodo Dragon (Varanus komodoensis)	PLOS ONE			English	Article							BITE-FORCE; PREDATORY BEHAVIOR; TYRANNOSAURUS REX; CRANIAL MECHANICS; PERFORMANCE; ALLIGATOR; MUSCLES; DESIGN; MARKS; SIZE	In addition to biting, it has been speculated that the forces resulting from pulling on food items may also contribute to feeding success in carnivorous vertebrates. We present an in vivo analysis of both bite and pulling forces in Varanus komodoensis, the Komodo dragon, to determine how they contribute to feeding behavior. Observations of cranial modeling and behavior suggest that V. komodoensis feeds using bite force supplemented by pulling in the caudal/ventrocaudal direction. We tested these observations using force gauges/transducers to measure biting and pulling forces. Maximum bite force correlates with both body mass and total body length, likely due to increased muscle mass. Individuals showed consistent behaviors when biting, including the typical medial-caudal head rotation. Pull force correlates best with total body length, longer limbs and larger postcranial motions. None of these forces correlated well with head dimensions. When pulling, V. komodoensis use neck and limb movements that are associated with increased caudal and ventral oriented force. Measured bite force in Varanus komodoensis is similar to several previous estimations based on 3D models, but is low for its body mass relative to other vertebrates. Pull force, especially in the ventrocaudal direction, would allow individuals to hunt and deflesh with high success without the need of strong jaw adductors. In future studies, pull forces need to be considered for a complete understanding of vertebrate carnivore feeding dynamics.	[D'Amore, Domenic C.] Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ 08903 USA; [D'Amore, Domenic C.] Daemen Coll, Dept Nat Sci, Amherst, NY USA; [Moreno, Karen; Wroe, Stephen] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Moreno, Karen] Univ Austral Chile, Lab Paleontol, Valdivia, Chile; [Moreno, Karen] Lab Anthropol Mol & Imagerie Synth, Toulouse, France; [Moreno, Karen] Geosci Environm Toulouse, Toulouse, France; [McHenry, Colin R.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia; [McHenry, Colin R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	Rutgers State University New Brunswick; University of New South Wales Sydney; Universidad Austral de Chile; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Newcastle; Monash University	D'Amore, DC (corresponding author), Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ 08903 USA.	ddamore@daemen.edu	Moreno, Karen/B-6127-2009; Wroe, Stephen/A-4462-2010	Moreno, Karen/0000-0002-5949-133X; Wroe, Stephen/0000-0002-5813-9182; Wroe, Stephen/0000-0002-6365-5915	Australian Research Council [DP0666374]; University of New South Wales Internal Strategic Initiatives	Australian Research Council(Australian Research Council); University of New South Wales Internal Strategic Initiatives	This research was funded by the Australian Research Council (DP0666374) and University of New South Wales Internal Strategic Initiatives Grants to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; BEMIS WE, 1983, ZOOL J LINN SOC-LOND, V77, P75, DOI 10.1111/j.1096-3642.1983.tb01722.x; Binder WJ, 2000, J ZOOL, V252, P273, DOI 10.1111/j.1469-7998.2000.tb00622.x; Burden W. D., 1928, American Museum Novitates, V316, P1; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; D'Amore DC, 2009, PALEOBIOLOGY, V35, P525, DOI 10.1666/0094-8373-35.4.525; D'Amore DC, 2009, ANAT REC, V292, P1297, DOI 10.1002/ar.20977; DECHOW PC, 1983, J BIOMECH, V16, P797, DOI 10.1016/0021-9290(83)90003-9; Ellis JL, 2008, J ANAT, V212, P769, DOI 10.1111/j.1469-7580.2008.00911.x; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Farlow J.O., 1991, Modern Geology, V16, P161; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; FRAZZETTA TH, 1988, ZOOMORPHOLOGY, V108, P93, DOI 10.1007/BF00539785; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; GANS C, 1985, AM J ANAT, V173, P219, DOI 10.1002/aja.1001730306; GANS C, 1969, COPEIA, P855, DOI 10.2307/1441816; Glamann Kristof, 1995, BEER MARBLE C JACOBS; Head JJ, 2009, ZOOL J LINN SOC-LOND, V155, P445, DOI 10.1111/j.1096-3642.2008.00448.x; HELFMAN GS, 1986, COPEIA, P679, DOI 10.2307/1444949; Herrel A, 2001, J EXP ZOOL, V290, P101, DOI 10.1002/jez.1039; Herrel A, 2002, J EVOLUTION BIOL, V15, P1083, DOI 10.1046/j.1420-9101.2002.00459.x; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Hocknull SA, 2009, PLOS ONE, V4; Huber DR, 2005, J EXP BIOL, V208, P3553, DOI 10.1242/jeb.01816; Huber DR, 2004, J EXP ZOOL PART A, V301A, P26, DOI 10.1002/jez.a.20003; LANGSTON W JR, 1975, Fieldiana Geology, V33, P291; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Measey GJ, 2006, BIOL LETTERS, V2, P485, DOI 10.1098/rsbl.2006.0516; Meers Mason B., 2002, Historical Biology, V16, P1; Mertens R., 1942, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, VNo. 462, 465-466, P1; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; OYEN OJ, 1991, AM J ORTHOD DENTOFAC, V99, P298, DOI 10.1016/0889-5406(91)70012-L; Paul G., 1988, PREDATORY DINOSAURS; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rieppel O., 1979, Gegenbaurs Morphologisches Jahrbuch, V125, P797; Rohlf FJ., 2006, TPSDIG VERSION 2 10; Sheets HD, 2005, CHAINMAN3D MORE IMP; SINCLAIR AG, 1987, J ZOOL, V213, P107, DOI 10.1111/j.1469-7998.1987.tb03681.x; Snively E, 2007, ANAT REC, V290, P934, DOI 10.1002/ar.20563; Therrien F, 2005, LIFE O PAST, P179; THOMASON JJ, 1990, CAN J ZOOL, V68, P318, DOI 10.1139/z90-047; Van Valkenburgh B, 2002, PALEOBIOLOGY, V28, P527, DOI 10.1666/0094-8373(2002)028<0527:DAMPC>2.0.CO;2; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906	50	21	21	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26226	10.1371/journal.pone.0026226	http://dx.doi.org/10.1371/journal.pone.0026226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028837	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800028
J	Duguay, D; Belanger-Nelson, E; Mongrain, V; Beben, A; Khatchadourian, A; Cermakian, N				Duguay, David; Belanger-Nelson, Erika; Mongrain, Valerie; Beben, Anna; Khatchadourian, Armen; Cermakian, Nicolas			Dynein Light Chain Tctex-Type 1 Modulates Orexin Signaling through Its Interaction with Orexin 1 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CYTOPLASMIC DYNEIN; DIFFERENTIAL EXPRESSION; SUBUNIT HETEROGENEITY; MULTIPLE MECHANISMS; INTERMEDIATE CHAIN; BETA-ARRESTIN; NEURONS; ENDOCYTOSIS; SLEEP	Orexins (OX-A, OX-B) are neuropeptides involved in the regulation of the sleep-wake cycle, feeding and reward, via activation of orexin receptors 1 and 2 (OX1R, OX2R). The loss of orexin peptides or functional OX2R has been shown to cause the sleep disorder, narcolepsy. Since the regulation of orexin receptors remains largely undefined, we searched for novel protein partners of the intracellular tail of orexin receptors. Using a yeast two-hybrid screening strategy in combination with co-immunoprecipitation experiments, we found interactions between OX1R and the dynein light chains Tctex-type 1 and 3 (Dynlt1, Dynlt3). These interactions were mapped to the C-terminal region of the dynein light chains and to specific residues within the last 10 amino acids of OX1R. Hence, we hypothesized that dynein light chains could regulate orexin signaling. In HEK293 cells expressing OX1R, stimulation with OX-A produced a less sustained extracellular signal-regulated kinases 1/2 (ERK1/2) activation when Dynlt1 was co-expressed, while it was prolonged under reduced Dynlt1 expression. The amount of OX1R located at the plasma membrane as well as the kinetics and extent of OX-A-induced internalization of OX1R (disappearance from membrane) were not altered by Dynlt1. However, Dynlt1 reduced the localization of OX1R in early endosomes following initial internalization. Taken together, these data suggest that Dynlt1 modulates orexin signaling by regulating OX1R, namely its intracellular localization following ligand-induced internalization.	[Duguay, David; Belanger-Nelson, Erika; Mongrain, Valerie; Beben, Anna; Khatchadourian, Armen; Cermakian, Nicolas] Douglas Mental Hlth Univ Inst, Lab Mol Chronobiol, Montreal, PQ, Canada; [Duguay, David; Mongrain, Valerie; Cermakian, Nicolas] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Belanger-Nelson, Erika; Cermakian, Nicolas] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University; McGill University	Duguay, D (corresponding author), Douglas Mental Hlth Univ Inst, Lab Mol Chronobiol, Montreal, PQ, Canada.	nicolas.cermakian@mcgill.ca	Mongrain, Valérie/A-3931-2012	Cermakian, Nicolas/0000-0003-4517-9131	Canadian Institutes of Health Research (CIHR) [MOP-67167, MOP-84441]; Fonds de la Recherche en Sante du Quebec (FRSQ); CIHR/Frederick Banting and Charles Best Canada Graduate Scholarship - Master's Award; Natural Sciences and Engineering Research Council; McGill Faculty of Medicine award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CIHR/Frederick Banting and Charles Best Canada Graduate Scholarship - Master's Award(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); McGill Faculty of Medicine award	This work was supported by Canadian Institutes of Health Research (CIHR) (CIHR MOP-67167 and MOP-84441). DD was supported by a fellowship from Fonds de la Recherche en Sante du Quebec (FRSQ). EB-N was supported by a CIHR/Frederick Banting and Charles Best Canada Graduate Scholarship - Master's Award. VM was supported by FRSQ and Natural Sciences and Engineering Research Council fellowships. NC was supported by an FRSQ salary award and a McGill Faculty of Medicine award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ammoun S, 2006, MOL ENDOCRINOL, V20, P80, DOI 10.1210/me.2004-0389; Boss C, 2009, J MED CHEM, V52, P891, DOI 10.1021/jm801296d; Campbell KS, 1998, J IMMUNOL, V161, P1728; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Carter ME, 2009, CURR OPIN PHARMACOL, V9, P39, DOI 10.1016/j.coph.2008.12.018; Chuang JZ, 2001, J NEUROSCI, V21, P5501, DOI 10.1523/JNEUROSCI.21-15-05501.2001; CONDE C, J NEUROSCI, V30, P6793; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; El Firar A, 2009, FASEB J, V23, P4069, DOI 10.1096/fj.09-131367; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Holmqvist T, 2005, J BIOL CHEM, V280, P6570, DOI 10.1074/jbc.M407397200; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; PASCHAL BM, 1987, NATURE, V330, P672, DOI 10.1038/330672a0; Peyron C, 1998, J NEUROSCI, V18, P9996; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SCHNEIDER MA, CELL MICROBIOL; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sugai M, 2003, BIOCHEM BIOPH RES CO, V311, P24, DOI 10.1016/j.bbrc.2003.09.157; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Voisin T, 2008, FASEB J, V22, P1993, DOI 10.1096/fj.07-098723; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wu HW, 2005, STRUCTURE, V13, P213, DOI 10.1016/j.str.2004.11.013; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	54	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26430	10.1371/journal.pone.0026430	http://dx.doi.org/10.1371/journal.pone.0026430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028875	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800042
J	Tano, N; Kim, HW; Ashraf, M				Tano, Nobuko; Kim, Ha Won; Ashraf, Muhammad			microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4	PLOS ONE			English	Article							STEM-CELLS; MYOCARDIAL-INFARCTION; ISCHEMIC MYOCARDIUM; NEOVASCULARIZATION; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION; REPAIR; ANGIOBLASTS; BIOGENESIS	The interaction between chemokine receptor type 4 (CXCR4) and its ligand, stromal cell-derived factor (SDF)-1, plays an important role in stem cell mobilization and migration in ischemic tissues. MicroRNAs (miRs) are key regulators of stem cell function and are involved in regulation of stem cell survival and differentiation to adopt different cell lineages. In this study, we show that ischemia inhibits the expression of miR-150 in BM-derived mononuclear cells (MNC) and activates its target Cxcr4 gene. Our results show that miR-150/CXCR4 cascade enhances MNC mobilization and migration. By using mouse acute myocardial infarction (MI) model, we found that MNCs in peripheral blood (PB) were increased significantly at day 5 after AMI as compared to control group and the number of CXCR4 positive MNCs both in bone marrow (BM) and PB was also markedly increased after MI. Analysis by microarray-based miRNA profiling and real-time PCR revealed that the expression of miR-150 which targets Cxcr4 gene as predicted was significantly downregulated in BM-MNCs after MI. Abrogation of miR-150 markedly increased CXCR4 protein expression suggesting its target gene. To show that miR-150 regulates MNC mobilization, knockdown of miR-150 in BM-MNCs by specific antisense inhibitor resulted in their higher migration ability in vitro as compared to scramble-transfected MNCs. Furthermore, in vivo BM transplantation of MNCs lacking miR-150 expression by lentiviral vector into the irradiated wild type mice resulted in the increased number of MNCs in PB after AMI as compared to control. In conclusion, this study demonstrates that ischemia mobilizes BM stem cells via miR-150/CXCR4 dependent mechanism and miR-150 may be a novel therapeutic target for stem cell migration to the ischemic tissue for neovascularization and repair.	[Tano, Nobuko; Kim, Ha Won; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Tano, N (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA.	Ashrafm@ucmail.uc.edu	Ashraf, Muhammad/ABB-3463-2021	Kim, Ha Won/0000-0001-6272-4248	National Institutes of Health [R37-HL074272, HL-080686, HL087246, HL087288, HL089535, HL106190-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106190, R37HL074272, R01HL087288, R01HL087246, R01HL089535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by National Institutes of Health grants R37-HL074272; HL-080686; HL087246 (M. A) and HL087288; HL089535; HL106190-01 (K. H. H). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x; Donahue RE, 2009, BLOOD, V114, P2530, DOI 10.1182/blood-2009-04-214403; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pokushalov E, 2010, J CARDIOVASC TRANSL, V3, P160, DOI 10.1007/s12265-009-9123-8; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yin YG, 2010, CARDIOVASC PATHOL, V19, P218, DOI 10.1016/j.carpath.2009.04.002; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	26	75	80	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e23114	10.1371/journal.pone.0023114	http://dx.doi.org/10.1371/journal.pone.0023114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039399	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500001
J	Zhao, JJ; Pan, K; Li, JJ; Chen, YB; Chen, JG; Lv, L; Wang, DD; Pan, QZ; Chen, MS; Xia, JC				Zhao, Jing-jing; Pan, Ke; Li, Jian-jun; Chen, Yi-bing; Chen, Ju-gao; Lv, Lin; Wang, Dan-dan; Pan, Qiu-zhong; Chen, Min-shan; Xia, Jian-chuan			Identification of LZAP as a New Candidate Tumor Suppressor in Hepatocellular Carcinoma	PLOS ONE			English	Article							BINDING PROTEIN; CHECKPOINT; EXPRESSION; KINASE	Background: LZAP was isolated as a binding protein of the Cdk5 activator p35. LZAP has been highly conserved during evolution and has been shown to function as a tumor suppressor in various cancers. This study aimed to investigate LZAP expression and its prognostic value in hepatocellular carcinoma (HCC). Meanwhile, the function of LZAP in hepatocarcinogenesis was further investigated in cell culture models and mouse models. Methods: Real-time quantitative PCR, western blot and immunohistochemistry were used to explore LZAP expression in HCC cell lines and primary HCC clinical specimens. The functions of LZAP in the proliferation, colony formation, cell cycle, migration, invasion and apoptosis of HCC cell lines were also analyzed by infecting cells with an adenovirus containing full-length LZAP. The effect of LZAP on tumorigenicity in nude mice was also investigated. Results: LZAP expression was significantly decreased in the tumor tissues and HCC cell lines. Clinicopathological analysis showed that LZAP expression was significantly correlated with tumor size, histopathological classification and serum alpha-fetoprotein (AFP). The Kaplan-Meier survival curves revealed that decreasing LZAP expression was associated with poor prognosis in HCC patients. LZAP expression was an independent prognostic marker of overall HCC patient survival in a multivariate analysis. The re-introduction of LZAP expression in the HepG2 and sk-Hep1 HCC cell lines significantly inhibited proliferation and colony formation in the HCC cells and induced G1 phase arrest and apoptosis of the HCC cells in vitro. Restoring LZAP expression in the HCC cell lines also inhibited migration and invasion. In addition, experiments with a mouse model revealed that LZAP overexpression could suppress HCC tumorigenicity in vivo. Conclusions: Our data suggest that LZAP may play an important role in HCC progression and could be a potential molecular therapy target for HCC.	[Zhao, Jing-jing; Pan, Ke; Li, Jian-jun; Chen, Yi-bing; Chen, Ju-gao; Lv, Lin; Wang, Dan-dan; Pan, Qiu-zhong; Chen, Min-shan; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Jing-jing; Pan, Ke; Li, Jian-jun; Chen, Yi-bing; Chen, Ju-gao; Lv, Lin; Wang, Dan-dan; Pan, Qiu-zhong; Chen, Min-shan; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Min-shan] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhao, JJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	xiajch@mail.sysu.edu.cn			National Natural Science Foundation of China [u0772002, 30700985, 30973398]; Guangdong Natural Science Foundation [925100890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (u0772002, 30700985, 30973398) and Guangdong Natural Science Foundation (925100890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding Y, 2009, INT J CANCER, V124, P653, DOI 10.1002/ijc.23954; Frau M, 2010, MOL ASPECTS MED, V31, P179, DOI 10.1016/j.mam.2010.02.007; Giannelli G, 2006, J CLIN GASTROENTEROL, V40, P842, DOI 10.1097/01.mcg.0000225543.11503.17; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Itoh S, 2004, CLIN CANCER RES, V10, P2812, DOI 10.1158/1078-0432.CCR-1046-03; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Okuda K, 1997, J GASTROEN HEPATOL, V12, pS314, DOI 10.1111/j.1440-1746.1997.tb00515.x; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960	13	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26608	10.1371/journal.pone.0026608	http://dx.doi.org/10.1371/journal.pone.0026608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028922	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500096
J	Torrado, M; Iglesias, R; Centeno, A; Lopez, E; Mikhailov, AT				Torrado, Mario; Iglesias, Raquel; Centeno, Alberto; Lopez, Eduardo; Mikhailov, Alexander T.			Targeted Gene-Silencing Reveals the Functional Significance of Myocardin Signaling in the Failing Heart	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; CARDIOVASCULAR DEVELOPMENT; MESSENGER-RNA; EXPRESSION; CELLS; FAILURE; DISEASE; GROWTH	Background: Myocardin (MYOCD), a potent transcriptional coactivator of smooth muscle (SM) and cardiac genes, is upregulated in failing myocardium in animal models and human end-stage heart failure (HF). However, the molecular and functional consequences of myocd upregulation in HF are still unclear. Methodology/Principal Findings: The goal of the present study was to investigate if targeted inhibition of upregulated expression of myocd could influence failing heart gene expression and function. To this end, we used the doxorubicin (Dox)-induced diastolic HF (DHF) model in neonatal piglets, in which, as we show, not only myocd but also myocd-dependent SM-marker genes are highly activated in failing left ventricular (LV) myocardium. In this model, intra-myocardial delivery of short-hairpin RNAs, designed to target myocd variants expressed in porcine heart, leads on day 2 post-delivery to: (1) a decrease in the activated expression of myocd and myocd-dependent SM-marker genes in failing myocardium to levels seen in healthy control animals, (2) amelioration of impaired diastolic dysfunction, and (3) higher survival rates of DHF piglets. The posterior restoration of elevated myocd expression (on day 7 post-delivery) led to overexpression of myocd-dependent SM-marker genes in failing LV-myocardium that was associated with a return to altered diastolic function. Conclusions/Significance: These data provide the first evidence that a moderate inhibition (e. g., normalization) of the activated MYOCD signaling in the diseased heart may be promising from a therapeutic point of view.	[Torrado, Mario; Iglesias, Raquel; Mikhailov, Alexander T.] Univ A Coruna, Inst Hlth Sci, Dev Biol Grp, La Coruna, Spain; [Centeno, Alberto; Lopez, Eduardo] Univ Hosp Ctr La Coruna, Expt Surg Unit, La Coruna, Spain	Universidade da Coruna; Complejo Hospitalario Universitario A Coruna	Torrado, M (corresponding author), Univ A Coruna, Inst Hlth Sci, Dev Biol Grp, La Coruna, Spain.	margot@udc.es	Mikhailov, Alexander T./H-1897-2012; Iglesias, Raquel/D-3212-2019	Mikhailov, Alexander/0000-0002-1146-4113; Iglesias, Raquel/0000-0002-0212-3616	Spanish Ministry of Science and Innovation [SAF2008-00337]; Autonomic Government of Galicia [08CSA008161PR]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomic Government of Galicia	This work was supported by a grant (SAF2008-00337) from the Spanish Ministry of Science and Innovation and by a grant (08CSA008161PR) from the Autonomic Government of Galicia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1998, LIFE SCI, V63, P1779, DOI 10.1016/S0024-3205(98)00452-4; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Berni R, 2009, AM J PHYSIOL-HEART C, V296, pH1625, DOI 10.1152/ajpheart.01057.2008; Cataliotti A, 2011, CIRCULATION, V123, P1297, DOI 10.1161/CIRCULATIONAHA.110.981720; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chen JF, 2008, ANAT REC, V291, P1200, DOI 10.1002/ar.20756; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Dunlay SM, 2008, CIRCULATION, V118, P625, DOI 10.1161/CIRCULATIONAHA.107.759191; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hoofnagle MH, 2011, AM J PHYSIOL-HEART C, V300, pH1707, DOI 10.1152/ajpheart.01192.2010; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Imamura M, 2010, GENE, V464, P1, DOI 10.1016/j.gene.2010.03.012; Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047; Kim M, 2008, J MOL CELL CARDIOL, V45, P270, DOI 10.1016/j.yjmcc.2008.05.006; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; Kontaraki JE, 2007, CARDIOVASC PATHOL, V16, P329, DOI 10.1016/j.carpath.2007.04.004; Kreusser MM, 2008, J MOL CELL CARDIOL, V44, P380, DOI 10.1016/j.yjmcc.2007.10.019; Lamarcq LH, 2006, J BIOMOL SCREEN, V11, P236, DOI 10.1177/1087057105284342; Leenders JJ, 2010, J BIOL CHEM, V285, P27449, DOI 10.1074/jbc.M110.107292; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Mikhailov AT, 2010, SHAPING HEART DEV DI, P145; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Most P, 2007, AM J PHYSIOL-REG I, V293, pR568, DOI 10.1152/ajpregu.00075.2007; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pattison JS, 2008, TRANSGENIC RES, V17, P157, DOI 10.1007/s11248-007-9139-2; Periasamy Muthu, 2008, Heart Fail Clin, V4, P13, DOI 10.1016/j.hfc.2007.10.007; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Rathinavel A, 2005, EUR J CARDIOV PREV R, V12, P601, DOI 10.1097/00149831-200512000-00014; Scherrer-Crosbie M, 2010, J MOL CELL CARDIOL, V48, P512, DOI 10.1016/j.yjmcc.2009.07.004; Schwartz RJ, 2010, HEART DEV REGENERATI, P617; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Steenman M, 2003, PHYSIOL GENOMICS, V12, P97, DOI 10.1152/physiolgenomics.00148.2002; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Torrado M, 2003, J MOL MED, V81, P566, DOI 10.1007/s00109-003-0470-7; Torrado M, 2006, FEBS LETT, V580, P4182, DOI 10.1016/j.febslet.2006.06.073; Torrado M, 2010, EXP BIOL MED, V235, P941, DOI 10.1258/ebm.2010.010078; Torrado M, 2009, INT J DEV BIOL, V53, P1457, DOI 10.1387/ijdb.072366mt; Torrado M, 2009, GENE, V440, P28, DOI 10.1016/j.gene.2009.03.017; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; van Gaal EVB, 2006, PHARM RES-DORDR, V23, P1053, DOI 10.1007/s11095-006-0164-2; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Xin YF, 2011, FOOD CHEM TOXICOL, V49, P259, DOI 10.1016/j.fct.2010.10.028; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yasuno S, 2009, AM J PHYSIOL-HEART C, V296, pH1804, DOI 10.1152/ajpheart.01033.2008; Zhang XM, 2004, J BIOL CHEM, V279, P55626, DOI 10.1074/jbc.M405945200	67	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26392	10.1371/journal.pone.0026392	http://dx.doi.org/10.1371/journal.pone.0026392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028870	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900058
J	Dawe, RJ; Bennett, DA; Schneider, JA; Arfanakis, K				Dawe, Robert J.; Bennett, David A.; Schneider, Julie A.; Arfanakis, Konstantinos			Neuropathologic Correlates of Hippocampal Atrophy in the Elderly: A Clinical, Pathologic, Postmortem MRI Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; ALZHEIMER-DISEASE; NEUROFIBRILLARY TANGLES; ENTORHINAL CORTEX; SHAPE-ANALYSIS; LEWY BODIES; DEMENTIA; VOLUME; MEMORY	The volume of the hippocampus measured with structural magnetic resonance imaging (MRI) is increasingly used as a biomarker for Alzheimer's disease (AD). However, the neuropathologic basis of structural MRI changes in the hippocampus in the elderly has not been directly assessed. Postmortem MRI of the aging human brain, combined with histopathology, could be an important tool to address this issue. Therefore, this study combined postmortem MRI and histopathology in 100 elderly subjects from the Rush Memory and Aging Project and the Religious Orders Study. First, to validate the information contained in postmortem MRI data, we tested the hypothesis that postmortem hippocampal volume is smaller in subjects with clinically diagnosed Alzheimer's disease compared to subjects with mild or no cognitive impairment, as observed in antemortem imaging studies. Subsequently, the relations of postmortem hippocampal volume to AD pathology, Lewy bodies, amyloid angiopathy, gross infarcts, microscopic infarcts, and hippocampal sclerosis were examined. It was demonstrated that hippocampal volume was smaller in persons with a clinical diagnosis of AD compared to those with no cognitive impairment (P = 2.6x10(-7)) or mild cognitive impairment (P = 9.6x10(-7)). Additionally, hippocampal volume was related to multiple cognitive abilities assessed proximate to death, with its strongest association with episodic memory. Among all pathologies investigated, the most significant factors related to lower hippocampal volume were shown to be AD pathology (P = 0.0018) and hippocampal sclerosis (P = 4.2x10(-7)). Shape analysis allowed for visualization of the hippocampal regions most associated with volume loss for each of these two pathologies. Overall, this investigation confirmed the relation of hippocampal volume measured postmortem to clinical diagnosis of AD and measures of cognition, and concluded that both AD pathology and hippocampal sclerosis affect hippocampal volume in old age, though the impacts of each pathology on the shape of the hippocampus may differ.	[Dawe, Robert J.; Arfanakis, Konstantinos] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Dawe, Robert J.; Bennett, David A.; Schneider, Julie A.; Arfanakis, Konstantinos] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Illinois Institute of Technology; Rush University	Dawe, RJ (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	arfanakis@iit.edu	Arfanakis, Konstantinos/AAN-3148-2021	Arfanakis, Konstantinos/0000-0001-9705-597X	National Institute on Aging [P30AG10161, R01AG15819, R01AG17917]; Illinois Department of Public Health; Chicago Chapter of the Achievement Rewards for College Scientists Foundation, Inc.; NATIONAL INSTITUTE ON AGING [R01AG017917, P30AG010161, R01AG015819] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Chicago Chapter of the Achievement Rewards for College Scientists Foundation, Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported with grants from the National Institute on Aging (P30AG10161, R01AG15819, R01AG17917), the Illinois Department of Public Health, and from the Chicago Chapter of the Achievement Rewards for College Scientists Foundation, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala TA, 2000, NEUROLOGY, V54, P843, DOI 10.1212/WNL.54.4.843; Apostolova LG, 2010, NEUROIMAGE, V51, P488, DOI 10.1016/j.neuroimage.2009.12.125; Arfanakis K, 2007, BRAIN IMAGING BEHAV, V1, P11, DOI 10.1007/s11682-007-9001-4; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Arvanitakis Z, 2011, ANN NEUROL, V69, P320, DOI 10.1002/ana.22112; Barber R, 2001, DEMENT GERIATR COGN, V12, P198, DOI 10.1159/000051258; Barkhof F, 2007, NEUROLOGY, V69, P1521, DOI 10.1212/01.wnl.0000277459.83543.99; Behl C, 2000, J NEURAL TRANSM, V107, P1325, DOI 10.1007/s007020070021; BEHL C, 1994, BRAIN RES, V645, P253, DOI 10.1016/0006-8993(94)91659-4; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; BOBINSKI M, 1995, DEMENTIA, V6, P205, DOI 10.1159/000106948; Bobinski M, 2000, NEUROSCIENCE, V95, P721; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; CoreyBloom J, 1997, NEUROLOGY, V48, P154, DOI 10.1212/WNL.48.1.154; Csernansky JG, 2005, NEUROIMAGE, V25, P783, DOI 10.1016/j.neuroimage.2004.12.036; Dawe RJ, 2009, MAGN RESON MED, V61, P810, DOI 10.1002/mrm.21909; deLeon MJ, 1997, NEUROBIOL AGING, V18, P1, DOI 10.1016/S0197-4580(96)00213-8; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Dickerson BC, 2001, NEUROBIOL AGING, V22, P747, DOI 10.1016/S0197-4580(01)00271-8; DICKSON DW, 1994, ACTA NEUROPATHOL, V88, P212; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; HUESGEN CT, 1993, NEUROLOGY, V43, P145, DOI 10.1212/WNL.43.1_Part_1.145; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Jack CR, 2002, NEUROLOGY, V58, P750, DOI 10.1212/WNL.58.5.750; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Jagust WJ, 2008, ANN NEUROL, V63, P72, DOI 10.1002/ana.21296; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Killiany RJ, 2002, NEUROLOGY, V58, P1188, DOI 10.1212/WNL.58.8.1188; Laakso MP, 1996, NEUROBIOL AGING, V17, P535, DOI 10.1016/0197-4580(96)00036-X; Li S, 2007, AM J NEURORADIOL, V28, P1339, DOI 10.3174/ajnr.A0620; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Mortimer JA, 2004, NEUROLOGY, V62, P428, DOI 10.1212/01.WNL.0000106463.66966.65; Paniagua B, 2009, INSIGHT J; Postle BR, 2000, NEUROIMAGE, V11, P409, DOI 10.1006/nimg.2000.0570; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Scher AI, 2007, NEUROIMAGE, V36, P8, DOI 10.1016/j.neuroimage.2006.12.036; Schneider JA, 2004, NEUROLOGY, V62, P1148, DOI 10.1212/01.WNL.0000118211.78503.F5; Schneider JA, 2007, ANN NEUROL, V62, P59, DOI 10.1002/ana.21142; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Seewann A, 2009, ACTA NEUROL SCAND, V119, P349, DOI 10.1111/j.1600-0404.2008.01137.x; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Styner M., 2006, INSIGHT J; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; van de Pol LA, 2006, NEUROLOGY, V66, P236, DOI 10.1212/01.wnl.0000194240.47892.4d; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wilson RS, 2007, NEUROLOGY, V68, P2085, DOI 10.1212/01.wnl.0000264930.97061.82; Wolf H, 2001, NEUROBIOL AGING, V22, P177, DOI 10.1016/S0197-4580(00)00238-4; Zarow C, 2008, CURR NEUROL NEUROSCI, V8, P363, DOI 10.1007/s11910-008-0057-3	66	69	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26286	10.1371/journal.pone.0026286	http://dx.doi.org/10.1371/journal.pone.0026286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043314	gold, Green Published, Green Submitted			2022-12-25	WOS:000295984400042
J	Sharif-Paghaleh, E; Sunassee, K; Tavare, R; Ratnasothy, K; Koers, A; Ali, N; Alhabbab, R; Blower, PJ; Lechler, RI; Smyth, LA; Mullen, GE; Lombardi, G				Sharif-Paghaleh, Ehsan; Sunassee, Kavitha; Tavare, Richard; Ratnasothy, Kulachelvy; Koers, Alexander; Ali, Niwa; Alhabbab, Rowa; Blower, Philip J.; Lechler, Robert I.; Smyth, Lesley A.; Mullen, Gregory E.; Lombardi, Giovanna			In Vivo SPECT Reporter Gene Imaging of Regulatory T Cells	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; TRANSPLANTATION TOLERANCE; SODIUM/IODIDE SYMPORTER; THERAPY; TUMORS	Regulatory T cells (Tregs) were identified several years ago and are key in controlling autoimmune diseases and limiting immune responses to foreign antigens, including alloantigens. In vivo imaging techniques including intravital microscopy as well as whole body imaging using bioluminescence probes have contributed to the understanding of in vivo Treg function, their mechanisms of action and target cells. Imaging of the human sodium/iodide symporter via Single Photon Emission Computed Tomography (SPECT) has been used to image various cell types in vivo. It has several advantages over the aforementioned imaging techniques including high sensitivity, it allows non-invasive whole body studies of viable cell migration and localisation of cells over time and lastly it may offer the possibility to be translated to the clinic. This study addresses whether SPECT/CT imaging can be used to visualise the migratory pattern of Tregs in vivo. Treg lines derived from CD4(+)CD25(+)FoxP3(+) cells were retrovirally transduced with a construct encoding for the human Sodium Iodide Symporter (NIS) and the fluorescent protein mCherry and stimulated with autologous DCs. NIS expressing self-specific Tregs were specifically radiolabelled in vitro with Technetium-99m pertechnetate ((TcO4-)-Tc-99m) and exposure of these cells to radioactivity did not affect cell viability, phenotype or function. In addition adoptively transferred Treg-NIS cells were imaged in vivo in C57BL/6 (BL/6) mice by SPECT/CT using (TcO4-)-Tc-99m. After 24 hours NIS expressing Tregs were observed in the spleen and their localisation was further confirmed by organ biodistribution studies and flow cytometry analysis. The data presented here suggests that SPECT/CT imaging can be utilised in preclinical imaging studies of adoptively transferred Tregs without affecting Treg function and viability thereby allowing longitudinal studies within disease models.	[Sharif-Paghaleh, Ehsan; Ratnasothy, Kulachelvy; Ali, Niwa; Alhabbab, Rowa; Lechler, Robert I.; Smyth, Lesley A.; Mullen, Gregory E.; Lombardi, Giovanna] Kings Coll London, MRC, Ctr Transplantat, Guys Hosp, London WC2R 2LS, England; [Sharif-Paghaleh, Ehsan; Sunassee, Kavitha; Tavare, Richard; Koers, Alexander; Blower, Philip J.; Mullen, Gregory E.] Kings Coll London, Div Imaging Sci, St Thomas Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Sharif-Paghaleh, E (corresponding author), Kings Coll London, MRC, Ctr Transplantat, Guys Hosp, London WC2R 2LS, England.	greg.mullen@kcl.ac.uk; giovanna.lombardi@kcl.ac.uk	Blower, Phil/GSD-5552-2022; Alhabbab, Rowa/AAY-5063-2020; Alhabbab, Rowa/L-9293-2015	Tavare, Richard/0000-0001-5150-5963; Ali, Niwa/0000-0003-4473-8747; Alhabbab, Rowa/0000-0001-7135-9967; Blower, Philip/0000-0001-6290-1590	King's College London, Medical Research Council Centre of Transplantation, Division of Imaging Sciences; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; British Heart Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040065] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish	King's College London, Medical Research Council Centre of Transplantation, Division of Imaging Sciences; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the financial support from King's College London, Medical Research Council Centre of Transplantation, Division of Imaging Sciences, The Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust and The British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2008, EUR J IMMUNOL, V38, P3282, DOI 10.1002/eji.200838373; Boland A, 2000, CANCER RES, V60, P3484; Che J, 2003, J NUCL MED, V44, p28P; Cho JY, 2002, GENE THER, V9, P1139, DOI 10.1038/sj.gt.3301787; Feng NH, 2004, CHINESE MED J-PEKING, V117, P1184; Geissler EK, 2009, GUT, V58, P452, DOI 10.1136/gut.2008.163527; Gong N, 2011, J NEUROIMMUNOL, V230, P33, DOI 10.1016/j.jneuroim.2010.08.014; Haberkorn U, 2001, EXP CLIN ENDOCR DIAB, V109, P60, DOI 10.1055/s-2001-11010; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; KANWAR B, 2008, METHODS, V329, P21; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; ONISHI Y, 2008, SCIENCES, V105, P10113; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pittet MJ, 2007, P NATL ACAD SCI USA, V104, P12457, DOI 10.1073/pnas.0704460104; Ribas A, 2010, FUTURE ONCOL, V6, P1671, DOI 10.2217/FON.10.137; Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076; Sagoo P, 2008, CURR OPIN ORGAN TRAN, V13, P645, DOI 10.1097/MOT.0b013e328317a476; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen DHY, 2001, THYROID, V11, P415, DOI 10.1089/105072501300176372; SIGNORE A, 2010, CHEM REV; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tang QZ, 2006, CURR OPIN IMMUNOL, V18, P496, DOI 10.1016/j.coi.2006.05.007; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tavare R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019662; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022	32	35	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25857	10.1371/journal.pone.0025857	http://dx.doi.org/10.1371/journal.pone.0025857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043296	Green Submitted, gold, Green Published			2022-12-25	WOS:000295984400024
J	Kleiman, A; Hubner, S; Parkitna, JMR; Neumann, A; Hofer, S; Weigand, MA; Bauer, M; Schmid, W; Schutz, G; Libert, C; Reichardt, HM; Tuckermann, JP				Kleiman, Anna; Huebner, Sabine; Parkitna, Jan M. Rodriguez; Neumann, Anita; Hofer, Stefan; Weigand, Markus A.; Bauer, Michael; Schmid, Wolfgang; Schuetz, Guenter; Libert, Claude; Reichardt, Holger M.; Tuckermann, Jan P.			Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages	FASEB JOURNAL			English	Article						IL-1 beta; GR; CLP	DNA-BINDING; INFLAMMATORY RESPONSES; GENE-EXPRESSION; MAP KINASE; KAPPA-B; REPRESSION; MICE; PHOSPHATASE-1; DEXAMETHASONE; ACTIVATION	Sepsis is controlled by endogenous glucocorticoids (GCs). Previous studies provided evidence that crosstalk of the monomeric GC receptor (GR) with proinflammatory transcription factors is the crucial mechanism underlying the suppressive GC effect. Here we demonstrate that mice with a dimerization-deficient GR (GR(dim)) are highly susceptible to sepsis in 2 different models, namely cecal ligation and puncture and lipopolysaccharide (LPS)-induced septic shock. TNF-alpha is normally regulated in these mice, but down-regulation of IL-6 and IL-1 beta is diminished. LPS-treated macrophages derived from GR(dim) mice are largely resistant to GC actions in vitro in terms of morphology, surface marker expression, and gene expression. Treatment with recombinant IL-1 receptor antagonist improved survival of GR(dim) mice and mice lacking the GR in macrophages (GR(LysMCre)) mice. This suggests that regulation of IL-1 beta in macrophages by GCs is pivotal to control sepsis.-Kleiman, A., Hubner, S., Rodriguez Parkitna, J. M., Neumann, A., Hofer, S., Weigand, M. A., Bauer, M., Schmid, W., Schutz, G., Libert, C., Reichardt, H. M., Tuckermann, J. P. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 26, 722-729 (2012). www.fasebj.org	[Kleiman, Anna; Huebner, Sabine; Neumann, Anita; Tuckermann, Jan P.] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Parkitna, Jan M. Rodriguez; Schmid, Wolfgang; Schuetz, Guenter] German Canc Res Ctr, Div Mol Biol Cell 1, D-6900 Heidelberg, Germany; [Hofer, Stefan] Univ Heidelberg, Dept Anesthesiol, Heidelberg, Germany; [Weigand, Markus A.] Univ Giessen, Giessen, Germany; [Bauer, Michael] Univ Klinikum Jena, Ctr Sepsis Control & Care, Jena, Germany; [Libert, Claude] Univ Ghent VIB, Dept Mol Biomed Res, Ghent, Belgium; [Reichardt, Holger M.] Univ Gottingen, Dept Cellular & Mol Immunol, Sch Med, Gottingen, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; Friedrich Schiller University of Jena; Flanders Institute for Biotechnology (VIB); Ghent University; University of Gottingen	Tuckermann, JP (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.	j.tuckermann@fli-leibniz.de	Rodriguez, Jan/I-2910-2012; Reichardt, Holger/AAF-3048-2020	Rodriguez, Jan/0000-0003-0367-2331; Reichardt, Holger/0000-0003-4647-057X; Bauer, Michael/0000-0002-1521-3514; Vettorazzi, Dr. Sabine/0000-0001-8667-9488	Deutsche Forschungsgemeinschaft [Tu220/3, Re1631/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Katrin Buder for excellent technical assistance, Dr. Walther Richter (Elektronenmikroskopisches Zentrum, Friedrich Schiller University, Jena, Germany) for scanning electron microscopy, Dr. Michael Kiehntopf (Institute for Clinical Chemistry and Laboratory Diagnostics, University Clinics Jena, Jena, Germany) for performing corticosterone measurements, and Dr. Katrin Ittrich for cluster analysis of gene expression profiles. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Tu220/3 to J.P.T. and Re1631/7-1 to H.M.R.). The authors declare no conflicts of interest.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; AURON PE, 1994, EUR CYTOKINE NETW, V5, P573; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Ghadially H, 2005, J IMMUNOL, V174, P5620, DOI 10.4049/jimmunol.174.9.5620; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; Mahony D, 1999, EUR J BIOCHEM, V263, P765, DOI 10.1046/j.1432-1327.1999.00552.x; Moreno Rui, 2006, Curr Infect Dis Rep, V8, P346, DOI 10.1007/s11908-006-0044-2; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nussler AK, 2006, NAT PROTOC, V1, P2223, DOI 10.1038/nprot.2006.341; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Prigent H, 2004, CRIT CARE, V8, P243, DOI 10.1186/cc2878; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Reily MM, 2006, EMBO J, V25, P108, DOI 10.1038/sj.emboj.7600919; Rivers EP, 2001, CHEST, V119, P889, DOI 10.1378/chest.119.3.889; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	32	114	115	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					722	729		10.1096/fj.11-192112	http://dx.doi.org/10.1096/fj.11-192112			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22042221				2022-12-25	WOS:000300485700023
J	Ivarsson, Y; Wawrzyniak, AM; Wuytens, G; Kosloff, M; Vermeiren, E; Raport, M; Zimmermann, P				Ivarsson, Ylva; Wawrzyniak, Anna Maria; Wuytens, Gunther; Kosloff, Mickey; Vermeiren, Elke; Raport, Marie; Zimmermann, Pascale			Cooperative Phosphoinositide and Peptide Binding by PSD-95/Discs Large/ZO-1 (PDZ) Domain of Polychaetoid, Drosophila Zonulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; EPITHELIAL-CELLS; MEMBRANE; RECOGNITION; ZO-1; MORPHOGENESIS; LOCALIZATION; DIMERIZATION; SELECTIVITY	PDZ domains are well known protein-protein interaction modules that, as part of multidomain proteins, assemble molecular complexes. Some PDZ domains have been reported to interact with membrane lipids, in particular phosphatidylinositol phosphates, but few studies have been aimed at elucidating the prevalence or the molecular details of such interactions. We screened 46 Drosophila PDZ domains for phosphoinositide-dependent cellular localization and discovered that the second PDZ domain of polychaetoid (Pyd PDZ2) interacts with phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) at the plasma membrane. Surface plasmon resonance binding experiments with recombinant protein established that Pyd PDZ2 interacts with phosphatidylinositol phosphates with apparent affinities in the micromolar range. Electrostatic interactions involving an extended positively charged surface of Pyd PDZ2 are crucial for the PtdIns(4,5)P-2-dependent membrane interactions as shown by a combination of three-dimensional modeling, mutagenesis, binding, and localization studies. In vivo localization studies further suggested that both lipid and peptide binding contribute to membrane localization. We identified the transmembrane protein Crumbs as a Pyd PDZ2 ligand and probed the relation between peptide and PtdIns(4,5)P-2 binding. Contrary to the prevalent view on PDZ/peptide/lipid binding, we did not find competition between peptide and lipid ligands. Instead, pre-loading the protein with the 10-mer Crb3 peptide increased the apparent affinity of Pyd PDZ2 for PtdIns(4,5)P-2 6-fold. Our results suggest that membrane localization of Pyd PDZ2 may be driven by a combination of peptide and PtdIns(4,5)P-2 binding, which raises the intriguing possibility that the domain may coordinate protein-and phospholipid-mediated signals.	[Ivarsson, Ylva; Wawrzyniak, Anna Maria; Wuytens, Gunther; Vermeiren, Elke; Raport, Marie; Zimmermann, Pascale] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Kosloff, Mickey] Duke Univ, Med Ctr, Durham, NC 27710 USA	KU Leuven; Duke University	Zimmermann, P (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Herestr 49, B-3000 Louvain, Belgium.	pascale.zimmermann@med.kuleuven.be	Ivarsson, Ylva/HGE-0283-2022; Zimmermann, Pascale/P-4190-2017; Kosloff, Mickey/B-5962-2008	Ivarsson, Ylva/0000-0002-7081-3846; Kosloff, Mickey/0000-0003-1807-4000	Fund for Scientific Research-Flanders (FWO); Concerted Actions Program of the Katholieke Universiteit Leuven; Belgian Federation against Cancer (BFK); Interuniversity Attraction Poles of the Prime Ministers Services (IUAP); EMBO	Fund for Scientific Research-Flanders (FWO)(FWO); Concerted Actions Program of the Katholieke Universiteit Leuven; Belgian Federation against Cancer (BFK); Interuniversity Attraction Poles of the Prime Ministers Services (IUAP); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by the Fund for Scientific Research-Flanders (FWO), the Concerted Actions Program of the Katholieke Universiteit Leuven, the Belgian Federation against Cancer (BFK), the Interuniversity Attraction Poles of the Prime Ministers Services (IUAP), and the EMBO young investigator program (to P. Z.).	Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gallardo R, 2010, CHEMBIOCHEM, V11, P456, DOI 10.1002/cbic.200900616; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956; Harris BZ, 2001, J CELL SCI, V114, P3219; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; Ivarsson Y, 2008, J BIOL CHEM, V283, P8954, DOI 10.1074/jbc.M707424200; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lee D, 1998, J BIOL CHEM, V273, P13022, DOI 10.1074/jbc.273.21.13022; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Medina E, 2002, BIOL CELL, V94, P305, DOI 10.1016/S0248-4900(02)00004-7; Meerschaert K, 2009, CELL MOL LIFE SCI, V66, P3951, DOI 10.1007/s00018-009-0156-6; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Seppa MJ, 2008, DEV BIOL, V318, P1, DOI 10.1016/j.ydbio.2008.02.022; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wei XR, 2001, MECH DEVELOP, V100, P217, DOI 10.1016/S0925-4773(00)00550-5; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	44	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44669	44678		10.1074/jbc.M111.285734	http://dx.doi.org/10.1074/jbc.M111.285734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22033935	Green Published, hybrid			2022-12-25	WOS:000298645500037
J	Hartung, S; Arvai, AS; Wood, T; Kolappan, S; Shin, DS; Craig, L; Tainer, JA				Hartung, Sophia; Arvai, Andrew S.; Wood, Timothy; Kolappan, Subramaniapillai; Shin, David S.; Craig, Lisa; Tainer, John A.			Ultrahigh Resolution and Full-length Pilin Structures with Insights for Filament Assembly, Pathogenic Functions, and Vaccine Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV PILUS STRUCTURE; FRANCISELLA-TULARENSIS; BACTEROIDES-NODOSUS; NATURAL TRANSFORMATION; ANTIGENIC VARIATION; PROTEASE SECRETION; TWITCHING MOTILITY; RECEPTOR-BINDING; ATOMIC MOBILITY; II SECRETION	Pilin proteins assemble into Type IV pili (T4P), surface-displayed bacterial filaments with virulence functions including motility, attachment, transformation, immune escape, and colony formation. However, challenges in crystallizing full-length fiber-forming and membrane protein pilins leave unanswered questions regarding pilin structures, assembly, functions, and vaccine potential. Here we report pilin structures of full-length DnFimA from the sheep pathogen Dichelobacter nodosus and FtPilE from the human pathogen Francisella tularensis at 2.3 and 1 angstrom resolution, respectively. The DnFimA structure reveals an extended kinked N-terminal alpha-helix, an unusual centrally located disulfide, conserved subdomains, and assembled epitopes informing serogroup vaccines. An interaction between the conserved Glu-5 carboxyl oxygen and the N-terminal amine of an adjacent subunit in the crystallographic dimer is consistent with the hypothesis of a salt bridge between these groups driving T4P assembly. The FtPilE structure identifies an authentic Type IV pilin and provides a framework for understanding the role of T4P in F. tularensis virulence. Combined results define a unified pilin architecture, specialized subdomain roles in pilus assembly and function, and potential therapeutic targets.	[Kolappan, Subramaniapillai; Craig, Lisa] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Hartung, Sophia; Shin, David S.; Tainer, John A.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Arvai, Andrew S.; Wood, Timothy; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Arvai, Andrew S.; Wood, Timothy; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Simon Fraser University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Scripps Research Institute; Scripps Research Institute	Craig, L (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	licraig@sfu.ca; jatainer@lbl.gov	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Craig, Lisa/0000-0001-8515-9915	National Institutes of Health [AI22160]; Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI22160.; Supported by the ENIGMA program of the Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy under Contract DE-AC02-05CH11231.; Supported by salary awards from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alphonse S, 2010, J STRUCT BIOL, V169, P75, DOI 10.1016/j.jsb.2009.09.003; Ark NM, 2011, MICROB PATHOGENESIS, V51, P110, DOI 10.1016/j.micpath.2011.05.001; Audette GF, 2004, BIOCHEMISTRY-US, V43, P11427, DOI 10.1021/bi048957s; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; BRADLEY DE, 1974, VIROLOGY, V58, P149, DOI 10.1016/0042-6822(74)90150-0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cagatay TI, 2008, VET MICROBIOL, V126, P160, DOI 10.1016/j.vetmic.2007.06.007; CLAXTON PD, 1983, AUST VET J, V60, P331, DOI 10.1111/j.1751-0813.1983.tb02834.x; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dhungyel OP, 2009, VACCINE, V28, P470, DOI 10.1016/j.vaccine.2009.10.012; EGERTON JR, 1969, J COMP PATHOL, V79, P207, DOI 10.1016/0021-9975(69)90007-3; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; EMERY DL, 1984, AUST VET J, V61, P237, DOI 10.1111/j.1751-0813.1984.tb05999.x; EMERY DL, 1989, VET IMMUNOL IMMUNOP, V21, P339, DOI 10.1016/0165-2427(89)90041-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forest KT, 1996, INFECT IMMUN, V64, P644, DOI 10.1128/IAI.64.2.644-652.1996; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; Forslund AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-227; Franz LP, 2011, ACTA CRYSTALLOGR D, V67, P124, DOI 10.1107/S0907444910051954; Ghosh A, 2011, BIOCHEM J, V437, P43, DOI 10.1042/BJ20110410; Gil H, 2004, INFECT IMMUN, V72, P3042, DOI 10.1128/IAI.72.5.3042-3047.2004; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Han XY, 2008, J BACTERIOL, V190, P3323, DOI 10.1128/JB.01807-07; Han XY, 2007, J BACTERIOL, V189, P5022, DOI 10.1128/JB.00138-07; Hansen JK, 2006, J MOL MICROB BIOTECH, V11, P192, DOI 10.1159/000094054; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Jia-xing Yao, 2005, Acta Crystallogr D Biol Crystallogr, V61, P1465, DOI 10.1107/S090744490502576X; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Keizer DW, 2001, J BIOMOL NMR, V19, P385, DOI 10.1023/A:1011285803129; Kennan RM, 2001, J BACTERIOL, V183, P4451, DOI 10.1128/JB.183.15.4451-4458.2001; Kennan RM, 2011, VET MICROBIOL, V153, P59, DOI 10.1016/j.vetmic.2011.04.005; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Korotkov KV, 2009, J BIOL CHEM, V284, P25466, DOI 10.1074/jbc.C109.037655; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lemkul JA, 2011, J PHYS CHEM B, V115, P8004, DOI 10.1021/jp202217f; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; MATTICK JS, 1987, J BACTERIOL, V169, P33, DOI 10.1128/jb.169.1.33-41.1987; MATTICK JS, 1991, MOL MICROBIOL, V5, P561, DOI 10.1111/j.1365-2958.1991.tb00727.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKERN NM, 1988, J PROTEIN CHEM, V7, P157, DOI 10.1007/BF01025245; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Petersen JM, 2005, VET RES, V36, P455, DOI 10.1051/vetres:2005006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salomonsson E, 2009, MICROBIOL-SGM, V155, P2546, DOI 10.1099/mic.0.028183-0; Salomonsson EN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00029; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHWARTZKOFF CL, 1993, AUST VET J, V70, P123, DOI 10.1111/j.1751-0813.1993.tb06101.x; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; TAINER JA, 1985, ANNU REV IMMUNOL, V3, P501, DOI 10.1146/annurev.iy.03.040185.002441; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VIRJI M, 1984, J GEN MICROBIOL, V130, P1089; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Zogaj X, 2008, MICROBIOL-SGM, V154, P2139, DOI 10.1099/mic.0.2008/018077-0	73	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44254	44265		10.1074/jbc.M111.297242	http://dx.doi.org/10.1074/jbc.M111.297242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027840	Green Published, hybrid			2022-12-25	WOS:000298402300065
J	Kiselar, JG; Datt, M; Chance, MR; Weiss, MA				Kiselar, Janna G.; Datt, Manish; Chance, Mark R.; Weiss, Michael A.			Structural Analysis of Proinsulin Hexamer Assembly by Hydroxyl Radical Footprinting and Computational Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; INSULIN GENE; SACCHAROMYCES-CEREVISIAE; DIABETES-MELLITUS; DISULFIDE BRIDGE; BINDING SURFACE; PROTEIN; MUTATIONS; RESOLUTION; MONOMER	Mutations in the insulin gene can impair proinsulin folding and cause diabetes mellitus. Although crystal structures of insulin dimers and hexamers are well established, proinsulin is refractory to crystallization. Although an NMR structure of an engineered proinsulin monomer has been reported, structures of the wild-type monomer and hexamer remain undetermined. We have utilized hydroxyl radical footprinting and molecular modeling to characterize these structures. Differences between the footprints of insulin and proinsulin, defining a "shadow" of the connecting (C) domain, were employed to refine the model. Our results demonstrate that in its monomeric form, (i) proinsulin contains a native-like insulin moiety and (ii) the C-domain footprint resides within an adjoining segment (residues B23-B29) that is accessible to modification in insulin but not proinsulin. Corresponding oxidation rates were observed within core insulin moieties of insulin and proinsulin hexamers, suggesting that the proinsulin hexamer retains an A/B structure similar to that of insulin. Further similarities in rates of oxidation between the respective C-domains of proinsulin monomers and hexamers suggest that this loop in each case flexibly projects from an outer surface. Although dimerization or hexamer assembly would not be impaired, an ensemble of predicted C-domain positions would block hexamer-hexamer stacking as visualized in classical crystal lattices. We anticipate that protein footprinting in combination with modeling, as illustrated here, will enable comparative studies of diabetes-associated mutant proinsulins and their aberrant modes of aggregation.	[Kiselar, Janna G.; Datt, Manish; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Chance, Mark R.] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kiselar, JG (corresponding author), Case Western Reserve Univ, Case Ctr Prote & Bioinformat, 10900 Euclid Ave, Cleveland, OH 44106 USA.	janna.kiselar@case.edu	Datt, Manish/AAD-6989-2019	Datt, Manish/0000-0002-9578-4113	National Institutes of Health, National Institute for Biomedical Imaging and Bioengineering [P30-EB-09998, R01-EB-09688]; National Institute for Biomedical Imaging and Bioengineering; National Institutes of Health through the NIDDK [DK069764, DK40949]; Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009688, P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health through the NIDDK; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-EB-09998 and R01-EB-09688 from the National Institute for Biomedical Imaging and Bioengineering (to M. R. C.) and by National Institutes of Health Grants DK069764 and DK40949 (to M. A. W.) through the NIDDK.; We thank Dr. N. F. Phillips for assistance with sample preparation and Dr. S. Gupta for assistance with sample irradiation at the Brookhaven National Laboratory (BNL). The National Synchrotron Light Source is supported by the Department of Energy under Contract DE-AC02-98CH10886.	ADAMS MJ, 1969, J MOL BIOL, V41, P159, DOI 10.1016/0022-2836(69)90383-0; Aguilar CF, 1997, J MOL BIOL, V267, P899, DOI 10.1006/jmbi.1996.0880; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHU YC, 1987, BIOCHEMISTRY-US, V26, P6975, DOI 10.1021/bi00396a018; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Davies M.J., 1997, RADICAL MEDIATED PRO; Dong J, 2003, J MOL BIOL, V330, P431, DOI 10.1016/S0022-2836(03)00536-9; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Gupta S, 2007, BIOCHEMISTRY-US, V46, P9886, DOI 10.1021/bi7003608; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Kiselar JG, 2007, P NATL ACAD SCI USA, V104, P1552, DOI 10.1073/pnas.0605380104; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; Kiselar JG, 2002, INT J RADIAT BIOL, V78, P101, DOI 10.1080/09553000110094805; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Maleknia SD, 1999, ANAL CHEM, V71, P3965, DOI 10.1021/ac990500e; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Steiner DF, 2004, EXP DIABESITY RES, V5, P7, DOI 10.1080/15438600490424389; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Takamoto K, 2007, STRUCTURE, V15, P39, DOI 10.1016/j.str.2006.11.005; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921; Ye J, 2001, BBA-PROTEIN STRUCT M, V1547, P18, DOI 10.1016/S0167-4838(01)00160-1; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033; Zoete V, 2006, J COMPUT CHEM, V27, P1843, DOI 10.1002/jcc.20512	39	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43710	43716		10.1074/jbc.M111.297853	http://dx.doi.org/10.1074/jbc.M111.297853			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033917	hybrid, Green Published			2022-12-25	WOS:000298402300014
J	Haeussinger, FB; Heinzel, S; Hahn, T; Schecklmann, M; Ehlis, AC; Fallgatter, AJ				Haeussinger, Florian B.; Heinzel, Sebastian; Hahn, Tim; Schecklmann, Martin; Ehlis, Ann-Christine; Fallgatter, Andreas J.			Simulation of Near-Infrared Light Absorption Considering Individual Head and Prefrontal Cortex Anatomy: Implications for Optical Neuroimaging	PLOS ONE			English	Article							BEER-LAMBERT LAW; ADULT HEAD; HUMAN BRAIN; SPECTROSCOPY FNIRS; PHOTON MIGRATION; PROPAGATION; SCATTERING; MODEL; TISSUES; MEDIA	Functional near-infrared spectroscopy (fNIRS) is an established optical neuroimaging method for measuring functional hemodynamic responses to infer neural activation. However, the impact of individual anatomy on the sensitivity of fNIRS measuring hemodynamics within cortical gray matter is still unknown. By means of Monte Carlo simulations and structural MRI of 23 healthy subjects (mean age: (25.0 +/- 2.8) years), we characterized the individual distribution of tissue-specific NIR-light absorption underneath 24 prefrontal fNIRS channels. We, thereby, investigated the impact of scalp-cortex distance (SCD), frontal sinus volume as well as sulcal morphology on gray matter volumes (V-gray) traversed by NIR-light, i.e. anatomy-dependent fNIRS sensitivity. The NIR-light absorption between optodes was distributed describing a rotational ellipsoid with a mean penetration depth of (23.6 +/- 0.7) mm considering the deepest 5% of light. Of the detected photon packages scalp and bone absorbed (96.4 +/- 9: 7)% and V-gray absorbed (3.1 +/- 1.8)% of the energy. The mean V-gray volume (1.1 +/- 0.4)cm(3) was negatively correlated (r = - .76) with the SCD and frontal sinus volume (r = - .57) and was reduced by 41.5% in subjects with relatively large compared to small frontal sinus. Head circumference was significantly positively correlated with the mean SCD (r = .46) and the traversed frontal sinus volume (r = .43). Sulcal morphology had no significant impact on V-gray. Our findings suggest to consider individual SCD and frontal sinus volume as anatomical factors impacting fNIRS sensitivity. Head circumference may represent a practical measure to partly control for these sources of error variance.	[Haeussinger, Florian B.; Heinzel, Sebastian; Ehlis, Ann-Christine; Fallgatter, Andreas J.] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Heinzel, Sebastian; Hahn, Tim] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Heinzel, Sebastian] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Hahn, Tim] Goethe Univ Frankfurt, Dept Cognit Psychol 2, Frankfurt, Germany; [Schecklmann, Martin] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany	Eberhard Karls University of Tubingen; University of Wurzburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Goethe University Frankfurt; University of Regensburg	Haeussinger, FB (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	Sebastian.Heinzel@med.uni-tuebingen.de	Heinzel, Sebastian/AFK-4188-2022; Hahn, Tim/C-7045-2011; Hahn, Tim/N-7250-2013	Hahn, Tim/0000-0002-1177-3346; Hahn, Tim/0000-0002-8929-4134; Heinzel, Sebastian/0000-0003-4516-0529; Ehlis, Ann-Christine/0000-0002-8142-9743				Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Binzoni T, 2006, PHYS MED BIOL, V51, pN313, DOI 10.1088/0031-9155/51/17/N04; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Brooks JO, 2009, PSYCHIAT RES-NEUROIM, V172, P200, DOI 10.1016/j.pscychresns.2008.06.007; CHANCE B, 1988, P NATL ACAD SCI USA, V85, P4971, DOI 10.1073/pnas.85.14.4971; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; CRIPPA PR, 1978, BIOCHIM BIOPHYS ACTA, V538, P164, DOI 10.1016/0304-4165(78)90260-X; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Cyranoski D, 2011, NATURE, V469, P148, DOI 10.1038/469148a; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Henyey L. G., 1940, ANN ASTROPHYS, V3, P117; Kawaguchi H, 2007, APPL OPTICS, V46, P1658, DOI 10.1364/AO.46.001658; Kim S, 2005, ETRI J, V27, P377, DOI 10.4218/etrij.05.0104.0056; Koyama T, 2005, APPL OPTICS, V44, P2094, DOI 10.1364/AO.44.002094; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lee CK, 2005, OPT EXPRESS, V13, P8339, DOI 10.1364/OPEX.13.008339; Linden DEJ, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.049.2009; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Minagawa-Kawai Y, 2009, CEREB CORTEX, V19, P284, DOI 10.1093/cercor/bhn081; Nenadic I, 2010, NEUROIMAGE, V49, P1153, DOI 10.1016/j.neuroimage.2009.10.014; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Okada E, 2010, ADV EXP MED BIOL, V662, P231, DOI 10.1007/978-1-4419-1241-1_33; Park IH, 2010, INT J PEDIATR OTORHI, V74, P1347, DOI 10.1016/j.ijporl.2010.08.018; Pawley J, 2006, HDB BIOL CONFOCAL MI; Pirner S, 2009, EUR ARCH OTO-RHINO-L, V266, P507, DOI 10.1007/s00405-008-0777-7; Plichta MM, 2007, HUM BRAIN MAPP, V28, P733, DOI 10.1002/hbm.20303; Plichta MM, 2006, NEUROIMAGE, V31, P116, DOI 10.1016/j.neuroimage.2005.12.008; Reynolds MD, 1999, NEUROLOGY, V53, P228, DOI 10.1212/WNL.53.1.228; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sassaroli A, 2004, PHYS MED BIOL, V49, pN255, DOI 10.1088/0031-9155/49/14/N07; Schecklmann M, 2008, NEUROIMAGE, V43, P147, DOI 10.1016/j.neuroimage.2008.06.032; TEARNEY GJ, 1995, OPT LETT, V20, P2258, DOI 10.1364/OL.20.002258; Toronov V, 2010, NEUROIMAGE, V34, P1136; Tsuchiya Y, 2001, PHYS MED BIOL, V46, P2067, DOI 10.1088/0031-9155/46/8/303; Van der Zee P, 1987, Adv Exp Med Biol, V215, P179; VANDERZEE P, 1990, ADV EXP MED BIOL, V277, P79; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang XF, 2005, OPT EXPRESS, V13, P5513, DOI 10.1364/OPEX.13.005513	43	165	166	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26377	10.1371/journal.pone.0026377	http://dx.doi.org/10.1371/journal.pone.0026377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039475	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200017
J	van Beilen, M; de Jong, BM; Gieteling, EW; Renken, R; Leenders, KL				van Beilen, Marije; de Jong, Bauke M.; Gieteling, Esther W.; Renken, Remco; Leenders, Klaus L.			Abnormal Parietal Function in Conversion Paresis	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN ACTIVATION; MOTOR IMAGERY; PARALYSIS; DISORDER; MECHANISMS; MOVEMENT; SYMPTOMS; PAIN; CONNECTIVITY	The etiology of medically unexplained symptoms such as conversion disorder is poorly understood. This is partly because the interpretation of neuroimaging results in conversion paresis has been complicated by the use of different control groups, tasks and statistical comparisons. The present study includes these different aspects in a single data set. In our study we included both normal controls and feigners to control for conversion paresis. We studied both movement execution and imagery, and we contrasted both within-group and between-group activation. Moreover, to reveal hemisphere-specific effects that have not been reported before, we performed these analyses using both flipped and unflipped data. This approach resulted in the identification of abnormal parietal activation which was specific for conversion paresis patients. Patients also showed reduced activity in the prefrontal cortex, supramarginal gyrus and precuneus, including hemisphere-specific activation that is lateralized in the same hemisphere, regardless of right-or left-sided paresis. We propose that these regions are candidates for an interface between psychological mechanisms and disturbed higher-order motor control. Our study presents an integrative neurophysiological view of the mechanisms that contribute to the etiology of this puzzling psychological disorder, which can be further investigated with other types of conversion symptoms.	[van Beilen, Marije; de Jong, Bauke M.; Gieteling, Esther W.; Leenders, Klaus L.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [van Beilen, Marije; de Jong, Bauke M.; Gieteling, Esther W.; Renken, Remco; Leenders, Klaus L.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	van Beilen, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	m.van.beilen@neuro.umcg.nl	van Beilen, Marije/A-7435-2011	Renken, Remco Jan/0000-0002-7777-9484; de Jong, Bauke M./0000-0002-6568-5739	University Medical Centre Groningen, University of Groningen	University Medical Centre Groningen, University of Groningen	This study was funded by the University Medical Centre Groningen, University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beudel M, 2009, CEREB CORTEX, V19, P2361, DOI 10.1093/cercor/bhn254; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Burgmer M, 2006, NEUROIMAGE, V29, P1336, DOI 10.1016/j.neuroimage.2005.08.033; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cojan Y, 2009, NEURON, V62, P862, DOI 10.1016/j.neuron.2009.05.021; Cojan Y, 2009, NEUROIMAGE, V47, P1026, DOI 10.1016/j.neuroimage.2009.05.023; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Lange FP, 2007, NEUROPSYCHOLOGIA, V45, P2051, DOI 10.1016/j.neuropsychologia.2007.02.002; de Lange FP, 2010, NEUROPSYCHOLOGIA, V48, P1782, DOI 10.1016/j.neuropsychologia.2010.02.029; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Elsinger CL, 2006, NEUROIMAGE, V31, P1177, DOI 10.1016/j.neuroimage.2006.01.041; FREUD S, 1909, STUDIES HYSTERIA SEL; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; Ghaffar O, 2006, NEUROLOGY, V67, P2036, DOI 10.1212/01.wnl.0000247275.68402.fc; Gieteling EW, 2008, PAIN, V134, P302, DOI 10.1016/j.pain.2007.04.029; Janet P, 1907, MAJOR SYMPTOMS HYSTE, DOI 10.1037/10008-000; Mailis-Gagnon A, 2003, NEUROLOGY, V60, P1501, DOI 10.1212/WNL.60.9.1501; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; Nahab FB, 2011, CEREB CORTEX, V21, P48, DOI 10.1093/cercor/bhq059; Oakley D A, 1999, Cogn Neuropsychiatry, V4, P243, DOI 10.1080/135468099395954; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Rizzolatti Giacomo, 2006, Novartis Found Symp, V270, P129; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Roelofs K, 2006, BIOL PSYCHOL, V71, P316, DOI 10.1016/j.biopsycho.2005.07.002; Roelofs K, 2005, J NERV MENT DIS, V193, P508, DOI 10.1097/01.nmd.0000172472.60197.4d; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Scott RL, 2009, MOTOR CONTROL, V13, P161, DOI 10.1123/mcj.13.2.161; Spence SA, 2000, LANCET, V355, P1243, DOI 10.1016/S0140-6736(00)02096-1; Stone J, 2007, PSYCHOSOM MED, V69, P961, DOI 10.1097/PSY.0b013e31815b6c14; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; TIIHONEN J, 1995, BIOL PSYCHIAT, V37, P134, DOI 10.1016/0006-3223(94)00230-Z; van Beilen M, 2009, EUR J NEUROL, V16, P1118, DOI 10.1111/j.1468-1331.2009.02655.x; van Beilen M, 2009, MOVEMENT DISORD, V24, P922, DOI 10.1002/mds.22428; Van Strien J. W., 1992, NEDERLANDS TIJDSCHRI, V47, P88; VANBEILEN N, 2009, J NEUROL SCI, P1878; VANDERHOEVEN R, 2011, PERSONALITY DI UNPUB; Vogt B. A., 2009, CINGULATE NEUROBIOLO; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Voon V, 2010, NEUROLOGY, V74, P223, DOI 10.1212/WNL.0b013e3181ca00e9; Vuilleumier P, 2001, BRAIN, V124, P1077, DOI 10.1093/brain/124.6.1077; Ward N S, 2003, Cogn Neuropsychiatry, V8, P295, DOI 10.1080/13546800344000200; Werring DJ, 2004, PSYCHOL MED, V34, P583, DOI 10.1017/S0033291703008985	51	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e25918	10.1371/journal.pone.0025918	http://dx.doi.org/10.1371/journal.pone.0025918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039428	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200004
J	Kolodziej, LE; Lodolce, JP; Chang, JE; Schneider, JR; Grimm, WA; Bartulis, SJ; Zhu, XR; Messer, JS; Murphy, SF; Reddy, N; Turner, JR; Boone, DL				Kolodziej, Lauren E.; Lodolce, James P.; Chang, Jonathan E.; Schneider, Jeffrey R.; Grimm, Wesley A.; Bartulis, Sarah J.; Zhu, Xiaorong; Messer, Jeannette S.; Murphy, Stephen F.; Reddy, Nishith; Turner, Jerrold R.; Boone, David L.			TNFAIP3 Maintains Intestinal Barrier Function and Supports Epithelial Cell Tight Junctions	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; MOLECULAR-BASIS; CROHNS-DISEASE; ENZYME A20; PERMEABILITY; ACTIVATION; PROTEIN; LIPOPOLYSACCHARIDE; UBIQUITINATION	Tight junctions between intestinal epithelial cells mediate the permeability of the intestinal barrier, and loss of intestinal barrier function mediated by TNF signaling is associated with the inflammatory pathophysiology observed in Crohn's disease and celiac disease. Thus, factors that modulate intestinal epithelial cell response to TNF may be critical for the maintenance of barrier function. TNF alpha-induced protein 3 (TNFAIP3) is a cytosolic protein that acts in a negative feedback loop to regulate cell signaling induced by Toll-like receptor ligands and TNF, suggesting that TNFAIP3 may play a role in regulating the intestinal barrier. To investigate the specific role of TNFAIP3 in intestinal barrier function we assessed barrier permeability in TNFAIP3(-/-) mice and LPS-treated villin-TNFAIP3 transgenic mice. TNFAIP3(-/-) mice had greater intestinal permeability compared to wild-type littermates, while villin-TNFAIP3 transgenic mice were protected from increases in permeability seen within LPS-treated wild-type littermates, indicating that barrier permeability is controlled by TNFAIP3. In cultured human intestinal epithelial cell lines, TNFAIP3 expression regulated both TNF-induced and myosin light chain kinase-regulated tight junction dynamics but did not affect myosin light chain kinase activity. Immunohistochemistry of mouse intestine revealed that TNFAIP3 expression inhibits LPS-induced loss of the tight junction protein occludin from the apical border of the intestinal epithelium. We also found that TNFAIP3 deubiquitinates polyubiquitinated occludin. These in vivo and in vitro studies support the role of TNFAIP3 in promoting intestinal epithelial barrier integrity and demonstrate its novel ability to maintain intestinal homeostasis through tight junction protein regulation.	[Kolodziej, Lauren E.; Lodolce, James P.; Chang, Jonathan E.; Schneider, Jeffrey R.; Grimm, Wesley A.; Bartulis, Sarah J.; Zhu, Xiaorong; Messer, Jeannette S.; Murphy, Stephen F.; Boone, David L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Reddy, Nishith] Illinois Math & Sci Acad, Aurora, IL USA; [Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kolodziej, LE (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	dboone@medicine.bsd.uchicago.edu	Turner, Jerrold/H-1502-2019	Messer, Jeannette/0000-0002-5072-3835	Gastrointestinal Research Foundation (GIRF); GIRF Associates Board; Crohn's and Colitis Foundation of America; National Institute of Allergy and Infectious Diseases [1F32AI077235-01A1]; National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK061931-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061931] Funding Source: NIH RePORTER	Gastrointestinal Research Foundation (GIRF); GIRF Associates Board; Crohn's and Colitis Foundation of America; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This research was completed with support from the Gastrointestinal Research Foundation (GIRF) and the GIRF Associates Board (http://girf.org/); and by the Crohn's and Colitis Foundation of America (http://www.ccfa.org) to DB; and National Institute of Allergy and Infectious Diseases 1F32AI077235-01A1 to JPL and National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK061931-10 to JRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; Arsenescu R, 2008, MUCOSAL IMMUNOL, V1, P399, DOI 10.1038/mi.2008.32; Beutler B, 1995, J CARDIOVASC PHARM, V25, pS1, DOI 10.1097/00005344-199500252-00002; Bishop BL, 2010, BIOCHEM BIOPH RES CO, V394, P254, DOI 10.1016/j.bbrc.2010.02.091; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; de Kort S, 2011, OBES REV, V12, P449, DOI 10.1111/j.1467-789X.2010.00845.x; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Ebert EC, 2011, J CLIN GASTROENTEROL, V45, P436, DOI 10.1097/MCG.0b013e31820f81b8; Ebert EC, 2011, DIGEST DIS SCI, V56, P295, DOI 10.1007/s10620-010-1508-7; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Gerova VA, 2011, WORLD J GASTROENTERO, V17, P2211, DOI [10.3748/wjg.v17.i17.2211, 10.3748/wjg.v17.i17.]; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawanishi M, 2000, VIROLOGY, V270, P258, DOI 10.1006/viro.2000.0296; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Lodolce JP, 2010, J IMMUNOL, V184, P7001, DOI 10.4049/jimmunol.1000324; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71; Meddings J, 2008, GUT, V57, P438, DOI 10.1136/gut.2007.143172; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Orozco G, 2009, HUM MOL GENET, V18, P2693, DOI 10.1093/hmg/ddp193; Oshima N, 2010, CLIN EXP IMMUNOL, V159, P185, DOI 10.1111/j.1365-2249.2009.04048.x; Owens SE, 2005, PHARM RES-DORDR, V22, P703, DOI 10.1007/s11095-005-2584-9; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Ruemmele FM, 2002, GUT, V51, P842, DOI 10.1136/gut.51.6.842; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Welcker K, 2004, EUR J MED RES, V9, P456; Weng M, 2007, PEDIATR RES, V62, P542, DOI 10.1203/PDR.0b013e318155a422; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	66	54	62	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26352	10.1371/journal.pone.0026352	http://dx.doi.org/10.1371/journal.pone.0026352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031828	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200017
J	Vallejo, AN; Hamel, DL; Mueller, RG; Ives, DG; Michel, JJ; Boudreau, RM; Newman, AB				Vallejo, Abbe N.; Hamel, David L., Jr.; Mueller, Robert G.; Ives, Diane G.; Michel, Joshua J.; Boudreau, Robert M.; Newman, Anne B.			NK-Like T Cells and Plasma Cytokines, but Not Anti-Viral Serology, Define Immune Fingerprints of Resilience and Mild Disability in Exceptional Aging	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; CARDIOVASCULAR HEALTH; COGNITIVE IMPAIRMENT; REPLICATIVE SENESCENCE; EXPRESSION; RECEPTORS; PHENOTYPE; PEOPLE; SPEED; DIFFERENTIATION	Exceptional aging has been defined as maintenance of physical and cognitive function beyond the median lifespan despite a history of diseases and/or concurrent subclinical conditions. Since immunity is vital to individual fitness, we examined immunologic fingerprint(s) of highly functional elders. Therefore, survivors of the Cardiovascular Health Study in Pittsburgh, Pennsylvania, USA were recruited (n = 140; mean age = 86 years) and underwent performance testing. Blood samples were collected and examined blindly for humoral factors and T cell phenotypes. Based on results of physical and cognitive performance testing, elders were classified as "impaired" or "unimpaired", accuracy of group assignment was verified by discriminant function analysis. The two groups showed distinct immune profiles as determined by factor analysis. The dominant immune signature of impaired elders consisted of interferon (IFN)-gamma, interleukin (IL)-6, tumor necrosis factor-a, and T cells expressing inhibitory natural killer-related receptors (NKR) CD158a, CD158e, and NKG2A. In contrast, the dominant signature of unimpaired elders consisted of IL-5, IL-12p70, and IL-13 with co-expression of IFN-gamma, IL-4, and IL-17, and T cells expressing stimulatory NKRs CD56, CD16, and NKG2D. In logistic regression models, unimpaired phenotype was predicted independently by IL-5 and by CD4(+)CD28(null)CD56(+)CD57(+) T cells. All elders had high antibody titers to common viruses including cytomegalovirus. In cellular bioassays, T cell receptor (TCR)-independent ligation of either CD56 or NKG2D elicited activation of T cells. Collectively, these data demonstrate the importance of immunological parameters in distinguishing between health phenotypes of older adults. NKR+ T cells and cytokine upregulation indicate a unique physiologic environment in old age. Correlation of particular NKR+ T cell subsets and IL-5 with unimpaired performance, and NKR-driven TCR-independent activation of T cells suggest novel immunopathway(s) that could be exploited to improve immunity in old age.	[Vallejo, Abbe N.; Hamel, David L., Jr.; Mueller, Robert G.; Michel, Joshua J.] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15261 USA; [Vallejo, Abbe N.] Univ Pittsburgh, Dept Immunol, Inst Canc, Pittsburgh, PA USA; [Vallejo, Abbe N.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Vallejo, Abbe N.; Hamel, David L., Jr.; Newman, Anne B.] Univ Pittsburgh, Sch Med, Med Student Training Aging Res Program, Div Geriatr Med, Pittsburgh, PA USA; [Ives, Diane G.; Boudreau, Robert M.; Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Ctr Aging & Populat Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vallejo, AN (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15261 USA.	andv26@pitt.edu	Newman, Anne B./C-6408-2013	Newman, Anne B./0000-0002-0106-1150; Boudreau, Robert/0000-0003-0162-5187	United States National Institutes of Health (NIH) [R01 AG030734, R01 AG022379S1, R01 AG023629]; center of excellence [P30 AG024827]; NIH [N01 HC85239, N01 HC85079, HC85086, N01 HC35129, N01 HC15103, N01 HC55222, N01 HC75150, N01 HC45133];  [T35 AG026778];  [U01 HL080295]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC075150, N01HC035129, N01HC015103, N01HC045133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, R01AG030734, R01AG023629, T35AG026778, R01AG022379] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); center of excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the United States National Institutes of Health (NIH) through investigator-initiated research grants R01 AG030734, R01 AG022379S1, and R01 AG023629, center of excellence grant P30 AG024827, and training grant T35 AG026778. The cohort of the Cardiovascular Health Study from which participants were recruited into this study was supported by NIH contracts N01 HC85239, N01 HC85079 through HC85086, N01 HC35129, N01 HC15103, N01 HC55222, N01 HC75150, and N01 HC45133, and by U01 HL080295. Neither the NIH nor the United States Federal Government had any role in the design and conduct of this study. Views expressed in this publication are those by the authors, and are neither those by nor constitute endorsement by the NIH or the United States Federal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin S, 2005, EXP GERONTOL, V40, P537, DOI 10.1016/j.exger.2005.04.012; Agrawal A, 2011, AGEING RES REV, V10, P336, DOI 10.1016/j.arr.2010.06.004; Anfossi N, 2004, J IMMUNOL, V173, P7223, DOI 10.4049/jimmunol.173.12.7223; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Bernstein E, 1999, VACCINE, V17, P82, DOI 10.1016/S0264-410X(98)00117-0; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Covinsky KE, 2006, MED CARE, V44, P149, DOI 10.1097/01.mlr.0000196955.99704.64; de Magalhaes JP, 2005, PHYSIOLOGY, V20, P252, DOI 10.1152/physiol.00010.2005; Deschenes MR, 2011, CURR AGING IN PRESS; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Frasca D, 2011, AGEING RES REV, V10, P330, DOI 10.1016/j.arr.2010.08.004; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Larbi A, 2011, AGEING RES REV, V10, P370, DOI 10.1016/j.arr.2010.09.008; Lemster BH, 2008, J IMMUNOL, V180, P1979, DOI 10.4049/jimmunol.180.3.1979; Leng SX, 2011, EXP GERONTOL, V46, P679, DOI 10.1016/j.exger.2011.04.002; Naumov YN, 2011, J IMMUNOL, V186, P6617, DOI 10.4049/jimmunol.1100091; NCHS, 2010, HLTH US 2009 SPEC FE; Newman Anne B, 2004, Am J Geriatr Cardiol, V13, P59, DOI 10.1111/j.1076-7460.2004.02126.x; Newman AB, 2009, J AM GERIATR SOC, V57, P432, DOI 10.1111/j.1532-5415.2008.02152.x; Novelli F, 2004, CYTOKINE GROWTH F R, V15, P367, DOI 10.1016/j.cytogfr.2004.03.009; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Peralbo E, 2007, EXP GERONTOL, V42, P703, DOI 10.1016/j.exger.2007.05.002; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Ridda I, 2009, VACCINE, V27, P1628, DOI 10.1016/j.vaccine.2008.11.098; Rosano C, 2010, J GERONTOL A-BIOL, V65, P639, DOI 10.1093/gerona/glq038; Schwaiger S, 2003, J IMMUNOL, V170, P613, DOI 10.4049/jimmunol.170.1.613; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Snyder MR, 2002, J IMMUNOL, V168, P3839, DOI 10.4049/jimmunol.168.8.3839; Soumare A, 2009, J GERONTOL A-BIOL, V64, P1058, DOI 10.1093/gerona/glp077; Strotmeyer ES, 2010, J AM GERIATR SOC, V58, P696, DOI 10.1111/j.1532-5415.2010.02770.x; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Vallejo AN, 2007, TRENDS MOL MED, V13, P94, DOI 10.1016/j.molmed.2007.01.005; Vallejo AN, 2011, AGEING RES REV, V10, P354, DOI 10.1016/j.arr.2010.09.006; Vallejo AN, 2005, IMMUNOL REV, V205, P158, DOI 10.1111/j.0105-2896.2005.00256.x; Vallejo AN, 1999, J IMMUNOL, V162, P6572; van Bergen J, 2004, J IMMUNOL, V173, P6719, DOI 10.4049/jimmunol.173.11.6719; van Bergen J, 2010, IMMUNOLOGY, V131, P301, DOI 10.1111/j.1365-2567.2010.03337.x; Venkatraman VK, 2010, NEUROIMAGE, V49, P3436, DOI 10.1016/j.neuroimage.2009.11.019; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Xu J, 2005, J BIOL CHEM, V280, P24277, DOI 10.1074/jbc.M500727200; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zwaan Bas J, 2003, Sci Aging Knowledge Environ, V2003, ppe32, DOI 10.1126/sageke.2003.47.pe32	60	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26558	10.1371/journal.pone.0026558	http://dx.doi.org/10.1371/journal.pone.0026558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028907	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000296510800053
J	von Oheimb, PV; Albrecht, C; Riedel, F; Du, LN; Yang, JX; Aldridge, DC; Bossneck, U; Zhang, HC; Wilke, T				von Oheimb, Parm Viktor; Albrecht, Christian; Riedel, Frank; Du, Lina; Yang, Junxing; Aldridge, David C.; Boessneck, Ulrich; Zhang, Hucai; Wilke, Thomas			Freshwater Biogeography and Limnological Evolution of the Tibetan Plateau - Insights from a Plateau-Wide Distributed Gastropod Taxon (Radix spp.)	PLOS ONE			English	Article							QUATERNARY GLACIATION; AQUATIC ORGANISMS; MOLECULAR CLOCK; CYTOCHROME-B; PHYLOGEOGRAPHY; CYPRINIDAE; DISPERSAL; PHYLOGENY; ALGORITHM; DNA	Background: The Tibetan Plateau is not only the highest and largest plateau on earth; it is also home to numerous freshwater lakes potentially harbouring endemic faunal elements. As it remains largely unknown whether these lakes have continuously existed during the Last Glacial Maximum (LGM), questions arise as to whether taxa have been able to exist on the plateau since before the latest Pleistocene, from where and how often the plateau was colonized, and by which mechanisms organisms conquered remote high altitude lentic freshwater systems. In this study, species of the plateau-wide distributed freshwater gastropod genus Radix are used to answer these biogeographical questions. Methodology/Principal Findings: Based on a broad spatial sampling of Radix spp. on the Tibetan Plateau, and phylogenetic analyses of mtDNA sequence data, three probably endemic and one widespread major Radix clade could be identified on the plateau. Two of the endemic clades show a remarkably high genetic diversity, indicating a relatively great phylogenetic age. Phylogeographical analyses of individuals belonging to the most widely distributed clade indicate that intra-plateau distribution cannot be explained by drainage-related dispersal alone. Conclusions/Significance: Our study reveals that Radix spp. persisted throughout the LGM on the Tibetan Plateau. Therefore, we assume the continuous existence of suitable water bodies during that time. The extant Radix diversity on the plateau might have been caused by multiple colonization events combined with a relatively long intra-plateau evolution. At least one colonization event has a Palaearctic origin. In contrast to freshwater fishes, passive dispersal, probably by water birds, might be an important mechanism for conquering remote areas on the plateau. Patterns found in Radix spp. are shared with some terrestrial plateau taxa, indicating that Radix may be a suitable model taxon for inferring general patterns of biotic origin, dispersal and survival on the Tibetan Plateau.	[von Oheimb, Parm Viktor; Albrecht, Christian; Wilke, Thomas] Univ Giessen, Dept Anim Ecol & Systemat, Giessen, Germany; [Riedel, Frank] Free Univ Berlin, Inst Geol Sci, Berlin, Germany; [Du, Lina; Yang, Junxing] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Aldridge, David C.] Univ Cambridge, Dept Zool, Cambridge, England; [Boessneck, Ulrich] Nat Hist Museum, Erfurt, Germany; [Zhang, Hucai] Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Coll Tourism & Geog, Kunming, Peoples R China; [Zhang, Hucai] Chinese Acad Sci, State Key Lab Lake Sci & Environm, Nanjing, Peoples R China	Justus Liebig University Giessen; Free University of Berlin; Chinese Academy of Sciences; University of Cambridge; Yunnan Normal University; Chinese Academy of Sciences	von Oheimb, PV (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, Giessen, Germany.	parm.v.oheimb@allzool.bio.uni-giessen.de	Albrecht, Christian/AFV-5313-2022; Wilke, Thomas/G-1517-2012; Albrecht, Christian/AAJ-5484-2020	Wilke, Thomas/0000-0001-8263-7758; Aldridge, David/0000-0001-9067-8592	Deutsche Forschungsgemeinschaft [WI 1902/7, RI 809/21, 1372]; World Bank GEF [DM01333]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); World Bank GEF	This study was funded by the Deutsche Forschungsgemeinschaft (WI 1902/7 and RI 809/21) within the priority programme 1372: "Tibetan Plateau: Formation - Climate - Ecosystems" (TiP). Collection of material from southwest China was supported by World Bank GEF Grant DM01333 to D. C. Aldridge and J. Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2008, HYDROBIOLOGIA, V615, P103, DOI 10.1007/s10750-008-9558-y; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Banarescu P, 1992, DISTRIBUTION DISPERS, V2, P520; Benke M, 2009, MOL ECOL, V18, P890, DOI 10.1111/j.1365-294X.2008.04073.x; Chang C.F., 1989, TECTONIC EVOLUTION T, P415, DOI [10.1007/978-94-009-2253-2_18, DOI 10.1007/978-94-009-2253-2_18]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cowie Robert H., 2003, P93; Cox CB, 2001, J BIOGEOGR, V28, P511; DERBYSHIRE E, 1991, QUATERNARY SCI REV, V10, P485, DOI 10.1016/0277-3791(91)90042-S; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Grabowski G, 1991, SIMPLE FOOLS GUIDE P, P46; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo XG, 2005, MOL PHYLOGENET EVOL, V35, P344, DOI 10.1016/j.ympev.2004.12.015; Haase M, 2010, J MOLLUS STUD, V76, P101, DOI 10.1093/mollus/eyp051; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jin YT, 2008, MOL ECOL, V17, P1971, DOI 10.1111/j.1365-294X.2008.03721.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kjer KM, 2009, SEQUENCE ALIGNMENT: METHODS, MODELS, CONCEPTS, AND STRATEGIES, P105; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lehmkuhl F, 2005, BOREAS, V34, P87, DOI 10.1080/03009480510012908; Lehmkuhl F, 2000, QUATERN INT, V65-6, P121, DOI 10.1016/S1040-6182(99)00040-3; Lehmkuhl F, 1998, QUATERN INT, V45-6, P123, DOI 10.1016/S1040-6182(97)00010-4; Li J, 2009, GLOBAL ECOL BIOGEOGR, V18, P264, DOI 10.1111/j.1466-8238.2008.00430.x; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; MALONE CR, 1965, ECOLOGY, V46, P551, DOI 10.2307/1934894; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Mischke S, 2010, J PALEOLIMNOL, V43, P589, DOI 10.1007/s10933-009-9355-2; MOLNAR P, 1975, SCIENCE, V189, P419, DOI 10.1126/science.189.4201.419; Morrone JJ, 2002, J BIOGEOGR, V29, P149, DOI 10.1046/j.1365-2699.2002.00662.x; Murphy MA, 2009, EARTH PLANET SC LETT, V282, P1, DOI 10.1016/j.epsl.2009.01.006; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRASHAD B., 1933, REC INDIAN MUS, V35, P1; Qi DL, 2007, FRESHWATER BIOL, V52, P1090, DOI 10.1111/j.1365-2427.2007.01731.x; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Revenga C., 1998, WATERSHEDS WORLD ECO; Ronquist F, 2010, ANNU REV ENTOMOL, V55, P189, DOI 10.1146/annurev.ento.54.110807.090529; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STAROBOGATOV Y.I., 1970, FAUNA MOLLYUSKOV ZOO; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wesselingh FP, 1999, GEOL MIJNBOUW-N J G, V78, P165, DOI 10.1023/A:1003766516646; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wilke T, 2000, BIOL J LINN SOC, V70, P89, DOI 10.1111/j.1095-8312.2000.tb00202.x; Wilke T, 2007, J BIOGEOGR, V34, P1807, DOI 10.1111/j.1365-2699.2007.01727.x; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; WILLIAMS WD, 1991, HYDROBIOLOGIA, V210, P39, DOI 10.1007/BF00014322; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Yang SJ, 2006, MOL PHYLOGENET EVOL, V41, P257, DOI 10.1016/j.ympev.2006.06.003; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yu G, 2001, 4243 MAXPLANCK I BIO, V4, P243; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang YH, 2010, MOL PHYLOGENET EVOL, V57, P1162, DOI 10.1016/j.ympev.2010.08.033; Zhao K, 2009, MOL ECOL, V18, P3616, DOI 10.1111/j.1365-294X.2009.04274.x; Zheng M., 1997, INTRO SALINE LAKES Q, DOI [10.1007/978-94-011-5458-1, DOI 10.1007/978-94-011-5458-1]	76	44	45	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26307	10.1371/journal.pone.0026307	http://dx.doi.org/10.1371/journal.pone.0026307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028853	Green Submitted, Green Published, gold			2022-12-25	WOS:000296510800034
J	Zhou, J; Zhu, XS; Cai, ZH				Zhou, Jin; Zhu, Xiao-Shan; Cai, Zhong-Hua			Influences of DMP on the Fertilization Process and Subsequent Embryogenesis of Abalone (Haliotis diversicolor supertexta) by Gametes Exposure	PLOS ONE			English	Article							MATERNAL EXPOSURE; PHTHALATE-ESTERS; MUSSEL; SPERM; REPRODUCTION; EXPRESSION; TOXICITY; SURVIVAL; EMBRYOS; COPPER	Di-methyl phthalate (DMP), a typical endocrine disrupting chemical (EDC), is ubiquitously distributed in aquatic environments; yet studies regarding its impact on gametes and the resulting effects on embryogenesis in marine gastropods are relatively scarce. In this study, the influences of DMP on the gametes and subsequent developmental process of abalone (Haliotis diversicolor supertexta, a representative marine benthic gastropod) were assessed. Newborn abalone eggs and sperm were exposed separately to different DMP concentrations (1, 10 or 100 ppb) for 60 min. At the end-point of exposure, the DMP-treated eggs and sperm were collected for analysis of their ultra-structures, ATPase activities and total lipid levels, and the fertilized gametes (embryos) were collected to monitor related reproductive parameters (fertilization rate, abnormal development rate and hatching success rate). Treatment with DMP did not significantly alter the structure or total lipid content of eggs at any of the doses tested. Hatching failures and morphological abnormalities were only observed with the highest dose of DMP (100 ppb). However, DMP exposure did suppress sperm ATPase activities and affect the morphological character of their mitochondria. DMP-treated sperm exhibited dose-dependent decreases in fertilization efficiency, morphogenesis and hatchability. Relatively obvious toxicological effects were observed when both sperm and eggs were exposed to DMP. Furthermore, RT-PCR results indicate that treatment of gametes with DMP changed the expression patterns of physiologically-regulated genes (cyp3a, 17 beta-HSD-11 and 17 beta-HSD-12) in subsequent embryogenesis. Taken together, this study proofed that pre-fertilization exposure of abalone eggs, sperm or both to DMP adversely affects the fertilization process and subsequent embryogenesis.	[Zhou, Jin; Zhu, Xiao-Shan; Cai, Zhong-Hua] Tsinghua Univ, Ocean Sci & Technol Div, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Zhou, J (corresponding author), Tsinghua Univ, Ocean Sci & Technol Div, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China.	caizh@sz.tsinghua.edu.cn	Zhu, Xiaoshan/HCG-9804-2022; Zhu, Xiaoshan/B-2179-2015	Zhu, Xiaoshan/0000-0003-1223-1415	National Natural Science Foundation of China [41106087]; Natural Science Foundation of Guangdong Province, China [10451805702004177]; SZSITIC Commission of Shenzhen [ZYA200903260036A]; Key Laboratory of Marine Environmental Science and Engineering, SOA [MESE-2010-02]; Laboratory of Marine Ecosystem and Biogeochemistry, SOA [LMEB201105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); SZSITIC Commission of Shenzhen; Key Laboratory of Marine Environmental Science and Engineering, SOA; Laboratory of Marine Ecosystem and Biogeochemistry, SOA	This study was supported by National Natural Science Foundation of China (41106087), the PhD Start-up Fund of the Natural Science Foundation of Guangdong Province, China (10451805702004177), the International Cooperative Project of the SZSITIC Commission of Shenzhen (ZYA200903260036A), the Open Fund of the Key Laboratory of Marine Environmental Science and Engineering, SOA (MESE-2010-02), and the Open Fund of the Laboratory of Marine Ecosystem and Biogeochemistry, SOA (LMEB201105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Akbarsha MA, 2000, J REPROD FERTIL, V120, P385, DOI 10.1530/reprod/120.2.385; Aluru N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010741; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown KH, 2008, P NATL ACAD SCI USA, V105, P19786, DOI 10.1073/pnas.0808333105; Castro LFC, 2008, CECE 2008 24 C EUR C; Cripe GM, 2010, ENVIRON TOXICOL CHEM, V29, P2079, DOI [10.1002/ete.261, 10.1002/etc.261]; Davidson E. H., 1986, GENE ACTIVITY EARLY; EARNSHAW MJ, 1986, MAR ENVIRON RES, V20, P261, DOI 10.1016/0141-1136(86)90052-8; EYSTER LS, 1984, ARCH ENVIRON CON TOX, V13, P641, DOI 10.1007/BF01056344; Fatta-Kassinos D, 2011, SCI TOTAL ENVIRON, V409, P3555, DOI 10.1016/j.scitotenv.2010.03.036; Favret KP, 2010, ARCH ENVIRON CON TOX, V58, P973, DOI 10.1007/s00244-009-9410-z; Fent K, 2004, TOXICOLOGY, V205, P223, DOI 10.1016/j.tox.2004.06.060; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forget-Leray J, 2005, ECOTOX ENVIRON SAFE, V60, P288, DOI 10.1016/j.ecoenv.2004.06.008; Fridman O, 2004, ENVIRON HEALTH PERSP, V112, P862, DOI 10.1289/ehp.6647; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; HINSHELWOOD MM, 1994, MOL BIOL FEMALE REPR, P129; His E, 2000, ADV MAR BIOL, V37, P1; Hollows CF, 2007, MAR ECOL PROG SER, V333, P51, DOI 10.3354/meps333051; HUM DW, 1993, CLIN CHEM, V39, P333; Imai Y, 2006, CLIN EXP ALLERGY, V36, P1462, DOI 10.1111/j.1365-2222.2006.02574.x; Ioannides C., 2008, CYTOCHROMES P450 ROL; Janer G, 2005, AQUAT TOXICOL, V75, P32, DOI 10.1016/j.aquatox.2005.01.012; Jiang H, 2008, J TOXICOL, V2, P48; Kikuchi S., 1982, B TOHOKU REG FISH R, V44, P83; Lafont R, 2007, ECOTOXICOLOGY, V16, P109, DOI 10.1007/s10646-006-0113-1; LEVINE AE, 1978, DEV BIOL, V63, P299, DOI 10.1016/0012-1606(78)90135-5; Lewis C, 2009, ENVIRON SCI TECHNOL, V43, P928, DOI 10.1021/es802215d; Lewis Ceri, 2010, Integr Environ Assess Manag, V6, P188, DOI 10.1002/ieam.23; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Mackintosh CE, 2006, ENVIRON SCI TECHNOL, V40, P3481, DOI 10.1021/es0519637; MELNICK RL, 1982, ENVIRON HEALTH PERSP, V45, P51, DOI 10.2307/3429383; Mwatibo JM, 1997, B ENVIRON CONTAM TOX, V58, P589, DOI 10.1007/s001289900375; Nye JA, 2007, AQUAT TOXICOL, V82, P242, DOI 10.1016/j.aquatox.2007.02.011; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Ostrach DJ, 2008, P NATL ACAD SCI USA, V105, P19354, DOI 10.1073/pnas.0802616105; Patyna PJ, 2006, ECOTOX ENVIRON SAFE, V65, P36, DOI 10.1016/j.ecoenv.2005.05.023; Pushpalatha T, 2003, NATURWISSENSCHAFTEN, V90, P40, DOI 10.1007/s00114-002-0384-1; Raloff J, 2011, SCIENCENEWS; Roepke TA, 2006, J EXP ZOOL PART A, V305A, P830, DOI 10.1002/jez.a.320; Schatten GP, CURRENT TOPICS DEV B; Schultz I, 2008, MAR ENVIRON RES, V66, P47, DOI 10.1016/j.marenvres.2008.02.018; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Shioda T, 2000, CHEMOSPHERE, V40, P239, DOI 10.1016/S0045-6535(99)00235-0; Soares J, 2009, AQUAT TOXICOL, V95, P330, DOI 10.1016/j.aquatox.2009.07.021; Song XL, 2007, FISHERIES SCI, V6, P34; Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Uren-Webster TM, 2010, AQUAT TOXICOL, V99, P360, DOI 10.1016/j.aquatox.2010.05.015; Wang KH, 2001, REPRO HLTH, V2, P56; Westerlund L, 2000, ENVIRON TOXICOL CHEM, V19, P1582, DOI 10.1002/etc.5620190615; Wilson JT, 2002, AQUAT TOXICOL, V59, P163, DOI 10.1016/S0166-445X(01)00249-1; Yang AG, 2006, HATCHERY SEED PRODUC; Zanette J, 2010, MAR ENVIRON RES, V69, pS1, DOI 10.1016/j.marenvres.2009.10.013; Zhou J, 2011, MOL CELL BIOCHEM, V354, P123, DOI 10.1007/s11010-011-0811-8; Zhou J, 2011, ENVIRON POLLUT, V159, P1114, DOI 10.1016/j.envpol.2011.02.016; Zhou Lin, 2010, Integrated Environmental Assessment and Management, V6, P492, DOI [10.1002/ieam.47, 10.1002/IEAM.47]; [No title captured]	60	7	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25951	10.1371/journal.pone.0025951	http://dx.doi.org/10.1371/journal.pone.0025951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028799	Green Submitted, Green Published, gold			2022-12-25	WOS:000296510800011
J	Cornaciu, I; Boeszoermenyi, A; Lindermuth, H; Nagy, HM; Cerk, IK; Ebner, C; Salzburger, B; Gruber, A; Schweiger, M; Zechner, R; Lass, A; Zimmermann, R; Oberer, M				Cornaciu, Irina; Boeszoermenyi, Andras; Lindermuth, Hanna; Nagy, Harald M.; Cerk, Ines K.; Ebner, Catharina; Salzburger, Barbara; Gruber, Astrid; Schweiger, Martina; Zechner, Rudolf; Lass, Achim; Zimmermann, Robert; Oberer, Monika			The Minimal Domain of Adipose Triglyceride Lipase (ATGL) Ranges until Leucine 254 and Can Be Activated and Inhibited by CGI-58 and G0S2, Respectively	PLOS ONE			English	Article							COMPARATIVE GENE IDENTIFICATION-58; HORMONE-SENSITIVE LIPASE; LIPID DROPLET BINDING; CRYSTAL-STRUCTURE; TERMINAL REGION; FAMILY-MEMBERS; PROTEIN; LIPOLYSIS; TRIACYLGLYCEROL; EXPRESSION	Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme of lipolysis. ATGL specifically hydrolyzes triacylglycerols (TGs), thereby generating diacylglycerols and free fatty acids. ATGL's enzymatic activity is co-activated by the protein comparative gene identification-58 (CGI-58) and inhibited by the protein G0/G1 switch gene 2 (G0S2). The enzyme is predicted to act through a catalytic dyad (Ser47, Asp166) located within the conserved patatin domain (Ile10-Leu178). Yet, neither an experimentally determined 3D structure nor a model of ATGL is currently available, which would help to understand how CGI-58 and G0S2 modulate ATGL's activity. In this study we determined the minimal active domain of ATGL. This minimal fragment of ATGL could still be activated and inhibited by CGI-58 and G0S2, respectively. Furthermore, we show that this minimal domain is sufficient for protein-protein interaction of ATGL with its regulatory proteins. Based on these data, we generated a 3D homology model for the minimal domain. It strengthens our experimental finding that amino acids between Leu178 and Leu254 are essential for the formation of a stable protein domain related to the patatin fold. Our data provide insights into the structure-function relationship of ATGL and indicate higher structural similarities in the N-terminal halves of mammalian patatin-like phospholipase domain containing proteins, (PNPLA1, -2,- 3 and -5) than originally anticipated.	[Cornaciu, Irina; Boeszoermenyi, Andras; Lindermuth, Hanna; Nagy, Harald M.; Cerk, Ines K.; Ebner, Catharina; Salzburger, Barbara; Gruber, Astrid; Schweiger, Martina; Zechner, Rudolf; Lass, Achim; Zimmermann, Robert; Oberer, Monika] Graz Univ, Inst Mol Biosci, Graz, Austria	University of Graz	Cornaciu, I (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	m.oberer@uni-graz.at	Lass, Achim/C-3332-2008; Boeszoermenyi, Andras/AAD-9808-2020	Lass, Achim/0000-0002-8190-7151; Boeszoermenyi, Andras/0000-0001-9810-7241; Schweiger, Martina/0000-0002-3419-1007; Zimmermann, Robert/0000-0002-7354-870X; Oberer, Monika/0000-0003-2525-9513; Zechner, Rudolf/0000-0001-5483-1182	GOLD III; Austrian Federal Ministry of Science and Research; FFG; SFB LIPOTOX [F30]; doctoral school 'DK Molecular Enzymology' [W901-B05]; Austrian Science Fund (FWF);  [P22170]; Austrian Science Fund (FWF) [F 3002, P 22170, Z 136, W 901] Funding Source: researchfish	GOLD III; Austrian Federal Ministry of Science and Research; FFG; SFB LIPOTOX(German Research Foundation (DFG)); doctoral school 'DK Molecular Enzymology'; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from 'GOLD III', which is part of the Austrian Genome Project 'GEN-AU Genome Research in Austria' and is funded by the Austrian Federal Ministry of Science and Research and FFG. Support is also provided by project P22170, the SFB LIPOTOX (F30), and the doctoral school 'DK Molecular Enzymology' (W901-B05), which are funded by the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coassin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001239; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kim SC, 2006, J PROTEOME RES, V5, P3446, DOI 10.1021/pr0603396; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KOBAYASHI K, 2008, J CLIN ENDOCRINOL ME; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Schweiger M, 2006, J BIOL CHEM; SCHWEIGER M, 2009, AM J PHYSL ENDOCRINO; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	36	62	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26349	10.1371/journal.pone.0026349	http://dx.doi.org/10.1371/journal.pone.0026349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039468	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500054
J	Cotter, MM; Loomis, DA; Simpson, SW; Latimer, B; Hernandez, CJ				Cotter, Meghan M.; Loomis, David A.; Simpson, Scott W.; Latimer, Bruce; Hernandez, Christopher J.			Human Evolution and Osteoporosis-Related Spinal Fractures	PLOS ONE			English	Article							FINITE-ELEMENT MODELS; BONE-MINERAL DENSITY; CANCELLOUS BONE; VERTEBRAL BODY; TRABECULAR MICROARCHITECTURE; JOINT; AGE; RISK; SIZE; STRENGTH	The field of evolutionary medicine examines the possibility that some diseases are the result of trade-offs made in human evolution. Spinal fractures are the most common osteoporosis-related fracture in humans, but are not observed in apes, even in cases of severe osteopenia. In humans, the development of osteoporosis is influenced by peak bone mass and strength in early adulthood as well as age-related bone loss. Here, we examine the structural differences in the vertebral bodies (the portion of the vertebra most commonly involved in osteoporosis-related fractures) between humans and apes before age-related bone loss occurs. Vertebrae from young adult humans and chimpanzees, gorillas, orangutans, and gibbons (T8 vertebrae, n = 8-14 per species, male and female, humans: 20-40 years of age) were examined to determine bone strength (using finite element models), bone morphology (external shape), and trabecular microarchitecture (micro-computed tomography). The vertebrae of young adult humans are not as strong as those from apes after accounting for body mass (p < 0.01). Human vertebrae are larger in size (volume, cross-sectional area, height) than in apes with a similar body mass. Young adult human vertebrae have significantly lower trabecular bone volume fraction (0.26 +/- 0.04 in humans and 0.37 +/- 0.07 in apes, mean +/- SD, p < 0.01) and thinner vertebral shells than apes (after accounting for body mass, p < 0.01). Since human vertebrae are more porous and weaker than those in apes in young adulthood (after accounting for bone mass), even modest amounts of age-related bone loss may lead to vertebral fracture in humans, while in apes, larger amounts of bone loss would be required before a vertebral fracture becomes likely. We present arguments that differences in vertebral bone size and shape associated with reduced bone strength in humans is linked to evolutionary adaptations associated with bipedalism.	[Cotter, Meghan M.; Simpson, Scott W.] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA; [Cotter, Meghan M.; Loomis, David A.] Case Western Reserve Univ, Musculoskeletal Mech & Mat Lab, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA; [Cotter, Meghan M.; Simpson, Scott W.; Latimer, Bruce; Hernandez, Christopher J.] Case Western Reserve Univ, Ctr Human Origins, Cleveland, OH 44106 USA; [Latimer, Bruce] Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; [Hernandez, Christopher J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cornell University	Cotter, MM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA.	cjh275@cornell.edu	Simpson, Scott/GRS-0081-2022; Hernandez, Christopher J/B-5290-2009	Hernandez, Christopher J/0000-0002-0712-6533	Case Western Reserve University	Case Western Reserve University	The study was funded by Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, ANN RHEUM DIS, V60, P554, DOI 10.1136/ard.60.6.554; Banse X, 2001, BONE, V28, P563, DOI 10.1016/S8756-3282(01)00425-2; BOBBERT MF, 1992, J BIOMECH, V25, P223, DOI 10.1016/0021-9290(92)90022-S; Brown KAR, 2002, J HUM EVOL, V43, P189, DOI 10.1006/jhev.2002.0568; Buckley JM, 2007, BONE, V40, P767, DOI 10.1016/j.bone.2006.10.025; Carlson K, 2008, INT J PRIMATOL, V29, P1401, DOI 10.1007/s10764-008-9297-y; Cerroni AM, 2000, AM J PHYS ANTHROPOL, V113, P389, DOI 10.1002/1096-8644(200011)113:3<389::AID-AJPA9>3.0.CO;2-I; Cooper Cyrus, 1996, P419; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; Cotter MM, 2011, GROSS MORPHOLOGY MIC; Crawford RP, 2003, BONE, V33, P744, DOI 10.1016/S8756-3282(03)00210-2; Crawford RP, 2003, J BIOMECH ENG-T ASME, V125, P434, DOI 10.1115/1.1589772; Currey J.D., 2002, BONES STRUCTURE MECH; Duan YB, 2001, J BONE MINER RES, V16, P2276, DOI 10.1359/jbmr.2001.16.12.2276; EASTELL R, 1991, J BONE MINER RES, V6, P207; Eswaran SK, 2007, BONE, V41, P733, DOI 10.1016/j.bone.2007.05.017; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; Glantz S, 2001, PRIMER APPL REGRESSI; Gunji H, 2003, PRIMATES, V44, P145, DOI 10.1007/s10329-002-0030-8; Heaney RP, 2003, BONE, V33, P457, DOI 10.1016/S8756-3282(03)00236-9; Hernandez CJ, 2009, J HUM EVOL, V56, P462, DOI 10.1016/j.jhevol.2008.12.007; Hernandez CJ, 2003, OSTEOPOROSIS INT, V14, P843, DOI 10.1007/s00198-003-1454-8; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Homminga J, 2001, SPINE, V26, P1555, DOI 10.1097/00007632-200107150-00010; Homminga J, 2004, BONE, V34, P510, DOI 10.1016/j.bone.2003.12.001; Hussein AI, 2009, PREDICTIONS VERTEBRA; Ismail AA, 1999, OSTEOPOROSIS INT, V9, P206, DOI 10.1007/s001980050138; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; Jurmain R, 2000, J HUM EVOL, V39, P185, DOI 10.1006/jhev.2000.0413; Karasik D, 2008, HUM GENET, V124, P349, DOI 10.1007/s00439-008-0559-8; Ketcham RA, 2004, J MICROSC-OXFORD, V213, P158, DOI 10.1111/j.1365-2818.2004.01277.x; KEYAK JH, 1994, J BIOMED MATER RES, V28, P1329, DOI 10.1002/jbm.820281111; Kneissel M, 1997, CALCIFIED TISSUE INT, V61, P95; KNEISSEL M, 1994, BONE, V15, P539, DOI 10.1016/8756-3282(94)90278-X; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; Latimer B, 2005, ANN BIOMED ENG, V33, P3, DOI 10.1007/s10439-005-8957-8; Lentle BC, 2007, CAN ASSOC RADIOL J, V58, P27; Lieberman DE, 2001, AM J PHYS ANTHROPOL, V116, P266, DOI 10.1002/ajpa.1123; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Lovell NC, 1990, PATTERNS INJURY ILLN; Maga M, 2006, AM J PHYS ANTHROPOL, V129, P410, DOI 10.1002/ajpa.20276; Mays S, 1998, INT J OSTEOARCHAEOL, V8, P97, DOI 10.1002/(SICI)1099-1212(199803/04)8:2<97::AID-OA412>3.0.CO;2-U; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; Oxnard C.E., 1981, Symposia of the Zoological Society of London, P127; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; Rizzoli R, 2001, J MOL ENDOCRINOL, V26, P79, DOI 10.1677/jme.0.0260079; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; RUFF C, 1988, J HUM EVOL, V17, P687, DOI 10.1016/0047-2484(88)90025-5; Ruff C. B., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P202; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; SHAPIRO LJ, 1994, AM J PHYS ANTHROPOL, V93, P491, DOI 10.1002/ajpa.1330930408; Sokol R.R., 1995, BIOMETRY; SUMNER DR, 1989, AM J PHYS ANTHROPOL, V79, P225, DOI 10.1002/ajpa.1330790210; Trevathan W., 2008, EVOLUTIONARY MED HLT; ZIHLMAN AL, 1990, J ZOOL, V221, P37, DOI 10.1111/j.1469-7998.1990.tb03773.x	58	19	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26658	10.1371/journal.pone.0026658	http://dx.doi.org/10.1371/journal.pone.0026658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028933	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500104
J	Moody, MA; Zhang, RJ; Walter, EB; Woods, CW; Ginsburg, GS; McClain, MT; Denny, TN; Chen, X; Munshaw, S; Marshall, DJ; Whitesides, JF; Drinker, MS; Amos, JD; Gurley, TC; Eudailey, JA; Foulger, A; DeRosa, KR; Parks, R; Meyerhoff, RR; Yu, JS; Kozink, DM; Barefoot, BE; Ramsburg, EA; Khurana, S; Golding, H; Vandergrift, NA; Alam, SM; Tomaras, GD; Kepler, TB; Kelsoe, G; Liao, HX; Haynes, BF				Moody, M. Anthony; Zhang, Ruijun; Walter, Emmanuel B.; Woods, Christopher W.; Ginsburg, Geoffrey S.; McClain, Micah T.; Denny, Thomas N.; Chen, Xi; Munshaw, Supriya; Marshall, Dawn J.; Whitesides, John F.; Drinker, Mark S.; Amos, Joshua D.; Gurley, Thaddeus C.; Eudailey, Joshua A.; Foulger, Andrew; DeRosa, Katherine R.; Parks, Robert; Meyerhoff, R. Ryan; Yu, Jae-Sung; Kozink, Daniel M.; Barefoot, Brice E.; Ramsburg, Elizabeth A.; Khurana, Surender; Golding, Hana; Vandergrift, Nathan A.; Alam, S. Munir; Tomaras, Georgia D.; Kepler, Thomas B.; Kelsoe, Garnett; Liao, Hua-Xin; Haynes, Barton F.			H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODIES; SEASONAL INFLUENZA; IMMUNE-RESPONSE; UNITED-STATES; A VIRUS; AFFINITY; BINDING	Background: During the recent H1N1 influenza pandemic, excess morbidity and mortality was seen in young but not older adults suggesting that prior infection with influenza strains may have protected older subjects. In contrast, a history of recent seasonal trivalent vaccine in younger adults was not associated with protection. Methods and Findings: To study hemagglutinin (HA) antibody responses in influenza immunization and infection, we have studied the day 7 plasma cell repertoires of subjects immunized with seasonal trivalent inactivated influenza vaccine (TIV) and compared them to the plasma cell repertoires of subjects experimentally infected (EI) with influenza H3N2 A/Wisconsin/67/2005. The majority of circulating plasma cells after TIV produced influenza-specific antibodies, while most plasma cells after EI produced antibodies that did not react with influenza HA. While anti-HA antibodies from TIV subjects were primarily reactive with single or few HA strains, anti-HA antibodies from EI subjects were isolated that reacted with multiple HA strains. Plasma cell-derived anti-HA antibodies from TIV subjects showed more evidence of clonal expansion compared with antibodies from EI subjects. From an H3N2-infected subject, we isolated a 4-member clonal lineage of broadly cross-reactive antibodies that bound to multiple HA subtypes and neutralized both H1N1 and H3N2 viruses. This broad reactivity was not detected in post-infection plasma suggesting this broadly reactive clonal lineage was not immunodominant in this subject. Conclusion: The presence of broadly reactive subdominant antibody responses in some EI subjects suggests that improved vaccine designs that make broadly reactive antibody responses immunodominant could protect against novel influenza strains.	[Moody, M. Anthony; Zhang, Ruijun; Denny, Thomas N.; Chen, Xi; Marshall, Dawn J.; Whitesides, John F.; Drinker, Mark S.; Amos, Joshua D.; Gurley, Thaddeus C.; Eudailey, Joshua A.; Foulger, Andrew; DeRosa, Katherine R.; Parks, Robert; Meyerhoff, R. Ryan; Yu, Jae-Sung; Kozink, Daniel M.; Barefoot, Brice E.; Ramsburg, Elizabeth A.; Vandergrift, Nathan A.; Alam, S. Munir; Tomaras, Georgia D.; Kepler, Thomas B.; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27706 USA; [Moody, M. Anthony; Walter, Emmanuel B.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Woods, Christopher W.; Ginsburg, Geoffrey S.; McClain, Micah T.; Denny, Thomas N.; Whitesides, John F.; Yu, Jae-Sung; Vandergrift, Nathan A.; Alam, S. Munir; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Woods, Christopher W.; Ginsburg, Geoffrey S.; Ramsburg, Elizabeth A.; Alam, S. Munir] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Tomaras, Georgia D.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Tomaras, Georgia D.; Kelsoe, Garnett; Haynes, Barton F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Munshaw, Supriya; Kepler, Thomas B.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Ramsburg, Elizabeth A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Woods, Christopher W.; Ginsburg, Geoffrey S.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA; [Woods, Christopher W.; McClain, Micah T.] Durham Vet Affairs Med Ctr, Div Infect Dis, Durham, NC USA; [Khurana, Surender; Golding, Hana] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Food & Drug Administration (FDA)	Moody, MA (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27706 USA.	moody007@mc.duke.edu	Tomaras, Georgia/J-5041-2016; Moody, M/AAB-6947-2020; Zhang, RUIJUN/AAD-6887-2021; Alam, S. Munir/AAC-6711-2019	Moody, M/0000-0002-3890-5855; Zhang, RUIJUN/0000-0001-6785-9619; Denny, Thomas/0000-0002-7364-8276; Vandergrift, Nathan/0000-0001-9994-5466; Kepler, Thomas/0000-0002-1383-6865; Meyerhoff, Ryan/0000-0003-1253-2250	Bill and Melinda Gates Foundation; Center For HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854]; United States Defense Advanced Research Projects Agency [N66001-07-C-2024]; Duke Translational Medicine Institute [NCRR/NIH 5UL1-RR024128-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081579, U19AI067854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000611] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Center For HIV/AIDS Vaccine Immunology (CHAVI); United States Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Duke Translational Medicine Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Support for this work was provided by a Collaboration for AIDS Vaccine Discovery grant to BH from the Bill and Melinda Gates Foundation and by the Center For HIV/AIDS Vaccine Immunology (CHAVI; grant U19 AI067854). Support was also provided by a contract to GG from the United States Defense Advanced Research Projects Agency (contract N66001-07-C-2024) and to EW from the Duke Translational Medicine Institute (Robert Califf PI, NCRR/NIH 5UL1-RR024128-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; CLARKE S, 1990, J IMMUNOL, V145, P2286; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; DESTFAZEKAS G, 1966, J EXP MED, V124, P331, DOI DOI 10.1084/JEM.124.3.331; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fazekas St de G, 1966, J EXP MED, V124, P347; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Forgie SE, 2011, CLIN INFECT DIS, V52, P10, DOI 10.1093/cid/ciq030; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kepler TB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-444; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; RENFREY S, 1994, VACCINE, V12, P747, DOI 10.1016/0264-410X(94)90227-5; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WEBSTER RG, 1966, J IMMUNOL, V97, P177; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHITTLE J, 2011, P NATL ACAD IN PRESS; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; 2009, MMWR MORB MORTAL WKL, V58, P1100; 2009, MMWR MORB MORTAL WKL, V58, P1009	60	132	140	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25797	10.1371/journal.pone.0025797	http://dx.doi.org/10.1371/journal.pone.0025797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039424	gold, Green Submitted, Green Published			2022-12-25	WOS:000296507500022
J	Carlsson, MC; Cederfur, C; Schaar, V; Balog, CIA; Lepur, A; Touret, F; Salomonsson, E; Deelder, AM; Ferno, M; Olsson, H; Wuhrer, M; Leffler, H				Carlsson, Michael C.; Cederfur, Cecilia; Schaar, Viveka; Balog, Crina I. A.; Lepur, Adriana; Touret, Franck; Salomonsson, Emma; Deelder, Andre M.; Ferno, Marten; Olsson, Hakan; Wuhrer, Manfred; Leffler, Hakon			Galectin-1-Binding Glycoforms of Haptoglobin with Altered Intracellular Trafficking, and Increase in Metastatic Breast Cancer Patients	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN SERUM GLYCOPROTEINS; MANNAN-BINDING LECTIN; CHRONIC INFLAMMATION; N-ACETYLLACTOSAMINE; TUMOR PROGRESSION; COLON-CANCER; HUMAN PLASMA; GALECTINS; GLYCOSYLATION	Sera from 25 metastatic breast cancer patients and 25 healthy controls were subjected to affinity chromatography using immobilized galectin-1. Serum from the healthy subjects contained on average 1.2 mg per ml (range 0.7-2.2) galectin-1 binding glycoproteins, whereas serum from the breast cancer patients contained on average 2.2 mg/ml (range 0.8-3.9), with a higher average for large primary tumours. The major bound glycoproteins were alpha-2-macroglobulin, IgM and haptoglobin. Both the IgM and haptoglobin concentrations were similar in cancer compared to control sera, but the percentage bound to galectin-1 was lower for IgM and higher for haptoglobin: about 50% (range 20-80) in cancer sera and about 30% (range 25-50) in healthy sera. Galectin-1 binding and non-binding fractions were separated by affinity chromatography from pooled haptoglobin from healthy sera. The N-glycans of each fraction were analyzed by mass spectrometry, and the structural differences and galectin-1 mutants were used to identify possible galectin-1 binding sites. Galectin-1 binding and non-binding fractions were also analyzed regarding their haptoglobin function. Both were similar in forming complex with haemoglobin and mediate its uptake into alternatively activated macrophages. However, after uptake there was a dramatic difference in intracellular targeting, with the galectin-1 non-binding fraction going to a LAMP-2 positive compartment (lysosomes), while the galectin-1 binding fraction went to larger galectin-1 positive granules. In conclusion, galectin-1 detects a new type of functional biomarker for cancer: a specific type of glycoform of haptoglobin, and possibly other serum glycoproteins, with a different function after uptake into tissue cells.	[Carlsson, Michael C.; Cederfur, Cecilia; Schaar, Viveka; Lepur, Adriana; Touret, Franck; Salomonsson, Emma; Leffler, Hakon] Lund Univ, Dept Lab Med, Sect MIG Microbiol Immunol Glycobiol, Lund, Sweden; [Balog, Crina I. A.; Deelder, Andre M.; Wuhrer, Manfred] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands; [Ferno, Marten; Olsson, Hakan] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden	Lund University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Lund University; Skane University Hospital	Carlsson, MC (corresponding author), Lund Univ, Dept Lab Med, Sect MIG Microbiol Immunol Glycobiol, Lund, Sweden.	michael.carlsson@med.lu.se; hakon.leffler@med.lu.se	Wuhrer, Manfred/ABE-9168-2020; Leffler, Hakon/A-2416-2019; Touret, Franck/ABD-3236-2020	Wuhrer, Manfred/0000-0002-0814-4995; Touret, Franck/0000-0002-4734-2249; Olsson, Hakan/0000-0002-8794-9635; Leffler, Hakon/0000-0003-4482-8945	Swedish Research Council (Vetenskapsradet); Swedish Cancer Society, Lund University Hospital Foundation; Region Skane	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society, Lund University Hospital Foundation(Swedish Cancer Society); Region Skane	This work was supported by grants from the Swedish Research Council (Vetenskapsradet) to HL and from the Swedish Cancer Society, Lund University Hospital Foundation and Region Skane to MF and HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Hamid UM, 2008, GLYCOBIOLOGY, V18, P1105, DOI 10.1093/glycob/cwn095; Allen HJ, 1998, GLYCOCONJUGATE J, V15, P691, DOI 10.1023/A:1006988515346; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Arnold JN, 2011, J PROTEOME RES, V10, P1755, DOI 10.1021/pr101034t; Arnold JN, 2006, J BIOL CHEM, V281, P6955, DOI 10.1074/jbc.M511432200; Arnold JN, 2005, J BIOL CHEM, V280, P29080, DOI 10.1074/jbc.M504528200; Bresalier RS, 2004, GASTROENTEROLOGY, V127, P741, DOI 10.1053/j.gastro.2004.06.016; Carlsson A, 2008, EUR J CANCER, V44, P472, DOI 10.1016/j.ejca.2007.11.025; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Dabelsteen E, 1996, J PATHOL, V179, P358; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Fajka-Boja R, 2008, CELL MOL LIFE SCI, V65, P2586, DOI 10.1007/s00018-008-8143-x; Ferens-Sieczkowska M, 2001, Z NATURFORSCH C, V56, P122; Fortin S, 2010, BRAIN PATHOL, V20, P39, DOI 10.1111/j.1750-3639.2008.00227.x; Fujita T, 2011, JPN J CLIN ONCOL, V41, P394, DOI 10.1093/jjco/hyq190; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; Hakomori S, 2002, FEBS LETT, V531, P88, DOI 10.1016/S0014-5793(02)03479-8; Harazono A, 2008, J CHROMATOGR B, V869, P20, DOI 10.1016/j.jchromb.2008.05.006; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Holmstrom B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3537; HUANG CL, 2011, PFLUGERS ARCH EUROPE; Kannagi R, 2008, BBA-GEN SUBJECTS, V1780, P525, DOI 10.1016/j.bbagen.2007.10.007; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Madsen M, 2001, REDOX REP, V6, P386, DOI 10.1179/135100001101536490; MEEZAN E, 1969, BIOCHEMISTRY-US, V8, P2518, DOI 10.1021/bi00834a039; Miyoshi E, 2008, PROTEOMICS, V8, P3257, DOI 10.1002/pmic.200800046; Nielsen MJ, 2007, J BIOL CHEM, V282, P1072, DOI 10.1074/jbc.M605684200; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Ohyama C, 2004, GLYCOBIOLOGY, V14, P671, DOI 10.1093/glycob/cwh071; Park SY, 2010, INT J CANCER, V126, P142, DOI 10.1002/ijc.24685; Polticelli F, 2008, FEBS J, V275, P5648, DOI 10.1111/j.1742-4658.2008.06690.x; Pucic M, 2010, GLYCOBIOLOGY, V20, P970, DOI 10.1093/glycob/cwq052; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Saussez S, 2008, ORAL ONCOL, V44, P86, DOI 10.1016/j.oraloncology.2006.12.014; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; STEEN H, 2002, SCI STKE 2002; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018; TANIUCHI K, 2011, ONCOGENE; Thompson IM, 2007, CAN MED ASSOC J, V176, P1853, DOI 10.1503/cmaj.060955; Tsai CM, 2011, J IMMUNOL, V187, P1643, DOI 10.4049/jimmunol.1100297; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; YAMASHITA K, 1989, J BIOL CHEM, V264, P2415; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	65	47	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26560	10.1371/journal.pone.0026560	http://dx.doi.org/10.1371/journal.pone.0026560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028908	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900074
J	Xiong, W; Liu, T; Wang, YS; Chen, XW; Sun, L; Guo, N; Zheng, H; Zheng, LH; Ruat, M; Han, WP; Zhang, CX; Zhou, Z				Xiong, Wei; Liu, Tao; Wang, Yeshi; Chen, Xiaowei; Sun, Lei; Guo, Ning; Zheng, Hui; Zheng, Lianghong; Ruat, Martial; Han, Weiping; Zhang, Claire Xi; Zhou, Zhuan			An Inhibitory Effect of Extracellular Ca2+ on Ca2+-Dependent Exocytosis	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; ROOT GANGLION NEURONS; CALCIUM-SENSING RECEPTOR; SYNAPTIC VESICLE EXOCYTOSIS; TRANSMITTER RELEASE; CA2+-SENSING RECEPTOR; CATION CHANNEL; NEUROTRANSMITTER RELEASE; PRESYNAPTIC CALCIUM; HIPPOCAMPAL-NEURONS	Aim: Neurotransmitter release is elicited by an elevation of intracellular Ca2+ concentration ([Ca2+](i)). The action potential triggers Ca2+ influx through Ca2+ channels which causes local changes of [Ca2+](i) for vesicle release. However, any direct role of extracellular Ca2+ (besides Ca2+ influx) on Ca2+-dependent exocytosis remains elusive. Here we set out to investigate this possibility on rat dorsal root ganglion (DRG) neurons and chromaffin cells, widely used models for studying vesicle exocytosis. Results: Using photolysis of caged Ca 2+ and caffeine-induced release of stored Ca2+, we found that extracellular Ca2+ inhibited exocytosis following moderate [Ca2+](i) rises (2-3 mM). The IC50 for extracellular Ca2+ inhibition of exocytosis (ECIE) was 1.38 mM and a physiological reduction (similar to 30%) of extracellular Ca2+ concentration ([Ca2+](o)) significantly increased the evoked exocytosis. At the single vesicle level, quantal size and release frequency were also altered by physiological [Ca2+](o). The calcimimetics Mg2+, Cd2+, G418, and neomycin all inhibited exocytosis. The extracellular Ca2+-sensing receptor (CaSR) was not involved because specific drugs and knockdown of CaSR in DRG neurons did not affect ECIE. Conclusion/Significance: As an extension of the classic Ca2+ hypothesis of synaptic release, physiological levels of extracellular Ca2+ play dual roles in evoked exocytosis by providing a source of Ca2+ influx, and by directly regulating quantal size and release probability in neuronal cells.	[Xiong, Wei; Liu, Tao; Wang, Yeshi; Chen, Xiaowei; Sun, Lei; Guo, Ning; Zheng, Hui; Zheng, Lianghong; Zhang, Claire Xi; Zhou, Zhuan] Peking Univ, State Key Lab Biomembrane Engn, Beijing 100871, Peoples R China; [Xiong, Wei; Liu, Tao; Wang, Yeshi; Chen, Xiaowei; Sun, Lei; Guo, Ning; Zheng, Hui; Zheng, Lianghong; Zhang, Claire Xi; Zhou, Zhuan] Peking Univ, Ctr Life Sci, Inst Mol Med, Beijing 100871, Peoples R China; [Ruat, Martial] CNRS, UPR9040, Inst Neurobiol Alfred Fessard IFR 2118, Gif Sur Yvette, France; [Zhang, Claire Xi] Agcy Sci Technol & Res, Lab Metab Med, Singapore Bioimaging Consortium, Singapore, Singapore	Peking University; Peking University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Xiong, W (corresponding author), Peking Univ, State Key Lab Biomembrane Engn, Beijing 100871, Peoples R China.	clairexz@pku.edu.cn; zzhou@pku.edu.cn	zheng, Hui/I-3573-2013; Ruat, Martial/E-5544-2016; Xiong, Wei/AAY-5944-2020; Xiong, Wei/A-6170-2012	zheng, Hui/0000-0002-2504-9092; Xiong, Wei/0000-0002-2784-7696; 	National Basic Research Program of China [G2000077800, 2012CB518006, 2006CB500800]; National Natural Science Foundation of China [30728009, 30770521, 30770788, 30970660, 30911120491, 30830043]; French Agence Nationale de la Recherche (ANR-PhysioPatho)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); French Agence Nationale de la Recherche (ANR-PhysioPatho)(French National Research Agency (ANR))	This work was supported by grants from the National Basic Research Program of China (G2000077800, 2012CB518006 and 2006CB500800) and the National Natural Science Foundation of China (30728009, 30770521, 30770788, 30970660, 30911120491 and 30830043). Dr. Ruat is supported by a grant from the French Agence Nationale de la Recherche (ANR-PhysioPatho). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Atlas D, 2010, CELL SIGNAL, V22, P1597, DOI 10.1016/j.cellsig.2010.04.003; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Awumey EM, 2007, AM J PHYSIOL-CELL PH, V292, pC1895, DOI 10.1152/ajpcell.00404.2006; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BURGOYNE RD, 1994, FEBS LETT, V344, P139, DOI 10.1016/0014-5793(94)00361-0; CAMPBELL DT, 1976, J GEN PHYSIOL, V67, P309, DOI 10.1085/jgp.67.3.309; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Chen XK, 2005, NAT NEUROSCI, V8, P1160, DOI 10.1038/nn1529; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cohen JE, 2004, NEUROSCIENTIST, V10, P12, DOI 10.1177/1073858403259440; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Ferry S, 2000, EUR J NEUROSCI, V12, P872, DOI 10.1046/j.1460-9568.2000.00980.x; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gillis Kevin D., 1995, P155; HABLITZ JJ, 1986, BIOPHYS J, V50, P753, DOI 10.1016/S0006-3495(86)83515-9; Han WP, 2005, J BIOL CHEM, V280, P5089, DOI 10.1074/jbc.M408757200; Heyeraas KJ, 2008, CALCIFIED TISSUE INT, V82, P57, DOI 10.1007/s00223-007-9096-z; Hille B, 2001, ION CHANNELS EXCITAB, P646; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Huang HP, 2007, P NATL ACAD SCI USA, V104, P1401, DOI 10.1073/pnas.0608897104; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; KATZ B, 1969, RELEASE NEURAL TRANS, P1; Kishimoto T, 2006, EMBO J, V25, P673, DOI 10.1038/sj.emboj.7600983; Lerner I, 2006, J NEUROCHEM, V97, P116, DOI 10.1111/j.1471-4159.2006.03709.x; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Moser T, 1997, J NEUROSCI, V17, P2314; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nemeth EF, 1999, TRENDS ENDOCRIN MET, V10, P66, DOI 10.1016/S1043-2760(98)00119-2; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Ouyang KF, 2005, P NATL ACAD SCI USA, V102, P12259, DOI 10.1073/pnas.0408494102; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Phillips CG, 2008, J NEUROSCI, V28, P12062, DOI 10.1523/JNEUROSCI.4134-08.2008; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; Stanley EF, 2000, J NEUROPHYSIOL, V83, P477, DOI 10.1152/jn.2000.83.1.477; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wu B, 2005, FRONT BIOSCI-LANDMRK, V10, P761, DOI 10.2741/1570; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang DY, 2004, J AM COLL NUTR, V23, p552S, DOI 10.1080/07315724.2004.10719402; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zheng H, 2009, BIOPHYS J, V96, P2449, DOI 10.1016/j.bpj.2008.11.037; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; Zhou Z, 1996, J BIOL CHEM, V271, P270, DOI 10.1074/jbc.271.1.270	65	6	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e24573	10.1371/journal.pone.0024573	http://dx.doi.org/10.1371/journal.pone.0024573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028769	gold, Green Published, Green Submitted			2022-12-25	WOS:000296186900002
J	Fujita, T; Fujii, H				Fujita, Toshitsugu; Fujii, Hodaka			Direct Identification of Insulator Components by Insertional Chromatin Immunoprecipitation	PLOS ONE			English	Article							ENHANCER-BLOCKING ACTIVITY; CTCF; EXPRESSION; PROTEIN; GENES; INTERFERENCE; PURIFICATION; MECHANISMS; BOUNDARIES; BINDING	Comprehensive understanding of mechanisms of epigenetic regulation requires identification of molecules bound to genomic regions of interest in vivo. However, non-biased methods to identify molecules bound to specific genomic loci in vivo are limited. Here, we applied insertional chromatin immunoprecipitation (iChIP) to direct identification of components of insulator complexes, which function as boundaries of chromatin domain. We found that the chicken beta-globin HS4 (cHS4) insulator complex contains an RNA helicase protein, p68/DDX5; an RNA species, steroid receptor RNA activator 1; and a nuclear matrix protein, Matrin-3, in vivo. Binding of p68 and Matrin-3 to the cHS4 insulator core sequence was mediated by CCCTC-binding factor (CTCF). Thus, our results showed that it is feasible to directly identify proteins and RNA bound to a specific genomic region in vivo by using iChIP.	[Fujita, Toshitsugu; Fujii, Hodaka] Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Osaka, Japan	Osaka University	Fujita, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, Osaka, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/N-9792-2019; Fujii, Hodaka/A-2420-2008; FUJITA, Toshitsugu/ABH-5101-2020; Fujita, Toshitsugu/AAB-4964-2022	Fujii, Hodaka/0000-0003-1296-4256; Fujii, Hodaka/0000-0003-1296-4256; FUJITA, Toshitsugu/0000-0002-9536-9999; 	Tokyo Biochemical Research Foundation [22710185]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23118516, 23114707]	Tokyo Biochemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Tokyo Biochemical Research Foundation (T. F.), http://www.tokyobrf.or.jp/english/; Grant-in-Aid for Young Scientists (B) (#22710185) (T. F.), Grant-in-Aid for Scientific Research on Innovative Areas (#23118516) (T. F.), (#23114707) (H. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, http://www.mext.go.jp/english/a06.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BOFFA LC, 1995, P NATL ACAD SCI USA, V92, P1901, DOI 10.1073/pnas.92.6.1901; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Fujita T, 2007, NUCLEIC ACIDS RES, V35, P1007, DOI 10.1093/nar/gkl1138; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Ghirlando R, 2008, J MOL BIOL, V376, P1417, DOI 10.1016/j.jmb.2007.12.051; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; Hanawa H, 2009, MOL THER, V17, P667, DOI 10.1038/mt.2009.1; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hoshino A, 2004, MOL CELL, V15, P153, DOI 10.1016/j.molcel.2004.06.017; Hoshino A, 2007, FEBS LETT, V581, P975, DOI 10.1016/j.febslet.2007.01.083; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Jasinskas A, 1999, CHROMOSOME RES, V7, P341, DOI 10.1023/A:1009211929408; Kurokawa R, 2009, RNA BIOL, V6, P233, DOI 10.4161/rna.6.3.8329; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; van Driel R, 2003, J CELL SCI, V116, P4067, DOI 10.1242/jcs.00779; WORKMAN JL, 1985, BIOCHEMISTRY-US, V24, P7486, DOI 10.1021/bi00346a068; Yahata K, 2007, J MOL BIOL, V374, P580, DOI 10.1016/j.jmb.2007.09.054; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; ZHANG XY, 1982, NUCLEIC ACIDS RES, V10, P1481, DOI 10.1093/nar/10.5.1481	31	35	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26109	10.1371/journal.pone.0026109	http://dx.doi.org/10.1371/journal.pone.0026109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043306	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400034
J	Buhimschi, CS; Bhandari, V; Dulay, AT; Nayeri, UA; Abdel-Razeq, SS; Pettker, CM; Thung, S; Zhao, GM; Han, YPW; Bizzarro, M; Buhimschi, IA				Buhimschi, Catalin S.; Bhandari, Vineet; Dulay, Antonette T.; Nayeri, Unzila A.; Abdel-Razeq, Sonya S.; Pettker, Christian M.; Thung, Stephen; Zhao, Guomao; Han, Yiping W.; Bizzarro, Matthew; Buhimschi, Irina A.			Proteomics Mapping of Cord Blood Identifies Haptoglobin "Switch- On" Pattern as Biomarker of Early-Onset Neonatal Sepsis in Preterm Newborns	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; INTRAAMNIOTIC INFLAMMATION; AMNIOTIC-FLUID; INTRAVENTRICULAR HEMORRHAGE; NECROTIZING ENTEROCOLITIS; WEEKS GESTATION; DIAGNOSIS; BIRTH; EXPRESSION; BINDING	Background: Intra-amniotic infection and/or inflammation (IAI) are important causes of preterm birth and early-onset neonatal sepsis (EONS). A prompt and accurate diagnosis of EONS is critical for improved neonatal outcomes. We sought to explore the cord blood proteome and identify biomarkers and functional protein networks characterizing EONS in preterm newborns. Methodology/Principal Findings: We studied a prospective cohort of 180 premature newborns delivered May 2004-September 2009. A proteomics discovery phase employing two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry identified 19 differentially-expressed proteins in cord blood of newborns with culture-confirmed EONS (n = 3) versus GA-matched controls (n = 3). Ontological classifications of the proteins included transfer/carrier, immunity/defense, protease/extracellular matrix. The 1(st)-level external validation conducted in the remaining 174 samples confirmed elevated haptoglobin and haptoglobin-related protein immunoreactivity (Hp&HpRP) in newborns with EONS (presumed and culture-confirmed) independent of GA at birth and birthweight (P<0.001). Western blot concurred in determining that EONS babies had conspicuous Hp&HpRP bands in cord blood ("switch-on pattern'') as opposed to non-EONS newborns who had near-absent "switch-off pattern'' (P<0.001). Fetal Hp phenotype independently impacted Hp&HpRP. A Bayesian latent-class analysis (LCA) was further used for unbiased classification of all 180 cases based on probability of "antenatal IAI exposure'' as latent variable. This was then subjected to 2(nd)-level validation against indicators of adverse short-term neonatal outcome. The optimal LCA algorithm combined Hp&HpRP switch pattern (most input), interleukin-6 and neonatal hematological indices yielding two non-overlapping newborn clusters with low (<= 20%) versus high (>= 70%) probability of IAI exposure. This approach reclassified -30% of clinical EONS diagnoses lowering the number needed to harm and increasing the odds ratios for several adverse outcomes including intra-ventricular hemorrhage. Conclusions/Significance: Antenatal exposure to IAI results in precocious switch-on of Hp&HpRP expression. As EONS biomarker, cord blood Hp&HpRP has potential to improve the selection of newborns for prompt and targeted treatment at birth.	[Buhimschi, Catalin S.; Bhandari, Vineet; Dulay, Antonette T.; Nayeri, Unzila A.; Abdel-Razeq, Sonya S.; Pettker, Christian M.; Thung, Stephen; Zhao, Guomao; Buhimschi, Irina A.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Bhandari, Vineet; Bizzarro, Matthew] Yale Univ, Sch Med, Dept Pediat, Div Perinatal Med, New Haven, CT 06510 USA; [Han, Yiping W.] Case Western Reserve Univ, Sch Dent Med, Dept Periodont, Cleveland, OH 44106 USA	Yale University; Yale University; Case Western Reserve University	Buhimschi, CS (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	catalin.buhimschi@yale.edu	Buhimschi, Irina/AAY-6619-2021; Bhandari, Vineet/AAS-3365-2020	Buhimschi, Irina/0000-0002-1701-1326	National Institutes of Health [RO1 HD 047321, R01HD062007-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062007] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grant RO1 HD 047321 (IAB) and R01HD062007-01A1 (CSB & IAB). The funders had no role in the design and conduct of the study, collection, management, analysis and interpretation of the data or the preparation, review or approval of the manuscript.	ACOG Committee on Practice Bulletins-Obstetrics, 2007, Obstet Gynecol, V109, P1007; Arnon S, 2008, CURR OPIN INFECT DIS, V21, P223, DOI 10.1097/QCO.0b013e3282fa15dd; Arredouani MS, 2005, IMMUNOLOGY, V114, P263, DOI 10.1111/j.1365-2567.2004.02071.x; BASELER MW, 1983, INFLAMMATION, V7, P387, DOI 10.1007/BF00916303; Benitz WE, 2010, CLIN PERINATOL, V37, P421, DOI 10.1016/j.clp.2009.12.001; BENSI G, 1985, EMBO J, V4, P119, DOI 10.1002/j.1460-2075.1985.tb02325.x; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; Bizzarro MJ, 2008, INFECT CONT HOSP EP, V29, P914, DOI 10.1086/591323; Buhimschi CS, 2009, BJOG-INT J OBSTET GY, V116, P257, DOI 10.1111/j.1471-0528.2008.01925.x; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi CS, 2009, CURR OPIN INFECT DIS, V22, P235, DOI 10.1097/QCO.0b013e32832a5963; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Buhimschi IA, 2005, CLIN DIAGN LAB IMMUN, V12, P837, DOI 10.1128/CDLI.12.7.837-844.2005; Buhimschi IA, 2010, CLIN PERINATOL, V37, P355, DOI 10.1016/j.clp.2010.03.002; Buttery JP, 2002, ARCH DIS CHILD-FETAL, V87, pF25, DOI 10.1136/fn.87.1.F25; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; DAY JR, 1992, INT J CLIN LAB RES, V21, P256, DOI 10.1007/BF02591656; DUDICH E, TUMOUR BIOL, V19, P30; Edwards R K, 2001, Infect Dis Obstet Gynecol, V9, P209, DOI 10.1155/S1064744901000345; FLEISCHER JG, 2011, INNATE IMMUN; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Garry D, 1996, AM J OBSTET GYNECOL, V175, P1336, DOI 10.1016/S0002-9378(96)70051-0; Gerdes JS, 2004, PEDIATR CLIN N AM, V51, P939, DOI 10.1016/j.pcl.2004.03.009; GITLIN D, 1967, J CLIN INVEST, V46, P1010, DOI 10.1172/JCI105590; Goldenberg RL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.033; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; Guetta J, 2007, ATHEROSCLEROSIS, V191, P48, DOI 10.1016/j.atherosclerosis.2006.04.032; HADLOCK FP, 1983, J CLIN ULTRASOUND, V11, P313, DOI 10.1002/jcu.1870110605; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Hatada S, 2003, GENE, V319, P55, DOI 10.1016/S0378-1119(03)00791-1; He QY, 2003, PROTEOMICS, V3, P666, DOI 10.1002/pmic.200300394; Hunt NH, 2001, REDOX REP, V6, P389, DOI 10.1179/135100001101536508; Irony-Tur-Sinai M, 2009, J NEUROL SCI, V279, P80, DOI 10.1016/j.jns.2008.12.014; Kalayci AG, 2000, TURK J MED SCI, V30, P151; KALENIC S, 1993, J HOSP INFECT, V23, P35, DOI 10.1016/0195-6701(93)90128-M; KANAKOUDI F, 1995, CLIN CHEM, V41, P605; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klinger G, 2010, PEDIATRICS, V125, pE736, DOI 10.1542/peds.2009-2017; Kolialexi A, 2008, MASS SPECTROM REV, V27, P624, DOI 10.1002/mas.20181; Langlois MR, 1996, CLIN CHEM, V42, P1589; MAEDA N, 1986, ANNU REV GENET, V20, P81; McCrea HL, 2008, CLIN PERINATOL, V35, P777, DOI 10.1016/j.clp.2008.07.014; MILLER ME, 1977, PEDIATR CLIN N AM, V24, P413; Miyano A, 1998, PEDIATR DEVEL PATHOL, V1, P513, DOI 10.1007/s100249900070; MTITIMILA EI, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004495.PUB2; Naef RW, 1998, AM J OBSTET GYNECOL, V178, P126, DOI 10.1016/S0002-9378(98)70638-6; Naeye RL., 1992, DISORDERS PLACENTA F, P118; Ng PC, 2010, J CLIN INVEST, V120, P2989, DOI 10.1172/JCI40196; NORDOY A, 1984, ATHEROSCLEROSIS, V50, P307, DOI 10.1016/0021-9150(84)90078-9; NYMAN M, 1959, Scand J Clin Lab Invest, V11 Supp 39, P1; OH SK, 1990, J LEUKOCYTE BIOL, V47, P142, DOI 10.1002/jlb.47.2.142; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; PAIK YK, 1988, J BIOL CHEM, V263, P13340; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Polonovski M, 1938, CR SOC BIOL, V129, P457; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Ramstrom M, 2005, J PROTEOME RES, V4, P410, DOI 10.1021/pr049812a; RAUSEN AR, 1961, NATURE, V191, P717, DOI 10.1038/191717a0; Reyes CS, 2003, ACTA PAEDIATR, V92, P221, DOI 10.1111/j.1651-2227.2003.tb00530.x; ROBERTSON CM, 2007, JAMA-J AM MED ASSOC, V24, P2733; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; ROVAMO L, 1984, PEDIATR RES, V18, P1104, DOI 10.1203/00006450-198411000-00010; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; SALMI TT, 1973, ACTA PAEDIATR SCAND, P1; Scott AN, 2008, STAT MED, V27, P140, DOI 10.1002/sim.2899; Shifman MA, 2007, J PROTEOME RES, V6, P4019, DOI 10.1021/pr070325f; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SPEER C, 1983, ACTA PAEDIATR SCAND, V72, P679, DOI 10.1111/j.1651-2227.1983.tb09793.x; Spitzer Alan R, 2005, J Perinatol, V25, P265, DOI 10.1038/sj.jp.7211252; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Thomson R, 2009, FUTURE MICROBIOL, V4, P789, DOI [10.2217/fmb.09.57, 10.2217/FMB.09.57]; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; UAUY RD, 1991, J PEDIATR-US, V119, P630, DOI 10.1016/S0022-3476(05)82418-7; Vergani P, 2000, PLACENTA, V21, P402, DOI 10.1053/plac.1999.0499; Vermunt JK, 2002, APPL LATENT CLASS AN, P89, DOI DOI 10.1017/CBO9780511499531.004; White TC, 2008, J THROMB HAEMOST, V6, P995, DOI 10.1111/j.1538-7836.2008.02979.x; Yurdakok M, 1998, TURKISH J PEDIATR, V40, P17	82	47	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26111	10.1371/journal.pone.0026111	http://dx.doi.org/10.1371/journal.pone.0026111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028810	Green Published, Green Submitted, gold			2022-12-25	WOS:000295971700040
J	Cheng, H; Yang, ZJ; Estabrook, MM; John, CM; Jarvis, GA; McLaughlin, S; Griffiss, JM				Cheng, Hui; Yang, Zhijie; Estabrook, Michele M.; John, Constance M.; Jarvis, Gary A.; McLaughlin, Stephanie; Griffiss, J. McLeod			Human Lipooligosaccharide IGG That Prevents Endemic Meningococcal Disease Recognizes an Internal Lacto-N-neotetraose Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-CORE LIPOPOLYSACCHARIDE; SERUM BACTERICIDAL ACTIVITY; NEISSERIA-MENINGITIDIS; IMMUNE-RESPONSE; GENETIC-BASIS; PYOCIN RESISTANCE; GONORRHOEAE; IDENTIFICATION; OLIGOSACCHARIDES; EXPRESSION	Antibodies that initiate complement-mediated killing of Neisseria meningitidis as they enter the bloodstream from the oropharynx protect against disseminated disease. Human IgGs that bind the neisserial L7 lipooligosaccharide (LOS) are bactericidal for L3,7 and L2,4 meningococci in the presence of human complement. These strains share a lacto-N-neotetraose (nLc(4)) LOS alpha chain. We used a set of mutants that have successive saccharide deletions from the nLc(4) alpha chain to characterize further the binding and bactericidal activity of nLc(4) LOS IgG. We found that the nLc(4) alpha chain conforms at least four different antigens. We separately purified IgG that required the nLc(4) (non-reducing) terminal galactose (Gal) for binding and IgG that bound the truncated nLc(3) alpha chain that lacks this Gal residue. IgG that bound the internal nLc(3) alpha chain killed both L3,7 and L2,4 strains, whereas IgG that required the nLc(4) terminal Gal residue for binding killed L2,4 stains but not L3,7 strains. These results show that the diversity of LOS antibodies in human serum is as much a function of the conformation of multiple antigens by a single glycoform as of the production of multiple glycoforms. Differences in sensitivity to killing by human nLc(4) LOS IgG may account for the fact that fully two-thirds of endemic group B meningococcal disease in infants and children is caused by L3,7 strains, but only 20% is caused by L2,4 stains.	[Cheng, Hui; Yang, Zhijie; Estabrook, Michele M.; John, Constance M.; Jarvis, Gary A.; McLaughlin, Stephanie; Griffiss, J. McLeod] Dept Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Estabrook, Michele M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94121 USA; [Jarvis, Gary A.; Griffiss, J. McLeod] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Griffiss, JM (corresponding author), VAMC 111W1,4150 Clement St, San Francisco, CA 94121 USA.	crapaud@loursage.org	McLaughlin, Stephanie/AFT-3454-2022	McLaughlin, Stephanie/0000-0002-6658-8260; Jarvis, Gary/0000-0002-7576-3702	National Institutes of Health [AI 053728, AI 065605, AI 063927]; Veterans Affairs Merit Review Award; Veterans Affairs Medical Center (San Francisco, CA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065605, R01AI053728, R01AI063927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Veterans Affairs Medical Center (San Francisco, CA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 053728 and AI 065605, administered by the Northern California Institute for Research and Education (to J. M. G.) and AI 063927 (to G. A. J.). This work was also supported by a Veterans Affairs Merit Review Award (to G. A. J.) and with resources of the Veterans Affairs Medical Center (San Francisco, CA). This is publication 109 from the Center for Immunochemistry.	APICELLA MA, 1976, J INFECT DIS, V134, P377, DOI 10.1093/infdis/134.4.377; APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BERTRAM MA, 1976, J IMMUNOL, V116, P842; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; DANAHER RJ, 1995, J BACTERIOL, V177, P7275, DOI 10.1128/jb.177.24.7275-7279.1995; DENSEN P, 1987, NEW ENGL J MED, V316, P922, DOI 10.1056/NEJM198704093161506; DIFABIO JL, 1990, CAN J CHEM, V68, P1029, DOI 10.1139/v90-160; DUDAS KC, 1988, INFECT IMMUN, V56, P499, DOI 10.1128/IAI.56.2.499-504.1988; Estabrook MM, 2007, INFECT IMMUN, V75, P1025, DOI 10.1128/IAI.00882-06; Estabrook MM, 1997, INFECT IMMUN, V65, P4436, DOI 10.1128/IAI.65.11.4436-4444.1997; ESTABROOK MM, 1993, J INFECT DIS, V167, P966, DOI 10.1093/infdis/167.4.966; ESTABROOK MM, 1990, INFECT IMMUN, V58, P2204, DOI 10.1128/IAI.58.7.2204-2213.1990; ESTABROOK MM, 1992, 92 ANN M AM SOC MICR, P43; GAMIAN A, 1992, J BIOL CHEM, V267, P922; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181; GRIFFISS JM, 1984, J INFECT DIS, V150, P71, DOI 10.1093/infdis/150.1.71; GRIFFISS JM, 1977, J INFECT DIS, V136, P733, DOI 10.1093/infdis/136.6.733; GRIFFISS JM, 1991, J IMMUNOL, V147, P298; Griffiss JM, 2000, J BIOL CHEM, V275, P9716, DOI 10.1074/jbc.275.13.9716; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; JOHN CM, 1991, J BIOL CHEM, V266, P19303; John CM, 2009, J BIOL CHEM, V284, P21515, DOI 10.1074/jbc.M109.004887; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; KASPER DL, 1973, J INFECT DIS, V127, P378, DOI 10.1093/infdis/127.4.378; KIM JJ, 1994, INFECT IMMUN, V62, P1566, DOI 10.1128/IAI.62.5.1566-1575.1994; KIM JJ, 1989, INFECT IMMUN, V57, P602, DOI 10.1128/IAI.57.2.602-608.1989; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; MANDRELL RE, 1991, J BACTERIOL, V173, P2823, DOI 10.1128/JB.173.9.2823-2832.1991; NICHOLSON A, 1979, SCIENCE, V205, P298, DOI 10.1126/science.451601; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; Rahman MM, 1998, CARBOHYD RES, V307, P311; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; SANDLIN RC, 1994, J BACTERIOL, V176, P6869, DOI 10.1128/JB.176.22.6869-6876.1994; SCHNEIDER H, 1982, J GEN MICROBIOL, V128, P13; SCHNEIDER H, 1988, INFECT IMMUN, V56, P942, DOI 10.1128/IAI.56.4.942-946.1988; SCHNEIDER H, 1984, INFECT IMMUN, V45, P544, DOI 10.1128/IAI.45.3.544-549.1984; SCHNEIDER H, 1991, J EXP MED, V174, P1601, DOI 10.1084/jem.174.6.1601; Swanson KV, 2006, CARBOHYD RES, V341, P388, DOI 10.1016/j.carres.2005.11.017; Weber MVR, 2006, INT J MED MICROBIOL, V296, P475, DOI 10.1016/j.ijmm.2006.05.004; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004; YAMASAKI R, 1988, MOL IMMUNOL, V25, P799, DOI 10.1016/0161-5890(88)90116-2; YAMASAKI R, 1993, J BACTERIOL, V175, P4565, DOI 10.1128/JB.175.14.4565-4568.1993; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P10566, DOI 10.1021/bi00107a028; Yang QL, 1996, J EXP MED, V183, P323, DOI 10.1084/jem.183.1.323; ZOLLINGER WD, 1977, INFECT IMMUN, V18, P424, DOI 10.1128/IAI.18.2.424-433.1977	54	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43622	43633		10.1074/jbc.M111.291583	http://dx.doi.org/10.1074/jbc.M111.291583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027827	hybrid, Green Published			2022-12-25	WOS:000298402300005
J	Zhou, XR; Green, AG; Singh, SP				Zhou, Xue-Rong; Green, Allan G.; Singh, Surinder P.			Caenorhabditis elegans Delta 12-Desaturase FAT-2 Is a Bifunctional Desaturase Able to Desaturate a Diverse Range of Fatty Acid Substrates at the Delta 12 and Delta 15 Positions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; IDENTIFICATION; REGIOSELECTIVITY; SERIES; GENE	Caenorhabditis elegans FAT-2 has been characterized as fatty acid Delta 12-desaturase able to desaturate C16 and C18 fatty acids. However, in this report we show that when expressed in yeast cells this enzyme can also catalyze Delta 15 desaturation. This results in the production of both linoleic acid (omega 6 C18:2(Delta 9,12)) and linolenic acid (omega 3 C18:3(Delta 9,12,15)) from oleic acid (C18:1(Delta 9)) substrate, and hexadecadienoic acid (omega 4 C16:2(Delta 9,12)) and hexadecatrienoic acid (omega 1 C16:3(Delta 9,12,15)) from palmitoleic acid (C16:1(Delta 9)) substrate. In addition, this enzyme can also produce C14:2 (Delta 9,12), C15:2(Delta 9,12), C17:2(Delta 9,12), and C18:4(Delta 6,9,12,15) when C14:1(Delta 9), C15:1(Delta 9), C17:1(Delta 9), and C18:3(Delta 6,9,12) substrates are available in yeast cells. Mass spectrometry analysis of 2,4-dimethyloxazoline modification of fatty acid methyl esters confirms the positions of all newly formed double bonds. These results indicate that when expressed in yeast the C. elegans Delta 12-desaturase CeFAT-2 shows a characteristic of a bifunctional Delta 12/Delta 15-desaturase and has a great deal of elasticity with respect to fatty acid chain length in being able to accept fatty acids ranging from C14 to C18. Interestingly, despite possessing a bifunctional Delta 12/Delta 15 desaturation activity, phylogenetic analysis suggests that C. elegans Delta 12-desaturase CeFAT-2 might have arisen independently from other reported dual Delta 12/Delta 15-desaturases from fungi and protozoa.	[Zhou, Xue-Rong; Green, Allan G.; Singh, Surinder P.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhou, XR (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, GPO Box 1600, Canberra, ACT 2601, Australia.	xue-rong.zhou@csiro.au	Green, Allan G/C-6572-2008; Green, Allan/AAM-6856-2021; Zhou, Xue-Rong/D-4706-2009; singh, surinder/C-9528-2009	Zhou, Xue-Rong/0000-0003-3717-2984; singh, surinder/0000-0003-4488-8147				Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; FAY L, 1991, J CHROMATOGR, V541, P89, DOI 10.1016/S0021-9673(01)95986-2; FELLENBERG AJ, 1987, BIOMED ENVIRON MASS, V14, P127, DOI 10.1002/bms.1200140306; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; MORTIMER RK, 1986, GENETICS, V113, P35; Napier JA, 2001, LIPIDS, V36, P761, DOI 10.1007/s11745-001-0782-9; Pan ZQ, 2007, J BIOL CHEM, V282, P4326, DOI 10.1074/jbc.M606343200; Peyou-Ndi MM, 2000, ARCH BIOCHEM BIOPHYS, V376, P399, DOI 10.1006/abbi.2000.1733; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Zhou XR, 2006, PLANT SCI, V170, P665, DOI 10.1016/j.plantsci.2005.10.021	15	57	62	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43644	43650		10.1074/jbc.M111.266114	http://dx.doi.org/10.1074/jbc.M111.266114			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22041902	Green Published, hybrid			2022-12-25	WOS:000298402300007
J	Moriwaki, K; Shinzaki, S; Miyoshi, E				Moriwaki, Kenta; Shinzaki, Shinichiro; Miyoshi, Eiji			GDP-mannose-4,6-dehydratase (GMDS) Deficiency Renders Colon Cancer Cells Resistant to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor- and CD95-mediated Apoptosis by Inhibiting Complex II Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE FUCOSYLATION; MOLECULAR-CLONING; SELECTIVE MUTANTS; DEATH; FUCOSE; ACTIVATION; FAS; SURVEILLANCE; SPECIFICITY; EXPRESSION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis through binding to TRAIL receptors, death receptor 4 (DR4), and DR5. TRAIL has potential therapeutic value against cancer because of its selective cytotoxic effects on several transformed cell types. Fucosylation of proteins and lipids on the cell surface is a very important post-translational modification that is involved in many cellular events. Recently, we found that a deficiency in GDP-mannose-4,6-dehydratase (GMDS) rendered colon cancer cells resistant to TRAIL-induced apoptosis, resulting in tumor development and metastasis by escape from tumor immune surveillance. GMDS is an indispensable regulator of cellular fucosylation. In this study, we investigated the molecular mechanism of inhibition of TRAIL signaling by GMDS deficiency. DR4, but not DR5, was found to be fucosylated; however, GMDS deficiency inhibited both DR4- and DR5-mediated apoptosis despite the absence of fucosylation on DR5. In addition, GMDS deficiency also inhibited CD95-mediated apoptosis but not the intrinsic apoptosis pathway induced by anti-cancer drugs. Binding of TRAIL and CD95 ligand to their cognate receptors primarily leads to formation of a complex comprising the receptor, FADD, and caspase-8, referred to as the death-inducing signaling complex (DISC). GMDS deficiency did not affect formation of the primary DISC or recruitment to and activation of caspase-8 on the DISC. However, formation of secondary FADD-dependent complex II, comprising caspase-8 and cFLIP, was significantly inhibited by GMDS deficiency. These results indicate that GMDS regulates the formation of secondary complex II from the primary DISC independent of direct fucosylation of death receptors.	[Moriwaki, Kenta; Shinzaki, Shinichiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan	Osaka University	Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Eiji Miyoshi,1-7,Yamada Oka, Suita, Osaka 5650871, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp		Moriwaki, Kenta/0000-0002-8724-4715	New Energy and Industrial Technology Development Organization (NEDO) in Japan; Japan Society for the Promotion of Science [21249038]; Global Centers of Excellence (COE) of Osaka University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22790643] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Centers of Excellence (COE) of Osaka University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the New Energy and Industrial Technology Development Organization (NEDO) as a part of the developing technology project for implementing sugar chain functions in Japan, Grant-in-Aid for Scientific Research (A) 21249038 from the Japan Society for the Promotion of Science, and the Global Centers of Excellence (COE) program of Osaka University funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Austin CD, 2006, P NATL ACAD SCI USA, V103, P10283, DOI 10.1073/pnas.0604044103; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; DeVries T, 1997, GLYCOBIOLOGY, V7, P921, DOI 10.1093/glycob/7.7.921; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Haltiwanger RS, 2009, GASTROENTEROLOGY, V137, P36, DOI 10.1053/j.gastro.2009.05.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moriwaki K, 2010, WORLD J HEPATOL, V2, P151, DOI 10.4254/wjh.v2.i4.151; Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak Henning, 2008, V414, P221; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200	37	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43123	43133		10.1074/jbc.M111.262741	http://dx.doi.org/10.1074/jbc.M111.262741			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027835	Green Published, hybrid			2022-12-25	WOS:000298351300033
J	Barlow, PG; Svoboda, P; Mackellar, A; Nash, AA; York, IA; Pohl, J; Davidson, DJ; Donis, RO				Barlow, Peter G.; Svoboda, Pavel; Mackellar, Annie; Nash, Anthony A.; York, Ian A.; Pohl, Jan; Davidson, Donald J.; Donis, Ruben O.			Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; HERPES-SIMPLEX-VIRUS; ANTIBACTERIAL PEPTIDES; HUMAN MACROPHAGES; EPITHELIAL-CELLS; INNATE IMMUNITY; NS1 PROTEIN; VITAMIN-D; A VIRUS; ALPHA	The extensive world-wide morbidity and mortality caused by influenza A viruses highlights the need for new insights into the host immune response and novel treatment approaches. Cationic Host Defense Peptides (CHDP, also known as antimicrobial peptides), which include cathelicidins and defensins, are key components of the innate immune system that are upregulated during infection and inflammation. Cathelicidins have immunomodulatory and anti-viral effects, but their impact on influenza virus infection has not been previously assessed. We therefore evaluated the effect of cathelicidin peptides on disease caused by influenza A virus in mice. The human cathelicidin, LL-37, and the murine cathelicidin, mCRAMP, demonstrated significant anti-viral activity in vivo, reducing disease severity and viral replication in infected mice to a similar extent as the well-characterized influenza virus-specific antiviral drug zanamivir. In vitro and in vivo experiments suggested that the peptides may act directly on the influenza virion rather than via receptor-based mechanisms. Influenza virus-infected mice treated with LL-37 had lower concentrations of pro-inflammatory cytokines in the lung than did infected animals that had not been treated with cathelicidin peptides. These data suggest that treatment of influenza-infected individuals with cathelicidin-derived therapeutics, or modulation of endogenous cathelicidin production may provide significant protection against disease.	[Barlow, Peter G.; York, Ian A.; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Svoboda, Pavel; Pohl, Jan] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Div Sci Resources, Atlanta, GA USA; [Mackellar, Annie; Davidson, Donald J.] Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Nash, Anthony A.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Nash, Anthony A.] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Barlow, PG (corresponding author), Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland.	rdonis@cdc.gov	Barlow, Peter/O-4078-2019; York, Ian/X-9351-2019	Barlow, Peter/0000-0002-6516-9312; York, Ian/0000-0002-3478-3344; Molodiuc, Veaceslav/0000-0002-3014-4203	Norman Salvesen Emphysema Research Trust; Medical Research Council [G1002046]; Medical Research Council [G0901697, G9900991B] Funding Source: researchfish; MRC [G1002046, G0901697] Funding Source: UKRI	Norman Salvesen Emphysema Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: Part of this work was funded by the Norman Salvesen Emphysema Research Trust, and DD is funded by a Medical Research Council Senior Non Clinical Fellow (G1002046). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2006, CURR TOP MICROBIOL, V306, P67; Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Benincasa M, 2003, PEPTIDES, V24, P1723, DOI 10.1016/j.peptides.2003.07.025; Bergman P, 2007, CURR HIV RES, V5, P410; Bjorstad A, 2009, ANTIMICROB AGENTS CH, V53, P1027, DOI 10.1128/AAC.01310-08; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Cheung QCK, 2008, ANTIMICROB AGENTS CH, V52, P1812, DOI 10.1128/AAC.01530-07; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Fortney K, 1998, ANTIMICROB AGENTS CH, V42, P2690, DOI 10.1128/AAC.42.10.2690; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li HN, 2009, J LEUKOCYTE BIOL, V86, P891, DOI 10.1189/jlb.0209050; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Steinstraesser L, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-2; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Urashima M, 2010, AM J CLIN NUTR; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; World Health Organization, 2002, WHO MAN AN INFL DIAG; Wu S, 2011, CURR OPIN INFECT DIS; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yasin B, 1996, INFECT IMMUN, V64, P709, DOI 10.1128/IAI.64.3.709-713.1996; Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457; Yu FS, 2010, J IMMUNOL, V185, P1142, DOI 10.4049/jimmunol.1000509; Yu J, 2007, J IMMUNOL, V179, P7684, DOI 10.4049/jimmunol.179.11.7684; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhang ZF, 2008, J LEUKOCYTE BIOL, V84, P780, DOI 10.1189/jlb.0208086; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496; Zughaier SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013627	62	223	234	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25333	10.1371/journal.pone.0025333	http://dx.doi.org/10.1371/journal.pone.0025333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031815	Green Published, Green Submitted, gold			2022-12-25	WOS:000296513200002
J	Wergeland, S; Torkildsen, O; Myhr, KM; Aksnes, L; Mork, SJ; Bo, L				Wergeland, Stig; Torkildsen, Oivind; Myhr, Kjell-Morten; Aksnes, Lage; Mork, Sverre Jarl; Bo, Lars			Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model	PLOS ONE			English	Article							SUPERIOR CEREBELLAR PEDUNCLE; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN-D LEVELS; CELL-DIFFERENTIATION; PARKINSON-DISEASE; MENSTRUAL-CYCLE; SERUM; RISK	Vitamin D is emerging as a probably important environmental risk factor in multiple sclerosis, affecting both susceptibility and disease progression. It is not known to what extent this effect is due to a modulation of peripheral lymphocyte function, or to intrathecal effects of vitamin D. We investigated the effect of dietary vitamin D3 content on de/remyelination in the cuprizone model, which is a well established toxic model of demyelination, with no associated lymphocyte infiltration. The mice received diets either deficient of (<50 IU/kg), or supplemented with low (500 IU/kg), high (6200 IU/kg) or very high (12500 IU/kg) amounts of vit D3. Cuprizone (0.2%) was added to the diet for six weeks, starting two weeks after onset of the experimental diets. Mouse brain tissue was histopathologically evaluated for myelin and oligodendrocyte loss, microglia/macrophage activation, and lymphocyte infiltration after six weeks of cuprizone exposure, and two weeks after discontinuation of cuprizone exposure. High and very high doses of vitamin D3 significantly reduced the extent of white matter demyelination (p = 0.004) and attenuated microglia activation (p = 0.001). No differences in the density of oligodendrocytes were observed between the diet groups. Two weeks after discontinuation of cuprizone exposure, remyelination was only detectable in the white matter of mice receiving diets deficient of or with low vitamin D3 content. In conclusion, high dietary doses of vitamin D3 reduce the extent of demyelination, and attenuate microglia activation and macrophage infiltration in a toxic model of demyelination, independent of lymphocyte infiltration.	[Wergeland, Stig; Torkildsen, Oivind; Myhr, Kjell-Morten; Bo, Lars] Haukeland Hosp, Norwegian Multiple Sclerosis Competence Ctr, Dept Neurol, N-5021 Bergen, Norway; [Wergeland, Stig; Torkildsen, Oivind; Myhr, Kjell-Morten; Bo, Lars] Haukeland Hosp, KG Jebsen Ctr Multiple Sclerosis Res, N-5021 Bergen, Norway; [Wergeland, Stig; Torkildsen, Oivind; Myhr, Kjell-Morten; Aksnes, Lage; Bo, Lars] Univ Bergen, Dept Clin Med, Bergen, Norway; [Mork, Sverre Jarl] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Wergeland, S (corresponding author), Haukeland Hosp, Norwegian Multiple Sclerosis Competence Ctr, Dept Neurol, N-5021 Bergen, Norway.	stig.wergeland@gmail.com	Torkildsen, Øivind/A-1606-2008; Mörk, Sverre Jarl/AAW-1330-2020; Myhr, Kjell-Morten/H-1528-2018	Torkildsen, Øivind/0000-0001-5294-2866; Myhr, Kjell-Morten/0000-0002-0980-510X	Western Norway Regional Health Authority; Biogen Idec	Western Norway Regional Health Authority; Biogen Idec(Biogen)	The study has been funded by the Western Norway Regional Health Authority, and supported by a grant from Biogen Idec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSKOG D, 1983, J CLIN ENDOCR METAB, V57, P1155, DOI 10.1210/jcem-57-6-1155; ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; AKSNES L, 1994, J PEDIATR GASTR NUTR, V18, P339, DOI 10.1097/00005176-199404000-00015; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; BLAKEMORE WF, 1974, J NEUROL SCI, V22, P121, DOI 10.1016/0022-510X(74)90059-8; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; CHEEMA C, 1989, J CLIN INVEST, V83, P537, DOI 10.1172/JCI113915; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Elenkov IJ, 2001, J CLIN ENDOCR METAB, V86, P4933, DOI 10.1210/jc.86.10.4933; Evatt ML, 2008, ARCH NEUROL-CHICAGO, V65, P1348, DOI 10.1001/archneur.65.10.1348; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; GRAY TK, 1982, AM J OBSTET GYNECOL, V144, P880, DOI 10.1016/0002-9378(82)90177-6; Griffin MD, 2000, BIOCHEM BIOPH RES CO, V270, P701, DOI 10.1006/bbrc.2000.2490; Grytten N, 2006, NEUROLOGY, V66, P182, DOI 10.1212/01.wnl.0000195549.95448.b9; Hesse A, 2010, NEUROBIOL DIS, V37, P362, DOI 10.1016/j.nbd.2009.10.016; Kampman MT, 2007, J NEUROL, V254, P471, DOI 10.1007/s00415-006-0395-5; Knekt P, 2010, ARCH NEUROL-CHICAGO, V67, P808, DOI 10.1001/archneurol.2010.120; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Mackay-Sim A, 2004, INT REV NEUROBIOL, V59, P351; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; MICHAYLOVA V, 1971, ANAL CHIM ACTA, V53, P194, DOI 10.1016/S0003-2670(01)80088-X; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Myhr KM, 2009, J NEUROL SCI, V286, P104, DOI 10.1016/j.jns.2009.05.002; Oudshoorn C, 2008, DEMENT GERIATR COGN, V25, P539, DOI 10.1159/000134382; Overbergh L, 2000, CLIN EXP IMMUNOL, V120, P139, DOI 10.1046/j.1365-2249.2000.01204.x; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sato Y, 1997, NEUROLOGY, V49, P1273, DOI 10.1212/WNL.49.5.1273; Seewann A, 2009, ARCH NEUROL-CHICAGO, V66, P601, DOI 10.1001/archneurol.2009.57; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; SUTHERLAND JM, 1962, BRAIN, V85, P149, DOI 10.1093/brain/85.1.149; Taylor DL, 2010, J NEUROSCI RES, V88, P1632, DOI 10.1002/jnr.22335; Taylor LC, 2010, J NEUROSCI RES, V88, P391, DOI 10.1002/jnr.22215; TJELLESEN L, 1983, ACTA ENDOCRINOL-COP, V102, P476, DOI 10.1530/acta.0.1020476; Torkildsen O, 2009, CLIN NUTR, V28, P83, DOI 10.1016/j.clnu.2008.10.015; Torkildsen O, 2009, EXP NEUROL, V215, P160, DOI 10.1016/j.expneurol.2008.09.026; van der Mei IAF, 2001, NEUROEPIDEMIOLOGY, V20, P168, DOI 10.1159/000054783; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	53	66	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26262	10.1371/journal.pone.0026262	http://dx.doi.org/10.1371/journal.pone.0026262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028844	gold, Green Published, Green Submitted			2022-12-25	WOS:000296510800032
J	Gibson, TM; Brennan, P; Han, S; Karami, S; Zaridze, D; Janout, V; Kollarova, H; Bencko, V; Navratilova, M; Szeszenia-Dabrowska, N; Mates, D; Slamova, A; Pfeiffer, RM; Stolzenberg-Solomon, RZ; Mayne, ST; Yeager, M; Chanock, S; Rothman, N; Chow, WH; Rosenberg, PS; Boffetta, P; Moore, LE				Gibson, Todd M.; Brennan, Paul; Han, Summer; Karami, Sara; Zaridze, David; Janout, Vladimir; Kollarova, Helen; Bencko, Vladimir; Navratilova, Marie; Szeszenia-Dabrowska, Neonila; Mates, Dana; Slamova, Alena; Pfeiffer, Ruth M.; Stolzenberg-Solomon, Rachael Z.; Mayne, Susan T.; Yeager, Meredith; Chanock, Stephen; Rothman, Nat; Chow, Wong-Ho; Rosenberg, Philip S.; Boffetta, Paolo; Moore, Lee E.			Comprehensive Evaluation of One-Carbon Metabolism Pathway Gene Variants and Renal Cell Cancer Risk	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; CASE-CONTROL ASSOCIATION; CENTRAL-EUROPE; METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR POLYMORPHISMS; COLORECTAL-CANCER; PANCREATIC-CANCER; VEGETABLE INTAKE; COMMON MUTATION; KIDNEY CANCER	Introduction: Folate and one-carbon metabolism are linked to cancer risk through their integral role in DNA synthesis and methylation. Variation in one-carbon metabolism genes, particularly MTHFR, has been associated with risk of a number of cancers in epidemiologic studies, but little is known regarding renal cancer. Methods: Tag single nucleotide polymorphisms (SNPs) selected to produce high genomic coverage of 13 gene regions of one-carbon metabolism (ALDH1L1, BHMT, CBS, FOLR1, MTHFR, MTR, MTRR, SHMT1, SLC19A1, TYMS) and the closely associated glutathione synthesis pathway (CTH, GGH, GSS) were genotyped for 777 renal cell carcinoma (RCC) cases and 1,035 controls in the Central and Eastern European Renal Cancer case-control study. Associations of individual SNPs (n = 163) with RCC risk were calculated using unconditional logistic regression adjusted for age, sex and study center. Minimum p-value permutation (Min-P) tests were used to identify gene regions associated with risk, and haplotypes were evaluated within these genes. Results: The strongest associations with RCC risk were observed for SLC19A1 (Pmin-P = 0.03) and MTHFR (Pmin-P = 0.13). A haplotype consisting of four SNPs in SLC19A1 (rs12483553, rs2838950, rs2838951, and rs17004785) was associated with a 37% increased risk (p = 0.02), and exploratory stratified analysis suggested the association was only significant among those in the lowest tertile of vegetable intake. Conclusions: To our knowledge, this is the first study to comprehensively examine variation in one-carbon metabolism genes in relation to RCC risk. We identified a novel association with SLC19A1, which is important for transport of folate into cells. Replication in other populations is required to confirm these findings.	[Gibson, Todd M.; Han, Summer; Karami, Sara; Pfeiffer, Ruth M.; Stolzenberg-Solomon, Rachael Z.; Yeager, Meredith; Chanock, Stephen; Rothman, Nat; Chow, Wong-Ho; Rosenberg, Philip S.; Moore, Lee E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gibson, Todd M.; Mayne, Susan T.] Yale Sch Publ Hlth, New Haven, CT USA; [Brennan, Paul; Boffetta, Paolo] Int Agcy Res Canc, F-69372 Lyon, France; [Zaridze, David] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; [Janout, Vladimir; Kollarova, Helen] Palacky Univ, Fac Med, Dept Prevent Med, CR-77147 Olomouc, Czech Republic; [Bencko, Vladimir; Slamova, Alena] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Navratilova, Marie] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Szeszenia-Dabrowska, Neonila] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Mates, Dana] Inst Publ Hlth, Bucharest, Romania; [Yeager, Meredith; Chanock, Stephen] NCI, Core Genotyping Facil, Gaithersburg, MD USA; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Canc Prevent Res Inst, Lyon, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University; World Health Organization; International Agency for Research on Cancer (IARC); Russian Academy of Medical Sciences; Palacky University Olomouc; Charles University Prague; Masaryk Memorial Cancer Institute; Nofer Institute of Occupational Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icahn School of Medicine at Mount Sinai	Gibson, TM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	gibsontm@mail.nih.gov	Boffetta, Paolo/AAI-7767-2021; Bencko, Vladimir/H-8598-2017; Stolzenberg-Solomon, Rachael/Y-9280-2018; Szeszenia-Dabrowska, Neonila/F-7190-2010; Gibson, Todd M/N-6999-2018; Zaridze, David/K-5605-2013; Yeager, Meredith/AAA-5322-2020; Slamova, Alena/C-8326-2017; Janout, Vladimir/M-5133-2014	Boffetta, Paolo/0000-0002-3811-2791; Bencko, Vladimir/0000-0003-1935-2228; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Gibson, Todd M/0000-0002-8718-699X; Slamova, Alena/0000-0002-2006-0225; mates, dana/0000-0002-6219-9807; Rosenberg, Philip/0000-0001-6349-9126; Kollarova, Helena/0000-0001-6951-6716	US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics [TU2-CA-105666]; NATIONAL CANCER INSTITUTE [ZIACP010136, TU2CA105666] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, and by grant TU2-CA-105666. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chen BSE, 2006, GENET EPIDEMIOL, V30, P495, DOI 10.1002/gepi.20162; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Devlin AM, 2006, AM J CLIN NUTR, V83, P708, DOI 10.1093/ajcn.83.3.708; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; Figueiredo JC, 2010, CANCER CAUSE CONTROL, V21, P597, DOI 10.1007/s10552-009-9489-6; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Fredriksen A, 2007, HUM MUTAT, V28, P856, DOI 10.1002/humu.20522; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gibson TM, 2010, CANCER CAUSE CONTROL, V21, P1061, DOI 10.1007/s10552-010-9534-5; Hsu CC, 2007, AM J EPIDEMIOL, V166, P62, DOI 10.1093/aje/kwm043; Hung RJ, 2007, CARCINOGENESIS, V28, P1334, DOI 10.1093/carcin/bgm067; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Kim YI, 2009, FUTURE ONCOL, V5, P523, DOI 10.2217/FON.09.26; Larsson SC, 2006, GASTROENTEROLOGY, V131, P1271, DOI 10.1053/j.gastro.2006.08.010; Lee Sang-Ah, 2009, J Prev Med Public Health, V42, P360, DOI 10.3961/jpmph.2009.42.6.360; Levine AJ, 2011, CANCER CAUSE CONTROL, V22, P541, DOI 10.1007/s10552-011-9726-7; Lissowska J, 2007, INT J CANCER, V120, P2696, DOI 10.1002/ijc.22604; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Moore LE, 2007, CARCINOGENESIS, V28, P1960, DOI 10.1093/carcin/bgm151; Moore LE, 2008, INT J CANCER, V122, P1710, DOI 10.1002/ijc.23318; Moore LE, 2007, INT J CANCER, V120, P2452, DOI 10.1002/ijc.22565; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Rosenberg PS, 2006, STAT MED, V25, P3134, DOI 10.1002/sim.2407; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Shen M, 2005, LUNG CANCER-J IASLC, V49, P299, DOI 10.1016/j.lungcan.2005.04.002; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Stolzenberg-Solomon RZ, 2001, AM J EPIDEMIOL, V153, P680, DOI 10.1093/aje/153.7.680; Ulrich CM, 2005, CANCER EPIDEM BIOMAR, V14, P2509, DOI 10.1158/1055-9965.EPI-05-0261; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wang LN, 2006, EUR J CANCER, V42, P3206, DOI 10.1016/j.ejca.2006.04.022; Westfall Peter H, 2002, Methods Mol Biol, V184, P143	38	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26165	10.1371/journal.pone.0026165	http://dx.doi.org/10.1371/journal.pone.0026165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039442	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500036
J	Wang, L; Si, YQ; Dedow, LK; Shao, Y; Liu, P; Brutnell, TP				Wang, Lin; Si, Yaqing; Dedow, Lauren K.; Shao, Ying; Liu, Peng; Brutnell, Thomas P.			A Low-Cost Library Construction Protocol and Data Analysis Pipeline for Illumina-Based Strand-Specific Multiplex RNA-Seq	PLOS ONE			English	Article							TRANSCRIPTOMES; EXPRESSION; ALIGNMENT	The emergence of NextGen sequencing technology has generated much interest in the exploration of transcriptomes. Currently, Illumina Inc. (San Diego, CA) provides one of the most widely utilized sequencing platforms for gene expression analysis. While Illumina reagents and protocols perform adequately in RNA-sequencing (RNA-seq), alternative reagents and protocols promise a higher throughput at a much lower cost. We have developed a low-cost and robust protocol to produce Illumina-compatible (GAIIx and HiSeq2000 platforms) RNA-seq libraries by combining several recent improvements. First, we designed balanced adapter sequences for multiplexing of samples; second, dUTP incorporation in 2(nd) strand synthesis was used to enforce strand-specificity; third, we simplified RNA purification, fragmentation and library size-selection steps thus drastically reducing the time and increasing throughput of library construction; fourth, we included an RNA spike-in control for validation and normalization purposes. To streamline informatics analysis for the community, we established a pipeline within the iPlant Collaborative. These scripts are easily customized to meet specific research needs and improve on existing informatics and statistical treatments of RNA-seq data. In particular, we apply significance tests for determining differential gene expression and intron retention events. To demonstrate the potential of both the library-construction protocol and data-analysis pipeline, we characterized the transcriptome of the rice leaf. Our data supports novel gene models and can be used to improve current rice genome annotation. Additionally, using the rice transcriptome data, we compared different methods of calculating gene expression and discuss the advantages of a strand-specific approach to detect bona-fide anti-sense transcripts and to detect intron retention events. Our results demonstrate the potential of this low cost and robust method for RNA-seq library construction and data analysis.	[Wang, Lin; Dedow, Lauren K.; Brutnell, Thomas P.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Si, Yaqing; Liu, Peng] Iowa State Univ, Dept Stat, Ames, IA USA; [Shao, Ying] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA	Cornell University; Boyce Thompson Institute for Plant Research; Iowa State University; Cornell University	Wang, L (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	tpb8@cornell.edu	Brutnell, Thomas/M-2840-2013	Brutnell, Thomas/0000-0002-3581-8211	National Science Foundation [IOS-0701736, IOS-0714978]; iPlant Collaborative [IOS-0735191]	National Science Foundation(National Science Foundation (NSF)); iPlant Collaborative(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by grants from the National Science Foundation (IOS-0701736 to TB and PL and IOS-0714978 to PL) and the iPlant Collaborative (IOS-0735191 to TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant DW, 2010, BIOINFORMATICS, V26, P1500, DOI 10.1093/bioinformatics/btq206; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Finocchiaro G, 2007, NUCLEIC ACIDS RES, V35, P1488, DOI 10.1093/nar/gkm027; Gadbury GL, 2004, STAT METHODS MED RES, V13, P325, DOI 10.1191/0962280204sm369ra; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hwang JTG, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1587; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lindberg J, 2010, GENOMICS, V95, P1, DOI 10.1016/j.ygeno.2009.08.010; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lonnstedt I, 2002, STAT SINICA, V12, P31; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sato M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001011; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87	36	98	108	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26426	10.1371/journal.pone.0026426	http://dx.doi.org/10.1371/journal.pone.0026426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039485	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500067
J	Garcia-Mayoral, MF; Castano, R; Fanarraga, ML; Zabala, JC; Rico, M; Bruix, M				Flor Garcia-Mayoral, Ma; Castano, Raquel; Fanarraga, Monica L.; Carlos Zabala, Juan; Rico, Manuel; Bruix, Marta			The Solution Structure of the N-Terminal Domain of Human Tubulin Binding Cofactor C Reveals a Platform for Tubulin Interaction	PLOS ONE			English	Article							BETA-TUBULIN; CRYSTAL-STRUCTURE; CAENORHABDITIS-ELEGANS; RETINITIS-PIGMENTOSA-2 PROTEIN; CYTOPLASMIC CHAPERONIN; ARABIDOPSIS-THALIANA; MICROTUBULE-BINDING; FUNCTIONAL-ANALYSIS; FOLDING COFACTOR; RELEASE FACTOR	Human Tubulin Binding Cofactor C (TBCC) is a post-chaperonin involved in the folding and assembly of alpha- and beta-tubulin monomers leading to the release of productive tubulin heterodimers ready to polymerize into microtubules. In this process it collaborates with other cofactors (TBC's A, B, D, and E) and forms a supercomplex with TBCD, beta-tubulin, TBCE and alpha-tubulin. Here, we demonstrate that TBCC depletion results in multipolar spindles and mitotic failure. Accordingly, TBCC is found at the centrosome and is implicated in bipolar spindle formation. We also determine by NMR the structure of the N-terminal domain of TBCC. The TBCC N-terminal domain adopts a spectrin-like fold topology composed of a left-handed 3-stranded a-helix bundle. Remarkably, the 30-residue N-terminal segment of the TBCC N-terminal domain is flexible and disordered in solution. This unstructured region is involved in the interaction with tubulin. Our data lead us to propose a testable model for TBCC N-terminal domain/tubulin recognition in which the highly charged N-terminus as well as residues from the three helices and the loops interact with the acidic hypervariable regions of tubulin monomers.	[Flor Garcia-Mayoral, Ma; Rico, Manuel; Bruix, Marta] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Madrid, Spain; [Castano, Raquel; Fanarraga, Monica L.; Carlos Zabala, Juan] Univ Cantabria, Dept Biol Mol, Inst Formac & Invest Marques de Valdecilla, Fac Med, E-39005 Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Garcia-Mayoral, MF (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Madrid, Spain.	mbruix@iqfr.csic.es	Fanarraga, Monica/AAE-5804-2019; Fanarraga, Mónica L./M-6177-2014; Zabala, Juan Carlos/K-5163-2014; Bruix, Marta/H-4161-2011	Fanarraga, Monica/0000-0003-4754-311X; Fanarraga, Mónica L./0000-0003-4754-311X; Zabala, Juan Carlos/0000-0003-2679-5473; Bruix, Marta/0000-0002-0096-3558	IFIMAV;  [Centrosome-3D];  [CSD2006-00023];  [Centrosome-CM S-GEN-0166-2006];  [BQU2008-0080];  [BFU2007-64882];  [BFU2010-18948]	IFIMAV; ; ; ; ; ; 	This work was supported by the projects Consolider-Ingenio Centrosome-3D CSD2006-00023, Centrosome-CM S-GEN-0166-2006, BQU2008-0080, BFU2007-64882, BFU2010-18948 and the IFIMAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; AVILA J, 2008, CURR PROTOC CELL BIO, pCH3; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; CAMPO R, 1994, FEBS LETT, V353, P162, DOI 10.1016/0014-5793(94)01036-6; Case D, 2006, AMBER 9; Cormier A, 2009, J BIOL CHEM, V284, P6909, DOI 10.1074/jbc.M808249200; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; FANARRAGA ML, METHODS CELL BIOL, V95, P59; Feldman JL, 2009, CURR BIOL, V19, P1238, DOI 10.1016/j.cub.2009.05.071; FONTALBA A, 1993, J CELL SCI, V106, P627; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; GAO Y, 1994, J CELL BIOL, V125, P989, DOI 10.1083/jcb.125.5.989; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Garcia-Mayoral MF, 2010, BIOMOL NMR ASSIGN, V4, P219, DOI 10.1007/s12104-010-9250-9; Goddard T.D., SPARKY 3; Goncalves J, 2010, EMBO REP, V11, P194, DOI 10.1038/embor.2010.5; Grynberg M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-46; Guasch A, 2002, J MOL BIOL, V318, P1139, DOI 10.1016/S0022-2836(02)00185-7; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hage-Sleiman R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-135; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kirik V, 2002, CURR BIOL, V12, P1519, DOI 10.1016/S0960-9822(02)01109-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Llosa M, 1996, FEBS LETT, V397, P283, DOI 10.1016/S0014-5793(96)01198-2; Lopez-Fanarraga M, 2007, J NEUROCHEM, V100, P1680, DOI 10.1111/j.1471-4159.2006.04328.x; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Lu L, 2010, FEBS LETT, V584, P3533, DOI 10.1016/j.febslet.2010.07.017; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Melki R, 1996, BIOCHEMISTRY-US, V35, P10422, DOI 10.1021/bi960788r; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; REUTER G, 1983, CHROMOSOMA, V88, P277, DOI 10.1007/BF00292904; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Steinbacher S, 1999, NAT STRUCT BIOL, V6, P1029, DOI 10.1038/14912; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VOTER WA, 1982, J ULTRA MOL STRUCT R, V80, P374, DOI 10.1016/S0022-5320(82)80051-8; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Zhu ZQC, 2009, J BIOL CHEM, V284, P32651, DOI 10.1074/jbc.M109.013466; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	58	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25912	10.1371/journal.pone.0025912	http://dx.doi.org/10.1371/journal.pone.0025912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028797	Green Published, gold			2022-12-25	WOS:000296186900022
J	Apidianakis, Y; Que, YA; Xu, WH; Tegos, GP; Zimniak, P; Hamblin, MR; Tompkins, RG; Xiao, WZ; Rahme, LG				Apidianakis, Yiorgos; Que, Yok-Ai; Xu, Weihong; Tegos, George P.; Zimniak, Piotr; Hamblin, Michael R.; Tompkins, Ronald G.; Xiao, Wenzhong; Rahme, Laurence G.			Down-regulation of glutatione S-transferase alpha 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection	FASEB JOURNAL			English	Article						reactive oxygen species; oxidative stress; 4-hydroxynonenal; lipid peroxidation; trauma; biomarker	BURN WOUND INFECTIONS; PSEUDOMONAS-AERUGINOSA; LIPID-PEROXIDATION; SKELETAL-MUSCLE; OXIDATIVE STRESS; GENE-EXPRESSION; TRAUMA; CONJUGATION; PRODUCTS; ENZYME	Patients with severe burns are highly susceptible to bacterial infection. While immunosuppression facilitates infection, the contribution of soft tissues to infection beyond providing a portal for bacterial entry remains unclear. We showed previously that glutathione S-transferase S1 (gstS1), an enzyme with conjugating activity against the lipid peroxidation by-product 4-hydroxynonenal (4HNE), is important for resistance against wound infection in Drosophila muscle. The importance of the mammalian functional counterpart of GstS1 in the context of wounds and infection has not been investigated. Here we demonstrate that the presence of a burn wound dramatically affects expression of both human (hGSTA4) and mouse (mGsta4) 4HNE scavengers. hGSTA4 is down-regulated significantly within 1 wk of thermal burn injury in the muscle and fat tissues of patients from the large-scale collaborative Inflammation and the Host Response to Injury multicentered study. Similarly, mGsta4, the murine GST with the highest catalytic efficiency for 4HNE, is down-regulated to approximately half of normal levels in mouse muscle immediately postburn. Consequently, 4HNE protein adducts are increased 4- to 5-fold in mouse muscle postburn. Using an open wound infection model, we show that deletion of mGsta4 renders mice more susceptible to infection with the prevalent wound pathogen Pseudomonas aeruginosa, while muscle hGSTA4 expression negatively correlates with burn wound infection episodes per patient. Our data suggest that hGSTA4 down-regulation and the concomitant increase in 4HNE adducts in human muscle are indicative of susceptibility to infection in individuals with severely thermal injuries.-Apidianakis, Y., Que, Y.-A., Xu, W., Tegos, G. P., Zimniak, P., Hamblin, M. R., Tompkins, R. G., Xiao, W., Rahme, L. G. Down-regulation of glutatione S-transferase alpha 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection. FASEB J. 26, 730-737 (2012). www.fasebj.org	[Apidianakis, Yiorgos; Que, Yok-Ai; Tompkins, Ronald G.; Xiao, Wenzhong; Rahme, Laurence G.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Tegos, George P.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Apidianakis, Yiorgos; Que, Yok-Ai; Tompkins, Ronald G.; Xiao, Wenzhong; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Tegos, George P.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Apidianakis, Yiorgos; Que, Yok-Ai; Tompkins, Ronald G.; Rahme, Laurence G.] Shriners Burn Inst, Boston, MA 02114 USA; [Xu, Weihong; Xiao, Wenzhong] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Zimniak, Piotr] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Zimniak, Piotr] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Tegos, George P.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Tegos, George P.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of New Mexico; University of New Mexico	Rahme, LG (corresponding author), Massachusetts Gen Hosp, Dept Surg, Thier 340, Boston, MA 02114 USA.	rahme@amber.mgh.harvard.edu	Xu, Weihong/C-4175-2012; Que, Yok Ai/AAE-5474-2020; Hamblin, Mike/AAB-2511-2022; Apidianakis, Yiorgos/ABF-7464-2020; Hamblin, Michael R/H-2758-2019	Xu, Weihong/0000-0002-3988-3571; Que, Yok Ai/0000-0001-9443-6101; Apidianakis, Yiorgos/0000-0002-7465-3560; Hamblin, Michael R/0000-0001-6431-4605; xiao, wenzhong/0000-0003-4944-6380	Shriners research grants [87100, 85600]; U.S. National Institutes of Health (NIH) [U54 GM-062119]; Swiss National Science Foundation/Swiss Medical Association [PASMP3-123226]; SICPA Foundation; NIH [AG-032643, AI050875]; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI105902, R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032643] Funding Source: NIH RePORTER	Shriners research grants; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation/Swiss Medical Association(Swiss National Science Foundation (SNSF)); SICPA Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Shriners research grants 87100 and 85600 and by the U.S. National Institutes of Health (NIH) Inflammation and the Host Response to Injury Large Scale Collaborative Project, U54 GM-062119. Y.A.Q. was supported by a Swiss National Science Foundation/Swiss Medical Association grant PASMP3-123226) and a grant from the SICPA Foundation. P.Z. was supported by NIH grant AG-032643 and by a U.S. Department of Veterans Affairs Research Career Scientist Award and M. R. H. by NIH grant AI050875.	Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Apidianakis Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001356; Astrakas LG, 2005, FASEB J, V19, P1431, DOI 10.1096/fj.04-2005com; Board PG, 2007, EXPERT OPIN DRUG MET, V3, P421, DOI 10.1517/17425255.3.3.421; Chai J, 2000, CHINESE MED J-PEKING, V113, P1142; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x; Finnerty CC, 2008, MOL MED, V14, P553, DOI 10.2119/2007-00132.Finnerty; Hamblin MR, 2003, J INFECT DIS, V187, P1717, DOI 10.1086/375244; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Horton JW, 2003, TOXICOLOGY, V189, P75, DOI 10.1016/S0300-483X(03)00154-9; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Lau GW, 2003, INFECT IMMUN, V71, P4059, DOI 10.1128/IAI.71.7.4059-4066.2003; Padfield KE, 2006, J TRAUMA, V61, P280, DOI 10.1097/01.ta.0000230567.56797.6c; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Polavarapu N, 2008, J CRANIOFAC SURG, V19, P899, DOI 10.1097/SCS.0b013e318175b4f0; Satoh K, 1999, ANAL BIOCHEM, V270, P323, DOI 10.1006/abio.1999.4073; Singh SP, 2010, J GERONTOL A-BIOL, V65, P14, DOI 10.1093/gerona/glp165; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Yang YS, 2003, ACTA BIOCHIM POL, V50, P319; Zaborina O, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030035; Zhou BY, 2010, P NATL ACAD SCI USA, V107, P9923, DOI 10.1073/pnas.1002757107	26	19	19	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					730	737		10.1096/fj.11-192484	http://dx.doi.org/10.1096/fj.11-192484			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22038048	Green Published			2022-12-25	WOS:000300485700024
J	Wangler, NJ; Santos, KL; Schadock, I; Hagen, FK; Escher, E; Bader, M; Speth, RC; Karamyan, VT				Wangler, Naomi J.; Santos, Kira L.; Schadock, Ines; Hagen, Fred K.; Escher, Emanuel; Bader, Michael; Speth, Robert C.; Karamyan, Vardan T.			Identification of Membrane-bound Variant of Metalloendopeptidase Neurolysin (EC 3.4.24.16) as the Non-angiotensin Type 1 (Non-AT1), Non-AT(2) Angiotensin Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; THIMET OLIGOPEPTIDASE; RAT-BRAIN; CONVERTING-ENZYME; BIOCHEMICAL-CHARACTERIZATION; SUBCELLULAR-DISTRIBUTION; TISSUE DISTRIBUTION; ENDOPEPTIDASE 24.15; MOLECULAR-CLONING; AT(1) RECEPTOR	Recently, we discovered a novel non-angiotensin type 1 (non-AT(1)), non-AT(2) angiotensin binding site in rodent and human brain membranes, which is distinctly different from angiotensin receptors and key proteases processing angiotensins. It is hypothesized to be a new member of the renin-angiotensin system. This study was designed to isolate and identify this novel angiotensin binding site. An angiotensin analog, photoaffinity probe I-125-SBpa-Ang II, was used to specifically label the non-AT(1), non-AT(2) angiotensin binding site in mouse forebrain membranes, followed by a two-step purification procedure based on the molecular size and isoelectric point of the photo-radiolabeled binding protein. Purified samples were subjected to two-dimensional gel electrophoresis followed by mass spectrometry identification of proteins in the two-dimensional gel sections containing radioactivity. LC-MS/MS analysis revealed eight protein candidates, of which the four most abundant were immunoprecipitated after photoradiolabeling. Immunoprecipitation studies indicated that the angiotensin binding site might be the membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16). To verify these observations, radioligand binding and photoradiolabeling experiments were conducted in membrane preparations of HEK293 cells overexpressing mouse neurolysin or thimet oligopeptidase (EC 3.4.24.15), a closely related metalloendopeptidase of the same family. These experiments also identified neurolysin as the non-AT(1), non-AT(2) angiotensin binding site. Finally, brain membranes of mice lacking neurolysin were nearly devoid of the non-AT(1), non-AT(2) angiotensin binding site, further establishing membrane-bound neurolysin as the binding site. Future studies will focus on the functional significance of this highly specific, high affinity interaction between neurolysin and angiotensins.	[Wangler, Naomi J.; Karamyan, Vardan T.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA; [Karamyan, Vardan T.] Texas Tech Univ, Hlth Sci Ctr, Vasc Drug Res Ctr, Sch Pharm, Amarillo, TX 79106 USA; [Santos, Kira L.; Speth, Robert C.] Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33328 USA; [Schadock, Ines; Bader, Michael] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Hagen, Fred K.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Prote Ctr, Rochester, NY 14642 USA; [Escher, Emanuel] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Speth, Robert C.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Nova Southeastern University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Rochester; University of Sherbrooke; State University System of Florida; University of Florida	Karamyan, VT (corresponding author), 1300 Coulter St, Amarillo, TX 79106 USA.	vardan.karamyan@ttuhsc.edu	Bader, Michael/K-2124-2013	Schadock, Ines/0000-0002-6717-6276; Bader, Michael/0000-0003-4780-4164	National Institutes of Health, NHLBI [HL-096357]; Texas Tech University Health Sciences Center School of Pharmacy; American Radiolabeled Chemicals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL096357] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Texas Tech University Health Sciences Center School of Pharmacy; American Radiolabeled Chemicals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant HL-096357. This work was also supported by Texas Tech University Health Sciences Center School of Pharmacy start-up funds and American Radiolabeled Chemicals.	Abadir PM, 2011, P NATL ACAD SCI USA, V108, P14849, DOI 10.1073/pnas.1101507108; Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; Alfonso LF, 2009, INT J ONCOL, V34, P597, DOI 10.3892/ijo_00000185; Baker KM, 2006, AM J PHYSIOL-CELL PH, V291, pC995, DOI 10.1152/ajpcell.00238.2006; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Bourassa EA, 2010, BRAIN RES, V1359, P98, DOI 10.1016/j.brainres.2010.08.081; Chai SY, 2004, CELL MOL LIFE SCI, V61, P2728, DOI 10.1007/s00018-004-4246-1; CHECLER F, 1986, J BIOL CHEM, V261, P1274; CHECLER F, 1995, METHOD ENZYMOL, V248, P593; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; DAHMS P, 1992, EUR J BIOCHEM, V208, P145, DOI 10.1111/j.1432-1033.1992.tb17168.x; DAUCH P, 1992, J NEUROCHEM, V59, P1862, DOI 10.1111/j.1471-4159.1992.tb11021.x; DAUCH P, 1995, J BIOL CHEM, V270, P27266, DOI 10.1074/jbc.270.45.27266; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Ferro ES, 2004, PROTEIN PEPTIDE LETT, V11, P415, DOI 10.2174/0929866043406706; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Gembardt F, 2008, MOL CELL BIOCHEM, V319, P115, DOI 10.1007/s11010-008-9884-4; HAGIWARA H, 1989, EUR J BIOCHEM, V185, P405, DOI 10.1111/j.1432-1033.1989.tb15129.x; Jeske NA, 2006, J NEUROCHEM, V97, P13, DOI 10.1111/j.1471-4159.2006.03706.x; Karamyan VT, 2008, LIFE SCI, V83, P421, DOI 10.1016/j.lfs.2008.07.003; Karamyan VT, 2008, EUR J PHARMACOL, V590, P87, DOI 10.1016/j.ejphar.2008.05.035; Karamyan VT, 2007, REGUL PEPTIDES, V143, P15, DOI 10.1016/j.regpep.2007.03.006; Karamyan VT, 2007, BRAIN RES, V1143, P83, DOI 10.1016/j.brainres.2007.01.051; Karamyan VT, 2010, ENDOCRINE, V37, P442, DOI 10.1007/s12020-010-9328-2; Karamyan VT, 2009, J PHARMACOL EXP THER, V331, P170, DOI 10.1124/jpet.109.157461; Karamyan VT, 2008, NEUROENDOCRINOLOGY, V88, P256, DOI 10.1159/000140635; KATO A, 1994, EUR J BIOCHEM, V221, P159, DOI 10.1111/j.1432-1033.1994.tb18725.x; Kato A, 1997, J BIOL CHEM, V272, P15313, DOI 10.1074/jbc.272.24.15313; Kim SI, 2003, BIOCHEM J, V375, P111, DOI 10.1042/BJ20030490; KIRON MAR, 1989, J BIOL CHEM, V264, P4138; LIND RW, 1985, NEUROENDOCRINOLOGY, V40, P2; Lucero HA, 2010, J BIOL CHEM, V285, P5555, DOI 10.1074/jbc.M109.074740; Marimuthu S, 2011, INT J ONCOL, V39, P1273, DOI 10.3892/ijo.2011.1113; Massarelli EE, 1999, BRAIN RES, V851, P261, DOI 10.1016/S0006-8993(99)02135-6; MCKIE N, 1993, BIOCHEM J, V295, P57, DOI 10.1042/bj2950057; MILLICAN PE, 1991, BIOCHEM J, V276, P583, DOI 10.1042/bj2760583; Nagata S, 2006, BIOCHEM BIOPH RES CO, V350, P1026, DOI 10.1016/j.bbrc.2006.09.146; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1942, DOI 10.1152/ajpheart.00948.2002; Portaro FCV, 1999, BIOCHEM BIOPH RES CO, V255, P596, DOI 10.1006/bbrc.1999.0251; Rabey FM, 2010, REGUL PEPTIDES, V162, P5, DOI 10.1016/j.regpep.2010.02.007; Rashid M, 2010, J PHARMACOL EXP THER, V335, P754, DOI 10.1124/jpet.110.171439; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; RODD D, 1995, J BIOL CHEM, V270, P10056, DOI 10.1074/jbc.270.17.10056; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; SERIZAWA A, 1995, J BIOL CHEM, V270, P2092, DOI 10.1074/jbc.270.5.2092; Servant G, 1997, J BIOL CHEM, V272, P8653, DOI 10.1074/jbc.272.13.8653; Smith AI, 2000, HYPERTENSION, V35, P626, DOI 10.1161/01.HYP.35.2.626; SUGIURA N, 1992, J BIOL CHEM, V267, P18067; Tadevosyan A, 2010, J BIOL CHEM, V285, P22338, DOI 10.1074/jbc.M110.121749; Thekkumkara TJ, 2003, BIOCHEM J, V370, P631, DOI 10.1042/BJ20020960; Tigerstedt R, 1898, SKAND ARCH PHYSL, V8, P223, DOI [10.1111/j.1748-1716.1898.tb00272.x, DOI 10.1111/J.1748-1716.1898.TB00272.X]; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Unger T, 1999, J HYPERTENS, V17, P1775, DOI 10.1097/00004872-199917121-00001; Vincent B, 1997, J NEUROCHEM, V68, P837; Vincent B, 1996, J NEUROSCI, V16, P5049; Vincent B, 1997, BRIT J PHARMACOL, V121, P705, DOI 10.1038/sj.bjp.0701182; Vincent B, 1997, EUR J PHARMACOL, V334, P49, DOI 10.1016/S0014-2999(97)01209-0; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; WOULFE J, 1992, EUR J NEUROSCI, V4, P1309, DOI 10.1111/j.1460-9568.1992.tb00156.x	65	30	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					114	122		10.1074/jbc.M111.273052	http://dx.doi.org/10.1074/jbc.M111.273052			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22039052	Green Published, hybrid			2022-12-25	WOS:000298682400014
J	Saini, V; Marchese, A; Tang, WJ; Majetschak, M				Saini, Vikas; Marchese, Adriano; Tang, Wei-Jen; Majetschak, Matthias			Structural Determinants of Ubiquitin-CXC Chemokine Receptor 4 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED FACTOR-1-ALPHA; EXOGENOUS UBIQUITIN; BINDING DOMAINS; SEVERE TRAUMA; INJURY; RECOGNITION; SDF-1-ALPHA; COMPLEX; IDENTIFICATION; RESUSCITATION	Ubiquitin, a post-translational protein modifier inside the functions as a CXC chemokine receptor (CXCR) 4 agonist outside the cell. However, the structural determinants of the interaction between extracellular ubiquitin and CXCR4 remain unknown. Utilizing C-terminal truncated ubiquitin and ubiquitin mutants, in which surface residues that are known to interact with ubiquitin binding domains in interacting proteins are mutated (Phe-4, Leu-8, Ile-44, Asp-58, Val-70), we provide evidence that the ubiquitin-CXCR4 interaction follows a two-site binding mechanism in which the hydrophobic surfaces surrounding Phe-4 and Val-70 are important for receptor binding, whereas the flexible C terminus facilitates receptor activation. Based on these findings and the available crystal structures, we then modeled the ubiquitin-CXCR4 interface with the Rosetta-Dock software followed by small manual adjustments, which were guided by charge complementarity and anticipation of a conformational switch of CXCR4 upon activation. This model suggests three residues of CXCR4 (Phe-29, Phe-189, Lys-271) as potential interaction sites. Binding studies with HEK293 cells overexpressing wild type and CXCR4 after site-directed mutagenesis confirm that these residues are important for ubiquitin binding but that they do not contribute to the binding of stromal cell-derived factor 1 alpha. Our findings suggest that the structural determinants of the CXCR4 agonist activity of ubiquitin mimic the typical structure-function relationship of chemokines. Furthermore, we provide evidence for separate and specific ligand binding sites on CXCR4. As exogenous ubiquitin has been shown to possess therapeutic potential, our findings are expected to facilitate the structure-based design of new compounds with ubiquitin-mimetic actions on CXCR4.	[Saini, Vikas; Majetschak, Matthias] Loyola Univ, Chicago Stritch Sch Med, Dept Surg, Burn & Shock Trauma Inst, Maywood, IL 60153 USA; [Marchese, Adriano; Majetschak, Matthias] Loyola Univ, Chicago Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Loyola University Chicago; Loyola University Chicago; University of Chicago	Majetschak, M (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	mmajetschak@lumc.edu		Tang, Wei-Jen/0000-0002-8267-8995	United States Army Medical Research and Materiel Command (USAMRMC); Telemedicine and Advanced Technology Research Center (TATRC) at Fort Detrick, MD [W81XWH1020122]; National Institutes of Health [GM075159, GM081539]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081539, R01GM075159] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine and Advanced Technology Research Center (TATRC) at Fort Detrick, MD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was made possible, in part, by a grant that was awarded and administered by the United States Army Medical Research and Materiel Command (USAMRMC) and the Telemedicine and Advanced Technology Research Center (TATRC) at Fort Detrick, MD, under Contract W81XWH1020122 (to M. M.). This work was also supported in part by National Institutes of Health Grants GM075159 (to A. M.) and GM081539 (to W. J. T.). Based on the results of this work, Loyola University Chicago has filed a provisional patent application. The authors are the inventors. None of the authors have received any income related to the patent or patent application.	Ahn HC, 2009, EXP NEUROL, V220, P120, DOI 10.1016/j.expneurol.2009.07.031; Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P186, DOI 10.1038/nsmb0306-186; Block EFJ, 2004, J TRAUMA, V56, P999; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Choi WT, 2005, J VIROL, V79, P15398, DOI 10.1128/JVI.79.24.15398-15404.2005; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Earle SA, 2006, TRANSPLANTATION, V82, P1544, DOI 10.1097/01.tp.0000236057.56721.d0; FAN H, 2011, INFLAMMATIO IN PRESS; Garcia-Covarrubias L, 2008, CRIT CARE MED, V36, P979, DOI 10.1097/CCM.0B013E318164E417; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Li MC, 2010, CELL REPROGRAM, V12, P405, DOI 10.1089/cell.2009.0088; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takada K, 1997, CLIN CHEM, V43, P1188; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp CT, 2010, J AM CHEM SOC, V132, P7242, DOI 10.1021/ja1002263; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286	49	30	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44145	44152		10.1074/jbc.M111.298505	http://dx.doi.org/10.1074/jbc.M111.298505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039044	hybrid, Green Published			2022-12-25	WOS:000298402300055
J	Li, YZ; Tong, XP; Rumala, C; Clemons, K; Wang, SX				Li, Yanzhang; Tong, Xiaopeng; Rumala, Courtney; Clemons, Kate; Wang, Shuxia			Thrombospondin1 Deficiency Reduces Obesity-Associated Inflammation and Improves Insulin Sensitivity in a Diet-Induced Obese Mouse Model	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ADIPOSE-TISSUE DEVELOPMENT; ENDOTHELIAL-CELLS; IN-VIVO; MAJOR ACTIVATOR; RESISTANCE; EXPRESSION; PROTEIN; BINDING; BLOOD	Background: Obesity is prevalent worldwide and is associated with insulin resistance. Advanced studies suggest that obesity-associated low-grade chronic inflammation contributes to the development of insulin resistance and other metabolic complications. Thrombospondin 1 (TSP1) is a multifunctional extracellular matrix protein that is up-regulated in inflamed adipose tissue. A recent study suggests a positive correlation of TSP1 with obesity, adipose inflammation, and insulin resistance. However, the direct effect of TSP1 on obesity and insulin resistance is not known. Therefore, we investigated the role of TSP1 in mediating obesity-associated inflammation and insulin resistance by using TSP1 knockout mice. Methodology/Principal Findings: Male TSP1-/- mice and wild type littermate controls were fed a low-fat (LF) or a high-fat (HF) diet for 16 weeks. Throughout the study, body weight and fat mass increased similarly between the TSP1-/- mice and WT mice under HF feeding conditions, suggesting that TSP1 deficiency does not affect the development of obesity. However, obese TSP1-/- mice had improved glucose tolerance and increased insulin sensitivity compared to the obese wild type mice. Macrophage accumulation and inflammatory cytokine expression in adipose tissue were reduced in obese TSP1-/- mice. Consistent with the local decrease in pro-inflammatory cytokine levels, systemic inflammation was also decreased in the obese TSP1-/- mice. Furthermore, in vitro data demonstrated that TSP1 deficient macrophages had decreased mobility and a reduced inflammatory phenotype. Conclusion: TSP1 deficiency did not affect the development of high-fat diet induced obesity. However, TSP1 deficiency reduced macrophage accumulation in adipose tissue and protected against obesity related inflammation and insulin resistance. Our data demonstrate that TSP1 may play an important role in regulating macrophage function and mediating obesity-induced inflammation and insulin resistance. These data suggest that TSP1 may serve as a potential therapeutic target to improve the inflammatory and metabolic complications of obesity.	[Li, Yanzhang; Tong, Xiaopeng; Rumala, Courtney; Clemons, Kate; Wang, Shuxia] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40536 USA	University of Kentucky	Li, YZ (corresponding author), Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40536 USA.	swang7@uky.edu			National Center for Research Resources [P20RR021954]; National Institutes of Health [DK081555]; Interdisciplinary Cardiovascular Training Program [T32 HL 072743]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081555] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Cardiovascular Training Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an award P20RR021954 from the National Center for Research Resources, a grant from National Institutes of Health DK081555 and an Interdisciplinary Cardiovascular Training Program-T32 HL 072743.	Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Chandrasekaran L, 2000, MOL BIOL CELL, V11, P2885, DOI 10.1091/mbc.11.9.2885; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Daniel C, 2004, KIDNEY INT, V65, P459, DOI 10.1111/j.1523-1755.2004.00395.x; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; DONOVIEL DB, 1990, J CELL PHYSIOL, V145, P16, DOI 10.1002/jcp.1041450104; Frazier WA, 1999, J BIOL CHEM, V274, P8554, DOI 10.1074/jbc.274.13.8554; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; HUGO C, 1995, KIDNEY INT, V48, P1846, DOI 10.1038/ki.1995.483; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Martin-Manso G, 2008, CANCER RES, V68, P7090, DOI 10.1158/0008-5472.CAN-08-0643; McMaken S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019654; Mertens I, 2006, INT J OBESITY, V30, P1308, DOI 10.1038/sj.ijo.0803189; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; MURPHYULLRICH JE, 1987, J CELL BIOL, V105, P1603, DOI 10.1083/jcb.105.4.1603; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Okuno M, 2002, FEBS LETT, V519, P108, DOI 10.1016/S0014-5793(02)02720-5; Olson BA, 1999, PHARMACOLOGY, V58, P200, DOI 10.1159/000028282; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Phelan MW, 1998, J LAB CLIN MED, V132, P519, DOI 10.1016/S0022-2143(98)90131-7; Ramis JM, 2002, CELL MOL LIFE SCI, V59, P1960, DOI 10.1007/PL00012518; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Shang CA, 2002, MOL CELL ENDOCRINOL, V189, P213, DOI 10.1016/S0303-7207(01)00590-1; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Voros G, 2006, J THROMB HAEMOST, V4, P277, DOI 10.1111/j.1538-7836.2005.01696.x; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Wang SX, 2004, J CELL BIOCHEM, V91, P766, DOI 10.1002/jcb.10781; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	43	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26656	10.1371/journal.pone.0026656	http://dx.doi.org/10.1371/journal.pone.0026656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039525	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200037
J	Furukawa, K; Furukawa, T; Hohmann, S				Furukawa, Kentaro; Furukawa, Takako; Hohmann, Stefan			Efficient Construction of Homozygous Diploid Strains Identifies Genes Required for the Hyper-Filamentous Phenotype in Saccharomyces cerevisiae	PLOS ONE			English	Article							LARGE-SCALE ANALYSIS; INVASIVE GROWTH; MAP KINASE; SIGNALING PATHWAYS; CANDIDA-ALBICANS; MATING-TYPE; FLO11 GENE; YEAST; MECHANISMS; GENOME	Yeast cells undergo diploid-specific developments such as spore formation via meiosis and pseudohyphal development under certain nutrient-limited conditions. Studies on these aspects require homozygous diploid mutants, which are generally constructed by crossing strains of opposite mating-type with the same genetic mutation. So far, there has been no direct way to generate and select diploids from haploid cells. Here, we developed a method for efficient construction of homozygous diploids using a PGAL1-HO gene (galactose-inducible mating-type switch) and a PSTE18-URA3 gene (counter selection marker for diploids). Diploids are generated by transient induction of the HO endonuclease, which is followed by mating of part of the haploid population. Since the STE18 promoter is repressed in diploids, diploids carrying PSTE18-URA3 can be selected on 5-fluoroorotic acid (5-FOA) plates where the uracil prototrophic haploids cannot grow. To demonstrate that this method is useful for genetic studies, we screened suppressor mutations of the complex colony morphology, strong agar invasion and/or hyper-filamentous growth caused by lack of the Hog1 MAPK in the diploid Sigma 1278b strain background. Following this approach, we identified 49 suppressor mutations. Those include well-known positive regulator genes for filamentous growth signaling pathways, genes involved in mitochondrial function, DNA damage checkpoint, chromatin remodeling, and cell cycle, and also previously uncharacterized genes. Our results indicate that combinatorial use of the PGAL1-HO and PSTE18-URA3 genes is suitable to efficiently construct and select diploids and that this approach is useful for genetic studies especially when combined with large-scale screening.	[Furukawa, Kentaro; Furukawa, Takako; Hohmann, Stefan] Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden	University of Gothenburg	Furukawa, K (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden.	kentaro.furukawa@cmb.gu.se; stefan.hohmann@gu.se	Hohmann, Stefan/K-9895-2013	Hohmann, Stefan/0000-0002-0809-1985; Furukawa, Kentaro/0000-0002-1551-1538	Swedish Research Council; Science Faculty at the University of Gothenburg; European Commission [043310, 201142]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Science Faculty at the University of Gothenburg; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Swedish Research Council, the Science Faculty at the University of Gothenburg Platform program, the European Commission funded projects FP6 CELLCOMPUT (Contract No. 043310) and FP7 UNICELLSYS (Contract No. 201142). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2009, MICROBIOL-SGM, V155, P413, DOI 10.1099/mic.0.023309-0; Amberg DC., 2005, METHODS YEAST GENETI; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Braus GH, 2003, MOL BIOL CELL, V14, P4272, DOI 10.1091/mbc.e03-01-0042; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Furukawa K, 2009, MOL MICROBIOL, V74, P1272, DOI 10.1111/j.1365-2958.2009.06933.x; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Granek JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000823; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Kang CM, 2005, YEAST, V22, P79, DOI 10.1002/yea.1195; Klar AJS, 2010, GENETICS, V186, P443, DOI 10.1534/genetics.110.122531; Li WS, 1997, GENETICS, V145, P63; Liu HP, 1996, GENETICS, V144, P967; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Loeb JDJ, 1999, GENETICS, V153, P1535; Mosch HU, 1997, GENETICS, V145, P671; NICKOLOFF JA, 1989, J MOL BIOL, V207, P527, DOI 10.1016/0022-2836(89)90462-2; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Park YU, 2006, EUKARYOT CELL, V5, P2120, DOI 10.1128/EC.00121-06; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152	32	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26584	10.1371/journal.pone.0026584	http://dx.doi.org/10.1371/journal.pone.0026584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039512	Green Submitted, Green Published, gold			2022-12-25	WOS:000296513200032
J	Landrette, SF; Cornett, JC; Ni, TK; Bosenberg, MW; Xu, T				Landrette, Sean F.; Cornett, Jonathan C.; Ni, Thomas K.; Bosenberg, Marcus W.; Xu, Tian			piggyBac Transposon Somatic Mutagenesis with an Activated Reporter and Tracker (PB-SMART) for Genetic Screens in Mice	PLOS ONE			English	Article							RENAL-CELL CARCINOMAS; INSERTIONAL MUTAGENESIS; SLEEPING-BEAUTY; MOUSE MODEL; DROSOPHILA; EXPRESSION; FUSION; DOMAIN; DIFFERENTIATION; GENOME	Somatic forward genetic screens have the power to interrogate thousands of genes in a single animal. Retroviral and transposon mutagenesis systems in mice have been designed and deployed in somatic tissues for surveying hematopoietic and solid tumor formation. In the context of cancer, the ability to visually mark mutant cells would present tremendous advantages for identifying tumor formation, monitoring tumor growth over time, and tracking tumor infiltrations and metastases into wild-type tissues. Furthermore, locating mutant clones is a prerequisite for screening and analyzing most other somatic phenotypes. For this purpose, we developed a system using the piggyBac (PB) transposon for somatic mutagenesis with an activated reporter and tracker, called PB-SMART. The PB-SMART mouse genetic screening system can simultaneously induce somatic mutations and mark mutated cells using bioluminescence or fluorescence. The marking of mutant cells enable analyses that are not possible with current somatic mutagenesis systems, such as tracking cell proliferation and tumor growth, detecting tumor cell infiltrations, and reporting tissue mutagenesis levels by a simple ex vivo visual readout. We demonstrate that PB-SMART is highly mutagenic, capable of tumor induction with low copy transposons, which facilitates the mapping and identification of causative insertions. We further integrated a conditional transposase with the PB-SMART system, permitting tissue-specific mutagenesis with a single cross to any available Cre line. Targeting the germline, the system could also be used to conduct F1 screens. With these features, PB-SMART provides an integrated platform for individual investigators to harness the power of somatic mutagenesis and phenotypic screens to decipher the genetic basis of mammalian biology and disease.	[Landrette, Sean F.; Cornett, Jonathan C.; Ni, Thomas K.; Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Boyer Ctr Mol Med,Dept Genet, New Haven, CT 06510 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Xu, Tian] Fudan Univ, Inst Dev Biol & Mol Med, Fudan Yale Ctr Biomed Res, Sch Life Sci, Shanghai 200433, Peoples R China	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Fudan University	Landrette, SF (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Boyer Ctr Mol Med,Dept Genet, New Haven, CT 06510 USA.	tian.xu@yale.edu	Ni, Thomas K/I-3604-2013; Wilson, Matthew H/K-3193-2013	Ni, Thomas K/0000-0003-2961-0593; 	Howard Hughes Medical Institute; National Cancer Institute [F32CA132320]; Anna Fuller Fund Fellowship in Molecular Oncology; American Cancer Society; Genetics Training Grant [T32 GM007499]; National Institutes of Health [T32 HG003198]; NATIONAL CANCER INSTITUTE [F32CA132320] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Anna Fuller Fund Fellowship in Molecular Oncology; American Cancer Society(American Cancer Society); Genetics Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute as well as the following sources: JCC was supported by a fellowship from the National Cancer Institute (F32CA132320); SFL was supported by an Anna Fuller Fund Fellowship in Molecular Oncology and an American Cancer Society New England Division Fellowship; TKN was supported by the Genetics Training Grant (T32 GM007499) and the Training Program in Genomics and Proteomics Technologies (T32 HG003198) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bender AM, CANC RES, P3557; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Haq R, J CLIN ONCOL, V3474-3482; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Joo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007608; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; KLECKNER N, 1977, J MOL BIOL, V116, P125, DOI 10.1016/0022-2836(77)90123-1; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang GY, CANC CELL, V19, P114; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; XU T, 1993, DEVELOPMENT, V117, P1223; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; YUAN Y, 1995, EMBO J, V14, P159, DOI 10.1002/j.1460-2075.1995.tb06986.x	47	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26650	10.1371/journal.pone.0026650	http://dx.doi.org/10.1371/journal.pone.0026650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039523	Green Submitted, Green Published, gold			2022-12-25	WOS:000296513200036
J	Pattanayak, GK; Tripathy, BC				Pattanayak, Gopal K.; Tripathy, Baishnab C.			Overexpression of Protochlorophyllide Oxidoreductase C Regulates Oxidative Stress in Arabidopsis	PLOS ONE			English	Article							INDUCED PHOTODYNAMIC DAMAGE; SINGLET OXYGEN; TETRAPYRROLE BIOSYNTHESIS; CHLOROPHYLL BIOSYNTHESIS; TEMPERATURE-STRESS; PROTOPORPHYRIN-IX; ACID SYNTHESIS; LIGHT; PROTEIN; PORB	Light absorbed by colored intermediates of chlorophyll biosynthesis is not utilized in photosynthesis; instead, it is transferred to molecular oxygen, generating singlet oxygen (O-1(2)). As there is no enzymatic detoxification mechanism available in plants to destroy O-1(2), its generation should be minimized. We manipulated the concentration of a major chlorophyll biosynthetic intermediate i.e., protochlorophyllide in Arabidopsis by overexpressing the light-inducible protochlorophyllide oxidoreductase C (PORC) that effectively phototransforms endogenous protochlorophyllide to chlorophyllide leading to minimal accumulation of the photosensitizer protochlorophyllide in light-grown plants. In PORC overexpressing (PORCx) plants exposed to high-light, the O-1(2) generation and consequent malonedialdehyde production was minimal and the maximum quantum efficiency of photosystem II remained unaffected demonstrating that their photosynthetic apparatus and cellular organization were intact. Further, PORCx plants treated with 5-aminolevulinicacid when exposed to light, photo-converted over-accumulated protochlorophyllide to chlorophyllide, reduced the generation of O-1(2) and malonedialdehyde production and reduced plasma membrane damage. So PORCx plants survived and bolted whereas, the 5-aminolevulinicacid-treated wild-type plants perished. Thus, overexpression of PORC could be biotechnologically exploited in crop plants for tolerance to O-1(2)-induced oxidative stress, paving the use of 5-aminolevulinicacid as a selective commercial light-activated biodegradable herbicide. Reduced protochlorophyllide content in PORCx plants released the protochlorophyllide-mediated feed-back inhibition of 5-aminolevulinicacid biosynthesis that resulted in higher 5-aminolevulinicacid production. Increase of 5-aminolevulinicacid synthesis upregulated the gene and protein expression of several downstream chlorophyll biosynthetic enzymes elucidating a regulatory net work of expression of genes involved in 5-aminolevulinicacid and tetrapyrrole biosynthesis.	[Pattanayak, Gopal K.; Tripathy, Baishnab C.] Jawaharlal Nehru Univ, Sch Life Sci, New Delphi, India		Pattanayak, GK (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	bctripathy@mail.jnu.ac.in			Department of Biotechnology, Government of India [BT/PR6074/AGR/02/311/2005]; CSIR, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology, Government of India (BT/PR6074/AGR/02/311/2005) to BCT. GKP was the recipient of a CSIR fellowship, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; ASADA K, 1984, METHOD ENZYMOL, V105, P422; Asada K, 1996, PHOTOSYNTHESIS ENV, P123, DOI DOI 10.1007/0-306-48135-9_5; BENNETT J, 1981, EUR J BIOCHEM, V118, P61, DOI 10.1111/j.1432-1033.1981.tb05486.x; Bozell JJ, 2000, RESOUR CONSERV RECY, V28, P227, DOI 10.1016/S0921-3449(99)00047-6; CHAKRABORTY N, 1992, PLANT PHYSIOL, V98, P7, DOI 10.1104/pp.98.1.7; Choi C, 1999, BIOTECHNOL LETT, V21, P551, DOI 10.1023/A:1005520007230; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dutta S, 2009, PLANT PHYSIOL, V150, P1050, DOI 10.1104/pp.109.137265; FEINBAUM RL, 1991, MOL GEN GENET, V226, P449, DOI 10.1007/BF00260658; Fischer BB, 2007, FEBS LETT, V581, P5555, DOI 10.1016/j.febslet.2007.11.003; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Franck F, 2000, PLANT PHYSIOL, V124, P1678, DOI 10.1104/pp.124.4.1678; Frick G, 2003, PLANT J, V35, P141, DOI 10.1046/j.1365-313X.2003.01798.x; Govindjee, 2004, ADV PHOTOSYNTH RESP, V19, P1; Graham MY, 2005, PLANT PHYSIOL, V139, P1784, DOI 10.1104/pp.105.068676; GRIFFITHS WT, 1978, BIOCHEM J, V174, P681, DOI 10.1042/bj1740681; Harpaz-Saad S, 2007, PLANT CELL, V19, P1007, DOI 10.1105/tpc.107.050633; Hayes DJ, 2006, BIOREFINERIES - INDUSTRIAL PROCESSES AND PRODUCTS: STATUS QUO AND FUTURE DIRECTIONS, VOL 1, P139; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HOLTORF H, 1995, P NATL ACAD SCI USA, V92, P3254, DOI 10.1073/pnas.92.8.3254; Holtorf S, 1995, PLANT MOL BIOL, V29, P637, DOI 10.1007/BF00041155; Horigome D, 2007, J BIOL CHEM, V282, P6525, DOI 10.1074/jbc.M609458200; Hu GS, 1998, PLANT CELL, V10, P1095, DOI 10.1105/tpc.10.7.1095; HUKMANI P, 1992, ANAL BIOCHEM, V206, P125, DOI 10.1016/S0003-2697(05)80021-1; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Jilani A, 1996, PHYSIOL PLANTARUM, V96, P139, DOI 10.1111/j.1399-3054.1996.tb00194.x; Jung S, 2008, PLANT MOL BIOL, V67, P535, DOI 10.1007/s11103-008-9338-0; KRUSE E, 1995, EMBO J, V14, P3712, DOI 10.1002/j.1460-2075.1995.tb00041.x; Lebedev N, 1995, PLANT CELL, V7, P2081, DOI 10.1105/tpc.7.12.2081; Ledford HK, 2007, EUKARYOT CELL, V6, P919, DOI 10.1128/EC.00207-06; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; Mohanty S, 2006, PLANTA, V224, P692, DOI 10.1007/s00425-006-0248-6; Mohapatra A, 2002, BIOCHEM BIOPH RES CO, V299, P751, DOI 10.1016/S0006-291X(02)02703-1; Mohapatra A, 2007, PHOTOSYNTH RES, V94, P401, DOI 10.1007/s11120-007-9209-6; Moulin M, 2005, BIOCHEM SOC T, V33, P737, DOI 10.1042/BST0330737; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Oosawa N, 2000, FEBS LETT, V474, P133, DOI 10.1016/S0014-5793(00)01568-4; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Paddock TN, 2010, PLANT MOL BIOL, V72, P445, DOI 10.1007/s11103-009-9582-y; Pattanayak GK, 2005, BIOCHEM BIOPH RES CO, V326, P466, DOI 10.1016/j.bbrc.2004.11.049; Pattanayak GK, 2002, BIOCHEM BIOPH RES CO, V291, P921, DOI 10.1006/bbrc.2002.6543; Pollmann S, 2007, P NATL ACAD SCI USA, V104, P2019, DOI 10.1073/pnas.0610934104; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REBEIZ CA, 1990, PHOTOCHEM PHOTOBIOL, V52, P1099, DOI 10.1111/j.1751-1097.1990.tb08451.x; REBEIZ CA, 1988, CRIT REV PLANT SCI, V6, P385, DOI 10.1080/07352688809382256; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; Richter A, 2010, PLANT CELL PHYSIOL, V51, P670, DOI 10.1093/pcp/pcq047; Runge S, 1996, PLANT J, V9, P513, DOI 10.1046/j.1365-313X.1996.09040513.x; Schmidt K, 2003, BIOCHEMISTRY-US, V42, P7427, DOI 10.1021/bi034207r; Shalygo NV, 1998, J PHOTOCH PHOTOBIO B, V42, P151, DOI 10.1016/S1011-1344(98)00067-0; Sperling U, 1997, PLANT J, V12, P649, DOI 10.1046/j.1365-313X.1997.00649.x; Sperling U, 1998, PLANT CELL, V10, P283, DOI 10.1105/tpc.10.2.283; STOBART AK, 1984, BIOCHEM J, V222, P419, DOI 10.1042/bj2220419; Su QX, 2001, PLANT MOL BIOL, V47, P805, DOI 10.1023/A:1013699721301; TANAKA A, 1994, PLANTA, V192, P92; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tewari AK, 1998, PLANT PHYSIOL, V117, P851, DOI 10.1104/pp.117.3.851; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Tripathy BC, 2007, BBA-BIOENERGETICS, V1767, P860, DOI 10.1016/j.bbabio.2007.03.008; Tripathy BC, 2010, ADV PHOTOSYNTH RESP, V31, P397; TRIPATHY BC, 1991, PLANT PHYSIOL, V96, P761, DOI 10.1104/pp.96.3.761; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Welburn AR, 1984, ADV PHOTOSYNTHESIS R, VII, P9	68	49	50	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26532	10.1371/journal.pone.0026532	http://dx.doi.org/10.1371/journal.pone.0026532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031838	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200027
J	Alcazar, MAA; Morty, RE; Lendzian, L; Vohlen, C; Oestreicher, I; Plank, C; Schneider, H; Dotsch, J				Alcazar, Miguel Angel Alejandre; Morty, Rory E.; Lendzian, Lisa; Vohlen, Christina; Oestreicher, Iris; Plank, Christian; Schneider, Holm; Doetsch, Joerg			Inhibition of TGF-beta Signaling and Decreased Apoptosis in IUGR-Associated Lung Disease in Rats	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; MOUSE LUNG; TRANSFORMING GROWTH-FACTOR-BETA-1; MATRIX METALLOPROTEINASE-1; BRANCHING MORPHOGENESIS; PLACENTAL INSUFFICIENCY; DEVELOPMENTAL ORIGINS; RESPIRATORY HEALTH; TISSUE INHIBITORS; EXPRESSION	Intrauterine growth restriction is associated with impaired lung function in adulthood. It is unknown whether such impairment of lung function is linked to the transforming growth factor (TGF)-beta system in the lung. Therefore, we investigated the effects of IUGR on lung function, expression of extracellular matrix (ECM) components and TGF-beta signaling in rats. IUGR was induced in rats by isocaloric protein restriction during gestation. Lung function was assessed with direct plethysmography at postnatal day (P) 70. Pulmonary activity of the TGF-beta system was determined at P1 and P70. TGF-beta signaling was blocked in vitro using adenovirus-delivered Smad7. At P70, respiratory airway compliance was significantly impaired after IUGR. These changes were accompanied by decreased expression of TGF-beta 1 at P1 and P70 and a consistently dampened phosphorylation of Smad2 and Smad3. Furthermore, the mRNA expression levels of inhibitors of TGF-beta signaling (Smad7 and Smurf2) were reduced, and the expression of TGF-beta-regulated ECM components (e. g. collagen I) was decreased in the lungs of IUGR animals at P1; whereas elastin and tenascin N expression was significantly upregulated. In vitro inhibition of TGF-beta signaling in NIH/3T3, MLE 12 and endothelial cells by adenovirus-delivered Smad7 demonstrated a direct effect on the expression of ECM components. Taken together, these data demonstrate a significant impact of IUGR on lung development and function and suggest that attenuated TGF-beta signaling may contribute to the pathological processes of IUGR-associated lung disease.	[Alcazar, Miguel Angel Alejandre; Vohlen, Christina; Doetsch, Joerg] Univ Cologne, Dept Pediat & Adolescent Med, Cologne, Germany; [Morty, Rory E.] Univ Giessen, Dept Internal Med, Lung Ctr, D-6300 Giessen, Germany; [Oestreicher, Iris] Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany; [Lendzian, Lisa; Plank, Christian; Schneider, Holm] Univ Hosp Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany	University of Cologne; Justus Liebig University Giessen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg	Alcazar, MAA (corresponding author), Univ Cologne, Dept Pediat & Adolescent Med, Cologne, Germany.	miguel.alejandre-alcazar@uk-koeln.de		Alejandre Alcazar, Miguel Angel/0000-0002-3176-0411	Deutsche Forschungsgemeinschaft, Bonn, Germany, Collaborative Research Centre of the German Research Foundation [SFB 423, B13]; Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Erlangen; Koln Fortune, University of Cologne	Deutsche Forschungsgemeinschaft, Bonn, Germany, Collaborative Research Centre of the German Research Foundation(German Research Foundation (DFG)); Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Erlangen; Koln Fortune, University of Cologne	The animal experiments were in part supported by a grant to Jorg Dotsch, Christian Plank and Wolfgang Rascher by the Deutsche Forschungsgemeinschaft, Bonn, Germany; SFB 423, Collaborative Research Centre of the German Research Foundation: Kidney Injury: Pathogenesis and Regenerative Mechanisms, Project B13; by a grant to Christian Plank and Miguel Angel Alejandre Alcazar by the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Erlangen; and by a grant to Miguel Angel Alejandre Alcazar by Koln Fortune, University of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Anand D, 2003, ARCH DIS CHILD, V88, P135, DOI 10.1136/adc.88.2.135; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Boezen HM, 2002, EUR RESPIR J, V20, P383, DOI 10.1183/09031936.02.00234102; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Chen CM, 2004, PEDIATR RES, V56, P329, DOI 10.1203/01.PDR.0000134254.83113.8E; Chen H, 2005, AM J PHYSIOL-LUNG C, V288, pL683, DOI 10.1152/ajplung.00298.2004; Chu WF, 2010, J CELL PHYS IN PRESS; Copland I, 2004, PAEDIAT RESP REV SA, V5, P259, DOI DOI 10.1016/S1526-0542(04)90049-8; Dezateux C, 2004, THORAX, V59, P60; Dik WA, 2001, PEDIATR RES, V50, P761, DOI 10.1203/00006450-200112000-00022; Freathy C, 2000, HEPATOLOGY, V32, P750, DOI 10.1053/jhep.2000.18329; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Hosford GE, 2004, PEDIATR RES, V56, P26, DOI 10.1203/01.PDR.0000130658.45564.1F; Jankov RP, 2004, PAEDIAT RESP REV SA, V5, P265; Joss-Moore LA, 2011, PHYSL GENOM IN PRESS; Joss-Moore LA, 2011, BIRTH DEF A IN PRESS; Joyce BJ, 2001, PEDIATR RES, V50, P641, DOI 10.1203/00006450-200111000-00018; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Ke XR, 2010, PHYSIOL GENOMICS, V42, P177, DOI 10.1152/physiolgenomics.00201.2009; Kotecha SJ, 2010, AM J RESP CRIT CARE, V181, P969, DOI 10.1164/rccm.200906-0897OC; LangleyEvans SC, 1997, J NUTR, V127, P202, DOI 10.1093/jn/127.2.202; Liu J, 2000, DEV DYNAM, V217, P343, DOI 10.1002/(SICI)1097-0177(200004)217:4<343::AID-DVDY2>3.0.CO;2-F; Maritz GS, 2005, EARLY HUM DEV, V81, P763, DOI 10.1016/j.earlhumdev.2005.07.002; Maritz GS, 2004, PEDIATR RES, V55, P287, DOI 10.1203/01.PDR.0000106314.99930.65; Maritz GS, 2001, PEDIATR PULM, V32, P201, DOI 10.1002/ppul.1109; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masumoto K, 2005, HISTOPATHOLOGY, V47, P410, DOI 10.1111/j.1365-2559.2005.02228.x; McDevitt TM, 2007, AM J PHYSIOL-LUNG C, V292, pL249, DOI 10.1152/ajplung.00088.2006; Morty Rory E, 2009, Proc Am Thorac Soc, V6, P607, DOI 10.1513/pats.200908-087RM; Nicola T, 2011, AM J PHYSIOL-LUNG C, V301, pL125, DOI 10.1152/ajplung.00074.2011; Nusken KD, 2011, ENDOCRINOLO IN PRESS; Nuyt AM, 2008, CLIN SCI, V114, P1, DOI 10.1042/CS20070113; Ostlund E, 2002, OBSTET GYNECOL, V100, P567, DOI 10.1016/S0029-7844(02)02173-7; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Plank C, 2006, KIDNEY INT, V70, P1974, DOI 10.1038/sj.ki.5001966; Pulichino AM, 2008, AM J RESP CELL MOL, V39, P324, DOI 10.1165/rcmb.2007-0186OC; RONA RJ, 1993, BMJ-BRIT MED J, V306, P817, DOI 10.1136/bmj.306.6881.817; Roth-Kleiner M, 2005, PEDIATR PULM, V40, P113, DOI 10.1002/ppul.20252; Roth-Kleiner M, 2003, BIOL NEONATE, V84, P83, DOI 10.1159/000071009; RYAN RM, 1994, AM J PHYSIOL, V266, pL17, DOI 10.1152/ajplung.1994.266.1.L17; Ryu J, 2005, THROMB HAEMOSTASIS, V94, P175, DOI 10.1160/TH04-10-0656; Simmons RA, 2007, PEDIATR RES, V61, p64R, DOI 10.1203/pdr.0b013e3180457623; Song JS, 2011, EXP MOL MED IN PRESS; Torrance HL, 2008, EARLY HUM DEV, V84, P465, DOI 10.1016/j.earlhumdev.2007.12.006; Undevia NS, 2004, AM J PHYSIOL-LUNG C, V287, pL515, DOI 10.1152/ajplung.00044.2004; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Vicencio AG, 2002, J APPL PHYSIOL, V93, P1123, DOI 10.1152/japplphysiol.00031.2002; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Warburton D, 2004, PAEDIAT RESP REV SA, V5, P283; Zhang FJ, 2004, AM J RESP CELL MOL, V31, P679, DOI 10.1165/rcmb.2004-0182OC; Zhao JS, 2000, J BIOL CHEM, V275, P23992, DOI 10.1074/jbc.M002433200; Zhao JS, 1998, DEV BIOL, V194, P182, DOI 10.1006/dbio.1997.8825; Zhao JS, 1996, DEV BIOL, V180, P242, DOI 10.1006/dbio.1996.0298; Zhao Y, 1999, MOL CELL ENDOCRINOL, V150, P91, DOI 10.1016/S0303-7207(99)00021-0	58	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26371	10.1371/journal.pone.0026371	http://dx.doi.org/10.1371/journal.pone.0026371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028866	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800038
J	Espinoza, JL; Takami, A; Nakata, K; Onizuka, M; Kawase, T; Akiyama, H; Miyamura, K; Morishima, Y; Fukuda, T; Kodera, Y; Nakao, S				Espinoza, J. Luis; Takami, Akiyoshi; Nakata, Katsuya; Onizuka, Makoto; Kawase, Takakazu; Akiyama, Hideki; Miyamura, Koichi; Morishima, Yasuo; Fukuda, Takahiro; Kodera, Yoshihisa; Nakao, Shinji		Japan Marrow Donor Program	A Genetic Variant in the IL-17 Promoter Is Functionally Associated with Acute Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS SYNOVIOCYTES; INFLAMMATORY-BOWEL-DISEASE; RENAL-ALLOGRAFT REJECTION; ACTIVATED T-CELLS; NUCLEAR FACTOR; HLA ALLELE; INTERLEUKIN-17; DONOR; EXPRESSION; RISK	Interleukin IL-17 is a proinflammatory cytokine that has been implicated in the pathogenesis of various autoimmune diseases. The single nucleotide polymorphism (SNP), rs2275913, in the promoter region of the IL-17 gene is associated with susceptibility to ulcerative colitis. When we examined the impact of rs2275913 in a cohort consisting of 438 pairs of patients and their unrelated donors transplanted through the Japan Marrow Donor Program, the donor IL-17 197A allele was found to be associated with a higher risk of acute graft-versus-host disease (GVHD; hazard ratio [HR], 1.46; 95% confidence interval [CI], 1.00 to 2.13; P = 0.05). Next, we investigated the functional relevance of the rs2275913 SNP. In vitro stimulated T cells from healthy individuals possessing the 197A allele produced significantly more IL-17 than those without the 197A allele. In a gene reporter assay, the 197A allele construct induced higher luciferase activity than the 197G allele, and the difference was higher in the presence of T cell receptor activation and was abrogated by cyclosporine treatment. Moreover, the 197A allele displayed a higher affinity for the nuclear factor activated T cells (NFAT), a critical transcription factor involved in IL-17 regulation. These findings substantiate the functional relevance of the rs2275913 polymorphism and indicate that the higher IL-17 secretion by individuals with the 197A allele likely accounts for their increased risk for acute GVHD and certain autoimmune diseases.	[Espinoza, J. Luis; Takami, Akiyoshi; Nakata, Katsuya; Nakao, Shinji] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan; [Onizuka, Makoto] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Kawase, Takakazu; Morishima, Yasuo] Aichi Canc Res Ctr, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Akiyama, Hideki] Komagome Hosp, Div Hematol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Dept Promot Blood & Marrow Transplantat, Nagoya, Aichi, Japan	Kanazawa University; Tokai University; Aichi Cancer Center; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Red Cross Nagoya Daiichi Hospital; National Cancer Center - Japan; Aichi Medical University	Espinoza, JL (corresponding author), Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan.	takami@med3.m.kanazawa-u.ac.jp	Takami, Akiyoshi/O-5677-2019; Espinoza, Luis/L-1586-2013	Takami, Akiyoshi/0000-0002-1822-9976; Espinoza, Luis/0000-0002-1794-6666; ONIZUKA, MAKOTO/0000-0003-3864-0823	Ministry of Health, Labor and Welfare of Japan [H23-010]; Ministry of Education, Culture, Sports and Technology of Japan; Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan); Hokkoku Gan Kikin Fund (Kanazawa, Japan)	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan); Hokkoku Gan Kikin Fund (Kanazawa, Japan)	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports and Technology of Japan, and Funds from the Mitani Research and Development Assistance Organization (Kanazawa, Japan), by the Japan Leukemia Research Fund (Tokyo, Japan), and by Hokkoku Gan Kikin Fund (Kanazawa, Japan). This work was supported in part by the Research on Allergic Disease and Immunology (H23-010) in Health and Labor Science Grant from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, J RHEUMATOL, V35, P515; Antonysamy MA, 1999, J IMMUNOL, V162, P577; Arisawa T, 2008, J CLIN IMMUNOL, V28, P44, DOI 10.1007/s10875-007-9125-8; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Chabaud M, 1998, J IMMUNOL, V161, P409; Ciprandi G., 2009, ALLERGY; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; ESPINOZA JL, 2011, BONE MARROW TRANSPLA; Espinoza LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023827; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; ICLOZAN C, 2009, BIOL BLOOD MARROW TR; Kappel LW, 2009, BLOOD, V113, P945, DOI 10.1182/blood-2008-08-172155; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Kim DH, 2007, TRANSPLANTATION, V84, P917, DOI 10.1097/01.tp.0000284583.15810.6e; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Kitamura N, 2006, J IMMUNOL METHODS, V312, P105, DOI 10.1016/j.jim.2006.02.015; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li X, 2010, BIOCHEM BIOPH RES CO, V397, P131, DOI 10.1016/j.bbrc.2010.05.111; Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Loong CC, 2002, J PATHOL, V197, P322, DOI 10.1002/path.1117; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Morishima Y, 2007, BIOL BLOOD MARROW TR, V13, P315, DOI 10.1016/j.bbmt.2006.10.027; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Rowlings PA, 1997, BRIT J HAEMATOL, V97, P855, DOI 10.1046/j.1365-2141.1997.1112925.x; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Shibata T, 2009, HUM IMMUNOL, V70, P547, DOI 10.1016/j.humimm.2009.04.030; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Soyland E, 2011, BRIT J DERMATOL, V164, P344, DOI 10.1111/j.1365-2133.2010.10149.x; Sugihara T, 2010, CLIN EXP IMMUNOL, V160, P386, DOI 10.1111/j.1365-2249.2010.04093.x; Tawara I, 2008, EXP HEMATOL, V36, P988, DOI 10.1016/j.exphem.2008.02.010; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Vanaudenaerde BM, 2006, EUR RESPIR J, V27, P779, DOI 10.1183/09031936.06.00019405; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	45	150	157	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26229	10.1371/journal.pone.0026229	http://dx.doi.org/10.1371/journal.pone.0026229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028838	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800029
J	Morard, R; Quillevere, F; Douady, CJ; de Vargas, C; de Garidel-Thoron, T; Escarguel, G				Morard, Raphael; Quillevere, Frederic; Douady, Christophe J.; de Vargas, Colomban; de Garidel-Thoron, Thibault; Escarguel, Gilles			Worldwide Genotyping in the Planktonic Foraminifer Globoconella inflata: Implications for Life History and Paleoceanography	PLOS ONE			English	Article							MOLECULAR EVIDENCE; GENETIC TYPES; DIVERSITY; BACILLARIOPHYCEAE; RECONSTRUCTION; DIVERGENCE; SIGNATURE	The planktonic foraminiferal morpho-species Globoconella inflata is widely used as a stratigraphic and paleoceanographic index. While G. inflata was until now regarded as a single species, we show that it rather constitutes a complex of two pseudo-cryptic species. Our study is based on SSU and ITS rDNA sequence analyses and genotyping of 497 individuals collected at 49 oceanic stations covering the worldwide range of the morpho-species. Phylogenetic analyses unveil the presence of two divergent genotypes. Type I inhabits transitional and subtropical waters of both hemispheres, while Type II is restricted to the Antarctic subpolar waters. The two genetic species exhibit a strictly allopatric distribution on each side of the Antarctic Subpolar Front. On the other hand, sediment data show that G. inflata was restricted to transitional and subtropical environments since the early Pliocene, and expanded its geographic range to southern subpolar waters similar to 700 kyrs ago, during marine isotopic stage 17. This datum may correspond to a peripatric speciation event that led to the partition of an ancestral genotype into two distinct evolutionary units. Biometric measurements performed on individual G. inflata from plankton tows north and south of the Antarctic Subpolar Front indicate that Types I and II display slight but significant differences in shell morphology. These morphological differences may allow recognition of the G. inflata pseudo-cryptic species back into the fossil record, which in turn may contribute to monitor past movements of the Antarctic Subpolar Front during the middle and late Pleistocene.	[Morard, Raphael; Quillevere, Frederic; Escarguel, Gilles] Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon Terre Planetes Environm, F-69622 Villeurbanne, France; [Morard, Raphael; de Vargas, Colomban] UPMC, CNRS, UMR Evolut Plancton & PaleoOceans 7144, Stn Biol Roscoff, Roscoff, France; [Douady, Christophe J.] Univ Lyon 1, CNRS, UMR Ecol Hydrosyst Fluviaux 5023, F-69622 Villeurbanne, France; [Douady, Christophe J.] Inst Univ France, Paris, France; [de Garidel-Thoron, Thibault] Aix Marseille Univ, CEREGE UMR6635, Aix En Provence, France; [de Garidel-Thoron, Thibault] CNRS, CEREGE UMR6635, Aix En Provence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Morard, R (corresponding author), Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon Terre Planetes Environm, F-69622 Villeurbanne, France.	raphael.morard@sb-roscoff.fr	Douady, Christophe J/N-1357-2014; Escarguel, Gilles/C-3297-2011; de Garidel-Thoron, Thibault/B-1204-2008; Douady, Christophe/N-3069-2019; Quillévéré, Frédéric/C-8317-2012	Douady, Christophe J/0000-0002-4503-8040; de Garidel-Thoron, Thibault/0000-0001-8983-9571; Douady, Christophe/0000-0002-4503-8040; Escarguel, Gilles/0000-0003-0985-6369; de Vargas, Colomban/0000-0002-6476-6019; Quillevere, Frederic/0000-0002-6248-0447	Universite Lyon 1 (Molecular analysis and morphometric analysis) [IFR41]; INSU INTERRVIE program (Molecular analysis and morphometric analysis); Fondation pour la Recherche sur la Biodiversite [ANR-06-JCJC-0142 PALEO-CTD]; ANR Blanc FORCLIM [ANR-09-BLAN-0348 POSEIDON]; BIOMARKS - Biodiversity of marine eukaryotes; Eranet Biodiversa	Universite Lyon 1 (Molecular analysis and morphometric analysis); INSU INTERRVIE program (Molecular analysis and morphometric analysis); Fondation pour la Recherche sur la Biodiversite; ANR Blanc FORCLIM(French National Research Agency (ANR)); BIOMARKS - Biodiversity of marine eukaryotes; Eranet Biodiversa	The authors declare funding from the following programs (see details for the role of each funders): Grants from the IFR41 of Universite Lyon 1 (Molecular analysis and morphometric analysis); INSU INTERRVIE program (Molecular analysis and morphometric analysis); Fondation pour la Recherche sur la Biodiversite: (morphometric analysis); ANR-06-JCJC-0142 PALEO-CTD (sample collection); ANR Blanc FORCLIM (sample collection); ANR-09-BLAN-0348 POSEIDON (molecular analysis); BIOMARKS - Biodiversity of marine eukaryotes, funded by the FP7 Eranet Biodiversa (Molecular analysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Be A.W.H., 1977, ECOLOGICAL ZOOGEOGRA; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; Beszteri B, 2005, PROTIST, V156, P317, DOI 10.1016/j.protis.2005.07.002; Bolli HM, 1985, PLANKTON STRATIGRAPH, P228; Bowser Samuel S., 2008, P78; Brayard A, 2005, J ZOOL SYST EVOL RES, V43, P178, DOI 10.1111/j.1439-0469.2005.00311.x; Carter L., 2008, DEV EARTH ENV SCI, P85, DOI DOI 10.1016/S1571-9197(08)00004-9; Casteleyn G, 2008, HARMFUL ALGAE, V7, P241, DOI 10.1016/j.hal.2007.08.004; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chiessi CM, 2007, MAR MICROPALEONTOL, V64, P52, DOI 10.1016/j.marmicro.2007.02.002; Cleroux C, 2007, GEOCHEMISTERY GEOPHY, V8, P1; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001189; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Vargas C, 2001, PALEOBIOLOGY, V27, P104, DOI 10.1666/0094-8373(2001)027<0104:PARIGT>2.0.CO;2; de Vargas C, 2002, MAR MICROPALEONTOL, V45, P101, DOI 10.1016/S0377-8398(02)00037-3; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; DIETRICH G, 1980, GEN OCEANOGRAPHY; FAIRBANKS RG, 1982, NATURE, V298, P841, DOI 10.1038/298841a0; Farmer EC, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001361; Ganssen GM, 2000, J GEOL SOC LONDON, V157, P693, DOI 10.1144/jgs.157.3.693; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Huber BT, 1997, PALEOBIOLOGY, V23, P33, DOI 10.1017/S0094837300016638; Katz ME, 2010, J FORAMIN RES, V40, P165, DOI 10.2113/gsjfr.40.2.165; KEANY J, 1972, DEEP-SEA RES, V19, P529, DOI 10.1016/0011-7471(72)90038-1; Keigwin LD, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001074; Kennett J.P., 1983, NEOGENE PLANKTONIC F; KENNETT JP, 1970, DEEP-SEA RES, V17, P125, DOI 10.1016/0011-7471(70)90092-6; King AL, 2005, MAR MICROPALEONTOL, V56, P1, DOI 10.1016/j.marmicro.2005.02.008; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kucera M, 2005, QUATERNARY SCI REV, V24, P813, DOI 10.1016/j.quascirev.2004.07.017; KUSTANOWICH S., 1963, NEW ZEALAND J GEOL AND GEOPHYS, V6, P534; Locarnini RA, 2006, WORLD OCEAN ATLAS, V61; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; NORRIS RD, 1994, MAR MICROPALEONTOL, V23, P121, DOI 10.1016/0377-8398(94)90004-3; Pawlowski J, 2007, MOL ECOL, V16, P4089, DOI 10.1111/j.1365-294X.2007.03465.x; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRELL WL, 1999, DATA CONTRIBUTION SE; Quillevere F, 2011, PALAEOGEOGR IN PRESS; Ravelo AC, 1992, PALEOCEANOGRAPHY, V7, P815, DOI 10.1029/92PA02092; Scott GH, 2007, MAR MICROPALEONTOL, V62, P235, DOI 10.1016/j.marmicro.2006.08.007; Sokal R. R., 2012, BIOMETRY; Stewart IA, 2001, MAR MICROPALEONTOL, V43, P143, DOI 10.1016/S0377-8398(01)00024-X; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Van Oppen MJH, 2005, MOL ECOL, V14, P2403, DOI 10.1111/j.1365-294X.2005.02545.x; Vanormelingen P, 2008, PROTIST, V159, P73, DOI 10.1016/j.protis.2007.08.004; Wilke I, 2006, MAR MICROPALEONTOL, V58, P243, DOI 10.1016/j.marmicro.2005.11.005	61	35	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26665	10.1371/journal.pone.0026665	http://dx.doi.org/10.1371/journal.pone.0026665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028935	Green Published, gold			2022-12-25	WOS:000296510800064
J	Sadik, CD; Kim, ND; Alekseeva, E; Luster, AD				Sadik, Christian D.; Kim, Nancy D.; Alekseeva, Elena; Luster, Andrew D.			IL-17RA Signaling Amplifies Antibody-Induced Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; AUTOANTIBODY-MEDIATED ARTHRITIS; RHEUMATOID-ARTHRITIS; T-CELLS; CXC CHEMOKINE; MAST-CELLS; TH17 CELLS; INTERLEUKIN-17; EXPRESSION; MICE	Objective: To investigate the role of IL-17RA signaling in the effector phase of inflammatory arthritis using the K/BxN serum-transfer model. Methods: Wild-type and Il17ra(-/-) mice were injected with serum isolated from arthritic K/BxN mice and their clinical score was recorded daily. Mice were also harvested on days 12 and 21 and ankles were analyzed for cytokine and chemokine mRNA expression by qPCR on day 12 and for bone and cartilage erosions by histology on day 21, respectively. The induction of cytokine and chemokine expression levels by IL-17A in synovial-like fibroblasts was also analyzed using qPCR. Results: Il17ra(-/-) mice were partially protected from clinical signs of arthritis and had markedly fewer cartilage and bone erosions. The expression of several pro-inflammatory mediators, including the chemokines KC/CXCL1, MIP-2/CXCL2, LIX/CXCL5 MIP-1c/CCL9, MCP-3/CCL7, MIP-3a/CCL20, the cytokines IL-1b, IL-6, RANKL and the matrix metalloproteinases MMP2, MMP3, and MMP13 were decreased in the ankles of Il17ra(-/-) mice compared to wild-type mice. Many of these proinflammatory genes attenuated in the ankles of Il17ra(-/-) mice were shown to be directly induced by IL-17A in synovial fibroblasts in vitro. Conclusions: IL-17RA signaling plays a role as an amplifier of the effector phase of inflammatory arthritis. This effect is likely mediated by direct activation of synovial fibroblasts by IL-17RA to produce multiple inflammatory mediators, including chemokines active on neutrophils. Therefore, interrupting IL-17RA signaling maybe a promising pharmacological target for the treatment of inflammatory arthritis.	[Sadik, Christian D.; Kim, Nancy D.; Alekseeva, Elena; Luster, Andrew D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sadik, CD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02115 USA.	aluster@mgh.harvard.edu	Sadik, Christian/E-8404-2012; Sadik, Christian David/G-9593-2014; Luster, Andrew/ABE-6504-2020	Sadik, Christian David/0000-0001-6701-048X; Luster, Andrew/0000-0001-9679-7912	Deutsche Forschungsgemeinschaft [Sa1960/1-1]; National Institutes of Health [R01-AI050892, K08-AR054094]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054094] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (Sa1960/1-1 to C. D. S.; www.dfg.de)) and of the National Institutes of Health (R01-AI050892 to A. D. L. and K08-AR054094 to N.D.K.; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Doodes PD, 2008, J IMMUNOL, V181, P329, DOI 10.4049/jimmunol.181.1.329; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hu Y, 2010, J IMMUNOL; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Koenders MI, 2006, J IMMUNOL, V176, P6262, DOI 10.4049/jimmunol.176.10.6262; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Lubberts E, 2010, SEMIN IMMUNOPATHOL, V32, P43, DOI 10.1007/s00281-009-0189-9; Matsui T, 2001, CLIN EXP IMMUNOL, V125, P155, DOI 10.1046/j.1365-2249.2001.01542.x; Matsuyama Y, 2010, J RHEUMATOL, V37, P18, DOI 10.3899/jrheum.090492; Monach PA, 2010, ARTHRITIS RHEUM-US, V62, P753, DOI 10.1002/art.27238; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Nigrovic PA, 2010, ARTHRITIS RHEUM-US, V62, P3322, DOI 10.1002/art.27659; Okamatsu Y, 2004, J IMMUNOL, V173, P2084, DOI 10.4049/jimmunol.173.3.2084; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pappu R, 2010, J CLIN IMMUNOL, V30, P185, DOI 10.1007/s10875-010-9369-6; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Verri Jr. W.A., 2010, ANN RHEUM DIS; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	44	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26342	10.1371/journal.pone.0026342	http://dx.doi.org/10.1371/journal.pone.0026342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028860	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800036
J	Kuwana, Y; Takei, M; Yajima, M; Imadome, KI; Inomata, H; Shiozaki, M; Ikumi, N; Nozaki, T; Shiraiwa, H; Kitamura, N; Takeuchi, J; Sawada, S; Yamamoto, N; Shimizu, N; Ito, M; Fujiwara, S				Kuwana, Yoshikazu; Takei, Masami; Yajima, Misako; Imadome, Ken-Ichi; Inomata, Hirotake; Shiozaki, Masaaki; Ikumi, Natsumi; Nozaki, Takamasa; Shiraiwa, Hidetaka; Kitamura, Noboru; Takeuchi, Jin; Sawada, Shigemasa; Yamamoto, Naoki; Shimizu, Norio; Ito, Mamoru; Fujiwara, Shigeyoshi			Epstein-Barr Virus Induces Erosive Arthritis in Humanized Mice	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; RHEUMATOID-ARTHRITIS; NUCLEAR ANTIGEN; GLYCOPROTEIN GP110; T-CELLS; EPITOPE; CHAIN; LOAD; INFECTION; FREQUENCY	Epstein-Barr virus (EBV) has been implicated in the pathogenesis of rheumatoid arthritis (RA) on the basis of indirect evidence, such as its presence in affected joint tissues, antigenic cross reactions between EBV and human proteins, and elevated humoral and cellular anti-EBV immune responses in patients. Here we report development of erosive arthritis closely resembling RA in humanized mice inoculated with EBV. Human immune system components were reconstituted in mice of the NOD/Shi-scid/IL-2R gamma(null) (NOG) strain by transplantation with CD34(+) hematopoietic stem cells isolated from cord blood. These humanized mice were then inoculated with EBV and examined pathologically for the signs of arthritis. Erosive arthritis accompanied by synovial membrane proliferation, pannus formation, and bone marrow edema developed in fifteen of twenty-three NOG mice transplanted with human HSC and inoculated with EBV, but not in the nine NOG mice that were transplanted with HSC but not inoculated with EBV. This is the first report of an animal model of EBV-induced arthritis and strongly suggest a causative role of the virus in RA.	[Kuwana, Yoshikazu; Takei, Masami; Inomata, Hirotake; Shiozaki, Masaaki; Ikumi, Natsumi; Nozaki, Takamasa; Shiraiwa, Hidetaka; Kitamura, Noboru; Takeuchi, Jin; Sawada, Shigemasa] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol, Tokyo, Japan; [Yajima, Misako; Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Imadome, Ken-Ichi; Fujiwara, Shigeyoshi] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo, Japan; [Shimizu, Norio] Tokyo Med & Dent Univ, Med Res Inst, Div Med Sci, Dept Virol, Tokyo, Japan; [Ito, Mamoru] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan	Nihon University; National University of Singapore; National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU)	Kuwana, Y (corresponding author), Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol, Tokyo, Japan.	takei.masami@nihon-u.ac.jp; shige@nch.go.jp	Yajima, Misako/ABH-7217-2020	Yajima, Misako/0000-0002-6437-1404	Ministry of Health, Labour and Welfare of Japan [H22-Nanchi-080, H22-AIDS-002]; National Center for Child Health and Development [22A-9]; MEXT [S0801033 2010]; Grants-in-Aid for Scientific Research [22590430] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Health, Labour and Welfare of Japan (H22-Nanchi-080 and H22-AIDS-002:http://www.mhlw.go.jp/), the Grant of National Center for Child Health and Development (22A-9:http://www.ncchd.go.jp/), and Strategic Research Base Development; Program for Private Universities subsidized by MEXT (S0801033 2010: http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAUGH MA, 1978, J EXP MED, V147, P1018, DOI 10.1084/jem.147.4.1018; Balandraud N, 2003, ARTHRITIS RHEUM, V48, P1223, DOI 10.1002/art.10933; BILLINGS PB, 1983, P NATL ACAD SCI-BIOL, V80, P7104, DOI 10.1073/pnas.80.23.7104; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; FOX R, 1986, J CLIN INVEST, V77, P1539, DOI 10.1172/JCI112469; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Lunemann JD, 2008, J IMMUNOL, V181, P991, DOI 10.4049/jimmunol.181.2.991; OCHI T, 1988, J RHEUMATOL, V15, P1609; RHODES G, 1985, J IMMUNOL, V134, P211; ROUDIER J, 1988, SCAND J IMMUNOL, V27, P367, DOI 10.1111/j.1365-3083.1988.tb02359.x; ROUDIER J, 1989, P NATL ACAD SCI USA, V86, P5104, DOI 10.1073/pnas.86.13.5104; RUMPOLD H, 1987, J IMMUNOL, V138, P593; Scotet E, 1996, J EXP MED, V184, P1791, DOI 10.1084/jem.184.5.1791; Takei M, 2001, INT IMMUNOL, V13, P559, DOI 10.1093/intimm/13.4.559; Takei M, 1997, INT IMMUNOL, V9, P739, DOI 10.1093/intimm/9.5.739; TOSATO G, 1981, NEW ENGL J MED, V305, P1238, DOI 10.1056/NEJM198111193052102; TOSATO G, 1984, J CLIN INVEST, V73, P1789, DOI 10.1172/JCI111388; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502; Yajima M, 2009, J INFECT DIS, V200, P1611, DOI 10.1086/644644	21	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26630	10.1371/journal.pone.0026630	http://dx.doi.org/10.1371/journal.pone.0026630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028930	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500101
J	Rothermel, M; Ng, BSW; Grabska-Barwinska, A; Hatt, H; Jancke, D				Rothermel, Markus; Ng, Benedict Shien Wei; Grabska-Barwinska, Agnieszka; Hatt, Hanns; Jancke, Dirk			Nasal Chemosensory-Stimulation Evoked Activity Patterns in the Rat Trigeminal Ganglion Visualized by In Vivo Voltage-Sensitive Dye Imaging	PLOS ONE			English	Article							OLFACTORY-BULB; CAPSAICIN RECEPTOR; RESPONSES; DYNAMICS; NEURONS; CORTEX; SYSTEM; ORGANIZATION; ACTIVATION; CHANNELS	Mammalian nasal chemosensation is predominantly mediated by two independent neuronal pathways, the olfactory and the trigeminal system. Within the early olfactory system, spatiotemporal responses of the olfactory bulb to various odorants have been mapped in great detail. In contrast, far less is known about the representation of volatile chemical stimuli at an early stage in the trigeminal system, the trigeminal ganglion (TG), which contains neurons directly projecting to the nasal cavity. We have established an in vivo preparation that allows high-resolution imaging of neuronal population activity from a large region of the rat TG using voltage-sensitive dyes (VSDs). Application of different chemical stimuli to the nasal cavity elicited distinct, stimulus-category specific, spatiotemporal activation patterns that comprised activated as well as suppressed areas. Thus, our results provide the first direct insights into the spatial representation of nasal chemosensory information within the trigeminal ganglion imaged at high temporal resolution.	[Rothermel, Markus; Hatt, Hanns] Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Bochum, Germany; [Grabska-Barwinska, Agnieszka; Jancke, Dirk] Ruhr Univ Bochum, Bernstein Grp Computat Neurosci, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Rothermel, M (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Bochum, Germany.	Hanns.Hatt@rub.de	Rothermel, Markus/T-6848-2018; Jancke, Dirk/A-6721-2015; Jancke, Dirk/A-2961-2015	Rothermel, Markus/0000-0002-0929-993X; Jancke, Dirk/0000-0001-8440-6259	DFG [SFB-509]; BMBF (Bundesministerium fur Bildung und Forschung); International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, Germany; Wilhelm und Gunter Esser Stiftung, Ruhr-University Bochum, Germany	DFG(German Research Foundation (DFG)); BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, Germany; Wilhelm und Gunter Esser Stiftung, Ruhr-University Bochum, Germany	Deutsche Forschungsgemeinschaft: Collaborative Research Centre SFB 874 (Integration and Representation of Sensory Processes), Graduiertenkolleg 736 "Development and Plasticity of the Nervous System: Molecular, Synaptic and Cellular Mechanisms'', Ruhr-University Bochum, Germany [http://www.ruhr-uni-bochum.de/neuro-gk/] (MR, HH), Ruhr-University Research School funded by the DFG in the framework of the Excellence Initiative [http://www.research-school.rub.de/] (MR, BN, HH, DJ), DFG Neurovision SFB-509 [http://www.dfg.de/]); BMBF (Bundesministerium fur Bildung und Forschung, start-up Junior Professorship, Bernstein Group for Computational Neuroscience) [http://www.bmbf.de/] (DJ), International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, Germany [http://www. ruhr-uni-bochum.de/igsn/index.shtml] (BN, HH, DJ), Wilhelm und Gunter Esser Stiftung, Ruhr-University Bochum, Germany [http://www.ruhr-uni-bochum.de/] (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohammadi H, 2000, CHEM SENSES, V25, P61, DOI 10.1093/chemse/25.1.61; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BELMONTE C, 1991, J PHYSIOL-LONDON, V437, P709, DOI 10.1113/jphysiol.1991.sp018621; Belmonte Carlos, 2004, Ocul Surf, V2, P248; Belmonte C, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-14; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Damann N, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-46; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Elsberg CA, 1935, B NEUROL I NY, V4, P270; FELDMAN JL, 1995, REGULATION BREATHING, P39; Greene E.C., 1935, T AM PHILOS SOC, V27, P1, DOI DOI 10.2307/1005513; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hummel T, 2000, INT J PSYCHOPHYSIOL, V36, P147, DOI 10.1016/S0167-8760(99)00108-7; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; JESSEL TM, 2000, PRINCIPLES NEURAL SC, P430; Laska M, 1997, CHEM SENSES, V22, P447, DOI 10.1093/chemse/22.4.447; Leiser SC, 2006, J NEUROPHYSIOL, V95, P3129, DOI 10.1152/jn.00157.2005; MARFURT CF, 1981, ANAT REC, V201, P105, DOI 10.1002/ar.1092010113; Palagina G, 2009, P NATL ACAD SCI USA, V106, P8743, DOI 10.1073/pnas.0900068106; Parker GH, 1912, J ACAD NATL SCI PHIL, V15, P221; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; RENNER B, 1998, 20 ANN M ASS CHEM SC, P602; Rothermel M, 2009, J NEUROVIROL, V15, P458, DOI 10.3109/13550280903473460; Sandler VM, 1998, NEUROSCIENCE, V83, P891, DOI 10.1016/S0306-4522(97)00415-6; Sekizawa S, 1996, RESP PHYSIOL, V103, P211, DOI 10.1016/0034-5687(95)00091-7; Sharon D, 2007, CEREB CORTEX, V17, P2866, DOI 10.1093/cercor/bhm019; SILVER WL, 1982, PHYSIOL BEHAV, V28, P927, DOI 10.1016/0031-9384(82)90216-5; SILVER WL, 1990, CHEM SENSES, V15, P701, DOI 10.1093/chemse/15.6.701; SILVER WL, 1991, SMELL TASTE HLTH DIS, P97; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Sterkin A, 1998, NEUROSCI LETT, pS41; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Thuerauf N, 1999, PSYCHOPHARMACOLOGY, V142, P236, DOI 10.1007/s002130050885; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; Tucker D., 1971, P151; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wise PM, 2003, CHEM SENSES, V28, P751, DOI 10.1093/chemse/bjg065; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; YU HH, 1974, BRAIN RES, V75, P328, DOI 10.1016/0006-8993(74)90756-2	44	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26158	10.1371/journal.pone.0026158	http://dx.doi.org/10.1371/journal.pone.0026158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039441	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500035
J	Zhang, WZ; Yano, N; Deng, MZ; Mao, QF; Shaw, SK; Tseng, YT				Zhang, Weizhi; Yano, Naohiro; Deng, Minzi; Mao, Quanfu; Shaw, Sunil K.; Tseng, Yi-Tang			beta-Adrenergic Receptor-PI3K Signaling Crosstalk in Mouse Heart: Elucidation of Immediate Downstream Signaling Cascades	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; FOXO TRANSCRIPTION FACTORS; PROTEIN-KINASE-B; CARDIAC-HYPERTROPHY; BETA(2)-ADRENERGIC RECEPTORS; CARDIOMYOCYTE HYPERTROPHY; MYOCARDIAL-CONTRACTILITY; MUSCLE ATROPHY; ACTIVATION; AKT	Sustained beta-adrenergic receptors (beta AR) activation leads to cardiac hypertrophy and prevents left ventricular (LV) atrophy during LV unloading. The immediate signaling pathways downstream from bAR stimulation, however, have not been well investigated. The current study was to examine the early cardiac signaling mechanism(s) following bAR stimulation. In adult C57BL/6 mice, acute beta AR stimulation induced significant increases in PI3K activity and activation of Akt and ERK1/2 in the heart, but not in lungs or livers. In contrast, the same treatment did not elicit these changes in beta(1)/beta(2)AR double knockout mice. We further showed the specificity of beta(2)AR in this crosstalk as treatment with formoterol, a beta(2)AR-selective agonist, but not dobutamine, a predominantly beta(1)AR agonist, activated cardiac Akt and ERK1/2. Acute beta AR stimulation also significantly increased the phosphorylation of mTOR (the mammalian target of rapamycin), P70S6K, ribosomal protein S6, GSK-3 alpha/beta (glycogen synthase kinase-3 alpha/beta), and FOXO1/3a (the forkhead box family of transcription factors 1 and 3a). Moreover, acute beta AR stimulation time-dependently decreased the mRNA levels of the muscle-specific E3 ligases atrogin-1 and muscle ring finger protein-1 (MuRF1) in mouse heart. Our results indicate that acute beta AR stimulation in vivo affects multiple cardiac signaling cascades, including the PI3K signaling pathway, ERK1/2, atrogin-1 and MuRF1. These data 1) provide convincing evidence for the crosstalk between beta AR and PI3K signaling pathways; 2) confirm the beta(2)AR specificity in this crosstalk in vivo; and 3) identify novel signaling factors involved in cardiac hypertrophy and LV unloading. Understanding of the intricate interplay between beta(2)AR activation and these signaling cascades should provide critical clues to the pathogenesis of cardiac hypertrophy and enable identification of targets for early clinical interaction of cardiac lesions.	[Zhang, Weizhi] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China; [Zhang, Weizhi; Yano, Naohiro; Deng, Minzi; Mao, Quanfu; Shaw, Sunil K.; Tseng, Yi-Tang] Brown Univ, Women & Infants Hosp, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02908 USA	Central South University; Brown University; Women & Infants Hospital Rhode Island	Zhang, WZ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China.	YTseng@wihri.org		Shaw, Sunil/0000-0001-9701-6065	National Institutes of Health [1 P20 RR018728, R21 HL093561]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant 1 P20 RR018728 (to Y.T.T and S. K. S), and by National Institutes of Health R21 HL093561 (to S. K. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; CARON MG, 1993, RECENT PROG HORM RES, V48, P277; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Gong HB, 2002, CIRCULATION, V105, P2497, DOI 10.1161/01.CIR.0000017187.61348.95; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jo SH, 2002, CIRC RES, V91, P46, DOI 10.1161/01.RES.0000024115.67561.54; Kinali M, 2002, NEUROLOGY, V59, P609, DOI 10.1212/WNL.59.4.609; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; Leblais V, 2004, CIRC RES, V95, P1183, DOI 10.1161/01.RES.0000150049.74539.8a; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; MARTINEAU L, 1992, CLIN SCI, V83, P615, DOI 10.1042/cs0830615; Mearini G, 2010, CARDIOVASC RES, V85, P357, DOI 10.1093/cvr/cvp348; Morisco C, 2005, CIRC RES, V96, P180, DOI 10.1161/01.RES.0000152968.71868.c3; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Morris JB, 2005, ENDOCRINOLOGY, V146, P4370, DOI 10.1210/en.2005-0162; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pavoine C, 2005, CELL SIGNAL, V17, P141, DOI 10.1016/j.cellsig.2004.09.001; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schluter KD, 1998, CARDIOVASC RES, V40, P174, DOI 10.1016/S0008-6363(98)00171-0; Shah AS, 2000, CIRCULATION, V101, P408, DOI 10.1161/01.CIR.101.4.408; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tevaearai HT, 2002, CIRCULATION, V106, P124, DOI 10.1161/01.CIR.0000020220.79105.FD; Tseng YT, 2005, AM J PHYSIOL-HEART C, V289, pH1834, DOI 10.1152/ajpheart.00435.2005; Tseng YT, 2001, FASEB J, V15, P1921, DOI 10.1096/fj.01-0151com; TUTTLE RR, 1975, CIRC RES, V36, P185, DOI 10.1161/01.RES.36.1.185; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Webb IG, 2010, CARDIOVASC RES, V87, P494, DOI 10.1093/cvr/cvq061; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; XIAO RP, 1993, CIRC RES, V73, P286, DOI 10.1161/01.RES.73.2.286; Yano N, 2008, AM J PHYSIOL-HEART C, V295, pH1690, DOI 10.1152/ajpheart.00531.2008; Yano N, 2007, AM J PHYSIOL-HEART C, V293, pH385, DOI 10.1152/ajpheart.01318.2006; Yano N, 2008, ENDOCRINOLOGY, V149, P6449, DOI 10.1210/en.2008-0292; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200; Zheng M, 2005, PHARMACOL THERAPEUT, V108, P257, DOI 10.1016/j.pharmthera.2005.04.006; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607; Zou YZ, 2001, CIRCULATION, V104, P102, DOI 10.1161/hc2601.090987	61	73	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26581	10.1371/journal.pone.0026581	http://dx.doi.org/10.1371/journal.pone.0026581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028912	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500090
J	Steingoetter, A; Menne, D; Braren, RF				Steingoetter, Andreas; Menne, Dieter; Braren, Rickmer F.			Assessing Antiangiogenic Therapy Response by DCE-MRI: Development of a Physiology Driven Multi-Compartment Model Using Population Pharmacometrics	PLOS ONE			English	Article							PARAMETERS; RAT	Dynamic contrast enhanced (DCE-) MRI is commonly applied for the monitoring of antiangiogenic therapy in oncology. Established pharmacokinetic (PK) analysis methods of DCE-MRI data do not sufficiently reflect the complex anatomical and physiological constituents of the analyzed tissue. Hence, accepted endpoints such as Ktrans reflect an unknown multitude of local and global physiological effects often rendering an understanding of specific local drug effects impossible. In this work a novel multi-compartment PK model is presented, which for the first time allows the separation of local and systemic physiological effects. DCE-MRI data sets from multiple, simultaneously acquired tissues, i.e. spinal muscle, liver and tumor tissue, of hepatocellular carcinoma (HCC) bearing rats were applied for model development. The full Markov chain Monte Carlo (MCMC) Bayesian analysis method was applied for model parameter estimation and model selection was based on histological and anatomical considerations and numerical criteria. A population PK model (MTL3 model) consisting of 3 measured and 6 latent (unobserved) compartments was selected based on Bayesian chain plots, conditional weighted residuals, objective function values, standard errors of model parameters and the deviance information criterion. Covariate model building, which was based on the histology of tumor tissue, demonstrated that the MTL3 model was able to identify and separate tumor specific, i.e. local, and systemic, i.e. global, effects in the DCE-MRI data. The findings confirm the feasibility to develop physiology driven multi-compartment PK models from DCE-MRI data. The presented MTL3 model allowed the separation of a local, tumor specific therapy effect and thus has the potential for identification and specification of effectors of vascular and tissue physiology in antiangiogenic therapy monitoring.	[Steingoetter, Andreas] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Steingoetter, Andreas] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Steingoetter, Andreas] ETH, Zurich, Switzerland; [Menne, Dieter] Menne Biomed Consulting, Tubingen, Germany; [Braren, Rickmer F.] Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-8000 Munich, Germany	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Munich	Steingoetter, A (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	steingoetter@biomed.ee.ethz.ch	Braren, Rickmer/U-3254-2018	Braren, Rickmer/0000-0001-6039-6957; Steingoetter, Andreas/0000-0001-8046-1314	German Research Foundation (DFG) within the SFB-Initiative [824, SFB824, C6]	German Research Foundation (DFG) within the SFB-Initiative(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the SFB-Initiative 824 (collaborative research center), "Imaging for Selection, Monitoring and Individualization of Cancer Therapies" (SFB824, project C6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal S, 1989, NONMEM USERS GUIDES; Brendel K, 2007, CLIN PHARMACOKINET, V46, P221, DOI 10.2165/00003088-200746030-00003; Brix G, 2010, EUR J NUCL MED MOL I, V37, pS30, DOI 10.1007/s00259-010-1448-7; DIMEOLA HJ, 1974, J APPL PHYSIOL, V36, P261, DOI 10.1152/jappl.1974.36.2.261; Gabrielsson J., 2007, PHARMACOKINETIC PHAR, V4th; Hastie TJ., 1990, GEN ADDITIVE MODELS; Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51, DOI 10.1016/S0169-2607(98)00067-4; Karcher JC, 2010, I S BIOMED IMAGING, P724, DOI 10.1109/ISBI.2010.5490074; Kwon Y., 2001, HDB ESSENTIAL PHARMA; Lunn DJ, 2002, J PHARMACOKINET PHAR, V29, P271, DOI 10.1023/A:1020206907668; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; R Core Team, 2022, R LANG ENV STAT COMP; Schmid VJ, 2006, IEEE T MED IMAGING, V25, P1627, DOI 10.1109/TMI.2006.884210; Schmid VJ, 2009, MAGN RESON MED, V61, P163, DOI 10.1002/mrm.21807; SHEINER LB, 1985, J PHARMACOKINET BIOP, V13, P515, DOI 10.1007/BF01059333; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steingoetter A, 2011, MAGN RESON MED, V65, P229, DOI 10.1002/mrm.22589; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Whitcher B, 2011, MAGN RESON MATER PHY, V24, P85, DOI 10.1007/s10334-010-0238-3; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013	20	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26366	10.1371/journal.pone.0026366	http://dx.doi.org/10.1371/journal.pone.0026366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028864	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000296186900054
J	Gallagher, EJ; Fierz, Y; Vijayakumar, A; Haddad, N; Yakar, S; LeRoith, D				Gallagher, E. J.; Fierz, Y.; Vijayakumar, A.; Haddad, N.; Yakar, S.; LeRoith, D.			Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia	ONCOGENE			English	Article						insulin resistance; diabetes; breast cancer; PI3K inhibitor	BREAST-CANCER; CELL-PROLIFERATION; GLUCOSE-UPTAKE; IGF-I; TRASTUZUMAB; PROGRESSION; CARCINOMA; ISOFORM; PATHWAY; KINASE	Women with type 2 diabetes mellitus (T2DM) are at a greater risk of developing and dying from breast cancer than women without T2DM. Insulin resistance and hyperinsulinemia underlie the pathogenesis of T2DM. In the MKR mouse model of insulin resistance, we have previously shown increased activation of the phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR pathway in association with accelerated mammary tumor growth. In this study, we demonstrate that inhibiting PI3K with the oral pan-class I PI3K inhibitor, NVP-BKM120 reduced the growth of Met-1 and MCNeuA mammary tumor orthografts in the MKR mouse. NVP-BKM120 treatment decreased phosphorylation of Akt and S6 ribosomal protein (S6rp); no change in Erk1/2 phosphorylation was seen. Hyperglycemia, hypertriglyceridemia and greater hyperinsulinemia developed in the MKR mice treated with NVP-BKM120. We previously reported reduced tumor growth using intraperitoneal rapamycin in the MKR mouse, with the development of hyperglycemia and hypertriglyceridemia. Therefore, we examined whether the oral PI3K/mTOR inhibitor NVP-BEZ235 augmented the tumor suppressing effects of PI3K inhibition. We also investigated the effect of targeted PI3K/mTOR inhibition on PI3K/Akt/mTOR and Erk1/2 signaling, and the potential effects on glycemia. NVP-BEZ235 suppressed the growth of Met-1 and MCNeuA tumor orthografts, and decreased Akt and S6rp phosphorylation, despite increased Erk1/2 phosphorylation in Met-1 orthografts of MKR mice. Less marked hyperglycemia and hyperinsulinemia developed with NVP-BEZ235 than NVP-BKM120. Overall, the results of this study demonstrated that inhibiting PI3K/Akt/mTOR signaling with the oral agents NVP-BKM120 and NVP-BEZ235 decreased mammary tumor growth in the hyperinsulinemic MKR mouse. Inhibiting PI3K alone led to more severe metabolic derangement than inhibiting both PI3K and mTOR. Therefore, PI3K may be an important target for the treatment of breast cancer in women with insulin resistance. Monitoring for hyperglycemia and dyslipidemia should be considered when using these agents in humans, given the metabolic changes detected in this study. Oncogene (2012) 31, 3213-3222; doi:10.1038/onc.2011.495; published online 31 October 2011	[Gallagher, E. J.; Fierz, Y.; Vijayakumar, A.; Haddad, N.; Yakar, S.; LeRoith, D.] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	LeRoith, D (corresponding author), Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, Box 1055,1 Gustave L Levy Pl, New York, NY 10029 USA.	Derek.LeRoith@mssm.edu			American Diabetes Association; National Cancer Institute [R01-5R01-CA128799]; Swiss National Science Foundation [PBBSB-120851, PBBSB3-120851]; Novartis Foundation; Roche Research Foundation; Oncosuisse Foundation; NATIONAL CANCER INSTITUTE [R01CA128799] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Roche Research Foundation; Oncosuisse Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DLR received a mentor award from the American Diabetes Association. This work was funded by National Cancer Institute grant R01-5R01-CA128799. YF received grants from the Swiss National Science Foundation [PBBSB-120851 and PBBSB3-120851] and the Novartis Foundation, the Roche Research Foundation and the Oncosuisse Foundation. NVP-BKM120 and NVP-BEZ235 were supplied by Novartis Pharma (Basel, Switzerland) free of charge.	Agnoli C, 2010, NUTR METAB CARDIOVAS, V20, P41, DOI 10.1016/j.numecd.2009.02.006; Arpino G, 2007, JNCI-J NATL CANCER I, V99, P694, DOI 10.1093/jnci/djk151; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Campbell MJ, 2002, IN VITRO CELL DEV-AN, V38, P326; Cannata D, 2010, ENDOCRINOLOGY, V151, P5751, DOI 10.1210/en.2010-0792; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Fierz Y, 2010, ENDOCR-RELAT CANCER, V17, P941, DOI 10.1677/ERC-10-0091; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Liu LZ, 2006, MOL BIOL CELL, V17, P2322, DOI 10.1091/mbc.E05-10-0969; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; PAPA V, 1990, J CLIN INVEST, V86, P1503, DOI 10.1172/JCI114868; Patterson RE, 2010, BREAST CANCER RES TR, V122, P859, DOI 10.1007/s10549-010-0732-3; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sopasakis VR, 2010, CELL METAB, V11, P220, DOI 10.1016/j.cmet.2010.02.002; Tan SX, 2010, BIOCHEM J, V432, P191, DOI 10.1042/BJ20100750; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wells V, 2007, ONCOGENE, V26, P7709, DOI 10.1038/sj.onc.1210580	26	57	57	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	27					3213	3222		10.1038/onc.2011.495	http://dx.doi.org/10.1038/onc.2011.495			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	970FL	22037215	Green Accepted			2022-12-25	WOS:000306113400001
J	Kidoya, H; Kunii, N; Naito, H; Muramatsu, F; Okamoto, Y; Nakayama, T; Takakura, N				Kidoya, H.; Kunii, N.; Naito, H.; Muramatsu, F.; Okamoto, Y.; Nakayama, T.; Takakura, N.			The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy	ONCOGENE			English	Article						tumor angiogenesis; immune therapy; vascular normalization; vascular maturation; apelin/APJ	KILLER T-CELLS; V-ALPHA-14 NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; IN-VIVO; ENDOTHELIAL-CELLS; ANGIOGENIC FACTOR; BLOOD-VESSELS; APJ RECEPTOR; CANCER; ACTIVATION	Immature and unstable tumor vasculature provides an aberrant tumor microenvironment and leads to resistance of tumors to conventional therapy. Hence, normalization of tumor vessels has been reported to improve the effect of immuno-, chemo- and radiation therapy. However, the humoral factors, which can effectively induce maturation of tumor vasculature, have not been elucidated. In this study, we found that the novel peptide apelin and its receptor APJ can induce the morphological and functional maturation of blood vessels in tumors. This apelin-induced tumor vascular maturation enhances the efficacy of cancer dendritic cell-based immunotherapy and significantly suppresses tumor growth by promoting the infiltration of invariant natural killer T cells into the central region of the tumor and thereby robustly inducing apoptosis of tumor cells. Additionally, we showed APJ expression to be enhanced in the tumor endothelium in comparison with normal-state endothelial cells. These findings provide a new target for tumor vascular-specific maturation, which is expected to improve the efficacy of conventional cancer therapies. Oncogene (2012) 31, 3254-3264; doi:10.1038/onc.2011.489; published online 31 October 2011	[Kidoya, H.; Naito, H.; Muramatsu, F.; Takakura, N.] Osaka Univ, Res Inst Microbial Dis, Dept Signal Transduct, Suita, Osaka 5650871, Japan; [Kunii, N.; Okamoto, Y.] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Chiba, Japan; [Kunii, N.; Nakayama, T.] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan	Osaka University; Chiba University; Chiba University	Takakura, N (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Signal Transduct, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ntakaku@biken.osaka-u.ac.jp	Nakayama, Toshinori/E-1067-2017	Nakayama, Toshinori/0000-0002-1434-2007; Naito, Hisamichi/0000-0002-0750-1743	Japan Society for the Promotion of Science (JSPS) and Research [KAKENHI 21890124]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; YASUDA Medical Foundation	Japan Society for the Promotion of Science (JSPS) and Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); YASUDA Medical Foundation	We thank Ms C Takeshita, Ms K Fukuhara and Ms N Fujimoto for technical assistance. Financial support: This work was supported by Grant-in-Aid for Research Activity Start-up (KAKENHI 21890124) from the Japan Society for the Promotion of Science (JSPS) and Research; a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; and the YASUDA Medical Foundation.	Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bottaro DP, 2003, NATURE, V423, P593, DOI 10.1038/423593a; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; Dai TY, 2006, EUR J PHARMACOL, V553, P222, DOI 10.1016/j.ejphar.2006.09.034; Dickson PV, 2007, CLIN CANCER RES, V13, P3942, DOI 10.1158/1078-0432.CCR-07-0278; Dings RPM, 2011, CLIN CANCER RES, V17, P3134, DOI 10.1158/1078-0432.CCR-10-2443; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gasparini G, 2005, NAT CLIN PRACT ONCOL, V2, P562, DOI 10.1038/ncponc0342; Gerber HP, 2005, CANCER RES, V65, P671; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kasai A, 2004, BIOCHEM BIOPH RES CO, V325, P395, DOI 10.1016/j.bbrc.2004.10.042; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kawano T, 1999, CANCER RES, V59, P5102; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007; Lambrecht NWG, 2006, PHYSIOL GENOMICS, V25, P153, DOI 10.1152/physiolgenomics.00271.2005; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Motohashi S, 2009, J IMMUNOL, V182, P2492, DOI 10.4049/jimmunol.0800126; Nieda M, 2001, BLOOD, V97, P2067, DOI 10.1182/blood.V97.7.2067; Nieda M, 2004, BLOOD, V103, P383, DOI 10.1182/blood-2003-04-1155; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; ROSENBERG SA, 1989, ANN SURG, V210, P474, DOI 10.1097/00000658-198910000-00008; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Seino K, 2005, SPRINGER SEMIN IMMUN, V27, P65, DOI 10.1007/s00281-004-0194-y; Shin T, 2001, INT J CANCER, V91, P523, DOI 10.1002/1097-0215(20010215)91:4<523::AID-IJC1087>3.0.CO;2-L; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Sorli SC, 2007, ONCOGENE, V26, P7692, DOI 10.1038/sj.onc.1210573; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Willett CG, 2006, SEMIN ONCOL, V33, pS35, DOI 10.1053/j.seminoncol.2006.08.007; Winzell MS, 2005, REGUL PEPTIDES, V131, P12, DOI 10.1016/j.regpep.2005.05.004; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373	52	56	66	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2012	31	27					3254	3264		10.1038/onc.2011.489	http://dx.doi.org/10.1038/onc.2011.489			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	970FL	22037214	Bronze			2022-12-25	WOS:000306113400005
J	Krumpochova, P; Sapthu, S; Brouwers, JF; de Haas, M; de Vos, R; Borst, P; van de Wetering, K				Krumpochova, Petra; Sapthu, Sunny; Brouwers, Jos F.; de Haas, Marcel; de Vos, Ric; Borst, Piet; van de Wetering, Koen			Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays	FASEB JOURNAL			English	Article						metabolomics; LC/MS; phytoestrogens; knockout mice	TANDEM MASS-SPECTROMETRY; MULTIDRUG-RESISTANCE PROTEIN; MRP2; METABOLISM; DISEASE; GENE; RATS; MICE; GLUCURONIDES; MUTATION	The ATP-binding cassette (ABC) genes encode the largest family of transmembrane proteins. ABC transporters translocate a wide variety of substrates across membranes, but their physiological function is often incompletely understood. We describe a new method to study the substrate spectrum of ABC transporters: We incubate extracts of mouse urine with membrane vesicles prepared from Spodoptera frugiperda Sf9 insect cells overproducing an ABC transporter and determine the compounds transported into the vesicles by LC/MS-based metabolomics. We illustrate the power of this simple "transportomics" approach using ABCC2, a protein present at sites of uptake and elimination. We identified many new substrates of ABCC2 in urine. These included glucuronides of plant-derived xenobiotics, a class of compounds to which humans are exposed on a daily basis. Moreover, we show that the excretion of these compounds in vivo depends on ABCC2: compared to wildtype mice, the urinary excretion of several glucuronides was increased up to 20-fold in Abcc2(-/-) mice. Transportomics has broad applicability, as it is not restricted to urine and can be applied to other ATP-dependent transport proteins as well.-Krumpochova, P., Sapthu, S., Brouwers, J. F., de Haas, M., de Vos, R., Borst, P., van de Wetering, K. Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays. FASEB J. 26, 738-747 (2012). www.fasebj.org	[Krumpochova, Petra; Sapthu, Sunny; de Haas, Marcel; Borst, Piet; van de Wetering, Koen] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Brouwers, Jos F.] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, Utrecht, Netherlands; [de Vos, Ric] Plant Res Int, Wageningen, Netherlands; [de Vos, Ric] Netherlands Metabol Ctr, Leiden, Netherlands	Netherlands Cancer Institute; Utrecht University	van de Wetering, K (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	k.vd.wetering@nki.nl	Brouwers, Jos F/AAH-1444-2019; De Vos, Ric/F-5012-2017	Brouwers, Jos F/0000-0003-2924-3279; 	ZonMw (TOP) [40-00812-98-07-028]; Netherlands Metabolomics Centre, under the Netherlands Genomics Initiative	ZonMw (TOP); Netherlands Metabolomics Centre, under the Netherlands Genomics Initiative	The authors thank Ton Schrauwers for excellent biotechnical assistance and their colleagues Alfred Schinkel, Jos Jonkers, and Robert Jansen (The Netherlands Cancer Institute), Ronald Oude Elferink (Division of Experimental Hepatology, University of Amsterdam, Amsterdam, The Netherlands), Jos Beijnen (Division of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, Amsterdam, The Netherlands), and Hiroyuki Kusuhara (Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan) for fruitful discussions and critical reading of the manuscript. The experimental work in the authors' laboratory is supported by ZonMw (TOP grant 40-00812-98-07-028, to K. V. and P. B.). R. D. gets additional financial support from The Netherlands Metabolomics Centre, which is under the auspices of the Netherlands Genomics Initiative. The authors declare no conflicts of interest.	Borst P, 2006, CANCER LETT, V234, P51, DOI 10.1016/j.canlet.2005.05.051; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; Buchler M, 1996, J BIOL CHEM, V271, P15091; Ci L, 2007, MOL PHARMACOL, V71, P1591, DOI 10.1124/mol.106.031823; Dieckhaus CM, 2005, CHEM RES TOXICOL, V18, P630, DOI 10.1021/tx049741u; Dixon RA, 2004, ANNU REV PLANT BIOL, V55, P225, DOI 10.1146/annurev.arplant.55.031903.141729; ELFERINK RPJO, 1991, BIOCHEM J, V274, P281, DOI 10.1042/bj2740281; Ito K, 1997, AM J PHYSIOL-GASTR L, V272, pG16, DOI 10.1152/ajpgi.1997.272.1.G16; Jager W, 1997, HEPATOLOGY, V26, P1467; Jansen GHE, 2005, ARCH BIOCHEM BIOPHYS, V435, P74, DOI 10.1016/j.abb.2004.12.015; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Katona M, 2009, RAPID COMMUN MASS SP, V23, P3372, DOI 10.1002/rcm.4259; Kruh GD, 2007, CANCER METAST REV, V26, P5, DOI 10.1007/s10555-007-9039-1; Lafaye A, 2004, J MASS SPECTROM, V39, P655, DOI 10.1002/jms.635; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Maher JM, 2005, DRUG METAB DISPOS, V33, P947, DOI 10.1124/dmd.105.003780; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Novakova L, 2009, ANAL CHIM ACTA, V656, P8, DOI 10.1016/j.aca.2009.10.004; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Qu J, 2001, J CHROMATOGR A, V928, P155, DOI 10.1016/S0021-9673(01)01111-6; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; van de Wetering K, 2007, MOL PHARMACOL, V72, P387, DOI 10.1124/mol.107.035592; Van De Wetering K, 2009, GASTROENTEROLOGY, V137, P1725, DOI 10.1053/j.gastro.2009.06.052; Vlaming MLH, 2006, J PHARMACOL EXP THER, V318, P319, DOI 10.1124/jpet.106.101774	26	48	50	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					738	747		10.1096/fj.11-195743	http://dx.doi.org/10.1096/fj.11-195743			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22034653	hybrid			2022-12-25	WOS:000300485700025
J	Toll, L; Khroyan, TV; Sonmez, K; Ozawa, A; Lindberg, I; McLaughlin, JP; Eans, SO; Shahien, AA; Kapusta, DR				Toll, Lawrence; Khroyan, Taline V.; Sonmez, Kemal; Ozawa, Akihiko; Lindberg, Iris; McLaughlin, Jay P.; Eans, Shainnel O.; Shahien, Amir A.; Kapusta, Daniel R.			Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociception	FASEB JOURNAL			English	Article						antinociception; neuropeptide	CORTICOTROPIN-RELEASING HORMONE; BARRINGTONS NUCLEUS; IN-VIVO; RAT; RECEPTOR; NEURONS; SYSTEM; IDENTIFICATION; NEUROPEPTIDE; AGONIST	Computational methods have led two groups to predict the endogenous presence of a highly conserved, amidated, 14-aa neuropeptide called either spexin or NPQ. NPQ/spexin is part of a larger prohormone that contains 3 sets of RR residues, suggesting that it could yield more than one bioactive peptide; however, no in vivo activity has been demonstrated for any peptide processed from this precursor. Here we demonstrate biological activity for two peptides present within proNPQ/spexin. NPQ/spexin (NWTPQAM-LYLKGAQ-NH2) and NPQ 53-70 (FISDQSRRKDLS-DRPLPE) have differing renal and cardiovascular effects when administered intracerebroventricularly or intravenously into rats. Intracerebroventricular injection of NPQ/spexin produced a 13 +/- 2 mmHg increase in mean arterial pressure, a 38 +/- 8 bpm decrease in heart rate, and a profound decrease in urine flow rate. Intracerebroventricular administration of NPQ 53-70 produced a 26 +/- 9 bpm decrease in heart rate with no change in mean arterial pressure, and a marked increase in urine flow rate. Intraventricular NPQ/spexin and NPQ 53-70 also produced antinociceptive activity in the warm water tail withdrawal assay in mice (ED50 < 30 and 10 nmol for NPQ/spexin and NPQ 53-70, respectively). We conclude that newly identified peptides derived from the NPQ/spexin precursor contribute to CNS-mediated control of arterial blood pressure and salt and water balance and modulate nociceptive responses.-Toll, L., Khroyan, T. V., Sonmez, K., Ozawa, A., Lindberg, I., McLaughlin, J. P., Eans, S. O., Shahien, A. A., Kapusta, D. R. Peptides derived from the prohormone proNPQ/spexin are potent central modulators of cardiovascular and renal function and nociception. FASEB J. 26, 947-954 (2012). www.fasebj.org	[Toll, Lawrence; McLaughlin, Jay P.; Eans, Shainnel O.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Sonmez, Kemal] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Ozawa, Akihiko; Lindberg, Iris] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Toll, Lawrence; Khroyan, Taline V.] SRI Int, Menlo Pk, CA USA; [Shahien, Amir A.; Kapusta, Daniel R.] Louisiana State Univ, Dept Pharmacol & Expt Therapeut, Hlth Sci Ctr, New Orleans, LA USA	Torrey Pines Institute for Molecular Studies, Florida; Oregon Health & Science University; University System of Maryland; University of Maryland Baltimore; SRI International; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Toll, L (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	ltoll@tpims.org	Ozawa, Akihiko/U-4426-2019; Sonmez, Kemal/ABF-3992-2020; Lindberg, Iris/Q-3825-2019	Sonmez, Kemal/0000-0002-2816-6438; 	U.S. National Institutes of Health (NIH) [R21-DA016629]; American Heart Association [0855293E]; NIH [P20-RR018766, DA027170]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027170, R21DA016629, R01DA005084] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U.S. National Institutes of Health (NIH) grant R21-DA016629 to L. T., American Heart Association grant 0855293E and NIH grant P20-RR018766 to D. R. K., and NIH grant DA027170 to I.L.	CAMERON A, 2001, ENZYMES; Cano G, 2000, J AUTONOM NERV SYST, V79, P117, DOI 10.1016/S0165-1838(99)00101-0; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DEVI L, 1991, FEBS LETT, V280, P189, DOI 10.1016/0014-5793(91)80290-J; DiBona GF, 2001, ANN NY ACAD SCI, V940, P395; FRICKER LD, 1991, PEPTIDE BIOSYNTHESIS, P199; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12, DOI 10.1111/j.1476-5381.1957.tb01354.x; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Kapusta DR, 2005, J PHARMACOL EXP THER, V314, P643, DOI 10.1124/jpet.104.082768; Kapusta DR, 1996, LIFE SCI, V60, pPL15, DOI 10.1016/S0024-3205(96)00593-0; Lamango NS, 1996, ARCH BIOCHEM BIOPHYS, V330, P238, DOI 10.1006/abbi.1996.0249; McLaughlin JP, 1999, J PHARMACOL EXP THER, V289, P304; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Mutt V, 1980, BIOCHEM SOC T, V8, P11, DOI 10.1042/bst0080011; PAVCOVICH LA, 1995, NEUROSCI LETT, V196, P185, DOI 10.1016/0304-3940(95)11873-U; Porzionato A, 2010, J HISTOCHEM CYTOCHEM, V58, P825, DOI 10.1369/jhc.2010.956300; Reilley KJ, 2010, AAPS J, V12, P318, DOI 10.1208/s12248-010-9191-3; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rouzade-Dominguez ML, 2003, EUR J NEUROSCI, V18, P3325, DOI 10.1111/j.1460-9568.2003.03072.x; Rucinski M, 2010, PEPTIDES, V31, P676, DOI 10.1016/j.peptides.2009.12.025; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SMYTH DG, 1989, J NEUROCHEM, V53, P489, DOI 10.1111/j.1471-4159.1989.tb07360.x; Sonmez K, 2007, INT CONF ACOUST SPEE, P377; Sonmez K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000258; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Sved AF, 2002, PHYSIOL BEHAV, V77, P737, DOI 10.1016/S0031-9384(02)00927-7; VALENTINO RJ, 1994, NEUROSCIENCE, V62, P125, DOI 10.1016/0306-4522(94)90320-4; Valentino RJ, 2000, J COMP NEUROL, V417, P399; VAUGHT JL, 1979, J PHARMACOL EXP THER, V208, P86; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; YI Z, 1993, J BIOL CHEM, V268, P5615	32	60	67	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					947	954		10.1096/fj.11-192831	http://dx.doi.org/10.1096/fj.11-192831			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22038051	Green Published			2022-12-25	WOS:000300485700044
J	Fagete, S; Rousseau, F; Magistrelli, G; Gueneau, F; Ravn, U; Kosco-Vilbois, MH; Fischer, N				Fagete, Severine; Rousseau, Francois; Magistrelli, Giovanni; Gueneau, Franck; Ravn, Ulla; Kosco-Vilbois, Marie H.; Fischer, Nicolas			Dual Specificity of Anti-CXCL10-CXCL9 Antibodies Is Governed by Structural Mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HUMAN POLYCLONAL ANTIBODIES; THERAPEUTIC ANTIBODIES; BOTULINUM NEUROTOXIN; CHEMOKINE; BINDING; CXCR3; OLIGOMERIZATION; LIGANDS; GLYCOSAMINOGLYCANS	Dual-specific antibodies are characterized by an antigen-combining site mediating specific interactions with two different antigens. We have generated five dual-specific single chain variable fragments (scFv) that neutralize the activity of the two chemokines, CXCL9 and CXCL10, to bind to their receptor CXCR3. To better understand how these dual-specific scFvs bind these two chemokines that only share a 37% sequence identity, we mapped their epitopes on human CXCL9 and CXCL10 and identified serine 13 (Ser(13)) as a critical residue. It is conserved between the two chemokines but not in the third ligand for CXCR3, CXCL11. Furthermore, Ser(13) is exposed in the tetrameric structure of CXCL10, which is consistent with our finding that the scFvs are able to bind to CXCL9 and CXCL10 immobilized on glycosaminoglycans. Overall, the data indicate that these dual-specific scFvs bind to a conserved surface involved in CXCR3 receptor interaction for CXCL10 and CXCL9. Thus, structural mimicry between the two targets is likely to be responsible for the observed dual specificity of these antibody fragments.	[Fagete, Severine; Rousseau, Francois; Magistrelli, Giovanni; Gueneau, Franck; Ravn, Ulla; Kosco-Vilbois, Marie H.; Fischer, Nicolas] NovImmune SA, CH-1228 Plan Les Ouates, Switzerland	NovImmune SA	Fischer, N (corresponding author), NovImmune SA, 14 Ch Des Aulx, CH-1228 Plan Les Ouates, Switzerland.	nfischer@novimmune.com						Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bregenholt S, 2006, CURR PHARM DESIGN, V12, P2007, DOI 10.2174/138161206777442173; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Fagete S, 2009, MABS-AUSTIN, V1, P288, DOI 10.4161/mabs.1.3.8527; Fischer N, 2007, PATHOBIOLOGY, V74, P3, DOI 10.1159/000101046; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Ishida Isao, 2002, Cloning and Stem Cells, V4, P91, DOI 10.1089/153623002753632084; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Magistrelli G, 2005, BIOCHEM BIOPH RES CO, V334, P370, DOI 10.1016/j.bbrc.2005.06.091; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Reid C, 2006, PROTEIN ENG DES SEL, V19, P317, DOI 10.1093/protein/gzl015; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Wiberg FC, 2006, BIOTECHNOL BIOENG, V94, P396, DOI 10.1002/bit.20865; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004	29	3	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1458	1467		10.1074/jbc.M111.253658	http://dx.doi.org/10.1074/jbc.M111.253658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22041899	Green Published, hybrid			2022-12-25	WOS:000299170300059
J	Azarkan, M; Martinez-Rodriguez, S; Buts, L; Baeyens-Volant, D; Garcia-Pino, A				Azarkan, Mohamed; Martinez-Rodriguez, Sergio; Buts, Lieven; Baeyens-Volant, Danielle; Garcia-Pino, Abel			The Plasticity of the beta-Trefoil Fold Constitutes an Evolutionary Platform for Protease Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE SCATTERING DATA; CHYMOTRYPSIN INHIBITOR; CRYSTAL-STRUCTURE; TRYPSIN-INHIBITOR; PLASMINOGEN-ACTIVATOR; ANGSTROM RESOLUTION; REACTIVE-SITE; PROTEINASES; LANDSCAPE; DEFENSES	Proteases carry out a number of crucial functions inside and outside the cell. To protect the cells against the potentially lethal activities of these enzymes, specific inhibitors are produced to tightly regulate the protease activity. Independent reports suggest that the Kunitz-soybean trypsin inhibitor (STI) family has the potential to inhibit proteases with different specificities. In this study, we use a combination of biophysical methods to define the structural basis of the interaction of papaya protease inhibitor (PPI) with serine proteases. We show that PPI is a multiple-headed inhibitor; a single PPI molecule can bind two trypsin units at the same time. Based on sequence and structural analysis, we hypothesize that the inherent plasticity of the beta-trefoil fold is paramount in the functional evolution of this family toward multiple protease inhibition.	[Martinez-Rodriguez, Sergio; Buts, Lieven; Garcia-Pino, Abel] Vrije Univ Brussel, Mol Recognit Unit, B-1050 Brussels, Belgium; [Azarkan, Mohamed; Baeyens-Volant, Danielle] Univ Libre Bruxelles, Fac Med, Prot Chem Unit, B-1070 Brussels, Belgium; [Martinez-Rodriguez, Sergio; Buts, Lieven; Garcia-Pino, Abel] VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium	Vrije Universiteit Brussel; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB)	Garcia-Pino, A (corresponding author), Vrije Univ Brussel, Mol Recognit Unit, Pleinlaan 2, B-1050 Brussels, Belgium.	agarciap@vub.ac.be	MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015	MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; Garcia-Pino, Abel/0000-0002-0634-0300	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Vrije Universiteit Brussel	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Vrije Universiteit Brussel	This work was supported by grants from the Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), and the Onderzoeksraad of the Vrije Universiteit Brussel.	Azarkan M, 2006, ACTA CRYSTALLOGR F, V62, P1239, DOI 10.1107/S1744309106046367; Azarkan M, 2006, BBA-PROTEINS PROTEOM, V1764, P1063, DOI 10.1016/j.bbapap.2006.02.014; Bao R, 2009, J BIOL CHEM, V284, P26676, DOI 10.1074/jbc.M109.022095; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; Chen CP, 2001, J BIOL CHEM, V276, P45079, DOI 10.1074/jbc.M106182200; *COLL COMP PROJ 4, 1994, TRUNCATE; Dasgupta J, 2006, BIOCHEMISTRY-US, V45, P6783, DOI 10.1021/bi060374q; Dattagupta JK, 1996, ACTA CRYSTALLOGR D, V52, P521, DOI 10.1107/S0907444996000224; Dattagupta JK, 1999, PROTEINS, V35, P321, DOI 10.1002/(SICI)1097-0134(19990515)35:3<321::AID-PROT6>3.3.CO;2-P; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Leo F, 2002, NUCLEIC ACIDS RES, V30, P347, DOI 10.1093/nar/30.1.347; de Meester P, 1998, ACTA CRYSTALLOGR D, V54, P589, DOI 10.1107/S0907444997015849; Gahloth D, 2010, ARCH BIOCHEM BIOPHYS, V494, P15, DOI 10.1016/j.abb.2009.11.008; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; McCoy AJ, 1997, J MOL BIOL, V269, P881, DOI 10.1006/jmbi.1997.1067; Micheelsen PO, 2008, J MOL BIOL, V380, P681, DOI 10.1016/j.jmb.2008.05.034; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Ravichandran S, 2001, PROTEIN ENG, V14, P349, DOI 10.1093/protein/14.5.349; Renko M, 2010, J BIOL CHEM, V285, P308, DOI 10.1074/jbc.M109.043331; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634	32	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43726	43734		10.1074/jbc.M111.291310	http://dx.doi.org/10.1074/jbc.M111.291310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027836	Green Published, hybrid			2022-12-25	WOS:000298402300016
J	Frobel, J; Rose, P; Muller, M				Froebel, Julia; Rose, Patrick; Mueller, Matthias			Early Contacts between Substrate Proteins and TatA Translocase Component in Twin-arginine Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; ESCHERICHIA-COLI; TRANSPORT SYSTEM; SIGNAL PEPTIDE; PRECURSOR PROTEINS; IN-VITRO; BACILLUS-SUBTILIS; MEMBRANE-BINDING; PATHWAY; COMPLEX	Twin-arginine translocation (Tat) is a unique protein transport pathway in bacteria, archaea, and plastids. It mediates the transmembrane transport of fully folded proteins, which harbor a consensus twin-arginine motif in their signal sequences. In Gram-negative bacteria and plant chloroplasts, three membrane proteins, named TatA, TatB, and TatC, are required to enable Tat translocation. Available data suggest that TatA assembles into oligomeric pore-like structures that might function as the protein conduit across the lipid bilayer. Using site-specific photo-cross-linking, we have investigated the molecular environment of TatA under resting and translocating conditions. We find that monomeric TatA is an early interacting partner of functionally targeted Tat substrates. This interaction with TatA likely precedes translocation of Tat substrates and is influenced by the proton-motive force. It strictly depends on the presence of TatB and TatC, the latter of which is shown to make contacts with the transmembrane helix of TatA.	[Froebel, Julia; Rose, Patrick; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Froebel, Julia; Rose, Patrick] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de			Sonderforschungsbereich 746; Deutsche Forschungsgemeinschaft	Sonderforschungsbereich 746(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Sonderforschungsbereich 746 and Forschergruppe 929 of the Deutsche Forschungsgemeinschaft.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder NN, 2003, FEBS LETT, V540, P96, DOI 10.1016/S0014-5793(03)00231-X; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Jakob M, 2009, BBA-MOL CELL RES, V1793, P388, DOI 10.1016/j.bbamcr.2008.09.006; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; Maldonado B, 2011, FEBS LETT, V585, P478, DOI 10.1016/j.febslet.2011.01.016; Mangels D, 2005, J MOL BIOL, V345, P415, DOI 10.1016/j.jmb.2004.10.043; Marrichi M, 2008, J BIOL CHEM, V283, P35223, DOI 10.1074/jbc.M802660200; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Maurer C, 2009, FEBS LETT, V583, P2849, DOI 10.1016/j.febslet.2009.07.038; McDevitt CA, 2005, BIOCHEM BIOPH RES CO, V329, P693, DOI 10.1016/j.bbrc.2005.02.038; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; Schlesier R, 2010, BIOL CHEM, V391, P1411, DOI 10.1515/BC.2010.138; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Turner RJ, 2004, CAN J MICROBIOL, V50, P225, DOI 10.1139/W03-117; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	62	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43679	43689		10.1074/jbc.M111.292565	http://dx.doi.org/10.1074/jbc.M111.292565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22041896	Green Published, hybrid			2022-12-25	WOS:000298402300011
J	McCarty, G; Awad, O; Loeb, DM				McCarty, Gregory; Awad, Ola; Loeb, David M.			WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOFT-TISSUE SARCOMAS; SUPPRESSOR WT1; GENE WT1; WILMS; DIFFERENTIATION; PROMOTER; VEGF; DNA	WT1 is a zinc finger transcription factor expressed at high levels in many types of solid tumors, and high WT1 expression is an adverse prognostic factor. How WT1 contributes to tumor growth and influences prognosis remains unclear. We investigated the hypothesis that WT1 up-regulates VEGF in solid tumors, augmenting the response to hypoxia. We found a correlation between levels of WT1 expression and VEGF expression in Ewing sarcoma cell lines. Transfecting WT1-null SK-ES-1 cells with WT1 up-regulated VEGF mRNA expression and resulted in increased angiogenic activity in vitro. Conversely, diminishing WT1 expression in WT1-positive cell lines using WT1-specific shRNA down-regulated VEGF mRNA expression and decreased angiogenic activity in vitro. Transient transfection assays demonstrated that WT1 can regulate the activity of the VEGF promoter, and chromatin immunoprecipitation assays showed that WT1 can bind directly to the VEGF promoter in intact cells. WT1 expression in Ewing sarcoma cells is up-regulated by hypoxia. Importantly, using shRNA to inhibit this up-regulation blunted the hypoxia-mediated increase in VEGF expression. Taken together, these data demonstrate that VEGF is a direct, bona fide WT1 target gene in sarcoma and that WT1 plays a key role in optimizing the response of tumor cells to hypoxia.	[McCarty, Gregory; Awad, Ola; Loeb, David M.] Johns Hopkins Univ, Dept Oncol, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Loeb, DM (corresponding author), Johns Hopkins Univ, Dept Oncol, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Bunting Blaustein Canc Res Bldg,Rm 2M51,1650 Orle, Baltimore, MD 21231 USA.	loebda@jhmi.edu			Flight Attendant Medical Research Institute; The Children's Cancer Foundation; Giant Foods; The Heather Brooke Foundation; Love for Luca Foundation	Flight Attendant Medical Research Institute; The Children's Cancer Foundation; Giant Foods; The Heather Brooke Foundation; Love for Luca Foundation	This work was supported by grants from the Flight Attendant Medical Research Institute and The Children's Cancer Foundation (both to D. M. L.), Giant Foods, The Heather Brooke Foundation, and the Love for Luca Foundation.	CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Carpentieri DF, 2002, MODERN PATHOL, V15, P1080, DOI 10.1097/01.MP.0000028646.03760.6B; DRUMMOND IA, 1994, MOL CELL BIOL, V14, P3800, DOI 10.1128/MCB.14.6.3800; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Graham K, 2006, GENE EXPRESSION, V13, P1, DOI 10.3727/000000006783991953; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hanson J, 2007, FRONT BIOSCI-LANDMRK, V12, P2279, DOI 10.2741/2230; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Loeb DM, 2001, CANCER RES, V61, P921; MIWA H, 1992, LEUKEMIA, V6, P405; Simpson LA, 2006, BLOOD, V107, P4695, DOI 10.1182/blood-2005-10-4025; Srivastava A, 2006, CLIN CANCER RES, V12, P4237, DOI 10.1158/1078-0432.CCR-05-2307; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; Ueda T, 2003, CANCER SCI, V94, P271, DOI 10.1111/j.1349-7006.2003.tb01432.x; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner N, 2008, ONCOGENE, V27, P3662, DOI 10.1038/sj.onc.1211044; Yoon SS, 2006, J SURG RES, V135, P282, DOI 10.1016/j.jss.2006.01.023	19	49	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43634	43643		10.1074/jbc.M111.310128	http://dx.doi.org/10.1074/jbc.M111.310128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22030397	Green Published, hybrid			2022-12-25	WOS:000298402300006
J	Nijeholt, JALA; Wu, ZC; Driessen, AJM				Nijeholt, Jelger A. Lycklama A.; Wu, Zht Cheng; Driessen, Arnold J. M.			Conformational Dynamics of the Plug Domain of the SecYEG Protein-conducting Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASCENT CHAIN COMPLEXES; COLI MEMBRANE-VESICLES; ESCHERICHIA-COLI; TRANSLOCATION CHANNEL; IN-VIVO; SIGNAL SEQUENCE; CROSS-LINKING; LATERAL GATE; SECA PROTEIN; RIBOSOME	The central pore of the SecYEG preprotein-conducting channel is closed at the periplasmic face of the membrane by a plug domain. To study its conformational dynamics, the plug was labeled site-specifically with an environment-sensitive fluorophore. In the presence of a stable preprotein translocation intermediate, the SecY plug showed an enhanced solvent exposure consistent with a displacement from the hydrophobic central pore region. In contrast, binding and insertion of a ribosome-bound nascent membrane protein did not alter the plug conformation. These data indicate different plug dynamics depending on the ligand bound state of the SecYEG channel.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012; Institute, Zernike/W-7033-2019	Driessen, Arnold J.M./0000-0001-9258-9104				ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; Bonardi F, 2010, ANGEW CHEM INT EDIT, V49, P7234, DOI 10.1002/anie.201002243; Bondar AN, 2010, STRUCTURE, V18, P847, DOI 10.1016/j.str.2010.04.010; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Fekkes P, 1998, MOL MICROBIOL, V29, P1179, DOI 10.1046/j.1365-2958.1998.00997.x; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Greenough KP, 2006, J PHYS CHEM B, V110, P6351, DOI 10.1021/jp057073v; Gumbart J, 2008, J GEN PHYSIOL, V132, P709, DOI 10.1085/jgp.200810062; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; KLOSE M, 1993, J BIOL CHEM, V268, P4504; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P129; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LIN S, 1991, PHOTOCHEM PHOTOBIOL, V54, P361, DOI 10.1111/j.1751-1097.1991.tb02028.x; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Manting EH, 1999, J BIOL CHEM, V274, P23868, DOI 10.1074/jbc.274.34.23868; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nijeholt JALA, 2010, J BIOL CHEM, V285, P23747, DOI 10.1074/jbc.M110.124636; OSBORNE RS, 1993, EMBO J, V12, P3391, DOI 10.1002/j.1460-2075.1993.tb06013.x; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Zhang B, 2010, P NATL ACAD SCI USA, V107, P5399, DOI 10.1073/pnas.0914752107; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	45	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43881	43890		10.1074/jbc.M111.297507	http://dx.doi.org/10.1074/jbc.M111.297507			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033919	Green Published, hybrid			2022-12-25	WOS:000298402300029
J	Kapri-Pardes, E; Katz, A; Haviv, H; Mahmmoud, Y; Ilan, M; Khalfin-Penigel, I; Carmeli, S; Yarden, O; Karlish, SJD				Kapri-Pardes, Einat; Katz, Adriana; Haviv, Haim; Mahmmoud, Yasser; Ilan, Micha; Khalfin-Penigel, Irena; Carmeli, Shmuel; Yarden, Oded; Karlish, Steven J. D.			Stabilization of the alpha 2 Isoform of Na,K-ATPase by Mutations in a Phospholipid Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; CARDIAC MYOCYTES; SKELETAL-MUSCLE; FXYD PROTEINS; SUBUNIT; NA+,K+-ATPASE; TRANSPORT	Background: The alpha 2 isoform of Na, K-ATPase is unstable compared with alpha 1 and alpha 3. Results: Mutations in TM8-10 strongly stabilize alpha 2. A novel phospholipid antagonist selectively inactivates alpha 2, and mutations in TM8-10 protect against inactivation. Conclusion: A phosphatidylserine binding pocket within TM8-10 has been identified. Significance: Mechanistic insights into alpha 2 instability and a possible physiological role have been obtained.	[Kapri-Pardes, Einat; Katz, Adriana; Haviv, Haim; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Mahmmoud, Yasser] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark; [Ilan, Micha; Khalfin-Penigel, Irena] Tel Aviv Univ, Dept Zool, George S Wise Fac Life Sci, IL-69978 Ramat Aviv, Israel; [Carmeli, Shmuel] Tel Aviv Univ, Sch Chem, Raymond & Beverly Sackler Fac Exact Sci, IL-69978 Ramat Aviv, Israel; [Yarden, Oded] Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Aarhus University; Tel Aviv University; Tel Aviv University; Hebrew University of Jerusalem	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il	Ilan, Micha/ABG-4106-2020; Yarden, Oded/J-5988-2012; Carmeli, shmuel/N-1273-2018	Ilan, Micha/0000-0002-4188-4573; Carmeli, shmuel/0000-0002-9641-9943	Minerva Foundation; Israel Science Foundation [ISF 996/06]	Minerva Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by a grant from the Minerva Foundation (to S.J.D.K.).; Supported by Israel Science Foundation Grant ISF 996/06.	ARYSTARKHOVA E, 1995, J BIOL CHEM, V270, P8785, DOI 10.1074/jbc.270.15.8785; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2009, IUBMB LIFE, V61, P215, DOI 10.1002/iub.163; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2006, AM J PHYSIOL-REG I, V290, pR514, DOI 10.1152/ajpregu.00819.2005; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Despa S, 2010, BIOPHYS J, V98, p201A, DOI 10.1016/j.bpj.2009.12.1075; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; Dostanic-Larson I, 2006, AM J PHYSIOL-REG I, V290, pR524, DOI 10.1152/ajpregu.00838.2005; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; Han F, 2009, AM J PHYSIOL-CELL PH, V297, pC699, DOI 10.1152/ajpcell.00063.2009; Hauck C, 2009, EUR J PHARMACOL, V622, P7, DOI 10.1016/j.ejphar.2009.08.039; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Hayashi Y, 1988, Prog Clin Biol Res, V268A, P205; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; McDonough AA, 2002, AM J PHYSIOL-RENAL, V282, pF967, DOI 10.1152/ajprenal.00360.2001; Miles AJ, 2011, BBA-BIOMEMBRANES, V1808, P2573, DOI 10.1016/j.bbamem.2011.06.009; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Muller-Ehmsen J, 2001, AM J PHYSIOL-CELL PH, V281, pC1355, DOI 10.1152/ajpcell.2001.281.4.C1355; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Paz Z, 2010, FUNGAL DIVERS, V42, P17, DOI 10.1007/s13225-010-0020-x; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; Rubio MB, 2009, FUNGAL GENET BIOL, V46, P17, DOI 10.1016/j.fgb.2008.10.008; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Sharabani-Yosef O, 1999, J CELL PHYSIOL, V180, P236, DOI 10.1002/(SICI)1097-4652(199908)180:2<236::AID-JCP11>3.3.CO;2-N; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Swift F, 2008, CARDIOVASC RES, V78, P71, DOI 10.1093/cvr/cvn013; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Swift F, 2010, CELL CALCIUM, V48, P54, DOI 10.1016/j.ceca.2010.06.006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Tavraz NN, 2009, CHANNELS, V3, P82, DOI 10.4161/chan.3.2.8085; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zhang J, 2005, J PHYSIOL-LONDON, V569, P243, DOI 10.1113/jphysiol.2005.091801	62	36	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42888	42899		10.1074/jbc.M111.293852	http://dx.doi.org/10.1074/jbc.M111.293852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027833	Green Published, hybrid			2022-12-25	WOS:000298351300011
J	Abdala-Valencia, H; Berdnikovs, S; Cook-Mills, JM				Abdala-Valencia, Hiam; Berdnikovs, Sergejs; Cook-Mills, Joan M.			Mechanisms for Vascular Cell Adhesion Molecule-1 Activation of ERK1/2 during Leukocyte Transendothelial Migration	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; MICROVASCULAR ENDOTHELIAL-CELLS; INTRACELLULAR SIGNAL-TRANSDUCTION; AIRWAY EPITHELIAL PERMEABILITY; NADPH OXIDASE; MAP KINASES; IN-VITRO; LYMPHOCYTE MIGRATION; REGULATED KINASES; VCAM-1 ACTIVATION	Background: During inflammation, adhesion molecules regulate recruitment of leukocytes to inflamed tissues. It is reported that vascular cell adhesion molecule-1 (VCAM-1) activates extracellular regulated kinases 1 and 2 (ERK1/2), but the mechanism for this activation is not known. Pharmacological inhibitors of ERK1/2 partially inhibit leukocyte transendothelial migration in a multi-receptor system but it is not known whether VCAM-1 activation of ERK1/2 is required for leukocyte transendothelial migration (TEM) on VCAM-1. Methodology/Principal Findings: In this study, we identified a mechanism for VCAM-1 activation of ERK1/2 in human and mouse endothelial cells. VCAM-1 signaling, which occurs through endothelial cell NADPH oxidase, protein kinase C alpha (PKC alpha), and protein tyrosine phosphatase 1B (PTP1B), activates endothelial cell ERK1/2. Inhibition of these signals blocked VCAM-1 activation of ERK1/2, indicating that ERK1/2 is activated downstream of PTP1B during VCAM-1 signaling. Furthermore, VCAM-1-specific leukocyte migration under physiological laminar flow of 2 dynes/cm(2) was blocked by pretreatment of endothelial cells with dominant-negative ERK2 K52R or the MEK/ERK inhibitors, PD98059 and U0126, indicating for the first time that ERK regulates VCAM-1-dependent leukocyte transendothelial migration. Conclusions/Significance: VCAM-1 activation of endothelial cell NADPH oxidase/PKC alpha/PTP1B induces transient ERK1/2 activation that is necessary for VCAM-1-dependent leukocyte TEM.	[Abdala-Valencia, Hiam; Berdnikovs, Sergejs; Cook-Mills, Joan M.] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Abdala-Valencia, H (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA.	j-cookmills@northwestern.edu		Abdala Valencia, Hiam/0000-0003-3384-5299	National Institutes of Health (NIH) [R01 AT004837]; American Heart Association [2260905]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by National Institutes of Health (NIH) Grant R01 AT004837 and American Heart Association Grant 2260905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Valencia H, 2007, AM J PHYSIOL-LUNG C, V292, pL1111, DOI 10.1152/ajplung.00208.2006; Abdala-Valencia H, 2006, J IMMUNOL, V177, P6379, DOI 10.4049/jimmunol.177.9.6379; AGER A, 1988, EUR J IMMUNOL, V18, P1265, DOI 10.1002/eji.1830180818; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; Berdnikovs S, 2009, J IMMUNOL, V182, P4395, DOI 10.4049/jimmunol.0803659; Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730; Cai S, 2005, J CELL SCI, V118, P889, DOI 10.1242/jcs.01674; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHEN L, 2011, VASCUL PHARM; Chin JE, 1997, AM J PHYSIOL-LUNG C, V272, pL219, DOI 10.1152/ajplung.1997.272.2.L219; Choi H, 2007, IMMUNOL INVEST, V36, P59, DOI 10.1080/08820130600745703; Cook-Mills JM, 2004, BIOCHEM J, V378, P539, DOI 10.1042/BJ20030794; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; CookMills JM, 1996, IN VITRO CELL DEV-AN, V32, P167; Cuvelier SL, 2005, J EXP MED, V202, P865, DOI 10.1084/jem.20041315; Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Deem TL, 2007, J IMMUNOL, V178, P3865, DOI 10.4049/jimmunol.178.6.3865; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gould MC, 2000, EXP CELL RES, V260, P175, DOI 10.1006/excr.2000.5014; Hartel FV, 2010, AM J PHYSIOL-CELL PH, V298, pC1501, DOI 10.1152/ajpcell.00333.2009; Harrington EO, 2003, AM J RESP CELL MOL, V28, P626, DOI 10.1165/rcmb.2002-0085OC; Hu YY, 2000, J IMMUNOL, V165, P2142, DOI 10.4049/jimmunol.165.4.2142; Huang Q, 2011, ACTA DIABETOL; Kempna P, 2003, FREE RADICAL BIO MED, V34, P1458, DOI 10.1016/S0891-5849(03)00173-4; Keshavan P, 2005, J IMMUNOL, V174, P3709, DOI 10.4049/jimmunol.174.6.3709; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Krunkosky TM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-12; LAWRENCE MB, 1987, BLOOD, V70, P1284; Lawson C, 1999, J IMMUNOL, V162, P2990; Lazaar AL, 2001, J IMMUNOL, V166, P155, DOI 10.4049/jimmunol.166.1.155; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Lee YH, 2010, MOL BIOL CELL, V21, P4240, DOI 10.1091/mbc.E10-04-0341; Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966; LUBOS E, 2011, J BIOL CHEM; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Montezano AC, 2010, CIRC RES, V106, P1363, DOI 10.1161/CIRCRESAHA.109.216036; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; NOBIS U, 1985, MICROVASC RES, V29, P295, DOI 10.1016/0026-2862(85)90020-2; Patibandla PK, 2009, J CELL PHYSIOL, V221, P195, DOI 10.1002/jcp.21845; Puddicombe SM, 2000, CLIN EXP ALLERGY, V30, P7; Qureshi MH, 2003, J IMMUNOL, V171, P4700, DOI 10.4049/jimmunol.171.9.4700; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Sano H, 1998, BIOCHEM BIOPH RES CO, V250, P694, DOI 10.1006/bbrc.1998.9385; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Serikov VB, 2004, AM J RESP CELL MOL, V30, P261, DOI 10.1165/rcmb.2003-0053OC; Shibata T, 2002, IMMUNOL CELL BIOL, V80, P226, DOI 10.1046/j.1440-1711.2002.01079.x; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Stein BN, 2003, J IMMUNOL, V171, P6097, DOI 10.4049/jimmunol.171.11.6097; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Tsakadze NL, 2002, TRENDS CARDIOVAS MED, V12, P101, DOI 10.1016/S1050-1738(01)00157-8; Tudor KSRS, 2000, BIOCHEM CELL BIOL, V78, P99, DOI 10.1139/bcb-78-2-99; Tudor KSRS, 2001, CYTOKINE, V15, P196, DOI 10.1006/cyto.2001.0922; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200; Wang Q, 2001, J IMMUNOL, V166, P6877, DOI 10.4049/jimmunol.166.11.6877; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263	65	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26706	10.1371/journal.pone.0026706	http://dx.doi.org/10.1371/journal.pone.0026706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031842	gold, Green Submitted, Green Published			2022-12-25	WOS:000296513200045
J	DiLeo, MV; Strahan, GD; den Bakker, M; Hoekenga, OA				DiLeo, Matthew V.; Strahan, Gary D.; den Bakker, Meghan; Hoekenga, Owen A.			Weighted Correlation Network Analysis (WGCNA) Applied to the Tomato Fruit Metabolome	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; REVEALS; IDENTIFICATION; INTEGRATION; PATHWAYS; ETHYLENE	Background: Advances in "omics'' technologies have revolutionized the collection of biological data. A matching revolution in our understanding of biological systems, however, will only be realized when similar advances are made in informatic analysis of the resulting "big data.'' Here, we compare the capabilities of three conventional and novel statistical approaches to summarize and decipher the tomato metabolome. Methodology: Principal component analysis (PCA), batch learning self-organizing maps (BL-SOM) and weighted gene co-expression network analysis (WGCNA) were applied to a multivariate NMR dataset collected from developmentally staged tomato fruits belonging to several genotypes. While PCA and BL-SOM are appropriate and commonly used methods, WGCNA holds several advantages in the analysis of highly multivariate, complex data. Conclusions: PCA separated the two major genetic backgrounds (AC and NC), but provided little further information. Both BL-SOM and WGCNA clustered metabolites by expression, but WGCNA additionally defined "modules'' of co-expressed metabolites explicitly and provided additional network statistics that described the systems properties of the tomato metabolic network. Our first application of WGCNA to tomato metabolomics data identified three major modules of metabolites that were associated with ripening-related traits and genetic background.	[DiLeo, Matthew V.; den Bakker, Meghan; Hoekenga, Owen A.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [DiLeo, Matthew V.; den Bakker, Meghan; Hoekenga, Owen A.] ARS, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA; [Strahan, Gary D.] ARS, Eastern Reg Res Ctr, USDA, Wyndmoor, PA USA	Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	DiLeo, MV (corresponding author), Keygene Inc, Rockville, MD USA.	Owen.Hoekenga@ars.usda.gov		Hoekenga, Owen/0000-0003-4427-2000	Agricultural Research Service of the US Department of Agriculture	Agricultural Research Service of the US Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Agricultural Research Service of the US Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Akiyama Kenji, 2008, In Silico Biology, V8, P339; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Andersen O. M., 2006, FLAVONOIDS CHEM BIOC; [Anonymous], 2010, R LANG ENV STAT COMP; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Aten JE, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-34; Bader DA, 2004, COMMUN ACM, V47, P34, DOI 10.1145/1029496.1029523; Bai YL, 2007, ANN BOT-LONDON, V100, P1085, DOI 10.1093/aob/mcm150; Barenco M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.84; Bertin N, 2009, J EXP BOT, V60, P237, DOI 10.1093/jxb/ern281; Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004; Carrari F, 2006, J EXP BOT, V57, P1883, DOI 10.1093/jxb/erj020; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; DAVIES JN, 1975, J SCI FOOD AGR, V26, P1103, DOI 10.1002/jsfa.2740260808; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Dunn WB, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/011001; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gardner RG, 2006, HORTSCIENCE, V41, P261, DOI 10.21273/HORTSCI.41.1.261; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Goddard T, 2008, SPARKY 3 COMPUTER PR; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Harborne JB, 1999, HDB NATURAL FLAVONOI, V2, P879; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hoekenga Owen A, 2008, J Biomol Tech, V19, P159; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jolliffe I, 2004, PRINCIPAL COMPONENT; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Le Gall G, 2003, J AGR FOOD CHEM, V51, P2447, DOI 10.1021/jf0259967; LINCOLN JE, 1988, PLANT PHYSIOL, V88, P370, DOI 10.1104/pp.88.2.370; Maltsev N, 2006, CTWATCH Q, V2; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Moco S, 2007, J EXP BOT, V58, P4131, DOI 10.1093/jxb/erm271; Mounet F, 2009, PLANT PHYSIOL, V149, P1505, DOI 10.1104/pp.108.133967; Neelam A, 2008, J EXP BOT, V59, P2337, DOI 10.1093/jxb/ern100; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P84, DOI 10.1104/pp.103.023572; Samal A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-118; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; Schripsema J, 2010, PHYTOCHEM ANALYSIS, V21, P14, DOI 10.1002/pca.1185; Slimestad R, 2009, J SCI FOOD AGR, V89, P1255, DOI 10.1002/jsfa.3605; Sobolev AP, 2003, MAGN RESON CHEM, V41, P237, DOI 10.1002/mrc.1176; Tiziani S, 2006, J AGR FOOD CHEM, V54, P6094, DOI 10.1021/jf061154m; USDA-ARS, 2007, DAT FLAV CONT SEL FO; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Zhang PF, 2010, PLANT PHYSIOL, V153, P1479, DOI 10.1104/pp.110.157396; [No title captured]	56	120	123	21	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26683	10.1371/journal.pone.0026683	http://dx.doi.org/10.1371/journal.pone.0026683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039529	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200039
J	Li, H; Zhang, XL; Bi, LJ; He, J; Jiang, T				Li, He; Zhang, Xiaoli; Bi, Lijun; He, Jin; Jiang, Tao			Determination of the Crystal Structure and Active Residues of FabV, the Enoyl-ACP Reductase from Xanthomonas oryzae	PLOS ONE			English	Article							CARRIER PROTEIN REDUCTASE; ESCHERICHIA-COLI; INHIBITION; TRICLOSAN; MECHANISM; RESISTANCE; NADH	Background: Enoyl-ACP reductase (ENR) catalyses the last reduction reaction in the fatty acid elongation cycle in bacteria and is a good antimicrobial target candidate. FabV is the most recently discovered class of ENR, but we lack information about the atomic structure and the key residues involved in reductase activity except for the known conserved tyrosine and lysine residues in the Y-X-8-K active site motif. Methodology/Principal Findings: Here we report the crystal structure of FabV from Xanthomonas oryzae (xoFabV). The crystal structure of this enzyme has been solved to 1.6A resolution in space group P2(1)2(1)2(1). The model of xoFabV consists of one monomer in the asymmetric unit which is composed of 13 alpha-helices and 11 beta-strands, representing a canonical Rossmann fold architecture. Structural comparison presents that the locations of the conserved tyrosine (Y236) and lysine (K245) residues in the Y-X-8-K active site motif of xoFabV and the Y-X-6-K motif of ecFabI are notably similar. However, the conformations of Y236 in xoFabV and Y156 in ecFabI are distinct. Structure-based site-directed mutagenesis and enzymatic activity assays reveal that in addition to the conserved Y236 and K245 in the Y-X-8-K motif, Y53, D111 and Y226 are key residues implicated in the reductase activity, and F113 and T276 are also important for enzyme function. Moreover, a proposed active lysine located immediately after the Y-X-8-K motif in FabV from Burkholderia mallei (bmFabV) is altered to an inactive V246 in xoFabV. Conclusions/Significance: We determine the first crystal structure of the FabV enzyme and identify several residues important for its enzymatic activity. These findings lay a solid foundation for the development of specific antibacterial inhibitors of the pathogenic bacteria, such as Vibrio cholerae, Burkholderia species and Xanthomonas species.	[Li, He; Zhang, Xiaoli; Bi, Lijun; Jiang, Tao] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhang, Xiaoli; He, Jin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Huazhong Agricultural University	Li, H (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	hejin@mail.hzau.edu.cn; tjiang@sun5.ibp.ac.cn			Chinese National Natural Science Funds [31070065]; Fundamental Research Funds for Central Universities of China [2009PY019]; Hubei Natural Science Fund of China [2010CDB10003]	Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities of China; Hubei Natural Science Fund of China	This work was supported by the Chinese National Natural Science Funds (Grant No. 31070065), the Fundamental Research Funds for Central Universities of China (2009PY019) and the Hubei Natural Science Fund of China (2010CDB10003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baldock C, 1996, SCIENCE, V274, P2107, DOI 10.1126/science.274.5295.2107; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Kim KH, 2011, J MOL BIOL, V406, P403, DOI 10.1016/j.jmb.2010.12.003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Lu H, 2010, BIOCHEMISTRY-US, V49, P1281, DOI 10.1021/bi902001a; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Massengo-Tiasse RP, 2009, CELL MOL LIFE SCI, V66, P1507, DOI 10.1007/s00018-009-8704-7; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; Min J, 2011, J MOL CATAL B-ENZYM, V68, P174, DOI 10.1016/j.molcatb.2010.10.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saito J, 2008, PROTEIN SCI, V17, P691, DOI 10.1110/ps.073288808; Seefeld MA, 2003, J MED CHEM, V46, P1627, DOI 10.1021/jm0204035; Sivaraman S, 2003, BIOCHEMISTRY-US, V42, P4406, DOI 10.1021/bi0300229; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; Yang H, 2010, BIOCONJUGATE CHEM, V21, P1341, DOI 10.1021/bc1001533; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	34	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26743	10.1371/journal.pone.0026743	http://dx.doi.org/10.1371/journal.pone.0026743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039545	Green Submitted, Green Published, gold			2022-12-25	WOS:000296513200049
J	Steven, P; Bock, F; Huttmann, G; Cursiefen, C				Steven, Philipp; Bock, Felix; Huettmann, Gereon; Cursiefen, Claus			Intravital Two-Photon Microscopy of Immune Cell Dynamics in Corneal Lymphatic Vessels	PLOS ONE			English	Article							IN-VIVO; LYMPHANGIOGENESIS; INFLAMMATION; ENDOTHELIUM; MACROPHAGES; EXPRESSION; INDUCTION; MIGRATION; TUMOR	Background: The role of lymphatic vessels in tissue and organ transplantation as well as in tumor growth and metastasis has drawn great attention in recent years. Methodology/Principal Findings: We now developed a novel method using non-invasive two-photon microscopy to simultaneously visualize and track specifically stained lymphatic vessels and autofluorescent adjacent tissues such as collagen fibrils, blood vessels and immune cells in the mouse model of corneal neovascularization in vivo. The mouse cornea serves as an ideal tissue for this technique due to its easy accessibility and its inducible and modifiable state of pathological hem-and lymphvascularization. Neovascularization was induced by suture placement in corneas of Balb/C mice. Two weeks after treatment, lymphatic vessels were stained intravital by intrastromal injection of a fluorescently labeled LYVE-1 antibody and the corneas were evaluated in vivo by two-photon microscopy (TPM). Intravital TPM was performed at 710 nm and 826 nm excitation wavelengths to detect immunofluorescence and tissue autofluorescence using a custom made animal holder. Corneas were then harvested, fixed and analyzed by histology. Time lapse imaging demonstrated the first in vivo evidence of immune cell migration into lymphatic vessels and luminal transport of individual cells. Cells immigrated within 1-5.5 min into the vessel lumen. Mean velocities of intrastromal corneal immune cells were around 9 mm/min and therefore comparable to those of T-cells and macrophages in other mucosal surfaces. Conclusions: To our knowledge we here demonstrate for the first time the intravital real-time transmigration of immune cells into lymphatic vessels. Overall this study demonstrates the valuable use of intravital autofluorescence two-photon microscopy in the model of suture-induced corneal vascularizations to study interactions of immune and subsequently tumor cells with lymphatic vessels under close as possible physiological conditions.	[Steven, Philipp] Univ Lubeck, Dept Ophthalmol, Lubeck, Germany; [Steven, Philipp] Univ Lubeck, Inst Anat, Lubeck, Germany; [Bock, Felix; Cursiefen, Claus] Univ Clin Cologne, Dept Ophthalmol, Cologne, Germany; [Bock, Felix; Cursiefen, Claus] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA; [Huettmann, Gereon] Univ Lubeck, Inst Biomed Opt, Lubeck, Germany	University of Lubeck; University of Lubeck; University of Cologne; Harvard University; Harvard Medical School; Schepens Eye Research Institute; University of Lubeck	Steven, P (corresponding author), Univ Lubeck, Dept Ophthalmol, Lubeck, Germany.	philipp.steven@uk-koeln.de	Cursiefen, Claus/ABE-5284-2020; Hüttmann, Gereon/A-9072-2012	Hüttmann, Gereon/0000-0002-5051-3037; Steven, Philipp/0000-0001-6892-3619; cursiefen, claus/0000-0002-1958-411X	German Research Foundation (DFG) [SFB 643 [TP B10]]; Interdisciplinary Center for Clinical Research (IZKF) Erlangen [A9]; Sektion Kornea, Deutsche Ophthalmologische Gesellschaft; University of Luebeck [TP3]	German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Erlangen; Sektion Kornea, Deutsche Ophthalmologische Gesellschaft; University of Luebeck	Funding provided by the German Research Foundation (DFG: SFB 643 [TP B10] to CC); Interdisciplinary Center for Clinical Research (IZKF) Erlangen (A9 to CC); Sektion Kornea, Deutsche Ophthalmologische Gesellschaft (to PS); University of Luebeck, Medical Faculty Grant (TP3 to PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038/nm1078; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Cursiefen C, 2006, P NATL ACAD SCI USA, V103, P11405, DOI 10.1073/pnas.0506112103; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dietrich T, 2010, J IMMUNOL, V184, P535, DOI 10.4049/jimmunol.0903180; Fisher KE, 2009, J CELL SCI, V122, P4558, DOI 10.1242/jcs.050724; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Hammer T, 2009, MICROVASC RES, V78, P25, DOI 10.1016/j.mvr.2009.02.007; Hamrah P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1132, DOI 10.1001/archopht.121.8.1132; Hamrah P, 2003, INVEST OPHTH VIS SCI, V44, P581, DOI 10.1167/iovs.02-0838; HOLLAND EJ, 1994, CORNEA, V13, P317, DOI 10.1097/00003226-199407000-00006; Johnson LA, 2008, ANN NY ACAD SCI, V1131, P119, DOI 10.1196/annals.1413.011; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kwon Sunkuk, 2007, Lymphatic Research and Biology, V5, P219, DOI 10.1089/lrb.2007.1013; LEE EJ, INVEST OPHTHALMOL VI, V51, P2101; LEU AJ, 1994, AM J PHYSIOL-HEART C, V267, pH1507, DOI 10.1152/ajpheart.1994.267.4.H1507; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; McElroy M, 2009, J SURG RES, V151, P68, DOI 10.1016/j.jss.2007.12.769; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; PEEBO BB, INVEST OPHTHALMOL VI, V51, P830; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Pillai RG, 2008, BRIT J OPHTHALMOL, V92, P259, DOI 10.1136/bjo.2007.115923; RICE WL, PLOS ONE, V5; Rosenbaum JT, 2002, CURR EYE RES, V24, P214, DOI 10.1076/ceyr.24.3.214.8303; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Steven P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275475; VANGOETHEM E, EUR J CELL BIOL, V90, P224; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	31	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26253	10.1371/journal.pone.0026253	http://dx.doi.org/10.1371/journal.pone.0026253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028842	Green Submitted, Green Published, gold			2022-12-25	WOS:000296510800031
J	Allen, JF; Santabarbara, S; Allen, CA; Puthiyaveetil, S				Allen, John F.; Santabarbara, Stefano; Allen, Carol A.; Puthiyaveetil, Sujith			Discrete Redox Signaling Pathways Regulate Photosynthetic Light-Harvesting and Chloroplast Gene Transcription	PLOS ONE			English	Article							CHLOROPHYLL PROTEIN COMPLEX; STATE TRANSITIONS; PHOTOSYSTEM-II; FLUORESCENCE SPECTROSCOPY; STATE-1-STATE-2 TRANSITIONS; CYANOBACTERIAL CELLS; PLASTOQUINONE POOL; ELECTRON FLOW; SIGMA-FACTOR; PHOSPHORYLATION	In photosynthesis in chloroplasts, two related regulatory processes balance the actions of photosystems I and II. These processes are short-term, post-translational redistribution of light-harvesting capacity, and long-term adjustment of photosystem stoichiometry initiated by control of chloroplast DNA transcription. Both responses are initiated by changes in the redox state of the electron carrier, plastoquinone, which connects the two photosystems. Chloroplast Sensor Kinase (CSK) is a regulator of transcription of chloroplast genes for reaction centres of the two photosystems, and a sensor of plastoquinone redox state. We asked whether CSK is also involved in regulation of absorbed light energy distribution by phosphorylation of light-harvesting complex II (LHC II). Chloroplast thylakoid membranes isolated from a CSK T-DNA insertion mutant and from wild-type Arabidopsis thaliana exhibit similar light-and redox-induced 32 P-labelling of LHC II and changes in 77 K chlorophyll fluorescence emission spectra, while room-temperature chlorophyll fluorescence emission transients from Arabidopsis leaves are perturbed by inactivation of CSK. The results indicate indirect, pleiotropic effects of reaction centre gene transcription on regulation of photosynthetic light-harvesting in vivo. A single, direct redox signal is transmitted separately to discrete transcriptional and post-translational branches of an integrated cytoplasmic regulatory system.	[Allen, John F.; Allen, Carol A.; Puthiyaveetil, Sujith] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Santabarbara, Stefano] CNR, Ist Biofis, I-20133 Milan, Italy	University of London; Queen Mary University London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Allen, JF (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	j.f.allen@qmul.ac.uk	Allen, John/K-6309-2019; Puthiyaveetil, Sujith/S-3098-2016	Allen, John/0000-0002-0950-0429; Puthiyaveetil, Sujith/0000-0001-7505-4511; Santabarbara, Stefano/0000-0002-7993-2614	Leverhulme Trust [F/07 476/AQ, ECF/2009/0180]	Leverhulme Trust(Leverhulme Trust)	The Leverhulme Trust, Research Grant F/07 476/AQ (http://www.leverhulme.ac.uk/); The Leverhulme Trust, Early Career Research Fellowship ECF/2009/0180 (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J.F., 2008, PHOTOSYNTHESIS ENERG, P1155; Allen JF, 2000, PHILOS T R SOC B, V355, P1351, DOI 10.1098/rstb.2000.0697; ALLEN JF, 1981, FEBS LETT, V123, P67, DOI 10.1016/0014-5793(81)80021-X; ALLEN JF, 1993, FEBS LETT, V332, P203, DOI 10.1016/0014-5793(93)80631-4; ALLEN JF, 1989, PHOTOSYNTH RES, V22, P157, DOI 10.1007/BF00034860; ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ALLEN JF, 1983, TRENDS BIOCHEM SCI, V8, P369, DOI 10.1016/0968-0004(83)90364-X; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; ALLEN JF, 2011, TRENDS PLAN IN PRESS; ANDERSSON B, 1982, FEBS LETT, V149, P181, DOI 10.1016/0014-5793(82)81097-1; [Anonymous], 2002, PHOTOSYNTHETICA; Baginsky S, 1999, PLANT MOL BIOL, V39, P1013, DOI 10.1023/A:1006177807844; Bauer C, 2003, PHILOS T R SOC B, V358, P147, DOI 10.1098/rstb.2002.1189; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; BENNETT J, 1980, EUR J BIOCHEM, V104, P85, DOI 10.1111/j.1432-1033.1980.tb04403.x; BENNETT J, 1979, EUR J BIOCHEM, V99, P133, DOI 10.1111/j.1432-1033.1979.tb13239.x; Bjorn LO, 2009, CURR SCI INDIA, V96, P1466; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; CHOW WS, 1990, P NATL ACAD SCI USA, V87, P7502, DOI 10.1073/pnas.87.19.7502; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; HARRISON MA, 1991, BIOCHIM BIOPHYS ACTA, V1058, P289, DOI 10.1016/S0005-2728(05)80249-X; HILL R, 1960, NATURE, V186, P136, DOI 10.1038/186136a0; KRAUSE GH, 1983, BIOCHIM BIOPHYS ACTA, V723, P176, DOI 10.1016/0005-2728(83)90117-2; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; KRAUSE GH, 1983, BIOCHIM BIOPHYS ACTA, V723, P169, DOI 10.1016/0005-2728(83)90116-0; LARSSON UK, 1983, EUR J BIOCHEM, V136, P25, DOI 10.1111/j.1432-1033.1983.tb07700.x; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; Li H, 2000, J BACTERIOL, V182, P4268, DOI 10.1128/JB.182.15.4268-4277.2000; Link G, 2003, ANTIOXID REDOX SIGN, V5, P79, DOI 10.1089/152308603321223568; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; MELIS A, 1989, Z NATURFORSCH C, V44, P109; MULLINEAUX CW, 1990, PHOTOSYNTH RES, V23, P297, DOI 10.1007/BF00034860; MULLINEAUX CW, 1986, FEBS LETT, V205, P155, DOI 10.1016/0014-5793(86)80885-7; Murakami A, 1997, PLANT CELL PHYSIOL, V38, P392, DOI 10.1093/oxfordjournals.pcp.a029181; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; MYERS J, 1971, ANN REV PLANT PHYSIO, V22, P289, DOI 10.1146/annurev.pp.22.060171.001445; Pesaresi P., 2010, BIOCHIM BIOPHYS ACTA, V1807, P887; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; Pfannschmidt T, 1999, IUBMB LIFE, V48, P271, DOI 10.1080/713803507; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; PUTHIYAVEETIL S, 2011, PLANT CELL IN PRESS; Puthiyaveetil S, 2008, P NATL ACAD SCI USA, V105, P10061, DOI 10.1073/pnas.0803928105; Puthiyaveetil S, 2008, BIOCHEM BIOPH RES CO, V368, P871, DOI 10.1016/j.bbrc.2008.01.167; Puthiyaveetil S, 2011, FEBS LETT, V585, P1717, DOI 10.1016/j.febslet.2011.04.076; Puthiyaveetil S, 2010, GENOME BIOL EVOL, V2, P888, DOI 10.1093/gbe/evq073; Puthiyaveetil S, 2009, P ROY SOC B-BIOL SCI, V276, P2133, DOI 10.1098/rspb.2008.1426; Raven JA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-209; Rochaix J, 2007, FEBS J, V274, P26; Schweer J, 2010, PLANT J, V62, P192, DOI 10.1111/j.1365-313X.2010.04138.x; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; SILVERSTEIN T, 1993, FEBS LETT, V334, P101, DOI 10.1016/0014-5793(93)81690-2; TELFER A, 1983, BIOCHIM BIOPHYS ACTA, V722, P176, DOI 10.1016/0005-2728(83)90171-8; Tullberg A, 2000, PLANT CELL PHYSIOL, V41, P1045, DOI 10.1093/pcp/pcd031; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; WILLIAMS WP, 1987, PHOTOSYNTH RES, V13, P19, DOI 10.1007/BF00032263; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	67	24	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26372	10.1371/journal.pone.0026372	http://dx.doi.org/10.1371/journal.pone.0026372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039472	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500057
J	Berg, JS; Lin, KK; Sonnet, C; Boles, NC; Weksberg, DC; Nguyen, H; Holt, LJ; Rickwood, D; Daly, RJ; Goodell, MA				Berg, Jonathan S.; Lin, Kuanyin K.; Sonnet, Corinne; Boles, Nathan C.; Weksberg, David C.; Hoang Nguyen; Holt, Lowenna J.; Rickwood, Danny; Daly, Roger J.; Goodell, Margaret A.			Imprinted Genes That Regulate Early Mammalian Growth Are Coexpressed in Somatic Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM; ADULT STEM; MOLECULAR SIGNATURE; PROGENITOR CELLS; NONCODING RNA; EXPRESSION; IDENTIFICATION; ACTIVATION; H19; P53	Lifelong, many somatic tissues are replenished by specialized adult stem cells. These stem cells are generally rare, infrequently dividing, occupy a unique niche, and can rapidly respond to injury to maintain a steady tissue size. Despite these commonalities, few shared regulatory mechanisms have been identified. Here, we scrutinized data comparing genes expressed in murine long-term hematopoietic stem cells with their differentiated counterparts and observed that a disproportionate number were members of the developmentally-important, monoallelically expressed imprinted genes. Studying a subset, which are members of a purported imprinted gene network (IGN), we found their expression in HSCs rapidly altered upon hematopoietic perturbations. These imprinted genes were also predominantly expressed in stem/progenitor cells of the adult epidermis and skeletal muscle in mice, relative to their differentiated counterparts. The parallel down-regulation of these genes postnatally in response to proliferation and differentiation suggests that the IGN could play a mechanistic role in both cell growth and tissue homeostasis.	[Berg, Jonathan S.; Weksberg, David C.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lin, Kuanyin K.; Sonnet, Corinne; Hoang Nguyen; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Boles, Nathan C.; Goodell, Margaret A.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Holt, Lowenna J.] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia; [Rickwood, Danny; Daly, Roger J.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Garvan Institute of Medical Research; Garvan Institute of Medical Research	Berg, JS (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	goodell@bcm.edu		Berg, Jonathan/0000-0003-2360-2664; Holt, Lowenna/0000-0002-4703-9696; Daly, Roger/0000-0002-5739-8027; Goodell, Margaret A./0000-0003-1111-2932	National Institutes of Health [HL086223, DK58192, AG034451, DK060445, EB005173, P50CA126752, 1RC2AG036562]; NATIONAL CANCER INSTITUTE [P30CA125123, P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL086223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445, R01DK058192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036562, R21AG034451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institutes of Health (HL086223 to Dr. Berg and DK58192, AG034451, and DK060445 to Dr. Goodell, and EB005173, P50CA126752, and 1RC2AG036562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beaudet AL, 2002, AM J HUM GENET, V70, P1389, DOI 10.1086/340969; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Fortunel NO, 2003, SCIENCE, V302, P393; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Hernandez L, 2003, P NATL ACAD SCI USA, V100, P13344, DOI 10.1073/pnas.2234026100; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Huang SM, 2001, ONCOGENE, V20, P2134, DOI 10.1038/sj.onc.1204298; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kernohan KD, 2010, DEV CELL, V18, P191, DOI 10.1016/j.devcel.2009.12.017; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KING KY, 2011, BLOOD; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nunez C, 2000, J PATHOL, V190, P61, DOI 10.1002/(SICI)1096-9896(200001)190:1<61::AID-PATH502>3.0.CO;2-#; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Pantoja C, 2005, CANCER RES, V65, P26; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Tessema M, 2005, INT J ONCOL, V26, P499; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Wu Q, 2008, J REPROD DEVELOP, V54, P177, DOI 10.1262/jrd.19146; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; ZACHAREK SJ, 2011, CELL STEM C IN PRESS, P1; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	63	56	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26410	10.1371/journal.pone.0026410	http://dx.doi.org/10.1371/journal.pone.0026410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039481	Green Submitted, gold, Green Published			2022-12-25	WOS:000296507500063
J	Gredeback, G; Melinder, A				Gredeback, Gustaf; Melinder, Annika			Teleological Reasoning in 4-Month-Old Infants: Pupil Dilations and Contextual Constraints	PLOS ONE			English	Article							GOAL; PERCEPTION	Four-month-old infants were presented with feeding actions performed in a rational or irrational manner. Infants reacted to the irrational feeding actions by dilating their pupils, but only in the presence of rich contextual constraints. The study demonstrates that teleological processes are online at 4 months of age and illustrates the usefulness of pupil dilations as a measure of social cognitive processes early in infancy.	[Gredeback, Gustaf] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Melinder, Annika] Univ Oslo, Dept Psychol, Oslo, Norway	Uppsala University; University of Oslo	Gredeback, G (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.	gustaf.gredeback@psyk.uu.se	Melinder, Annika/L-6782-2016; Gredebäck, Gustaf/C-1676-2009	Melinder, Annika/0000-0001-7773-0579; Gredebäck, Gustaf/0000-0003-3046-0043	Norwegian Directorate for Children, Youth and Family Affairs [06/34707]; Marie-Curie ITN RobotDoc	Norwegian Directorate for Children, Youth and Family Affairs; Marie-Curie ITN RobotDoc	The study was supported by grants from the Norwegian Directorate for Children, Youth and Family Affairs (06/34707) and Marie-Curie ITN RobotDoc (2010-2013). http://www.sv.uio.no/psi/forskning/grupper/ekup/. www.robotdoc.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin DA, 2001, TRENDS COGN SCI, V5, P171, DOI 10.1016/S1364-6613(00)01615-6; Craighero L, 2011, COGNITION, V120, P26, DOI 10.1016/j.cognition.2011.02.011; Csibra G, 2008, COGNITION, V107, P705, DOI 10.1016/j.cognition.2007.08.001; Csibra G, 2007, ACTA PSYCHOL, V124, P60, DOI 10.1016/j.actpsy.2006.09.007; D'Entremont B, 2000, DEVELOPMENTAL SCI, V3, P302, DOI 10.1111/1467-7687.00124; Daum MM, 2011, EXP BRAIN RES, V208, P297, DOI 10.1007/s00221-010-2479-9; Dionisio DP, 2001, PSYCHOPHYSIOLOGY, V38, P205, DOI 10.1017/S0048577201990717; Falck-Ytter T, 2008, AUTISM RES, V1, P297, DOI 10.1002/aur.45; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GREDEBACK G, INFANCY IN PRESS; Gredeback G, 2010, DEVELOPMENTAL SCI, V13, P839, DOI 10.1111/j.1467-7687.2009.00945.x; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Gredeback G, 2009, DEV PSYCHOL, V45, P1190, DOI 10.1037/a0015667; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Hespos SJ, 2009, DEV PSYCHOL, V45, P575, DOI 10.1037/a0014145; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Kamewari K, 2005, COGNITIVE DEV, V20, P303, DOI 10.1016/j.cogdev.2005.04.004; Kochukhova O, 2010, CHILD DEV, V81, P1729, DOI 10.1111/j.1467-8624.2010.01506.x; LAENG B, PERSPECTIVE IN PRESS; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; RUFFMAN T, BRIT J DEV IN PRESS; Saylor MM, 2007, J COGN DEV, V8, P113, DOI 10.1207/s15327647jcd0801_6; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Vo MLH, 2008, PSYCHOPHYSIOLOGY, V45, P130, DOI 10.1111/j.1469-8986.2007.00606.x; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132	28	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26487	10.1371/journal.pone.0026487	http://dx.doi.org/10.1371/journal.pone.0026487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039499	Green Published, gold			2022-12-25	WOS:000296507500077
J	Lazaro, E; Tram, LT; Bellecave, P; Guidicelli, GL; Anies, G; Huynh, HKT; Debelleix, MP; Vray, M; Recordon-Pinson, P; Taupin, JL; Truong, TXL; Fleury, H				Lazaro, Estibaliz; Luong Thu Tram; Bellecave, Pantxika; Guidicelli, Gwenda-Line; Anies, Guerric; Huynh Hoang Khanh Thu; Debelleix, Marie Pillot; Vray, Muriel; Recordon-Pinson, Patricia; Taupin, Jean-Luc; Truong Thi Xuan Lien; Fleury, Herve			Molecular Characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and Impact of T-Cell Epitope Mutations on HLA Recognition (ANRS 12159)	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE-RESPONSES; SEQUENCE-ANALYSIS; CLASS-I; ESCAPE; POPULATION; HAPLOTYPES; INFECTION; GAG	Background: To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The underlying reason why their distribution is so heterogeneous is not clear. Host genetic factors could partly explain this distribution. The aim of this study was to describe HIV-1 strains circulating in an unexplored area of Mekong Delta, Vietnam, and to assess the impact of optimal epitope mutations on HLA binding. Methods: We recruited 125 chronically antiretroviral-naive HIV-1-infected subjects from five cities in the Mekong Delta. We performed high-resolution DNA typing of HLA class I alleles, sequencing of Gag and RT-Prot genes and phylogenetic analysis of the strains. Epitope mutations were analyzed in patients bearing the HLA allele restricting the studied epitope. Optimal wild-type epitopes from the Los Alamos database were used as reference. T-cell epitope recognition was predicted using the immune epitope database tool according to three different scores involved in antigen processing (TAP and proteasome scores) and HLA binding (MHC score). Results: All sequences clustered with CRF01_AE. HLA class I genotyping showed the predominance of Asian alleles as A*11:01 and B*46:01 with a Vietnamese specificity held by two different haplotypes. The percentage of homology between Mekong and B consensus HIV-1 sequences was above 85%. Divergent epitopes had TAP and proteasome scores comparable with wild-type epitopes. MHC scores were significantly lower in divergent epitopes with a mean of 2.4 (+/- 0.9) versus 2 (+/- 0.7) in non-divergent ones (p<0.0001). Conclusions: Our study confirms the wide predominance of CRF01_AE in the Mekong Delta where patients harbor a specific HLA pattern. Moreover, it demonstrates the lower MHC binding affinity among divergent epitopes. This weak immune pressure combined with a narrow genetic diversity favors immune escape and could explain why CRF01_AE is still predominant in Vietnam, particularly in the Mekong area.	[Lazaro, Estibaliz; Bellecave, Pantxika; Debelleix, Marie Pillot; Recordon-Pinson, Patricia; Fleury, Herve] CHU Bordeaux, Virol Lab, Bordeaux, France; [Lazaro, Estibaliz; Bellecave, Pantxika; Debelleix, Marie Pillot; Recordon-Pinson, Patricia; Fleury, Herve] Univ Bordeaux 2, CNRS, UMR 5234, F-33076 Bordeaux, France; [Luong Thu Tram; Huynh Hoang Khanh Thu; Truong Thi Xuan Lien] Inst Pasteur, Ho Chi Minh City, Vietnam; [Guidicelli, Gwenda-Line; Anies, Guerric; Taupin, Jean-Luc] CHU Bordeaux, Lab Immunol & Immunogenet, Bordeaux, France; [Anies, Guerric; Taupin, Jean-Luc] Univ Bordeaux 2, UMR 5164, CNRS, F-33076 Bordeaux, France; [Vray, Muriel] Inst Pasteur, Paris, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lazaro, E (corresponding author), CHU Bordeaux, Virol Lab, Bordeaux, France.	herve.fleury@viro.u-bordeaux2.fr	Vray, Muriel/M-7947-2018; Recordon-Pinson, Patricia/AAV-1295-2021	Recordon-Pinson, Patricia/0000-0001-6002-0941; Huynh, Hoang Khanh Thu/0000-0001-9199-6103	Agence Nationale de Recherches Sur le sida et les hepatites virales (ANRS) [ANRS 12159]; European Community [223131]	Agence Nationale de Recherches Sur le sida et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); European Community(European Commission)	This study was supported by Agence Nationale de Recherches Sur le sida et les hepatites virales (ANRS) (ANRS 12159). PB was supported by a fellowship from the European Community's Seventh Framework Program (FP7/2007-2013) under the "Collaborative HIV and Anti-HIV Drug Resistance Network'' project (grant no. 223131). The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Aidoo M, 2008, VACCINE, V26, P4830, DOI 10.1016/j.vaccine.2008.06.097; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Brumme ZL, 2009, J EXP MED, V206, P1215, DOI 10.1084/jem.20091094; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Caumont A, 2001, AIDS RES HUM RETROV, V17, P1285, DOI 10.1089/088922201750461357; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hudgens MG, 2002, AM J EPIDEMIOL, V155, P159, DOI 10.1093/aje/155.2.159; Ishizaki A, 2009, AIDS RES HUM RETROV, V25, P175, DOI 10.1089/aid.2008.0193; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kent SJ, 2005, TRENDS MICROBIOL, V13, P243, DOI 10.1016/j.tim.2005.03.011; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lazaro E, 2005, AIDS RES HUM RETROV, V21, P586, DOI 10.1089/aid.2005.21.586; Lazaro E, 2009, J INFECT DIS, V200, P236, DOI 10.1086/599837; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nguyen THL, 2003, AIDS RES HUM RETROV, V19, P925, DOI 10.1089/088922203322493111; Rolland M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012463; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shi L, 2010, INT J IMMUNOGENET, V37, P467, DOI 10.1111/j.1744-313X.2010.00949.x; Shi L, 2008, HUM IMMUNOL, V69, P58, DOI 10.1016/j.humimm.2007.11.007; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Phan TTC, 2010, AIDS RES HUM RETROV, V26, P233, DOI 10.1089/aid.2009.0206; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Tran TTH, 2004, AIDS RES HUM RETROV, V20, P341; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26244	10.1371/journal.pone.0026244	http://dx.doi.org/10.1371/journal.pone.0026244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039450	gold, Green Submitted, Green Published			2022-12-25	WOS:000296507500044
J	Liu, M; Gao, H; Shang, P; Zhou, XL; Ashforth, E; Zhuo, Y; Chen, DF; Ren, BA; Liu, ZH; Zhang, LX				Liu, Mei; Gao, Hong; Shang, Peng; Zhou, Xianlong; Ashforth, Elizabeth; Zhuo, Ying; Chen, Difei; Ren, Biao; Liu, Zhiheng; Zhang, Lixin			Magnetic Field Is the Dominant Factor to Induce the Response of Streptomyces avermitilis in Altered Gravity Simulated by Diamagnetic Levitation	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; GROWTH; MICROGRAVITY; COELICOLOR	Background: Diamagnetic levitation is a technique that uses a strong, spatially varying magnetic field to simulate an altered gravity environment, as in space. In this study, using Streptomyces avermitilis as the test organism, we investigate whether changes in magnetic field and altered gravity induce changes in morphology and secondary metabolism. We find that a strong magnetic field (12T) inhibit the morphological development of S. avermitilis in solid culture, and increase the production of secondary metabolites. Methodology/Principal Findings: S. avermitilis on solid medium was levitated at 0 g*, 1 g* and 2 g* in an altered gravity environment simulated by diamagnetic levitation and under a strong magnetic field, denoted by the asterix. The morphology was obtained by electromicroscopy. The production of the secondary metabolite, avermectin, was determined by OD245 nm. The results showed that diamagnetic levitation could induce a physiological response in S. avermitilis. The difference between 1 g* and the control group grown without the strong magnetic field (1 g), showed that the magnetic field was a more dominant factor influencing changes in morphology and secondary metabolite production, than altered gravity. Conclusion/Significance: We have discovered that magnetic field, rather than altered gravity, is the dominant factor in altered gravity simulated by diamagnetic levitation, therefore care should to be taken in the interpretation of results when using diamagnetic levitation as a technique to simulate altered gravity. Hence, these results are significant, and timely to researchers considering the use of diamagnetic levitation to explore effects of weightlessness on living organisms and on physical phenomena.	[Liu, Mei; Gao, Hong; Zhou, Xianlong; Ashforth, Elizabeth; Zhuo, Ying; Chen, Difei; Ren, Biao; Liu, Zhiheng; Zhang, Lixin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Liu, Mei; Zhuo, Ying; Chen, Difei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Shang, Peng] Northwestern Polytech Univ, Fac Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, M (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	Zhanglixin@im.ac.cn	Ren, Biao/P-1067-2015	Ren, Biao/0000-0003-4215-2873; Gao, Hong/0000-0002-8544-7826; Zhang, Lixin/0000-0003-0894-9520	National Natural Science Foundation of China [31000057]; 973 Program [2012CB721000]; National Key Technology RD Program [2007BAI26B02]; Key Project of International Cooperation [2007DFB31620]; National Science & Technology Pillar Program [200703295000-02]; Important National Science & Technology Specific Projects [2008ZX09401-005]; Hundred Talents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); Key Project of International Cooperation; National Science & Technology Pillar Program; Important National Science & Technology Specific Projects; Hundred Talents Program(Chinese Academy of Sciences)	This work was supported in part by a grant from National Natural Science Foundation of China (No. 31000057), 973 Program (No. 2012CB721000), National Key Technology R&D Program 2007BAI26B02, Key Project of International Cooperation (2007DFB31620), the National Science & Technology Pillar Program (No. 200703295000-02), Important National Science & Technology Specific Projects (No. 2008ZX09401-005). LZ received funding from the Hundred Talents Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuls E, 2009, ASTROBIOLOGY, V9, P797, DOI 10.1089/ast.2009.0383; Coleman CB, 2007, BIOTECHNOL BIOENG, V98, P854, DOI 10.1002/bit.21526; Dijkstra CE, 2011, J R SOC INTERFACE, V8, P334, DOI 10.1098/rsif.2010.0294; Fang A, 2000, APPL MICROBIOL BIOT, V54, P33, DOI 10.1007/s002539900303; Gao H, 2010, APPL ENVIRON MICROB, V76, P4583, DOI 10.1128/AEM.01682-09; Gao H, 2010, APPL MICROBIOL BIOT, V85, P1219, DOI 10.1007/s00253-009-2345-5; Gao H, 2009, BIORESOURCE TECHNOL, V100, P4012, DOI 10.1016/j.biortech.2009.03.013; Guevorkian K, 2006, P NATL ACAD SCI USA, V103, P13051, DOI 10.1073/pnas.0601839103; Hejnowicz Z, 1998, PLANT CELL ENVIRON, V21, P1293, DOI 10.1046/j.1365-3040.1998.00375.x; Ikehata M, 1999, MUTAT RES-FUND MOL M, V427, P147, DOI 10.1016/S0027-5107(99)00087-1; Iwasaka M, 2004, BIOELECTROCHEMISTRY, V65, P59, DOI 10.1016/j.bioelechem.2004.04.002; Ji YL, 2010, BIORESOURCE TECHNOL, V101, P8535, DOI 10.1016/j.biortech.2010.05.094; Kuznetsov OA, 1996, PLANTA, V198, P87; Lewis RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-682; Liu YM, 2010, ADV SPACE RES, V45, P208, DOI 10.1016/j.asr.2009.08.033; Qi F, 2011, APPL BIOCHEM BIOTECH, V163, P162, DOI 10.1007/s12010-010-9025-x; Qian AR, 2009, IEEE T APPL SUPERCON, V19, P42, DOI 10.1109/TASC.2009.2012422; Valles JM, 1997, BIOPHYS J, V73, P1130, DOI 10.1016/S0006-3495(97)78145-1; VALLES JM, 2002, J GRAVIT PHYSL, V9, P11; Viollier PH, 2003, MOL MICROBIOL, V47, P699, DOI 10.1046/j.1365-2958.2003.03302.x; Wakayama NI, 2006, ANN NY ACAD SCI, V1077, P184, DOI 10.1196/annals.1362.024; Wang CX, 2010, MICROBIOL RES, V165, P221, DOI 10.1016/j.micres.2009.05.003; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Zhang QM, 2003, INT J RADIAT BIOL, V79, P281, DOI 10.1080/0955300031000096289; Zhang SF, 2002, ANALYST, V127, P373, DOI 10.1039/b109617f	25	18	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e24697	10.1371/journal.pone.0024697	http://dx.doi.org/10.1371/journal.pone.0024697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039402	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500003
J	Lund, O; Nascimento, EJM; Maciel, M; Nielsen, M; Larsen, MV; Lundegaard, C; Harndahl, M; Lamberth, K; Buus, S; Salmon, J; August, TJ; Marques, ETA				Lund, Ole; Nascimento, Eduardo J. M.; Maciel, Milton, Jr.; Nielsen, Morten; Larsen, Mette Voldby; Lundegaard, Claus; Harndahl, Mikkel; Lamberth, Kasper; Buus, Soren; Salmon, Jerome; August, Thomas J.; Marques, Ernesto T. A., Jr.			Human Leukocyte Antigen (HLA) Class I Restricted Epitope Discovery in Yellow Fewer and Dengue Viruses: Importance of HLA Binding Strength	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS VACCINES; T-LYMPHOCYTE RESPONSES; DOUBLE-KNOCKOUT MICE; CELL RESPONSES; FEVER VACCINE; CTL EPITOPES; PROTEINS; TARGETS; CONSULTATION; SAFETY	Epitopes from all available full-length sequences of yellow fever virus (YFV) and dengue fever virus (DENV) restricted by Human Leukocyte Antigen class I (HLA-I) alleles covering 12 HLA-I supertypes were predicted using the NetCTL algorithm. A subset of 179 predicted YFV and 158 predicted DENV epitopes were selected using the EpiSelect algorithm to allow for optimal coverage of viral strains. The selected predicted epitopes were synthesized and approximately 75% were found to bind the predicted restricting HLA molecule with an affinity, K-D, stronger than 500 nM. The immunogenicity of 25 HLA-A*02:01, 28 HLA-A*24:02 and 28 HLA-B*07:02 binding peptides was tested in three HLA-transgenic mice models and led to the identification of 17 HLA-A*02: 01, 4 HLA-A*2402 and 4 HLA-B*07: 02 immunogenic peptides. The immunogenic peptides bound HLA significantly stronger than the non-immunogenic peptides. All except one of the immunogenic peptides had K-D below 100 nM and the peptides with K-D below 5 nM were more likely to be immunogenic. In addition, all the immunogenic peptides that were identified as having a high functional avidity had K-D below 20 nM. A*02:01 transgenic mice were also inoculated twice with the 17DD YFV vaccine strain. Three of the YFV A*02:01 restricted peptides activated T-cells from the infected mice in vitro. All three peptides that elicited responses had an HLA binding affinity of 2 nM or less. The results indicate the importance of the strength of HLA binding in shaping the immune response.	[Lund, Ole; Nielsen, Morten; Larsen, Mette Voldby; Lundegaard, Claus] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Harndahl, Mikkel; Lamberth, Kasper; Buus, Soren] Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, Div Expt Immunol, DK-2200 Copenhagen, Denmark; [Nascimento, Eduardo J. M.; Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Maciel, Milton, Jr.; Salmon, Jerome; August, Thomas J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Marques, Ernesto T. A., Jr.] Oswaldo Cruz Fdn FIOCRUZ, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil	Technical University of Denmark; University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Fundacao Oswaldo Cruz	Lund, O (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	lund@cbs.dtu.dk	Marques, Ernesto T. A/L-4967-2013; Buus, Soren/F-5446-2010; Lundegaard, Claus/B-3938-2012; Nascimento, Eduardo/J-4590-2014; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Lund, Ole/F-4437-2014; Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013	Marques, Ernesto T. A/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332; Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Marques, Ernesto/0000-0003-3826-9358; Buus, Soren/0000-0001-8363-1999	NIAID [HHSN266200400083C, HHSN266200400025C]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID contracts HHSN266200400083C, HHSN266200400025C (http://www.niaid.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braga-Neto UM, 2006, PLOS COMPUT BIOL, V2, P651, DOI 10.1371/journal.pcbi.0020081; Brusic V, 2005, EXPERT REV VACCINES, V4, P407, DOI 10.1586/14760584.4.3.407; Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; De Groot AS, 2006, DRUG DISCOV TODAY, V11, P203, DOI 10.1016/S1359-6446(05)03720-7; Domingo C, 2009, EXPERT OPIN DRUG SAF, V8, P211, DOI [10.1517/14740330902808086, 10.1517/14740330902808086 ]; Duggan ST, 2009, DRUGS, V69, P115, DOI 10.2165/00003495-200969010-00008; Ferguson M, 2007, VACCINE, V25, P5233, DOI 10.1016/j.vaccine.2007.05.034; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pedersen LO, 2001, EUR J IMMUNOL, V31, P2986, DOI 10.1002/1521-4141(2001010)31:10<2986::AID-IMMU2986>3.0.CO;2-R; Pengsaa K, 2009, PEDIATR INFECT DIS J, V28, P335, DOI 10.1097/INF.0b013e3181906351; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136; Rohrlich PS, 2003, INT IMMUNOL, V15, P765, DOI 10.1093/intimm/dxg073; Roukens AH, 2008, EXPERT OPIN BIOL TH, V8, P1787, DOI [10.1517/14712598.8.11.1787, 10.1517/14712598.8.11.1787 ]; Screaton Gavin, 2006, Novartis Found Symp, V277, P164, DOI 10.1002/0470058005.ch12; Sette Alessandro, 2005, Immunity, V22, P155, DOI 10.1016/j.immuni.2005.01.009; Sylvester-Hvid C, 2004, TISSUE ANTIGENS, V63, P395, DOI 10.1111/j.0001-2815.2004.00221.x; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tauber E, 2008, BIOL CHEM, V389, P547, DOI 10.1515/BC.2008.062; Thomas SJ, 2009, VACCINE, V27, P355, DOI 10.1016/j.vaccine.2008.10.086; van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26494	10.1371/journal.pone.0026494	http://dx.doi.org/10.1371/journal.pone.0026494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039500	Green Accepted, Green Published, gold			2022-12-25	WOS:000296507500078
J	Stamper, BD; Park, SS; Beyer, RP; Bammler, TK; Farin, FM; Mecham, B; Cunningham, ML				Stamper, Brendan D.; Park, Sarah S.; Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.; Mecham, Brig; Cunningham, Michael L.			Differential Expression of Extracellular Matrix-Mediated Pathways in Single-Suture Craniosynostosis	PLOS ONE			English	Article							FETAL HEAD CONSTRAINT; PROBE LEVEL DATA; CORONAL SYNOSTOSIS; IN-VITRO; APERT CRANIOSYNOSTOSIS; MATERNAL SMOKING; BETA-CATENIN; CELL FATE; GROWTH; WNT	Craniosynostosis is a disease defined by premature fusion of one or more cranial sutures. The mechanistic pathology of single-suture craniosynostosis is complex and while a number of genetic biomarkers and environmental predispositions have been identified, in many cases the causes remain controversial and inconclusive. In this study, gene expression data from 199 patients with isolated sagittal (n = 100), unilateral coronal (n = 50), and metopic (n = 49) synostosis are compared against both a control population (n = 50), as well as each other. After controlling for variables contributing to potential bias, FGF7, SFRP4, and VCAM1 emerged as genes associated with single-suture craniosynostosis due to their significantly large changes in gene expression compared to the control population. Pathway analysis implicated focal adhesion and extracellular matrix (ECM)-receptor interaction as differentially regulated gene networks when comparing all cases of singlesuture synostosis and controls. Lastly, overall gene expression was found to be highly conserved between coronal and metopic cases, as evidenced by the fact that WNT2 and IGFBP2 were the only genes differentially regulated to a significantly large extent in a direct comparison. The identification of genes and gene networks associated with Fgf/Igf/Wnt signaling and ECM-mediated focal adhesion not only support the involvement of biomarkers previously reported to be related to craniosynostosis, but also introduce novel transcripts and pathways that may play critical roles in its pathogenesis.	[Stamper, Brendan D.; Park, Sarah S.; Cunningham, Michael L.] Seattle Childrens Res Inst, Ctr Tissue & Cell Sci, Seattle, WA USA; [Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Mecham, Brig] Sage Bionetworks, Seattle, WA USA; [Cunningham, Michael L.] Univ Washington, Div Craniofacial Med, Seattle, WA 98195 USA; [Cunningham, Michael L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamper, BD (corresponding author), Seattle Childrens Res Inst, Ctr Tissue & Cell Sci, Seattle, WA USA.	brendan.stamper@seattlechildrens.org			National Institute of Health (NIH) [NIH/NIDCR R01 DE018227, NIH/NIEHS P30ES07033, NIH/NICHD P30HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the following National Institute of Health (NIH) grants: (NIH/NIDCR R01 DE018227) awarded to MLC, (NIH/NIEHS P30ES07033), (NIH/NICHD P30HD02274). MLC also obtained support for this work from the Jean Renny Endowment for Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleck Kirk, 2004, Semin Pediatr Neurol, V11, P256, DOI 10.1016/j.spen.2004.10.005; Bayle J, 2008, J INVEST DERMATOL, V128, P871, DOI 10.1038/sj.jid.5701101; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochukova EG, 2010, J MED GENET, V47, P803, DOI 10.1136/jmg.2009.069617; Bodo M, 1997, EUR J CLIN INVEST, V27, P36, DOI 10.1046/j.1365-2362.1997.660618.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boulet SL, 2008, AM J MED GENET A, V146A, P984, DOI 10.1002/ajmg.a.32208; Brault V, 2001, DEVELOPMENT, V128, P1253; Carinci F, 2002, MOL MED, V8, P638, DOI 10.1007/BF03402174; COHEN MM, 2000, EPIDEMIOLOGY CRANIOS; Coussens AK, 2008, DIFFERENTIATION, V76, P531, DOI 10.1111/j.1432-0436.2007.00244.x; Coussens AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-458; Cunningham ML, 2007, ORTHOD CRANIOFAC RES, V10, P67, DOI 10.1111/j.1601-6343.2007.00389.x; Cunningham ML, 2011, AM J MED GENET A, V155A, P91, DOI 10.1002/ajmg.a.33781; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fanganiello RD, 2007, MOL MED, V13, P422, DOI 10.2119/2007-00027.Fanganiello; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRAHAM JM, 1979, J PEDIATR-US, V95, P747, DOI 10.1016/S0022-3476(79)80728-3; GRAHAM JM, 1980, PEDIATRICS, V65, P1000; GRAHAM JM, 1980, PEDIATRICS, V65, P995; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoflich A, 1998, FEBS LETT, V434, P329, DOI 10.1016/S0014-5793(98)01011-4; Honein MA, 2000, TERATOLOGY, V62, P145, DOI 10.1002/1096-9926(200009)62:3<145::AID-TERA1>3.0.CO;2-7; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kallen K, 1999, TERATOLOGY, V60, P146; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kuang ZH, 2007, BIOCHEMISTRY-US, V46, P13720, DOI 10.1021/bi701251d; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; Lan Y, 2006, DEV DYNAM, V235, P1448, DOI 10.1002/dvdy.20723; Le Floch N, 2004, FASEB J, V18, P144, DOI 10.1096/fj.04-2373fje; Lee JM, 2008, DEV BIOL, V314, P341, DOI 10.1016/j.ydbio.2007.11.033; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; LEPPIG KA, 1987, J PEDIATR-US, V110, P531, DOI 10.1016/S0022-3476(87)80543-7; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lomri A, 1998, J CLIN INVEST, V101, P1310; Maruyama T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000727; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; Miraoui H, 2010, HUM MOL GENET, V19, P1678, DOI 10.1093/hmg/ddq045; Muenke M, 1997, AM J HUM GENET, V60, P555; Mulliken JB, 1999, PLAST RECONSTR SURG, V104, P1603, DOI 10.1097/00006534-199911000-00001; Mulliken JB, 2004, PLAST RECONSTR SURG, V113, P1899, DOI 10.1097/01.PRS.0000122202.26792.bf; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Niemann S, 2004, AM J HUM GENET, V74, P558, DOI 10.1086/382196; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Rasmussen SA, 2008, AM J MED GENET A, V146A, P149, DOI 10.1002/ajmg.a.32106; Reefhuis J, 2003, PEDIATRICS, V111, P1163; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Renier D, 2000, J NEUROSURG, V92, P631, DOI 10.3171/jns.2000.92.4.0631; Seto ML, 2007, AM J MED GENET A, V143A, P678, DOI 10.1002/ajmg.a.31630; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sousa KM, 2010, J BIOL CHEM, V285, P7246, DOI 10.1074/jbc.M109.079822; Speltz ML, 2007, PLAST RECONSTR SURG, V119, P1874, DOI 10.1097/01.prs.0000259184.88265.3f; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	69	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26557	10.1371/journal.pone.0026557	http://dx.doi.org/10.1371/journal.pone.0026557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028906	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500089
J	Becerra, L; Pendse, G; Chang, PC; Bishop, J; Borsook, D				Becerra, Lino; Pendse, Gautam; Chang, Pei-Ching; Bishop, James; Borsook, David			Robust Reproducible Resting State Networks in the Awake Rodent Brain	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BOLD SIGNAL FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; SPATIOTEMPORAL DYNAMICS; INSULAR CORTEX; DEFAULT MODE; FREQUENCY; RATS; ORGANIZATION; INTEROCEPTION	Resting state networks (RSNs) have been studied extensively with functional MRI in humans in health and disease to reflect brain function in the un-stimulated state as well as reveal how the brain is altered with disease. Rodent models of disease have been used comprehensively to understand the biology of the disease as well as in the development of new therapies. RSN reported studies in rodents, however, are few, and most studies are performed with anesthetized rodents that might alter networks and differ from their non-anesthetized state. Acquiring RSN data in the awake rodent avoids the issues of anesthesia effects on brain function. Using high field fMRI we determined RSNs in awake rats using an independent component analysis (ICA) approach, however, ICA analysis can produce a large number of components, some with biological relevance (networks). We further have applied a novel method to determine networks that are robust and reproducible among all the components found with ICA. This analysis indicates that 7 networks are robust and reproducible in the rat and their putative role is discussed.	[Becerra, Lino; Pendse, Gautam; Chang, Pei-Ching; Bishop, James; Borsook, David] Massachusetts Gen Hosp, Pain & Analgesia Imaging Neurosci Grp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Becerra, L (corresponding author), Massachusetts Gen Hosp, Pain & Analgesia Imaging Neurosci Grp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA.	becerra@nmr.mgh.harvard.edu	Håkansson, Gustaf/F-5409-2011		National Institute of Drug Abuse [K24NS064050-DB]; Herlands Fund for Pain Research; National Center For Research Resources [S10RR031599, 1S10RR023401, 1S10RR019307, 1S10RR023043]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031599, S10RR019307, S10RR023043, S10RR023401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Herlands Fund for Pain Research; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by National Institute of Drug Abuse (grant number K24NS064050-DB) and The Herlands Fund for Pain Research (DB, LB). The project described was supported by Award Numbers S10RR031599, 1S10RR023401, 1S10RR019307, and 1S10RR023043 from the National Center For Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Barbas H, 2007, ANN NY ACAD SCI, V1121, P10, DOI 10.1196/annals.1401.015; Bardin L, 2009, BEHAV BRAIN RES, V205, P360, DOI 10.1016/j.bbr.2009.07.005; Becerra L, 2011, NEUROIMAGE, V54, P1355, DOI 10.1016/j.neuroimage.2010.08.056; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Benarroch EE, 1998, BRAIN PATHOL, V8, P527; Berridge CW, 2008, BRAIN RES REV, V58, P1, DOI 10.1016/j.brainresrev.2007.10.013; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Carreno M, 2011, SEIZURE-EUR J EPILEP, V20, P580, DOI 10.1016/j.seizure.2011.04.010; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Habas C, 2010, CEREBELLUM, V9, P22, DOI 10.1007/s12311-009-0119-3; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hutchison RM, 2011, NEUROIMAGE, V56, P1546, DOI 10.1016/j.neuroimage.2011.02.063; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Jones CL, 2010, J NEUROL NEUROSUR PS, V81, P611, DOI 10.1136/jnnp.2009.193672; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Liu XA, 2011, NEUROIMAGE, V54, P2278, DOI 10.1016/j.neuroimage.2010.10.001; LOEWY AD, 1991, PROG BRAIN RES, V87, P253; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Majeed W, 2011, NEUROIMAGE, V54, P1140, DOI 10.1016/j.neuroimage.2010.08.030; Majeed W, 2009, J MAGN RESON IMAGING, V30, P384, DOI 10.1002/jmri.21848; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason P, 2005, J COMP NEUROL, V493, P2, DOI 10.1002/cne.20751; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pendse GV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027594; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rempel-Clower NL, 1998, J COMP NEUROL, V398, P393, DOI 10.1002/(SICI)1096-9861(19980831)398:3<393::AID-CNE7>3.0.CO;2-V; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Shibata H, 1998, EUR J NEUROSCI, V10, P3210, DOI 10.1046/j.1460-9568.1998.00328.x; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Toni R, 2004, J Endocrinol Invest, V27, P73; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Wang K, 2011, NMR BIOMED, V24, P61, DOI 10.1002/nbm.1556; Woolrich MW, 2006, IEEE T MED IMAGING, V25, P1380, DOI 10.1109/TMI.2006.880682; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	62	85	88	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25701	10.1371/journal.pone.0025701	http://dx.doi.org/10.1371/journal.pone.0025701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028788	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900016
J	Cot, M; Ray, A; Gilleron, M; Vercellone, A; Larrouy-Maumus, G; Armau, E; Gauthier, S; Tiraby, G; Puzo, G; Nigou, J				Cot, Marlene; Ray, Aurelie; Gilleron, Martine; Vercellone, Alain; Larrouy-Maumus, Gerald; Armau, Elise; Gauthier, Sophie; Tiraby, Gerard; Puzo, Germain; Nigou, Jerome			Lipoteichoic Acid in Streptomyces hygroscopicus: Structural Model and Immunomodulatory Activities	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; TOLL-LIKE RECEPTOR-2; STAPHYLOCOCCUS-AUREUS; CELL-WALL; CYTOKINE INDUCTION; TEICHOIC-ACIDS; MYCOBACTERIUM-TUBERCULOSIS; LIPOARABINOMANNAN; ACTINOMYCETE; MACROAMPHIPHILES	Gram positive bacteria produce cell envelope macroamphiphile glycopolymers, i.e. lipoteichoic acids or lipoglycans, whose functions and biosynthesis are not yet fully understood. We report for the first time a detailed structure of lipoteichoic acid isolated from a Streptomyces species, i.e. Streptomyces hygroscopicus subsp. hygroscopicus NRRL 2387T. Chemical, MS and NMR analyses revealed a polyglycerolphosphate backbone substituted with alpha-glucosaminyl and alpha-N-acetyl-glucosaminyl residues but devoid of any amino-acid substituent. This structure is very close, if not identical, to that of the wall teichoic acid of this organism. These data not only contribute to the growing recognition that lipoteichoic acid is a cell envelope component of Gram positive Actinobacteria but also strongly support the recently proposed hypothesis of an overlap between the pathways of lipoteichoic acid and wall teichoic acid synthesis in these bacteria. S. hygroscopicus lipoteichoic acid induced signalling by human innate immune receptor TLR2, confirming its role as a microbe-associated molecular pattern. Its activity was partially dependant on TLR1, TLR6 and CD14. Moreover, it stimulated TNF-alpha and IL-6 production by a human macrophage cell line to an extent similar to that of Staphylococcus aureus lipoteichoic acid. These results provide new clues on lipoteichoic acid structure/function relationships, most particularly on the role of the polyglycerolphosphate backbone substituents.	[Cot, Marlene; Ray, Aurelie; Gilleron, Martine; Vercellone, Alain; Larrouy-Maumus, Gerald; Puzo, Germain; Nigou, Jerome] CNRS, IPBS, Toulouse, France; [Cot, Marlene; Ray, Aurelie; Gilleron, Martine; Vercellone, Alain; Larrouy-Maumus, Gerald; Puzo, Germain; Nigou, Jerome] Univ Toulouse, UPS, IPBS, Toulouse, France; [Armau, Elise; Gauthier, Sophie; Tiraby, Gerard] Cayla InvivoGen, Res Dept, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cot, M (corresponding author), CNRS, IPBS, Toulouse, France.	jerome.nigou@ipbs.fr	Nigou, Jérôme/D-6802-2019	Nigou, Jérôme/0000-0002-6233-2487; GILLERON, Martine/0000-0002-2581-3302; Larrouy-Maumus, Gerald/0000-0001-6614-8698	French Research Ministry; CNRS; Universite Paul Sabatier; Region Midi-Pyrenees; European structural funds	French Research Ministry(Ministry of Research, France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European structural funds	The IPBS NMR equipment was financed by the French Research Ministry, CNRS, Universite Paul Sabatier, the Region Midi-Pyrenees, and European structural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Bunk S, 2010, J IMMUNOL, V185, P3708, DOI 10.4049/jimmunol.0901660; Chen FTA, 1998, GLYCOBIOLOGY, V8, P1045, DOI 10.1093/glycob/8.11.1045; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Draing C, 2008, IMMUNOBIOLOGY, V213, P285, DOI 10.1016/j.imbio.2007.12.001; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; FISCHER W, 1993, ANAL BIOCHEM, V208, P49, DOI 10.1006/abio.1993.1007; FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Fischer W, 1994, BACTERIAL CELL WALL, P199; Garton NJ, 2002, J BIOL CHEM, V277, P31722, DOI 10.1074/jbc.M203008200; Gibson KJC, 2005, J BIOL CHEM, V280, P28347, DOI 10.1074/jbc.M505498200; Gilleron M, 2000, J BIOL CHEM, V275, P677, DOI 10.1074/jbc.275.1.677; Gilleron M, 2005, J BACTERIOL, V187, P854, DOI 10.1128/JB.187.3.854-861.2005; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; GNILOZUB VA, 1994, MICROBIOLOGY+, V63, P275; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hashimoto M, 2007, INFECT IMMUN, V75, P1926, DOI 10.1128/IAI.02083-05; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hoischen C, 1997, J BACTERIOL, V179, P3430, DOI 10.1128/jb.179.11.3430-3436.1997; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; POTEKHINA N V, 1983, Mikrobiologiya, V52, P434; Rahman O, 2009, LETT APPL MICROBIOL, V48, P226, DOI 10.1111/j.1472-765X.2008.02514.x; Rahman O, 2009, TRENDS MICROBIOL, V17, P219, DOI 10.1016/j.tim.2009.03.003; Rahman O, 2009, J BACTERIOL, V191, P152, DOI 10.1128/JB.01105-08; Seo HS, 2008, J BACTERIOL, V190, P2379, DOI 10.1128/JB.01795-07; Seo HS, 2008, INFECT IMMUN, V76, P206, DOI 10.1128/IAI.01140-07; Seo HS, 2009, CLIN VACCINE IMMUNOL, V16, P1187, DOI 10.1128/CVI.00115-09; Shashkov AS, 2006, CARBOHYD RES, V341, P796, DOI 10.1016/j.carres.2006.01.020; Shashkov AS, 2002, EUR J BIOCHEM, V269, P6020, DOI 10.1046/j.1432-1033.2002.03274.x; Shashkov AS, 2002, CARBOHYD RES, V337, P2255, DOI 10.1016/S0008-6215(02)00188-X; Siri N, 2006, ELECTROPHORESIS, V27, P4446, DOI 10.1002/elps.200600165; Sutcliffe Iain C., 1994, Systematic and Applied Microbiology, V17, P467; SUTCLIFFE IC, 1991, J BACTERIOL, V173, P7065, DOI 10.1128/jb.173.22.7065-7069.1991; Sutcliffe IC, 1995, ARCH ORAL BIOL, V40, P1119, DOI 10.1016/0003-9969(95)00086-0; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Tulskaya EM, 1997, BIOCHEMISTRY-MOSCOW+, V62, P289; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Whale GA, 2004, ANTON LEEUW INT J G, V86, P77, DOI 10.1023/B:ANTO.0000024911.67625.27; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	48	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26316	10.1371/journal.pone.0026316	http://dx.doi.org/10.1371/journal.pone.0026316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028855	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900048
J	Kim, TW; Moon, Y; Kim, K; Lee, JE; Koh, HC; Rhyu, IJ; Kim, H; Sun, W				Kim, Tae Woo; Moon, Younghye; Kim, Kyungjin; Lee, Jeong Eun; Koh, Hyun Chul; Rhyu, Im Joo; Kim, Hyun; Sun, Woong			Dissociation of Progressive Dopaminergic Neuronal Death and Behavioral Impairments by Bax Deletion in a Mouse Model of Parkinson's Diseases	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; PROGRAMMED CELL-DEATH; SUBSTANTIA-NIGRA; GENE-TRANSFER; FACTOR AIF; RAT MODEL; POLY(ADP-RIBOSE) POLYMERASE-1; NEUROMUSCULAR DEVELOPMENT; NEUROTROPHIC FACTOR; MOTOR DYSFUNCTION	Parkinson's disease (PD) is a common, late-onset movement disorder with selective degeneration of dopaminergic (DA) neurons in the substantia nigra (SN). Although the neurotoxin 6-hydroxydopamine (6-OHDA) has been used to induce progressive degeneration of DA neurons in various animal models of PD, the precise molecular pathway and the impact of anti-apoptotic treatment on this neurodegeneration are less understood. Following a striatal injection of 6-OHDA, we observed atrophy and progressive death of DA neurons in wild-type mice. These degenerating DA neurons never exhibited signs of apoptosis (i.e., caspase-3 activation and cytoplasmic release of cytochrome C), but rather show nuclear translocation of apoptosis-inducing factor (AIF), a hallmark of regulated necrosis. However, mice with genetic deletion of the proapoptotic gene Bax (Bax-KO) exhibited a complete absence of 6-OHDA-induced DA neuron death and nuclear translocation of AIF, indicating that 6-OHDA-induced DA neuronal death is mediated by Bax-dependent AIF activation. On the other hand, DA neurons that survived in Bax-KO mice exhibited marked neuronal atrophy, without significant improvement of PD-related behavioral deficits. These findings suggest that anti-apoptotic therapy may not be sufficient for PD treatment, and the prevention of Bax-independent neuronal atrophy may be an important therapeutic target.	[Kim, Tae Woo; Moon, Younghye; Rhyu, Im Joo; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Program BK21, Dept Anat, Seoul 136705, South Korea; [Moon, Younghye; Kim, Kyungjin] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Lee, Jeong Eun; Koh, Hyun Chul] Hanyang Univ, Dept Pharmacol, Coll Med, Seoul 133791, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Hanyang University	Kim, TW (corresponding author), Korea Univ, Coll Med, Program BK21, Dept Anat, Seoul 136705, South Korea.	woongsun@korea.ac.kr		sun, woong/0000-0003-1792-4894; Moon, Younghye/0000-0002-3737-0043; Kim, Hyun/0000-0002-7210-5798; Rhyu, Im Joo/0000-0002-5558-6278	Korean Ministry of Education, Science and Technology [2010K000803, 20100020237, 20100000143]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korean Ministry of Education, Science and Technology Grants 2010K000803 (WS), 20100020237 (WS), and 20100000143 (WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Burguillos MA, 2011, NEUROBIOL DIS, V41, P177, DOI 10.1016/j.nbd.2010.09.005; Buss RR, 2006, J NEUROSCI, V26, P13413, DOI 10.1523/JNEUROSCI.3528-06.2006; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Cheung ECC, 2005, J NEUROSCI, V25, P1324, DOI 10.1523/JNEUROSCI.4261-04.2005; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Chu CT, 2005, J NEUROCHEM, V94, P1685, DOI 10.1111/j.1471-4159.2005.03329.x; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Crocker SJ, 2001, EUR J NEUROSCI, V14, P391, DOI 10.1046/j.0953-816x.2001.01653.x; Cutillas B, 1999, NEUROREPORT, V10, P2605, DOI 10.1097/00001756-199908200-00030; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; deTorres C, 1997, NEUROSCI LETT, V230, P1, DOI 10.1016/S0304-3940(97)00445-X; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Eberhardt O, 2000, J NEUROSCI, V20, P9126; Ebert AD, 2008, J NEUROSCI RES, V86, P317, DOI 10.1002/jnr.21480; Fonfria E, 2002, EUR J NEUROSCI, V16, P2013, DOI 10.1046/j.1460-9568.2002.02269.x; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Han BS, 2003, J NEUROSCI, V23, P5069; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; ICHITANI Y, 1994, EXP NEUROL, V130, P269, DOI 10.1006/exnr.1994.1205; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Jung AR, 2008, J NEUROSCI, V28, P2941, DOI 10.1523/JNEUROSCI.3897-07.2008; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kirik D, 2000, J NEUROSCI, V20, P4686, DOI 10.1523/JNEUROSCI.20-12-04686.2000; Kramer BC, 2004, J NEUROCYTOL, V33, P213, DOI 10.1023/B:NEUR.0000030696.62829.ec; Lim J, 2011, AUTOPHAGY, V7, P51, DOI 10.4161/auto.7.1.13909; Marti MJ, 2002, BRAIN RES, V958, P185, DOI 10.1016/S0006-8993(02)03694-6; Mladenovic A, 2004, BRAIN RES, V996, P237, DOI 10.1016/j.brainres.2003.10.035; Mogi M, 2000, J NEURAL TRANSM, V107, P335, DOI 10.1007/s007020050028; Mori A, 2005, NEUROSCI RES, V51, P265, DOI 10.1016/j.neures.2004.11.008; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Novikova L, 2006, NEUROSCIENCE, V140, P67, DOI 10.1016/j.neuroscience.2006.02.007; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; Oiwa Y, 2003, J NEUROSURG, V98, P136, DOI 10.3171/jns.2003.98.1.0136; Park OH, 2007, EUR J NEUROSCI, V26, P1421, DOI 10.1111/j.1460-9568.2007.05787.x; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Reix S, 2007, NEUROBIOL AGING, V28, P351, DOI 10.1016/j.neurobiolaging.2006.01.003; Roucou X, 2001, CELL DEATH DIFFER, V8, P875, DOI 10.1038/sj.cdd.4400910; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Spooren WPJM, 1998, NEUROSCIENCE, V85, P649; Sun W, 2003, MOL CELL NEUROSCI, V24, P875, DOI 10.1016/S1044-7431(03)00219-7; Sun W, 2003, J NEUROSCI, V23, P7298, DOI 10.1523/jneurosci.23-19-07298.2003; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Turmel H, 2001, MOVEMENT DISORD, V16, P185, DOI 10.1002/mds.1037; Vaudano E, 2001, EUR J NEUROSCI, V13, P1, DOI 10.1046/j.1460-9568.2001.01356.x; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang HM, 2003, ANN NY ACAD SCI, V991, P132; Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Yang LC, 1998, J NEUROSCI, V18, P8145; Yu SW, 2009, ASN NEURO, V1, DOI 10.1042/AN20090046; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zheng JS, 2005, MOL BRAIN RES, V134, P155, DOI 10.1016/j.molbrainres.2004.06.029; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x	76	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25346	10.1371/journal.pone.0025346	http://dx.doi.org/10.1371/journal.pone.0025346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043283	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400010
J	Lee, S; Jia, YL; Jia, M; Gealy, DR; Olsen, KM; Caicedo, AL				Lee, Seonghee; Jia, Yulin; Jia, Melissa; Gealy, David R.; Olsen, Kenneth M.; Caicedo, Ana L.			Molecular Evolution of the Rice Blast Resistance Gene Pi-ta in Invasive Weedy Rice in the USA	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; RED RICE; ORYZA-SATIVA; CULTIVATED RICE; FLOW; INFERENCE; INTROGRESSION; REGISTRATION; POLYMORPHISM; MUTATIONS	The Pi-ta gene in rice has been effectively used to control rice blast disease caused by Magnaporthe oryzae worldwide. Despite a number of studies that reported the Pi-ta gene in domesticated rice and wild species, little is known about how the Pi-ta gene has evolved in US weedy rice, a major weed of rice. To investigate the genome organization of the Pi-ta gene in weedy rice and its relationship to gene flow between cultivated and weedy rice in the US, we analyzed nucleotide sequence variation at the Pi-ta gene and its surrounding 2 Mb region in 156 weedy, domesticated and wild rice relatives. We found that the region at and around the Pi-ta gene shows very low genetic diversity in US weedy rice. The patterns of molecular diversity in weeds are more similar to cultivated rice (indica and aus), which have never been cultivated in the US, rather than the wild rice species, Oryza rufipogon. In addition, the resistant Pi-ta allele (Pi-ta) found in the majority of US weedy rice belongs to the weedy group strawhull awnless (SH), suggesting a single source of origin for Pi-ta. Weeds with Pita were resistant to two M. oryzae races, IC17 and IB49, except for three accessions, suggesting that component(s) required for the Pi-ta mediated resistance may be missing in these accessions. Signatures of flanking sequences of the Pi-ta gene and SSR markers on chromosome 12 suggest that the susceptible pi-ta allele (pi-ta), not Pi-ta, has been introgressed from cultivated to weedy rice by out-crossing.	[Lee, Seonghee] Univ Arkansas, Rice Res Extens Ctr, Stuttgart, AR 72160 USA; [Lee, Seonghee] Samuel Roberts Noble Fdn Inc, Ardmore, OK USA; [Jia, Yulin; Jia, Melissa; Gealy, David R.] ARS, Dale Bumpers Natl Rice Res Ctr, USDA, Stuttgart, AR USA; [Olsen, Kenneth M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Caicedo, Ana L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Arkansas System; University of Arkansas Fayetteville; Noble Research Institute; United States Department of Agriculture (USDA); Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Amherst	Lee, S (corresponding author), Univ Arkansas, Rice Res Extens Ctr, Stuttgart, AR 72160 USA.	yulin.jia@usda.ars.gov	jia, yu/HHR-9047-2022; Jia, Yulin/T-8235-2019	Jia, Yulin/0000-0002-2132-0498; Olsen, Kenneth/0000-0002-8338-3638	National Science Foundation [DBI-0638820]; United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [NP301]	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported in part by the National Science Foundation Plant Genome Research Program under grant DBI-0638820 to Y. Jia, K. Olsen, and A. Caicedo. Additional funding for this project is from the United States Department of Agriculture-Agricultural Research Service (USDA-ARS) National Program NP301 project titled 'Response of Diverse Rice Germplasm to Biotic and Abiotic Stresses'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gealy DR, 2006, WEED TECHNOL, V20, P839, DOI 10.1614/WT-05-066.1; Gealy DR, 2009, WEED SCI, V57, P627, DOI 10.1614/WS-09-018.1; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Gross BL, 2010, MOL ECOL, V19, P3380, DOI 10.1111/j.1365-294X.2010.04707.x; Gross BL, 2009, NEW PHYTOL, V184, P842, DOI 10.1111/j.1469-8137.2009.02957.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang CL, 2008, GENETICS, V179, P1527, DOI 10.1534/genetics.108.089805; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jia Y, 2009, HEREDITY, V103, P333, DOI 10.1038/hdy.2009.95; Jia YL, 2004, EUPHYTICA, V138, P97, DOI 10.1023/B:EUPH.0000047079.42768.4d; Jia YL, 2003, PHYTOPATHOLOGY, V93, P1452, DOI 10.1094/PHYTO.2003.93.11.1452; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; Jia Y, 2008, MOL PLANT MICROBE IN, V21, P396, DOI 10.1094/MPMI-21-4-0396; Jia YL, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P137, DOI 10.1007/978-1-4020-9500-9_14; Lee S, 2009, GENETICS, V183, P1315, DOI 10.1534/genetics.109.108266; LEWONTIN RC, 1964, GENETICS, V49, P49; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Messeguer J, 2004, MOL BREEDING, V13, P103, DOI 10.1023/B:MOLB.0000012285.39859.9d; Moldenhauer KAK, 2007, CROP SCI, V47, P446, DOI 10.2135/cropsci2006.06.0415; MOLDENHAUER KAK, 1990, CROP SCI, V30, P747, DOI 10.2135/cropsci1990.0011183X003000030065x; Pritchard JK, 2000, GENETICS, V155, P945; Rajguru SN, 2005, WEED SCI, V53, P567, DOI 10.1614/WS-04-111R1.1; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rybka K, 1997, MOL PLANT MICROBE IN, V10, P517, DOI 10.1094/MPMI.1997.10.4.517; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shivrain VK, 2007, CROP PROT, V26, P349, DOI 10.1016/j.cropro.2005.09.019; Shivrain VK, 2006, WEED TECHNOL, V20, P576, DOI 10.1614/WT-05-067R1.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x; Wang X, 2008, PHYTOPATHOLOGY, V98, P1305, DOI 10.1094/PHYTO-98-12-1305; Webster T.M., 2000, P S WEED SCI SOC, V53, P247	39	12	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26260	10.1371/journal.pone.0026260	http://dx.doi.org/10.1371/journal.pone.0026260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043312	Green Submitted, gold, Green Published			2022-12-25	WOS:000295984400040
J	Hughes, BG; Hekimi, S				Hughes, Bryan G.; Hekimi, Siegfried			A Mild Impairment of Mitochondrial Electron Transport Has Sex-Specific Effects on Lifespan and Aging in Mice	PLOS ONE			English	Article							C-OXIDASE DEFICIENCY; MN SUPEROXIDE-DISMUTASE; SYSTEMATIC RNAI SCREEN; LIVED MCLK1(+/-) MICE; OXIDATIVE-PHOSPHORYLATION; CAENORHABDITIS-ELEGANS; RESPIRATORY-CHAIN; BRAIN MITOCHONDRIA; METABOLIC-RATE; COMPLEX-III	Impairments of various aspects of mitochondrial function have been associated with increased lifespan in various model organisms ranging from Caenorhabditis elegans to mice. For example, disruption of the function of the 'Rieske' iron-sulfur protein (RISP) of complex III of the mitochondrial electron transport chain can result in increased lifespan in the nematode worm C. elegans. However, the mechanisms by which impaired mitochondrial function affects aging remain under investigation, including whether or not they require decreased electron transport. We have generated knock-in mice with a loss-of-function Risp mutation that is homozygous lethal. However, heterozygotes (Risp(+/P224S)) were viable and had decreased levels of RISP protein and complex III enzymatic activity. This decrease was sufficient to impair mitochondrial respiration and to decrease overall metabolic rate in males, but not females. These defects did not appear to exert an overtly deleterious effect on the health of the mutants, since young Risp(+/P224S) mice are outwardly normal, with unaffected performance and fertility. Furthermore, biomarkers of oxidative stress were unaffected in both young and aged animals. Despite this, the average lifespan of male Risp(+/P224S) mice was shortened and aged Risp(+/P224S) males showed signs of more rapidly deteriorating health. In spite of these differences, analysis of Gompertz mortality parameters showed that Risp heterozygosity decreased the rate of increase of mortality with age and increased the intrinsic vulnerability to death in both sexes. However, the intrinsic vulnerability was increased more dramatically in males, which resulted in their shortened lifespan. For females, the slower acceleration of age-dependent mortality results in significantly increased survival of Risp(+/P224S) mice in the second half of lifespan. These results demonstrate that even relatively small perturbations of the mitochondrial electron transport chain can have significant physiological effects in mammals, and that the severity of those effects can be sex-dependent.	[Hughes, Bryan G.; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hughes, BG (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	Siegfried.Hekimi@McGill.ca	Hughes, Bryan/L-4964-2017	Hughes, Bryan/0000-0002-2718-3818; Hekimi, Siegfried/0000-0002-3592-5711	Canadian Institute of Health Research [89761]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by a grant from the Canadian Institute of Health Research (89761) to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Arguelles S, 2004, BBA-GEN SUBJECTS, V1674, P251, DOI 10.1016/j.bbagen.2004.06.023; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; CRAWLEY JN, 2000, MOTOR FUNCTIONS WHAT; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Davey GP, 1996, J NEUROCHEM, V66, P1617; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Doubal S, 1997, AGE, V20, P229, DOI 10.1007/s11357-997-0023-z; Edmond Jane C, 2009, Int Ophthalmol Clin, V49, P27, DOI 10.1097/IIO.0b013e3181a8de58; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finch CE, 1990, LONGEVITY SENESCENCE; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Lapointe J, 2009, J BIOL CHEM, V284, P20364, DOI 10.1074/jbc.M109.006569; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; McLean J., 1987, ANIMAL HUMAN CALORIM; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Ran Q, 2007, J GERONTOL A-BIOL, V62, P932, DOI 10.1093/gerona/62.9.932; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; SHIMADA A, 1992, J NEUROPATH EXP NEUR, V51, P440, DOI 10.1097/00005072-199207000-00006; TAYLOR RW, 1994, J BIOL CHEM, V269, P3523; Thouvarecq R, 2001, BEHAV BRAIN RES, V118, P209, DOI 10.1016/S0166-4328(00)00330-2; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; Yang H, 2010, HUM MOL GENET, V19, P170, DOI 10.1093/hmg/ddp477; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zini R, 2007, FREE RADICAL RES, V41, P1159, DOI 10.1080/10715760701635074	62	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26116	10.1371/journal.pone.0026116	http://dx.doi.org/10.1371/journal.pone.0026116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028811	gold, Green Submitted, Green Published			2022-12-25	WOS:000295971700041
J	Biglione, S; Tsytsykova, AV; Goldfeld, AE				Biglione, Sebastian; Tsytsykova, Alla V.; Goldfeld, Anne E.			Monocyte-specific Accessibility of a Matrix Attachment Region in the Tumor Necrosis Factor Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA GENE; RNA-POLYMERASE-II; DROSOPHILA TOPOISOMERASE-II; CREB-BINDING-PROTEIN; STRAND DNA CLEAVAGE; HISTONE HYPERACETYLATION; WEB SERVER; TNF GENE; T-CELLS; EXPRESSION	Regulation of TNF gene expression is cell type-and stimulus-specific. We have previously identified highly conserved non-coding regulatory elements within DNase I-hypersensitive sites (HSS) located 9 kb upstream (HSS-9) and 3 kb downstream (HSS+3) of the TNF gene, which play an important role in the transcriptional regulation of TNF in T cells. They act as enhancers and interact with the TNF promoter and with each other, generating a higher order chromatin structure. Here, we report a novel monocyte-specific AT-rich DNase I-hypersensitive element located 7 kb upstream of the TNF gene (HSS-7), which serves as a matrix attachment region in monocytes. We show that HSS-7 associates with topoisomerase II alpha (Top2) in vivo and that induction of endogenous TNF mRNA expression is suppressed by etoposide, a Top2 inhibitor. Moreover, Top2 binds to and cleaves HSS-7 in in vitro analysis. Thus, HSS-7, which is selectively accessible in monocytes, can tether the TNF locus to the nuclear matrix via matrix attachment region formation, potentially promoting TNF gene expression by acting as a Top2 substrate.	[Goldfeld, Anne E.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Goldfeld, AE (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	goldfeld@idi.harvard.edu	Goldfeld, Anne/AAF-1818-2019		National Institutes of Health [R01 GM076685]; Glaxo-SmithKline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaxo-SmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076685 (to A. E. G.). This work was also supported by Glaxo-SmithKline (to A. E. G.).	Baena A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000621; Balakrishnan L, 2007, J MOL BIOL, V371, P1022, DOI 10.1016/j.jmb.2007.06.080; Balakrishnan L, 2007, J MOL BIOL, V365, P18, DOI 10.1016/j.jmb.2006.09.044; Barthel R, 2003, J IMMUNOL, V171, P3612, DOI 10.4049/jimmunol.171.7.3612; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Bode J, 2003, CHROMOSOME RES, V11, P435, DOI 10.1023/A:1024918525818; Bode J, 1996, CRIT REV EUKAR GENE, V6, P115, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.20; Boulikas T, 1995, INT REV CYTOL, V162A, P279; Chattopadhyay Samit, 2007, Subcell Biochem, V41, P213; Cockerill P N, 2000, Methods Mol Biol, V130, P29; Cockerill PN, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe15; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Falvo JV, 2000, P NATL ACAD SCI USA, V97, P3925, DOI 10.1073/pnas.97.8.3925; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Horiguchi-Yamada J, 2002, ANTICANCER RES, V22, P3827; Hostert A, 1997, J IMMUNOL, V158, P4270; Jiao W, 2005, CANCER RES, V65, P4067, DOI 10.1158/0008-5472.CAN-04-3999; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; LEE MP, 1989, J BIOL CHEM, V264, P21779; LEE MP, 1989, J BIOL CHEM, V264, P13510; Lehar SM, 1996, ONCOGENE, V12, P1181; Lei JX, 2005, CELL DEATH DIFFER, V12, P1368, DOI 10.1038/sj.cdd.4401671; Leung JY, 2000, P NATL ACAD SCI USA, V97, P6614, DOI 10.1073/pnas.97.12.6614; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Mitchell R, 2003, MOL THER, V8, P674, DOI 10.1016/S1525-0016(03)00215-6; Molto Eduardo, 2009, Briefings in Functional Genomics & Proteomics, V8, P283, DOI 10.1093/bfgp/elp031; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; Tsytsykova AV, 2000, J EXP MED, V192, P581, DOI 10.1084/jem.192.4.581; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Wang JC, 2009, UNTANGLING DOUBLE HE; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44126	44133		10.1074/jbc.M111.272476	http://dx.doi.org/10.1074/jbc.M111.272476			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027829	Green Published, hybrid			2022-12-25	WOS:000298402300053
J	Ishikita, H				Ishikita, Hiroshi			Tyrosine Deprotonation and Associated Hydrogen Bond Rearrangements in a Photosynthetic Reaction Center	PLOS ONE			English	Article							INDUCED STRUCTURAL-CHANGES; PANCREATIC RIBONUCLEASE-A; ELECTRON-TRANSFER; PHOTOSYSTEM-II; RHODOPSEUDOMONAS-VIRIDIS; HISTIDINE-RESIDUES; PROTON-TRANSFER; IMIDAZOLE RING; SPECIAL PAIR; PROTEINS	Photosynthetic reaction centers from Blastochloris viridis possess Tyr-L162 located mid-way between the special pair chlorophyll (P) and the heme (heme3). While mutation of the tyrosine does not affect the kinetics of electron transfer from heme3 to P, recent time-resolved Laue diffraction studies reported displacement of Tyr-L162 in response to the formation of the photo-oxidized P+center dot N, implying a possible tyrosine deprotonation event. pK(a) values for Tyr-L162 were calculated using the corresponding crystal structures. Movement of deprotonated Tyr-L162 toward Thr-M185 was observed in P+center dot formation. It was associated with rearrangement of the H-bond network that proceeds to P via Thr-M185 and His-L168.	[Ishikita, Hiroshi] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto, Japan; [Ishikita, Hiroshi] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Ishikita, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto, Japan.	hiro@cp.kyoto-u.ac.jp	Ishikita, Hiroshi/G-9864-2018	Ishikita, Hiroshi/0000-0002-5849-8150	JST; Ministry of Education, Science, Sport and Culture of Japan [21770163]; MEXT; Takeda Science Foundation	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sport and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the JST PRESTO program, Grant-in-Aid for Science Research from the Ministry of Education, Science, Sport and Culture of Japan (21770163), Special Coordination Fund for Promoting Science and Technology of MEXT, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARTLING B, 1992, CHEM PHYS LETT, V196, P128, DOI 10.1016/0009-2614(92)85941-3; DOHSE B, 1995, BIOCHEMISTRY-US, V34, P11335, DOI 10.1021/bi00036a006; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Ishikita H, 2005, P NATL ACAD SCI USA, V102, P16215, DOI 10.1073/pnas.0503826102; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P14772, DOI 10.1021/bi051099v; Ishikita H, 2005, J AM CHEM SOC, V127, P14714, DOI 10.1021/ja052567r; Ishikita H, 2005, J BIOL CHEM, V280, P12446, DOI 10.1074/jbc.M413531200; Ishikita H, 2005, FEBS LETT, V579, P712, DOI 10.1016/j.febslet.2004.12.049; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Ishikita H, 2006, BIOPHYS J, V90, P3886, DOI 10.1529/biophysj.105.076984; KNAPP EW, 1987, J CHEM PHYS, V87, P3880, DOI 10.1063/1.452943; LENDZIAN F, 1988, CHEM PHYS LETT, V148, P377, DOI 10.1016/0009-2614(88)87191-4; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; NOZAKI Y, 1967, J AM CHEM SOC, V89, P736, DOI 10.1021/ja00980a002; Ortega JM, 1998, BIOPHYS J, V74, P1135, DOI 10.1016/S0006-3495(98)77831-2; Popovic DM, 2002, J AM CHEM SOC, V124, P3775, DOI 10.1021/ja016249d; Rabenstein B, 1998, EUR BIOPHYS J BIOPHY, V27, P626, DOI 10.1007/s002490050174; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; SEBBAN P, 1995, BIOCHEMISTRY-US, V34, P8390, DOI 10.1021/bi00026a021; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P586, DOI 10.1016/0167-4838(83)90277-7; TANOKURA M, 1983, J BIOCHEM-TOKYO, V94, P51, DOI 10.1093/oxfordjournals.jbchem.a134353; Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159	29	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26808	10.1371/journal.pone.0026808	http://dx.doi.org/10.1371/journal.pone.0026808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039551	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200050
J	Botwinick, IC; Shonkwiler, RJ; Steele, J; Yu, G; Chabot, JA				Botwinick, Isadora C.; Shonkwiler, R. Joseph; Steele, John; Yu, Gary; Chabot, John A.			Atrial Fibrillation and Delayed Gastric Emptying	PLOS ONE			English	Article							POSTOPERATIVE ILEUS; SURGERY; CELLS	Background: Atrial fibrillation and delayed gastric emptying (DGE) are common after pancreaticoduodenectomy. Our aim was to investigate a potential relationship between atrial fibrillation and DGE, which we defined as failure to tolerate a regular diet by the 7(th) postoperative day. Methods: We performed a retrospective chart review of 249 patients who underwent pancreaticoduodenectomy at our institution between 2000 and 2009. Data was analyzed with Fisher exact test for categorical variables and Mann-Whitney U or unpaired T-test for continuous variables. Results: Approximately 5% of the 249 patients included in the analysis experienced at least one episode of postoperative atrial fibrillation. Median age of patients with atrial fibrillation was 74 years, compared with 66 years in patients without atrial fibrillation (p = 0.0005). Patients with atrial fibrillation were more likely to have a history of atrial fibrillation (p = 0.03). 92% of the patients with atrial fibrillation suffered from DGE, compared to 46% of patients without atrial fibrillation (p = 0.0007). This association held true when controlling for age. Conclusion: Patients with postoperative atrial fibrillation are more likely to experience delayed gastric emptying. Interventions to manage delayed gastric function might be prudent in patients at high risk for postoperative atrial fibrillation.	[Botwinick, Isadora C.; Shonkwiler, R. Joseph; Steele, John; Yu, Gary; Chabot, John A.] Columbia Univ, Dept Surg, New York Presbyterian Hosp, Columbia Univ Med Ctr, New York, NY 10027 USA	Columbia University; NewYork-Presbyterian Hospital	Botwinick, IC (corresponding author), Columbia Univ, Dept Surg, New York Presbyterian Hosp, Columbia Univ Med Ctr, New York, NY 10027 USA.	Isadora.botwinick@gmail.com						Aranha GV, 2003, J AM COLL SURGEONS, V197, P223, DOI 10.1016/S1072-7515(03)00331-4; Bielefeldt K, 2005, NEUROGASTROENT MOTIL, V17, P488, DOI 10.1111/j.1365-2982.2005.00671.x; Cha YM, 2004, CIRCULATION, V109, P2839, DOI 10.1161/01.CIR.0000132470.78896.A8; CHUNG SA, 1994, AM J PHYSIOL-GASTR L, V267, pG800, DOI 10.1152/ajpgi.1994.267.5.G800; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; ECKBERG DL, 1983, J APPL PHYSIOL, V54, P961, DOI 10.1152/jappl.1983.54.4.961; Engel DR, 2010, NAT MED, V16, P1407, DOI 10.1038/nm.2255; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Liebregts T, 2011, AM J GASTROENTEROL, V106, P1089, DOI 10.1038/ajg.2010.512; McCarthy DO, 2000, RES NURS HEALTH, V23, P222, DOI 10.1002/1098-240X(200006)23:3<222::AID-NUR6>3.0.CO;2-3; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Polanczyk CA, 1998, ANN INTERN MED, V129, P279, DOI 10.7326/0003-4819-129-4-199808150-00003; Rosso R, 2010, J CARDIOVASC ELECTR, V21, P489, DOI 10.1111/j.1540-8167.2009.01658.x; van den Berg MP, 2003, HEART, V89, P333, DOI 10.1136/heart.89.3.333; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25499	10.1371/journal.pone.0025499	http://dx.doi.org/10.1371/journal.pone.0025499			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028778	Green Submitted, Green Published, gold			2022-12-25	WOS:000296510800007
J	Samuel, S; Gaur, P; Fan, F; Xia, L; Gray, MJ; Dallas, NA; Bose, D; Rodriguez-Aguayo, C; Lopez-Berestein, G; Plowman, G; Bagri, A; Sood, AK; Ellis, LM				Samuel, Shaija; Gaur, Puja; Fan, Fan; Xia, Ling; Gray, Michael J.; Dallas, Nikolaos A.; Bose, Debashish; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Plowman, Greg; Bagri, Anil; Sood, Anil K.; Ellis, Lee M.			Neuropilin-2 Mediated beta-Catenin Signaling and Survival in Human Gastro-Intestinal Cancer Cell Lines	PLOS ONE			English	Article							WNT PATHWAY ACTIVATION; EXPRESSION; GROWTH; SUPPRESSION; VEGF; RNA	NRP-2 is a high-affinity kinase-deficient receptor for ligands belonging to the class 3 semaphorin and vascular endothelial growth factor families. NRP-2 has been detected on the surface of several types of human cancer cells, but its expression and function in gastrointestinal (GI) cancer cells remains to be determined. We sought to determine the function of NRP-2 in mediating downstream signals regulating the growth and survival of human gastrointestinal cancer cells. In human gastric cancer specimens, NRP-2 expression was detected in tumor tissues but not in adjacent normal mucosa. In CNDT 2.5 cells, shRNA mediated knockdown NRP-2 expression led to decreased migration and invasion in vitro (p < 0.01). Focused gene-array analysis demonstrated that loss of NRP-2 reduced the expression of a critical metastasis mediator gene, S100A4. Steady-state levels and function of beta-catenin, a known regulator of S100A4, were also decreased in the shNRP-2 clones. Furthermore, knockdown of NRP-2 sensitized CNDT 2.5 cells in vitro to 5FU toxicity. This effect was associated with activation of caspases 3 and 7, cleavage of PARP, and downregulation of Bcl-2. In vivo growth of CNDT 2.5 cells in the livers of nude mice was significantly decreased in the shNRP-2 group (p < 0.05). Intraperitoneal administration of NRP-2 siRNA-DOPC decreased the tumor burden in mice (p = 0.01). Collectively, our results demonstrate that tumor cell-derived NRP-2 mediates critical survival signaling in gastrointestinal cancer cells.	[Samuel, Shaija; Fan, Fan; Xia, Ling; Lopez-Berestein, Gabriel; Sood, Anil K.; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Gaur, Puja; Gray, Michael J.; Dallas, Nikolaos A.; Bose, Debashish; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Plowman, Greg; Bagri, Anil] Genentech Inc, Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Roche Holding; Genentech	Samuel, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	lellis@mdanderson.org	Plowman, Greg/O-8032-2019; Khaitan, Puja/AAQ-6413-2020	Khaitan, Puja/0000-0001-8654-062X; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723	R. E. "Bob" Smith Fund for Cancer Research; National Institutes of Health [5 T32 CA09599, R01 CA112390]; Center for RNA Interference and Non-Coding RNA; Ovarian Cancer Research Fund; The William C. Liedtke, Jr., Chair for Cancer Research; Cytometry Core Facility (NIH) [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009599, R01CA112390] Funding Source: NIH RePORTER	R. E. "Bob" Smith Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for RNA Interference and Non-Coding RNA; Ovarian Cancer Research Fund; The William C. Liedtke, Jr., Chair for Cancer Research; Cytometry Core Facility (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R. E. "Bob" Smith Fund for Cancer Research (SS); National Institutes of Health grant 5 T32 CA09599 (ND, PG, and DB); the Center for RNA Interference and Non-Coding RNA (GL-B, AS), and a Program Project Development Grant form the Ovarian Cancer Research Fund (GL-B, AS); The William C. Liedtke, Jr., Chair for Cancer Research (LE); National Institutes of Health grant R01 CA112390 (LE). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genentech, Inc. paid for salary and research infrastructure for their employees GP and AB, but had no role in study design, data collection and analysis, or preparation of the manuscript. Genentech, Inc. approved the publication of the manuscript.; We thank Pablo Elias Vivas-Mejia, Hua Wang, and Huang Li for generation of lentiviral and liposomal reagents. We thank the Cytometry Core Facility (NIH Grant CA16672) at M. D. Anderson Cancer Center for assistance with flow cytometry. We thank Sunita Patterson (Department of Scientific Publications) and Rita Hernandez for editorial assistance.	Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Clements WM, 2002, CANCER RES, V62, P3503; Cohen T, 2002, J PATHOL, V198, P77, DOI 10.1002/path.1179; Dallas NA, 2008, CLIN CANCER RES, V14, P8052, DOI 10.1158/1078-0432.CCR-08-1520; Ellis LM, 2010, CLIN CANCER RES, V16, P5365, DOI 10.1158/1078-0432.CCR-10-2550; Fakhari M, 2002, CANCER-AM CANCER SOC, V94, P258, DOI 10.1002/cncr.10177; Gray MJ, 2008, J NATL CANCER I, V100, P109, DOI 10.1093/jnci/djm279; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Handa A, 2000, INT J ONCOL, V17, P291; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Mahon PC, 2007, CANCER RES, V67, P6786, DOI 10.1158/0008-5472.CAN-07-0440; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Van Buren G, 2007, CLIN CANCER RES, V13, P4704, DOI 10.1158/1078-0432.CCR-06-2723; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018	23	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e23208	10.1371/journal.pone.0023208	http://dx.doi.org/10.1371/journal.pone.0023208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028766	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800001
J	Vitoriano, I; Saraiva-Pava, KD; Rocha-Goncalves, A; Santos, A; Lopes, AI; Oleastro, M; Roxo-Rosa, M				Vitoriano, Ines; Saraiva-Pava, Kathy D.; Rocha-Goncalves, Alexandra; Santos, Andrea; Lopes, Ana I.; Oleastro, Monica; Roxo-Rosa, Monica			Ulcerogenic Helicobacter pylori Strains Isolated from Children: A Contribution to Get Insight into the Virulence of the Bacteria	PLOS ONE			English	Article							PEPTIC-ULCER DISEASE; GASTRIC MUCIN SYNTHESIS; GASTRODUODENAL DISEASES; RISK-FACTORS; INFECTION; IDENTIFICATION; ACID; COLONIZATION; METABOLISM; HP0958	Infection with Helicobacter pylori is the major cause for the development of peptic ulcer disease (PUD). In children, with no other etiology for the disease, this rare event occurs shortly after infection. In these young patients, habits of smoking, diet, consumption of alcohol and non-steroid anti-inflammatory drugs and stress, in addition to the genetic susceptibility of the patient, represent a minor influence. Accordingly, the virulence of the implicated H. pylori strain should play a crucial role in the development of PUD. Corroborating this, our in vitro infection assays comparing a pool of five H. pylori strains isolated from children with PUD to a pool of five other pediatric clinical isolates associated with non-ulcer dyspepsia (NUD) showed the greater ability of PUD strains to induce a marked decrease in the viability of gastric cells and to cause severe damage in the cells cytoskeleton as well as an impairment in the production/secretion of mucins. To uncover virulence features, we compared the proteome of these two groups of H. pylori strains. Two-dimensional gel electrophoresis followed by mass-spectrometry allowed us to detect 27 differentially expressed proteins between them. In addition to the presence of genes encoding well established virulence factors, namely cagA, vacAs1, oipA "on'' status, homB and jhp562 genes, the pediatric ulcerogenic strains shared a proteome profile characterized by changes in the abundance of: motility-associated proteins, accounting for higher motility; antioxidant proteins, which may confer increased resistance to inflammation; and enzymes involved in key steps in the metabolism of glucose, amino acids and urea, which may be advantageous to face fluctuations of nutrients. In conclusion, the enhanced virulence of the pediatric ulcerogenic H. pylori strains may result from a synergy between their natural ability to better adapt to the hostile human stomach and the expression of the established virulence factors.	[Vitoriano, Ines; Saraiva-Pava, Kathy D.; Roxo-Rosa, Monica] Univ Catolica Portuguesa, Fac Engn, Rio De Mouro, Portugal; [Rocha-Goncalves, Alexandra] Univ Coimbra, Dept Quim, Coimbra, Portugal; [Santos, Andrea; Oleastro, Monica] Inst Nacl Saude Dr Ricardo Jorge, Dept Doencas Infecciosas, Lisbon, Portugal; [Lopes, Ana I.] Hosp Univ Santa Maria, Fac Med Lisboa, Dept Pediat, Lisbon, Portugal	Universidade Catolica Portuguesa; Universidade de Coimbra; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; Hospital Santa Maria	Vitoriano, I (corresponding author), Univ Catolica Portuguesa, Fac Engn, Rio De Mouro, Portugal.	roxorosa@hotmail.com	Roxo-Rosa, Mónica/J-7890-2013; lopes, ana isabel g c f/R-2042-2017	/0000-0002-9575-2592; Roxo-Rosa, Monica/0000-0002-5719-039X; Oleastro, Monica/0000-0001-6360-2576; Santos, Andrea/0000-0002-5857-8599	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PPCDT/SAL-IMI/57297/2004]; FCT [SFRH/BD/38634/2007, SFRH/BD/72849/2011]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by PPCDT/SAL-IMI/57297/2004 research grant from the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. I. Vitoriano and K.D. Saraiva-Pava are the recipients of doctoral fellowships (SFRH/BD/38634/2007, FCT and SFRH/BD/72849/2011, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREICA V, 1990, GASTROEN CLIN BIOL, V14, P437; Ang S, 2001, INFECT IMMUN, V69, P1679, DOI 10.1128/IAI.69.3.1679-1686.2001; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Basque JR, 2001, J CELL BIOCHEM, V81, P241, DOI 10.1002/1097-4644(20010501)81:2&lt;241::AID-JCB1039&gt;3.0.CO;2-B; Bottomley JR, 1996, BIOCHEM J, V319, P559, DOI 10.1042/bj3190559; Byrd JC, 2000, GASTROENTEROLOGY, V118, P1072, DOI 10.1016/S0016-5085(00)70360-X; Byrd JC, 2000, WORLD J GASTROENTERO, V6, P475; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Cornally D, 2008, FEBS J, V275, P3041, DOI 10.1111/j.1742-4658.2008.06456.x; CorthesyTheulaz IE, 1997, J BIOL CHEM, V272, P25659, DOI 10.1074/jbc.272.41.25659; D'Elios MM, 2007, CLIN CHIM ACTA, V381, P32, DOI 10.1016/j.cca.2007.02.026; Doig P, 1999, MICROBIOL MOL BIOL R, V63, P675, DOI 10.1128/MMBR.63.3.675-707.1999; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; Gao L, 2009, CANCER RES, V69, P6164, DOI 10.1158/0008-5472.CAN-09-0596; HUGHES NJ, 1995, J BACTERIOL, V177, P3953, DOI 10.1128/jb.177.14.3953-3959.1995; Icatlo FC, 2000, GASTROENTEROLOGY, V119, P358, DOI 10.1053/gast.2000.9372; Kalach N, 2010, EUR J GASTROEN HEPAT, V22, P1174, DOI 10.1097/MEG.0b013e32833d36de; Kelly DJ, 2001, J APPL MICROBIOL, V90, p16S, DOI 10.1046/j.1365-2672.2001.01350.x; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Krah A, 2004, INT J CANCER, V108, P456, DOI 10.1002/ijc.11557; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lai LH, 2007, BEST PRACT RES CL GA, V21, P261, DOI 10.1016/j.bpg.2006.10.002; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Linden S, 2010, HELICOBACTER, V15, P251, DOI 10.1111/j.1523-5378.2010.00765.x; Loke MF, 2007, FEMS IMMUNOL MED MIC, V50, P231, DOI 10.1111/j.1574-695X.2007.00248.x; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; Mendz GL, 1996, MICROBIOL-UK, V142, P2959, DOI 10.1099/13500872-142-10-2959; Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003; Mouery K, 2006, J BACTERIOL, V188, P5494, DOI 10.1128/JB.00366-06; Oleastro M, 2006, INFECT IMMUN, V74, P4064, DOI 10.1128/IAI.00123-06; Oleastro M, 2008, J INFECT DIS, V198, P1379, DOI 10.1086/592166; Oleastro M, 2011, J ANTIMICROB CHEMOTH, V66, P2308, DOI 10.1093/jac/dkr293; Oleastro M, 2011, HELICOBACTER, V16, P363, DOI 10.1111/j.1523-5378.2011.00858.x; Oleastro M, 2010, J CLIN MICROBIOL, V48, P2885, DOI 10.1128/JCM.00401-10; Oleastro M, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-12; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Pereira L, 2005, J BACTERIOL, V187, P4463, DOI 10.1128/JB.187.13.4463-4469.2005; Pyndiah S, 2007, MOL CELL PROTEOMICS, V6, P193, DOI 10.1074/mcp.M600363-MCP200; Ryan KA, 2005, FEMS MICROBIOL LETT, V248, P47, DOI 10.1016/j.femsle.2005.05.022; SCHUBERT TT, 1993, AM J MED, V94, P413, DOI 10.1016/0002-9343(93)90153-G; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Stingl K, 2005, INT J MED MICROBIOL, V295, P307, DOI 10.1016/j.ijmm.2005.06.006; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Vitoriano I, 2011, HELICOBACTER, V16, P153, DOI 10.1111/j.1523-5378.2011.00825.x; Waidner B, 2002, INFECT IMMUN, V70, P3923, DOI 10.1128/IAI.70.7.3923-3929.2002; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; WALSH JH, 1995, NEW ENGL J MED, V333, P984, DOI 10.1056/NEJM199510123331508; Wang G, 2006, INFECT IMMUN, V74, P6839, DOI 10.1128/IAI.00991-06; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	52	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26265	10.1371/journal.pone.0026265	http://dx.doi.org/10.1371/journal.pone.0026265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039453	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500046
J	Ding, D; Li, WH; Song, GL; Qi, HY; Liu, JB; Tang, JH				Ding, Dong; Li, Weihua; Song, Guiliang; Qi, Hongyuan; Liu, Jingbao; Tang, Jihua			Identification of QTLs for Arsenic Accumulation in Maize (Zea mays L.) Using a RIL Population	PLOS ONE			English	Article							ORYZA-SATIVA L.; OXIDATIVE STRESS; PHOSPHATE-TRANSPORT; HOLCUS-LANATUS; CHEMICAL FORM; WEST-BENGAL; PADDY RICE; GROWTH; TOLERANCE; CONTAMINATION	The Arsenic (As) concentration in different tissues of maize was analyzed using a set of RIL populations derived from an elite hybrid, Nongda108. The results showed that the trend of As concentration in the four measured tissues was leaves>stems>bracts>kernels. Eleven QTLs for As concentration were detected in the four tissues. Three QTLs for As concentration in leaves were mapped on chromosomes 1, 5, and 8, respectively. For As concentration in the bracts, two QTLs were identified, with 9.61% and 10.03% phenotypic variance. For As concentration in the stems, three QTLs were detected with 8.24%, 14.86%, and 15.23% phenotypic variance. Three QTLs were identified for kernels on chromosomes 3, 5, and 7, respectively, with 10.73%, 8.52%, and 9.10% phenotypic variance. Only one common chromosomal region between SSR marker bnlg1811 and umc1243 was detected for QTLs qLAV1 and qSAC1. The results implied that the As accumulation in different tissues in maize was controlled by different molecular mechanism. The study demonstrated that maize could be a useful plant for phytoremediation of As-contaminated paddy soil, and the QTLs will be useful for selecting inbred lines and hybrids with low As concentration in their kernels.	[Ding, Dong; Li, Weihua; Song, Guiliang; Qi, Hongyuan; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Liu, Jingbao] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Henan Agricultural University; Huazhong Agricultural University	Ding, D (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	Tangjihua1@163.com			National Nature Foundation of China [30871537]; Major State Basic Research Development Program of China [2009CB118401]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was supported by a grant from the National Nature Foundation of China (30871537) and the Major State Basic Research Development Program of China (2009CB118401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2002, PLANT SOIL, V240, P311, DOI 10.1023/A:1015792723288; Abedin MJ, 2002, PLANT SOIL, V243, P57, DOI 10.1023/A:1019918100451; Abercrombie JM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-87; Alam MGM, 2003, SCI TOTAL ENVIRON, V308, P83, DOI 10.1016/S0048-9697(02)00651-4; Baig JA, 2010, FOOD CHEM TOXICOL, V48, P3051, DOI 10.1016/j.fct.2010.07.043; BARRACHINA AC, 1995, J PLANT NUTR, V18, P1237, DOI 10.1080/01904169509364975; Carbonell-Barrachina AA, 1998, PLANT SOIL, V198, P33, DOI 10.1023/A:1004285625998; Catarecha P, 2007, PLANT CELL, V19, P1123, DOI 10.1105/tpc.106.041871; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cox MS, 1996, J PLANT NUTR, V19, P1599, DOI 10.1080/01904169609365224; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; Dasgupta T, 2004, NEW PHYTOL, V163, P45, DOI 10.1111/j.1469-8137.2004.01109.x; Hartley-Whitaker J, 2001, PLANT CELL ENVIRON, V24, P713, DOI 10.1046/j.0016-8025.2001.00721.x; Huang RQ, 2006, SCI TOTAL ENVIRON, V368, P531, DOI 10.1016/j.scitotenv.2006.03.013; Kabata-Pendias A., 1992, TRACE ELEMENTS SOIL; Kamiya T, 2009, J BIOL CHEM, V284, P2114, DOI 10.1074/jbc.M806881200; Kang LiJuan, 1996, Journal of Jilin Agricultural University, V18, P58; Knauer K, 1999, AQUAT TOXICOL, V46, P221, DOI 10.1016/S0166-445X(98)00131-3; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liu WJ, 2006, ENVIRON SCI TECHNOL, V40, P5730, DOI 10.1021/es060800v; Liu XL, 2005, CHEMOSPHERE, V61, P293, DOI 10.1016/j.chemosphere.2005.01.088; MARIN AR, 1993, J PLANT NUTR, V16, P865, DOI 10.1080/01904169309364580; MARIN AR, 1992, PLANT SOIL, V139, P175, DOI 10.1007/BF00009308; MARIN AR, 1993, PLANT SOIL, V152, P245, DOI 10.1007/BF00029094; Meharg AA, 2004, TRENDS PLANT SCI, V9, P415, DOI 10.1016/j.tplants.2004.07.002; Meharg AA, 2003, NEW PHYTOL, V157, P39, DOI 10.1046/j.1469-8137.2003.00655.x; Meharg AA, 2001, ARS AS PAC REG WORKS, P45; Mylona PV, 1998, FREE RADICAL BIO MED, V25, P576, DOI 10.1016/S0891-5849(98)00090-2; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Norton GJ, 2008, J EXP BOT, V59, P2277, DOI 10.1093/jxb/ern098; ODANAKA Y, 1987, J PESTIC SCI, V12, P199; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Quaghebeur M, 2003, PLANT PHYSIOL, V132, P1600, DOI 10.1104/pp.103.021741; Rahman MA, 2007, CHEMOSPHERE, V69, P942, DOI 10.1016/j.chemosphere.2007.05.044; Rahman MA, 2007, CHEMOSPHERE, V67, P1072, DOI 10.1016/j.chemosphere.2006.11.061; Rahman MA, 2006, SCI TOTAL ENVIRON, V370, P51, DOI 10.1016/j.scitotenv.2006.05.018; Requejo R, 2005, PHYTOCHEMISTRY, V66, P1519, DOI 10.1016/j.phytochem.2005.05.003; Roychowdhury T, 2003, SCI TOTAL ENVIRON, V308, P15, DOI 10.1016/S0048-9697(02)00612-5; SCOTT N, 1993, CHEM RES TOXICOL, V6, P102, DOI 10.1021/tx00031a016; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Shri M, 2009, ECOTOX ENVIRON SAFE, V72, P1102, DOI 10.1016/j.ecoenv.2008.09.022; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Smith E, 2008, SCI TOTAL ENVIRON, V392, P277, DOI 10.1016/j.scitotenv.2007.11.023; Stone R, 2008, SCIENCE, V321, P184, DOI 10.1126/science.321.5886.184; Sung DY, 2009, PLANT J, V59, P802, DOI 10.1111/j.1365-313X.2009.03914.x; TAKAMATSU T, 1982, SOIL SCI, V133, P239, DOI 10.1097/00010694-198204000-00007; TSUTSUMI M, 1980, SOIL SCI PLANT NUTR, V26, P561, DOI 10.1080/00380768.1980.10431243; Ullah S. M., 1998, INT C ARS POLL GROUN; ULLRICHEBERIUS CI, 1989, J EXP BOT, V40, P119, DOI 10.1093/jxb/40.1.119; Williams PN, 2006, ENVIRON SCI TECHNOL, V40, P4903, DOI 10.1021/es060222i; Wu C, 2011, J EXPT BOT, V3, P1; Xie HL, 2010, GENES GENOM, V32, P55, DOI 10.1007/s13258-010-0801-3; ZENG ZB, 1994, GENETICS, V136, P1457; Zhu YG, 2008, ENVIRON SCI TECHNOL, V42, P5008, DOI 10.1021/es8001103	61	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25646	10.1371/journal.pone.0025646	http://dx.doi.org/10.1371/journal.pone.0025646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028786	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900015
J	Andreini, C; Bertini, I; Cavallaro, G				Andreini, Claudia; Bertini, Ivano; Cavallaro, Gabriele			Minimal Functional Sites Allow a Classification of Zinc Sites in Proteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BINDING SITES; STRUCTURAL CLASSIFICATION; ALCOHOL-DEHYDROGENASE; METAL SITES; DOMAIN; SELECTIVITY; INSIGHTS; DATABASE; FINGERS	Zinc is indispensable to all forms of life as it is an essential component of many different proteins involved in a wide range of biological processes. Not differently from other metals, zinc in proteins can play different roles that depend on the features of the metal-binding site. In this work, we describe zinc sites in proteins with known structure by means of three-dimensional templates that can be automatically extracted from PDB files and consist of the protein structure around the metal, including the zinc ligands and the residues in close spatial proximity to the ligands. This definition is devised to intrinsically capture the features of the local protein environment that can affect metal function, and corresponds to what we call a minimal functional site (MFS). We used MFSs to classify all zinc sites whose structures are available in the PDB and combined this classification with functional annotation as available in the literature. We classified 77% of zinc sites into ten clusters, each grouping zinc sites with structures that are highly similar, and an additional 16% into seven pseudo-clusters, each grouping zinc sites with structures that are only broadly similar. Sites where zinc plays a structural role are predominant in eight clusters and in two pseudo-clusters, while sites where zinc plays a catalytic role are predominant in two clusters and in five pseudo-clusters. We also analyzed the amino acid composition of the coordination sphere of zinc as a function of its role in the protein, highlighting trends and exceptions. In a period when the number of known zinc proteins is expected to grow further with the increasing awareness of the cellular mechanisms of zinc homeostasis, this classification represents a valuable basis for structure-function studies of zinc proteins, with broad applications in biochemistry, molecular pharmacology and de novo protein design.	[Andreini, Claudia; Bertini, Ivano; Cavallaro, Gabriele] Univ Florence, Magnet Resonance Ctr CERM, Sesto Fiorentino, Italy; [Andreini, Claudia; Bertini, Ivano] Univ Florence, Dept Chem, Sesto Fiorentino, Italy	University of Florence; University of Florence	Andreini, C (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Sesto Fiorentino, Italy.	bertini@cerm.unifi.it	Cavallaro, Gabriele/C-6991-2008; Andreini, Claudia/AAB-2364-2022; Cavallaro, Gabriele/GRE-9439-2022; Andreini, Claudia/D-5614-2014	Andreini, Claudia/0000-0003-4329-8225; Andreini, Claudia/0000-0003-4329-8225	MIUR (Ministero Italiano dell'Universita e della Ricerca) [RBFR08WGXT]	MIUR (Ministero Italiano dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	This work was supported by MIUR (Ministero Italiano dell'Universita e della Ricerca) through the FIRB (Fondo per gli Investimenti della Ricerca di Base) project RBFR08WGXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Andreini C, 2009, J MOL BIOL, V388, P356, DOI 10.1016/j.jmb.2009.02.052; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Baker PJ, 2009, P NATL ACAD SCI USA, V106, P779, DOI 10.1073/pnas.0807529106; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertini I., 2001, HDB METALLOPROTEINS; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; EKLUND H, 1981, J MOL BIOL, V146, P561, DOI 10.1016/0022-2836(81)90047-4; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Janda I, 2004, STRUCTURE, V12, P1901, DOI 10.1016/j.str.2004.08.003; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14225, DOI 10.1073/pnas.94.26.14225; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kumasaka T, 2007, J BIOL CHEM, V282, P37103, DOI 10.1074/jbc.M704476200; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee YM, 2008, J MOL BIOL, V379, P545, DOI 10.1016/j.jmb.2008.04.004; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Maret W, 2009, BIOMETALS, V22, P149, DOI 10.1007/s10534-008-9186-z; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MYERS LC, 1993, BIOCHEMISTRY-US, V32, P14089, DOI 10.1021/bi00214a003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pauly TA, 2003, STRUCTURE, V11, P1071, DOI 10.1016/S0969-2126(03)00167-9; Peroza EA, 2009, J MOL BIOL, V387, P207, DOI 10.1016/j.jmb.2009.01.035; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; PETTERSSON G, 1987, CRIT REV BIOCHEM MOL, V21, P349, DOI 10.3109/10409238609113616; Qian CM, 2003, J BIOL INORG CHEM, V8, P394, DOI 10.1007/s00775-002-0428-1; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Smith GD, 2000, ACTA CRYSTALLOGR D, V56, P1541, DOI 10.1107/S0907444900012749; Sun YN, 2009, J VIROL, V83, P10931, DOI 10.1128/JVI.02579-08; Tanaka Y, 2005, J BIOCHEM, V138, P263, DOI 10.1093/jb/mvi120; VALLEE BL, 1984, ADV ENZYMOL RAMB, V56, P283; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	49	98	98	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26325	10.1371/journal.pone.0026325	http://dx.doi.org/10.1371/journal.pone.0026325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043316	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400047
J	Hakansson, J; Stahlberg, A; Sand, FW; Gerhardt, H; Semb, H				Hakansson, Joakim; Stahlberg, Anders; Sand, Fredrik Wolfhagen; Gerhardt, Holger; Semb, Henrik			N-CAM Exhibits a Regulatory Function in Pathological Angiogenesis in Oxygen Induced Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; NITRIC-OXIDE SYNTHASE; RETINAL NEOVASCULARIZATION; NEURITE OUTGROWTH; FACTOR VEGF; CELL; PREMATURITY; EXPRESSION; HYPOXIA	Background: Diabetic retinopathy and retinopathy of prematurity are diseases caused by pathological angiogenesis in the retina as a consequence of local hypoxia. The underlying mechanism for epiretinal neovascularization (tuft formation), which contributes to blindness, has yet to be identified. Neural cell adhesion molecule (N-CAM) is expressed by Muller cells and astrocytes, which are in close contact with the retinal vasculature, during normal developmental angiogenesis. Methodology/Principal Findings: Notably, during oxygen induced retinopathy (OIR) N-CAM accumulated on astrocytes surrounding the epiretinal tufts. Here, we show that N-CAM ablation results in reduced vascular tuft formation due to reduced endothelial cell proliferation despite an elevation in VEGFA mRNA expression, whereas retinal developmental angiogenesis was unaffected. Conclusion/Significance: We conclude that N-CAM exhibits a regulatory function in pathological angiogenesis in OIR. This is a novel finding that can be of clinical relevance in diseases associated with proliferative vasculopathy.	[Hakansson, Joakim; Sand, Fredrik Wolfhagen; Gerhardt, Holger; Semb, Henrik] Gothenburg Univ, Dept Med Biochem, Sahlgrenska Acad, Gothenburg, Sweden; [Stahlberg, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Stahlberg, Anders] TATAA Bioctr, Gothenburg, Sweden; [Sand, Fredrik Wolfhagen; Semb, Henrik] Lund Univ, Stem Cell Ctr, Dept Lab Med, Lund, Sweden; [Gerhardt, Holger] London Res Inst Canc Res UK, Vasc Biol Lab, London, England	University of Gothenburg; University of Gothenburg; Lund University; University of London; Institute of Cancer Research - UK	Hakansson, J (corresponding author), PharmaSurg Sweden AB, Gothenburg, Sweden.	Fredrik.Wolfhagen_Sand@med.lu.se; Henrik.Semb@med.lu.se	Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Semb, Henrik/0000-0002-6747-787X; Stahlberg, Anders/0000-0003-4243-0191; Gerhardt, Holger/0000-0001-9228-7472	Swedish Cancer Foundation; Swedish Research Council; IngaBritt and Arne Lundberg Foundation; Medical Faculty at Lund University; Goljes Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); IngaBritt and Arne Lundberg Foundation; Medical Faculty at Lund University; Goljes Foundation	This work was supported by the Swedish Cancer Foundation: www.cancerfonden.se, the Swedish Research Council: http://www.vr.se/, IngaBritt and Arne Lundberg Foundation: www.lundbergsstiftelsen.se and Goljes Foundation: http://www.lindhes.se. FWS was supported by the Medical Faculty at Lund University. JH is presently employed by PharmaSurgics and AS is a share holder in TATAA Biocenter; during this project JH and AS were employed by academic departments and not by the companies. Neither of the companies did fund any part of these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTSCH U, 1990, J NEUROCYTOL, V19, P550, DOI 10.1007/BF01257243; Bohnsack BL, 2004, CELL CYCLE, V3, P1506, DOI 10.4161/cc.3.12.1334; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Chiarugi V, 2000, ONCOL RES, V12, P1; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; CONNOLLY DT, 1991, J CELL BIOCHEM, V47, P219, DOI 10.1002/jcb.240470306; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; EDVARDSEN K, 1993, P NATL ACAD SCI USA, V90, P11463, DOI 10.1073/pnas.90.24.11463; FERRARA N, 1991, J CELL BIOCHEM, V47, P211, DOI 10.1002/jcb.240470305; FLOWER RW, 1985, INVEST OPHTH VIS SCI, V26, P957; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; GIBSON DL, 1990, PEDIATRICS, V86, P405; GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311; Hedin Ulf, 1999, Thrombosis and Haemostasis, V82, P23; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; KAHN HA, 1974, AM J OPHTHALMOL, V78, P58, DOI 10.1016/0002-9394(74)90010-5; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; KUWABARA K, 1995, P NATL ACAD SCI USA, V92, P4606, DOI 10.1073/pnas.92.10.4606; LIEPE BA, 1994, J NEUROSCI, V14, P7641; McColm J, 2004, MOL VIS, V10, P512; MILLER JW, 1994, AM J PATHOL, V145, P574; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; PEER J, 1995, LAB INVEST, V72, P638; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Povlsen GK, 2008, J NEUROCHEM, V104, P624, DOI 10.1111/j.1471-4159.2007.05033.x; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sawaguchi A, 1999, J HISTOCHEM CYTOCHEM, V47, P919, DOI 10.1177/002215549904700709; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Smith LEH, 2005, BIOL NEONATE, V88, P237, DOI 10.1159/000087587; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Stupack DG, 2003, ONCOGENE, V22, P9022, DOI 10.1038/sj.onc.1207110; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wojciechowski AB, 2004, GLIA, V47, P58, DOI 10.1002/glia.20033; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705	47	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26026	10.1371/journal.pone.0026026	http://dx.doi.org/10.1371/journal.pone.0026026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043302	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295984400030
J	Wu, Y; Szestak, T; Stins, M; Craig, AG				Wu, Yang; Szestak, Tadge; Stins, Monique; Craig, Alister G.			Amplification of P. falciparum Cytoadherence through Induction of a Pro-Adhesive State in Host Endothelium	PLOS ONE			English	Article							HUMAN CEREBRAL MALARIA; TUMOR-NECROSIS-FACTOR; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; IN-VITRO; GENE-TRANSCRIPTION; PLASMA-LEVELS; TNF-ALPHA; BRAIN	This study examined the ability of P. falciparum-infected erythrocytes (IE) to induce a pro-adhesive environment in the host endothelium during malaria infection, prior to the systemic cytokine activation seen in the later phase of disease. Previous work had shown increases in receptor levels but had not measured to actual impact on IE binding. Using a co-culture system with a range of endothelial cells (EC) and IE with different cytoadherent properties, we have characterised the specific expression of adhesion receptors and subsequent IE binding by FACS and adhesion assays. We have also examined the specific signalling pathways induced during co-culture that are potentially involved in the induction of receptor expression. The results confirmed that ICAM-1 is up-regulated, albeit at much lower levels than seen with TNF activation, in response to co-culture with infected erythrocytes in all three tissue endothelial cell types tested but that up-regulation of VCAM-1 is tissue-dependent. This small increase in the levels of EC receptors correlated with large changes in IE adhesion ability. Co-culture with either RBC or IE increased the potential of subsequent adhesion indicating priming/modulation effects on EC which make them more susceptible to adhesion and thereby the recruitment of IE. Trypsin surface digestion of IE and the use of a Pfsbp1-knockout (ko) parasite line abrogated the up-regulation of ICAM-1 and reduced IE binding to EC suggesting that PfEMP-1 and other molecules exported to the IE surface via the PfSBP1 pathway are major mediators of this phenotype. This was also supported by the higher induction of EC adhesion receptors by adherent IE compared to isogenic, non-adherent lines.	[Wu, Yang; Szestak, Tadge; Craig, Alister G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Stins, Monique] Johns Hopkins Sch Med, RT Johnson Div NeuroImmunol, Baltimore, MD USA	Liverpool School of Tropical Medicine; University of Liverpool; Johns Hopkins University; Johns Hopkins Medicine	Wu, Y (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	agcraig@liv.ac.uk	Stins, Monique/W-2621-2018	Craig, Alister/0000-0003-0914-6164	Wellcome Trust [085391]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (grant number 085391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEKHUIZEN H, 1994, J VASC RES, V31, P230, DOI 10.1159/000159048; BERENDT AR, 1994, PARASITOL TODAY, V10, P412, DOI 10.1016/0169-4758(94)90238-0; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; Brown H, 1999, J INFECT DIS, V180, P1742, DOI 10.1086/315078; Chakravorty SJ, 2007, INT J PARASITOL, V37, P975, DOI 10.1016/j.ijpara.2007.02.006; CLARK IA, 1992, AM J PATHOL, V140, P325; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Cooke BM, 2000, PARASITOL TODAY, V16, P416, DOI 10.1016/S0169-4758(00)01753-1; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; GRANINGER W, 1994, J CLIN PATHOL, V47, P653, DOI 10.1136/jcp.47.7.653; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Ho M, 2005, INFECT IMMUN, V73, P8179, DOI 10.1128/IAI.73.12.8179-8187.2005; Hughes KR, 2010, MOL BIOCHEM PARASIT, V169, P71, DOI 10.1016/j.molbiopara.2009.09.007; Jenkins N, 2007, J INFECT DIS, V196, P321, DOI 10.1086/518795; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kawai S, 2003, J VET MED SCI, V65, P629, DOI 10.1292/jvms.65.629; Kita E, 2000, INFECT IMMUN, V68, P1207, DOI 10.1128/IAI.68.3.1207-1214.2000; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lu ZY, 2006, J IMMUNOL, V177, P6344, DOI 10.4049/jimmunol.177.9.6344; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Maude RJ, 2009, T ROY SOC TROP MED H, V103, P665, DOI 10.1016/j.trstmh.2009.03.001; McCormick CJ, 1997, J CLIN INVEST, V100, P2521, DOI 10.1172/JCI119794; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; PETZELBAUER P, 1993, J IMMUNOL, V151, P5062; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; Qureshi MH, 2003, J IMMUNOL, V171, P4700, DOI 10.4049/jimmunol.171.9.4700; Richards AL, 1997, INT J PARASITOL, V27, P1251, DOI 10.1016/S0020-7519(97)00122-7; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; ROTHLEIN R, 1994, J IMMUNOL, V152, P2488; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Shin YT, 2000, BLOOD, V95, P3232; Stins MF, 1999, INFECT IMMUN, V67, P5522, DOI 10.1128/IAI.67.10.5522-5525.1999; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Tripathi AK, 2006, INFECT IMMUN, V74, P3262, DOI 10.1128/IAI.01625-05; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; TURNER GDH, 1994, AM J PATHOL, V145, P1057; UDEINYA IJ, 1981, SCIENCE, V213, P555, DOI 10.1126/science.7017935; UDEINYA IJ, 1993, AM J TROP MED HYG, V48, P488, DOI 10.4269/ajtmh.1993.48.488; Viebig NK, 2005, INFECT IMMUN, V73, P3271, DOI 10.1128/IAI.73.6.3271-3277.2005; White VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004317; Wu Y, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-67; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298	64	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24784	10.1371/journal.pone.0024784	http://dx.doi.org/10.1371/journal.pone.0024784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043276	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000295984400003
J	Gorjestani, S; Yu, M; Tang, B; Zhang, DK; Wang, DM; Lin, X				Gorjestani, Sara; Yu, Mei; Tang, Bing; Zhang, Dekai; Wang, Demin; Lin, Xin			Phospholipase C gamma 2 (PLC gamma 2) Is Key Component in Dectin-2 Signaling Pathway, Mediating Anti-fungal Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTOR; NUCLEOTIDE EXCHANGE FACTOR; C-TYPE LECTINS; CANDIDA-ALBICANS; HOST-DEFENSE; FUNGAL-INFECTION; ADAPTER PROTEIN; TYROSINE KINASE; SYK	C-type lectin receptors (CLRs) such as Dectin-2 function as pattern recognition receptors to sense fungal infection. However, the signaling pathways induced by these receptors remain largely unknown. Previous studies suggest that the CLR-induced signaling pathway may utilize similar signaling components as the B cell receptor-induced signaling pathway. Phospholipase C gamma 2 (PLC gamma 2) is a key component in B cell receptor signaling, but its role in other signaling pathways has not been fully characterized. Here, we show that PLC gamma 2 functions downstream of Dectin-2 in response to the stimulation by the hyphal form of Candida albicans, an opportunistic pathogenic fungus. Using PLC gamma 2-and PLC gamma 1-deficient macrophages, we found that the lack of PLC gamma 2, but not PLC gamma 1, impairs cytokine production in response to infection with C. albicans. PLC gamma 2 deficiency results in the defective activation of NF-kappa B and MAPK and a significantly reduced production of reactive oxygen species following fungal challenge. In addition, PLC gamma 2-deficient mice are defective in clearing C. albicans infection in vivo. Together, these findings demonstrate that PLC gamma 2 plays a critical role in CLR-induced signaling pathways, governing antifungal innate immune responses.	[Gorjestani, Sara; Tang, Bing; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Cellular Oncol, Houston, TX 77030 USA; [Gorjestani, Sara; Lin, Xin] Univ Texas Houston, Canc Biol Program, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Gorjestani, Sara; Tang, Bing; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol Oncol, Houston, TX 77030 USA; [Yu, Mei; Wang, Demin] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Yu, Mei] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; [Zhang, Dekai] Texas A&M Univ, Inst Biosci & Technol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Versiti Blood Center of Wisconsin; Nanjing University; Texas A&M University System	Lin, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA.	xllin@mdanderson.org	Yu, Mei/K-2206-2017; Wang, Demin/AAX-4449-2020	Wang, Demin/0000-0001-5549-3795	National Institutes of Health [RO1AI050848, RO1GM065899, RO1AI079087, PO1HL44612]; Leukemia & Lymphoma Society; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087, R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI050848 and RO1GM065899 (to X. L.) and RO1AI079087 and PO1HL44612 (to D. W.). This work was also supported by a Scholar Award from the Leukemia & Lymphoma Society (to D. W.). This study was also supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA016672.	Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HIRASAWA N, 1995, J BIOL CHEM, V270, P10960, DOI 10.1074/jbc.270.18.10960; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Turner H, 1997, J EXP MED, V185, P43, DOI 10.1084/jem.185.1.43; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	40	43	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43651	43659		10.1074/jbc.M111.307389	http://dx.doi.org/10.1074/jbc.M111.307389			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22041900	Green Published, hybrid			2022-12-25	WOS:000298402300008
J	Gasnereau, I; Herr, P; Chia, PZC; Basler, K; Gleeson, PA				Gasnereau, Isabelle; Herr, Patrick; Chia, Pei Zhi Cheryl; Basler, Konrad; Gleeson, Paul A.			Identification of an Endocytosis Motif in an Intracellular Loop of Wntless Protein, Essential for Its Recycling and the Control of Wnt Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TRANS-GOLGI NETWORK; RETROMER COMPLEX; TRANSMEMBRANE PROTEIN; RETROGRADE TRANSPORT; GRADIENT FORMATION; ADAPTER COMPLEX; SECRETION; MEMBRANE; WINGLESS	The secretion of Wnt signaling proteins is dependent upon the transmembrane sorting receptor, Wntless (Wls), which recycles between the trans-Golgi network and the cell surface. Loss of Wls results in impairment of Wnt secretion and defects in development and homeostasis in Drosophila, Caenorhabditis elegans, and the mouse. The sorting signals for the internalization and trafficking of Wls have not been defined. Here, we demonstrate that Wls internalization requires clathrin and dynamin I, components of the clathrin-mediated endocytosis pathway. Moreover, we have identified a conserved YXX phi endocytosis motif in the third intracellular loop of the multipass membrane protein Wls. Mutation of the tyrosine-based motif YEGL to AEGL (Y425A) resulted in the accumulation of human mutant Wls on the cell surface of transfected HeLa cells. The cell surface accumulation of Wls(AEGL) was rescued by the insertion of a classical YXX phi motif in the cytoplasmic tail. Significantly, a Drosophila Wls(AEGL) mutant displayed a wing notch phenotype, with reduced Wnt secretion and signaling. These findings demonstrate that YXX phi endocytosis motifs can occur in the intracellular loops of multipass membrane proteins and, moreover, provide direct evidence that the trafficking of Wls is required for efficient secretion of Wnt signaling proteins.	[Gasnereau, Isabelle; Chia, Pei Zhi Cheryl; Gleeson, Paul A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Gasnereau, Isabelle; Chia, Pei Zhi Cheryl; Gleeson, Paul A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Herr, Patrick; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Melbourne; University of Melbourne; University of Zurich	Gleeson, PA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	pgleeson@unimelb.edu.au	Herr, Patrick/ABA-6092-2021	Herr, Patrick/0000-0003-2945-966X; Basler, Konrad/0000-0003-3534-1529; Gleeson, Paul/0000-0002-5336-6503	National Health and Medical Research Council of Australia; Swiss National Science Foundation; Melbourne International Graduate scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Melbourne International Graduate scholarship	This work was supported by the National Health and Medical Research Council of Australia and the Swiss National Science Foundation.; Supported by a Melbourne International Graduate scholarship.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Kim H, 2009, MOL CELL BIOL, V29, P2118, DOI 10.1128/MCB.01503-08; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004	38	36	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43324	43333		10.1074/jbc.M111.307231	http://dx.doi.org/10.1074/jbc.M111.307231			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027831	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000298351300052
J	Liu, JM; Fukuda, K; Xu, Z; Ma, YQ; Hirbawi, J; Mao, X; Wu, CY; Plow, EF; Qin, J				Liu, Jianmin; Fukuda, Koichi; Xu, Zhen; Ma, Yan-Qing; Hirbawi, Jamila; Mao, Xian; Wu, Chuanyue; Plow, Edward F.; Qin, Jun			Structural Basis of Phosphoinositide Binding to Kindlin-2 Protein Pleckstrin Homology Domain in Regulating Integrin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUT SIGNAL-TRANSDUCTION; LEUKOCYTE ADHESION; TALIN; ALPHA(IIB)BETA(3); NMR; MECHANISMS; MIG-2	Kindlins are a subclass of FERM-containing proteins that have recently emerged as key regulators of integrin receptor activation and signaling. As compared with the conventional FERM domain, the kindlin FERM domain contains an inserted pleckstrin homology (PH) domain that recognizes membrane phosphoinositides, including phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 3,4,5-trisphosphate (PIP3). Using NMR spectroscopy, we show that PIP3 site-specifically binds to kindlin-2 PH with substantial chemical shift changes that are much larger than PIP2. This suggests an enhanced association of kindlin-2 with membrane as mediated by PIP3 upon its conversion from PIP2 by phosphoinositide-3 kinase, a known regulator of integrin activation. We determined the NMR structure of the kindlin-2 PH domain bound to the head group of PIP3, inositol 1,3,4,5-tetraphosphate (IP4). The structure reveals a canonical PH domain fold, yet with a distinct IP4 binding pocket that appears highly conserved for the kindlin family members. Functional experiments demonstrate that although wild type kindlin-2 is capable of cooperating with integrin activator talin to induce synergistic integrin alpha(IIb)beta(3) activation, this ability is significantly impaired for a phosphoinositide binding-defective kindlin-2 mutant. These results define a specific PIP3 recognition mode for the kindlin PH domain. Moreover, they shed light upon a mechanism as to how the PH domain mediates membrane engagement of kindlin-2 to promote its binding to integrin and cooperation with talin for regulation of integrin activation.	[Liu, Jianmin; Fukuda, Koichi; Xu, Zhen; Ma, Yan-Qing; Hirbawi, Jamila; Plow, Edward F.; Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Mao, Xian; Qin, Jun] Cleveland Ctr Struct & Membrane Biol, Cleveland, OH 44106 USA; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Plow, EF (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org; qinj@ccf.org		Qin, Jun/0000-0002-2647-9270	National Institutes of Health [GM62823, P01 HL073311, GM65188, DK54639]; American Heart Association [10SDG2610277]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823, R01GM065188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62823 (to J. Q.), P01 HL073311 (to E. F. P.), and GM65188 and DK54639 (to C. W.). This work was also supported by American Heart Association Scientist Development Grant 10SDG2610277 (to Y. M.).; Supported by the Kirschstein-National Research Service Award (NRSA) research training grant through the National Institutes of Health.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Fukuda M, 1996, J BIOL CHEM, V271, P18838, DOI 10.1074/jbc.271.31.18838; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6	36	77	79	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43334	43342		10.1074/jbc.M111.295352	http://dx.doi.org/10.1074/jbc.M111.295352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22030399	hybrid, Green Published			2022-12-25	WOS:000298351300053
J	LaCrue, AN; Scheel, M; Kennedy, K; Kumar, N; Kyle, DE				LaCrue, Alexis N.; Scheel, Misty; Kennedy, Katherine; Kumar, Nikesh; Kyle, Dennis E.			Effects of Artesunate on Parasite Recrudescence and Dormancy in the Rodent Malaria Model Plasmodium vinckei	PLOS ONE			English	Article							FALCIPARUM-MALARIA; MURINE MALARIA; ARTEMISININ; MICE; SPLENECTOMY; SENSITIVITY; MEFLOQUINE; QINGHAOSU; KINETICS; FAILURE	Artemisinin (ART) is the recommended first line therapy for treating uncomplicated and drug-resistant Plasmodium falciparum, the most pathogenic form of malaria. However, treatment failure following ART monotherapy is not uncommon and resistance to this rapidly acting drug has been reported in the Thai-Cambodian border. Recent in vitro studies have shown that following treatment with dihydroartemisinin (DHA), the development of ring-stage parasites is arrested for up to 20 days. These arrested (i.e. dormant) rings could be responsible for the recrudescence of infection that is observed following ART monotherapy. To develop a better understanding of the stage-specific effects of ART and determine if dormancy occurs in vivo, the ART derivative artesunate (AS) was used to treat mice infected with the synchronous rodent malaria parasites P. vinckei petteri (non-lethal) and P. v. vinckei (lethal). Results show that in both the non-lethal and lethal strains, ring-stage parasites are the least susceptible to treatment with AS and that the day of treatment has more of an impact on recrudescence than the total dose administered. Additionally, 24 hrs post-treatment with AS, dormant forms similar in morphology to those seen in vitro were observed. Finally, rate of recrudescence studies suggest that there is a positive correlation between the number of dormant parasites present and when recrudescence occurs in the vertebrate host. Collectively, these data suggest that dormancy occurs in vivo and contributes to recrudescence that is observed following AS treatment. It is possible that this may represent a novel mechanism of parasite survival following treatment with AS.	[LaCrue, Alexis N.; Scheel, Misty; Kennedy, Katherine; Kumar, Nikesh; Kyle, Dennis E.] Univ S Florida, Dept Global Hlth, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	LaCrue, AN (corresponding author), Univ S Florida, Dept Global Hlth, Tampa, FL 33620 USA.	alacrue@health.usf.edu; dkyle@health.usf.edu		Kyle, Dennis/0000-0002-0238-965X	National Institutes of Health NIAID [R01 AI058973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058973] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institutes of Health NIAID (grant #R01 AI058973), http://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei AK, 2010, AM J HEMATOL, V85, P234, DOI 10.1002/ajh.21642; BETHELL D, PLOS ONE, V6; BOONE KE, 1995, BRIT MED J, V311, P1273, DOI 10.1136/bmj.311.7015.1273; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Buffet PA, 2006, BLOOD, V107, P3745, DOI 10.1182/blood-2005-10-4094; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; CAILLARD V, 1995, J PARASITOL, V81, P295, DOI 10.2307/3283937; CAILLARD V, 1992, EXP PARASITOL, V75, P449, DOI 10.1016/0014-4894(92)90258-C; CODD A, MALAR J, V10, P56; Negreiros RMD, 2009, ACTA CIR BRAS, V24, P437, DOI 10.1590/S0102-86502009000600003; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; GROOM AC, 1991, SCANNING MICROSCOPY, V5, P159; HIEN TT, 1993, LANCET, V341, P603; Ittarat W, 2003, AM J TROP MED HYG, V68, P147, DOI 10.4269/ajtmh.2003.68.147; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Kyle D E, 1998, Med Trop (Mars), V58, P38; Menard D, 2005, AM J TROP MED HYG, V73, P616, DOI 10.4269/ajtmh.2005.73.616; MOK S, BMC GENOMICS, V12, P391; Moore BR, 2008, EXP PARASITOL, V118, P458, DOI 10.1016/j.exppara.2007.10.011; Nakazawa S, 1995, EXP PARASITOL, V81, P556, DOI 10.1006/expr.1995.1149; Newton PN, 2001, BLOOD, V98, P450, DOI 10.1182/blood.V98.2.450; PERLMANN H, 1995, INFECT IMMUN, V63, P3987, DOI 10.1128/IAI.63.10.3987-3993.1995; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; SAINTYVES IFM, 1977, PAPUA NEW GUINEA MED, V20, P33; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Tuteja R, 2007, FEBS J, V274, P4670, DOI 10.1111/j.1742-4658.2007.05997.x; Voza T, 2005, INFECT IMMUN, V73, P4777, DOI 10.1128/IAI.73.8.4777-4786.2005; WASSERMAN GM, 1993, INFECT IMMUN, V61, P1958, DOI 10.1128/IAI.61.5.1958-1963.1993; White N J, 1998, Med Trop (Mars), V58, P54; *WHO, 2008, GLOB MAL ACT PLAN KE; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; Xie LH, 2006, ANTIMICROB AGENTS CH, V50, P1649, DOI 10.1128/AAC.50.5.1649-1655.2006	33	49	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26689	10.1371/journal.pone.0026689	http://dx.doi.org/10.1371/journal.pone.0026689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039533	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200042
J	Bansal, P; Wang, SL; Liu, SH; Xiang, YY; Lu, WY; Wang, QH				Bansal, Paul; Wang, Shuanglian; Liu, Shenghao; Xiang, Yun-Yan; Lu, Wei-Yang; Wang, Qinghua			GABA Coordinates with Insulin in Regulating Secretory Function in Pancreatic INS-1 beta-Cells	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; ISLET ALPHA-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; GLUCAGON-SECRETION; ENDOCRINE PANCREAS; GLUCOSE-INHIBITION; RECEPTOR; RELEASE; EXPRESSION; CHANNELS	Pancreatic islet beta-cells produce large amounts of c-aminobutyric acid (GABA), which is co-released with insulin. GABA inhibits glucagon secretion by hyperpolarizing alpha-cells via type-A GABA receptors (GABA(A)Rs). We and others recently reported that islet beta-cells also express GABA(A)Rs and that activation of GABA(A)Rs increases insulin release. Here we investigate the effects of insulin on the GABA-GABA(A)R system in the pancreatic INS-1 cells using perforated-patch recording. The results showed that GABA produces a rapid inward current and depolarizes INS-1 cells. However, pre-treatment of the cell with regular insulin (1 mu M) suppressed the GABA-induced current (I-GABA) by 43%. Zinc-free insulin also suppressed I-GABA to the same extent of inhibition by regular insulin. The inhibition of I-GABA occurs within 30 seconds after application of insulin. The insulin-induced inhibition of I-GABA persisted in the presence of PI3-kinase inhibitor, but was abolished upon inhibition of ERK, indicating that insulin suppresses GABA(A)Rs through a mechanism that involves ERK activation. Radioimmunoassay revealed that the secretion of C-peptide was enhanced by GABA, which was blocked by pre-incubating the cells with picrotoxin (50 mu M, p<0.01) and insulin (1 mu M, p<0.01), respectively. Together, these data suggest that autocrine GABA, via activation of GABA(A)Rs, depolarizes the pancreatic beta-cells and enhances insulin secretion. On the other hand, insulin down-regulates GABA-GABA(A)R signaling presenting a feedback mechanism for fine-tuning beta-cell secretion.	[Bansal, Paul; Liu, Shenghao; Wang, Qinghua] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Bansal, Paul; Liu, Shenghao; Wang, Qinghua] Univ Toronto, Fac Med, Dept Med, Toronto, ON M5S 1A8, Canada; [Bansal, Paul; Liu, Shenghao; Wang, Qinghua] St Michaels Hosp, Div Endocrinol & Metab, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Wang, Shuanglian; Xiang, Yun-Yan; Lu, Wei-Yang] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Wang, Shuanglian; Xiang, Yun-Yan; Lu, Wei-Yang] Univ Western Ontario, Robarts Res Inst, London, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario)	Bansal, P (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada.	wlu53@uwo.ca; qinghua.wang@utoronto.ca	Lu, Wei-Yang/K-4404-2013; Wang, Qinghua/GVT-3252-2022		Canadian Institute for Health Research (CIHR) [MOP-79534, MOP-84517]; Canadian Diabetes Association (CDA); Juvenile Diabetes Research Foundation	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association (CDA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	Funding: This work was supported by grants from the Canadian Institute for Health Research (CIHR) (MOP-79534 to Q. Wang and MOP-84517 to W. Y. Lu). Research in Dr. Wang's laboratory was also supported by grants from the Canadian Diabetes Association (CDA) and the Juvenile Diabetes Research Foundation. Q. Wang is presently supported by the New Investigator Program from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, TISSUE CELL, V34, P1, DOI 10.1054/tice.2002.0217; AGUAYO LG, 1993, J PHARMACOL EXP THER, V267, P1414; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bailey SJ, 2007, DIABETES, V56, P320, DOI 10.2337/db06-0712; Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Bell-Horner CL, 2006, J NEUROBIOL, V66, P1467, DOI 10.1002/neu.20327; Blankenfeld G, 1995, PFLUGERS ARCH, V430, P381, DOI [10.1007/BF00373913, DOI 10.1007/BF00373913]; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; Collier JJ, 2004, BIOCHEM BIOPH RES CO, V324, P1018, DOI 10.1016/j.bbrc.2004.09.149; Davies SL, 2004, BBA-BIOMEMBRANES, V1667, P7, DOI 10.1016/j.bbamem.2004.08.005; Dong H, 2006, DIABETOLOGIA, V49, P697, DOI 10.1007/s00125-005-0123-1; ELAHI D, 1982, NEW ENGL J MED, V306, P1196, DOI 10.1056/NEJM198205203062002; Eto K, 2002, DIABETES, V51, P87, DOI 10.2337/diabetes.51.1.87; GERBER JC, 1979, DIABETES, V28, P1073, DOI 10.2337/diabetes.28.12.1073; Glassmeier G, 1998, ANN NY ACAD SCI, V859, P241, DOI 10.1111/j.1749-6632.1998.tb11138.x; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Jimenez-Feltstrom J, 2004, REGUL PEPTIDES, V122, P109, DOI 10.1016/j.regpep.2004.06.004; Khan FA, 2001, DIABETES, V50, P2192, DOI 10.2337/diabetes.50.10.2192; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Li J, 2007, BRIT J PHARMACOL, V151, P483, DOI 10.1038/sj.bjp.0707259; Ligon B, 2007, DIABETOLOGIA, V50, P764, DOI 10.1007/s00125-007-0601-8; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Persaud SJ, 2002, FEBS LETT, V510, P225, DOI 10.1016/S0014-5793(01)03268-9; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Smismans A, 1997, DIABETOLOGIA, V40, P1411, DOI 10.1007/s001250050843; SMITH GD, 1984, P NATL ACAD SCI-BIOL, V81, P7093, DOI 10.1073/pnas.81.22.7093; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Sugita M, 2004, J GEN PHYSIOL, V124, P59, DOI 10.1085/jgp.200308948; Takayama C, 2010, NEUROSCI RES, V67, P137, DOI 10.1016/j.neures.2010.02.010; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; VINCENT SR, 1983, NEUROENDOCRINOLOGY, V36, P197, DOI 10.1159/000123456; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Wang QH, 2009, ISLETS, V1, P95, DOI 10.4161/isl.1.2.9263; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Williams DB, 2008, NEUROSCI LETT, V443, P27, DOI 10.1016/j.neulet.2008.07.038; Winnock F, 2002, AM J PHYSIOL-ENDOC M, V282, pE937, DOI 10.1152/ajpendo.00071.2001; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Xu GG, 1998, DIABETES, V47, P1243, DOI 10.2337/diabetes.47.8.1243; Zhang Y, 2008, DIABETOLOGIA, V51, P2290, DOI 10.1007/s00125-008-1166-x; Zhao JW, 2008, CELL PHYSIOL BIOCHEM, V21, P445, DOI 10.1159/000129637	53	43	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26225	10.1371/journal.pone.0026225	http://dx.doi.org/10.1371/journal.pone.0026225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031825	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200012
J	Fermino, ML; Polli, CD; Toledo, KA; Liu, FT; Hsu, DK; Roque-Barreira, MC; Pereira-da-Silva, G; Bernardes, ES; Halbwachs-Mecarelli, L				Fermino, Marise Lopes; Polli, Claudia Danella; Toledo, Karina Alves; Liu, Fu-Tong; Hsu, Dan K.; Roque-Barreira, Maria Cristina; Pereira-da-Silva, Gabriela; Bernardes, Emerson Soares; Halbwachs-Mecarelli, Lise			LPS-Induced Galectin-3 Oligomerization Results in Enhancement of Neutrophil Activation	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; IGE-BINDING PROTEIN; LUNG INJURY; SOLUBLE CD14; STREPTOCOCCUS-PNEUMONIAE; ISCHEMIA-REPERFUSION; SIGNAL-TRANSDUCTION; PRIMES NEUTROPHILS; BETA-2 INTEGRINS; IMMUNE-RESPONSE	Galectin-3 (Gal 3) is a glycan-binding protein that can be secreted by activated macrophages and mast cells at inflammation sites and plays an important role in inflammatory diseases caused by Bacteria and their products, such as lipopolysaccharides (LPS). Although it is well established that Gal 3 can interact with LPS, the pathophysiological importance of LPS/Gal 3 interactions is not fully understood. Data presented herein demonstrate for the first time that the interaction of Gal 3, either via its carbohydrate binding C-terminal domain or via its N-terminal part, with LPS from different bacterial strains, enhances the LPS-mediated neutrophil activation in vitro. Gal 3 allowed low LPS concentrations (1 mu g/mL without serum, 1 ng/mL with serum) to upregulate CD11b expression and reactive oxygen species (ROS) generation on human neutrophils in vitro and drastically enhanced the binding efficiency of LPS to the neutrophil surface. These effects required LPS preincubation with Gal 3, before neutrophil stimulation and involved specific Gal 3/LPS interaction. A C-terminal Gal-3 fragment, which retains the lectin domain but lacks the N-terminal part, was still able to bind both to Escherichia coli LPS and to neutrophils, but had lost the ability to enhance neutrophil response to LPS. This result emphasizes the importance of an N-terminus-mediated Gal 3 oligomerization induced by its interaction with LPS. Finally we demonstrated that Balb/C mice were more susceptible to LPS-mediated shock when LPS was pretreated with Gal 3. Altogether, these results suggest that multimeric interactions between Gal 3 oligomers and LPS potentiate its proinflammatory effects on neutrophils.	[Fermino, Marise Lopes; Polli, Claudia Danella; Toledo, Karina Alves; Halbwachs-Mecarelli, Lise] Univ Paris 05, Paris, France; [Fermino, Marise Lopes; Toledo, Karina Alves; Roque-Barreira, Maria Cristina; Halbwachs-Mecarelli, Lise] Univ Sao Paulo, Fac Med, Dept Cellular & Mol Biol & Pathogen Bioagents, Sao Paulo, Brazil; [Polli, Claudia Danella] Univ Sao Paulo, Fac Med, Program Basic & Appl Immunol, Sao Paulo, Brazil; [Toledo, Karina Alves] Univ Sao Paulo, Dept Biol Sci, Sao Paulo, Brazil; [Pereira-da-Silva, Gabriela] Univ Sao Paulo, Ribeirao Preto Coll Nursing, Sao Paulo, Brazil; [Liu, Fu-Tong; Hsu, Dan K.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Bernardes, Emerson Soares] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal	UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of California System; University of California Davis; Universidade do Porto	Fermino, ML (corresponding author), Univ Paris 05, Paris, France.	ebernardes@ipatimup.pt; lise.halbwachs@inserm.fr	Bisson, Gabriela/Q-2383-2016; Roque-Barreira, Maria-Cristina/A-4552-2008; Bernardes, Emerson Soares/D-3711-2017; Toledo, Karina Alves/C-9452-2012; Liu, FU-TONG/A-5749-2019	Bisson, Gabriela/0000-0002-6743-0553; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Bernardes, Emerson Soares/0000-0002-0029-7313; Toledo, Karina Alves/0000-0001-7212-6794; Liu, FU-TONG/0000-0002-3354-1001	Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB) [597/08]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/60757-4]	Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding: This work was supported by fellowships granted to MLF, CDP and KAT: Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB, 597/08). Support was also received from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2006/60757-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Almkvist J, 2004, EXP CELL RES, V298, P74, DOI 10.1016/j.yexcr.2004.04.006; Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Barboni E, 2005, FEBS LETT, V579, P6749, DOI 10.1016/j.febslet.2005.11.005; BREWER FC, 2002, BIOCHIM BIOPHYS ACTA, V1572, P255; de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; FEIZI T, 1994, BIOCHEMISTRY-US, V33, P6342, DOI 10.1021/bi00186a038; Fernandez GC, 2005, GLYCOBIOLOGY, V15, P519, DOI 10.1093/glycob/cwi026; Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HO MK, 1982, J IMMUNOL, V128, P2281; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; HSU DK, 1992, J BIOL CHEM, V267, P14167; JAESCHKE H, 1990, FASEB J, V4, P3355, DOI 10.1096/fasebj.4.15.2253850; JAESCHKE H, 1991, AM J PHYSIOL, V261, pG1051, DOI 10.1152/ajpgi.1991.261.6.G1051; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Karlsson A, 1998, BLOOD, V91, P3430, DOI 10.1182/blood.V91.9.3430.3430_3430_3438; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Liew Alan Wee-Chung, 2005, Int J Bioinform Res Appl, V1, P181, DOI 10.1504/IJBRA.2005.007577; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Liu Fu-Tong, 2002, Expert Opin Ther Targets, V6, P461, DOI 10.1517/14728222.6.4.461; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Mey A, 1996, J IMMUNOL, V156, P1572; MULLIGAN MS, 1993, J IMMUNOL, V150, P2407; MULLIGAN MS, 1993, J IMMUNOL, V150, P2401; Nieminen J, 2005, J LEUKOCYTE BIOL, V78, P1127; Nieminen J, 2008, J IMMUNOL, V180, P2466, DOI 10.4049/jimmunol.180.4.2466; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Remer KA, 2003, IMMUNOL LETT, V85, P75, DOI 10.1016/S0165-2478(02)00210-9; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sarter K, 2009, BIOCHEM BIOPH RES CO, V379, P155, DOI 10.1016/j.bbrc.2008.12.024; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SEEKAMP A, 1993, AM J PATHOL, V143, P464; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Villar J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006818; WORTHEN GS, 1992, J CLIN INVEST, V90, P2526, DOI 10.1172/JCI116146; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; YEE J, 1993, J IMMUNOL, V150, P1988; Yu B, 1996, J BIOL CHEM, V271, P4100	49	61	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26004	10.1371/journal.pone.0026004	http://dx.doi.org/10.1371/journal.pone.0026004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031821	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200008
J	Jain, RA; Wolman, MA; Schmidt, LA; Burgess, HA; Granato, M				Jain, Roshan A.; Wolman, Marc A.; Schmidt, Lauren A.; Burgess, Harold A.; Granato, Michael			Molecular-Genetic Mapping of Zebrafish Mutants with Variable Phenotypic Penetrance	PLOS ONE			English	Article							LARVAL ZEBRAFISH; PREPULSE INHIBITION; BEHAVIORAL SCREEN; GATING DEFICITS; STARTLE REFLEX; SCHIZOPHRENIA; MODULATION; NEURONS; DISEASE; MARKERS	Forward genetic screens in vertebrates are powerful tools to generate models relevant to human diseases, including neuropsychiatric disorders. Variability in phenotypic penetrance and expressivity is common in these disorders and behavioral mutant models, making their molecular-genetic mapping a formidable task. Using a 'phenotyping by segregation' strategy, we molecularly map the hypersensitive zebrafish houdini mutant despite its variable phenotypic penetrance, providing a generally applicable strategy to map zebrafish mutants with subtle phenotypes.	[Jain, Roshan A.; Wolman, Marc A.; Schmidt, Lauren A.; Burgess, Harold A.; Granato, Michael] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Jain, RA (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu	Burgess, Harold/B-8474-2015	Burgess, Harold/0000-0003-1966-7801; Jain, Roshan/0000-0003-3838-6044	NRSA [5F32NS065637-02, 5F32EY019434-03]; National Institutes of Health [MH092257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008884] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY019434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS065637] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a NRSA postdoctoral fellowship (5F32NS065637-02) to R.A.J., a NRSA postdoctoral fellowship (5F32EY019434-03) to M. A. W., and a National Institutes of Health grant (MH092257) to M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; Bakker Mirte J, 2009, J Psychiatry Neurosci, V34, P314; Brennan CH, 2011, REV NEUROSCIENCE, V22, P37, DOI 10.1515/RNS.2011.006; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Burgess HA, 2009, GENES BRAIN BEHAV, V8, P500, DOI 10.1111/j.1601-183X.2009.00499.x; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Burgess Harold A., 2008, Briefings in Functional Genomics & Proteomics, V7, P474, DOI 10.1093/bfgp/eln039; Downes GB, 2004, DEV BIOL, V270, P232, DOI 10.1016/j.ydbio.2004.02.027; Duley AR, 2007, INT J PSYCHOPHYSIOL, V64, P157, DOI 10.1016/j.ijpsycho.2007.01.006; Gomes Erissandra, 2008, Pró-Fono R. Atual. Cient., V20, P279, DOI 10.1590/S0104-56872008000400013; Gould KA, 1996, GENETICS, V144, P1777; Granato M, 1996, DEVELOPMENT, V123, P399; GREENSPAN SI, 1997, J DEV LEARNING DISOR, V1, P1; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; GUO S, 2011, DEV NEUROBI IN PRESS; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; Knapik EW, 1996, DEVELOPMENT, V123, P451; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; Meincke U, 2004, PSYCHIAT RES, V126, P51, DOI 10.1016/j.psychres.2004.01.003; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Moens PB, 2006, GENOME, V49, P205, DOI 10.1139/G06-021; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; RAUCH GJ, 1997, POLYMORPHIC ZEBRAFIS; Schneider K, 1997, DEVELOPMENT, V124, P1789; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; WOLMAN M, 2011, DEV NEUROBI IN PRESS; Wolman MA, 2011, P NATL ACAD SCI USA, V108, P15468, DOI 10.1073/pnas.1107156108; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26510	10.1371/journal.pone.0026510	http://dx.doi.org/10.1371/journal.pone.0026510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039502	Green Published, gold			2022-12-25	WOS:000296507500080
J	Mahar, I; Tan, S; Davoli, MA; Dominguez-Lopez, S; Qiang, C; Rachalski, A; Turecki, G; Mechawar, N				Mahar, Ian; Tan, Stephanie; Davoli, Maria Antonietta; Dominguez-Lopez, Sergio; Qiang, Calvin; Rachalski, Adeline; Turecki, Gustavo; Mechawar, Naguib			Subchronic Peripheral Neuregulin-1 Increases Ventral Hippocampal Neurogenesis and Induces Antidepressant-Like Effects	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ADULT-RAT HIPPOCAMPUS; NEURAL STEM-CELLS; CEREBRAL-CORTEX; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; BIPOLAR DISORDER; RADIAL GLIA; ASSOCIATION ANALYSIS; CHRONIC FLUOXETINE	Background: Adult hippocampal neurogenesis has been implicated in the mechanism of antidepressant action, and neurotrophic factors can mediate the neurogenic changes underlying these effects. The neurotrophic factor neuregulin-1 (NRG1) is involved in many aspects of brain development, from cell fate determination to neuronal maturation. However, nothing is known about the influence of NRG1 on neurodevelopmental processes occurring in the mature hippocampus. Methods: Adult male mice were given subcutaneous NRG1 or saline to assess dentate gyrus proliferation and neurogenesis, as well as cell fate determination. Mice also underwent behavioral testing. Expression of ErbB3 and ErbB4 NRG1 receptors in newborn dentate gyrus cells was assessed at various time points between birth and maturity. The phenotype of ErbB-expressing progenitor cells was also characterized with cell type-specific markers. Results: The current study shows that subchronic peripheral NRG1 beta administration selectively increased cell proliferation (by 71%) and neurogenesis (by 50%) in the caudal dentate gyrus within the ventral hippocampus. This pro-proliferative effect did not alter neuronal fate, and may have been mediated by ErbB3 receptors, which were expressed by newborn dentate gyrus cells from cell division to maturity and colocalized with SOX2 in the subgranular zone. Furthermore, four weeks after cessation of subchronic treatment, animals displayed robust antidepressant-like behavior in the absence of changes in locomotor activity, whereas acute treatment did not produce antidepressant effects. Conclusions: These results show that neuregulin-1 beta has pro-proliferative, neurogenic and antidepressant properties, further highlight the importance of peripheral neurotrophic factors in neurogenesis and mood, and support the role of hippocampal neurogenesis in mediating antidepressant effects.	[Mahar, Ian; Tan, Stephanie; Davoli, Maria Antonietta; Qiang, Calvin; Rachalski, Adeline; Turecki, Gustavo; Mechawar, Naguib] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Verdun, PQ, Canada; [Dominguez-Lopez, Sergio; Turecki, Gustavo; Mechawar, Naguib] Dept Psychiat, Montreal, PQ, Canada; [Mahar, Ian; Turecki, Gustavo; Mechawar, Naguib] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University; McGill University	Mahar, I (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Verdun, PQ, Canada.	naguib.mechawar@mcgill.ca	Mahar, Ian/R-8226-2017; Turecki, Gustavo/K-5100-2015; Tan, Stephanie/GRR-6503-2022	Mahar, Ian/0000-0002-8792-0437; Turecki, Gustavo/0000-0003-4075-2736; Dominguez-Lopez, Sergio/0000-0001-9534-4727	NSERC [341479-07, 345952-07]; Reseau Quebecois de Recherche sur le Suicide (FRSQ)	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Reseau Quebecois de Recherche sur le Suicide (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This research was supported by NSERC Discovery (#341479-07) and RTI (345952-07) grants (http://www.nserc-crsng.gc.ca/) to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Cell Imaging and Analysis Network (CIAN) at McGill University, Montreal, for expert advice in confocal microscopy, as well as Amanda Knezevic for technical assistance and Marissa Maheu, Jesse Jackson, Sylvain Williams and Lalit Srivastava for constructive feedback on the manuscript. We thank the laboratory of Dr. Derek van der Kooy for the generous donation of nestin-GFP mice. IM was supported in part by a scholarship from the Reseau Quebecois de Recherche sur le Suicide (FRSQ). SDL is a CONACYT scholar. NM is an FRSQ chercheur-boursier.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Anton ES, 1997, DEVELOPMENT, V124, P3501; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bertram I, 2007, ANN NY ACAD SCI, V1096, P147, DOI 10.1196/annals.1397.080; Bjarkam CR, 2003, HIPPOCAMPUS, V13, P21, DOI 10.1002/hipo.10042; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Boucher AA, 2007, NEUROSCIENCE, V149, P861, DOI 10.1016/j.neuroscience.2007.08.020; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Carlsson T, 2011, J NEUROCHEM, V117, P1066, DOI 10.1111/j.1471-4159.2011.07284.x; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Cui K, 2009, SCHIZOPHR RES, V113, P288, DOI 10.1016/j.schres.2009.05.003; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Detke MJ, 1997, EXP CLIN PSYCHOPHARM, V5, P107, DOI 10.1037/1064-1297.5.2.107; Diniz BS, 2010, WORLD J BIOL PSYCHIA, V11, P550, DOI 10.3109/15622970903544620; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman CH, 2009, BEHAV BRAIN RES, V198, P366, DOI 10.1016/j.bbr.2008.11.016; Elizalde N, 2010, PSYCHOPHARMACOLOGY, V210, P393, DOI 10.1007/s00213-010-1835-6; Eto K, 2010, MOL CELL BIOCHEM, V339, P119, DOI 10.1007/s11010-009-0375-z; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; FRANKLIN KBJ, 2007, MOUSE BRAIN STEREOTA, P351; GAGE FH, 1980, BRAIN RES BULL, V5, P771, DOI 10.1016/0361-9230(80)90220-8; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Georgieva L, 2008, BIOL PSYCHIAT, V64, P419, DOI 10.1016/j.biopsych.2008.03.025; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Gierdalski M, 2005, J NEUROSCI, V25, P8498, DOI 10.1523/JNEUROSCI.1476-05.2005; Goes FS, 2009, AM J MED GENET B, V150B, P693, DOI 10.1002/ajmg.b.30895; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kastin AJ, 2004, J NEUROCHEM, V88, P965, DOI 10.1046/j.1471-4159.2003.02224.x; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Lee D, 2009, J CLIN INVEST, V119, P2702, DOI 10.1172/JCI36435; Lipska BK, 2002, NEUROTOX RES, V4, P469, DOI 10.1080/1029842021000022089; Liu Y, 2005, DEV BIOL, V283, P437, DOI 10.1016/j.ydbio.2005.04.038; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Lu CL, 2010, NEUROSCI LETT, V481, P120, DOI 10.1016/j.neulet.2010.06.067; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maggio N, 2007, HIPPOCAMPUS, V17, P10, DOI 10.1002/hipo.20237; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miller EJ, 2010, NEUROSCIENCE, V165, P601, DOI 10.1016/j.neuroscience.2009.10.036; Nason MW, 2011, NEUROPSYCHOPHARMACOL, V36, P488, DOI 10.1038/npp.2010.180; Naz M, 2011, MOL BIOL REP, V38, P4709, DOI 10.1007/s11033-010-0606-0; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Nettles KW, 2000, BRAIN RES, V858, P181, DOI 10.1016/S0006-8993(99)02281-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Paizanis E, 2009, INT J NEUROPSYCHOPH, P1; Parlapani E, 2010, WORLD J BIOL PSYCHIA, V11, P243, DOI 10.3109/15622970802022376; Pentkowski NS, 2006, EUR J NEUROSCI, V23, P2185, DOI 10.1111/j.1460-9568.2006.04754.x; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Prata DP, 2009, PSYCHIAT GENET, V19, P113, DOI 10.1097/YPG.0b013e32832a4f69; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rieff HI, 2006, EUR J NEUROSCI, V23, P2225, DOI 10.1111/j.1460-9568.2006.04727.x; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; SCHMIDT HD, 2010, NEUROPSYCHOPHARMACOL; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Seshadri S, 2010, P NATL ACAD SCI USA, V107, P5622, DOI 10.1073/pnas.0909284107; Shibuya M, 2010, J NEURAL TRANSM, V117, P887, DOI 10.1007/s00702-010-0418-3; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SNYDER JS, 2011, NATURE; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Talmage DA, 2004, J COMP NEUROL, V472, P134, DOI 10.1002/cne.20091; Vaidya Vidita A, 2007, Expert Rev Neurother, V7, P853, DOI 10.1586/14737175.7.7.853; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Walker RM, 2010, NEUROSCI LETT, V478, P9, DOI 10.1016/j.neulet.2010.04.056; Wang JW, 2008, BIOL PSYCHIAT, V63, P640, DOI 10.1016/j.biopsych.2008.01.008; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; Wilson Christina, 2010, Clin Schizophr Relat Psychoses, V4, P124, DOI 10.3371/CSRP.4.2.4; WILSON MA, 1991, NEUROSCIENCE, V44, P555, DOI 10.1016/0306-4522(91)90077-2; Xu ZF, 2006, J CEREBR BLOOD F MET, V26, P527, DOI 10.1038/sj.jcbfm.9600212; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zhang HX, 2008, NEUROSCI LETT, V438, P1, DOI 10.1016/j.neulet.2007.09.051	100	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26610	10.1371/journal.pone.0026610	http://dx.doi.org/10.1371/journal.pone.0026610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028923	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500097
J	McKenzie, AJ; Campbell, SL; Howe, AK				McKenzie, Andrew J.; Campbell, Shirley L.; Howe, Alan K.			Protein Kinase A Activity and Anchoring Are Required for Ovarian Cancer Cell Migration and Invasion	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; AKAP SIGNALING COMPLEXES; ALPHA SUBUNIT; EPAC PROTEINS; LEADING-EDGE; PKA; METASTASIS; INVASIVENESS; ACTIVATION; DYNAMICS	Epithelial ovarian cancer (EOC) is the deadliest of the gynecological malignancies, due in part to its clinically occult metastasis. Therefore, understanding the mechanisms governing EOC dissemination and invasion may provide new targets for antimetastatic therapies or new methods for detection of metastatic disease. The cAMP-dependent protein kinase (PKA) is often dysregulated in EOC. Furthermore, PKA activity and subcellular localization by A-kinase anchoring proteins (AKAPs) are important regulators of cytoskeletal dynamics and cell migration. Thus, we sought to study the role of PKA and AKAP function in both EOC cell migration and invasion. Using the plasma membrane-directed PKA biosensor, pmAKAR3, and an improved migration/invasion assay, we show that PKA is activated at the leading edge of migrating SKOV-3 EOC cells, and that inhibition of PKA activity blocks SKOV-3 cell migration. Furthermore, we show that while the PKA activity within the leading edge of these cells is mediated by anchoring of type-II regulatory PKA subunits (RII), inhibition of anchoring of either RI or RII PKA subunits blocks cell migration. Importantly, we also show - for the first time - that PKA activity is up-regulated at the leading edge of SKOV-3 cells during invasion of a three-dimensional extracellular matrix and, as seen for migration, inhibition of either PKA activity or AKAP-mediated PKA anchoring blocks matrix invasion. These data are the first to demonstrate that the invasion of extracellular matrix by cancer cells elicits activation of PKA within the invasive leading edge and that both PKA activity and anchoring are required for matrix invasion. These observations suggest a role for PKA and AKAP activity in EOC metastasis.	[McKenzie, Andrew J.; Howe, Alan K.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [McKenzie, Andrew J.; Campbell, Shirley L.; Howe, Alan K.] Univ Vermont, Coll Med, Vermont Canc Ctr, Burlington, VT USA	University of Vermont; University of Vermont	McKenzie, AJ (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA.	Alan.Howe@uvm.edu			National Institutes of Health/National Institute of General Medical Sciences [R01GM074204]; Vermont Cancer Center; Lake Champlain Cancer Research Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097495, R01GM074204] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vermont Cancer Center; Lake Champlain Cancer Research Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant #R01GM074204 (to AKH) from the National Institutes of Health/National Institute of General Medical Sciences (http://www.nigms.nih.gov) and from a postdoctoral fellowship (to SLC) from the Vermont Cancer Center and Lake Champlain Cancer Research Organization (http://www.vermontcancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Alper O, 1999, ONCOGENE, V18, P4999, DOI 10.1038/sj.onc.1202830; Bai F, 2006, INT J GYNECOL CANCER, V16, P202, DOI 10.1111/j.1525-1438.2006.00296.x; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; Cheadle C, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-43; ChoChung YS, 1995, CRIT REV ONCOL HEMAT, V21, P33, DOI 10.1016/1040-8428(94)00166-9; Choi JH, 2006, CANCER RES, V66, P3912, DOI 10.1158/0008-5472.CAN-05-1785; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Dabizzi S, 2003, CANCER RES, V63, P4281; Deming PB, 2008, J BIOL CHEM, V283, P35199, DOI 10.1074/jbc.M804448200; Diviani D, 2001, J CELL SCI, V114, P1431; Dutta S, 2010, CANCER BIOL THER, V9, P668, DOI 10.4161/cbt.9.9.11610; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Estecha A, 2009, J CELL SCI, V122, P3492, DOI 10.1242/jcs.053157; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fernando HS, 2008, J UROLOGY, V180, P1515, DOI 10.1016/j.juro.2008.06.004; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gilles C, 1999, J CELL SCI, V112, P4615; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gubbels JAA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-8; Hanprasertpong J, 2011, EUR J CANCER CARE, V20, P287, DOI 10.1111/j.1365-2354.2010.01224.x; Hasegawa K, 2004, INT J CANCER, V108, P86, DOI 10.1002/ijc.11565; Hochbaum D, 2011, J BIOL CHEM, V286, P859, DOI 10.1074/jbc.M110.163816; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; HOWE AK, 2011, CURR OPIN C IN PRESS, V23; Hundsrucker C, 2006, BIOCHEM SOC T, V34, P472, DOI 10.1042/BST0340472; Iwashita S, 2004, BIOCHEM BIOPH RES CO, V320, P1063, DOI 10.1016/j.bbrc.2004.06.067; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones SL, 2005, J LEUKOCYTE BIOL, V78, P248, DOI 10.1189/jlb.0804459; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Lyle KS, 2008, CELL SIGNAL, V20, P1104, DOI 10.1016/j.cellsig.2008.01.018; Mai PL, 2011, CANCER PREV RES, V4, P303, DOI 10.1158/1940-6207.CAPR-11-0053; McDaid HM, 1999, BRIT J CANCER, V79, P933, DOI 10.1038/sj.bjc.6690149; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Ni Q, 2006, METHODS, V40, P279, DOI 10.1016/j.ymeth.2006.06.013; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Pignata S, 2011, CANCER LETT, V303, P73, DOI 10.1016/j.canlet.2011.01.026; Ramirez I, 2011, CANCER CONTROL, V18, P22, DOI 10.1177/107327481101800104; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rivard RL, 2009, CELL MOTIL CYTOSKEL, V66, P693, DOI 10.1002/cm.20399; Sabbisetti VS, 2005, INT J CANCER, V117, P551, DOI 10.1002/ijc.21158; Schafer C, 2010, CELL ADHES MIGR, V4, P215, DOI 10.4161/cam.4.2.10745; Sharma S, 2005, GYNECOL ONCOL, V99, P183, DOI 10.1016/j.ygyno.2005.06.006; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xia W, 2001, CANCER RES, V61, P5644; Ydrenius L, 1997, BIOCHEM BIOPH RES CO, V235, P445, DOI 10.1006/bbrc.1997.6822; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; YOUNG MRI, 1995, INT J CANCER, V61, P104, DOI 10.1002/ijc.2910610118; Zhang DL, 2010, MOL CELL BIOCHEM, V335, P1, DOI 10.1007/s11010-009-0234-y	71	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26552	10.1371/journal.pone.0026552	http://dx.doi.org/10.1371/journal.pone.0026552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028904	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500088
J	Quiroz, TS; Nieto, PA; Tobar, HE; Salazar-Echegarai, FJ; Lizana, RJ; Quezada, CP; Santiviago, CA; Araya, DV; Riedel, CA; Kalergis, AM; Bueno, SM				Quiroz, Tania S.; Nieto, Pamela A.; Tobar, Hugo E.; Salazar-Echegarai, Francisco J.; Lizana, Rodrigo J.; Quezada, Carolina P.; Santiviago, Carlos A.; Araya, Daniela V.; Riedel, Claudia A.; Kalergis, Alexis M.; Bueno, Susan M.			Excision of an Unstable Pathogenicity Island in Salmonella enterica Serovar Enteritidis Is Induced during Infection of Phagocytic Cells	PLOS ONE			English	Article							PRECISE EXCISION; VIBRIO-CHOLERAE; IDENTIFICATION; EVOLUTIONARY; RESISTANCE; INTEGRASE; MUTATIONS; DELETION; PROTEIN; TET	The availability of the complete genome sequence of several Salmonella enterica serovars has revealed the presence of unstable genetic elements in these bacteria, such as pathogenicity islands and prophages. This is the case of Salmonella enterica serovar Enteritidis (S. Enteritidis), a bacterium that causes gastroenteritis in humans and systemic infection in mice. The whole genome sequence analysis for S. Enteritidis unveiled the presence of several genetic regions that are absent in other Salmonella serovars. These regions have been denominated "regions of difference'' (ROD). In this study we show that ROD21, one of such regions, behaves as an unstable pathogenicity island. We observed that ROD21 undergoes spontaneous excision by two independent recombination events, either under laboratory growth conditions or during infection of murine cells. Importantly, we also found that one type of excision occurred at higher rates when S. Enteritidis was residing inside murine phagocytic cells. These data suggest that ROD21 is an unstable pathogenicity island, whose frequency of excision depends on the environmental conditions found inside phagocytic cells.	[Quiroz, Tania S.; Nieto, Pamela A.; Tobar, Hugo E.; Salazar-Echegarai, Francisco J.; Lizana, Rodrigo J.; Araya, Daniela V.; Kalergis, Alexis M.; Bueno, Susan M.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Quezada, Carolina P.; Santiviago, Carlos A.] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Riedel, Claudia A.] Univ Andres Bello, Millennium Inst Immunol & Immunotherapy, Fac Ciencias Biol, Santiago, Chile; [Riedel, Claudia A.] Univ Andres Bello, Millennium Inst Immunol & Immunotherapy, Fac Med, Santiago, Chile; [Kalergis, Alexis M.] Pontificia Univ Catolica Chile, Fac Med, Dept Reumatol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad Andres Bello; Universidad Andres Bello; Pontificia Universidad Catolica de Chile	Quiroz, TS (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Inst Immunol & Immunotherapy, Alameda 340, Santiago, Chile.	sbueno@bio.puc.cl	Quezada, Carolina Paz/AAG-1981-2019; Santiviago, Carlos/N-9991-2018	Quezada, Carolina Paz/0000-0002-0260-5754; Santiviago, Carlos/0000-0002-7043-7908; Kalergis, Alexis/0000-0001-7622-5263; Bueno, Susan M./0000-0002-7551-8088; Salazar-Echegarai, Francisco/0000-0001-6709-699X; Riedel, Claudia/0000-0001-6168-8601	FONDEYT [11075060, 1070352, 1050979, 1040349, 1100971, 1100092, SavinMuco-Path-INCO-CT-2006-032296]; IFS [B/3764-1]; Anillo [ADI-08/2006, VRAID-INICIO 20/2007, Red 15 PBCT]; Millennium Nucleus on Immunology and Immunotherapy [P-07-088-F]	FONDEYT; IFS(International Foundation for Science); Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Millennium Nucleus on Immunology and Immunotherapy	Support for this study was provided by: FONDEYT n<SUP>o</SUP> 11075060, FONDECYT n<SUP>o</SUP> 1070352, FONDECYT n<SUP>o</SUP> 1050979, FONDECYT n<SUP>o</SUP> 1040349, FONDECYT 1100971, FONDECYT 1100092, SavinMuco-Path-INCO-CT-2006-032296; IFS#B/3764-1, Anillo ADI-08/2006, VRAID-INICIO 20/2007, Red 15 PBCT, and Millennium Nucleus on Immunology and Immunotherapy (P-07-088-F). HET and PAN are CONICYT Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-306; Araya DV, 2010, VACCINE, V28, P5458, DOI 10.1016/j.vaccine.2010.05.073; Bach S, 1999, INFECT IMMUN, V67, P5091, DOI 10.1128/IAI.67.10.5091-5099.1999; Banks DJ, 2003, INFECT IMMUN, V71, P7079, DOI 10.1128/IAI.71.12.7079-7086.2003; Bueno SM, 2004, J BACTERIOL, V186, P3202, DOI 10.1128/JB.186.10.3202-3213.2004; Bueno SM, 2008, IMMUNOLOGY, V124, P522, DOI 10.1111/j.1365-2567.2008.02805.x; Cotter PA, 2000, ANNU REV MICROBIOL, V54, P519, DOI 10.1146/annurev.micro.54.1.519; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Guard-Petter J, 2001, ENVIRON MICROBIOL, V3, P421, DOI 10.1046/j.1462-2920.2001.00213.x; Hidalgo AA, 2004, GENETICS, V167, P1069, DOI 10.1534/genetics.104.026682; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kobayashi H, 2005, J FOOD PROTECT, V68, P932, DOI 10.4315/0362-028X-68.5.932; Lesic B, 2005, J BACTERIOL, V187, P3352, DOI 10.1128/JB.187.10.3352-3358.2005; Lesic B, 2004, MOL MICROBIOL, V52, P1337, DOI 10.1111/j.1365-2958.2004.04073.x; Lovell HC, 2009, CURR BIOL, V19, P1586, DOI 10.1016/j.cub.2009.08.018; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Manson JM, 2006, MOL MICROBIOL, V61, P555, DOI 10.1111/j.1365-2958.2006.05262.x; MCMURRY LM, 1992, J BACTERIOL, V174, P6294, DOI 10.1128/JB.174.19.6294-6297.1992; Middendorf B, 2004, J BACTERIOL, V186, P3086, DOI 10.1128/JB.186.10.3086-3096.2004; MOYED HS, 1983, J BACTERIOL, V155, P549, DOI 10.1128/JB.155.2.549-556.1983; MOYED HS, 1983, J BACTERIOL, V155, P557, DOI 10.1128/JB.155.2.557-564.1983; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Porwollik S, 2005, J BACTERIOL, V187, P6545, DOI 10.1128/JB.187.18.6545-6555.2005; Ramsay JP, 2009, MOL MICROBIOL, V73, P1141, DOI 10.1111/j.1365-2958.2009.06843.x; Sambrook J., 1982, MOL CLONING LAB MANU, P545; Santiviago CA, 2010, J BACTERIOL, V192, P2246, DOI 10.1128/JB.00270-09; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Turner SA, 2001, J BACTERIOL, V183, P5535, DOI 10.1128/JB.183.19.5535-5543.2001; Williamson HS, 2005, MOL MICROBIOL, V55, P808, DOI 10.1111/j.1365-2958.2004.04421.x	35	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26031	10.1371/journal.pone.0026031	http://dx.doi.org/10.1371/journal.pone.0026031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039432	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500028
J	Sieber, MW; Claus, RA; Witte, OW; Frahm, C				Sieber, Matthias W.; Claus, Ralf A.; Witte, Otto W.; Frahm, Christiane			Attenuated Inflammatory Response in Aged Mice Brains following Stroke	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; IMMUNE-SYSTEM; RAT-BRAIN; FOCAL ISCHEMIA; YOUNG-RATS; INJURY; CYTOKINES; EXPRESSION	Background: Increased age is a major risk factor for stroke incidence, post-ischemic mortality, and severe and long-term disability. Stroke outcome is considerably influenced by post-ischemic mechanisms. We hypothesized that the inflammatory response following an ischemic injury is altered in aged organisms. Methods and Results: To that end, we analyzed the expression pattern of pro-inflammatory cytokines (TNF, IL-1 alpha, IL-1 beta, IL-6), anti-inflammatory cytokines (IL-10, TGF beta 1), and chemokines (Mip-1 alpha, MCP-1, RANTES) of adult (2 months) and aged (24 months) mice brains at different reperfusion times (6 h, 12 h, 24 h, 2 d, 7 d) following transient occlusion of the middle cerebral artery. The infarct size was assessed to monitor possible consequences of an altered inflammatory response in aged mice. Our data revealed an increased neuro-inflammation with age. Above all, we found profound age-related alterations in the reaction to stroke. The response of pro-inflammatory cytokines (TNF, and IL-1 beta) and the level of chemokines (Mip-1 alpha, and MCP-1) were strongly diminished in the aged post-ischemic brain tissue. IL-6 showed the strongest age-dependent decrease in its post-ischemic expression profile. Anti-inflammatory cytokines (TGF beta 1, and IL-10) revealed no significant age dependency after ischemia. Aged mice brains tend to develop smaller infarcts. Conclusion: The attenuated inflammatory response to stroke in aged animals may contribute to their smaller infarcts. The results presented here highlight the importance of using aged animals to investigate age-associated diseases like stroke, and should be considered as a major prerequisite in the development of age-adjusted therapeutic interventions.	[Sieber, Matthias W.; Witte, Otto W.; Frahm, Christiane] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Thuringia, Germany; [Sieber, Matthias W.; Claus, Ralf A.] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Thuringia, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Sieber, MW (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Thuringia, Germany.	Otto.Witte@med.uni-jena.de	Witte, Otto/P-4127-2018; Claus, Ralf A./Q-4035-2016	Witte, Otto/0000-0003-2101-4105; Claus, Ralf A./0000-0001-7232-4088	European Union [LSHB-CT-2006-018936]; Jena centre for systems biology of ageing - Jenage [BMBF 0315581]	European Union(European Commission); Jena centre for systems biology of ageing - Jenage	The study was funded by the European Union (STREP, FP6, 'Age-dependent inflammatory response after stroke' - ARGES [LSHB-CT-2006-018936]) and is part of the research program of the Jena centre for systems biology of ageing - Jenage (BMBF 0315581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Barone FC, 2006, CLIN NEUROSCI RES, V6, P329, DOI 10.1016/j.cnr.2006.09.010; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Campuzano O, 2009, J NEUROSCI RES, V87, P2484, DOI 10.1002/jnr.22074; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; DiNapoli VA, 2010, NEUROSCIENCE, V170, P633, DOI 10.1016/j.neuroscience.2010.07.011; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Doyle KP, J NEUROINFLAMMATION, V7, P62; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; Engelter ST, 2003, CEREBROVASC DIS, V15, P188, DOI 10.1159/000068826; Felzien LK, 2001, BRAIN RES, V890, P137, DOI 10.1016/S0006-8993(00)03090-0; Feuerstein GZ, 2001, ARCH NEUROL-CHICAGO, V58, P672, DOI 10.1001/archneur.58.4.672; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Lee JC, 2009, J NEUROTRAUM, V26, P1567, DOI 10.1089/neu.2008.0630; Lee WH, 2010, NEUROSCI LETT, V476, P89, DOI 10.1016/j.neulet.2010.04.009; Makinodan T, 1980, Adv Immunol, V29, P287, DOI 10.1016/S0065-2776(08)60047-4; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; Perera MN, 2006, J CLIN NEUROSCI, V13, P1, DOI 10.1016/j.jocn.2005.07.005; Petcu EB, 2008, GERONTOLOGY, V54, P6, DOI 10.1159/000112845; Planas AM, 2006, BIOCHEM SOC T, V34, P1267, DOI 10.1042/BST0341267; Popa-Wagner A, 1998, STROKE, V29, P2196, DOI 10.1161/01.STR.29.10.2196; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Rosen CL, 2005, J NEUROSURG, V103, P687, DOI 10.3171/jns.2005.103.4.0687; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Saposnik G, 2009, STROKE, V40, P3328, DOI 10.1161/STROKEAHA.109.558759; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229, DOI 10.1007/s004010050792; Sieber MW, 2010, NEUROBIOL AGING, V31, P654, DOI 10.1016/j.neurobiolaging.2008.05.023; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Takami S, 2001, J CEREBR BLOOD F MET, V21, P1430, DOI 10.1097/00004647-200112000-00007; Terao S, 2008, STROKE, V39, P2560, DOI 10.1161/STROKEAHA.107.513150; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; Whitaker JN, 2001, ARCH NEUROL-CHICAGO, V58, P674, DOI 10.1001/archneur.58.4.674; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhao CS, 2005, BEHAV BRAIN RES, V156, P85, DOI 10.1016/j.bbr.2004.05.011; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	57	74	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26288	10.1371/journal.pone.0026288	http://dx.doi.org/10.1371/journal.pone.0026288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028848	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900042
J	Mausberg, AK; Horste, GMZ; Dehmel, T; Stettner, M; Lehmann, HC; Sheikh, KA; Kieseier, BC				Mausberg, Anne K.; Hoerste, Gerd Meyer Zu; Dehmel, Thomas; Stettner, Mark; Lehmann, Helmar C.; Sheikh, Kazim A.; Kieseier, Bernd C.			Erythropoietin Ameliorates Rat Experimental Autoimmune Neuritis by Inducing Transforming Growth Factor-Beta in Macrophages	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; PERIPHERAL-NERVE; TGF-BETA-1; SYSTEM; ENCEPHALOMYELITIS; INFLAMMATION; PROTECTION; CELLS	Erythropoietin (EPO) is a pleiotropic cytokine originally identified for its role in erythropoiesis. In addition, in various preclinical models EPO exhibited protective activity against tissue injury. There is an urgent need for potent treatments of autoimmune driven disorders of the peripheral nervous system (PNS), such as the Guillain-Barre syndrome (GBS), a disabling autoimmune disease associated with relevant morbidity and mortality. To test the therapeutic potential of EPO in experimental autoimmune neuritis (EAN) - an animal model of human GBS - immunological and clinical effects were investigated in a preventive and a therapeutic paradigm. Treatment with EPO reduced clinical disease severity and if given therapeutically also shortened the recovery phase of EAN. Clinical findings were mirrored by decreased inflammation within the peripheral nerve, and myelin was well maintained in treated animals. In contrast, EPO increased the number of macrophages especially in later stages of the experimental disease phase. Furthermore, the anti-inflammatory cytokine transforming growth factor (TGF)-beta was upregulated in the treated cohorts. In vitro experiments revealed less proliferation of T cells in the presence of EPO and TGF-beta was moderately induced, while the secretion of other cytokines was almost not altered by EPO. Our data suggest that EPO revealed its beneficial properties by the induction of beneficial macrophages and the modulation of the immune system towards anti-inflammatory responses in the PNS. Further studies are warranted to elaborate the clinical usefulness of EPO for treating immune-mediated neuropathies in affected patients.	[Mausberg, Anne K.; Hoerste, Gerd Meyer Zu; Dehmel, Thomas; Stettner, Mark; Lehmann, Helmar C.; Kieseier, Bernd C.] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Sheikh, Kazim A.] Univ Texas Med Sch Houston, Dept Neurol, Houston, TX USA	Heinrich Heine University Dusseldorf; University of Texas System; University of Texas Health Science Center Houston	Mausberg, AK (corresponding author), Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany.	mausberg@uni-duesseldorf.de	Lehmann, Helmar C/G-4998-2016; Horste, Gerd Meyer zu/O-9549-2016; Stettner, Mark/GQY-7516-2022	Lehmann, Helmar C/0000-0001-6205-2293; Horste, Gerd Meyer zu/0000-0002-4341-4719; Mausberg, Anne K/0000-0001-9026-1703	GBS/CIDP Foundation International	GBS/CIDP Foundation International	Part of this study was supported by the GBS/CIDP Foundation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Brines M, 2006, ERYTHROPOIETIN AND THE NERVOUS SYSTEM: NOVEL THERAPEUTIC OPTIONS FOR NEUROPROTECTION, P147, DOI 10.1007/978-0-387-30011-5_9; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; CRAGGS RI, 1984, ACTA NEUROPATHOL, V62, P316, DOI 10.1007/BF00687614; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; FORTIER AH, 2001, CURR PROTOC IMMUNOL; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GRIFFIN JW, 2005, PERIPHERAL NEUROPATH, P2197; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; JOHNS LD, 1993, J NEUROIMMUNOL, V47, P1, DOI 10.1016/0165-5728(93)90278-7; Jung S, 1995, NEUROSCI LETT, V200, P167, DOI 10.1016/0304-3940(95)12115-K; JUNG S, 1993, J NEUROL SCI, V119, P195, DOI 10.1016/0022-510X(93)90134-K; KADLUBOWSKI M, 1980, J NEUROL SCI, V48, P171, DOI 10.1016/0022-510X(80)90198-7; Kiefer R, 1996, AM J PATHOL, V148, P211; Kiefer R, 1998, BRAIN, V121, P469, DOI 10.1093/brain/121.3.469; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2000, J NEUROIMMUNOL, V110, P121, DOI 10.1016/S0165-5728(00)00323-4; King CE, 2007, EXP NEUROL, V205, P48, DOI 10.1016/j.expneurol.2007.01.017; Lehmann HC, 2007, J NEUROSCI, V27, P27, DOI 10.1523/JNEUROSCI.4017-06.2007; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Shaheen MA, 2009, HEMATOLOGY BASIC PRI, P253; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; THORBECKE GJ, 1992, P NATL ACAD SCI USA, V89, P7375, DOI 10.1073/pnas.89.16.7375; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; 2007, LANCET NEUROL, V6, P589	36	28	30	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26280	10.1371/journal.pone.0026280	http://dx.doi.org/10.1371/journal.pone.0026280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043313	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400041
J	Acosta, A; Hurtado, MD; Gorbatyuk, O; La Sala, M; Duncan, D; Aslanidi, G; Campbell-Thompson, M; Zhang, L; Herzog, H; Voutetakis, A; Baum, BJ; Zolotukhin, S				Acosta, Andres; Hurtado, Maria D.; Gorbatyuk, Oleg; La Sala, Michael; Duncan, David; Aslanidi, George; Campbell-Thompson, Martha; Zhang, Lei; Herzog, Herbert; Voutetakis, Antonis; Baum, Bruce J.; Zolotukhin, Sergei			Salivary PYY: A Putative Bypass to Satiety	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; TASTE SENSITIVITY; EXPRESSION; RECEPTOR; GLANDS; MICE; LEPTIN; SECRETION; CELLS; CHOLECYSTOKININ	Peptide YY3-36 is a satiation hormone released postprandially into the bloodstream from L-endocrine cells in the gut epithelia. In the current report, we demonstrate PYY3-36 is also present in murine as well as in human saliva. In mice, salivary PYY3-36 derives from plasma and is also synthesized in the taste cells in taste buds of the tongue. Moreover, the cognate receptor Y2R is abundantly expressed in the basal layer of the progenitor cells of the tongue epithelia and von Ebner's gland. The acute augmentation of salivary PYY3-36 induced stronger satiation as demonstrated in feeding behavioral studies. The effect is mediated through the activation of the specific Y2 receptor expressed in the lingual epithelial cells. In a longterm study involving diet-induced obese (DIO) mice, a sustained increase in PYY3-36 was achieved using viral vector-mediated gene delivery targeting salivary glands. The chronic increase in salivary PYY3-36 resulted in a significant long-term reduction in food intake (FI) and body weight (BW). Thus this study provides evidence for new functions of the previously characterized gut peptide PYY3-36 suggesting a potential simple and efficient alternative therapeutic approach for the treatment of obesity.	[Acosta, Andres; Hurtado, Maria D.; Gorbatyuk, Oleg; La Sala, Michael; Duncan, David; Aslanidi, George; Campbell-Thompson, Martha; Zolotukhin, Sergei] Univ Florida, Gainesville, FL 32611 USA; [Zhang, Lei; Herzog, Herbert] Garvan Inst Med Res, Sydney, NSW, Australia; [Voutetakis, Antonis; Baum, Bruce J.] NIDCR, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA	State University System of Florida; University of Florida; Garvan Institute of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Acosta, A (corresponding author), Univ Florida, Gainesville, FL 32611 USA.	szlt@ufl.edu	/B-6258-2012; Herzog, Herbert/B-8294-2008; Campbell-Thompson, Martha/A-7584-2010; Aslanidi, George/C-5680-2019	Hurtado, Maria Daniela/0000-0002-2322-7334; Campbell-Thompson, Martha/0000-0001-6878-1235; Duncan, David/0000-0003-2768-576X; , Herbert/0000-0002-1713-1029; Aslanidi, George/0000-0002-2726-8627	NIH/NIDDK [1R01DK62302-01]; The Division of Intramural Research of the National Institute of Dental and Craniofacial Research; NHMRC of Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062302] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); The Division of Intramural Research of the National Institute of Dental and Craniofacial Research; NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by the following: SZ - 1R01DK62302-01 (NIH/NIDDK); BB - The Division of Intramural Research of the National Institute of Dental and Craniofacial Research in part supported this research, HH is funded by a NHMRC of Australia Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi G, 2007, AM J PHYSIOL-ENDOC M, V293, pE726, DOI 10.1152/ajpendo.00248.2007; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; BOHORQUEZ DV, J MOL HISTOL; Castle D, 1998, CRIT REV ORAL BIOL M, V9, P4, DOI 10.1177/10454411980090010301; Chen ZW, 2001, FEBS LETT, V492, P119, DOI 10.1016/S0014-5793(01)02234-7; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Doods H, 1999, EUR J PHARMACOL, V384, pR3, DOI 10.1016/S0014-2999(99)00650-0; Elson AET, 2010, FASEB J, V24, P3960, DOI 10.1096/fj.10-158105; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Groschl M, 2005, CLIN CHEM, V51, P997, DOI 10.1373/clinchem.2004.040667; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; HERNESS MS, 1989, NEUROSCIENCE, V33, P411, DOI 10.1016/0306-4522(89)90220-0; Herness S, 2002, J NEUROSCI, V22, P10018; Hoque ATMS, 2001, J DRUG TARGET, V9, P485, DOI 10.3109/10611860108998782; Katano H, 2006, GENE THER, V13, P594, DOI 10.1038/sj.gt.3302691; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Keire DA, 2008, REGUL PEPTIDES, V151, P61, DOI 10.1016/j.regpep.2008.04.001; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Michlig S, 2007, J COMP NEUROL, V502, P1003, DOI 10.1002/cne.21354; Morimoto R, 2008, NUTRITION, V24, P878, DOI 10.1016/j.nut.2008.06.011; Nguyen CQ, 2007, J IMMUNOL, V179, P2318, DOI 10.4049/jimmunol.179.4.2318; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Raimondi AR, 2006, AM J PATHOL, V168, P1654, DOI 10.2353/ajpath.2006.050847; SAHARA N, 1984, CELL TISSUE RES, V235, P427; Seta Y, 2006, ARCH HISTOL CYTOL, V69, P273, DOI 10.1679/aohc.69.273; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Tang SC, 2003, BIOCHEM BIOPH RES CO, V303, P645, DOI 10.1016/S0006-291X(03)00399-1; Toda M, 2007, ACTA DIABETOL, V44, P20, DOI 10.1007/s00592-007-0236-8; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Tschop M, 2004, NATURE, V430, DOI 10.1038/nature02665; VALLEJO G, 1984, DIABETOLOGIA, V27, P437, DOI 10.1007/BF00273907; Voutetakis A, 2004, P NATL ACAD SCI USA, V101, P3053, DOI 10.1073/pnas.0400136101; Wang JH, 2005, HUM GENE THER, V16, P571, DOI 10.1089/hum.2005.16.571; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	42	38	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26137	10.1371/journal.pone.0026137	http://dx.doi.org/10.1371/journal.pone.0026137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028819	gold, Green Published, Green Submitted			2022-12-25	WOS:000295971700043
J	Catalano-Dupuy, DL; Musumeci, MA; Lopez-Rivero, A; Ceccarelli, EA				Catalano-Dupuy, Daniela L.; Musumeci, Matias A.; Lopez-Rivero, Arleth; Ceccarelli, Eduardo A.			A Highly Stable Plastidic-Type Ferredoxin-NADP(H) Reductase in the Pathogenic Bacterium Leptospira interrogans	PLOS ONE			English	Article							CATALYTIC EFFICIENCY; ELECTRON-TRANSFER; HEME OXYGENASE; BINDING-SITE; ISOPRENOID BIOSYNTHESIS; PSEUDOMONAS-AERUGINOSA; AZOTOBACTER-VINELANDII; PLASMODIUM-FALCIPARUM; 2FE-2S FERREDOXIN; COMPLEX-FORMATION	Leptospira interrogans is a bacterium that is capable of infecting animals and humans, and its infection causes leptospirosis with a range of symptoms from flu-like to severe illness and death. Despite being a bacteria, Leptospira interrogans contains a plastidic class ferredoxin-NADP(H) reductase (FNR) with high catalytic efficiency, at difference from the bacterial class FNRs. These flavoenzymes catalyze the electron transfer between NADP(H) and ferredoxins or flavodoxins. The inclusion of a plastidic FNR in Leptospira metabolism and in its parasitic life cycle is not currently understood. Bioinformatic analyses of the available genomic and proteins sequences showed that the presence of this enzyme in nonphotosynthetic bacteria is restricted to the Leptospira genus and that a [4Fe-4S] ferredoxin (LB107) encoded by the Leptospira genome may be the natural substrate of the enzyme. Leptospira FNR (LepFNR) displayed high diaphorase activity using artificial acceptors and functioned as a ferric reductase. LepFNR displayed cytochrome c reductase activity with the Leptospira LB107 ferredoxin with an optimum at pH 6.5. Structural stability analysis demonstrates that LepFNR is one of the most stable FNRs analyzed to date. The persistence of a native folded LepFNR structure was detected in up to 6 M urea, a condition in which the enzyme retains 38% activity. In silico analysis indicates that the high LepFNR stability might be due to robust interactions between the FAD and the NADP(+) domains of the protein. The limited bacterial distribution of plastidic class FNRs and the biochemical and structural properties of LepFNR emphasize the uniqueness of this enzyme in the Leptospira metabolism. Our studies show that in L. interrogans a plastidic-type FNR exchanges electrons with a bacterial-type ferredoxin, process which has not been previously observed in nature.	[Catalano-Dupuy, Daniela L.; Musumeci, Matias A.; Lopez-Rivero, Arleth; Ceccarelli, Eduardo A.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR,CONICET, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Catalano-Dupuy, DL (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR,CONICET, RA-2000 Rosario, Santa Fe, Argentina.	ceccarelli@ibr.gov.ar	Ceccarelli, Eduardo A./V-2600-2019; Ceccarelli, Eduardo A./M-8699-2014	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306; Lopez-Rivero, Arleth S./0000-0002-0859-0418; Musumeci, Matias/0000-0003-2358-1365; Catalano-Dupuy, Daniela L./0000-0003-2864-0133	ANCYPT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina [PICT-2007 01-00645, 00739]; CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 252, 114-200901-00337]; Fundacion Bunge y Born, Argentina [FBBEI2/08]; University of Rosario, Argentina [BIO187]	ANCYPT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Bunge y Born, Argentina; University of Rosario, Argentina	This work was supported by grants PICT-2007 01-00645 and 00739, ANCYPT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina (www.agencia.mincyt.gov.ar); PIP 252 and 114-200901-00337 from CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (www.conicet.gov.ar); FBBEI2/08 from Fundacion Bunge y Born, Argentina (http://www.fundacionbyb.org); and BIO187 from the University of Rosario, Argentina (www.unr.edu.ar.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Aliverti A, 2004, BBA-PROTEINS PROTEOM, V1696, P93, DOI 10.1016/j.bbapap.2003.09.011; Aliverti A, 2008, ARCH BIOCHEM BIOPHYS, V474, P283, DOI 10.1016/j.abb.2008.02.014; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Catalano-Dupuy DL, 2006, BIOCHEMISTRY-US, V45, P13899, DOI 10.1021/bi061152v; Catalano-Dupuy DL, 2008, FLAVINS FLAVOPROTEIN, P249; Ceccarelli EA, 2004, BBA-PROTEINS PROTEOM, V1698, P155, DOI 10.1016/j.bbapap.2003.12.005; CHANG SL, 1948, J INFECT DIS, V82, P256, DOI 10.1093/infdis/82.3.256; Chatelet C, 1999, BIOCHEM BIOPH RES CO, V261, P885, DOI 10.1006/bbrc.1999.1138; Elsen S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-271; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Hermoso JA, 2002, J MOL BIOL, V319, P1133, DOI 10.1016/S0022-2836(02)00388-1; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung YS, 1999, J BIOL CHEM, V274, P2978, DOI 10.1074/jbc.274.5.2978; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Karplus PA, 2004, PHOTOSYNTH RES, V81, P303, DOI 10.1023/B:PRES.0000036884.57303.2e; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kimata-Ariga Y, 2007, J BIOCHEM, V141, P421, DOI 10.1093/jb/mvm046; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee YH, 2007, J BIOL CHEM, V282, P5959, DOI 10.1074/jbc.M608417200; Liang XY, 2010, BIOPHYS J, V99, P273, DOI 10.1016/j.bpj.2010.04.002; Maeda M, 2002, J BIOL CHEM, V277, P17101, DOI 10.1074/jbc.M112002200; Martinez-Julvez M, 1998, BIOCHEMISTRY-US, V37, P13604, DOI 10.1021/bi9807411; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Medina M, 2009, FEBS J, V276, P3942, DOI 10.1111/j.1742-4658.2009.07122.x; Miethke M, 2011, J BIOL CHEM, V286, P2245, DOI 10.1074/jbc.M110.192468; Milani M, 2007, J MOL BIOL, V367, P501, DOI 10.1016/j.jmb.2007.01.005; Mohamed ME, 2001, J BACTERIOL, V183, P1899, DOI 10.1128/JB.183.6.1899-1908.2001; Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010; Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014; Musumeci MA, 2011, BIOCHEMISTRY-US, V50, P2111, DOI 10.1021/bi101772a; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nascimento AS, 2006, ACTA CRYSTALLOGR F, V62, P662, DOI 10.1107/S1744309106020136; Nascimento AS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-69; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Okada K, 2005, J BIOL CHEM, V280, P20672, DOI 10.1074/jbc.M500865200; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Paladini DH, 2009, BIOCHEMISTRY-US, V48, P5760, DOI 10.1021/bi9004232; Pandini V, 2006, BIOCHEMISTRY-US, V45, P3563, DOI 10.1021/bi052326w; Pandini V, 2002, J BIOL CHEM, V277, P48463, DOI 10.1074/jbc.M209388200; Pereira MM, 2002, BBA-PROTEINS PROTEOM, V1601, P1, DOI 10.1016/S1570-9639(02)00406-5; Privalov Peter L., 1992, P83; Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280; Peregrina JR, 2010, BBA-BIOENERGETICS, V1797, P1638, DOI 10.1016/j.bbabio.2010.05.006; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Rohrich RC, 2005, FEBS LETT, V579, P6433, DOI 10.1016/j.febslet.2005.10.037; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos J, 2007, BIOPHYS J, V93, P1707, DOI 10.1529/biophysj.106.103804; Seeber F, 2005, CURR PHARM DESIGN, V11, P3159, DOI 10.2174/1381612054864957; Seeber Frank, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P99, DOI 10.2174/1568008033340261; Shukla N, 2005, FEBS J, V272, P2216, DOI 10.1111/j.1742-4658.2005.2005.04645.x; Singh K, 2008, PROTEINS, V71, P1879, DOI 10.1002/prot.21872; Singh K, 2009, J BIOCHEM, V145, P721, DOI 10.1093/jb/mvp029; Takeda K, 2010, BIOMETALS, V23, P727, DOI 10.1007/s10534-010-9339-8; Thomsen-Zieger N, 2004, FEBS LETT, V576, P375, DOI 10.1016/j.febslet.2004.09.042; Trueba G, 2004, INT MICROBIOL, V7, P35; Vollmer M, 2001, J BIOL CHEM, V276, P5483, DOI 10.1074/jbc.M009452200; Wang A, 2007, BIOCHEMISTRY-US, V46, P12198, DOI 10.1021/bi7013135; Yeh AP, 2000, J MOL BIOL, V300, P587, DOI 10.1006/jmbi.2000.3871; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; Yoneyama H, 2006, BIOSCI BIOTECH BIOCH, V70, P1060, DOI 10.1271/bbb.70.1060; ZANETTI G, 1976, BIOCHIM BIOPHYS ACTA, V445, P14, DOI 10.1016/0005-2744(76)90157-1	69	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26736	10.1371/journal.pone.0026736	http://dx.doi.org/10.1371/journal.pone.0026736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039544	Green Submitted, Green Published, gold			2022-12-25	WOS:000296515200048
J	Kreshuk, A; Straehle, CN; Sommer, C; Koethe, U; Cantoni, M; Knott, G; Hamprecht, FA				Kreshuk, Anna; Straehle, Christoph N.; Sommer, Christoph; Koethe, Ullrich; Cantoni, Marco; Knott, Graham; Hamprecht, Fred A.			Automated Detection and Segmentation of Synaptic Contacts in Nearly Isotropic Serial Electron Microscopy Images	PLOS ONE			English	Article							NEURAL TISSUE; RANDOM FOREST; SYNAPSES; RECONSTRUCTION; CLASSIFICATION; VOLUME; SELECTION; NUMBER	We describe a protocol for fully automated detection and segmentation of asymmetric, presumed excitatory, synapses in serial electron microscopy images of the adult mammalian cerebral cortex, taken with the focused ion beam, scanning electron microscope (FIB/SEM). The procedure is based on interactive machine learning and only requires a few labeled synapses for training. The statistical learning is performed on geometrical features of 3D neighborhoods of each voxel and can fully exploit the high z-resolution of the data. On a quantitative validation dataset of 111 synapses in 409 images of 194861342 pixels with manual annotations by three independent experts the error rate of the algorithm was found to be comparable to that of the experts (0.92 recall at 0.89 precision). Our software offers a convenient interface for labeling the training data and the possibility to visualize and proofread the results in 3D. The source code, the test dataset and the ground truth annotation are freely available on the website http://www.ilastik.org/synapse-detection.	[Kreshuk, Anna; Straehle, Christoph N.; Sommer, Christoph; Koethe, Ullrich; Hamprecht, Fred A.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany; [Cantoni, Marco; Knott, Graham] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kreshuk, A (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany.	fred.hamprecht@iwr.uni-heidelberg.de	Cantoni, Marco/C-4227-2011	Cantoni, Marco/0000-0002-1356-9541; Kreshuk, Anna/0000-0003-1334-6388; Koethe, Ullrich/0000-0001-6036-1287; Knott, Graham W/0000-0002-2956-9052	Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences; Excellence Cluster Cellular Networks; SBcancer research initiatives; Robert Bosch GmbH; German Research Foundation (DFG) [HA-4364/6-1]	Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences; Excellence Cluster Cellular Networks; SBcancer research initiatives; Robert Bosch GmbH; German Research Foundation (DFG)(German Research Foundation (DFG))	Funding: The authors gratefully acknowledge partial funding by the Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences (http://mathcomp.uni-heidelberg.de/), by the Excellence Cluster Cellular Networks (http://www.cellnetworks.uni-hd.de/), by the ViroQuant (http://www.viroquant.uni-hd.de/) and SBcancer (http://www.dkfz.de/en/sbcancer/index.html) research initiatives, the Robert Bosch GmbH (http://www.bosch.com/worldsite_startpage/en/default.aspx) and the German Research Foundation (DFG, http://www.dfg.de/en/index.jsp) under grant no. HA-4364/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Geinisman Y, 1996, J NEUROCYTOL, V25, P805, DOI 10.1007/BF02284843; Guo L, 2004, 15TH INTERNATIONAL SYMPOSIUM ON SOFTWARE RELIABILITY ENGINEERING, PROCEEDINGS, P417; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Herold J, 2010, J BIOTECHNOL, V149, P299, DOI 10.1016/j.jbiotec.2010.03.004; Jain V, 2010, PROC CVPR IEEE, P2488, DOI 10.1109/CVPR.2010.5539950; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Jurrus E, 2010, MED IMAGE ANAL, V14, P770, DOI 10.1016/j.media.2010.06.002; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Kaynig V, 2010, PROC CVPR IEEE, P2902, DOI 10.1109/CVPR.2010.5540029; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kreshuk A, 2011, P ISBI CHIC IL US; Kubota Y, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.004.2009; Lucchi A, 2010, P MICCAI BEIJ CHIN; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; Narasimha R, 2009, PATTERN RECOGN, V42, P1067, DOI 10.1016/j.patcog.2008.08.009; Schmitz SK, J NEUROSCIENCE UNPUB; Schroeder W., 2006, VISUALIZATION TOOLKI, DOI DOI 10.1016/B978-012387582-2/50003-4; Sommer C, 2011, P ISBI CHIC IL US; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Turaga SC, 2009, P NIPS; Vazquez-Reina A, 2009, PROC CVPR IEEE, P2020, DOI 10.1109/CVPRW.2009.5206524	36	92	94	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e24899	10.1371/journal.pone.0024899	http://dx.doi.org/10.1371/journal.pone.0024899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031814	Green Submitted, gold, Green Published			2022-12-25	WOS:000296513200001
J	Stephens, R; Seddon, B; Langhorne, J				Stephens, Robin; Seddon, Benedict; Langhorne, Jean			Homeostatic Proliferation and IL-7R Alpha Expression Do Not Correlate with Enhanced T Cell Proliferation and Protection in Chronic Mouse Malaria	PLOS ONE			English	Article							PLASMODIUM-CHABAUDI-CHABAUDI; RECEPTOR-DEFICIENT MICE; PHENOTYPE CD8(+) CELLS; MEMORY CELLS; IMMUNOLOGICAL MEMORY; CD4; INTERLEUKIN-7; GENERATION; INFECTION; EXPANSION	While chronic infection has been shown to enhance protection from disease caused by several pathogens, the mechanisms are not known. The gamma-c family of cytokines IL-7, IL-2, and IL-15 are implicated in homeostatic proliferation, which is thought to maintain T cell memory. However in chronic infection, prolonged antigen exposure itself may contribute to lymphocyte survival. We have previously observed that chronic malaria infection enhances protection to re-infection, as well as enhancing B cell responses. Here, we show that chronic Plasmodium chabaudi malaria infection in mice enhances the expansion of CD4(+) T cells in a second infection, and that this correlates with increased expression of the IL-2/15 Receptor beta (CD122) on memory T cells, as well as increasing IL-2 producers on re-infection. IL-2 has been recently linked to improved secondary proliferation, while the role of IL-7 in maintenance of CD4(+) memory cells has been demonstrated in homeostatic proliferation, but its role in protective memory populations in infectious disease protective has not been fully investigated. Increased IL-7R alpha (CD127) expression correlated, as previously reported with increased turnover of CD4 memory cells, however, this was not linked to protection or enhanced response to rechallenge, These data support the idea that antigen or IL-2 production resulting from chronic stimulation may play a role in an enhanced secondary T cell response.	[Stephens, Robin; Langhorne, Jean] MRC Natl Inst Med Res, Div Parasitol, London, England; [Seddon, Benedict] MRC Natl Inst Med Res, Div Immune Cell Biol, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Stephens, R (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA.	jlangho@nimr.mrc.ac.uk		Seddon, Benedict/0000-0003-4352-3373; Langhorne, Jean/0000-0002-2257-9733	MRC, UK [U117584248]; Evimalar European Network of Excellence; Medical Research Council [MC_U117584248, MC_U117573801] Funding Source: researchfish; MRC [MC_U117573801, MC_U117584248] Funding Source: UKRI	MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Evimalar European Network of Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the MRC, UK (U117584248, www.mrc.ac.uk) and the Evimalar European Network of Excellence in the 7th Framework Programme (www.evimalar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; HAND T, 2007, P NATL ACAD SCI US, V104; Haring JS, 2008, J IMMUNOL, V180, P2855, DOI 10.4049/jimmunol.180.5.2855; Hunt P, 2004, MOL BIOCHEM PARASIT, V133, P27, DOI 10.1016/j.molbiopara.2003.08.010; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Li C, 2000, INFECT IMMUN, V68, P5724, DOI 10.1128/IAI.68.10.5724-5730.2000; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; MacLeod MKL, 2008, P NATL ACAD SCI USA, V105, P14521, DOI 10.1073/pnas.0807449105; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Okwor I, 2008, IMMUNOL RES, V41, P123, DOI 10.1007/s12026-008-8016-2; PERIGNON JL, 1994, MEM I OSWALDO CRUZ, V89, P51, DOI 10.1590/S0074-02761994000600013; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; STEPHENS R, 2005, BLOOD; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26686	10.1371/journal.pone.0026686	http://dx.doi.org/10.1371/journal.pone.0026686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039531	Green Published, Green Submitted, gold			2022-12-25	WOS:000296513200041
J	Filik, R; Barber, E				Filik, Ruth; Barber, Emma			Inner Speech during Silent Reading Reflects the Reader's Regional Accent	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; PHONOLOGICAL CODES; EYE-MOVEMENTS; AUDITORY IMAGERY; MUSICAL IMAGERY; MINDS EAR; ACTIVATION; REPRESENTATION; HEARING; IDENTIFICATION	While reading silently, we often have the subjective experience of inner speech. However, there is currently little evidence regarding whether this inner voice resembles our own voice while we are speaking out loud. To investigate this issue, we compared reading behaviour of Northern and Southern English participants who have differing pronunciations for words like 'glass', in which the vowel duration is short in a Northern accent and long in a Southern accent. Participants' eye movements were monitored while they silently read limericks in which the end words of the first two lines (e. g., glass/class) would be pronounced differently by Northern and Southern participants. The final word of the limerick (e. g., mass/sparse) then either did or did not rhyme, depending on the reader's accent. Results showed disruption to eye movement behaviour when the final word did not rhyme, determined by the reader's accent, suggesting that inner speech resembles our own voice.	[Filik, Ruth; Barber, Emma] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	University of Nottingham	Filik, R (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	ruth.filik@nottingham.ac.uk						Abramson M, 1997, PERCEPT PSYCHOPHYS, V59, P1059, DOI 10.3758/BF03205520; Aleman A, 2005, CEREB CORTEX, V15, P221, DOI 10.1093/cercor/bhh124; Alexander JD, 2008, J EXP PSYCHOL HUMAN, V34, P446, DOI 10.1037/0096-1523.34.2.446; Ashby J, 2006, J EXP PSYCHOL LEARN, V32, P416, DOI 10.1037/0278-7393.32.2.416; Ashby J, 2005, COGNITION, V96, pB89, DOI 10.1016/j.cognition.2004.12.006; Ashby J, 2008, J EXP PSYCHOL HUMAN, V34, P224, DOI 10.1037/0096-1523.34.1.224; Bader M., 1998, REANALYSIS SENTENCE, P1; BERENT I, 1995, PSYCHOL REV, V102, P146, DOI 10.1037/0033-295X.102.1.146; Breen M, 2011, J MEM LANG, V64, P153, DOI 10.1016/j.jml.2010.11.001; Bunzeck N, 2005, NEUROIMAGE, V26, P1119, DOI 10.1016/j.neuroimage.2005.03.013; Corley M, 2011, J EXP PSYCHOL LEARN, V37, P162, DOI 10.1037/a0021321; Drieghe D, 2002, J EXP PSYCHOL LEARN, V28, P951, DOI 10.1037//0278-7393.28.5.951; Eiter BM, 2008, PSYCHOL RES-PSYCH FO, V72, P666, DOI 10.1007/s00426-008-0166-2; Folk JR, 1999, J EXP PSYCHOL LEARN, V25, P892, DOI 10.1037/0278-7393.25.4.892; Ford JM, 2001, AM J PSYCHIAT, V158, P1914, DOI 10.1176/appi.ajp.158.11.1914; Ford JM, 2004, J PSYCHIATR RES, V38, P37, DOI 10.1016/S0022-3956(03)00095-5; Frost R, 1998, PSYCHOL BULL, V123, P71, DOI 10.1037/0033-2909.123.1.71; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hirose Y, 2003, J PSYCHOLINGUIST RES, V32, P167, DOI 10.1023/A:1022448308035; Hirotani M, 2006, J MEM LANG, V54, P425, DOI 10.1016/j.jml.2005.12.001; Huestegge L, 2010, J EYE MOVEMENT RES, V3; Hwang H, 2009, J PSYCHOLINGUIST RES, V38, P151, DOI 10.1007/s10936-008-9091-1; Inhoff AW, 2004, PSYCHON B REV, V11, P320, DOI 10.3758/BF03196577; KLAPP ST, 1971, J EXP PSYCHOL, V91, P262, DOI 10.1037/h0031852; Klin CM, 2010, PSYCHON B REV, V17, P231, DOI 10.3758/PBR.17.2.231; KOSSLYN SM, 1977, B PSYCHONOMIC SOC, V9, P250, DOI 10.3758/BF03336990; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Kurby CA, 2009, COGNITION, V112, P457, DOI 10.1016/j.cognition.2009.05.007; Lee YA, 1999, J EXP PSYCHOL HUMAN, V25, P948, DOI 10.1037/0096-1523.25.4.948; LEUTHARDT EC, 2011, J NEURAL EN IN PRESS; Lukatela G, 2004, J EXP PSYCHOL HUMAN, V30, P151, DOI 10.1037/0096-1523.30.1.151; MCCUTCHEN D, 1982, J VERB LEARN VERB BE, V21, P672, DOI 10.1016/S0022-5371(82)90870-2; MCCUTCHEN D, 1991, READ RES QUART, V26, P87, DOI 10.2307/747733; McGuire PK, 1996, PSYCHOL MED, V26, P29, DOI 10.1017/S0033291700033699; Oppenheim GM, 2008, COGNITION, V106, P528, DOI 10.1016/j.cognition.2007.02.006; Pei XM, 2011, NEUROIMAGE, V54, P2960, DOI 10.1016/j.neuroimage.2010.10.029; PERFETTI CA, 1991, J MEM LANG, V30, P473, DOI 10.1016/0749-596X(91)90017-E; POLLATSEK A, 1992, J EXP PSYCHOL HUMAN, V18, P148, DOI 10.1037/0096-1523.18.1.148; RAYNER K, 1995, PSYCHOL SCI, V6, P26, DOI 10.1111/j.1467-9280.1995.tb00300.x; Rayner K, 1998, J EXP PSYCHOL LEARN, V24, P476, DOI 10.1037/0278-7393.24.2.476; Rayner K, 1989, LANG COGNITIVE PROC, V4, pSI21, DOI 10.1080/01690968908406362; VANORDEN GC, 1987, MEM COGNITION, V15, P181, DOI 10.3758/BF03197716; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29; ZHANG SL, 1993, J EXP PSYCHOL LEARN, V19, P1082, DOI 10.1037/0278-7393.19.5.1082; Ziegler JC, 2000, Q J EXP PSYCHOL-A, V53, P671, DOI 10.1080/027249800410508	47	31	31	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25782	10.1371/journal.pone.0025782	http://dx.doi.org/10.1371/journal.pone.0025782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039423	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500021
J	Freitas, LM; dos Santos, SL; Rodrigues-Luiz, GF; Mendes, TAO; Rodrigues, TS; Gazzinelli, RT; Teixeira, SMR; Fujiwara, RT; Bartholomeu, DC				Freitas, Leandro M.; dos Santos, Sara Lopes; Rodrigues-Luiz, Gabriela F.; Mendes, Tiago A. O.; Rodrigues, Thiago S.; Gazzinelli, Ricardo T.; Teixeira, Santuza M. R.; Fujiwara, Ricardo T.; Bartholomeu, Daniella C.			Genomic Analyses, Gene Expression and Antigenic Profile of the Trans-Sialidase Superfamily of Trypanosoma cruzi Reveal an Undetected Level of Complexity	PLOS ONE			English	Article							COMPLEMENT REGULATORY PROTEIN; SURFACE PROTEIN; BINDING; FAMILY; IDENTIFICATION; SEQUENCE; DIVERSITY; INFECTION; DOMAIN; FORMS	The protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas disease, a highly debilitating human pathology that affects millions of people in the Americas. The sequencing of this parasite's genome reveals that trans-sialidase/trans-sialidase-like (TcS), a polymorphic protein family known to be involved in several aspects of T. cruzi biology, is the largest T. cruzi gene family, encoding more than 1,400 genes. Despite the fact that four TcS groups are well characterized and only one of the groups contains active trans-sialidases, all members of the family are annotated in the T. cruzi genome database as trans-sialidase. After performing sequence clustering analysis with all TcS complete genes, we identified four additional groups, demonstrating that the TcS family is even more heterogeneous than previously thought. Interestingly, members of distinct TcS groups show distinctive patterns of chromosome localization. Members of the TcSgroupII, which harbor proteins involved in host cell attachment/invasion, are preferentially located in subtelomeric regions, whereas members of the largest and new TcSgroupV have internal chromosomal locations. Real-time RT-PCR confirms the expression of genes derived from new groups and shows that the pattern of expression is not similar within and between groups. We also performed B-cell epitope prediction on the family and constructed a TcS specific peptide array, which was screened with sera from T. cruzi-infected mice. We demonstrated that all seven groups represented in the array are antigenic. A highly reactive peptide occurs in sixty TcS proteins including members of two new groups and may contribute to the known cross-reactivity of T. cruzi epitopes during infection. Taken together, our results contribute to a better understanding of the real complexity of the TcS family and open new avenues for investigating novel roles of this family during T. cruzi infection.	[Freitas, Leandro M.; dos Santos, Sara Lopes; Rodrigues-Luiz, Gabriela F.; Mendes, Tiago A. O.; Fujiwara, Ricardo T.; Bartholomeu, Daniella C.] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Rodrigues, Thiago S.] Ctr Fed Educ Tecnol Minas Gerais, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.; Teixeira, Santuza M. R.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Freitas, LM (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.	daniella@icb.ufmg.br	Fujiwara, Ricardo Toshio/J-7579-2012; Freitas, Leandro/AAK-3005-2020; Mendes, Tiago/AAG-1709-2021; Rodrigues-Luiz, Gabriela Flavia/AAE-4937-2020; TEIXEIRA, SANTUZA MR/I-8137-2013; Bartholomeu, Daniella C./J-4714-2015	Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Freitas, Leandro/0000-0003-4327-2922; Mendes, Tiago/0000-0002-5569-4893; Rodrigues-Luiz, Gabriela Flavia/0000-0003-3838-1008; Bartholomeu, Daniella C./0000-0003-0974-7357; Gazzinelli, Ricardo/0000-0003-2427-7699	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Azuaje F, 2007, IEEE T NANOBIOSCI, V6, P223, DOI 10.1109/TNB.2007.903482; Azuaje Francisco J, 2007, Kinetoplastid Biol Dis, V6, P6, DOI 10.1186/1475-9292-6-6; Bartholomeu DC, 2002, EXP PARASITOL, V102, P123, DOI 10.1016/S0014-4894(03)00034-1; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beucher M, 2008, INFECT IMMUN, V76, P750, DOI 10.1128/IAI.01104-07; BRIONES MRS, 1995, J MOL EVOL, V41, P120, DOI 10.1007/BF00170663; BURNS JM, 1992, P NATL ACAD SCI USA, V89, P1239, DOI 10.1073/pnas.89.4.1239; Buschiazzo A, 1997, GLYCOBIOLOGY, V7, P1167, DOI 10.1093/glycob/7.8.1167; Campos PC, 2008, INT J PARASITOL, V38, P1383, DOI 10.1016/j.ijpara.2008.07.001; Cano MIN, 2001, TRENDS PARASITOL, V17, P425, DOI 10.1016/S1471-4922(01)02014-1; Chiurillo MA, 2002, MOL BIOCHEM PARASIT, V120, P305, DOI 10.1016/S0166-6851(02)00005-1; COLLI W, 1993, FASEB J, V7, P1257, DOI 10.1096/fasebj.7.13.8405811; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; Cremona ML, 1999, GLYCOBIOLOGY, V9, P581, DOI 10.1093/glycob/9.6.581; CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P385, DOI 10.1146/annurev.mi.47.100193.002125; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ENGSTLER M, 1992, MOL BIOCHEM PARASIT, V54, P21, DOI 10.1016/0166-6851(92)90091-W; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; GIORDANO R, 1994, BRAZ J MED BIOL RES, V27, P2315; Grisard EC, 2010, MOL BIOCHEM PARASIT, V174, P18, DOI 10.1016/j.molbiopara.2010.06.008; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Kim D, 2005, GENE, V346, P153, DOI 10.1016/j.gene.2004.10.014; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Magdesian MH, 2007, EXP CELL RES, V313, P210, DOI 10.1016/j.yexcr.2006.10.008; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; NORRIS KA, 1991, J IMMUNOL, V147, P2240; Oppezzo P, 2011, BBA-PROTEINS PROTEOM, V1814, P1154, DOI 10.1016/j.bbapap.2011.04.012; Ouaissi A, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P502; Pereira-Chioccola VL, 2000, J CELL SCI, V113, P1299; Pitcovsky TA, 2002, J INFECT DIS, V186, P397, DOI 10.1086/341463; POLLEVICK GD, 1991, MOL BIOCHEM PARASIT, V47, P247, DOI 10.1016/0166-6851(91)90185-9; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; R Core Team, 2021, R LANG ENV STAT COMP; Ratier L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003524; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Santana JM, 1997, BIOCHEM J, V325, P129, DOI 10.1042/bj3250129; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; SOUZA W, 2010, INT J CELL BIOL, P1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Todeschini AR, 2004, J BIOL CHEM, V279, P5323, DOI 10.1074/jbc.M310663200; Todeschini AR, 2000, GLYCOBIOLOGY, V10, P213, DOI 10.1093/glycob/10.2.213; Tonelli RR, 2011, PARASITOLOGY, V138, P481, DOI 10.1017/S0031182010001411; Tonelli RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000864; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; VANVOORHIS WC, 1989, J EXP MED, V169, P641, DOI 10.1084/jem.169.3.641; VELGE P, 1988, PARASITOLOGY, V97, P255, DOI 10.1017/S0031182000058467; Vercelli CA, 2005, TRANSPL P, V37, P4594, DOI 10.1016/j.transproceed.2005.10.013; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; WHO, 2002, WHO TECHN REP SER, V912; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368	62	63	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25914	10.1371/journal.pone.0025914	http://dx.doi.org/10.1371/journal.pone.0025914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039427	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500024
J	Wang, JP; Lee, CK; Akalin, A; Finberg, RW; Levitz, SM				Wang, Jennifer P.; Lee, Chrono K.; Akalin, Ali; Finberg, Robert W.; Levitz, Stuart M.			Contributions of the MyD88-Dependent Receptors IL-18R, IL-1R, and TLR9 to Host Defenses following Pulmonary Challenge with Cryptococcus neoformans	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; INFECTION; MICE; MYD88; CELLS; TOLL-LIKE-RECEPTOR-4; INTERLEUKIN-12; INVOLVEMENT; MENINGITIS; INDUCTION	Signaling via the adapter protein, MyD88, is important in the host defense against Cryptococcus neoformans infection. While certain Toll-like receptors (TLRs) can enhance the clearance of Cryptococcus, the contributions of MyD88-dependent, TLR-independent pathways have not been fully investigated. We examined the roles of IL-1R and IL-18R in vivo by challenging C57BL/6 mice with a lethal strain of Cryptococcus. We found that the absence of IL-18R, but not IL-1R, causes a shift in the survival curve following pulmonary delivery of a virulent strain of C. neoformans (H99). Specifically, IL-18R-deficient mice have significantly shorter median survival times compared to wild-type mice following infection. Cytokine analysis of lung homogenates revealed that deficiency of IL-IR, IL-18R, or MyD88 is associated with diminished lung levels of IL-1 beta. In order to compare these findings with those related to TLR-deficiency, we studied the effects of TLR9-deficiency and found that deficiency of TLR9 also affects the survival curve of mice following challenge with C. neoformans. Yet the lungs from infected TLR9-deficient mice have robust levels of IL-1 beta. In summary, we found that multiple signaling components can contribute the MyD88-dependent host responses to cryptococcal infection in vivo and each drives distinct pulmonary responses.	[Wang, Jennifer P.; Lee, Chrono K.; Akalin, Ali; Finberg, Robert W.; Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Wang, JP (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	Jennifer.wang@umassmed.edu	Akalin, Ali/GMW-6237-2022; Akalin, Ali/AAH-1266-2019	wang, jennifer/0000-0002-2556-9100	National Institutes of Health [R01 AI025780, P01AI083215, R01 AI092105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083215, R01AI025780, R01AI092105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding sources include National Institutes of Health grants R01 AI025780 (SL), P01AI083215 (RF), and R01 AI092105 (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Auais A, 2003, AM J PHYSIOL-LUNG C, V285, pL105, DOI 10.1152/ajplung.00004.2003; Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Biondo C, 2005, EUR J IMMUNOL, V35, P870, DOI 10.1002/eji.200425799; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Giles SS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001370; Herring AC, 2002, INFECT IMMUN, V70, P2959, DOI 10.1128/IAI.70.6.2959-2964.2002; Kawakami K, 2000, J IMMUNOL, V165, P941, DOI 10.4049/jimmunol.165.2.941; Kawakami K, 2000, FEMS IMMUNOL MED MIC, V27, P191, DOI 10.1111/j.1574-695X.2000.tb01430.x; Kawakami K, 1997, J IMMUNOL, V159, P5528; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; McQuiston T, 2010, INFECT IMMUN, V78, P2342, DOI 10.1128/IAI.01140-09; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Nakamura K, 2008, J IMMUNOL, V180, P4067, DOI 10.4049/jimmunol.180.6.4067; Nakamura K, 2006, FEMS IMMUNOL MED MIC, V47, P148, DOI 10.1111/j.1574-695X.2006.00078.x; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1980, AM J PATHOL, V101, P177; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; Yauch LE, 2004, INFECT IMMUN, V72, P5373, DOI 10.1128/IAI.72.9.5373-5382.2004; Zhang YM, 2010, AM J PATHOL, V177, P754, DOI 10.2353/ajpath.2010.091104; Zhang YM, 2009, AM J PATHOL, V175, P2489, DOI 10.2353/ajpath.2009.090530	25	21	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26232	10.1371/journal.pone.0026232	http://dx.doi.org/10.1371/journal.pone.0026232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039448	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500042
J	Abate-Daga, D; Andreu, N; Camacho-Sanchez, J; Alemany, R; Herance, R; Millan, O; Fillat, C				Abate-Daga, Daniel; Andreu, Nuria; Camacho-Sanchez, Juan; Alemany, Ramon; Herance, Raul; Millan, Olga; Fillat, Cristina			Oncolytic Adenoviruses Armed with Thymidine Kinase Can Be Traced by PET Imaging and Show Potent Antitumoural Effects by Ganciclovir Dosing	PLOS ONE			English	Article							REPORTER GENE-EXPRESSION; POSITRON-EMISSION-TOMOGRAPHY; PANCREATIC TUMOR-REGRESSION; EFFECT IN-VIVO; PRECLINICAL MODEL; NONHUMAN-PRIMATES; MOUSE MODELS; THERAPY; CANCER; EFFICACY	Replication-competent adenoviruses armed with thymidine kinase (TK) combine the concepts of virotherapy and suicide gene therapy. Moreover TK-activity can be detected by noninvasive positron emission-computed tomography (PET) imaging, what could potentially facilitate virus monitoring in vivo. Here, we report the generation of a novel oncolytic adenovirus that incorporates the Tat8-TK gene under the control of the Major Late Promoter in a highly selective backbone thus providing selectivity by targeting the retinoblastoma pathway. The selective oncolytic TK virus, termed ICOVIR5-TK-L, showed reduced potency compared to a non-selective counterpart. However the combination of ICOVIR5-TK-L with ganciclovir (GCV) induced a potent antitumoural effect similar to that of wild type adenovirus in a preclinical model of pancreatic cancer. Although the treatment with GCV provoked a reduction in the viral yield, both in vitro and in vivo, a two-cycle treatment of virus and GCV resulted in an enhanced antitumoral response that correlated with high TK-activity, based on microPET measurements. Thus, TK-expressing oncolytic adenoviruses can be traced by PET imaging providing real time information on the activity of the virus and its antitumoral potency can be optimized by GCV dosing.	[Abate-Daga, Daniel; Fillat, Cristina] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Abate-Daga, Daniel; Andreu, Nuria; Fillat, Cristina] UPF, CRG, Barcelona, Spain; [Andreu, Nuria; Fillat, Cristina] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Camacho-Sanchez, Juan; Alemany, Ramon] IDIBELL Catalan Inst Oncol ICO, Gene & Viral Therapy Grp, Barcelona, Spain; [Herance, Raul; Millan, Olga] PRBB Fundacio Privada, Inst Alta Tecnol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Pompeu Fabra University	Abate-Daga, D (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.	cristina.fillat@crg.es	Fillat, Cristina/ABH-1674-2020; Andreu, Nuria/H-2576-2015	Andreu, Nuria/0000-0003-1999-8483; Abate-Daga, Daniel/0000-0002-2571-0215; Fillat, Cristina/0000-0002-0801-3338; Herance, Jose Raul/0000-0001-7178-3290	Spanish Ministry of Science and Innovation (MICINN) [BIO2005-08682-C03-02/01, BIO2008-04692-C03-02/01]; Fundacion Carolina; Generalitat de Catalunya [01A104]; CIBERER; Instituto de Salud Carlos III [IIS10/00014]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Carolina; Generalitat de Catalunya(Generalitat de Catalunya); CIBERER; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Spanish Ministry of Science and Innovation (MICINN), BIO2005-08682-C03-02/01, BIO2008-04692-C03-02/01 and received partial support from the Generalitat de Catalunya SGR091527. Daniel Abate-Daga was a recipient of a Fundacion Carolina fellowship. Nuria Andreu was partially financed by the Generalitat de Catalunya (01A104). Fillat's group is also partially funded by CIBERER, and by IIS10/00014 from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Alauddin MM, 2002, J LABELLED COMPD RAD, V45, P583, DOI 10.1002/jlcr.549; Alauddin MM, 2000, J FLUORINE CHEM, V106, P87, DOI 10.1016/S0022-1139(00)00307-9; Alonso MM, 2007, CANCER RES, V67, P8255, DOI 10.1158/0008-5472.CAN-06-4675; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; BERANEK J, 1976, NUCLEIC ACIDS RES, V3, P1387, DOI 10.1093/nar/3.5.1387; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Carrio M, 1999, GENE THER, V6, P547, DOI 10.1038/sj.gt.3300846; Cascallo M, 2007, MOL THER, V15, P1607, DOI 10.1038/sj.mt.6300239; Cascante A, 2007, GENE THER, V14, P1471, DOI 10.1038/sj.gt.3303008; Cascante A, 2005, HUM GENE THER, V16, P1377, DOI 10.1089/hum.2005.16.1377; Cho SY, 2005, J NUCL MED, V46, P1923; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Fontanellas A, 2009, GENE THER, V16, P136, DOI 10.1038/gt.2008.122; Fontanellas A, 2010, MOL THER, V18, P754, DOI 10.1038/mt.2009.312; Freytag SO, 2007, MOL THER, V15, P1600, DOI 10.1038/sj.mt.6300212; Fridlender ZG, 2010, MOL THER, V18, P1947, DOI 10.1038/mt.2010.159; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333; Garcia-Rodriguez L, 2011, GENE THER, V18, P73, DOI 10.1038/gt.2010.114; Hajitou A, 2008, P NATL ACAD SCI USA, V105, P4471, DOI 10.1073/pnas.0712184105; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; HOWELL HG, 1988, J ORG CHEM, V53, P85, DOI 10.1021/jo00236a017; Huch M, 2009, NEOPLASIA, V11, P518, DOI 10.1593/neo.81674; Iyer M, 2001, J NUCL MED, V42, P96; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Penuelas I, 2005, GASTROENTEROLOGY, V128, P1787, DOI 10.1053/j.gastro.2005.03.024; Pujal J, 2006, BBA-MOL BASIS DIS, V1762, P73, DOI 10.1016/j.bbadis.2005.08.002; Shibata MA, 2008, MED MOL MORPHOL, V41, P34, DOI 10.1007/s00795-007-0388-1; Soghomonyan S, 2007, NAT PROTOC, V2, P416, DOI 10.1038/nprot.2007.49; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; VILE RG, 1994, CANCER RES, V54, P6228; Villanueva A, 1998, ONCOGENE, V17, P1969, DOI 10.1038/sj.onc.1202118; Xiong ZM, 2006, J NUCL MED, V47, P130	34	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26142	10.1371/journal.pone.0026142	http://dx.doi.org/10.1371/journal.pone.0026142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028820	gold, Green Published, Green Submitted			2022-12-25	WOS:000296186900030
J	Agnani, D; Acharya, P; Martinez, E; Tran, TT; Abraham, F; Tobin, F; Ellens, H; Bentz, J				Agnani, Deep; Acharya, Poulomi; Martinez, Esteban; Thuy Thanh Tran; Abraham, Feby; Tobin, Frank; Ellens, Harma; Bentz, Joe			Fitting the Elementary Rate Constants of the P-gp Transporter Network in the hMDR1-MDCK Confluent Cell Monolayer Using a Particle Swarm Algorithm	PLOS ONE			English	Article							GLYCOPROTEIN-MEDIATED TRANSPORT; DRUG TRANSPORT; ATP HYDROLYSIS; BINDING; PERMEABILITY; PURIFICATION; INHIBITION; MODEL; LINE	P-glycoprotein, a human multidrug resistance transporter, has been extensively studied due to its importance to human health and disease. In order to understand transport kinetics via P-gp, confluent cell monolayers overexpressing P-gp are widely used. The purpose of this study is to obtain the mass action elementary rate constants for P-gp's transport and to functionally characterize members of P-gp's network, i.e., other transporters that transport P-gp substrates in hMDR1-MDCKII confluent cell monolayers and are essential to the net substrate flux. Transport of a range of concentrations of amprenavir, loperamide, quinidine and digoxin across the confluent monolayer of cells was measured in both directions, apical to basolateral and basolateral to apical. We developed a global optimization algorithm using the Particle Swarm method that can simultaneously fit all datasets to yield accurate and exhaustive fits of these elementary rate constants. The statistical sensitivity of the fitted values was determined by using 24 identical replicate fits, yielding simple averages and standard deviations for all of the kinetic parameters, including the efflux active P-gp surface density. Digoxin required additional basolateral and apical transporters, while loperamide required just a basolateral tranporter. The data were better fit by assuming bidirectional transporters, rather than active importers, suggesting that they are not MRP or active OATP transporters. The P-gp efflux rate constants for quinidine and digoxin were about 3-fold smaller than reported ATP hydrolysis rate constants from P-gp proteoliposomes. This suggests a roughly 3: 1 stoichiometry between ATP hydrolysis and P-gp transport for these two drugs. The fitted values of the elementary rate constants for these P-gp substrates support the hypotheses that the selective pressures on P-gp are to maintain a broad substrate range and to keep xenobiotics out of the cytosol, but not out of the apical membrane.	[Agnani, Deep; Acharya, Poulomi; Martinez, Esteban; Bentz, Joe] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Thuy Thanh Tran; Ellens, Harma] GlaxoSmithKline, Preclin Drug Metab & Pharmacokinet, King Of Prussia, PA USA; [Abraham, Feby; Tobin, Frank] GlaxoSmithKline, Sci Comp & Math Modeling, King Of Prussia, PA USA	Drexel University; GlaxoSmithKline; GlaxoSmithKline	Agnani, D (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	bentzj@drexel.edu		Martinez, Esteban/0000-0002-4798-3548				Aanismaa P, 2008, BIOCHEMISTRY-US, V47, P10197, DOI 10.1021/bi800209h; Acharya P, 2008, DRUG METAB DISPOS, V36, P452, DOI 10.1124/dmd.107.017301; Acharya P, 2006, BIOCHEMISTRY-US, V45, P15505, DOI 10.1021/bi060593b; Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bartholome K, 2007, DRUG METAB DISPOS, V35, P1476, DOI 10.1124/dmd.107.015636; Bentz J, 2005, PHARM RES-DORDR, V22, P1667, DOI 10.1007/s11095-005-6627-z; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Chang C, 2006, ADV DRUG DELIVER REV, V58, P1431, DOI 10.1016/j.addr.2006.09.006; Chang JH, 2005, MOL PHARMACEUT, V2, P428, DOI 10.1021/mp050018m; Doppenschmitt S, 1999, J PHARM SCI, V88, P1067, DOI 10.1021/js980378j; Endres CJ, 2006, EUR J PHARM SCI, V27, P501, DOI 10.1016/j.ejps.2005.11.002; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Ho NFH, 2000, DRUGS PHARM SCI, V102, P219; HORIO M, 1990, BIOCHIM BIOPHYS ACTA, V1027, P116, DOI 10.1016/0005-2736(90)90074-X; Ito S, 1999, AM J PHYSIOL-RENAL, V277, pF84, DOI 10.1152/ajprenal.1999.277.1.F84; Kalvass JC, 2007, PHARM RES-DORDR, V24, P265, DOI 10.1007/s11095-006-9135-x; Kannan P, 2009, CLIN PHARMACOL THER, V86, P368, DOI 10.1038/clpt.2009.138; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Litman T, 2003, J PHARMACOL EXP THER, V307, P846, DOI 10.1124/jpet.103.056960; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Lumen AA, 2011, STRUCTURE FUNCTION B, P241; Lumen AA, 2010, DRUG METAB DISPOS, V38, P260, DOI 10.1124/dmd.109.029843; Modok S, 2004, J LIPID RES, V45, P1910, DOI 10.1194/jlr.M400220-JLR200; Moussatova A, 2008, BBA-BIOMEMBRANES, V1778, P1757, DOI 10.1016/j.bbamem.2008.06.009; Nervi P, 2010, BBA-BIOMEMBRANES, V1798, P515, DOI 10.1016/j.bbamem.2009.11.022; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Rebbeor JF, 1998, BBA-BIOMEMBRANES, V1369, P85, DOI 10.1016/S0005-2736(97)00185-5; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Senior AE, 2000, J EXP BIOL, V203, P35; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Sharom FJ, 2007, DRUG TRANSPORTERS MO; Shirasaka Y, 2008, J PHARM SCI-US, V97, P553, DOI 10.1002/jps.21114; Shitara Y, 2006, EUR J PHARM SCI, V27, P425, DOI 10.1016/j.ejps.2005.12.003; Sun HD, 2008, DRUG METAB DISPOS, V36, P102, DOI 10.1124/dmd.107.015321; Taub ME, 2005, DRUG METAB DISPOS, V33, P1679, DOI 10.1124/dmd.105.005421; Tombline G, 2008, BIOCHEMISTRY-US, V47, P3294, DOI 10.1021/bi7021393; Tran TT, 2004, J PHARM SCI-US, V93, P2108, DOI 10.1002/jps.20105; Tran TT, 2005, BIOPHYS J, V88, P715, DOI 10.1529/biophysj.104.045633; Vaz AIF, 2007, J GLOBAL OPTIM, V39, P197, DOI 10.1007/s10898-007-9133-5	42	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25086	10.1371/journal.pone.0025086	http://dx.doi.org/10.1371/journal.pone.0025086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028772	gold, Green Submitted, Green Published			2022-12-25	WOS:000296186900005
J	de Andrade, RB; Barlow, J; Louzada, J; Vaz-de-Mello, FZ; Souza, M; Silveira, JM; Cochrane, MA				de Andrade, Rafael Barreto; Barlow, Jos; Louzada, Julio; Vaz-de-Mello, Fernando Zagury; Souza, Mateus; Silveira, Juliana M.; Cochrane, Mark A.			Quantifying Responses of Dung Beetles to Fire Disturbance in Tropical Forests: The Importance of Trapping Method and Seasonality	PLOS ONE			English	Article							RAIN-FOREST; COLEOPTERA SCARABAEIDAE; INSECT CONSERVATION; RECURRENT WILDFIRES; BIODIVERSITY; DIVERSITY; ABUNDANCE; ASSEMBLAGES; COMMUNITY; EXTINCTIONS	Understanding how biodiversity responds to environmental changes is essential to provide the evidence-base that underpins conservation initiatives. The present study provides a standardized comparison between unbaited flight intercept traps (FIT) and baited pitfall traps (BPT) for sampling dung beetles. We examine the effectiveness of the two to assess fire disturbance effects and how trap performance is affected by seasonality. The study was carried out in a transitional forest between Cerrado (Brazilian Savanna) and Amazon Forest. Dung beetles were collected during one wet and one dry sampling season. The two methods sampled different portions of the local beetle assemblage. Both FIT and BPT were sensitive to fire disturbance during the wet season, but only BPT detected community differences during the dry season. Both traps showed similar correlation with environmental factors. Our results indicate that seasonality had a stronger effect than trap type, with BPT more effective and robust under low population numbers, and FIT more sensitive to fine scale heterogeneity patterns. This study shows the strengths and weaknesses of two commonly used methodologies for sampling dung beetles in tropical forests, as well as highlighting the importance of seasonality in shaping the results obtained by both sampling strategies.	[de Andrade, Rafael Barreto; Cochrane, Mark A.] S Dakota State Univ, Brookings, SD 57007 USA; [Barlow, Jos] Univ Lancaster, Lancaster, Lancs, England; [Louzada, Julio; Silveira, Juliana M.] Univ Fed Lavras, Lavras, MG, Brazil; [Vaz-de-Mello, Fernando Zagury; Souza, Mateus] Univ Fed Mato Grosso, Cuiaba, Mato Grosso, Brazil	South Dakota State University; Lancaster University; Universidade Federal de Lavras; Universidade Federal de Mato Grosso	de Andrade, RB (corresponding author), S Dakota State Univ, Brookings, SD 57007 USA.	rb.andrade@ymail.com	Louzada, Julio/F-1265-2010; Vaz-de-Mello, Fernando Z/A-1023-2009; Bioterra Amazonia, Inct/J-9890-2013; Barlow, Jos/E-7861-2014; Barlow, Jos/HGE-9486-2022; Cochrane, Mark A/A-1735-2018	Louzada, Julio/0000-0002-1481-3112; Vaz-de-Mello, Fernando Z/0000-0001-9697-320X; Cochrane, Mark A/0000-0002-4573-568X	Earth Science Division of the NASA Science Mission Directorate [NNX07AF16G]; Fundacao de Amparo a Pesquisa do Estado de Mato Grosso; Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa de Minas Gerais; Engineering and Physical Sciences Research Council [EP/E500811/1] Funding Source: researchfish	Earth Science Division of the NASA Science Mission Directorate; Fundacao de Amparo a Pesquisa do Estado de Mato Grosso(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Biological Diversity Program of the Earth Science Division of the NASA Science Mission Directorate (NNX07AF16G); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso; Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa de Minas Gerais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen E, 2005, BIOTROPICA, V37, P291, DOI 10.1111/j.1744-7429.2005.00039.x; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barlow J, 2006, BIODIVERS CONSERV, V15, P985, DOI 10.1007/s10531-004-3952-1; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; Blanche KR, 2001, ECOL APPL, V11, P86, DOI 10.1890/1051-0761(2001)011[0086:RCDOFI]2.0.CO;2; Canhedo Virginia Luzia, 2006, Arquivos de Zoologia (Sao Paulo), V37, P349; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cleary DFR, 2004, GLOBAL ECOL BIOGEOGR, V13, P129, DOI 10.1111/j.1466-882X.2004.00074.x; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 2001, ENVIRONMENT, V43, P28, DOI 10.1080/00139150109604505; Cochrane MA, 2009, GLOBAL CHANGE BIOL, V15, P601, DOI 10.1111/j.1365-2486.2008.01786.x; Colwell RK, 2004, ESTIMATES STAT ESTIM; Davis AJ, 2000, COLEOPTS BULL, V54, P221, DOI 10.1649/0010-065X(2000)054[0221:SRODFB]2.0.CO;2; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Dawes-Gromadzki TZ, 2007, AUSTRAL ECOL, V32, P663, DOI 10.1111/j.1442-9993.2007.01752.x; Didham RK, 2010, INSECT CONSERV DIVER, V3, P1, DOI 10.1111/j.1752-4598.2009.00076.x; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; Edmonds W.D., 2004, Folia Heyrovskyana Supplementum, V11, P1; Edmonds W.D., 2010, Insecta Mundi, V0129, P1; Errouissi F, 2004, ENVIRON ENTOMOL, V33, P45, DOI 10.1603/0046-225X-33.1.45; Favila Mario E., 1997, Acta Zoologica Mexicana Nueva Serie, V72, P1; Feer F, 2000, ANN SOC ENTOMOL FR, V36, P29; Filgueiras BKC, 2009, REV BRAS ENTOMOL, V53, P422, DOI 10.1590/S0085-56262009000300017; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gardner TA, 2007, BIOTROPICA, V39, P25, DOI 10.1111/j.1744-7429.2006.00228.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gill B.D., 1991, P211; Halffter G, 2002, BIOTROPICA, V34, P144, DOI 10.1111/j.1744-7429.2002.tb00250.x; Halffter Gonzalo, 1993, Biology International, V27, P15; Halffter Gonzalo, 2009, Boletin de la SEA, V45, P1; Hanski I., 1991, P305; Flechtmann CAH, 2009, ENTOMOL EXP APPL, V132, P211, DOI 10.1111/j.1570-7458.2009.00885.x; HOWDEN H F, 1981, Contributions of the American Entomological Institute, V18, P1; Hyvarinen E, 2006, EUR J ENTOMOL, V103, P397, DOI 10.14411/eje.2006.054; Ivanauskas NM, 2003, FOREST ECOL MANAG, V184, P239, DOI 10.1016/S0378-1127(03)00156-7; Jacobs CT, 2010, J INSECT CONSERV, V14, P389, DOI 10.1007/s10841-010-9270-x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Leather SR, 2008, INSECT CONSERV DIVER, V1, P1, DOI 10.1111/j.1752-4598.2007.00009.x; Lee JSH, 2009, RAFFLES B ZOOL, V57, P537; Lindenmayer DB, 2009, CONSERV LETT, V2, P271, DOI 10.1111/j.1755-263X.2009.00080.x; Lopes J, 2011, ZOOLOGIA-CURITIBA, V28, P72, DOI 10.1590/S1984-46702011000100011; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Louzada J, 2010, LANDSCAPE ECOL, V25, P631, DOI 10.1007/s10980-010-9448-3; Milhomem MS, 2003, PESQUI AGROPECU BRAS, V38, P1249, DOI 10.1590/S0100-204X2003001100001; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nyeko P, 2009, BIOTROPICA, V41, P476, DOI 10.1111/j.1744-7429.2009.00499.x; PECK S B, 1980, Coleopterists Bulletin, V34, P237; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; PECK SB, 1984, BIOTROPICA, V16, P235, DOI 10.2307/2388057; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; Pinheiro F, 2002, AUSTRAL ECOL, V27, P132, DOI 10.1046/j.1442-9993.2002.01165.x; Qie L, 2011, J BIOGEOGR, V38, P792, DOI 10.1111/j.1365-2699.2010.02439.x; RATCLIFFE B C, 1980, Coleopterists Bulletin, V34, P337; Ribeiro MA, 2008, J HERPETOL, V42, P733, DOI 10.1670/07-097R3.1; Ridsdill-Smith J., 1991, P264; Samu F, 2010, COMMUNITY ECOL, V11, P129, DOI 10.1556/ComEc.11.2010.2.1; SAMWAYS MJ, 1993, BIODIVERS CONSERV, V2, P258, DOI 10.1007/BF00056672; Silveira JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012877; Solis Angel, 2004, Giornale Italiano di Entomologia, V11, P1; Vaz-De-Mello FZ, 2008, ZOOTAXA, P1; Vulinec K, 2000, FLA ENTOMOL, V83, P229, DOI 10.2307/3496341; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; YOUNG O P, 1981, Coleopterists Bulletin, V35, P427	70	33	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26208	10.1371/journal.pone.0026208	http://dx.doi.org/10.1371/journal.pone.0026208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028831	Green Published, Green Accepted, gold			2022-12-25	WOS:000296186900033
J	Hodl, I; Hodl, J; Worman, A; Singer, G; Besemer, K; Battin, TJ				Hoedl, Iris; Hoedl, Josef; Worman, Anders; Singer, Gabriel; Besemer, Katharina; Battin, Tom J.			Voronoi Tessellation Captures Very Early Clustering of Single Primary Cells as Induced by Interactions in Nascent Biofilms	PLOS ONE			English	Article							MICROBIAL BIOFILMS; PSEUDOMONAS-AERUGINOSA; SURFACE; QUORUM; STREAM; COMMUNICATION; HETEROGENEITY; ENVIRONMENT; BACTERIA; ADHESION	Biofilms dominate microbial life in numerous aquatic ecosystems, and in engineered and medical systems, as well. The formation of biofilms is initiated by single primary cells colonizing surfaces from the bulk liquid. The next steps from primary cells towards the first cell clusters as the initial step of biofilm formation remain relatively poorly studied. Clonal growth and random migration of primary cells are traditionally considered as the dominant processes leading to organized microcolonies in laboratory grown monocultures. Using Voronoi tessellation, we show that the spatial distribution of primary cells colonizing initially sterile surfaces from natural streamwater community deviates from uniform randomness already during the very early colonisation. The deviation from uniform randomness increased with colonisation - despite the absence of cell reproduction - and was even more pronounced when the flow of water above biofilms was multidirectional and shear stress elevated. We propose a simple mechanistic model that captures interactions, such as cell-to-cell signalling or chemical surface conditioning, to simulate the observed distribution patterns. Model predictions match empirical observations reasonably well, highlighting the role of biotic interactions even already during very early biofilm formation despite few and distant cells. The transition from single primary cells to clustering accelerated by biotic interactions rather than by reproduction may be particularly advantageous in harsh environments - the rule rather than the exception outside the laboratory.	[Hoedl, Iris; Singer, Gabriel; Besemer, Katharina; Battin, Tom J.] Univ Vienna, Dept Limnol, Vienna, Austria; [Hoedl, Iris; Singer, Gabriel; Besemer, Katharina; Battin, Tom J.] WasserCluster Lunz GmbH, Lunz Am See, Austria; [Worman, Anders] Royal Inst Technol, Dept Land & Water Resources Engn, Stockholm, Sweden	University of Vienna; Royal Institute of Technology	Hodl, I (corresponding author), Univ Vienna, Dept Limnol, Vienna, Austria.	tom.battin@univie.ac.at	Singer, Gabriel/C-6285-2012; BAttin, Tom/H-7971-2012; Worman, Anders/O-8866-2014	Singer, Gabriel/0000-0002-7389-9788; Worman, Anders/0000-0003-2726-6821	Austrian Science Fund [START Y420-B17]; European Science Foundation [ERAS-CT-2003-980409]; Initiativkolleg Symbiosis of the University of Vienna; Austrian Science Fund (FWF) [Y 420] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); European Science Foundation(European Science Foundation (ESF)European Commission); Initiativkolleg Symbiosis of the University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was financially supported by the Austrian Science Fund (START Y420-B17) and the European Science Foundation (COMX, ERAS-CT-2003-980409) grants to TJB and by the Initiativkolleg Symbiosis of the University of Vienna to IH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghini S, 2009, FEMS MICROBIOL LETT, V292, P149, DOI 10.1111/j.1574-6968.2008.01478.x; Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Banavar JR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068104; Battin TJ, 2003, APPL ENVIRON MICROB, V69, P5443, DOI 10.1128/AEM.69.9.5443-5452.2003; Battin TJ, 2003, APPL ENVIRON MICROB, V67, P799; Berg, 2018, RANDOM WALKS BIOL; Bohn S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.054503; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; BOTT TL, 1975, LIMNOL OCEANOGR, V20, P191, DOI 10.4319/lo.1975.20.2.0191; Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302; Costa LD, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011913; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Decho AW, 2011, CHEM REV, V111, P86, DOI 10.1021/cr100311q; Dulla G, 2008, P NATL ACAD SCI USA, V105, P3082, DOI 10.1073/pnas.0711723105; Dusenbery D. B., 2009, LIVING MICROSCALE; Egland PG, 2004, P NATL ACAD SCI USA, V101, P16917, DOI 10.1073/pnas.0407457101; Ferenc JS, 2007, PHYSICA A, V385, P518, DOI 10.1016/j.physa.2007.07.063; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Gantner S, 2006, FEMS MICROBIOL ECOL, V56, P188, DOI 10.1111/j.1574-6941.2005.00037.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harris HW, 2010, P NATL ACAD SCI USA, V107, P326, DOI 10.1073/pnas.0907468107; Hill J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068101; Holland EP, 2007, PLOS COMPUT BIOL, V3, P1979, DOI 10.1371/journal.pcbi.0030200; Hondzo M, 2009, ENVIRON SCI TECHNOL, V43, P764, DOI 10.1021/es801655p; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; Houchmandzadeh B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.078103; Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039; KENKEL NC, 1989, ECOLOGY, V70, P272, DOI 10.2307/1938433; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078; Ledoux H, 2005, DEVELOPMENTS IN SPATIAL DATA HANDLING, P97, DOI 10.1007/3-540-26772-7_8; MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198; Mitchell JG, 2006, FEMS MICROBIOL ECOL, V55, P3, DOI 10.1111/j.1574-6941.2005.00003.x; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; PEDLEY TJ, 1992, SCI PROG, V76, P105; Pfeiffer T, 2003, P NATL ACAD SCI USA, V100, P1095, DOI 10.1073/pnas.0335420100; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; Pineda E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066119; Pineda E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.040107; Rice AR, 2000, MICROBIAL ECOL, V40, P8, DOI 10.1007/s002480000011; Singer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009988; Smalyukh II, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.030701; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Ulrich S, 2004, LANGMUIR, V20, P1763, DOI 10.1021/la030348i; Volfson D, 2008, P NATL ACAD SCI USA, V105, P15346, DOI 10.1073/pnas.0706805105; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901	58	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26368	10.1371/journal.pone.0026368	http://dx.doi.org/10.1371/journal.pone.0026368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028865	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900055
J	Kritis, A; Pourzitaki, C; Klagas, I; Chourdakis, M; Albani, M				Kritis, Aristidis; Pourzitaki, Chryssa; Klagas, Ioannis; Chourdakis, Michael; Albani, Maria			Proteases Inhibition Assessment on PC12 and NGF Treated Cells after Oxygen and Glucose Deprivation Reveals a Distinct Role for Aspartyl Proteases	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NERVE GROWTH-FACTOR; OXIDATIVE STRESS; NEURONAL DEATH; MITOCHONDRIAL DYSFUNCTION; HYPOXIA-ISCHEMIA; CATHEPSIN-D; CALPAIN-I; APOPTOSIS; ACTIVATION	Hypoxia is a severe stressful condition and induces cell death leading to neuronal loss both to the developing and adult nervous system. Central theme to cellular death is the activation of different classes of proteases such as caspases calpains and cathepsins. In the present study we investigated the involvement of these proteases, in the hypoxia-induced PC12 cell death. Rat PC12 is a model cell line for experimentation relevant to the nervous system and several protocols have been developed for either lethal hypoxia (oxygen and glucose deprivation OGD) or ischemic preconditioning (IPS). Nerve Growth Factor (NGF) treated PC12 differentiate to a sympathetic phenotype, expressing neurites and excitability. Lethal hypoxia was established by exposing undifferentiated and NGF-treated PC12 cells to a mixture of N(2)/CO(2) (93:5%) in DMEM depleted of glucose and sodium pyruvate for 16 h. The involvement of caspases, calpains and lysosomal cathepsins D and E to the cell death induced by lethal OGD was investigated employing protease specific inhibitors such as z-VAD-fmk for the caspases, MDL28170 for the calpains and pepstatin A for the cathepsins D and E. Our findings show that pepstatin A provides statistically significant protection from cell death of both naive and NGF treated PC12 cells exposed to lethal OGD. We propose that apart from the established processes of apoptosis and necrosis that are integral components of lethal OGD, the activation of cathepsins D and E launches additional cell death pathways in which these proteases are key partners.	[Kritis, Aristidis; Klagas, Ioannis; Albani, Maria] Aristotle Univ Thessaloniki, Physiol Lab, Sch Med, GR-54006 Thessaloniki, Greece; [Pourzitaki, Chryssa; Chourdakis, Michael] Aristotle Univ Thessaloniki, Pharmacol Lab, Sch Med, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Kritis, A (corresponding author), Aristotle Univ Thessaloniki, Physiol Lab, Sch Med, GR-54006 Thessaloniki, Greece.	kritis@med.auth.gr	Kritis, Aristeidis/AAG-7474-2019	Kritis, Aristeidis/0000-0002-2067-8842; Chourdakis, Michael/0000-0002-9490-8356	Hellenic Ministry of Education; European Union/European Social Fund	Hellenic Ministry of Education; European Union/European Social Fund(European Social Fund (ESF)European Commission)	The present work was supported by the Hellenic Ministry of Education and the European Union/European Social Fund EPEAEK PYTHGORAS II. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABU RS, 1993, J NEUROSCI METH, V50, P197; Artal-Sanz M, 2005, FEBS LETT, V579, P3287, DOI 10.1016/j.febslet.2005.03.052; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Brana C, 1999, EUR J NEUROSCI, V11, P2375, DOI 10.1046/j.1460-9568.1999.00653.x; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Charlier N, 2002, MOL BRAIN RES, V104, P21, DOI 10.1016/S0169-328X(02)00198-5; Chen J, 1998, J NEUROSCI, V18, P4914; CHOI DW, 1993, RES P ARNMD, V71, P23; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hillion JA, 2005, J CEREBR BLOOD F MET, V25, P154, DOI 10.1038/sj.jcbfm.9600003; Hol EM, 2008, J MOL NEUROSCI, V34, P23, DOI 10.1007/s12031-007-0013-8; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; HOSSMANN KA, 1994, BRAIN PATHOL, V4, P23; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Koubi D, 2005, NEUROCHEM INT, V46, P73, DOI 10.1016/j.neuint.2004.06.006; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kritis A, 2006, ACTA PHARMACOL SIN, V27, P408; Larsen EC, 2007, NEUROSCIENCE, V146, P946, DOI 10.1016/j.neuroscience.2007.02.022; Liu Y, 2003, J CELL MOL MED, V7, P49, DOI 10.1111/j.1582-4934.2003.tb00202.x; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Minarowska A, 2007, FOLIA HISTOCHEM CYTO, V45, P159; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Park HK, 2009, NEUROSCI LETT, V451, P16, DOI 10.1016/j.neulet.2008.12.019; Pourzitaki C, 2008, FEBS J, V275, P310; Pourzitaki C., 2008, REV CLIN PHARM PHARM, V22, P304; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Sadasivan S, 2006, APOPTOSIS, V11, P1573, DOI 10.1007/s10495-006-7690-6; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; Tabakman R, 2004, J NEUROSCI RES, V75, P499, DOI 10.1002/jnr.20008; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wu LY, 2010, CELL STRESS CHAPERON, V15, P387, DOI 10.1007/s12192-009-0153-6; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25950	10.1371/journal.pone.0025950	http://dx.doi.org/10.1371/journal.pone.0025950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028798	Green Submitted, gold, Green Published			2022-12-25	WOS:000296186900023
J	Krenzer, M; Anaclet, C; Vetrivelan, R; Wang, NS; Vong, L; Lowell, BB; Fuller, PM; Lu, J				Krenzer, Martina; Anaclet, Christelle; Vetrivelan, Ramalingam; Wang, Nishang; Linh Vong; Lowell, Bradford B.; Fuller, Patrick M.; Lu, Jun			Brainstem and Spinal Cord Circuitry Regulating REM Sleep and Muscle Atonia	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; PARADOXICAL SLEEP; GABAERGIC NEURONS; BEHAVIOR DISORDER; LOCALIZATION; TEGMENTUM; NUCLEUS; RAT; CAT; MICROINJECTIONS	Background: Previous work has suggested, but not demonstrated directly, a critical role for both glutamatergic and GABAergic neurons of the pontine tegmentum in the regulation of rapid eye movement (REM) sleep. Methodology/Principal Findings: To determine the in vivo roles of these fast-acting neurotransmitters in putative REM pontine circuits, we injected an adeno-associated viral vector expressing Cre recombinase (AAV-Cre) into mice harboring lox-P modified alleles of either the vesicular glutamate transporter 2 (VGLUT2) or vesicular GABA-glycine transporter (VGAT) genes. Our results show that glutamatergic neurons of the sublaterodorsal nucleus (SLD) and glycinergic/GABAergic interneurons of the spinal ventral horn contribute to REM atonia, whereas a separate population of glutamatergic neurons in the caudal laterodorsal tegmental nucleus (cLDT) and SLD are important for REM sleep generation. Our results further suggest that presynaptic GABA release in the cLDT-SLD, ventrolateral periaqueductal gray matter (vlPAG) and lateral pontine tegmentum (LPT) are not critically involved in REM sleep control. Conclusions/Significance: These findings reveal the critical and divergent in vivo role of pontine glutamate and spinal cord GABA/glycine in the regulation of REM sleep and atonia and suggest a possible etiological basis for REM sleep behavior disorder (RBD).	[Krenzer, Martina; Anaclet, Christelle; Vetrivelan, Ramalingam; Wang, Nishang; Fuller, Patrick M.; Lu, Jun] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Sleep Med, Boston, MA 02215 USA; [Linh Vong; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Krenzer, Martina] Univ Marburg, Dept Neurol, Marburg, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Philipps University Marburg	Krenzer, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Sleep Med, Boston, MA 02215 USA.	jlu@bidmc.harvard.edu		Anaclet, Christelle/0000-0002-0526-8132	Public Service Grants [NS062727, NS061841, NS051609, AG09975, NS073613, NS072337]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073613, R01NS051609, R01NS062727, R01NS061841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER	Public Service Grants; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by Public Service Grants NS062727, NS061841, NS051609, AG09975, NS073613 and NS072337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANACLET C, PLOS ONE, V5, pE8788; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Chou TC, 2003, J NEUROSCI, V23, P10691; Clement O, 2011, SLEEP, V34, P419, DOI 10.1093/sleep/34.4.419; Crochet S, 2006, EUR J NEUROSCI, V24, P1404, DOI 10.1111/j.1460-9568.2006.04995.x; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Fuller PM, 2007, J PHYSIOL-LONDON, V584, P735, DOI 10.1113/jphysiol.2007.140160; Gagnon JF, 2006, LANCET NEUROL, V5, P424, DOI 10.1016/S1474-4422(06)70441-0; JOUVET M, 1959, CR SOC BIOL, V153, P422; Kaur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006346; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; SAKAI K, 1986, CR ACAD SCI III-VIE, V303, P317; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; Scherfler C, 2011, ANN NEUROL, V69, P400, DOI 10.1002/ana.22245; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; SIEGEL JM, 1984, NEUROSCI LETT, V45, P241, DOI 10.1016/0304-3940(84)90233-7; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Vanini G, 2007, NEUROSCIENCE, V145, P1157, DOI 10.1016/j.neuroscience.2006.12.051; VANNIMERCIER G, 1991, NEUROSCI LETT, V130, P41, DOI 10.1016/0304-3940(91)90222-F; Vetrivelan R, 2009, J NEUROSCI, V29, P9361, DOI 10.1523/JNEUROSCI.0737-09.2009; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; ZERNICKI B, 1986, ARCH ITAL BIOL, V124, P133; Zhang X, 2009, SLEEP MED, V10, P143, DOI 10.1016/j.sleep.2007.12.002	32	96	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24998	10.1371/journal.pone.0024998	http://dx.doi.org/10.1371/journal.pone.0024998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043278	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400005
J	Farrar, CA; Keogh, B; McCormack, W; O'Shaughnessy, A; Parker, A; Reilly, M; Sacks, SH				Farrar, Conrad A.; Keogh, Brian; McCormack, William; O'Shaughnessy, Aisling; Parker, Andrew; Reilly, Mary; Sacks, Steven H.			Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury	FASEB JOURNAL			English	Article						kidney; Toll-like receptor	TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; ACUTE REJECTION; P-SELECTIN; COMPLEMENT; ACTIVATION; KIDNEY; EXPRESSION; CELLS; C3	Toll-like receptors (TLRs) are important molecules involved in the activation of innate and subsequent development of adaptive immunity. TLRs are ligated by exogenous ligands from pathogens and by endogenous ligands released in inflammatory diseases. Activation of TLR leads to activation of NF-kappa B and release of proinflammatory cytokines, such as IL-6 and TNF-alpha. TLRs play an important role in the pathogenesis of renal diseases. Increased expression of TLRs have been associated with ischemic kidney damage, acute kidney injury, end-stage renal failure, acute renal transplant rejection, and delayed allograft function. OPN301 is a mouse anti-human TLR2 antibody that cross-reacts with mouse TLR2. We show that inhibition of TLR2 promotes graft function in an isograft model of renal transplantation. Recipient mice were treated intravenously with OPN301 before reperfusion of the transplanted kidney that had been subjected to 30 min of cold ischemia. After 5 d, the residual native kidney was removed, and renal transplant function was assessed 24 h later by measurement of blood urea nitrogen. Renal function in both saline-and isotype-treated mice was similar, with significant improvement in OPN301-treated mice (isotypetreated vs. OPN301-treated: 33.9 +/- 3.2 vs. 19.8 +/- 1.9 mu M; P<0.01). The histopathological appearance corresponded with renal functional results. In OPN301-treated recipients, renal structure was well preserved, whereas in the saline-treated group, tubular injury was severe, with marked tubular thinning, epithelial shedding, cast formation and necrosis. Inhibition of TLR2 also leads to a decrease in C3d deposition, although it is unclear whether this is due directly to TLR2 inhibition or a decrease in renal inflammation. This study shows that inhibition of TLR2 with a therapeutic agent (OPN301) provides significant protection from ischemia/reperfusion injury in amodel of kidney transplantation.-Farrar, C. A., Keogh, B., McCormack, W., O'Shaughnessy, A., Parker, A., Reilly, M., Sacks, S. H. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J. 26, 799-807 (2012). www.fasebj.org	[Sacks, Steven H.] Kings Coll London, Sch Med Guys, Div Transplantat Immunol & Mucosal Biol, MRC Ctr Transplantat,Dept Nephrol & Transplantat, London SE1 9RT, England; [Sacks, Steven H.] Guys Hosp, St Thomas Hosp, London SE1 9RT, England; [Keogh, Brian; McCormack, William; O'Shaughnessy, Aisling; Parker, Andrew; Reilly, Mary] Trinity Coll Dublin, Inst Mol Med, Trinity Ctr Hlth Sci, St James Hosp, Dublin, Ireland	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Trinity College Dublin	Sacks, SH (corresponding author), Kings Coll London, Sch Med Guys, Div Transplantat Immunol & Mucosal Biol, MRC Ctr Transplantat,Dept Nephrol & Transplantat, London SE1 9RT, England.	steven.sacks@kcl.ac.uk		McCormack, William/0000-0003-3748-5729; Sacks, Steven/0000-0001-6361-9095	Medical Research Council Centre for Transplantation; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; St. Thomas' National Health Service (NHS) Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; National Institute for Health Research [NF-SI-0510-10142] Funding Source: researchfish	Medical Research Council Centre for Transplantation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St. Thomas' National Health Service (NHS) Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge the support of the Medical Research Council Centre for Transplantation and acknowledge financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; BONVENTRE JV, 1993, KIDNEY INT, V43, P1160, DOI 10.1038/ki.1993.163; Breslin JW, 2008, SHOCK, V29, P349, DOI 10.1097/shk.0b013e3181454975; Damman J, 2011, AM J TRANSPLANT, V11, P660, DOI 10.1111/j.1600-6143.2011.03475.x; Farrar CA, 2004, AM J PATHOL, V164, P133, DOI 10.1016/S0002-9440(10)63104-5; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Gerondakis S, 2007, IMMUNOL CELL BIOL, V85, P471, DOI 10.1038/sj.icb.7100097; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hadley JS, 2007, SHOCK, V27, P466, DOI 10.1097/01.shk.0000245033.69977.c5; Halloran PF, 1997, TRANSPL P, V29, P79, DOI 10.1016/S0041-1345(96)00015-2; He HZ, 2002, TRANSPLANTATION, V73, P853, DOI 10.1097/00007890-200203270-00005; Hoffmann U, 2011, NEPHROL DIAL TRANSPL, V26, P1080, DOI 10.1093/ndt/gfq420; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; KALINA SL, 1993, AUST NZ J SURG, V63, P213, DOI 10.1111/j.1445-2197.1993.tb00521.x; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Land Walter Gottlieb, 2006, Exp Clin Transplant, V4, P406; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Moller-Kristensen M, 2005, SCAND J IMMUNOL, V61, P426, DOI 10.1111/j.1365-3083.2005.01591.x; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; Pagtalunan ME, 1999, J AM SOC NEPHROL, V10, P366; Pope MR, 2010, MOL IMMUNOL, V48, P356, DOI 10.1016/j.molimm.2010.07.004; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Raymond Tracy, 2007, Proc Am Thorac Soc, V4, P635, DOI 10.1513/pats.200706-067TH; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Singbartl K, 2000, FASEB J, V14, P48, DOI 10.1096/fasebj.14.1.48; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Wang MY, 2011, CELL MOL IMMUNOL, V8, P265, DOI 10.1038/cmi.2011.1; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636; ZHANG Z, 1995, MICROSURG, V16, P103, DOI 10.1002/micr.1920160212; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	38	61	70	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					799	807		10.1096/fj.11-195396	http://dx.doi.org/10.1096/fj.11-195396			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22042224				2022-12-25	WOS:000300485700031
J	Liu, P; Chen, BJ; Wang, ZW				Liu, Ping; Chen, Bojun; Wang, Zhao-Wen			Gap Junctions Synchronize Action Potentials and Ca2+ Transients in Caenorhabditis elegans Body Wall Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; SYNAPTIC-TRANSMISSION; ELECTRICAL SYNAPSES; NERVE CORD; GABA; OSCILLATIONS; LOCOMOTION; NETWORKS; RECEPTOR; ENCODES	The sinusoidal locomotion of Caenorhabditis elegans requires synchronous activities of neighboring body wall muscle cells. However, it is unknown whether the synchrony results from muscle electrical coupling or neural inputs. We analyzed the effects of mutating gap junction proteins and blocking neuromuscular transmission on the synchrony of action potentials (APs) and Ca2+ transients among neighboring body wall muscle cells. In wild-type worms, the percentage of synchronous APs between two neighboring cells varied depending on the anatomical relationship and junctional conductance (G(j)) between them, and Ca2+ transients were synchronous among neighboring muscle cells. Compared with the wild type, knock-out of the gap junction gene unc-9 resulted in greatly reduced coupling coefficient and asynchronous APs and Ca2+ transients. Inhibition of unc-9 expression specifically in muscle by RNAi also reduced the synchrony of APs and Ca2+ transients, whereas expression of wild-type UNC-9 specifically in muscle rescued the synchrony defect. Loss of the stomatin-like protein UNC-1, which is a regulator of UNC-9-based gap junctions, similarly impaired muscle synchrony as unc-9 mutant did. The blockade of muscle ionotropic acetylcholine receptors by (+)-tubocurarine decreased the frequencies of APs and Ca2+ transients, whereas blockade of muscle GABA(A) receptors by gabazine had opposite effects. However, both APs and Ca2+ transients remained synchronous after the application of (+)-tubocurarine and/or gabazine. These observations suggest that gap junctions in C. elegans body wall muscle cells are responsible for synchronizing muscle APs and Ca2+ transients.	[Liu, Ping; Chen, Bojun; Wang, Zhao-Wen] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA	University of Connecticut	Wang, ZW (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	zwwang@uchc.edu	Liu, Ping/B-1509-2014		National Institutes of Health [5R01GM083049, 1R01MH085927]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM083049 and 1R01MH085927 (to Z.-W. W.).	Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Bamber BA, 1999, J NEUROSCI, V19, P5348; Barnes TM, 1997, J NEUROCHEM, V69, P2251; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Boyle JH, 2008, BIOSYSTEMS, V94, P170, DOI 10.1016/j.biosystems.2008.05.025; BRENNER S, 1974, GENETICS, V77, P71; Bryden J, 2008, BIOL CYBERN, V98, P339, DOI 10.1007/s00422-008-0212-6; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Chen BJ, 2007, CURR BIOL, V17, P1334, DOI 10.1016/j.cub.2007.06.060; Chen BJ, 2010, EMBO J, V29, P3184, DOI 10.1038/emboj.2010.194; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; DEBELL JT, 1963, J CELL COMPAR PHYSL, V62, P159, DOI 10.1002/jcp.1030620206; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; EVANS T, 2006, WORMBOOK C ELEGANS R; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GOODMAN MB, 2006, WORMBOOK C ELEGANS R; Haspel G, 2010, J NEUROSCI, V30, P11151, DOI 10.1523/JNEUROSCI.2244-10.2010; Hobert O, 2003, J NEUROBIOL, V54, P203, DOI 10.1002/neu.10168; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Karbowski J, 2008, J COMPUT NEUROSCI, V24, P253, DOI 10.1007/s10827-007-0054-6; LEWIS JA, 1980, GENETICS, V95, P905; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Liu Q, 2005, J NEUROSCI, V25, P6745, DOI 10.1523/JNEUROSCI.1730-05.2005; Liu Q, 2007, DEV NEUROBIOL, V67, P123, DOI 10.1002/dneu.20307; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Norman KR, 2007, CURR BIOL, V17, pR812, DOI 10.1016/j.cub.2007.07.043; OKKEMA PG, 1993, GENETICS, V135, P385; PARK EC, 1986, GENETICS, V113, P821; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Rajaram S, 1998, P NATL ACAD SCI USA, V95, P8761, DOI 10.1073/pnas.95.15.8761; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; SEDENSKY MM, 1987, SCIENCE, V236, P952, DOI 10.1126/science.3576211; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Ueno S, 1997, J NEUROSCI, V17, P625; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; WEISBLAT DA, 1976, J COMP PHYSIOL, V107, P293, DOI 10.1007/BF00656739; WERMUTH CG, 1986, TRENDS PHARMACOL SCI, V7, P421, DOI 10.1016/0165-6147(86)90408-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Zhang Y, 1998, J NEUROSCI, V18, P9256; Zhou B, 2009, IEEE ENG MED BIO, P4937, DOI 10.1109/IEMBS.2009.5332713	53	18	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44285	44293		10.1074/jbc.M111.292078	http://dx.doi.org/10.1074/jbc.M111.292078			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033926	hybrid, Green Published			2022-12-25	WOS:000298402300068
J	Banasavadi-Siddegowda, YK; Mai, JB; Fan, YF; Bhattacharya, S; Giovannucci, DR; Sanchez, ER; Fischer, G; Wang, XD				Banasavadi-Siddegowda, Yeshavanth K.; Mai, Junbo; Fan, Yifei; Bhattacharya, Sumit; Giovannucci, David R.; Sanchez, Edwin R.; Fischer, Gunter; Wang, Xiaodong			FKBP38 Peptidylprolyl Isomerase Promotes the Folding of Cystic Fibrosis Transmembrane Conductance Regulator in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN 38 FKBP38; MAMMALIAN TARGET; GLUCOCORTICOID-RECEPTOR; DYNEIN INTERACTION; CFTR; DEGRADATION; INHIBITOR; BINDING; DOMAIN; BCL-2	FK506-binding protein 38 (FKBP38), a membrane-anchored, tetratricopeptide repeat (TPR)-containing immunophilin, associates with nascent plasma membrane ion channels in the endoplasmic reticulum (ER). It promotes the maturation of the human ether-a-go-go-related gene (HERG) potassium channel and maintains the steady state level of the cystic fibrosis transmembrane conductance regulator (CFTR), but the underlying mechanisms remain unclear. Using a combination of steady state and pulse-chase analyses, we show that FKBP38 knockdown increases protein synthesis but inhibits the post-translational folding of CFTR, leading to reduced steady state levels of CFTR in the ER, decreased processing, and impaired cell surface functional expression in Calu-3 human airway epithelial cells. The membrane anchorage of FKBP38 is necessary for the inhibition of protein synthesis but not for CFTR post-translational folding. In contrast, the peptidylprolyl cis/trans isomerase active site is utilized to promote CFTR post-translational folding but is not important for regulation of protein synthesis. Uncoupling FKBP38 from Hsp90 by substituting a conserved lysine in the TPR domain modestly enhances CFTR maturation and further reduces its synthesis. Removing the N-terminal glutamate-rich domain (ERD) slightly enhances CFTR synthesis but reduces its maturation, suggesting that the ERD contributes to FKBP38 biological activities. Our data support a dual role for FKBP38 in regulating CFTR synthesis and post-translational folding. In contrast to earlier prediction but consistent with in vitro enzymological studies, FKBP38 peptidylprolyl cis/trans isomerase plays an important role in membrane protein biogenesis on the cytoplasmic side of the ER membrane, whose activity is negatively regulated by Hsp90 through the TPR domain.	[Banasavadi-Siddegowda, Yeshavanth K.; Mai, Junbo; Fan, Yifei; Sanchez, Edwin R.; Wang, Xiaodong] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Bhattacharya, Sumit; Giovannucci, David R.] Univ Toledo, Coll Med, Dept Neurosci, Toledo, OH 43614 USA; [Sanchez, Edwin R.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Fischer, Gunter] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Max Planck Society	Wang, XD (corresponding author), 3000 Arlington Ave,Mail Stop 1008, Toledo, OH 43614 USA.	xiaodong.wang@utoledo.edu	Mai, Junbo/HHC-4505-2022; Giovannucci, David R/A-5657-2018	/0000-0002-4730-6918	American Heart Association; University of Toledo Health Science Campus; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070127] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Toledo Health Science Campus; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Scientist Development Grant from the American Heart Association (to X. W.) and the University of Toledo Health Science Campus (to X. W.).	Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Choi BH, 2010, J BIOL CHEM, V285, P9770, DOI 10.1074/jbc.M109.032466; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Edlich E, 2006, HANDB EXP PHARM, V172, P359; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; Edlich F, 2011, CURR OPIN PHARMACOL, V11, P348, DOI 10.1016/j.coph.2011.03.011; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Fischer G, 2006, MOL MICROBIOL, V61, P1388, DOI 10.1111/j.1365-2958.2006.05349.x; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Galigniana MD, 2002, BIOCHEMISTRY-US, V41, P13602, DOI 10.1021/bi020399z; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; GERMAIN M, 2003, SCI STKE, pPE10; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; Kang CB, 2005, BIOCHEM BIOPH RES CO, V337, P30, DOI 10.1016/j.bbrc.2005.09.023; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Munkonge Felix, 2004, J Cyst Fibros, V3 Suppl 2, P171, DOI 10.1016/j.jcf.2004.05.036; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Norville IH, 2011, BIOCHEM J, V437, P413, DOI 10.1042/BJ20110345; Oberdorf J, 2005, J BIOL CHEM, V280, P38193, DOI 10.1074/jbc.M504200200; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	54	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43071	43080		10.1074/jbc.M111.269993	http://dx.doi.org/10.1074/jbc.M111.269993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22030396	Green Published, hybrid			2022-12-25	WOS:000298351300028
J	O'Neill, AK; Gallegos, LL; Justilien, V; Garcia, EL; Leitges, M; Fields, AP; Hall, RA; Newton, AC				O'Neill, Audrey K.; Gallegos, Lisa L.; Justilien, Verline; Garcia, Erin L.; Leitges, Michael; Fields, Alan P.; Hall, Randy A.; Newton, Alexandra C.			Protein Kinase C alpha Promotes Cell Migration through a PDZ-Dependent Interaction with its Novel Substrate Discs Large Homolog 1 (DLG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TUMOR-SUPPRESSOR; PKC-ALPHA; ANTISENSE OLIGONUCLEOTIDE; DOMAINS; EXPRESSION; DROSOPHILA; PHOSPHORYLATION; ASSOCIATION; POLARITY; COMPLEX	Protein scaffolds maintain precision in kinase signaling by coordinating kinases with components of specific signaling pathways. Such spatial segregation is particularly important in allowing specificity of signaling mediated by the 10-member family of protein kinase C (PKC) isozymes. Here we identified a novel interaction between PKC alpha and the Discs large homolog (DLG) family of scaffolds that is mediated by a class I C-terminal PDZ (PSD-95, disheveled, and ZO1) ligand unique to this PKC isozyme. Specifically, use of a proteomic array containing 96 purified PDZ domains identified the third PDZ domains of DLG1/SAP97 and DLG4/PSD95 as interaction partners for the PDZ binding motif of PKC alpha. Co-immunoprecipitation experiments verified that PKC alpha and DLG1 interact in cells by a mechanism dependent on an intact PDZ ligand. Functional assays revealed that the interaction of PKC alpha with DLG1 promotes wound healing; scratch assays using cells depleted of PKC alpha and/or DLG1 have impaired cellular migration that is no longer sensitive to PKC inhibition, and the ability of exogenous PKC alpha to rescue cellular migration is dependent on the presence of its PDZ ligand. Furthermore, we identified Thr-656 as a novel phosphorylation site in the SH3-Hook region of DLG1 that acts as a marker for PKC alpha activity at this scaffold. Increased phosphorylation of Thr-656 is correlated with increased invasiveness in non-small cell lung cancer lines from the NCI-60, consistent with this phosphorylation site serving as a marker of PKC alpha mediated invasion. Taken together, these data establish the requirement of scaffolding to DLG1 for PKC alpha to promote cellular migration.	[O'Neill, Audrey K.; Gallegos, Lisa L.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [O'Neill, Audrey K.; Gallegos, Lisa L.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Justilien, Verline; Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Garcia, Erin L.; Hall, Randy A.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway	University of California System; University of California San Diego; University of California System; University of California San Diego; Mayo Clinic; Emory University; University of Oslo	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Leitges, Michael/AAN-1953-2021	Hall, Randy/0000-0002-8318-8728; Leitges, Michael/0000-0003-4203-6995	National Institutes of Health [GM43154, P01 DK54441, CA081436, 1F31GM083628]; University of California at San Diego through NIGMS, National Institutes of Health [T32 GM007752]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at San Diego through NIGMS, National Institutes of Health	This work was supported, in whole or in part, by National Institutes of Health Grants GM43154 and P01 DK54441 (both to A. C. N.) and CA081436 (to A. P. F.).; Supported in part by the University of California at San Diego Graduate Training Program in Cellular and Molecular Pharmacology through NIGMS, National Institutes of Health Institutional Training Grant T32 GM007752.; Supported by National Research Service Award Grant National Institutes of Health 1F31GM083628. Present address: Dept. of Cell Biology, Harvard Medical School, Cambridge, MA 02115.	Abeyweera TP, 2009, J BIOL CHEM, V284, P17648, DOI 10.1074/jbc.M902005200; Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; Arora S, 2011, INT J CANCER, V129, P2621, DOI 10.1002/ijc.25939; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Cavatorta AL, 2004, INT J CANCER, V111, P373, DOI 10.1002/ijc.20275; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dean N, 1996, CANCER RES, V56, P3499; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Fields AP, 2008, ADV ENZYME REGUL, V48, P166, DOI 10.1016/j.advenzreg.2007.11.014; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Guo JJ, 2008, CANCER RES, V68, P8473, DOI 10.1158/0008-5472.CAN-08-0131; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Hsu YC, 2009, CLIN CANCER RES, V15, P7309, DOI 10.1158/1078-0432.CCR-09-1572; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Kim J, 2011, ONCOGENE, V30, P323, DOI 10.1038/onc.2010.415; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Kunkel MT, 2009, J BIOL CHEM, V284, P24653, DOI 10.1074/jbc.M109.024547; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lin CW, 2010, J CELL PHYSIOL, V225, P472, DOI 10.1002/jcp.22226; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Manneville JB, 2010, J CELL BIOL, V191, P585, DOI 10.1083/jcb.201002151; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Park ES, 2010, MOL CANCER THER, V9, P257, DOI 10.1158/1535-7163.MCT-09-0743; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Paz-Ares L, 2006, J CLIN ONCOL, V24, P1428, DOI 10.1200/JCO.2005.04.3299; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Roberts S, 2007, EXP CELL RES, V313, P2521, DOI 10.1016/j.yexcr.2007.05.017; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Unno K, 2008, EXP CELL RES, V314, P3118, DOI 10.1016/j.yexcr.2008.07.032; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493	56	42	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43559	43568		10.1074/jbc.M111.294603	http://dx.doi.org/10.1074/jbc.M111.294603			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027822	Green Published, hybrid			2022-12-25	WOS:000298351300075
J	Corin, K; Baaske, P; Ravel, DB; Song, JY; Brown, E; Wang, XQ; Geissler, S; Wienken, CJ; Jerabek-Willemsen, M; Duhr, S; Braun, D; Zhang, SG				Corin, Karolina; Baaske, Philipp; Ravel, Deepali B.; Song, Junyao; Brown, Emily; Wang, Xiaoqiang; Geissler, Sandra; Wienken, Christoph J.; Jerabek-Willemsen, Moran; Duhr, Stefan; Braun, Dieter; Zhang, Shuguang			A Robust and Rapid Method of Producing Soluble, Stable, and Functional G-Protein Coupled Receptors	PLOS ONE			English	Article							CELL-FREE EXPRESSION; MEMBRANE-PROTEINS; HUMAN ENDOTHELIN; BINDING; PURIFICATION; DETERGENTS	Membrane proteins, particularly G-protein coupled receptors (GPCRs), are notoriously difficult to express. Using commercial E. coli cell-free systems with the detergent Brij-35, we could rapidly produce milligram quantities of 13 unique GPCRs. Immunoaffinity purification yielded receptors at >90% purity. Secondary structure analysis using circular dichroism indicated that the purified receptors were properly folded. Microscale thermophoresis, a novel label-free and surface-free detection technique that uses thermal gradients, showed that these receptors bound their ligands. The secondary structure and ligand-binding results from cell-free produced proteins were comparable to those expressed and purified from HEK293 cells. Our study demonstrates that cell-free protein production using commercially available kits and optimal detergents is a robust technology that can be used to produce sufficient GPCRs for biochemical, structural, and functional analyses. This robust and simple method may further stimulate others to study the structure and function of membrane proteins.	[Corin, Karolina; Ravel, Deepali B.; Song, Junyao; Brown, Emily; Wang, Xiaoqiang; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Baaske, Philipp; Geissler, Sandra; Jerabek-Willemsen, Moran; Duhr, Stefan] NanoTemper Technol GmbH, Munich, Germany; [Wang, Xiaoqiang] China Univ Petr E China, Ctr Bioengn & Biotechnol, Qingdao, Shandong, Peoples R China; [Wienken, Christoph J.; Braun, Dieter] Univ Munich, Munich, Germany	Massachusetts Institute of Technology (MIT); China University of Petroleum; University of Munich	Corin, K (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu		Zhang, Shuguang/0000-0002-3856-3752; Corin, Karolina/0000-0003-3080-5742	MIT UROP Funding;  [DARPA-HR0011-09-C-0012]	MIT UROP Funding; 	This work is supported by DARPA-HR0011-09-C-0012 and MIT UROP Funding. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philipp Baaske, Moran Jerabek-Willemsen and Stefan Duhr are employees of NanoTemper Technologies GmbH; these authors contributed to all aspects of the study.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; DENIAUD A, 2008, BIOCHIM BIOPHYS ACTA, V1798, P1540; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013; Junge F, 2010, J STRUCT BIOL, V172, P94, DOI 10.1016/j.jsb.2010.05.004; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Kaiser L, 2008, P NATL ACAD SCI USA, V105, P15726, DOI 10.1073/pnas.0804766105; KAMONCHANOK S, 2008, J PROTEOME RES, V7, P621; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Klammt C, 2007, FEBS J, V274, P3257, DOI 10.1111/j.1742-4658.2007.05854.x; Klammt C, 2007, J STRUCT BIOL, V158, P482, DOI 10.1016/j.jsb.2007.01.006; Leck KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015027; Liguori L., 2008, CURR PROTOC PROTEIN, V5, P22; Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107; Rasband W., 2006, IMAGEJ; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Schwarz D, 2008, PROTEOMICS, V8, P3933, DOI 10.1002/pmic.200800171; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093	28	36	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e23036	10.1371/journal.pone.0023036	http://dx.doi.org/10.1371/journal.pone.0023036			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22039398	Green Published, Green Submitted, gold			2022-12-25	WOS:000296517000001
J	Demougeot, L; Toupet, M; Van Nechel, C; Papaxanthis, C				Demougeot, Laurent; Toupet, Michel; Van Nechel, Christian; Papaxanthis, Charalambos			Action Representation in Patients with Bilateral Vestibular Impairments	PLOS ONE			English	Article							MOTOR IMAGERY; TEMPORAL FEATURES; SIMULATED MOVEMENTS; MENTAL PRACTICE; BODY; GAIT; PERFORMANCE; LOCOMOTION; EXECUTION; DOMINANT	During mental actions subjects feel themselves performing a movement without any corresponding motor output. Although broad information is available regarding the influence of central lesions on action representation, little is known about how peripheral damages affect mental events. In the current study, we investigated whether lack of vestibular information influences action representation. Twelve healthy adults and twelve patients with bilateral vestibular damage actually performed and mentally simulated walking and drawing. The locomotor paths implied one (first walking task) and four (second walking task) changes in the walking direction. In the drawing task, participants drew on a sheet of paper a path that was similar to that of the second walking task. We recorded and compared between the two groups the timing of actual and mental movements. We found significant temporal discrepancies between actual and mental walking movements in the group of patients. Conversely, drawing actual and drawing mental durations were similar. For the control group, an isochrony between mental and actual movements was observed for the three tasks. This result denotes an inconsistency between action representation and action execution following vestibular damage, which is specific to walking movements, and emphasizes the role of the vestibular system upon mental states of actions. This observation may have important clinical implications. During action planning vestibular patients may overestimate the capacity of their motor system (imaging faster, executing slower) with harmful consequences for their health.	[Demougeot, Laurent; Papaxanthis, Charalambos] Univ Bourgogne, UFR STAPS, Dijon, France; [Demougeot, Laurent; Papaxanthis, Charalambos] Motricite & Plasticite, Unite 887, Inst Natl Sante & Rech Med, Dijon, France; [Toupet, Michel] Ctr Explorat Fonct Oto Neurol, Paris, France; [Toupet, Michel; Van Nechel, Christian] Inst Rech Oto Neurol, IRON, Paris, France; [Van Nechel, Christian] CHU Brugmann, Unite Troubles Equilibre & Vertiges, Brussels, Belgium; [Van Nechel, Christian] CHU Erasme, Unite Neuro Ophtalmol, Brussels, Belgium	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Libre de Bruxelles	Demougeot, L (corresponding author), Univ Bourgogne, UFR STAPS, Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr			INSERM (Institut National de la Sante et de la Recherche Medicale); Conseil Regional de Bourgogne	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte)	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale) and by the Conseil Regional de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allami N, 2008, EXP BRAIN RES, V184, P105, DOI 10.1007/s00221-007-1086-x; Allum J H, 1994, J Vestib Res, V4, P49; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; BLACK FO, 1984, ACTA OTO-LARYNGOL, P110; Borel L, 2004, BEHAV BRAIN RES, V150, P191, DOI 10.1016/S0166-4328(03)00257-2; Cerritelli B, 2000, BEHAV BRAIN RES, V108, P91, DOI 10.1016/S0166-4328(99)00138-2; Collet C, 2011, EXERC SPORT SCI REV, V39, P85, DOI 10.1097/JES.0b013e31820ac5e0; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; Danckert J, 2002, NEUROCASE, V8, P194, DOI 10.1076/neur.8.2.194.16204; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Demougeot L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006769; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fox C R, 1990, J Vestib Res, V1, P153; Frak V, 2004, NEUROREPORT, V15, P1489, DOI 10.1097/01.wnr.0000132429.68206.48; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; GENTILI RJ, 2010, J NEUROPHYSIOL; Gentili R, 2010, J NEUROPHYSIOL, V104, P774, DOI 10.1152/jn.00257.2010; Grabherr L, 2007, J VESTIBUL RES-EQUIL, V17, P279; Grabherr L, 2011, EXP BRAIN RES, V209, P205, DOI 10.1007/s00221-011-2535-0; GROSSMAN GE, 1990, ANN NEUROL, V27, P528, DOI 10.1002/ana.410270512; Gueugneau N, 2008, BRAIN RES, V1187, P95, DOI 10.1016/j.brainres.2007.10.042; Gueugneau N, 2010, CHRONOBIOL INT, V27, P620, DOI 10.3109/07420521003664205; Gueugneau N, 2009, NEUROREHAB NEURAL RE, V23, P237, DOI 10.1177/1545968308321775; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kagerer FA, 1998, EXP BRAIN RES, V121, P125, DOI 10.1007/s002210050444; Lenggenhager B, 2008, EXP BRAIN RES, V184, P211, DOI 10.1007/s00221-007-1095-9; Lopez C, 2011, MED HYPOTHESES, V76, P816, DOI 10.1016/j.mehy.2011.02.026; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Malouin F, 2004, NEUROREPORT, V15, P1349, DOI 10.1097/01.wnr.0000127465.94899.72; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Malouin F, 2010, PHYS THER, V90, P240, DOI 10.2522/ptj.20090029; Maruff P, 2003, SCHIZOPHR RES, V60, P229, DOI 10.1016/S0920-9964(02)00214-1; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P379, DOI 10.1016/S0028-3932(98)00064-5; Mast FW, 2006, NEUROPSYCHOLOGIA, V44, P101, DOI 10.1016/j.neuropsychologia.2005.04.005; METCALFE T, 1992, ANN NY ACAD SCI, V656, P695; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Peruch P, 2005, COGNITIVE BRAIN RES, V25, P862, DOI 10.1016/j.cogbrainres.2005.09.012; POZZO T, 1991, ACTA OTO-LARYNGOL, P322; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; Rodrigues EC, 2010, NEUROSCIENCE, V169, P743, DOI 10.1016/j.neuroscience.2010.04.081; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; vonBrevern M, 1997, AM J OTOL, V18, P484; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Yaguez L, 1998, BEHAV BRAIN RES, V90, P95, DOI 10.1016/S0166-4328(97)00087-9	56	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26764	10.1371/journal.pone.0026764	http://dx.doi.org/10.1371/journal.pone.0026764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039548	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200049
J	Minge, D; Bahring, R				Minge, Daniel; Baehring, Robert			Acute Alterations of Somatodendritic Action Potential Dynamics in Hippocampal CA1 Pyramidal Cells after Kainate-Induced Status Epilepticus in Mice	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; POTASSIUM CHANNEL SUBUNITS; LONG-LASTING MODIFICATION; PILOCARPINE MODEL; SODIUM CURRENTS; DOWN-REGULATION; AFTER-HYPERPOLARIZATION; CURRENT CONTRIBUTES; ALTERED EXPRESSION; VOLTAGE CLAMP	Pathophysiological remodeling processes at an early stage of an acquired epilepsy are critical but not well understood. Therefore, we examined acute changes in action potential (AP) dynamics immediately following status epilepticus (SE) in mice. SE was induced by intraperitoneal (i.p.) injection of kainate, and behavioral manifestation of SE was monitored for 3-4 h. After this time interval CA1 pyramidal cells were studied ex vivo with whole-cell current-clamp and Ca2+ imaging techniques in a hippocampal slice preparation. Following acute SE both resting potential and firing threshold were modestly depolarized (2-5 mV). No changes were seen in input resistance or membrane time constant, but AP latency was prolonged and AP upstroke velocity reduced following acute SE. All cells showed an increase in AP halfwidth and regular (rather than burst) firing, and in a fraction of cells the notch, typically preceding spike afterdepolarization (ADP), was absent following acute SE. Notably, the typical attenuation of backpropagating action potential (b-AP)-induced Ca2+ signals along the apical dendrite was strengthened following acute SE. The effects of acute SE on the retrograde spread of excitation were mimicked by applying the Kv4 current potentiating drug NS5806. Our data unveil a reduced somatodendritic excitability in hippocampal CA1 pyramidal cells immediately after acute SE with a possible involvement of both Na+ and K+ current components.	[Minge, Daniel; Baehring, Robert] Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Zellulare & Integrat Physiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Minge, D (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Zellulare & Integrat Physiol, Hamburg, Germany.	r.baehring@uke.uni-hamburg.de		Bahring, Robert/0000-0002-0406-5958	Deutsche Forschungsgemeinschaft (DFG) [BA 2055/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant BA 2055/4-1 from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Berger M L, 1986, Adv Exp Med Biol, V203, P199; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chen S, 2011, J NEUROPHYSIOL, V105, P117, DOI 10.1152/jn.00184.2010; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dichter MA, 2009, ARCH NEUROL-CHICAGO, V66, P443, DOI 10.1001/archneurol.2009.10; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Ermolinsky B, 2008, NEUROREPORT, V19, P1291, DOI 10.1097/WNR.0b013e3283094bb6; Francis J, 1997, NEUROSCI LETT, V232, P91, DOI 10.1016/S0304-3940(97)00593-4; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; HajDahmane S, 1997, J NEUROPHYSIOL, V78, P1983, DOI 10.1152/jn.1997.78.4.1983; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jones-Davis DM, 2003, CURR OPIN PHARMACOL, V3, P12, DOI 10.1016/S1471-4892(02)00015-2; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Ketelaars SOM, 2001, NEUROSCIENCE, V105, P109, DOI 10.1016/S0306-4522(01)00176-2; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lugo JN, 2008, J NEUROCHEM, V106, P1929, DOI 10.1111/j.1471-4159.2008.05508.x; Lundby A, 2010, BRIT J PHARMACOL, V160, P2028, DOI 10.1111/j.1476-5381.2010.00859.x; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Magistretti J, 2006, J PHYSIOL-LONDON, V573, P83, DOI 10.1113/jphysiol.2006.106682; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; Mitterdorfer J, 2002, J NEUROSCI, V22, P10106; Monaghan MM, 2008, NEUROSCIENCE, V156, P550, DOI 10.1016/j.neuroscience.2008.07.057; Morrison RS, 1996, J NEUROSCI, V16, P1337; Otalora LFP, 2008, BRAIN RES, V1200, P116, DOI 10.1016/j.brainres.2008.01.017; Pedarzani P, 2005, J BIOL CHEM, V280, P41404, DOI 10.1074/jbc.M509610200; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Remy S, 2010, CURR OPIN NEUROBIOL, V20, P503, DOI 10.1016/j.conb.2010.06.006; Sanabria ERC, 2001, J PHYSIOL-LONDON, V532, P205, DOI 10.1111/j.1469-7793.2001.0205g.x; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; Sloviter RS, 2008, EPILEPSIA, V49, P85, DOI 10.1111/j.1528-1167.2008.01931.x; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Spitzer NC, 2002, CURR OPIN NEUROBIOL, V12, P315, DOI 10.1016/S0959-4388(02)00330-6; STORM JF, 1990, PROG BRAIN RES, V83, P161; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Su H, 2002, J NEUROSCI, V22, P3645; Su T, 2008, NEUROSCIENCE, V157, P566, DOI 10.1016/j.neuroscience.2008.09.027; Swensen AM, 2003, J NEUROSCI, V23, P9650; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Vreugdenhil M, 1998, NEUROSCIENCE, V86, P99, DOI 10.1016/S0306-4522(98)00041-4; Waters J, 2005, PROG BIOPHYS MOL BIO, V87, P145, DOI 10.1016/j.pbiomolbio.2004.06.009; Wellmer J, 2002, EUR J NEUROSCI, V16, P259, DOI 10.1046/j.1460-9568.2002.02086.x; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Yaari Y, 2007, J PHYSIOL-LONDON, V580, P435, DOI 10.1113/jphysiol.2007.127670; YAMADA N, 1991, BRAIN RES, V561, P324, DOI 10.1016/0006-8993(91)91611-4	73	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26664	10.1371/journal.pone.0026664	http://dx.doi.org/10.1371/journal.pone.0026664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039527	Green Submitted, Green Published, gold			2022-12-25	WOS:000296515200039
J	Sullivan, C; Chen, YY; Shan, Y; Hu, YG; Peng, C; Zhang, HJ; Kong, LH; Li, SG				Sullivan, Con; Chen, Yaoyu; Shan, Yi; Hu, Yiguo; Peng, Cong; Zhang, Haojian; Kong, Linghong; Li, Shaoguang			Functional Ramifications for the Loss of P-Selectin Expression on Hematopoietic and Leukemic Stem Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; MICE; INFLAMMATION	Hematopoiesis is a tightly regulated biological process that relies upon complicated interactions between blood cells and their microenvironment to preserve the homeostatic balance of long-term hematopoietic stem cells (LT-HSCs), short-term HSCs (ST-HSCs), multipotent progenitors (MPPs), and differentiated cells. Adhesion molecules like P-selectin (encoded by the Selp gene) are essential to hematopoiesis, and their dysregulation has been linked to leukemogenesis. Like HSCs, leukemic stem cells (LSCs) depend upon their microenvironments for survival and propagation. P-selectin plays a crucial role in Philadelphia chromosome -positive (Ph(+)) chronic myeloid leukemia (CML). In this paper, we show that cells deficient in P-selectin expression can repopulate the marrow more efficiently than wild type controls. This results from an increase in HSC self-renewal rather than alternative possibilities like increased homing velocity or cell cycle defects. We also show that P-selectin expression on LT-HSCs, but not ST-HSCs and MPPs, increases with aging. In the absence of P-selectin expression, mice at 6 months of age possess increased levels of short-term HSCs and multipotent progenitors. By 11 months of age, there is a shift towards increased levels of long-term HSCs. Recipients of BCR-ABL-transduced bone marrow cells from P-selectin-deficient donors develop a more aggressive CML, with increased percentages of LSCs and progenitors. Taken together, our data reveal that P-selectin expression on HSCs and LSCs has important functional ramifications for both hematopoiesis and leukemogenesis, which is most likely attributable to an intrinsic effect on stem cell self-renewal.	[Sullivan, Con] Maine Inst Human Genet & Hlth, Bangor, ME USA; [Chen, Yaoyu; Shan, Yi; Peng, Cong; Zhang, Haojian; Li, Shaoguang] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA; [Sullivan, Con; Chen, Yaoyu; Hu, Yiguo; Peng, Cong; Zhang, Haojian; Kong, Linghong; Li, Shaoguang] Jackson Lab, Bar Harbor, ME 04609 USA; [Hu, Yiguo] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory; Harvard University; Dana-Farber Cancer Institute	Sullivan, C (corresponding author), Maine Inst Human Genet & Hlth, Bangor, ME USA.	shaoguang.li@umassmed.edu	Zhang, Haojian/H-7897-2013; Peng, Cong/H-2286-2011; Shan, Yi/E-3862-2016	Hu, Yiguo/0000-0002-3973-2140	National Institutes of Health [CA122142, CA114199]; NATIONAL CANCER INSTITUTE [R01CA122142, R01CA114199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (CA122142,CA114199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007; Chambers SM, 2007, STEM CELL REV, V3, P201, DOI 10.1007/s12015-007-0027-1; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Ludwig RJ, 2007, EXPERT OPIN THER TAR, V11, P1103, DOI 10.1517/14728222.11.8.1103; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Pelletier SD, 2004, BLOOD, V104, P2163, DOI 10.1182/blood-2003-09-3033; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102	15	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26246	10.1371/journal.pone.0026246	http://dx.doi.org/10.1371/journal.pone.0026246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039451	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200007
J	Lebbink, RJ; Lowe, M; Chan, T; Khine, H; Wang, XY; McManus, MT				Lebbink, Robert Jan; Lowe, Maggie; Chan, Theresa; Khine, Htet; Wang, Xiaoyin; McManus, Michael T.			Polymerase II Promoter Strength Determines Efficacy of microRNA Adapted shRNAs	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; CAENORHABDITIS-ELEGANS; EXPRESSION VECTORS; INTERFERING RNAS; GENE-EXPRESSION; REGULATORY RNA; HAIRPIN RNAS; C-ELEGANS; SYSTEM	Since the discovery of RNAi and microRNAs more than 10 years ago, much research has focused on the development of systems that usurp microRNA pathways to downregulate gene expression in mammalian cells. One of these systems makes use of endogenous microRNA pri-cursors that are expressed from polymerase II promoters where the mature microRNA sequence is replaced by gene specific duplexes that guide RNAi (shRNA-miRs). Although shRNA-miRs are effective in directing target mRNA knockdown and hence reducing protein expression in many cell types, variability of RNAi efficacy in cell lines has been an issue. Here we show that the choice of the polymerase II promoter used to drive shRNA expression is of critical importance to allow effective mRNA target knockdown. We tested the abundance of shRNA-miRs expressed from five different polymerase II promoters in 6 human cell lines and measured their ability to drive target knockdown. We observed a clear positive correlation between promoter strength, siRNA expression levels, and protein target knockdown. Differences in RNAi from the shRNA-miRs expressed from the various promoters were particularly pronounced in immune cells. Our findings have direct implications for the design of shRNA-directed RNAi experiments and the preferred RNAi system to use for each cell type.	[Lebbink, Robert Jan; Lowe, Maggie; Chan, Theresa; Khine, Htet; Wang, Xiaoyin; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lebbink, RJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	michael.mcmanus@ucsf.edu	Lebbink, Robert Jan/GNH-5209-2022; mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Lebbink, Robert Jan/0000-0002-1981-0420	NIH [RO1GM80783]; Netherlands Organization for Scientific Research (NWO); UCSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); UCSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was funded by NIH RO1GM80783 to MTM, a Rubicon grant from The Netherlands Organization for Scientific Research (NWO) to RJL, and a grant from the UCSF Program for Breakthrough Biomedical Research to RJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2000, J VIROL, V74, P1286, DOI 10.1128/JVI.74.3.1286-1295.2000; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Ehlert EM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-20; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Ku G, 2008, HUM GENE THER, V19, P17, DOI 10.1089/hum.2007.1226; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rossi JJ, 2008, HUM GENE THER, V19, P313, DOI 10.1089/hum.2008.026; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salmon P, 2000, BLOOD, V96, P3392; Shan ZX, 2009, MOL BIOL REP, V36, P1483, DOI 10.1007/s11033-008-9339-8; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	35	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26213	10.1371/journal.pone.0026213	http://dx.doi.org/10.1371/journal.pone.0026213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031824	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200011
J	Alanazi, M; Abduljaleel, Z; Khan, W; Warsy, AS; Elrobh, M; Khan, Z; Al Amri, A; Bazzi, MD				Alanazi, Mohammed; Abduljaleel, Zainularifeen; Khan, Wajahatullah; Warsy, Arjumand S.; Elrobh, Mohamed; Khan, Zahid; Al Amri, Abdullah; Bazzi, Mohammad D.			In Silico Analysis of Single Nucleotide Polymorphism (SNPs) in Human beta-Globin Gene	PLOS ONE			English	Article							STABILITY CHANGES; PROTEIN-STRUCTURE; DATABASE; MUTATIONS; VARIANTS; HEMOGLOBINOPATHIES; SEQUENCE; IMPACT	Single amino acid substitutions in the globin chain are the most common forms of genetic variations that produce hemoglobinopathies- the most widespread inherited disorders worldwide. Several hemoglobinopathies result from homozygosity or compound heterozygosity to beta-globin (HBB) gene mutations, such as that producing sickle cell hemoglobin (HbS), HbC, HbD and HbE. Several of these mutations are deleterious and result in moderate to severe hemolytic anemia, with associated complications, requiring lifelong care and management. Even though many hemoglobinopathies result from single amino acid changes producing similar structural abnormalities, there are functional differences in the generated variants. Using in silico methods, we examined the genetic variations that can alter the expression and function of the HBB gene. Using a sequence homology-based Sorting Intolerant from Tolerant (SIFT) server we have searched for the SNPs, which showed that 200 (80%) non-synonymous polymorphism were found to be deleterious. The structure-based method via PolyPhen server indicated that 135 (40%) non-synonymous polymorphism may modify protein function and structure. The Pupa Suite software showed that the SNPs will have a phenotypic consequence on the structure and function of the altered protein. Structure analysis was performed on the key mutations that occur in the native protein coded by the HBB gene that causes hemoglobinopathies such as: HbC (E -> K), HbD (E -> Q), HbE (E -> K) and HbS (E -> V). Atomic Non-Local Environment Assessment (ANOLEA), Yet Another Scientific Artificial Reality Application (YASARA), CHARMM-GUI webserver for macromolecular dynamics and mechanics, and Normal Mode Analysis, Deformation and Refinement (NOMAD-Ref) of Gromacs server were used to perform molecular dynamics simulations and energy minimization calculations on beta-Chain residue of the HBB gene before and after mutation. Furthermore, in the native and altered protein models, amino acid residues were determined and secondary structures were observed for solvent accessibility to confirm the protein stability. The functional study in this investigation may be a good model for additional future studies.	[Alanazi, Mohammed; Abduljaleel, Zainularifeen; Khan, Wajahatullah; Warsy, Arjumand S.; Elrobh, Mohamed; Khan, Zahid; Al Amri, Abdullah; Bazzi, Mohammad D.] King Saud Univ, Coll Sci, Genome Res Chair Unit, Dept Biochem, Riyadh 11451, Saudi Arabia	King Saud University	Alanazi, M (corresponding author), King Saud Univ, Coll Sci, Genome Res Chair Unit, Dept Biochem, Riyadh 11451, Saudi Arabia.	zarifeen@ksu.edu.sa	Alamri, Abdullah M/C-3108-2012; Warsy, Arjumand/D-5274-2015; Elrobh, Mohamed S/H-5696-2012; Khan, Wajahatullah/J-9574-2012; abduljaleel, zainularifeen/AAE-8036-2021	Alamri, Abdullah M/0000-0002-3045-1350; Warsy, Arjumand/0000-0001-6957-203X; abduljaleel, zainularifeen/0000-0001-9791-1924; , Mohamed/0000-0003-1967-8850	King Saud University [RGP-VPP-081]	King Saud University(King Saud University)	The funding for this research was provided by the Deanship of scientific research at King Saud University (Project No RGP-VPP-081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow-Stewart K, 2007, GENETICS FAMILY MED; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cavallo A, 2005, BIOINFORMATICS, V21, P1443, DOI 10.1093/bioinformatics/bti220; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Doss CGP, 2009, NEW BIOTECHNOL, V25, P214, DOI 10.1016/j.nbt.2009.01.004; Driscoll MC, 2007, PEDIATR REV, V28, P259, DOI 10.1542/pir.28-7-259; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Fucharoen S, 1997, HEMOGLOBIN, V21, P299, DOI 10.3109/03630269709000664; Gilis D, 1996, J MOL BIOL, V257, P1112, DOI 10.1006/jmbi.1996.0226; Gilis D, 1997, J MOL BIOL, V272, P276, DOI 10.1006/jmbi.1997.1237; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gromiha MM, 2000, NUCLEIC ACIDS RES, V28, P283, DOI 10.1093/nar/28.1.283; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Hockney R. W., 1981, COMPUTER SIMULATION; Hurst JM, 2009, HUM MUTAT, V30, P616, DOI 10.1002/humu.20898; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Livingstone F. B., 1985, FREQUENCIES HEMOGLOB; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rees DC, 1998, ANN NY ACAD SCI, V850, P334, DOI 10.1111/j.1749-6632.1998.tb10490.x; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Savas S, 2004, CANCER EPIDEM BIOMAR, V13, P801; Sherry ST, 1999, GENOME RES, V9, P677; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016	40	34	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25876	10.1371/journal.pone.0025876	http://dx.doi.org/10.1371/journal.pone.0025876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028795	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800010
J	Bonazzi, VF; Nancarrow, DJ; Stark, MS; Moser, RJ; Boyle, GM; Aoude, LG; Schmidt, C; Hayward, NK				Bonazzi, Vanessa F.; Nancarrow, Derek J.; Stark, Mitchell S.; Moser, Ralf J.; Boyle, Glen M.; Aoude, Lauren G.; Schmidt, Christopher; Hayward, Nicholas K.			Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in Melanoma	PLOS ONE			English	Article							EXPRESSION PROFILING REVEALS; DNA METHYLATION; PROMOTER METHYLATION; TUMOR-SUPPRESSOR; ABERRANT METHYLATION; PGP9.5 METHYLATION; PROGNOSTIC-FACTOR; DECOY RECEPTORS; POOR-PROGNOSIS; MULTIPLE GENES	Epigenetic regulation of tumor suppressor genes (TSGs) has been shown to play a central role in melanomagenesis. By integrating gene expression and methylation array analysis we identified novel candidate genes frequently methylated in melanoma. We validated the methylation status of the most promising genes using highly sensitive Sequenom Epityper assays in a large panel of melanoma cell lines and resected melanomas, and compared the findings with those from cultured melanocytes. We found transcript levels of UCHL1, COL1A2, THBS1 and TNFRSF10D were inversely correlated with promoter methylation. For THBS1 and UCHL1 the effect of this methylation on expression was confirmed at the protein level. Identification of these candidate TSGs and future research designed to understand how their silencing is related to melanoma development will increase our understanding of the etiology of this cancer and may provide tools for its early diagnosis.	[Bonazzi, Vanessa F.; Nancarrow, Derek J.; Stark, Mitchell S.; Aoude, Lauren G.; Hayward, Nicholas K.] Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia; [Moser, Ralf J.] Queensland Inst Med Res, SEQUENOM, Asia Pacific Off, Brisbane, Qld 4006, Australia; [Boyle, Glen M.] Queensland Inst Med Res, Drug Discovery Grp, Brisbane, Qld 4006, Australia; [Schmidt, Christopher] Queensland Inst Med Res, Canc Immunotherapy Grp, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute	Bonazzi, VF (corresponding author), Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia.	vanessa.bonazzi@qimr.edu.au	hayward, nick/AAV-8802-2020; hayward, nicholas k/C-1367-2015; Stark, Mitchell S/E-3542-2010; Schmidt, Christopher W/A-4353-2009; Stark, Mitchell/K-6794-2019; Boyle, Glen/G-1347-2013; Bonazzi, Vanessa F/R-1676-2018; Aoude, Lauren/C-7484-2014; Stark, Mitchell/K-3874-2019	hayward, nicholas k/0000-0003-4760-1033; Stark, Mitchell S/0000-0002-4510-2161; Schmidt, Christopher W/0000-0002-3955-5076; Stark, Mitchell/0000-0002-4510-2161; Boyle, Glen/0000-0002-1385-529X; Bonazzi, Vanessa F/0000-0002-2574-0334; Aoude, Lauren/0000-0003-1448-3923; 	Cure Cancer Australia [552466]; National Health and Medical Research Council of Australia [442919]	Cure Cancer Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by Cure Cancer Australia, grant number 552466. NKH is a recipient of a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia, grant number 442919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton JA, 2008, NEURO-ONCOLOGY, V10, P981, DOI 10.1215/15228517-2008-048; Bauer AP, 2010, NUCLEIC ACIDS RES, V38, P3891, DOI 10.1093/nar/gkq115; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bonazzi VF, 2009, GENE CHROMOSOME CANC, V48, P10, DOI 10.1002/gcc.20615; Box NF, 2008, PIGM CELL MELANOMA R, V21, P525, DOI 10.1111/j.1755-148X.2008.00495.x; Castellano M, 1997, CANCER RES, V57, P4868; Chiba T, 2005, EUR J CANCER, V41, P1185, DOI 10.1016/j.ejca.2005.02.014; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1134; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Ghosh AK, 2004, J BIOL CHEM, V279, P47455, DOI 10.1074/jbc.M403477200; Gonzalez-Gomez P, 2004, INT J MOL MED, V13, P93; Guerrero D, 2008, BJU INT, V102, P747, DOI 10.1111/j.1464-410X.2008.07603.x; Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721485; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kagara I, 2008, J UROLOGY, V180, P343, DOI 10.1016/j.juro.2008.02.044; Kim JH, 2009, ONCOL REP, V21, P1251, DOI 10.3892/or_00000348; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Koga Y, 2009, GENOME RES; Lee S, 2004, LAB INVEST, V84, P884, DOI 10.1038/labinvest.3700108; Leonard JH, 2003, PIGM CELL RES, V16, P198, DOI 10.1034/j.1600-0749.2003.00033.x; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Loss LA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-305; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Mizukami H, 2008, ANTICANCER RES, V28, P2697; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Oue N, 2003, ONCOLOGY-BASEL, V64, P423, DOI 10.1159/000070302; Packer LM, 2007, INT J CANCER, V121, P784, DOI 10.1002/ijc.22725; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Paz MF, 2003, CANCER RES, V63, P1114; Richards HW, 2009, PIGM CELL MELANOMA R, V22, P14, DOI 10.1111/j.1755-148X.2008.00534.x; Rojas A, 2008, INT J CANCER, V123, P14, DOI 10.1002/ijc.23608; Rothhammer T, 2007, PIGM CELL RES, V20, P92, DOI 10.1111/j.1600-0749.2007.00367.x; Schinke C, 2010, MELANOMA RES, V20, P253, DOI 10.1097/CMR.0b013e328338a35a; Sengupta PK, 2003, CANCER RES, V63, P1789; Sheikh MS, 2000, LEUKEMIA, V14, P1509, DOI 10.1038/sj.leu.2401865; Shivapurkar N, 2004, INT J CANCER, V109, P786, DOI 10.1002/ijc.20041; Sjahputera O, 2007, IEEE ACM T COMPUT BI, V4, P176, DOI 10.1109/TCBB.2007.070205; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tezel E, 2000, CLIN CANCER RES, V6, P4764; Tokumaru Y, 2008, INT J CANCER, V123, P753, DOI 10.1002/ijc.23354; Van der Velden PA, 2003, INT J CANCER, V106, P472, DOI 10.1002/ijc.11262; van Noesel MM, 2002, CANCER RES, V62, P2157; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; WEISENBERGER D, 2008, COMPREHENSIVE DNA ME; Yamashita K, 2006, CANCER RES, V66, P3921, DOI 10.1158/0008-5472.CAN-05-1511; Yang QW, 2007, CLIN CANCER RES, V13, P3191, DOI 10.1158/1078-0432.CCR-06-2846; Yang QW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-286; Yang QW, 2003, CANCER RES, V63, P6299; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343	63	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26121	10.1371/journal.pone.0026121	http://dx.doi.org/10.1371/journal.pone.0026121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028813	gold, Green Published, Green Submitted			2022-12-25	WOS:000296510800018
J	Shah, V; Shah, S; Kambhampati, MS; Ambrose, J; Smith, N; Dowd, SE; McDonnell, KT; Panigrahi, B; Green, T				Shah, Vishal; Shah, Shreya; Kambhampati, Murty S.; Ambrose, Jeffery; Smith, Nyesha; Dowd, Scot E.; McDonnell, Kevin T.; Panigrahi, Bishnu; Green, Timothy			Bacterial and Archaea Community Present in the Pine Barrens Forest of Long Island, NY: Unusually High Percentage of Ammonia Oxidizing Bacteria	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; SOIL; PATTERNS	Of the few preserved areas in the northeast of United States, the soil in the Pine Barrens Forests presents a harsh environment for the microorganisms to grow and survive. In the current study we report the use of clustering methods to scientifically select the sampling locations that would represent the entire forest and also report the microbial diversity present in various horizons of the soil. Sixty six sampling locations were selected across the forest and soils were collected from three horizons (sampling depths). The three horizons were 0-10 cm (Horizon O); 11-25 cm (Horizon A) and 26-40 cm (Horizon B). Based on the total microbial substrate utilization pattern and K-means clustering analysis, the soil in the Pine Barrens Forest can be classified into four distinct clusters at each of the three horizons. One soil sample from each of the four clusters were selected and archaeal and bacterial populations within the soil studied using pyrosequencing method. The results show the microbial communities present in each of these clusters are different. Within the microbial communities present, microorganisms involved in nitrogen cycle occupy a major fraction of microbial community in the soil. High level of diversity was observed for nitrogen fixing bacteria. In contrast, Nitrosovibrio and Nitrosocaldus spp are the single bacterial and archaeal population respectively carrying out ammonia oxidation in the soil.	[Shah, Vishal; Shah, Shreya; Panigrahi, Bishnu] Dowling Coll, Dept Biol, Oakdale, NY USA; [Kambhampati, Murty S.; Ambrose, Jeffery; Smith, Nyesha] So Univ New Orleans, Dept Biol, New Orleans, LA USA; [Dowd, Scot E.] Res & Testing Lab, Lubbock, TX USA; [McDonnell, Kevin T.] Dowling Coll, Dept Math & Comp Sci, Oakdale, NY USA; [Green, Timothy] Brookhaven Natl Lab, Upton, NY 11973 USA	Southern University System; Southern University New Orleans; United States Department of Energy (DOE); Brookhaven National Laboratory	Shah, V (corresponding author), Dowling Coll, Dept Biol, Oakdale, NY USA.	ShahV@dowling.edu	Dowd, Scot E/M-5386-2017; Shah, Shreya/HDN-1499-2022	Dowd, Scot E/0000-0002-6296-1427; 	Dowling College; Foundation for Ecological Research in the Northeast; National Science Foundation [HRD-0102620]; Department of Education (DOE) [MSEIP - P120A050086]; DOE Faculty and Student Teams	Dowling College; Foundation for Ecological Research in the Northeast; National Science Foundation(National Science Foundation (NSF)); Department of Education (DOE)(United States Department of Energy (DOE)); DOE Faculty and Student Teams(United States Department of Energy (DOE))	VS thanks Dowling College and Foundation for Ecological Research in the Northeast for the research funding. JA, NS and MK were supported by National Science Foundation (HRD-0102620), Department of Education (DOE) (MSEIP - P120A050086) grants and 2008 DOE Faculty and Student Teams program. KM received support from Dowling College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenderfer MS., 1984, CLUSTER ANAL; Batcher MS, 2006, MONITORING PROTOCOLS; Boyd HP., 1991, FIELD GUIDE PINE BAR; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; CHEPLICK GP, 1987, OECOLOGIA, V73, P459, DOI 10.1007/BF00385265; Dillner AM, 2005, ATMOS ENVIRON, V39, P1525, DOI 10.1016/j.atmosenv.2004.11.035; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Guillen G, 2004, J MARINE SYST, V45, P221, DOI 10.1016/j.jmarsys.2003.11.006; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hill GT, 2000, APPL SOIL ECOL, V15, P25, DOI 10.1016/S0929-1393(00)00069-X; Joffe JS, 1933, SOIL SCI, V35, P313, DOI 10.1097/00010694-193304000-00007; Kumar N, 2011, PERTURBATION ARCTIC, DOI DOI 10.1016/J.JHAZMAT.2011.04.005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Markley M. L., 1998, Pine barrens: ecosystem and landscape., P81; McCormick J, 1998, PINE BARRENS ECOSYST, pxxi; Pampulha ME, 2007, J BASIC MICROB, V47, P325, DOI 10.1002/jobm.200610274; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; Yao B, 2011, INFLUENCE AMMONIUM N, DOI [10.1093/jpe/rtq033, DOI 10.1093/JPE/RTQ033]	27	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26263	10.1371/journal.pone.0026263	http://dx.doi.org/10.1371/journal.pone.0026263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028845	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800033
J	Simpson, CR; Buckley, BS; McLernon, DJ; Sheikh, A; Murphy, A; Hannaford, PC				Simpson, Colin R.; Buckley, Brian S.; McLernon, David J.; Sheikh, Aziz; Murphy, Andrew; Hannaford, Philip C.			Five-Year Prognosis in an Incident Cohort of People Presenting with Acute Myocardial Infarction	PLOS ONE			English	Article							GENERAL-PRACTICE; HEART-FAILURE; PRIMARY-CARE; POPULATION; TERM; SURVIVAL; MANAGEMENT; MORTALITY; SCOTLAND; OUTCOMES	Background: Following an AMI, it is important for patients and their physicians to appreciate the subsequent risk of death, and the potential benefits of invasive cardiac procedures and secondary preventive therapy. Studies, to-date, have focused largely on high-risk populations. We wished to determine the risk of death in a population-derived cohort of 2,887 patients after a first acute myocardial infarction (AMI). Methods: Logistic regression and survival analysis were conducted to investigate the effect of different baseline characteristics, pharmacological therapies and revascularization procedures on coronary heart disease (CHD) and all-cause mortality outcomes. Results: Within five years 44.4% of patients died (27.1% short-term [<30 days] and 23.7% longer-term [>= 30 days]). Percutaneous transluminal coronary angioplasty (Adjusted Hazards Ratio (AHR) = 0.49, 95% Confidence Interval (CI) 0.26-0.93), beta-blockers (AHR = 0.58, 95% CI 0.46-0.74) and statins (AHR = 0.60, 95% CI 0.47-0.77) were all associated with significant reductions in longer-term CHD-related mortality. However, not all patients received secondary preventive therapy (8.7%). Diabetes (AHR = 1.83, 95% CI 1.43-2.34), stroke (AHR = 1.73, 95% CI 1.35-2.22), heart failure (AHR = 1.69, 95% CI 1.28-2.22), smoking (AHR = 1.72, 95% CI 1.18-2.51) and obesity (>30 kg/m(2); AHR = 1.39, 95% CI 1.01-1.90) increased the risk of longer-term mortality independent of other risk factors. Conclusions: It is encouraging that the coronary procedure PTCA and pharmacological secondary prevention therapies were found to be strongly associated with an important reduced risk of subsequent death, although not all patients received these interventions. Smoking, being obese and having cardiovascular related disease at baseline were also associated with an increased likelihood of longer-term mortality, independent of other baseline characteristics. Thus, the provision of smoking cessation, advice on diet (for obese patients) and optimal treatment is likely to be crucial for reducing mortality in all patients after AMI.	[Simpson, Colin R.; Sheikh, Aziz] Univ Edinburgh, Sch Med, eHlth Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Buckley, Brian S.; Murphy, Andrew] Natl Univ Ireland, Dept Gen Practice, Galway, Ireland; [McLernon, David J.] Univ Aberdeen, Med Stat Team, Sect Populat Hlth, Aberdeen, Scotland; [Hannaford, Philip C.] Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland	University of Edinburgh; Ollscoil na Gaillimhe-University of Galway; University of Aberdeen; University of Aberdeen	Simpson, CR (corresponding author), Univ Edinburgh, Sch Med, eHlth Res Grp, Ctr Populat Hlth Sci, Teviot Pl, Edinburgh, Midlothian, Scotland.	c.simpson@ed.ac.uk	Hannaford, Philip C/B-7867-2012; Sheikh, Aziz/D-2818-2009; Simpson, Colin/I-3974-2019; Simpson, Colin R/L-7180-2014; McLernon, David/D-5167-2012	Sheikh, Aziz/0000-0001-7022-3056; Simpson, Colin/0000-0002-5194-8083; Simpson, Colin R/0000-0002-5194-8083; McLernon, David/0000-0001-8905-2429; Buckley, Brian/0000-0002-6007-9238; Murphy, Andrew/0000-0001-5549-8246	Chief Scientist Office of the Scottish Government [PDF/08/02]; Chief Scientist Office [PDF/08/02] Funding Source: researchfish	Chief Scientist Office of the Scottish Government; Chief Scientist Office	Colin Simpson was supported by a health services and health of the public post-doctoral fellowship from the Chief Scientist Office of the Scottish Government [PDF/08/02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mallah MH, 2006, J AM COLL CARDIOL, V47, P1576, DOI 10.1016/j.jacc.2005.11.073; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; BARBASH GI, 1993, CIRCULATION, V87, P53, DOI 10.1161/01.CIR.87.1.53; Botkin NF, 2006, AM HEART J, V151, P199, DOI 10.1016/j.ahj.2005.03.016; Buckley B, 2009, BRIT MED J, V339, P438; Capewell S, 2006, HEART, V92, P1563, DOI 10.1136/hrt.2005.085399; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Glynn LG, 2008, BRIT J GEN PRACT, V58, P488, DOI 10.3399/bjgp08X319459; Goodman SG, 2009, AM HEART J, V158, P193, DOI 10.1016/j.ahj.2009.06.003; Harley K, 1996, Health Bull (Edinb), V54, P410; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; LEHTO S, 1994, J INTERN MED, V236, P291, DOI 10.1111/j.1365-2796.1994.tb00799.x; Lundberg V, 1997, J INTERN MED, V241, P485; Mant J, 2006, BMJ-BRIT MED J, V332, P635, DOI 10.1136/bmj.38758.600116.AE; McAlister FA, 2004, BMJ-BRIT MED J, V328, P1110, DOI 10.1136/bmj.38043.414074.EE; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-44; Setoguchi S, 2008, AM J CARDIOL, V101, P1531, DOI 10.1016/j.amjcard.2008.02.033; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; Whitelaw FG, 1996, BRIT J GEN PRACT, V46, P181; [Writing Group Members Heart Disease and Stroke Statistics-2009 Update], 2011, CIRCULATION, V123, pe18	22	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26573	10.1371/journal.pone.0026573	http://dx.doi.org/10.1371/journal.pone.0026573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028911	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800056
J	Dorji, S; Vernes, K; Rajaratnam, R				Dorji, Sangay; Vernes, Karl; Rajaratnam, Rajanathan			Habitat Correlates of the Red Panda in the Temperate Forests of Bhutan	PLOS ONE			English	Article							AILURUS-FULGENS; SHIFTING CULTIVATION; WOLONG RESERVE; NATIONAL-PARK; CONSERVATION; GIANT; BIODIVERSITY; REGENERATION; SEPARATION; ECOLOGY	Anthropogenic activities and associated global climate change are threatening the biodiversity in the Himalayas against a backdrop of poor knowledge of the region's threatened species. The red panda (Ailurus fulgens) is a threatened mammal confined to the eastern Himalayas, and because of Bhutan's central location in the distributional range of red pandas, its forests are integral to the long-term viability of wild populations. Detailed habitat requirements of the red panda are largely speculative, and there is virtually no ecological information available on this species in Bhutan. Between 2007 and 2009, we established 615 presence/absence plots in a systematic sampling of resident habitat types within Jigme Dorji and Thrumshingla National Parks, Bhutan, to investigate broad and fine-scale red panda habitat associations. Additional locality records of red pandas were obtained from interviewing 664 park residents. Red pandas were generally confined to cool broadleaf and conifer forests from 2,110-4,389 m above sea level (asl), with the majority of records between 2,400-3,700 m asl on south and east-facing slopes. At a finer scale, multivariate analysis revealed that red pandas were strongly associated with old growth Bhutan Fir (Abies densa) forest dominated by a dense cover of Yushania and Arundanaria bamboo with a high density of fallen logs and tree stumps at ground level; a high density of trees, dead snags, and rhododendron shrubs in the mid-storey; and locations that were close to water. Because Bhutan's temperate forests that encompass prime red panda habitat are also integral to human subsistence and socio-economic development, there exists an inadvertent conflict between the needs of people and red pandas. As such, careful sustainable management of Bhutan's temperate forests is necessary if a balance is to be met between the socioeconomic needs of people and the conservation goals for red pandas.	[Dorji, Sangay; Vernes, Karl; Rajaratnam, Rajanathan] Univ New England, Armidale, NSW, Australia	University of New England		kvernes@une.edu.au	Rajaratnam, Rajanathan/U-8690-2019; Vernes, Karl/A-2925-2011; Rajaratnam, Rajanathan/K-2445-2016	Rajaratnam, Rajanathan/0000-0002-5932-7935; Vernes, Karl/0000-0003-1635-9950; Rajaratnam, Rajanathan/0000-0002-5932-7935; Dorji, Sangay/0000-0002-5078-7118	WWF-Bhutan [BU72]; Ugyen Wangchuck Institute of Environmental Conservation, Bhutan; Rotterdam Zoo; WWF [9Z0533.01]; Columbus Zoological Park Association Inc.; University of New England	WWF-Bhutan; Ugyen Wangchuck Institute of Environmental Conservation, Bhutan; Rotterdam Zoo; WWF; Columbus Zoological Park Association Inc.; University of New England	SD was awarded a CEPF (Critical Ecosystem Partnership Fund) Small Grant from WWF-Bhutan (Agreement # BU72) (URL: www.wwfbhutan.org/), and grants from the Ugyen Wangchuck Institute of Environmental Conservation, Bhutan (www.uwice.gov.bt/), and Rotterdam Zoo (www.rotterdamzoo.nl/) to assist with field research and living costs. SD also received a WWF Prince Bernhard Scholarship (Grant Number 9Z0533.01) (URL: www.panda.org) and a grant from the Columbus Zoological Park Association Inc. (www.colszoo.org/) to assist with living costs while writing and analysing data in Australia. A University of New England Research Scholarship (www.une.edu.au) awarded to SD covered tuition fees at the University of New England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahuguna C.C., 1998, Small Carnivore Conservation, V19, P11; Bhattari S., 2005, ECOSYSTEM PROFILE E, P1; Choudhury A, 2001, ORYX, V35, P250, DOI 10.1046/j.1365-3008.2001.00181.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CURTIS JT, 1971, VEGETATION WISCONSIN; Darabant A, 2007, FOREST ECOL MANAG, V252, P73, DOI 10.1016/j.foreco.2007.06.018; *DEP FOR PARK SERV, 1998, CONS MAN PLAN JIGM D; *DEP FOR PARK SERV, 2008, CONS MAN PLAN THRUMS; Dorjee K., 2014, BHUTAN J RES DEV, V3, P87; DORJI S, ORYX IN PRESS; GITTLEMAN JL, 1988, ETHOLOGY, V79, P13; Glatston A.R, 1994, STATUS SURVEY CONSER; Gratzer G, 1999, CAN J FOREST RES, V29, P1518, DOI 10.1139/cjfr-29-10-1518; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gyamtsho P., 2000, J BHUTAN STUDIES, V2, P86; Hu J.C., 2004, B BIOL, V39, P7, DOI [10.3969/j.issn.0006-3193.2004.09.003, DOI 10.3969/J.ISSN.0006-3193.2004.09.003]; JOHNSON KG, 1988, J MAMMAL, V69, P552, DOI 10.2307/1381347; Mahato N. K., 2004, Tigerpaper, V31, P7; Mahato N. K., 2005, NEPAL J FORESTRY, V12, P32; MESSERCHMIDT D, 2001, KATHMANDU; MOKTAN MR, 2004, P WORKSH FOR POV RED, P101; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Namgyel U, 2008, CONSERV BIOL, V22, P1349, DOI 10.1111/j.1523-1739.2008.01019.x; OLSON DM, 1998, ANN MISSOURI BOT GAR, V89, P199; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; Pradhan Sunita, 2001, Journal of the Bombay Natural History Society, V98, P224; REID DG, 1991, J ZOOL, V225, P347, DOI 10.1111/j.1469-7998.1991.tb03821.x; Roder W, 2002, MT RES DEV, V22, P368, DOI 10.1659/0276-4741(2002)022[0368:CGITCF]2.0.CO;2; RODER W, 1992, AGROFOREST SYST, V19, P149, DOI 10.1007/BF00138505; *ROYAL GOV BHUT, 2000, REN NAT RES CENS REP; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Vernes K, 2003, AUSTRAL ECOL, V28, P471, DOI 10.1046/j.1442-9993.2003.01303.x; Wangda P, 2006, FOREST ECOL MANAG, V230, P136, DOI 10.1016/j.foreco.2006.04.027; Wei F, 1999, MAMMALIA, V63, P417, DOI 10.1515/mamm.1999.63.4.417; Wei F, 1999, MAMMALIA, V63, P3, DOI 10.1515/mamm.1999.63.1.3; Wei FW, 1999, BIOL CONSERV, V89, P285, DOI 10.1016/S0006-3207(98)00156-6; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; Williams BH., 2003, CONSERV BIOL ASIA, V16, P236; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; YONZON P, 1991, AMBIO, V20, P285; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhang ZJ, 2009, ACTA THERIOL, V54, P225, DOI 10.4098/j.at.0001-7051.017.2008; Zhang ZJ, 2006, J WILDLIFE MANAGE, V70, P231, DOI 10.2193/0022-541X(2006)70[231:WMSBGA]2.0.CO;2; Zhou Ben-zhi, 2005, Journal of Forestry Research (Harbin), V16, P143, DOI 10.1007/BF02857909; [No title captured]	47	28	39	3	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26483	10.1371/journal.pone.0026483	http://dx.doi.org/10.1371/journal.pone.0026483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039497	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500075
J	Geiger, K; Leiherer, A; Muendlein, A; Stark, N; Geller-Rhomberg, S; Saely, CH; Wabitsch, M; Fraunberger, P; Drexel, H				Geiger, Kathrin; Leiherer, Andreas; Muendlein, Axel; Stark, Nicole; Geller-Rhomberg, Simone; Saely, Christoph H.; Wabitsch, Martin; Fraunberger, Peter; Drexel, Heinz			Identification of Hypoxia-Induced Genes in Human SGBS Adipocytes by Microarray Analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR 1-ALPHA; FOXO TRANSCRIPTION FACTORS; ADIPOSE-TISSUE HYPOXIA; PAS DOMAIN PROTEIN-1; MACROPHAGE INFILTRATION; WD-REPEAT; EXPRESSION; ADRENOMEDULLIN; OBESITY	Hypoxia in adipose tissue is suggested to be involved in the development of a chronic mild inflammation, which in obesity can further lead to insulin resistance. The effect of hypoxia on gene expression in adipocytes appears to play a central role in this inflammatory response observed in obesity. However, the global impact of hypoxia on transcriptional changes in human adipocytes is unclear. Therefore, we compared gene expression profiles of human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes under normoxic or hypoxic conditions to detect hypoxia-responsive genes in adipocytes by using whole human genome microarrays. Microarray analysis showed more than 500 significantly differentially regulated mRNAs after incubation of the cells under low oxygen levels. To gain further insight into the biological processes, hypoxia-regulated genes after 16 hours of hypoxia were classified according to their function. We identified an enrichment of genes involved in important biological processes such as glycolysis, response to hypoxia, regulation of cellular component movement, response to nutrient levels, regulation of cell migration, and transcription regulator activity. Real-time PCR confirmed eight genes to be consistently upregulated in response to 3, 6 and 16 hours of hypoxia. For adipocytes the hypoxia-induced regulation of these genes is shown here for the first time. Moreover in six of these eight genes we identified HIF response elements in the proximal promoters, specific for the HIF transcription factor family members HIF1A and HIF2A. In the present study, we demonstrated that hypoxia has an extensive effect on gene expression of SGBS adipocytes. In addition, the identified hypoxia-regulated genes are likely involved in the regulation of obesity, the incidence of type 2 diabetes, and the metabolic syndrome.	[Geiger, Kathrin; Leiherer, Andreas; Muendlein, Axel; Stark, Nicole; Geller-Rhomberg, Simone; Saely, Christoph H.; Drexel, Heinz] VIVIT, Feldkirch, Austria; [Saely, Christoph H.; Drexel, Heinz] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Geiger, Kathrin; Leiherer, Andreas; Muendlein, Axel; Stark, Nicole; Geller-Rhomberg, Simone; Saely, Christoph H.; Drexel, Heinz] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Wabitsch, Martin] Univ Ulm, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Leiherer, Andreas; Fraunberger, Peter] Med Cent Labs, Feldkirch, Austria; [Drexel, Heinz] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Ulm University; Drexel University	Geiger, K (corresponding author), VIVIT, Feldkirch, Austria.	vivit@lkhf.at	Muendlein, Axel/AAS-5313-2021; Leiherer, Andreas/X-5539-2019	Leiherer, Andreas/0000-0003-3776-5704; Muendlein, Axel/0000-0002-5582-4125	Austrian Science Fund (FWF) [21057]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF, Project 21057). The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Bunton DC, 2004, PHARMACOL THERAPEUT, V103, P179, DOI 10.1016/j.pharmthera.2004.07.002; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Fleischmann E, 2005, OBES SURG, V15, P813, DOI 10.1381/0960892054222867; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fruhbeck Gema, 2008, V456, P1, DOI 10.1007/978-1-59745-245-8_1; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Gardner LB, 2008, CELL CYCLE, V7, P1916, DOI 10.4161/cc.7.13.6203; Geiger K, 2011, HORM METAB RES, V43, P380, DOI 10.1055/s-0031-1273767; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Harmancey R, 2007, DIABETES, V56, P553, DOI 10.2337/db06-0857; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Isner JM, 1998, AM J CARDIOL, V82, p63S, DOI 10.1016/S0002-9149(98)00764-4; Jeninga EH, 2009, J BIOL CHEM, V284, P26385, DOI 10.1074/jbc.M109.040741; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kinoshita H, 2000, DIABETES CARE, V23, P253, DOI 10.2337/diacare.23.2.253; Kitamuro T, 2000, J NEUROCHEM, V75, P1826, DOI 10.1046/j.1471-4159.2000.0751826.x; Lahnalampi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012991; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Liu Y, 2010, GENES CELLS, V15, P315, DOI 10.1111/j.1365-2443.2010.01381.x; Lolmede K, 2003, INT J OBESITY, V27, P1187, DOI 10.1038/sj.ijo.0802407; Marfella R, 2004, DIABETES, V53, P2383, DOI 10.2337/diabetes.53.9.2383; Minchenko O, 2004, FEBS LETT, V576, P14, DOI 10.1016/j.febslet.2004.08.053; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Nagata D, 1999, KIDNEY INT, V55, P1259, DOI 10.1046/j.1523-1755.1999.00361.x; Nakayama M, 2000, EUR J BIOCHEM, V267, P3559, DOI 10.1046/j.1432-1327.2000.01384.x; Nakayama M, 1998, BIOCHEM BIOPH RES CO, V243, P514, DOI 10.1006/bbrc.1998.8131; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Onita T, 2002, CLIN CANCER RES, V8, P471; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Regazzetti C, 2010, J BIOL CHEM, V285, P5157, DOI 10.1074/jbc.M109.047688; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenow A, 2010, J PROTEOME RES, V9, P5389, DOI 10.1021/pr100621g; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Sar A, 2009, CELL TISSUE RES, V337, P223, DOI 10.1007/s00441-009-0805-y; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Vadivel A, 2010, AM J RESP CELL MOL, V43, P152, DOI 10.1165/rcmb.2009-0004OC; Verstraeten VLRM, 2011, HISTOCHEM CELL BIOL, V135, P251, DOI 10.1007/s00418-011-0792-4; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Wu Z., 2004, DEP BIOSTATISTICS WO; Xia GB, 2001, CANCER-AM CANCER SOC, V91, P1429, DOI 10.1002/1097-0142(20010415)91:8<1429::AID-CNCR1149>3.0.CO;2-V; Yamada N, 2005, J CLIN ENDOCR METAB, V90, P5841, DOI 10.1210/jc.2005-0991; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	83	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26465	10.1371/journal.pone.0026465	http://dx.doi.org/10.1371/journal.pone.0026465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039494	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500072
J	Zhang, AM; Bandelt, HJ; Jia, XY; Zhang, W; Li, SQ; Yu, DD; Wang, D; Zhuang, XY; Zhang, QJ; Yao, YG				Zhang, A-Mei; Bandelt, Hans-Juergen; Jia, Xiaoyun; Zhang, Wen; Li, Shiqiang; Yu, Dandan; Wang, Dong; Zhuang, Xin-Ying; Zhang, Qingjiong; Yao, Yong-Gang			Is Mitochondrial tRNA(phe) Variant m.593T > C a Synergistically Pathogenic Mutation in Chinese LHON Families with m. 11778G > A?	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; TRANSLATIONAL QUALITY-CONTROL; TRANSFER-RNA MUTATIONS; CLINICAL EXPRESSION; DNA; MTDNA; DISEASE; GENOME; GENE; MECHANISM	Mitochondrial transfer RNA (mt-tRNA) mutations have been reported to be associated with a variety of diseases. In a previous paper that studied the mtDNA background effect on clinical expression of Leber's hereditary optic neuropathy (LHON) in 182 Chinese families with m.11778G>A, we found a strikingly high frequency (7/182) of m.593T>C in the mitochondrially encoded tRNA phenylalanine (MT-TF) gene in unrelated LHON patients. To determine the potential role of m.593T>C in LHON, we compared the frequency of this variant in 479 LHON patients with m.11778G>A, 843 patients with clinical features of LHON but without the three known primary mutations, and 2374 Han Chinese from the general populations. The frequency of m.593T>C was higher in LHON patients (14/479) than in suspected LHON subjects (12/843) or in general controls (49/2374), but the difference was not statistically significant. The overall penetrance of LHON in families with both m.11778G>A and m.593T>C (44.6%) was also substantially higher than that of families with only m.11778G>A (32.9%) (P = 0.083). Secondary structure prediction of the MT-TF gene with the wild type or m.593T>C showed that this nucleotide change decreases the free energy. Electrophoretic mobility of the MT-TF genes with the wild type or m.593T>C transcribed in vitro further confirmed the change of secondary structure in the presence of this variant. Although our results could suggest a modest synergistic effect of variant m.593T>C on the LHON causing mutation m.11778G>A, the lack of statistical significance probably due to the relatively small sample size analyzed, makes necessary more studies to confirm this effect.	[Zhang, A-Mei; Zhang, Wen; Yu, Dandan; Wang, Dong; Zhuang, Xin-Ying; Yao, Yong-Gang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Zhang, A-Mei; Zhang, Wen; Yu, Dandan; Wang, Dong; Zhuang, Xin-Ying; Yao, Yong-Gang] Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Jia, Xiaoyun; Li, Shiqiang; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, Hamburg, Germany; [Zhang, A-Mei; Zhang, Wen; Wang, Dong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Sun Yat Sen University; University of Hamburg; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, AM (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	qingjiongzhang@yahoo.com; ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; Zhang, Qingjiong/AAR-6331-2021	Yao, Yong-Gang/0000-0002-2955-0693; Zhang, Qingjiong/0000-0001-7508-848X	Ministry of Science and Technology of China [2011CB910900]; National Natural Science Foundation of China [30925021]; National Natural Science Foundation of Yunnan Province [2009CI119]; National Natural Science Foundation of Guangdong Province [2009B091300150]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Yunnan Province; National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Ministry of Science and Technology of China (2011CB910900), the National Natural Science Foundation of China (30925021), Yunnan Province (2009CI119), and Guangdong Province (2009B091300150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2; Kaewsutthi S, 2011, INVEST OPHTH VIS SCI, V52, P4742, DOI 10.1167/iovs.10-5816; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Li PTX, 2008, ANNU REV BIOCHEM, V77, P77, DOI 10.1146/annurev.biochem.77.061206.174353; Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104; Ling J, 2007, P NATL ACAD SCI USA, V104, P72, DOI 10.1073/pnas.0606272104; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tarassov I, 2007, CELL CYCLE, V6, P2473, DOI 10.4161/cc.6.20.4783; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang CY, 2007, INT J CANCER, V121, P1253, DOI 10.1002/ijc.22822; Wang HW, 2008, MUTAT RES-FUND MOL M, V643, P48, DOI 10.1016/j.mrfmmm.2008.06.004; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yu DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013426; Yu DD, 2010, NEUROGENETICS, V11, P349, DOI 10.1007/s10048-010-0236-7; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zhang AM, 2010, HUM GENET, V128, P465, DOI 10.1007/s00439-010-0875-7; Zhang Q, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P441; Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548; Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051	43	14	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26511	10.1371/journal.pone.0026511	http://dx.doi.org/10.1371/journal.pone.0026511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039503	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500081
J	Zhang, B; Tran, U; Wessely, O				Zhang, Bo; Tran, Uyen; Wessely, Oliver			Expression of Wnt Signaling Components during Xenopus Pronephros Development	PLOS ONE			English	Article							FRIZZLED FAMILY-MEMBER; PLANAR CELL POLARITY; KIDNEY DEVELOPMENT; EPITHELIAL TRANSFORMATION; MORPHOGENETIC MOVEMENTS; METANEPHRIC MESENCHYME; DEVELOPING EYE; GENE; MESODERM; LAEVIS	Background: The formation of the vertebrate kidney is tightly regulated and relies on multiple evolutionarily conserved inductive events. These are present in the complex metanephric kidney of higher vertebrates, but also in the more primitive pronephric kidney functional in the larval stages of amphibians and fish. Wnts have long been viewed as central in this process. Canonical beta-Catenin-dependent Wnt signaling establishes kidney progenitors and non-canonical beta-Cateninin-dependent Wnt signaling participate in the morphogenetic processes that form the highly sophisticated nephron structure. While some individual Wnt signaling components have been studied extensively in the kidney, the overall pathway has not yet been analyzed in depth. Methodology/Principal Findings: Here we report a detailed expression analysis of all Wnt ligands, receptors and several downstream Wnt effectors during pronephros development in Xenopus laevis using in situ hybridization. Out of 19 Wnt ligands, only three, Wnt4, Wnt9a and Wnt11, are specifically expressed in the pronephros. Others such as Wnt8a are present, but in a broader domain comprising adjacent tissues in addition to the kidney. The same paradigm is observed for the Wnt receptors and its downstream signaling components. Fzd1, Fzd4, Fzd6, Fzd7, Fzd8 as well as Celsr1 and Prickle1 show distinct expression domains in the pronephric kidney, whereas the non-traditional Wnt receptors, Ror2 and Ryk, as well as the majority of the effector molecules are rather ubiquitous. In addition to this spatial regulation, the timing of expression is also tightly regulated. In particular, non-canonical Wnt signaling seems to be restricted to later stages of pronephros development. Conclusion/Significance: Together these data suggest a complex cross talk between canonical and non-canonical Wnt signaling is required to establish a functional pronephric kidney.	[Zhang, Bo; Tran, Uyen; Wessely, Oliver] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Zhang, Bo] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA	Cleveland Clinic Foundation; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, B (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA.	wesselo@ccf.org			NIH/NIDDK [7RO1DK080745-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080745] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported from NIH/NIDDK (www.niddk.nih.gov/) with the RO1 grant #7RO1DK080745-03 to OW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Brown JD, 2000, DEV GROWTH DIFFER, V42, P347; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Carroll TJ, 1999, DEV GENET, V24, P199, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<199::AID-DVG3>3.0.CO;2-D; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Damianitsch K, 2009, DEV BIOL, V329, P327, DOI 10.1016/j.ydbio.2009.03.004; Deardorf MA, 1999, MECH DEVELOP, V87, P229, DOI 10.1016/S0925-4773(99)00161-6; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Garriock RJ, 2007, DEV DYNAM, V236, P1249, DOI 10.1002/dvdy.21156; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Gray RS, 2009, DEV DYNAM, V238, P2044, DOI 10.1002/dvdy.22028; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kispert A, 1998, DEVELOPMENT, V125, P4225; KU M, 1993, DEVELOPMENT, V119, P1161; Lavery DL, 2008, DEV DYNAM, V237, P768, DOI 10.1002/dvdy.21440; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyons JP, 2009, MECH DEVELOP, V126, P142, DOI 10.1016/j.mod.2008.11.007; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mccoy KE, 2011, DEV DYNAM, V240, P1558, DOI 10.1002/dvdy.22626; MCGREW LL, 1992, DEVELOPMENT, V115, P463; McNeill H, 2009, J AM SOC NEPHROL, V20, P2104, DOI 10.1681/ASN.2008111173; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; MOON RT, 1993, DEVELOPMENT, V119, P97; Moriwaki J, 2000, BIOCHEM BIOPH RES CO, V278, P377, DOI 10.1006/bbrc.2000.3808; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Satow R, 2004, BIOCHEM BIOPH RES CO, V321, P487, DOI 10.1016/j.bbrc.2004.06.166; Saulnier DME, 2002, DEV BIOL, V248, P13, DOI 10.1006/dbio.2002.0712; Saxen L., 1987, ORGANOGENESIS KIDNEY; Shi DL, 2000, MECH DEVELOP, V94, P243, DOI 10.1016/S0925-4773(00)00294-X; Shi DL, 1998, MECH DEVELOP, V70, P35, DOI 10.1016/S0925-4773(97)00166-4; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith H. W., 1953, FISH PHILOS; SOKOL SY, 1993, DEVELOPMENT, V118, P1335; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Sumanas S, 2001, MECH DEVELOP, V103, P133, DOI 10.1016/S0925-4773(01)00327-6; Tetelin S, 2010, DEV DYNAM, V239, P148, DOI 10.1002/dvdy.22012; Tour E, 2002, MECH DEVELOP, V110, P3, DOI 10.1016/S0925-4773(01)00591-3; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Vize PD, 2003, KIDNEY NORMAL DEV CO, P19, DOI [10.1016/B978-012722441-1/50005-1, DOI 10.1016/B978-012722441-1/50005-1]; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2002, MECH DEVELOP, V116, P183, DOI 10.1016/S0925-4773(02)00133-8; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; WESSELY O, 2011, PEDIAT NEPH IN PRESS; Wheeler GN, 1999, MECH DEVELOP, V86, P203, DOI 10.1016/S0925-4773(99)00117-3; White JT, 2010, DEVELOPMENT, V137, P1863, DOI 10.1242/dev.042887; Yin A, 2010, GENE EXPR PATTERNS, V10, P338, DOI 10.1016/j.gep.2010.07.005; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	65	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26533	10.1371/journal.pone.0026533	http://dx.doi.org/10.1371/journal.pone.0026533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028899	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500085
J	Anguissola, S; McCormack, WJ; Morrin, MA; Higgins, WJ; Fox, DM; Worrall, DM				Anguissola, Sergio; McCormack, William J.; Morrin, Michelle A.; Higgins, Wayne J.; Fox, Denise M.; Worrall, D. Margaret			Pigment Epithelium-Derived Factor (PEDF) Interacts with Transportin SR2, and Active Nuclear Import Is Facilitated by a Novel Nuclear Localization Motif	PLOS ONE			English	Article							NEUROTROPHIC ACTIVITY; RS DOMAIN; IDENTIFICATION; SERPIN; PROTEINS; CELLS; ANGIOGENESIS; RECEPTOR; PROLIFERATION; VASCULATURE	PEDF (Pigment epithelium-derived factor) is a non-inhibitory member of the serpin gene family (serpinF1) that displays neurotrophic and anti-angiogenic properties. PEDF contains a secretion signal sequence, but although originally regarded as a secreted extracellular protein, endogenous PEDF is found in the cytoplasm and nucleus of several mammalian cell types. In this study we employed a yeast two-hybrid interaction trap screen to identify transportin-SR2, a member of the importin-beta family of nuclear transport karyopherins, as a putative PEDF binding partner. The interaction was supported in vitro by GST-pulldown and co-immunoprecipitation. Following transfection of HEK293 cells with GFP-tagged PEDF the protein was predominantly localised to the nucleus, suggesting that active import of PEDF occurs. A motif (YxxYRVRS) shared by PEDF and the unrelated transportin-SR2 substrate, RNA binding motif protein 4b, was identified and we investigated its potential as a nuclear localization signal (NLS) sequence. Site-directed mutagenesis of this helix A motif in PEDF resulted in a GFP-tagged mutant protein being excluded from the nucleus, and mutation of two arginine residues (R67, R69) was sufficient to abolish nuclear import and PEDF interaction with transportin-SR2. These results suggest a novel NLS and mechanism for serpinF1 nuclear import, which may be critical for anti-angiogenic and neurotrophic function.	[Anguissola, Sergio; McCormack, William J.; Morrin, Michelle A.; Higgins, Wayne J.; Fox, Denise M.; Worrall, D. Margaret] Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland	University College Dublin	Anguissola, S (corresponding author), Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland.	mworrall@ucd.ie		McCormack, William/0000-0003-3748-5729	Irish Cancer Society [CRP08WOR]	Irish Cancer Society	The study was funded by the Irish Cancer Society (Research Grant CRP08WOR) http://www.cancer.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Chuang TL, 1999, J BIOL CHEM, V274, P11194, DOI 10.1074/jbc.274.16.11194; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Famulla S, 2011, INT J OBESITY, V35, P762, DOI 10.1038/ijo.2010.212; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Karakousis PC, 2001, MOL VIS, V7, P154; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kawaguchi T, 2010, CURR MOL MED, V10, P302, DOI 10.2174/156652410791065255; Kawaguchi T, 2010, AM J PATHOL, V176, P168, DOI 10.2353/ajpath.2010.090242; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; NAIDOO N, 1995, J BIOL CHEM, V270, P14548, DOI 10.1074/jbc.270.24.14548; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; PIGNOLO RJ, 1993, J BIOL CHEM, V268, P8949; Sawant S, 2004, BIOCHEM BIOPH RES CO, V325, P408, DOI 10.1016/j.bbrc.2004.10.041; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Tombran-Tink J, 2005, J STRUCT BIOL, V151, P130, DOI 10.1016/j.jsb.2005.05.005; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; Truant R, 1999, J BIOL CHEM, V274, P32167, DOI 10.1074/jbc.274.45.32167; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200	40	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26234	10.1371/journal.pone.0026234	http://dx.doi.org/10.1371/journal.pone.0026234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028839	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900037
J	Langford-Smith, A; Langford-Smith, KJ; Jones, SA; Wynn, RF; Wraith, JE; Wilkinson, FL; Bigger, BW				Langford-Smith, Alex; Langford-Smith, Kia J.; Jones, Simon A.; Wynn, Robert F.; Wraith, J. E.; Wilkinson, Fiona L.; Bigger, Brian W.			Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test	PLOS ONE			English	Article							ALPHA-N-ACETYLGLUCOSAMINIDASE; MEDIATED GENE-TRANSFER; SYNDROME TYPE-B; MOUSE MODEL; SANFILIPPO-SYNDROME; MPS-IIIA; SLEEP DISTURBANCE; MURINE MODEL; BEHAVIOR; SULFAMIDASE	Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natural history of disease and evaluate the efficacy of novel therapies. Mucopolysaccharidosis IIIA (MPS IIIA or Sanfilippo A), is a severe, neurodegenerative lysosomal storage disorder caused by a deficiency in the heparan sulphate catabolising enzyme, sulfamidase. Undegraded heparan sulphate accumulates, resulting in lysosomal enlargement and cellular dysfunction. Patients suffer a progressive loss of motor and cognitive function with severe behavioural manifestations and premature death. There is currently no treatment. A spontaneously occurring mouse model of the disease has been described, that has approximately 3% of normal enzyme activity levels. Behavioural phenotyping of the MPS IIIA mouse has been previously reported, but the results are conflicting and variable, even after full backcrossing to the C57BL/6 background. Therefore we have independently backcrossed the MPS IIIA model onto the C57BL/6J background and evaluated the behaviour of male and female MPS IIIA mice at 4, 6 and 8 months of age using the open field test, elevated plus maze, inverted screen and horizontal bar crossing at the same circadian time point. Using a 60 minute open field, we have demonstrated that female MPS IIIA mice are hyperactive, have a longer path length, display rapid exploratory behaviour and spend less time immobile than WT mice. Female MPS IIIA mice also display a reduced sense of danger and spend more time in the centre of the open field. There were no significant differences found between male WT and MPS IIIA mice and no differences in neuromuscular strength were seen with either sex. The altered natural history of behaviour that we observe in the MPS IIIA mouse will allow more accurate evaluation of novel therapeutics for MPS IIIA and potentially other neurodegenerative disorders.	[Langford-Smith, Alex; Langford-Smith, Kia J.; Wilkinson, Fiona L.; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Sch Biomed, Manchester, Lancs, England; [Jones, Simon A.; Wraith, J. E.] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Wynn, Robert F.] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 1HA, Lancs, England	University of Manchester; University of Manchester; Royal Manchester Children's Hospital	Langford-Smith, A (corresponding author), Univ Manchester, Fac Med & Human Sci, Sch Biomed, Manchester, Lancs, England.	Brian.Bigger@Manchester.ac.uk	Langford-Smith, Alex/K-7624-2017; Langford-Smith, Alex/H-5249-2011; Langford-Smith, Kia/H-5255-2011; Bigger, Brian/I-3553-2012	Langford-Smith, Alex/0000-0001-7006-0592; Langford-Smith, Alex/0000-0001-7006-0592; Wynn, robert/0000-0002-6046-8428; Wilkinson, Fiona/0000-0002-0358-3489; Bigger, Brian/0000-0002-9708-1112	UK Society for Mucopolysaccharide Diseases; Irish Society for Mucopolysaccharide Diseases; Sanfilippo Children's Research Foundation; Biotechnology and Biological Sciences Research Council	UK Society for Mucopolysaccharide Diseases; Irish Society for Mucopolysaccharide Diseases; Sanfilippo Children's Research Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Society for Mucopolysaccharide Diseases, The Irish Society for Mucopolysaccharide Diseases, The Sanfilippo Children's Research Foundation, and the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfi A, 2011, MOL GENET METAB, V103, P18, DOI 10.1016/j.ymgme.2011.01.015; Arndt SS, 2009, PHYSIOL BEHAV, V97, P385, DOI 10.1016/j.physbeh.2009.03.008; BAX MCO, 1995, ARCH DIS CHILD, V73, P77, DOI 10.1136/adc.73.1.77; Benjamini Y, 2010, NEUROSCI BIOBEHAV R, V34, P1351, DOI 10.1016/j.neubiorev.2010.04.004; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; CLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Fraldi A, 2007, HUM MOL GENET, V16, P2693, DOI 10.1093/hmg/ddm223; Fraser J, 2005, ARCH DIS CHILD, V90, P1239, DOI 10.1136/adc.2004.065482; Fraser J, 2002, CLIN GENET, V62, P418, DOI 10.1034/j.1399-0004.2002.620512.x; Fu H, 2007, GENE THER, V14, P1065, DOI 10.1038/sj.gt.3302961; Fu HY, 2010, J GENE MED, V12, P624, DOI 10.1002/jgm.1480; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gliddon BL, 2004, PEDIATR RES, V56, P65, DOI 10.1203/01.PDR.0000129661.40499.12; Gografe SI, 2009, COMPARATIVE MED, V59, P139; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Heldermon CD, 2010, MOL THER, V18, P873, DOI 10.1038/mt.2010.17; Hemsley KM, 2008, GENES BRAIN BEHAV, V7, P740, DOI 10.1111/j.1601-183X.2008.00413.x; Hemsley KM, 2007, MOL GENET METAB, V90, P313, DOI 10.1016/j.ymgme.2006.10.005; Hemsley KM, 2009, MOL GENET METAB, V98, P383, DOI 10.1016/j.ymgme.2009.07.013; Hemsley KM, 2009, EUR J NEUROSCI, V29, P1197, DOI 10.1111/j.1460-9568.2009.06666.x; Hemsley KM, 2005, BEHAV BRAIN RES, V158, P191, DOI 10.1016/j.bbr.2004.08.019; Heron B, 2011, AM J MED GENET A, V155A, P58, DOI 10.1002/ajmg.a.33779; Kafkafi N, 2003, BEHAV NEUROSCI, V117, P464, DOI 10.1037/0735-7044.117.3.464; KRESSE H, 1973, BIOCHEM BIOPH RES CO, V54, P1111, DOI 10.1016/0006-291X(73)90807-3; KRESSE H, 1972, J BIOL CHEM, V247, P2164; Lamberty Y, 1996, PHYSIOL BEHAV, V59, P439, DOI 10.1016/0031-9384(96)84912-2; Langford-Smith A, 2011, GENES BRAIN BEHAV, V10, P673, DOI 10.1111/j.1601-183X.2011.00706.x; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Langford-Smith KJ, 2011, J INHERIT METAB DIS, V34, P499, DOI 10.1007/s10545-010-9254-8; Lau AA, 2008, BEHAV BRAIN RES, V191, P130, DOI 10.1016/j.bbr.2008.03.024; Lau AA, 2010, EXP NEUROL, V225, P445, DOI 10.1016/j.expneurol.2010.07.024; Lau AA, 2010, MOL GENET METAB, V100, P168, DOI 10.1016/j.ymgme.2010.02.006; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; Malm G, 2010, ACTA PAEDIATR, V99, P1253, DOI 10.1111/j.1651-2227.2010.01800.x; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; McIntyre C, 2008, MOL GENET METAB, V93, P411, DOI 10.1016/j.ymgme.2007.11.008; McIntyre C, 2010, J GENE MED, V12, P717, DOI 10.1002/jgm.1489; Meyer A, 2007, PEDIATRICS, V120, pE1255, DOI 10.1542/peds.2007-0282; Roberts ALK, 2007, MOL GENET METAB, V92, P115, DOI 10.1016/j.ymgme.2007.06.016; Savas PS, 2004, MOL GENET METAB, V82, P273, DOI 10.1016/j.ymgme.2004.05.005; SCOTT HS, 1995, NAT GENET, V11, P465, DOI 10.1038/ng1295-465; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; Valstar MJ, 2010, ANN NEUROL, V68, P876, DOI 10.1002/ana.22092; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x	52	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25717	10.1371/journal.pone.0025717	http://dx.doi.org/10.1371/journal.pone.0025717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028789	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900017
J	Tingley, R; Shine, R				Tingley, Reid; Shine, Richard			Desiccation Risk Drives the Spatial Ecology of an Invasive Anuran (Rhinella marina) in the Australian Semi-Desert	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; ESTABLISHMENT SUCCESS; BUFO-MARINUS; CANE TOADS; RAPID EVOLUTION; CLIMATE; TEMPERATURE; AMPHIBIANS; MOVEMENT; RANGE	Some invasive species flourish in places that impose challenges very different from those faced in their native geographic ranges. Cane toads (Rhinella marina) are native to tropical and subtropical habitats of South and Central America, but have colonised extremely arid regions over the course of their Australian invasion. We radio-tracked 44 adult cane toads at a semi-arid invasion front to investigate how this invasive anuran has managed to expand its geographic range into arid areas that lie outside of its native climatic niche. As predicted from their low physiological control over rates of evaporative water loss, toads selected diurnal shelter sites that were consistently cooler and damper (and thus, conferred lower water loss rates) than nearby random sites. Desiccation risk also had a profound influence on rates of daily movement. Under wet conditions, toads that were far from water moved further between shelter sites than did conspecifics that remained close to water, presumably in an attempt to reach permanent water sources. However, this relationship was reversed under dry conditions, such that only toads that were close to permanent water bodies made substantial daily movements. Toads that were far from water bodies also travelled along straighter paths than did conspecifics that generally remained close to water. Thus, behavioural flexibility-in particular, an ability to exploit spatial and temporal heterogeneity in the availability of moist conditions-has allowed this invasive anuran to successfully colonize arid habitats in Australia. This finding illustrates that risk assessment protocols need to recognise that under some circumstances an introduced species may be able to thrive in conditions far removed from any that it experiences in its native range.	[Tingley, Reid; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Tingley, R (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	reid.tingley@gmail.com	Tingley, Reid/D-7388-2011	Tingley, Reid/0000-0002-7630-7434	Natural Sciences and Engineering Research Council of Canada; University of Sydney; Caring for Our Country; Australian Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Sydney(University of Sydney); Caring for Our Country; Australian Research Council(Australian Research Council)	RT was funded by a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship, an Endeavour International Postgraduate Research Scholarship, and a University of Sydney International Postgraduate Award. Additional funding was provided by Caring for Our Country and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2009, WILDLIFE RES, V36, P23, DOI 10.1071/WR08021; Amiel JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018277; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cassey P, 2002, BIOL J LINN SOC, V76, P465, DOI 10.1046/j.1095-8312.2002.00086.x; Curnutt JL, 2000, BIOL CONSERV, V94, P341, DOI 10.1016/S0006-3207(99)00186-X; Darwin C, 2009, ON THE ORIGIN OF SPECIES, P1, DOI 10.1017/CBO9780511694295.004; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Florance D, 2011, P R SOC B IN PRESS; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Jeschke JM, 2008, DIVERS DISTRIB, V14, P913, DOI 10.1111/j.1472-4642.2008.00488.x; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolbe JJ, 2010, ECOL APPL, V20, P2273, DOI 10.1890/09-1973.1; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2003, CONSERV BIOL, V17, P1738, DOI 10.1111/j.1523-1739.2003.00353.x; R Core Team, 2021, R LANG ENV STAT COMP; Rodriguez-Cabal MA, 2009, DIVERS DISTRIB, V15, P911, DOI 10.1111/j.1472-4642.2009.00583.x; Schwarzkopf L, 1996, FUNCT ECOL, V10, P193, DOI 10.2307/2389843; Schwarzkopf L, 2002, OIKOS, V96, P492, DOI 10.1034/j.1600-0706.2002.960311.x; Seebacher F, 1999, J HERPETOL, V33, P208, DOI 10.2307/1565716; Seebacher F, 2002, J HERPETOL, V36, P69, DOI 10.1670/0022-1511(2002)036[0069:SMDBTA]2.0.CO;2; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Smith James G., 2006, Pacific Conservation Biology, V12, P40; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; Tingley R, 2010, GLOBAL ECOL BIOGEOGR, V19, P496, DOI 10.1111/j.1466-8238.2010.00530.x; Tracy CR, 2007, J HERPETOL, V41, P597, DOI 10.1670/07-006.1; Ujvari B, 2009, HERPETOL CONSERV BIO, V4, P248; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; WYGODA ML, 1984, PHYSIOL ZOOL, V57, P329, DOI 10.1086/physzool.57.3.30163722; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	40	56	56	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25979	10.1371/journal.pone.0025979	http://dx.doi.org/10.1371/journal.pone.0025979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043300	Green Published, gold			2022-12-25	WOS:000295984400028
J	Malapaka, RRV; Khoo, S; Zhang, JF; Choi, JH; Zhou, XE; Xu, Y; Gong, YH; Li, J; Yong, EL; Chalmers, MJ; Chang, L; Resau, JH; Griffin, PR; Chen, YE; Xu, HE				Malapaka, Raghu R. V.; Khoo, SokKean; Zhang, Jifeng; Choi, Jang H.; Zhou, X. Edward; Xu, Yong; Gong, Yinhan; Li, Jun; Yong, Eu-Leong; Chalmers, Michael J.; Chang, Lin; Resau, James H.; Griffin, Patrick R.; Chen, Y. Eugene; Xu, H. Eric			Identification and Mechanism of 10-Carbon Fatty Acid as Modulating Ligand of Peroxisome Proliferator-activated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-CHAIN TRIGLYCERIDES; WEIGHT-LOSS DIET; PPAR-GAMMA; DIFFERENTIAL EXPRESSION; BINDING SELECTIVITY; NUCLEAR RECEPTORS; GENE-EXPRESSION; RISK-FACTORS; OIL; CONSUMPTION	Peroxisome proliferator-activated receptors (PPAR alpha, -beta/delta, and -gamma) are a subfamily of nuclear receptors that plays key roles in glucose and lipid metabolism. PPAR gamma is the molecular target of the thiazolidinedione class of antidiabetic drugs that has many side effects. PPAR gamma is also activated by long chain unsaturated or oxidized/nitrated fatty acids, but its relationship with the medium chain fatty acids remains unclear even though the medium chain triglyceride oils have been used to control weight gain and glycemic index. Here, we show that decanoic acid (DA), a 10-carbon fatty acid and a major component of medium chain triglyceride oils, is a direct ligand of PPAR gamma. DA binds and partially activates PPAR gamma without leading to adipogenesis. Crystal structure reveals that DA occupies a novel binding site and only partially stabilizes the AF-2 helix. DA also binds weakly to PPAR alpha and PPAR beta/delta. Treatments with DA and its triglyceride form improve glucose sensitivity and lipid profiles without weight gain in diabetic mice. Together, these results suggest that DA is a modulating ligand for PPARs, and the structure can aid in designing better and safer PPAR gamma-based drugs.	[Malapaka, Raghu R. V.; Zhou, X. Edward; Xu, Yong; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Khoo, SokKean] Van Andel Res Inst, Lab Microarray Technol, Grand Rapids, MI 49503 USA; [Khoo, SokKean; Resau, James H.] Van Andel Res Inst, Lab Analyt Cellular & Mol Microscopy, Grand Rapids, MI 49503 USA; [Zhang, Jifeng; Chang, Lin; Chen, Y. Eugene] Univ Michigan, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Choi, Jang H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Choi, Jang H.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gong, Yinhan; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Dept Obstet & Gynaecol, Singapore 119228, Singapore; [Chalmers, Michael J.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Xu, H. Eric] Chinese Acad Sci, VARI SIMM Ctr Drug Discovery, Ctr Struct & Funct Drug Targets, State Key Lab Drug Res,Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Van Andel Institute; Van Andel Institute; Van Andel Institute; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; National University of Singapore; Scripps Research Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Malapaka, RRV (corresponding author), Brigham & Womens Hosp, Ctr Interdisciplinary Cardiovasc Sci, 3 Blackfan Circle Dr, Boston, MA 02115 USA.	vmalapaka@rics.bwh.harvard.edu	Choi, Jang Hyun/B-3055-2012; Malapaka, Raghu/B-6185-2012; Gong, Yinhan/D-1932-2013; Xu, H. Eric/ABD-7487-2021	Chalmers, Michael/0000-0002-2139-6089; Yong, Eu-Leong/0000-0001-6511-770X; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301, HL68878, HL089544]; American Heart Association [0835237N, 0840025N]; Jay and Betty Van Andel Foundation, Amway (China) Ltd.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068878, R01HL089301, R01HL089544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Jay and Betty Van Andel Foundation, Amway (China) Ltd.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662 and DK066202 and HL089301 (to H. E. X.) and Grants HL68878 and HL089544 (to Y. E. C.). This work was also supported by American Heart Association Grant 0835237N (to J. Z.).; Established Investigator and supported by American Heart Association Grant 0840025N. To whom correspondence may be addressed: Cardiovascular Center, Dept. of Internal Medicine, University of Michigan, Ann Arbor, MI 48109. E-mail:echenum@med.umich.edu.; Supported by the Jay and Betty Van Andel Foundation, Amway (China) Ltd. To whom correspondence may be addressed: Laboratory of Structural Sciences, Van Andel Research Institute, Grand Rapids, MI 49503. Tel.: 616-234-5772; Fax: 616-234-5773; E-mail:eric.xu@vai.org.	Akiyama Taro E, 2005, Curr Diab Rep, V5, P45, DOI 10.1007/s11892-005-0067-3; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Bonacci G, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.225029; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Guo W, 2003, J NUTR, V133, P2512, DOI 10.1093/jn/133.8.2512; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; HILL JO, 1990, J LIPID RES, V31, P407; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Knopp RH, 2004, AM J CLIN NUTR, V80, P1102, DOI 10.1093/ajcn/80.5.1102; Krotkiewski M, 2001, INT J OBESITY, V25, P1393, DOI 10.1038/sj.ijo.0801682; Labarthe F, 2008, CARDIOVASC DRUG THER, V22, P97, DOI 10.1007/s10557-008-6084-0; LEPAGE G, 1986, J LIPID RES, V27, P114; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; MIYATA KS, 1994, GENE, V148, P327, DOI 10.1016/0378-1119(94)90707-2; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; NAVAZA J, 1992, MOL REPLACEMENT, P87; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oliveira MDR, 2008, NEUROSCI LETT, V434, P66, DOI 10.1016/j.neulet.2008.01.032; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; St-Onge MP, 2008, J AM COLL NUTR, V27, P547, DOI 10.1080/07315724.2008.10719737; St-Onge MP, 2008, AM J CLIN NUTR, V87, P621, DOI 10.1093/ajcn/87.3.621; St-Onge MP, 2003, INT J OBESITY, V27, P95, DOI 10.1038/sj.ijo.0802169; St-Onge MP, 2002, J NUTR, V132, P329; Su LL, 2010, ANN ACAD MED SINGAP, V39, P675; Sulistio MS, 2008, CURR ATHEROSCLER REP, V10, P134, DOI 10.1007/s11883-008-0020-4; Tsuji H, 2001, J NUTR, V131, P2853, DOI 10.1093/jn/131.11.2853; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198	52	92	98	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					183	195		10.1074/jbc.M111.294785	http://dx.doi.org/10.1074/jbc.M111.294785			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22039047	hybrid, Green Published			2022-12-25	WOS:000298682400020
J	Lagasse, LP; Rimal, RN; Smith, KC; Storey, JD; Rhoades, E; Barnett, DJ; Omer, SB; Links, J				Lagasse, Lisa P.; Rimal, Rajiv N.; Smith, Katherine C.; Storey, J. Douglas; Rhoades, Elizabeth; Barnett, Daniel J.; Omer, Saad B.; Links, Jonathan			How Accessible Was Information about H1N1 Flu? Literacy Assessments of CDC Guidance Documents for Different Audiences	PLOS ONE			English	Article							WORLD-WIDE-WEB; PATIENT EDUCATION MATERIALS; PROSTATE-CANCER; QUALITY; HEALTH	We assessed the literacy level and readability of online communications about H1N1/09 influenza issued by the Centers for Disease Control and Prevention (CDC) during the first month of outbreak. Documents were classified as targeting one of six audiences ranging in technical expertise. Flesch-Kincaid (FK) measure assessed literacy level for each group of documents. ANOVA models tested for differences in FK scores across target audiences and over time. Readability was assessed for documents targeting non-technical audiences using the Suitability Assessment of Materials (SAM). Overall, there was a main-effect by audience, F(5, 82) = 29.72, P<.001, but FK scores did not vary over time, F(2, 82) = .34, P>.05. A time-by-audience interaction was significant, F(10, 82) = 2.11, P<.05. Documents targeting non-technical audiences were found to be text-heavy and densely-formatted. The vocabulary and writing style were found to adequately reflect audience needs. The reading level of CDC guidance documents about H1N1/09 influenza varied appropriately according to the intended audience; sub-optimal formatting and layout may have rendered some text difficult to comprehend.	[Lagasse, Lisa P.; Rimal, Rajiv N.; Smith, Katherine C.; Storey, J. Douglas; Rhoades, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Barnett, Daniel J.; Links, Jonathan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Omer, Saad B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lagasse, LP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.	llagasse@jhsph.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474; Barnett, Daniel/0000-0003-1382-6197	Johns Hopkins Preparedness and Emergency Response Research Center (PERRC) through the Centers for Disease Control [P01TP000288]	Johns Hopkins Preparedness and Emergency Response Research Center (PERRC) through the Centers for Disease Control	This research is funded by the Johns Hopkins Preparedness and Emergency Response Research Center (PERRC) through the Centers for Disease Control grant no. P01TP000288. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	BONIME A, 1998, WRITING NEW MEDIA; BRANDT HM, 2005, CANC CONTROL CANC S; CALLAGHAN JD, 2004, EFFECTIVE RISK COMMU; Croft DR, 2002, CHEST, V121, P1301, DOI 10.1378/chest.121.4.1301; D'Alessandro DM, 2001, ARCH PEDIAT ADOL MED, V155, P807, DOI 10.1001/archpedi.155.7.807; DOAK C, 1993, SUITABILITY ASSESSME; Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691; Fagerlin A, 2004, ANN INTERN MED, V140, P721, DOI 10.7326/0003-4819-140-9-200405040-00012; Flesh R, 1974, ART READABLE WRITING; FRIEDMAN DB, 2006, INFORM HLTH SOCIAL C, V31, P67; GARRAND T, 2001, WRITING MULTIMEDIA; Hoffmann T, 2006, PATIENT EDUC COUNS, V60, P286, DOI 10.1016/j.pec.2005.06.020; Kaphingst KA, 2006, CANCER CAUSE CONTROL, V17, P147, DOI 10.1007/s10552-005-5116-3; Kirsch I. S., 2002, ADULT LITERACY AM 1; PASSCHEORLOW MK, 2003, JAMA-J AM MED ASSOC, V348, P721; Rimal RN, 2009, B WORLD HEALTH ORGAN, V87, P247, DOI 10.2471/BLT.08.056713; Smith P T, 1998, Clin Nurse Spec, V12, P140, DOI 10.1097/00002800-199807000-00006; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Wallace LS, 2005, J WOMENS HEALTH, V14, P936, DOI 10.1089/jwh.2005.14.936; Weintraub D, 2004, PATIENT EDUC COUNS, V55, P275, DOI 10.1016/j.pec.2003.10.003; WHO, 2005, WHO HDB JOURN INFL P; Wolf MS, 2006, PATIENT EDUC COUNS, V62, P316, DOI 10.1016/j.pec.2006.06.010; World Health Organization, 2010, PAND H1N1 2009 UPD 1	23	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e23583	10.1371/journal.pone.0023583	http://dx.doi.org/10.1371/journal.pone.0023583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841MS	22039401	Green Published, gold			2022-12-25	WOS:000296517000002
J	Duhoux, FP; Ameye, G; Lambot, V; Herens, C; Lambert, F; Raynaud, S; Wlodarska, I; Michaux, L; Roche-Lestienne, C; Labis, E; Taviaux, S; Chapiro, E; Khac, FN; Struski, S; Dobbelstein, S; Dastugue, N; Lippert, E; Speleman, F; Van Roy, N; De Weer, A; Rack, K; Talmant, P; Richebourg, S; Mugneret, F; Tigaud, I; Mozziconacci, MJ; Laibe, S; Nadal, N; Terre, C; Libouton, JM; Decottignies, A; Vikkula, M; Poirel, HA				Duhoux, Francois P.; Ameye, Genevieve; Lambot, Virginie; Herens, Christian; Lambert, Frederic; Raynaud, Sophie; Wlodarska, Iwona; Michaux, Lucienne; Roche-Lestienne, Catherine; Labis, Elise; Taviaux, Sylvie; Chapiro, Elise; Florence Nguyen Khac; Struski, Stephanie; Dobbelstein, Sophie; Dastugue, Nicole; Lippert, Eric; Speleman, Frank; Van Roy, Nadine; De Weer, An; Rack, Katrina; Talmant, Pascaline; Richebourg, Steven; Mugneret, Francine; Tigaud, Isabelle; Mozziconacci, Marie-Joelle; Laibe, Sophy; Nadal, Nathalie; Terre, Christine; Libouton, Jeanne-Marie; Decottignies, Anabelle; Vikkula, Miikka; Poirel, Helene A.		GFCH; BCG-HO	Refinement of 1p36 Alterations Not Involving PRDM16 in Myeloid and Lymphoid Malignancies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMAS; TUMOR-SUPPRESSOR GENE; IN-SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; COPY NUMBER; CHROMOSOMAL TRANSLOCATIONS; MYELODYSPLASTIC SYNDROME; CYTOGENETIC ANALYSIS; NEUROBLASTOMA	Fluorescence in situ hybridization was performed to characterize 81 cases of myeloid and lymphoid malignancies with cytogenetic 1p36 alterations not affecting the PRDM16 locus. In total, three subgroups were identified: balanced translocations (N = 27) and telomeric rearrangements (N = 15), both mainly observed in myeloid disorders; and unbalanced non-telomeric rearrangements (N = 39), mainly observed in lymphoid proliferations and frequently associated with a highly complex karyotype. The 1p36 rearrangement was isolated in 12 cases, mainly myeloid disorders. The breakpoints on 1p36 were more widely distributed than previously reported, but with identifiable rare breakpoint cluster regions, such as the TP73 locus. We also found novel partner loci on 1p36 for the known multi-partner genes HMGA2 and RUNX1. We precised the common terminal 1p36 deletion, which has been suggested to have an adverse prognosis, in B-cell lymphomas [follicular lymphomas and diffuse large B-cell lymphomas with t(14;18)(q32;q21) as well as follicular lymphomas without t(14;18)]. Intrachromosomal telomeric repetitive sequences were detected in at least half the cases of telomeric rearrangements. It is unclear how the latter rearrangements occurred and whether they represent oncogenic events or result from chromosomal instability during oncogenesis.	[Duhoux, Francois P.; Ameye, Genevieve; Lambot, Virginie; Libouton, Jeanne-Marie; Poirel, Helene A.] Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium; [Herens, Christian; Lambert, Frederic] Ctr Hosp Univ, Ctr Genet Humaine, Liege, Belgium; [Raynaud, Sophie] Ctr Hosp Univ, Nice, France; [Wlodarska, Iwona; Michaux, Lucienne] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Roche-Lestienne, Catherine; Labis, Elise] Ctr Hosp Univ, Lille, France; [Taviaux, Sylvie] Hop Arnaud de Villeneuve, Montpellier, France; [Chapiro, Elise; Florence Nguyen Khac] Grp Hosp Pitie Salpetriere, Unite Cytogenet Hematol, F-75634 Paris, France; [Struski, Stephanie; Dobbelstein, Sophie; Dastugue, Nicole] Hop Purpan, Toulouse, France; [Lippert, Eric] Ctr Hosp Univ, Bordeaux, France; [Speleman, Frank; Van Roy, Nadine; De Weer, An] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Rack, Katrina] Inst Pathol & Genet, Gosselies, Belgium; [Talmant, Pascaline; Richebourg, Steven] Ctr Hosp Univ, Nantes, France; [Mugneret, Francine] Ctr Hosp Univ, Dijon, France; [Tigaud, Isabelle] Ctr Hosp Lyon Sud, Lyon, France; [Mozziconacci, Marie-Joelle; Laibe, Sophy] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Nadal, Nathalie] Ctr Hosp Univ Hop Nord, St Etienne, France; [Terre, Christine] Ctr Hosp Versailles, Versailles, France; [Decottignies, Anabelle; Vikkula, Miikka] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Liege; CHU Nice; KU Leuven; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; CHU Bordeaux; Ghent University; Ghent University Hospital; Nantes Universite; CHU de Nantes; CHU Dijon Bourgogne; CHU Lyon; UNICANCER; Institut Paoli-Calmette (IPC); CHU de St Etienne; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain	Duhoux, FP (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium.	helene.antoine-poirel@uclouvain.be	Vikkula, Miikka/Q-1038-2018; speleman, frank/AAR-5184-2020; STRUSKI, stephanie/X-4836-2019	Vikkula, Miikka/0000-0002-6236-338X; speleman, frank/0000-0002-6628-8559; Duhoux, Francois/0000-0002-5429-7888; Roche-Lestienne, Catherine/0000-0002-7998-3817; Nguyen-Khac, Florence/0000-0003-3107-6668	Salus Sanguinis foundation; Maisin foundation; Action de Recherches Concertees (Communaute Francaise de Belgique)	Salus Sanguinis foundation; Maisin foundation; Action de Recherches Concertees (Communaute Francaise de Belgique)	Funding: This work was supported by grants from the Salus Sanguinis and Maisin foundations and the Action de Recherches Concertees (Communaute Francaise de Belgique). FPD is a Fund for Scientific Research (FRS-FNRS) research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2011, BLOOD; Battaglia A, 2005, BRAIN DEV-JPN, V27, P358, DOI 10.1016/j.braindev.2004.03.011; Caren H, 2007, BRIT J CANCER, V97, P1416, DOI 10.1038/sj.bjc.6604032; Cheung KJJ, 2009, BLOOD, V113, P137, DOI 10.1182/blood-2008-02-140616; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Cheung KJJ, 2010, GENE CHROMOSOME CANC, V49, P669, DOI 10.1002/gcc.20780; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; D'Angelo CS, 2009, HUM GENET, V125, P551, DOI 10.1007/s00439-009-0650-9; Dave BJ, 1999, CLIN CANCER RES, V5, P1401; Dave BJ, 1999, CANCER GENET CYTOGEN, V108, P120, DOI 10.1016/S0165-4608(98)00138-1; DAVIS RJ, 1994, CANCER RES, V54, P2869; Della Peruta M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-61; Duhoux FP, 2010, LEUK RES; ELLMEIER W, 1992, EMBO J, V11, P2563, DOI 10.1002/j.1460-2075.1992.tb05321.x; ENOMOTO H, 1994, ONCOGENE, V9, P2785; Ferrand N, 2010, CANCER RES, V70, P8457, DOI 10.1158/0008-5472.CAN-09-4088; Gajecka M, 2010, AM J MED GENET A, V152A, P3074, DOI 10.1002/ajmg.a.33733; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hofmann WK, 2001, LEUKEMIA RES, V25, P855, DOI 10.1016/S0145-2126(01)00037-6; Hoglund M, 2004, GENE CHROMOSOME CANC, V39, P195, DOI 10.1002/gcc.10314; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Kang MA, 2009, J CANCER RES CLIN, V135, P761, DOI 10.1007/s00432-008-0510-3; Katzenberger T, 2009, BLOOD, V113, P1053, DOI 10.1182/blood-2008-07-168682; Lahortiga I, 2005, HUM GENET, V116, P476, DOI 10.1007/s00439-005-1268-1; Lestou VS, 2003, GENE CHROMOSOME CANC, V36, P375, DOI 10.1002/gcc.10181; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Martinez-Delgado B, 2002, INT J CANCER, V102, P15, DOI 10.1002/ijc.10618; Mayr C, 2006, BLOOD, V107, P742, DOI 10.1182/blood-2005-05-2093; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Mori N, 2003, BRIT J HAEMATOL, V122, P226, DOI 10.1046/j.1365-2141.2003.04434.x; Nguyen TDT, 2006, GENE CHROMOSOME CANC, V45, P918, DOI 10.1002/gcc.20355; O'Shea D, 2009, BLOOD, V113, P2298, DOI 10.1182/blood-2008-08-174953; Odero MD, 2005, LEUKEMIA, V19, P245, DOI 10.1038/sj.leu.2403605; Odero MD, 2002, GENE CHROMOSOME CANC, V35, P11, DOI 10.1002/gcc.10090; Okawa ER, 2008, ONCOGENE, V27, P803, DOI 10.1038/sj.onc.1210675; Oswald C, 2008, CELL CYCLE, V7, P1726, DOI 10.4161/cc.7.12.6148; Rajgopal A, 2003, CANCER GENET CYTOGEN, V142, P46, DOI 10.1016/S0165-4608(02)00740-9; Ross CW, 2007, CLIN CANCER RES, V13, P4777, DOI 10.1158/1078-0432.CCR-07-0456; Sakai I, 2005, GENE CHROMOSOME CANC, V44, P265, DOI 10.1002/gcc.20241; Schwaenen C, 2009, GENE CHROMOSOME CANC, V48, P39, DOI 10.1002/gcc.20617; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stoffel A, 2004, LEUKEMIA RES, V28, P1341, DOI 10.1016/j.leukres.2004.04.010; Theate I, 2011, ANN ONCOL, V22, P211; Tilman G, 2009, ONCOGENE, V28, P1682, DOI 10.1038/onc.2009.23; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Urashima M, 1996, LEUKEMIA, V10, P1576; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; WHITE PS, 1993, GENE CHROMOSOME CANC, V7, P102, DOI 10.1002/gcc.2870070207; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254	53	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26311	10.1371/journal.pone.0026311	http://dx.doi.org/10.1371/journal.pone.0026311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039459	Green Published, Green Submitted, gold			2022-12-25	WOS:000296513200016
J	Wynn, AN; Rueschhoff, EE; Franks, RG				Wynn, April N.; Rueschhoff, Elizabeth E.; Franks, Robert G.			Transcriptomic Characterization of a Synergistic Genetic Interaction during Carpel Margin Meristem Development in Arabidopsis thaliana	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; OVULE DEVELOPMENT; REGULATORY PROTEINS; FLOWER DEVELOPMENT; ORGAN SIZE; AINTEGUMENTA; EXPRESSION; FAMILY; GYNOECIUM; GROWTH	In flowering plants the gynoecium is the female reproductive structure. In Arabidopsis thaliana ovules initiate within the developing gynoecium from meristematic tissue located along the margins of the floral carpels. When fertilized the ovules will develop into seeds. SEUSS (SEU) and AINTEGUMENTA (ANT) encode transcriptional regulators that are critical for the proper formation of ovules from the carpel margin meristem (CMM). The synergistic loss of ovule initiation observed in the seu ant double mutant suggests that SEU and ANT share overlapping functions during CMM development. However the molecular mechanism underlying this synergistic interaction is unknown. Using the ATH1 transcriptomics platform we identified transcripts that were differentially expressed in seu ant double mutant relative to wild type and single mutant gynoecia. In particular we sought to identify transcripts whose expression was dependent on the coordinated activities of the SEU and ANT gene products. Our analysis identifies a diverse set of transcripts that display altered expression in the seu ant double mutant tissues. The analysis of overrepresented Gene Ontology classifications suggests a preponderance of transcriptional regulators including multiple members of the REPRODUCTIVE MERISTEMS (REM) and GROWTH-REGULATING FACTOR (GRF) families are mis-regulated in the seu ant gynoecia. Our in situ hybridization analyses indicate that many of these genes are preferentially expressed within the developing CMM. This study is the first step toward a detailed description of the transcriptional regulatory hierarchies that control the development of the CMM and ovule initiation. Understanding the regulatory hierarchy controlled by SEU and ANT will clarify the molecular mechanism of the functional redundancy of these two genes and illuminate the developmental and molecular events required for CMM development and ovule initiation.	[Wynn, April N.; Franks, Robert G.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Rueschhoff, Elizabeth E.] Indiana Univ SE, Dept Biol, New Albany, IN 47150 USA	University of North Carolina; North Carolina State University; Indiana University System; Indiana University Southeast	Franks, RG (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	rgfranks@ncsu.edu		Franks, Robert G./0000-0002-3978-1030	National Science Foundation [NSF IOS 0821896]	National Science Foundation(National Science Foundation (NSF))	Funding: This work is supported by a grant from the National Science Foundation (NSF IOS 0821896). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Ferreira M, 2007, PLANT PHYSIOL, V145, P747, DOI 10.1104/pp.107.104422; Azhakanandam S, 2008, PLANT PHYSIOL, V146, P1165, DOI 10.1104/pp.107.114751; Bao F, 2010, PLANT PHYSIOL, V152, P821, DOI 10.1104/pp.109.146183; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Bowman JL, 1999, CURR TOP DEV BIOL, V45, P155, DOI 10.1016/S0070-2153(08)60316-6; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Chuang CF, 1999, GENE DEV, V13, P334, DOI 10.1101/gad.13.3.334; Colombo L, 2008, TRENDS PLANT SCI, V13, P444, DOI 10.1016/j.tplants.2008.04.011; Colombo M, 2010, DEV BIOL, V337, P294, DOI 10.1016/j.ydbio.2009.10.043; Conner J, 2000, P NATL ACAD SCI USA, V97, P12902, DOI 10.1073/pnas.230352397; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Franco-Zorrilla JM, 2002, PLANT PHYSIOL, V128, P418, DOI 10.1104/pp.010323; Franks RG, 2002, DEVELOPMENT, V129, P253; Ge XC, 2010, CURR BIOL, V20, pR988, DOI 10.1016/j.cub.2010.09.040; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gonzalez D, 2007, MOL CELL BIOL, V27, P5306, DOI 10.1128/MCB.01912-06; Gregis V, 2006, PLANT CELL, V18, P1373, DOI 10.1105/tpc.106.041798; HILL JP, 1989, CAN J BOT, V67, P2922, DOI 10.1139/b89-375; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Kagi C, 2007, CURR OPIN PLANT BIOL, V10, P633, DOI 10.1016/j.pbi.2007.07.011; KATARI MS, PLANT PHYSL, V152, P500; Kelley DR, 2009, SEX PLANT REPROD, V22, P229, DOI 10.1007/s00497-009-0107-2; Kim JG, 2004, EUR J ENTOMOL, V101, P1; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krizek BA, 2000, PLANT CELL, V12, P1357, DOI 10.1105/tpc.12.8.1357; Krizek BA, 1999, DEV GENET, V25, P224, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;224::AID-DVG5&gt;3.0.CO;2-Y; Krizek BA, 2009, PLANT PHYSIOL, V150, P1916, DOI 10.1104/pp.109.141119; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Liu ZC, 2000, PLANT CELL, V12, P1879, DOI 10.1105/tpc.12.10.1879; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Maier AT, 2009, DEVELOPMENT, V136, P1613, DOI 10.1242/dev.033647; Matias-Hernandez L, 2010, PLANT CELL, V22, P1702, DOI 10.1105/tpc.109.068627; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Nole-Wilson S, 2006, PLANT PHYSIOL, V141, P977, DOI 10.1104/pp.106.076604; Nole-Wilson S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-198; Note-Wilson S, 2010, DEV BIOL, V346, P181, DOI 10.1016/j.ydbio.2010.07.016; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Romanel E, 2011, INT J DEV BIOL, V55, P657, DOI 10.1387/ijdb.113340er; Romanel EAC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005791; Scofield S, 2007, PLANT J, V50, P767, DOI 10.1111/j.1365-313X.2007.03095.x; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shi DQ, 2011, CURR OPIN PLANT BIOL, V14, P74, DOI 10.1016/j.pbi.2010.09.001; Sieber P, 2004, DEV BIOL, V273, P321, DOI 10.1016/j.ydbio.2004.05.037; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Skinner DJ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-29; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Sridhar VV, 2004, P NATL ACAD SCI USA, V101, P11494, DOI 10.1073/pnas.0403055101; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Trigueros M, 2009, PLANT CELL, V21, P1394, DOI 10.1105/tpc.109.065508; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yung MH, 1999, PLANT J, V17, P203, DOI 10.1046/j.1365-313X.1999.00359.x; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139; Zhong RQ, 2004, PLANT CELL PHYSIOL, V45, P369, DOI 10.1093/pcp/pch051	70	35	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26231	10.1371/journal.pone.0026231	http://dx.doi.org/10.1371/journal.pone.0026231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031826	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200013
J	Yuan, C; Li, C; Yan, LJ; Jackson, AO; Liu, ZY; Han, CG; Yu, JL; Li, DW				Yuan, Cheng; Li, Cui; Yan, Lijie; Jackson, Andrew O.; Liu, Zhiyong; Han, Chenggui; Yu, Jialin; Li, Dawei			A High Throughput Barley Stripe Mosaic Virus Vector for Virus Induced Gene Silencing in Monocots and Dicots	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; TOBACCO RATTLE VIRUS; TO-CELL MOVEMENT; DISEASE-RESISTANCE; NICOTIANA-BENTHAMIANA; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; MOLECULAR ANALYSIS; HEXAPLOID WHEAT; CAPSID PROTEIN	Barley stripe mosaic virus (BSMV) is a single-stranded RNA virus with three genome components designated alpha, beta, and gamma. BSMV vectors have previously been shown to be efficient virus induced gene silencing (VIGS) vehicles in barley and wheat and have provided important information about host genes functioning during pathogenesis as well as various aspects of genes functioning in development. To permit more effective use of BSMV VIGS for functional genomics experiments, we have developed an Agrobacterium delivery system for BSMV and have coupled this with a ligation independent cloning (LIC) strategy to mediate efficient cloning of host genes. Infiltrated Nicotiana benthamiana leaves provided excellent sources of virus for secondary BSMV infections and VIGS in cereals. The Agro/LIC BSMV VIGS vectors were able to function in high efficiency down regulation of phytoene desaturase (PDS), magnesium chelatase subunit H (ChlH), and plastid transketolase (TK) gene silencing in N. benthamiana and in the monocots, wheat, barley, and the model grass, Brachypodium distachyon. Suppression of an Arabidopsis orthologue cloned from wheat (TaPMR5) also interfered with wheat powdery mildew (Blumeria graminis f. sp. tritici) infections in a manner similar to that of the A. thaliana PMR5 loss-of-function allele. These results imply that the PMR5 gene has maintained similar functions across monocot and dicot families. Our BSMV VIGS system provides substantial advantages in expense, cloning efficiency, ease of manipulation and ability to apply VIGS for high throughput genomics studies.	[Yuan, Cheng; Li, Cui; Yan, Lijie; Liu, Zhiyong; Han, Chenggui; Yu, Jialin; Li, Dawei] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Jackson, Andrew O.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	China Agricultural University; University of California System; University of California Berkeley	Yuan, C (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	Dawei.Li@cau.edu.cn	Li, Dawei/I-8751-2016; Li, Dawei/CAJ-5076-2022	Li, Dawei/0000-0003-4133-1263; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233; Yuan, Cheng/0000-0003-2582-4041	National Basic Research Program (973 program) [2009CB118306]; National Natural Science Foundation of China [30325001]; National Science & Technology Specific Projects of China [2008ZX08009-002]; SKLAB [2008SKLAB06-01]; United States Department of Agriculture [CSREES-2008-35319-19225]	National Basic Research Program (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Specific Projects of China; SKLAB; United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding: This work was supported by the National Basic Research Program (973 program, No. 2009CB118306), the National Natural Science Foundation of China (30325001) and the National Science & Technology Specific Projects of China (2008ZX08009-002) to DL, The Project for Extramural Scientists of SKLAB (2008SKLAB06-01) and United States Department of Agriculture Competitive Grant CSREES-2008-35319-19225 to AOJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai P, 2005, VIROLOGY, V338, P96, DOI 10.1016/j.virol.2005.05.013; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Bragg JN, 2004, MOL PLANT PATHOL, V5, P465, DOI [10.1111/j.1364-3703.2004.00246.x, 10.1111/J.1364-3703.2004.00246.X]; Bragg JN, 2008, ENCY VIROLOGY, P459; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Brueggeman R, 2008, P NATL ACAD SCI USA, V105, P14970, DOI 10.1073/pnas.0807270105; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1323, DOI 10.1094/MPMI-20-11-1323; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Cakir C, 2010, CROP SCI, V50, pS77, DOI 10.2135/cropsci2009.10.0567; Campbell J., 2010, J BIOTECH RES, V2, P12; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Carrillo-Tripp J, 2006, CURR OPIN PLANT BIOL, V9, P209, DOI 10.1016/j.pbi.2006.01.012; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Constantin GD, 2004, PLANT J, V40, P622, DOI 10.1111/j.1365-313X.2004.02233.x; Delteil A, 2010, RICE, V3, P56, DOI 10.1007/s12284-009-9035-x; Demircan T, 2010, PLANT CELL TISS ORG, V100, P91, DOI 10.1007/s11240-009-9623-x; Ding XS, 2006, MOL PLANT MICROBE IN, V19, P1229, DOI 10.1094/MPMI-19-1229; DONALD RGK, 1994, PLANT CELL, V6, P1593, DOI 10.1105/tpc.6.11.1593; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Eckardt NA, 2002, PLANT CELL, V14, P1983, DOI 10.1105/tpc.140910; Eichmann R, 2010, MOL PLANT MICROBE IN, V23, P1217, DOI 10.1094/MPMI-23-9-1217; Engler JD, 2005, CURR OPIN BIOTECH, V16, P112, DOI 10.1016/j.copbio.2005.01.009; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Gossele V, 2002, PLANT J, V32, P859, DOI 10.1046/j.1365-313X.2002.01471.x; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Held MA, 2008, P NATL ACAD SCI USA, V105, P20534, DOI 10.1073/pnas.0809408105; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hiriart JB, 2003, MOL PLANT MICROBE IN, V16, P99, DOI 10.1094/MPMI.2003.16.2.99; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hu PS, 2009, MOL PLANT MICROBE IN, V22, P311, DOI 10.1094/MPMI-22-3-0311; Huang CJ, 2009, PLANT BIOTECHNOL J, V7, P254, DOI 10.1111/j.1467-7652.2008.00395.x; Igarashi A, 2009, VIROLOGY, V386, P407, DOI 10.1016/j.virol.2009.01.039; Jackson AO, 2009, ANNU REV PHYTOPATHOL, V47, P385, DOI 10.1146/annurev-phyto-080508-081733; Jackson AO, 1981, HDB PLANT VIRUS INFE, P565; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Lawrence DM, 2001, MOL PLANT PATHOL, V2, P65, DOI 10.1046/j.1364-3703.2001.00052.x; Lawrence DM, 2001, J VIROL, V75, P8712, DOI 10.1128/JVI.75.18.8712-8723.2001; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; Maeda K, 2009, MOL PLANT MICROBE IN, V22, P1331, DOI 10.1094/MPMI-22-11-1331; Manning VA, 2010, NEW PHYTOL, V187, P1034, DOI 10.1111/j.1469-8137.2010.03363.x; Meng Y, 2009, PLANT PHYSIOL, V149, P271, DOI 10.1104/pp.108.129031; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Oikawa A, 2007, J EXP BOT, V58, P2617, DOI 10.1093/jxb/erm109; Pacak A, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-26; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; PETTY ITD, 1989, VIROLOGY, V171, P342, DOI 10.1016/0042-6822(89)90601-6; Pflieger S, 2008, PLANT J, V56, P678, DOI 10.1111/j.1365-313X.2008.03620.x; Pignatta D, 2007, MOL PLANT MICROBE IN, V20, P609, DOI 10.1094/MPMI-20-6-0609; Purkayastha A, 2010, PLANTA, V232, P1531, DOI 10.1007/s00425-010-1273-z; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Renner T, 2009, MOL PLANT, V2, P1084, DOI 10.1093/mp/ssp033; Robertson D, 2004, ANNU REV PLANT BIOL, V55, P495, DOI 10.1146/annurev.arplant.55.031903.141803; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Scholthof HB, 1996, ANNU REV PHYTOPATHOL, V34, P299, DOI 10.1146/annurev.phyto.34.1.299; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Scofield SR, 2009, PLANT PHYSIOL, V149, P152, DOI 10.1104/pp.108.128702; Sindhu A, 2008, P NATL ACAD SCI USA, V105, P1762, DOI 10.1073/pnas.0711406105; Tai YS, 2005, BIOTECHNIQUES, V39, P310, DOI 10.2144/05393BM03; van der Linde K, 2011, NEW PHYTOL, V189, P471, DOI 10.1111/j.1469-8137.2010.03474.x; van Eck L, 2010, PLANT BIOTECHNOL J, V8, P1023, DOI 10.1111/j.1467-7652.2010.00539.x; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Vogel J, 2009, PLANT GENET GENOMICS, V7, P427, DOI 10.1007/978-0-387-77489-3_16; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Wang GF, 2011, NEW PHYTOL, V191, P418, DOI 10.1111/j.1469-8137.2011.03715.x; Wang XY, 2010, MOL BIOL REP, V37, P967, DOI 10.1007/s11033-009-9766-1; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yamagishi N, 2009, PLANT MOL BIOL, V71, P15, DOI 10.1007/s11103-009-9505-y; Yelina NE, 2002, J VIROL, V76, P12981, DOI 10.1128/JVI.76.24.12981-12991.2002; Yin CT, 2011, MOL PLANT MICROBE IN, V24, P554, DOI 10.1094/MPMI-10-10-0229; Zhang CQ, 2010, PLANT PHYSIOL, V153, P52, DOI 10.1104/pp.109.151639; Zhang L, 2009, THEOR APPL GENET, V118, P385, DOI 10.1007/s00122-008-0910-4; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x	82	177	195	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26468	10.1371/journal.pone.0026468	http://dx.doi.org/10.1371/journal.pone.0026468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031834	Green Published, Green Submitted, gold			2022-12-25	WOS:000296513200023
J	Acharya, P; Pallavi, R; Chandran, S; Dandavate, V; Sayeed, SK; Rochani, A; Acharya, J; Middha, S; Kochar, S; Kochar, D; Ghosh, SK; Tatu, U				Acharya, Pragyan; Pallavi, Rani; Chandran, Syama; Dandavate, Vrushali; Sayeed, Syed Khund; Rochani, Ankit; Acharya, Jyoti; Middha, Sheetal; Kochar, Sanjay; Kochar, Dhanpat; Ghosh, Susanta Kumar; Tatu, Utpal			Clinical Proteomics of the Neglected Human Malarial Parasite Plasmodium vivax	PLOS ONE			English	Article							FALCIPARUM LIFE-CYCLE; CRYSTAL-STRUCTURE; BINDING-SITE; PROTEIN; RESISTANCE; INHIBITION; ALDOLASE; IDENTIFICATION; TRANSCRIPTOME; EXPRESSION	Recent reports highlight the severity and the morbidity of disease caused by the long neglected malaria parasite Plasmodium vivax. Due to inherent difficulties in the laboratory-propagation of P. vivax, the biology of this parasite has not been adequately explored. While the proteome of P. falciparum, the causative agent of cerebral malaria, has been extensively explored from several sources, there is limited information on the proteome of P. vivax. We have, for the first time, examined the proteome of P. vivax isolated directly from patients without adaptation to laboratory conditions. We have identified 153 proteins from clinical P. vivax, majority of which do not show homology to any previously known gene products. We also report 29 new proteins that were found to be expressed in P. vivax for the first time. In addition, several proteins previously implicated as anti-malarial targets, were also found in our analysis. Most importantly, we found several unique proteins expressed by P. vivax. This study is an important step in providing insight into physiology of the parasite under clinical settings.	[Acharya, Pragyan; Pallavi, Rani; Chandran, Syama; Dandavate, Vrushali; Sayeed, Syed Khund; Rochani, Ankit; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Acharya, Jyoti; Middha, Sheetal; Kochar, Sanjay; Kochar, Dhanpat] SP Med Coll, Dept Med, Bikaner, Rajasthan, India; [Ghosh, Susanta Kumar] Natl Inst Malaria Res, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Acharya, P (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in	Rochani, Ankit/J-8162-2019; Pallavi, Rani/AAR-7824-2020; Khund Sayeed, Syed/AAB-3149-2022	Khund Sayeed, Syed/0000-0002-0404-4233; Tatu, Utpal/0000-0003-0404-8872; Rochani, Ankit/0000-0002-0119-0462	Department of Biotechnology [DBTO201]	Department of Biotechnology	Grant No: DBTO201, "A Systems Biology Approach towards Understanding Severe Malaria with Special Reference to the Transcriptome and Proteome of the Parasite and the Host" funded by Department of Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2009, PROTEOM CLIN APPL, V3, P1314, DOI 10.1002/prca.200900090; Baird J Kevin, 2007, Curr Infect Dis Rep, V9, P39, DOI 10.1007/s11908-007-0021-4; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Becker JVW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-235; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Collins WE, 1996, AM J TROP MED HYG, V55, P243, DOI 10.4269/ajtmh.1996.55.243; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Ersmark K, 2006, BIOORGAN MED CHEM, V14, P2197, DOI 10.1016/j.bmc.2005.11.003; Fernandez-Becerra C, 2009, TRENDS PARASITOL, V25, P44, DOI 10.1016/j.pt.2008.09.012; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Huh AJ, 2011, J KOREAN MED SCI, V26, P42, DOI 10.3346/jkms.2011.26.1.42; ITIN C, 1993, MOL BIOCHEM PARASIT, V58, P135, DOI 10.1016/0166-6851(93)90097-H; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Joubert F, 2001, PROTEINS, V45, P136, DOI 10.1002/prot.1133; Kim H, 1998, BIOCHEMISTRY-US, V37, P4388, DOI 10.1021/bi972233h; Korsinczky M, 2004, ANTIMICROB AGENTS CH, V48, P2214, DOI 10.1128/AAC.48.6.2214-2222.2004; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; LeRoux M, 2009, TRENDS PARASITOL, V25, P474, DOI 10.1016/j.pt.2009.07.005; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pesce E. -R, 2010, Infectious Disorders - Drug Targets, V10, P147; PESCE ER, 2009, BIOORGAN MED CHEM, V17, P1527; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; ROOBSONG W, 2011, J PROTEOMICS    0413; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trenholme Katharine R., 2010, Infectious Disorders - Drug Targets, V10, P217; Velanker SS, 1997, STRUCTURE, V5, P751, DOI 10.1016/S0969-2126(97)00230-X; Wanidworanun C, 1999, MOL BIOCHEM PARASIT, V102, P91, DOI 10.1016/S0166-6851(99)00087-0; Westenberger SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000653; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200	41	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26623	10.1371/journal.pone.0026623	http://dx.doi.org/10.1371/journal.pone.0026623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028927	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800062
J	Maan, NS; Maan, S; Nomikou, K; Belaganahalli, MN; Bachanek-Bankowska, K; Mertens, PPC				Maan, Narender S.; Maan, Sushila; Nomikou, Kyriaki; Belaganahalli, Manjunatha N.; Bachanek-Bankowska, Katarzyna; Mertens, Peter P. C.			Serotype Specific Primers and Gel-Based RT-PCR Assays for 'Typing' African Horse Sickness Virus: Identification of Strains from Africa	PLOS ONE			English	Article							EPIZOOTIC HEMORRHAGIC-DISEASE; REAL-TIME PCR; BLUETONGUE VIRUS; HORSESICKNESS-VIRUS; COMPLETE SET; VP2 GENES; SEQUENCE; ORBIVIRUS; AMPLIFICATION; GENOME	African horse sickness is a devastating, transboundary animal disease, that is 'listed' by the Office International des Epizooties (OIE). Although attenuated, inactivated and subunit vaccines have been developed for African horse sickness virus (AHSV), these are serotype-specific and their effective deployment therefore relies on rapid and reliable identification of virus type. AHSV serotype is controlled by the specificity of interactions between neutralising antibodies, and components of the outer-capsid, particularly protein VP2 (encoded by AHSV genome segment 2 (Seg-2)). We report the development and evaluation of novel gel based reverse transcription-PCR (RT-PCR) assays targeting AHSV Seg-2, which can be used to very significantly increase the speed and reliability of detection and identification (compared to virus neutralisation tests) of the nine serotypes of AHSV. Primer sets were designed targeting regions of Seg-2 that are conserved between strains within each of the AHSV serotype (types 1 to 9). These assays were evaluated using multiple AHSV strains from the orbivirus reference collection at IAH (www.reoviridae.org/dsRNA_virus_proteins/ReoID/AHSV-isolates.htm). In each case the Seg-2 primers showed a high level of specificity and failed to cross-amplify the most closely related heterologous AHSV types, or other related orbiviruses (such as bluetongue virus (BTV), or equine encephalosis virus (EEV)). The assays are rapid and sensitive, and can be used to detect and type viral RNA in blood, tissue samples, or cultivated viral suspensions within 24 h. They were used to identify AHSV strains from recent outbreaks in sub-Saharan African countries. These methods also generate cDNAs suitable for sequencing and phylogenetic analyses of Seg-2, identifying distinct virus lineages within each virus-type and helping to identify strain movements/origins. The RT-PCR methods described here provide a robust and versatile tool for rapid and specific detection and identification of AHSV serotypes 1 to 9.	[Maan, Narender S.; Maan, Sushila; Nomikou, Kyriaki; Belaganahalli, Manjunatha N.; Bachanek-Bankowska, Katarzyna; Mertens, Peter P. C.] AFRC, Inst Anim Hlth, Pirbright Lab, Vector Borne Dis Programme, Woking GU24 0NF, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute	Maan, NS (corresponding author), LLR Univ Vet & Anim Sci, Dept Anim Biotechnol, Hisar, Haryana, India.	peter.mertens@iah.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019; Nomikou, Kyriaki/Q-5555-2016; Nomikou, Kyriaki/P-1840-2018	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; Department for Environment, Food and Rural Affairs (DEFRA) [SE2617]; Commonwealth Scholarship Commission; Institute for Animal Health (IAH)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Commonwealth Scholarship Commission; Institute for Animal Health (IAH)	This work was partly funded by Biotechnology and Biological Sciences Research Council (BBSRC) and the European Union (EU) (SANCO/940/2002) awarded to NSM and PM. SM and KN were part of this work funded by the Department for Environment, Food and Rural Affairs (DEFRA)(SE2617). For part of this work, MB was funded by Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/), and KB was funded by an Institute for Animal Health (IAH) studentship (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1995, VET MICROBIOL, V47, P133, DOI 10.1016/0378-1135(95)00059-J; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Blacksell SD, 1996, AUST VET J, V73, P33, DOI 10.1111/j.1751-0813.1996.tb09953.x; BURRAGE TG, 1993, VIROLOGY, V196, P799, DOI 10.1006/viro.1993.1537; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; Coetzer JAW, AFRICAN HORSE SICKNE, P1231; DAVIES FG, 1971, RES VET SCI, V12, P181; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Du Toit R. M., 1944, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V19, P7; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hess WR, 1988, ARBOVIRUS EPIDEMIOLO, P2; HOWELL P G, 1970, Onderstepoort Journal of Veterinary Research, V37, P59; IWATA H, 1992, VIROLOGY, V191, P251, DOI 10.1016/0042-6822(92)90187-T; JEGGO MH, 1986, RES VET SCI, V40, P386, DOI 10.1016/S0034-5288(18)30556-3; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Koekemoer JJO, 2008, J VIROL METHODS, V154, P104, DOI 10.1016/j.jviromet.2008.08.010; Koekemoer JJO, 2000, J VIROL METHODS, V88, P135, DOI 10.1016/S0166-0934(00)00191-9; Koekemoer JJO, 2004, J VIROL METHODS, V122, P49, DOI 10.1016/j.jviromet.2004.08.002; LAEGREID WW, 1993, VIROLOGY, V195, P836, DOI 10.1006/viro.1993.1440; Lubroth J., 1988, Equine Practice, V10, P26; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MELLOR PS, 1993, VET RES, V24, P199; MELLOR PS, 2008, ENCY VIROLOGY, P37; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; Mertens PPC, 2011, RNAS PROTEINS DSRNA; NAMP, 2009, NAT ARB MON PROGR NA; NEWSHOLME SJ, 1983, ONDERSTEPOORT J VET, V50, P7; O'Hara RS, 1998, ARCH VIROL, P259; Oura CAL, 2011, EPIDEMIOLOG IN PRESS; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Potgieter AC, 2003, J GEN VIROL, V84, P1317, DOI 10.1099/vir.0.18919-0; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rodriguez-Sanchez B, 2008, J VIROL METHODS, V151, P87, DOI 10.1016/j.jviromet.2008.03.029; ROY P, 1994, COMP IMMUNOL MICROB, V17, P243, DOI 10.1016/0147-9571(94)90046-9; Sailleau C, 2000, J GEN VIROL, V81, P831, DOI 10.1099/0022-1317-81-3-831; Stoltz MA, 1996, ONDERSTEPOORT J VET, V63, P57; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDIJK AA, 1982, ONDERSTEPOORT J VET, V49, P227; VANRENSBURG IBJ, 1981, J S AFR VET ASSOC, V52, P323; VREEDE FT, 1994, J GEN VIROL, V75, P3629, DOI 10.1099/0022-1317-75-12-3629; Wilson A, 2009, VET RES, V40, DOI 10.1051/vetres:2008054; World Organization for Animal Health (OIE), 2000, MAN STAND DIAGN TEST, P178; Zientara S, 1998, ARCH VIROL, P317	53	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25686	10.1371/journal.pone.0025686	http://dx.doi.org/10.1371/journal.pone.0025686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028787	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000296510800008
J	Tobin, VA; Douglas, AJ; Leng, G; Ludwig, M				Tobin, Vicky A.; Douglas, Alison J.; Leng, Gareth; Ludwig, Mike			The Involvement of Voltage-Operated Calcium Channels in Somato-Dendritic Oxytocin Release	PLOS ONE			English	Article							RAT SUPRAOPTIC NEURONS; BAG CELL NEURONS; PROTEIN-KINASE-C; MAGNOCELLULAR NEUROSECRETORY-CELLS; GATED ION CHANNELS; CA2+ CHANNELS; NERVE-TERMINALS; AXON TERMINALS; NEUROTRANSMITTER RELEASE; NEUROPEPTIDE RELEASE	Magnocellular neurons of the supraoptic nucleus (SON) secrete oxytocin and vasopressin from axon terminals in the neurohypophysis, but they also release large amounts of peptide from their somata and dendrites, and this can be regulated both by activity-dependent Ca2+ influx and by mobilization of intracellular Ca2+. This somato-dendritic release can also be primed by agents that mobilise intracellular Ca2+, meaning that the extent to which it is activity-dependent, is physiologically labile. We investigated the role of different Ca2+ channels in somato-dendritic release; blocking N-type channels reduced depolarisation-induced oxytocin release from SONs in vitro from adult and post-natal day 8 (PND-8) rats, blocking L-type only had effect in PND-8 rats, while blocking other channel types had no significant effect. When oxytocin release was primed by prior exposure to thapsigargin, both N- and L-type channel blockers reduced release, while P/Q and R-type blockers were ineffective. Using confocal microscopy, we found immunoreactivity for Ca(v)1.2 and 1.3 channel subunits (which both form L-type channels), 2.1 (P/Q type), 2.2 (N-type) and 2.3 (R-type) in the somata and dendrites of both oxytocin and vasopressin neurons, and the intensity of the immunofluorescence signal for different subunits differed between PND-8, adult and lactating rats. Using patch-clamp electrophysiology, the N-type Ca2+ current density increased after thapsigargin treatment, but did not alter the voltage sensitivity of the channel. These results suggest that the expression, location or availability of N-type Ca2+ channels is altered when required for high rates of somato-dendritic peptide release.	[Tobin, Vicky A.; Douglas, Alison J.; Leng, Gareth; Ludwig, Mike] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Tobin, VA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	mike.ludwig@ed.ac.uk	Leng, Gareth/C-6688-2011	Leng, Gareth/0000-0002-2388-8466	BBSRC [BB/F019009/1]; MRC [G0700176]; Biotechnology and Biological Sciences Research Council [BB/F019009/1] Funding Source: researchfish; Medical Research Council [G0700176] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the BBSRC (BB/F019009/1) and MRC (G0700176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; CAZALIS M, 1987, J PHYSIOL-LONDON, V390, P71, DOI 10.1113/jphysiol.1987.sp016687; Chevaleyre V, 2000, J NEUROSCI, V20, P5813, DOI 10.1523/JNEUROSCI.20-15-05813.2000; DISCALAGUENOT D, 1987, NEUROSCI LETT, V76, P209, DOI 10.1016/0304-3940(87)90717-8; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Fisher TE, 1995, J PHYSIOL-LONDON, V489, P383, DOI 10.1113/jphysiol.1995.sp021059; Fisher TE, 2000, FEBS LETT, V482, P131, DOI 10.1016/S0014-5793(00)02043-3; Fisher TE, 1996, TRENDS NEUROSCI, V19, P440; FISHER TE, 1995, J PHYSIOL-LONDON, V486, P571, DOI 10.1113/jphysiol.1995.sp020835; Fisher TE, 2001, PROG BIOPHYS MOL BIO, V77, P269, DOI 10.1016/S0079-6107(01)00017-7; Foehring RC, 1996, J NEUROPHYSIOL, V76, P977, DOI 10.1152/jn.1996.76.2.977; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Huang H, 2002, NEUROSCI LETT, V332, P141, DOI 10.1016/S0304-3940(02)00836-4; Joux N, 2001, J NEUROENDOCRINOL, V13, P638, DOI 10.1046/j.1365-2826.2001.00679.x; KNOX RJ, 1992, NEURON, V8, P883, DOI 10.1016/0896-6273(92)90202-O; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; LAMBERT RC, 1994, J PHYSIOL-LONDON, V478, P275, DOI 10.1113/jphysiol.1994.sp020249; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LEMOS JR, 1989, NEURON, V2, P1419, DOI 10.1016/0896-6273(89)90187-6; Leng G, 2008, NEUROCHEM RES, V33, P668, DOI 10.1007/s11064-007-9500-0; LEVINA NN, 1994, J CELL SCI, V107, P127; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Ludwig M, 2005, J PHYSIOL-LONDON, V564, P515, DOI 10.1113/jphysiol.2005.083931; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; LUDWIG M, 1992, BRAIN RES, V576, P231, DOI 10.1016/0006-8993(92)90685-3; Ludwig M, 2003, TRENDS NEUROSCI, V26, P255, DOI 10.1016/S0166-2236(03)00072-9; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Passafaro M, 1996, J BIOL CHEM, V271, P30096, DOI 10.1074/jbc.271.47.30096; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; Sabatier N, 2003, J NEUROSCI, V23, P10351; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schubert T, 2004, NEUROSCIENCE, V125, P583, DOI 10.1016/j.neuroscience.2004.02.009; SMITH PR, 1995, J MEMBRANE BIOL, V147, P195; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; Tobin VA, 2004, EUR J NEUROSCI, V19, P2909, DOI 10.1111/j.1460-9568.2004.03388.x; Tobin VA, 2007, J PHYSIOL-LONDON, V582, P1337, DOI 10.1113/jphysiol.2007.132639; TURNER TJ, 1993, P NATL ACAD SCI USA, V90, P9518, DOI 10.1073/pnas.90.20.9518; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; WANG XM, 1993, J NEUROPHYSIOL, V70, P1617, DOI 10.1152/jn.1993.70.4.1617; WANG XM, 1992, J PHYSIOL-LONDON, V445, P181, DOI 10.1113/jphysiol.1992.sp018919; White BH, 1997, J NEUROSCI, V17, P1582; White BH, 1998, J NEUROPHYSIOL, V80, P2514, DOI 10.1152/jn.1998.80.5.2514; Zhang LX, 2000, J NEUROCYTOL, V29, P19, DOI 10.1023/A:1007108012667; Zhang YL, 2008, J NEUROSCI, V28, P2601, DOI 10.1523/JNEUROSCI.4314-07; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zilberter Y, 2005, NEUROSCIENTIST, V11, P334, DOI 10.1177/1073858405275827	52	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25366	10.1371/journal.pone.0025366	http://dx.doi.org/10.1371/journal.pone.0025366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028774	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800005
J	Yang, S; Jongejans, E; Yang, S; Bishop, JG				Yang, Suann; Jongejans, Eelke; Yang, Sylvia; Bishop, John G.			The Effect of Consumers and Mutualists of Vaccinium membranaceum at Mount St. Helens: Dependence on Successional Context	PLOS ONE			English	Article							FOOD WEBS; INTERACTION STRENGTH; BIOLOGICAL INVASION; VEGETATION DYNAMICS; PLANT SUCCESSION; HERBIVORES SLOW; MYRICA-FAYA; MECHANISMS; DEMOGRAPHY; COMMUNITY	In contrast to secondary succession, studies of terrestrial primary succession largely ignore the role of biotic interactions, other than plant facilitation and competition, despite the expectation that simplified interaction webs and propagule-dependent demographics may amplify the effects of consumers and mutualists. We investigated whether successional context determined the impact of consumers and mutualists by quantifying their effects on reproduction by the shrub Vaccinium membranaceum in primary and secondary successional sites at Mount St. Helens (Washington, USA), and used simulations to explore the effects of these interactions on colonization. Species interactions differed substantially between sites, and the combined effect of consumers and mutualists was much more strongly negative for primary successional plants. Because greater local control of propagule pressure is expected to increase successional rates, we evaluated the role of dispersal in the context of these interactions. Our simulations showed that even a small local seed source greatly increases population growth rates, thereby balancing strong consumer pressure. The prevalence of strong negative interactions in the primary successional site is a reminder that successional communities will not exhibit the distribution of interaction strengths characteristic of stable communities, and suggests the potential utility of modeling succession as the consequence of interaction strengths.	[Yang, Suann] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Jongejans, Eelke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands; [Yang, Sylvia] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bishop, John G.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA	Washington State University; Radboud University Nijmegen; University of Washington; University of Washington Seattle; Washington State University	Yang, S (corresponding author), Presbyterian Coll, Clinton, SC USA.	suy14@psu.edu; suy14@psu.edu	Jongejans, Eelke/B-4832-2008	Jongejans, Eelke/0000-0003-1148-7419; Yang, Suann/0000-0001-7985-3011	Mazamas Graduate Student Research Grant; Washington Native Plant Society; WSU; National Science Foundation [DEB-0089843, DEB-0614065]; Netherlands Organisation for Scientific Research [863.08.006]	Mazamas Graduate Student Research Grant; Washington Native Plant Society; WSU; National Science Foundation(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was partially funded with a Mazamas Graduate Student Research Grant, a Washington Native Plant Society Research Grant, a WSU Betty Higinbotham Travel Award and a National Science Foundation Graduate Research Fellowship to Suann Y, National Science Foundation award DEB-0089843 to JB and National Science Foundation award DEB-0614065 and Netherlands Organisation for Scientific Research veni grant 863.08.006 to EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Anderson KJ, 2007, AM NAT, V169, P780, DOI 10.1086/516653; Aunapuu M, 2008, AM NAT, V171, P249, DOI 10.1086/524951; Bach CE, 2001, ECOLOGY, V82, P1401, DOI 10.1890/0012-9658(2001)082[1401:LTEOIH]2.0.CO;2; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Bishop JG, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P151, DOI 10.1007/0-387-28150-9_11; Bishop JG, 2002, ECOLOGY, V83, P191; Bosch M, 1999, AM J BOT, V86, P871, DOI 10.2307/2656707; BRYANT JP, 1985, ECOLOGY, V66, P1564, DOI 10.2307/1938018; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Crisafulli CM, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P199, DOI 10.1007/0-387-28150-9_14; DAVIDSON DW, 1993, OIKOS, V68, P23, DOI 10.2307/3545305; del Moral R, 2007, J VEG SCI, V18, P479, DOI 10.1111/j.1654-1103.2007.tb02562.x; del Moral R, 2005, PLANT ECOL, V181, P203, DOI 10.1007/s11258-005-6627-4; Del Moral R, 2005, AM J BOT, V92, P27, DOI 10.3732/ajb.92.1.27; Duncan DH, 2004, J ECOL, V92, P977, DOI 10.1111/j.1365-2745.2004.00933.x; Fagan WF, 2005, AM NAT, V166, P669, DOI 10.1086/497621; Fagan WF, 2000, AM NAT, V155, P238, DOI 10.1086/303320; FARRELL TM, 1991, ECOL MONOGR, V61, P95, DOI 10.2307/1943001; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Franklin JF, 2000, SCIENCE, V288, P1183, DOI 10.1126/science.288.5469.1183; Fuller RN, 2003, J VEG SCI, V14, P637, DOI 10.1111/j.1654-1103.2003.tb02195.x; Glenn-Lewin D.C., 1992, PLANT SUCCESSION; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Howe HF, 2004, BIOSCIENCE, V54, P651, DOI 10.1641/0006-3568(2004)054[0651:WSDM]2.0.CO;2; Jongejans E, 2006, BASIC APPL ECOL, V7, P71, DOI 10.1016/j.baae.2005.04.004; Kielland K, 1998, OIKOS, V82, P377, DOI 10.2307/3546979; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.2307/176946; LUBCHENCO J, 1983, ECOLOGY, V64, P1116, DOI 10.2307/1937822; Marleau JN, 2011, AM NAT, V177, P233, DOI 10.1086/658066; Miles J. D., 1993, PRIMARY SUCCESSION L; MORRIS WF, 1989, ECOLOGY, V70, P697, DOI 10.2307/1940220; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Parker MA, 2006, DIVERS DISTRIB, V12, P563, DOI 10.1111/j.1366-9516.2006.00255.x; Pulido FJ, 2005, ECOSCIENCE, V12, P92, DOI 10.2980/i1195-6860-12-1-92.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAUSHER MD, 1981, ANIM BEHAV, V29, P1220, DOI 10.1016/S0003-3472(81)80073-5; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Seeds JD, 2009, PLANT SOIL, V323, P225, DOI 10.1007/s11104-009-9930-3; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; STRIK B, 1993, PACIFIC NW EXTENSION, V215; Swanson FJ, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P27, DOI 10.1007/0-387-28150-9_3; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thornton IWB, 1996, J BIOGEOGR, V23, P577, DOI 10.1111/j.1365-2699.1996.tb00019.x; Titus JH, 1998, AM J BOT, V85, P370, DOI 10.2307/2446330; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Vander Kloet S.P., 1988, GENUS VACCINIUM N AM; Virgo N, 2006, J ANIM ECOL, V75, P377, DOI 10.1111/j.1365-2656.2006.01058.x; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; WALKER LR, 1987, OIKOS, V50, P131, DOI 10.2307/3565409; WALKER LR, 1986, ECOLOGY, V67, P1508, DOI 10.2307/1939082; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; Wootton JT, 2002, ECOL RES, V17, P249, DOI 10.1046/j.1440-1703.2002.00484.x; Yang S, 2008, MOL ECOL, V17, P731, DOI [10.1111/j.1365-294X.2007.03625.x, 10.1111/j.1365-294X.2008.03976.x]; Yang S, 2006, VACCINIUM MEMBRANACE	62	5	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26094	10.1371/journal.pone.0026094	http://dx.doi.org/10.1371/journal.pone.0026094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028808	Green Published, gold			2022-12-25	WOS:000296510800016
J	Adelman, ZN; Kilcullen, KA; Koganemaru, R; Anderson, MAE; Anderson, TD; Miller, DM				Adelman, Zach N.; Kilcullen, Kathleen A.; Koganemaru, Reina; Anderson, Michelle A. E.; Anderson, Troy D.; Miller, Dini M.			Deep Sequencing of Pyrethroid-Resistant Bed Bugs Reveals Multiple Mechanisms of Resistance within a Single Population	PLOS ONE			English	Article							SCHIZAPHIS-GRAMINUM HOMOPTERA; INSECTICIDE RESISTANCE; DETOXIFICATION ENZYMES; EVOLUTION	A frightening resurgence of bed bug infestations has occurred over the last 10 years in the U. S. and current chemical methods have been inadequate for controlling this pest due to widespread insecticide resistance. Little is known about the mechanisms of resistance present in U.S. bed bug populations, making it extremely difficult to develop intelligent strategies for their control. We have identified bed bugs collected in Richmond, VA which exhibit both kdr-type (L925I) and metabolic resistance to pyrethroid insecticides. Using LD50 bioassays, we determined that resistance ratios for Richmond strain bed bugs were similar to 5200-fold to the insecticide deltamethrin. To identify metabolic genes potentially involved in the detoxification of pyrethroids, we performed deep-sequencing of the adult bed bug transcriptome, obtaining more than 2.5 million reads on the 454 titanium platform. Following assembly, analysis of newly identified gene transcripts in both Harlan (susceptible) and Richmond (resistant) bed bugs revealed several candidate cytochrome P450 and carboxylesterase genes which were significantly over-expressed in the resistant strain, consistent with the idea of increased metabolic resistance. These data will accelerate efforts to understand the biochemical basis for insecticide resistance in bed bugs, and provide molecular markers to assist in the surveillance of metabolic resistance.	[Adelman, Zach N.; Kilcullen, Kathleen A.; Anderson, Michelle A. E.; Anderson, Troy D.] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA; [Adelman, Zach N.; Kilcullen, Kathleen A.; Anderson, Michelle A. E.; Anderson, Troy D.] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Koganemaru, Reina; Miller, Dini M.] Virginia Tech, Dodson Urban Pest Management Lab, Blacksburg, VA USA; [Koganemaru, Reina; Miller, Dini M.] Virginia Tech, Dept Entomol, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Adelman, ZN (corresponding author), Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.	zachadel@vt.edu		Adelman, Zach/0000-0001-5901-7171; Anderson, Troy/0000-0002-9403-2833; Anderson, Michelle/0000-0003-1510-2942	Fralin Life Science Institute/Virginia Bioinformatics Institute	Fralin Life Science Institute/Virginia Bioinformatics Institute	This work was funded by a grant from the Fralin Life Science Institute/Virginia Bioinformatics Institute to D.M.M. and Z.N.A.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson TD, 2004, PESTIC BIOCHEM PHYS, V80, P54, DOI 10.1016/j.pestbp.2004.06.003; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BUSVINE JR, 1958, ORGANIZATION, V19, P1041; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FEROZ M, 1969, B ENTOMOL RES, V59, P377, DOI 10.1017/S0007485300003345; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FEYEREISEN R, 2005, INSECT CYTOCHROME CO, V4; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Francischetti IMB, 2010, J PROTEOME RES, V9, P3820, DOI 10.1021/pr1000169; Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P102, DOI 10.1016/j.pestbp.2006.09.006; LOFGREN CS, 1958, J EC ENTOMOL, V99; Moore DJ, 2006, J ECON ENTOMOL, V99, P2080, DOI 10.1603/0022-0493-99.6.2080; Nelson David R, 2006, Methods Mol Biol, V320, P1; Oakeshott J.G, 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [DOI 10.1016/B0-44-451924-6/00073-9, 10.1016/B0-44-451924-6/00073-9]; Polanco Andrea M., 2011, Insects, V2, P173, DOI 10.3390/insects2020173; Potter Michael F., 2011, American Entomologist, V57, P14; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Romero A., 2009, J EC ENTOMOL, V102; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valles SM, 1996, J ECON ENTOMOL, V89, P21, DOI 10.1093/jee/89.1.21; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355; Zhu KY, 1998, PESTIC BIOCHEM PHYS, V62, P135, DOI 10.1006/pest.1998.2376; Zhu KY, 2000, PESTIC BIOCHEM PHYS, V68, P138, DOI 10.1006/pest.2000.2510	30	82	84	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26228	10.1371/journal.pone.0026228	http://dx.doi.org/10.1371/journal.pone.0026228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039447	gold, Green Submitted, Green Published			2022-12-25	WOS:000296507500041
J	Dennig, A; Shivange, AV; Marienhagen, J; Schwaneberg, U				Dennig, Alexander; Shivange, Amol V.; Marienhagen, Jan; Schwaneberg, Ulrich			OmniChange: The Sequence Independent Method for Simultaneous Site-Saturation of Five Codons	PLOS ONE			English	Article							DIRECTED PROTEIN EVOLUTION; SYNTHETIC BIOLOGY; MUTAGENESIS; PCR; LIBRARIES; ENZYMES; DNA; PERFORMANCE; MUTATIONS; DIVERSITY	Focused mutant library generation methods have been developed to improve mainly "localizable'' enzyme properties such as activity and selectivity. Current multi-site saturation methods are restricted by the gene sequence, require subsequent PCR steps and/or additional enzymatic modifications. Here we report, a multiple site saturation mutagenesis method, OmniChange, which simultaneously and efficiently saturates five independent codons. As proof of principle, five chemically cleaved DNA fragments, each carrying one NNK-degenerated codon, were generated and assembled to full gene length in a one-pot-reaction without additional PCR-amplification or use of restriction enzymes or ligases. Sequencing revealed the presence of up to 27 different codons at individual positions, corresponding to 84.4% of the theoretical diversity offered by NNK-degeneration. OmniChange is absolutely sequence independent, does not require a minimal distance between mutated codons and can be accomplished within a day.	[Dennig, Alexander; Shivange, Amol V.; Marienhagen, Jan; Schwaneberg, Ulrich] Rhein Westfal TH Aachen, Lehrstuhl Biotechnol, Aachen, Germany	RWTH Aachen University	Dennig, A (corresponding author), Rhein Westfal TH Aachen, Lehrstuhl Biotechnol, Aachen, Germany.	u.schwaneberg@biotec.rwth-aachen.de	Dennig, Alexander/D-7362-2012; Shivange, Amol/E-1166-2011; Shivange, Amol V./AAE-9481-2019; Schwaneberg, Ulrich/E-7234-2014; Marienhagen, Jan/E-9593-2011	Shivange, Amol V./0000-0002-4169-2969; Schwaneberg, Ulrich/0000-0003-4026-701X; Marienhagen, Jan/0000-0001-5513-3730	BASF Societas Europaea (BASF SE)	BASF Societas Europaea (BASF SE)	Financial support for this research was provided by BASF Societas Europaea (BASF SE) (http://www.basf.com/group/corporate/en/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold F. H., 2003, DIRECTED EVOLUTION L; Blanusa M, 2010, ANAL BIOCHEM, V406, P141, DOI 10.1016/j.ab.2010.07.011; Brouk M, 2010, APPL ENVIRON MICROB, V76, P6397, DOI 10.1128/AEM.00878-10; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Chiang L W, 1993, PCR Methods Appl, V2, P210; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; ECKSTEIN F, 1989, TRENDS BIOCHEM SCI, V14, P97, DOI 10.1016/0968-0004(89)90130-8; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Garrett JB, 2004, APPL ENVIRON MICROB, V70, P3041, DOI 10.1128/AEM.70.5.3041-3046.2004; GISH G, 1988, SCIENCE, V240, P1520, DOI 10.1126/science.2453926; Hamamatsu N, 2006, PROTEIN ENG DES SEL, V19, P483, DOI 10.1093/protein/gzl034; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hogrefe HH, 2002, BIOTECHNIQUES, V33, P1158, DOI 10.2144/02335pf01; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jochens H, 2010, CHEMBIOCHEM, V11, P1861, DOI 10.1002/cbic.201000284; KEGLEREBO DM, 1994, NUCLEIC ACIDS RES, V22, P1593, DOI 10.1093/nar/22.9.1593; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Liang J, 2011, WIRES SYST BIOL MED, V3, P7, DOI 10.1002/wsbm.104; Matsumura I, 2005, BIOMOL ENG, V22, P73, DOI 10.1016/j.bioeng.2004.10.004; Peng RH, 2006, APPL MICROBIOL BIOT, V73, P234, DOI 10.1007/s00253-006-0583-3; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2010, J AM CHEM SOC, V132, P9144, DOI 10.1021/ja1030479; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; Reetz MT, 2005, ANGEW CHEM INT EDIT, V44, P4192, DOI 10.1002/anie.200500767; Sambrook J., 1982, MOL CLONING LAB MANU, V1; Seyfang A, 2004, ANAL BIOCHEM, V324, P285, DOI 10.1016/j.ab.2003.10.012; Shen ZY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-143; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Tabuchi I, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-19; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Vroom JA, 2008, BIOTECHNIQUES, V44, P924, DOI 10.2144/000112808; Wang HH, 2010, J MOL CELL BIOL, V2, P178, DOI 10.1093/jmcb/mjq015; Wong TS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh028; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Yang GY, 2009, CHEMBIOCHEM, V10, P2704, DOI 10.1002/cbic.200900384	38	66	71	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26222	10.1371/journal.pone.0026222	http://dx.doi.org/10.1371/journal.pone.0026222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039444	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500038
J	Yang, SJ; Xiao, X; Meng, XB; Leslie, KK				Yang, Shujie; Xiao, Xue; Meng, Xiangbing; Leslie, Kimberly K.			A Mechanism for Synergy with Combined mTOR and PI3 Kinase Inhibitors	PLOS ONE			English	Article							ENDOMETRIAL CANCER; PTEN EXPRESSION; 3-KINASE/MAMMALIAN TARGET; TRANSLATIONAL CONTROL; AKT PHOSPHORYLATION; ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; IN-VIVO; RAPAMYCIN; PATHWAY	Dysregulation of the mammalian target of rapamycin (mTOR) signaling has been found in many human cancers, particularly those with loss of the tumor suppressor PTEN. However, mTORC1 inhibitors such as temsirolimus have only modest activity when used alone and may induce acquired resistance by activating upstream mTORC2 and Akt. Other tumors that do not depend upon PI3K/Akt/mTOR signaling for survival are primarily resistant. This study tested the hypothesis that the limited clinical efficacy of temsirolimus is due to a compensatory increase in survival signaling pathways downstream of Akt as well as an incomplete block of 4E-BP1-controlled proliferative processes downstream of mTOR. We explored the addition of a PI3K inhibitor to temsirolimus and identified the mechanism of combinatorial synergy. Proliferation assays revealed that BEZ235 (dual PI3K/mTOR inhibitor) or ZSTK474 (pan PI3K inhibitor) combined with temsirolimus synergistically inhibited cell growth compared to cells treated with any of the agents alone. Co-treatment resulted in G0/G1 cell cycle arrest and up-regulation of p27. Cell death occurred through massive autophagy and subsequent apoptosis. While molecular profiling revealed that, in most cases, sensitivity to temsirolimus alone was most marked in cells with high basal phospho-Akt resulting from PTEN inactivation, combining a PI3K inhibitor with temsirolimus prevented compensatory Akt phosphorylation and synergistically enhanced cell death regardless of PTEN status. Another molecular correlate of synergy was the finding that temsirolimus treatment alone blocks downstream S6 kinase signaling, but not 4E-BP1. Adding BEZ235 completely abrogated 4E-BP1 phosphorylation. We conclude that the addition of a PI3K inhibitor overcomes cellular resistance to mTORC1 inhibitors regardless of PTEN status, and thus substantially expands the molecular phenotype of tumors likely to respond.	[Yang, Shujie; Xiao, Xue; Meng, Xiangbing; Leslie, Kimberly K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Yang, Shujie; Xiao, Xue; Meng, Xiangbing; Leslie, Kimberly K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Yang, SJ (corresponding author), Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.	kimberly-leslie@uiowa.edu		Yang, Shujie/0000-0003-1753-3068; Leslie, Kimberly/0000-0002-2704-8990; meng, xiangbing/0000-0002-9612-6438	NIH [R01CA99908]; Department of Obstetrics and Gynecology; NATIONAL CANCER INSTITUTE [R01CA099908] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by NIH R01CA99908 to KKL and Department of Obstetrics and Gynecology Research Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albitar L, 2007, GYNECOL ONCOL, V106, P52, DOI 10.1016/j.ygyno.2007.02.033; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Burris H, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3005; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dan S, 2009, BIOCHEM BIOPH RES CO, V379, P104, DOI 10.1016/j.bbrc.2008.12.015; Degtyarev M, 2009, AUTOPHAGY, V5, P415, DOI 10.4161/auto.5.3.7827; Delmonte A, 2008, CURR OPIN ONCOL, V20, P554, DOI 10.1097/CCO.0b013e32830b0deb; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; GARRIDOLAGUNA I, 2010, J CLIN ONCOL, V28; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gupta M, 2009, BLOOD, V114, P2926, DOI 10.1182/blood-2009-05-220889; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jin N, 2009, J CLIN ENDOCR METAB, V94, P4107, DOI 10.1210/jc.2009-0662; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; Konecny GE, 2008, BRIT J CANCER, V98, P1076, DOI 10.1038/sj.bjc.6604278; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Shoji K, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.5074; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Steelman LS, 2008, ONCOGENE, V27, P4086, DOI 10.1038/onc.2008.49; Tashiro H, 1997, CANCER RES, V57, P3935; Terakawa N, 2003, ENDOCR-RELAT CANCER, V10, P203, DOI 10.1677/erc.0.0100203; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wang XR, 2009, EXPERT OPIN THER TAR, V13, P1193, DOI 10.1517/14728220903225008; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yazbeck VY, 2008, EXP HEMATOL, V36, P443, DOI 10.1016/j.exphem.2007.12.008	43	41	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26343	10.1371/journal.pone.0026343	http://dx.doi.org/10.1371/journal.pone.0026343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039466	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500053
J	Rouyar, A; Party, V; Presern, J; Blejec, A; Renou, M				Rouyar, Angela; Party, Virginie; Presern, Janez; Blejec, Andrej; Renou, Michel			A General Odorant Background Affects the Coding of Pheromone Stimulus Intermittency in Specialist Olfactory Receptor Neurones	PLOS ONE			English	Article							TEMPORAL RESOLUTION; RESPONSES; CELLS; PULSES; PLUMES; STIMULATION; LEPIDOPTERA; MECHANISMS; PHYSIOLOGY; BEHAVIOR	In nature the aerial trace of pheromone used by male moths to find a female appears as a train of discontinuous pulses separated by gaps among a complex odorant background constituted of plant volatiles. We investigated the effect of such background odor on behavior and coding of temporal parameters of pheromone pulse trains in the pheromone olfactory receptor neurons of Spodoptera littoralis. Effects of linalool background were tested by measuring walking behavior towards a source of pheromone. While velocity and orientation index did drop when linalool was turned on, both parameters recovered back to pre-background values after 40 s with linalool still present. Photo-ionization detector was used to characterize pulse delivery by our stimulator. The photo-ionization detector signal reached 71% of maximum amplitude at 50 ms pulses and followed the stimulus period at repetition rates up to 10 pulses/s. However, at high pulse rates the concentration of the odorant did not return to base level during inter-pulse intervals. Linalool decreased the intensity and shortened the response of receptor neurons to pulses. High contrast (> 10 dB) in firing rate between pulses and inter-pulse intervals was observed for 1 and 4 pulses/s, both with and without background. Significantly more neurons followed the 4 pulses/s pattern when delivered over linalool; at the same time the information content was preserved almost to the control values. Rapid recovery of behavior shows that change of perceived intensity is more important than absolute stimulus intensity. While decreasing the response intensity, background odor preserved the temporal parameters of the specific signal.	[Rouyar, Angela; Party, Virginie; Renou, Michel] Univ Paris 06, Inst Natl Rech Agron, PISC, UMR1272, Versailles, France; [Presern, Janez; Blejec, Andrej] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	INRAE; UDICE-French Research Universities; Sorbonne Universite; National Institute of Biology - Slovenia	Rouyar, A (corresponding author), Univ Paris 06, Inst Natl Rech Agron, PISC, UMR1272, Versailles, France.	michel.renou@versailles.inra.fr	Blejec, Andrej/M-5215-2019; Blejec, Andrej/A-8470-2010; RENOU, Michel/AAT-7340-2021	Blejec, Andrej/0000-0001-7484-6031; Blejec, Andrej/0000-0001-7484-6031; RENOU, Michel/0000-0001-6172-0210	"Sante des Plantes et Environnement" Department of INRA; Proteus project [20221UH]	"Sante des Plantes et Environnement" Department of INRA; Proteus project	This study was supported by a research project from the "Sante des Plantes et Environnement" Department of INRA (http://www4.inra.fr/sante-plantes-environnement). Travel between France and Slovenia was supported by Proteus project 20221UH (http://www.egide.asso.fr/jahia/Jahia/). The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Barrozo RB, 2002, J INSECT PHYSIOL, V48, P825, DOI 10.1016/S0022-1910(02)00109-9; Bau J, 2005, CHEM SENSES, V30, P771, DOI 10.1093/chemse/bji069; Bau J, 2002, J INSECT PHYSIOL, V48, P433, DOI 10.1016/S0022-1910(02)00062-8; Blejec A, 2005, NEUROCOMPUTING, V65, P557, DOI 10.1016/j.neucom.2004.10.103; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; DENOTTER CJ, 1978, ENTOMOL EXP APPL, V24, P570, DOI 10.1007/BF02385110; Durand N, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00939.x; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; GOMEZ G, 1994, J COMP PHYSIOL A, V174, P803; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Hillier NK, 2011, CHEM SENSES, V36, P93, DOI 10.1093/chemse/bjq102; Iyengar A, 2010, P NATL ACAD SCI USA, V107, P9855, DOI 10.1073/pnas.1003856107; Jarriault D, 2010, CHEM SENSES, V35, P705, DOI 10.1093/chemse/bjq069; Justus KA, 2005, J NEUROPHYSIOL, V93, P2233, DOI 10.1152/jn.00888.2004; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Kaissling KE, 1974, BIOCH SENSORY FUNCTI, P243; Kelling FJ, 2002, MED VET ENTOMOL, V16, P161, DOI 10.1046/j.1365-2915.2002.00359.x; Kodadova B, 1996, J COMP PHYSIOL A, V179, P301, DOI 10.1007/BF00194984; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Lemon WC, 1997, J EXP BIOL, V200, P1809; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Marion-Poll F., 1995, J NEUROSCI METH, V63, P591, DOI [10.1016/0165-0270(95)00110-7, DOI 10.1016/0165-0270(95)00110-7]; MARIONPOLL F, 1992, J COMP PHYSIOL A, V171, P505, DOI 10.1007/BF00194583; Mustaparta H, 1997, INSECT PHEROMONE RESEARCH, P144; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; PARTY V, 2009, EUR S INS TAST OLF V, V11; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Quero C, 1996, J CHEM ECOL, V22, P1087, DOI 10.1007/BF02027947; RUMBO ER, 1989, J COMP PHYSIOL A, V165, P281, DOI 10.1007/BF00619348; SCHNEIDER D, 1964, Z VERGL PHYSIOL, V48, P632, DOI 10.1007/BF00333745; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	38	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26443	10.1371/journal.pone.0026443	http://dx.doi.org/10.1371/journal.pone.0026443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028879	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900063
J	Hogerkorp, CM; Nishimura, Y; Song, KM; Martin, MA; Roederer, M				Hogerkorp, Carl-Magnus; Nishimura, Yoshiaki; Song, Kaimei; Martin, Malcolm A.; Roederer, Mario			The Simian Immunodeficiency Virus Targets Central Cell Cycle Functions through Transcriptional Repression In vivo	PLOS ONE			English	Article							CD4(+) T-CELLS; GENE-EXPRESSION PROFILES; BLOOD MONONUCLEAR-CELLS; HUMAN PERIPHERAL-BLOOD; TOLL-LIKE RECEPTOR; IMMUNE ACTIVATION; TYPE-1 INFECTION; HIV-1 INFECTION; DENDRITIC CELLS; INDUCIBLE GENES	A massive and selective loss of CD4+ memory T cells occurs during the acute phase of immunodeficiency virus infections. The mechanism of this depletion is poorly understood but constitutes a key event with implications for progression. We assessed gene expression of purified T cells in Rhesus Macaques during acute SIVmac239 infection in order to define mechanisms of pathogenesis. We observe a general transcriptional program of over 1,600 interferon- stimulated genes induced in all T cells by the infection. Furthermore, we identify 113 transcriptional changes that are specific to virally infected cells. A striking downregulation of several key cell cycle regulator genes was observed and shared promotor-region E2F binding sites in downregulated genes suggested a targeted transcriptional control of an E2F regulated cell cycle program. In addition, the upregulation of the gene for the fundamental regulator of RNA polymerase II, TAF7, demonstrates that viral interference with the cell cycle and transcriptional regulation programs may be critical components during the establishment of a pathogenic infection in vivo.	[Hogerkorp, Carl-Magnus; Song, Kaimei; Roederer, Mario] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nishimura, Yoshiaki; Martin, Malcolm A.] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hogerkorp, CM (corresponding author), Novo Nordisk AS, Dept Mol Genet, Malov, Denmark.	CMGH@novonordisk.com; Roederer@nih.gov	Roederer, Mario/G-1887-2011		National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005019, ZIAAI000998] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKEL H, 1994, VIROLOGY, V205, P34, DOI 10.1006/viro.1994.1617; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Battistini A, 2002, J INTERF CYTOK RES, V22, P27, DOI 10.1089/107999002753452638; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Brother MB, 1996, VIROLOGY, V222, P252, DOI 10.1006/viro.1996.0416; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; CAPOBIANCHI MR, 1992, AIDS RES HUM RETROV, V8, P575, DOI 10.1089/aid.1992.8.575; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chan Gordon K, 2003, Prog Cell Cycle Res, V5, P431; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; *COMM CAR US LAB A, 1985, GUID CAR US LAB AN; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Devaiah BN, 2010, J BIOL CHEM, V285, P38772, DOI 10.1074/jbc.M110.173864; Eberly MD, 2009, J IMMUNOL, V182, P1439, DOI 10.4049/jimmunol.182.3.1439; Endo Y, 2000, J VIROL, V74, P6935, DOI 10.1128/JVI.74.15.6935-6945.2000; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gegonne A, 2006, P NATL ACAD SCI USA, V103, P602, DOI 10.1073/pnas.0510031103; Gegonne A, 2001, P NATL ACAD SCI USA, V98, P12432, DOI 10.1073/pnas.211444798; Gegonne A, 2008, P NATL ACAD SCI USA, V105, P5367, DOI 10.1073/pnas.0801637105; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; George MD, 2003, VIROLOGY, V312, P84, DOI 10.1016/S0042-6822(03)00207-1; Gibellini D, 2002, VIRUS RES, V90, P337, DOI 10.1016/S0168-1702(02)00253-8; Gordon SN, 2007, J IMMUNOL, V179, P3026, DOI 10.4049/jimmunol.179.5.3026; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Igarashi T, 2002, J VIROL, V76, P379, DOI 10.1128/JVI.76.1.379-391.2002; Imbeault M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-5; Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kashanchi F, 2000, J VIROL, V74, P652, DOI 10.1128/JVI.74.2.652-660.2000; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Ketloy C, 2008, VET IMMUNOL IMMUNOP, V125, P18, DOI 10.1016/j.vetimm.2008.05.001; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Lace MJ, 2010, VIROLOGY, V399, P270, DOI 10.1016/j.virol.2009.12.025; Lace MJ, 2009, CARCINOGENESIS, V30, P1336, DOI 10.1093/carcin/bgp150; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Motomura K, 2004, INT IMMUNOPHARMACOL, V4, P1829, DOI 10.1016/j.intimp.2004.07.031; NAIDU YM, 1988, J VIROL, V62, P4691, DOI 10.1128/JVI.62.12.4691-4696.1988; Nekhai S, 2000, VIROLOGY, V266, P246, DOI 10.1006/viro.1999.0035; Nilsson J, 2004, BIOINFORMATICS, V20, P874, DOI 10.1093/bioinformatics/btg496; Nishimura Y, 2009, P NATL ACAD SCI USA, V106, P8015, DOI 10.1073/pnas.0903022106; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; Pijnappel WWMP, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-46; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Schaefer TM, 2006, MICROBES INFECT, V8, P1839, DOI 10.1016/j.micinf.2006.02.022; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Shaheduzzaman S, 2002, J BIOMED SCI, V9, P82, DOI 10.1007/BF02256581; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; van't Wout AB, 2003, J VIROL, V77, P1392, DOI 10.1128/JVI.77.2.1392-1402.2003; van 't Wout AB, 2005, J VIROL, V79, P10053, DOI 10.1128/JVI.79.15.10053-10058.2005; Wang Y, 2010, NEUROSCI LETT, V479, P97, DOI 10.1016/j.neulet.2010.05.032; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994	75	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25684	10.1371/journal.pone.0025684	http://dx.doi.org/10.1371/journal.pone.0025684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043290	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400018
J	Leventis, PA; Da Sylva, TR; Rajwans, N; Wasiak, S; McPherson, PS; Boulianne, GL				Leventis, Peter A.; Da Sylva, Tanya R.; Rajwans, Nimerta; Wasiak, Sylwia; McPherson, Peter S.; Boulianne, Gabrielle L.			Liquid facets-Related (lqfR) Is Required for Egg Chamber Morphogenesis during Drosophila Oogenesis	PLOS ONE			English	Article							ENTH-DOMAIN; COOPERATIVE BINDING; CELL-SIZE; PROTEIN; CLATHRIN; GENE; EPSIN; AMPLIFICATION; SYNTAXIN-16; TRAFFICKING	Clathrin interactor 1 [CLINT1] (also called enthoprotin/EpsinR) is an Epsin N-terminal homology (ENTH) domain-containing adaptor protein that functions in anterograde and retrograde clathrin-mediated trafficking between the trans-Golgi network and the endosome. Removal of both Saccharomyces cerevisiae homologs, Ent3p and Ent5p, result in yeast that are viable, but that display a cold-sensitive growth phenotype and mistrafficking of various vacuolar proteins. Similarly, either knockdown or overexpression of vertebrate CLINT1 in cell culture causes mistrafficking of proteins. Here, we have characterized Drosophila CLINT1, liquid-facets Related (lqfR). LqfR is ubiquitously expressed throughout development and is localized to the Golgi and endosome. Strong hypomorphic mutants generated by imprecise P-element excision exhibit extra macrochaetae, rough eyes and are female sterile. Although essentially no eggs are laid, the ovaries do contain late-stage egg chambers that exhibit abnormal morphology. Germline clones reveal that LqfR expression in the somatic follicle cells is sufficient to rescue the oogenesis defects. Clones of mutant lqfR follicle cells have a decreased cell size consistent with a downregulation of Akt1. We find that while total Akt1 levels are increased there is also a significant decrease in activated phosphorylated Akt1. Taken together, these results show that LqfR function is required to regulate follicle cell size and signaling during Drosophila oogenesis.	[Leventis, Peter A.; Da Sylva, Tanya R.; Rajwans, Nimerta; Boulianne, Gabrielle L.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Leventis, Peter A.; Boulianne, Gabrielle L.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Wasiak, Sylwia; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Boulianne, Gabrielle L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; University of Toronto	Leventis, PA (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	gboul@sickkids.ca			Natural Sciences and Engineering Council of Canada; Canadian Institutes of Health Research [MOP14143, MOP 62684]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Natural Sciences and Engineering Council of Canada and the Canadian Institutes of Health Research to GLB (MOP14143) and to PSM (MOP 62684). PAL and SW were supported by CIHR Doctoral Research Awards and GLB is the recipient of a Tier I Canada Research Chair in Molecular and Developmental Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Bandura JL, 2005, CURR BIOL, V15, P755, DOI 10.1016/j.cub.2005.02.063; Benard C, 2001, DEVELOPMENT, V128, P4045; Cavaliere V, 2005, DEV DYNAM, V232, P845, DOI 10.1002/dvdy.20333; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chou TB, 1996, GENETICS, V144, P1673; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Eugster A, 2004, MOL BIOL CELL, V15, P3031, DOI 10.1091/mbc.e03-11-0793; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Friant S, 2003, DEV CELL, V5, P499, DOI 10.1016/S1534-5807(03)00238-7; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hussain NK, 2003, J BIOL CHEM, V278, P28823, DOI 10.1074/jbc.M300995200; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jin J, 2001, DEV CELL, V1, P817, DOI 10.1016/S1534-5807(01)00090-9; Kalthoff C, 2003, J CHROMATOGR B, V786, P247, DOI 10.1016/S1570-0232(02)00908-X; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kim SY, 2006, GENE EXPR PATTERNS, V6, P504, DOI 10.1016/j.modgep.2005.10.009; Landis G, 1997, P NATL ACAD SCI USA, V94, P3888, DOI 10.1073/pnas.94.8.3888; Lee JH, 2009, DEV BIOL, V331, P1, DOI 10.1016/j.ydbio.2009.03.029; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Morgan JR, 2000, J NEUROSCI, V20, P8667; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Robinson DN, 1997, GENETICS, V145, P1063; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; SNYDER PB, 1986, P NATL ACAD SCI USA, V83, P3341, DOI 10.1073/pnas.83.10.3341; Sokol NS, 1999, CURR BIOL, V9, P1221, DOI 10.1016/S0960-9822(99)80502-8; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Spradling AC, 1999, GENETICS, V153, P135; Spradling Allan C., 1993, P1; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; STAPLETON M, 2002, GENOME BIOL, V0003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Wasiak S, 2003, FEBS LETT, V555, P437, DOI 10.1016/S0014-5793(03)01299-7; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25466	10.1371/journal.pone.0025466	http://dx.doi.org/10.1371/journal.pone.0025466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043285	gold, Green Published, Green Submitted			2022-12-25	WOS:000295984400012
J	Nasi, T; Virtanen, J; Noponen, T; Toppila, J; Salmi, T; Ilmoniemi, RJ				Nasi, Tiina; Virtanen, Jaakko; Noponen, Tommi; Toppila, Jussi; Salmi, Tapani; Ilmoniemi, Risto J.			Spontaneous Hemodynamic Oscillations during Human Sleep and Sleep Stage Transitions Characterized with Near-Infrared Spectroscopy	PLOS ONE			English	Article							LOW-FREQUENCY OSCILLATIONS; RAPID EYE-MOVEMENTS; CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; NEUROIMAGING INSIGHTS; NEURAL ACTIVITY; FLUCTUATIONS; VARIABILITY; OXYGENATION; MECHANISMS	Understanding the interaction between the nervous system and cerebral vasculature is fundamental to forming a complete picture of the neurophysiology of sleep and its role in maintaining physiological homeostasis. However, the intrinsic hemodynamics of slow-wave sleep (SWS) are still poorly known. We carried out 30 all-night sleep measurements with combined near-infrared spectroscopy (NIRS) and polysomnography to investigate spontaneous hemodynamic behavior in SWS compared to light (LS) and rapid-eye-movement sleep (REM). In particular, we concentrated on slow oscillations (3-150 mHz) in oxy- and deoxyhemoglobin concentrations, heart rate, arterial oxygen saturation, and the pulsation amplitude of the photoplethysmographic signal. We also analyzed the behavior of these variables during sleep stage transitions. The results indicate that slow spontaneous cortical and systemic hemodynamic activity is reduced in SWS compared to LS, REM, and wakefulness. This behavior may be explained by neuronal synchronization observed in electrophysiological studies of SWS and a reduction in autonomic nervous system activity. Also, sleep stage transitions are asymmetric, so that the SWS-to-LS and LS-to-REM transitions, which are associated with an increase in the complexity of cortical electrophysiological activity, are characterized by more dramatic hemodynamic changes than the opposite transitions. Thus, it appears that while the onset of SWS and termination of REM occur only as gradual processes over time, the termination of SWS and onset of REM may be triggered more abruptly by a particular physiological event or condition. The results suggest that scalp hemodynamic changes should be considered alongside cortical hemodynamic changes in NIRS sleep studies to assess the interaction between the autonomic and central nervous systems.	[Nasi, Tiina; Virtanen, Jaakko; Ilmoniemi, Risto J.] Aalto Univ, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland; [Nasi, Tiina; Virtanen, Jaakko; Ilmoniemi, Risto J.] Univ Helsinki, Cent Hosp, BioMag Lab, HUSLAB, Helsinki, Finland; [Noponen, Tommi] Turku Univ Hosp, Dept Nucl Med, FIN-20520 Turku, Finland; [Noponen, Tommi] Turku Univ Hosp, Turku PET Ctr, FIN-20520 Turku, Finland; [Toppila, Jussi; Salmi, Tapani] Univ Helsinki, Cent Hosp, Dept Clin Neurophysiol, Helsinki, Finland	Aalto University; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital	Nasi, T (corresponding author), Aalto Univ, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland.	jaakko.virtanen@aalto.fi	Näsi, Tiina/E-7314-2012; Ilmoniemi, Risto/E-9704-2012	Näsi, Tiina/0000-0002-5311-3530; Ilmoniemi, Risto/0000-0002-3340-2618	Finnish Cultural Foundation	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was primarily funded by personal research grants to Nasi and Virtanen from the Finnish Cultural Foundation (http://www.skr.fi/, grant numbers not given). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; Ayalon L, 2007, CURR OPIN PULM MED, V13, P479, DOI 10.1097/MCP.0b013e3282f0e9fb; Bangash MF, 2008, SLEEP, V31, P321, DOI 10.1093/sleep/31.3.321; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011356; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brassard P, 2010, J APPL PHYSIOL, V108, P1472, DOI 10.1152/japplphysiol.01206.2009; Busek P, 2005, PHYSIOL RES, V54, P369, DOI 10.33549/physiolres.930645; Camm AJ, 1996, EUR HEART J, V17, P354; Chua ECP, 2010, ANN BIOMED ENG, V38, P945, DOI 10.1007/s10439-009-9882-z; Cope M, 1991, THESIS U COLL LONDON; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; Dang-Vu TT, 2005, NEUROIMAGE, V28, P14, DOI 10.1016/j.neuroimage.2005.05.028; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Desseilles M, 2008, SLEEP, V31, P777, DOI 10.1093/sleep/31.6.777; Earley CJ, 2010, SLEEP MED, V11, P807, DOI 10.1016/j.sleep.2010.07.007; Elwell CE, 1999, ADV EXP MED BIOL, V471, P57; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Germon TJ, 1998, J CLIN MONITOR COMP, V14, P353, DOI 10.1023/A:1009957032554; Haddock RE, 2005, J PHYSIOL-LONDON, V566, P645, DOI 10.1113/jphysiol.2005.086405; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hong CCH, 2009, HUM BRAIN MAPP, V30, P1705, DOI 10.1002/hbm.20635; HOSHI Y, 1994, BRAIN RES, V652, P257, DOI 10.1016/0006-8993(94)90235-6; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Iber C., 2007, AASM MANUAL SCORING; Igawa M, 2001, PSYCHIAT CLIN NEUROS, V55, P187, DOI 10.1046/j.1440-1819.2001.00819.x; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Kubota Y, 2011, BRAIN RES, V1389, P83, DOI 10.1016/j.brainres.2011.02.061; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Maquet P, 2000, J SLEEP RES, V9, P207; Massimini M, 2009, EUR J NEUROSCI, V29, P1761, DOI 10.1111/j.1460-9568.2009.06720.x; Meadows GE, 2004, J APPL PHYSIOL, V97, P1343, DOI 10.1152/japplphysiol.01101.2003; Miyauchi S, 2009, EXP BRAIN RES, V192, P657, DOI 10.1007/s00221-008-1579-2; Muller T, 2003, MED BIOL ENG COMPUT, V41, P69, DOI 10.1007/BF02343541; Nissila I, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1884193; Nissila I, 2005, ADV ELECTROMAG FIELD, V4, P77, DOI 10.1007/0-387-24024-1_3; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Olopade CO, 2007, SLEEP, V30, P1747, DOI 10.1093/sleep/30.12.1747; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; Peigneux P, 2004, PSYCHOL BELG, V44, P121; Pizza F, 2010, SLEEP, V33, P205, DOI 10.1093/sleep/33.2.205; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Shelley KH, 2007, ANESTH ANALG, V105, pS31, DOI 10.1213/01.ane.0000269512.82836.c9; Shiotsuka S, 1998, PSYCHIAT CLIN NEUROS, V52, P172, DOI 10.1111/j.1440-1819.1998.tb01012.x; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; SNYDER F, 1964, J APPL PHYSIOL, V19, P417, DOI 10.1152/jappl.1964.19.3.417; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Spielman AJ, 2000, BRAIN RES, V866, P313, DOI 10.1016/S0006-8993(00)02320-9; Tachtsidis I, 2004, PHYSIOL MEAS, V25, P437, DOI 10.1088/0967-3334/25/2/003; Uchida-Ota M, 2008, NEUROIMAGE, V42, P357, DOI 10.1016/j.neuroimage.2008.03.055; Valentini M, 2009, PROG CARDIOVASC DIS, V52, P11, DOI 10.1016/j.pcad.2009.05.004; Virtanen J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606576; Virtanen J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253323; Weerakkody RA, 2010, ACTA NEUROCHIR, V152, P1763, DOI 10.1007/s00701-010-0748-9; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Zoccoli G, 2002, SLEEP MED REV, V6, P443, DOI 10.1053/smrv.2001.0194	59	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25415	10.1371/journal.pone.0025415	http://dx.doi.org/10.1371/journal.pone.0025415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043284	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400011
J	Kim, SK; Yun, SJ; Kim, J; Lee, OJ; Bae, SC; Kim, WJ				Kim, Seon-Kyu; Yun, Seok-Joong; Kim, Jiyeon; Lee, Ok-Jun; Bae, Suk-Chul; Kim, Wun-Jae			Identification of Gene Expression Signature Modulated by Nicotinamide in a Mouse Bladder Cancer Model	PLOS ONE			English	Article							URINARY-BLADDER; NIACIN; CARCINOGENESIS; CARCINOMA; PROFILES; TUMORS; N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE; EPIDEMIOLOGY; OCCUPATION; DIAGNOSIS	Background: Urinary bladder cancer is often a result of exposure to chemical carcinogens such as cigarette smoking. Because of histological similarity, chemically-induced rodent cancer model was largely used for human bladder cancer studies. Previous investigations have suggested that nicotinamide, water-soluble vitamin B3, may play a key role in cancer prevention through its activities in cellular repair. However, to date, evidence towards identifying the genetic alterations of nicotinamide in cancer prevention has not been provided. Here, we search for the molecular signatures of cancer prevention by nicotinamide using a N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)-induced urinary bladder cancer model in mice. Methodology/Principal Findings: Via microarray gene expression profiling of 20 mice and 233 human bladder samples, we performed various statistical analyses and immunohistochemical staining for validation. The expression patterns of 893 genes associated with nicotinamide activity in cancer prevention were identified by microarray data analysis. Gene network analyses of these 893 genes revealed that the Myc and its associated genes may be the most important regulator of bladder cancer prevention, and the gene expression signature correlated well with protein expression data. Comparison of gene expression between human and mouse revealed that BBN-induced mouse bladder cancers exhibited gene expression profiles that were more similar to those of invasive human bladder cancers than to those of non-invasive human bladder cancers. Conclusions/Significance: This study demonstrates that nicotinamide plays an important role as a chemo-preventive and therapeutic agent in bladder cancer through the regulation of the Myc oncogenic signature. Nicotinamide may represent a promising therapeutic modality in patients with muscle-invasive bladder cancer.	[Kim, Seon-Kyu; Yun, Seok-Joong; Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Coll Med, Chonju, South Korea; [Kim, Seon-Kyu; Yun, Seok-Joong; Kim, Wun-Jae] Chungbuk Natl Univ, Chungbuk Biomed Sci Ctr BK21, Sch Med, Chonju, South Korea; [Kim, Jiyeon] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Lee, Ok-Jun] Chungbuk Natl Univ, Dept Pathol, Coll Med, Chonju, South Korea; [Bae, Suk-Chul] Chungbuk Natl Univ, Dept Biochem, Coll Med, Chonju, South Korea	Chungbuk National University; Chungbuk National University; Duke University; Chungbuk National University; Chungbuk National University	Kim, SK (corresponding author), Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea.	wjkim@chungbuk.ac.kr		Kim, Seon-Kyu/0000-0002-4176-5187; Yun, Seok-Joong/0000-0001-7737-4746	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0001042, R16-2003-002-01001-02006]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0001042 and R16-2003-002-01001-02006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffa R, 2006, J EXP CLIN CANC RES, V25, P145; Chen JL, 2009, J CEREBR BLOOD F MET, V29, P911, DOI 10.1038/jcbfm.2009.11; COLE P, 1972, CANCER, V29, P1250, DOI 10.1002/1097-0142(197205)29:5<1250::AID-CNCR2820290518>3.0.CO;2-T; DRUCKREY H., 1964, Z KREBSFORSCH, V66, P280, DOI 10.1007/BF00524156; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GRUBBS CJ, 1977, SCIENCE, V198, P743, DOI 10.1126/science.910158; Grubbs CJ, 2000, CANCER RES, V60, P5599; Gurujeyalakshmi G, 2000, J PHARMACOL EXP THER, V293, P82; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hoskin PJ, 2010, J CLIN ONCOL, V28, P4912, DOI 10.1200/JCO.2010.28.4950; HOWE GR, 1980, JNCI-J NATL CANCER I, V64, P701; JACOBSON EL, 1993, J INTERN MED, V233, P59, DOI 10.1111/j.1365-2796.1993.tb00649.x; JACOBSON EL, 1995, BIOCHIMIE, V77, P394, DOI 10.1016/0300-9084(96)88152-1; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; KIM WJ, 2011, J UROLOGY; Kirkland JB, 2009, MOL CANCER THER, V8, P725, DOI 10.1158/1535-7163.MCT-09-0042; Kirkland JB, 2003, NUTR CANCER, V46, P110, DOI 10.1207/S15327914NC4602_02; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lee CWL, 2010, CANCER RES, V70, P4243, DOI 10.1158/0008-5472.CAN-09-3805; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; MATANOSKI GM, 1981, EPIDEMIOL REV, V3, P203, DOI 10.1093/oxfordjournals.epirev.a036234; OHTANI M, 1986, CANCER RES, V46, P2001; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schultz L, 2010, CANCER-AM CANCER SOC, V116, P5517, DOI 10.1002/cncr.25502; Shah GM, 2005, AM J GASTROENTEROL, V100, P2307, DOI 10.1111/j.1572-0241.2005.00268.x; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129; WYNDER EL, 1977, CANCER-AM CANCER SOC, V40, P1246, DOI 10.1002/1097-0142(197709)40:3<1246::AID-CNCR2820400340>3.0.CO;2-5; Yao RS, 2004, NEOPLASIA, V6, P569, DOI 10.1593/neo.04223; Yao RS, 2007, NEOPLASIA, V9, P207, DOI 10.1593/neo.06814	41	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26131	10.1371/journal.pone.0026131	http://dx.doi.org/10.1371/journal.pone.0026131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028816	Green Published, gold			2022-12-25	WOS:000295971700042
J	Li, DJ; Lanigan, G; Humphreys, J				Li, Dejun; Lanigan, Gary; Humphreys, James			Measured and Simulated Nitrous Oxide Emissions from Ryegrass- and Ryegrass/White Clover-Based Grasslands in a Moist Temperate Climate	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; CLAY-LOAM SOIL; SPATIAL VARIABILITY; MANAGED GRASSLANDS; GRAZED GRASSLANDS; RAINFALL EVENTS; N2O EMISSIONS; DAIRY-COWS; DENITRIFICATION; PASTURES	There is uncertainty about the potential reduction of soil nitrous oxide (N2O) emission when fertilizer nitrogen (FN) is partially or completely replaced by biological N fixation (BNF) in temperate grassland. The objectives of this study were to 1) investigate the changes in N2O emissions when BNF is used to replace FN in permanent grassland, and 2) evaluate the applicability of the process-based model DNDC to simulate N2O emissions from Irish grasslands. Three grazing treatments were: (i) ryegrass (Lolium perenne) grasslands receiving 226 kg FN ha(-1) yr(-1) (GG+FN), (ii) ryegrass/white clover (Trifolium repens) grasslands receiving 58 kg FN ha(-1) yr(-1) (GWC+FN) applied in spring, and (iii) ryegrass/white clover grasslands receiving no FN (GWC-FN). Two background treatments, un-grazed swards with ryegrass only (G-B) or ryegrass/white clover (WC-B), did not receive slurry or FN and the herbage was harvested by mowing. There was no significant difference in ;annual N2O emissions between G-B (2.38 +/- 0.12 kg N ha(-1) yr(-1) (mean +/- SE)) and WC-B (2.45 +/- 0.85 kg N ha(-1) yr(-1)), indicating that N2O emission due to BNF itself and clover residual decomposition from permanent ryegrass/clover grassland was negligible. N2O emissions were 7.82 +/- 1.67, 6.35 +/- 1.14 and 6.54 +/- 1.70 kg N ha(-1) yr(-1), respectively, from GG+FN, GWC+FN and GWC-FN. N2O fluxes simulated by DNDC agreed well with the measured values with significant correlation between simulated and measured daily fluxes for the three grazing treatments, but the simulation did not agree very well for the background treatments. DNDC overestimated annual emission by 61% for GG+FN, and underestimated by 45% for GWC-FN, but simulated very well for GWC+FN. Both the measured and simulated results supported that there was a clear reduction of N2O emissions when FN was replaced by BNF.	[Li, Dejun; Humphreys, James] TEAGASC, Livestock Syst Res Dept, Fermoy, County Cork, Ireland; [Li, Dejun] Univ Coll Dublin, UCD Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [Lanigan, Gary] TEAGASC, Environm Soils & Land Use Res Dept, Johnstown Castle, County Wexford, Ireland	Teagasc; University College Dublin; Teagasc	Li, DJ (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	dejunl@gmail.com	Lanigan, Gary J/C-6864-2012	Lanigan, Gary J/0000-0003-0813-3097	Irish Department of Agriculture, Fisheries and Food Research [RSF 07 516, RSF 07 511]	Irish Department of Agriculture, Fisheries and Food Research	This work was financially supported by the Irish Department of Agriculture, Fisheries and Food Research Stimulus Fund (RSF 07 516, RSF 07 511) under the National Development Plan 2007-2013 (http://www.agriculture.gov.ie/research/researchstimulusfundrsf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla M, 2010, ATMOS ENVIRON, V44, P2961, DOI 10.1016/j.atmosenv.2010.05.018; Abdalla M, 2009, SOIL USE MANAGE, V25, P376, DOI 10.1111/j.1475-2743.2009.00237.x; Abdalla M, 2009, GEODERMA, V151, P327, DOI 10.1016/j.geoderma.2009.04.021; [Anonymous], 2006, IPCC 2006 GUIDELINES; [Anonymous], 2009, FAO STAT YB; Carter MS, 2006, NUTR CYCL AGROECOSYS, V74, P13, DOI 10.1007/s10705-005-4111-0; Dalal RC, 2003, AUST J SOIL RES, V41, P165, DOI 10.1071/SR02064; Davies DA, 1996, OCCASIONAL S BRIT GR, P72; *EEA, 2006, ANN EUR COMM GREENH; Flechard CR, 2007, AGR ECOSYST ENVIRON, V121, P135, DOI 10.1016/j.agee.2006.12.024; Garcia-Montiel DC, 2003, BIOGEOCHEMISTRY, V64, P319, DOI 10.1023/A:1024968802018; Giltrap DL, 2010, AGR ECOSYST ENVIRON, V136, P292, DOI 10.1016/j.agee.2009.06.014; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hsieh CI, 2005, NUTR CYCL AGROECOSYS, V73, P15, DOI 10.1007/s10705-005-7129-4; Humphreys J, 2008, GRASS FORAGE SCI, V63, P467, DOI 10.1111/j.1365-2494.2008.00660.x; Humphreys J, 2009, IRISH J AGR FOOD RES, V48, P189; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Hyde BP, 2006, NUTR CYCL AGROECOSYS, V75, P187, DOI 10.1007/s10705-006-9026-x; Jarvis SC, 1996, GRASS FORAGE SCI, V51, P21, DOI 10.1111/j.1365-2494.1996.tb02034.x; Keogh B, 2010, P 23 GEN M EUR GRASS, P907; Kim DG, 2010, NUTR CYCL AGROECOSYS, V88, P397, DOI 10.1007/s10705-010-9365-5; Klumpp K, 2010, PLANT SOIL, DOI [10.1007/s11104-11010-10526-11108, DOI 10.1007/S11104-11010-10526-11108]; Lampe C, 2006, SOIL BIOL BIOCHEM, V38, P2602, DOI 10.1016/j.soilbio.2006.03.016; Leahy P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021161; Ledgard S, 2009, IRISH J AGR FOOD RES, V48, P209; Ledgard SF, 2001, PLANT SOIL, V229, P177, DOI 10.1023/A:1004833804002; Ledgard SF, 1999, J AGR SCI-CAMBRIDGE, V132, P215, DOI 10.1017/S002185969800625X; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; Li Y, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002392; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Ludwig B, 2011, J PLANT NUTR SOIL SC, V174, P350, DOI 10.1002/jpln.201000040; McGettigan M., 2010, IRELAND NATL INVENTO; Metz ORDB, 2007, CLIMATE CHANGE 2007; Nyfeler D, 2011, AGR ECOSYST ENVIRON, V140, P155, DOI 10.1016/j.agee.2010.11.022; Olesen JE, 2006, AGR ECOSYST ENVIRON, V112, P207, DOI 10.1016/j.agee.2005.08.022; Parkin TB, 2008, J ENVIRON QUAL, V37, P1390, DOI 10.2134/jeq2007.0333; Phelan P, 2011, AGR RES FORUM; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rochette P, 2005, NUTR CYCL AGROECOSYS, V73, P171, DOI 10.1007/s10705-005-0357-9; Rochon JJ, 2004, GRASS FORAGE SCI, V59, P197, DOI 10.1111/j.1365-2494.2004.00423.x; RUZJEREZ BE, 1994, SOIL BIOL BIOCHEM, V26, P29, DOI 10.1016/0038-0717(94)90192-9; Saggar S, 2004, NUTR CYCL AGROECOSYS, V68, P243, DOI 10.1023/B:FRES.0000019463.92440.a3; Saggar S, 2007, AGR ECOSYST ENVIRON, V119, P205, DOI 10.1016/j.agee.2006.07.010; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; Schils RLM, 2006, GLOBAL CHANGE BIOL, V12, P382, DOI 10.1111/j.1365-2486.2005.01090.x; Simek M, 2004, SOIL BIOL BIOCHEM, V36, P9, DOI 10.1016/j.soilbio.2003.08.010; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Turner DA, 2008, PLANT SOIL, V309, P77, DOI 10.1007/s11104-008-9639-8; USEPA, 2006, GLOB ANTHR NON GREEN; Velthof GL, 1996, PLANT SOIL, V181, P263, DOI 10.1007/BF00012061; Velthof GL, 1996, SOIL BIOL BIOCHEM, V28, P1215, DOI 10.1016/0038-0717(96)00129-0; Velthof GL, 1998, ENVIRON POLLUT, V102, P173, DOI 10.1016/S0269-7491(98)80030-4; Virkajarvi P, 2010, AGR ECOSYST ENVIRON, V137, P59, DOI 10.1016/j.agee.2009.12.015; Weng ES, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000539; Williams DL, 1999, SOIL BIOL BIOCHEM, V31, P779, DOI 10.1016/S0038-0717(98)00186-2; WMO, 2009, STAT GREENH GAS ATM; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Xu-Ri, 2003, PLANT SOIL, V255, P513, DOI 10.1023/A:1026076914167; Zhang F, 2010, BIOGEOSCIENCES, V7, P2039, DOI 10.5194/bg-7-2039-2010	59	36	36	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26176	10.1371/journal.pone.0026176	http://dx.doi.org/10.1371/journal.pone.0026176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028829	Green Submitted, gold, Green Published			2022-12-25	WOS:000295971700046
J	Bian, Y; Hall, B; Sun, ZJ; Molinolo, A; Chen, W; Gutkind, JS; Waes, CV; Kulkarni, AB				Bian, Y.; Hall, B.; Sun, Z-J; Molinolo, A.; Chen, W.; Gutkind, J. S.; Waes, C. V.; Kulkarni, A. B.			Loss of TGF-beta signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation	ONCOGENE			English	Article						TGF-beta; PI3K/Akt; head and neck squamous cell carcinoma; conditional knockout; cancer mouse model	GROWTH-FACTOR-BETA; FACTOR-KAPPA-B; MAMMARY-CARCINOMA; TUMOR-SUPPRESSOR; COLON-CANCER; ACTIVATION; PATHWAYS; GENE; EXPRESSION; EPITHELIA	The molecular mechanisms that contribute to the initiation and progression of head and neck squamous cell carcinoma (HNSCC) have not been completely delineated. Our observations indicate that defects in the transforming growth factor-beta and PI3K/Akt signaling pathways are common in human HNSCCs. Conditional activation of the PI3K/Akt pathway due to Pten deletion in the mouse head and neck epithelia gives rise to hyperproliferation, but only a few lesions progress to HNSCC. However, Pten-deficient mice developed full-penetrance HNSCC in combination with type I TGF-beta receptor (Tgfbr1) deletion. Molecular analysis revealed enhanced cell proliferation, decreased apoptosis, and increased expression of CCND1 in the basal layer of the head and neck epithelia, as well as in the tumors of Tgfbr1/Pten double conditional knockout (2cKO) mice. Furthermore, neoplastic transformation involves senescence evasion, and is associated with an increased number of putative cancer stem cells. In addition, the nuclear factor-kappa B pathway activation, myeloid-derived suppressor cell infiltration, angiogenesis and immune suppression in the tumor microenvironment, all of which are characteristics of human HNSCCs, contribute significantly to head and neck carcinogenesis in 2cKO mice. These tumors display pathology and multiple molecular alterations resembling human HNSCCs. This suggests that the Tgfbr1/Pten 2cKO mouse model is suitable for preclinical intervention, and that it has significant implications in the development of diagnostic cancer biomarkers and effective strategies for prevention and treatment of HNSCCs. Oncogene (2012) 31, 3322-3332; doi: 10.1038/onc.2011.494; published online 31 October 2011	[Kulkarni, A. B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Molinolo, A.; Gutkind, J. S.] Oral & Pharyngeal Canc Branch, Bethesda, MD USA; [Chen, W.] Natl Inst Dent & Craniofacial Res, Mucosal Immun Sect, Oral Immun & Infect Branch, Bethesda, MD 20892 USA; [Bian, Y.; Waes, C. V.] Natl Inst Deafness & Other Commun Disorders, Tumor Biol Sect, Head & Neck Surg Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Kulkarni, AB (corresponding author), Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, 30 Convent Dr,Bldg 30,Room 130, Bethesda, MD 20892 USA.	ak40m@nih.gov	Sun, Zhi-Jun/AAD-8791-2022; Gutkind, J. Silvio/J-1201-2016	Sun, Zhi-Jun/0000-0003-0932-8013; Gutkind, J. Silvio/0000-0002-5150-4482	Divisions of Intramural Research, National Institute of Dental and Craniofacial Research [Z01-DE-000698]; National Institute on Deafness and Communication Disorders, NIH [ZIA-DC-000073]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664, ZIADE000101, ZIADE000723, ZIADE000551, ZIADE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000073] Funding Source: NIH RePORTER	Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; National Institute on Deafness and Communication Disorders, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank Dr Stefan Karlsson for providing us with the Tgfbr1 flox mice, Drs Raj Puri and Lalage Wakefield for critical reading of the manuscript, Drs Juan Du, Ping Zhang, Zhong Chen and Anita Terse for technical help, and Shelagh Johnson for the expert editorial assistance. This work was supported by the Divisions of Intramural Research, National Institute of Dental and Craniofacial Research (Z01-DE-000698), and National Institute on Deafness and Communication Disorders (ZIA-DC-000073), NIH.	Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Bierie B, 2008, CANCER RES, V68, P1809, DOI 10.1158/0008-5472.CAN-07-5597; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Chen TP, 2001, INT J CANCER, V93, P653, DOI 10.1002/ijc.1381; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen Z, 2009, J ONCOL, V2009, DOI 10.1155/2009/894064; Cohen J, 2009, CANCER RES, V69, P3415, DOI 10.1158/0008-5472.CAN-08-3704; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Deshpande AM, 2008, EXPERT REV ANTICANC, V8, P799, DOI 10.1586/14737140.8.5.799; Engle SJ, 1999, CANCER RES, V59, P3379; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Henderson YC, 1998, LARYNGOSCOPE, V108, P1553, DOI 10.1097/00005537-199810000-00024; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Lee JY, 2009, ONCOGENE, V28, P824, DOI 10.1038/onc.2008.451; Lee JI, 2001, ARCH OTOLARYNGOL, V127, P1441, DOI 10.1001/archotol.127.12.1441; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Lu SL, 2004, CANCER RES, V64, P4405, DOI 10.1158/0008-5472.CAN-04-1032; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Moral M, 2009, CANCER RES, V69, P1099, DOI 10.1158/0008-5472.CAN-08-3240; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Pasche B, 2005, JAMA-J AM MED ASSOC, V294, P1634, DOI 10.1001/jama.294.13.1634; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Piek E, 2001, ADV CANCER RES, V83, P1, DOI 10.1016/S0065-230X(01)83001-3; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Shao XY, 1998, INT J CANCER, V77, P684, DOI 10.1002/(SICI)1097-0215(19980831)77:5<684::AID-IJC4>3.3.CO;2-8; Squarize CH, 2008, CANCER RES, V68, P7066, DOI 10.1158/0008-5472.CAN-08-0922; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Vijayachandra K, 2009, MOL CARCINOGEN, V48, P181, DOI 10.1002/mc.20472; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; White RA, 2010, ONCOGENE, V29, P5437, DOI 10.1038/onc.2010.306; Xie W, 2003, ONCOL RES, V14, P61, DOI 10.3727/000000003108748612; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	51	120	124	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	28					3322	3332		10.1038/onc.2011.494	http://dx.doi.org/10.1038/onc.2011.494			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	973NT	22037217	Green Accepted			2022-12-25	WOS:000306367600002
J	Reiss, DJ; Mobley, HLT				Reiss, Daniel J.; Mobley, Harry L. T.			Determination of Target Sequence Bound by PapX, Repressor of Bacterial Motility, in flhD Promoter Using Systematic Evolution of Ligands by Exponential Enrichment (SELEX) and High Throughput Sequencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; URINARY-TRACT INFECTIONS; MARR-FAMILY; TRANSCRIPTIONAL REGULATION; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; I-TASSER; EXPRESSION; VIRULENCE; STRAINS	Most uncomplicated urinary tract infections (UTIs) are caused by uropathogenic Escherichia coli (UPEC). Both motility and adherence are integral to UTI pathogenesis, yet they represent opposing forces. Therefore, it is logical to reciprocally regulate these functions. In UPEC strain CFT073, PapX, a nonstructural protein encoded by one of the two pap operons encoding P fimbria adherence factor, represses flagella-mediated motility and is a putative member of the winged helix transcription factor family. The mechanism of this repression, however, is not understood. papX is found preferentially in more virulent UPEC isolates, being significantly more prevalent in pyelonephritis strains (53% of isolates) than in asymptomatic bacteriuria (32%) or fecal/commensal (12.5%) strains. To examine PapX structure-function, we generated papX linker insertion and site-directed mutants, which identified two key residues for PapX function (Lys(54) and Arg(127)) within domains predicted by modeling with I-TASSER software to be important for dimerization and DNA binding, respectively. To determine the PapX binding site in the CFT073 genome, systematic evolution of ligands by exponential enrichment (SELEX) in conjunction with high throughput sequencing was utilized for the first time to determine a novel binding site for a bacterial transcription factor. This method identified a 29-bp binding site within the flhDC promoter (TTACGGTGAGTTATTT-TAACTGTGCGCAA), centered 410 bp upstream of the flhD translational start site. Gel shift experiments demonstrated that PapX binds directly to this site to repress transcription of flagellar genes.	[Reiss, Daniel J.; Mobley, Harry L. T.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Mobley, HLT (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 1150 W Med Ctr Dr,5641 Med Sci Bldg 2, Ann Arbor, MI 48104 USA.	hmobley@umich.edu		Mobley, Harry/0000-0001-9195-7665	National Institutes of Health Public Health Service [AI43363, AI59722, AI007528, T32 GM07863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007528, R01AI043363, R56AI043363, R01AI059722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grants AI43363, AI59722, AI007528, and T32 GM07863.	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEFRANCES CJ, 2008, NATL HLTH STAT REPOR, V5, P1; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Hagan EC, 2009, MOL MICROBIOL, V71, P79, DOI 10.1111/j.1365-2958.2008.06509.x; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; KORHONEN TK, 1982, INFECT IMMUN, V37, P286, DOI 10.1128/IAI.37.1.286-291.1982; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kumarevel T, 2008, J STRUCT BIOL, V161, P9, DOI 10.1016/j.jsb.2007.08.017; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; Litwin M, 2005, J UROLOGY, V173, P1065, DOI 10.1097/01.ju.0000156555.89385.54; LUND B, 1987, P NATL ACAD SCI USA, V84, P5898, DOI 10.1073/pnas.84.16.5898; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MOBLEY HLT, 1993, MOL MICROBIOL, V10, P143, DOI 10.1111/j.1365-2958.1993.tb00911.x; MULHOLLAND SG, 1984, UROLOGY, V24, P232; Nichols CE, 2009, ACTA CRYSTALLOGR F, V65, P204, DOI 10.1107/S174430910900414X; OTT M, 1986, INFECT IMMUN, V54, P646, DOI 10.1128/IAI.54.3.646-653.1986; Pearson MM, 2008, MOL MICROBIOL, V69, P548, DOI 10.1111/j.1365-2958.2008.06307.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito K, 2003, J BACTERIOL, V185, P6195, DOI 10.1128/JB.185.20.6195-6198.2003; Sampson T., 2003, World Patent Information, V25, P123, Patent No. 25123; Schwan WR, 2008, INT J MED MICROBIOL, V298, P441, DOI 10.1016/j.ijmm.2007.05.009; Simms AN, 2008, INFECT IMMUN, V76, P4833, DOI 10.1128/IAI.00630-08; Simms AN, 2008, J BACTERIOL, V190, P3747, DOI 10.1128/JB.01870-07; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Spurbeck RR, 2011, INFECT IMMUN, V79, P4753, DOI 10.1128/IAI.05621-11; Svanborg C, 1997, INFECT DIS CLIN N AM, V11, P513, DOI 10.1016/S0891-5520(05)70371-8; Vigil PD, 2011, MBIO, V2, DOI 10.1128/mBio.00066-11; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zimmermann B, 2010, METHODS, V52, P125, DOI 10.1016/j.ymeth.2010.06.004	46	24	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44726	44738		10.1074/jbc.M111.290684	http://dx.doi.org/10.1074/jbc.M111.290684			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039053	Green Published, hybrid			2022-12-25	WOS:000298645500043
J	Dawson, LF; Valiente, E; Donahue, EH; Birchenough, G; Wren, BW				Dawson, Lisa F.; Valiente, Esmeralda; Donahue, Elizabeth H.; Birchenough, George; Wren, Brendan W.			Hypervirulent Clostridium difficile PCR-Ribotypes Exhibit Resistance to Widely Used Disinfectants	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED COLITIS; INFECTION; EPIDEMIOLOGY; BIOCIDE; CONTAMINATION; ENVIRONMENT; DIARRHEA; STRAINS; TRICLOSAN; MORTALITY	The increased prevalence of Clostridium difficile infection (CDI) has coincided with enhanced transmissibility and severity of disease, which is often linked to two distinct clonal lineages designated PCR-ribotype 027 and 017 responsible for CDI outbreaks in the USA, Europe and Asia. We assessed sporulation and susceptibility of three PCR-ribotypes; 012, 017 and 027 to four classes of disinfectants; chlorine releasing agents (CRAs), peroxygens, quaternary ammonium compounds (QAC) and biguanides. The 017 PCR-ribotype, showed the highest sporulation frequency under these test conditions. The oxidizing biocides and CRAs were the most efficacious in decontamination of C. difficile vegetative cells and spores, the efficacy of the CRAs were concentration dependent irrespective of PCR-ribotype. However, there were differences observed in the susceptibility of the PCR-ribotypes, independent of the concentrations tested for Virkon (R), Newgenn (R), Proceine 40 (R) and Hibiscrub (R). Whereas, for Steri7 (R) and Biocleanse (R) the difference observed between the disinfectants were dependent on both PCR-ribotype and concentration. The oxidizing agent Perasafe (R) was consistently efficacious across all three PCR ribotypes at varying concentrations; with a consistent five Log10 reduction in spore titre. The PCR-ribotype and concentration dependent differences in the efficacy of the disinfectants in this study indicate that disinfectant choice is a factor for llimiting the survival and transmission of C. difficile spores in healthcare settings.	[Dawson, Lisa F.; Valiente, Esmeralda; Donahue, Elizabeth H.; Birchenough, George; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Dawson, LF (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	Brendan.Wren@lshtm.ac.uk			Wellcome Trust [WT086418MA]; Marie Curie Grant [PIEF-GA-2009-252207]; MRC [G1000214] Funding Source: UKRI; Medical Research Council [G1000214] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Grant(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding came from Wellcome Trust Grant number WT086418MA and Marie Curie Grant number PIEF-GA-2009-252207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT JG, 1994, CLIN INFECT DIS, V18, pS265, DOI 10.1093/clinids/18.Supplement_4.S265; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Best EL, 2010, CLIN INFECT DIS, V50, P1450, DOI 10.1086/652648; Block SS, 1991, DISINFECTION STERILI, V4th, P167; CERAGIOLI M, 2010, APPL ENV MICROBIOL; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; DRUDY D, 2006, J ANTIMICROB CHEMOTH; FEKETY R, 1981, AM J MED, V70, P906, DOI 10.1016/0002-9343(81)90553-2; Fraise AP, 2002, J ANTIMICROB CHEMOTH, V49, P11, DOI 10.1093/jac/49.1.11; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; KIM KH, 1981, J INFECT DIS, V143, P42, DOI 10.1093/infdis/143.1.42; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; KULIKOVSKY A, 1975, J APPL BACTERIOL, V38, P39, DOI 10.1111/j.1365-2672.1975.tb00498.x; Lawley TD, 2010, APPL ENVIRON MICROB, V76, P6895, DOI 10.1128/AEM.00718-10; Levy SB, 2000, PEDIATR INFECT DIS J, V19, pS120, DOI 10.1097/00006454-200010001-00008; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MALAMOULADAS H, 1983, J CLIN PATHOL, V36, P88, DOI 10.1136/jcp.36.1.88; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P4770, DOI 10.1128/AEM.69.8.4770-4776.2003; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; MULLIGAN ME, 1984, ANTIMICROB AGENTS CH, V26, P343, DOI 10.1128/AAC.26.3.343; MULLIGAN ME, 1980, AM J CLIN NUTR, V33, P2533, DOI 10.1093/ajcn/33.11.2533; NY O, 2011, LANCET, V377, P1407; ONEILL G, 1993, EPIDEMIOL INFECT, V111, P257, DOI 10.1017/S095026880005696X; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Russell AD, 1999, J MED MICROBIOL, V48, P613, DOI 10.1099/00222615-48-7-613; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Settle CD, 2008, LANCET, V371, P810, DOI 10.1016/S0140-6736(08)60373-6; Shapey S, 2008, J HOSP INFECT, V70, P136, DOI 10.1016/j.jhin.2008.06.008; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Thomas L, 2005, J APPL MICROBIOL, V98, P533, DOI 10.1111/j.1365-2672.2004.02402.x; Vrtis Mary C, 2008, Home Healthc Nurse, V26, P563, DOI 10.1097/01.NHH.0000338518.64238.07; VRTIS MC, 2008, HOME HEALTHC NURSE, V26, P570; Wilcox MH, 2003, J HOSP INFECT, V54, P109, DOI 10.1016/S0195-6701(02)00400-0; WUST J, 1982, J CLIN MICROBIOL, V16, P1096	44	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25754	10.1371/journal.pone.0025754	http://dx.doi.org/10.1371/journal.pone.0025754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22039420	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000296517000010
J	Dahm, T; Neshat-Doost, HT; Golden, AM; Horn, E; Hagger, M; Dalgleish, T				Dahm, Theresa; Neshat-Doost, Hamid Taher; Golden, Ann-Marie; Horn, Elizabeth; Hagger, Martin; Dalgleish, Tim			Age Shall Not Weary Us: Deleterious Effects of Self-Regulation Depletion Are Specific to Younger Adults	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY SPECIFICITY; EXECUTIVE CONTROL; REDUCED SPECIFICITY; EMOTION REGULATION; PREFRONTAL CORTEX; STRENGTH MODEL; SYSTEM	Self-regulation depletion (SRD), or ego-depletion, refers to decrements in self-regulation performance immediately following a different self-regulation-demanding activity. There are now over a hundred studies reporting SRD across a broad range of tasks and conditions. However, most studies have used young student samples. Because prefrontal brain regions thought to subserve self-regulation do not fully mature until 25 years of age, it is possible that SRD effects are confined to younger populations and are attenuated or disappear in older samples. We investigated this using the Stroop color task as an SRD induction and an autobiographical memory task as the outcome measure. We found that younger participants (<25 years) were susceptible to depletion effects, but found no support for such effects in an older group (40-65 years). This suggests that the widely-reported phenomenon of SRD has important developmental boundary conditions casting doubt on claims that it represents a general feature of human cognition.	[Dahm, Theresa; Golden, Ann-Marie; Horn, Elizabeth; Dalgleish, Tim] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Neshat-Doost, Hamid Taher] Univ Isfahan, Esfahan, Iran; [Hagger, Martin] Univ Nottingham, Nottingham NG7 2RD, England	University of Isfahan; University of Nottingham	Dahm, T (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge, England.	tim.dalgleish@mrc-cbu.cam.ac.uk	Dalgleish, Tim/E-8341-2010; Doost, Hamid Taher Neshat/AAD-9380-2019; Hagger, Martin S./G-5211-2012	Dalgleish, Tim/0000-0002-7304-2231; Doost, Hamid Taher Neshat/0000-0001-6368-0769; Hagger, Martin S./0000-0002-2685-1546	 [U.1055.02.002.00001.01]; Medical Research Council [MC_U105579215] Funding Source: researchfish	; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Grant: U.1055.02.002.00001.01, Ethics: Cambridge Local Research Ethics Committee No. 4: CAM REC 4 NO: 11/H0305/001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Dalgleish T, 2008, J ABNORM PSYCHOL, V117, P236, DOI 10.1037/0021-843X.117.1.236; Dalgleish T, 2007, J EXP PSYCHOL GEN, V136, P23, DOI 10.1037/0096-3445.136.1.23; DeWall CN, 2007, J EXP SOC PSYCHOL, V43, P62, DOI 10.1016/j.jesp.2005.12.005; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Gailhot MT, 2007, J EXP SOC PSYCHOL, V43, P894, DOI 10.1016/j.jesp.2006.10.011; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Jones D, 2010, SCIENCE, V328, P1627, DOI 10.1126/science.328.5986.1627; Konishi S, 2003, J NEUROSCI, V23, P7776; Lewis MD, 2006, J COGNITIVE NEUROSCI, V18, P430, DOI 10.1162/089892906775990633; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Muraven M, 2002, PSYCHOL ADDICT BEHAV, V16, P113, DOI 10.1037//0893-164X.16.2.113; Neshat-Doost HT, 2008, EMOTION, V8, P731, DOI 10.1037/a0013507; Oaten M, 2007, J ECON PSYCHOL, V28, P487, DOI 10.1016/j.joep.2006.11.003; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122	21	22	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26351	10.1371/journal.pone.0026351	http://dx.doi.org/10.1371/journal.pone.0026351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039469	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200015
J	Ljungqvist, MG; Nielsen, ME; Ersboll, BK; Frosch, S				Ljungqvist, Martin Georg; Nielsen, Michael Engelbrecht; Ersboll, Bjarne Kjaer; Frosch, Stina			Image Analysis of Pellet Size for a Control System in Industrial Feed Production	PLOS ONE			English	Article							FOOD PARTICLE-SIZE; GROWTH; GRANULOMETRY	When producing aquaculture fish feed pellets, the size of the output product is of immense importance. As the production method cannot produce pellets of constant and uniform size using constant machine settings, there is a demand for size control. Fish fed with feed pellets of improper size are prone to not grow as expected, which is undesirable to the aquaculture industry. In this paper an image analysis method is proposed for automatic size-monitoring of pellets. This is called granulometry and the method used here is based on the mathematical morphological opening operation. In the proposed method, no image object segmentation is needed. The results show that it is possible to extract a general size distribution from an image of piled disordered pellets representing both length and diameter of the pellets in combination as an area.	[Ljungqvist, Martin Georg; Ersboll, Bjarne Kjaer] Tech Univ Denmark, Dept Informat & Math Modelling, DK-2800 Lyngby, Denmark; [Ljungqvist, Martin Georg; Nielsen, Michael Engelbrecht; Frosch, Stina] Tech Univ Denmark, Div Ind Food Res, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Ljungqvist, MG (corresponding author), Tech Univ Denmark, Dept Informat & Math Modelling, DK-2800 Lyngby, Denmark.	malj@imm.dtu.dk; sfro@food.dtu.dk	Nielsen, Michael Canova Engelbrecht/L-4911-2019	Nielsen, Michael Canova Engelbrecht/0000-0001-5044-4441; Ersboll, Bjarne Kjaer/0000-0003-1262-7890; Ljungqvist, Martin/0000-0002-0115-869X	BioMar A/S; EU [214505.10]	BioMar A/S; EU(European Commission)	Funding: The work presented has received funding from BioMar A/S and the EU under the Seventh Framework Programme FP7/2007-2013 under grant agreement number 214505.10. http://biomar.com/. http://epp.eurostat.ec.europa.eu/portal/page/portal/research_methodology/research/seventh_framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1993, CVGIP-GRAPH MODEL IM, V55, P325, DOI 10.1006/cgip.1993.1024; Angulo J, 2008, I S BIOMED IMAGING, P360, DOI 10.1109/ISBI.2008.4541007; Azaza MS, 2010, AQUACULTURE, V309, P193, DOI 10.1016/j.aquaculture.2010.09.026; Clemmensen LH, 2010, MACH VISION APPL, V21, P959, DOI 10.1007/s00138-009-0193-z; Devaux MF, 2008, POSTHARVEST BIOL TEC, V47, P199, DOI 10.1016/j.postharvbio.2007.06.017; FOSTER M, 1995, AQUACULT ENG, V14, P251, DOI 10.1016/0144-8609(94)00006-M; JAGERSAND M, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P195, DOI 10.1109/ICCV.1995.466786; Jones R, 1996, PATTERN RECOGN LETT, V17, P1057, DOI 10.1016/0167-8655(96)00066-9; Lassoued N, 2007, FOOD RES INT, V40, P1087, DOI 10.1016/j.foodres.2007.06.004; Lindeberg T, 1998, INT J COMPUT VISION, V30, P79, DOI 10.1023/A:1008045108935; Lindeberg T, 1996, CERN REPORT, V96, P27; Lindeberg T., 1999, HDB COMPUTER VISION, P239; MARAGOS P, 1989, IEEE T PATTERN ANAL, V11, P701, DOI 10.1109/34.192465; Matheron G, 2002, MATHEMATICAL MORPHOLOGY, PROCEEDINGS, P1; Matheron G., 1975, RANDOM SETS INTEGRAL; Montgomery DC, 2005, INTRO STAT QUALITY E; Morales-Hernandez LA, 2010, J MATER PROCESS TECH, V210, P335, DOI 10.1016/j.jmatprotec.2009.09.020; Parsonage KD, 2001, THESIS U BRIT COLUMB; Serra J., 1982, IMAGE ANAL MATH MORP; TABACHEK JAL, 1988, AQUACULTURE, V71, P319, DOI 10.1016/0044-8486(88)90201-3; Vincent L, 1994, COMP IMAG VIS, V2, P265; Vincent L., 2000, PROC 11 ANN S S AFRI, P119; Wang X, 2006, INT C SIGN PROC P, V8; WANKOWSKI JWJ, 1979, J FISH BIOL, V14, P351, DOI 10.1111/j.1095-8649.1979.tb03530.x; Zadorozny A, 2002, INT C VIS INT, V15, P433	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26492	10.1371/journal.pone.0026492	http://dx.doi.org/10.1371/journal.pone.0026492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031836	Green Published, Green Submitted, gold			2022-12-25	WOS:000296513200025
J	Pandya, AD; Al-Jaderi, Z; Hoglund, RA; Holmoy, T; Harbo, HF; Norgauer, J; Maghazachi, AA				Pandya, Abhilash D.; Al-Jaderi, Zaidoon; Hoglund, Rune A.; Holmoy, Trygve; Harbo, Hanne F.; Norgauer, Johannes; Maghazachi, Azzam A.			Identification of Human NK17/NK1 Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HETEROTRIMERIC G-PROTEINS; HUMAN NK CELLS; ROR-GAMMA-T; CHEMOKINE RECEPTORS; DIFFERENTIATION; SUBSETS; MOBILIZATION; PRECURSORS; EXPRESSION	Background: Natural killer (NK) cells have both cytolytic and immunoregulatory functions. We recently described that these cells release the inflammatory cytokines IL-17 and IFN-gamma. However, the precise identity of the NK cell subset(s) that secrete these cytokines is not known. Methodology/Principal Findings: To isolate the cells secreting IL-17 and IFN-gamma, we took advantage of the findings that Th17/Th1 cells express chemokine receptors. Therefore, CD56(+) NK cells were stained with antibodies against various chemokine receptors and intracellularly with antibodies toward IL-17 and IFN-gamma. Consequently, we identified previously unrecognized subset of NK cells generated from normal human peripheral blood after activation with IL-2 but not PMA plus ionomycin. The cells are characterized by the expression of CD56(+) and CCR4(+), produce IL-17 and IFN-gamma and are consequently named NK17/NK1 cells. They also express CD161, NKp30, NKp44, NKp46, NKG2D, CD158, CCL22, IL-2R beta and the common gamma chain but not CD127 or IL-23R. Further, they possess T-bet and ROR gamma t transcription factors. Antibodies to IL-1 beta, IL-6, IL-21, or TGF-beta 1 do not inhibit IL-2-induced generation of NK17/NK1 cells, suggesting that IL-2 has the capacity to polarize these cells. Notably, NK17/NK1 cells are abundant in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) without activation, and are generated from the peripheral blood of these patients after activation with IL-2. Conclusions/Significance: NK17/NK1 cells identified here have not been previously described in healthy or MS patients.	[Pandya, Abhilash D.; Al-Jaderi, Zaidoon; Hoglund, Rune A.; Maghazachi, Azzam A.] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Physiol, Oslo, Norway; [Holmoy, Trygve] Oslo Univ Hosp, Inst Immunol, Oslo, Norway; [Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Norgauer, Johannes] Jena Univ Hosp, Dept Dermatol, Jena, Germany	University of Oslo; University of Oslo; University of Oslo; Friedrich Schiller University of Jena	Pandya, AD (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Physiol, Oslo, Norway.	azzam.maghazachi@medisin.uio.no	Salim, Zaidon/E-7928-2017	Salim, Zaidon/0000-0002-8445-1161; Pandya, Abhilash D./0000-0002-7713-3050; Maghazachi, Azzam/0000-0002-3310-678X; Hoglund, Rune Alexander/0000-0002-5801-3360	University of Oslo; Halvor Hoies Fond; Norwegian Cancer Society; Forskerlinjen fellowship	University of Oslo; Halvor Hoies Fond; Norwegian Cancer Society(Norwegian Cancer Society); Forskerlinjen fellowship	This work was supported by grants from the University of Oslo, Halvor Hoies Fond, and the Norwegian Cancer Society. AP is supported by a student fellowship from the University of Oslo, and RH is supported by Forskerlinjen fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aoukaty A, 1998, IMMUNOLOGY, V95, P618; Al-Falahi Y, 2009, J CELL MOL MED, V13, P2693, DOI 10.1111/j.1582-4934.2008.00640.x; Annunziato F, 2008, INT IMMUNOL, V20, P1361, DOI 10.1093/intimm/dxn106; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Bernardini G, 2008, BLOOD, V111, P3626, DOI 10.1182/blood-2007-08-106203; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048, DOI 10.4049/jimmunol.164.8.4048; Inngjerdingen M, 2001, BLOOD, V97, P367, DOI 10.1182/blood.V97.2.367; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Maghazachi AA, 1997, BIOCHEM BIOPH RES CO, V236, P270, DOI 10.1006/bbrc.1997.6937; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Moretta L, 2011, BLOOD, V117, P764, DOI 10.1182/blood-2010-08-264085; Peritt D, 1998, J IMMUNOL, V161, P5821; Robertson MJ, 2000, CELL IMMUNOL, V199, P8, DOI 10.1006/cimm.1999.1601; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Rolin J, 2010, CANCER IMMUNOL IMMUN, V59, P575, DOI 10.1007/s00262-009-0775-7; Sand KL, 2009, CELL MOL LIFE SCI, V66, P1446, DOI 10.1007/s00018-009-8726-1; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Shi FD, 2011, AUTOIMMUNITY, V44, P3, DOI 10.3109/08916931003782122; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3	27	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26780	10.1371/journal.pone.0026780	http://dx.doi.org/10.1371/journal.pone.0026780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039549	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200052
J	Carrancio, S; Blanco, B; Romo, C; Muntion, S; Lopez-Holgado, N; Blanco, JF; Brinon, JG; San Miguel, JF; Sanchez-Guijo, FM; del Canizo, MC				Carrancio, Soraya; Blanco, Belen; Romo, Carlos; Muntion, Sandra; Lopez-Holgado, Natalia; Blanco, Juan F.; Brinon, Jesus G.; San Miguel, Jesus F.; Sanchez-Guijo, Fermin M.; Consuelo del Canizo, M.			Bone Marrow Mesenchymal Stem Cells for Improving Hematopoietic Function: An In Vitro and In Vivo Model. Part 2: Effect on Bone Marrow Microenvironment	PLOS ONE			English	Article							STROMAL CELLS; PERIPHERAL-BLOOD; TRANSPLANTATION; ENGRAFTMENT; EXPANSION; COTRANSPLANTATION; MOBILIZATION; RECOVERY; LEUKEMIA; FAILURE	The aim of the present study was to determine how mesenchymal stem cells (MSC) could improve bone marrow (BM) stroma function after damage, both in vitro and in vivo. Human MSC from 20 healthy donors were isolated and expanded. Mobilized selected CD34(+) progenitor cells were obtained from 20 HSCT donors. For in vitro study, long-term bone marrow cultures (LTBMC) were performed using a etoposide damaged stromal model to test MSC effect in stromal confluence, capability of MSC to lodge in stromal layer as well as some molecules (SDF1, osteopontin,) involved in hematopoietic niche maintenance were analyzed. For the in vivo model, 64 NOD/SCID recipients were transplanted with CD34(+) cells administered either by intravenous (IV) or intrabone (IB) route, with or without BM derived MSC. MSC lodgement within the BM niche was assessed by FISH analysis and the expression of SDF1 and osteopontin by immunohistochemistry. In vivo study showed that when the stromal damage was severe, TP-MSC could lodge in the etoposide-treated BM stroma, as shown by FISH analysis. Osteopontin and SDF1 were differently expressed in damaged stroma and their expression restored after TP-MSC addition. Human in vivo MSC lodgement was observed within BM niche by FISH, but MSC only were detected and not in the contralateral femurs. Human MSC were located around blood vessels in the subendoestal region of femurs and expressed SDF1 and osteopontin. In summary, our data show that MSC can restore BM stromal function and also engraft when a higher stromal damage was done. Interestingly, MSC were detected locally where they were administered but not in the contralateral femur.	[Carrancio, Soraya; Blanco, Belen; Romo, Carlos; Muntion, Sandra; Lopez-Holgado, Natalia; San Miguel, Jesus F.; Sanchez-Guijo, Fermin M.; Consuelo del Canizo, M.] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain; [Carrancio, Soraya; Blanco, Belen; Romo, Carlos; Muntion, Sandra; Lopez-Holgado, Natalia; San Miguel, Jesus F.; Sanchez-Guijo, Fermin M.; Consuelo del Canizo, M.] ISCIII, Ctr Red Med Regenerat & Terapia Celular Castilla, Castilla Y Leon, Spain; [Carrancio, Soraya; Blanco, Belen; Romo, Carlos; Muntion, Sandra; Lopez-Holgado, Natalia; San Miguel, Jesus F.; Sanchez-Guijo, Fermin M.; Consuelo del Canizo, M.] ISCIII, Red Nacl Terapia Celular Tercel, Castilla Y Leon, Spain; [Carrancio, Soraya; Blanco, Belen; Romo, Carlos; San Miguel, Jesus F.; Consuelo del Canizo, M.] Univ Salamanca, CSIC, Ctr Invest Canc, IBMCC, E-37008 Salamanca, Spain; [Blanco, Juan F.] Hosp Univ Salamanca, Serv Traumatol, Salamanca, Spain; [Brinon, Jesus G.] Univ Salamanca, Dept Biol Celular & Patol, E-37008 Salamanca, Spain	University of Salamanca; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca	Carrancio, S (corresponding author), Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain.	concarol@usal.es	San-Miguel, Jesús F./V-8977-2018; Blanco, Belén/S-5796-2018; Sanchez-Guijo, Fermin/D-8542-2018; Blanco, Belén/GRX-4894-2022; Blanco, Juan F/AAI-5787-2021; Brinon, Jesus G./L-7316-2014	San-Miguel, Jesús F./0000-0002-9183-4857; Sanchez-Guijo, Fermin/0000-0002-7076-7739; Blanco, Juan F/0000-0001-7803-9149; Brinon, Jesus G./0000-0002-3503-0539; Muntion Olave, Sandra/0000-0001-7164-0767	Consejeria de Educacion de Castilla y Leon [HUS003A10-2]; Gerencia Regional de Salud de Castilla y Leon [GRS/222/A/08]; Fondo de Investigaciones Sanitarias (ISCIII), Ministerio de Sanidad, Spain [PS09/01530]; Junta de Castilla y Leon (FPI) [EDU/1878/2006]; Fondo de Investigaciones Sanitarias (FIS) from the Instituto de Salud Carlos III [CD06/00042]	Consejeria de Educacion de Castilla y Leon; Gerencia Regional de Salud de Castilla y Leon; Fondo de Investigaciones Sanitarias (ISCIII), Ministerio de Sanidad, Spain(Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon (FPI)(Junta de Castilla y LeonSpanish Government); Fondo de Investigaciones Sanitarias (FIS) from the Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This study was supported in part by a grant from Consejeria de Educacion de Castilla y Leon (ref: HUS003A10-2), Gerencia Regional de Salud de Castilla y Leon (ref: GRS/222/A/08) and Fondo de Investigaciones Sanitarias (ISCIII) (ref: PS09/01530), Ministerio de Sanidad, Spain. S. C. was supported by Junta de Castilla y Leon (FPI Grant EDU/1878/2006). B. B. was supported by Fondo de Investigaciones Sanitarias (FIS) from the Instituto de Salud Carlos III (ref. CD06/00042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Baron F, 2010, BIOL BLOOD MARROW TR, V16, P838, DOI 10.1016/j.bbmt.2010.01.011; Bartsch K, 2009, TRANSPLANTATION, V87, P217, DOI 10.1097/TP.0b013e3181938998; Blanco B, 2006, BLOOD, V107, P3575, DOI 10.1182/blood-2005-05-2118; Burt RK, 2008, J AUTOIMMUN, V30, P116, DOI 10.1016/j.jaut.2007.12.010; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Carrancio S, 2008, EXP HEMATOL, V36, P1014, DOI 10.1016/j.exphem.2008.03.012; Carrancio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026241; Clutter SD, 2006, EXP HEMATOL, V34, P1522, DOI 10.1016/j.exphem.2006.06.021; del Canizo MC, 2003, HAEMATOLOGICA, V88, P402; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Fujita S, 2008, CELL TRANSPLANT, V17, P1169, DOI 10.3727/096368908787236611; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Gibson L F, 1997, Biol Blood Marrow Transplant, V3, P122; Gomez C, 2007, J NEUROCHEM, V100, P924, DOI 10.1111/j.1471-4159.2006.04229.x; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Guezguez B, 2008, CURR OPIN ORGAN TRAN, V13, P44, DOI 10.1097/MOT.0b013e3282f42486; Gutierrez NC, 2004, BLOOD, V104, P2661, DOI 10.1182/blood-2004-04-1319; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; Hiwase SD, 2009, STEM CELLS, V27, P2293, DOI 10.1002/stem.157; Horvat-Karajz K, 2009, LASER SURG MED, V41, P463, DOI 10.1002/lsm.20791; Ikehara S, 2005, ANN NY ACAD SCI, V1051, P626, DOI 10.1196/annals.1361.107; Janczewska S, 2003, CELL TRANSPLANT, V12, P399, DOI 10.3727/000000003108746948; Jing DH, 2010, HAEMATOL-HEMATOL J, V95, P542, DOI 10.3324/haematol.2009.010736; Jones CV, 2009, FUTURE ONCOL, V5, P559, DOI 10.2217/FON.09.20; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kemp K, 2010, ANN HEMATOL, V89, P701, DOI 10.1007/s00277-009-0896-2; Koestenbauer S, 2009, CELL TRANSPLANT, V18, P1059, DOI 10.3727/096368909X471288; Lopez-Holgado N, 2005, HAEMATOLOGICA, V90, P353; Meuleman N, 2009, STEM CELLS DEV, V18, P1247, DOI 10.1089/scd.2009.0029; Mishima S, 2010, EUR J HAEMATOL  0105; Mishima S, 2010, EUR J HAEMATOL, V84, P538, DOI 10.1111/j.1600-0609.2010.01419.x; Myers KC, 2009, BIOL BLOOD MARROW TR, V15, P279, DOI 10.1016/j.bbmt.2008.11.037; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Ramirez PA, 2010, BONE MARROW TRANSPL, V45, P1127, DOI 10.1038/bmt.2010.39; Renstrom J, 2010, CHEM-BIOL INTERACT, V184, P7, DOI 10.1016/j.cbi.2009.11.012; Rettig MP, 2009, METHOD ENZYMOL, V460, P57, DOI 10.1016/S0076-6879(09)05203-3; Spyridonidis A, 2005, STEM CELLS DEV, V14, P213, DOI 10.1089/scd.2005.14.213; Sumitomo A, 2010, MOL CELL BIOL, V30, P4818, DOI 10.1128/MCB.01348-09; Trouche E, 2010, CELL TRANSPLANT, V19, P1623, DOI 10.3727/096368910X514297; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van Velthoven CTJ, 2010, PEDIATR RES, V68, P419, DOI 10.1203/PDR.0b013e3181f1c289; Villaron EM, 2004, HAEMATOLOGICA, V89, P1421	46	34	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26241	10.1371/journal.pone.0026241	http://dx.doi.org/10.1371/journal.pone.0026241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028841	Green Published, gold			2022-12-25	WOS:000296510800030
J	Sohn, JW; Yu, WJ; Lee, D; Shin, HS; Lee, SH; Ho, WK				Sohn, Jong-Woo; Yu, Weon-Jin; Lee, Doyun; Shin, Hee-Sup; Lee, Suk-Ho; Ho, Won-Kyung			Cyclic ADP Ribose-Dependent Ca2+ Release by Group I Metabotropic Glutamate Receptors in Acutely Dissociated Rat Hippocampal Neurons	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; LONG-TERM DEPRESSION; BACKPROPAGATING ACTION-POTENTIALS; SEA-URCHIN EGGS; MOLECULAR CHARACTERIZATION; RYANODINE RECEPTOR; CALCIUM RELEASE; CADP-RIBOSE; EXCITABILITY; MODULATION	Group I metabotropic glutamate receptors (group I mGluRs; mGluR1 and mGluR5) exert diverse effects on neuronal and synaptic functions, many of which are regulated by intracellular Ca2+. In this study, we characterized the cellular mechanisms underlying Ca2+ mobilization induced by (RS)-3,5-dihydroxyphenylglycine (DHPG; a specific group I mGluR agonist) in the somata of acutely dissociated rat hippocampal neurons using microfluorometry. We found that DHPG activates mGluR5 to mobilize intracellular Ca2+ from ryanodine-sensitive stores via cyclic adenosine diphosphate ribose (cADPR), while the PLC/IP3 signaling pathway was not involved in Ca2+ mobilization. The application of glutamate, which depolarized the membrane potential by 28.5 +/- 4.9 mV (n = 4), led to transient Ca2+ mobilization by mGluR5 and Ca2+ influx through L-type Ca2+ channels. We found no evidence that mGluR5-mediated Ca2+ release and Ca2+ influx through L-type Ca2+ channels interact to generate supralinear Ca2+ transients. Our study provides novel insights into the mechanisms of intracellular Ca2+ mobilization by mGluR5 in the somata of hippocampal neurons.	[Sohn, Jong-Woo; Yu, Weon-Jin; Lee, Doyun; Lee, Suk-Ho; Ho, Won-Kyung] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Sohn, Jong-Woo; Yu, Weon-Jin; Lee, Doyun; Lee, Suk-Ho; Ho, Won-Kyung] Seoul Natl Univ, Coll Med, Biomembrane Plast Res Ctr, Seoul, South Korea; [Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST)	Sohn, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA.	wonkyung@snu.ac.kr	Lee, Suk-Ho/D-6344-2012; Lee, Doyun/AAK-5369-2020; Sohn, Jong Woo/D-6700-2014; Ho, Won-Kyung/J-2798-2012	Lee, Doyun/0000-0002-9968-9113; Lee, Suk-Ho/0000-0003-4117-5619	Korean Ministry of Education, Science, and Technology [2010-0029394, R32-10084]	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korean Ministry of Education, Science, and Technology [SRC program (2010-0029394) and WCU Neurocytomics program (R32-10084) to W.K.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Barnes SJ, 2010, J NEUROSCI, V30, P12996, DOI 10.1523/JNEUROSCI.1847-10.2010; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bloodgood BL, 2008, J PHYSIOL-LONDON, V586, P1475, DOI 10.1113/jphysiol.2007.148353; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Chuang SC, 2001, J NEUROSCI, V21, P6387, DOI 10.1523/JNEUROSCI.21-16-06387.2001; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; D'Ascenzo M, 2009, J PHYSIOL-LONDON, V587, P3233, DOI 10.1113/jphysiol.2009.172593; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hashii M, 2000, BIOCHEM J, V345, P207, DOI 10.1042/0264-6021:3450207; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Higashida H, 2003, J NEUROCHEM, V85, P1148, DOI 10.1046/j.1471-4159.2003.01751.x; Ireland DR, 2004, J NEUROPHYSIOL, V92, P2811, DOI 10.1152/jn.01236.2003; Ireland DR, 2002, J NEUROPHYSIOL, V88, P107, DOI 10.1152/jn.2002.88.1.107; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Kleppisch T, 2001, J NEUROSCI, V21, P4943, DOI 10.1523/JNEUROSCI.21-14-04943.2001; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Krause M, 2002, J NEUROSCI, V22, P666, DOI 10.1523/JNEUROSCI.22-03-00666.2002; Lee D, 2007, J NEUROSCI, V27, P13603, DOI 10.1523/JNEUROSCI.3985-07.2007; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; Lopatina O, 2010, NEUROPHARMACOLOGY, V58, P50, DOI 10.1016/j.neuropharm.2009.06.012; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; Morgan AJ, 2008, METHODS, V46, P194, DOI 10.1016/j.ymeth.2008.09.013; Morikawa H, 2003, J NEUROSCI, V23, P149; Mushtaq M, 2011, J BIOL CHEM, V286, P12952, DOI 10.1074/jbc.M110.207100; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; Rae MG, 2000, J NEUROSCI, V20, P8628; Reyes-Harde M, 1999, J NEUROPHYSIOL, V82, P1569, DOI 10.1152/jn.1999.82.3.1569; Sethi JK, 1996, BIOCHEM J, V319, P613, DOI 10.1042/bj3190613; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Sohn JW, 2007, J PHYSIOL-LONDON, V580, P411, DOI 10.1113/jphysiol.2006.125914; Sourdet V, 2003, J NEUROSCI, V23, P10238; Topolnik L, 2009, J NEUROSCI, V29, P4658, DOI 10.1523/JNEUROSCI.0493-09.2009; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xu JH, 2007, CURR OPIN NEUROBIOL, V17, P352, DOI 10.1016/j.conb.2007.04.005; Young SR, 2004, J PHYSIOL-LONDON, V554, P371, DOI 10.1113/jphysiol.2003.051847; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zheng J, 2010, CELL CALCIUM, V47, P449, DOI 10.1016/j.ceca.2010.03.006	58	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26625	10.1371/journal.pone.0026625	http://dx.doi.org/10.1371/journal.pone.0026625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028929	Green Submitted, Green Published, gold			2022-12-25	WOS:000296510800063
J	Wang, XH; Kang, GH; Campan, M; Weisenberger, DJ; Long, TI; Cozen, W; Bernstein, L; Wu, AH; Siegmund, KD; Shibata, D; Laird, PW				Wang, Xinhui; Kang, Gyeong Hoon; Campan, Mihaela; Weisenberger, Daniel J.; Long, Tiffany I.; Cozen, Wendy; Bernstein, Leslie; Wu, Anna H.; Siegmund, Kimberly D.; Shibata, Darryl; Laird, Peter W.			Epigenetic Subgroups of Esophageal and Gastric Adenocarcinoma with Differential GATA5 DNA Methylation Associated with Clinical and Lifestyle Factors	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; UNITED-STATES; BARRETTS-ESOPHAGUS; CANCER; GENES; PATTERNS; RISK; CARCINOMA; PROFILES; CARCINOGENESIS	Background: Adenocarcinomas located near the gastroesophageal junction have unclear etiology and are difficult to classify. We used DNA methylation analysis to identify subtype-specific markers and new subgroups of gastroesophageal adenocarcinomas, and studied their association with epidemiological risk factors and clinical outcomes. Methodology/Principal Findings: We used logistic regression models and unsupervised hierarchical cluster analysis of 74 DNA methylation markers on 45 tumor samples (44 patients) of esophageal and gastric adenocarcinomas obtained from a population-based case-control study to uncover epigenetic markers and cluster groups of gastroesophageal adenocarcinomas. No distinct epigenetic differences were evident between subtypes of gastric and esophageal cancers. However, we identified two gastroesophageal adenocarcinoma subclusters based on DNA methylation profiles. Group membership was best predicted by GATA5 DNA methylation status. We analyzed the associations between these two epigenetic groups and exposure using logistic regression, and the associations with survival time using Cox regression in a larger set of 317 tumor samples (278 patients). There were more males with esophageal and gastric cardia cancers in Cluster Group 1 characterized by higher GATA5 DNA methylation values (all p < 0.05). This group also showed associations of borderline statistical significance with having ever smoked (p-value = 0.07), high body mass index (p-value = 0.06), and symptoms of gastroesophageal reflux (p-value = 0.07). Subjects in cluster Group 1 showed better survival than those in Group 2 after adjusting for tumor differentiation grade, but this was not found to be independent of tumor stage. Conclusions/Significance: DNA methylation profiling can be used in population-based studies to identify epigenetic subclasses of gastroesophageal adenocarcinomas and class-specific DNA methylation markers that can be linked to epidemiological data and clinical outcome. Two new epigenetic subgroups of gastroesophageal adenocarcinomas were identified that differ to some extent in their survival rates, risk factors of exposure, and GATA5 DNA methylation.	[Wang, Xinhui; Cozen, Wendy; Wu, Anna H.; Siegmund, Kimberly D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Campan, Mihaela; Long, Tiffany I.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Canc Res Inst, Seoul 151, South Korea; [Bernstein, Leslie] City Hope Natl Med Ctr, Div Populat Sci, Duarte, CA 91010 USA; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Weisenberger, Daniel J.; Laird, Peter W.] Univ So Calif, Epigenome Ctr, Los Angeles, CA USA; [Weisenberger, Daniel J.; Laird, Peter W.] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA	University of Southern California; University of Southern California; Seoul National University (SNU); City of Hope; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Wang, XH (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	plaird@usc.edu	Kang, Gyeong Hoon/F-1051-2010; Laird, Peter W/G-8683-2012; Weisenberger, Daniel/AAA-8314-2020	Kang, Gyeong Hoon/0000-0003-2380-6675; Laird, Peter W/0000-0001-9117-3641; Weisenberger, Daniel/0000-0001-8303-2603	US National Cancer Institute (NCI) [5R01 CA 001815]; California Tobacco Related Research Program [3RT-0122, 10RT-0251]; California Department of Health Services; NCI's Division of Cancer Prevention and Control Surveillance [N01 CN 25403]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025403] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA001815] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Tobacco Related Research Program; California Department of Health Services; NCI's Division of Cancer Prevention and Control Surveillance; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Cancer Institute (NCI) grant 5R01 CA 001815 (P.W. Laird), and California Tobacco Related Research Program grant 3RT-0122 and 10RT-0251 (A.H. Wu). Incident cancer cases for this study were collected by the University of Southern California Center Surveillance Program (CSP), which is supported under subcontract by the California Department of Health Services. The CSP is also part of the NCI's Division of Cancer Prevention and Control Surveillance, Epidemiology and End Results Program, under contract number N01 CN 25403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Arasaradnam RP, 2008, EPIGENETICS-US, V3, P193, DOI 10.4161/epi.3.4.6508; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Crane SJ, 2007, AM J GASTROENTEROL, V102, P1596, DOI 10.1111/j.1572-0241.2007.01234.x; DeMeester SR, 2000, ANN SURG, V231, P303, DOI 10.1097/00000658-200003000-00003; DEVESA SS, 1987, J NATL CANCER I, V79, P701; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Eads CA, 2001, CANCER RES, V61, P3410; Eads CA, 2000, CANCER RES, V60, P5021; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Fu BJ, 2007, CANCER BIOL THER, V6, P1546, DOI 10.4161/cbt.6.10.4708; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Guo MZ, 2006, INT J CANCER, V119, P2078, DOI 10.1002/ijc.22092; Guo MZ, 2004, CLIN CANCER RES, V10, P7917, DOI 10.1158/1078-0432.CCR-04-1140; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; Kimmons Joel E, 2006, MedGenMed, V8, P59; Lagarde SM, 2006, J CLIN ONCOL, V24, P4347, DOI 10.1200/JCO.2005.04.9445; Lagergren J, 2006, LANCET ONCOL, V7, P347, DOI 10.1016/S1470-2045(06)70660-X; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Leng S, 2008, CANCER RES, V68, P3049, DOI 10.1158/0008-5472.CAN-07-6344; Lyon CM, 2007, RADIAT RES, V168, P409, DOI 10.1667/RR0825.1; MACDONALD WC, 1987, CANCER, V60, P1094, DOI 10.1002/1097-0142(19870901)60:5<1094::AID-CNCR2820600529>3.0.CO;2-4; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Sato F, 2006, CANCER-AM CANCER SOC, V106, P483, DOI 10.1002/cncr.21657; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siewert JR, 1998, BRIT J SURG, V85, P1457; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Wakana K, 2006, CANCER LETT, V241, P281, DOI 10.1016/j.canlet.2005.10.039; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Wu HY, 2009, CANCER EPIDEM BIOMAR, V18, P1945, DOI 10.1158/1055-9965.EPI-09-0250; Yamamoto E, 2011, DIGESTION, V83, P241, DOI 10.1159/000320453	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25985	10.1371/journal.pone.0025985	http://dx.doi.org/10.1371/journal.pone.0025985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028801	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800012
J	Chen, MQ; Zhang, JB; Li, N; Qian, ZP; Zhu, MQ; Li, Q; Zheng, JM; Wang, XY; Shi, GF				Chen, Mingquan; Zhang, Jianbin; Li, Ning; Qian, Zhiping; Zhu, Mengqi; Li, Qian; Zheng, Jianming; Wang, Xinyu; Shi, Guangfeng			Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer	PLOS ONE			English	Article							DAMAGE; GENES; DNA	FBP1, fructose-1,6-bisphosphatase-1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. The mechanism that it functions to antagonize glycolysis and was epigenetically inactivated through NF-kappaB pathway in gastric cancer has been reported. However, its role in the liver carcinogenesis still remains unknown. Here, we investigated the expression and DNA methylation of FBP1 in primary HCC and colon tumor. FBP1 was lowly expressed in 80% (8/10) human hepatocellular carcinoma, 66.7% (6/9) liver cancer cell lines and 100% (6/6) colon cancer cell lines, but was higher in paired adjacent non-tumor tissues and immortalized normal cell lines, which was well correlated with its promoter methylation status. Methylation was further detected in primary HCCs, gastric and colon tumor tissues, but none or occasionally in paired adjacent non-tumor tissues. Detailed methylation analysis of 29 CpG sites at a 327-bp promoter region by bisulfite genomic sequencing confirmed its methylation. FBP1 silencing could be reversed by chemical demethylation treatment with 5-aza-2'-deoxycytidine (Aza), indicating direct epigenetic silencing. Restoring FBP1 expression in low expressed cells significantly inhibited cell growth and colony formation ability through the induction of G2-M phase cell cycle arrest. Moreover, the observed effects coincided with an increase in reactive oxygen species (ROS) generation. In summary, epigenetic inactivation of FBP1 is also common in human liver and colon cancer. FBP1 appears to be a functional tumor suppressor involved in the liver and colon carcinogenesis.	[Chen, Mingquan; Li, Ning; Qian, Zhiping; Zhu, Mengqi; Li, Qian; Zheng, Jianming; Wang, Xinyu; Shi, Guangfeng] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Zhang, Jianbin] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China	Fudan University; Zhejiang University	Chen, MQ (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	gfshi@shmu.edu.cn			Major Science and Technology Special Project of China Eleventh Five-Year Plan [2008ZX1002-004]; Chinese State Basic Research Foundation [2007CB512904]; Shanghai Sci and Tech Research Program [08JC1403900]; program for Outstanding Medical Academic Leader of Shanghai [08GWD19]	Major Science and Technology Special Project of China Eleventh Five-Year Plan; Chinese State Basic Research Foundation; Shanghai Sci and Tech Research Program; program for Outstanding Medical Academic Leader of Shanghai	This work was supported by grants from Major Science and Technology Special Project of China Eleventh Five-Year Plan (No. 2008ZX1002-004), the Chinese State Basic Research Foundation Grant (2007CB512904), Shanghai Sci and Tech Research Program (08JC1403900), and the program for Outstanding Medical Academic Leader of Shanghai (08GWD19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Bigl M, 2008, BIOCHEM BIOPH RES CO, V377, P720, DOI 10.1016/j.bbrc.2008.10.045; Cabello CM, 2007, CURR OPIN INVEST DR, V8, P1022; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kitanovic A, 2006, MUTAT RES-FUND MOL M, V594, P135, DOI 10.1016/j.mrfmmm.2005.08.005; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957	13	102	112	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25564	10.1371/journal.pone.0025564	http://dx.doi.org/10.1371/journal.pone.0025564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039417	Green Submitted, gold, Green Published			2022-12-25	WOS:000296507500015
J	Meng, QL; Guo, HK; Hou, SP; Jiang, ZX; Kijlstra, A; Yang, PZ				Meng, Qianli; Guo, Haike; Hou, Shengping; Jiang, Zhengxuan; Kijlstra, Aize; Yang, Peizeng			Lack of an Association of PD-1 and Its Ligand Genes with Behcet's Disease in a Chinese Han Population	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PDCD1 GENE; RHEUMATOID-ARTHRITIS; REGULATORY POLYMORPHISM; NO EVIDENCE; SILK ROAD; SUSCEPTIBILITY; HAPLOTYPE; MANIFESTATIONS; HLA-B51	Background: Behcet's disease is a chronic, multi-systemic autoimmune disease. Programmed cell death 1 (PD-1) gene is one of non-human leucocyte antigen genes. It has been demonstrated to be associated with several autoimmune diseases. However, only a few studies have addressed the association of ligand genes of PD-1, PD-L1 and PD-L2 with autoimmune disease. The purpose of this study was to analyze the potential association of the PD-1 and its ligand genes with Behcet's disease in a Chinese Han population. Methodology/Principal Findings: Four single-nucleotide polymorphism (SNPs) rs2227981 and rs10204525 of PD-1, rs1970000 of PD-L1 and rs7854303 of PD-L2 were genotyped in 405 Behcet's patients and 414 age-, sex-, ethnic-matched healthy controls using polymerase chain reaction-restriction fragment length polymorphism assay. The results revealed that there were no significant differences in the genotype and allele frequencies of PD-1 rs2227981 and rs10204525 between the Behcet's patients and controls. A similar result was found for PD-L1 rs1970000 versus healthy controls. Only the C allele and the CC genotype of PD-L2 rs7854303 were identified in patients and controls. Stratification analysis based on gender and clinical findings did not show any associations between PD-1 or its ligand polymorphisms and Behcet's disease. Conclusions/Significance: None of the currently studied SNPs, PD-1 rs2227981 and rs10204525, PD-L1 rs1970000 and PD-L2 rs7854303, are associated with the susceptibility to Behcet's disease in a Chinese Han population. More studies are needed to confirm these findings in Behcet's patients with other ethnic backgrounds.	[Meng, Qianli; Guo, Haike] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Eye Inst, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Hou, Shengping; Jiang, Zhengxuan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Meng, QL (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Eye Inst, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China.	peizengycum@126.com	Hou, Shengping/E-5250-2013; Yang, Peizeng/C-6336-2013		Fund for National Natural Science Foundation [30901653]; Natural Science Foundation of Guangdong Province [7301447]; Project of Medical Science and Technology of Chongqing; Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Natural Science Foundation [30910103912]; Chongqing Municipality; Fund for PAR-EU Scholars Program and National Basic Research	Fund for National Natural Science Foundation; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Project of Medical Science and Technology of Chongqing; Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing Municipality; Fund for PAR-EU Scholars Program and National Basic Research	This work was supported by Fund for National Natural Science Foundation (30901653), Natural Science Foundation of Guangdong Province (7301447), Project of Medical Science and Technology of Chongqing, Key Project of Health Bureau of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), Natural Science Foundation Major International (Regional) Joint Research Project (30910103912), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality and Fund for PAR-EU Scholars Program and National Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson AK, 2007, GENES IMMUN, V8, P69, DOI 10.1038/sj.gene.6364360; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Chou WC, 1999, BIOTECHNOL BIOENG, V65, P160, DOI 10.1002/(SICI)1097-0290(19991020)65:2<160::AID-BIT5>3.0.CO;2-U; Cohen R, 2002, ANN RHEUM DIS, V61, P157, DOI 10.1136/ard.61.2.157; Direskeneli H, 2006, RHEUMATOLOGY, V45, P1461, DOI 10.1093/rheumatology/kel329; Fawwaz S, 2007, DIABETIC MED, V24, P1473, DOI 10.1111/j.1464-5491.2007.02297.x; Ferreiros-Vidal I, 2007, GENES IMMUN, V8, P138, DOI 10.1038/sj.gene.6364370; Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM-US, V50, P2590, DOI 10.1002/art.20436; Gul Ahmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P81, DOI 10.2174/1568010053622894; Hayashi M, 2008, EUR J ENDOCRINOL, V158, P817, DOI 10.1530/EJE-07-0649; Hou SP, 2008, CLIN IMMUNOL, V129, P170, DOI 10.1016/j.clim.2008.06.006; Iwamoto T, 2007, J HUM GENET, V52, P557, DOI 10.1007/s10038-007-0145-2; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Keino H, 2007, BRIT J OPHTHALMOL, V91, P1573, DOI 10.1136/bjo.2007.124875; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kong EKP, 2005, ARTHRITIS RHEUM-US, V52, P1058, DOI 10.1002/art.20966; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; Lee SH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2071; Lin SC, 2004, ARTHRITIS RHEUM-US, V50, P770, DOI 10.1002/art.20040; Meng QL, 2006, INVEST OPHTH VIS SCI, V47, P4444, DOI 10.1167/iovs.06-0201; Meng QL, 2009, MOL VIS, V15, P386; Mizuki N, 2002, TISSUE ANTIGENS, V60, P396, DOI 10.1034/j.1399-0039.2002.600506.x; Newby PR, 2007, CLIN ENDOCRINOL, V67, P125, DOI 10.1111/j.1365-2265.2007.02848.x; Ni RH, 2007, HUM GENET, V121, P223, DOI 10.1007/s00439-006-0309-8; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Park K, 2006, J KOREAN MED SCI, V21, P596, DOI 10.3346/jkms.2006.21.4.596; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Sanghera DK, 2004, HUM GENET, V115, P393, DOI 10.1007/s00439-004-1172-0; SILMAN AJ, 1990, LANCET, V335, P1078; Thorburn CM, 2007, GENES IMMUN, V8, P279, DOI 10.1038/sj.gene.6364383; Velazquez-Cruz R, 2007, EUR J HUM GENET, V15, P336, DOI 10.1038/sj.ejhg.5201767; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Wang SC, 2007, J RHEUMATOL, V34, P721; Wang SC, 2006, J CLIN IMMUNOL, V26, P506, DOI 10.1007/s10875-006-9048-9; Yabuki K, 1999, INVEST OPHTH VIS SCI, V40, P1921; Yang PZ, 2008, OPHTHALMOLOGY, V115, P312, DOI 10.1016/j.ophtha.2007.04.056	40	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25345	10.1371/journal.pone.0025345	http://dx.doi.org/10.1371/journal.pone.0025345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039410	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500010
J	Mitha, F; Herodotou, H; Borisov, N; Jiang, C; Yoder, J; Owzar, K				Mitha, Faheem; Herodotou, Herodotos; Borisov, Nedyalko; Jiang, Chen; Yoder, Josh; Owzar, Kouros			SNPpy - Database Management for SNP Data from Genome Wide Association Studies	PLOS ONE			English	Article							GENOTYPE IMPUTATION; INFERENCE	Background: We describe SNPpy, a hybrid script database system using the Python SQLAlchemy library coupled with the PostgreSQL database to manage genotype data from Genome-Wide Association Studies (GWAS). This system makes it possible to merge study data with HapMap data and merge across studies for meta-analyses, including data filtering based on the values of phenotype and Single-Nucleotide Polymorphism (SNP) data. SNPpy and its dependencies are open source software. Results: The current version of SNPpy offers utility functions to import genotype and annotation data from two commercial platforms. We use these to import data from two GWAS studies and the HapMap Project. We then export these individual datasets to standard data format files that can be imported into statistical software for downstream analyses. Conclusions: By leveraging the power of relational databases, SNPpy offers integrated management and manipulation of genotype and phenotype data from GWAS studies. The analysis of these studies requires merging across GWAS datasets as well as patient and marker selection. To this end, SNPpy enables the user to filter the data and output the results as standardized GWAS file formats. It does low level and flexible data validation, including validation of patient data. SNPpy is a practical and extensible solution for investigators who seek to deploy central management of their GWAS data.	[Mitha, Faheem; Jiang, Chen; Yoder, Josh; Owzar, Kouros] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Herodotou, Herodotos; Borisov, Nedyalko] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA	Duke University; Duke University	Mitha, F (corresponding author), Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27706 USA.	faheem@faheem.info		Herodotou, Herodotos/0000-0002-8717-1691	National Cancer Institute [P01CA142538, CA33601]; PAAR-Pharmacogenomics of Anticancer Agents Research Group; National Institute Of General Medical Sciences [U01GM061393]; NATIONAL CANCER INSTITUTE [U10CA033601, P01CA142538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PAAR-Pharmacogenomics of Anticancer Agents Research Group; National Institute Of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by Award Number P01CA142538 (KO) and Award Number CA33601 (FM, CJ, JY, KO) from the National Cancer Institute and the PAAR-Pharmacogenomics of Anticancer Agents Research Group and Award Number U01GM061393 (KO) from the National Institute Of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLU GENOTYPE LIB UTI; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Conway JE, 2009, PL R POSTGRESQL LOAD; Fong C, 2010, BIOINFORMATICS, V26, P560, DOI 10.1093/bioinformatics/btp714; Halperin E, 2009, NAT BIOTECHNOL, V27, P349, DOI 10.1038/nbt0409-349; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Orro A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S13; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795	13	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e24982	10.1371/journal.pone.0024982	http://dx.doi.org/10.1371/journal.pone.0024982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039405	Green Submitted, gold, Green Published			2022-12-25	WOS:000296507500006
J	Fields, DM; Durif, CMF; Bjelland, RM; Shema, SD; Skiftesvik, AB; Browman, HI				Fields, David M.; Durif, Caroline M. F.; Bjelland, Reidun M.; Shema, Steven D.; Skiftesvik, Anne B.; Browman, Howard I.			Grazing Rates of Calanus finmarchicus on Thalassiosira weissflogii Cultured under Different Levels of Ultraviolet Radiation	PLOS ONE			English	Article							COPEPOD ACARTIA-TONSA; SOLAR UV-RADIATION; EGG-PRODUCTION; B RADIATION; ACID-COMPOSITION; NORTH-ATLANTIC; FECAL PELLETS; FOOD QUALITY; MARINE; PHYTOPLANKTON	UVB alters photosynthetic rate, fatty acid profiles and morphological characteristics of phytoplankton. Copepods, important grazers of primary production, select algal cells based upon their size, morphological traits, nutritional status, and motility. We investigated the grazing rates of the copepod Calanus finmarchicus on the diatom Thalassiosira weissflogii cultured under 3 levels of ultraviolet radiation (UVR): photosynthetically active radiation (PAR) only (4 kJ-m(-2)/day), and PAR supplemented with UVR radiation at two intensities (24 kJ-m(-2)/day and 48 kJ-m(-2)/day). There was no significant difference in grazing rates between the PAR only treatment and the lower UVR treatment. However, grazing rates were significantly (similar to 66%) higher for copepods feeding on cells treated with the higher level of UVR. These results suggest that a short-term increase in UVR exposure results in a significant increase in the grazing rate of copepods and, thereby, potentially alters the flow rate of organic matter through this component of the ecosystem.	[Fields, David M.; Shema, Steven D.] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Durif, Caroline M. F.; Bjelland, Reidun M.; Skiftesvik, Anne B.; Browman, Howard I.] Inst Marine Res, Austevoll Res Stn, Storebo, Norway	Bigelow Laboratory for Ocean Sciences; Institute of Marine Research - Norway	Fields, DM (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA.	dfields@bigelow.org	Skiftesvik, Anne Berit/M-1266-2013; Browman, Howard/B-4441-2009; Browman, Howard/CAA-2802-2022; Durif, Caroline/A-6406-2011	Skiftesvik, Anne Berit/0000-0002-7754-5661; Browman, Howard/0000-0002-6282-7316; Browman, Howard/0000-0002-6282-7316; Fields, David/0000-0002-8291-912X	Norwegian Institute of Marine Research; Research Council of Norway [178731/S40]; NSF [0648346]	Norwegian Institute of Marine Research; Research Council of Norway(Research Council of Norway); NSF(National Science Foundation (NSF))	This research was supported by the Norwegian Institute of Marine Research (Sensory Biology and Behaviour Project to HIB) and the Research Council of Norway project "Cascading effects of climate change and UV envirotoxins on the nutritional quality of the food base in marine ecosystems" (Project # 178731/S40 to HIB). Additional funding was provided by NSF (# 0648346 awarded to DMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrady A, 2009, PHOTOCH PHOTOBIO SCI, V8, P13, DOI 10.1039/b820432m; Bancroft BA, 2008, CONSERV BIOL, V22, P987, DOI 10.1111/j.1523-1739.2008.00966.x; Bancroft BA, 2007, ECOL LETT, V10, P332, DOI 10.1111/j.1461-0248.2007.01022.x; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Bundy MH, 1998, J PLANKTON RES, V20, P2129, DOI 10.1093/plankt/20.11.2129; Cabrera S, 1997, J PLANKTON RES, V19, P1565, DOI 10.1093/plankt/19.11.1565; Conover DO, 1988, FISHERIES, V13, P58; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; De Lange HJ, 2003, HYDROBIOLOGIA, V491, P133, DOI 10.1023/A:1024485320677; De Lange HJ, 2003, FRESHWATER BIOL, V48, P678, DOI 10.1046/j.1365-2427.2003.01036.x; DEMOTT WR, 1991, J PLANKTON RES, V13, P1203, DOI 10.1093/plankt/13.6.1203; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; DOWNS JN, 1985, LIMNOL OCEANOGR, V30, P1024, DOI 10.4319/lo.1985.30.5.1024; Fauchot J, 2000, J PHYCOL, V36, P484, DOI 10.1046/j.1529-8817.2000.99011.x; Fields DM, 1996, INTERACTION CALANOID, P353; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; GOES JI, 1994, MAR ECOL PROG SER, V114, P259, DOI 10.3354/meps114259; Gonçalves Rodrigo J, 2010, Ecol. austral, V20, P129; Guisande C, 1999, LIMNOL OCEANOGR, V44, P691, DOI 10.4319/lo.1999.44.3.0691; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hargreaves BR, 2003, COMP SER PHOTOCHEM, V1, P59; Helbling EW, 2003, MAR ECOL PROG SER, V259, P59, DOI 10.3354/meps259059; Helbling EW, 2003, UV EFFECTS AQUATIC O, p[XXI, 575]; Hessen DO, 1997, FRESHWATER BIOL, V38, P513, DOI 10.1046/j.1365-2427.1997.00223.x; HESSEN DO, 1992, AM NAT, V140, P799, DOI 10.1086/285441; HONJO S, 1978, J MAR RES, V36, P45; INFANTE A, 1985, LIMNOL OCEANOGR, V30, P1046, DOI 10.4319/lo.1985.30.5.1046; Jonasdottir SH, 2002, MAR BIOL, V140, P1195, DOI 10.1007/s00227-002-0782-0; JONASDOTTIR SH, 1995, MAR ECOL PROG SER, V119, P87, DOI 10.3354/meps119087; Kjeldstad B, 2003, MAR ECOL PROG SER, V256, P1, DOI 10.3354/meps256001; Kleppel GS, 1998, ESTUARIES, V21, P328, DOI 10.2307/1352479; Kouwenberg JHM, 2007, J EXP MAR BIOL ECOL, V341, P239, DOI 10.1016/j.jembe.2006.10.047; Leu E, 2007, LIMNOL OCEANOGR, V52, P787, DOI 10.4319/lo.2007.52.2.0787; Leu E, 2006, J EXP MAR BIOL ECOL, V337, P65, DOI 10.1016/j.jembe.2006.06.005; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; MULLIN MM, 1963, LIMNOL OCEANOGR, V8, P239, DOI 10.4319/lo.1963.8.2.0239; Nahon S, 2010, J EXP MAR BIOL ECOL, V383, P164, DOI 10.1016/j.jembe.2009.12.006; PAFFENHOFER GA, 1984, MAR BIOL, V80, P323, DOI 10.1007/BF00392828; PENRY DL, 1991, LIMNOL OCEANOGR, V36, P147, DOI 10.4319/lo.1991.36.1.0147; Petzold TJ, 1988, CHARACTERIZATION MER; Planque B, 2000, ICES J MAR SCI, V57, P1528, DOI 10.1006/jmsc.2000.0970; Pond D, 1996, MAR ECOL PROG SER, V143, P45, DOI 10.3354/meps143045; Santas R, 1996, PHOTOCHEM PHOTOBIOL, V64, P435, DOI 10.1111/j.1751-1097.1996.tb03088.x; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Steemann Nielsen E., 1964, J CONS INT EXPLOR ME, V29, P130; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Swaim Zachary T., 2009, Endangered Species Research, V6, P259, DOI 10.3354/esr00163; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; VANDONK E, 1995, HYDROBIOLOGIA, V307, P147, DOI 10.1007/BF00032006; VANDONK E, 1993, OECOLOGIA, V93, P508, DOI 10.1007/BF00328958; Von Elert E, 2000, FRESHWATER BIOL, V45, P189, DOI 10.1046/j.1365-2427.2000.00671.x; Worrest R. C., 1986, EFFECTS CHANGES STRA, P175; Wu HY, 2009, FUNCT PLANT BIOL, V36, P137, DOI 10.1071/FP08172; Zudaire L, 2001, J PHOTOCH PHOTOBIO B, V62, P26, DOI 10.1016/S1011-1344(01)00150-6	58	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26333	10.1371/journal.pone.0026333	http://dx.doi.org/10.1371/journal.pone.0026333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028858	gold, Green Published, Green Submitted			2022-12-25	WOS:000296186900051
J	Geng, H; Law, PPY; Ng, MCY; Li, T; Liang, LY; Ge, TF; Wong, KB; Liang, C; Ma, RC; So, WY; Chan, JCN; Ho, YY				Geng, Hua; Law, Peggy P. Y.; Ng, Maggie C. Y.; Li, Ting; Liang, Li-Yun; Ge, Tian-Fang; Wong, Kam-Bo; Liang, Chun; Ma, Ronald C.; So, Wing-Yee; Chan, Juliana C. N.; Ho, Yuan-Yuan			APOE Genotype-Function Relationship: Evidence of -491 A/T Promoter Polymorphism Modifying Transcription Control but Not Type 2 Diabetes Risk	PLOS ONE			English	Article							PLASMA APOLIPOPROTEIN-E; GENE REGULATORY REGION; HONG-KONG CHINESE; ALZHEIMERS-DISEASE; PROTEIN; STRESS; ATF4; DYSLIPIDEMIA; METAANALYSIS; APOPTOSIS	Background: The apolipoprotein E gene (APOE) coding polymorphism modifies the risks of Alzheimer's disease, type 2 diabetes, and coronary heart disease. Aside from the coding variants, single nucleotide polymorphism (SNP) of the APOE promoter has also been shown to modify the risk of Alzheimer's disease. Methodology/Principal Findings: In this study we investigate the genotype-function relationship of APOE promoter polymorphism at molecular level and at physiological level: i.e., in transcription control of the gene and in the risk of type 2 diabetes. In molecular studies, the effect of the APOE -491A/T (rs449647) polymorphism on gene transcription was accessed by dual-luciferase reporter gene assays. The 2491 A to T substitution decreased the activity (p<0.05) of the cloned APOE promoter (-1017 to +406). Using the -501 to -481 nucleotide sequence of the APOE promoter as a 'bait' to screen the human brain cDNA library by yeast one-hybrid system yielded ATF4, an endoplasmic reticulum stress response gene, as one of the interacting factors. Electrophoretic-mobility-shift assays (EMSA) and chromatin immuno-precipitation (ChIP) analyses further substantiated the physical interaction between ATF4 and the APOE promoter. Over-expression of ATF4 stimulated APOE expression whereas siRNA against ATF4 suppressed the expression of the gene. However, interaction between APOE promoter and ATF4 was not 2491A/T-specific. At physiological level, the genotype-function relationship of APOE promoter polymorphism was studied in type 2 diabetes. In 630 cases and 595 controls, three APOE promoter SNPs -491A/T, -219G/T (rs405509), and + 113G/C (rs440446) were genotyped and tested for association with type 2 diabetes in Hong Kong Chinese. No SNP or haplotype association with type 2 diabetes was detected. Conclusions/Significance: At molecular level, polymorphism 2491A/T and ATF4 elicit independent control of APOE gene expression. At physiological level, no genotype-risk association was detected between the studied APOE promoter SNPs and type 2 diabetes in Hong Kong Chinese.	[Geng, Hua; Law, Peggy P. Y.; Li, Ting; Liang, Li-Yun; Ge, Tian-Fang; Wong, Kam-Bo; Ho, Yuan-Yuan] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China; [Ng, Maggie C. Y.; Ma, Ronald C.; So, Wing-Yee; Chan, Juliana C. N.] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Liang, Chun] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Ho, Yuan-Yuan] Columbia Univ, Dept Biostat, Genet Complex Disorder Program, New York, NY USA; [Ho, Yuan-Yuan] Columbia Univ, Dept Psychiat, Genet Complex Disorder Program, New York, NY USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong University of Science & Technology; Columbia University; Columbia University	Geng, H (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China.	yyh2@columbia.edu	Wong, Kam-Bo/G-4258-2013; Ma, Ronald/C-2788-2009; Chan, Juliana/B-7918-2016; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194; Wong, Kam-Bo/0000-0002-6984-5373	Faculty of Medicine, The Chinese University of Hong Kong [2041183]; National Institute of Mental Health, USA [T32-MH-65213]; Division of Statistical Genetics, Department of Biostatistics, Columbia University, New York; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065213] Funding Source: NIH RePORTER	Faculty of Medicine, The Chinese University of Hong Kong(Chinese University of Hong Kong); National Institute of Mental Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division of Statistical Genetics, Department of Biostatistics, Columbia University, New York; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was partially supported by the following grants: 1) Direct Grant (No. 2041183), Faculty of Medicine, The Chinese University of Hong Kong. 2) T32-MH-65213, National Institute of Mental Health, USA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the support of the Division of Statistical Genetics, Department of Biostatistics, Columbia University, New York.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Anthopoulos PG, 2010, MOL GENET METAB, V100, P283, DOI 10.1016/j.ymgme.2010.03.008; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; Chahil TJ, 2006, ENDOCRIN METAB CLIN, V35, P491, DOI 10.1016/j.ecl.2006.06.002; Cheung YY, 2004, ACTA CRYSTALLOGR D, V60, P1308, DOI 10.1107/S0907444904010996; Corbo RM, 2001, CLIN CHEM LAB MED, V39, P2, DOI 10.1515/CCLM.2001.002; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Laws SM, 1999, NEUROREPORT, V10, P879, DOI 10.1097/00001756-199903170-00038; Laws SM, 2003, J NEUROCHEM, V84, P1215, DOI 10.1046/j.1471-4159.2003.01615.x; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lipson KL, 2006, CURR MOL MED, V6, P71, DOI 10.2174/156652406775574613; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Malhotra A, 2007, DIABETES, V56, P890, DOI 10.2337/db06-1057; Maloney B, 2010, AM J MED GENET B, V153B, P185, DOI 10.1002/ajmg.b.30973; Ng MCY, 2004, DIABETES, V53, P2676, DOI 10.2337/diabetes.53.10.2676; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Scacchi R, 2001, DEMENT GERIATR COGN, V12, P63, DOI 10.1159/000051237; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Tan KCB, 2006, DIABETES-METAB RES, V22, P307, DOI 10.1002/dmrr.616; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; van Vliet P, 2007, ANN NY ACAD SCI, V1100, P140, DOI 10.1196/annals.1395.012; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhou JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017324	30	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e24669	10.1371/journal.pone.0024669	http://dx.doi.org/10.1371/journal.pone.0024669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028770	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900003
J	Abul-Husn, NS; Annangudi, SP; Ma'ayan, A; Ramos-Ortolaza, DL; Stockton, SD; Gomes, I; Sweedler, JV; Devi, LA				Abul-Husn, Noura S.; Annangudi, Suresh P.; Ma'ayan, Avi; Ramos-Ortolaza, Dinah L.; Stockton, Steven D., Jr.; Gomes, Ivone; Sweedler, Jonathan V.; Devi, Lakshmi A.			Chronic Morphine Alters the Presynaptic Protein Profile: Identification of Novel Molecular Targets Using Proteomics and Network Analysis	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; DORSAL STRIATUM; CEREBRAL-CORTEX; DATABASE; EXPRESSION; COMPONENTS; INHIBITION; EXPOSURE; COCAINE	Opiates produce significant and persistent changes in synaptic transmission; knowledge of the proteins involved in these changes may help to understand the molecular mechanisms underlying opiate dependence. Using an integrated quantitative proteomics and systems biology approach, we explored changes in the presynaptic protein profile following a paradigm of chronic morphine administration that leads to the development of dependence. For this, we isolated presynaptic fractions from the striata of rats treated with saline or escalating doses of morphine, and analyzed the proteins in these fractions using differential isotopic labeling. We identified 30 proteins that were significantly altered by morphine and integrated them into a protein-protein interaction (PPI) network representing potential morphine-regulated protein complexes. Graph theory-based analysis of this network revealed clusters of densely connected and functionally related morphine-regulated clusters of proteins. One of the clusters contained molecular chaperones thought to be involved in regulation of neurotransmission. Within this cluster, cysteine-string protein (CSP) and the heat shock protein Hsc70 were downregulated by morphine. Interestingly, Hsp90, a heat shock protein that normally interacts with CSP and Hsc70, was upregulated by morphine. Moreover, treatment with the selective Hsp90 inhibitor, geldanamycin, decreased the somatic signs of naloxone-precipitated morphine withdrawal, suggesting that Hsp90 upregulation at the presynapse plays a role in the expression of morphine dependence. Thus, integration of proteomics, network analysis, and behavioral studies has provided a greater understanding of morphine-induced alterations in synaptic composition, and identified a potential novel therapeutic target for opiate dependence.	[Abul-Husn, Noura S.; Ma'ayan, Avi; Ramos-Ortolaza, Dinah L.; Stockton, Steven D., Jr.; Gomes, Ivone; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Annangudi, Suresh P.; Sweedler, Jonathan V.] Univ Illinois Urban Champaign, Dept Chem, Beckman Inst, Urbana, IL USA	Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Urbana-Champaign	Abul-Husn, NS (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	lakshmi.devi@mssm.edu	Sweedler, Jonathan V/A-9405-2009; Devi P, Lakshmi/GXM-5982-2022; Ma'ayan, Avi/AAG-3131-2019; Annangudi, Suresh/AAD-6408-2020	Sweedler, Jonathan V/0000-0003-3107-9922; Devi P, Lakshmi/0000-0001-9274-4776; Ma'ayan, Avi/0000-0002-6904-1017; Abul-Husn, Noura/0000-0002-5179-1944	National Institutes of Health [DA08863, DA019521, DA017940, 2P30DA018310, 1P50GM071558-01A27398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310, K05DA019521, R01DA008863, R56DA008863, R01DA017940, R37DA008863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health DA08863 and DA019521 to L. A. D., DA017940 and 2P30DA018310 to J.V.S., and 1P50GM071558-01A27398 to L. A. D., A. M. and D. L. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Husn NS, 2009, PROTEOMICS, V9, P3303, DOI 10.1002/pmic.200800767; Abul-Husn NS, 2006, J PHARMACOL EXP THER, V318, P3303; Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bierczynska-Krzysik A, 2006, INT J MOL MED, V18, P775; Bierczynska-Krzysik A, 2006, NEUROCHEM INT, V49, P401, DOI 10.1016/j.neuint.2006.01.024; Bodzon-Kulakowska A, 2009, J SEP SCI, V32, P1200, DOI 10.1002/jssc.200800464; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Chen S, 2007, J NEUROSCI RES, V85, P402, DOI 10.1002/jnr.21124; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; DICHIARA G, 1988, J PHARMACOL EXP THER, V244, P1067; Evans GJO, 2003, TRAFFIC, V4, P653, DOI 10.1034/j.1600-0854.2003.00127.x; Fadda P, 2005, SYNAPSE, V56, P29, DOI 10.1002/syn.20122; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Koshimizu T, 2010, BIOCHEM BIOPH RES CO, V392, P603, DOI 10.1016/j.bbrc.2010.01.089; Li HH, 2006, NEUROREPORT, V17, P71, DOI 10.1097/01.wnr.0000192731.62417.be; Li KW, 2006, PROTEOMICS, V6, P2003, DOI 10.1002/pmic.200500045; Li Q, 2009, EUR J PHARMACOL, V612, P21, DOI 10.1016/j.ejphar.2009.03.049; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Ma'ayan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-10; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Mouledous L, 2005, MOL PHARMACOL, V68, P467, DOI 10.1124/mol.105.013391; Murphy NP, 2001, J NEUROCHEM, V79, P626, DOI 10.1046/j.1471-4159.2001.00599.x; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Prokai L, 2005, J MASS SPECTROM, V40, P169, DOI 10.1002/jms.736; Ramos-Ortolaza DL, 2010, METHODS MOL BIOL, V615, P227, DOI 10.1007/978-1-60761-535-4_18; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; SCHRATER PR, 1993, LIFE SCI, V52, P1535, DOI 10.1016/0024-3205(93)90054-7; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SHOAIB M, 1995, PSYCHOPHARMACOLOGY, V117, P240, DOI 10.1007/BF02245193; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Suder P, 2009, J PROTEOME RES, V8, P4633, DOI 10.1021/pr900443r; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Trang T, 2003, BRIT J PHARMACOL, V140, P295, DOI 10.1038/sj.bjp.0705440; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; WISE RA, 1987, PHARMACOL THERAPEUT, V35, P227, DOI 10.1016/0163-7258(87)90108-2; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Xu NJ, 2004, J BIOL CHEM, V279, P40601, DOI 10.1074/jbc.M406896200; Yang L, 2007, J PROTEOME RES, V6, P2239, DOI 10.1021/pr060649o; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	53	41	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25535	10.1371/journal.pone.0025535	http://dx.doi.org/10.1371/journal.pone.0025535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043286	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400013
J	Carr, CA; Stuckey, DJ; Tan, JJ; Tan, SC; Gomes, RSM; Camelliti, P; Messina, E; Giacomello, A; Ellison, GM; Clarke, K				Carr, Carolyn A.; Stuckey, Daniel J.; Tan, Jun Jie; Tan, Suat Cheng; Gomes, Renata S. M.; Camelliti, Patrizia; Messina, Elisa; Giacomello, Alessandro; Ellison, Georgina M.; Clarke, Kieran			Cardiosphere-Derived Cells Improve Function in the Infarcted Rat Heart for at Least 16 Weeks - an MRI Study	PLOS ONE			English	Article							CARDIAC PROGENITOR CELLS; ISCHEMIA-REPERFUSION INJURY; LEFT-VENTRICULAR FUNCTION; STEM-CELLS; IN-VIVO; MYOCARDIAL-ISCHEMIA; REGENERATION; VALIDATION; EXPANSION; SURVIVAL	Aims: Endogenous cardiac progenitor cells, expanded from explants via cardiosphere formation, present a promising cell source to prevent heart failure following myocardial infarction. Here we used cine-magnetic resonance imaging (MRI) to track administered cardiosphere-derived cells (CDCs) and to measure changes in cardiac function over four months in the infarcted rat heart. Methods and Results: CDCs, cultured from neonatal rat heart, comprised a heterogeneous population including cells expressing the mesenchymal markers CD90 and CD105, the stem cell marker c-kit and the pluripotency markers Sox2, Oct3/4 and Klf-4. CDCs (2 x 10(6)) expressing green fluorescent protein (GFP+) were labelled with fluorescent micron-sized particles of iron oxide (MPIO). Labelled cells were administered to the infarcted rat hearts (n = 7) by intramyocardial injection immediately following reperfusion, then by systemic infusion (4 x 10(6)) 2 days later. A control group (n = 7) was administered cell medium. MR hypointensities caused by the MPIOs were detected at all times and GFP+ cells containing MPIO particles were identified in tissue slices at 16 weeks. At two days after infarction, cardiac function was similar between groups. By 6 weeks, ejection fractions in control hearts had significantly decreased (47+/-2%), but this was not evident in CDC-treated hearts (56+/-3%). The significantly higher ejection fractions in the CDC-treated group were maintained for a further 10 weeks. In addition, CDC-treated rat hearts had significantly increased capillary density in the peri-infarct region and lower infarct sizes. MPIO-labelled cells also expressed cardiac troponin I, von Willebrand factor and smooth muscle actin, suggesting their differentiation along the cardiomyocyte lineage and the formation of new blood vessels. Conclusions: CDCs were retained in the infarcted rat heart for 16 weeks and improved cardiac function.	[Carr, Carolyn A.; Stuckey, Daniel J.; Tan, Jun Jie; Tan, Suat Cheng; Gomes, Renata S. M.; Camelliti, Patrizia; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Stuckey, Daniel J.; Camelliti, Patrizia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Tan, Jun Jie] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia; [Messina, Elisa; Giacomello, Alessandro] Univ Roma La Sapienza, Dept Expt Med, Cenci Bolognetti Fdn, Inst Pasteur, Rome, Italy; [Ellison, Georgina M.] Liverpool JM Univ, Stem Cell & Mol Physiol Lab, Liverpool, Merseyside, England	University of Oxford; Imperial College London; Universiti Sains Malaysia; Fondazione Cenci Bolognetti; Sapienza University Rome; Liverpool John Moores University	Carr, CA (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	Carolyn.Carr@dpag.ox.ac.uk	Tan, Jun Jie/D-9864-2012; Camelliti, Patrizia/F-8012-2018; Camelliti, Patrizia/AAA-4489-2020; Ellison-Hughes, Georgina M./B-4597-2016; Messina, Elisa/I-5401-2018; Tan, Suat Cheng/C-8835-2016	Tan, Jun Jie/0000-0002-7027-6657; Camelliti, Patrizia/0000-0002-1346-8089; Camelliti, Patrizia/0000-0002-1346-8089; Ellison-Hughes, Georgina M./0000-0002-2733-3361; Messina, Elisa/0000-0002-1654-9001; Tan, Suat Cheng/0000-0001-5869-6096; Gomes, Renata/0000-0002-9197-8279; stuckey, daniel/0000-0001-8888-627X	British Heart Foundation [PG/07/059/23259]; Malaysian Ministry of Higher Education; EU [PIRG02-GA-2007-224853]; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Malaysian Ministry of Higher Education; EU(European Commission); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (grant number PG/07/059/23259). Dr. Jun Tan and Dr. Suat Tan thank the Malaysian Ministry of Higher Education for studentships. Dr. Ellison is a recipient of a Marie Curie International Re-integration grant from the FP7 EU Marie Curie Actions (PIRG02-GA-2007-224853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; De Celle T, 2004, EXP PHYSIOL, V89, P605, DOI 10.1113/expphysiol.2004.027649; DEBOER MJ, 1994, CIRCULATION, V90, P753, DOI 10.1161/01.CIR.90.2.753; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Levitsky S, 2006, CIRCULATION, V114, pI339, DOI 10.1161/CIRCULATIONAHA.105.001685; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Miyamoto S, 2009, STEM CELLS DEV; Neuzil J, 2005, REDOX REP, V10, P187, DOI 10.1179/135100005X57391; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Shenje LT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001929; Shintani Y, 2009, J MOL CELL CARDIOL, V47, P288, DOI 10.1016/j.yjmcc.2009.05.009; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stuckey DJ, 2008, NMR BIOMED, V21, P765, DOI 10.1002/nbm.1268; Stuckey DJ, 2006, STEM CELLS, V24, P1968, DOI 10.1634/stemcells.2006-0074; Tyler DJ, 2006, J CARDIOVASC MAGN R, V8, P327, DOI 10.1080/10976640500451903; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	33	51	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25669	10.1371/journal.pone.0025669	http://dx.doi.org/10.1371/journal.pone.0025669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043289	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000295984400017
J	Nepliouev, I; Zhang, ZS; Stiber, JA				Nepliouev, Igor; Zhang, Zhu-Shan; Stiber, Jonathan A.			Effect of Oxidative Stress on Homer Scaffolding Proteins	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROLINE-RICH MOTIF; MUSCULAR-DYSTROPHY; SYNAPTIC PROTEINS; IP3 RECEPTORS; BINDS; SKELETAL; CHANNELS; DISEASE; KINASE	Homer proteins are a family of multifaceted scaffolding proteins that participate in the organization of signaling complexes at the post-synaptic density and in a variety of tissues including striated muscle. Homer isoforms form multimers via their C-terminal coiled coil domains, which allows for the formation of a polymeric network in combination with other scaffolding proteins. We hypothesized that the ability of Homer isoforms to serve as scaffolds would be influenced by oxidative stress. We have found by standard SDS-PAGE of lysates from adult mouse skeletal muscle exposed to air oxidation that Homer migrates as both a dimer and monomer in the absence of reducing agents and solely as a monomer in the presence of a reducing agent, suggesting that Homer dimers exposed to oxidation could be modified by the presence of an intermolecular disulfide bond. Analysis of the peptide sequence of Homer 1b revealed the presence of only two cysteine residues located adjacent to the C-terminal coiled-coil domain. HEK 293 cells were transfected with wild-type and cysteine mutant forms of Homer 1b and exposed to oxidative stress by addition of menadione, which resulted in the formation of disulfide bonds except in the double mutant (C246G, C365G). Exposure of myofibers from adult mice to oxidative stress resulted in decreased solubility of endogenous Homer isoforms. This change in solubility was dependent on disulfide bond formation. In vitro binding assays revealed that cross-linking of Homer dimers enhanced the ability of Homer 1b to bind Drebrin, a known interacting partner. Our results show that oxidative stress results in disulfide cross-linking of Homer isoforms and loss of solubility of Homer scaffolds. This suggests that disulfide cross-linking of a Homer polymeric network may contribute to the pathophysiology seen in neurodegenerative diseases and myopathies characterized by oxidative stress.	[Nepliouev, Igor] Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Nepliouev, I (corresponding author), Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC 27708 USA.	stibe001@mc.duke.edu			National Institutes of Health/National Heart Lung and Blood Institute [K08 HL077520]; Muscular Dystrophy Association; Howard Hughes Medical Institute; Robert J. Lefkowitz Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077520] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Muscular Dystrophy Association(Muscular Dystrophy Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert J. Lefkowitz Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by the following: National Institutes of Health/National Heart Lung and Blood Institute (K08 HL077520), Muscular Dystrophy Association Research Grant, Howard Hughes Medical Institute Physician-Scientist Early Career Award, and Robert J. Lefkowitz Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brodsky JL, 2010, METHOD ENZYMOL, V470, P661, DOI 10.1016/S0076-6879(10)70027-6; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Mizutani A, 2008, J NEUROSCI, V28, P5369, DOI 10.1523/JNEUROSCI.4738-07.2008; Rabinovic AD, 2000, NEUROSCIENCE, V101, P67, DOI 10.1016/S0306-4522(00)00293-1; Sandona D, 2000, BIOCHEM BIOPH RES CO, V279, P348, DOI 10.1006/bbrc.2000.3948; SETH M, 2009, CIRC RES; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; Stiber JA, 2008, MOL CELL BIOL, V28, P2637, DOI 10.1128/MCB.01601-07; THOR H, 1982, J BIOL CHEM, V257, P2419; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Williams IA, 2007, AM J PHYSIOL-HEART C, V293, pH1969, DOI 10.1152/ajpheart.00489.2007; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	24	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26128	10.1371/journal.pone.0026128	http://dx.doi.org/10.1371/journal.pone.0026128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043307	Green Submitted, gold, Green Published			2022-12-25	WOS:000295984400035
J	Luo, GPS; Ibrahim, AS; French, SW; Edwards, JE; Fu, Y				Luo, Guanpingsheng; Ibrahim, Ashraf S.; French, Samuel W.; Edwards, John E., Jr.; Fu, Yue			Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis	PLOS ONE			English	Article							INFLUENZAE TYPE-B; HUMAN-IMMUNODEFICIENCY-VIRUS; BETA-GLUCAN ANTIBODIES; N-TERMINAL DOMAIN; IMPROVES SURVIVAL; ALBICANS; VACCINE; CONJUGATE; ALS1P; IMMUNOGENICITY	We previously reported that Candida albicans cell surface protein Hyr1 encodes a phagocyte killing resistance factor and active vaccination with a recombinant N-terminus of Hyr1 protein (rHyr1p-N), significantly protects immunocompetent mice from disseminated candidiasis. Here we report the marked efficacy of rHyr1p-N vaccine on improving the survival and reducing the fungal burden of disseminated candidiasis in both immunocompetent and immunocompromised mice using the FDA-approved adjuvant, alum. Importantly, we also show that pooled rabbit anti-Hyr1p polyclonal antibodies raised against 8 different peptide regions of rHyr1p-N protected mice in a hematogenously disseminated candidiasis model, raising the possibility of developing a successful passive immunotherapy strategy to treat this disease. Our data suggest that the rabbit anti-Hyr1p antibodies directly neutralized the Hyr1p virulence function, rather than enhanced opsonophagocytosis for subsequent killing by neutrophil in vitro. Finally, the rHyr1p-N vaccine was protective against non-albicans Candida spp. These preclinical data demonstrate that rHyr1p-N is likely to be a novel target for developing both active and passive immunization strategies against Candida infections.	[Luo, Guanpingsheng; Ibrahim, Ashraf S.; Edwards, John E., Jr.; Fu, Yue] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90509 USA; [Ibrahim, Ashraf S.; French, Samuel W.; Edwards, John E., Jr.; Fu, Yue] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [French, Samuel W.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Pathol, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Luo, GPS (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90509 USA.	yfu@labiomed.org			Public Health Service [R01 AI19990, AI063382, R21 AI066010, R03 AI083251, R01 AI063503, R21 AI082414]; NovaDigm Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063382, R21AI082414, R21AI066010, R03AI083251, R01AI019990, R01AI063503] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NovaDigm Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R01 AI19990 and AI063382 to JEE and R21 AI066010 and R03 AI083251 to YF. ASI is supported by Public Health Service grant R01 AI063503 and R21 AI082414. NovaDigm Therapeutics, Inc. partially provided financial support for these studies. ASI, JEE, and YF did have a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The Public Health Service had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Chokephaibulkit K, 2004, VACCINE, V22, P2018, DOI 10.1016/j.vaccine.2003.10.033; d'Enfert C, 2005, NUCLEIC ACIDS RES, V33, pD353, DOI 10.1093/nar/gki124; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Dockrell DH, 1999, VACCINE, V17, P2779, DOI 10.1016/S0264-410X(99)00089-4; Dos Santos SD, 2004, AIDS RES HUM RETROV, V20, P493, DOI 10.1089/088922204323087732; Fu Y, 2008, EUKARYOT CELL, V7, P483, DOI 10.1128/EC.00445-07; Groll AH, 1998, ADV PHARMACOL, V44, P343, DOI 10.1016/S1054-3589(08)60129-5; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Ibrahim AS, 2006, INFECT IMMUN, V74, P3039, DOI 10.1128/IAI.74.5.3039-3041.2006; Ibrahim AS, 2005, INFECT IMMUN, V73, P999, DOI 10.1128/IAI.73.2.999-1005.2005; King JC, 1996, PEDIATR INFECT DIS J, V15, P192, DOI 10.1097/00006454-199603000-00003; Kullberg BJ, 2002, EUR J MED RES, V7, P183; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Matthews RC, 2003, ANTIMICROB AGENTS CH, V47, P2208, DOI 10.1128/AAC.47.7.2208-2216.2003; Neely MN, 2000, EUR J CLIN MICROBIOL, V19, P897, DOI 10.1007/s100960000395; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Nucci Marcio, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P397, DOI 10.1590/S0036-46651995000500004; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pietrella D, 2010, VACCINE, V28, P1717, DOI 10.1016/j.vaccine.2009.12.021; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Spellberg BJ, 2005, INFECT IMMUN, V73, P6191, DOI 10.1128/IAI.73.9.6191-6193.2005; Spellberg BJ, 2005, J LEUKOCYTE BIOL, V78, P338, DOI 10.1189/jlb.0205072; Spellberg BJ, 2006, CLIN INFECT DIS, V42, P244, DOI 10.1086/499057; Spellberg B, 2008, J INFECT DIS, V197, P967, DOI 10.1086/529204; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105	32	37	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25909	10.1371/journal.pone.0025909	http://dx.doi.org/10.1371/journal.pone.0025909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028796	Green Published, Green Submitted, gold			2022-12-25	WOS:000295971700024
J	Horiguchi, K; Sakamoto, K; Koinuma, D; Semba, K; Inoue, A; Inoue, S; Fujii, H; Yamaguchi, A; Miyazawa, K; Miyazono, K; Saitoh, M				Horiguchi, K.; Sakamoto, K.; Koinuma, D.; Semba, K.; Inoue, A.; Inoue, S.; Fujii, H.; Yamaguchi, A.; Miyazawa, K.; Miyazono, K.; Saitoh, M.			TGF-beta drives epithelial-mesenchymal transition through delta EF1-mediated downregulation of ESRP	ONCOGENE			English	Article						alternative splicing; delta EF1; EMT; TGF-beta; ESRP; breast cancer	GROWTH-FACTOR-BETA; BREAST-CANCER; CELL-LINES; METASTASIS; NETWORKS; PROGRESSION; EXPRESSION; RECEPTORS; INDUCTION; INSIGHTS	Epithelial-mesenchymal transition (EMT) is a crucial event in wound healing, tissue repair and cancer progression in adult tissues. We have recently shown that transforming growth factor (TGF)-beta-induced EMT involves isoform switching of fibroblast growth factor receptors by alternative splicing. We performed a microarray-based analysis at single exon level to elucidate changes in splicing variants generated during TGF-beta-induced EMT, and found that TGF-beta induces broad alteration of splicing patterns by downregulating epithelial splicing regulatory proteins (ESRPs). This was achieved by TGF-beta-mediated upregulation of delta EF1 family proteins, delta EF1 and SIP1. delta EF1 and SIP1 each remarkably repressed ESRP2 transcription through binding to the ESRP2 promoter in NMuMG cells. Silencing of both delta EF1 and SIP1, but not either alone, abolished the TGF-beta-induced ESRP repression. The expression profiles of ESRPs were inversely related to those of delta EF1 and SIP in human breast cancer cell lines and primary tumor specimens. Further, overexpression of ESRPs in TGF-beta-treated cells resulted in restoration of the epithelial splicing profiles as well as attenuation of certain phenotypes of EMT. Therefore, delta EF1 family proteins repress the expression of ESRPs to regulate alternative splicing during TGF-beta-induced EMT and the progression of breast cancers. Oncogene (2012) 31, 3190-3201; doi:10.1038/onc.2011.493; published online 31 October 2011	[Miyazono, K.] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Sakamoto, K.; Yamaguchi, A.] Tokyo Med & Dent Univ, Sect Oral Pathol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Semba, K.] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Inoue, A.; Inoue, S.; Fujii, H.] Univ Yamanashi, Dept Surg 1, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi, Japan; [Miyazawa, K.; Saitoh, M.] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Tamaho, Yamanashi, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Waseda University; University of Yamanashi; University of Yamanashi	Miyazono, K (corresponding author), Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp; msaitoh-ind@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Koinuma, Daizo/Y-8716-2018	Koinuma, Daizo/0000-0001-5611-2122	University of Yamanashi from Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Waseda University from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22249061, 22112002, 09J05735, 22390052, 11F01113] Funding Source: KAKEN	University of Yamanashi from Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Waseda University from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs T Shirakihara, S Ehata, M Morikawa and C Iwata for their helpful discussions. This work was supported by KAKENHI (Grants-in-Aid for Scientific Research) and Cooperative Program for Graduate Student Education between University of Yamanashi and Waseda University from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Japan Society for the Promotion of Science.	Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Chaffer CL, 2007, DIFFERENTIATION, V75, P831, DOI 10.1111/j.1432-0436.2007.00210.x; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Dutertre M, 2010, CANCER RES, V70, P896, DOI 10.1158/0008-5472.CAN-09-2703; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Lee B, 2008, BIOINFORMATICS, V24, P1026, DOI 10.1093/bioinformatics/btn068; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Rasche A, 2010, BIOINFORMATICS, V26, P84, DOI 10.1093/bioinformatics/btp626; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Yamaguchi N, 2008, BIOCHEM BIOPH RES CO, V365, P711, DOI 10.1016/j.bbrc.2007.11.064; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	33	157	160	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2012	31	26					3190	3201		10.1038/onc.2011.493	http://dx.doi.org/10.1038/onc.2011.493			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	967UX	22037216	hybrid, Green Published			2022-12-25	WOS:000305934400007
J	Yu, X; Wang, FS; Liu, HS; Adams, G; Aikhionbare, F; Liu, D; Cao, XW; Fan, LB; Hu, GH; Chen, Y; Frost, A; Partridge, E; Ding, X; Yao, XB				Yu, Xue; Wang, Fengsong; Liu, Hongsheng; Adams, Gregory; Aikhionbare, Felix; Liu, Dong; Cao, Xinwang; Fan, Libin; Hu, Guohong; Chen, Yong; Frost, Andra; Partridge, Edward; Ding, Xia; Yao, Xuebiao			ACAP4 Protein Cooperates with Grb2 Protein to Orchestrate Epidermal Growth Factor-stimulated Integrin beta 1 Recycling in Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR TYROSINE KINASES; ENDOCYTIC TRANSPORT; SIGNAL-TRANSDUCTION; BREAST-CANCER; RHOA ACTIVITY; SH3 DOMAINS; RAS PATHWAY; ADHESION; ARF6	ARF6 GTPase is an important regulator of membrane trafficking and actin-based cytoskeleton dynamics active at the leading edge of migrating cells. The integrin family heterodimeric transmembrane proteins serve as major receptors for extracellular matrix proteins, which play essential roles in cell adhesion and migration. Our recent proteomic analyses of ARF6 effectors have identified a novel ARF6 GTPase-activating protein, ACAP4, essential for EGF-induced cell migration. However, molecular mechanisms underlying ACAP4-mediated cell migration have remained elusive. Here, we show that ACAP4 regulates integrin beta 1 dynamics during EGF-stimulated cell migration by interaction with Grb2. Our biochemical study shows that EGF stimulation induces phosphorylation of tyrosine 733, which enables ACAP4 to bind Grb2. This interaction of ACAP4 with Grb2 regulates integrin beta 1 recycling to the plasma membrane. Importantly, knockdown of ACAP4 by siRNA or overexpression of ACAP4 decreased recycling of integrin beta 1 to the plasma membrane and reduced integrin-mediated cell migration. Taken together, these results suggest a novel function for ACAP4 in the regulation cell migration through controlling integrin beta 1 dynamics.	[Yu, Xue; Wang, Fengsong; Liu, Hongsheng; Cao, Xinwang; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China; [Wang, Fengsong; Adams, Gregory; Aikhionbare, Felix; Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Liu, Dong; Chen, Yong] Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China; [Cao, Xinwang; Fan, Libin] Anhui Med Univ, Sch Life Sci, Hefei 230027, Peoples R China; [Hu, Guohong] SIBS SJTU Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Frost, Andra; Partridge, Edward] Univ Alabama, Sch Med, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Ding, Xia] Beijing Univ Chinese Med, Sch Grad Studies, Beijing 100029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Air Force Military Medical University; Anhui Medical University; University of Alabama System; University of Alabama Birmingham; Beijing University of Chinese Medicine	Wang, FS (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China.	fengsong@ustc.edu.cn; xyao@msm.edu	Yao, Xuebiao/P-5771-2014; Cao, Xinwang/W-2883-2019	cao, xinwang/0000-0002-8052-7333; Hu, Guohong/0000-0002-2980-5166	National Institutes of Health [DK-56292, U54CA118948, P20CA132389]; NCRR [UL1 RR025008, G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB945000, 2007CB914503, 2002CB713700]; Chinese Natural Science Foundation [30900497, 30500183, 30870990, 91129714, 90508002, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R-195, 2009DFA31010]; Anhui Province [08040102005]; NATIONAL CANCER INSTITUTE [U54CA118948, P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese 973 Project(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, U54CA118948, and P20CA132389 (to X. Y.), NCRR Grant UL1 RR025008 from the Clinical and Translational Science Award Program, and NCRR Grant G12RR03034 (for use of facilities). This work was supported in part by Chinese 973 Project Grants 2010CB912103, 2012CB945000, 2007CB914503, and 2002CB713700 (to X. Y.), Chinese Natural Science Foundation Grants 30900497 (to F. W.), 30500183, 30870990, and 91129714 (to X. D.), and 90508002 and 90913016 (to X. Y.), Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, and KSCX2-YW-R-195, International Collaboration Grant 2009DFA31010 (to X. D.), and Anhui Province Project Grant 08040102005 (to X. Y.).	Bretscher MS, 1998, CURR BIOL, V8, P721, DOI 10.1016/S0960-9822(98)70281-7; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Oh SJ, 2010, J BIOL CHEM, V285, P14610, DOI 10.1074/jbc.M109.043935; Okabe H, 2004, INT J ONCOL, V24, P43; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Robertson SE, 2006, MOL BIOL CELL, V17, P645, DOI 10.1091/mbc.E05-07-0662; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SCHLAEPFER DD, 1994, NATURE, V372, P786; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Valderrama F, 2008, NAT CELL BIOL, V10, P16, DOI 10.1038/ncb0108-16; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yamazaki T, 2002, J CELL SCI, V115, P1791	49	16	19	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43735	43747		10.1074/jbc.M111.278770	http://dx.doi.org/10.1074/jbc.M111.278770			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027826	Green Published, hybrid			2022-12-25	WOS:000298402300017
J	Lahti, M; Bligt, E; Niskanen, H; Parkash, V; Brandt, AM; Jokinen, J; Patrikainen, P; Kapyla, J; Heino, J; Salminen, TA				Lahti, Matti; Bligt, Eva; Niskanen, Henri; Parkash, Vimal; Brandt, Anna-Maria; Jokinen, Johanna; Patrikainen, Pekka; Kapyla, Jarmo; Heino, Jyrki; Salminen, Tiina A.			Structure of Collagen Receptor Integrin alpha I-1 Domain Carrying the Activating Mutation E317A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-DOMAIN; CRYSTAL-STRUCTURE; CELL-ADHESION; A-DOMAIN; ALPHA-1-BETA-1; BINDING; RECOGNITION; AFFINITY; INTEGRIN-ALPHA-1-BETA-1; ALPHA(1)BETA(1)	We have analyzed the structure and function of the integrin alpha I-1 domain harboring a gain-of-function mutation E317A. To promote protein crystallization, a double variant with an additional C139S mutation was used. In cell adhesion assays, the E317A mutation promoted binding to collagen. Similarly, the double mutation C139S/E317A increased adhesion compared with C139S alone. Furthermore, soluble alpha I-1 C139S/E317A was a higher avidity collagen binder than alpha I-1 C139S, indicating that the double variant represents an activated form. The crystal structure of the activated variant of alpha I-1 was solved at 1.9 angstrom resolution. The E317A mutation results in the unwinding of the alpha C helix, but the metal ion has moved toward loop 1, instead of loop 2 in the open alpha I-2. Furthermore, unlike in the closed alpha I domains, the metal ion is pentacoordinated and, thus, prepared for ligand binding. Helix 7, which has moved downward in the open alpha I-2 structure, has not changed its position in the activated alpha I-1 variant. During the integrin activation, Glu(335) on helix 7 binds to the metal ion at the metal ion-dependent adhesion site (MIDAS) of the beta(1) subunit. Interestingly, in our cell adhesion assays E317A could activate collagen binding even after mutating Glu(335). This indicates that the stabilization of helix 7 into its downward position is not required if the alpha(1) MIDAS is already open. To conclude, the activated alpha I-1 domain represents a novel conformation of the alpha I domain, mimicking the structural state where the Arg(287)-Glu(317) ion pair has just broken during the integrin activation.	[Bligt, Eva; Parkash, Vimal; Brandt, Anna-Maria; Salminen, Tiina A.] Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, FI-20520 Turku, Finland; [Lahti, Matti; Niskanen, Henri; Jokinen, Johanna; Patrikainen, Pekka; Kapyla, Jarmo; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland	Abo Akademi University; University of Turku	Salminen, TA (corresponding author), Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, FI-20520 Turku, Finland.	tiina.salminen@abo.fi	Salminen, Tiina A./AAM-5443-2021; Salminen, Tiina A/G-7492-2019	Salminen, Tiina A./0000-0002-4135-8020; Salminen, Tiina A/0000-0002-4135-8020; Patrikainen, Pekka/0000-0002-4931-1817; Niskanen, Henri/0000-0002-8361-5531; Kapyla, Jarmo/0000-0003-3036-713X	Academy of Finland; Sigrid Juselius Foundation; Cancer Society of Finland; Cancer Society of Southwestern Finland; Tor, Joe, and Pentti Borgs Foundation; Finnish Cultural Foundation; Varsinais-Suomi Regional fund; Turku graduate school of Biomedical Sciences; National Doctoral Programme in Informational and Structural Biology	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Cancer Society of Southwestern Finland; Tor, Joe, and Pentti Borgs Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Varsinais-Suomi Regional fund; Turku graduate school of Biomedical Sciences; National Doctoral Programme in Informational and Structural Biology	This work was supported by the Academy of Finland; the Sigrid Juselius Foundation; the Cancer Society of Finland; the Cancer Society of Southwestern Finland; the Tor, Joe, and Pentti Borgs Foundation; the Finnish Cultural Foundation; the Varsinais-Suomi Regional fund; the Turku graduate school of Biomedical Sciences; and the National Doctoral Programme in Informational and Structural Biology.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Gardner H, 1999, J CELL SCI, V112, P263; Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMATA T, 1994, J BIOL CHEM, V269, P26006; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; McCleverty CJ, 2003, BIOCHEM J, V372, P121, DOI 10.1042/BJ20021273; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolte M, 1999, FEBS LETT, V452, P379, DOI 10.1016/S0014-5793(99)00666-3; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pozzi M, 1998, J CELL BIOL, V142, P587; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Salminen TA, 1999, ACTA CRYSTALLOGR D, V55, P1365, DOI 10.1107/S0907444999006009; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOIGT S, 1995, HISTOCHEM J, V27, P123; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022	58	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43343	43351		10.1074/jbc.M111.261909	http://dx.doi.org/10.1074/jbc.M111.261909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22030389	Green Published, hybrid			2022-12-25	WOS:000298351300054
J	Sugai, Y; Ueno, Y; Hayashi, K; Oogami, S; Toyomasu, T; Matsumoto, S; Natsume, M; Nozaki, H; Kawaide, H				Sugai, Yoshinori; Ueno, Yohei; Hayashi, Ken-ichiro; Oogami, Shingo; Toyomasu, Tomonobu; Matsumoto, Sadamu; Natsume, Masahiro; Nozaki, Hiroshi; Kawaide, Hiroshi			Enzymatic C-13 Labeling and Multidimensional NMR Analysis of Miltiradiene Synthesized by Bifunctional Diterpene Cyclase in Selaginella moellendorffii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENT-KAURENE SYNTHASE; FIR ABIES GRANDIS; GIBBERELLIN BIOSYNTHESIS; PHYSCOMITRELLA-PATENS; ABIETADIENE SYNTHASE; COPALYL DIPHOSPHATE; FUNCTIONAL-ANALYSIS; C-13-ENRICHED PROTEINS; BACTERIAL EXPRESSION; TERPENE SYNTHASES	Background: A model lycophyte, Selaginella moellendorffii, has a unique bifunctional terpene cyclase gene. Results: The bifunctional cyclase synthesized miltiradiene from geranylgeranyl diphosphate via (+)-copalyl diphosphate. Conclusion: Fully C-13-labeled miltiradiene was unambiguously elucidated by multidimensional NMR analyses. Significance: Enzymatic synthesis of highly enriched biosynthetic products enables one-dimensional and multidimensional C-13 NMR studies.	[Sugai, Yoshinori; Ueno, Yohei; Natsume, Masahiro; Kawaide, Hiroshi] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan; [Hayashi, Ken-ichiro; Oogami, Shingo; Nozaki, Hiroshi] Okayama Univ Sci, Fac Sci, Okayama 7000005, Japan; [Toyomasu, Tomonobu] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Matsumoto, Sadamu] Natl Museum Nat & Sci, Tsukuba Bot Garden, Tsukuba, Ibaraki 3050005, Japan	Tokyo University of Agriculture & Technology; Okayama University of Science; Yamagata University; National Museum of Nature and Science	Kawaide, H (corresponding author), Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan.	hkawaide@cc.tuat.ac.jp	Kawaide, Hiroshi/F-9243-2013; Natsume, Masahiro/C-2373-2013	Kawaide, Hiroshi/0000-0001-6693-1332; 	NMR facility of RIKEN Yokohama Institute; Research Fellowship for Young Scientists [227977]; Japan Society for Promotion of Science [20510210]; Grants-in-Aid for Scientific Research [10J07977] Funding Source: KAKEN	NMR facility of RIKEN Yokohama Institute; Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the NMR facility of RIKEN Yokohama Institute (non-proprietary use) and Research Fellowship for Young Scientists 227977 (to Y. S.) and Grant-in-aid for Scientific Research C 20510210 (to H. N.) from the Japan Society for Promotion of Science.	Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; CLARIDGE TDW, 2009, HIGH RESOLUTION NMR, P189; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Gehring K, 1998, J MAGN RESON, V135, P185, DOI 10.1006/jmre.1998.1543; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kawaide H, 2006, BIOSCI BIOTECH BIOCH, V70, P583, DOI 10.1271/bbb.70.583; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2011, J BIOL CHEM, V286, P21145, DOI 10.1074/jbc.M111.245951; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Koksal M, 2011, NAT CHEM BIOL, V7, P431, DOI [10.1038/NCHEMBIO.578, 10.1038/nchembio.578]; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; MACMILLAN J, 1999, COMPREHENSIVE NATURA, V2, P217; Mafu S, 2011, CHEMBIOCHEM, V12, P1984, DOI 10.1002/cbic.201100336; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; NAGAYAMA K, 1980, J MAGN RESON, V40, P321, DOI 10.1016/0022-2364(80)90255-3; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Richman AS, 1999, PLANT J, V19, P411, DOI 10.1046/j.1365-313X.1999.00531.x; Sugai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P128, DOI 10.1271/bbb.100733; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Toyomasu T, 2000, BIOSCI BIOTECH BIOCH, V64, P660, DOI 10.1271/bbb.64.660; Toyomasu T, 2008, BIOSCI BIOTECH BIOCH, V72, P1038, DOI 10.1271/bbb.70790; Toyomasu T, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P643; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; YAMANE H, 1988, TETRAHEDRON LETT, V29, P3959; Zhou K, 2009, PHYTOCHEMISTRY, V70, P366, DOI 10.1016/j.phytochem.2008.12.022	38	34	37	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42840	42847		10.1074/jbc.M111.302703	http://dx.doi.org/10.1074/jbc.M111.302703			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027823	hybrid, Green Published			2022-12-25	WOS:000298351300005
J	Costa, SM; Yorio, AP; Goncalves, AJS; Vidale, MM; Costa, ECB; Mohana-Borges, R; Motta, MA; Freire, MS; Alves, AMB				Costa, Simone M.; Yorio, Anna Paula; Goncalves, Antonio J. S.; Vidale, Mariana M.; Costa, Emmerson C. B.; Mohana-Borges, Ronaldo; Motta, Marcia A.; Freire, Marcos S.; Alves, Ada M. B.			Induction of a Protective Response in Mice by the Dengue Virus NS3 Protein Using DNA Vaccines	PLOS ONE			English	Article							T-CELL RESPONSES; ACTIVATOR SIGNAL SEQUENCE; HEMORRHAGIC-FEVER; NONSTRUCTURAL PROTEIN-3; MONOCLONAL-ANTIBODIES; JAPANESE ENCEPHALITIS; IMMUNE-RESPONSES; DRUG DESIGN; TYPE-2; IMMUNIZATION	The dengue non-structural 3 (NS3) is a multifunctional protein, containing a serino-protease domain, located at the N-terminal portion, and helicase, NTPase and RTPase domains present in the C-terminal region. This protein is considered the main target for CD4+ and CD8+ T cell responses during dengue infection, which may be involved in protection. However, few studies have been undertaken evaluating the use of this protein as a protective antigen against dengue, as well as other flavivirus. In the present work, we investigate the protective efficacy of DNA vaccines based on the NS3 protein from DENV2. Different recombinant plasmids were constructed, encoding either the full-length NS3 protein or only its functional domains (protease and helicase), fused or not to a signal peptide (t-PA). The recombinant proteins were successfully expressed in transfected BHK-21 cells, and only plasmids encoding the t-PA signal sequence mediated protein secretion. Balb/c mice were immunized with the different DNA vaccines and challenged with a lethal dose of DENV2. Most animals immunized with plasmids encoding the full-length NS3 or the helicase domain survived challenge, regardless of the presence of the t-PA. However, some mice presented clinical signs of infection with high morbidity (hind leg paralysis and hunched posture), mainly in animal groups immunized with the DNA vaccines based on the helicase domain. On the other hand, inoculation with plasmids encoding the protease domain did not induce any protection, since mortality and morbidity rates in these mouse groups were similar to those detected in the control animals. The cellular immune response was analyzed by ELISPOT with a specific-CD8+ T cell NS3 peptide. Results revealed that the DNA vaccines based on the full-length protein induced the production of INF-gamma, thus suggesting the involvement of this branch of the immune system in the protection.	[Costa, Simone M.; Yorio, Anna Paula; Goncalves, Antonio J. S.; Vidale, Mariana M.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil; [Costa, Emmerson C. B.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil; [Motta, Marcia A.; Freire, Marcos S.] Fundacao Oswaldo Cruz Fdn, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Costa, SM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.	ada@ioc.fiocruz.br	Borges, Ronaldo S Mohana/C-5575-2013	Mohana Borges, Ronaldo/0000-0002-1796-475X	Fundacao Oswaldo Cruz (FIOCRUZ); Instituto Oswaldo Cruz (IOC)/FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq/FAPERJ	Fundacao Oswaldo Cruz (FIOCRUZ); Instituto Oswaldo Cruz (IOC)/FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/FAPERJ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding: This work was supported by Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz (FIOCRUZ), Instituto Oswaldo Cruz (IOC)/FIOCRUZ, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Programa de apoio a Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AMB, 1999, BRAZ J MED BIOL RES, V32, P223, DOI 10.1590/S0100-879X1999000200011; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; AZEVEDO AS, 2011, PLOS ONE IN PRESS; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Beaumier CM, 2008, J INFECT DIS, V197, P608, DOI 10.1086/526790; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Brinton MA, 1998, CLIN DIAGN VIROL, V10, P129, DOI 10.1016/S0928-0197(98)00039-7; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; Dmitriev IP, 1996, J BIOTECHNOL, V44, P97, DOI 10.1016/0168-1656(95)00141-7; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P276; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427; Konishi E, 2003, VACCINE, V21, P3675, DOI 10.1016/S0264-410X(03)00382-7; Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010; Lazaro-Olan L, 2008, VECTOR-BORNE ZOONOT, V8, P69, DOI 10.1089/vbz.2007.0117; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lin CF, 2008, LAB INVEST, V88, P1079, DOI 10.1038/labinvest.2008.70; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Luo MC, 2008, J VIROL METHODS, V154, P121, DOI 10.1016/j.jviromet.2008.08.011; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Morozova OV, 1999, VIRAL IMMUNOL, V12, P277, DOI 10.1089/vim.1999.12.277; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Qi RF, 2008, ACTA BIOCH BIOPH SIN, V40, P91, DOI 10.1111/j.1745-7270.2008.00382.x; Rau H, 2006, VET RES, V37, P155, DOI 10.1051/vetres:2005049; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996; Sambrook J., 2002, MOL CLONING LAB MANU; Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; TAN CHC, 1990, J GEN VIROL, V71, P745, DOI 10.1099/0022-1317-71-3-745; Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000; Valle RPC, 1998, J VIROL, V72, P624, DOI 10.1128/JVI.72.1.624-632.1998; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; WHO/TDR, 2009, DENG GUID DIAGN TREA; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Young NJ, 2005, PREV VET MED, V72, P115, DOI 10.1016/j.prevetmed.2005.08.013; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959	64	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25685	10.1371/journal.pone.0025685	http://dx.doi.org/10.1371/journal.pone.0025685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031819	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200006
J	Maillard, P; Walic, M; Meuleman, P; Roohvand, F; Huby, T; Le Goff, W; Leroux-Roels, G; Pecheur, EI; Budkowska, A				Maillard, Patrick; Walic, Marine; Meuleman, Philip; Roohvand, Farzin; Huby, Thierry; Le Goff, Wilfried; Leroux-Roels, Geert; Pecheur, Eve-Isabelle; Budkowska, Agata			Lipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; VIRION-ASSOCIATED CHOLESTEROL; UPA-SCID MOUSE; APOLIPOPROTEIN-B; HUMAN HEPATOCYTES; HUMAN LIVER; RICH LIPOPROTEINS; BUOYANT DENSITY; BINDING; ASSOCIATION	A distinctive feature of HCV is that its life cycle depends on lipoprotein metabolism. Viral morphogenesis and secretion follow the very low-density lipoprotein (VLDL) biogenesis pathway and, consequently, infectious HCV in the serum is associated with triglyceride-rich lipoproteins (TRL). Lipoprotein lipase (LPL) hydrolyzes TRL within chylomicrons and VLDL but, independently of its catalytic activity, it has a bridging activity, mediating the hepatic uptake of chylomicrons and VLDL remnants. We previously showed that exogenously added LPL increases HCV binding to hepatoma cells by acting as a bridge between virus-associated lipoproteins and cell surface heparan sulfate, while simultaneously decreasing infection levels. We show here that LPL efficiently inhibits cell infection with two HCV strains produced in hepatoma cells or in primary human hepatocytes transplanted into uPA-SCID mice with fully functional human ApoB-lipoprotein profiles. Viruses produced in vitro or in vivo were separated on iodixanol gradients into low and higher density populations, and the infection of Huh 7.5 cells by both virus populations was inhibited by LPL. The effect of LPL depended on its enzymatic activity. However, the lipase inhibitor tetrahydrolipstatin restored only a minor part of HCV infectivity, suggesting an important role of the LPL bridging function in the inhibition of infection. We followed HCV cell entry by immunoelectron microscopy with anti-envelope and anti-core antibodies. These analyses demonstrated the internalization of virus particles into hepatoma cells and their presence in intracellular vesicles and associated with lipid droplets. In the presence of LPL, HCV was retained at the cell surface. We conclude that LPL efficiently inhibits HCV infection by acting on TRL associated with HCV particles through mechanisms involving its lipolytic function, but mostly its bridging function. These mechanisms lead to immobilization of the virus at the cell surface. HCV-associated lipoproteins may therefore be a promising target for the development of new therapeutic approaches.	[Maillard, Patrick; Walic, Marine; Roohvand, Farzin; Budkowska, Agata] Inst Pasteur, Dept Virol, Unite Hepacivirus & Immunite Innee, Paris, France; [Maillard, Patrick; Walic, Marine; Roohvand, Farzin; Budkowska, Agata] CNRS, URA3015, Paris, France; [Walic, Marine] Univ Paris Diderot, Paris, France; [Meuleman, Philip; Leroux-Roels, Geert] Ghent Univ & Hosp, Ctr Vaccinol, Ghent, Belgium; [Roohvand, Farzin] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran, Iran; [Huby, Thierry; Le Goff, Wilfried] INSERM, UMRS939, Paris, France; [Pecheur, Eve-Isabelle] Univ Lyon 1, F-69365 Lyon, France; [Pecheur, Eve-Isabelle] CNRS, UMR5086, Lyon, France; [Pecheur, Eve-Isabelle] IBCP, Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Ghent University; Ghent University Hospital; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS)	Maillard, P (corresponding author), Inst Pasteur, Dept Virol, Unite Hepacivirus & Immunite Innee, Paris, France.	agata.budkowska@pasteur.fr	Le Goff, Wilfried/N-6326-2017; HUBY, Thierry/N-4820-2019; Huby, Thierry/E-6768-2017; Roohvand, Farzin/K-8931-2018; Meuleman, Philip/H-2899-2013; Le Goff, Wilfried/N-7593-2019	Le Goff, Wilfried/0000-0002-7611-9644; HUBY, Thierry/0000-0001-6634-551X; Huby, Thierry/0000-0001-6634-551X; Roohvand, Farzin/0000-0002-9597-3555; Meuleman, Philip/0000-0001-6821-234X; Le Goff, Wilfried/0000-0002-7611-9644; Pecheur, Eve/0000-0002-8613-862X	Agence nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS); Ghent University (CRA) [01G00507]; Belgian state [IUAP: P6/36-HEPRO]; Research Foundation - Flanders [31500910]	Agence nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Ghent University (CRA)(Ghent University); Belgian state; Research Foundation - Flanders(FWO)	This work was supported by a grant from Agence nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS), and from the Ghent University (CRA n<SUP>o</SUP> 01G00507), the Belgian state (IUAP: P6/36-HEPRO) and the The Research Foundation - Flanders (31500910. MW was granted a fellowship from ANRS and Pasteur-Weizmann, FR a fellowship from ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Bartenschlager R, 2010, J HEPATOL, V53, P583, DOI 10.1016/j.jhep.2010.04.015; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bassendine MF, 2011, J HEPATOL IN PRESS; Beigneux AP, 2009, J LIPID RES, V50, pS57, DOI 10.1194/jlr.R800030-JLR200; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BERRYMAN DE, 1995, J BIOL CHEM, V270, P24525, DOI 10.1074/jbc.270.41.24525; Boren J, 2001, J BIOL CHEM, V276, P26916, DOI 10.1074/jbc.M011090200; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; BRADLEY DW, 1990, GASTROENTEROLOGY, V99, P1054, DOI 10.1016/0016-5085(90)90626-C; BRADLEY WA, 1984, J BIOL CHEM, V259, P4728; Bukh J, 2006, P NATL ACAD SCI USA, V103, P3500, DOI 10.1073/pnas.0600551103; Bukh J, 2010, J INFECT DIS, V201, P1381, DOI 10.1086/651579; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Casaroli-Marano RP, 1998, J LIPID RES, V39, P789; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cooper AD, 1997, J LIPID RES, V38, P2173; Cribier B, 1998, ARCH VIROL, V143, P375, DOI 10.1007/s007050050293; Dallinga-Thie GM, 2010, ATHEROSCLEROSIS, V211, P1, DOI 10.1016/j.atherosclerosis.2009.12.027; Ehrhardt M, 2011, HEPATOLOGY, V54, P1112, DOI 10.1002/hep.24366; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gustafsson M, 2007, CIRC RES, V101, P777, DOI 10.1161/CIRCRESAHA.107.149666; Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Heeren J, 2002, J MOL MED-JMM, V80, P576, DOI 10.1007/s00109-002-0351-5; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Keam SJ, 2008, DRUGS, V68, P1273, DOI 10.2165/00003495-200868090-00006; Khalil MF, 2004, ARTERIOSCL THROM VAS, V24, P2211, DOI 10.1161/01.ATV.0000147163.54024.70; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, P832, DOI 10.1161/01.ATV.8.6.832; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; Milosavljevic D, 2003, BBA-MOL CELL BIOL L, V1631, P51, DOI 10.1016/S1388-1981(02)00355-4; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Petit JM, 2003, AM J GASTROENTEROL, V98, P1150, DOI 10.1016/S0002-9270(03)00106-0; Piver E, 2010, INT J BIOCHEM CELL B, V42, P869, DOI 10.1016/j.biocel.2010.01.005; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; RAISONNIER A, 1995, COMP BIOCHEM PHYS B, V111, P385, DOI 10.1016/0305-0491(95)00006-T; Sabahi A, 2010, VIROLOGY, V407, P110, DOI 10.1016/j.virol.2010.07.026; Salinelli S, 1996, J BIOL CHEM, V271, P21906, DOI 10.1074/jbc.271.36.21906; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Steenbergen RHG, 2010, AM J PHYSIOL-GASTR L, V299, pG844, DOI 10.1152/ajpgi.00200.2010; Tao WY, 2009, VIROLOGY, V395, P67, DOI 10.1016/j.virol.2009.09.006; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Thomssen R, 2002, MED MICROBIOL IMMUN, V191, P17, DOI 10.1007/s00430-001-0106-x; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; Yamamoto M, 2011, J GEN VIROL, V92, P2082, DOI 10.1099/vir.0.032391-0; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Zheng CY, 2006, ARTERIOSCL THROM VAS, V26, P891, DOI 10.1161/01.ATV.0000203512.01007.3d; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	80	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26637	10.1371/journal.pone.0026637	http://dx.doi.org/10.1371/journal.pone.0026637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039521	gold, Green Published			2022-12-25	WOS:000296513200035
J	Gomez, JMD				Diaz Gomez, Juan Manuel			Estimating Ancestral Ranges: Testing Methods with a Clade of Neotropical Lizards (Iguania: Liolaemidae)	PLOS ONE			English	Article							AREAS; EVOLUTION; VICARIANCE; BIOGEOGRAPHY; COLEOPTERA; DISPERSAL	Establishing the ancestral ranges of distribution of a monophyletic clade, called the ancestral area, is one of the central objectives of historical biogeography. In this study, I used three common methodologies to establish the ancestral area of an important clade of Neotropical lizards, the family Liolaemidae. The methods used were: Fitch optimization, Weighted Ancestral Area Analysis and Dispersal-Vicariance Analysis (DIVA). A main difference from previous studies is that the areas used in the analysis are defined based on actual distributions of the species of Liolaemidae, instead of areas defined arbitrarilyor based on other taxa. The ancestral area of Liolaemidae found by Fitch optimization is Prepuna on Argentina, Central Chile and Coastal Peru. Weighted Ancestral Area Analysis found Central Chile, Coquimbo, Payunia, Austral Patagonia and Coastal Peru. Dispersal-Vicariance analysis found an ancestral area that includes almost all the areas occupied by Liolaemidae, except Atacama, Coquimbo and Austral Patagonia. The results can be resumed on two opposing hypothesis: a restricted ancestral area for the ancestor of Liolaemidae in Central Chile and Patagonia, or a widespread ancestor distributed along the Andes. Some limitations of the methods were identified, for example the excessive importance of plesiomorphic areas in the cladograms.	Univ Nacl Salta, Catedra Diversidad Biol 4, Fac Ciencias Nat, CONICET IBIGEO, Salta, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gomez, JMD (corresponding author), Univ Nacl Salta, Catedra Diversidad Biol 4, Fac Ciencias Nat, CONICET IBIGEO, Salta, Argentina.	jmdiaz@unsa.edu.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo de Investigacion de la Universidad Nacional de Salta (CIUNSa) [1783]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo de Investigacion de la Universidad Nacional de Salta (CIUNSa)	The work was funded by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET - www.conicet.gob.ar), in form of a doctoral fellowship to the author, and the Consejo de Investigacion de la Universidad Nacional de Salta (CIUNSa), Proyecto N<SUP>o</SUP> 1783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala CS, 2007, ZOOTAXA, P1; Abdala CS, 2008, HERPETOLOGICA, V64, P458, DOI 10.1655/08-022R1.1; Albino AM, 1998, 7 C ARG PAL BIOESTR; [Anonymous], [No title captured]; Baez A.M, 1979, MUSEUM NATURAL HIST, V7, P309; BREMER K, 1992, SYST BIOL, V41, P436, DOI 10.2307/2992585; Brown J. H., 1998, BIOGEOGRAPHY; Carine MA, 2009, J BIOGEOGR, V36, P593, DOI 10.1111/j.1365-2699.2008.02016.x; Cei J, 1986, MUSEO REGIONALE SCI, VIV; Cei J.M., 1979, University of Kansas Museum of Natural History Monograph, P309; Cei J. M., 1993, MUSEO REGIONALE SCI, VXIV, P949; Cei JM, 1975, PAYUNIA PAESSAGIO VU, V6, P1121; Crisci-V. Jorge, 2001, Caldasia, V23, P21; Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; DEMUIZON C, 1983, GEOBIOS-LYON, V16, P747, DOI 10.1016/S0016-6995(83)80091-6; Díaz Gómez Juan Manuel, 2006, Pap. Avulsos Zool. (São Paulo), V46, P261, DOI 10.1590/S0031-10492006002400001; Diaz Gomez Juan Manuel, 2007, South American Journal of Herpetology, V2, P59; Gomez JMD, 2009, ZOOL SCR, V38, P1, DOI 10.1111/j.1463-6409.2008.00357.x; Donadio O. E., 1983, CIRCULAR INFORM ASOC, V11, P5; Donoso-Barros R., 1966, REPTILES CHILE; Drovetski SV, 2003, J BIOGEOGR, V30, P1173, DOI 10.1046/j.1365-2699.2003.00920.x; Ebach MC, 1999, CLADISTICS, V15, P387, DOI 10.1111/j.1096-0031.1999.tb00275.x; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; ESTES R, 1973, SCIENCE, V180, P748, DOI 10.1126/science.180.4087.748; Etheridge Richard, 1995, American Museum Novitates, V3142, P1; Flores GE, 2001, J NEW YORK ENTOMOL S, V109, P309, DOI 10.1664/0028-7199(2001)109[0309:CABAOT]2.0.CO;2; FROST D R, 1989, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Frost DR, 2001, MOL PHYLOGENET EVOL, V21, P352, DOI 10.1006/mpev.2001.1015; Goloboff P.A., 2003, TREE ANAL USING NEW; Hausdorf B, 1998, SYST BIOL, V47, P445, DOI 10.1080/106351598260815; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Hovenkamp P, 1997, CLADISTICS, V13, P67, DOI 10.1111/j.1096-0031.1997.tb00241.x; Humphries C. J., 1986, CLADISTIC BIOGEOGRAP; Kodandaramaiah U, 2010, J BIOGEOGR, V37, P3, DOI 10.1111/j.1365-2699.2009.02221.x; Krell FT, 2004, SYST ENTOMOL, V29, P279, DOI 10.1111/j.0307-6970.2004.00262.x; Laurent R.F., 1992, Breviora, V494, P1; Laurent R.F, 1985, CUAD HERPETOL, V1, P1; LAURENT RF, 1983, B ASOCIACION HERPETO, V1, P16; Lobo F, 2001, HERPETOL J, V11, P137; Lobo F, 2005, ACTA ZOOLOGICA LILLO, V49, P67; Lobo Fernando, 2005, Pap. Avulsos Zool. (São Paulo), V45, P143, DOI 10.1590/S0031-10492005001300001; Lobo F, 2010, ZOOTAXA, P1; Morrone J.J., 1996, NEOTROPICA, V42, P104; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; MORRONE JJ, 1994, GLOBAL ECOL BIOGEOGR, V4, P188, DOI 10.2307/2997650; Morrone Juan J., 2002, Revista de la Sociedad Entomologica Argentina, V61, P1; Nelson G., 1981, SYSTEMATICS BIOGEORA; Pereyra E. A., 1992, THESIS U CHILE; Ree RH, 2005, EVOLUTION, V59, P257; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Roig-Juuent S., 2001, INTRO BIOGEOGRAFIA L, P257; ROIGJUNENT S, 2002, PROYECTO RED IBEROAM, V2, P247; RONQUIST F, 1994, SYST BIOL, V43, P267, DOI 10.2307/2413467; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2001, EVOLUTION, V55, P2503; Santos CMD, 2007, J BIOGEOGR, V34, P1470, DOI 10.1111/j.1365-2699.2007.01723.x; Schulte JA, 2000, BIOL J LINN SOC, V69, P75, DOI 10.1006/bijl.1999.0346; Schulte JA, 2003, HERPETOLOGICA, V59, P399, DOI 10.1655/02-48; Scolaro Jose A., 2003, Historia Natural (Corrientes), V2, P73; SIMPSON B B, 1975, Paleobiology, V1, P273; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; TAYLOR DW, 1991, PALAEOGEOGR PALAEOCL, V88, P69, DOI 10.1016/0031-0182(91)90015-J; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Young-Downey A. R., 1998, THESIS U MIAMI CORAL; [No title captured]	66	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26412	10.1371/journal.pone.0026412	http://dx.doi.org/10.1371/journal.pone.0026412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028873	Green Published, gold			2022-12-25	WOS:000296510800041
J	Wong, HEE; Li, MS; Kroll, JS; Hibberd, ML; Langford, PR				Wong, Hazel En En; Li, Ming-Shi; Kroll, J. Simon; Hibberd, Martin L.; Langford, Paul R.			Genome Wide Expression Profiling Reveals Suppression of Host Defence Responses during Colonisation by Neisseria meningitides but not N. lactamica	PLOS ONE			English	Article							EPITHELIAL-CELL RESPONSES; GENE-EXPRESSION; MENINGOCOCCAL DISEASE; ENDOTHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; SECRETED PROTEINS; IDENTIFICATION; MODULATION; INHIBITION; SEQUENCE	Both Neisseria meningitidis and the closely related bacterium Neisseria lactamica colonise human nasopharyngeal mucosal surface, but only N. meningitidis invades the bloodstream to cause potentially life-threatening meningitis and septicaemia. We have hypothesised that the two neisserial species differentially modulate host respiratory epithelial cell gene expression reflecting their disease potential. Confluent monolayers of 16HBE14 human bronchial epithelial cells were exposed to live and/or dead N. meningitidis (including capsule and pili mutants) and N. lactamica, and their transcriptomes were compared using whole genome microarrays. Changes in expression of selected genes were subsequently validated using Q-RT-PCR and ELISAs. Live N. meningitidis and N. lactamica induced genes involved in host energy production processes suggesting that both bacterial species utilise host resources. N. meningitidis infection was associated with down-regulation of host defence genes. N. lactamica, relative to N. meningitidis, initiates up-regulation of proinflammatory genes. Bacterial secreted proteins alone induced some of the changes observed. The results suggest N. meningitidis and N. lactamica differentially regulate host respiratory epithelial cell gene expression through colonisation and/or protein secretion, and that this may contribute to subsequent clinical outcomes associated with these bacteria.	[Wong, Hazel En En; Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Wong, Hazel En En; Li, Ming-Shi; Kroll, J. Simon; Langford, Paul R.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London, England	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Imperial College London	Wong, HEE (corresponding author), Genome Inst Singapore, Singapore, Singapore.	p.langford@imperial.ac.uk	Langford, Paul R/B-9092-2008; Hibberd, Martin L/D-5050-2009; Langford, Paul/AAU-4189-2020	Langford, Paul R/0000-0002-6368-4724; Langford, Paul/0000-0002-6368-4724; Hibberd, Martin/0000-0001-8587-1849	Agency for Science, Technology and Research, Singapore (A*-Star); George John and Sheilah Livanos Charitable Trust	Agency for Science, Technology and Research, Singapore (A*-Star)(Agency for Science Technology & Research (A*STAR)); George John and Sheilah Livanos Charitable Trust	HEEW and MLH are funded by the Agency for Science, Technology and Research, Singapore (A*-Star), while MSL, JSK, and PRL are funded by the George John and Sheilah Livanos Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baart GJE, 2010, MICROBIOL-SGM, V156, P530, DOI 10.1099/mic.0.031641-0; Beisswenger C, 2007, J BIOL CHEM, V282, P28700, DOI 10.1074/jbc.M703576200; Bennett JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-652; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; BLAKE MS, 1989, J EXP MED, V170, P1727, DOI 10.1084/jem.170.5.1727; Bonnah RA, 2004, CELL MICROBIOL, V6, P473, DOI 10.1111/j.1462-5822.2004.00376.x; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dietrich G, 2003, J BACTERIOL, V185, P155, DOI 10.1128/JB.185.1.155-164.2003; Evans CM, 2011, CLIN INFECT DIS, V52, P70, DOI 10.1093/cid/ciq065; Exley RM, 2009, INFECT IMMUN, V77, P45, DOI 10.1128/IAI.00968-08; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fowler MI, 2006, INFECT IMMUN, V74, P6467, DOI 10.1128/IAI.00644-06; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; Gorringe AR, 2009, CLIN VACCINE IMMUNOL, V16, P1113, DOI 10.1128/CVI.00118-09; Grifantini R, 2002, ANN NY ACAD SCI, V975, P202, DOI 10.1111/j.1749-6632.2002.tb05953.x; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Hartman AL, 2008, J VIROL, V82, P5348, DOI 10.1128/JVI.00215-08; Higashimoto Y, 2005, RESPIRATION, V72, P629, DOI 10.1159/000089579; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Li MS, 2009, MED MICROBIOL IMMUN, V198, P57, DOI 10.1007/s00430-008-0105-2; Linhartova I, 2006, FEMS MICROBIOL LETT, V263, P109, DOI 10.1111/j.1574-6968.2006.00407.x; Liu XP, 2010, INFECT IMMUN, V78, P5314, DOI 10.1128/IAI.00681-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Meyer-Hoffert U, 2003, EXP DERMATOL, V12, P418, DOI 10.1034/j.1600-0625.2002.120409.x; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Mukhopadhyay TK, 2005, BIOTECHNOL APPL BIOC, V41, P175; Mukhopadhyay TK, 2008, THESIS U LONDON; O'Dwyer CA, 2004, INFECT IMMUN, V72, P6511, DOI 10.1128/IAI.72.11.6511-6518.2004; O'Grady E, 2007, NAT REV MICROBIOL, V5, P337, DOI 10.1038/nrmicro1641; OLSEN SF, 1991, EPIDEMIOL INFECT, V106, P445, DOI 10.1017/S0950268800067492; Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3; Plant L, 2004, CELL MICROBIOL, V6, P663, DOI 10.1111/j.1462-5822.2004.00393.x; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Read RC, 1996, INFECT IMMUN, V64, P3210, DOI 10.1128/IAI.64.8.3210-3217.1996; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Robinson K, 2004, CELL MICROBIOL, V6, P927, DOI 10.1111/j.1462-5822.2004.00410.x; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Schubert-Unkmeir A, 2007, INFECT IMMUN, V75, P899, DOI 10.1128/IAI.01508-06; Schubert-Unkmeir A, 2009, EXPERT REV MOL DIAGN, V9, P833, DOI 10.1586/ERM.09.68; Serruto D, 2004, J BIOTECHNOL, V113, P15, DOI 10.1016/j.jbiotec.2004.03.024; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tezera L, 2010, CELL MICROBIOL; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uronen-Hansson H, 2004, CELL MICROBIOL, V6, P625, DOI 10.1111/j.1462-5822.2004.00387.x; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; van Ulsen P, 2006, FEMS MICROBIOL REV, V30, P292, DOI 10.1111/j.1574-6976.2006.00013.x; Vaughan TE, 2006, VACCINE, V24, P5277, DOI 10.1016/j.vaccine.2006.03.013; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; Virji M, 1996, TRENDS MICROBIOL, V4, P466, DOI 10.1016/S0966-842X(97)82905-8; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Wells DB, 2001, INFECT IMMUN, V69, P2718, DOI 10.1128/IAI.69.4.2718-2722.2001; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhou LM, 2004, RESP PHYSIOL NEUROBI, V140, P89, DOI 10.1016/j.resp.2003.12.003	66	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26130	10.1371/journal.pone.0026130	http://dx.doi.org/10.1371/journal.pone.0026130			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028815	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000296510800019
J	Zhang, JY; Zhang, XL; Wu, C; Lu, DS; Guo, G; Mao, XH; Zhang, Y; Wang, DC; Li, DF; Zou, QM				Zhang, Jinyong; Zhang, Xiaoli; Wu, Chao; Lu, Dongshui; Guo, Gang; Mao, Xuhu; Zhang, Ying; Wang, Da-Cheng; Li, Defeng; Zou, Quanming			Expression, Purification and Characterization of Arginase from Helicobacter pylori in Its Apo Form	PLOS ONE			English	Article							BINUCLEAR MANGANESE CLUSTER; HUMAN LIVER; INFECTION; INHIBITION; PATHOGENESIS; SUPERFAMILY; ACTIVATION; ESCAPE; ENZYME; IONS	Arginase, a manganese-dependent enzyme that widely distributed in almost all creatures, is a urea cycle enzyme that catalyzes the hydrolysis of L-arginine to generate L-ornithine and urea. Compared with the well-studied arginases from animals and yeast, only a few eubacterial arginases have been characterized, such as those from H. pylori and B. anthracis. However, these enzymes used for arginase activity assay were all expressed with LB medium, as low concentration of Mn2+ was detectable in the medium, protein obtained were partially Mn2+ bonded, which may affect the results of arginase activity assay. In the present study, H. pylori arginase (RocF) was expressed in a Mn2+ and Co2+ free minimal medium, the resulting protein was purified through affinity and gel filtration chromatography and the apo-form of RocF was confirmed by flame photometry analysis. Gel filtration indicates that the enzyme exists as monomer in solution, which was unique as compared with homologous enzymes. Arginase activity assay revealed that apo-RocF had an acidic pH optimum of 6.4 and exhibited metal preference of Co2+>Ni2+>Mn2+. We also confirmed that heat-activation and reducing regents have significant impact on arginase activity of RocF, and inhibits S-(2-boronoethyl)-L-Cysteine (BEC) and N omega-hydroxy-nor-Arginine (nor-NOHA) inhibit the activity of RocF in a dose-dependent manner.	[Zhang, Jinyong; Zhang, Xiaoli; Wu, Chao; Lu, Dongshui; Guo, Gang; Mao, Xuhu; Zou, Quanming] Third Mil Med Univ, Dept Clin Microbiol & Immunol, Coll Med Lab, Chongqing, Peoples R China; [Zhang, Ying; Wang, Da-Cheng; Li, Defeng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Army Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, JY (corresponding author), Third Mil Med Univ, Dept Clin Microbiol & Immunol, Coll Med Lab, Chongqing, Peoples R China.	lidefeng@moon.ibp.ac.cn; qmzou2007@163.com		Zhang, Jinyong/0000-0001-9622-5834	National Science Foundation of China [31000336]; National Basic Research Program of China [2011CB910304, 2011CB91103]; Chinese Academy of Sciences [KSCXZ-EW-J-3]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by funding from the National Science Foundation of China (31000336), the grants from National Basic Research Program of China (2011CB910304, 2011CB91103) and the Chinese Academy of Sciences (KSCXZ-EW-J-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldari CT, 2005, TRENDS IMMUNOL, V26, P199, DOI 10.1016/j.it.2005.01.007; Bewley MC, 1999, STRUCT FOLD DES, V7, P435, DOI 10.1016/S0969-2126(99)80056-2; Cama E, 2004, BIOCHEMISTRY-US, V43, P8987, DOI 10.1021/bi0491705; CARVAJAL N, 1995, COMP BIOCHEM PHYS B, V112, P153, DOI 10.1016/0305-0491(95)00027-6; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; Di Costanzo L, 2005, P NATL ACAD SCI USA, V102, P13058, DOI 10.1073/pnas.0504027102; Di Costanzo L, 2010, ARCH BIOCHEM BIOPHYS, V496, P101, DOI 10.1016/j.abb.2010.02.004; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; HIRSCHKOLB H, 1970, COMP BIOCHEM PHYSIOL, V37, P345, DOI 10.1016/0010-406X(70)90563-3; Hovey JG, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-26; IKEMOTO M, 1990, BIOCHEM J, V270, P697, DOI 10.1042/bj2700697; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; KUHN NJ, 1995, ARCH BIOCHEM BIOPHYS, V320, P24, DOI 10.1006/abbi.1995.1338; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; McGee DJ, 2006, J BIOL CHEM, V281, P3290, DOI 10.1074/jbc.M506139200; McGee DJ, 2004, EUR J BIOCHEM, V271, P1952, DOI 10.1111/j.1432-1033.2004.04105.x; McGee DJ, 1999, J BACTERIOL, V181, P7314, DOI 10.1128/JB.181.23.7314-7322.1999; Mendz GL, 1998, BBA-PROTEIN STRUCT M, V1388, P465, DOI 10.1016/S0167-4838(98)00207-6; Molnar B, 2010, DIGEST DIS, V28, P604, DOI 10.1159/000320060; MUSZYNSKA G, 1972, ACTA BIOCHIM POL, V19, P109; Shishova EY, 2009, BIOCHEMISTRY-US, V48, P121, DOI 10.1021/bi801911v; Srivastava A, 2010, IUBMB LIFE, V62, P906, DOI 10.1002/iub.401; Srivastava A, 2010, BIOCHEM BIOPH RES CO, V395, P348, DOI 10.1016/j.bbrc.2010.04.014; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tormanen CD, 2001, J ENZYM INHIB, V16, P443, DOI 10.1080/14756360109162393; Viator Ryan J., 2008, BMC Biochemistry, V9, P15, DOI 10.1186/1471-2091-9-15; Walker J M, 1994, Methods Mol Biol, V32, P5; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057; Yuan JP, 2009, CELL MOL IMMUNOL, V6, P191, DOI 10.1038/cmi.2009.26; Zabaleta J, 2004, J IMMUNOL, V173, P586, DOI 10.4049/jimmunol.173.1.586; Zhang JY, 2011, ACTA CRYSTALLOGR F, V67, P707, DOI 10.1107/S1744309111014242	33	14	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26205	10.1371/journal.pone.0026205	http://dx.doi.org/10.1371/journal.pone.0026205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028830	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800025
J	Andersson, K; Norman, D; Werdelin, L				Andersson, Ki; Norman, David; Werdelin, Lars			Sabretoothed Carnivores and the Killing of Large Prey	PLOS ONE			English	Article							LEOPARD NEOFELIS-NEBULOSA; LION PANTHERA-LEO; LATE MIOCENE; MORPHOLOGY; MACHAIRODONTINAE; PREFERENCES; EVOLUTION; ORIGINS; FELIDAE; MAMMALS	Sabre-like canines clearly have the potential to inflict grievous wounds leading to massive blood loss and rapid death. Hypotheses concerning sabretooth killing modes include attack to soft parts such as the belly or throat, where biting deep is essential to generate strikes reaching major blood vessels. Sabretoothed carnivorans are widely interpreted as hunters of larger and more powerful prey than that of their present-day nonsabretoothed relatives. However, the precise functional advantage of the sabretooth bite, particularly in relation to prey size, is unknown. Here, we present a new point-to-point bite model and show that, for sabretooths, depth of the killing bite decreases dramatically with increasing prey size. The extended gape of sabretooths only results in considerable increase in bite depth when biting into prey with a radius of less than similar to 10 cm. For sabretooths, this size-reversed functional advantage suggests predation on species within a similar size range to those attacked by present-day carnivorans, rather than "megaherbivores" as previously believed. The development of the sabretooth condition appears to represent a shift in function and killing behaviour, rather than one in predator-prey relations. Furthermore, our results demonstrate how sabretoothed carnivorans are likely to have evolved along a functionally continuous trajectory: beginning as an extension of a jaw-powered killing bite, as adopted by present-day pantherine cats, followed by neck-powered biting and thereafter shifting to neck-powered shear-biting. We anticipate this new insight to be a starting point for detailed study of the evolution of pathways that encompass extreme specialisation, for example, understanding how neck-powered biting shifts into shear-biting and its significance for predator-prey interactions. We also expect that our model for point-to-point biting and bite depth estimations will yield new insights into the behaviours of a broad range of extinct predators including therocephalians (gorgonopsian + cynodont, sabretoothed mammal-like reptiles), sauropterygians (marine reptiles) and theropod dinosaurs.	[Andersson, Ki; Norman, David] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Andersson, Ki; Werdelin, Lars] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden	University of Cambridge; Swedish Museum of Natural History	Andersson, K (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	andersson.ki@gmail.com			Swedish Research Council [623-2004-2206]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by a postdoctoral stipend (no: 623-2004-2206) to KA from the Swedish Research Council and a research grant to LW from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEN W, 1985, LOS ANGELES COUNTY M, V356, P1; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; ANTON M, 2004, SOCIETY, V140, P207; Bohlin B., 1940, B GEOL I U UPPSALA, V28, P156; BRAMBLE DM, 1978, PALEOBIOLOGY, V4, P271, DOI 10.1017/S009483730000600X; Bryant Harold N., 1996, P283; BRYANT HN, 1987, NATURE, V325, P488, DOI 10.1038/325488a0; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2005, J ZOOL, V266, P153, DOI 10.1017/s0952836905006710; CHRISTIANSEN P, 2011, ZOOLOGICAL J LINNEAN; Christiansen P, 2008, J MAMM EVOL, V15, P155, DOI 10.1007/s10914-007-9069-z; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; DIAMOND JM, 1986, NATURE, V322, P773, DOI 10.1038/322773a0; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Evans G.L., 1961, B TEX MEM MUS, V2, P7; Ewer, 1998, CARNIVORES; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KITCHENER A., 1991, NATURAL HIST WILD CA; Lewis ME, 1997, J HUM EVOL, V32, P257, DOI 10.1006/jhev.1996.0103; MARTIN L D, 1980, Transactions of the Nebraska Academy of Sciences, V8, P141; Martin LD, 2000, NATURWISSENSCHAFTEN, V87, P41, DOI 10.1007/s001140050007; Matthew WD, 1910, B AM MUS NAT HIST, V28, P289; RADINSKY LB, 1981, BIOL J LINN SOC, V15, P369, DOI 10.1111/j.1095-8312.1981.tb00770.x; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; SALESA MJ, 2006, J ZOOLOGY LONDON, V268, P2543; SCHULTZ C B, 1970, Bulletin of the University of Nebraska State Museum, V9, P1; SIMPSON GEORGE GAYLORD, 1941, AMER MUS NOVITATES, V1130, P1; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Turner A., 1997, BIG CATS THEIR FOSSI; VANVALKENBURGH B, 1988, PALEOBIOLOGY, V14, P155, DOI 10.1017/S0094837300011891; Werdelin L, 2010, BIOL CONSERVATION WI, P59	37	28	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e24971	10.1371/journal.pone.0024971	http://dx.doi.org/10.1371/journal.pone.0024971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039403	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500004
J	Kobayashi, S; Takebe, T; Zheng, YW; Mizuno, M; Yabuki, Y; Maegawa, J; Taniguchi, H				Kobayashi, Shinji; Takebe, Takanori; Zheng, Yun-Wen; Mizuno, Mitsuru; Yabuki, Yuichiro; Maegawa, Jiro; Taniguchi, Hideki			Presence of Cartilage Stem/Progenitor Cells in Adult Mice Auricular Perichondrium	PLOS ONE			English	Article							LABEL-RETAINING CELLS; STEM-CELLS; ARTICULAR CHONDROCYTES; EXTRACELLULAR-MATRIX; INTEGRIN EXPRESSION; COSTAL CARTILAGE; IN-VITRO; RECONSTRUCTION; TISSUE; CD44	Background: Based on evidence from several other tissues, cartilage stem/progenitor cells in the auricular cartilage presumably contribute to tissue development or homeostasis of the auricle. However, no definitive studies have identified or characterized a stem/progenitor population in mice auricle. Methodology/Principal Findings: The 5-bromo-2'-deoxyuridine (BrdU) label-retaining technique was used to label dividing cells in fetal mice. Observations one year following the labeling revealed that label-retaining cells (LRCs) were present specifically in auricular perichondrium at a rate of 0.08 +/- 0.06%, but LRCs were not present in chondrium. Furthermore, LRCs were successfully isolated and cultivated from auricular cartilage. Immunocytochemical analyses showed that LRCs express CD44 and integrin-alpha(5). These LRCs, putative stem/progenitor cells, possess clonogenicity and chondrogenic capability in vitro. Conclusions/Significance: We have identified a population of putative cartilage stem/progenitor cells in the auricular perichondrium of mice. Further characterization and utilization of the cell population should improve our understanding of basic cartilage biology and lead to advances in cartilage tissue engineering and novel therapeutic strategies for patients with craniofacial defects, including long-term tissue restoration.	[Kobayashi, Shinji; Takebe, Takanori; Zheng, Yun-Wen; Mizuno, Mitsuru; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Kanagawa, Japan; [Yabuki, Yuichiro; Maegawa, Jiro] Yokohama City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kanazawa Ku, Kanagawa, Japan; [Taniguchi, Hideki] Yokohama City Univ, Adv Med Res Ctr, Kanagawa, Japan; [Kobayashi, Shinji] Kanagawa Childrens Med Ctr, Dept Plast & Reconstruct Surg, Minami Ku, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Kobayashi, S (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Kanagawa, Japan.	zoukisai@yokohama-cu.ac.jp	Mitsuru, Mizuno/K-3962-2017; Zheng, Yun-Wen/R-2874-2019	Mitsuru, Mizuno/0000-0002-4410-3621; Zheng, Yun-Wen/0000-0001-9002-3190	Ministry of Education, Science and Culture [20592101]; Health and Labour Sciences Research Grants Research on intractable disease [2011-164]; Yokohama City University, Japan [19-15]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants Research on intractable disease; Yokohama City University, Japan	This work was supported by grant from Grant-in-aid for Developmental Scientific Research, The Ministry of Education, Science and Culture (No. 20592101) and Health and Labour Sciences Research Grants Research on intractable disease (No. 2011-164). This work was also supported by the grant for Research and Development Project (No. 19-15) of Yokohama City University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bairati A, 1996, TISSUE CELL, V28, P455, DOI 10.1016/S0040-8166(96)80031-0; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Brandl C, 2009, EXP EYE RES, V89, P209, DOI 10.1016/j.exer.2009.03.009; CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; ENGKVIST O, 1979, SCAND J PLAST RECONS, V13, P371, DOI 10.3109/02844317909013085; EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124; Hausler G, 2002, CALCIFIED TISSUE INT, V71, P212, DOI 10.1007/s00223-001-2083-x; HOLMVALL K, 1995, EXP CELL RES, V221, P496, DOI 10.1006/excr.1995.1401; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P938, DOI 10.1053/joca.2002.0854; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ito M, 2002, J INVEST DERMATOL, V119, P1310, DOI 10.1046/j.1523-1747.2002.19644.x; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kawanabe Y, 2007, PLAST RECONSTR SURG, V119, P308, DOI 10.1097/01.prs.0000244880.12256.7c; Kawanabe Y, 2006, PLAST RECONSTR SURG, V117, P2011, DOI 10.1097/01.prs.0000210015.28620.1c; Kim SJ, 2003, YONSEI MED J, V44, P493, DOI 10.3349/ymj.2003.44.3.493; Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0; Nakamura H, 2005, J HISTOCHEM CYTOCHEM, V53, P113, DOI 10.1369/jhc.4A6354.2005; Nishimura K, 1999, ARTHRITIS RHEUM, V42, P2631, DOI 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H; PELTOMAKI T, 1992, J ANAT, V181, P259; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; Tavella S, 1997, J CELL SCI, V110, P2261; Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409; VANDERMEULEN JCH, 1984, PLAST RECONSTR SURG, V74, P687, DOI 10.1097/00006534-198411000-00018; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Yanaga H, 2006, PLAST RECONSTR SURG, V117, P2019, DOI 10.1097/01.prs.0000210662.12267.de; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	33	27	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26393	10.1371/journal.pone.0026393	http://dx.doi.org/10.1371/journal.pone.0026393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039478	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500060
J	Neri, P; Tokoro, S; Kobayashi, R; Sugiyama, T; Umeda, K; Shimizu, T; Tsuji, T; Kodama, Y; Oguma, K; Mori, H				Neri, Paola; Tokoro, Shunji; Kobayashi, Ryo; Sugiyama, Tsuyoshi; Umeda, Kouji; Shimizu, Takeshi; Tsuji, Takao; Kodama, Yoshikatsu; Oguma, Keiji; Mori, Hiroshi			Specific Egg Yolk Immunoglobulin as a New Preventive Approach for Shiga-Toxin-Mediated Diseases	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; HEMOLYTIC-UREMIC SYNDROME; HUMAN MONOCLONAL-ANTIBODY; CARBOHYDRATE LIGANDS; ANTIBIOTIC-TREATMENT; EPITHELIAL-CELLS; VERO TOXIN; B-SUBUNIT; IN-VITRO; MICE	Shiga toxins (Stxs) are involved in the development of severe systemic complications associated with enterohemorrhagic Escherichia coli (EHEC) infection. Various neutralizing agents against Stxs are under investigation for management of EHEC infection. In this study, we immunized chickens with formalin-inactivated Stx-1 or Stx-2, and obtained immunoglobulin Y (IgY) from the egg yolk. Anti-Stx-1 IgY and anti-Stx-2 IgY recognized the corresponding Stx A subunit and polymeric but not monomeric B subunit. Anti-Stx-1 IgY and anti-Stx-2 IgY suppressed the cytotoxicity of Stx-1 and Stx-2 to HeLa 229 cells, without cross-suppressive activity. The suppressive activity of these IgY was abrogated by pre-incubation with the corresponding recombinant B subunit, which suggests that the antibodies directed to the polymeric B subunits were predominantly involved in the suppression. In vivo, the intraperitoneal or intravenous administration of these IgY rescued mice from death caused by intraperitoneal injection of the corresponding toxin at a lethal dose. Moreover, oral administration of anti-Stx-2 IgY reduced the mortality of mice infected intestinally with EHEC O157:H7. Our results therefore suggest that anti-Stx IgY antibodies may be considered as preventive agents for Stx-mediated diseases in EHEC infection.	[Neri, Paola; Tokoro, Shunji; Kobayashi, Ryo; Sugiyama, Tsuyoshi; Mori, Hiroshi] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Gifu, Japan; [Umeda, Kouji; Kodama, Yoshikatsu] GHEN Corp, Immunol Res Inst, Gifu, Japan; [Shimizu, Takeshi] Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chiba, Japan; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Aichi, Japan; [Oguma, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Bacteriol, Okayama 7008530, Japan	Gifu Pharmaceutical University; Chiba University; Fujita Health University; Okayama University	Neri, P (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Gifu, Japan.	morih@gifu-pu.ac.jp			Grants-in-Aid for Scientific Research [21590497] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Acheson DWK, 1996, INFECT IMMUN, V64, P3294, DOI 10.1128/IAI.64.8.3294-3300.1996; Amaral JA, 2002, RES VET SCI, V72, P229, DOI 10.1053/rvsc.2002.0551; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Cook SR, 2005, CAN J ANIM SCI, V85, P291, DOI 10.4141/A04-076; Dohi H, 2002, ORG LETT, V4, P355, DOI 10.1021/ol017135+; DOWNES FP, 1988, INFECT IMMUN, V56, P1926, DOI 10.1128/IAI.56.8.1926-1933.1988; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Ergonul Z, 2003, J INFECT DIS, V187, P154, DOI 10.1086/345861; Flagler MJ, 2007, INFECT IMMUN, V75, P760, DOI 10.1128/IAI.01594-06; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361, DOI 10.1128/JCM.12.3.361-366.1980; Girard F, 2006, FEMS IMMUNOL MED MIC, V46, P340, DOI 10.1111/j.1574-695X.2005.00030.x; HEAD SC, 1988, FEMS MICROBIOL LETT, V51, P211, DOI 10.1111/j.1574-6968.1988.tb02999.x; Hurley BP, 1999, INFECT IMMUN, V67, P6670; JACKSON MP, 1987, FEMS MICROBIOL LETT, V44, P109, DOI 10.1016/0378-1097(87)90210-2; Jeong KI, 2010, J INFECT DIS, V201, P1081, DOI 10.1086/651198; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Kiyokawa N, 1998, J INFECT DIS, V178, P178, DOI 10.1086/515592; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; LINDGREN SW, 1994, INFECT IMMUN, V62, P623, DOI 10.1128/IAI.62.2.623-631.1994; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Mine Yoshinori, 2002, Journal of Medicinal Food, V5, P159, DOI 10.1089/10966200260398198; Mukherjee J, 2002, INFECT IMMUN, V70, P5896, DOI 10.1128/IAI.70.10.5896-5899.2002; Mulvey GL, 2003, J INFECT DIS, V187, P640, DOI 10.1086/373996; Nagano K, 2003, J PHARMACOL SCI, V91, P219; Nagano K, 2003, MICROBIOL IMMUNOL, V47, P125, DOI 10.1111/j.1348-0421.2003.tb02795.x; Nakajima H, 2001, J BIOL CHEM, V276, P42915, DOI 10.1074/jbc.M106015200; Nakajima H, 2001, PROTEIN EXPRES PURIF, V22, P267, DOI 10.1006/prep.2001.1449; Neri P, 2007, BIOL PHARM BULL, V30, P1697, DOI 10.1248/bpb.30.1697; Neri P, 2007, MICROBIOL IMMUNOL, V51, P581, DOI 10.1111/j.1348-0421.2007.tb03944.x; Nishikawa K, 2005, J INFECT DIS, V191, P2097, DOI 10.1086/430388; OBRIEN AD, 1983, INFECT IMMUN, V40, P675, DOI 10.1128/IAI.40.2.675-683.1983; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; OSTROFF SM, 1989, JAMA-J AM MED ASSOC, V262, P355, DOI 10.1001/jama.262.3.355; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; SAXENA SK, 1989, J BIOL CHEM, V264, P596; Sheoran AS, 2005, INFECT IMMUN, V73, P4607, DOI 10.1128/IAI.73.8.4607-4613.2005; Shimizu K, 2003, MICROB PATHOGENESIS, V35, P1, DOI 10.1016/S0882-4010(03)00065-2; Shimizu T, 2007, MICROB PATHOGENESIS, V43, P88, DOI 10.1016/j.micpath.2007.04.003; Shimizu T, 2007, INFECT IMMUN, V75, P2189, DOI 10.1128/IAI.01546-06; Shin JH, 2002, CLIN DIAGN LAB IMMUN, V9, P1061, DOI 10.1128/CDLI.9.5.1061-1066.2002; Smith MJ, 2006, VACCINE, V24, P4122, DOI 10.1016/j.vaccine.2006.02.035; STROCKBINE NA, 1986, INFECT IMMUN, V53, P135, DOI 10.1128/IAI.53.1.135-140.1986; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Tsuji T, 2008, VACCINE, V26, P469, DOI 10.1016/j.vaccine.2007.11.038; Uzawa H, 2007, CHEMBIOCHEM, V8, P2117, DOI 10.1002/cbic.200700439; Wang Q, 2010, CAN J MICROBIOL, V56, P1003, DOI 10.1139/W10-087; Watanabe M, 2004, J INFECT DIS, V189, P360, DOI 10.1086/381124; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Yamagami S, 2001, J INFECT DIS, V184, P738, DOI 10.1086/323082; Yoh M, 1997, EPIDEMIOL INFECT, V119, P101, DOI 10.1017/S0950268897007541; Yokoyama H, 1998, VACCINE, V16, P388, DOI 10.1016/S0264-410X(97)80916-4; Yokoyama S, 2001, J CLIN BIOCHEM NUTR, V30, P33; YUTSUDO T, 1987, MICROB PATHOGENESIS, V3, P21, DOI 10.1016/0882-4010(87)90034-9; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zumbrun SD, 2010, INFECT IMMUN, V78, P4488, DOI 10.1128/IAI.00620-10	60	17	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26526	10.1371/journal.pone.0026526	http://dx.doi.org/10.1371/journal.pone.0026526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028896	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500083
J	Oostindjer, M; Bolhuis, JE; Simon, K; van den Brand, H; Kemp, B				Oostindjer, Marije; Bolhuis, J. Elizabeth; Simon, Kristina; van den Brand, Henry; Kemp, Bas			Perinatal Flavour Learning and Adaptation to Being Weaned: All the Pig Needs Is Smell	PLOS ONE			English	Article							TRANSNATAL OLFACTORY CONTINUITY; FULL-TERM NEWBORNS; AMNIOTIC-FLUID; MOTHERS MILK; FEEDING PREFERENCES; DOMESTIC RUMINANTS; HUMAN AMYGDALA; FAMILIAR ODOR; GROWING PIGS; IN-UTERO	Perinatal flavour learning through the maternal diet is known to enhance flavour preference and acceptance of flavoured food in many species, yet still little is known about the mechanism underlying perinatal flavour learning. Previously we found positive effects of perinatal flavour learning on food intake, growth and behaviour of piglets postweaning, but no increased preference for the flavour. This suggests that flavour learning in pigs works through a reduction of weaning stress by the presence of the familiar flavour instead. The aim of this study was to investigate whether perinatal flavour learning reduces stress at weaning, and whether the effect is stronger when the familiar flavour is present in the food. Sows were offered an anethol-flavoured diet (Flavour treatment) or control diet (Control treatment) during late gestation and lactation. Flavour and Control piglets were provided with anethol either in their food (Food treatment) or in the air (Air treatment) after weaning. Preweaning and postweaning treatments did not affect food intake, preference or growth in the first two weeks postweaning but flavour treatment reduced the latency to eat (24 versus 35 hours, P = 0.02) and within-pen variation in growth (SD within-pen: 0.7 versus 1.2 kg, P < 0.001). Salivary cortisol levels tended to be lower four and seven hours postweaning for Flavour piglets compared to Control piglets (4 hours: 2.5 versus 3.0 ng/ml, P = 0.05, 7 hours: 3.1 versus 3.4 ng/ml, P = 0.08). Flavour piglets played more and showed less damaging behaviours than Control piglets, indicating that the familiar flavour reduced stress around weaning. Few interaction effects were found between preweaning and postweaning treatment, and no effects of postweaning treatment. We conclude that in the newly weaned pig, perinatal flavour learning results in a reduction of stress when the familiar flavour is present, regardless of providing the flavour in the food or in the air.	[Oostindjer, Marije; Bolhuis, J. Elizabeth; Simon, Kristina; van den Brand, Henry; Kemp, Bas] Wageningen Univ, Wageningen Inst Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	Wageningen University & Research	Oostindjer, M (corresponding author), Wageningen Univ, Wageningen Inst Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands.	marije.oostindjer@wur.nl	Bolhuis, J. Elizabeth/P-7978-2015	Bolhuis, J. Elizabeth/0000-0002-5172-7635; Oostindjer, Marije/0000-0002-0997-0041	Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWO-STW) [07722]; Product Boards for Livestock and Meat (PVV); Product Board Animal Feed (PDV); Lucta S.A.; Nutreco Nederland B.V.; Verbakel B.V.; Nutreco B.V.	Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWO-STW)(Netherlands Organization for Scientific Research (NWO)); Product Boards for Livestock and Meat (PVV); Product Board Animal Feed (PDV); Lucta S.A.; Nutreco Nederland B.V.; Verbakel B.V.; Nutreco B.V.	This work was supported by the Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWO-STW, grant number 07722), with co-financers Product Boards for Livestock and Meat (PVV), Product Board Animal Feed (PDV), Lucta S.A., Nutreco Nederland B.V., and Verbakel B.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The work was co-financed by three commercial funders: Lucta S.A., Verbakel B.V. and Nutreco B.V. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arias C, 2007, DEV PSYCHOBIOL, V49, P139, DOI 10.1002/dev.20205; Becques A, 2010, CHEM SENSES, V35, P41, DOI 10.1093/chemse/bjp080; BILKO A, 1994, PHYSIOL BEHAV, V56, P907, DOI 10.1016/0031-9384(94)90322-0; Birch LL, 1998, P NUTR SOC, V57, P617, DOI 10.1079/PNS19980090; Bolhuis JE, 2009, VOLUNTARY FEED INTAKE IN PIGS, P37; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Botermans JAM, 2000, ACTA AGR SCAND A-AN, V50, P237, DOI 10.1080/090647000750069430; BRAKE SC, 1981, SCIENCE, V211, P506, DOI 10.1126/science.7192882; Buchanan TW, 2003, LEARN MEMORY, V10, P319, DOI 10.1101/lm.62303; Burritt EA, 1997, APPL ANIM BEHAV SCI, V54, P317, DOI 10.1016/S0168-1591(97)00005-1; Chaloupkova H, 2007, J ANIM SCI, V85, P1741, DOI 10.2527/jas.2006-504; CHESLER P, 1969, SCIENCE, V166, P901, DOI 10.1126/science.166.3907.901; Chu S, 2000, COGNITION, V75, pB41, DOI 10.1016/S0010-0277(00)00065-2; Chu S, 2000, CHEM SENSES, V25, P111, DOI 10.1093/chemse/25.1.111; Coureaud G, 2002, DEV PSYCHOBIOL, V40, P372, DOI 10.1002/dev.10038; Dudink S, 2006, APPL ANIM BEHAV SCI, V101, P86, DOI 10.1016/j.applanim.2005.12.008; Dunshea FR, 2001, ASIAN AUSTRAL J ANIM, V14, P1610, DOI 10.5713/ajas.2001.1610; DYBKJAER L, 1992, APPL ANIM BEHAV SCI, V35, P135, DOI 10.1016/0168-1591(92)90004-U; El-Haddad MA, 2005, J MATERN-FETAL NEO M, V18, P123, DOI 10.1080/14767050500233860; Epple G, 1999, DEV PSYCHOBIOL, V35, P103, DOI 10.1002/(SICI)1098-2302(199909)35:2<103::AID-DEV3>3.0.CO;2-4; Forestell CA, 2007, PEDIATRICS, V120, P1247, DOI 10.1542/peds.2007-0858; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; GALEF BG, 1972, J COMP PHYSIOL PSYCH, V78, P213, DOI 10.1037/h0032186; Goubet N, 2007, J DEV BEHAV PEDIATR, V28, P189, DOI 10.1097/dbp.0b013e31802d0b8d; Guiraudie-Capraz G, 2005, CHEM SENSES, V30, P241, DOI 10.1093/chemse/bji020; Hausner H., 2009, e-SPEN, V4, pe231; Hausner H, 2008, PHYSIOL BEHAV, V95, P118, DOI 10.1016/j.physbeh.2008.05.007; Hepper PG, 2006, CHEM SENSES, V31, P207, DOI 10.1093/chemse/bjj020; HEPPER PG, 1992, Q J EXP PSYCHOL-B, V44B, P179; HEPPER PG, 1988, ANIM BEHAV, V36, P935, DOI 10.1016/S0003-3472(88)80177-5; Herz RS, 2002, OLFACTION, TASTE, AND COGNITION, P160, DOI 10.1017/CBO9780511546389.016; Herz RS, 2004, INT J COMP PSYCHOL, P17; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Hudson R, 1999, SCHWEIZ MED WSCHR, V129, P176; Jones RB, 2002, ANIM BEHAV, V63, P659, DOI 10.1006/anbe.2001.1943; JONES RB, 1985, PHYSIOL BEHAV, V34, P917, DOI 10.1016/0031-9384(85)90014-9; Launchbaugh KL, 1997, APPL ANIM BEHAV SCI, V54, P327, DOI 10.1016/S0168-1591(96)01194-X; Macri S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001015; Marlier L, 1998, DEV PSYCHOBIOL, V33, P133, DOI 10.1002/(SICI)1098-2302(199809)33:2<133::AID-DEV4>3.0.CO;2-K; MCGAUGH JL, 1993, BEHAV BRAIN RES, V58, P81, DOI 10.1016/0166-4328(93)90092-5; MENNELLA JA, 1995, CHEM SENSES, V20, P207, DOI 10.1093/chemse/20.2.207; Mennella JA, 1999, DEV PSYCHOBIOL, V35, P197, DOI 10.1002/(SICI)1098-2302(199911)35:3&lt;197::AID-DEV4&gt;3.0.CO;2-J; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mennella JA, 1998, CHEM SENSES, V23, P11, DOI 10.1093/chemse/23.1.11; Mennella JA, 2009, AM J CLIN NUTR, V90, p780S, DOI 10.3945/ajcn.2009.27462O; Nicolaidis S, 2008, METABOLISM, V57, pS22, DOI 10.1016/j.metabol.2008.07.004; Oostindjer M, 2010, PHYSIOL BEHAV, V99, P579, DOI 10.1016/j.physbeh.2010.01.031; Oostindjer M, 2009, CHEM SENSES, V34, P775, DOI 10.1093/chemse/bjp063; PROVENZA FD, 1987, APPL ANIM BEHAV SCI, V18, P211, DOI 10.1016/0168-1591(87)90218-8; Rattaz C, 2005, J DEV BEHAV PEDIATR, V26, P86, DOI 10.1097/00004703-200504000-00003; Ruis MAW, 1997, PHYSIOL BEHAV, V62, P623, DOI 10.1016/S0031-9384(97)00177-7; SCHAAL B, 1995, BEHAVIOUR, V132, P351, DOI 10.1163/156853995X00603; SCHAAL B, 1995, BIOL NEONATE, V67, P397; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Sevelinges Y, 2009, BEHAV BRAIN RES, V198, P313, DOI 10.1016/j.bbr.2008.11.003; Simitzis PE, 2008, PHYSIOL BEHAV, V93, P529, DOI 10.1016/j.physbeh.2007.10.013; Sneddon H, 1998, PHYSIOL BEHAV, V64, P133, DOI 10.1016/S0031-9384(98)00037-7; Sullivan RM, 1998, BIOL NEONATE, V74, P402, DOI 10.1159/000014061; Todrank J, 2011, P ROY SOC B-BIOL SCI, V278, P1949, DOI 10.1098/rspb.2010.2314; Varendi H, 1998, EARLY HUM DEV, V51, P47, DOI 10.1016/S0378-3782(97)00082-0; Villalba JJ, 2000, J ANIM SCI, V78, P3060; Weary DM, 1997, APPL ANIM BEHAV SCI, V53, P249, DOI 10.1016/S0168-1591(96)01173-2; Wells DL, 2006, ANIM BEHAV, V72, P681, DOI 10.1016/j.anbehav.2005.12.008; Willander J, 2006, PSYCHON B REV, V13, P240, DOI 10.3758/BF03193837; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; WUENSCH KL, 1978, J GEN PSYCHOL, V99, P163, DOI 10.1080/00221309.1978.9710501	66	30	30	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25318	10.1371/journal.pone.0025318	http://dx.doi.org/10.1371/journal.pone.0025318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039409	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500009
J	Scotti, C; Olivieri, C; Boeri, L; Canzonieri, C; Ornati, F; Buscarini, E; Pagella, F; Danesino, C				Scotti, Claudia; Olivieri, Carla; Boeri, Laura; Canzonieri, Cecilia; Ornati, Federica; Buscarini, Elisabetta; Pagella, Fabio; Danesino, Cesare			Bioinformatic Analysis of Pathogenic Missense Mutations of Activin Receptor Like Kinase 1 Ectodomain	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; MULTIPLE SEQUENCE ALIGNMENT; HEREDITARY HEMORRHAGIC TELANGIECTASIA; TRANSMEMBRANE CONDUCTANCE REGULATOR; SUPPORT VECTOR MACHINES; TGF-BETA; STRUCTURAL BASIS; CYSTIC-FIBROSIS; STABILITY CHANGES; CRYSTAL-STRUCTURE	Activin A receptor, type II-like kinase 1 (also called ALK1), is a serine-threonine kinase predominantly expressed on endothelial cells surface. Mutations in its ACVRL1 encoding gene (12q11-14) cause type 2 Hereditary Haemorrhagic Telangiectasia (HHT2), an autosomal dominant multisystem vascular dysplasia. The study of the structural effects of mutations is crucial to understand their pathogenic mechanism. However, while an X-ray structure of ALK1 intracellular domain has recently become available (PDB ID: 3MY0), structure determination of ALK1 ectodomain (ALK1(EC)) has been elusive so far. We here describe the building of a homology model for ALK1(EC), followed by an extensive bioinformatic analysis, based on a set of 38 methods, of the effect of missense mutations at the sequence and structural level. ALK1(EC) potential interaction mode with its ligand BMP9 was then predicted combining modelling and docking data. The calculated model of the ALK1(EC) allowed mapping and a preliminary characterization of HHT2 associated mutations. Major structural changes and loss of stability of the protein were predicted for several mutations, while others were found to interfere mainly with binding to BMP9 or other interactors, like Endoglin (CD105), whose encoding ENG gene (9q34) mutations are known to cause type 1 HHT. This study gives a preliminary insight into the potential structure of ALK1(EC) and into the structural effects of HHT2 associated mutations, which can be useful to predict the potential effect of each single mutation, to devise new biological experiments and to interpret the biological significance of new mutations, private mutations, or non-synonymous polymorphisms.	[Scotti, Claudia] Univ Pavia, Dept Expt Med, Sect Gen Pathol, I-27100 Pavia, Italy; [Olivieri, Carla; Boeri, Laura; Canzonieri, Cecilia; Ornati, Federica; Danesino, Cesare] Univ Pavia, Dept Human & Hereditary Pathol, Sect Gen Biol & Med Genet, I-27100 Pavia, Italy; [Buscarini, Elisabetta] Maggiore Hosp, Dept Gastroenterol, Crema, Italy; [Pagella, Fabio] Fdn IRCCS Policlin San Matteo, Dept Otorhinolaryngol, ENT Unit, Pavia, Italy	University of Pavia; University of Pavia; IRCCS Fondazione San Matteo	Scotti, C (corresponding author), Univ Pavia, Dept Expt Med, Sect Gen Pathol, Via Palestro 3, I-27100 Pavia, Italy.	claudia.scotti@unipv.it	Scotti, Claudia/AAM-3372-2021; Scotti, Claudia/A-7126-2012; Olivieri, Carla/D-8525-2011	Scotti, Claudia/0000-0002-5790-1833; Olivieri, Carla/0000-0001-5812-3175; Ornati, Federica/0000-0002-6299-7761	Italian HHT Patients' Association "Fondazione Italiana Onilde Carini per la Teleangectasia Emorragica Ereditaria"	Italian HHT Patients' Association "Fondazione Italiana Onilde Carini per la Teleangectasia Emorragica Ereditaria"	This work has been performed with the financial support of the Italian HHT Patients' Association "Fondazione Italiana Onilde Carini per la Teleangectasia Emorragica Ereditaria". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bilandzic M, 2011, MOL CELL ENDOCRINOL, V339, P180, DOI 10.1016/j.mce.2011.04.014; Bone LJ, 1997, NEUROBIOL DIS, V4, P221, DOI 10.1006/nbdi.1997.0152; Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Bujnicki JM, 2003, CURR PROTEIN PEPT SC, V4, P327, DOI 10.2174/1389203033487072; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2003, BIOINFORMATICS, V19, P899, DOI 10.1093/bioinformatics/btg110; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; FINN RD, NUCL ACIDS RES, V38, pD211; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Godzik Adam, 2003, Methods Biochem Anal, V44, P525; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; Grateau G, 2005, M S-MED SCI, V21, P627, DOI 10.1051/medsci/2005216-7627; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Higa RH, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-107; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Huang LT, 2007, BIOINFORMATICS, V23, P1292, DOI 10.1093/bioinformatics/btm100; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kosinski J, 2003, PROTEINS, V53, P369, DOI 10.1002/prot.10545; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Kwasigroch JM, 2002, BIOINFORMATICS, V18, P1701, DOI 10.1093/bioinformatics/18.12.1701; Lappalainen I, 2002, PROTEIN ENG, V15, P1005, DOI 10.1093/protein/15.12.1005; Lappalainen I, 2000, BIOCHEM BIOPH RES CO, V269, P124, DOI 10.1006/bbrc.2000.2146; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Mahadeva R, 1998, THORAX, V53, P1022, DOI 10.1136/thx.53.12.1022; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mooney SD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-24; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olivieri C, 2007, J HUM GENET, V52, P820, DOI 10.1007/s10038-007-0187-5; Parthiban V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-54; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; PENG I, 2010, MULTIPLE TEMPL UNPUB; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Rong SB, 2000, MOL MED, V6, P155, DOI 10.1007/BF03402111; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Runker AE, 2003, J NEUROSCI, V23, P277; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shen B, 2004, PROTEIN ENG DES SEL, V17, P267, DOI 10.1093/protein/gzh030; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimizu K, 2007, BIOINFORMATICS, V23, P2337, DOI 10.1093/bioinformatics/btm330; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; THOMAS PJ, 1991, SCIENCE, V251, P555, DOI 10.1126/science.1703660; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Thusberg J, 2006, HUM MUTAT, V27, P1230, DOI 10.1002/humu.20407; Tramontano A, 1998, METHODS, V14, P293, DOI 10.1006/meth.1998.0585; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; van Meeteren LA, 2011, CURR PHARM BIOTECHNO; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Wallner B, 2005, BIOINFORMATICS, V21, P4248, DOI 10.1093/bioinformatics/bti702; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; WARD CL, 1994, J BIOL CHEM, V269, P25710; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Westhead DR, 1998, CURR OPIN BIOTECH, V9, P383, DOI 10.1016/S0958-1669(98)80012-8; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winn MD, ACTA CRYSTALLOGR D, V67, P235; XU Y, 2006, COMPUTATIONAL METHOD, V1, P389; XU Y, 2006, COMPUTATIONAL METHOD, V2, P389; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	104	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26431	10.1371/journal.pone.0026431	http://dx.doi.org/10.1371/journal.pone.0026431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028876	gold, Green Published			2022-12-25	WOS:000296186900061
J	Stam, J; Abdulahad, W; Huitema, MG; Roozendaal, C; Limburg, PC; van Stuijvenberg, M; Scholvinck, EH				Stam, Jose; Abdulahad, Wayel; Huitema, Minke G.; Roozendaal, Caroline; Limburg, Pieter C.; van Stuijvenberg, Margriet; Scholvinck, Elisabeth H.			Fluorescent Cell Barcoding as a Tool to Assess the Age-Related Development of Intracellular Cytokine Production in Small Amounts of Blood from Infants	PLOS ONE			English	Article							GAMMA-INTERFERON; FLOW-CYTOMETRY; IFN-GAMMA; PHYTOHEMAGGLUTININ; RESPONSES; CHILDREN; ONTOGENY; TYPE-1	Fluorescent Cell Barcoding (FCB) is a flow cytometric technique which has been used for assessing signaling proteins. This FCB technique has the potential to be applied in other multiparameter analyses. Since data on antigen (Ag)-specific T-cell immune responses, like intracellular cytokine production, are still lacking in infants because limited blood volumes can be obtained for analysis, the FCB technique could be very useful for this purpose. The objectives of this study were to modify the FCB method to be able to measure multiple Ag-specific cytokine reponses in T-cells upon simultaneous stimulation by various antigens and mitogens in small amounts of blood and to investigate the cytokine pattern of T-cell subsets in healthy infants aged six and twelve months. Blood samples, collected from 20 healthy infants aged six and twelve months, were stimulated in vitro with the antigens: phorbol-myristate-acetate (PMA), purified-protein-derivative (PPD), Tetanus-toxoid (TT), Staphylococcal-enterotoxin-B (SEB), and phytohemagglutinin (PHA). Each stimulus was barcoded by labelling with different intensities of fluorescent cell barcoding (FCB) markers. Intracellular production of interleukin-2, interferon-gamma, and tumor necrosis factor-alpha was measured simultaneously in just one blood sample of 600 ml whole blood. Significant age-related differences in cytokine production were shown for PMA, PHA, and TT in CD4(+) T-cells, and for PMA, PHA, SEB, and TT in CD8(+) T-cells. The intracellular cytokine production by CD4(+) and CD8+ T-cells was higher at twelve months compared to six months of age for all antigens, except for PMA, which was lower at the age of twelve months. Based on the consistency in both T-cell subsets, we conclude that the new FCB method is a promising tool to investigate the age-related development of intracellular cytokine production in infants.	[Stam, Jose; van Stuijvenberg, Margriet; Scholvinck, Elisabeth H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9713 AV Groningen, Netherlands; [Abdulahad, Wayel; Huitema, Minke G.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands; [Roozendaal, Caroline; Limburg, Pieter C.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Stam, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9713 AV Groningen, Netherlands.	j.stam@umcg.nl		/0000-0003-3109-4487	Danone Research	Danone Research(Danone Nutricia)	This study was funded by Danone Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Berdat PA, 2003, CLIN CHEM LAB MED, V41, P1335, DOI 10.1515/CCLM.2003.204; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Corbett NP, 2011, PLOS ONE, V5; ELGHAZALI GEB, 1993, EUR J IMMUNOL, V23, P2740, DOI 10.1002/eji.1830231103; FRENKEL L, 1987, J PEDIATR-US, V111, P97, DOI 10.1016/S0022-3476(87)80353-0; Garcia M, 2002, TUBERCULOSIS, V82, P37, DOI 10.1054/tube.2001.0321; Gasparoni A, 2003, BIOL NEONATE, V84, P297, DOI 10.1159/000073638; Hanna-Wakim R, 2009, J INFECT DIS, V200, P1921, DOI 10.1086/648375; Hoffmann F, 2005, EUR CYTOKINE NETW, V16, P283; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; Krampera M, 1999, CLIN EXP IMMUNOL, V117, P291; Krouwels FH, 1997, J IMMUNOL METHODS, V203, P89, DOI 10.1016/S0022-1759(97)00016-1; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lappalainen M, 2009, PEDIAT ALLERG IMM-UK, V20, P714, DOI 10.1111/j.1399-3038.2009.00865.x; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; MIYAWAKI T, 1985, CLIN EXP IMMUNOL, V59, P505; Morosini M, 2003, INT J TUBERC LUNG D, V7, P994; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Rowe J, 2000, INFECT IMMUN, V68, P3873, DOI 10.1128/IAI.68.7.3873-3877.2000; Smart JM, 2001, PEDIATR ALLERGY IMMU, V12, P181, DOI 10.1034/j.1399-3038.2001.012004181.x; Talreja J, 2003, CLIN EXP IMMUNOL, V131, P292, DOI 10.1046/j.1365-2249.2003.02072.x; van Stuijvenberg M, 2011, BR J NUTR IN PRESS; Vigano A, 1999, BIOL NEONATE, V75, P1, DOI 10.1159/000014071	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25690	10.1371/journal.pone.0025690	http://dx.doi.org/10.1371/journal.pone.0025690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043291	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400019
J	Portugal, CC; da Encarnacao, TG; Socodato, R; Moreira, SR; Brudzewsky, D; Ambrosio, AF; Paes-de-Carvalho, R				Portugal, Camila Cabral; da Encarnacao, Thaisa Godinho; Socodato, Renato; Moreira, Sarah Rodrigues; Brudzewsky, Dan; Ambrosio, Antonio Francisco; Paes-de-Carvalho, Roberto			Nitric Oxide Modulates Sodium Vitamin C Transporter 2 (SVCT-2) Protein Expression via Protein Kinase G (PKG) and Nuclear Factor-kappa B (NF-kappa B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH-SY5Y NEUROBLASTORNA CELLS; SOLUBLE GUANYLATE-CYCLASE; CHICK-EMBRYO RETINA; ASCORBIC-ACID; S-NITROSYLATION; CREB PHOSPHORYLATION; RECEPTOR REGULATION; SIGNALING PATHWAY; NERVOUS-SYSTEM; NEURONAL CELLS	Ascorbate is an important antioxidant, which also displays important functions in neuronal tissues, including the retina. The retina is responsible for the initial steps of visual processing, which is further refined in cerebral high-order centers. The retina is also a prototypical model for studying physiologic aspects of cells that comprise the nervous system. Of major importance also is the cellular messenger nitric oxide (NO). Previous studies have demonstrated the significance of NO for both survival and proliferation of cultured embryonic retinal cells. Cultured retinal cells express a high-affinity ascorbate transporter, and the release of ascorbate is delicately regulated by ionotropic glutamate receptors. Therefore, we proposed whether there is interplay between the ascorbate transport system and NO signaling pathway in retinal cells. Here we show compelling evidence that ascorbate uptake is tightly controlled by NO and its downstream signaling pathway in culture. NO also modulates the expression of SVCT-2, an effect mediated by cGMP and PKG. Kinetic studies suggest that NO increases the transport capacity for ascorbate, but not the affinity of SVCT-2 for its substrate. Interestingly, NO utilizes the NF-kappa B pathway, in a PKG-dependent manner, to modulate both SVCT-2 expression and ascorbate uptake. These results demonstrate that NO exerts a fine-tuned control of the availability of ascorbate to cultured retinal cells and strongly reinforces ascorbate as an important bioactive molecule in neuronal tissues.	[Portugal, Camila Cabral; da Encarnacao, Thaisa Godinho; Socodato, Renato; Moreira, Sarah Rodrigues; Paes-de-Carvalho, Roberto] Univ Fed Fluminense, Inst Biol, Dept Neurobiol, BR-24001970 Niteroi, RJ, Brazil; [Portugal, Camila Cabral; da Encarnacao, Thaisa Godinho; Socodato, Renato; Moreira, Sarah Rodrigues; Paes-de-Carvalho, Roberto] Univ Fed Fluminense, Inst Biol, Program Neurosci, BR-24001970 Niteroi, RJ, Brazil; [Portugal, Camila Cabral; Socodato, Renato; Brudzewsky, Dan; Ambrosio, Antonio Francisco] Univ Coimbra, Inst Biomed Res Light & Image, Ctr Ophthalmol & Vis Sci, Fac Med, P-3004548 Coimbra, Portugal	Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade de Coimbra	Paes-de-Carvalho, R (corresponding author), Caixa Postal 100180, BR-24001970 Niteroi, RJ, Brazil.	robpaes@vm.uff.br	Ambrósio, António F/I-3722-2012; Socodato, Renato/A-7237-2013; Paes-de-Carvalho, Roberto/F-8788-2018; Portugal, Camila C/A-6267-2013	Ambrósio, António F/0000-0002-0477-1641; Socodato, Renato/0000-0002-6882-5020; Paes-de-Carvalho, Roberto/0000-0002-4081-7547; Portugal, Camila C/0000-0002-1093-6545; Rodrigues Moreira, Sarah/0000-0002-0166-7312	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro; Programa de Apoio de Nucleos de Excelencia/Ministerio da Ciencia e Tecnologia; FCT, Portugal [C/SAU/UI3282/2011]; FEDER-COMPETE-POFC	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro; Programa de Apoio de Nucleos de Excelencia/Ministerio da Ciencia e Tecnologia; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER-COMPETE-POFC	This work was supported in part by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro, Programa de Apoio de Nucleos de Excelencia/Ministerio da Ciencia e Tecnologia, and Projeto Estrategico C/SAU/UI3282/2011 (FCT, Portugal, and FEDER-COMPETE-POFC).	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Araujo AV, 2011, VASC PHARMACOL, V54, P44, DOI 10.1016/j.vph.2010.12.002; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Bonthius DJ, 2009, NEUROPHARMACOLOGY, V56, P716, DOI 10.1016/j.neuropharm.2008.12.006; Brahma B, 2000, J NEUROCHEM, V74, P1263; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CAREY DJ, 1987, DEV BRAIN RES, V32, P95, DOI 10.1016/0165-3806(87)90142-8; Cossenza M, 2000, J NEUROCHEM, V74, P1885, DOI 10.1046/j.1471-4159.2000.0741885.x; Socodato RED, 2009, J NEUROCHEM, V108, P417, DOI 10.1111/j.1471-4159.2008.05778.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Daruwala R, 1999, FEBS LETT, V460, P480, DOI 10.1016/S0014-5793(99)01393-9; DECARVALHO RP, 1982, J NEUROCHEM, V38, P493; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; GARTHWAITE J, 1987, J NEUROCHEM, V48, P29, DOI 10.1111/j.1471-4159.1987.tb13123.x; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Gonzalez-Polo RA, 2004, CELL BIOL INT, V28, P373, DOI 10.1016/j.cellbi.2004.03.005; GOTO K, 1981, BRAIN RES, V207, P239, DOI 10.1016/0006-8993(81)90701-0; Grant MM, 2005, PROTEOMICS, V5, P534, DOI 10.1002/pmic.200300924; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang JJ, 2006, BRAIN RES, V1097, P52, DOI 10.1016/j.brainres.2006.04.047; Huerta-Yepez S, 2004, ONCOGENE, V23, P4993, DOI 10.1038/sj.onc.1207655; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; LAM KW, 1993, EXP EYE RES, V56, P601, DOI 10.1006/exer.1993.1074; Lee NPY, 2003, ENDOCRINOLOGY, V144, P3114, DOI 10.1210/en.2002-0167; Li X, 2003, BIOCHEM BIOPH RES CO, V305, P656, DOI 10.1016/S0006-291X(03)00836-2; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; Magalhaes CR, 2006, INT J DEV NEUROSCI, V24, P53, DOI 10.1016/j.ijdevneu.2005.10.004; MAJEWSKA MD, 1990, BRAIN RES, V537, P328, DOI 10.1016/0006-8993(90)90379-P; Makino Y, 1999, ANTICANCER RES, V19, P3125; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Mejia-Garcia TA, 2007, J NEUROCHEM, V100, P382, DOI 10.1111/j.1471-4159.2006.04244.x; NG YC, 1985, BIOCHEM PHARMACOL, V34, P2525, DOI 10.1016/0006-2952(85)90537-4; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portugal CC, 2009, J NEUROCHEM, V108, P507, DOI 10.1111/j.1471-4159.2008.05786.x; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Qiu S, 2007, J NEUROSCI RES, V85, P1046, DOI 10.1002/jnr.21204; Rameau GA, 2003, NEUROBIOL AGING, V24, P1123, DOI 10.1016/j.neurobiolaging.2003.07.002; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Savini I, 2007, BIOCHEM BIOPH RES CO, V361, P385, DOI 10.1016/j.bbrc.2007.07.007; Socodato R, 2011, J NEUROCHEM, V116, P227, DOI 10.1111/j.1471-4159.2010.07096.x; Song SH, 2009, INT IMMUNOPHARMACOL, V9, P298, DOI 10.1016/j.intimp.2008.12.003; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Venugopal M, 1996, LIFE SCI, V59, P1389, DOI 10.1016/0024-3205(96)00466-3; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; Wiesinger H, 2001, PROG NEUROBIOL, V64, P365, DOI 10.1016/S0301-0082(00)00056-3	62	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3860	3872		10.1074/jbc.M111.260166	http://dx.doi.org/10.1074/jbc.M111.260166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22041898	hybrid, Green Published			2022-12-25	WOS:000300410900023
J	Almeida, M; Han, L; Ambrogini, E; Weinstein, RS; Manolagas, SC				Almeida, Maria; Han, Li; Ambrogini, Elena; Weinstein, Robert S.; Manolagas, Stavros C.			Glucocorticoids and Tumor Necrosis Factor alpha Increase Oxidative Stress and Suppress Wnt Protein Signaling in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; EXTENDS LIFE-SPAN; FORKHEAD-BOX-O; T-CELL-FACTOR; NF-KAPPA-B; REACTIVE OXYGEN; BETA-CATENIN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION	Endogenous glucocorticoids (GCs) and inflammatory cytokines contribute to the age-associated loss of bone mass and strength, but the molecular mechanisms responsible for their deleterious effects on the aging skeleton are unclear. Based on evidence that oxidative stress is a causal mechanism of the insulin resistance produced by either one of these two agents, we tested the hypothesis that their adverse skeletal effects also result from increased oxidative stress. We report that administration of prednisolone to mice increased reactive oxygen species (ROS) and the phosphorylation of p66(shc) (an amplifier of H2O2 generation in mitochondria) in bone. Dexamethasone (Dex) and TNF alpha had a similar effect on osteoblastic cells in vitro. The generation of ROS by Dex and TNF alpha required PKC beta/p66(shc) signaling and was responsible for the activation of JNK and induction of apoptosis by both agents. The activity of Forkhead box O (FoxO) transcription factors was also increased in response to ROS; however, FoxO activation opposed apoptosis induced by Dex and TNF alpha. In addition, both agents suppressed Akt phosphorylation as well as Wnt-induced proliferation and osteoblast differentiation. However, the inhibitory actions on Wnt signaling were independent of PKC beta/p66(shc). Instead, they were mediated by inhibition of Akt and stimulation of FoxOs. These results demonstrate that ROS-induced activation of a PKC beta/p66(shc)/JNK signaling cascade is responsible for the pro-apoptotic effects of Dex and TNF alpha on osteoblastic cells. Moreover, modulation of Akt and FoxOs by GCs and TNF alpha are cell-autonomous mechanisms of Wnt/beta-catenin antagonism contributing to the adverse effects of GC excess and inflammatory cytokines on bone alike.	[Almeida, Maria] Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Almeida, M (corresponding author), Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, 4301 W Markham St 587, Little Rock, AR 72205 USA.	schullermaria@uams.edu		Almeida, Maria/0000-0002-6722-9200; Warren, Aaron D./0000-0002-0042-9021	National Institutes of Health [P01 AG13918, R01 AR56679]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG13918 and R01 AR56679. This work was also supported by Department of Veterans Affairs Merit Review grants (to S. C. M. and R. S. W.).	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Almeida M, 2010, MOL ENDOCRINOL, V24, P2030, DOI 10.1210/me.2010-0189; Almeida M, 2009, J BIOL CHEM, V284, P27438, DOI 10.1074/jbc.M109.023572; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Boyce BF, 2006, CURR OPIN RHEUMATOL, V18, P427, DOI 10.1097/01.bor.0000231913.32364.32; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Byun CH, 2005, J BONE MINER RES, V20, P1125, DOI 10.1359/JBMR.050302; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Camm EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021142; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cooper MS, 2002, J BONE MINER RES, V17, P979, DOI 10.1359/jbmr.2002.17.6.979; Dennison E, 1999, J CLIN ENDOCR METAB, V84, P3058, DOI 10.1210/jc.84.9.3058; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ding C, 2008, J CLIN ENDOCR METAB, V93, P1952, DOI 10.1210/jc.2007-2325; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hurson CJ, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-12; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jilka RL, 2010, AGING CELL, V9, P851, DOI 10.1111/j.1474-9726.2010.00616.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Morgan MJ, 2010, MOL CELLS, V30, P1, DOI 10.1007/s10059-010-0105-0; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Neels JG, 2006, AM J PATHOL, V168, P435, DOI 10.2353/ajpath.2006.050699; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; PFEFFER KD, 1994, J IMMUNOL, V153, P1789; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Plotkin LI, 2007, J BIOL CHEM, V282, P24120, DOI 10.1074/jbc.M611435200; Poulsen RC, 2011, ENDOCRINOLOGY, V152, P503, DOI 10.1210/en.2010-1087; Purnell JQ, 2004, J CLIN ENDOCR METAB, V89, P281, DOI 10.1210/jc.2003-030440; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Reynolds RM, 2005, CALCIFIED TISSUE INT, V77, P134, DOI 10.1007/s00223-004-0270-2; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; SUZUKI H, 1995, HYPERTENSION, V25, P1083, DOI 10.1161/01.HYP.25.5.1083; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]; Wang FS, 2008, ENDOCRINOLOGY, V149, P1793, DOI 10.1210/en.2007-0910; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Wilkinson CW, 2001, J CLIN ENDOCR METAB, V86, P545, DOI 10.1210/jc.86.2.545; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206	73	187	197	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44326	44335		10.1074/jbc.M111.283481	http://dx.doi.org/10.1074/jbc.M111.283481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22030390	Green Published, hybrid			2022-12-25	WOS:000298645500004
J	Song, EK; Rah, SY; Lee, YR; Yoo, CH; Kim, YR; Yeom, JH; Park, KH; Kim, JS; Kim, UH; Han, MK				Song, Eun-Kyung; Rah, So-Young; Lee, Young-Rae; Yoo, Chae-Hwa; Kim, Yu-Ri; Yeom, Ji-Hyun; Park, Kwang-Hyun; Kim, Jong-Suk; Kim, Uh-Hyun; Han, Myung-Kwan			Connexin-43 Hemichannels Mediate Cyclic ADP-ribose Generation and Its Ca2+-mobilizing Activity by NAD(+)/Cyclic ADP-ribose Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES INTRACELLULAR CALCIUM; PHAGOCYTOSIS OCCURS; SPHINGOSINE KINASE; CD38; CA2+; MACROPHAGES; RELEASE; INFLUX; MOBILIZATION; METABOLISM	The ADP-ribosyl cyclase CD38 whose catalytic domain resides in outside of the cell surface produces the second messenger cyclic ADP-ribose (cADPR) from NAD(+). cADPR increases intracellular Ca2+ through the intracellular ryanodine receptor/Ca2+ release channel (RyR). It has been known that intracellularNAD(+) approaches ecto-CD38 via its export by connexin (Cx43) hemichannels, a component of gap junctions. However, it is unclear how cADPR extracellularly generated by ecto-CD38 approaches intracellular RyR although CD38 itself or nucleoside transporter has been proposed to import cADPR. Moreover, it has been unknown what physiological stimulation can trigger Cx43-mediated export of NAD(+). Here we demonstrate that Cx43 hemichannels, but not CD38, import cADPR to increase intracellular calcium through RyR. We also demonstrate that physiological stimulation such as Fc gamma receptor (Fc gamma R) ligation induces calcium mobilization through three sequential steps, Cx43-mediated NAD(+) export, CD38-mediated generation of cADPR and Cx43-mediated cADPR import in J774 cells. Protein kinase A (PKA) activation also induced calcium mobilization in the same way as Fc gamma R stimulation. Fc gamma R stimulation-induced calcium mobilization was blocked by PKA inhibition, indicating that PKA is a linker between Fc gamma R stimulation and NAD(+)/cADPR transport. Cx43 knockdown blocked extracellular cADPR import and extracellular cADPR-induced calcium mobilization in J774 cells. Cx43 overexpression in Cx43-negative cells conferred extracellular cADPR-induced calcium mobilization by the mediation of cADPR import. Our data suggest that Cx43 has a dual function exporting NAD(+) and importing cADPR into the cell to activate intracellular calcium mobilization.	[Rah, So-Young; Lee, Young-Rae; Park, Kwang-Hyun; Kim, Jong-Suk; Kim, Uh-Hyun] Chonbuk Natl Univ Med Sch & Hosp, Dept Biochem, Jeonju 561182, South Korea; [Song, Eun-Kyung; Yoo, Chae-Hwa; Kim, Yu-Ri; Yeom, Ji-Hyun; Han, Myung-Kwan] Chonbuk Natl Univ Med Sch & Hosp, Dept Microbiol, Jeonju 561182, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ Med Sch & Hosp, Inst Med Sci, Jeonju 561182, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital	Kim, UH (corresponding author), Chonbuk Natl Univ Med Sch & Hosp, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr; iamtom@chonbuk.ac.kr		Han, Myung-Kwan/0000-0003-1931-8898; Kim, Uh-Hyun/0000-0003-3304-7190; Rah, So-Young/0000-0002-0255-1960	Ministry of Health, Welfare & Family Affairs, Republic of Korea [A091087]	Ministry of Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Grant [A091087] from the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea.	Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Bruzzone S, 2001, J BIOL CHEM, V276, P48300, DOI 10.1074/jbc.M107308200; Bruzzone S, 2001, FASEB J, V15, P10; Choi OH, 1996, NATURE, V380, P634; De Flora A, 2000, CHEM IMMUNOL, V75, P79; De Vuyst E, 2009, CELL CALCIUM, V46, P176, DOI 10.1016/j.ceca.2009.07.002; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Franco L, 1998, FASEB J, V12, P1507; FUNARO A, 1990, J IMMUNOL, V145, P2390; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Han MK, 2002, J BIOL CHEM, V277, P5315, DOI 10.1074/jbc.M106439200; Han MK, 2000, J BIOL CHEM, V275, P20799, DOI 10.1074/jbc.M001189200; HISHIKAWA T, 1991, J CELL BIOL, V115, P59, DOI 10.1083/jcb.115.1.59; Kim SY, 2006, EXP MOL MED, V38, P535, DOI 10.1038/emm.2006.63; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; KRUSKAL BA, 1987, J CELL BIOL, V105, P2685, DOI 10.1083/jcb.105.6.2685; LEE HC, 1994, VITAM HORM, V48, P199, DOI 10.1016/S0083-6729(08)60499-9; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MCNEIL PL, 1986, J CELL BIOL, V102, P1586, DOI 10.1083/jcb.102.5.1586; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Rakovic S, 1996, CURR BIOL, V6, P989, DOI 10.1016/S0960-9822(02)00643-7; ROSALES C, 1992, J BIOL CHEM, V267, P5265; Schwarzmann N, 2002, J BIOL CHEM, V277, P50636, DOI 10.1074/jbc.M209061200; SHEN SS, 1993, DEV BIOL, V157, P157, DOI 10.1006/dbio.1993.1120; Song EK, 2008, BIOCHEM BIOPH RES CO, V367, P156, DOI 10.1016/j.bbrc.2007.12.131; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Tang WX, 2002, AM J PHYSIOL-HEART C, V282, pH1304, DOI 10.1152/ajpheart.00843.2001; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; YOUNG JDE, 1984, P NATL ACAD SCI-BIOL, V81, P5430, DOI 10.1073/pnas.81.17.5430; ZEMBALA M, 1970, IMMUNOLOGY, V19, P677	34	40	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44480	44490		10.1074/jbc.M111.307645	http://dx.doi.org/10.1074/jbc.M111.307645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22033928	Green Published, hybrid			2022-12-25	WOS:000298645500020
J	Badiola, N; de Oliveira, RM; Herrera, F; Guardia-Laguarta, C; Goncalves, SA; Pera, M; Suarez-Calvet, M; Clarimon, J; Outeiro, TF; Lleo, A				Badiola, Nahuai; de Oliveira, Rita Machado; Herrera, Federico; Guardia-Laguarta, Cristina; Goncalves, Susana A.; Pera, Marta; Suarez-Calvet, Marc; Clarimon, Jordi; Outeiro, Tiago Fleming; Lleo, Alberto			Tau Enhances alpha-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL PARKINSONS-DISEASE; LEWY BODY DEMENTIA; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; DOWNS-SYNDROME; BODIES; INCLUSIONS; HYPERPHOSPHORYLATION	Background: The simultaneous accumulation of different misfolded proteins in the central nervous system is a common feature in many neurodegenerative diseases. In most cases, co-occurrence of abnormal deposited proteins is observed in different brain regions and cell populations, but, in some instances, the proteins can be found in the same cellular aggregates. Co-occurrence of tau and alpha-synuclein (alpha-syn) aggregates has been described in neurodegenerative disorders with primary deposition of alpha-syn, such as Parkinson's disease and dementia with Lewy bodies. Although it is known that tau and alpha-syn have pathological synergistic effects on their mutual fibrillization, the underlying biological effects remain unclear. Methodology/Principal Findings: We used different cell models of synucleinopathy to investigate the effects of tau on alpha-syn aggregation. Using confocal microscopy and FRET-based techniques we observed that tau colocalized and interacted with alpha-syn aggregates. We also found that tau overexpression changed the pattern of alpha-syn aggregation, reducing the size and increasing the number of aggregates. This shift was accompanied by an increase in the levels of insoluble alpha-syn. Furthermore, co-transfection of tau increased secreted alpha-syn and cytotoxicity. Conclusions/Significance: Our data suggest that tau enhances alpha-syn aggregation and toxicity and disrupts alpha-syn inclusion formation. This pathological synergistic effect between tau and syn may amplify the deleterious process and spread the damage in neurodegenerative diseases that show co-occurrence of both pathologies.	[Badiola, Nahuai; Guardia-Laguarta, Cristina; Pera, Marta; Suarez-Calvet, Marc; Clarimon, Jordi; Lleo, Alberto] Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau, Barcelona, Spain; [Badiola, Nahuai; Guardia-Laguarta, Cristina; Pera, Marta; Suarez-Calvet, Marc; Clarimon, Jordi; Lleo, Alberto] CIBERNED, Madrid, Spain; [de Oliveira, Rita Machado; Herrera, Federico; Goncalves, Susana A.; Outeiro, Tiago Fleming] Inst Mol Med, Cell & Mol Neurosci Unit, Lisbon, Portugal; [Outeiro, Tiago Fleming] Univ Lisbon, Fac Med, P-1699 Lisbon, Portugal	Hospital of Santa Creu i Sant Pau; CIBERNED; Universidade de Lisboa; Universidade de Lisboa	Badiola, N (corresponding author), Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau, Barcelona, Spain.	alleo@santpau.es	Outeiro, Tiago/M-8106-2019; Badiola, Nahuai/C-6526-2011; Lleó, Alberto/K-5783-2019; Herrera, Federico/F-2261-2011; Outeiro, Tiago F/C-1067-2008; Suárez-Calvet, Marc/W-8633-2019; de Oliveira, Rita M/E-9696-2015; Outeiro, Tiago/L-7351-2019; Goncalves, Susana/B-4663-2015	Badiola, Nahuai/0000-0001-9488-5628; Herrera, Federico/0000-0002-9596-9353; Outeiro, Tiago F/0000-0003-1679-1727; de Oliveira, Rita M/0000-0002-0970-4501; Outeiro, Tiago/0000-0003-1679-1727; Goncalves, Susana/0000-0002-8025-2624; Hempsall, Ann-Maree/0000-0001-8610-0106; Guardia-Laguarta, Cristina/0000-0003-0811-9068; Pera, Marta/0000-0003-4317-6623; Suarez-Calvet, Marc/0000-0002-2993-569X; Clarimon, Jordi/0000-0002-6824-6942	Ministerio de Ciencia e Innovacion [FISPI071137]; Fundacio Marato TV3 [072610]; Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED); Marie Curie International Reintegration Grant (Neurofold); EMBO; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/41416/2007, SFRH/BPD/63530/2009]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio Marato TV3; Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED); Marie Curie International Reintegration Grant (Neurofold)(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (FISPI071137), the Fundacio Marato TV3 (072610) and Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED) to AL. TFO is supported by a Marie Curie International Reintegration Grant (Neurofold) and an EMBO Installation Grant. RMO and FH are supported by the Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/41416/2007 and SFRH/BPD/63530/2009, respectively). The funders (including CIBERNED) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiola N, 2010, CNS NEUROL DISORD-DR, V9, P727, DOI 10.2174/187152710793237403; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Berezovska O, 2003, J NEUROSCI, V23, P4560; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Clarimon J, 2009, J NEUROPATH EXP NEUR, V68, P73, DOI 10.1097/NEN.0b013e3181927577; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2006, NEUROTOX RES, V10, P1, DOI 10.1007/BF03033329; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Forman MS, 2002, AM J PATHOL, V160, P1725, DOI 10.1016/S0002-9440(10)61119-4; GALLOWAY PG, 1988, J NEUROPATH EXP NEUR, V47, P654, DOI 10.1097/00005072-198811000-00008; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Iseki E, 1999, NEUROSCI LETT, V265, P9, DOI 10.1016/S0304-3940(99)00178-0; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Judkins AR, 2002, ACTA NEUROPATHOL, V103, P526, DOI 10.1007/s00401-001-0483-7; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RAGHAVAN R, 1993, CAN J NEUROL SCI, V20, P48, DOI 10.1017/S0317167100047405; Schmidt ML, 1996, ACTA NEUROPATHOL, V91, P475, DOI 10.1007/s004010050454; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Terni B, 2007, ACTA NEUROPATHOL, V113, P403, DOI 10.1007/s00401-006-0192-3; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wilhelmsen KC, 2004, ARCH NEUROL-CHICAGO, V61, P398, DOI 10.1001/archneur.61.3.398; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Yancopoulou D, 2005, J NEUROPATH EXP NEUR, V64, P245, DOI 10.1093/jnen/64.3.245; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	57	100	103	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26609	10.1371/journal.pone.0026609	http://dx.doi.org/10.1371/journal.pone.0026609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039514	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200029
J	Francou, B; Bouligand, J; Voican, A; Amazit, L; Trabado, S; Fagart, J; Meduri, G; Brailly-Tabard, S; Chanson, P; Lecomte, P; Guiochon-Mantel, A; Young, J				Francou, Bruno; Bouligand, Jerome; Voican, Adela; Amazit, Larbi; Trabado, Severine; Fagart, Jerome; Meduri, Geri; Brailly-Tabard, Sylvie; Chanson, Philippe; Lecomte, Pierre; Guiochon-Mantel, Anne; Young, Jacques			Normosmic Congenital Hypogonadotropic Hypogonadism Due to TAC3/TACR3 Mutations: Characterization of Neuroendocrine Phenotypes and Novel Mutations	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; NEUROKININ-B; ARCUATE NUCLEUS; KISSPEPTIN NEURONS; TACR3 MUTATIONS; ALPHA-SUBUNIT; DYNORPHIN-A; RECEPTOR; SECRETION; BETA	Context: TAC3/TACR3 mutations have been reported in normosmic congenital hypogonadotropic hypogonadism (nCHH) (OMIM #146110). In the absence of animal models, studies of human neuroendocrine phenotypes associated with neurokinin B and NK3R receptor dysfunction can help to decipher the pathophysiology of this signaling pathway. Objective: To evaluate the prevalence of TAC3/TACR3 mutations, characterize novel TACR3 mutations and to analyze neuroendocrine profiles in nCHH caused by deleterious TAC3/TACR3 biallelic mutations. Results: From a cohort of 352 CHH, we selected 173 nCHH patients and identified nine patients carrying TAC3 or TACR3 variants (5.2%). We describe here 7 of these TACR3 variants (1 frameshift and 2 nonsense deleterious mutations and 4 missense variants) found in 5 subjects. Modeling and functional studies of the latter demonstrated the deleterious consequence of one missense mutation (Tyr267Asn) probably caused by the misfolding of the mutated NK3R protein. We found a statistically significant (p<0.0001) higher mean FSH/LH ratio in 11 nCHH patients with TAC3/TACR3 biallelic mutations than in 47 nCHH patients with either biallelic mutations in KISS1R, GNRHR, or with no identified mutations and than in 50 Kallmann patients with mutations in KAL1, FGFR1 or PROK2/PROKR2. Three patients with TAC3/TACR3 biallelic mutations had an apulsatile LH profile but low-frequency alpha-subunit pulses. Pulsatile GnRH administration increased alpha-subunit pulsatile frequency and reduced the FSH/LH ratio. Conclusion: The gonadotropin axis dysfunction associated with nCHH due to TAC3/TACR3 mutations is related to a low GnRH pulsatile frequency leading to a low frequency of alpha-subunit pulses and to an elevated FSH/LH ratio. This ratio might be useful for pre-screening nCHH patients for TAC3/TACR3 mutations.	[Francou, Bruno; Bouligand, Jerome; Voican, Adela; Amazit, Larbi; Trabado, Severine; Brailly-Tabard, Sylvie; Chanson, Philippe; Guiochon-Mantel, Anne; Young, Jacques] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Francou, Bruno; Bouligand, Jerome; Trabado, Severine; Meduri, Geri; Brailly-Tabard, Sylvie; Guiochon-Mantel, Anne] Hop Bicetre, Assistance Publ Hop Paris, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Francou, Bruno; Bouligand, Jerome; Voican, Adela; Amazit, Larbi; Trabado, Severine; Fagart, Jerome; Meduri, Geri; Brailly-Tabard, Sylvie; Chanson, Philippe; Guiochon-Mantel, Anne; Young, Jacques] INSERM, U693, IFR93, F-94275 Le Kremlin Bicetre, France; [Voican, Adela] Univ Med & Farm, Craiova, Romania; [Chanson, Philippe; Young, Jacques] Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Chanson, Philippe; Young, Jacques] Ctr Reference Malad Endocriniennes Rares Croissan, Le Kremlin Bicetre, France; [Lecomte, Pierre] Hop Bretonneau, Serv Endocrinol, Tours, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Medicine & Pharmacy of Craiova; CHU Tours	Francou, B (corresponding author), Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France.	anne.mantel@bct.aphp.fr	Francou, Bruno/AAX-7301-2020; Guiochon-Mantel, Anne S/S-8408-2018; Chanson, Philippe/F-8511-2013; Francou, Bruno/B-8156-2015; BOULIGAND, Jérôme/S-5716-2018; Young, Jacques/T-2976-2018; Fagart, Jerome/S-4581-2018; Young, Jacques/N-5251-2019	Francou, Bruno/0000-0002-3903-2320; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Chanson, Philippe/0000-0001-5096-5722; Young, Jacques/0000-0001-9286-5631; Fagart, Jerome/0000-0002-7965-0553; Young, Jacques/0000-0001-9286-5631; Trabado, Severine/0000-0002-1925-1999	Paris-Sud 11 University; INSERM ANR [KalGenopath 09-GENO-017]; PHRC HYPOPROTEO [P081212]; Fondation pour la Recherche Medicale	Paris-Sud 11 University; INSERM ANR(Institut National de la Sante et de la Recherche Medicale (Inserm)French National Research Agency (ANR)); PHRC HYPOPROTEO; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Funding: This work was supported in part by grants from Paris-Sud 11 University (Bonus Qualite Recherche 2009), INSERM ANR KalGenopath 09-GENO-017, PHRC HYPOPROTEO P081212 and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazit L, 2007, MOL CELL BIOL, V27, P6913, DOI 10.1128/MCB.01695-06; Amstalden M, 2010, J NEUROENDOCRINOL, V22, P1, DOI 10.1111/j.1365-2826.2009.01930.x; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; Chanson P, 1997, J CLIN ENDOCR METAB, V82, P1397, DOI 10.1210/jc.82.5.1397; Ciccone NA, 2009, CURR OPIN ENDOCRINOL, V16, P321, DOI 10.1097/MED.0b013e32832d88fb; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Conn PM, 2009, MOL CELL ENDOCRINOL, V299, P137, DOI 10.1016/j.mce.2008.10.051; Corander MP, 2010, J NEUROENDOCRINOL, V22, P181, DOI 10.1111/j.1365-2826.2009.01951.x; Crowley WF, 1994, GLYCOPROTEIN HORMONE, P253; De Luca F, 2008, EUR J ENDOCRINOL, V158, P921, DOI 10.1530/EJE-07-0494; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Duarte CR, 2006, CELL TISSUE RES, V323, P43, DOI 10.1007/s00441-005-0027-x; Eswar N, 2006, CURR PROTOC BIOINFOR, V50, P291; Fukami M, 2010, HORM RES PAEDIAT, V73, P477, DOI 10.1159/000313373; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Goze C, 2010, EUR J PHARMACOL, V643, P153, DOI 10.1016/j.ejphar.2010.06.018; Guran T, 2009, J CLIN ENDOCR METAB, V94, P3633, DOI 10.1210/jc.2009-0551; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Latronico AC, 2009, NAT GENET, V41, P269, DOI 10.1038/ng0309-269; Luan XH, 2007, EUR J ENDOCRINOL, V157, P113, DOI 10.1530/EJE-07-0061; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pitteloud N, 2002, J CLIN ENDOCR METAB, V87, P4128, DOI 10.1210/jc.2002-020518; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Rance NE, 2010, BRAIN RES, V1364, P116, DOI 10.1016/j.brainres.2010.08.059; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Salenave S, 2008, J CLIN ENDOCR METAB, V93, P758, DOI 10.1210/jc.2007-1168; Sandoval-Guzman T, 2004, BRAIN RES, V1026, P307, DOI 10.1016/j.brainres.2004.08.026; Schmidlin F, 2003, AM J PHYSIOL-CELL PH, V285, pC945, DOI 10.1152/ajpcell.00541.2002; Siuciak JA, 2007, PSYCHOPHARMACOLOGY, V194, P185, DOI 10.1007/s00213-007-0828-6; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; WHITCOMB RW, 1990, J CLIN ENDOCR METAB, V70, P1654, DOI 10.1210/jcem-70-6-1654; WINTERS SJ, 1988, J CLIN ENDOCR METAB, V66, P338, DOI 10.1210/jcem-66-2-338; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600	42	59	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25614	10.1371/journal.pone.0025614	http://dx.doi.org/10.1371/journal.pone.0025614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031817	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200004
J	Koorem, K; Price, JN; Moora, M				Koorem, Kadri; Price, Jodi N.; Moora, Mari			Species-Specific Effects of Woody Litter on Seedling Emergence and Growth of Herbaceous Plants	PLOS ONE			English	Article							TREE LEAF LITTER; UNDERSTORY VEGETATION; DECOMPOSITION RATES; BOREONEMORAL FOREST; DECIDUOUS WOODLAND; TEMPERATE FORESTS; SOIL QUALITY; OAK STANDS; RICHNESS; DIVERSITY	The effect of litter on seedling establishment can influence species richness in plant communities. The effect of litter depends on amount, and also on litter type, but relatively little is known about the species-specific effects of litter. We conducted a factorial greenhouse experiment to examine the effect of litter type, using two woody species that commonly co-occur in boreonemoral forest-evergreen spruce (Picea abies), deciduous hazel (Corylus avellana), and a mixture of the two species-and litter amount-shallow (4 mm), deep (12 mm) and leachate-on seedling emergence and biomass of three understorey species. The effect of litter amount on seedling emergence was highly dependent on litter type; while spruce needle litter had a significant negative effect that increased with depth, seedling emergence in the presence of hazel broadleaf litter did not differ from control pots containing no litter. Mixed litter of both species also had a negative effect on seedling emergence that was intermediate compared to the single-species treatments. Spruce litter had a marginally positive (shallow) or neutral effect (deep) on seedling biomass, while hazel and mixed litter treatments had significant positive effects on biomass that increased with depth. We found non-additive effects of litter mixtures on seedling biomass indicating that high quality hazel litter can reduce the negative effects of spruce. Hazel litter does not inhibit seedling emergence; it increases seedling growth, and creates better conditions for seedling growth in mixtures by reducing the suppressive effect of spruce litter, having a positive effect on understorey species richness.	[Koorem, Kadri; Price, Jodi N.; Moora, Mari] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Koorem, K (corresponding author), Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	kadri.koorem@ut.ee	Price, Jodi/J-6534-2012; Moora, Mari/D-1961-2009	Moora, Mari/0000-0002-4819-7506; Koorem, Kadri/0000-0002-3376-9372	Estonian Science Foundation [7371, SF0180098s08]; Centre of Excellence FIBIR; MOBILITAS post doctoral grant [MJD47]	Estonian Science Foundation; Centre of Excellence FIBIR; MOBILITAS post doctoral grant	The project was supported by Estonian Science Foundation grants 7371, SF0180098s08 (University of Tartu), by the European Regional Development Fund (Centre of Excellence FIBIR) and by MOBILITAS post doctoral grant (MJD47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2009, ANN BOT FENN, V46, P326, DOI 10.5735/085.046.0408; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Augusto L, 2003, ANN FOREST SCI, V60, P823, DOI 10.1051/forest:2003077; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BOSY JL, 1995, FUNCT ECOL, V9, P635, DOI 10.2307/2390155; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Donath TW, 2008, J ECOL, V96, P272, DOI 10.1111/j.1365-2745.2007.01338.x; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; Eckstein RL, 2005, J ECOL, V93, P807, DOI 10.1111/j.1365-2745.2005.01015.x; FACELLI JM, 1991, ECOLOGY, V72, P1024, DOI 10.2307/1940602; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hoorens B, 2010, OECOLOGIA, V162, P479, DOI 10.1007/s00442-009-1454-2; Janisova M, 2007, ANN BOT FENN, V44, P256; Jogar U, 2008, RESTOR ECOL, V16, P382, DOI 10.1111/j.1526-100X.2008.00435.x; Jonsson M, 2008, OIKOS, V117, P1674, DOI 10.1111/j.1600-0706.2008.16810.x; Kooijman AM, 2010, FUNCT ECOL, V24, P469, DOI 10.1111/j.1365-2435.2009.01640.x; Koorem K, 2010, FOREST ECOL MANAG, V260, P1407, DOI 10.1016/j.foreco.2010.07.043; Kostel-Hughes F, 2005, J TORREY BOT SOC, V132, P50, DOI 10.3159/1095-5674(2005)132[50:EOLLDO]2.0.CO;2; Li W, 2009, ECOL RES, V24, P761, DOI 10.1007/s11284-008-0546-5; Molder A, 2008, FOREST ECOL MANAG, V256, P272, DOI 10.1016/j.foreco.2008.04.012; Mohr D, 2005, GEODERMA, V129, P45, DOI 10.1016/j.geoderma.2004.12.029; Mohr D, 2005, ANN FOREST SCI, V62, P23, DOI 10.1051/forest:2004090; Moora M, 2007, FOREST ECOL MANAG, V250, P64, DOI 10.1016/j.foreco.2007.03.010; Nilsson MC, 1999, OIKOS, V86, P16, DOI 10.2307/3546566; Quested H, 2006, FUNCT ECOL, V20, P522, DOI 10.1111/j.1365-2435.2006.01131.x; Quested HM, 2003, OECOLOGIA, V135, P606, DOI 10.1007/s00442-003-1225-4; Richards AE, 2010, TREE PHYSIOL, V30, P1192, DOI 10.1093/treephys/tpq035; Royal Botanical Gardens KEW, 2008, SEED INF DAT SID VER; Ruprecht E, 2010, J VEG SCI, V21, P1069, DOI 10.1111/j.1654-1103.2010.01206.x; Saetre P, 1999, ECOGRAPHY, V22, P183, DOI 10.1111/j.1600-0587.1999.tb00467.x; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; SYDES C, 1981, J ECOL, V69, P249, DOI 10.2307/2259829; SYDES C, 1981, J ECOL, V69, P237, DOI 10.2307/2259828; Tinya F, 2009, PLANT ECOL, V204, P69, DOI 10.1007/s11258-008-9566-z; van Oijen D, 2005, APPL VEG SCI, V8, P155, DOI 10.1658/1402-2001(2005)008[0155:EOTSCO]2.0.CO;2; Vogt DR, 2010, AM NAT, V175, P73, DOI 10.1086/648556; Wulf M, 2009, J VEG SCI, V20, P517, DOI 10.1111/j.1654-1103.2009.05713.x; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x; Zobel M, 2007, FOREST ECOL MANAG, V250, P71, DOI 10.1016/j.foreco.2007.03.011	42	22	25	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26505	10.1371/journal.pone.0026505	http://dx.doi.org/10.1371/journal.pone.0026505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028890	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800047
J	Wu, CH; Chen, SY; Shortreed, MR; Kreitinger, GM; Yuan, Y; Frey, BL; Zhang, Y; Mirza, S; Cirillo, LA; Olivier, M; Smith, LM				Wu, Cheng-Hsien; Chen, Siyuan; Shortreed, Michael R.; Kreitinger, Gloria M.; Yuan, Yuan; Frey, Brian L.; Zhang, Yi; Mirza, Shama; Cirillo, Lisa A.; Olivier, Michael; Smith, Lloyd M.			Sequence-Specific Capture of Protein-DNA Complexes for Mass Spectrometric Protein Identification	PLOS ONE			English	Article							FORMALDEHYDE CROSS-LINKING; CHROMATIN IMMUNOPRECIPITATION; TELOMERIC HETEROCHROMATIN; TRANSCRIPTION FACTORS; BINDING PROTEINS; GENOME; HISTONE; GENE; OLIGONUCLEOTIDES; ASSOCIATION	The regulation of gene transcription is fundamental to the existence of complex multicellular organisms such as humans. Although it is widely recognized that much of gene regulation is controlled by gene-specific protein-DNA interactions, there presently exists little in the way of tools to identify proteins that interact with the genome at locations of interest. We have developed a novel strategy to address this problem, which we refer to as GENECAPP, for Global ExoNuclease-based Enrichment of Chromatin-Associated Proteins for Proteomics. In this approach, formaldehyde cross-linking is employed to covalently link DNA to its associated proteins; subsequent fragmentation of the DNA, followed by exonuclease digestion, produces a single-stranded region of the DNA that enables sequence-specific hybridization capture of the protein-DNA complex on a solid support. Mass spectrometric (MS) analysis of the captured proteins is then used for their identification and/or quantification. We show here the development and optimization of GENECAPP for an in vitro model system, comprised of the murine insulin-like growth factor-binding protein 1 (IGFBP1) promoter region and FoxO1, a member of the forkhead rhabdomyosarcoma (FoxO) subfamily of transcription factors, which binds specifically to the IGFBP1 promoter. This novel strategy provides a powerful tool for studies of protein-DNA and protein-protein interactions.	[Wu, Cheng-Hsien; Chen, Siyuan; Shortreed, Michael R.; Kreitinger, Gloria M.; Yuan, Yuan; Frey, Brian L.; Smith, Lloyd M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Wu, Cheng-Hsien; Smith, Lloyd M.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA; [Zhang, Yi; Mirza, Shama; Olivier, Michael] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Mirza, Shama] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Cirillo, Lisa A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Olivier, Michael] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Smith, Lloyd M.] Genome Ctr Wisconsin, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Wu, CH (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	smith@chem.wisc.edu	Frey, Brian L/M-5035-2015; SHORTREED, MICHAEL/A-8371-2018; Chen, Siyuan/C-6163-2012	Frey, Brian L/0000-0002-0397-7269; SHORTREED, MICHAEL/0000-0003-4626-0863; 	Wisconsin Center of Excellence in Genomics Science through the National Human Genome Research Institute, National Institutes of Health [1P50HG004952]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004952] Funding Source: NIH RePORTER	Wisconsin Center of Excellence in Genomics Science through the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Wisconsin Center of Excellence in Genomics Science through the National Human Genome Research Institute, National Institutes of Health [1P50HG004952]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Butala M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp043; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; DEDON PC, 1991, MOL CELL BIOL, V11, P1729, DOI 10.1128/MCB.11.3.1729; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Griffin TJ, 2001, J BIOL CHEM, V276, P45497, DOI 10.1074/jbc.R100014200; GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Himeda CL, 2004, MOL CELL BIOL, V24, P2132, DOI 10.1128/MCB.24.5.2132-2143.2004; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; JOHNSON DS, 2007, GENOME WIDE MAPPING; KATZHENDLER J, 1989, TETRAHEDRON, V45, P2777, DOI 10.1016/S0040-4020(01)80108-3; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Little J W, 1981, Gene Amplif Anal, V2, P135; Lockett MR, 2008, LANGMUIR, V24, P69, DOI 10.1021/la702493u; McGall GH, 1997, J AM CHEM SOC, V119, P5081, DOI 10.1021/ja964427a; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Nordhoff E, 1999, NAT BIOTECHNOL, V17, P884, DOI 10.1038/12873; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Richmond KE, 2004, NUCLEIC ACIDS RES, V32, P5011, DOI 10.1093/nar/gkh793; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rogers S G, 1980, Methods Enzymol, V65, P201; ROGERS SG, 1980, GENE, V11, P187, DOI 10.1016/0378-1119(80)90059-1; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smith LM, 2011, ANALYST, V136, P3060, DOI 10.1039/c1an15037e; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Stead JA, 2006, MOL CELL PROTEOMICS, V5, P1697, DOI 10.1074/mcp.T600027-MCP200; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; THOMAS KR, 1978, J BIOL CHEM, V253, P424	43	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26217	10.1371/journal.pone.0026217	http://dx.doi.org/10.1371/journal.pone.0026217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028835	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800026
J	Pappalardo, F; Forero, IM; Pennisi, M; Palazon, A; Melero, I; Motta, S				Pappalardo, Francesco; Martinez Forero, Ivan; Pennisi, Marzio; Palazon, Asis; Melero, Ignacio; Motta, Santo			SimB16: Modeling Induced Immune System Response against B16-Melanoma	PLOS ONE			English	Article							IMMUNOSTIMULATORY MONOCLONAL-ANTIBODIES; CANCER; EFFICACY; CD137; IMMUNOTHERAPY; EXPRESSION; CELLS	Immunological therapy of progressive tumors requires not only activation and expansion of tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including migration of CTLs in the tumor tissue followed by conjugation and killing of target cells. We report the application of an agent-based model to recapitulate both the effect of a specific immunotherapy strategy against B16-melanoma in mice and the tumor progression in a generic tissue section. A comparison of the in silico results with the in vivo experiments shows excellent agreement. We therefore use the model to predict a critical role for CD137 expression on tumor vessel endothelium for successful therapy and other mechanistic aspects. Experimental results are fully compatible with the model predictions. The biologically oriented in silico model derived in this work will be used to predict treatment failure or success in other pre-clinical conditions eventually leading new promising in vivo experiments.	[Pappalardo, Francesco; Pennisi, Marzio; Motta, Santo] Univ Catania, Catania, Italy; [Martinez Forero, Ivan; Palazon, Asis; Melero, Ignacio] CIMA, Pamplona, Spain; [Martinez Forero, Ivan; Palazon, Asis; Melero, Ignacio] CUN Univ Navarra Pamplona, Pamplona, Spain	University of Catania; University of Navarra	Pappalardo, F (corresponding author), Univ Catania, Catania, Italy.	imelero@unav.es	Palazon, Asis/ABI-1748-2020; Pennisi, Marzio/AAC-7947-2019; Melero, Ignacio/T-7600-2019; Pappalardo, Francesco/C-5832-2011; Pennisi, Marzio/G-4618-2015	Palazon, Asis/0000-0002-7172-7229; Pennisi, Marzio/0000-0003-0231-7653; Melero, Ignacio/0000-0002-1360-348X; Pappalardo, Francesco/0000-0003-1668-3320; Pennisi, Marzio/0000-0003-0231-7653; Joyce, Melinda/0000-0002-2791-5425; Motta, Santo/0000-0003-3533-2972	MEC/MICINN [SAF2005-03131, SAF2008- 03294]; Departamento de Educacion de Navarra (Beca Ortiz de Landazuri), Redes Tematicas de Investigacion Cooperativa RETIC [RD06/0020/0065]; Fondo de Investigacion Sanitaria [FIS PI060932]; European Commission; Fundacion Mutua Madrilena; FIS; UTE	MEC/MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departamento de Educacion de Navarra (Beca Ortiz de Landazuri), Redes Tematicas de Investigacion Cooperativa RETIC; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); UTE	Financial support was from MEC/MICINN (SAF2005-03131 and SAF2008- 03294), Departamento de Educacion de Navarra (Beca Ortiz de Landazuri), Redes Tematicas de Investigacion Cooperativa RETIC (RD06/0020/0065), Fondo de Investigacion Sanitaria (FIS PI060932), European Commission 7th Framework Program (ENCITE) and SUDOE-IMMUNONET, Fundacion Mutua Madrilena, and "UTE for project FIMA''. AP receives a scholarship from FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldazzi V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-387; Broll K, 2001, AM J CLIN PATHOL, V115, P543, DOI 10.1309/E343-KMYX-W3Y2-10KY; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Dubrot J, 2010, CANCER IMMUNOL IMMUN, V59, P1223, DOI 10.1007/s00262-010-0846-9; Halling-Brown M, 2010, PHILOS T R SOC A, V368, P2799, DOI 10.1098/rsta.2010.0067; Ito F, 2004, CANCER RES, V64, P8411, DOI 10.1158/0008-5472.CAN-04-0590; May KF, 2002, CANCER RES, V62, P3459; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Melero I, 2009, CLIN CANCER RES, V15, P1507, DOI 10.1158/1078-0432.CCR-08-2931; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Motta Santo, 2005, Immunome Res, V1, P5, DOI 10.1186/1745-7580-1-5; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Palazon A, 2011, CANCER RES, V71, P801, DOI 10.1158/0008-5472.CAN-10-1733; Palladini A, 2010, CANCER RES, V70, P7755, DOI 10.1158/0008-5472.CAN-10-0701; Pappalardo F, 2006, LECT NOTES ARTIF INT, V3849, P223; Pappalardo F, 2008, BIOINFORMATICS, V24, P1715, DOI 10.1093/bioinformatics/btn306; Pappalardo Francesco, 2010, Immunome Res, V6, P1, DOI 10.1186/1745-7580-6-1; Pappalardo F, 2010, BIOTECHNOL ADV, V28, P82, DOI 10.1016/j.biotechadv.2009.10.001; Pappalardo F, 2009, BRIEF BIOINFORM, V10, P330, DOI 10.1093/bib/bbp014; Pennisi M, 2008, BIOINFORMATICS, V24, P1740, DOI 10.1093/bioinformatics/btn260; Pennisi M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S13; Perez-Gracia JL, 2009, IMMUNOTHERAPY-UK, V1, P845, DOI 10.2217/IMT.09.51; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Tirapu I, 2006, CANCER RES, V66, P2442, DOI 10.1158/0008-5472.CAN-05-1681; Tirapu I, 2004, INT J CANCER, V110, P51, DOI 10.1002/ijc.20093	28	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26523	10.1371/journal.pone.0026523	http://dx.doi.org/10.1371/journal.pone.0026523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028894	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500082
J	Pfeilschifter, W; Spitzer, D; Pfeilschifter, J; Steinmetz, H; Foerch, C				Pfeilschifter, Waltraud; Spitzer, Daniel; Pfeilschifter, Josef; Steinmetz, Helmuth; Foerch, Christian			Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; RAPID REVERSAL; THROMBOLYSIS; GUIDELINE; OUTCOMES; MODEL	Background: Oral anticoagulant therapy (OAT) with warfarin is the standard of stroke prevention in patients with atrial fibrillation. Approximately 30% of patients with cardioembolic strokes are on OAT at the time of symptom onset. We investigated whether warfarin exacerbates the risk of thrombolysis-associated hemorrhagic transformation (HT) in a mouse model of ischemic stroke. Methods: 62 C57BL/6 mice were used for this study. To achieve effective anticoagulation, warfarin was administered orally. We performed right middle cerebral artery occlusion (MCAO) for 3 h and assessed functional deficit and HT blood volume after 24 h. Results: In non-anticoagulated mice, treatment with rt-PA (10 mg/kg i.v.) after 3 h MCAO led to a 5-fold higher degree of HT compared to vehicle-treated controls (4.0 +/- 0.5 mu l vs. 0.8 +/- 0.1, p<0.001). Mice on warfarin revealed larger amounts of HT after rt-PA treatment in comparison to non-anticoagulated mice (9.2 +/- 3.2 mu l vs. 2.8 +/- 1.0, p<0.05). The rapid reversal of anticoagulation by means of prothrombin complex concentrates (PCC, 100 IU/kg) at the end of the 3 h MCAO period, but prior to rt-PA administration, neutralized the exacerbated risk of HT as compared to sham-treated controls (3.8 +/- 0.7 mu l vs. 15.0 +/- 3.8, p<0.001). Conclusion: In view of the vastly increased risk of HT, it seems to be justified to withhold tPA therapy in effectively anticoagulated patients with acute ischemic stroke. The rapid reversal of anticoagulation with PCC prior to tPA application reduces the risk attributed to warfarin pretreatment and may constitute an interesting therapeutic option.	[Pfeilschifter, Waltraud; Spitzer, Daniel; Steinmetz, Helmuth; Foerch, Christian] Goethe Univ Hosp, Dept Neurol, Frankfurt, Germany; [Pfeilschifter, Josef] Goethe Univ Hosp, Dept Gen Pharmacol & Toxicol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Pfeilschifter, W (corresponding author), Goethe Univ Hosp, Dept Neurol, Frankfurt, Germany.	w.pfeilschifter@med.uni-frankfurt.de	Pfeilschifter, Waltraud/K-6134-2012; Spitzer, Daniel/GQO-7467-2022	Pfeilschifter, Waltraud/0000-0001-6935-8842; 	Medical Faculty of the Goethe-University (Patenschaftsmodell)	Medical Faculty of the Goethe-University (Patenschaftsmodell)	W. Pfeilschifter was supported by a stipend of the Medical Faculty of the Goethe-University (Patenschaftsmodell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; *BRYST MYERS SQUIB, PRESCR INF COUM WARF; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Collen D., 1994, MOL BASIS BLOOD DIS, P662; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Foerch C, 2009, J CEREBR BLOOD F MET, V29, P1015, DOI 10.1038/jcbfm.2009.27; Foerch C, 2008, STROKE, V39, P3397, DOI 10.1161/STROKEAHA.108.517482; *GEN, PRESCR INF ACT ALT; Janjua N, 2007, NEUROCRIT CARE, V7, P152, DOI 10.1007/s12028-007-0027-7; Kim YD, 2010, J NEUROL SCI, V298, P101, DOI 10.1016/j.jns.2010.07.025; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; O'Donnell M, 2006, LANCET NEUROL, V5, P749, DOI 10.1016/S1474-4422(06)70536-1; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Pfeilschifter W, 2011, STROKE, V42, P1116, DOI 10.1161/STROKEAHA.110.604652; Prabhakaran S, 2010, ARCH NEUROL-CHICAGO, V67, P1414, DOI 10.1001/archneurol.2010.288; Prabhakaran S, 2010, ARCH NEUROL-CHICAGO, V67, P559, DOI 10.1001/archneurol.2010.25; Preston FE, 2002, BRIT J HAEMATOL, V116, P619, DOI 10.1046/j.0007-1048.2001.03295.x; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; A PRIORI SAMPLE SIZE; GRUBBS TEST OUTLIERS	22	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26087	10.1371/journal.pone.0026087	http://dx.doi.org/10.1371/journal.pone.0026087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039437	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500031
J	Zhang, C; Tang, WJ; Li, Y; Yang, F; Dowd, DR; MacDonald, PN				Zhang, Chi; Tang, Wanjin; Li, Yang; Yang, Fan; Dowd, Diane R.; MacDonald, Paul N.			Osteoblast-Specific Transcription Factor Osterix Increases Vitamin D Receptor Gene Expression in Osteoblasts	PLOS ONE			English	Article							BONE-FORMATION; MEDIATED TRANSCRIPTION; DIFFERENTIATION; RICKETS; PROTEIN; CELLS; MICE; 1,25-DIHYDROXYVITAMIN-D; HOMEOSTASIS; ALOPECIA	Osterix (Osx) is an osteoblast-specific transcription factor required for osteoblast differentiation from mesenchymal stem cells. In Osx knock-out mice, no bone formation occurs. The vitamin D receptor (VDR) is a member of the nuclear hormone receptor superfamily that regulates target gene transcription to ensure appropriate control of calcium homeostasis and bone development. Here, we provide several lines of evidence that show that the VDR gene is a target for transcriptional regulation by Osx in osteoblasts. For example, calvaria obtained from Osx-null embryos displayed dramatic reductions in VDR expression compared to wild-type calvaria. Stable overexpression of Osx stimulated VDR expression in C2C12 mesenchymal cells. Inhibition of Osx expression by siRNA led to downregulation of VDR. In contrast, Osx levels remained unchanged in osteoblasts in VDR-null mice. Mechanistic approaches using transient transfection assays showed that Osx directly activated a 1 kb fragment of the VDR promoter in a dose-dependent manner. To define the region of the VDR promoter that was responsive to Osx, a series of VDR promoter deletion mutants were examined and the minimal Osx-responsive region was refined to the proximal 120 bp of the VDR promoter. Additional point mutants were used to identify two GC-rich regions that were responsible for VDR promoter activation by Osx. Chromatin immunoprecipitation assays demonstrated that endogenous Osx was associated with the native VDR promoter in primary osteoblasts in vivo. Cumulatively, these data strongly support a direct regulatory role for Osx in VDR gene expression. They further provide new insight into potential mechanisms and pathways that Osx controls in osteoblasts and during the process of osteoblastic cell differentiation.	[Zhang, Chi; Tang, Wanjin; Li, Yang; Yang, Fan] Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Dowd, Diane R.; MacDonald, Paul N.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University	Zhang, C (corresponding author), Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75390 USA.	Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012		Arthritis Foundation; Texas Scottish Rite Hospital for Children; NIH [RO1-DK53980]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053980] Funding Source: NIH RePORTER	Arthritis Foundation; Texas Scottish Rite Hospital for Children; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by Arthritis Foundation (http://www.arthritis.org) and Texas Scottish Rite Hospital for Children (http://www.tsrh.org). This work is also supported by NIH Grant RO1-DK53980 (to PNM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock PA, 2006, J BONE MINER RES, V21, P1618, DOI 10.1359/JBMR.060714; BALSAN S, 1986, J CLIN INVEST, V77, P1661, DOI 10.1172/JCI112483; Ellison TI, 2007, J BIOL CHEM, V282, P10953, DOI 10.1074/jbc.M609717200; Gardiner EM, 2000, FASEB J, V14, P1908, DOI 10.1096/fj.99-1075com; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Jehan F, 1997, P NATL ACAD SCI USA, V94, P10138, DOI 10.1073/pnas.94.19.10138; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; OWEN TA, 1991, ENDOCRINOLOGY, V128, P1496, DOI 10.1210/endo-128-3-1496; PRINCE CW, 1987, COLLAGEN REL RES, V7, P305; RITCHIE HH, 1989, P NATL ACAD SCI USA, V86, P9783, DOI 10.1073/pnas.86.24.9783; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sooy K, 2005, J CELL BIOCHEM, V94, P81, DOI 10.1002/jcb.20313; St-Arnaud R, 2008, ARCH BIOCHEM BIOPHYS, V473, P225, DOI 10.1016/j.abb.2008.03.038; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tanaka H, 2004, J STEROID BIOCHEM, V89-90, P343, DOI 10.1016/j.jsbmb.2004.03.021; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	29	28	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26504	10.1371/journal.pone.0026504	http://dx.doi.org/10.1371/journal.pone.0026504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028889	Green Submitted, gold, Green Published			2022-12-25	WOS:000296186900070
J	Mao, L				Mao, Liang			Evaluating the Combined Effectiveness of Influenza Control Strategies and Human Preventive Behavior	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SPREAD; MODEL; SIMULATION; DIFFUSION; AWARENESS	Control strategies enforced by health agencies are a major type of practice to contain influenza outbreaks. Another type of practice is the voluntary preventive behavior of individuals, such as receiving vaccination, taking antiviral drugs, and wearing face masks. These two types of practices take effects concurrently in influenza containment, but little attention has been paid to their combined effectiveness. This article estimates this combined effectiveness using established simulation models in the urbanized area of Buffalo, NY, USA. Three control strategies are investigated, including: Targeted Antiviral Prophylaxis (TAP), workplace/school closure, community travel restriction, as well as the combination of the three. All control strategies are simulated with and without regard to individual preventive behavior, and the resulting effectiveness are compared. The simulation outcomes suggest that weaker control strategies could suffice to contain influenza epidemics, because individuals voluntarily adopt preventive behavior, rendering these weaker strategies more effective than would otherwise have been expected. The preventive behavior of individuals could save medical resources for control strategies and avoid unnecessary socio-economic interruptions. This research adds a human behavioral dimension into the simulation of control strategies and offers new insights into disease containment. Health policy makers are recommended to review current control strategies and comprehend preventive behavior patterns of local populations before making decisions on influenza containment.	Univ Florida, Dept Geog, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Mao, L (corresponding author), Univ Florida, Dept Geog, Gainesville, FL 32611 USA.	liangmao@ufl.edu		Mao, Liang/0000-0002-7363-0308	University at Buffalo, State University of New York; University of Florida	University at Buffalo, State University of New York; University of Florida(University of Florida)	This research was supported in part by the Mark Diamond Research Fund and the Hugh Calkins Applied GIS Award, both from the University at Buffalo, State University of New York. Publication of this article was funded by the University of Florida Open-Access publishing fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER M, 1976, HLTH BELIEF MODEL PE; Bian L, 2004, ENVIRON PLANN B, V31, P381, DOI 10.1068/b2833; Brooks RJ, 1996, MATH COMPUT MODEL, V24, P1, DOI 10.1016/0895-7177(96)00103-3; Burke DS, 2006, ACAD EMERG MED, V13, P1142, DOI 10.1111/j.1553-2712.2006.tb01638.x; Camitz M, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-32; CDC, 2008, KEY FACTS SEAS INFL; CDC, 2009, UPD CDC EST 2009 H1N; CDC, 2008, PREV SEAS FLU; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dutta A, 2008, 4524 WORLD BANK SOC; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Funk S, 2010, J THEOR BIOL, V264, P501, DOI 10.1016/j.jtbi.2010.02.032; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hatzopoulos V, 2011, MATH BIOSCIENCES; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mao L, 2011, INT J GEOGR INF SCI, V25, P1371, DOI 10.1080/13658816.2011.556121; Mao L, 2010, COMPUT ENVIRON URBAN, V34, P204, DOI 10.1016/j.compenvurbsys.2010.03.004; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; ReferenceUSA, 2009, US BUS DAT; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; USCensus, 2000, US CENS 2000 DAT REL; Valente TW, 1996, SOC NETWORKS, V18, P69, DOI 10.1016/0378-8733(95)00256-1; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085; WEINSTEIN ND, 1992, HEALTH PSYCHOL, V11, P170, DOI 10.1037/0278-6133.11.3.170	38	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24706	10.1371/journal.pone.0024706	http://dx.doi.org/10.1371/journal.pone.0024706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834SM	22043275	Green Published, Green Submitted, gold			2022-12-25	WOS:000295984400002
J	Wang, WX				Wang, Weixun			Identification of Respective Lysine Donor and Glutamine Acceptor Sites Involved in Factor XIIIa-catalyzed Fibrin alpha Chain Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; AMINO-ACID SEQUENCE; LINKED PEPTIDES; C-DOMAINS; LARGE-SCALE; LOCALIZATION; PROTEINS; NOMENCLATURE; ASSIGNMENT; FRAGMENTS	Factor XIIIa-catalyzed epsilon-(gamma-glutamyl)-lysyl bonds between glutamine and lysine residues on fibrin alpha and gamma chains stabilize the fibrin clot and protect it from mechanical and proteolytic damage. The cross-linking of gamma chains is known to involve the reciprocal linkages between Gln(398) and Lys(406.) In alpha chains, however, the respective lysine and glutamine partners remain largely unknown. Traditional biochemical approaches have only identified the possible lysine donor and glutamine acceptor sites but have failed to define the respective relationships between them. Here, a differential mass spectrometry method was implemented to characterize cross-linked alpha chain peptides originating from native fibrin. Tryptic digests of fibrin that underwent differential cross-linking conditions were analyzed by high resolution Fourier transform mass spectrometry. Differential intensities associated with monoisotopic masses of cross-linked peptides were selected for further characterization. A fit-for-purpose algorithm was developed to assign cross-linked peptide pairs of fibrin alpha chains to the monoisotopic masses relying on accurate mass measurement as the primary criterion for identification. Equipped with hypothesized sequences, tandem mass spectrometry was then used to confirm the identities of the cross-linked peptides. In addition to the reciprocal cross-links between Gln(398) and Lys(406) on the gamma chains of fibrin (the positive control of the study), nine specific cross-links (Gln(223)-Lys(508), Gln(223)-Lys(539), Gln(237)-Lys(418), Gln(237)-Lys(508), Gln(237)-Lys(539), Gln(237)-Lys(556), Gln(366)-Lys(539), Gln(563)-Lys(539), and Gln(563)-Lys(601)) on the alpha chains of fibrin were newly identified. These findings provide novel structural details with respect to the alpha chain cross-linking compared with earlier efforts.	Merck Res Labs, Rahway, NJ 07065 USA	Merck & Company	Wang, WX (corresponding author), Merck Res Labs, 126 E Lincoln Ave, Rahway, NJ 07065 USA.	weixun_wang@merck.com						Anderson GA, 2007, J PROTEOME RES, V6, P3412, DOI 10.1021/pr070035z; Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590; BLOMBACK B, 1994, THROMB RES, V75, P327, DOI 10.1016/0049-3848(94)90245-3; BLOMBACK B, 1957, ACTA CHEM SCAND, V11, P194, DOI 10.3891/acta.chem.scand.11-0194; Breuker K, 2008, J AM SOC MASS SPECTR, V19, P1045, DOI 10.1016/j.jasms.2008.05.013; Chen R, 1971, Biochemistry, V10, P4487; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150; Coon JJ, 2005, BIOTECHNIQUES, V38, P519, DOI 10.2144/05384TE01; CORCORAN DH, 1980, THROMB RES, V19, P883, DOI 10.1016/0049-3848(80)90016-X; COTTRELL BA, 1979, BIOCHEMISTRY-US, V18, P5405, DOI 10.1021/bi00591a023; DOOLITTLE RF, 1977, BIOCHEMISTRY-US, V16, P1715, DOI 10.1021/bi00627a030; Doolittle RF, 2003, J THROMB HAEMOST, V1, P1559, DOI 10.1046/j.1538-7836.2003.00278.x; GALANAKIS DK, 1983, THROMB RES, V31, P403, DOI 10.1016/0049-3848(83)90405-X; Han XM, 2008, CURR OPIN CHEM BIOL, V12, P483, DOI 10.1016/j.cbpa.2008.07.024; Hanss M, 2001, ANN NY ACAD SCI, V936, P89; Iglesias AH, 2010, ANAL CHEM, V82, P909, DOI 10.1021/ac902051q; KIMURA S, 1986, J BIOL CHEM, V261, P5591; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Litvinov RI, 2007, BIOCHEMISTRY-US, V46, P9133, DOI 10.1021/bi700944j; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x; Matsuda M, 2001, ANN NY ACAD SCI, V936, P65; Matsuka YV, 1996, BIOCHEMISTRY-US, V35, P5810, DOI 10.1021/bi952294k; Medved L, 2009, J THROMB HAEMOST, V7, P355, DOI 10.1111/j.1538-7836.2008.03242.x; Medzihradszky KF, 2005, METHOD ENZYMOL, V402, P209, DOI 10.1016/S0076-6879(05)02007-0; Meng FY, 2005, MASS SPECTROM REV, V24, P126, DOI 10.1002/mas.20009; MOSESSON MW, 1995, J STRUCT BIOL, V115, P88, DOI 10.1006/jsbi.1995.1033; Novak P, 2005, ANAL CHEM, V77, P5101, DOI 10.1021/ac040194r; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ping LF, 2011, BIOCHEMISTRY-US, V50, P9066, DOI 10.1021/bi201094v; PISANO JJ, 1968, SCIENCE, V160, P892, DOI 10.1126/science.160.3830.892; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559; SOBEL JH, 1995, BLOOD, V86, P989, DOI 10.1182/blood.V86.3.989.bloodjournal863989; SOBEL JH, 1994, BLOOD, V84, P535; Sobel JH, 1996, J BIOL CHEM, V271, P19288, DOI 10.1074/jbc.271.32.19288; Tipton JD, 2011, J BIOL CHEM, V286, P25451, DOI 10.1074/jbc.R111.239442; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458; Tsurupa G, 2011, BIOCHEMISTRY-US, V50, P8028, DOI 10.1021/bi2008189; Tsurupa G, 2009, BIOCHEMISTRY-US, V48, P12191, DOI 10.1021/bi901640e; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Weisel JW, 2001, ANN NY ACAD SCI, V936, P312; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]; Yang B., 2011, P 59 ANN C MASS SPEC	49	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44952	44964		10.1074/jbc.M111.297119	http://dx.doi.org/10.1074/jbc.M111.297119			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22030394	Green Published, hybrid			2022-12-25	WOS:000298645500064
J	Zoraghi, R; Worrall, L; See, RH; Strangman, W; Popplewell, WL; Gong, HS; Samaai, T; Swayze, RD; Kaur, S; Vuckovic, M; Finlay, BB; Brunham, RC; McMaster, WR; Davies-Coleman, MT; Strynadka, NC; Andersen, RJ; Reiner, NE				Zoraghi, Roya; Worrall, Liam; See, Raymond H.; Strangman, Wendy; Popplewell, Wendy L.; Gong, Huansheng; Samaai, Toufiek; Swayze, Richard D.; Kaur, Sukhbir; Vuckovic, Marija; Finlay, B. Brett; Brunham, Robert C.; McMaster, William R.; Davies-Coleman, Michael T.; Strynadka, Natalie C.; Andersen, Raymond J.; Reiner, Neil E.			Methicillin-resistant Staphylococcus aureus (MRSA) Pyruvate Kinase as a Target for Bis-indole Alkaloids with Antibacterial Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARINE SPONGE; MISCELLANEOUS MECHANISMS; BIS(INDOLE) ALKALOIDS; ANTIVIRAL ACTIVITIES; NERVOUS SYSTEMS; BISINDOLE ALKALOIDS; ALLOSTERIC REGULATION; HAMACANTHIN CLASSES; CRYSTAL-STRUCTURE; ANTIFUNGAL	Novel classes of antimicrobials are needed to address the emergence of multidrug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). We have recently identified pyruvate kinase (PK) as a potential novel drug target based upon it being an essential hub in the MRSA interactome (Cherkasov, A., Hsing, M., Zoraghi, R., Foster, L. J., See, R. H., Stoynov, N., Jiang, J., Kaur, S., Lian, T., Jackson, L., Gong, H., Swayze, R., Amandoron, E., Hormozdiari, F., Dao, P., Sahinalp, C., Santos-Filho, O., Axerio-Cilies, P., Byler, K., McMaster, W. R., Brunham, R. C., Finlay, B. B., and Reiner, N. E. (2011) J. Proteome Res. 10, 1139-1150; Zoraghi, R., See, R. H., Axerio-Cilies, P., Kumar, N. S., Gong, H., Moreau, A., Hsing, M., Kaur, S., Swayze, R. D., Worrall, L., Amandoron, E., Lian, T., Jackson, L., Jiang, J., Thorson, L., Labriere, C., Foster, L., Brunham, R. C., McMaster, W. R., Finlay, B. B., Strynadka, N. C., Cherkasov, A., Young, R. N., and Reiner, N. E. (2011) Antimicrob. Agents Chemother. 55, 2042-2053). Screening of an extract library of marine invertebrates against MRSA PK resulted in the identification of bis-indole alkaloids of the spongotine (A), topsentin (B, D), and hamacanthin (C) classes isolated from the Topsentia pachastrelloides as novel bacterial PK inhibitors. These compounds potently and selectively inhibited both MRSA PK enzymatic activity and S. aureus growth in vitro. The most active compounds, cis-3,4-dihyrohyrohamacanthin B (C) and bromodeoxytopsentin (D), were identified as highly potent MRSA PK inhibitors (IC50 values of 16-60 nM) with at least 166-fold selectivity over human PK isoforms. These novel anti-PK natural compounds exhibited significant antibacterial activities against S. aureus, including MRSA (minimal inhibitory concentrations (MIC) of 12.5 and 6.25 mu g/ml, respectively) with selectivity indices (CC50/MIC)>4. We also report the discrete structural features of the MRSA PK tetramer as determined by x-ray crystallography, which is suitable for selective targeting of the bacterial enzyme. The co-crystal structure of compound C with MRSA PK confirms that the latter is a target for bis-indole alkaloids. It elucidates the essential structural requirements for PK inhibitors in "small" interfaces that provide for tetramer rigidity and efficient catalytic activity. Our results identified a series of natural products as novel MRSA PK inhibitors, providing the basis for further development of potential novel antimicrobials.	[Zoraghi, Roya; See, Raymond H.; Gong, Huansheng; Swayze, Richard D.; Kaur, Sukhbir; Brunham, Robert C.; McMaster, William R.; Reiner, Neil E.] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V5Z 3J5, Canada; [Worrall, Liam; Vuckovic, Marija; Finlay, B. Brett; Strynadka, Natalie C.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 3J5, Canada; [See, Raymond H.; Brunham, Robert C.] Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 3J5, Canada; [Strangman, Wendy; Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC V5Z 3J5, Canada; [Finlay, B. Brett; McMaster, William R.; Reiner, Neil E.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 3J5, Canada; [Popplewell, Wendy L.; Davies-Coleman, Michael T.] Rhodes Univ, Dept Chem, ZA-6140 Grahamstown, South Africa; [Samaai, Toufiek] Dept Environm Affairs Ocean & Coast Biodivers & E, Cape Town, South Africa	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Rhodes University	Reiner, NE (corresponding author), 2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	ethan@interchange.ubc.ca		Davies-Coleman, Michael/0000-0001-5344-894X; Swayze, Richard/0000-0003-0692-5648; Popplewell, Wendy/0000-0001-9848-5939	Genome Canada; Genome British Columbia; Vancouver General Hospital & University of British Columbia Hospital Foundation; Natural Sciences and Engineering Research Council of Canada; SARS Accelerated Vaccine Initiative; South African National Research Foundation; Department of Environmental Affairs	Genome Canada(Genome Canada); Genome British Columbia; Vancouver General Hospital & University of British Columbia Hospital Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); SARS Accelerated Vaccine Initiative; South African National Research Foundation(National Research Foundation - South Africa); Department of Environmental Affairs	This work was supported by grants from Genome Canada and Genome British Columbia, Vancouver General Hospital & University of British Columbia Hospital Foundation, The Natural Sciences and Engineering Research Council of Canada, SARS Accelerated Vaccine Initiative to the PRoteomics for Emerging PAthogen REsponse (PREPARE) Project, and the South African National Research Foundation and Department of Environmental Affairs through the SeaChange research program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao BQ, 2007, J NAT PROD, V70, P2, DOI 10.1021/np060206z; Bao BQ, 2005, J NAT PROD, V68, P711, DOI 10.1021/np049577a; Barrett CT, 2003, CURR OPIN BIOTECH, V14, P621, DOI 10.1016/j.copbio.2003.10.003; Casapullo A, 2000, J NAT PROD, V63, P447, DOI 10.1021/np9903292; Chan Maurice, 2007, Travel Med Infect Dis, V5, P125, DOI 10.1016/j.tmaid.2006.01.015; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherkasov A, 2011, J PROTEOME RES, V10, P1139, DOI 10.1021/pr100918u; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garcia-Lara J, 2005, DRUG DISCOV TODAY, V10, P643, DOI 10.1016/S1359-6446(05)03432-X; Gupta L, 2007, BIOORG MED CHEM LETT, V17, P4075, DOI 10.1016/j.bmcl.2007.04.035; Gupta L, 2007, CURR MED CHEM, V14, P1789; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; Mayer AMS, 2007, COMP BIOCHEM PHYS C, V145, P553, DOI 10.1016/j.cbpc.2007.01.015; Mayer AMS, 2009, BBA-GEN SUBJECTS, V1790, P283, DOI 10.1016/j.bbagen.2009.03.011; Mayer AMS, 2005, COMP BIOCHEM PHYS C, V140, P265, DOI 10.1016/j.cca.2005.04.004; Mayer AMS, 2004, MAR BIOTECHNOL, V6, P37, DOI 10.1007/s10126-003-0007-7; Mayer AMS, 2002, COMP BIOCHEM PHYS C, V132, P315, DOI 10.1016/S1532-0456(02)00094-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monroe S, 2000, CURR OPIN MICROBIOL, V3, P496, DOI 10.1016/S1369-5274(00)00129-6; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; MORRIS SA, 1990, TETRAHEDRON, V46, P715, DOI 10.1016/S0040-4020(01)81355-7; Murai K, 2007, J ORG CHEM, V72, P8947, DOI 10.1021/jo701668s; Nowicki MW, 2008, BIOORGAN MED CHEM, V16, P5050, DOI 10.1016/j.bmc.2008.03.045; Oh KB, 2006, BIOL PHARM BULL, V29, P570, DOI 10.1248/bpb.29.570; Oh KB, 2005, BIOORG MED CHEM LETT, V15, P4927, DOI 10.1016/j.bmcl.2005.08.021; Opperdoes FR, 2001, INT J PARASITOL, V31, P482, DOI 10.1016/S0020-7519(01)00155-2; Pathania R, 2008, BIOCHEM CELL BIOL, V86, P111, DOI 10.1139/O08-011; Phife DW, 1996, BIOORG MED CHEM LETT, V6, P2103, DOI 10.1016/0960-894X(96)00376-9; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; SAKEMI S, 1991, J ORG CHEM, V56, P4304, DOI 10.1021/jo00013a044; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scheiber J, 2009, J MED CHEM, V52, P3103, DOI 10.1021/jm801546k; Shaffer C, 2005, DRUG DISCOV TODAY, V10, P1489, DOI 10.1016/S1359-6446(05)03653-6; Shin J, 1999, J NAT PROD, V62, P647, DOI 10.1021/np980507b; Song JH, 2005, MOL CELLS, V19, P365; SPERANZA ML, 1989, BIOL CHEM H-S, V370, P211, DOI 10.1515/bchm3.1989.370.1.211; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Suree N, 2009, BIOORGAN MED CHEM, V17, P7174, DOI 10.1016/j.bmc.2009.08.067; Suzuki K, 2008, J BIOCHEM, V144, P305, DOI 10.1093/jb/mvn069; TSUJII S, 1988, J ORG CHEM, V53, P5446, DOI 10.1021/jo00258a009; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Watts J. L., 2008, M31A3 CLIN LAB STAND, V28, pM31; WRIGHT AE, 1992, J ORG CHEM, V57, P4772, DOI 10.1021/jo00043a045; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zoraghi R, 2011, ANTIMICROB AGENTS CH, V55, P2042, DOI 10.1128/AAC.01250-10; Zoraghi R, 2010, BIOCHEMISTRY-US, V49, P7733, DOI 10.1021/bi100780t	59	86	87	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44716	44725		10.1074/jbc.M111.289033	http://dx.doi.org/10.1074/jbc.M111.289033			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22030393	Green Published, hybrid			2022-12-25	WOS:000298645500042
J	Sclip, A; Antoniou, X; Colombo, A; Camici, GG; Pozzi, L; Cardinetti, D; Feligioni, M; Veglianese, P; Bahlmann, FH; Cervo, L; Balducci, C; Costa, C; Tozzi, A; Calabresi, P; Forloni, G; Borsello, T				Sclip, Alessandra; Antoniou, Xanthi; Colombo, Alessio; Camici, Giovanni G.; Pozzi, Laura; Cardinetti, Daniele; Feligioni, Marco; Veglianese, Pietro; Bahlmann, Ferdinand H.; Cervo, Luigi; Balducci, Claudia; Costa, Cinzia; Tozzi, Alessandro; Calabresi, Paolo; Forloni, Gianluigi; Borsello, Tiziana			c-Jun N-terminal Kinase Regulates Soluble A beta Oligomers and Cognitive Impairment in AD Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; TAU-HYPERPHOSPHORYLATION; SYNAPTIC PLASTICITY; CEREBRAL-ISCHEMIA; CELL-DEATH; PHOSPHORYLATION; JNK; STRESS	Alzheimer disease (AD) is characterized by cognitive impairment that starts with memory loss to end in dementia. Loss of synapses and synaptic dysfunction are closely associated with cognitive impairment in AD patients. Biochemical and pathological evidence suggests that soluble A beta oligomers correlate with cognitive impairment. Here, we used the TgCRND8 AD mouse model to investigate the role of JNK in long term memory deficits. TgCRND8 mice were chronically treated with the cell-penetrating c-Jun N-terminal kinase inhibitor peptide (D-JNKI1). D-JNKI1, preventing JNK action, completely rescued memory impairments (behavioral studies) as well as the long term potentiation deficits of TgCRND8 mice. Moreover, D-JNKI1 inhibited APP phosphorylation in Thr-668 and reduced the amyloidogenic cleavage of APP and A beta oligomers in brain parenchyma of treated mice. In conclusion, by regulating key pathogenic mechanisms of AD, JNK might hold promise as innovative therapeutic target.	[Sclip, Alessandra; Antoniou, Xanthi; Colombo, Alessio; Pozzi, Laura; Cardinetti, Daniele; Feligioni, Marco; Veglianese, Pietro; Cervo, Luigi; Balducci, Claudia; Forloni, Gianluigi; Borsello, Tiziana] Ist Ric Farmacol Mario Negri, Dept Neurosci, Neuronal Death & Neuroprotect Lab, I-20156 Milan, Italy; [Camici, Giovanni G.] Univ Zurich, Inst Physiol, Cardiovasc Res Lab, CH-8057 Zurich, Switzerland; [Bahlmann, Ferdinand H.] Univ Saarland, Med Ctr, Dept Internal Med 4, D-66421 Homburg, Germany; [Costa, Cinzia; Tozzi, Alessandro; Calabresi, Paolo] Univ Perugia, Clin Neurol Div, Osped S Maria della Misericordia, I-06156 Perugia, Italy; [Calabresi, Paolo] Fdn Santa Lucia, Ist Ricovero & Cura Carattere Sci, I-00143 Rome, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Zurich; Saarland University; Hospital Santa Maria della Misericordia; University of Perugia; IRCCS Santa Lucia	Borsello, T (corresponding author), Ist Ric Farmacol Mario Negri, Dept Neurosci, Neuronal Death & Neuroprotect Lab, Via Masa 19, I-20156 Milan, Italy.	tiziana.borsello@marionegri.it	Costa, Cinzia/K-8485-2016; Pozzi, Laura/F-8687-2011; Veglianese, Pietro/AAA-7394-2020; Balducci, Claudia/AAA-8465-2020; Cervo, Luigi/AAA-8081-2020; Borsello, Tiziana/ABG-7759-2020; Forloni, Gianluigi/AAB-2115-2020; Tozzi, Alessandro/AAB-8707-2022; Camici, Giovanni/H-1631-2018; Tozzi, Alessandro/G-7254-2011; Veglianese, Pietro/R-1871-2019; Calabresi, Paolo/G-8496-2011; Feligioni, Marco/F-8649-2012; Borsello, Tiziana/J-8232-2016	Costa, Cinzia/0000-0002-4862-4221; Pozzi, Laura/0000-0001-7662-2904; Balducci, Claudia/0000-0002-3870-835X; Cervo, Luigi/0000-0003-1314-1876; Forloni, Gianluigi/0000-0001-5374-3914; Camici, Giovanni/0000-0002-0523-0695; Veglianese, Pietro/0000-0002-0183-9428; Calabresi, Paolo/0000-0003-0326-5509; Borsello, Tiziana/0000-0002-9729-7642; Tozzi, Alessandro/0000-0003-3153-2424	Marie Curie Industry-Academia Partnerships and Pathways Cpads; San Paolo [2008-2437]; Cassa di Risparmio delle Provincie Lombarde (CARIPLO) [2009-2425]; Swiss National Foundation (SNF) [310030_130500]	Marie Curie Industry-Academia Partnerships and Pathways Cpads; San Paolo; Cassa di Risparmio delle Provincie Lombarde (CARIPLO)(Fondazione Cariplo); Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by Marie Curie Industry-Academia Partnerships and Pathways Cpads (to T. B.), San Paolo 2008-2437 (to T. B.), Cassa di Risparmio delle Provincie Lombarde (CARIPLO) 2009-2425 (to T.B.), and Swiss National Foundation (SNF) Grant 310030_130500 (to G. G. C.).	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bellucci A, 2007, NEUROBIOL DIS, V27, P328, DOI 10.1016/j.nbd.2007.06.008; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colombo A, 2007, CELL DEATH DIFFER, V14, P1845, DOI 10.1038/sj.cdd.4402202; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; FRANCIS BM, 2010, NEUROBIOL AGING; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jedlicka P, 2008, BEHAV BRAIN RES, V192, P12, DOI 10.1016/j.bbr.2008.02.033; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00005; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Minogue AM, 2003, J BIOL CHEM, V278, P27971, DOI 10.1074/jbc.M302530200; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; Muresan Z, 2007, MOL BIOL CELL, V18, P3835, DOI 10.1091/mbc.E06-07-0625; O'Donnell E, 2000, EUR J NEUROSCI, V12, P345, DOI 10.1046/j.1460-9568.2000.00900.x; OLTON DS, 1987, BRAIN RES, V404, P180, DOI 10.1016/0006-8993(87)91369-2; Pastorino L, 2006, EUR J PHARMACOL, V545, P29, DOI 10.1016/j.ejphar.2006.06.078; Ploia C, 2011, J ALZHEIMERS DIS, V26, P315, DOI 10.3233/JAD-2011-110320; Puig B, 2004, NEUROPATH APPL NEURO, V30, P491, DOI 10.1111/j.1365-2990.2004.00569.x; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ramin M, 2011, BEHAV BRAIN RES, V217, P424, DOI 10.1016/j.bbr.2010.11.017; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Repici M, 2009, NEUROSCIENCE, V159, P94, DOI 10.1016/j.neuroscience.2008.11.049; Savage MJ, 2002, J NEUROSCI, V22, P3376; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; SELKOE DJ, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican1191-68; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sherrin T, 2010, J NEUROSCI, V30, P13348, DOI 10.1523/JNEUROSCI.3492-10.2010; Small BJ, 2007, GERIATRICS-US, V62, P19; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; SQUIRE LR, 1988, BEHAV NEUROSCI, V102, P210, DOI 10.1037/0735-7044.102.2.210; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Vogel J, 2009, NEUROPHARMACOLOGY, V57, P539, DOI 10.1016/j.neuropharm.2009.07.021; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	48	67	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43871	43880		10.1074/jbc.M111.297515	http://dx.doi.org/10.1074/jbc.M111.297515			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033930	Green Published, hybrid			2022-12-25	WOS:000298402300028
J	McVicker, DP; Chrin, LR; Berger, CL				McVicker, Derrick P.; Chrin, Lynn R.; Berger, Christopher L.			The Nucleotide-binding State of Microtubules Modulates Kinesin Processivity and the Ability of Tau to Inhibit Kinesin-mediated Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-REPEAT TAU; MYOSIN-V; TUBULIN; MOTOR; PROTEINS; MOLECULES; ISOFORMS; 3-REPEAT; SURFACE; LENGTH	Background: Tau inhibits kinesin on GDP-microtubules in vitro, but the physiological significance in neurons is unclear. Results: On GTP-microtubules, Tau loses its inhibitory effect, and kinesin becomes less processive. Conclusion: The nucleotide-binding state of the microtubule influences the behavior of both kinesin and Tau. Significance: Tau has different functions, both inhibitory and non-inhibitory, in regulating axonal transport.	[Chrin, Lynn R.; Berger, Christopher L.] Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [McVicker, Derrick P.] Univ Vermont, Coll Med, Cell & Mol Biol Program, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Berger, CL (corresponding author), Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	cberger@uvm.edu			National Institutes of Health, NINDS [R21 NS066249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066249] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R21 NS066249 (to C. L. B.).; We thank Dr. Steven King for the 3RS- nd 4RLTau cDNA constructs and the laboratory of Dr. Kathy Trybus for the kinesin cDNA and ongoing support throughout this project.	Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Higuchi H, 1997, P NATL ACAD SCI USA, V94, P4395, DOI 10.1073/pnas.94.9.4395; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Lakamper S, 2005, BIOPHYS J, V89, P3223, DOI 10.1529/biophysj.104.057505; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Meurer-Grob P, 2001, BIOCHEMISTRY-US, V40, P8000, DOI 10.1021/bi010343p; Morfini Gerardo, 2007, Methods Mol Biol, V392, P51; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; Munson KM, 2007, J PHYS CHEM B, V111, P5053, DOI 10.1021/jp0716637; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Peck A, 2011, CYTOSKELETON, V68, P44, DOI 10.1002/cm.20494; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Sigala R, 2007, CURR BIOL, V17, pR18, DOI 10.1016/j.cub.2006.11.036; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tran PT, 1997, J STRUCT BIOL, V118, P107, DOI 10.1006/jsbi.1997.3844; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; VALE RD, 1994, J BIOL CHEM, V269, P23769; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; YU WQ, 1994, J NEUROSCI, V14, P2818	39	56	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42873	42880		10.1074/jbc.M111.292987	http://dx.doi.org/10.1074/jbc.M111.292987			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22039058	hybrid, Green Published			2022-12-25	WOS:000298351300009
J	Kallio, S; Hyona, J; Revonsuo, A; Sikka, P; Nummenmaa, L				Kallio, Sakari; Hyona, Jukka; Revonsuo, Antti; Sikka, Pilleriin; Nummenmaa, Lauri			The Existence of a Hypnotic State Revealed by Eye Movements	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; HYPNOSIS	Hypnosis has had a long and controversial history in psychology, psychiatry and neurology, but the basic nature of hypnotic phenomena still remains unclear. Different theoretical approaches disagree as to whether or not hypnosis may involve an altered mental state. So far, a hypnotic state has never been convincingly demonstrated, if the criteria for the state are that it involves some objectively measurable and replicable behavioural or physiological phenomena that cannot be faked or simulated by non-hypnotized control subjects. We present a detailed case study of a highly hypnotizable subject who reliably shows a range of changes in both automatic and volitional eye movements when given a hypnotic induction. These changes correspond well with the phenomenon referred to as the "trance stare" in the hypnosis literature. Our results show that this 'trance stare' is associated with large and objective changes in the optokinetic reflex, the pupillary reflex and programming a saccade to a single target. Control subjects could not imitate these changes voluntarily. For the majority of people, hypnotic induction brings about states resembling normal focused attention or mental imagery. Our data nevertheless highlight that in some cases hypnosis may involve a special state, which qualitatively differs from the normal state of consciousness.	[Kallio, Sakari; Revonsuo, Antti; Sikka, Pilleriin] Univ Skovde, Sch Humanities & Informat, Skovde, Sweden; [Kallio, Sakari; Revonsuo, Antti; Sikka, Pilleriin] Univ Turku, Ctr Cognit Neurosci, Turku, Finland; [Kallio, Sakari; Hyona, Jukka; Revonsuo, Antti; Sikka, Pilleriin] Univ Turku, Dept Psychol, Turku, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Low Temp Lab, Brain Res Unit, Espoo, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Nummenmaa, Lauri] Univ Turku, Turku PET Ctr, Turku, Finland	University of Skovde; University of Turku; University of Turku; Aalto University; Aalto University; University of Turku	Kallio, S (corresponding author), Univ Skovde, Sch Humanities & Informat, Skovde, Sweden.	sakari.kallio@his.se	Hyönä, Jukka/K-5280-2019; Nummenmaa, Lauri/G-6910-2012	Hyönä, Jukka/0000-0002-5950-3361; Nummenmaa, Lauri/0000-0002-2497-9757; Lauwereyns, Jan/0000-0003-0551-2550; Sikka, Pilleriin/0000-0002-1926-6138	Signe and Ane Gyllenberg Foundation; Academy of Finland; Aalto University [121031]	Signe and Ane Gyllenberg Foundation; Academy of Finland(Academy of Finland); Aalto University	This study was supported by the Signe and Ane Gyllenberg Foundation (http://www.gyllenberg-foundation.fi/en/foundation/) (S. K. and P. S.), the Academy of Finland and by the aivoAALTO Grant (121031) from Aalto University (L.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; Capgras J., 1923, B SOC CLIN MED MENT, V11, P6; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DIETRICH M, 2009, ANN NY ACAD SCI, V1664, P282; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Fingelkurts AA, 2007, CONT HYPNOSIS, V24, P3, DOI DOI 10.1002/CH.327; Fingelkurts AA, 2007, NEUROPSYCHOLOGIA, V45, P1452, DOI 10.1016/j.neuropsychologia.2006.11.018; Gauld A., 1992, HIST HYPNOTISM; Gruzelier J., 2005, CONT HYPN, V22, P1; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hilgard E. R., 1965, HYPNOTIC SUSCEPTIBIL; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; Ilg UJ, 1997, PROG NEUROBIOL, V53, P293, DOI 10.1016/S0301-0082(97)00039-7; Kallio S, 1999, NEUROREPORT, V10, P3579, DOI 10.1097/00001756-199911260-00021; Kallio S., 2005, CONT HYPNOSIS, V22, P46, DOI DOI 10.1002/(ISSN)1557-0711; Kallio S., 2003, CONT HYPNOSIS, V20, P111, DOI [10.1002/ch.273, DOI 10.1002/CH.273]; KIRSCH I, 1995, AM PSYCHOL, V50, P846, DOI 10.1037/0003-066X.50.10.846; LILIENFELD SO, 2009, 50 GREAT MYTHS POP P; LINDSAY S, 1993, INT J CLIN EXP HYP, V41, P92, DOI 10.1080/00207149308414540; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; NOREIKA V, 2011, INT J CLIN IN PRESS; Oakley DA, 2009, TRENDS COGN SCI, V13, P264, DOI 10.1016/j.tics.2009.03.004; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Rainville P, 2002, J COGNITIVE NEUROSCI, V14, P887, DOI 10.1162/089892902760191117; Shor R. E., 1962, HARVARD GROUP SCALE; TADA T, 1990, PERCEPT MOTOR SKILL, V71, P832; WEITZENHOFFER A M, 1969, American Journal of Clinical Hypnosis, V11, P221; WEITZENHOFFER A M, 1971, American Journal of Clinical Hypnosis, V14, P102; Weitzenhoffer A. M., 1962, STANFORD HYPNOTIC SU; Weitzenhoffer A. M., 2000, PRACTICE HYPNOTISM; WEITZENHOFFER AM, 1969, PERCEPT MOTOR SKILL, V28, P671, DOI 10.2466/pms.1969.28.2.671; Weitzenhoffer AM, 1980, AM J CLIN HYPN, V44, P69	36	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26374	10.1371/journal.pone.0026374	http://dx.doi.org/10.1371/journal.pone.0026374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039474	Green Published, gold			2022-12-25	WOS:000296515200016
J	Zhang, HL; Zhang, A; Guo, CF; Shi, CZ; Zhang, Y; Liu, Q; Sparatore, A; Wang, CQ				Zhang, Huili; Zhang, Alian; Guo, Changfa; Shi, Chunzhi; Zhang, Yang; Liu, Qing; Sparatore, Anna; Wang, Changqian			S-diclofenac Protects against Doxorubicin-Induced Cardiomyopathy in Mice via Ameliorating Cardiac Gap Junction Remodeling	PLOS ONE			English	Article							PROGENITOR-CELL FUNCTION; HYDROGEN-SULFIDE; ACUTE-PANCREATITIS; LUNG INJURY; CONNEXIN43; ISCHEMIA; CARDIOTOXICITY; ANTHRACYCLINES; ACTIVATION; SEQUENCE	Hydrogen sulfide (H2S), as a novel gaseous mediator, plays important roles in mammalian cardiovascular tissues. In the present study, we investigated the cardioprotective effect of S-diclofenac (2-[(2,6-dichlorophenyl)amino] benzeneacetic acid 4-(3H-1,2,dithiol-3-thione-5-yl) phenyl ester), a novel H2S-releasing derivative of diclofenac, in a murine model of doxorubicin-induced cardiomyopathy. After a single dose injection of doxorubicin (15 mg/kg, i.p.), male C57BL/6J mice were given daily treatment of S-diclofenac (25 and 50 mu mol/kg, i.p.), diclofenac (25 and 50 mu mol/kg, i.p.), NaHS (50 mu mol/kg, i.p.), or same volume of vehicle. The cardioprotective effect of S-diclofenac was observed after 14 days. It showed that S-diclofenac, but not diclofenac, dose-dependently inhibited the doxorubicin-induced downregulation of cardiac gap junction proteins (connexin 43 and connexin 45) and thus reversed the remodeling of gap junctions in hearts. It also dose-dependently suppressed doxorubicin-induced activation of JNK in hearts. Furthermore, S-diclofenac produced a dose-dependent anti-inflammatory and anti-oxidative effect in this model. As a result, S-diclofenac significantly attenuated doxorubicin-related cardiac injury and cardiac dysfunction, and improved the survival rate of mice with doxorubicin-induced cardiomyopathy. These effects of S-diclofenac were mimicked in large part by NaHS. Therefore, we propose that H2S released from S-diclofenac in vivo contributes to the protective effect in doxorubicin-induced cardiomyopathy. These data also provide evidence for a critical role of H2S in the pathogenesis of doxorubicin-induced cardiomyopathy.	[Zhang, Huili; Zhang, Alian; Shi, Chunzhi; Zhang, Yang; Liu, Qing; Wang, Changqian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China; [Guo, Changfa] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200433, Peoples R China; [Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, Milan, Italy	Shanghai Jiao Tong University; Fudan University; University of Milan	Zhang, HL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China.	huili.zhang815@gmail.com; changqianwang@hotmail.com	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022; Sparatore, Anna/J-8634-2015	Sparatore, Anna/0000-0003-2135-2649	National Natural Science Foundation of China [30900522]; Shanghai Pujiang Program [09PJ1407000]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by the National Natural Science Foundation of China grant (Grant No. 30900522) www.nsfc.gov.cn, the Shanghai Pujiang Program (Grant No. 09PJ1407000) www.stcsm.gov.cn, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China www.cscse.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge D, 2001, BIOSCIENCE REP, V21, P683, DOI 10.1023/A:1014777111259; Bass SE, 2009, CLIN CANCER RES, V15, P1964, DOI 10.1158/1078-0432.CCR-08-1870; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Bhatia M, 2008, SHOCK, V29, P84, DOI 10.1097/shk.0b013e31806ec26; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Desplantez T, 2007, J MEMBRANE BIOL, V218, P13, DOI 10.1007/s00232-007-9046-8; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Geimonen E, 1996, J BIOL CHEM, V271, P23667, DOI 10.1074/jbc.271.39.23667; Hrdina R, 2000, Acta Medica (Hradec Kralove), V43, P75; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Jones RL, 2006, EXPERT OPIN DRUG SAF, V5, P791, DOI 10.1517/14740338.5.6.791; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; LING L, 2005, FASEB J, V19, P1196; Lowicka E, 2007, PHARMACOL REP, V59, P4; LUKE RA, 1991, J CLIN INVEST, V87, P1594, DOI 10.1172/JCI115173; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Rossoni G, 2008, BRIT J PHARMACOL, V153, P100, DOI 10.1038/sj.bjp.0707540; Saffitz JE, 2000, AM J PHYSIOL-HEART C, V278, pH1662, DOI 10.1152/ajpheart.2000.278.5.H1662; Schulz R, 2003, FASEB J, V17, P1355, DOI 10.1096/fj.02-0975fje; Sidhapuriwala J, 2007, EUR J PHARMACOL, V569, P149, DOI 10.1016/j.ejphar.2007.05.003; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Su YW, 2009, CIRC J, V73, P741, DOI 10.1253/circj.CJ-08-0636; Teunissen BEJ, 2004, CARDIOVASC RES, V62, P246, DOI 10.1016/j.cardiores.2003.12.011; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Whiteman M, 2006, BIOCHEM BIOPH RES CO, V343, P303, DOI 10.1016/j.bbrc.2006.02.154; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2007, AM J PHYSIOL-LUNG C, V292, pL960, DOI 10.1152/ajplung.00388.2006; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	35	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26441	10.1371/journal.pone.0026441	http://dx.doi.org/10.1371/journal.pone.0026441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039489	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200019
J	Dumont, M; Massot, S; Doutriaux, MP; Gratias, A				Dumont, Marilyn; Massot, Sophie; Doutriaux, Marie-Pascale; Gratias, Ariane			Characterization of Brca2-Deficient Plants Excludes the Role of NHEJ and SSA in the Meiotic Chromosomal Defect Phenotype	PLOS ONE			English	Article							HUMAN BRCA2 PROTEIN; DNA BREAK REPAIR; ARABIDOPSIS MUTANTS; NUCLEAR ABNORMALITIES; DEFICIENT PLANTS; TELOMERE LENGTH; LIGASE-IV; GENE; RAD51; RECOMBINATION	In somatic cells, three major pathways are involved in the repair of DNA double-strand breaks (DBS): Non-Homologous End Joining (NHEJ), Single-Strand Annealing (SSA) and Homologous Recombination (HR). In somatic and meiotic HR, DNA DSB are 59 to 39 resected, producing long 39 single-stranded DNA extensions. Brca2 is essential to load the Rad51 recombinase onto these 39 overhangs. The resulting nucleofilament can thus invade a homologous DNA sequence to copy and restore the original genetic information. In Arabidopsis, the inactivation of Brca2 specifically during meiosis by an RNAi approach results in aberrant chromosome aggregates, chromosomal fragmentation and missegregation leading to a sterility phenotype. We had previously suggested that such chromosomal behaviour could be due to NHEJ. In this study, we show that knock-out plants affected in both BRCA2 genes show the same meiotic phenotype as the RNAi-inactivated plants. Moreover, it is demonstrated that during meiosis, neither NHEJ nor SSA compensate for HR deficiency in BRCA2-inactivated plants. The role of the plant-specific DNA Ligase6 is also excluded. The possible mechanism(s) involved in the formation of these aberrant chromosomal bridges in the absence of HR during meiosis are discussed.	[Dumont, Marilyn; Massot, Sophie; Doutriaux, Marie-Pascale; Gratias, Ariane] Univ Paris 11, CNRS, UMR8618, Inst Biol Plantes, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Dumont, M (corresponding author), Univ Paris 11, CNRS, UMR8618, Inst Biol Plantes, F-91405 Orsay, France.	ariane.gratias-weill@u-psud.fr			Centre National de la Recherche Scientifique; Universite Paris Sud-11; French Ministere de L'Enseignement Superieur et de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Sud-11; French Ministere de L'Enseignement Superieur et de la Recherche	This work was supported by the Centre National de la Recherche Scientifique and the Universite Paris Sud-11. M. D. is the recipient of a French Ministere de L'Enseignement Superieur et de la Recherche doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2009, J EXP BOT, V60, P2751, DOI 10.1093/jxb/erp135; Andreuzza S, 2010, DEVELOPMENT, V137, P73, DOI 10.1242/dev.041020; Bonatto D, 2005, BRAZ J MED BIOL RES, V38, P321, DOI 10.1590/S0100-879X2005000300002; Bundock P, 2002, NUCLEIC ACIDS RES, V30, P3395, DOI 10.1093/nar/gkf445; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Charbonnel C, 2011, DNA REPAIR IN PRESS; Charbonnel C, 2010, PLANT J, V64, P280, DOI 10.1111/j.1365-313X.2010.04331.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Couteau F, 1999, PLANT CELL, V11, P1623, DOI 10.1105/tpc.11.9.1623; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Dray E, 2006, PLANT PHYSIOL, V140, P1059, DOI 10.1104/pp.105.075838; Dubest S, 2004, PLANT J, V39, P334, DOI 10.1111/j.1365-313X.2004.02136.x; Dubest S, 2002, EMBO REP, V3, P1049, DOI 10.1093/embo-reports/kvf211; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fidantsef AL, 2000, PLANT PHYSIOL, V124, P579, DOI 10.1104/pp.124.2.579; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friesner J, 2003, PLANT J, V34, P427, DOI 10.1046/j.1365-313X.2003.01738.x; Gallego ME, 2003, PLANT J, V35, P557, DOI 10.1046/j.1365-313X.2003.01827.x; Hartsuiker E, 2009, MOL CELL BIOL, V29, P1671, DOI 10.1128/MCB.01182-08; Heacock ML, 2007, NUCLEIC ACIDS RES, V35, P6490, DOI 10.1093/nar/gkm472; Hefner E, 2003, J EXP BOT, V54, P669, DOI 10.1093/jxb/erg069; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Milman N, 2009, MOL CELL BIOL, V29, P5998, DOI 10.1128/MCB.01127-09; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Preuss SB, 1999, MOL GEN GENET, V261, P623, DOI 10.1007/s004380050004; Riha K, 2002, EMBO J, V21, P2819, DOI 10.1093/emboj/21.11.2819; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Siaud N, 2004, EMBO J, V23, P1392, DOI 10.1038/sj.emboj.7600146; Tamura K, 2002, PLANT J, V29, P771, DOI 10.1046/j.1365-313X.2002.01258.x; Tanaka S, 2010, BIOCHEM BIOPH RES CO, V396, P289, DOI 10.1016/j.bbrc.2010.04.082; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; van Attikum H, 2003, NUCLEIC ACIDS RES, V31, P4247, DOI 10.1093/nar/gkg458; Wang S, 2010, P NATL ACAD SCI USA, V107, P22716, DOI 10.1073/pnas.1005978107; Wang YK, 2010, PLANT MOL BIOL, V74, P453, DOI 10.1007/s11103-010-9685-5; Waterworth WM, 2010, PLANT J, V63, P848, DOI 10.1111/j.1365-313X.2010.04285.x; Waterworth WM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-79; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; West CE, 2000, PLANT J, V24, P67, DOI 10.1046/j.1365-313x.2000.00856.x; West CE, 2002, PLANT J, V31, P517, DOI 10.1046/j.1365-313X.2002.01370.x; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yu VPCC, 2000, GENE DEV, V14, P1400	57	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26696	10.1371/journal.pone.0026696	http://dx.doi.org/10.1371/journal.pone.0026696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039535	Green Submitted, Green Published, gold			2022-12-25	WOS:000296513200044
J	Drozd, M; Gangaiah, D; Liu, Z; Rajashekara, G				Drozd, Mary; Gangaiah, Dharanesh; Liu, Zhe; Rajashekara, Gireesh			Contribution of TAT System Translocated PhoX to Campylobacter jejuni Phosphate Metabolism and Resilience to Environmental Stresses	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS PF0-1; BIOFILM FORMATION; INORGANIC POLYPHOSPHATE; ALKALINE-PHOSPHATASE; REGULON; EXPRESSION; PROTEIN; SURVIVAL; COLI; HOMEOSTASIS	Campylobacter jejuni is a common gastrointestinal pathogen that colonizes food animals; it is transmitted via fecal contamination of food, and infections in immune-compromised people are more likely to result in serious long-term illness. Environmental phosphate is likely an important sensor of environmental fitness and the ability to obtain extracellular phosphate is central to the bacteria's core metabolic responses. PhoX is the sole alkaline phosphatase in C. jejuni, a substrate of the TAT transport system. Alkaline phosphatases mediate the hydrolytic removal of inorganic phosphate (Pi) from phospho-organic compounds and thereby contribute significantly to the polyphosphate kinase 1 (ppk1) mediated formation of poly P, a molecule that regulates bacterial response to stresses and virulence. Similarly, deletion of the tatC gene, a key component of the TAT system, results in diverse phenotypes in C. jejuni including reduced stress tolerance and in vivo colonization. Therefore, here we investigated the contribution of phoX in poly P synthesis and in TAT-system mediated responses. The phoX deletion mutant showed significant decrease (P<0.05) in poly P accumulation in stationary phase compared to the wild-type, suggesting that PhoX is a major contributor to the inorganic phosphate pool in the cell which is essential for poly P synthesis. The phoX deletion is sufficient for a nutrient stress defect similar to the defect previously described for the Delta tatC mutant. Additionally, the phoX deletion mutant has increased resistance to certain antimicrobials. The Delta phoX mutant was also moderately defective in invasion and intracellular survival within human intestinal epithelial cells as well as in chicken colonization. Further, the Delta phoX mutant produced increased biofilm that can be rescued with 1 mM inorganic phosphate. The qRT-PCR of the Delta phoX mutant revealed transcriptional changes that suggest potential mechanisms for the increased biofilm phenotype.	[Drozd, Mary; Gangaiah, Dharanesh; Liu, Zhe; Rajashekara, Gireesh] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA	Ohio State University	Drozd, M (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA.	rajashekara.2@osu.edu	Drozd, Mary/AAC-4533-2021; Rajashekara, Gireesh/E-3913-2011		United States Department of Agriculture [2007-35201-18414]; Ohio Agricultural Research and Development Center, The Ohio State University	United States Department of Agriculture(United States Department of Agriculture (USDA)); Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University)	The research in Dr. Rajashekara's lab is supported by the United States Department of Agriculture grant 2007-35201-18414 and by the SEEDS grant from Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Centers for Disease Control and Prevention Centers for Disease Control and Prevention Division of Foodborne Bacterial and Mycotic Diseases National Center for Zoonotic Vector-Borne and Enteric Diseases, 2010, CAMP TECHN INF; Chaveerach P, 2003, APPL ENVIRON MICROB, V69, P711, DOI 10.1128/AEM.69.1.711-714.2003; Crushell E, 2004, PEDIATR RES, V55, P3, DOI 10.1203/01.PDR.0000099794.06260.71; Danhorn T, 2004, J BACTERIOL, V186, P4492, DOI 10.1128/JB.186.14.4492-4501.2004; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; Fields JA, 2008, J BACTERIOL, V192, P2182; Gangaiah D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012142; Gangaiah D, 2009, APPL ENVIRON MICROB, V75, P7838, DOI 10.1128/AEM.01603-09; Garenaux A, 2008, RES MICROBIOL, V159, P718, DOI 10.1016/j.resmic.2008.08.001; Gillespie IA, 2008, EPIDEMIOL INFECT, V136, P1717, DOI 10.1017/S0950268808000319; Greig JD, 2009, INT J FOOD MICROBIOL, V130, P77, DOI 10.1016/j.ijfoodmicro.2008.12.031; Hall SJ, 2008, J BACTERIOL, V190, P8075, DOI 10.1128/JB.00821-08; Hartley LE, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-13; Hitchcock A, 2010, MICROBIOL-SGM, V156, P2994, DOI 10.1099/mic.0.042788-0; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; Kim SK, 2000, J BACTERIOL, V182, P5596, DOI 10.1128/JB.182.19.5596-5599.2000; Kopecko DJ, 2001, TRENDS MICROBIOL, V9, P389, DOI 10.1016/S0966-842X(01)02107-2; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kuramitsu HK, 2005, J PERIODONTOL, V76, P2047, DOI 10.1902/jop.2005.76.11-S.2047; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Mendz GL, 2005, ARCH MICROBIOL, V183, P113, DOI 10.1007/s00203-004-0752-7; Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Newell DG, INT J FOOD MICROB S1, V139, pS3; Pichereau V, 2000, INT J FOOD MICROBIOL, V55, P19, DOI 10.1016/S0168-1605(00)00208-7; Pigrau C, 1997, CLIN INFECT DIS, V25, P1414, DOI 10.1086/516127; Pratt JT, 2009, J BACTERIOL, V191, P6632, DOI 10.1128/JB.00708-09; Rajashekara G, 2009, FOODBORNE PATHOG DIS, V6, P935, DOI 10.1089/fpd.2009.0298; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rashid MH, 2000, J BACTERIOL, V182, P225, DOI 10.1128/JB.182.1.225-227.2000; Romeo T, 2008, CURRENT TOPICS MICRO; Salloway S, 1996, INFECT IMMUN, V64, P2945, DOI 10.1128/IAI.64.8.2945-2949.1996; Sambrook J, 2001, MOL CLONING LAB MANU; Scharff R.L., 2010, PRODUCE SAFETY PROJE; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10; Silby MW, 2009, APPL ENVIRON MICROB, V75, P3872, DOI 10.1128/AEM.00017-09; Spira B, 1998, MOL GEN GENET, V257, P469, DOI 10.1007/s004380050671; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Taschner NP, 2004, MICROBIOL-SGM, V150, P2985, DOI 10.1099/mic.0.27124-0; Vaishnava S, 2007, CELL HOST MICROBE, V2, P365, DOI 10.1016/j.chom.2007.11.004; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; VanBogelen RA, 1996, J BACTERIOL, V178, P4344, DOI 10.1128/jb.178.15.4344-4366.1996; Vincent G. K., 2010, CURRENT POPULATION R, VP25, P1; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Yuan ZC, 2005, MOL MICROBIOL, V58, P877, DOI 10.1111/j.1365-2958.2005.04874.x; Zaheer R, 2009, ENVIRON MICROBIOL, V11, P1572, DOI 10.1111/j.1462-2920.2009.01885.x	62	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26336	10.1371/journal.pone.0026336	http://dx.doi.org/10.1371/journal.pone.0026336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028859	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800035
J	Li, FW; Kuo, LY; Rothfels, CJ; Ebihara, A; Chiou, WL; Windham, MD; Pryer, KM				Li, Fay-Wei; Kuo, Li-Yaung; Rothfels, Carl J.; Ebihara, Atsushi; Chiou, Wen-Liang; Windham, Michael D.; Pryer, Kathleen M.			rbcL and matK Earn Two Thumbs Up as the Core DNA Barcode for Ferns	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHLOROPLAST GENOME; EVOLUTION; HYMENOPHYLLACEAE; GAMETOPHYTES; PHYLOGENY; CLASSIFICATION; IDENTIFICATION; DISCRIMINATE; POSITION	Background: DNA barcoding will revolutionize our understanding of fern ecology, most especially because the accurate identification of the independent but cryptic gametophyte phase of the fern's life history-an endeavor previously impossible-will finally be feasible. In this study, we assess the discriminatory power of the core plant DNA barcode (rbcL and matK), as well as alternatively proposed fern barcodes (trnH-psbA and trnL-F), across all major fern lineages. We also present plastid barcode data for two genera in the hyperdiverse polypod clade-Deparia (Woodsiaceae) and the Cheilanthes marginata group (currently being segregated as a new genus of Pteridaceae)-to further evaluate the resolving power of these loci. Principal Findings: Our results clearly demonstrate the value of matK data, previously unavailable in ferns because of difficulties in amplification due to a major rearrangement of the plastid genome. With its high sequence variation, matK complements rbcL to provide a two-locus barcode with strong resolving power. With sequence variation comparable to matK, trnL-F appears to be a suitable alternative barcode region in ferns, and perhaps should be added to the core barcode region if universal primer development for matK fails. In contrast, trnH-psbA shows dramatically reduced sequence variation for the majority of ferns. This is likely due to the translocation of this segment of the plastid genome into the inverted repeat regions, which are known to have a highly constrained substitution rate. Conclusions: Our study provides the first endorsement of the two-locus barcode (rbcL+matK) in ferns, and favors trnL-F over trnH-psbA as a potential back-up locus. Future work should focus on gathering more fern matK sequence data to facilitate universal primer development.	[Li, Fay-Wei; Rothfels, Carl J.; Windham, Michael D.; Pryer, Kathleen M.] Duke Univ, Dept Biol, Durham, NC 27710 USA; [Kuo, Li-Yaung] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Chiou, Wen-Liang] Taiwan Forestry Res Inst, Div Bot Garden, Taipei, Taiwan	Duke University; National Taiwan University; National Museum of Nature and Science	Li, FW (corresponding author), Duke Univ, Dept Biol, Durham, NC 27710 USA.	fl43@duke.edu	Pryer, Kathleen/X-4635-2019; Pryer, Kathleen M./ABF-4908-2020	Pryer, Kathleen M./0000-0002-9776-6736; Li, Fay-Wei/0000-0002-0076-0152; Rothfels, Carl/0000-0002-6605-1770	National Science Foundation [DEB-0717398]	National Science Foundation(National Science Foundation (NSF))	A National Science Foundation (www.nsf.gov) grant #DEB-0717398 to KMP and MDW (co-authors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRKY CW, 1992, GENETICS, V130, P677; BOWMAN CM, 1983, THEOR APPL GENET, V65, P247, DOI 10.1007/BF00308076; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; CURTIS SE, 1984, MOL BIOL EVOL, V1, P291; Dassler CL, 2001, BRITTONIA, V53, P352, DOI 10.1007/BF02812705; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Duffy AM, 2009, GENE, V438, P17, DOI 10.1016/j.gene.2009.02.006; Ebihara A, 2008, AM J BOT, V95, P1645, DOI 10.3732/ajb.0800122; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Ebihara A, 2009, MOL ECOL, V18, P4904, DOI 10.1111/j.1365-294X.2009.04406.x; FARRAR DR, 1967, SCIENCE, V155, P1266, DOI 10.1126/science.155.3767.1266; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gureyeva II, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P341; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li FW, 2010, MOL ECOL RESOUR, V10, P92, DOI 10.1111/j.1755-0998.2009.02745.x; Li FW, 2009, PLANT SYST EVOL, V281, P77, DOI 10.1007/s00606-009-0188-2; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Mickel JT, 2004, MEMOIR NEW YORK BOT, V88, P176; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; PALMER JD, 1983, MOL GEN GENET, V190, P13, DOI 10.1007/BF00330318; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Pryer KM, 2010, MOL ECOL RESOUR, V10, P979, DOI 10.1111/j.1755-0998.2010.02858.x; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Pryer KM, 2001, AM J BOT, V88, P1118, DOI 10.2307/2657095; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Rothfels CJ, IN PRESS; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rumsey F. J., 1998, Watsonia, V22, P1; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tate JA, 2003, SYST BOT, V28, P723; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van den Heede CJ, 2003, AM J BOT, V90, P481, DOI 10.3732/ajb.90.3.481; Wang CN, 2004, SYST BOT, V29, P407, DOI 10.1600/036364404774195593; Watkins JE, 2007, AM J BOT, V94, P701, DOI 10.3732/ajb.94.4.701; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Zhao ZL, 2007, PLANTA MED, V73, P1230, DOI 10.1055/s-2007-981588	62	69	83	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26597	10.1371/journal.pone.0026597	http://dx.doi.org/10.1371/journal.pone.0026597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028918	gold, Green Published, Green Submitted			2022-12-25	WOS:000296510800059
J	Bystrom, J; Wray, JA; Sugden, MC; Holness, MJ; Swales, KE; Warner, TD; Edin, ML; Zeldin, DC; Gilroy, DW; Bishop-Bailey, D				Bystrom, Jonas; Wray, Jessica A.; Sugden, Mary C.; Holness, Mark J.; Swales, Karen E.; Warner, Timothy D.; Edin, Matthew L.; Zeldin, Darryl C.; Gilroy, Derek W.; Bishop-Bailey, David			Endogenous Epoxygenases Are Modulators of Monocyte/Macrophage Activity	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; KAPPA-B ACTIVITY; ENDOTHELIAL-CELLS; LAMINAR-FLOW; IN-VITRO; CYTOCHROME-P450; ACID; EXPRESSION; CYP2J2; GAMMA	Background: Arachidonic acid is metabolized through three major metabolic pathways, the cyclooxygenase, lipoxygenase and CYP450 enzyme systems. Unlike cyclooxygenase and lipoxygenases, the role of CYP450 epoxygenases in monocyte/macrophage-mediated responses is not known. Methodology/Principal Findings: When transfected in vitro, CYP2J2 is an efficient activator of anti-inflammatory pathways through the nuclear receptor peroxisome proliferator-activated receptor (PPAR) alpha. Human monocytes and macrophages contain PPAR alpha and here we show they express the epoxygenases CYP2J2 and CYP2C8. Inhibition of constitutive monocyte epoxygenases using the epoxygenase inhibitor SKF525A induces cyclooxygenase (COX)-2 expression and activity, and the release of TNF alpha, and can be reversed by either add back of the endogenous epoxygenase products and PPAR alpha ligand 11,12-epoxyeicosatrienoic acid (EET) or the addition of the selective synthetic PPAR alpha ligand GW7647. In alternatively activated (IL-4-treated) monocytes, in contrast to classically activated cells, epoxygenase inhibition decreased TNF alpha release. Epoxygenases can be pro-inflammatory via superoxide anion production. The suppression of TNF alpha by SKF525A in the presence of IL-4 was associated with a reduction in superoxide anion generation and reproduced by the superoxide dismutase MnCl2. Similar to these acute activation studies, in monocyte derived macrophages, epoxygenase inhibition elevates M1 macrophage TNF alpha mRNA and further decreases M2 macrophage TNF alpha. Conclusions/Significance: In conclusion, epoxygenase activity represents an important endogenous pathway which limits monocyte activation. Moreover endogenous epoxygenases are immuno-modulators regulating monocyte/macrophage activation depending on the underlying activation state.	[Bystrom, Jonas; Wray, Jessica A.; Swales, Karen E.; Warner, Timothy D.; Bishop-Bailey, David] Queen Mary Univ London, William Harvey Res Inst, London, England; [Sugden, Mary C.; Holness, Mark J.] Queen Mary Univ London, Blizzard Inst Cell & Mol Sci, London, England; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Gilroy, Derek W.] UCL, Div Med, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; University College London	Bystrom, J (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London, England.	d.bishop-bailey@qmul.ac.uk	Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020; Zeldin, Darryl C/Y-7091-2018; Warner, Timothy D/A-1980-2009; Edin, Matthew/AAI-1934-2019	Gilroy, Derek/0000-0003-3476-0844; Zeldin, Darryl C/0000-0002-2087-7307; Warner, Timothy D/0000-0003-3988-4408; Edin, Matthew/0000-0002-7042-500X; Bishop-Bailey, David/0000-0003-2455-596X	British Heart Foundation [FS/04/075, BS/02/002, PG/08/070/25464]; Wellcome Trust [074361/Z/04/Z]; National Institutes of Health, NIEHS; European Community [LSHM-CT-2004-0050333]; National Institute of Health Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Community(European Commission); National Institute of Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partly funded by grants from the British Heart Foundation (FS/04/075; BS/02/002; PG/08/070/25464), the Wellcome Trust (074361/Z/04/Z) and the Intramural Research Programs of the National Institutes of Health, NIEHS (to DZ), and European Community FP6 funding (LSHM-CT-2004-0050333). Derek Gilroy holds a Wellcome Trust Senior Fellowship. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON SL, 1990, J IMMUNOL, V144, P625; BAIN B, 1972, TRANSPLANT P, V4, P163; BHASKARAN G, 1992, J LEUKOCYTE BIOL, V52, P218, DOI 10.1002/jlb.52.2.218; Bishop-Bailey D, 2000, BRIT J PHARMACOL, V129, P823, DOI 10.1038/sj.bjp.0703149; Bishop-Bailey D, 2003, PROSTAG OTH LIPID M, V71, P1, DOI 10.1016/S0090-6980(03)00003-0; Bishop-Bailey D, 2002, CIRC RES, V91, P210, DOI 10.1161/01.RES.0000029080.15742.85; Brown PJ, 2001, BIOORG MED CHEM LETT, V11, P1225, DOI 10.1016/S0960-894X(01)00188-3; Campbell W.B., PFLUGERS ARCH, V459, P881; Capdevila JH, 2000, J LIPID RES, V41, P163; CHEN C, J PHARM EXP THER, V336, P344; Deng Y., FASEB J, V25, P703; DENG Y, FASEB J; Donato MT, 1998, J PHARMACOL EXP THER, V284, P760; DONNELLY RP, 1993, J IMMUNOL, V151, P5603; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; Harrington LS, 2004, EUR J PHARMACOL, V506, P165, DOI 10.1016/j.ejphar.2004.09.062; HARRINGTON LS, BIOCH BIOPHYS RES CO, V408, P511; Kaipainen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000260; KONKEL A, BIOCH BIOPHYS ACTA, V1814, P210; Lee CR, 2007, PHARMACOGENET GENOM, V17, P349, DOI 10.1097/FPC.0b013e32809913ea; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Liu Y, 2004, CIRCULATION, V110, P1128, DOI 10.1161/01.CIR.0000139850.08365.EC; MacKenzie A, 1999, BRIT J PHARMACOL, V127, P1159, DOI 10.1038/sj.bjp.0702670; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Sun JX, 2002, CIRC RES, V90, P1020, DOI 10.1161/01.RES.0000017727.35930.33; Thieu VT, 2007, J LEUKOCYTE BIOL, V82, P370, DOI 10.1189/jlb.1106707; Werner K, 2002, PROSTAG LEUKOTR ESS, V67, P397, DOI 10.1054/plef.2002.0449; Wray J, 2008, EXP PHYSIOL, V93, P148, DOI 10.1113/expphysiol.2007.038612; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421; Wu S, 1996, J BIOL CHEM, V271, P3460; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; Zaric J, 2005, J BIOL CHEM, V280, P1077, DOI 10.1074/jbc.M410006200; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200	41	64	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26591	10.1371/journal.pone.0026591	http://dx.doi.org/10.1371/journal.pone.0026591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028915	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500092
J	Fowler, ZL; Shah, K; Panepinto, JC; Jacobs, A; Koffas, MAG				Fowler, Zachary L.; Shah, Karan; Panepinto, John C.; Jacobs, Amy; Koffas, Mattheos A. G.			Development of Non-Natural Flavanones as Antimicrobial Agents	PLOS ONE			English	Article							NATURAL-PRODUCTS; ESCHERICHIA-COLI; PUMP INHIBITORS; DERIVATIVES; SUSCEPTIBILITY; BIOSYNTHESIS; PERSPECTIVES; FLAVONOIDS; CHALCONES; TRENDS	With growing concerns over multidrug resistance microorganisms, particularly strains of bacteria and fungi, evolving to become resistant to the antimicrobial agents used against them, the identification of new molecular targets becomes paramount for novel treatment options. Recently, the use of new treatments containing multiple active ingredients has been shown to increase the effectiveness of existing molecules for some infections, often with these added compounds enabling the transport of a toxic molecule into the infecting species. Flavonoids are among the most abundant plant secondary metabolites and have been shown to have natural abilities as microbial deterrents and anti-infection agents in plants. Combining these ideas we first sought to investigate the potency of natural flavonoids in the presence of efflux pump inhibitors to limit Escherichia coli growth. Then we used the natural flavonoid scaffold to synthesize non-natural flavanone molecules and further evaluate their antimicrobial efficacy on Escherichia coli, Bacillus subtilis and the fungal pathogens Cryptococcus neoformans and Aspergillus fumigatus. Of those screened, we identified the synthetic molecule 4-chloro-flavanone as the most potent antimicrobial compound with a MIC value of 70 mu g/mL in E. coli when combined with the inhibitor Phe-Arg-beta-naphthylamide, and MICs of 30 mu g/mL in S. cerevesiae and 30 mu g/mL in C. neoformans when used alone. Through this study we have demonstrated that combinatorial synthesis of non-natural flavonones can identify novel antimicrobial agents with activity against bacteria and fungi but with minimal toxicity to human cells.	[Fowler, Zachary L.] Praxair Inc, BioPharma Res & Dev, Burr Ridge, IL USA; [Shah, Karan] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Panepinto, John C.; Jacobs, Amy] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Koffas, Mattheos A. G.] Rensalear Polytech Inst, Dept Chem Engn, Troy, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Fowler, ZL (corresponding author), Praxair Inc, BioPharma Res & Dev, Burr Ridge, IL USA.	koffam@rpi.edu		Koffas, Mattheos/0000-0002-1405-0565	University at Buffalo, the State University of New York	University at Buffalo, the State University of New York	Funds were provided from the Dean of Engineering, University at Buffalo, the State University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif T, 2009, J ASIAN NAT PROD RES, V11, P621, DOI 10.1080/10286020902942350; BALL PR, 1977, BIOCHEM BIOPH RES CO, V77, P1500, DOI 10.1016/S0006-291X(77)80148-4; Bavaresco L, 2008, J AGR FOOD CHEM, V56, P2085, DOI 10.1021/jf073456+; Cazarolli LH, 2008, MINI-REV MED CHEM, V8, P1429, DOI 10.2174/138955708786369564; Chemier Joseph A., 2009, V76, P151; Chemler JA, 2007, ORG LETT, V9, P1855, DOI 10.1021/ol0703736; Chen ZH, 2010, EUR J MED CHEM, V45, P5739, DOI 10.1016/j.ejmech.2010.09.031; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Fowler ZL, 2011, YEAST, V28, P181, DOI 10.1002/yea.1829; Fowler ZL, 2009, APPL ENVIRON MICROB, V75, P5831, DOI 10.1128/AEM.00270-09; Fowler ZL, 2009, APPL MICROBIOL BIOT, V83, P799, DOI 10.1007/s00253-009-2039-z; Ghani SBA, 2008, BIOORG MED CHEM LETT, V18, P518, DOI 10.1016/j.bmcl.2007.11.081; Hannula M, 2008, J MED MICROBIOL, V57, P851, DOI 10.1099/jmm.0.47823-0; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Jakobsen A, 2005, J CLIN ONCOL, V23, P1365, DOI 10.1200/JCO.2005.06.219; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Lombardino JG, 2004, NAT REV DRUG DISCOV, V3, P853, DOI 10.1038/nrd1523; Moorthy NSHN, 2006, CHEM PHARM BULL, V54, P1384, DOI 10.1248/cpb.54.1384; Nowakowska Z, 2007, EUR J MED CHEM, V42, P125, DOI 10.1016/j.ejmech.2006.09.019; Rusin A, 2010, ACTA BIOCHIM POL, V57, P23; Saleem M, 2010, NAT PROD REP, V27, P238, DOI 10.1039/b916096e; Schumacher A, 2006, J ANTIMICROB CHEMOTH, V57, P344, DOI 10.1093/jac/dki446; SELIK RM, 1995, ANN INTERN MED, V123, P933, DOI 10.7326/0003-4819-123-12-199512150-00006; Sivakumar PM, 2010, CHEM BIOL DRUG DES, V76, P407, DOI 10.1111/j.1747-0285.2010.01020.x; Sobolev VS, 2009, J AGR FOOD CHEM, V57, P62, DOI 10.1021/jf802891v; Srinivas NR, 2010, XENOBIOTICA, V40, P357, DOI 10.3109/00498251003663724; Suzuki K, 2010, CHEM REC, V10, P291, DOI 10.1002/tcr.201000030; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Vooturi SK, 2010, CURR MED CHEM, V17, P2292, DOI 10.2174/092986710791331059; Yaipakdee P, 2001, PHYTOCHEMISTRY, V57, P341, DOI 10.1016/S0031-9422(01)00075-9; Zhou H, 2008, CURR OPIN BIOTECH, V19, P590, DOI 10.1016/j.copbio.2008.10.012; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	34	27	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25681	10.1371/journal.pone.0025681	http://dx.doi.org/10.1371/journal.pone.0025681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039419	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500017
J	Idikio, HA				Idikio, Halliday A.			Galectin-3 and Beclin1/Atg6 Genes In Human Cancers: Using cDNA Tissue Panel, qRT-PCR, and Logistic Regression Model to Identify Cancer Cell Biomarkers	PLOS ONE			English	Article							HUMAN BREAST-CARCINOMA; REAL-TIME PCR; INDUCED APOPTOSIS; MAMMALIAN TARGET; RIP KINASES; AUTOPHAGY; EXPRESSION; INHIBITION; DEATH; PROGRESSION	Background: Cancer biomarkers are sought to support cancer diagnosis, predict cancer patient response to treatment and survival. Identifying reliable biomarkers for predicting cancer treatment response needs understanding of all aspects of cancer cell death and survival. Galectin-3 and Beclin1 are involved in two coordinated pathways of programmed cell death, apoptosis and autophagy and are linked to necroptosis/necrosis. The aim of the study was to quantify galectin-3 and Beclin1 mRNA in human cancer tissue cDNA panels and determine their utility as biomarkers of cancer cell survival. Methods and Results: A panel of 96 cDNAs from eight (8) different normal and cancer tissue types were used for quantitative real-time polymerase chain reaction (qRT-PCR) using ABI7900HT. Miner2.0, a web-based 4- and 3-parameter logistic regression software was used to derive individual well polymerase chain reaction efficiencies (E) and cycle threshold (Ct) values. Miner software derived formula was used to calculate mRNA levels and then fold changes. The ratios of cancer to normal tissue levels of galectin-3 and Beclin1 were calculated (using the mean for each tissue type). Relative mRNA expressions for galectin-3 were higher than for Beclin1 in all tissue (normal and cancer) types. In cancer tissues, breast, kidney, thyroid and prostate had the highest galectin-3 mRNA levels compared to normal tissues. High levels of Beclin1 mRNA levels were in liver and prostate cancers when compared to normal tissues. Breast, kidney and thyroid cancers had high galectin-3 levels and low Beclin1 levels. Conclusion: Galectin-3 expression patterns in normal and cancer tissues support its reported roles in human cancer. Beclin1 expression pattern supports its roles in cancer cell survival and in treatment response. qRT-PCR analysis method used may enable high throughput studies to generate molecular biomarker sets for diagnosis and predicting cancer treatment response.	Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada	University of Alberta	Idikio, HA (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	hidikio@ualberta.ca						Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Ahmed H, 2009, TRANSL ONCOL, V2, P146, DOI 10.1593/tlo.09118; Akahani S, 1997, CANCER RES, V57, P5272; Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Bartolazzi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003768; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chiariotti L, 2002, GLYCOCONJUGATE J, V19, P441, DOI 10.1023/B:GLYC.0000014073.23096.3a; CRIOLLO A, 2007, CELL DEATH DIFFERENT, V14; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Ellerhorst J, 1999, UROL RES, V27, P362, DOI 10.1007/s002400050164; Ellerhorst JA, 2002, PROSTATE, V50, P64, DOI 10.1002/pros.10033; Finley DJ, 2004, ANN SURG, V240, P425, DOI 10.1097/01.sla.0000137128.64978.bc; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Galluzzi L, 2009, J MOL CELL BIOL, V1, P8, DOI 10.1093/jmcb/mjp007; Glinsky VV, 2009, NEOPLASIA, V11, P901, DOI 10.1593/neo.09594; GOLDSTEIN P, 2007, EMBO REP, V8, P829; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52; Idikio H, 1998, INT J ONCOL, V12, P1287; Jiang W, 2007, J NATL CANCER I, V99, P1036, DOI 10.1093/jnci/djm022; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; John S, 2008, CANCER RES, V68, P7855, DOI 10.1158/0008-5472.CAN-07-5875; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lavra L, 2009, J PATHOL, V218, P66, DOI 10.1002/path.2510; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Liang XH, 2001, CANCER RES, V61, P3443; Lin CL, 2009, MOL CANCER RES, V7, P1655, DOI 10.1158/1541-7786.MCR-09-0274; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Matsuda Y, 2008, HEPATOL RES, V38, P1098, DOI 10.1111/j.1872-034X.2008.00387.x; Merseburger AS, 2008, PROSTATE, V68, P72, DOI 10.1002/pros.20688; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Oka N, 2005, CANCER RES, V65, P7546, DOI 10.1158/0008-5472.CAN-05-1197; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Sakaki M, 2010, J MED INVESTIG, V57, P152, DOI 10.2152/jmi.57.152; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shalom-Feuerstein R, 2005, CANCER RES, V65, P7292, DOI 10.1158/0008-5472.CAN-05-0775; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; SUN Q, 2008, PNAS, V196, P19211; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Taube SE, 2009, JNCI-J NATL CANCER I, V101, P1453, DOI 10.1093/jnci/djp334; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang Y, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.79; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; XU XC, 1995, AM J PATHOL, V147, P815; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Young AN, 2001, AM J PATHOL, V158, P1639, DOI 10.1016/S0002-9440(10)64120-X; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2007, CLIN CANCER RES, V13, P1315, DOI 10.1158/1078-0432.CCR-06-1517; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	92	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26150	10.1371/journal.pone.0026150	http://dx.doi.org/10.1371/journal.pone.0026150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039439	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500033
J	Pappalardo, AM; Guarino, F; Reina, S; Messina, A; De Pinto, V				Pappalardo, Anna Maria; Guarino, Francesca; Reina, Simona; Messina, Angela; De Pinto, Vito			Geographically Widespread Swordfish Barcode Stock Identification: A Case Study of Its Application	PLOS ONE			English	Article							GLOBAL POPULATION-STRUCTURE; DNA CONTROL REGION; XIPHIAS GLADIUS L; VARIABILITY; PHYLOGENIES; EVOLUTION; GENETICS; PROGRAM; NUCLEAR; FISHES	Background: The swordfish (Xiphias gladius) is a cosmopolitan large pelagic fish inhabiting tempered and tropical waters and it is a target species for fisheries all around the world. The present study investigated the ability of COI barcoding to reliably identify swordfish and particularly specific stocks of this commercially important species. Methodology: We applied the classical DNA barcoding technology, upon a 682 bp segment of COI, and compared swordfish sequences from different geographical sources (Atlantic, Indian Oceans and Mediterranean Sea). The sequences of the 5' hyper-variable fragment of the control region (5'dloop), were also used to validate the efficacy of COI as a stock-specific marker. Case Report: This information was successfully applied to the discrimination of unknown samples from the market, detecting in some cases mislabeled seafood products. Conclusions: The NJ distance-based phenogram (K2P model) obtained with COI sequences allowed us to correlate the swordfish haplotypes to the different geographical stocks. Similar results were obtained with 5'dloop. Our preliminary data in swordfish Xiphias gladius confirm that Cytochrome Oxidase I can be proposed as an efficient species-specific marker that has also the potential to assign geographical provenance. This information might speed the samples analysis in commercial application of barcoding.	[Pappalardo, Anna Maria; Guarino, Francesca; Reina, Simona; Messina, Angela; De Pinto, Vito] Univ Catania, Sect Biochem & Mol Biol, Dept Biol Geol & Environm Sci, Natl Inst Biomembranes & Biosyst,Sect Catania, Catania, Italy	University of Catania	Pappalardo, AM (corresponding author), Univ Catania, Sect Biochem & Mol Biol, Dept Biol Geol & Environm Sci, Natl Inst Biomembranes & Biosyst,Sect Catania, Catania, Italy.	mess@unict.it; vdpbiofa@unict.it	Messina, Angela/ABC-9518-2020; Pappalardo, Anna Maria/AAD-3410-2019; De Pinto, Vito/AAC-2634-2019	De Pinto, Vito/0000-0001-5513-2906; GUARINO, Francesca Maria/0000-0002-0704-7333; MESSINA, Angela Anna/0000-0002-5745-9846	University of Catania PRA	University of Catania PRA	Authors acknowledge funding from University of Catania PRA 2007-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bremer JRA, 2006, B MAR SCI, V79, P493; Bremer JRA, 1996, J EXP MAR BIOL ECOL, V197, P295, DOI 10.1016/0022-0981(95)00164-6; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; BREMER JRA, 1995, CAN J FISH AQUAT SCI, V52, P1720, DOI 10.1139/f95-764; Caccone A, 1996, INSECT MOL BIOL, V5, P51, DOI 10.1111/j.1365-2583.1996.tb00040.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chow S, 1997, MAR BIOL, V127, P359, DOI 10.1007/s002270050022; Chow S, 2000, J FISH BIOL, V56, P1087, DOI 10.1006/jfbi.2000.1229; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COSTA FO, 2007, GENOMICS SOC POLICY, V3, P29, DOI DOI 10.1186/1746-5354-3-2-29; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Greig T.W., 1999, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V49, P476; GrijalvaChon JM, 1996, FISH B-NOAA, V94, P589; GRIJALVACHON JM, 1994, MAR ECOL PROG SER, V115, P15, DOI 10.3354/meps115015; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; KOTOULAS G, 1995, MOL ECOL, V4, P473, DOI 10.1111/j.1365-294X.1995.tb00241.x; Lu CP, 2006, ZOOL STUD, V45, P269; MAGOULAS A, 1993, ICCAT COIL VOL SCI P, V40, P26; NEI M, 1981, GENETICS, V97, P145; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pujolar JM, 2002, J EXP MAR BIOL ECOL, V276, P19, DOI 10.1016/S0022-0981(02)00245-9; Reeb CA, 2000, MAR BIOL, V136, P1123, DOI 10.1007/s002270000291; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Smith PJ, 2008, J FISH BIOL, V72, P464, DOI 10.1111/j.1095-8649.2007.01745.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WARD RD, 2001, POPULATION STRUCTURE; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	42	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25516	10.1371/journal.pone.0025516	http://dx.doi.org/10.1371/journal.pone.0025516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039414	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500012
J	Samaha, AN; Minogianis, EA; Nachar, W				Samaha, Anne-Noel; Minogianis, Ellie-Anna; Nachar, Walid			Cues Paired with either Rapid or Slower Self-Administered Cocaine Injections Acquire Similar Conditioned Rewarding Properties	PLOS ONE			English	Article							INTRAVENOUS COCAINE; ATTENTIONAL BIAS; D-AMPHETAMINE; DELIVERY; ACQUISITION; RATS; SENSITIZATION; REINSTATEMENT; STIMULUS; ALTERS	The faster drugs of abuse reach the brain, the more addictive they can be. It is not known why this is. Environmental stimuli associated with drugs can promote the development and persistence of addiction by invigorating and precipitating drug-seeking behaviour. We determined, therefore, whether cues associated with the self-administration of rapidly delivered cocaine (injected intravenously over 5 versus 90 seconds) would acquire greater conditioned rewarding properties, as assessed by the performance of an operant response reinforced solely by the cues. Rats nose-poked for intravenous cocaine infusions delivered either over 5 or 90 seconds. Discrete visual cues accompanied each infusion. The rats could then press a lever to obtain the cues-now a conditioned reward-or an inactive lever. Rats in both the 5- and 90-second groups pressed more on the active versus inactive lever following extensive (24 sessions) but not following limited (3 sessions) self-administration training. There were no group differences in this behaviour. Following withdrawal from cocaine self-administration, lever discrimination progressively abated in both groups and was lost by withdrawal day 30. However, the rewarding properties of the cues were not "forgotten" because on withdrawal days 32-33, amphetamine selectively enhanced active-lever pressing, and did so to a similar extent in both groups. Thus, cues paired with rapid or slower cocaine delivery acquire similar conditioned rewarding properties. We conclude, therefore, that the rapid delivery of cocaine to the brain promotes addiction by mechanisms that might not involve a greater ability of drug cues to control behaviour.	[Samaha, Anne-Noel; Minogianis, Ellie-Anna; Nachar, Walid] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Samaha, Anne-Noel] Univ Montreal, Fac Med, CNS Res Grp, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Samaha, AN (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	Anna.samaha@umontreal.ca			Canadian Institutes of Health Research [97841]; Fonds de la Recherche en Sante du Quebec [16193]; Canada Foundation for Innovation [24326]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by an operating grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to ANS (Grant No. 97841), a salary award from the Fonds de la Recherche en Sante du Quebec (http://www.frsq.gouv.qc.ca/en/index.shtml) to ANS (Grant No. 16193) and an infrastructure grant from the Canada Foundation for Innovation (http://www.innovation.ca/en) to ANS (Grant No. 24326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ME, 2001, PSYCHOPHARMACOLOGY, V154, P76, DOI 10.1007/s002130000624; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; BALSTER RL, 1973, J EXP ANAL BEHAV, V20, P119, DOI 10.1901/jeab.1973.20-119; BEDARD AM, 2011, CHRONIC TREATMENT TY; Brown PL, 2005, PSYCHOPHARMACOLOGY, V181, P299, DOI 10.1007/s00213-005-2244-0; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carroll ME, 1997, PSYCHOPHARMACOLOGY, V129, P206, DOI 10.1007/s002130050182; Chen CY, 2004, PSYCHOPHARMACOLOGY, V172, P78, DOI 10.1007/s00213-003-1624-6; Crombag HS, 2008, PHARMACOL BIOCHEM BE, V90, P797, DOI 10.1016/j.pbb.2008.06.003; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; DEWIT H, 1993, PSYCHOPHARMACOLOGY, V112, P324, DOI 10.1007/BF02244928; Di Ciano P, 2004, NEUROPHARMACOLOGY, V47, P202, DOI 10.1016/j.neuropharm.2004.06.005; Di Ciano P, 2008, NEUROPSYCHOPHARMACOL, V33, P1426, DOI 10.1038/sj.npp.1301542; DICKINSON A, 1987, Q J EXP PSYCHOL-B, V39, P201; DICKINSON A, 1978, ANNU REV PSYCHOL, V29, P587, DOI 10.1146/annurev.ps.29.020178.003103; DMELLO GD, 1977, BRIT J PHARMACOL, V61, P415, DOI 10.1111/j.1476-5381.1977.tb08434.x; Duka T, 2004, PSYCHOPHARMACOLOGY, V176, P353, DOI 10.1007/s00213-004-1906-7; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Ferrario CR, 2008, BRAIN RES, V1209, P151, DOI 10.1016/j.brainres.2008.02.081; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; GAWIN FH, 1988, NEW ENGL J MED, V318, P1173, DOI 10.1056/NEJM198805053181806; GORELICK DA, 1992, AM J DRUG ALCOHOL AB, V18, P13, DOI 10.3109/00952999209001607; GOSSOP M, 1992, BRIT J ADDICT, V87, P1527; GOSSOP M, 1994, BRIT J PSYCHIAT, V164, P660, DOI 10.1192/bjp.164.5.660; Hatsukami DK, 1996, JAMA-J AM MED ASSOC, V276, P1580; HENNINGFIELD JE, 1993, J CONSULT CLIN PSYCH, V61, P743, DOI 10.1037/0022-006X.61.5.743; JAVAID JI, 1978, SCIENCE, V202, P227, DOI 10.1126/science.694530; Jones R T, 1990, NIDA Res Monogr, V99, P30; KATO S, 1987, PHARMACOL BIOCHEM BE, V28, P407; KELLEHER ROGER T., 1962, JOUR EXPTL ANALYSIS BEHAVIOR, V5, P543, DOI 10.1901/jeab.1962.5-s543; LEVINE DG, 1974, AM J PSYCHIAT, V131, P297, DOI 10.1176/ajp.131.3.297; Liu Y, 2005, EUR J NEUROSCI, V22, P195, DOI 10.1111/j.1460-9568.2005.04195.x; LOVIBOND PF, 1983, J EXP PSYCHOL ANIM B, V9, P225, DOI 10.1037/0097-7403.9.3.225; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Nelson RA, 2006, DRUG ALCOHOL DEPEN, V82, P19, DOI 10.1016/j.drugalcdep.2005.08.004; O'Brien MS, 2005, NEUROPSYCHOPHARMACOL, V30, P1006, DOI 10.1038/sj.npp.1300681; OBRIEN CP, 1992, ANN NY ACAD SCI, V654, P400, DOI 10.1111/j.1749-6632.1992.tb25984.x; Panlilio LV, 1996, PSYCHOPHARMACOLOGY, V125, P202, DOI 10.1007/BF02247329; Panlilio LV, 1998, PSYCHOPHARMACOLOGY, V137, P253, DOI 10.1007/s002130050618; PORRINO LJ, 1993, PSYCHOPHARMACOLOGY, V112, P343, DOI 10.1007/BF02244931; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; ROBBINS TW, 1983, PSYCHOPHARMACOLOGY, V80, P113, DOI 10.1007/BF00427952; ROBBINS TW, 1978, PSYCHOPHARMACOLOGY, V58, P79, DOI 10.1007/BF00426794; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Samaha AN, 2004, J NEUROSCI, V24, P6362, DOI 10.1523/JNEUROSCI.1205-04.2004; Samaha AN, 2005, BIOL PSYCHIAT, V57, P351, DOI 10.1016/j.biopsych.2004.11.040; Samaha AN, 2005, TRENDS PHARMACOL SCI, V26, P82, DOI 10.1016/j.tips.2004.12.007; Samaha AN, 2002, J NEUROSCI, V22, P3244, DOI 10.1523/JNEUROSCI.22-08-03244.2002; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Schindler CW, 2011, PHARMACOL BIOCHEM BE, V99, P301, DOI 10.1016/j.pbb.2011.05.005; Schoenmakers T, 2008, PSYCHOPHARMACOLOGY, V197, P169, DOI 10.1007/s00213-007-1023-5; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Uslaner JM, 2006, BEHAV BRAIN RES, V169, P320, DOI 10.1016/j.bbr.2006.02.001; Wakabayashi KT, 2010, J NEUROSCI, V30, P11346, DOI 10.1523/JNEUROSCI.2524-10.2010; Wise RA, 2011, NAT REV NEUROSCI, V12, DOI 10.1038/nrn3043-c2; Wise RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002846	56	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26481	10.1371/journal.pone.0026481	http://dx.doi.org/10.1371/journal.pone.0026481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039496	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500074
J	Kajiro, M; Tsuchiya, M; Kawabe, Y; Furumai, R; Iwasaki, N; Hayashi, Y; Katano, M; Nakajima, Y; Goto, N; Watanabe, T; Murayama, A; Oishi, H; Ema, M; Takahashi, S; Kishimoto, H; Yanagisawa, J				Kajiro, Masashi; Tsuchiya, Mai; Kawabe, Yoh-ichi; Furumai, Ryohei; Iwasaki, Naoya; Hayashi, Yuki; Katano, Miyuki; Nakajima, Yuka; Goto, Natsuka; Watanabe, Tatsuya; Murayama, Akiko; Oishi, Hisashi; Ema, Masatsugu; Takahashi, Satoru; Kishimoto, Hiroyuki; Yanagisawa, Junn			The E3 Ubiquitin Ligase Activity of Trip12 Is Essential for Mouse Embryogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; N-MYC EXPRESSION; CONTRASTING PATTERNS; THYROID-HORMONE; HECT FAMILY; C-MYC; CANCER; RECEPTOR; SUBUNIT; CELLS	Protein ubiquitination is a post-translational protein modification that regulates many biological conditions [1,2,3,4]. Trip12 is a HECT-type E3 ubiquitin ligase that ubiquitinates ARF and APP-BP1 [5,6]. However, the significance of Trip12 in vivo is largely unknown. Here we show that the ubiquitin ligase activity of Trip12 is indispensable for mouse embryogenesis. A homozygous mutation in Trip12 (Trip12(mt/mt)) that disrupts the ubiquitin ligase activity resulted in embryonic lethality in the middle stage of development. Trip12(mt/mt) embryos exhibited growth arrest and increased expression of the negative cell cycle regulator p16 [7,8,9,10]. In contrast, Trip12(mt/mt) ES cells were viable. They had decreased proliferation, but maintained both the undifferentiated state and the ability to differentiate. Trip12(mt/mt) ES cells had increased levels of the BAF57 protein (a component of the SWI/SNF chromatin remodeling complex) and altered gene expression patterns. These data suggest that Trip12 is involved in global gene expression and plays an important role in mouse development.	[Kajiro, Masashi; Tsuchiya, Mai; Iwasaki, Naoya; Hayashi, Yuki; Nakajima, Yuka; Goto, Natsuka; Watanabe, Tatsuya; Murayama, Akiko; Kishimoto, Hiroyuki; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kawabe, Yoh-ichi; Furumai, Ryohei; Katano, Miyuki; Nakajima, Yuka; Murayama, Akiko; Kishimoto, Hiroyuki; Yanagisawa, Junn] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Oishi, Hisashi; Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Kajiro, M (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	junny@agbi.tsukuba.ac.jp	Furumai, Ryohei/L-2220-2013	Ema, Masatsugu/0000-0003-0645-6183	Nuclear System to Decipher Operation [17064005]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [MPB2]	Nuclear System to Decipher Operation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Nuclear System to Decipher Operation Code (DECODE) (ID: 17064005), and Targeted Proteins Research Program (TPRP) (ID: MPB2) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DOWNS KM, 1989, GENE DEV, V3, P860, DOI 10.1101/gad.3.6.860; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Hah N, 2010, CANCER RES, V70, P4402, DOI 10.1158/0008-5472.CAN-09-2767; HARRIS LL, 1992, DEVELOPMENT, V115, P813; Harte MT, 2010, CANCER RES, V70, P2538, DOI 10.1158/0008-5472.CAN-09-2089; Heimeier RA, 2008, MOL ENDOCRINOL, V22, P1065, DOI 10.1210/me.2007-0492; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Yokomizo T, 2007, EMBO J, V26, P184, DOI 10.1038/sj.emboj.7601480	31	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25871	10.1371/journal.pone.0025871	http://dx.doi.org/10.1371/journal.pone.0025871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028794	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900021
J	Liu, LT; Huang, B; Li, CQ; Zhuang, Y; Wang, J; Zhou, Y				Liu, Lan-Tao; Huang, Bo; Li, Chang-Qing; Zhuang, Ying; Wang, Jian; Zhou, Yue			Characteristics of Stem Cells Derived from the Degenerated Human Intervertebral Disc Cartilage Endplate	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; BONE-MARROW; EXTRACELLULAR-MATRIX; BACK-PAIN; DIFFERENTIATION; TISSUES; CHONDROCYTES; THERAPY; SOX9; CALCIFICATION	Mesenchymal stem cells (MSCs) derived from adult tissues are an important candidate for cell-based therapies and regenerative medicine due to their multipotential differentiation capability. MSCs have been identified in many adult tissues but have not reported in the human intervertebral disc cartilage endplate (CEP). The initial purpose of this study was to determine whether MSCs exist in the degenerated human CEP. Next, the morphology, proliferation capacity, cell cycle, cell surface epitope profile and differentiation capacity of these CEP-derived stem cells (CESCs) were compared with bone-marrow MSCs (BM-MSCs). Lastly, whether CESCs are a suitable candidate for BM-MSCs was evaluated. Isolated cells from degenerated human CEP were seeded in an agarose suspension culture system to screen the proliferative cell clusters. Cell clusters were chosen and expanded in vitro and were compared with BM-MSCs derived from the same patient. The morphology, proliferation rate, cell cycle, immunophenotype and stem cell gene expression of the CESCs were similar to BM-MSCs. In addition, the CESCs could be induced into osteoblasts, adipocytes, chondrocytes, and are superior to BM-MSCs in terms of osteogenesis and chondrogenesis. This study is first to demonstrate the presence of stem cells in the human degenerated CEP. These results may improve our understanding of intervertebral disc (IVD) pathophysiology and the degeneration process, and could provide cell candidates for cell-based regenerative medicine and tissue engineering.	[Liu, Lan-Tao; Huang, Bo; Li, Chang-Qing; Zhuang, Ying; Wang, Jian; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China	Army Medical University	Liu, LT (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	younglee881@163.com; happyzhou@vip.163.com			National Natural Science Foundation of China [81071498, 81071496, 81101364]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81071498, 81071496 and 81101364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Ariga K, 2001, SPINE, V26, P2414, DOI 10.1097/00007632-200111150-00004; Bajada S, 2008, J TISSUE ENG REGEN M, V2, P169, DOI 10.1002/term.83; Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313; Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Cortes F, 1999, BLOOD, V93, P826, DOI 10.1182/blood.V93.3.826.403k28_826_837; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang BJ, 2009, BIOTECHNOL LETT, V31, P929, DOI 10.1007/s10529-009-9968-6; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gruber HE, 2005, SPINE, V30, P625, DOI 10.1097/01.brs.0000155420.01444.c6; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hattori S, 2007, BIOCHEM BIOPH RES CO, V358, P99, DOI 10.1016/j.bbrc.2007.04.142; Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785; HOLM S, 1981, CONNECT TISSUE RES, V8, P101, DOI 10.3109/03008208109152130; Huang B, 2010, J BIOMED MATER RES B, V92B, P322, DOI 10.1002/jbm.b.31518; Jackson WM, 2009, J ORTHOP RES, V27, P1645, DOI 10.1002/jor.20924; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Li FC, 2010, MED HYPOTHESES, V75, P169, DOI 10.1016/j.mehy.2010.02.012; Lian JB, 1998, J CELL BIOCHEM, P62, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<62::AID-JCB10>3.0.CO;2-S; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Okazaki R, 2002, ENDOCRINOLOGY, V143, P2349, DOI 10.1210/en.143.6.2349; Paul R, 2003, SPINE, V28, P755, DOI 10.1097/00007632-200304150-00006; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; Peng BG, 2001, CHINESE MED J-PEKING, V114, P308; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rajasekaran S, 2008, EUR SPINE J, V17, P626, DOI 10.1007/s00586-008-0645-6; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; REEMS JA, 1995, BLOOD, V85, P1480, DOI 10.1182/blood.V85.6.1480.bloodjournal8561480; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Thornemo M, 2005, CELLS TISSUES ORGANS, V180, P141, DOI 10.1159/000088242; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x	47	131	153	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26285	10.1371/journal.pone.0026285	http://dx.doi.org/10.1371/journal.pone.0026285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028847	gold, Green Published			2022-12-25	WOS:000296186900041
J	Zhang, W; Tian, QB; Li, QK; Wang, JM; Wang, CN; Liu, T; Liu, DW; Wang, MW				Zhang, Wei; Tian, Qing-Bao; Li, Qing-Kai; Wang, Jian-Min; Wang, Chao-Nan; Liu, Tian; Liu, Dian-Wu; Wang, Ming-Wei			Lysine 92 Amino Acid Residue of USP46, a Gene Associated with 'Behavioral Despair' in Mice, Influences the Deubiquitinating Enzyme Activity	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASES; DISEASE; ONCOGENE; PATHWAY; DOMAIN; MOUSE	Deubiquitinating enzymes (DUBs) regulate diverse cellular functions by their activity of cleaving ubiquitin from specific protein substrates. Ubiquitin-Specific Protease 46 (USP46) has recently been identified as a quantitative trait gene responsible for immobility in the tail suspension test and forced swimming test in mice. Mice with a lysine codon (Lys 92) deletion in USP46 exhibited loss of 'behavioral despair' under inescapable stresses in addition to abnormalities in circadian behavioral rhythms and the GABAergic system. However, whether this deletion affects enzyme activity is unknown. Here we show that USP46 has deubiquitinating enzyme activity detected by USP cleavage assay using GST-Ub52 as a model substrate. Interestingly, compared to wild type, the Lys 92 deletion mutant resulted in a decreased deubiquitinating enzyme activity of 27.04%. We also determined the relative expression levels of Usp46 in rat tissues using real-time RT-PCR. Usp46 mRNA was expressed in various tissues examined including brain, with the highest expression in spleen. In addition, like rat USP46, both human and mouse USP46 are active toward to the model substrate, indicating the USP cleavage assay is a simple method for testing the deubiquitinating enzyme activity of USP46. These results suggest that the Lys 92 deletion of USP46 could influence enzyme activity and thereby provide a molecular clue how the enzyme regulating the pathogenesis of mental illnesses.	[Zhang, Wei; Tian, Qing-Bao; Li, Qing-Kai; Wang, Jian-Min; Wang, Chao-Nan; Liu, Tian; Liu, Dian-Wu] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Shijiazhuang, Peoples R China; [Wang, Ming-Wei] Hebei Med Univ, Hosp 1, Brain Aging & Cognit Neurosci Lab Hebei Prov, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, W (corresponding author), Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Shijiazhuang, Peoples R China.	tianqingbao1980@yahoo.com.cn	Wang, Chao/GXF-8353-2022; wang, jian/GVS-0711-2022	Liu, Dian-Wu/0000-0003-2087-6299; Zhang, Wei/0000-0001-7284-530X; Liu, Dian-wu/0000-0001-8037-4448	National Natural Science Foundation of China [30840035, 30970915]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (30840035 and 30970915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Bernardi R, 2000, ONCOGENE, V19, P2447, DOI 10.1038/sj.onc.1203564; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Kilroy GE, 2009, OBESITY, V17, P665, DOI 10.1038/oby.2008.616; Kushima I, 2010, J HUM GENET, V55, P133, DOI 10.1038/jhg.2009.139; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; ONNO M, 1993, DNA CELL BIOL, V12, P107, DOI 10.1089/dna.1993.12.107; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Reyes-Turcu FE, 2009, CHEM REV, V109, P1495, DOI 10.1021/cr800470j; Shanmugham A, 2008, CURR OPIN DRUG DISC, V11, P688; Singhal S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S3; Takayama Y, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-18; Tian QB, 2003, J NEUROCHEM, V87, P665, DOI 10.1046/j.1471-4159.2003.02024.x; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Wu YR, 2010, CLIN CHIM ACTA, V411, P955, DOI 10.1016/j.cca.2010.03.013; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200	23	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26297	10.1371/journal.pone.0026297	http://dx.doi.org/10.1371/journal.pone.0026297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043315	gold, Green Submitted, Green Published			2022-12-25	WOS:000295984400044
J	Georis, I; Tate, JJ; Cooper, TG; Dubois, E				Georis, Isabelle; Tate, Jennifer J.; Cooper, Terrance G.; Dubois, Evelyne			Nitrogen-responsive Regulation of GATA Protein Family Activators Gln3 and Gat1 Occurs by Two Distinct Pathways, One Inhibited by Rapamycin and the Other by Methionine Sulfoximine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE GENE-EXPRESSION; CATABOLITE REPRESSION; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; TOR PROTEINS; INTRACELLULAR-LOCALIZATION; GLUTAMATE-DEHYDROGENASES; CARBON STARVATION; DAL5 GENE; TRANSCRIPTION	Nitrogen availability regulates the transcription of genes required to degrade non-preferentially utilized nitrogen sources by governing the localization and function of transcription activators, Gln3 and Gat1. TorC1 inhibitor, rapamycin (Rap), and glutamine synthetase inhibitor, methionine sulfoximine (Msx), elicit responses grossly similar to those of limiting nitrogen, implicating both glutamine synthesis and TorC1 in the regulation of Gln3 and Gat1. To better understand this regulation, we compared Msx-versus Rap-elicited Gln3 and Gat1 localization, their DNA binding, nitrogen catabolite repression-sensitive gene expression, and the TorC1 pathway phosphatase requirements for these responses. Using this information we queried whether Rap and Msx inhibit sequential steps in a single, linear cascade connecting glutamine availability to Gln3 and Gat1 control as currently accepted or alternatively inhibit steps in two distinct parallel pathways. We find that Rap most strongly elicits nuclear Gat1 localization and expression of genes whose transcription is most Gat1-dependent. Msx, on the other hand, elicits nuclear Gln3 but not Gat1 localization and expression of genes that are most Gln3-dependent. Importantly, Rap-elicited nuclear Gln3 localization is absolutely Sit4-dependent, but that elicited by Msx is not. PP2A, although not always required for nuclear GATA factor localization, is highly required for GATA factor binding to nitrogen-responsive promoters and subsequent transcription irrespective of the gene GATA factor specificities. Collectively, our data support the existence of two different nitrogen-responsive regulatory pathways, one inhibited by Msx and the other by rapamycin.	[Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Georis, Isabelle; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642]; Commission Communautaire Francaise; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commission Communautaire Francaise; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642 (to J. J. T. and T. G. C.). This work was also supported by Commission Communautaire Francaise (to E. D. and I. G.).	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; CHISHOLM G, 1982, MOL CELL BIOL, V2, P1088, DOI 10.1128/MCB.2.9.1088; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; COFFMAN JA, 1995, J BACTERIOL, V177, P6910, DOI 10.1128/jb.177.23.6910-6918.1995; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COORNAERT D, 1992, CURR GENET, V21, P301, DOI 10.1007/BF00351687; COURCHESNE WE, 1988, J BACTERIOL, V170, P708, DOI 10.1128/jb.170.2.708-713.1988; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; CUNNINGHAM TS, 1991, MOL CELL BIOL, V11, P6205, DOI 10.1128/MCB.11.12.6205; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DAUGHERTY JR, 1993, J BACTERIOL, V175, P64, DOI 10.1128/JB.175.1.64-73.1993; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; DUBOIS E, 1974, EUR J BIOCHEM, V48, P603, DOI 10.1111/j.1432-1033.1974.tb03803.x; DUBOIS EL, 1974, BIOCHEM BIOPH RES CO, V60, P150, DOI 10.1016/0006-291X(74)90185-5; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; GRENSON M, 1972, BIOCHEM BIOPH RES CO, V48, P749, DOI 10.1016/0006-291X(72)90670-5; GRENSON M, 1974, MOL GEN GENET, V128, P73, DOI 10.1007/BF00267295; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MITCHELL AP, 1984, MOL CELL BIOL, V4, P2758, DOI 10.1128/MCB.4.12.2758; RAI R, 1987, J BACTERIOL, V169, P3521, DOI 10.1128/jb.169.8.3521-3524.1987; Rohde JR, 2003, CURR TOP MICROBIOL, V279, P53; ROON RJ, 1973, J BACTERIOL, V116, P367, DOI 10.1128/JB.116.1.367-372.1973; Scherens B, 2006, FEMS YEAST RES, V6, P777, DOI 10.1111/j.1567-1364.2006.00060.x; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Tate JJ, 2008, FEMS YEAST RES, V8, P1223, DOI 10.1111/j.1567-1364.2008.00441.x; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; TUROSCY V, 1979, J BACTERIOL, V140, P971, DOI 10.1128/JB.140.3.971-979.1979; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	64	37	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44897	44912		10.1074/jbc.M111.290577	http://dx.doi.org/10.1074/jbc.M111.290577			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039046	Green Published, hybrid			2022-12-25	WOS:000298645500058
J	Hsieh, YH; Zhang, H; Lin, BR; Cui, NR; Na, B; Yang, HC; Jiang, C; Sui, SF; Tai, PC				Hsieh, Ying-hsin; Zhang, Hao; Lin, Bor-ruei; Cui, Ningren; Na, Bing; Yang, Hsiuchin; Jiang, Chun; Sui, Sen-fang; Tai, Phang C.			SecA Alone Can Promote Protein Translocation and Ion Channel Activity SecYEG INCREASES EFFICIENCY AND SIGNAL PEPTIDE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI MEMBRANE-VESICLES; ESCHERICHIA-COLI; CONDUCTING CHANNELS; IN-VITRO; PLUG DOMAIN; COMPLEX; ATP; EXPORT; STATE; PRLA	SecA is an essential component of the Sec-dependent protein translocation pathway across cytoplasmic membranes in bacteria. Escherichia coli SecA binds to cytoplasmic membranes at SecYEG high affinity sites and at phospholipid low affinity sites. It has been widely viewed that SecYEG functions as the essential protein-conducting channel through which precursors cross the membranes in bacterial Sec-dependent pathways, and that SecA functions as a motor to hydrolyze ATP in translocating precursors through SecYEG channels. We have now found that SecA alone can promote precursor translocation into phospholiposomes. Moreover, SecA-liposomes elicit ionic currents in Xenopus oocytes. Patch-clamp recordings further show that SecA alone promotes signal peptide-or precursor-dependent single channel activity. These activities were observed with the functional SecA at about 1-2 mu M. The results show that SecA alone is sufficient to promote protein translocation into liposomes and to elicit ionic channel activity at the phospholipids low affinity binding sites, thus indicating that SecA is able to form the protein-conducting channels. Even so, such SecA-liposomes are less efficient than those with a full complement of Sec proteins, and lose the signal-peptide proofreading function, resembling the effects of PrlA mutations. Addition of purified SecYEG restores the signal peptide specificity and increases protein translocation and ion channel activities. These data show that SecA can promote protein translocation and ion channel activities both when it is bound to lipids at low affinity sites and when it is bound to SecYEG with high affinity. The latter of the two interactions confers high efficiency and specificity.	[Tai, Phang C.] Georgia State Univ, Dept Biol, Ctr Biotechnol & Drug Design, Atlanta, GA 30303 USA; [Sui, Sen-fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	University System of Georgia; Georgia State University; Tsinghua University	Tai, PC (corresponding author), Georgia State Univ, Dept Biol, Petit Sci Ctr, 161 Jesse Hill Dr,Suite 490, Atlanta, GA 30303 USA.	biopct@gsu.edu	Zhang, Hao/H-4026-2014		National Institutes of Health [GM34676]; Chinese NNSF [30830028]; NBRP [2010CD833706/2010CB912400]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese NNSF(National Natural Science Foundation of China (NSFC)); NBRP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant GM34676 (to P. C. T.) and Chinese NNSF Grant 30830028 and NBRP Grant 2010CD833706/2010CB912400 (to S.-f. S.).	Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHEN LL, 1987, NATURE, V328, P164, DOI 10.1038/328164a0; CHEN LL, 1985, P NATL ACAD SCI USA, V82, P4384, DOI 10.1073/pnas.82.13.4384; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen XC, 1998, J BACTERIOL, V180, P527, DOI 10.1128/JB.180.3.527-537.1998; Chen Y, 2007, J STRUCT BIOL, V159, P149, DOI 10.1016/j.jsb.2007.01.015; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Das S, 2008, J BACTERIOL, V190, P7302, DOI 10.1128/JB.00593-08; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; KELLER RCA, 1995, FEBS LETT, V358, P251, DOI 10.1016/0014-5793(94)01439-8; KIM YJ, 1994, CELL, V78, P845; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Lin BR, 2006, J MEMBRANE BIOL, V214, P103, DOI 10.1007/s00232-006-0079-1; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; OLIVER DB, 1982, J BACTERIOL, V150, P686, DOI 10.1128/JB.150.2.686-691.1982; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Or E, 2007, FEBS LETT, V581, P2616, DOI 10.1016/j.febslet.2007.04.083; Pohlschroder M, 2005, ANNU REV MICROBIOL, V59, P91, DOI 10.1146/annurev.micro.59.030804.121353; SILHAVY TJ, 1983, METHOD ENZYMOL, V97, P11; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; TAI PC, 1991, METHOD CELL BIOL, V34, P167; TAKAMATSU H, 1994, J BIOCHEM-TOKYO, V116, P1287, DOI 10.1093/oxfordjournals.jbchem.a124677; Tang Y, 2010, SCI CHINA LIFE SCI, V53, P1049, DOI 10.1007/s11427-010-4061-x; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; Wang HY, 2008, J BACTERIOL, V190, P1413, DOI 10.1128/JB.01633-07; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; WATANABE M, 1990, P NATL ACAD SCI USA, V87, P1960, DOI 10.1073/pnas.87.5.1960; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514; WOLIN SL, 1994, CELL, V77, P787, DOI 10.1016/0092-8674(94)90124-4; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Yang YB, 1997, J BIOL CHEM, V272, P13660, DOI 10.1074/jbc.272.21.13660; Yang YB, 1997, J BACTERIOL, V179, P7386, DOI 10.1128/jb.179.23.7386-7393.1997; Yu LY, 2006, PROTEIN EXPRES PURIF, V50, P179, DOI 10.1016/j.pep.2006.06.023; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	44	32	34	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44702	44709		10.1074/jbc.M111.300111	http://dx.doi.org/10.1074/jbc.M111.300111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22033925	hybrid, Green Published			2022-12-25	WOS:000298645500040
J	Hu, Y; Ma, DX; Shan, NN; Zhu, YY; Liu, XG; Zhang, L; Yu, S; Ji, CY; Hou, M				Hu, Yu; Ma, Dao-xin; Shan, Ning-ning; Zhu, Yuan-yuan; Liu, Xin-guang; Zhang, Lei; Yu, Shuang; Ji, Chun-yan; Hou, Ming			Increased Number of Tc17 and Correlation with Th17 Cells in Patients with Immune Thrombocytopenia	PLOS ONE			English	Article							T-CELLS; ROR-GAMMA; PURPURA; DIFFERENTIATION; PATHOPHYSIOLOGY; PROFILE; IL-17	Background: IL-17-secreting CD8+ T cells (Tc17 subset) have recently been defined as a subpopulation of effector T cells implicated in the pathogenesis of autoimmune diseases. The role of Tc17 and correlation with Th17 cells in the pathophysiology of immune thrombocytopenia (ITP) remain unsettled. Design and Methods: We studied 47 ITP patients (20 newly-diagnosed and 27 with complete response) and 34 healthy controls. IL-17-producing CD3+CD8+ cells (Tc17) and IL-17-producing CD3+CD8- cells (Th17) were evaluated by flow cytometry and expressed as a percentage of the total number of CD3+ cells. Specific anti-platelet glycoprotein (GP) GPIIb/IIIa and/or GPIb/IX autoantibodies were measured by modified monoclonal antibody specific immobilization of platelet antigens. Peripheral blood mononuclear cells of ITP patients were isolated, incubated in the presence of 0, 0.25, 0.5, or 1 mu mol/L of dexamethasone for 72 h, and collected to detect Tc17 and Th17 cells by flow cytometric analysis. Results: IL-17 was expressed on CD3+CD8- and CD3+ CD8+ T cells. The percentages of Tc17 and Th17 cells in newly-diagnosed patients were significantly elevated compared to controls, and Tc17 was decreased after clinical treatment. The Th17:Tc17 ratio was significantly lower in newly-diagnosed patients compared with controls, and was increased in patients who had complete response. There was a significantly positive correlation between Tc17 and Th17 cells in the control group, but not in the ITP patients. A positive correlation existed between Tc17 and the CD8:CD4 ratio, as well as CD8+ cells in patients with ITP. The frequencies of Tc17 were marginally higher in autoantibody-negative patients than autoantibody-positive patients. Moreover, both Tc17 and Th17 cell percentages decreased as the concentration of dexamethasone in the culture media increased in ITP patients. Conclusions: Tc17 and the Th17 subset are involved in the immunopathology of ITP. Blocking the abnormally increased number of Tc17 may be a reasonable therapeutic strategy for ITP.	[Hu, Yu; Ma, Dao-xin; Zhu, Yuan-yuan; Liu, Xin-guang; Yu, Shuang; Ji, Chun-yan; Hou, Ming] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Shan, Ning-ning] Shandong Univ, Prov Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Zhang, Lei] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Ma, DX (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	daoxinma@hotmail.com			National Natural Science Foundation [30600680, 81070396, 81070407, 81170515]; Shandong Technological Development Project [2005BS03022, Q 2008C 07, BS2009SW014]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry (SRF); Independent Innovation Foundation of Shandong University (IIFSDU) [2009TS063, 2009TS071, 21300070613233]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry (SRF); Independent Innovation Foundation of Shandong University (IIFSDU)	This study was partially supported by research funding from the National Natural Science Foundation (30600680, 81070396, 81070407, 81170515), the Shandong Technological Development Project (2005BS03022, Q 2008C 07, and BS2009SW014), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM), and Independent Innovation Foundation of Shandong University (IIFSDU; 2009TS063, 2009TS071, and 21300070613233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi LJ, 2010, J PERIPHER NERV SYST, V15, P345, DOI 10.1111/j.1529-8027.2010.00294.x; Chow L, 2010, BLOOD, V115, P1247, DOI 10.1182/blood-2009-09-244772; Garcia-Hernandez MD, 2010, J IMMUNOL, V184, P4215, DOI 10.4049/jimmunol.0902995; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Henriques A, 2010, CELL IMMUNOL, V264, P97, DOI 10.1016/j.cellimm.2010.05.004; Hou M, 2003, EUR J HAEMATOL, V70, P353, DOI 10.1034/j.1600-0609.2003.00076.x; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Ma DX, 2008, ANN HEMATOL, V87, P899, DOI 10.1007/s00277-008-0535-3; Nicoletti F, 2009, CLIN EXP IMMUNOL, V155, P28, DOI 10.1111/j.1365-2249.2008.03780.x; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Sakakura M, 2007, THROMB RES, V120, P187, DOI 10.1016/j.thromres.2006.09.008; Semple JW, 2002, BLOOD REV, V16, P9, DOI 10.1054/blre.2001.0172; Semple JW, 1996, BLOOD, V87, P4245, DOI 10.1182/blood.V87.10.4245.bloodjournal87104245; Stasi R, 2008, THROMB HAEMOSTASIS, V99, P4, DOI 10.1160/TH07-08-0513; SYRJALA H, 1991, CLIN EXP IMMUNOL, V83, P326; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang JB, 2009, HAEMATOL-HEMATOL J, V94, P1326, DOI 10.3324/haematol.2009.007823; Zhao XY, 2011, EUR J IMMUNOL, V41, P514, DOI 10.1002/eji.201040793; Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu XJ, 2010, J CLIN IMMUNOL, V30, P253, DOI 10.1007/s10875-009-9353-1	27	43	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26522	10.1371/journal.pone.0026522	http://dx.doi.org/10.1371/journal.pone.0026522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039505	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200023
J	Marcelin, G; DuBois, R; Rubrum, A; Russell, CJ; McElhaney, JE; Webby, RJ				Marcelin, Glendie; DuBois, Rebecca; Rubrum, Adam; Russell, Charles J.; McElhaney, Janet E.; Webby, Richard J.			A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus	PLOS ONE			English	Article							HELPER T-CELLS; IMMUNOLOGICAL RESPONSE; ANTIGENIC-COMPETITION; UNPRIMED POPULATIONS; EXTRACELLULAR DOMAIN; VIRAL HEMAGGLUTININ; PROTECTIVE IMMUNITY; CROSS-PROTECTION; PRIOR EXPERIENCE; VACCINE	Background: Exposure to contemporary seasonal influenza A viruses affords partial immunity to pandemic H1N1 2009 influenza A virus (pH1N1) infection. The impact of antibodies to the neuraminidase (NA) of seasonal influenza A viruses to cross-immunity against pH1N1 infection is unknown. Methods and Results: Antibodies to the NA of different seasonal H1N1 influenza strains were tested for cross-reactivity against A/California/04/09 (pH1N1). A panel of reverse genetic (rg) recombinant viruses was generated containing 7 genes of the H1N1 influenza strain A/Puerto Rico/08/34 (PR8) and the NA gene of either the pandemic H1N1 2009 strain (pH1N1) or one of the following contemporary seasonal H1N1 strains: A/Solomon/03/06 (rg Solomon) or A/Brisbane/59/07 (rg Brisbane). Convalescent sera collected from mice infected with recombinant viruses were measured for cross-reactive antibodies to pH1N1 via Hemagglutinin Inhibition (HI) or Enzyme-Linked Immunosorbent Assay (ELISA). The ectodomain of a recombinant NA protein from the pH1N1 strain (pNA-ecto) was expressed, purified and used in ELISA to measure cross-reactive antibodies. Analysis of sera from elderly humans immunized with trivalent split-inactivated influenza (TIV) seasonal vaccines prior to 2009 revealed considerable cross-reactivity to pNA-ecto. High titers of cross-reactive antibodies were detected in mice inoculated with either rg Solomon or rg Brisbane. Convalescent sera from mice inoculated with recombinant viruses were used to immunize naive recipient Balb/c mice by passive transfer prior to challenge with pH1N1. Mice receiving rg California sera were better protected than animals receiving rg Solomon or rg Brisbane sera. Conclusions: The NA of contemporary seasonal H1N1 influenza strains induces a cross-reactive antibody response to pH1N1 that correlates with reduced lethality from pH1N1 challenge, albeit less efficiently than anti-pH1N1 NA antibodies. These findings demonstrate that seasonal NA antibodies contribute to but are not sufficient for cross-reactive immunity to pH1N1.	[Marcelin, Glendie; DuBois, Rebecca; Rubrum, Adam; Russell, Charles J.; Webby, Richard J.] St Jude Childrens Hosp, Div Virol, Dept Infect Dis, Memphis, TN 38105 USA; [DuBois, Rebecca] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [McElhaney, Janet E.] Univ Connecticut, Sch Med, Dept Immunol, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Connecticut	Webby, RJ (corresponding author), St Jude Childrens Hosp, Div Virol, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.webby@stjude.org	Russell, Charles/AAU-6006-2020; Russell, Charles/K-4824-2013; Webby, Richard J/N-5657-2018	Russell, Charles/0000-0001-5683-3990; Russell, Charles/0000-0001-5683-3990; DuBois, Rebecca/0000-0003-4185-5673	National Institute of Allergy and Infectious Diseases [HHSN266200700005C]; Centers of Excellence for Influenza Research and Surveillance [HHSN266200700005C]; American Lebanese Syrian Associated Charities	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers of Excellence for Influenza Research and Surveillance; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This study was supported by the National Institute of Allergy and Infectious Diseases (contract number HHSN266200700005C), Centers of Excellence for Influenza Research and Surveillance (contract number HHSN266200700005C) and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMERDING D, 1982, J INFECT DIS, V145, P320, DOI 10.1093/infdis/145.3.320; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Bragstad K, 2011, INFLUENZA OTHER RESP, V5, P13, DOI 10.1111/j.1750-2659.2010.00177.x; Brecht H, 1971, Virology, V46, P337; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cate TR, 2010, VACCINE, V28, P2076, DOI 10.1016/j.vaccine.2009.12.041; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; ELLEBEDY AH, 2010, VACCINE; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; HANCOCK EJ, 1986, J INFECT DIS, V154, P1031, DOI 10.1093/infdis/154.6.1031; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; HOLMES KT, 1982, EUR J IMMUNOL, V12, P523, DOI 10.1002/eji.1830120614; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; JOHANSSON BE, 1987, P NATL ACAD SCI USA, V84, P6869, DOI 10.1073/pnas.84.19.6869; JOHANSSON BE, 1987, J IMMUNOL, V139, P2015; JOHANSSON BE, 1993, VACCINE, V11, P1037, DOI 10.1016/0264-410X(93)90130-P; JOHANSSON BE, 1994, P NATL ACAD SCI USA, V91, P2358, DOI 10.1073/pnas.91.6.2358; Johansson BE, 1998, VACCINE, V16, P1009, DOI 10.1016/S0264-410X(97)00279-X; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; JOHANSSON BE, 1987, J IMMUNOL, V139, P2010; Kayamuro H, 2010, J VIROL, V84, P12703, DOI 10.1128/JVI.01182-10; KENDAL AP, 1977, J INFECT DIS, V136, pS415, DOI 10.1093/infdis/136.Supplement_3.S415; KENDAL AP, 1980, INFECT IMMUN, V29, P966; KILBOURNE ED, 1968, J VIROL, V2, P281, DOI 10.1128/JVI.2.4.281-288.1968; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Marcelin G, 2010, J INFECT DIS, V202, P1634, DOI 10.1086/657084; McCullers JA, 2010, CLIN INFECT DIS, V50, P1487, DOI 10.1086/652441; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; Pearce MB, 2011, VACCINE, V29, P2887, DOI 10.1016/j.vaccine.2011.02.014; Powers DC, 1996, CLIN DIAGN LAB IMMUN, V3, P511, DOI 10.1128/CDLI.3.5.511-516.1996; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; Scheible K, 2011, VACCINE, V29, P2159, DOI 10.1016/j.vaccine.2010.12.073; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Subbramanian RA, 2010, HUM IMMUNOL, V71, P957, DOI 10.1016/j.humimm.2010.07.005; Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEBSTER RG, 1967, J IMMUNOL, V99, P49; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	56	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26335	10.1371/journal.pone.0026335	http://dx.doi.org/10.1371/journal.pone.0026335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039464	Green Submitted, Green Published, gold			2022-12-25	WOS:000296515200013
J	Bansal, N; Kadamb, R; Mittal, S; Vig, L; Sharma, R; Dwarakanath, BS; Saluja, D				Bansal, Nidhi; Kadamb, Rama; Mittal, Shilpi; Vig, Leena; Sharma, Raisha; Dwarakanath, Bilikere S.; Saluja, Daman			Tumor Suppressor Protein p53 Recruits Human Sin3B/HDAC1 Complex for Down-Regulation of Its Target Promoters in Response to Genotoxic Stress	PLOS ONE			English	Article							ALPHA-FETOPROTEIN GENE; CELL-CYCLE ARREST; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; BINDING-SITE; CHROMATIN MODIFICATIONS; FUNCTIONAL DOMAIN; INDUCED APOPTOSIS; DNA-BINDING; LYSINE 9	Master regulator protein p53, popularly known as the "guardian of genome" is the hub for regulation of diverse cellular pathways. Depending on the cell type and severity of DNA damage, p53 protein mediates cell cycle arrest or apoptosis, besides activating DNA repair, which is apparently achieved by regulation of its target genes, as well as direct interaction with other proteins. p53 is known to repress target genes via multiple mechanisms one of which is via recruitment of chromatin remodelling Sin3/HDAC1/2 complex. Sin3 proteins (Sin3A and Sin3B) regulate gene expression at the chromatin-level by serving as an anchor onto which the core Sin3/HDAC complex is assembled. The Sin3/HDAC co-repressor complex can be recruited by a large number of DNA-binding transcription factors. Sin3A has been closely linked to p53 while Sin3B is considered to be a close associate of E2Fs. The theme of this study was to establish the role of Sin3B in p53-mediated gene repression. We demonstrate a direct protein-protein interaction between human p53 and Sin3B (hSin3B). Amino acids 1-399 of hSin3B protein are involved in its interaction with N-terminal region (amino acids 1-108) of p53. Genotoxic stress induced by Adriamycin treatment increases the levels of hSin3B that is recruited to the promoters of p53-target genes (HSPA8, MAD1 and CRYZ). More importantly recruitment of hSin3B and repression of the three p53-target promoters upon Adriamycin treatment were observed only in p53(+/+) cell lines. Additionally an increased tri-methylation of the H3K9 residue at the promoters of HSPA8 and CRYZ was also observed following Adriamycin treatment. The present study highlights for the first time the essential role of Sin3B as an important associate of p53 in mediating the cellular responses to stress and in the transcriptional repression of genes encoding for heat shock proteins or proteins involved in regulation of cell cycle and apoptosis.	[Bansal, Nidhi; Kadamb, Rama; Mittal, Shilpi; Vig, Leena; Sharma, Raisha; Saluja, Daman] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Dwarakanath, Bilikere S.] Inst Nucl Med & Allied Sci, Delhi, India	University of Delhi; Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Bansal, N (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	dsalujach59@gmail.com	Kadamb, Rama/AAE-7233-2022	Kadamb, Rama/0000-0002-0157-2305; Dwarakanath, Bilikere S./0000-0001-6988-2601; Bansal, Nidhi/0000-0001-6502-3930	Department of Science and Technology [R/SO/BB- 55/2004]; Council of Scientific and Industrial Research, Government of India [37/1431/10/EMRII]; Council of Scientific and Industrial Research; University Grants Commission; Indian Council of Medical Research	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by grants from Department of Science and Technology (R/SO/BB- 55/2004) and Council of Scientific and Industrial Research (37/1431/10/EMRII), Government of India to Prof. Daman Saluja. The research fellowships of the authors were funded by Council of Scientific and Industrial Research (authors NB and RK), University Grants Commission (author SM) and Indian Council of Medical Research (author LV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2001, J BIOL CHEM, V276, P14649, DOI 10.1074/jbc.M100200200; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARRANCO SC, 1973, CANCER RES, V33, P11; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Chun ACS, 2003, J BIOL CHEM, V278, P37439, DOI 10.1074/jbc.M307185200; Crosby ME, 2004, J ENVIRON PATHOL TOX, V23, P67, DOI 10.1615/JEnvPathToxOncol.v23.i1.70; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Grandinetti KB, 2009, CANCER RES, V69, P6430, DOI 10.1158/0008-5472.CAN-09-0537; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lapucci A, 2010, FASEB J, V24, P1852, DOI 10.1096/fj.09-140459; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen TT, 2005, MOL CELL BIOL, V25, P2147, DOI 10.1128/MCB.25.6.2147-2157.2005; Osheroff N, 1994, Adv Pharmacol, V29B, P105; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Siu WY, 1999, FEBS LETT, V461, P299, DOI 10.1016/S0014-5793(99)01481-7; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Xu Y, 2008, J BIOL CHEM, V283, P1243, DOI 10.1074/jbc.M707180200; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	49	31	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26156	10.1371/journal.pone.0026156	http://dx.doi.org/10.1371/journal.pone.0026156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028823	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800021
J	Kassa, FA; Shio, MT; Bellemare, MJ; Faye, B; Ndao, M; Olivier, M				Kassa, Fikregabrail Aberra; Shio, Marina Tiemi; Bellemare, Marie-Josee; Faye, Babacar; Ndao, Momar; Olivier, Martin			New Inflammation-Related Biomarkers during Malaria Infection	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CEREBRAL MALARIA; UNCOMPLICATED MALARIA; COMPLEMENT ACTIVATION; CHILDREN; HEMOZOIN; SEVERITY; PROTEINS; PIGMENT; IL-10	Malaria is one of the most prevalent infectious diseases worldwide with more than 250 million cases and one million deaths each year. One of the well-characterized malarial-related molecules is hemozoin (HZ), which is a dark-brown crystal formed by the parasite and released into the host during the burst of infected red blood cells. HZ has a stimulatory effect on the host immune system such as its ability to induce pro-inflammatory mediators responsible for some of the malaria related clinical symptoms such as fever. However, the host serum proteins interacting with malarial HZ as well as how this interaction modifies its recognition by phagocytes remained elusive. In the actual study, using proteomic liquid chromatographic mass spectrometry (LC-MS/MS) and immunochemical approaches, we compared the serum protein profiles of malaria patients and healthy individuals. Particularly, we utilized the malarial HZ itself to capture serum proteins capable to bind to HZ, enabling us to identify several proteins such as apolipoprotein E (ApoE), serum amyloid A (SAA), gelsolin, complement factor H and fibrinogen that were found to differ among healthy and malaria individual. Of particular interest is LPS binding protein (LBP), which is reported herein for the first time in the context of malaria. LBP is usually produced during innate inflammatory response to gram-negative bacterial infections. The exact role of these biomarkers and acute phase responses in malaria in general and HZ in particular remains to be investigated. The identification of these inflammation-related biomarkers in malaria paves the way to potentially utilize them as diagnostic and therapeutic targets.	[Kassa, Fikregabrail Aberra; Shio, Marina Tiemi; Bellemare, Marie-Josee; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Kassa, Fikregabrail Aberra; Shio, Marina Tiemi; Bellemare, Marie-Josee; Ndao, Momar; Olivier, Martin] McGill Univ, Ctr Study Host Resistance, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Faye, Babacar] Cheikh Anta Diop Univ, Fac Med, Dept Parasitol & Mycol, Dakar, Senegal; [Ndao, Momar] Montreal Gen Hosp, Natl Reference Ctr Parasitol, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; University Cheikh Anta Diop Dakar; McGill University	Kassa, FA (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	martin.olivier@mcgill.ca	Shio, Marina Tiemi/E-6466-2019	Shio, Marina Tiemi/0000-0002-2494-6816	Canadian Institute of Health Research; Burroughs Wellcome Fund; Research Institute of the McGill University Health Center and Faculty of Medicine	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Research Institute of the McGill University Health Center and Faculty of Medicine	This study is supported by operating grants from the Canadian Institute of Health Research to M.O. M.O. is a Canadian Institute of Health Research Investigator and a Burroughs Wellcome Fund Fellow. F. A. K. is recipient of fellowships from the Research Institute of the McGill University Health Center and Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM C, 1981, INFECT IMMUN, V31, P530, DOI 10.1128/IAI.31.2.530-535.1981; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Bellemare MJ, 2009, J PHYS CHEM B, V113, P8391, DOI 10.1021/jp8104375; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; GILLESPIE SH, 1991, J CLIN PATHOL, V44, P228, DOI 10.1136/jcp.44.3.228; GREENWOOD BM, 1974, CLIN EXP IMMUNOL, V18, P267; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Jaramillo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006957; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Nesvizhskii AI, 2004, DRUG DISCOV TODAY, V9, P173, DOI 10.1016/S1359-6446(03)02978-7; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; PHANUPHAK P, 1985, CLIN EXP IMMUNOL, V59, P571; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SALE FO, 2005, EUR J HAEMATOL, V74, P324; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shio MT, 2010, MICROBES INFECT, V12, P889, DOI 10.1016/j.micinf.2010.07.001; SRICHAIKUL T, 1975, LANCET, V1, P770; TAYLOR TE, 1993, Q J MED, V86, P99; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105	27	36	36	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26495	10.1371/journal.pone.0026495	http://dx.doi.org/10.1371/journal.pone.0026495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028888	gold, Green Published, Green Submitted			2022-12-25	WOS:000296510800046
J	Niwayama, S; Kassar, AS; Zhao, T; Sutton, RB; Altenberg, GA				Niwayama, Satomi; Kassar, Abdullatif S.; Zhao, Tian; Sutton, Roger B.; Altenberg, Guillermo A.			A Pyrene Maleimide with a Flexible Linker for Sampling of Longer Inter-Thiol Distances by Excimer Formation	PLOS ONE			English	Article							ESCHERICHIA-COLI; LACTOSE PERMEASE; PROXIMITY RELATIONSHIPS; FLUORESCENT-PROBE; VIRUS MEMBRANE; DYNAMICS; BINDING; FUSION; DOMAIN	Pyrene-containing compounds are commonly used in a number of fluorescence-based applications because they can form excited-state dimers (excimers) by stacking interaction between excited-state and ground-state monomers. Their usefulness arises from the facts that excimer formation requires close proximity between the pyrenes and that the excimer emission spectrum is very different from that of the monomers. One of many applications is to assess proximity between specific sites of macromolecules labeled with pyrenes. This has been done using pyrene maleimide, a reagent that reacts with reduced thiols of cysteines, but its use for structural studies of proteins has been rather limited. This is because the introduction of two cysteines at sufficiently close distance from each other to obtain excimer fluorescence upon labeling with pyrene maleimide requires detailed knowledge of the protein structure or extensive site-directed mutagenesis trials. We synthesized and tested a new compound with a 4-carbon methylene linker placed between the maleimide and the pyrene (pyrene-4-maleimide), with the aim of increasing the sampling distance for excimer formation and making the use of excimer fluorescence simpler and more widespread. We tested the new compound on thiol-modified oligonucleotides and showed that it can detect proximity between thiols beyond the reach of pyrene maleimide. Based on its spectroscopic and chemical properties, we suggest that pyrene-4-maleimide is an excellent probe to assess proximities between cysteines in proteins and thiols in other macromolecules, as well as to follow conformational changes.	[Niwayama, Satomi; Zhao, Tian] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Kassar, Abdullatif S.; Sutton, Roger B.; Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX USA; [Kassar, Abdullatif S.; Sutton, Roger B.; Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Niwayama, S (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.	g.altenberg@ttuhsc.edu	Niwayama, Satomi/O-1598-2015; Zhao, Tian/AAM-9541-2021	Niwayama, Satomi/0000-0001-6385-5274; Altenberg, Guillermo/0000-0002-8932-740X	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Cancer Prevention & Research Institute of Texas [RP101073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention & Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (R01GM79629 and 3R01GM079629-03S1) and Cancer Prevention & Research Institute of Texas (RP101073). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETCHERLANGE SL, 1978, J BIOL CHEM, V253, P3757; Boens N, 2007, ANAL CHEM, V79, P2137, DOI 10.1021/ac062160k; Boschek CB, 2008, BIOCHEMISTRY-US, V47, P1640, DOI 10.1021/bi701987n; Conlon P, 2008, J AM CHEM SOC, V130, P336, DOI 10.1021/ja076411y; GRACEFFA P, 1980, J BIOL CHEM, V255, P1296; JUNG K, 1994, BIOCHEMISTRY-US, V33, P3980, DOI 10.1021/bi00179a026; JUNG K, 1993, BIOCHEMISTRY-US, V32, P12273, DOI 10.1021/bi00097a001; Karuppannan S, 2011, CHEM-ASIAN J, V6, P964, DOI 10.1002/asia.201000724; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; Liou YM, 2007, BBA-PROTEINS PROTEOM, V1774, P466, DOI 10.1016/j.bbapap.2007.01.004; Liou YM, 2003, EUR J BIOCHEM, V270, P3092, DOI 10.1046/j.1432-1033.2003.03700.x; Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0; PAL R, 1988, BIOCHEMISTRY-US, V27, P30, DOI 10.1021/bi00401a006; Patel AB, 2010, BIOCHEMISTRY-US, V49, P1766, DOI 10.1021/bi901902e; Pearson JT, 2005, ARCH BIOCHEM BIOPHYS, V436, P397, DOI 10.1016/j.abb.2005.02.008; Santra MK, 2006, PHOTOCHEM PHOTOBIOL, V82, P480, DOI 10.1562/2005-09-26-RA-698; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; WALKER MA, 1995, J ORG CHEM, V60, P5352, DOI 10.1021/jo00121a070; WELTMAN JK, 1973, J BIOL CHEM, V248, P3173; West JM, 2004, J BIOL CHEM, V279, P945, DOI 10.1074/jbc.M304018200; Wu CC, 2010, BIOSENS BIOELECTRON, V25, P2232, DOI 10.1016/j.bios.2010.02.030; Wu CC, 2009, J BIOMED NANOTECHNOL, V5, P495, DOI 10.1166/jbn.2009.1074; Xu Z, 2009, J AM CHEM SOC, V131, P15528, DOI 10.1021/ja906855a; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	24	10	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26691	10.1371/journal.pone.0026691	http://dx.doi.org/10.1371/journal.pone.0026691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028936	Green Submitted, gold, Green Published			2022-12-25	WOS:000296510800065
J	Belda-Ferre, P; Cabrera-Rubio, R; Moya, A; Mira, A				Belda-Ferre, Pedro; Cabrera-Rubio, Raul; Moya, Andres; Mira, Alex			Mining Virulence Genes Using Metagenomics	PLOS ONE			English	Article							WEB-BASED RESOURCE; SPECIES DEFINITION; GENOME SEQUENCE; ISLANDS; PATHOGENOMICS; PROKARYOTES; MICROBIOME; DIVERSITY	When a bacterial genome is compared to the metagenome of an environment it inhabits, most genes recruit at high sequence identity. In free-living bacteria (for instance marine bacteria compared against the ocean metagenome) certain genomic regions are totally absent in recruitment plots, representing therefore genes unique to individual bacterial isolates. We show that these Metagenomic Islands (MIs) are also visible in bacteria living in human hosts when their genomes are compared to sequences from the human microbiome, despite the compartmentalized structure of human-related environments such as the gut. From an applied point of view, MIs of human pathogens (e. g. those identified in enterohaemorragic Escherichia coli against the gut metagenome or in pathogenic Neisseria meningitidis against the oral metagenome) include virulence genes that appear to be absent in related strains or species present in the microbiome of healthy individuals. We propose that this strategy (i.e. recruitment analysis of pathogenic bacteria against the metagenome of healthy subjects) can be used to detect pathogenicity regions in species where the genes involved in virulence are poorly characterized. Using this approach, we detect well-known pathogenicity islands and identify new potential virulence genes in several human pathogens.	[Belda-Ferre, Pedro; Cabrera-Rubio, Raul; Moya, Andres; Mira, Alex] Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Moya, Andres] Ctr Invest Biomed Red Especializado Epidemiol & S, Madrid, Spain	University of Valencia	Belda-Ferre, P (corresponding author), Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	mira_ale@gva.es	Mira, Alex/A-7244-2010; Belda-Ferre, Pedro/E-7699-2013; Belda-Ferre, Pedro/C-9825-2010; Moya, Andrés/A-8190-2008; Cabrera-Rubio, Raúl/K-3720-2014	Belda-Ferre, Pedro/0000-0001-6532-1161; Moya, Andrés/0000-0002-2867-1119; Mira, Alex/0000-0002-9127-3877	Spanish Ministerio De Ciencia E Innovacion [SAF2009-13032-C02-01, SAF2009-13032-C02-02]; EXPLORA program [BIO2008-03419-E]; Consolider-Ingenio program [MICROGEN CSD2009-00006]	Spanish Ministerio De Ciencia E Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); EXPLORA program; Consolider-Ingenio program(Spanish Government)	This work was funded by the following projects from the Spanish Ministerio De Ciencia E Innovacion: SAF2009-13032-C02-01 and SAF2009-13032-C02-02 from the I+D program, BIO2008-03419-E from the EXPLORA program and MICROGEN CSD2009-00006 from the Consolider-Ingenio program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Fan X, 2007, J BIOL CHEM, V282, P35143, DOI 10.1074/jbc.M706296200; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Haley BJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-154; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mira A, 2002, MOL BIOL EVOL, V19, P1350, DOI 10.1093/oxfordjournals.molbev.a004196; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Yoon SH, 2007, NUCLEIC ACIDS RES, V35, pD395, DOI 10.1093/nar/gkl790; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	26	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e24975	10.1371/journal.pone.0024975	http://dx.doi.org/10.1371/journal.pone.0024975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039404	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500005
J	Sanchez, CJ; Hinojosa, CA; Shivshankar, P; Hyams, C; Camberlein, E; Brown, JS; Orihuela, CJ				Sanchez, Carlos J.; Hinojosa, Cecilia A.; Shivshankar, Pooja; Hyams, Catherine; Camberlein, Emilie; Brown, Jeremy S.; Orihuela, Carlos J.			Changes in Capsular Serotype Alter the Surface Exposure of Pneumococcal Adhesins and Impact Virulence	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE ADHESIN; COMPLEMENT DEPOSITION; EPITHELIAL-CELLS; CONJUGATE VACCINE; BINDING-PROTEIN; MULTIPLEX PCR; POLYSACCHARIDE; DISEASE; MICE; PSPA	We examined the contribution of serotype on Streptococcus pneumoniae adhesion and virulence during respiratory tract infection using a panel of isogenic TIGR4 (serotype 4) mutants expressing the capsule types 6A (+6A), 7F (+7F) and 23F (+23F) as well as a deleted and restored serotype 4 (+4) control strain. Immunoblots, bacterial capture assays with immobilized antibody, and measurement of mean fluorescent intensity by flow cytometry following incubation of bacteria with antibody, all determined that the surface accessibility, but not total protein levels, of the virulence determinants Pneumococcal surface protein A (PspA), Choline binding protein A (CbpA), and Pneumococcal serine-rich repeat protein (PsrP) changed with serotype. In vitro, bacterial adhesion to Detroit 562 pharyngeal or A549 lung epithelial cells was modestly but significantly altered for +6A, +7F and +23F. In a mouse model of nasopharyngeal colonization, the number of +6A, +7F, and +23F pneumococci in the nasopharynx was reduced 10 to 100-fold versus +4; notably, only mice challenged with +4 developed bacteremia. Intratracheal challenge of mice confirmed that capsule switch strains were highly attenuated for virulence. Compared to +4, the +6A, +7F, and +23F strains were rapidly cleared from the lungs and were not detected in the blood. In mice challenged intraperitoneally, a marked reduction in bacterial blood titers was observed for those challenged with +6A and +7F versus +4 and +23F was undetectable. These findings show that serotype impacts the accessibility of surface adhesins and, in particular, affects virulence within the respiratory tract. They highlight the complex interplay between capsule and protein virulence determinants.	[Sanchez, Carlos J.; Hinojosa, Cecilia A.; Shivshankar, Pooja; Orihuela, Carlos J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Hyams, Catherine; Camberlein, Emilie; Brown, Jeremy S.] Royal Free & Univ Coll Med Sch, Rayne Inst, Ctr Resp Res, Dept Med, London WC1E 6BT, England	University of Texas System; University of Texas Health San Antonio; University of London; King's College London; University College London	Sanchez, CJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	orihuela@uthscsa.edu	Hyams, Catherine/AAH-1721-2019	Hyams, Catherine/0000-0003-3923-1773; Brown, Jeremy/0000-0002-5650-5361	United States National Institutes of Health, National Institute of Dental and Craniofacial [DE14318]; Astor Foundation; Glaxo Smith Kline through University College London, MB; United Kingdom Medical Research Council; United States National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI078972]; United Kingdom Department of Health, National Institute for Health Research Biomedical Research Centre; U.S. National Institutes of Health, National Cancer Institute [CA54174, UL1 RR025767]; Glaxo Smith Kline through University College London, MD; MRC [G0700829] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; Medical Research Council [G0700829] Funding Source: researchfish	United States National Institutes of Health, National Institute of Dental and Craniofacial(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Astor Foundation; Glaxo Smith Kline through University College London, MB; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United Kingdom Department of Health, National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Glaxo Smith Kline through University College London, MD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Sanchez is supported through the United States National Institutes of Health, National Institute of Dental and Craniofacial Research grant DE14318 for the Craniofacial Oral-Biology Student Training in Academic Research (COSTAR) program. Dr. Hinojosa was supported by the Astor Foundation and Glaxo Smith Kline through the University College London, MB, PhD program. Dr. Camberlein was supported by the United Kingdom Medical Research Council. Dr. Orihuela is supported by United States National Institutes of Health, National Institute of Allergy and Infectious Diseases grant AI078972. For work at University College London Hospitals/University College London a proportion of funding was obtained from the United Kingdom Department of Health, National Institute for Health Research Biomedical Research Centre's funding scheme. The University of Texas Health Science Center Flow Cytometry Core Facility is supported by U.S. National Institutes of Health, National Cancer Institute grant CA54174 and UL1 RR025767. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Hinojosa was supported by an unrestricted educational grant from Glaxo Smith Kline through the University College London, MD, PhD program. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Daniely D, 2006, CLIN EXP IMMUNOL, V144, P254, DOI 10.1111/j.1365-2249.2006.03047.x; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Iannelli F, 2004, INFECT IMMUN, V72, P3077, DOI 10.1128/IAI.72.5.3077-3080.2004; Imai S, 2011, CLIN MICROBIOL INFEC, V17, P1409, DOI 10.1111/j.1469-0691.2010.03446.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lu PJ, 2010, AM J PREV MED, V39, P287, DOI 10.1016/j.amepre.2010.06.004; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; Mann B, 2006, INFECT IMMUN, V74, P821, DOI 10.1128/IAI.74.2.821-829.2006; Melin M, 2010, INFECT IMMUN, V78, P5252, DOI 10.1128/IAI.00739-10; Melin M, 2010, INFECT IMMUN, V78, P5262, DOI 10.1128/IAI.00740-10; Melin M, 2009, INFECT IMMUN, V77, P676, DOI 10.1128/IAI.01186-08; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Munoz-Almagro C, 2010, CLIN VACCINE IMMUNOL, V17, P1672, DOI 10.1128/CVI.00271-10; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; Quin LR, 2007, INFECT IMMUN, V75, P2067, DOI 10.1128/IAI.01727-06; Ren B, 2003, INFECT IMMUN, V71, P75, DOI 10.1128/IAI.71.1.75-85.2003; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; *WHO, 1999, WKLY EPIDEMIOL REC, V74, P177; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	51	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26587	10.1371/journal.pone.0026587	http://dx.doi.org/10.1371/journal.pone.0026587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028914	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500091
J	Heather, LC; Howell, NJ; Emmanuel, Y; Cole, MA; Frenneaux, MP; Pagano, D; Clarke, K				Heather, Lisa C.; Howell, Neil J.; Emmanuel, Yaso; Cole, Mark A.; Frenneaux, Michael P.; Pagano, Domenico; Clarke, Kieran			Changes in Cardiac Substrate Transporters and Metabolic Proteins Mirror the Metabolic Shift in Patients with Aortic Stenosis	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; FAILING HUMAN HEART; IDIOPATHIC DILATED CARDIOMYOPATHY; GENE-EXPRESSION; RAT-HEART; CD36 DEFICIENCY; SKELETAL-MUSCLE; BINDING-PROTEIN; FAT/CD36; MYOCYTES	In the hypertrophied human heart, fatty acid metabolism is decreased and glucose utilisation is increased. We hypothesized that the sarcolemmal and mitochondrial proteins involved in these key metabolic pathways would mirror these changes, providing a mechanism to account for the modified metabolic flux measured in the human heart. Echocardiography was performed to assess in vivo hypertrophy and aortic valve impairment in patients with aortic stenosis (n = 18). Cardiac biopsies were obtained during valve replacement surgery, and used for western blotting to measure metabolic protein levels. Protein levels of the predominant fatty acid transporter, fatty acid translocase (FAT/CD36) correlated negatively with levels of the glucose transporters, GLUT1 and GLUT4. The decrease in FAT/CD36 was accompanied by decreases in the fatty acid binding proteins, FABPpm and H-FABP, the beta-oxidation protein medium chain acyl-coenzyme A dehydrogenase, the Krebs cycle protein alpha-ketoglutarate dehydrogenase and the oxidative phosphorylation protein ATP synthase. FAT/CD36 and complex I of the electron transport chain were downregulated, whereas the glucose transporter GLUT4 was upregulated with increasing left ventricular mass index, a measure of cardiac hypertrophy. In conclusion, coordinated downregulation of sequential steps involved in fatty acid and oxidative metabolism occur in the human heart, accompanied by upregulation of the glucose transporters. The profile of the substrate transporters and metabolic proteins mirror the metabolic shift from fatty acid to glucose utilisation that occurs in vivo in the human heart.	[Heather, Lisa C.; Emmanuel, Yaso; Cole, Mark A.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Cardiac Metab Res Grp, Oxford, England; [Howell, Neil J.; Pagano, Domenico] Univ Hosp NHS Fdn Trust, Dept Cardiothorac Surg, Birmingham, W Midlands, England; [Frenneaux, Michael P.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Oxford; University of Aberdeen	Heather, LC (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Cardiac Metab Res Grp, Oxford, England.	Lisa.Heather@dpag.ox.ac.uk		Howell, Neil/0000-0003-2851-089X; Heather, Lisa/0000-0002-7246-1338; Cole, Mark/0000-0002-0727-7833	British Heart Foundation [RG/07/004/22659]; British Heart Foundation [PG/08/076/25549, PS/02/002/14893] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The work was supported by the British Heart Foundation (grant number RG/07/004/22659). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; BING RJ, 1954, AM J MED, V16, P504, DOI 10.1016/0002-9343(54)90365-4; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Chabowski A, 2006, AM J PHYSIOL-ENDOC M, V291, pE675, DOI 10.1152/ajpendo.00096.2006; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; de las Fuentes L, 2003, HYPERTENSION, V41, P83, DOI 10.1161/01.HYP.0000047668.48494.39; Fabris R, 2001, DIABETES, V50, P601, DOI 10.2337/diabetes.50.3.601; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Goikoetxea MJ, 2006, CARDIOVASC RES, V69, P899, DOI 10.1016/j.cardiores.2005.11.016; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Irie H, 2003, P NATL ACAD SCI USA, V100, P6819, DOI 10.1073/pnas.1132094100; Luiken JJFP, 1999, J LIPID RES, V40, P1007; Neglia D, 2007, AM J PHYSIOL-HEART C, V293, pH3270, DOI 10.1152/ajpheart.00887.2007; OFFNER GD, 1986, J BIOL CHEM, V261, P5584; Opie L.H., 2004, HEART PHYSL CELL CIR, DOI 10.1161/01.CIR.0000143724.99618.; Otsuka Y, 2002, CIRC J, V66, P41, DOI 10.1253/circj.66.41; Razeghi P, 2002, CARDIOLOGY, V97, P203, DOI 10.1159/000063122; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Scheubel RJ, 2002, J AM COLL CARDIOL, V40, P2174, DOI 10.1016/S0735-1097(02)02600-1; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Sharov VG, 2000, J MOL CELL CARDIOL, V32, P2361, DOI 10.1006/jmcc.2000.1266; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SORRENTINO D, 1988, J CLIN INVEST, V82, P928, DOI 10.1172/JCI113700; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Tanaka T, 1997, J MOL CELL CARDIOL, V29, P121, DOI 10.1006/jmcc.1996.0257; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Zorzano A, 1997, AM J CARDIOL, V80, pA65, DOI 10.1016/S0002-9149(97)00459-1	33	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26326	10.1371/journal.pone.0026326	http://dx.doi.org/10.1371/journal.pone.0026326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028857	gold, Green Submitted, Green Published			2022-12-25	WOS:000296186900050
J	Pierron, D; Opazo, JC; Heiske, M; Papper, Z; Uddin, M; Chand, G; Wildman, DE; Romero, R; Goodman, M; Grossman, LI				Pierron, Denis; Opazo, Juan C.; Heiske, Margit; Papper, Zack; Uddin, Monica; Chand, Gopi; Wildman, Derek E.; Romero, Roberto; Goodman, Morris; Grossman, Lawrence I.			Silencing, Positive Selection and Parallel Evolution: Busy History of Primate Cytochromes c	PLOS ONE			English	Article							PHOSPHORYLATED IN-VIVO; MOLECULAR EVOLUTION; ANTHROPOID PRIMATES; OXIDASE SUBUNIT; ADAPTIVE EVOLUTION; LIKELIHOOD METHOD; DIVERGENCE TIME; HOX CLUSTERS; BINDING-SITE; MITOCHONDRIAL	Cytochrome c (cyt c) participates in two crucial cellular processes, energy production and apoptosis, and unsurprisingly is a highly conserved protein. However, previous studies have reported for the primate lineage (i) loss of the paralogous testis isoform, (ii) an acceleration and then a deceleration of the amino acid replacement rate of the cyt c somatic isoform, and (iii) atypical biochemical behavior of human cyt c. To gain insight into the cause of these major evolutionary events, we have retraced the history of cyt c loci among primates. For testis cyt c, all primate sequences examined carry the same nonsense mutation, which suggests that silencing occurred before the primates diversified. For somatic cyt c, maximum parsimony, maximum likelihood, and Bayesian phylogenetic analyses yielded the same tree topology. The evolutionary analyses show that a fast accumulation of non-synonymous mutations (suggesting positive selection) occurred specifically on the anthropoid lineage root and then continued in parallel on the early catarrhini and platyrrhini stems. Analysis of evolutionary changes using the 3D structure suggests they are focused on the respiratory chain rather than on apoptosis or other cyt c functions. In agreement with previous biochemical studies, our results suggest that silencing of the cyt c testis isoform could be linked with the decrease of primate reproduction rate. Finally, the evolution of cyt c in the two sister anthropoid groups leads us to propose that somatic cyt c evolution may be related both to COX evolution and to the convergent brain and body mass enlargement in these two anthropoid clades.	[Pierron, Denis; Opazo, Juan C.; Papper, Zack; Uddin, Monica; Chand, Gopi; Wildman, Derek E.; Romero, Roberto; Goodman, Morris; Grossman, Lawrence I.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Pierron, Denis; Chand, Gopi; Wildman, Derek E.; Romero, Roberto] NICHD, Perinatol Res Branch, NIH, Bethesda, MD USA; [Pierron, Denis; Chand, Gopi; Wildman, Derek E.; Romero, Roberto] NICHD, Perinatol Res Branch, NIH, Detroit, MI USA; [Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ecol & Evoluc, Valdivia, Chile; [Heiske, Margit] Univ Victor Segalen Bordeaux 2, INSERM, Lab Physiopathol Mitochondriale, Bordeaux, France; [Uddin, Monica] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Wildman, Derek E.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Goodman, Morris] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidad Austral de Chile; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Michigan System; University of Michigan; Wayne State University; Wayne State University	Pierron, D (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA.	lgrossman@wayne.edu	Opazo, Juan C./A-9363-2009; Romero, Roberto/A-5268-2019	Opazo, Juan C./0000-0001-7938-4083; Romero, Roberto/0000-0002-4448-5121; Wildman, Derek/0000-0002-6374-5136	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health [GM65580]; Department of Health and Human Services; National Science Foundation [BCS-0550209, BCS0827546, BCS 9910679]; Wayne State Research Excellence fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM065580] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Science Foundation(National Science Foundation (NSF)); Wayne State Research Excellence fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, by NIH GM65580, and by the National Science Foundation (grants BCS-0550209, BCS0827546 and BCS 9910679) and the Wayne State Research Excellence fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA ML, 1981, J MOL EVOL, V17, P197, DOI 10.1007/BF01732758; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; CRAIG DB, 1991, BIOCHEM J, V279, P781, DOI 10.1042/bj2790781; CZELUSNIAK J, 1982, NATURE, V298, P297, DOI 10.1038/298297a0; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Doan JW, 2005, J BIOENERG BIOMEMBR, V37, P35, DOI 10.1007/s10863-005-4121-2; Doan JW, 2004, MOL PHYLOGENET EVOL, V33, P944, DOI 10.1016/j.ympev.2004.07.016; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Goldberg A, 2003, P NATL ACAD SCI USA, V100, P5873, DOI 10.1073/pnas.0931463100; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; HENNIG B, 1975, EUR J BIOCHEM, V55, P167, DOI 10.1111/j.1432-1033.1975.tb02149.x; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Lee TS, 2006, EVOL BIOINFORM, V2, P321; Liu Z, 2006, P NATL ACAD SCI USA, V103, P8965, DOI 10.1073/pnas.0603327103; Lynch VJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000349; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002; OSHEROFF N, 1983, J BIOL CHEM, V258, P5731; Patriarca A, 2009, BIOCHEMISTRY-US, V48, P3279, DOI 10.1021/bi801837e; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Rodriguez-Roldan V, 2006, BIOCHEM BIOPH RES CO, V346, P1108, DOI 10.1016/j.bbrc.2006.06.022; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Schmidt TR, 2005, P NATL ACAD SCI USA, V102, P6379, DOI 10.1073/pnas.0409714102; Schmidt TR, 2001, MOL BIOL EVOL, V18, P563, DOI 10.1093/oxfordjournals.molbev.a003836; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Sundstrom G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-254; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Uddin M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-8; VANKUILENBURG ABP, 1992, EUR J BIOCHEM, V205, P1145; Wildman DE, 2002, MOL BIOL EVOL, V19, P1812, DOI 10.1093/oxfordjournals.molbev.a004005; Williams BA, 2010, P NATL ACAD SCI USA, V107, P4797, DOI 10.1073/pnas.0908320107; Wu W, 2000, MOL PHYLOGENET EVOL, V17, P294, DOI 10.1006/mpev.2000.0833; Wu W, 1997, J MOL EVOL, V44, P477, DOI 10.1007/PL00006172; Yang ZH, 2002, CURR OPIN GENET DEV, V12, P688, DOI 10.1016/S0959-437X(02)00348-9; Ying TL, 2009, J BIOENERG BIOMEMBR, V41, P251, DOI 10.1007/s10863-009-9223-9; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Yuasa K, 2000, J BIOL CHEM, V275, P31469, DOI 10.1074/jbc.M003041200; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang ZL, 2003, GENE, V312, P61, DOI 10.1016/S0378-1119(03)00579-1	52	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26269	10.1371/journal.pone.0026269	http://dx.doi.org/10.1371/journal.pone.0026269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028846	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900040
J	Anton, R; Chatterjee, SS; Simundza, J; Cowin, P; DasGupta, R				Anton, Roman; Chatterjee, Sujash S.; Simundza, Julia; Cowin, Pamela; DasGupta, Ramanuj			A Systematic Screen for Micro-RNAs Regulating the Canonical Wnt Pathway	PLOS ONE			English	Article							COLORECTAL-CARCINOMA CELLS; BETA-CATENIN; NEGATIVE REGULATOR; HUMAN CANCER; C-MET; TARGET; GROWTH; INHIBITION; EXPRESSION; APOPTOSIS	MicroRNAs (miRs) and the canonical Wnt pathway are known to be dysregulated in human cancers and play key roles during cancer initiation and progression. To identify miRs that can modulate the activity of the Wnt pathway we performed a cell-based overexpression screen of 470 miRs in human HEK293 cells. We identified 38 candidate miRs that either activate or repress the canonical Wnt pathway. A literature survey of all verified candidate miRs revealed that the Wnt-repressing miRs tend to be anti-oncomiRs and down-regulated in cancers while Wnt-activating miRs tend to be oncomiRs and upregulated during tumorigenesis. Epistasis-based functional validation of three candidate miRs, miR-1, miR-25 and miR-613, confirmed their inhibitory role in repressing the Wnt pathway and suggest that while miR-25 may function at the level of (a) over cap -catenin (beta-cat), miR-1 and miR-613 act upstream of beta-cat. Both miR-25 and miR-1 inhibit cell proliferation and viability during selection of human colon cancer cell lines that exhibit dysregulated Wnt signaling. Finally, transduction of miR-1 expressing lentiviruses into primary mammary organoids derived from Conductin-lacZ mice significantly reduced the expression of the Wnt-sensitive beta-gal reporter. In summary, these findings suggest the potential use of Wnt-modulating miRs as diagnostic and therapeutic tools in Wnt-dependent diseases, such as cancer.	[Anton, Roman; Chatterjee, Sujash S.; DasGupta, Ramanuj] NYU, Dept Pharmacol, Langone Med Ctr, Inst Canc, New York, NY 10016 USA; [Simundza, Julia; Cowin, Pamela] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Simundza, Julia; Cowin, Pamela] NYU, Langone Med Ctr, Dept Dermatol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Anton, R (corresponding author), NYU, Dept Pharmacol, Langone Med Ctr, Inst Canc, 550 1St Ave, New York, NY 10016 USA.	ramanuj.dasgupta@nyumc.org	Xie, Huangming/B-2260-2012	Dasgupta, Ramanuj/0000-0001-9015-3729; Anton, Roman/0000-0002-9036-0012; Cowin, Pamela/0000-0002-1827-1154	Department of Defense [W81XWH-07-1-0541]; NYSTEM [N09S-012]; Kimmel Stem Cell Biology training program fellowship;  [DOD-BC093088]; NATIONAL CANCER INSTITUTE [R01CA155125] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NYSTEM; Kimmel Stem Cell Biology training program fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by Department of Defense/Breast Cancer Research Program concept award (W81XWH-07-1-0541) and NYSTEM grant (N09S-012) to RD, DOD-BC093088 to PC, and Kimmel Stem Cell Biology training program fellowship to SSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2008, SEMIN REPROD MED, V26, P522, DOI 10.1055/s-0028-1096132; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Chen JS, 2009, PHARMAZIE, V64, P126, DOI 10.1691/ph.2009.8678; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Herynk MH, 2003, CLIN EXP METASTAS, V20, P291, DOI 10.1023/A:1024024218529; Hsi LC, 1999, CARCINOGENESIS, V20, P2045, DOI 10.1093/carcin/20.11.2045; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; KUMAR M, 2010, NEGATIVE REGULATION; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; LIU Q, 2010, ANN REV BIOCH; Liu W, 2007, WORLD J GASTROENTERO, V13, P497, DOI 10.3748/wjg.v13.i4.497; Lu WY, 2009, EUR J PHARMACOL, V602, P8, DOI 10.1016/j.ejphar.2008.10.053; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; MOSER AR, 1995, EUR J CANCER, V31A, P1061, DOI 10.1016/0959-8049(95)00181-H; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Quaiser T, 2006, BIOESSAYS, V28, P339, DOI 10.1002/bies.20386; Ryu MJ, 2008, BIOCHEM BIOPH RES CO, V377, P1304, DOI 10.1016/j.bbrc.2008.10.171; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Shan BE, 2009, CANCER INVEST, V27, P604, DOI 10.1080/07357900802337191; Silver SJ, 2007, P NATL ACAD SCI USA, V104, P18151, DOI 10.1073/pnas.0706673104; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; THATCHER EJ, 2008, P NATL ACAD SCI USA; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; WANG T, 2010, BIOCH BIOPHYS RES CO; Wieczorek M, 2008, CANCER BIOL THER, V7, P268, DOI 10.4161/cbt.7.2.5300; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Xu WL, 2010, CANCER BIOTHER RADIO, V25, P529, DOI 10.1089/cbr.2010.0768; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002	55	62	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26257	10.1371/journal.pone.0026257	http://dx.doi.org/10.1371/journal.pone.0026257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043311	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400039
J	Rudyk, O; Makra, P; Jansen, E; Shattock, MJ; Poston, L; Taylor, PD				Rudyk, Olena; Makra, Peter; Jansen, Eugene; Shattock, Michael J.; Poston, Lucilla; Taylor, Paul D.			Increased Cardiovascular Reactivity to Acute Stress and Salt-Loading in Adult Male Offspring of Fat Fed Non-Obese Rats	PLOS ONE			English	Article							DIET-INDUCED OBESITY; BLOOD-PRESSURE; INSULIN-RESISTANCE; HYPERTENSIVE-RATS; PRENATAL STRESS; NERVOUS-SYSTEM; SENSITIVE HYPERTENSION; ARTERIAL-PRESSURE; RESTRAINT STRESS; SEX-DIFFERENCES	Diet-induced obesity in rat pregnancy has been shown previously to be associated with consistently raised blood pressure in the offspring, attributed to sympathetic over-activation, but the relative contributions to this phenotype of maternal obesity versus raised dietary fat is unknown. Sprague-Dawley female rats were fed either a control (4.3% fat, n = 11) or lard-enriched (23.6% fat, n = 16) chow 10 days prior to mating, throughout pregnancy and lactation. In conscious adult (9-month-old) offspring cardiovascular parameters were measured (radiotelemetry). The short period of fat-feeding did not increase maternal weight versus controls and the baseline blood pressure was similar in offspring of fat fed dams (OF) and controls (OC). However, adult male OF showed heightened cardiovascular reactivity to acute restraint stress (p<0.01; Delta systolic blood pressure (SBP) and Delta heart rate (HR)) with a prolonged recovery time compared to male OC. alpha 1/beta-adrenergic receptor blockade normalised the response. Also, after dietary salt-loading (8%-NaCl ad libitum for 1 week) male OF demonstrated higher SBP (p<0.05) in the awake phase (night-time) and increased low/high frequency ratio of power spectral density of HR variability versus OC. Baroreflex gain and basal power spectral density components of the heart rate or blood pressure were similar in male OF and OC. Minor abnormalities were evident in female OF. Fat feeding in the absence of maternal obesity in pregnant rats leads to altered sympathetic control of cardiovascular function in adult male offspring, and hypertension in response to stressor stimuli.	[Rudyk, Olena; Poston, Lucilla; Taylor, Paul D.] Kings Coll London, Div Womens Hlth, Sch Med, London WC2R 2LS, England; [Rudyk, Olena; Shattock, Michael J.] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England; [Makra, Peter] Univ Szeged, Dept Expt Phys, Szeged, Hungary; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands	University of London; King's College London; University of London; King's College London; Szeged University; Netherlands National Institute for Public Health & the Environment	Rudyk, O (corresponding author), Kings Coll London, Div Womens Hlth, Sch Med, London WC2R 2LS, England.	paul.taylor@kcl.ac.uk	Makra, Péter/GOH-1065-2022; Rudyk, Olena/AAY-3789-2020	Rudyk, Olena/0000-0001-9422-9233; Taylor, Paul David/0000-0002-4740-4307; Shattock, Michael/0000-0001-6242-7585; Poston, Lucilla/0000-0003-1100-2821	British Heart Foundation [PG/06/081/21195]; OTKA, Hungary [404 K69018]; Tommy's Charity (UK)	British Heart Foundation(British Heart Foundation); OTKA, Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Tommy's Charity (UK)	This work was supported by the British Heart Foundation (PG/06/081/21195). P. Makra is funded by OTKA, Hungary (grant 404 K69018). L. Poston is supported by Tommy's Charity (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Cammisotto PG, 2003, AM J PHYSIOL-ENDOC M, V285, pE521, DOI 10.1152/ajpendo.00052.2003; Carlyle M, 2002, HYPERTENSION, V39, P496, DOI 10.1161/hy0202.104398; Cerf ME, 2010, HORM METAB RES, V42, P307, DOI 10.1055/s-0030-1248303; Correia MLG, 2001, HYPERTENSION, V37, P936, DOI 10.1161/01.HYP.37.3.936; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; da Silva AA, 2008, HYPERTENSION, V51, P884, DOI 10.1161/HYPERTENSIONAHA.107.100636; De Wardener HE, 2001, PHYSIOL REV, V81, P1599, DOI 10.1152/physrev.2001.81.4.1599; Elmes MJ, 2007, BRIT J NUTR, V98, P93, DOI 10.1017/S000711450769182X; Ely D, 2010, STEROIDS, V75, P747, DOI 10.1016/j.steroids.2009.10.015; Ely DL, 1997, AM J CLIN NUTR, V65, P594; FOLKOW B, 1989, AM J HYPERTENS, V2, pS103, DOI 10.1093/ajh/2.3.103S; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Galipeau D, 2002, AM J PHYSIOL-HEART C, V283, pH2478, DOI 10.1152/ajpheart.00243.2002; Gomez-Merino D, 2002, MED SCI SPORT EXER, V34, P1594, DOI 10.1097/00005768-200210000-00010; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Huang BS, 2006, CURR OPIN CARDIOL, V21, P295, DOI 10.1097/01.hco.0000231398.64362.94; Igosheva N, 2004, J PHYSIOL-LONDON, V557, P273, DOI 10.1113/jphysiol.2003.056911; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kok P, 2006, J CLIN ENDOCR METAB, V91, P3236, DOI 10.1210/jc.2005-2529; Korotkova M, 2005, AM J PHYSIOL-REG I, V288, pR575, DOI 10.1152/ajpregu.00342.2004; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; LIMAS C, 1981, HYPERTENSION, V3, P219, DOI 10.1161/01.HYP.3.2.219; Lombardi Federico, 2002, Card Electrophysiol Rev, V6, P245, DOI 10.1023/A:1016329008921; Maccari S, 2003, NEUROSCI BIOBEHAV R, V27, P119, DOI 10.1016/S0149-7634(03)00014-9; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Maris ME, 2005, CLIN EXP PHARMACOL P, V32, P35, DOI 10.1111/j.1440-1681.2005.04156.x; Matthews SG, 2011, EXP NEUROL IN PRESS; Mitra A, 2009, AM J PHYSIOL-REG I, V296, pR20, DOI 10.1152/ajpregu.90553.2008; Muntzel MS, 2007, METABOLISM, V56, P373, DOI 10.1016/j.metabol.2006.10.020; Nehiri T, 2008, DIABETES, V57, P2167, DOI 10.2337/db07-0780; Ngampramuan S, 2008, AM J PHYSIOL-REG I, V294, pR132, DOI 10.1152/ajpregu.00464.2007; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Nuyt AM, 2009, CURR OPIN NEPHROL HY, V18, P144, DOI 10.1097/MNH.0b013e328326092c; O'Regan D, 2008, J ENDOCRINOL, V196, P343, DOI 10.1677/JOE-07-0327; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; PARE WP, 1986, NEUROSCI BIOBEHAV R, V10, P339, DOI 10.1016/0149-7634(86)90017-5; Pechere-Bertschi A, 2004, AM J HYPERTENS, V17, P994, DOI 10.1016/j.amjhyper.2004.08.009; Peyronnet J, 2002, PFLUG ARCH EUR J PHY, V443, P858, DOI 10.1007/s00424-001-0766-9; Pierce JP, 2009, NEUROSCIENCE, V163, P329, DOI 10.1016/j.neuroscience.2009.06.006; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Porter JP, 2009, AUTON NEUROSCI-BASIC, V150, P140, DOI 10.1016/j.autneu.2009.04.006; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Rayner DV, 2001, J MOL MED, V79, P8, DOI 10.1007/s001090100198; Ricci MR, 1999, OBES RES, V7, P233, DOI 10.1002/j.1550-8528.1999.tb00401.x; Rocchini AP, 2000, NUTR METAB CARDIOVAS, V10, P287; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Samuelsson AM, 2010, HYPERTENSION, V55, P76, DOI 10.1161/HYPERTENSIONAHA.109.139402; Schreuder MF, 2007, HYPERTENSION, V50, pE158, DOI 10.1161/HYPERTENSIONAHA.107.099994; Song L, 2009, NEUROCHEM RES, V34, P739, DOI 10.1007/s11064-008-9838-y; Souza HCD, 2001, AM J PHYSIOL-HEART C, V280, pH844, DOI 10.1152/ajpheart.2001.280.2.H844; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Taylor PD, 2003, EXP PHYSIOL, V88, P389, DOI 10.1113/eph8802495; Taylor PD, J PHYSL, V558, P943; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; Vieau D, 2007, PSYCHONEUROENDOCRINO, V32, pS16, DOI 10.1016/j.psyneuen.2007.03.014; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x	63	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25250	10.1371/journal.pone.0025250	http://dx.doi.org/10.1371/journal.pone.0025250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043281	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400008
J	Hu, JX; Thor, D; Zhou, YR; Liu, T; Wang, Y; McMillin, SM; Mistry, R; Challiss, RAJ; Costanzi, S; Wess, J				Hu, Jianxin; Thor, Doreen; Zhou, Yaru; Liu, Tong; Wang, Yan; McMillin, Sara M.; Mistry, Rajendra; Challiss, R. A. John; Costanzi, Stefano; Wess, Juergen			Structural aspects of M-3 muscarinic acetylcholine receptor dimer formation and activation	FASEB JOURNAL			English	Article						G-protein-coupled receptor; GPCR; disulfidescanning mutagenesis	PROTEIN-COUPLED RECEPTOR; CROSS-LINKING STRATEGY; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; DRUG DISCOVERY; GPCR; DIMERIZATION; AGONIST; INTERFACE	To explore the structural mechanisms underlying the assembly and activation of family A GPCR dimers, we used the rat M-3 muscarinic acetylcholine receptor (M3R) as a model system. Studies with Cys-substituted mutant M3Rs expressed in COS-7 cells led to the identification of several mutant M3Rs that exclusively existed as cross-linked dimers under oxidizing conditions. The cross-linked residues were located at the bottom of transmembrane domain 5 (TM5) and within the N-terminal portion of the third intracellular loop (i3 loop). Studies with urea-stripped membranes demonstrated that M3R disulfide cross-linking did not require the presence of heterotrimeric G proteins. Molecular modeling studies indicated that the cross-linking data were in excellent agreement with the existence of a low-energy M3R dimer characterized by a TM5-TM5 interface. [S-35]GTP gamma S binding/G alpha(q/11) immunoprecipitation assays revealed that an M3R dimer that was cross-linked within the N-terminal portion of the i3 loop (264C) was functionally severely impaired (similar to 50% reduction in receptor-G-protein coupling, as compared to control M3R). These data support the novel concept that agonist-induced activation of M3R dimers requires a conformational change of the N-terminal segment of the i3 loop. Given the high degree of structural homology among family A GPCRs, these findings should be of broad significance.-Hu, J., Thor, D., Zhou, Y., Liu, T., Wang, Y., McMillin, S. M., Mistry, R., Challiss, R. A. J., Costanzi, S., Wess, J. Structural aspects of M-3 muscarinic acetylcholine receptor dimer formation and activation. FASEB J. 26, 604-616 (2012). www.fasebj.org	[Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Costanzi, Stefano] NIDDK, Lab Biol Modeling, Bethesda, MD 20892 USA; [Zhou, Yaru] Hebei Med Univ, Dept Endocrinol, Hosp 3, Shijiazhuang, Peoples R China; [Mistry, Rajendra; Challiss, R. A. John] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Hebei Medical University; University of Leicester	Wess, J (corresponding author), NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bldg 8A,Rm B1A-05,8 Ctr Dr,MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov	Thor, Doreen/P-6778-2019; Costanzi, Stefano/G-8990-2013	Thor, Doreen/0000-0002-9522-5098; Challiss, John/0000-0001-5506-2848; Costanzi, Stefano/0000-0003-3183-7332	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129, ZIADK013025] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The authors thank Ms. Vanivilasini Balachandran and Mr. Zifan Xiang (NIH, NIDDK) for excellent technical assistance.	Akam EC, 2001, BRIT J PHARMACOL, V132, P950, DOI 10.1038/sj.bjp.0703892; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; [Anonymous], 2010, MOL OP ENV MOE VERS; Burstein ES, 1996, J BIOL CHEM, V271, P2882, DOI 10.1074/jbc.271.6.2882; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Costanzi S, 2010, CHIM OGGI, V28, P26; Filizola M, 2005, FEBS J, V272, P2926, DOI 10.1111/j.1742-4658.2005.04730.x; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Song GJ, 2007, P NATL ACAD SCI USA, V104, P18303, DOI 10.1073/pnas.0702857104; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zeng FY, 1999, J BIOL CHEM, V274, P16629, DOI 10.1074/jbc.274.23.16629	38	34	35	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					604	616		10.1096/fj.11-191510	http://dx.doi.org/10.1096/fj.11-191510			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22031716	Green Published			2022-12-25	WOS:000300485700014
J	de Paula, CAA; Coulson-Thomas, VJ; Ferreira, JG; Maza, PK; Suzuki, E; Nakahata, AM; Nader, HB; Sampaio, MU; Oliva, MLV				Andrade de Paula, Claudia Alessandra; Coulson-Thomas, Vivien Jane; Ferreira, Joana Gasperazzo; Maza, Paloma Korehisa; Suzuki, Erika; Nakahata, Adriana Miti; Nader, Helena Bonciani; Sampaio, Misako Uemura; Oliva, Maria Luiza V.			Enterolobium contortisiliquum Trypsin Inhibitor (EcTI), a Plant Proteinase Inhibitor, Decreases in Vitro Cell Adhesion and Invasion by Inhibition of Src Protein-Focal Adhesion Kinase (FAK) Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-TUMOR CELLS; BONE-MARROW STROMA; INVADOPODIA FORMATION; CANCER CELLS; N-WASP; PROSTATE-CANCER; MATRIX METALLOPROTEINASES; COLON-CANCER; C-SRC; MIGRATION	Tumor cell invasion is vital for cancer progression and metastasis. Adhesion, migration, and degradation of the extracellular matrix are important events involved in the establishment of cancer cells at a new site, and therefore molecular targets are sought to inhibit such processes. The effect of a plant proteinase inhibitor, Enterolobium contortisiliquum trypsin inhibitor (EcTI), on the adhesion, migration, and invasion of gastric cancer cells was the focus of this study. EcTI showed no effect on the proliferation of gastric cancer cells or fibroblasts but inhibited the adhesion, migration, and cell invasion of gastric cancer cells; however, EcTI had no effect upon the adhesion of fibroblasts. EcTI was shown to decrease the expression and disrupt the cellular organization of molecules involved in the formation and maturation of invadopodia, such as integrin beta 1, cortactin, neuronal Wiskott-Aldrich syndrome protein, membrane type 1 metalloprotease, and metalloproteinase-2. Moreover, gastric cancer cells treated with EcTI presented a significant decrease in intracellular phosphorylated Src and focal adhesion kinase, integrin-dependent cell signaling components. Together, these results indicate that EcTI inhibits the invasion of gastric cancer cells through alterations in integrin-dependent cell signaling pathways.	[Andrade de Paula, Claudia Alessandra; Coulson-Thomas, Vivien Jane; Ferreira, Joana Gasperazzo; Nakahata, Adriana Miti; Nader, Helena Bonciani; Sampaio, Misako Uemura; Oliva, Maria Luiza V.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biochem & Mol Biol, BR-04044020 Sao Paulo, Brazil; [Maza, Paloma Korehisa; Suzuki, Erika] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, BR-04044020 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Oliva, MLV (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Rua Tres Maio 100, BR-04044020 Sao Paulo, Brazil.	olivaml.bioq@epm.br	SAMPAIO, MISAKO/D-8718-2013; Nader, Helena Bonciani/D-9253-2012; de Paula, Claudia/X-2904-2018; Nakahata, Adriana/K-4898-2012; Oliva, Maria Luiza V/B-9537-2012; Vilela Oliva, Maria Luiza/AGI-6283-2022; Suzuki, Erika/B-3456-2008	Suzuki, Erika/0000-0002-4010-8716; NADER, HELENA/0000-0002-7569-2166; Oliva, Maria Luiza Vilela/0000-0001-7346-6328; Gasperazzo Ferreira, Jona/0000-0002-6713-1123; Oliva, Maria Luiza/0000-0002-5822-0060	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/53766-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 2009/53766-5, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Albrechtsen R, 2011, EXP CELL RES, V317, P195, DOI 10.1016/j.yexcr.2010.10.003; Ammer Amanda Gatesman, 2009, J Cancer Sci Ther, V1, P52; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Armstrong AJ, 2010, CLIN CANCER RES, V16, P3057, DOI 10.1158/1078-0432.CCR-10-0124; Artym VV, 2011, EUR J CELL BIOL, V90, P172, DOI 10.1016/j.ejcb.2010.06.006; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ateeq B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001498; Balzer EM, 2010, ONCOGENE, V29, P6402, DOI 10.1038/onc.2010.360; Batista IFC, 1996, PHYTOCHEMISTRY, V41, P1017, DOI 10.1016/0031-9422(95)00710-5; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Bolos V, 2010, ONCOTARGETS THER, V3, P83; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Boykin C, 2011, BRIT J CANCER, V104, P781, DOI 10.1038/bjc.2011.10; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Canel M, 2008, BRIT J CANCER, V98, P1274, DOI 10.1038/sj.bjc.6604286; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chuu CP, 2011, MED HYPOTHESES, V76, P697, DOI 10.1016/j.mehy.2011.01.037; Coulson-Thomas VJ, 2011, CELL TISSUE RES, V346, P223, DOI 10.1007/s00441-011-1254-y; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Di Florio A, 2007, ENDOCR-RELAT CANCER, V14, P111, DOI 10.1677/erc.1.01318; Donia M, 2011, CELL CYCLE, V10, P492, DOI 10.4161/cc.10.3.14727; Donkor IO, 2011, EXPERT OPIN THER PAT, V21, P601, DOI 10.1517/13543776.2011.568480; Dutta A, 2009, J ONCOL, V2009, DOI 10.1155/2009/627840; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Gjorevski N, 2009, CYTOKINE GROWTH F R, V20, P459, DOI 10.1016/j.cytogfr.2009.10.013; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Hecker TP, 2002, CANCER RES, V62, P2699; Hwang Y. S., 2011, ARCH ORAL B IN PRESS; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JY, 2005, BIOCHEM BIOPH RES CO, V330, P921, DOI 10.1016/j.bbrc.2005.03.057; Korting HC, 1999, ANTIMICROB AGENTS CH, V43, P2038, DOI 10.1128/AAC.43.8.2038; Kwiatkowska A, 2011, BBA-MOL CELL RES, V1813, P655, DOI 10.1016/j.bbamcr.2011.01.020; Lang SH, 1997, CLIN EXP METASTAS, V15, P218, DOI 10.1023/A:1018465213641; Lauzier A, 2011, ARTHRITIS RHEUM-US, V63, P1591, DOI 10.1002/art.30305; Lee SH, 2011, J CELL PHYSIOL, V226, P1850, DOI 10.1002/jcp.22510; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HY, 2006, MOL PHARMACOL, V69, P1207, DOI 10.1124/mol.105.019075; Lu L, 2011, ANTICANCER RES, V31, P1; Macedo MLR, 2004, J AGR FOOD CHEM, V52, P2533, DOI 10.1021/jf035389z; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; McCoy AJ, 1997, J MOL BIOL, V269, P881, DOI 10.1006/jmbi.1997.1067; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Misra A, 2007, BIOCHEM BIOPH RES CO, V364, P908, DOI 10.1016/j.bbrc.2007.10.086; Miyata S, 2007, HUM CELL, V20, P100, DOI 10.1111/j.1749-0774.2007.00035.x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakahata AM, 2011, BIOL CHEM, V392, P327, DOI [10.1515/bc.2011.031, 10.1515/BC.2011.031]; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Patsenker E, 2007, J HEPATOL, V46, P878, DOI 10.1016/j.jhep.2006.11.011; Pick A, 2011, BIOORGAN MED CHEM, V19, P2090, DOI 10.1016/j.bmc.2010.12.043; Pinkaew D, 2009, BBA-GEN SUBJECTS, V1790, P31, DOI 10.1016/j.bbagen.2008.09.006; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Ramsay AK, 2011, BRIT J CANCER, V104, P664, DOI 10.1038/sj.bjc.6606062; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sanchez AM, 2010, MOL ENDOCRINOL, V24, P2114, DOI 10.1210/me.2010-0252; Schneider JG, 2011, BONE, V48, P54, DOI 10.1016/j.bone.2010.09.016; See AP, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-25; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Shin JS, 2011, INT J MOL MED, V27, P401, DOI 10.3892/ijmm.2011.599; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Stahtea XN, 2007, INT J CANCER, V121, P2808, DOI 10.1002/ijc.23029; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Sumikawa JT, 2010, PHYTOCHEMISTRY, V71, P214, DOI 10.1016/j.phytochem.2009.10.009; Sun Meng, 2010, Genes Cancer, V1, P283, DOI 10.1177/1947601910368849; Sun XL, 2009, CARCINOGENESIS, V30, P2109, DOI 10.1093/carcin/bgp251; Takino T, 2010, BIOCHEM BIOPH RES CO, V396, P1042, DOI 10.1016/j.bbrc.2010.05.059; Tanjoni I, 2010, CANCER BIOL THER, V9, P764, DOI 10.4161/cbt.9.10.11434; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; Yamamoto H, 2011, J UROLOGY, V185, P1930, DOI 10.1016/j.juro.2010.12.027; Yoon JR, 2011, BREAST CANCER RES TR, V129, P691, DOI 10.1007/s10549-010-1239-7; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	80	32	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					170	182		10.1074/jbc.M111.263996	http://dx.doi.org/10.1074/jbc.M111.263996			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22039045	hybrid, Green Published			2022-12-25	WOS:000298682400019
J	Zhang, D; Guo, M; Zhang, W; Lu, XY				Zhang, Di; Guo, Ming; Zhang, Wei; Lu, Xin-Yun			Adiponectin Stimulates Proliferation of Adult Hippocampal Neural Stem/Progenitor Cells through Activation of p38 Mitogen-activated Protein Kinase (p38MAPK)/Glycogen Synthase Kinase 3 beta (GSK-3 beta)/beta-Catenin Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; INSULIN SENSITIVITY; PROGENITOR CELLS; IN-VIVO; HORMONE ADIPONECTIN; CARCINOMA-CELLS; PRECURSOR CELLS; DENTATE GYRUS; STEM-CELLS; C-JUN	Adiponectin is the most abundant adipokine secreted from adipocytes. Accumulating evidence suggests that the physiological roles of adiponectin go beyond its metabolic effects. In the present study, we demonstrate that adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2) are expressed in adult hippocampal neural stem/progenitor cells (hNSCs). Adiponectin treatment increases proliferation of cultured adult hNSCs in a dose-and time-dependent manner, whereas apoptosis and differentiation of adult hNSCs into neuronal or glial lineage were not affected. Adiponectin activates AMP-activated protein kinase and p38 mitogen-activated protein kinase (p38MAPK) signaling pathways in adult hNSCs. Pretreatment with the p38MAPK inhibitor SB203580, but not the AMP-activated protein kinase inhibitor Compound C, attenuates adiponectin-induced cell proliferation. Moreover, adiponectin induces phosphorylation of Ser-389, a key inhibitory site of glycogen synthase kinase 3 beta (GSK-3 beta), and this effect can be blocked by inhibition of p38MAPK with SB203580. Levels of total and nuclear beta-catenin, the primary substrate of GSK-3 beta, were increased by adiponectin treatment. These results indicate that adiponectin stimulates proliferation of adult hNSCs, via acting on GSK-3 beta to promote nuclear accumulation of beta-catenin. Thus, our studies uncover a novel role for adiponectin signaling in regulating proliferation of adult neural stem cells.	[Zhang, Di; Guo, Ming; Zhang, Wei; Lu, Xin-Yun] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Lu, Xin-Yun] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Lu, XY (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	lux3@uthscsa.edu	Lu, Xin-Yun/M-8657-2016	Guo, Ming/0000-0002-3698-5580	National Institutes of Health [MH073844, MH076929]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076929, R01MH073844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health Grants MH073844 and MH076929 (to X.-Y.L.). This work was also supported by a National Alliance for Research on Schizophrenia and Depression Independent Investigator Award (to X.-Y.L.).	Arditi JD, 2007, HORM METAB RES, V39, P9, DOI 10.1055/s-2007-956518; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Bluher M, 2005, BIOCHEM BIOPH RES CO, V329, P1127, DOI 10.1016/j.bbrc.2005.02.081; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Cacci E, 2005, J NEUROSCI RES, V80, P789, DOI 10.1002/jnr.20531; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Cong L, 2007, ENDOCR-RELAT CANCER, V14, P713, DOI 10.1677/ERC-07-0065; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ebinuma H, 2007, CLIN CHEM, V53, P1541, DOI 10.1373/clinchem.2007.085654; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fry M, 2006, J NEUROSCI, V26, P9695, DOI 10.1523/JNEUROSCI.2014-06.2006; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garza JC, 2008, J BIOL CHEM, V283, P18238, DOI 10.1074/jbc.M800053200; Gomez-Nicola D., MOL BIOL CELL, V22, P1960; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Kim CS, 2007, J RADIAT RES, V48, P407, DOI 10.1269/jrr.07032; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kos K, 2007, J CLIN ENDOCR METAB, V92, P1129, DOI 10.1210/jc.2006-1841; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kusminski CM, 2007, DIABETOLOGIA, V50, P634, DOI 10.1007/s00125-006-0577-9; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Ma DK, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-16; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Neumeier M, 2005, BIOCHEM BIOPH RES CO, V334, P924, DOI 10.1016/j.bbrc.2005.06.187; Neumeier M, 2007, AM J PHYSIOL-ENDOC M, V293, pE965, DOI 10.1152/ajpendo.00119.2007; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Okamoto SI, 2007, CELL STEM CELL, V1, P230, DOI 10.1016/j.stem.2007.07.010; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Pan WH, 2006, PEPTIDES, V27, P911, DOI 10.1016/j.peptides.2005.12.014; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Sanalkumar R, 2010, J NEUROCHEM, V113, P807, DOI 10.1111/j.1471-4159.2010.06574.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sirerol-Piquer M, 2011, HIPPOCAMPUS, V21, P910, DOI 10.1002/hipo.20805; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Spranger J, 2006, DIABETES, V55, P141, DOI 10.2337/diabetes.55.1.141; Staiger H, 2004, DIABETES, V53, P2195, DOI 10.2337/diabetes.53.9.2195; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tian HP, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-139; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	75	98	104	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44913	44920		10.1074/jbc.M111.310052	http://dx.doi.org/10.1074/jbc.M111.310052			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039048	Green Published, hybrid			2022-12-25	WOS:000298645500059
J	Li, ZH; Alvarez, VE; De Gaudenzi, JG; Sant'Anna, C; Frasch, ACC; Cazzulo, JJ; Docampo, R				Li, Zhu-Hong; Alvarez, Vanina E.; De Gaudenzi, Javier G.; Sant'Anna, Celso; Frasch, Alberto C. C.; Cazzulo, Juan J.; Docampo, Roberto			Hyperosmotic Stress Induces Aquaporin-dependent Cell Shrinkage, Polyphosphate Synthesis, Amino Acid Accumulation, and Global Gene Expression Changes in Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE COMPLEX; MESSENGER-RNA; SYSTEM-A; COMPATIBLE OSMOLYTES; HSP70 EXPRESSION; YEAST-CELLS; TRANSPORT; ACIDOCALCISOMES; DIFFERENTIATION; PROTEIN	The protist parasite Trypanosoma cruzi has evolved the ability to transit between completely different hosts and to replicate in adverse environments. In particular, the epimastigote form, the replicative stage inside the vector, is subjected to nutritional and osmotic stresses during its development. In this work, we describe the biochemical and global gene expression changes of epimastigotes under hyperosmotic conditions. Hyperosmotic stress resulted in cell shrinking within a few minutes. Depending on the medium osmolarity, this was followed by lack of volume recovery for at least 2 h or by slow recovery. Experiments with inhibitors, or with cells in which an aquaporin gene (TcAQP1) was knocked down or overexpressed, revealed its importance for the cellular response to hyperosmotic stress. Furthermore, the adaptation to this new environment was shown to involve the regulation of the polyphosphate polymerization state as well as changes in amino acid catabolism to generate compatible osmolytes. A genome-wide transcriptional analysis of stressed parasites revealed down-regulation of genes belonging to diverse functional categories and up-regulation of genes encoding trans-sialidase-like and ribosomal proteins. Several of these changes were confirmed by Northern blot analyses. Sequence analysis of the 3'UTRs of up- and down-regulated genes allowed the identification of conserved structural RNA motifs enriched in each group, suggesting that specific ribonucleoprotein complexes could be of great importance in the adaptation of this parasite to different environments through regulation of transcript abundance.	[Li, Zhu-Hong; Alvarez, Vanina E.; Sant'Anna, Celso; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Li, Zhu-Hong; Alvarez, Vanina E.; Sant'Anna, Celso; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Alvarez, Vanina E.; De Gaudenzi, Javier G.; Frasch, Alberto C. C.; Cazzulo, Juan J.] Univ Nacl Gen San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol, RA-1650 Buenos Aires, DF, Argentina	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 350B Paul D Coverdell Ctr,500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@uga.edu		Alvarez, Vanina/0000-0002-9890-6980; Frasch, Alberto Carlos/0000-0001-7532-653X	National Institutes of Health [AI068647, TW07820, TW07888]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; Howard Hughes Medical Institute; NIAID; FOGARTY INTERNATIONAL CENTER [R03TW007820, D43TW007888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI068647, TW07820, and TW07888 (to R. D.).; Supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, and by the Howard Hughes Medical Institute.; We thank Todd Minning for initial help with the use of microarrays, Melina Galizzi for help in maintaining T. cruzi cultures, and the NIAID-sponsored Pathogen Functional Genomics Resource Center for providing the microarrays.	Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Alfieri RR, 2005, J GEN PHYSIOL, V125, P37, DOI 10.1085/jgp.200409195; Alfieri RR, 2002, J PHYSIOL-LONDON, V540, P499, DOI 10.1113/jphysiol.2001.013395; Alfieri RR, 2001, BIOCHEM BIOPH RES CO, V283, P174, DOI 10.1006/bbrc.2001.4729; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Benz C, 2005, MOL BIOCHEM PARASIT, V143, P125, DOI 10.1016/j.molbiopara.2005.05.008; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Brandao A, 2009, PARASITOL INT, V58, P215, DOI 10.1016/j.parint.2009.06.001; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Bussolati O, 2001, MOL MEMBR BIOL, V18, P27, DOI 10.1080/09687680110033756; Campos PC, 2008, INT J PARASITOL, V38, P1383, DOI 10.1016/j.ijpara.2008.07.001; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; COHEN DM, 1991, AM J PHYSIOL, V261, pC594, DOI 10.1152/ajpcell.1991.261.4.C594; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; Franchi-Gazzola R, 2004, BBA-BIOMEMBRANES, V1667, P157, DOI 10.1016/j.bbamem.2004.09.012; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Kitamura H, 1997, AM J PHYSIOL-RENAL, V272, pF267, DOI 10.1152/ajprenal.1997.272.2.F267; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; PETRONINI PG, 1993, BRIT J CANCER, V67, P493, DOI 10.1038/bjc.1993.92; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Rohloff P, 2008, EXP PARASITOL, V118, P17, DOI 10.1016/j.exppara.2007.04.013; Rohloff P, 2006, MOL BIOCHEM PARASIT, V150, P249, DOI 10.1016/j.molbiopara.2006.08.010; Ruben L, 1996, MOL BIOCHEM PARASIT, V81, P191, DOI 10.1016/0166-6851(96)02707-7; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; SKEIKY YAW, 1992, J EXP MED, V176, P201, DOI 10.1084/jem.176.1.201; Soveral G, 2007, APPL ENVIRON MICROB, V73, P2341, DOI 10.1128/AEM.02519-06	44	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43959	43971		10.1074/jbc.M111.311530	http://dx.doi.org/10.1074/jbc.M111.311530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039054	hybrid, Green Published			2022-12-25	WOS:000298402300037
J	Anand, PK; Tait, SWG; Lamkanfi, M; Amer, AO; Nunez, G; Pages, G; Pouyssegur, J; McGargill, MA; Green, DR; Kanneganti, TD				Anand, Paras K.; Tait, Stephen W. G.; Lamkanfi, Mohamed; Amer, Amal O.; Nunez, Gabriel; Pages, Gilles; Pouyssegur, Jacques; McGargill, Maureen A.; Green, Douglas R.; Kanneganti, Thirumala-Devi			TLR2 and RIP2 Pathways Mediate Autophagy of Listeria monocytogenes via Extracellular Signal-regulated Kinase (ERK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; INNATE IMMUNITY; INTRACELLULAR PATHOGENS; CRYOPYRIN INFLAMMASOME; ADAPTIVE IMMUNITY; EPITHELIAL-CELLS; CROHN-DISEASE; HOST-DEFENSE; EARLY PHASE; INFECTION	Background: Listeria monocytogenes is an intracellular pathogen that invades the host cytoplasm. Results: Cells deficient in TLR2 and NOD2 show defective autophagy of Listeria monocytogenes. Conclusion: Autophagy of Listeria is dependent on ERK pathway that is perturbed in TLR2- and NOD2-deficient cells. Significance: Our study establishes the role of innate immune receptors in autophagy of intracellular pathogens.	[Anand, Paras K.; Tait, Stephen W. G.; McGargill, Maureen A.; Green, Douglas R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Flanders Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; [Amer, Amal O.] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Amer, Amal O.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Pages, Gilles; Pouyssegur, Jacques] CNRS UMR 6543 Ctr A, Inst Dev Biol & Canc Res, F-06189 Nice, France	St Jude Children's Research Hospital; Ghent University; Flanders Institute for Biotechnology (VIB); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@stjude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; McGargill, Maureen/N-8131-2018; Pages, Gilles/N-7135-2017; Anand, Paras/D-3219-2012; Green, Douglas R/N-8083-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; McGargill, Maureen/0000-0002-0916-0372; Green, Douglas R/0000-0002-7332-1417; Anand, Paras/0000-0003-2503-3653; Tait, Stephen/0000-0001-7697-132X	National Institute of Health [AR056296, AI088177]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institute of Health Grants AR056296 and AI088177.	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Anand PK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00012; Anand PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010136; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Colombo MI, 2006, AUTOPHAGY, V2, P162, DOI 10.4161/auto.2827; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Deretic V., 2009, CURR OPIN CELL BIOL, V22, P1; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; GARCIADELPORTILLO F, 1995, TRENDS MICROBIOL, V3, P373, DOI 10.1016/S0966-842X(00)88982-9; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Grundling A, 2003, J BACTERIOL, V185, P6295, DOI 10.1128/JB.185.21.6295-6307.2003; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ireton K, 2007, CELL MICROBIOL, V9, P1365, DOI 10.1111/j.1462-5822.2007.00933.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Monack DM, 2001, CELL MICROBIOL, V3, P633, DOI 10.1046/j.1462-5822.2001.00143.x; Mosa A, 2009, INFECT IMMUN, V77, P2908, DOI 10.1128/IAI.01068-08; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Poussin MA, 2005, INFECT IMMUN, V73, P4410, DOI 10.1128/IAI.73.7.4410-4413.2005; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	60	97	101	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42981	42991		10.1074/jbc.M111.310599	http://dx.doi.org/10.1074/jbc.M111.310599			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033934	Green Published, hybrid			2022-12-25	WOS:000298351300019
J	Rezabkova, L; Man, P; Novak, P; Herman, P; Vecer, J; Obsilova, V; Obsil, T				Rezabkova, Lenka; Man, Petr; Novak, Petr; Herman, Petr; Vecer, Jaroslav; Obsilova, Veronika; Obsil, Tomas			Structural Basis for the 14-3-3 Protein-dependent Inhibition of the Regulator of G Protein Signaling 3 (RGS3) Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; GTPASE-ACTIVATING PROTEINS; LIGAND-BINDING; CRYSTAL-STRUCTURE; FACTOR FOXO4; SUBCELLULAR-LOCALIZATION; NUCLEAR IMPORT; ALPHA-SUBUNITS; DNA-BINDING; COMPLEXES	Regulator of G protein signaling (RGS) proteins function as GTPase-activating proteins for the alpha-subunit of heterotrimeric G proteins. The function of certain RGS proteins is negatively regulated by 14-3-3 proteins, a family of highly conserved regulatory molecules expressed in all eukaryotes. In this study, we provide a structural mechanism for 14-3-3-dependent inhibition of RGS3-G alpha interaction. We have used small angle x-ray scattering, hydrogen/deuterium exchange kinetics, and Forster resonance energy transfer measurements to determine the low-resolution solution structure of the 14-3-3 zeta.RGS3 complex. The structure shows the RGS domain of RGS3 bound to the 14-3-3 zeta dimer in an as-yet-unrecognized manner interacting with less conserved regions on the outer surface of the 14-3-3 dimer outside its central channel. Our results suggest that the 14-3-3 protein binding affects the structure of the G alpha interaction portion of RGS3 as well as sterically blocks the interaction between the RGS domain and the G alpha subunit of heterotrimeric G proteins.	[Rezabkova, Lenka; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Man, Petr; Novak, Petr] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic; [Rezabkova, Lenka; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague, Czech Republic; [Man, Petr; Novak, Petr] Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic; [Herman, Petr; Vecer, Jaroslav] Charles Univ Prague, Fac Math & Phys, Inst Phys, CR-12116 Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Hlavova 8, Prague 12843, Czech Republic.	obsil@natur.cuni.cz	Man, Petr/H-2451-2014; Herman, Petr/A-2626-2008; Rezabkova, Lenka/O-8229-2017; Obsilova, Veronika/B-7116-2012; Novak, Petr/F-9655-2014; Obsil, Tomas/B-7142-2012	Man, Petr/0000-0002-1485-2197; Herman, Petr/0000-0001-6918-2576; Rezabkova, Lenka/0000-0002-7274-8080; Obsilova, Veronika/0000-0003-4887-0323; Novak, Petr/0000-0001-8688-529X; Obsil, Tomas/0000-0003-4602-1272	Grant Agency of the Academy of Sciences of the Czech Republic [IAA501110801]; Grant Agency of Charles University [28510]; Czech Science Foundation [P305/11/0708, P207/10/1040]; Ministry of Education, Youth, and Sports of the Czech Republic [MSM0021620857, MSM0021620835]; Ministry of Education, Youth, and Sports of the Czech Republic Center of Neurosciences [LC554]; Academy of Sciences of the Czech Republic [AV0Z50110509, AV0Z50200510]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of Charles University; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic Center of Neurosciences; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by the Grant Agency of the Academy of Sciences of the Czech Republic (Grant IAA501110801); Grant Agency of Charles University (Grant 28510); Czech Science Foundation (Projects P305/11/0708 and P207/10/1040); Ministry of Education, Youth, and Sports of the Czech Republic Research (Projects MSM0021620857 and MSM0021620835 and Center of Neurosciences LC554); and Academy of Sciences of the Czech Republic (Research Projects AV0Z50110509 and AV0Z50200510).	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Abramow-Newerly M, 2006, CELL SIGNAL, V18, P2209, DOI 10.1016/j.cellsig.2006.05.011; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Bridges D, 2004, SCI STKE, pre10; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P321; LEE RH, 1988, EXP EYE RES, V46, P829, DOI 10.1016/S0014-4835(88)80035-6; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Marcoux J, 2010, J BIOL CHEM, V285, P28980, DOI 10.1074/jbc.M110.139824; Margolis SS, 2004, CELL CYCLE, V3, P425; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Niu JX, 2002, BIOCHEM J, V365, P677, DOI 10.1042/BJ20020390; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Obsilova V, 2004, J BIOL CHEM, V279, P4531, DOI 10.1074/jbc.M306939200; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rezabkova L, 2010, J STRUCT BIOL, V170, P451, DOI 10.1016/j.jsb.2010.03.009; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Silhan J, 2009, J BIOL CHEM, V284, P19349, DOI 10.1074/jbc.M109.002725; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vecer J, 2011, J FLUORESC, V21, P873, DOI 10.1007/s10895-009-0589-1; Veisova D, 2010, BIOCHEMISTRY-US, V49, P3853, DOI 10.1021/bi100273k; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward RJ, 2005, MOL PHARMACOL, V68, P1821, DOI 10.1124/moi.105.015073; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Willardson BM, 1996, P NATL ACAD SCI USA, V93, P1475, DOI 10.1073/pnas.93.4.1475; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	58	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43527	43536		10.1074/jbc.M111.273573	http://dx.doi.org/10.1074/jbc.M111.273573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027839	Green Published, hybrid			2022-12-25	WOS:000298351300072
J	Hopkins, RC; Sun, JS; Jenney, FE; Chandrayan, SK; McTernan, PM; Adams, MWW				Hopkins, R. Christopher; Sun, Junsong; Jenney, Francis E., Jr.; Chandrayan, Sanjeev K.; McTernan, Patrick M.; Adams, Michael W. W.			Homologous Expression of a Subcomplex of Pyrococcus furiosus Hydrogenase that Interacts with Pyruvate Ferredoxin Oxidoreductase	PLOS ONE			English	Article							ARCHAEON; AGMATINE; ENZYMES; RNA	furiosus Hydrogen gas is an attractive alternative fuel as it is carbon neutral and has higher energy content per unit mass than fossil fuels. The biological enzyme responsible for utilizing molecular hydrogen is hydrogenase, a heteromeric metalloenzyme requiring a complex maturation process to assemble its O-2-sensitive dinuclear-catalytic site containing nickel and iron atoms. To facilitate their utility in applied processes, it is essential that tools are available to engineer hydrogenases to tailor catalytic activity and electron carrier specificity, and decrease oxygen sensitivity using standard molecular biology techniques. As a model system we are using hydrogen-producing Pyrococcus furiosus, which grows optimally at 100 degrees C. We have taken advantage of a recently developed genetic system that allows markerless chromosomal integrations via homologous recombination. We have combined a new gene marker system with a highly-expressed constitutive promoter to enable high-level homologous expression of an engineered form of the cytoplasmic NADP-dependent hydrogenase (SHI) of P. furiosus. In a step towards obtaining 'minimal' hydrogenases, we have successfully produced the heterodimeric form of SHI that contains only two of the four subunits found in the native heterotetrameric enzyme. The heterodimeric form is highly active (150 units mg(-1) in H-2 production using the artificial electron donor methyl viologen) and thermostable (t(1/2) similar to 0.5 hour at 90 degrees C). Moreover, the heterodimer does not use NADPH and instead can directly utilize reductant supplied by pyruvate ferredoxin oxidoreductase from P. furiosus. The SHI heterodimer and POR therefore represent a two-enzyme system that oxidizes pyruvate and produces H-2 in vitro without the need for an intermediate electron carrier.	[Hopkins, R. Christopher; Sun, Junsong; Jenney, Francis E., Jr.; Chandrayan, Sanjeev K.; McTernan, Patrick M.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hopkins, RC (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	McTernan, Patrick/HGV-0762-2022; CHANDRAYAN, SANJEEV/M-1662-2016	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Jenney, Francis/0000-0002-1667-6924; Adams, Michael/0000-0002-9796-5014	Chemical Sciences, Geosciences and Biosciences Division, Office of 307 Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG05-95ER20175, DE-FG02-306 05ER15710]	Chemical Sciences, Geosciences and Biosciences Division, Office of 307 Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by grants (DE-FG05-95ER20175 and DE-FG02-306 05ER15710) from the Chemical Sciences, Geosciences and Biosciences Division, Office of 307 Basic Energy Sciences, Office of Science, U.S. Department of Energy (http://science.energy.gov/bes/csgb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; Charon MH, 1999, CURR OPIN STRUC BIOL, V9, P663, DOI 10.1016/S0959-440X(99)00027-5; Dorian JP, 2006, ENERG POLICY, V34, P1984, DOI 10.1016/j.enpol.2005.03.010; Edwards PP, 2007, PHILOS T R SOC A, V365, P1043, DOI 10.1098/rsta.2006.1965; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Grzeszik C, 1997, ARCH MICROBIOL, V167, P172, DOI 10.1007/s002030050431; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; Ma KS, 2001, METHOD ENZYMOL, V331, P208; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Pfromm PH, 2011, BIORESOURCE TECHNOL, V102, P1185, DOI 10.1016/j.biortech.2010.09.050; Sambrook J, 2001, MOL CLONING LAB MANU; Santangelo TJ, 2010, APPL ENVIRON MICROB, V76, P1044, DOI 10.1128/AEM.02497-09; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Sigfusson TI, 2007, PHILOS T R SOC A, V365, P1025, DOI 10.1098/rsta.2006.1960; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Stephenson M, 1931, BIOCHEM J, V25, P205, DOI 10.1042/bj0250205; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Verhagen MFJM, 2001, METHOD ENZYMOL, V330, P25; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Wackett LP, 2010, CURR OPIN B IN PRESS	31	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26569	10.1371/journal.pone.0026569	http://dx.doi.org/10.1371/journal.pone.0026569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039508	Green Submitted, gold, Green Published			2022-12-25	WOS:000296515200026
J	Long, MA; Rossi, FMV				Long, Michael A.; Rossi, Fabio M. V.			Targeted Cell Fusion Facilitates Stable Heterokaryon Generation In Vitro and In Vivo	PLOS ONE			English	Article							ONCOLYTIC MEASLES VIRUSES; SKELETAL-MUSCLE; MYOBLAST TRANSPLANTATION; SATELLITE CELLS; EXPRESSION; ANTIBODY; SPECIFICITY; HEPATOCYTES; ACTIVATION; INDUCTION	Induced cell fusion has enabled several important discoveries, including the phenomenon of nuclear reprogramming and may yet be applied as a novel therapy for degenerative diseases. However, existing fusogens lack the efficiency required to enable investigation of the epigenetic modifications underlying nuclear reprogramming and the specificity required for clinical application. Here we present a chimeric measles hemagglutinin, H alpha 7, which specifically and efficiently mediates the fusion of diverse cell types with skeletal muscle both in vitro and in vivo. When compared directly to polyethylene glycol, H alpha 7 consistently generated a substantial increase in heterokaryon yield and exhibited insignificant levels of toxicity. Moreover, this increased fusion efficiency enabled detection of chromatin modifications associated with nuclear reprogramming following H alpha 7-mediated fusion of human fibroblasts and mouse myotubes. Finally, H alpha 7 was also capable of increasing the contribution of transplanted fibroblasts to skeletal muscle repair in vivo, suggesting that this strategy could be used for therapeutic gene delivery.	[Long, Michael A.; Rossi, Fabio M. V.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	University of British Columbia	Long, MA (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	fabio@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620	Jesse's Journey; Stem Cell Network; Muscular Dystrophy Canada	Jesse's Journey; Stem Cell Network; Muscular Dystrophy Canada(Muscular Dystrophy Association)	This research was supported by a research grant from Jesse's Journey (www.jessesjourney.com). MAL was supported by training grants from the Stem Cell Network (www.stemcellnetwork.ca) and Muscular Dystrophy Canada (www.muscle.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2008, MOL THER, V16, P1556, DOI 10.1038/mt.2008.152; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; ALVAREZERVITI L, NAT BIOTECHNOL, V29, P341; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Bouchentouf M, 2006, NEUROMUSCULAR DISORD, V16, P518, DOI 10.1016/j.nmd.2006.06.003; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; Hallak LK, 2005, CANCER RES, V65, P5292, DOI 10.1158/0008-5472.CAN-04-2879; Held PK, 2006, MOL THER, V13, P49, DOI 10.1016/j.ymthe.2005.09.004; Iankov ID, 2007, MOL THER, V15, P114, DOI 10.1038/sj.mt.6300020; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139; LIPTON BH, 1979, SCIENCE, V205, P1292, DOI 10.1126/science.472747; Nakamura T, 2004, NAT BIOTECHNOL, V22, P331, DOI 10.1038/nbt942; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; OKADA Y, 1962, EXP CELL RES, V26, P98, DOI 10.1016/0014-4827(62)90205-7; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Peng KW, 2003, BLOOD, V101, P2557, DOI 10.1182/blood-2002-07-2195; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; Pomerantz JH, 2009, J CELL SCI, V122, P1045, DOI 10.1242/jcs.041376; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; Relvas JB, 1997, BASIC APPL MYOL, V7, P211; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schneider U, 2000, J VIROL, V74, P9928, DOI 10.1128/JVI.74.21.9928-9936.2000; SCHUT TCB, 1993, BIOPHYS J, V65, P568, DOI 10.1016/S0006-3495(93)81128-7; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Skuk D, 1999, EXP NEUROL, V155, P22, DOI 10.1006/exnr.1998.6973; Stromberg A, 2000, P NATL ACAD SCI USA, V97, P7, DOI 10.1073/pnas.97.1.7; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Warthin AS, 1931, ARCH PATHOL, V11, P864; WILD TF, 1991, J GEN VIROL, V72, P439, DOI 10.1099/0022-1317-72-2-439; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104; ZIMMERMANN U, 1982, J MEMBRANE BIOL, V67, P165, DOI 10.1007/BF01868659	43	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26381	10.1371/journal.pone.0026381	http://dx.doi.org/10.1371/journal.pone.0026381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039476	gold, Green Published, Green Submitted			2022-12-25	WOS:000296515200018
J	Abdel-Motal, UM; Sarkis, PTN; Han, T; Pudney, J; Anderson, DJ; Zhu, Q; Marasco, WA				Abdel-Motal, Ussama M.; Sarkis, Phuong T. N.; Han, Thomas; Pudney, Jeffery; Anderson, Deborah J.; Zhu, Quan; Marasco, Wayne A.			Anti-gp120 Minibody Gene Transfer to Female Genital Epithelial Cells Protects against HIV-1 Virus Challenge In Vitro	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; IMMUNODEFICIENCY-VIRUS; ADENOASSOCIATED VIRUS; MONOCLONAL-ANTIBODY; VAGINAL EPITHELIUM; LONG-TERM; EXPRESSION; VECTOR; NEUTRALIZATION; TRANSDUCTION	Background: Although cervico-vaginal epithelial cells of the female lower genital tract provide the initial defense system against HIV-1 infection, the protection is sometimes incomplete. Thus, enhancing anti-HIV-1 humoral immunity at the mucosal cell surface by local expression of anti-HIV-1 broadly neutralizing antibodies (BnAb) that block HIV-1 entry would provide an important new intervention that could slow the spread of HIV/AIDS. Methods and Findings: This study tested the hypothesis that adeno-associated virus (AAV)-BnAb gene transfer to cervico-vaginal epithelial cells will lead to protection against HIV-1. Accordingly, a recombinant AAV vector that encodes human b12 anti-HIV gp120 BnAb as a single-chain variable fragment Fc fusion (scFvFc), or "minibody'' was constructed. The secreted b12 minibody was shown to be biologically functional in binding to virus envelope protein, neutralizing HIV-1 and importantly, blocking transfer and infectivity of HIV-1(bal) in an organotypic human vaginal epithelial cell (VEC) model. Furthermore, cervico-vaginal epithelial stem cells were found to be efficiently transduced by the optimal AAV serotype mediated expression of GFP. Conclusion: This study provides the foundation for a novel microbicide strategy to protect against sexual transmission of HIV-1 by AAV transfer of broadly neutralizing antibody genes to cervico-vaginal epithelial stem cells that could replenish b12 BnAb secreting cells through multiple menstrual cycles.	[Abdel-Motal, Ussama M.; Sarkis, Phuong T. N.; Han, Thomas; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Pudney, Jeffery; Anderson, Deborah J.] Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston University	Abdel-Motal, UM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	wayne_marasco@dfci.harvard.edu		Anderson, Deborah/0000-0002-2848-7290; Pudney, Jeffrey/0000-0001-8121-8586	National Institutes of Health (NIH) [AI079767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R21AI079767, R33AI079767] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the National Institutes of Health (NIH) grant AI079767 to Dr. Marasco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bobardt MD, 2010, ANTIMICROB AGENTS CH, V54, P2753, DOI 10.1128/AAC.01606-09; Bosch A, 2000, MOL THER, V1, P63, DOI 10.1006/mthe.1999.0005; Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cole AM, 2008, AM J REPROD IMMUNOL, V59, P27, DOI 10.1111/j.1600-0897.2007.00561.x; de Parseval A, 2005, J BIOL CHEM, V280, P39493, DOI 10.1074/jbc.M504233200; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; FLOTTE TR, 1993, P NATL ACAD SCI USA, V90, P10613, DOI 10.1073/pnas.90.22.10613; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; King AE, 2000, MOL HUM REPROD, V6, P191, DOI 10.1093/molehr/6.2.191; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Koup RA, 2001, CURR PROTOC IMMUNOL; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Livingston JB, 1998, INFECT IMMUN, V66, P322, DOI 10.1128/IAI.66.1.322-329.1998; Mantis NJ, 2007, J IMMUNOL, V179, P3144, DOI 10.4049/jimmunol.179.5.3144; Marasco WA, 2005, NAT BIOTECHNOL, V23, P551, DOI 10.1038/nbt0505-551; Martens JE, 2004, ANTICANCER RES, V24, P771; Nakai H, 1998, BLOOD, V91, P4600, DOI 10.1182/blood.V91.12.4600.412k22_4600_4607; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Poonia B, 2006, J ENDOCRINOL, V190, P829, DOI 10.1677/joe.1.06873; Schmidt M, 2008, J VIROL, V82, P1399, DOI 10.1128/JVI.02012-07; Tomescu C, 2011, CLIN EXP IMMUNOL, V164, P158, DOI 10.1111/j.1365-2249.2011.04379.x; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Warrington KH, 2006, HUM GENET, V119, P571, DOI 10.1007/s00439-006-0165-6; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Xiao WD, 1998, J VIROL, V72, P10222, DOI 10.1128/JVI.72.12.10222-10226.1998	39	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26473	10.1371/journal.pone.0026473	http://dx.doi.org/10.1371/journal.pone.0026473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031835	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200024
J	Arjomandi, M; Frelinger, J; Donde, A; Wong, H; Yellamilli, A; Raymond, W				Arjomandi, Mehrdad; Frelinger, Jessica; Donde, Aneesh; Wong, Hofer; Yellamilli, Amritha; Raymond, Wilfred			Secreted Osteopontin Is Highly Polymerized in Human Airways and Fragmented in Asthmatic Airway Secretions	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; POSTTRANSLATIONAL MODIFICATIONS; STRUCTURAL REQUIREMENTS; INTEGRIN ALPHA-9-BETA-1; NEUTROPHIL INFILTRATION; TISSUE TRANSGLUTAMINASE; BOVINE OSTEOPONTIN; DEFICIENT MICE; CROSS-LINKING; MURINE MODEL	Background: Osteopontin (OPN) is a member of the small integrin-binding ligand N-linked glycoprotein (SIBLING) family and a cytokine with diverse biologic roles. OPN undergoes extensive post-translational modifications, including polymerization and proteolytic fragmentation, which alters its biologic activity. Recent studies suggest that OPN may contribute to the pathogenesis of asthma. Methodology: To determine whether secreted OPN (sOPN) is polymerized in human airways and whether it is qualitatively different in asthma, we used immunoblotting to examine sOPN in bronchoalveolar lavage (BAL) fluid samples from 12 healthy and 21 asthmatic subjects (and in sputum samples from 27 healthy and 21 asthmatic subjects). All asthmatic subjects had mild to moderate asthma and abstained from corticosteroids during the study. Furthermore, we examined the relationship between airway sOPN and cellular inflammation. Principal Findings: We found that sOPN in BAL fluid and sputum exists in polymeric, monomeric, and cleaved forms, with most of it in polymeric form. Compared to healthy subjects, asthmatic subjects had proportionately less polymeric sOPN and more monomeric and cleaved sOPN. Polymeric sOPN in BAL fluid was associated with increased alveolar macrophage counts in airways in all subjects. Conclusions: These results suggest that sOPN in human airways (1) undergoes extensive post-translational modification by polymerization and proteolytic fragmentation, (2) is more fragmented and less polymerized in subjects with mild to moderate asthma, and (3) may contribute to recruitment or survival of alveolar macrophages.	[Arjomandi, Mehrdad; Frelinger, Jessica] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Arjomandi, Mehrdad; Frelinger, Jessica; Donde, Aneesh; Wong, Hofer; Yellamilli, Amritha] Univ Calif San Francisco, Dept Med, Human Exposure Lab, San Francisco, CA USA; [Raymond, Wilfred] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; [Arjomandi, Mehrdad; Frelinger, Jessica; Raymond, Wilfred] San Francisco VA Med Ctr, Pulm Res Grp, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Arjomandi, M (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	mehrdad.arjomandi@ucsf.edu	Arjomandi, Mehrdad/ABB-4327-2021	Arjomandi, Mehrdad/0000-0002-0116-9217	National Institutes of Health (NIH) [K23 HL083099, NIH P01 HL024136]; NIH/NCRR/OD [KL2 RR024130]; Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083099, P01HL024136] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR/OD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by National Institutes of Health (NIH) K23 HL083099, NIH P01 HL024136, NIH/NCRR/OD UCSF-CTSI Grant Number KL2 RR024130, Northern California Institute for Research and Education, and University of California San Francisco Cardiovascular Research Institute Faculty Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Arjomandi M, 2005, CHEST, V128, P416, DOI 10.1378/chest.128.1.416; ARJOMANDI M, 2009, AM J RESP CRIT CARE, V175, pA1393; ARJOMANDI M, 2011, PEDIAT ALLE IN PRESS; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; BENINATI S, 1994, J BIOCHEM-TOKYO, V115, P675, DOI 10.1093/oxfordjournals.jbchem.a124395; Burdo TH, 2007, J LEUKOCYTE BIOL, V81, P1504, DOI 10.1189/jlb.1106711; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; DELIMPOURA V, THORAX, V65, P782; Delimpoura V, 2010, THORAX, V65, P782, DOI 10.1136/thx.2010.138552; Frenzel DF, 2011, EXPERT REV CLIN IMMU, V7, P93, DOI 10.1586/ECI.10.82; Giachelli CM, 1998, AM J PATHOL, V152, P353; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Hallstrand TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008583; HALLSTRAND TS, PLOS ONE, V5, pE8583; Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018; Holgate ST, 1997, CIBA F SYMP, V206, P5; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; KANNER RE, 1994, AM J RESP CRIT CARE, V150, P956, DOI 10.1164/ajrccm.150.4.7921469; KIEFER MC, 1989, NUCLEIC ACIDS RES, V17, P3306, DOI 10.1093/nar/17.8.3306; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; Kohan M, 2007, CLIN EXP ALLERGY, V37, P1444, DOI 10.1111/j.1365-2222.2007.02801.x; KOHAN M, 2009, AM J RESP CELL MOL B; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Liaw L, 1998, J CLIN INVEST, V101, P1468; Marcinkiewicz C, 2000, J BIOL CHEM, V275, P31930, DOI 10.1074/jbc.M003209200; Marcondes MCG, 2008, CELL IMMUNOL, V254, P56, DOI 10.1016/j.cellimm.2008.06.012; MIYAZAKI Y, 1990, J BIOL CHEM, V265, P14432; NISHIMICHI N, J BIOL CHEM, V286, P11170; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Ohshima S, 2002, ARTHRITIS RHEUM, V46, P1094, DOI 10.1002/art.10143; Okamoto H, 2007, MOL CELL BIOCHEM, V300, P1, DOI 10.1007/s11010-006-9368-3; PATARCA R, 1993, CRIT REV IMMUNOL, V13, P225; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; PUXEDDU I, ALLERGY, V65, P168; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rollo EE, 1996, J LEUKOCYTE BIOL, V60, P397, DOI 10.1002/jlb.60.3.397; Rollo EE, 1996, IMMUNOLOGY, V88, P642, DOI 10.1046/j.1365-2567.1996.d01-691.x; Sakata M, 2001, J RHEUMATOL, V28, P1492; SAMITAS K, EUR RESP J; Seiffge D, 1996, J RHEUMATOL, V23, P2086; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Simoes DCM, 2009, AM J RESP CRIT CARE, V179, P894, DOI 10.1164/rccm.200807-1081OC; SINGH K, 1990, J BIOL CHEM, V265, P18696; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SORENSEN ES, 1994, BIOCHEM BIOPH RES CO, V198, P200, DOI 10.1006/bbrc.1994.1028; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; Takahashi A, 2009, CLIN EXP ALLERGY, V39, P1152, DOI 10.1111/j.1365-2222.2009.03249.x; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Weber Georg F., 1996, Cytokine and Growth Factor Reviews, V7, P241, DOI 10.1016/S1359-6101(96)00030-5; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zohar R, 1997, J CELL PHYSIOL, V170, P88	69	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25678	10.1371/journal.pone.0025678	http://dx.doi.org/10.1371/journal.pone.0025678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031818	Green Submitted, gold, Green Published			2022-12-25	WOS:000296513200005
J	Park, EJ; Roh, J; Kang, MS; Kim, SN; Kim, Y; Choi, S				Park, Eun-Jung; Roh, Jinkyu; Kang, Min-Sung; Kim, Soo Nam; Kim, Younghun; Choi, Sangdun			Biological Responses to Diesel Exhaust Particles (DEPs) Depend on the Physicochemical Properties of the DEPs	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; P53; HYDROCARBONS; INFLAMMATION; PARTICULATE; EXPRESSION; INDUCTION; DAMAGE; COX-2; DNA	Diesel exhaust particles (DEPs) are the main components of ambient particulate materials, including polyaromatic hydrocarbons (PAHs), n-PAHs, heavy metals, and gaseous materials. Many epidemiological, clinical, and toxicological studies have shown that ambient particles, including DEPs, are associated with respiratory disorders, such as asthma, allergic rhinitis, and lung cancer. However, the relationship between the biological response to DEPs and their chemical composition remains unclear. In this study, we investigated the physicochemical properties of DEPs before toxicological studies, and then administered a single intratracheal instillation of DEPs to mice. The mice were then killed 1, 7, 14 and 28 days after DEP exposure to observe the biological responses induced by DEPs over time. Our findings suggest that DEPs engulfed into cells induced a Th2-type inflammatory response followed by DNA damage, whereas DEPs not engulfed into cells induced a Th1-type inflammatory response. Further, the physicochemical properties, including surface charge, particle size, and chemical composition, of DEPs play a crucial role in determining the biological responses to DEPs. Consequently, we suggest that the biological response to DEPs depend on cell-particle interaction and the physicochemical properties of the particles.	[Park, Eun-Jung; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Roh, Jinkyu; Kim, Younghun] Kwangwoon Univ, Dept Chem Engn, Seoul, South Korea; [Kang, Min-Sung; Kim, Soo Nam] Korea Inst Toxicol, Inhalat Toxicol Ctr, Jeongeup, South Korea	Ajou University; Kwangwoon University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT)	Park, EJ (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Park, Eun-Jung/Y-4427-2019		National Research Foundation of Korea (NRF) [2010-0028294]; Ministry of Education, Science and Technology [2010-0015356]; Korea Food & Drug Administration [10182KFDA992-2302]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0015356). This work was also partly supported by a grant from the Korea Food & Drug Administration (10182KFDA992-2302) and the Priority Research Centers Program (NRF 2010-0028294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LZ, 2007, TOXICOLOGY, V229, P91, DOI 10.1016/j.tox.2006.10.007; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Braun A, 2010, TOXICOL SCI, V113, P85, DOI 10.1093/toxsci/kfp239; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Chiarugi V, 1998, INT J MOL MED, V2, P715; DiazSanchez D, 1997, ALLERGY, V52, P52; Dupont J, 2004, GYNECOL ONCOL, V94, P449, DOI 10.1016/j.ygyno.2004.05.014; Dupont S, 2004, CANCER LETT, V213, P129, DOI 10.1016/j.canlet.2004.06.008; Inoue K, 2009, EXP BIOL MED, V234, P200, DOI 10.3181/0809-RM-285; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Jardim MJ, 2009, ENVIRON HEALTH PERSP, V117, P1745, DOI 10.1289/ehp.0900756; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Lehninger A., 2005, LEHNINGER PRINCIPLES; Li N, 2006, EUR RESPIR J, V27, P667, DOI 10.1183/09031936.06.00025006; Ma JYC, 2002, J ENVIRON SCI HEAL C, V20, P117, DOI 10.1081/GNC-120016202; Maes T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-7; Moller P, 2008, CANCER LETT, V266, P84, DOI 10.1016/j.canlet.2008.02.030; Nemmar A, 2010, TOXICOL LETT, V194, P58, DOI 10.1016/j.toxlet.2010.02.001; Nikasinovic L, 2004, J TOXICOL ENV HEAL B, V7, P81, DOI 10.1080/10937400490241952; Ohtani T, 2005, J IMMUNOL, V174, P2412, DOI 10.4049/jimmunol.174.4.2412; Park EJ, 2010, TOXICOL APPL PHARM, V244, P226, DOI 10.1016/j.taap.2009.12.036; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Ris C, 2007, INHAL TOXICOL, V19, P229, DOI 10.1080/08958370701497960; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Schins RPF, 2007, INHAL TOXICOL, V19, P189, DOI 10.1080/08958370701496202; Schober W, 2007, INHAL TOXICOL, V19, P151, DOI 10.1080/08958370701496046; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766; Wan JX, 2007, INHAL TOXICOL, V19, P177, DOI 10.1080/08958370701496145; Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075; Xu XH, 2009, TOXICOL LETT, V191, P57, DOI 10.1016/j.toxlet.2009.08.006; Yun YP, 2009, TOXICOL IN VITRO, V23, P21, DOI 10.1016/j.tiv.2008.09.018	33	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26749	10.1371/journal.pone.0026749	http://dx.doi.org/10.1371/journal.pone.0026749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039547	gold, Green Submitted, Green Published			2022-12-25	WOS:000296513200051
J	Kita, A; Sakurai, Y; Myers, DR; Rounsevell, R; Huang, JN; Seok, TJ; Yu, K; Wu, MC; Fletcher, DA; Lam, WA				Kita, Ashley; Sakurai, Yumiko; Myers, David R.; Rounsevell, Ross; Huang, James N.; Seok, Tae Joon; Yu, Kyoungsik; Wu, Ming C.; Fletcher, Daniel A.; Lam, Wilbur A.			Microenvironmental Geometry Guides Platelet Adhesion and Spreading: A Quantitative Analysis at the Single Cell Level	PLOS ONE			English	Article							ACTIVATION; GENERATION; FIBRINOGEN; DYNAMICS; COLLAGEN	To activate clot formation and maintain hemostasis, platelets adhere and spread onto sites of vascular injury. Although this process is well-characterized biochemically, how the physical and spatial cues in the microenvironment affect platelet adhesion and spreading remain unclear. In this study, we applied deep UV photolithography and protein micro/nanostamping to quantitatively investigate and characterize the spatial guidance of platelet spreading at the single cell level and with nanoscale resolution. Platelets adhered to and spread only onto micropatterned collagen or fibrinogen surfaces and followed the microenvironmental geometry with high fidelity and with single micron precision. Using micropatterned lines of different widths, we determined that platelets are able to conform to micropatterned stripes as thin as 0.6 mu m and adopt a maximum aspect ratio of 19 on those protein patterns. Interestingly, platelets were also able to span and spread over non-patterned regions of up to 5 mu m, a length consistent with that of maximally extended filopodia. This process appears to be mediated by platelet filopodia that are sensitive to spatial cues. Finally, we observed that microenvironmental geometry directly affects platelet biology, such as the spatial organization and distribution of the platelet actin cytoskeleton. Our data demonstrate that platelet spreading is a finely-tuned and spatially-guided process in which spatial cues directly influence the biological aspects of how clot formation is regulated.	[Kita, Ashley; Sakurai, Yumiko; Myers, David R.; Lam, Wilbur A.] Emory Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Atlanta, GA 30322 USA; [Kita, Ashley; Sakurai, Yumiko; Myers, David R.; Lam, Wilbur A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Kita, Ashley; Sakurai, Yumiko; Myers, David R.; Lam, Wilbur A.] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA; [Kita, Ashley; Rounsevell, Ross; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Huang, James N.] Univ Calif San Francisco, Dept Pediat, Div Pediat Hematol Oncol, San Francisco, CA USA; [Seok, Tae Joon; Wu, Ming C.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Yu, Kyoungsik] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea; [Fletcher, Daniel A.] Univ Calif Berkeley, Grad Grp Biophys, Berkeley, CA 94720 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Berkeley	Kita, A (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Atlanta, GA 30322 USA.	wilbur.lam@emory.edu	Yu, Kyoungsik/C-2078-2011; Wu, Ming C/J-9906-2012; Huang, James/W-5976-2019; Kita, Ashley/GPT-0506-2022; Myers, David Richard/G-7542-2017	Wu, Ming C/0000-0003-4808-6686; Myers, David Richard/0000-0001-9659-3274	National Institutes of Health (NIH) [K08-HL093360]; UCSF REAC; NIH Nanomedicine Development Center [PN2EY018244, PN2EY018228]; Center for Endothelial Cell Biology of Children's Healthcare of Atlanta; National Science Foundation (NSF); NATIONAL EYE INSTITUTE [PN2EY018244, PN2EY018228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF REAC; NIH Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Endothelial Cell Biology of Children's Healthcare of Atlanta; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support for this work was provided by a K08-HL093360 National Institutes of Health (NIH) grant, a UCSF REAC award, an NIH Nanomedicine Development Center Award PN2EY018244, and Center for Endothelial Cell Biology of Children's Healthcare of Atlanta funding to W. A. L., an NIH Nanomedicine Development Center PN2EY018228 to M. C. W., and a National Science Foundation (NSF) CAREER Award to D. A. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhosravi A, 2002, BLOOD COAGUL FIBRIN, V13, P505, DOI 10.1097/00001721-200209000-00005; Basabe-Desmonts L, 2010, LANGMUIR, V26, P14700, DOI 10.1021/la9039682; Briede JJ, 2001, THROMB HAEMOSTASIS, V85, P509, DOI 10.1055/s-0037-1615613; Corum LE, 2011, LANGMUIR, V27, P8316, DOI 10.1021/la201064d; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Inoue O, 2006, BLOOD, V107, P1405, DOI 10.1182/blood-2005-06-2406; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Kehrel B, 1998, BLOOD, V91, P491; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Loncar Robert, 2007, Thromb J, V5, P2, DOI 10.1186/1477-9560-5-2; Medalia O, 2007, CURR BIOL, V17, P79, DOI 10.1016/j.cub.2006.11.022; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Rivera J, 2009, HAEMATOL-HEMATOL J, V94, P700, DOI 10.3324/haematol.2008.003178; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251	15	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26437	10.1371/journal.pone.0026437	http://dx.doi.org/10.1371/journal.pone.0026437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028878	gold, Green Submitted, Green Published			2022-12-25	WOS:000296510800043
J	Callahan, JE; Munro, CL; Kitten, T				Callahan, Jill E.; Munro, Cindy L.; Kitten, Todd			The Streptococcus sanguinis Competence Regulon Is Not Required for Infective Endocarditis Virulence in a Rabbit Model	PLOS ONE			English	Article							SIGNATURE-TAGGED MUTAGENESIS; REGULATORY SYSTEM; PNEUMONIAE VIRULENCE; ADDITIVE ATTENUATION; GENETIC COMPETENCE; IDENTIFICATION; GORDONII; PEPTIDE; GENOME; MUTANS	Streptococcus sanguinis is an important component of dental plaque and a leading cause of infective endocarditis. Genetic competence in S. sanguinis requires a quorum sensing system encoded by the early comCDE genes, as well as late genes controlled by the alternative sigma factor, ComX. Previous studies of Streptococcus pneumoniae and Streptococcus mutans have identified functions for the >100-gene com regulon in addition to DNA uptake, including virulence. We investigated this possibility in S. sanguinis. Strains deleted for the comCDE or comX master regulatory genes were created. Using a rabbit endocarditis model in conjunction with a variety of virulence assays, we determined that both mutants possessed infectivity equivalent to that of a virulent control strain, and that measures of disease were similar in rabbits infected with each strain. These results suggest that the com regulon is not required for S. sanguinis infective endocarditis virulence in this model. We propose that the different roles of the S. sanguinis, S. pneumoniae, and S. mutans com regulons in virulence can be understood in relation to the pathogenic mechanisms employed by each species.	[Callahan, Jill E.; Kitten, Todd] Virginia Commonwealth Univ, VCU Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA USA; [Callahan, Jill E.; Kitten, Todd] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Munro, Cindy L.] Virginia Commonwealth Univ, Dept Adult Hlth Nursing, Richmond, VA 23298 USA; [Kitten, Todd] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Callahan, JE (corresponding author), St Peters Coll, Dept Biol, Jersey City, NJ USA.	tkitten@vcu.edu	Kitten, Todd/O-6531-2014	Kitten, Todd/0000-0001-6097-7583	Hazel Thorpe and George Gay Carman Trust [C-VCU-07]; NIDCR, National Institutes of Health [F31DE020963]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE020963] Funding Source: NIH RePORTER	Hazel Thorpe and George Gay Carman Trust; NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant C-VCU-07 from the Hazel Thorpe and George Gay Carman Trust. JEC received additional support from grant F31DE020963 from the NIDCR, National Institutes of Health (www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Bashore TM, 2006, CURR PROB CARDIOLOGY, V31, P274, DOI 10.1016/j.cpcardiol.2005.12.001; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Di Filippo S, 2006, HEART, V92, P1490, DOI 10.1136/hrt.2005.085332; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; GUNTHEROTH WG, 1984, AM J CARDIOL, V54, P797, DOI 10.1016/S0002-9149(84)80211-8; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Hensel M, 1998, ELECTROPHORESIS, V19, P608, DOI 10.1002/elps.1150190425; HERZBERG MC, 1992, INFECT IMMUN, V60, P4809, DOI 10.1128/IAI.60.11.4809-4818.1992; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kowalko JE, 2008, INFECT IMMUN, V76, P3131, DOI 10.1128/IAI.01696-07; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Li YH, 2008, MICROBIOL-SGM, V154, P3256, DOI 10.1099/mic.0.2008/019455-0; LOWRANCE JH, 1990, J CLIN INVEST, V86, P7, DOI 10.1172/JCI114717; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Okinaga T, 2010, MOL ORAL MICROBIOL, V25, P165, DOI 10.1111/j.2041-1014.2010.00574.x; Okinaga T, 2010, J BACTERIOL, V192, P1844, DOI 10.1128/JB.01667-09; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Perry JA, 2009, MOL MICROBIOL, V72, P905, DOI 10.1111/j.1365-2958.2009.06693.x; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Rodriguez AM, 2011, MOL ORAL MICROBIOL, V26, P99, DOI 10.1111/j.2041-1014.2011.00606.x; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Takahashi Y, 2006, INFECT IMMUN, V74, P740, DOI 10.1128/IAI.74.1.740-743.2006; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Turner LS, 2009, MICROBIOL-SGM, V155, P2573, DOI 10.1099/mic.0.024513-0; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Zhu L, 2011, MOL ORAL MICROBIOL, V26, P117, DOI 10.1111/j.2041-1014.2010.00602.x	43	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26403	10.1371/journal.pone.0026403	http://dx.doi.org/10.1371/journal.pone.0026403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039480	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500062
J	Li, BY; Qing, LT; Yan, JQ; Kong, QZ				Li, Baiya; Qing, Liuting; Yan, Jianqun; Kong, Qingzhong			Instability of the Octarepeat Region of the Human Prion Protein Gene	PLOS ONE			English	Article							DNA MISMATCH REPAIR; OCTAPEPTIDE REPEAT INSERTIONS; TRANSGENIC MICE; MICROSATELLITE INSTABILITY; DISEASE PATHOGENESIS; COPPER HOMEOSTASIS; SOMATIC EXPANSION; INVERTED REPEATS; IRON UPTAKE; CAG REPEAT	Prion diseases are a family of unique fatal transmissible neurodegenerative diseases that affect humans and many animals. Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common prion disease in humans, accounting for 85-90% of all human prion cases, and exhibits a high degree of diversity in phenotypes. The etiology of sCJD remains to be elucidated. The human prion protein gene has an octapeptide repeat region (octarepeats) that normally contains 5 repeats of 24-27 bp (1 nonapeptide and 4 octapeptide coding sequences). An increase of the octarepeat numbers to six or more or a decrease of the octarepeat number to three is linked to genetic prion diseases with heterogeneous phenotypes in humans. Here we report that the human octarepeat region is prone to either contraction or expansion when subjected to PCR amplification in vitro using Taq or Pwo polymerase and when replicated in wild type E. coli cells. Octarepeat insertion mutants were even less stable, and the mutation rate for the wild type octarepeats was much higher when replicated in DNA mismatch repair-deficient E. coli cells. All observed octarepeat mutants resulting from DNA replication in E. coli were contained in head-to-head plasmid dimers and DNA mfold analysis (http://mfold.rna.albany.edu/?q = mfold/DNA-Folding-Form) indicates that both DNA strands of the octarepeat region would likely form multiple stable hairpin structures, suggesting that the octarepeat sequence may form stable hairpin structures during DNA replication or repair to cause octarepeat instability. These results provide the first evidence supporting a somatic octarepeat mutation-based model for human sCJD etiology: 1) the instability of the octarepeat region leads to accumulation of somatic octarepeat mutations in brain cells during development and aging, 2) this instability is augmented by compromised DNA mismatch repair in aged cells, and 3) eventually some of the octarepeat mutation-containing brain cells start spontaneous de novo prion formation and replication to initiate sCJD.	[Li, Baiya; Yan, Jianqun] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Li, Baiya; Qing, Liuting; Kong, Qingzhong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Xi'an Jiaotong University; Case Western Reserve University	Li, BY (corresponding author), Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Xian 710049, Shaanxi, Peoples R China.	qxk2@case.edu			National Institutes of Health [R01 NS052319]; Creutzfeldt-Jakob Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creutzfeldt-Jakob Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by National Institutes of Health R01 NS052319 and the Creutzfeldt-Jakob Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzualde A, 2010, AM J MED GENET B, V153B, P1283, DOI 10.1002/ajmg.b.31099; Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Ben Yehuda A, 2000, MECH AGEING DEV, V121, P173; Biasini E, 2008, J NEUROCHEM, V104, P1293, DOI 10.1111/j.1471-4159.2007.05082.x; Bois P, 1997, HUM MOL GENET, V6, P1565, DOI 10.1093/hmg/6.9.1565; Bois PRJ, 2003, GENOMICS, V81, P349, DOI 10.1016/S0888-7543(03)00021-1; Botta A, 2008, J MED GENET, V45, P639, DOI 10.1136/jmg.2008.058909; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brooks PJ, 2002, MUTAT RES-FUND MOL M, V509, P93, DOI 10.1016/S0027-5107(02)00222-1; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2003, J NEUROCHEM, V87, P377, DOI 10.1046/j.1471-4159.2003.02046.x; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Buard J, 2000, GENOMICS, V65, P95, DOI 10.1006/geno.2000.6161; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Choi CJ, 2006, NEUROTOXICOLOGY, V27, P777, DOI 10.1016/j.neuro.2006.06.004; Coolbaugh-Murphy MI, 2005, MECH AGEING DEV, V126, P1051, DOI 10.1016/j.mad.2005.06.005; Croes EA, 2004, J NEUROL NEUROSUR PS, V75, P1166, DOI 10.1136/jnnp.2003.020198; DEROOIJ KE, 1995, HUM GENET, V95, P270, DOI 10.1007/BF00225192; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Felton KEA, 2007, CLIN GENET, V71, P483, DOI 10.1111/j.1399-0004.2007.00803.x; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Hardwick RJ, 2009, MOL BIOL EVOL, V26, P2647, DOI 10.1093/molbev/msp182; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; Hiraga C, 2009, BIOCHEM BIOPH RES CO, V382, P715, DOI 10.1016/j.bbrc.2009.03.093; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002; Kaliman P, 2008, CELL SIGNAL, V20, P1935, DOI 10.1016/j.cellsig.2008.05.005; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kiaris H, 1996, ATHEROSCLEROSIS, V125, P47, DOI 10.1016/0021-9150(96)05841-8; Kong Qingzhong, 2004, VVolume 41, P673; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Lin CT, 1997, NUCLEIC ACIDS RES, V25, P3009, DOI 10.1093/nar/25.15.3009; Lin CT, 2001, NUCLEIC ACIDS RES, V29, P3529, DOI 10.1093/nar/29.17.3529; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Metzgar D, 2002, GENOME RES, V12, P408, DOI 10.1101/gr.198602; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Neri S, 2008, REJUV RES, V11, P565, DOI 10.1089/rej.2007.0639; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Priola SA, 1998, J BIOL CHEM, V273, P11980, DOI 10.1074/jbc.273.19.11980; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; SCHAAPER RM, 1991, GENETICS, V129, P317; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Simpson AJG, 1997, ADV CANCER RES, V71, P209, DOI 10.1016/S0065-230X(08)60100-1; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; Varela-Nallar L, 2006, BIOL RES, V39, P39, DOI 10.4067/S0716-97602006000100005; Vassallo N, 2003, J NEUROCHEM, V86, P538, DOI 10.1046/j.1471-4159.2003.01882.x; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Yin SM, 2006, J BIOL CHEM, V281, P10698, DOI 10.1074/jbc.M511819200; Yu SL, 2008, FEBS J, V275, P5564, DOI 10.1111/j.1742-4658.2008.06680.x; Yu SL, 2007, BIOCHEM J, V403, P343, DOI 10.1042/BJ20061592; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094	68	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26635	10.1371/journal.pone.0026635	http://dx.doi.org/10.1371/journal.pone.0026635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028931	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500102
J	Lam, SM; Tong, L; Yong, SS; Li, BW; Chaurasia, SS; Shui, GH; Wenk, MR				Lam, Sin Man; Tong, Louis; Yong, Siew Sian; Li, Bowen; Chaurasia, Shyam S.; Shui, Guanghou; Wenk, Markus R.			Meibum Lipid Composition in Asians with Dry Eye Disease	PLOS ONE			English	Article							MEIBOMIAN GLAND SECRETIONS; MASS-SPECTROMETRIC ANALYSIS; OCULAR SURFACE DISEASE; CHAIN FATTY-ACIDS; INTERNATIONAL WORKSHOP; OXIDIZED PHOSPHOLIPIDS; DYSFUNCTION REPORT; SUBCOMMITTEE; IDENTIFICATION; PREVALENCE	Background: Previous lipidomic analyses of the human meibum had largely focused on individuals from non-Asian populations, despite the higher prevalence of dysfunctional tear syndrome (DTS) observed across Asia. Information pertaining to the alterations in lipid profiles in relation to DTS onset and progression is also lacking and warrants comprehensive experimental analysis. Methodologies/Principal Findings: We examined the meibum lipidome of 27 DTS patients and 10 control subjects for a total of 256 lipid species from 12 major lipid classes, including cholesteryl ester (CE), wax ester (WE), triacylglyceride (TAG), (O-acyl)-omega-hydroxy fatty acid (OAHFA), glycerophospholipids (phosphatidylcholine, PC; phosphatidylethanolamine, PE; phosphatidylinositol, PI; phosphatidylglycerol, PG) and sphingolipids (sphingomyelin, SM; ceramide, Cer; glucosylceramide, GluCer; dihexosylceramide, DihexCer). Neutral lipids were analysed using high-performance liquid-chromatography coupled with mass spectrometry (HPLC/MS) and tandem mass spectrometry (MS/MS) was used for the qualitative and quantitative analysis of polar lipid species. DTS patients were classified into three severity groups (i.e. mild, moderate and severe) based on the ocular surface disease index (OSDI). A significantly lower level of TAG (p<0.05) was observed in patients under the moderate category compared to the mild category. Notably, a number of OAHFA species displayed consistently decreasing levels that correlate with increasing disease severity. An attempt was also made to investigate the changes in meibum lipid profiles of DTS patients compared to normal individuals classified based on OSDI score. Several unsaturated TAG and PC species were found at significantly higher levels (p<0.05) in patients than controls. Conclusion: The current study presents, for the first time, a comprehensive lipidome of meibum from individuals of an Asian ethnicity, which can potentially offer new insights into the higher prevalence of DTS observed amongst Asian populations. This study also represents an attempt towards identification of lipid species in meibum which could serve as marker for DTS.	[Lam, Sin Man; Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Tong, Louis; Yong, Siew Sian; Chaurasia, Shyam S.] Singapore Eye Res Inst, Singapore, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore, Singapore; [Li, Bowen; Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore	Lam, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	guanghou_shui@nuhs.edu.sg; bchmrw@nus.edu.sg	Chaurasia, Shyam/AAB-4709-2019; Wenk, Markus Rene/D-1441-2014	Chaurasia, Shyam/0000-0001-8725-676X; Shui, Guanghou/0000-0002-1621-9643; Lam, Sin Man/0000-0001-9037-904X; Tong, Louis/0000-0002-3986-6552	National Medical Research Council [NMRC/1206/2009, NMRC/CSA/013/2009]; Singapore National Research Foundation [2007-04]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore National Research Foundation(National Research Foundation, Singapore)	This work was supported by National Medical Research Council grants (NMRC/1206/2009, NMRC/CSA/013/2009) and a grant from the Singapore National Research Foundation under CRP Award No. 2007-04. The authors wish to express their sincere gratitude to Dr. Martin Lear's laboratory for the synthesis of OAHFA 18:1/16:0. They would also like to thank Mr. Andri Riau for his help with meibum sample collection and transport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, OCUL SURF, V5, P75; ARCINIEGA J, 2010, 6284D912 ARVO; Ashraf MZ, 2009, INT J BIOCHEM CELL B, V41, P1241, DOI 10.1016/j.biocel.2008.11.002; Barr JT, 1999, CORNEA, V18, P34, DOI 10.1097/00003226-199901000-00007; Behrens A, 2006, CORNEA, V25, P900, DOI 10.1097/01.ico.0000214802.40313.fa; Butovich IA, 2008, INVEST OPHTH VIS SCI, V49, P3779, DOI 10.1167/iovs.08-1889; Butovich IA, 2007, J LIPID RES, V48, P2220, DOI 10.1194/jlr.M700237-JLR200; Butovich IA, 2007, LIPIDS, V42, P765, DOI 10.1007/s11745-007-3080-2; Butovich IA, 2011, PROG LIPID RES, V50, P278, DOI 10.1016/j.plipres.2011.03.003; Butovich IA, 2009, PROG RETIN EYE RES, V28, P483, DOI 10.1016/j.preteyeres.2009.07.002; Butovich IA, 2009, J LIPID RES, V50, P2471, DOI 10.1194/jlr.M900252-JLR200; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; Chen JZ, 2010, INVEST OPHTH VIS SCI, V51, P6220, DOI 10.1167/iovs.10-5687; Dogru M, 2005, AM J OPHTHALMOL, V140, P507, DOI 10.1016/j.ajo.2005.04.034; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Green-Church KB, 2011, INVEST OPHTH VIS SCI, V52, P1979, DOI 10.1167/iovs.10-6997d; HAMILTON JA, 1989, BIOCHEMISTRY-US, V28, P2514, DOI 10.1021/bi00432a025; HARVEY DJ, 1987, J CHROMATOGR-BIOMED, V414, P253, DOI 10.1016/0378-4347(87)80051-8; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Joffre C, 2008, BRIT J OPHTHALMOL, V92, P116, DOI 10.1136/bjo.2007.126144; Landreville S, 2004, INVEST OPHTH VIS SCI, V45, P3997, DOI 10.1167/iovs.04-0084; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Liu SH, 2011, INVEST OPHTH VIS SCI, V52, P2727, DOI 10.1167/iovs.10-6482; Mathers WD, 1998, ADV EXP MED BIOL, V438, P349; McCulley J P, 1997, Trans Am Ophthalmol Soc, V95, P79; McCulley JP, 2004, EXP EYE RES, V78, P361, DOI 10.1016/S0014-4835(03)00203-3; Nichols KK, 2007, INVEST OPHTH VIS SCI, V48, P34, DOI 10.1167/iovs.06-0753; NICOLAIDES N, 1981, INVEST OPHTH VIS SCI, V20, P522; Ousler GW, 2005, OCUL SURF, V3, P143, DOI 10.1016/S1542-0124(12)70196-9; Rantamaki AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019553; Saville JT, 2011, EXP EYE RES, V92, P238, DOI 10.1016/j.exer.2010.12.012; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shine WE, 2003, CURR EYE RES, V26, P89, DOI 10.1076/ceyr.26.2.89.14515; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Song CH, 1999, INVEST OPHTH VIS SCI, V40, P2744; Subbanagounder G, 2000, FREE RADICAL BIO MED, V28, P1751, DOI 10.1016/S0891-5849(00)00233-1; Sullivan BD, 2006, ARCH OPHTHALMOL-CHIC, V124, P1286, DOI 10.1001/archopht.124.9.1286; Sullivan BD, 2010, INVEST OPHTH VIS SCI, V51, P6125, DOI 10.1167/iovs.10-5390; TIFFANY JM, 1978, EXP EYE RES, V27, P289, DOI 10.1016/0014-4835(78)90164-1; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Tong L, 2011, BRIT J OPHTHALMOL, V95, P848, DOI 10.1136/bjo.2010.185256; Uchino M, 2006, OPTOMETRY VISION SCI, V83, P797, DOI 10.1097/01.opx.0000232814.39651.fa; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Wang JM, 2010, BIOCHIMIE, V92, P611, DOI 10.1016/j.biochi.2010.04.007; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wojtowicz JC, 2009, OCUL SURF, V7, P145, DOI 10.1016/S1542-0124(12)70309-9; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s; 2007, OCUL SURF, V5, P93	50	154	163	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24339	10.1371/journal.pone.0024339	http://dx.doi.org/10.1371/journal.pone.0024339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043274	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400001
J	Losse, A; Ullrich, S; Katzmann, E; Borg, S; Wanner, G; Richter, M; Voigt, B; Schweder, T; Schuler, D				Losse, Anna; Ullrich, Susanne; Katzmann, Emanuel; Borg, Sarah; Wanner, Gerd; Richter, Michael; Voigt, Birgit; Schweder, Thomas; Schueler, Dirk			Functional Analysis of the Magnetosome Island in Magnetospirillum gryphiswaldense: The mamAB Operon Is Sufficient for Magnetite Biomineralization	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MAGNETOTACTIC BACTERIA; GENE CLUSTERS; PROTEIN; MEMBRANE; DELETION; REVEALS; IDENTIFICATION; SYSTEM; MUTANT	Bacterial magnetosomes are membrane-enveloped, nanometer-sized crystals of magnetite, which serve for magnetotactic navigation. All genes implicated in the synthesis of these organelles are located in a conserved genomic magnetosome island (MAI). We performed a comprehensive bioinformatic, proteomic and genetic analysis of the MAI in Magnetospirillum gryphiswaldense. By the construction of large deletion mutants we demonstrate that the entire region is dispensable for growth, and the majority of MAI genes have no detectable function in magnetosome formation and could be eliminated without any effect. Only <25% of the region comprising four major operons could be associated with magnetite biomineralization, which correlated with high expression of these genes and their conservation among magnetotactic bacteria. Whereas only deletion of the mamAB operon resulted in the complete loss of magnetic particles, deletion of the conserved mms6, mamGFDC, and mamXY operons led to severe defects in morphology, size and organization of magnetite crystals. However, strains in which these operons were eliminated together retained the ability to synthesize small irregular crystallites, and weakly aligned in magnetic fields. This demonstrates that whereas the mamGFDC, mms6 and mamXY operons have crucial and partially overlapping functions for the formation of functional magnetosomes, the mamAB operon is the only region of the MAI, which is necessary and sufficient for magnetite biomineralization. Our data further reduce the known minimal gene set required for magnetosome formation and will be useful for future genome engineering approaches.	[Losse, Anna; Ullrich, Susanne; Katzmann, Emanuel; Borg, Sarah; Wanner, Gerd; Schueler, Dirk] Univ Munich, Dept Biol 1, Bereich Mikrobiol, LMU Biozentrum, Planegg Martinsried, Germany; [Richter, Michael] Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Res Grp, Bremen, Germany; [Voigt, Birgit] Ernst Moritz Arndt Univ Greifswald, Dept Microbial Physiol, Inst Microbiol, Greifswald, Germany; [Schweder, Thomas] Ernst Moritz Arndt Univ Greifswald, Pharmaceut Biotechnol Res Grp, Inst Pharm, Greifswald, Germany	University of Munich; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Losse, A (corresponding author), Univ Munich, Dept Biol 1, Bereich Mikrobiol, LMU Biozentrum, Planegg Martinsried, Germany.	dirk.schueler@lmu.de		Schweder, Thomas/0000-0002-7213-3596; Schuler, Dirk/0000-0002-2327-0762	Deutsche Forschungsgemeinschaft [DFG Schu1080/13-1]; Konrad-Adenauer-Stiftung e.V.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Konrad-Adenauer-Stiftung e.V.	This work was funded by the Deutsche Forschungsgemeinschaft (DFG Schu1080/13-1; www.dfg.de/index.jsp). A. L. was supported by the Konrad-Adenauer-Stiftung e.V. (www.kas.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu F, 2011, ISME J, P1; Arakaki A, 2010, J COLLOID INTERF SCI, V343, P65, DOI 10.1016/j.jcis.2009.11.043; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Ding Y, 2010, J BACTERIOL, V192, P1097, DOI 10.1128/JB.01292-09; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; Faivre D, 2010, BIOPHYS J, V99, P1268, DOI 10.1016/j.bpj.2010.05.034; Frankel R B, 2007, MICROBIOL MONOGR, V3, DOI DOI 10.1007/7171_2006_036; Frankel RB, 2006, TRENDS MICROBIOL, V14, P329, DOI 10.1016/j.tim.2006.06.004; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Grunberg K, 2001, APPL ENVIRON MICROB, V67, P4573, DOI 10.1128/AEM.67.10.4573-4582.2001; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Jogler C, 2011, P NATL ACAD SCI USA, V108, P1134, DOI 10.1073/pnas.1012694108; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Jogler C, 2009, APPL ENVIRON MICROB, V75, P3972, DOI 10.1128/AEM.02701-08; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Kolinko I, 2011, J BACTERIOL IN PRESS; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Lang C, 2006, J PHYS-CONDENS MAT, V18, pS2815, DOI 10.1088/0953-8984/18/38/S19; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; Murat D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000422; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Richter M, 2007, J BACTERIOL, V189, P4899, DOI 10.1128/JB.00119-07; Richter M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-177; Rioux JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009151; Sambrook J., 2001, MOL CLONING LAB MANU, P1, DOI DOI 10.1002/HUMU.1186.ABS; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Scheffel A, 2008, J BACTERIOL, V190, P377, DOI 10.1128/JB.01371-07; Scheffel A, 2007, J BACTERIOL, V189, P6437, DOI 10.1128/JB.00421-07; Schubbe S, 2003, J BACTERIOL, V185, P5779, DOI 10.1128/JB.185.19.5779-5790.2003; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Schuler D, 2004, ARCH MICROBIOL, V181, P1, DOI 10.1007/s00203-003-0631-7; SCHULER D, 1995, FEMS MICROBIOL LETT, V132, P139, DOI 10.1016/0378-1097(95)00300-T; Schultheiss D, 2004, APPL ENVIRON MICROB, V70, P3624, DOI 10.1128/aem.70.6.3624-3631.2004; Schultheiss D, 2003, ARCH MICROBIOL, V179, P89, DOI 10.1007/s00203-002-0498-z; Stevenson SE, 2009, J PROTEOMICS, V72, P555, DOI 10.1016/j.jprot.2008.11.005; Suzuki N, 2005, APPL ENVIRON MICROB, V71, P8472, DOI 10.1128/AEM.71.12.8472-8480.2005; Suzuki N, 2005, APPL ENVIRON MICROB, V71, P3369, DOI 10.1128/AEM.71.6.3369-3372.2005; Tanaka M, 2011, J BIOL CHEM, V286, P6386, DOI 10.1074/jbc.M110.183434; Tanaka M, 2010, MOL MICROBIOL, V76, P480, DOI 10.1111/j.1365-2958.2010.07117.x; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; Ullrich S, 2005, J BACTERIOL, V187, P7176, DOI 10.1128/JB.187.21.7176-7184.2005; Ullrich S, 2010, APPL ENVIRON MICROB, V76, P2439, DOI 10.1128/AEM.02805-09; Voigt B, 2006, PROTEOMICS, V6, P268, DOI 10.1002/pmic.200500091; Wolff S, 2008, MOL CELL PROTEOMICS, V7, P1460, DOI 10.1074/mcp.M700554-MCP200; Yu BJ, 2002, NAT BIOTECHNOL, V20, P1018, DOI 10.1038/nbt740	53	48	52	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25561	10.1371/journal.pone.0025561	http://dx.doi.org/10.1371/journal.pone.0025561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043287	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400014
J	Ji, JP; Kinders, RJ; Zhang, YP; Rubinstein, L; Kummar, S; Parchment, RE; Tomaszewski, JE; Doroshow, JH				Ji, Jiuping; Kinders, Robert J.; Zhang, Yiping; Rubinstein, Larry; Kummar, Shivaani; Parchment, Ralph E.; Tomaszewski, Joseph E.; Doroshow, James H.			Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							0 CLINICAL-TRIAL; POLY(ADP-RIBOSE) POLYMERASE; DRUG DEVELOPMENT; PARP INHIBITORS; BIOMARKERS; EXPRESSION; TUMORS; ASSAY	Background: Poly(ADP-ribose) polymerase (PARP) facilitates DNA repair and PARP inhibitors may potentiate the effect of DNA-damaging chemotherapeutic agents in patients with cancer. Collection of peripheral blood mononuclear cells (PBMCs) as a surrogate tissue to monitor PARP inhibitor pharmacodynamic effects has several advantages over tumor biopsy collection, including minimally invasive sample collection and the ability to collect multiple samples for longitudinal assessment of drug effect. Methodology/Principal Findings: Using our previously validated immunoassay for measuring poly(ADP-ribose) (PAR), a product of PARP, in tumor biopsies, we validated a method to quantify PAR levels in PBMCs to monitor the pharmacodynamic effects of the PARP inhibitor ABT-888 in clinical trials. The inter-individual variation in PAR levels was large. No significant difference (P = 0.67) was measured between median baseline PAR levels in 144 healthy volunteers (131.7 pg/1 x 10(7) PBMCs [interquartile range, 79.5-241.6]) and 49 patients with cancer (149.2 pg/1610 7 PBMCs [interquartile range, 83.2-249.3]). In addition, PAR levels monitored in healthy volunteers over 3 weeks had considerable intra-and inter-individual variation (range, 44-1073 pg PAR/1 x 10(7) PBMCs). As a pharmacodynamic model, we quantified changes in PAR levels in human PBMCs treated ex vivo with clinically relevant concentrations of ABT-888. Of 40 healthy volunteer PBMC samples treated with ABT-888, 47.5% had greater than 50% PAR reduction compared to vehicle-treated controls. Considerable inter-sample heterogeneity in PAR levels was measured, and several ABT-888-insensitive samples were identified. Conclusions/Significance: Our results emphasize the importance of using a validated method to measure PAR levels, and support further investigation into the role of PARP in PBMCs. To this end, the PAR immunoassay has been validated for use with PBMCs and incorporated into clinical trials to assess PBMCs as a potential pharmacodynamic surrogate for tumor biopsies in clinical trials of PARP inhibitors.	[Ji, Jiuping; Zhang, Yiping] NCI, Natl Clin Target Validat Lab, Frederick, MD 21701 USA; [Kinders, Robert J.; Parchment, Ralph E.] NCI, Lab Human Toxicol & Pharmacol, Appl Dev Res Support Directorate, SAIC Frederick Inc, Frederick, MD 21701 USA; [Rubinstein, Larry; Kummar, Shivaani; Tomaszewski, Joseph E.; Doroshow, James H.] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [Kummar, Shivaani; Doroshow, James H.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, JP (corresponding author), NCI, Natl Clin Target Validat Lab, Frederick, MD 21701 USA.	jijiupi@mail.nih.gov		Rubinstein, Lawrence/0000-0002-9720-9737	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institutes of Health (NIH) National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011078] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH) National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH) National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Curtin Nicola J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940500904X; DCTD, DCTD RES RES BIOM; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kinders RJ, 2008, CLIN CANCER RES, V14, P6877, DOI 10.1158/1078-0432.CCR-08-0214; Kummar S, 2007, NAT REV CANCER, V7, P131, DOI 10.1038/nrc2066; Kummar S, 2009, J CLIN ONCOL, V27, P2705, DOI 10.1200/JCO.2008.19.7681; Kunzmann Andrea, 2006, Immun Ageing, V3, P8, DOI 10.1186/1742-4933-3-8; Liu X, 2008, ANAL BIOCHEM, V381, P240, DOI 10.1016/j.ab.2008.07.007; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Park JW, 2004, CLIN CANCER RES, V10, P3885, DOI 10.1158/1078-0432.CCR-03-0785; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rubinstein LV, 2010, STAT MED, V29, P1072, DOI 10.1002/sim.3840; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Zaremba T, 2009, BRIT J CANCER, V101, P256, DOI 10.1038/sj.bjc.6605166; Zaremba T, 2011, BIOCHEM J, V436, P671, DOI 10.1042/BJ20101723	21	40	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26152	10.1371/journal.pone.0026152	http://dx.doi.org/10.1371/journal.pone.0026152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028822	Green Published, gold, Green Submitted			2022-12-25	WOS:000295971700045
J	Anavi-Goffer, S; Baillie, G; Irving, AJ; Gertsch, J; Greig, IR; Pertwee, RG; Ross, RA				Anavi-Goffer, Sharon; Baillie, Gemma; Irving, Andrew J.; Gertsch, Juerg; Greig, Iain R.; Pertwee, Roger G.; Ross, Ruth A.			Modulation of L-alpha-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ALPHA-LYSOPHOSPHATIDYLINOSITOL; CANCER-CELL PROLIFERATION; CB1 RECEPTOR ANTAGONIST; B-RAF INHIBITORS; ALLOSTERIC MODULATION; PLANT CANNABINOIDS; ENDOTHELIAL-CELLS; NEUROPATHIC PAIN; GPR55; IDENTIFICATION	GPR55 is activated by L-alpha-lysophosphatidylinositol (LPI) but also by certain cannabinoids. In this study, we investigated the GPR55 pharmacology of various cannabinoids, including analogues of the CB1 receptor antagonist Rimonabant (R), CB2 receptor agonists, and Cannabis sativa constituents. To test ERK1/2 phosphorylation, a primary downstream signaling pathway that conveys LPI-induced activation of GPR55, a high throughput system, was established using the AlphaScreen (R) SureFire (R) assay. Here, we show that CB1 receptor antagonists can act both as agonists alone and as inhibitors of LPI signaling under the same assay conditions. This study clarifies the controversy surrounding the GPR55-mediated actions of SR141716A; some reports indicate the compound to be an agonist and some report antagonism. In contrast, we report that the CB2 ligand GW405833 behaves as a partial agonist of GPR55 alone and enhances LPI signaling. GPR55 has been implicated in pain transmission, and thus our results suggest that this receptor may be responsible for some of the antinociceptive actions of certain CB2 receptor ligands. The phytocannabinoids Delta(9)-tetrahydrocannabivarin, cannabidivarin, and cannabigerovarin are also potent inhibitors of LPI. These Cannabis sativa constituents may represent novel therapeutics targeting GPR55.	[Anavi-Goffer, Sharon; Baillie, Gemma; Greig, Iain R.; Pertwee, Roger G.; Ross, Ruth A.] Univ Aberdeen, Kosterlitz Ctr Therapeut, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Irving, Andrew J.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland; [Gertsch, Juerg] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Anavi-Goffer, Sharon] Ariel Univ, Ctr Samaria, Dept Behav Sci, IL-40700 Ariel, Israel; [Anavi-Goffer, Sharon] Ariel Univ, Ctr Samaria, Dept Mol Biol, IL-40700 Ariel, Israel	University of Aberdeen; University of Dundee; University of Bern; Ariel University; Ariel University	Anavi-Goffer, S (corresponding author), Univ Aberdeen, Kosterlitz Ctr Therapeut, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland.	s.goffer@ariel.ac.il	Ross, R./AAG-7468-2019; Anavi-Goffer, Sharon/H-6111-2019	Anavi-Goffer, Sharon/0000-0002-3364-5134; Gertsch, Jurg/0000-0003-0978-1555; Pertwee, Roger/0000-0003-3227-2783; Greig, Iain/0000-0003-0603-3383	National Institutes of Health [DA-03672, DA-09789]; University of Aberdeen; GW Pharmaceuticals; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA003672, P01DA009789, R01DA003672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Aberdeen; GW Pharmaceuticals; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA-03672 and DA-09789 (to R. A. R. and R. G. P.). This work was also supported by a Knowledge Transfer Grant Award from the University of Aberdeen. R. G. P. and R. A. R. received funding from GW Pharmaceuticals.	Adwanikar H, 2004, PAIN, V111, P125, DOI 10.1016/j.pain.2004.06.009; Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Aragona M, 2009, CLIN NEUROPHARMACOL, V32, P41, DOI 10.1097/WNF.0b013e3181633497; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Beltramo M, 2009, MINI-REV MED CHEM, V9, P11, DOI 10.2174/138955709787001785; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Comelli F, 2010, EUR J PHARMACOL, V637, P62, DOI 10.1016/j.ejphar.2010.03.061; Costa B, 2005, PAIN, V116, P52, DOI 10.1016/j.pain.2005.03.043; De Petrocellis L, 2008, J PHARMACOL EXP THER, V325, P1007, DOI 10.1124/jpet.107.134809; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; Ford LA, 2010, BRIT J PHARMACOL, V160, P762, DOI 10.1111/j.1476-5381.2010.00743.x; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Ishiguro H, 2011, SYNAPSE, V65, P103, DOI 10.1002/syn.20821; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Jafari MR, 2007, BEHAV PHARMACOL, V18, P691, DOI 10.1097/FBP.0b013e3282f00c10; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Johnson JR, 2010, J PAIN SYMPTOM MANAG, V39, P167, DOI 10.1016/j.jpainsymman.2009.06.008; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Kotsikorou E, 2011, BIOCHEMISTRY-US, V50, P5633, DOI 10.1021/bi200010k; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Li HF, 2010, CURR MED CHEM, V17, P1618, DOI 10.2174/092986710791111242; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Lin YW, 2003, J BIOL CHEM, V278, P21534, DOI 10.1074/jbc.M301854200; Marcu JP, 2010, MOL CANCER THER, V9, P180, DOI 10.1158/1535-7163.MCT-09-0407; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Osmond RIW, 2010, ANAL BIOCHEM, V403, P94, DOI 10.1016/j.ab.2010.04.007; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Riedel G, 2009, BRIT J PHARMACOL, V156, P1154, DOI 10.1111/j.1476-5381.2008.00107.x; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Schuelert N, 2010, OSTEOARTHR CARTILAGE, V18, P1536, DOI 10.1016/j.joca.2010.09.005; Shepherd C, 2010, CURR ONCOL REP, V12, P146, DOI 10.1007/s11912-010-0095-2; Shih HH, 2009, AM J PHYSIOL-HEART C, V296, pH1643, DOI 10.1152/ajpheart.00938.2008; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Szydlowska K, 2010, J NEUROCHEM, V113, P904, DOI 10.1111/j.1471-4159.2010.06656.x; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137; Valant C, 2009, MOL INTERV, V9, P125, DOI 10.1124/mi.9.3.6; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Wigle TJ, 2010, J BIOMOL SCREEN, V15, P62, DOI 10.1177/1087057109352902; Xu ZW, 2009, J BIOMOL SCREEN, V14, P1257, DOI 10.1177/1087057109349356; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	62	108	111	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					91	104		10.1074/jbc.M111.296020	http://dx.doi.org/10.1074/jbc.M111.296020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22027819	Green Published, hybrid			2022-12-25	WOS:000298682400012
J	Huang, JH; Vogel, G; Yu, ZB; Almazan, G; Richard, S				Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Almazan, Guillermina; Richard, Stephane			Type II Arginine Methyltransferase PRMT5 Regulates Gene Expression of Inhibitors of Differentiation/DNA Binding Id2 and Id4 during Glial Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN PROTEOLIPID PROTEIN; C6 GLIOMA-CELLS; OLIGODENDROCYTE DIFFERENTIATION; TRANSCRIPTIONAL REPRESSION; TUMOR-SUPPRESSOR; PROMOTER METHYLATION; STEM-CELLS; RAT-BRAIN; HISTONE; CANCER	PRMT5 is a type II protein arginine methyltranferase that catalyzes monomethylation and symmetric dimethylation of arginine residues. PRMT5 is functionally involved in a variety of biological processes including embryo development and circadian clock regulation. However, the role of PRMT5 in oligodendrocyte differentiation and central nervous system myelination is unknown. Here we show that PRMT5 expression gradually increases throughout postnatal brain development, coinciding with the period of active myelination. PRMT5 expression was observed in neurons, astrocytes, and oligodendrocytes. siRNA-mediated depletion of PRMT5 in mouse primary oligodendrocyte progenitor cells abrogated oligodendrocyte differentiation. In addition, the PRMT5-depleted oligodendrocyte progenitor and C6 glioma cells expressed high levels of the inhibitors of differentiation/DNA binding, Id2 and Id4, known repressors of glial cell differentiation. We observed that CpG-rich islands within the Id2 and Id4 genes were bound by PRMT5 and were hypomethylated in PRMT5-deficient cells, suggesting that PRMT5 plays a role in gene silencing during glial cell differentiation. Our findings define a role of PRMT5 in glial cell differentiation and link PRMT5 to epigenetic changes during oligodendrocyte differentiation.	[Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Richard, Stephane] Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; [Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Richard, Stephane] Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Almazan, Guillermina] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Richard, S (corresponding author), Segal Canc Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca			Canadian Institutes of Health Research [MOP-67070]; Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada	This work was supported by Grant MOP-67070 from the Canadian Institutes of Health Research (to S. R.).; Supported by the Multiple Sclerosis Society of Canada.	ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Carey JPW, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-173; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Chittka A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013807; COYLE DE, 1995, J NEUROSCI RES, V41, P374, DOI 10.1002/jnr.490410310; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Hou ZY, 2010, P NATL ACAD SCI USA, V107, P2938, DOI 10.1073/pnas.0908656107; Huddleston JE, 2011, NAT REV MOL CELL BIO, V12, DOI 10.1038/nrm3056; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Leisewitz AV, 2008, J CELL PHYSIOL, V217, P367, DOI 10.1002/jcp.21509; MCMORRIS FA, 1977, P NATL ACAD SCI USA, V74, P4501, DOI 10.1073/pnas.74.10.4501; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; NAVE KA, 1991, J NEUROSCI, V11, P3060; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Swiss VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018088; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yu Y, 2010, EPIGENETICS-US, V5, P124, DOI 10.4161/epi.5.2.11160; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	46	49	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44424	44432		10.1074/jbc.M111.277046	http://dx.doi.org/10.1074/jbc.M111.277046			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22041901	Green Published, hybrid			2022-12-25	WOS:000298645500014
J	Revez, J; Rossi, M; Ellstrom, P; de Haan, C; Rautelin, H; Hanninen, ML				Revez, Joana; Rossi, Mirko; Ellstrom, Patrik; de Haan, Caroline; Rautelin, Hilpi; Hanninen, Marja-Liisa			Finnish Campylobacter jejuni Strains of Multilocus Sequence Type ST-22 Complex Have Two Lineages with Different Characteristics	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; LIPO-OLIGOSACCHARIDE; REACTIVE ARTHRITIS; BIOFILM FORMATION; BIOSYNTHESIS; CELLS; COLI; GENES; CORE; CHICKENS	Background: Campylobacter jejuni is the major cause of human bacterial gastroenteritis worldwide, and in a minority of cases, post-infectious complications may occur. ST-22 complex (usually Penner serotype 19) strains have been overrepresented among patients with postinfectious complications of campylobacteriosis. We here present a characterization of a collection of 27 Finnish C. jejuni strains of ST-22 complex, from humans (22 strains) and animal sources (five strains), with the aim of contributing to our knowledge of the pathogenesis of C. jejuni infections. Methodology/Principal Findings: All strains were analyzed by pulsed-field gel electrophoresis (PFGE) genotyping, lipooligosaccharide (LOS) locus class, Y-glutamyl transpeptidase (GGT) activity, in vitro biofilm formation ability, invasion and adhesion in HeLa cells and induction of IL-8 production. ST-22 complex contained five STs (ST-22; ST-1947; ST-1966; ST-3892; ST-3996) which were homogeneous in having sialylated LOS class A(1) but on the other hand were distinguished into two major lineages according to the major STs (ST-22 and ST-1947) by different PFGE genotypes and certain other characteristics. All ST-22 strains had similar SmaI PFGE profiles, were GGT positive, and formed biofilms, except one strain, while ST-1947 strains were all GGT negative, did not form biofilm, had significantly higher motility than ST-22 (p<0.05) and had their SmaI PFGE profile. Invasion and adhesion as well as induction of IL-8 production on HeLa cells were strain-dependent characteristics. Conclusions/Significance: ST-22 complex strains, reveal potential for molecular mimicry in host interactions upon infection as they all express sialylated LOS class A1. The two major STs, ST-22 and ST-1947 formed two homogeneous lineages, which differed from each other both phenotypically and genetically, suggesting that the strains may have evolved separately, perhaps by interacting with different spectra of hosts. Further studies are needed in order to understand if these two lineages are associated with different disease outcomes.	[Revez, Joana; Rossi, Mirko; de Haan, Caroline; Hanninen, Marja-Liisa] Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland; [Ellstrom, Patrik; Rautelin, Hilpi] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Rautelin, Hilpi] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Rautelin, Hilpi] Helsinki Univ Cent Hosp Lab, HUSLAB, Helsinki, Finland	University of Helsinki; Uppsala University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Revez, J (corresponding author), Univ Helsinki, Dept Food Hyg & Environm Hlth, Fac Vet Med, Helsinki, Finland.	joana.revez@helsinki.fi	Rossi, Mirko/D-1509-2012; de Haan, Astrid/G-2723-2013	Rossi, Mirko/0000-0002-1585-6384; 	Academy of Finland [118602, 118042]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland grant on behalf of CoE-MiFoSa (no 118602) and ELVIRA grant no 118042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P6942, DOI 10.1128/AEM.01605-10; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; EVEREST PH, 1992, J MED MICROBIOL, V37, P319, DOI 10.1099/00222615-37-5-319; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Gonzalez M, 2009, APPL ENVIRON MICROB, V75, P1208, DOI 10.1128/AEM.01879-08; Guccione E, 2008, MOL MICROBIOL, V69, P77, DOI 10.1111/j.1365-2958.2008.06263.x; Hakkinen M, 2007, APPL ENVIRON MICROB, V73, P3232, DOI 10.1128/AEM.02579-06; Hanninen ML, 2001, APPL ENVIRON MICROB, V67, P1581, DOI 10.1128/AEM.67.4.1581-1586.2001; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Hannu T, 2004, J RHEUMATOL, V31, P528; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Hotter GS, 2010, EPIDEMIOL INFECT, V138, P992, DOI 10.1017/S0950268809991075; Islam Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007257; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P1683, DOI 10.1128/AEM.02338-06; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Kelly DJ, 2001, J APPL MICROBIOL, V90, p16S, DOI 10.1046/j.1365-2672.2001.01350.x; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Mortensen NP, 2009, MICROBES INFECT, V11, P988, DOI 10.1016/j.micinf.2009.07.004; Nielsen LN, 2010, J APPL MICROBIOL, V108, P591, DOI 10.1111/j.1365-2672.2009.04444.x; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Perera VN, 2007, FEMS IMMUNOL MED MIC, V50, P27, DOI 10.1111/j.1574-695X.2007.00225.x; Rautelin H, 1999, J MED MICROBIOL, V48, P617, DOI 10.1099/00222615-48-7-617; Reeser RJ, 2007, APPL ENVIRON MICROB, V73, P1908, DOI 10.1128/AEM.00740-06; Schonberg-Norio D, 2010, EPIDEMIOL INFECT, V138, P1004, DOI 10.1017/S0950268809991099; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Taboada EN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-359; Taboada EN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-229; Teh KH, 2010, INT J FOOD MICROBIOL, V143, P118, DOI 10.1016/j.ijfoodmicro.2010.07.037; Verhoeff-Bakkenes L, 2008, EPIDEMIOL INFECT, V136, P1401, DOI 10.1017/S0950268807000040; Yabe S, 2010, MICROBIOL IMMUNOL, V54, P362, DOI 10.1111/j.1348-0421.2010.00222.x; Zautner AE, 2011, APPL ENVIRON MICROB, V77, P2359, DOI 10.1128/AEM.02403-10; Zheng J, 2006, J FOOD PROTECT, V69, P768, DOI 10.4315/0362-028X-69.4.768	42	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26880	10.1371/journal.pone.0026880	http://dx.doi.org/10.1371/journal.pone.0026880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039552	gold, Green Published, Green Submitted			2022-12-25	WOS:000296515200051
J	Russo, TA; Shon, AS; Beanan, JM; Olson, R; MacDonald, U; Pomakov, AO; Visitacion, MP				Russo, Thomas A.; Shon, Alyssa S.; Beanan, Janet M.; Olson, Ruth; MacDonald, Ulrike; Pomakov, Alexander O.; Visitacion, Mark P.			Hypervirulent K. Pneumoniae Secretes More and More Active Iron-Acquisition Molecules than "Classical" K. Pneumoniae Thereby Enhancing its Virulence	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; SEROTYPE K1; SEPTIC ENDOPHTHALMITIS; EMERGING DISEASE; INFECTION; ASSOCIATION; BACTEREMIA; STRAINS	Background: A new hypervirulent (hypermucoviscous) clinical variant of Klebsiella pneumoniae (hvKP) has emerged over the last decade. Our goal is to identify new mechanisms, which increase the virulence hvKP compared to "classic" K. pneumoniae (cKP). Methodology/Principal Findings: Various growth assays were performed in human ascites, human serum, and laboratory medium with the hvKP strain hvKP1 (wt), randomly chosen blood isolates of cKP strains (cKP1-4), and mutant constructs deficient in the secretion of selected compounds. An in vivo mouse model that mimics infection due to hvKP and a quantitative siderophore assay were also used. It was established that a molecule(s)/factor(s) was secreted by hvKP1 significantly enhanced its growth and/or survival in human ascites. This molecule(s)/factor(s) also increased the growth and/or survival of hvKP1 in serum ex vivo and in an in vivo mouse model that measures metastatic spread after subcutaneous challenge, thereby further establishing biologic significance. Although features such as a size of <3kD, heat stability, and growth characteristics in ascites suggested this molecule(s) was a quorum-sensing compound, data presented demonstrates that this molecule(s)/factor(s) is involved in iron uptake and is likely a siderophore(s) or another iron-acquisition molecule. Although it is known that iron acquisition is critical for virulence, a novel aspect of this observation is that hvKP1 produces quantitatively more siderophores that appear to be biologically more active (increased affinity for iron or more resistant to host factors) than those produced by cKP strains. Conclusions/Significance: The data presented delineates a new mechanism by which hvKP increases its pathogenic potential compared to cKP strains. This paradigm may be broadly applicable to other extraintestinal gram-negative bacilli.	[Russo, Thomas A.; Shon, Alyssa S.; Beanan, Janet M.; Olson, Ruth; MacDonald, Ulrike; Visitacion, Mark P.] SUNY Buffalo, Vet Adm Western New York Healthcare Syst, Buffalo, NY 14260 USA; [Russo, Thomas A.; Shon, Alyssa S.; Beanan, Janet M.; Olson, Ruth; MacDonald, Ulrike; Pomakov, Alexander O.; Visitacion, Mark P.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Russo, Thomas A.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Russo, Thomas A.; Beanan, Janet M.; Olson, Ruth; MacDonald, Ulrike] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Russo, TA (corresponding author), SUNY Buffalo, Vet Adm Western New York Healthcare Syst, Buffalo, NY 14260 USA.	trusso@acsu.buffalo.edu	Russo, Thomas/ABE-9633-2020		National Institutes of Health [1R21AI088318 - 01A1]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grant 1R21AI088318 - 01A1 (Dr. Russo) and by a VA Merit Review from the Department of Veterans Affairs (Dr. Russo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Caza M, 2011, MOL MICROBIOL, V80, P266, DOI 10.1111/j.1365-2958.2011.07570.x; Chang Feng-Yee, 1995, Journal of the Formosan Medical Association, V94, P232; Chen YT, 2004, GENE, V337, P189, DOI 10.1016/j.gene.2004.05.008; CHENG DL, 1991, ARCH INTERN MED, V151, P1557; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; De Araujo C, 2010, RES MICROBIOL, V161, P595, DOI 10.1016/j.resmic.2010.05.014; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Dylewski JS, 1998, CLIN INFECT DIS, V27, P1561, DOI 10.1086/517760; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2000, QJM-MON J ASSOC PHYS, V93, P45, DOI 10.1093/qjmed/93.1.45; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; HAN SHB, 1995, WESTERN J MED, V162, P220; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Jang Tsrang-Neng, 1993, Journal of the Formosan Medical Association, V92, P540; Jones MB, 2003, INFECT IMMUN, V71, P3914, DOI 10.1128/IAI.71.7.3914-3919.2003; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; Kendall MM, 2007, CURR OPIN GASTROEN, V23, P10, DOI 10.1097/MOG.0b013e3280118289; Keynan Y, 2007, SCAND J INFECT DIS, V39, P828, DOI 10.1080/00365540701266763; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Ku YH, 2008, J MICROBIOL IMMUNOL, V41, P311; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lee HC, 2006, J INTERN MED, V259, P606, DOI 10.1111/j.1365-2796.2006.01641.x; Lee WS, 2011, YONSEI MED J, V52, P288, DOI 10.3349/ymj.2011.52.2.288; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; Lu C H, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V60, P296; Luke NR, 2004, INFECT IMMUN, V72, P6262, DOI 10.1128/IAI.72.11.6262-6270.2004; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; McCabe R, 2010, EMERG INFECT DIS, V16, P1490, DOI 10.3201/eid1609.100386; MERINO S, 1992, INFECT IMMUN, V60, P2529, DOI 10.1128/IAI.60.6.2529-2535.1992; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Nagano N, 2008, J MED MICROBIOL, V57, P121, DOI 10.1099/jmm.0.47380-0; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; POMAKOVA DK, 2011, EUR J CLIN MICROBIOL; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Russo TA, 1999, INFECT IMMUN, V67, P5306, DOI 10.1128/IAI.67.10.5306-5314.1999; Russo TA, 2008, INFECT IMMUN, V76, P3577, DOI 10.1128/IAI.00269-08; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; SIMOONSSMIT AM, 1984, J MED MICROBIOL, V17, P67, DOI 10.1099/00222615-17-1-67; SIMOONSSMIT AM, 1986, J MED MICROBIOL, V21, P133, DOI 10.1099/00222615-21-2-133; Su SC, 2008, ANTIMICROB AGENTS CH, V52, P804, DOI 10.1128/AAC.01269-07; Tang LM, 1997, EPIDEMIOL INFECT, V119, P135, DOI 10.1017/S0950268897007930; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Turovskiy Y, 2007, ADV APPL MICROBIOL, V62, P191, DOI 10.1016/S0065-2164(07)62007-3; Turovskiy Y, 2006, J MICROBIOL METH, V66, P497, DOI 10.1016/j.mimet.2006.02.001; Turton JF, 2007, J MED MICROBIOL, V56, P593, DOI 10.1099/jmm.0.46964-0; Walters M, 2006, INFECT IMMUN, V74, P5445, DOI 10.1128/IAI.00099-06; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yeh KM, 2006, J MED MICROBIOL, V55, P803, DOI 10.1099/jmm.0.46368-0; Yu WL, 2008, DIAGN MICR INFEC DIS, V62, P1, DOI 10.1016/j.diagmicrobio.2008.04.007; Yu WL, 2006, CLIN INFECT DIS, V42, P1351, DOI 10.1086/503420	61	74	90	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26734	10.1371/journal.pone.0026734	http://dx.doi.org/10.1371/journal.pone.0026734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039542	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200047
J	Todorova, D; Sabatier, F; Doria, E; Lyonnet, L; Coponat, HV; Robert, S; Despoix, N; Legris, T; Moal, V; Loundou, A; Morange, S; Berland, Y; George, FD; Burtey, S; Paul, P				Todorova, Dilyana; Sabatier, Florence; Doria, Evelyne; Lyonnet, Luc; Coponat, Henri Vacher; Robert, Stephane; Despoix, Nicolas; Legris, Tristan; Moal, Valerie; Loundou, Anderson; Morange, Sophie; Berland, Yvon; George, Francoise Dignat; Burtey, Stephane; Paul, Pascale			Fractalkine Expression Induces Endothelial Progenitor Cell Lysis by Natural Killer Cells	PLOS ONE			English	Article							RENAL-ALLOGRAFT REJECTION; INTERSTITIAL FIBROSIS; RECEPTOR CX(3)CR1; VASCULAR REPAIR; CD34(+) CELLS; IFN-GAMMA; NK CELLS; KIDNEY; INJURY; CHEMOKINE	Background: Circulating CD34(+) cells, a population that includes endothelial progenitors, participate in the maintenance of endothelial integrity. Better understanding of the mechanisms that regulate their survival is crucial to improve their regenerative activity in cardiovascular and renal diseases. Chemokine-receptor cross talk is critical in regulating cell homeostasis. We hypothesized that cell surface expression of the chemokine fractalkine (FKN) could target progenitor cell injury by Natural Killer (NK) cells, thereby limiting their availability for vascular repair. Methodology/Principal Findings: We show that CD34(+)-derived Endothelial Colony Forming Cells (ECFC) can express FKN in response to TNF-alpha and IFN-gamma inflammatory cytokines and that FKN expression by ECFC stimulates NK cell adhesion, NK cell-mediated ECFC lysis and microparticles release in vitro. The specific involvement of membrane FKN in these processes was demonstrated using FKN-transfected ECFC and anti-FKN blocking antibody. FKN expression was also evidenced on circulating CD34(+) progenitor cells and was detected at higher frequency in kidney transplant recipients, when compared to healthy controls. The proportion of CD34(+) cells expressing FKN was identified as an independent variable inversely correlated to CD34(+) progenitor cell count. We further showed that treatment of CD34(+) circulating cells isolated from adult blood donors with transplant serum or TNF-alpha/IFN-gamma can induce FKN expression. Conclusions: Our data highlights a novel mechanism by which FKN expression on CD34(+) progenitor cells may target their NK cell mediated killing and participate to their immune depletion in transplant recipients. Considering the numerous diseased contexts shown to promote FKN expression, our data identify FKN as a hallmark of altered progenitor cell homeostasis with potential implications in better evaluation of vascular repair in patients.	[Todorova, Dilyana; Sabatier, Florence; Robert, Stephane; Despoix, Nicolas; George, Francoise Dignat; Burtey, Stephane; Paul, Pascale] Aix Marseille Univ, INSERM, UMR S 608, Lab Physiopathol Endothelium, F-13005 Marseille, France; [Doria, Evelyne; Lyonnet, Luc; George, Francoise Dignat; Paul, Pascale] CHU Concept, Assistance Publ Hop Marseille, Hematol Lab, Marseille, France; [Coponat, Henri Vacher; Legris, Tristan; Moal, Valerie; Berland, Yvon; Burtey, Stephane] Hop Conception, Assistance Publ Hop Marseille, Ctr Nephrol & Transplantat Renale, Marseille, France; [Loundou, Anderson] Assistance Publ Hop Marseille, DRRC, Unite Aide Methodol Rech Clin & Epidemiol, Marseille, France; [Morange, Sophie; Berland, Yvon] Hop Conception, Ctr Invest Clin, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Todorova, D (corresponding author), Aix Marseille Univ, INSERM, UMR S 608, Lab Physiopathol Endothelium, F-13005 Marseille, France.	pascale.paul@univmed.fr	DIGNAT-GEORGE, Françoise/R-1129-2016; PAUL, Pascale/AAI-1772-2020; PAUL, Pascale/R-1484-2016; Burtey, Stéphane/S-2433-2019	DIGNAT-GEORGE, Françoise/0000-0001-7006-4462; PAUL, Pascale/0000-0002-6734-4479; PAUL, Pascale/0000-0002-6734-4479; Burtey, Stéphane/0000-0003-1813-7884	Institut National de la Sante et de la Recherche Medicale (INSERM); Aix-Marseille University; L'institut National Du Cancer (INCa); la Direction de l'Hospitalisation et de l'Organisation des Soins (DHOS) [FEG CO8-17, ID 2008-A00604-51]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Aix-Marseille University; L'institut National Du Cancer (INCa)(Institut National du Cancer (INCA) France); la Direction de l'Hospitalisation et de l'Organisation des Soins (DHOS)	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM) and Aix-Marseille University. Evaluation of blood samples was supported on the basis of a translational research grant funded by Institut National de la Sante et de la Recherche Medicale (INSERM), L'institut National Du Cancer (INCa) and la Direction de l'Hospitalisation et de l'Organisation des Soins (DHOS) (Appel a Projet 2008, Acronym FEG CO8-17, ID 2008-A00604-51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bobryshev YV, 2005, ATHEROSCLEROSIS, V180, P423, DOI 10.1016/j.atherosclerosis.2005.01.046; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; de Groot K, 2005, TRANSPLANTATION, V79, P941, DOI 10.1097/00007890-200504270-00012; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; Farris AB, 2011, AM J TRANSPLANT, V11, P1464, DOI 10.1111/j.1600-6143.2011.03572.x; Furuichi K, 2006, AM J PATHOL, V169, P372, DOI 10.2353/ajpath.2006.060043; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Hidalgo LG, 2010, AM J TRANSPLANT, V10, P1812, DOI 10.1111/j.1600-6143.2010.03201.x; Hoffmann U, 2010, TRANSPL IMMUNOL, V23, P204, DOI 10.1016/j.trim.2010.06.006; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jie KE, 2010, NEPHROL DIAL TRANSPL, V25, P1875, DOI 10.1093/ndt/gfp749; Jourde-Chiche N, 2009, J THROMB HAEMOST, V7, P1576, DOI 10.1111/j.1538-7836.2009.03540.x; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Kitchens WH, 2006, TRANSPLANTATION, V81, P811, DOI 10.1097/01.tp.0000202844.33794.0e; KUTUKCULER N, 1995, TRANSPLANT INT, V8, P45, DOI 10.1007/BF00366710; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Lagaaij EL, 2001, LANCET, V357, P33, DOI 10.1016/S0140-6736(00)03569-8; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Lavergne M, 2011, CELL PROLIFERAT, V44, P44, DOI 10.1111/j.1365-2184.2010.00722.x; Osto E, 2011, J HEART LUNG TRANSPL, V30, P70, DOI 10.1016/j.healun.2010.07.004; Quyyumi AA, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.025; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Romo N, 2011, ARTERIOSCL THROM VAS, V31, P2314, DOI 10.1161/ATVBAHA.111.233288; Scandling JD, 2008, NEW ENGL J MED, V358, P362, DOI 10.1056/NEJMoa074191; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shimizu A, 2000, CLIN TRANSPLANT, V14, P6, DOI 10.1034/j.1399-0012.2000.0140s3006.x; Shimizu K, 2011, HYPERTENS RES, V34, P747, DOI 10.1038/hr.2011.23; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Tongers J, 2007, J AM SOC NEPHROL, V18, P2843, DOI 10.1681/ASN.2007050597; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Whitman SC, 2004, ARTERIOSCL THROM VAS, V24, P1049, DOI 10.1161/01.ATV.0000124923.95545.2c; Yoneda O, 2000, J IMMUNOL, V164, P4055, DOI 10.4049/jimmunol.164.8.4055; Yoneda O, 2003, EUR J IMMUNOL, V33, P53, DOI 10.1002/immu.200390007; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	43	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26663	10.1371/journal.pone.0026663	http://dx.doi.org/10.1371/journal.pone.0026663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039526	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200038
J	Diaz-Sylvester, PL; Porta, M; Copello, JA				Diaz-Sylvester, Paula L.; Porta, Maura; Copello, Julio A.			Modulation of Cardiac Ryanodine Receptor Channels by Alkaline Earth Cations	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNELS; RETICULUM LUMENAL CA2+; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; LUMINAL CA2+; DIVALENT-CATIONS; VENTRICULAR MYOCYTES; INACTIVATION SITES; CYTOSOLIC CA2+; SINGLE-CHANNEL	Cardiac ryanodine receptor (RyR2) function is modulated by Ca2+ and Mg2+. To better characterize Ca2+ and Mg2+ binding sites involved in RyR2 regulation, the effects of cytosolic and luminal earth alkaline divalent cations (M2+: Mg2+, Ca2+, Sr2+, Ba2+) were studied on RyR2 from pig ventricle reconstituted in bilayers. RyR2 were activated by M2+ binding to high affinity activating sites at the cytosolic channel surface, specific for Ca2+ or Sr2+. This activation was interfered by Mg2+ and Ba2+ acting at low affinity M2+-unspecific binding sites. When testing the effects of luminal M2+ as current carriers, all M2+ increased maximal RyR2 open probability (compared to Cs+), suggesting the existence of low affinity activating M2+-unspecific sites at the luminal surface. Responses to M2+ vary from channel to channel (heterogeneity). However, with luminal Ba2+ or Mg2+, RyR2 were less sensitive to cytosolic Ca2+ and caffeine-mediated activation, openings were shorter and voltage-dependence was more marked (compared to RyR2 with luminal Ca2+ or Sr2+). Kinetics of RyR2 with mixtures of luminal Ba2+/Ca2+ and additive action of luminal plus cytosolic Ba2+ or Mg2+ suggest luminal M2+ differentially act on luminal sites rather than accessing cytosolic sites through the pore. This suggests the presence of additional luminal activating Ca2+/Sr2+-specific sites, which stabilize high Po mode (less voltage-dependent) and increase RyR2 sensitivity to cytosolic Ca2+ activation. In summary, RyR2 luminal and cytosolic surfaces have at least two sets of M2+ binding sites (specific for Ca2+ and unspecific for Ca2+/Mg2+) that dynamically modulate channel activity and gating status, depending on SR voltage.	[Diaz-Sylvester, Paula L.; Copello, Julio A.] So Illinois Sch Med, Dept Pharmacol, Springfield, IL USA; [Porta, Maura] Midwestern Univ, Dept Physiol, Downers Grove, IL 60515 USA	Southern Illinois University System; Southern Illinois University; Midwestern University	Diaz-Sylvester, PL (corresponding author), So Illinois Sch Med, Dept Pharmacol, Springfield, IL USA.	jcopello@siumed.edu		Diaz-Sylvester, Paula/0000-0002-1531-1958	National Institutes of Health [R01 GM078665]; Bernie L. Eskridge Heart Disease Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bernie L. Eskridge Heart Disease Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01 GM078665 to JAC) and by the Bernie L. Eskridge Heart Disease Research Fund (to JAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON K, 1989, J BIOL CHEM, V264, P1329; Armisen R, 1996, AM J PHYSIOL-CELL PH, V271, pC144, DOI 10.1152/ajpcell.1996.271.1.C144; Beard NA, 2005, BIOPHYS J, V88, P3444, DOI 10.1529/biophysj.104.051441; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Carafoli E, 1999, CALCIUM CELLULAR REG, Vxiii; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602; Ching LL, 2000, CIRC RES, V87, P201, DOI 10.1161/01.RES.87.3.201; CHU A, 1993, J MEMBRANE BIOL, V135, P49; Copello JA, 2002, J MEMBRANE BIOL, V187, P51, DOI 10.1007/s00232-001-0150-x; Copello JA, 1997, BIOPHYS J, V73, P141, DOI 10.1016/S0006-3495(97)78055-X; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Diaz-Sylvester P, 2010, BIOPHYSICAL J, V98; Diaz-Sylvester PL, 2002, BIOPHYS J, V82, p74A; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gaburjakova J, 2006, J MEMBRANE BIOL, V212, P17, DOI 10.1007/s00232-006-7018-z; HOLMBERG SRM, 1990, BIOCHIM BIOPHYS ACTA, V1022, P187, DOI 10.1016/0005-2736(90)90113-3; Hu XF, 2003, BIOCHEMISTRY-US, V42, P5515, DOI 10.1021/bi034016o; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Lancaster B, 2000, J PHYSIOL-LONDON, V522, P231, DOI 10.1111/j.1469-7793.2000.t01-1-00231.x; Laver DR, 2008, J GEN PHYSIOL, V132, P429, DOI 10.1085/jgp.200810001; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202; LAVER DR, 1995, J MEMBRANE BIOL, V147, P7; Liu W, 1998, AM J PHYSIOL-CELL PH, V274, pC120, DOI 10.1152/ajpcell.1998.274.1.C120; Liu YW, 2010, J GEN PHYSIOL, V135, P15, DOI 10.1085/jgp.200910273; Lukyanenko V, 1996, PFLUG ARCH EUR J PHY, V432, P1047, DOI 10.1007/s004240050233; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; McHugh JM, 2004, AM J PHYSIOL-CELL PH, V286, pC342, DOI 10.1152/ajpcell.00270.2003; Mead-Savery FC, 2009, BIOPHYS J, V96, P1374, DOI 10.1016/j.bpj.2008.10.054; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Porta M, 2004, BIOPHYS J, V86, p241A; Porta M, 2011, BIOPHYS J, V100, P931, DOI 10.1016/j.bpj.2011.01.017; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Rosales RA, 2004, J GEN PHYSIOL, V123, P533, DOI 10.1085/jgp.200308868; ROUSSEAU E, 1986, BIOPHYS J, V50, P1009, DOI 10.1016/S0006-3495(86)83543-3; ROUSSEAU E, 1992, CAN J PHYSIOL PHARM, V70, P394, DOI 10.1139/y92-049; Shelley C, 2010, J GEN PHYSIOL, V135, P461, DOI 10.1085/jgp.200910331; Sitsapesan R, 1997, J MEMBRANE BIOL, V159, P179, DOI 10.1007/s002329900281; Sitsapesan R, 1999, STRUCTURE FUNCTION R; Sitsapesan R, 1998, STRUCTURE FUNCTION R, Vxvii; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Xu L, 1998, BIOPHYS J, V75, P2302, DOI 10.1016/S0006-3495(98)77674-X; Zahradnikova A, 1995, BIOPHYS J, V69, P1780, DOI 10.1016/S0006-3495(95)80048-2; Zoghbi ME, 2004, CELL CALCIUM, V36, P119, DOI 10.1016/j.ceca.2004.01.023	48	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26693	10.1371/journal.pone.0026693	http://dx.doi.org/10.1371/journal.pone.0026693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039534	Green Submitted, gold, Green Published			2022-12-25	WOS:000296513200043
J	Lebarbenchon, C; Yang, M; Keeler, SP; Ramakrishnan, MA; Brown, JD; Stallknecht, DE; Sreevatsan, S				Lebarbenchon, Camille; Yang, My; Keeler, Shamus P.; Ramakrishnan, Muthannan A.; Brown, Justin D.; Stallknecht, David E.; Sreevatsan, Srinand			Viral Replication, Persistence in Water and Genetic Characterization of Two Influenza A Viruses Isolated from Surface Lake Water	PLOS ONE			English	Article							AVIAN INFLUENZA; BORNE TRANSMISSION; SEQUENCES; DYNAMICS; DUCKS; PCR; AMPLIFICATION; INFECTIVITY; TEMPERATURE; RESERVOIRS	Water-borne transmission has been suggested as an important transmission mechanism for Influenza A (IA) viruses in wild duck populations; however, relatively few studies have attempted to detect IA viruses from aquatic habitats. Water-isolated viruses have rarely been genetically characterized and evaluation for persistence in water and infectivity in natural hosts has never been documented. In this study, we focused on two IA viruses (H3N8 and H4N6 subtypes) isolated from surface lake water in Minnesota, USA. We investigated the relative prevalence of the two virus subtypes in wild duck populations at the sampling site and their genetic relatedness to IA viruses isolated in wild waterbirds in North America. Viral persistence under different laboratory conditions (temperature and pH) and replication in experimentally infected Mallards (Anas platyrhynchos) were also characterized. Both viruses were the most prevalent subtype one year following their isolation in lake water. The viruses persisted in water for an extended time period at constant temperature (several weeks) but infectivity rapidly reduced under multiple freeze-thaw cycles. Furthermore, the two isolates efficiently replicated in Mallards. The complete genome characterization supported that these isolates originated from genetic reassortments with other IA viruses circulating in wild duck populations during the year of sampling. Based on phylogenetic analyses, we couldn't identify genetically similar viruses in duck populations in the years following their isolation from lake water. Our study supports the role for water-borne transmission for IA viruses but also highlights that additional field and experimental studies are required to support inter-annual persistence in aquatic habitats.	[Lebarbenchon, Camille; Keeler, Shamus P.; Brown, Justin D.; Stallknecht, David E.] Univ Georgia, Coll Vet Med, SE Cooperat Wildlife Dis Study, Dept Populat Hlth, Athens, GA 30602 USA; [Yang, My; Ramakrishnan, Muthannan A.; Sreevatsan, Srinand] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA	University System of Georgia; University of Georgia; University of Minnesota System; University of Minnesota Twin Cities	Lebarbenchon, C (corresponding author), Univ Georgia, Coll Vet Med, SE Cooperat Wildlife Dis Study, Dept Populat Hlth, Athens, GA 30602 USA.	cleb@uga.edu	Keeler, Shamus/A-3237-2013; Lebarbenchon, Camille/H-7245-2013; Sreevatsan, Srinand/V-6808-2019; Keeler, Shamus/ABC-1774-2020; Ramakrishnan, Muthannan Andavar/Y-3338-2019; Lebarbenchon, Camille/GLQ-7287-2022	Lebarbenchon, Camille/0000-0002-0922-7573; Sreevatsan, Srinand/0000-0002-5162-2403; Keeler, Shamus/0000-0002-1301-0852; Lebarbenchon, Camille/0000-0002-0922-7573; Ramakrishnan, Muthannan Andavar/0000-0001-7789-328X	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN266200700007C]; Center of Disease Control [1U19CI0004501]; Fondation pour la Recherche Medicale; CLINICAL CENTER [Z01CL000045] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center of Disease Control; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CLINICAL CENTER	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, under Contract No. HHSN266200700007C. The 2006 data were collected under Cooperative Agreement 1U19CI0004501 with the Center of Disease Control. CL was supported by a 'Fondation pour la Recherche Medicale' post-doctoral fellowship during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Domanska-Blicharz K, 2010, AVIAN DIS, V54, P734, DOI 10.1637/8786-040109-ResNote.1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faust C, 2009, P ROY SOC B-BIOL SCI, V276, P3727, DOI 10.1098/rspb.2009.0572; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; HALVORSON D, 1983, AVIAN DIS, V27, P77, DOI 10.2307/1590374; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; MARKWELL DD, 1982, APPL ENVIRON MICROB, V43, P110, DOI 10.1128/AEM.43.1.110-115.1982; Nazir J, 2010, AVIAN DIS, V54, P720, DOI 10.1637/8754-033109-ResNote.1; R Development Core Team, 2009, R FDN STAT COMP; Ramakrishnan MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007105; Rambaut A., 2007, TRACER V1 5; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; SIVANANDAN V, 1991, AVIAN DIS, V35, P974, DOI 10.2307/1591638; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Stumpf P, 2010, AVIAN DIS, V54, P1183, DOI 10.1637/9162-111709-Reg.1; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swayne D. E., 2008, LAB MANUAL ISOLATION, P128; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Zarkov IS, 2006, REV MED VET-TOULOUSE, V157, P471; Zhang HB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-42; Zhang HB, 2011, ARCH VIROL, V156, P95, DOI 10.1007/s00705-010-0836-4; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	44	49	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26566	10.1371/journal.pone.0026566	http://dx.doi.org/10.1371/journal.pone.0026566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028909	gold, Green Submitted, Green Published			2022-12-25	WOS:000296510800054
J	Ji, HK; Wu, G; Zhan, XC; Nolan, A; Koh, C; De Marzo, A; Doan, HM; Fan, JS; Cheadle, C; Fallahi, M; Cleveland, JL; Dang, CV; Zeller, KI				Ji, Hongkai; Wu, George; Zhan, Xiangcan; Nolan, Alexandra; Koh, Cheryl; De Marzo, Angelo; Hoang Mai Doan; Fan, Jinshui; Cheadle, Christopher; Fallahi, Mohammad; Cleveland, John L.; Dang, Chi V.; Zeller, Karen I.			Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation	PLOS ONE			English	Article							PROTEIN-KINASE-A; C-MYC; TRANSCRIPTIONAL NETWORK; RIBOSOME BIOGENESIS; GENOMIC TARGETS; STEM-CELLS; RNA; DIFFERENTIATION; EXPRESSION; CYCLE	The functions of key oncogenic transcription factors independent of context have not been fully delineated despite our richer understanding of the genetic alterations in human cancers. The MYC oncogene, which produces the Myc transcription factor, is frequently altered in human cancer and is a major regulatory hub for many cancers. In this regard, we sought to unravel the primordial signature of Myc function by using high-throughput genomic approaches to identify the cell-type independent core Myc target gene signature. Using a model of human B lymphoma cells bearing inducible MYC, we identified a stringent set of direct Myc target genes via chromatin immunoprecipitation (ChIP), global nuclear run-on assay, and changes in mRNA levels. We also identified direct Myc targets in human embryonic stem cells (ESCs). We further document that a Myc core signature (MCS) set of target genes is shared in mouse and human ESCs as well as in four other human cancer cell types. Remarkably, the expression of the MCS correlates with MYC expression in a cell-type independent manner across 8,129 microarray samples, which include 312 cell and tissue types. Furthermore, the expression of the MCS is elevated in vivo in Em-Myc transgenic murine lymphoma cells as compared with premalignant or normal B lymphocytes. Expression of the MCS in human B cell lymphomas, acute leukemia, lung cancers or Ewing sarcomas has the highest correlation with MYC expression. Annotation of this gene signature reveals Myc's primordial function in RNA processing, ribosome biogenesis and biomass accumulation as its key roles in cancer and stem cells.	[Ji, Hongkai; Wu, George] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Zhan, Xiangcan] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Zhan, Xiangcan] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD USA; [Nolan, Alexandra; Hoang Mai Doan; Fan, Jinshui; Cheadle, Christopher; Zeller, Karen I.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Koh, Cheryl; De Marzo, Angelo] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fallahi, Mohammad; Cleveland, John L.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Dang, Chi V.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Scripps Research Institute; University of Pennsylvania; Pennsylvania Medicine	Ji, HK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.	hji@jhsph.edu; dangvchi@exchange.upenn.edu; kzeller@jhmi.edu	Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522	NIH [R01CA57341, CA076379, DK44158, R01HG005220]; Maryland Stem Cell Research Fund [007-MSCRFE-0167-00, 2008-MSCRFE-0156-00]; State of Florida; NATIONAL CANCER INSTITUTE [R01CA057341, R01CA076379] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044158] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund; State of Florida; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01CA57341 to CVD, Maryland Stem Cell Research Fund grants 2007-MSCRFE-0167-00 (KIZ) and 2008-MSCRFE-0156-00 (CVD) and NIH grants CA076379 and DK44158 to JLC, and by monies from the State of Florida to Scripps Florida to JLC. HJ is partially supported by NIH grant R01HG005220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 2005, CANCER RES, V65, P8754, DOI 10.1158/0008-5472.CAN-04-3569; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Berta MA, 2010, EMBO MOL MED, V2, P16, DOI 10.1002/emmm.200900047; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Carrour TL, 2010, OPEN BIOINFORMATICS, V4, P5, DOI [10.2174/1875036201004010005, DOI 10.2174/1875036201004010005]; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Hartl M, 2010, P NATL ACAD SCI USA, V107, P4051, DOI 10.1073/pnas.0911060107; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koh CM, 2011, AM J PATHOL, V178, P1824, DOI 10.1016/j.ajpath.2010.12.040; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-7; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lippman SI, 2009, P NATL ACAD SCI USA, V106, P19928, DOI 10.1073/pnas.0907027106; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; PLOTON D, 1986, HISTOCHEM J, V18, P5, DOI 10.1007/BF01676192; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; ROSENBLOOM KR, NUCL ACIDS RES, V38, pD620; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; SHEINESS D, 1979, J VIROL, V31, P514, DOI 10.1128/JVI.31.2.514-521.1979; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	62	116	117	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26057	10.1371/journal.pone.0026057	http://dx.doi.org/10.1371/journal.pone.0026057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039435	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500030
J	Wang, J; Wu, YX; Ren, GP; Guo, QH; Liu, JQ; Lascoux, M				Wang, Juan; Wu, Yuxia; Ren, Guangpeng; Guo, Qiuhong; Liu, Jianquan; Lascoux, Martin			Genetic Differentiation and Delimitation between Ecologically Diverged Populus euphratica and P. pruinosa	PLOS ONE			English	Article							POPULATION-STRUCTURE; DNA VARIATION; CHLOROPLAST; NUCLEAR; POPLAR; INTROGRESSION; HYBRIDIZATION; MITOCHONDRIAL; RATES; FLOW	Background: The fixed genetic differences between ecologically divergent species were found to change greatly depending on the markers examined. With such species it is difficult to differentiate between shared ancestral polymorphisms and past introgressions between the diverging species. In order to disentangle these possibilities and provide a further case for DNA barcoding of plants, we examine genetic differentiation between two ecologically divergent poplar species, Populus euphratica Oliver and P. pruinosa Schrenk using three different types of genetic marker. Methodology/Principal Findings: We genotyped 290 individuals from 29 allopatric and sympatric populations, using chloroplast (cp) DNA, nuclear (nr) ITS sequences and eight simple sequence repeat (SSR) loci. Three major cpDNA haplotypes were widely shared between the two species and between-species cpDNA differentiation (FCT) was very low, even lower than among single species populations. The average SSR FCT values were higher. Bayesian clustering analysis of all loci allowed a clear delineation of the two species. Gene flow, determined by examining all SSR loci, was obvious but only slightly asymmetrical. However, the two species were almost fixed for two different nrITS genotypes that had the highest FCT, although a few introgressed individuals were detected both in allopatric and sympatric populations. Conclusions: The two species shared numerous ancestral polymorphisms at cpDNA and a few SSR loci. Both ITS and a combination of nuclear SSR data could be used to differentiate between the two species. Introgressions and gene flow were obvious between the two species either during or after their divergence. Our findings underscore the complex genetic differentiations between ecologically diverged species and highlight the importance of nuclear DNA (especially ITS) differentiation for delimiting closely related plant species.	[Wang, Juan; Wu, Yuxia; Ren, Guangpeng; Guo, Qiuhong; Liu, Jianquan] Lanzhou Univ, State Key Lab Grassland Farming Syst, Mol Ecol Grp, Lanzhou 730000, Gansu, Peoples R China; [Lascoux, Martin] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Lab Evolutionary Genom, Shanghai, Peoples R China; [Lascoux, Martin] Uppsala Univ, Evolutionary Biol Ctr, Program Evolutionary Funct Genom, Uppsala, Sweden	Lanzhou University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Uppsala University	Wang, J (corresponding author), Lanzhou Univ, State Key Lab Grassland Farming Syst, Mol Ecol Grp, Lanzhou 730000, Gansu, Peoples R China.	liujq@nwipb.ac.cn	Ren, Guangpeng/HHC-4750-2022	Ren, Guangpeng/0000-0002-4052-9115; Lascoux, Martin/0000-0003-1699-9042	Natural Science Foundation of China [30725004, 30430560]; National Key Project for Basic Research	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Basic Research(National Basic Research Program of China)	This research was supported by grants from the Natural Science Foundation of China (Grant numbers 30725004, 30430560) and the National Key Project for Basic Research to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ML is part of the Evoltree Network of Excellence and would like to thank the Chinese Academy of Sciences for granting him a Visiting Professorship in 2010-2011 and HL his hospitality in Shanghai.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dickmann D, 2008, POPLARS WILLOWS WORL; Ding MQ, 2010, PLANT MOL BIOL, V73, P251, DOI 10.1007/s11103-010-9612-9; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; DU FK, 2011, NEW PHYTOL IN PRESS; Edwards CE, 2008, MOL ECOL, V17, P5157, DOI 10.1111/j.1365-294X.2008.03985.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Hamilton MB, 1999, MOL ECOL, V8, P521; Hamzeh M, 2007, CAN J BOT, V85, P1227, DOI 10.1139/B07-105; Hoelzer GA, 1997, EVOLUTION, V51, P622, DOI 10.1111/j.1558-5646.1997.tb02451.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kikuchi R, 2010, NEW PHYTOL, V188, P879, DOI 10.1111/j.1469-8137.2010.03398.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; Li Li, 2006, Forestry Studies in China, V8, P10, DOI 10.1007/s11632-006-0002-y; Liu PX, 2007, J INTEGR PLANT BIOL, V49, P150, DOI 10.1111/j.1744-7909.2007.00425.x; MA C, 1997, FOREST ECOL MANAG, V93, P56; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; McKinnon GE, 2010, MOL ECOL, V19, P1367, DOI 10.1111/j.1365-294X.2010.04579.x; McKinnon GE, 2004, PHILOS T R SOC B, V359, P275, DOI 10.1098/rstb.2003.1391; McKinnon GE, 2001, EVOLUTION, V55, P703, DOI 10.1554/0014-3820(2001)055[0703:CSITTE]2.0.CO;2; Mims MC, 2010, MOL ECOL, V19, P940, DOI 10.1111/j.1365-294X.2010.04529.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Okumura S, 2006, TRANSGENIC RES, V15, P637, DOI 10.1007/s11248-006-9009-3; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Palme AE, 2004, MOL ECOL, V13, P167, DOI 10.1046/j.1365-294X.2003.02034.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Petit RJ, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P23, DOI 10.1007/1-4020-4904-8_2; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Polezhaeva MA, 2010, MOL ECOL, V19, P1239, DOI 10.1111/j.1365-294X.2010.04552.x; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rottenberg A, 2000, CAN J FOREST RES, V30, P482, DOI 10.1139/cjfr-30-3-482; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Schemske DW, 2010, AM NAT, V176, pS4, DOI 10.1086/657060; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schnittler M, 2010, EVOL ECOL, V24, P1417, DOI 10.1007/s10682-010-9389-y; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOLLEFSRUD MM, 2008, THESIS OSLO U; WANG J, 2011, ANN FOR SCI; WANG J, 2011, HEREDITY IN PRESS; Wang RG, 2008, TREE PHYSIOL, V28, P947, DOI 10.1093/treephys/28.6.947; Wang RG, 2007, TREES-STRUCT FUNCT, V21, P581, DOI 10.1007/s00468-007-0154-y; WANG SJ, 1995, EUPHRATES POPLAR FOR, P12; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; Weisgerber H, 2001, FOREST CHRON, V77, P227, DOI 10.5558/tfc77227-2; Wendel J. F, 1998, MOL SYSTEMATICS PLAN, P265, DOI DOI 10.1007/978-1-4615-5419-6_10; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright S, 1943, GENETICS, V28, P139; WRIGHT S, 1943, GENETICS, V28, P515; Wu YX, 2008, MOL ECOL RESOUR, V8, P1142, DOI 10.1111/j.1755-0998.2008.02202.x; Wu YX, 2007, PLANT MOL BIOL, V65, P1, DOI 10.1007/s11103-007-9170-y; Zhang F, 2007, PLANT CELL ENVIRON, V30, P775, DOI 10.1111/j.1365-3040.2007.01667.x; Zhang H, 2003, J ARID ENVIRON, V55, P545, DOI 10.1016/S0140-1963(02)00283-5; Zhou YF, 2010, EVOLUTION, V64, P2342, DOI 10.1111/j.1558-5646.2010.00988.x	72	38	45	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26530	10.1371/journal.pone.0026530	http://dx.doi.org/10.1371/journal.pone.0026530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028897	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500084
J	Zhao, T; Krokene, P; Hu, J; Christiansen, E; Bjorklund, N; Langstrom, B; Solheim, H; Borg-Karlson, AK				Zhao, Tao; Krokene, Paal; Hu, Jiang; Christiansen, Erik; Bjorklund, Niklas; Langstrom, Bo; Solheim, Halvor; Borg-Karlson, Anna-Karin			Induced Terpene Accumulation in Norway Spruce Inhibits Bark Beetle Colonization in a Dose-Dependent Manner	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; METHYL JASMONATE; PICEA-ABIES; CERATOCYSTIS-POLONICA; INDUCED RESPONSES; FUNGAL-INFECTION; MONOTERPENE CONCENTRATIONS; ENANTIOMERIC COMPOSITION; DISEASE RESISTANCE; CHEMICAL DEFENSES	Background: Tree-killing bark beetles (Coleoptera, Scolytinae) are among the most economically and ecologically important forest pests in the northern hemisphere. Induction of terpenoid-based oleoresin has long been considered important in conifer defense against bark beetles, but it has been difficult to demonstrate a direct correlation between terpene levels and resistance to bark beetle colonization. Methods: To test for inhibitory effects of induced terpenes on colonization by the spruce bark beetle Ips typographus (L.) we inoculated 20 mature Norway spruce Picea abies (L.) Karsten trees with a virulent fungus associated with the beetle, Ceratocystis polonica (Siem.) C. Moreau, and investigated induced terpene levels and beetle colonization in the bark. Results: Fungal inoculation induced very strong and highly variable terpene accumulation 35 days after inoculation. Trees with high induced terpene levels (n = 7) had only 4.9% as many beetle attacks (5.1 vs. 103.5 attacks m(-2)) and 2.6% as much gallery length (0.029 m m(-2) vs. 1.11 m m(-2)) as trees with low terpene levels (n = 6). There was a highly significant rank correlation between terpene levels at day 35 and beetle colonization in individual trees. The relationship between induced terpene levels and beetle colonization was not linear but thresholded: above a low threshold concentration of similar to 100 mg terpene g(-1) dry phloem trees suffered only moderate beetle colonization, and above a high threshold of similar to 200 mg terpene g(-1) dry phloem trees were virtually unattacked. Conclusion/Significance: This is the first study demonstrating a dose-dependent relationship between induced terpenes and tree resistance to bark beetle colonization under field conditions, indicating that terpene induction may be instrumental in tree resistance. This knowledge could be useful for developing management strategies that decrease the impact of tree-killing bark beetles.	[Zhao, Tao; Hu, Jiang; Borg-Karlson, Anna-Karin] Royal Inst Technol, Ecol Chem Grp, Dept Chem, Stockholm, Sweden; [Krokene, Paal; Christiansen, Erik; Solheim, Halvor] Norwegian Forest & Landscape Inst, As, Norway; [Bjorklund, Niklas; Langstrom, Bo] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Royal Institute of Technology; The Norwegian Forest & Landscape Institute; Swedish University of Agricultural Sciences	Zhao, T (corresponding author), Royal Inst Technol, Ecol Chem Grp, Dept Chem, Stockholm, Sweden.	akbk@kth.se	Björklund, Niklas/F-2220-2011; Björklund, Niklas/J-7812-2015; Solheim, Halvor/N-9691-2013; Bjørklund, Geir/B-7319-2014; Krokene, Paal/A-1835-2008	Björklund, Niklas/0000-0001-8526-407X; Björklund, Niklas/0000-0001-8526-407X; Solheim, Halvor/0000-0002-6808-1615; Bjørklund, Geir/0000-0003-2632-3935; Krokene, Paal/0000-0002-7205-0715; Zhao, Tao/0000-0001-5909-2841	FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning); Swedish University of Agriculture Sciences; Norwegian Forest and Landscape Institute	FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas); Swedish University of Agriculture Sciences; Norwegian Forest and Landscape Institute	This study was supported by FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning), the Swedish University of Agriculture Sciences and Norwegian Forest and Landscape Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2009, CAN J FOREST RES, V39, P1133, DOI 10.1139/X09-034; Bakke A., 1983, Meddelelser fra Norsk Institutt for Skogforskning, V38, P1; BORGKARLSON AK, 1993, ACTA CHEM SCAND, V47, P138, DOI 10.3891/acta.chem.scand.47-0138; BRIGNOLAS F, 1995, PLANT PHYSIOL, V109, P821, DOI 10.1104/pp.109.3.821; Christiansen E, 1999, TREE PHYSIOL, V19, P399; Christiansen E., 1988, P479; COOK SP, 1988, J ENTOMOL SCI, V23, P287, DOI 10.18474/0749-8004-23.3.287; Erbilgin N, 2003, AGR FOREST ENTOMOL, V5, P269, DOI 10.1046/j.1461-9563.2003.00186.x; Erbilgin N, 2006, OECOLOGIA, V148, P426, DOI 10.1007/s00442-006-0394-3; Erbilgin N, 2009, AGR FOREST ENTOMOL, V11, P255, DOI 10.1111/j.1461-9563.2009.00435.x; Faldt J, 2006, J CHEM ECOL, V32, P1779, DOI 10.1007/s10886-006-9109-9; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Franceschi VR, 2002, AM J BOT, V89, P578, DOI 10.3732/ajb.89.4.578; Jost RW, 2008, J WOOD CHEM TECHNOL, V28, P37, DOI 10.1080/02773810801916407; Kane JM, 2010, OECOLOGIA, V164, P601, DOI 10.1007/s00442-010-1683-4; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; Klepzig KD, 1996, J CHEM ECOL, V22, P1367, DOI 10.1007/BF02027719; Klepzig KD, 2005, TREE PHYSIOL, V25, P681, DOI 10.1093/treephys/25.6.681; KLIMETZEK D, 1980, EXPERIENTIA, V36, P1343, DOI 10.1007/BF01960087; Kopper BJ, 2005, ENVIRON ENTOMOL, V34, P486, DOI 10.1603/0046-225X-34.2.486; Krokene P, 1996, CAN J FOREST RES, V26, P2115, DOI 10.1139/x26-240; Krokene P, 1998, PHYTOPATHOLOGY, V88, P39, DOI 10.1094/PHYTO.1998.88.1.39; Krokene P, 2003, TREE PHYSIOL, V23, P191, DOI 10.1093/treephys/23.3.191; Krokene P, 2001, PLANT PATHOL, V50, P230, DOI 10.1046/j.1365-3059.2001.00559.x; Krokene P, 1999, PLANT PHYSIOL, V121, P565, DOI 10.1104/pp.121.2.565; Krokene P, 2000, EUR J PLANT PATHOL, V106, P537, DOI 10.1023/A:1008776002248; Krokene P, 2008, TREE PHYSIOL, V28, P29, DOI 10.1093/treephys/28.1.29; Krokene Paal, 2008, P147, DOI 10.1007/978-1-4020-8182-8_7; Lieutier F, 1995, J APPL ENTOMOL, V119, P591, DOI 10.1111/j.1439-0418.1995.tb01341.x; Miller DR, 2000, CAN ENTOMOL, V132, P183, DOI 10.4039/Ent132183-2; Nagy NE, 2000, AM J BOT, V87, P302, DOI 10.2307/2656626; Nagy NE, 2004, TREE PHYSIOL, V24, P505, DOI 10.1093/treephys/24.5.505; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAFFA KF, 1983, CAN ENTOMOL, V115, P723, DOI 10.4039/Ent115723-7; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; RAFFA KF, 1982, CAN ENTOMOL, V114, P797, DOI 10.4039/Ent114797-9; RAFFA KF, 1995, OECOLOGIA, V102, P285, DOI 10.1007/BF00329795; Sandnes A, 2002, SCAND J FOREST RES, V17, P522, DOI 10.1080/02827580260417170; Seybold Steven J., 2006, Phytochemistry Reviews, V5, P143, DOI 10.1007/s11101-006-9002-8; Smith RH, 1965, J ECON ENTOMOL, P58; SOLHEIM H, 1992, EUR J FOREST PATHOL, V22, P136; SOLHEIM H, 1992, CAN J BOT, V70, P1, DOI 10.1139/b92-001; SOLHEIM H, 1991, MYCOL RES, V95, P1387, DOI 10.1016/S0953-7562(09)80390-0; Viiri H, 2001, TREES-STRUCT FUNCT, V15, P112, DOI 10.1007/s004680000082; Zeneli G, 2006, TREE PHYSIOL, V26, P977, DOI 10.1093/treephys/26.8.977; Zhao T, 2010, PHYTOCHEMISTRY, V71, P1332, DOI 10.1016/j.phytochem.2010.05.017	49	56	56	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26649	10.1371/journal.pone.0026649	http://dx.doi.org/10.1371/journal.pone.0026649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028932	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000296507500103
J	Chan, LN; Fiji, HDG; Watanabe, M; Kwon, O; Tamanoi, F				Chan, Lai N.; Fiji, Hannah D. G.; Watanabe, Masaru; Kwon, Ohyun; Tamanoi, Fuyuhiko			Identification and Characterization of Mechanism of Action of P61-E7, a Novel Phosphine Catalysis-Based Inhibitor of Geranylgeranyltransferase-I	PLOS ONE			English	Article							HIGHLY FUNCTIONALIZED TETRAHYDROPYRIDINES; FARNESYLTRANSFERASE INHIBITORS; 4+2 ANNULATION; GROWTH; CELLS; RAS; APOPTOSIS; TRANSFORMATION; ALLENOATES; CANCER	Small molecule inhibitors of protein geranylgeranyltransferase-I (GGTase-I) provide a promising type of anticancer drugs. Here, we first report the identification of a novel tetrahydropyridine scaffold compound, P61-E7, and define effects of this compound on pancreatic cancer cells. P61-E7 was identified from a library of allenoate-derived compounds made through phosphine-catalyzed annulation reactions. P61-E7 inhibits protein geranylgeranylation and blocks membrane association of geranylgeranylated proteins. P61-E7 is effective at inhibiting both cell proliferation and cell cycle progression, and it induces high p21(CIP1/WAF1) level in human cancer cells. P61-E7 also increases p27(Kip1) protein level and inhibits phosphorylation of p27(Kip1) on Thr187. We also report that P61-E7 treatment of Panc-1 cells causes cell rounding, disrupts actin cytoskeleton organization, abolishes focal adhesion assembly and inhibits anchorage independent growth. Because the cellular effects observed pointed to the involvement of RhoA, a geranylgeranylated small GTPase protein shown to influence a number of cellular processes including actin stress fiber organization, cell adhesion and cell proliferation, we have evaluated the significance of the inhibition of RhoA geranylgeranylation on the cellular effects of inhibitors of GGTase-I (GGTIs). Stable expression of farnesylated RhoA mutant (RhoA-F) results in partial resistance to the anti-proliferative effect of P61-E7 and prevents induction of p21(CIP1/WAF1) and p27(Kip1) by P61-E7 in Panc-1 cells. Moreover, stable expression of RhoA-F rescues Panc-1 cells from cell rounding and inhibition of focal adhesion formation caused by P61-E7. Taken together, these findings suggest that P61-E7 is a promising GGTI compound and that RhoA is an important target of P61-E7 in Panc-1 pancreatic cancer cells.	[Chan, Lai N.; Watanabe, Masaru; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Chan, Lai N.; Kwon, Ohyun; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Fiji, Hannah D. G.; Kwon, Ohyun] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chan, LN (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	fuyut@microbio.ucla.edu			National Institutes of Health (NIH) [CA41996, GM071779, GM081282, GM07185]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071779, P41GM081282, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grants CA41996, GM071779, GM081282 and GM07185. The funders had no role in study design, data collection and analysis, decision to publish. or preparation of the manuscript.	Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Allal C, 2002, CELL CYCLE, V1, P430, DOI 10.4161/cc.1.6.272; Andrews IP, 2011, ORG SYNTH, V88, P138, DOI 10.15227/orgsyn.088.0138; Castellano S, 2007, J AM CHEM SOC, V129, P5843, DOI 10.1021/ja070274n; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Creech GS, 2008, TETRAHEDRON, V64, P6935, DOI 10.1016/j.tet.2008.04.075; Creech GS, 2008, ORG LETT, V10, P429, DOI 10.1021/ol702462w; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Gau CL, 2005, MOL CANCER THER, V4, P918, DOI 10.1158/1535-7163.MCT-04-0347; Guo HC, 2009, J AM CHEM SOC, V131, P6318, DOI 10.1021/ja8097349; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hirai A, 1997, J BIOL CHEM, V272, P13; Hu WM, 1999, J BIOL CHEM, V274, P3396, DOI 10.1074/jbc.274.6.3396; Joyce PL, 2003, CANCER RES, V63, P7959; Kato-Stankiewicz J, 2002, P NATL ACAD SCI USA, V99, P14398, DOI 10.1073/pnas.222222699; Kazi A, 2009, MOL CELL BIOL, V29, P2254, DOI 10.1128/MCB.01029-08; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lu J, 2009, MOL CANCER THER, V8, P1218, DOI 10.1158/1535-7163.MCT-08-1122; Lu K, 2009, ORG SYNTH, V86, P212, DOI 10.15227/orgsyn.086.0212; Miquel K, 1997, CANCER RES, V57, P1846; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Peterson YK, 2006, J BIOL CHEM, V281, P12445, DOI 10.1074/jbc.M600168200; Peterson YK, 2009, J MED CHEM, V52, P4210, DOI 10.1021/jm8013772; Sarma KD, 2006, EUR J ORG CHEM, P3730, DOI DOI 10.1002/EJ0C.200600153; Sebti SM, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2003.12.012; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Sun JZ, 2003, CANCER RES, V63, P8922; Sun JZ, 1999, CANCER RES, V59, P4919; Sun JZ, 1998, ONCOGENE, V16, P1467, DOI 10.1038/sj.onc.1201656; Sung JZ, 1999, J BIOL CHEM, V274, P6930; Tamanoi F., 2001, ENZYMES, V21; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Tran YS, 2007, J AM CHEM SOC, V129, P12632, DOI 10.1021/ja0752181; Vasudevan A, 1999, J MED CHEM, V42, P1333, DOI 10.1021/jm9900873; Watanabe M, 2008, J BIOL CHEM, V283, P9571, DOI 10.1074/jbc.M706229200; Wittchen Erika S, 2011, Small GTPases, V2, P65; Zhu XF, 2005, TETRAHEDRON, V61, P6276, DOI 10.1016/j.tet.2005.03.104; Zhu XF, 2005, ORG LETT, V7, P2977, DOI 10.1021/ol050946j; Zhu XF, 2005, ORG LETT, V7, P1387, DOI 10.1021/ol050203y; Zhu XF, 2003, J AM CHEM SOC, V125, P4716, DOI 10.1021/ja0344009	45	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26135	10.1371/journal.pone.0026135	http://dx.doi.org/10.1371/journal.pone.0026135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028818	Green Submitted, gold, Green Published			2022-12-25	WOS:000296186900029
J	Kofstad, T; Jonassen, CM				Kofstad, Tone; Jonassen, Christine M.			Screening of Feral and Wood Pigeons for Viruses Harbouring a Conserved Mobile Viral Element: Characterization of Novel Astroviruses and Picornaviruses	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; RNA RECOMBINATION; DIVERGENT PICORNAVIRUS; DIVERSE ASTROVIRUSES; ENTRY SITES; ANSER-ANSER; SEQUENCE; TURKEY; ENTEROVIRUS; IDENTIFICATION	A highly conserved RNA-motif of yet unknown function, called stem-loop-2-like motif (s2m), has been identified in the 39 end of the genomes of viruses belonging to different RNA virus families which infect a broad range of mammal and bird species, including Astroviridae, Picornaviridae, Coronaviridae and Caliciviridae. Since s2m is such an extremely conserved motif, it is an ideal target for screening for viruses harbouring it. In this study, we have detected and characterized novel viruses harbouring this motif in pigeons by using a s2m-specific amplification. 84% and 67% of the samples from feral pigeons and wood pigeons, respectively, were found to contain a virus harbouring s2m. Four novel viruses were identified and characterized. Two of the new viruses belong to the genus Avastrovirus in the Astroviridae family. We propose two novel species to be included in this genus, Feral pigeon astrovirus and Wood pigeon astrovirus. Two other novel viruses, Pigeon picornavirus A and Pigeon picornavirus B, belong to the Picornaviridae family, presumably to the genus Sapelovirus. Both of the novel picornaviruses harboured two adjacent s2m, called (s2m) 2, suggesting a possible increased functional effect of s2m when present in two copies.	[Kofstad, Tone; Jonassen, Christine M.] Natl Vet Inst, Dept Lab Serv, Oslo, Norway; [Jonassen, Christine M.] Akershus Univ Hosp, Div Diagnost & Technol, Lorenskog, Norway	Norwegian Veterinary Institute; University of Oslo	Kofstad, T (corresponding author), Natl Vet Inst, Dept Lab Serv, Oslo, Norway.	cjon@ahus.no						Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; Chard LS, 2006, J VIROL, V80, P1271, DOI 10.1128/JVI.80.3.1271-1279.2006; Chetverin AB, 1997, CELL, V88, P503, DOI 10.1016/S0092-8674(00)81890-5; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chu DKW, 2010, J GEN VIROL, V91, P2457, DOI 10.1099/vir.0.022764-0; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Fernandez-Miragall O, 2009, VIRUS RES, V139, P172, DOI 10.1016/j.virusres.2008.07.009; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; Gallei A, 2004, J VIROL, V78, P6271, DOI 10.1128/JVI.78.12.6271-6281.2004; Gmyl AP, 2003, RNA, V9, P1221, DOI 10.1261/rna.5111803; Harris JR, 2005, J VIROL, V79, P5363, DOI 10.1128/JVI.79.9.5363-5373.2005; Hellen CUT, 2007, J VIROL, V81, P5850, DOI 10.1128/JVI.02403-06; Jonassen Christine Monceyron, 2008, V454, P27, DOI 10.1007/978-1-59745-181-9_3; Jonassen CM, 1998, J GEN VIROL, V79, P715, DOI 10.1099/0022-1317-79-4-715; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Jonassen CM, 2003, VIRUS RES, V91, P195, DOI 10.1016/S0168-1702(02)00269-1; Jonassen CM, 2001, J GEN VIROL, V82, P1061, DOI 10.1099/0022-1317-82-5-1061; Kaku Y, 2001, J GEN VIROL, V82, P417, DOI 10.1099/0022-1317-82-2-417; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Koci MD, 2000, J VIROL, V74, P6173, DOI 10.1128/JVI.74.13.6173-6177.2000; Koci MD, 2002, AVIAN PATHOL, V31, P213, DOI 10.1080/03079450220136521; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Krishna NK, 2005, VIRAL IMMUNOL, V18, P17, DOI 10.1089/vim.2005.18.17; Krumbholz A, 2002, J VIROL, V76, P5813, DOI 10.1128/JVI.76.11.5813-5821.2002; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lillehaug A, 2005, ACTA VET SCAND, V46, P193, DOI 10.1186/1751-0147-46-4-193; Mandoki M, 2006, AVIAN PATHOL, V35, P224, DOI 10.1080/03079450600711037; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Martella V, 2009, J VIROL, V83, P11391, DOI 10.1128/JVI.01385-09; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Mittelholzer C, 2003, J GEN VIROL, V84, P3087, DOI 10.1099/vir.0.19267-0; Monceyron C, 1997, ARCH VIROL, V142, P699, DOI 10.1007/s007050050112; MONCEYRON JC, 2006, DEV BIOL BASEL, V126, P161; Moser LA, 2005, VIRAL IMMUNOL, V18, P4, DOI 10.1089/vim.2005.18.4; Oberste MS, 2003, VIROLOGY, V314, P283, DOI 10.1016/S0042-6822(03)00420-3; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Pantin-Jackwood MJ, 2006, AVIAN DIS, V50, P397, DOI 10.1637/7512-020606R.1; Pantin-Jackwood MJ, 2006, VIRUS GENES, V32, P187, DOI 10.1007/s11262-005-6875-3; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; Rivera R, 2010, J GEN VIROL, V91, P166, DOI 10.1099/vir.0.015222-0; Robertson MP, 2005, PLOS BIOL, V3, P86, DOI 10.1371/journal.pbio.0030005; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Strain E, 2008, J VIROL, V82, P5099, DOI 10.1128/JVI.01993-07; Tang Y, 2005, AVIAN DIS, V49, P182, DOI 10.1637/7255-080504R; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Thiel HJ, 1999, VET MICROBIOL, V69, P55, DOI 10.1016/S0378-1135(99)00088-7; Toffan A, 2009, VET MICROBIOL, V139, P147, DOI 10.1016/j.vetmic.2009.04.031; Tseng CH, 2007, VIRUS RES, V129, P104, DOI 10.1016/j.virusres.2007.06.023; Walter JE, 2001, ARCH VIROL, V146, P2357, DOI 10.1007/s007050170008; Wang QH, 2001, J MED VIROL, V64, P245, DOI 10.1002/jmv.1043; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Wutz G, 1996, J GEN VIROL, V77, P1719, DOI 10.1099/0022-1317-77-8-1719; Zhu HC, 2009, J GEN VIROL, V90, P883, DOI 10.1099/vir.0.007732-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25964	10.1371/journal.pone.0025964	http://dx.doi.org/10.1371/journal.pone.0025964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043297	gold, Green Submitted, Green Published			2022-12-25	WOS:000295984400025
J	Njimona, I; Lamparter, T				Njimona, Ibrahim; Lamparter, Tilman			Temperature Effects on Agrobacterium Phytochrome Agp1	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; CHROMOPHORE-BINDING DOMAIN; HISTIDINE KINASE; PSEUDOMONAS-AERUGINOSA; LIGHT; PROTEIN; CYANOBACTERIAL; TUMEFACIENS; BACTERIOPHYTOCHROME; REVEALS	Phytochromes are widely distributed biliprotein photoreceptors with a conserved N-terminal chromophore-binding domain. Most phytochromes bear a light-regulated C-terminal His kinase or His kinase-like region. We investigated the effects of light and temperature on the His kinase activity of the phytochrome Agp1 from Agrobacterium tumefaciens. As in earlier studies, the phosphorylation activity of the holoprotein after far-red irradiation (where the red-light absorbing Pr form dominates) was stronger than that of the holoprotein after red irradiation (where the far red-absorbing Pfr form dominates). Phosphorylation activities of the apoprotein, far red-irradiated holoprotein, and red-irradiated holoprotein decreased when the temperature increased from 25 degrees C to 35 degrees C; at 40 degrees C, almost no kinase activity was detected. The activity of a holoprotein sample incubated at 40 degrees C was nearly completely restored when the temperature returned to 25 degrees C. UV/visible spectroscopy indicated that the protein was not denatured up to 45 degrees C. At 50 degrees C, however, Pfr denatured faster than the dark-adapted sample containing the Pr form of Agp1. The Pr visible spectrum was unaffected by temperatures of 20-45 degrees C, whereas irradiated samples exhibited a clear temperature effect in the 30-40 degrees C range in which prolonged irradiation resulted in the photoconversion of Pfr into a new spectral species termed Prx. Pfr to Prx photoconversion was dependent on the His-kinase module of Agp1; normal photoconversion occurred at 40 degrees C in the mutant Agp1-M15, which lacks the C-terminal His-kinase module, and in a domain-swap mutant in which the His-kinase module of Agp1 is replaced by the Hiskinase/response regulator module of the other A. tumefaciens phytochrome, Agp2. The temperature-dependent kinase activity and spectral properties in the physiological temperature range suggest that Agp1 serves as an integrated light and temperature sensor in A. tumefaciens.	[Njimona, Ibrahim; Lamparter, Tilman] KIT, Inst Bot, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Njimona, I (corresponding author), KIT, Inst Bot, Campus South, Karlsruhe, Germany.	tilman.lamparter@kit.edu	Lamparter, Tilman/E-4421-2013	Lamparter, Tilman/0000-0003-4327-9737	Deutsche Forschungsgemeinschaft [La 799/10-1]; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	This work was supported be the Deutsche Forschungsgemeinschaft, La 799/10-1. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Barkovits K, 2008, FEMS MICROBIOL LETT, V280, P160, DOI 10.1111/j.1574-6968.2007.01058.x; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Brandt S, 2008, J BIOL CHEM, V283, P34605, DOI 10.1074/jbc.M805506200; Braun Y, 2008, MICROBIOL-SGM, V154, P2700, DOI 10.1099/mic.0.2008/018820-0; Elich TD, 1997, CELL, V91, P713, DOI 10.1016/S0092-8674(00)80458-4; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Evans K, 2006, J MOL BIOL, V364, P655, DOI 10.1016/j.jmb.2006.09.045; FIELDING A, 1992, PHOTOCHEM PHOTOBIOL, V56, P623, DOI 10.1111/j.1751-1097.1992.tb02212.x; Foreman J, 2011, PLANT J, V65, P441, DOI 10.1111/j.1365-313X.2010.04434.x; Franklin KA, 2009, CURR OPIN PLANT BIOL, V12, P63, DOI 10.1016/j.pbi.2008.09.007; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Heath J.D., 1995, 2 COMPONENT SIGNAL T, P367; Heschel MS, 2007, NEW PHYTOL, V174, P735, DOI 10.1111/j.1469-8137.2007.02044.x; Hubschmann T, 2001, EUR J BIOCHEM, V268, P3383, DOI 10.1046/j.1432-1327.2001.02229.x; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; JIN SG, 1993, J BACTERIOL, V175, P6830, DOI 10.1128/jb.175.21.6830-6835.1993; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Kyndt JA, 2010, BIOCHEMISTRY-US, V49, P1744, DOI 10.1021/bi901591m; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2005, BIOCHEMISTRY-US, V44, P8461, DOI 10.1021/bi047510g; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Mancinelli Alberto L., 1994, P211; Mikami K, 2002, MOL MICROBIOL, V46, P905, DOI 10.1046/j.1365-2958.2002.03202.x; Mutsuda M, 2003, J BIOL CHEM, V278, P19102, DOI 10.1074/jbc.M213255200; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; Noack S, 2007, METHOD ENZYMOL, V423, P203, DOI 10.1016/S0076-6879(07)23009-5; PAYNE PI, 1972, NATURE-NEW BIOL, V235, P145, DOI 10.1038/newbio235145a0; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rottwinkel G, 2010, J BACTERIOL, V192, P5124, DOI 10.1128/JB.00672-10; Rottwinkel GStudienzuVerbreitung, THESIS KIT KARLSRUHE; Sambrook J, 2001, MOL CLONING LAB MAN; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; SCHEIBE J, 1969, PHOTOCHEM PHOTOBIOL, V9, P143, DOI 10.1111/j.1751-1097.1969.tb05918.x; SCHNEIDERPOETSCH HAW, 1992, PHOTOCHEM PHOTOBIOL, V56, P839, DOI 10.1111/j.1751-1097.1992.tb02241.x; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	48	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25977	10.1371/journal.pone.0025977	http://dx.doi.org/10.1371/journal.pone.0025977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043299	Green Published, gold			2022-12-25	WOS:000295984400027
J	Ito, K; Igarashi, M; Miyazaki, Y; Murakami, T; Iida, S; Kida, H; Takada, A				Ito, Kimihito; Igarashi, Manabu; Miyazaki, Yutaka; Murakami, Teiji; Iida, Syaka; Kida, Hiroshi; Takada, Ayato			Gnarled-Trunk Evolutionary Model of Influenza A Virus Hemagglutinin	PLOS ONE			English	Article							AMINO-ACID CHANGES; POSITIVE SELECTION; GENETIC EVOLUTION; ANTIGENIC DRIFT; H3N2; EPIDEMIC; VACCINE; DETERMINANTS; VARIANTS; CLUSTERS	Human influenza A viruses undergo antigenic changes with gradual accumulation of amino acid substitutions on the hemagglutinin (HA) molecule. A strong antigenic mismatch between vaccine and epidemic strains often requires the replacement of influenza vaccines worldwide. To establish a practical model enabling us to predict the future direction of the influenza virus evolution, relative distances of amino acid sequences among past epidemic strains were analyzed by multidimensional scaling (MDS). We found that human influenza viruses have evolved along a gnarled evolutionary pathway with an approximately constant curvature in the MDS-constructed 3D space. The gnarled pathway indicated that evolution on the trunk favored multiple substitutions at the same amino acid positions on HA. The constant curvature was reasonably explained by assuming that the rate of amino acid substitutions varied from one position to another according to a gamma distribution. Furthermore, we utilized the estimated parameters of the gamma distribution to predict the amino acid substitutions on HA in subsequent years. Retrospective prediction tests for 12 years from 1997 to 2009 showed that 70% of actual amino acid substitutions were correctly predicted, and that 45% of predicted amino acid substitutions have been actually observed. Although it remains unsolved how to predict the exact timing of antigenic changes, the present results suggest that our model may have the potential to recognize emerging epidemic strains.	[Ito, Kimihito; Igarashi, Manabu; Murakami, Teiji; Iida, Syaka; Kida, Hiroshi; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Ito, Kimihito] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Miyazaki, Yutaka] Osaka Univ Econ & Law, Fac Liberal Arts & Sci, Yao, Japan; [Kida, Hiroshi] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] OIE Reference Lab Highly Pathogen Avian Influenza, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Japan Sci & Technol Agcy, SORST, Saitama, Japan; [Takada, Ayato] Univ Zambia, Sch Vet Med, Lusaka, Zambia	Hokkaido University; Japan Science & Technology Agency (JST); Hokkaido University; Japan Science & Technology Agency (JST); University of Zambia	Ito, K (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	Igarashi, Manabu/F-6871-2012; Takada, Ayato/A-6679-2012; Ito, Kimihito/E-9975-2012; Kida, Hiroshi/F-7244-2012	Ito, Kimihito/0000-0003-4986-1795; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This project was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), the Global COE Program, Grants-in-Aid, all from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and PRESTO and SORST from Japan Science and Technology Agency (JST) Basic Research Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Borg I, 2010, MODERN MULTIDIMENSIO; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cox NJ, 1995, SEMIN VIROL, V6, P359, DOI 10.1016/S1044-5773(05)80013-7; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferguson NM, 2002, NAT MED, V8, P562, DOI 10.1038/nm0602-562; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; He JK, 2010, PROTEIN ENG DES SEL, V23, P935, DOI 10.1093/protein/gzq078; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kryazhimskiy S, 2008, P ROY SOC B-BIOL SCI, V275, P2455, DOI 10.1098/rspb.2008.0521; Lavenu A, 2006, EPIDEMIOL INFECT, V134, P514, DOI 10.1017/S0950268805005686; LAVER WG, 1981, J MOL BIOL, V145, P339, DOI 10.1016/0022-2836(81)90209-6; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Nakajima K, 2003, J VIROL, V77, P10088, DOI 10.1128/JVI.77.18.10088-10098.2003; NEI M, 1976, P NATL ACAD SCI USA, V73, P4164, DOI 10.1073/pnas.73.11.4164; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OTA T, 1994, J MOL EVOL, V38, P642; Palese P., 2007, FIELDS VIROLOGY, P1647; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Suzuki Y, 2004, MOL BIOL EVOL, V21, P2352, DOI 10.1093/molbev/msh249; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; WEBSTER RG, 1980, VIROLOGY, V104, P139, DOI 10.1016/0042-6822(80)90372-4; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	40	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25953	10.1371/journal.pone.0025953	http://dx.doi.org/10.1371/journal.pone.0025953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028800	Green Published, gold			2022-12-25	WOS:000295971700027
J	Havard, M; Dautry, F; Tchenio, T				Havard, Maryline; Dautry, Francois; Tchenio, Thierry			A Dormant State Modulated by Osmotic Pressure Controls Clonogenicity of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; METASTATIC INEFFICIENCY; EPITHELIAL-CELLS; STEM-CELLS; P53; PROGRESSION; SENESCENCE; BONE	Cell dormancy constitutes a limiting step of the metastatic process by preventing the proliferation of isolated cancer cells disseminated at distant sites from the primary tumor. The study of cancer cell dormancy is severely hampered by the lack of biological samples so that the mechanisms that regulate cell dormancy have not been extensively explored. In this work, we describe the rapid induction in vitro of a dormant state in prostate cancer cells by exposure to a slightly hypertonic growth medium. This quiescence is observed only when cells are seeded at low density and, once established, requires additional stimuli besides osmotic pressure to be reversed. Media conditioned by cells grown at high density can partially prevent or reverse dormancy, a phenomenon which can be reproduced with citric acid. In addition to this role of small metabolites, inactivation of the p53 and smad pathways also counters the entry into dormancy, whereas exposure to activin A induces it to some extent. Thus, this easily inducible dormancy reproduces several features associated with the dormancy of stem cells and cancer cells in vivo.	[Havard, Maryline; Dautry, Francois; Tchenio, Thierry] Ecole Normale Super, CNRS, LBPA, UMR8113, F-94235 Cachan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Tchenio, T (corresponding author), Ecole Normale Super, CNRS, LBPA, UMR8113, 61 Ave President Wilson, F-94235 Cachan, France.	ttchenio@ens-cachan.fr	Tchenio, Thierry/O-8336-2017	Tchenio, Thierry/0000-0002-6969-3138				Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Cameron MD, 2000, CANCER RES, V60, P2541; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Chambers AF, 2000, BREAST CANCER RES, V2, P400, DOI 10.1186/bcr86; Chambers AF, 2001, SURG ONCOL CLIN N AM, V10, pvii; Costello LC, 1997, UROLOGY, V50, P3, DOI 10.1016/S0090-4295(97)00124-6; Di K, 2006, BIOL CELL, V98, P523, DOI 10.1042/BC20060026; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Guba M, 2001, CANCER RES, V61, P5575; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Junger WG, 1997, J TRAUMA, V42, P437, DOI 10.1097/00005373-199703000-00011; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Singer G.G., 2008, HARRISONS PRINCIPLES, P274; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tchenio T, 2006, MOL CELL BIOL, V26, P580, DOI 10.1128/MCB.26.2.580-591.2006; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Tumminello FM, 2010, CLIN EXP METASTAS, V27, P549, DOI 10.1007/s10585-010-9344-x; Wiig H, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-12; Wu Kai-Jie, 2009, Zhonghua Nan Ke Xue, V15, P41; Yamazaki S, 2009, CURR OPIN HEMATOL, V16, P255, DOI 10.1097/MOH.0b013e32832c6705; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827	26	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44177	44186		10.1074/jbc.M111.262709	http://dx.doi.org/10.1074/jbc.M111.262709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039055	Green Published, hybrid			2022-12-25	WOS:000298402300058
J	Lynagh, T; Webb, TI; Dixon, CL; Cromer, BA; Lynch, JW				Lynagh, Timothy; Webb, Timothy I.; Dixon, Christine L.; Cromer, Brett A.; Lynch, Joseph W.			Molecular Determinants of Ivermectin Sensitivity at the Glycine Receptor Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; TRYPTOPHAN-SCANNING MUTAGENESIS; GABA(A) RECEPTOR; TRANSMEMBRANE DOMAIN; ONCHOCERCA-VOLVULUS; ION-CHANNEL; AGONIST; ACID; LOOP; ACTIVATION	Ivermectin is an anthelmintic drug that works by activating glutamate-gated chloride channel receptors (GluClRs) in nematode parasites. GluClRs belong to the Cys-loop receptor family that also includes glycine receptor (GlyR) chloride channels. GluClRs and A288G mutant GlyRs are both activated by low nanomolar ivermectin concentrations. The crystal structure of the Caenorhabditis elegans alpha GluClR complexed with ivermectin has recently been published. Here, we probed ivermectin sensitivity determinants on the alpha 1 GlyR using site-directed mutagenesis and electrophysiology. Based on a mutagenesis screen of transmembrane residues, we identified Ala(288) and Pro(230) as crucial sensitivity determinants. A comparison of the actions of selamectin and ivermectin suggested the benzofuran C05-OH was required for high efficacy. When taken together with docking simulations, these results supported a GlyR ivermectin binding orientation similar to that seen in the GluClR crystal structure. However, whereas the crystal structure shows that ivermectin interacts with the alpha GluClR via H-bonds with Leu(218), Ser(260), and Thr(285) (alpha GluClR numbering), our data indicate that H-bonds with residues homologous to Ser(260) and Thr(285) are not important for high ivermectin sensitivity or direct agonist efficacy in A288G alpha 1 GlyRs or three other GluClRs. Our data also suggest that van der Waals interactions between the ivermectin disaccharide and GlyR M2-M3 loop residues are unimportant for high ivermectin sensitivity. Thus, although our results corroborate the ivermectin binding orientation as revealed by the crystal structure, they demonstrate that some of the binding interactions revealed by this structure do not pertain to other highly ivermectin-sensitive Cys-loop receptors.	[Lynagh, Timothy; Webb, Timothy I.; Dixon, Christine L.; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Cromer, Brett A.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 2476, Australia	University of Queensland; University of Queensland; Royal Melbourne Institute of Technology (RMIT)	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Webb, Timothy I/H-6941-2015; Lynch, Joseph/C-8636-2009; Cromer, Brett/AAQ-6533-2020	Webb, Timothy I/0000-0002-6263-6296; Cromer, Brett/0000-0003-0743-1535; Lynagh, Timothy/0000-0003-4888-4098	Australian Research Council; National Health and Medical Research Council of Australia; Australian postgraduate awards	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate awards(Australian Government)	This work was supported in part by the Australian Research Council and the National Health and Medical Research Council of Australia.; Supported by Australian postgraduate awards.	Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Bertaccini EJ, 2010, J CHEM INF MODEL, V50, P2248, DOI 10.1021/ci100266c; Bourguinat C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000072; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Otero-Cruz JD, 2007, J BIOL CHEM, V282, P9162, DOI 10.1074/jbc.M607492200; Forrester SG, 2003, MOL BIOCHEM PARASIT, V129, P115, DOI 10.1016/S0166-6851(03)00102-6; Gilbert DF, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.017.2009; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Kane NS, 2000, P NATL ACAD SCI USA, V97, P13949, DOI 10.1073/pnas.240464697; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Kwon DH, 2010, INSECT MOL BIOL, V19, P583, DOI 10.1111/j.1365-2583.2010.01017.x; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; Lynagh T, 2010, INT J PARASITOL, V40, P1477, DOI 10.1016/j.ijpara.2010.07.010; Lynagh T, 2010, J BIOL CHEM, V285, P14890, DOI 10.1074/jbc.M110.107789; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; Michael B, 2001, J PARASITOL, V87, P692, DOI 10.1645/0022-3395(2001)087[0692:COIDSA]2.0.CO;2; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; MROZIK H, 1982, J MED CHEM, V25, P658, DOI 10.1021/jm00348a010; Navedo M, 2004, BIOCHEMISTRY-US, V43, P78, DOI 10.1021/bi0356496; Nevin ST, 2003, J BIOL CHEM, V278, P28985, DOI 10.1074/jbc.M300097200; Njue AI, 2004, J NEUROCHEM, V89, P1137, DOI 10.1111/j.1471-4159.2004.02379.x; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pan ZH, 1997, P NATL ACAD SCI USA, V94, P6490, DOI 10.1073/pnas.94.12.6490; Perkins DI, 2008, J NEUROCHEM, V106, P1337, DOI 10.1111/j.1471-4159.2008.05476.x; Perkins DI, 2009, J BIOL CHEM, V284, P27304, DOI 10.1074/jbc.M109.023598; Raymond V, 2000, NEUROSCIENCE, V101, P785, DOI 10.1016/S0306-4522(00)00279-7; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Ueno S, 2000, BRIT J PHARMACOL, V131, P296, DOI 10.1038/sj.bjp.0703504; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218	43	46	51	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43913	43924		10.1074/jbc.M111.262634	http://dx.doi.org/10.1074/jbc.M111.262634			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033924	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000298402300032
J	Scott-Craig, JS; Borrusch, MS; Banerjee, G; Harvey, CM; Walton, JD				Scott-Craig, John S.; Borrusch, Melissa S.; Banerjee, Goutami; Harvey, Christopher M.; Walton, Jonathan D.			Biochemical and Molecular Characterization of Secreted alpha-Xylosidase from Aspergillus niger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XYLOGLUCAN OLIGOSACCHARIDES; DEGRADING ENZYMES; CLASSIFICATION; DECONSTRUCTION; PURIFICATION; MIXTURES; PROTEINS; REVEALS; CLONING	Background: Microbial secreted alpha-xylosidases are rare. Results: An alpha-xylosidase of Aspergillus niger (AxlA) was purified and expressed in Pichia pastoris. Conclusion: Native and recombinant AxlA act on pNP alpha X and isoprimeverose. Together with beta-glucosidase, AxlA degrades xyloglucan (XG) heptasaccharide. Together with xyloglucanase, beta-galactosidase, and beta-glucosidase, it degrades tamarind XG. Significance: The biochemical function of AxlA is established.	[Walton, Jonathan D.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Energy, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE)	Walton, JD (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	walton@msu.edu			U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science BER ) [DE-FC02-07ER64494]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG02-91ER200021]	U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science BER )(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science BER DE-FC02-07ER64494) and by Grant DE-FG02-91ER200021 to the Michigan State University-Plant Research Laboratory from the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences.	Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Banerjee G, 2010, BIORESOURCE TECHNOL, V101, P9097, DOI 10.1016/j.biortech.2010.07.028; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; Banerjee G, 2010, BIOENERG RES, V3, P82, DOI 10.1007/s12155-009-9067-5; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Chaillou S, 1998, J BACTERIOL, V180, P2312, DOI 10.1128/JB.180.9.2312-2320.1998; de Oliveira JMPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020865; Foster CE, 2010, J VIS EXP, DOI [10.3791/1837, DOI 10.3791/1837]; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gonzalez-Vogel A, 2011, APPL MICROBIOL BIOT, V89, P145, DOI 10.1007/s00253-010-2953-0; Grishutin SG, 2004, BBA-GEN SUBJECTS, V1674, P268, DOI 10.1016/j.bbagen.2004.07.001; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hsieh YSY, 2009, MOL PLANT, V2, P943, DOI 10.1093/mp/ssp061; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; LORENCES EP, 1994, CARBOHYD RES, V263, P285, DOI 10.1016/0008-6215(94)00170-7; Matsuo M, 1996, BIOSCI BIOTECH BIOCH, V60, P341, DOI 10.1271/bbb.60.341; MATSUSHITA J, 1987, AGR BIOL CHEM TOKYO, V51, P2015, DOI 10.1080/00021369.1987.10868301; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Moracci M, 2000, J BIOL CHEM, V275, P22082, DOI 10.1074/jbc.M910392199; Nagendran S, 2009, FUNGAL GENET BIOL, V46, P427, DOI 10.1016/j.fgb.2009.02.001; Nakai H, 2007, J BIOCHEM, V142, P491, DOI 10.1093/jb/mvm174; Okuyama M, 2004, PROTEIN EXPRES PURIF, V37, P170, DOI 10.1016/j.pep.2004.05.008; ONEILL RA, 1989, J BIOL CHEM, V264, P20430; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Sampedro J, 2001, PLANT PHYSIOL, V126, P910, DOI 10.1104/pp.126.2.910; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; YOSHIKAWA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1392, DOI 10.1271/bbb.58.1392; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7	35	21	26	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42848	42854		10.1074/jbc.M111.307397	http://dx.doi.org/10.1074/jbc.M111.307397			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033931	Green Published, hybrid			2022-12-25	WOS:000298351300006
J	Hansen, B; Oturai, AB; Harbo, HF; Celius, EG; Nissen, KK; Laska, MJ; Sondergaard, HB; Petersen, T; Nexo, BA				Hansen, Bettina; Oturai, Annette B.; Harbo, Hanne F.; Celius, Elisabeth G.; Nissen, Kari K.; Laska, Magdalena J.; Sondergaard, Helle B.; Petersen, Thor; Nexo, Bjorn A.			Genetic Association of Multiple Sclerosis with the Marker rs391745 near the Endogenous Retroviral Locus HERV-Fc1: Analysis of Disease Subtypes	PLOS ONE			English	Article							RISK	We have previously described the occurrence of multiple sclerosis (MS) to be associated with human endogenous retroviruses, specifically the X-linked viral locus HERV-Fc1. The aim of this study was to investigate a possible association of the HERV-Fc1 locus with subtypes of MS. MS patients are generally subdivided into three categories: Remitting/Relapsing and Secondary Progressive, which together constitute Bout Onset MS, and Primary Progressive. In this study of 1181 MS patients and 1886 controls we found that Bout Onset MS was associated with the C-allele of the marker rs391745 near the HERV-Fc1 locus (p = 0.003), while primary progressive disease was not. The ability to see genetic differences between subtypes of MS near this gene speaks for the involvement of the virus HERV-Fc1 locus in modifying the disease course of MS.	[Hansen, Bettina; Nissen, Kari K.; Laska, Magdalena J.; Nexo, Bjorn A.] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Oturai, Annette B.; Sondergaard, Helle B.] Rigshosp, Dept Neurol, Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark; [Harbo, Hanne F.; Celius, Elisabeth G.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Petersen, Thor] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark	Aarhus University; Rigshospitalet; University of Copenhagen; University of Oslo; University of Oslo; Aarhus University	Hansen, B (corresponding author), Aarhus Univ, Dept Biomed, Aarhus C, Denmark.	nexo@humgen.au.dk	Celius, Elisabeth Gulowsen/S-1387-2019	Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Laska, Magdalena Janina/0000-0001-5188-3446; Sondergaard, Helle Bach/0000-0001-9435-0658; Petersen, Thor/0000-0001-5633-2600	Lundbeck Foundation; Danish Multiple Sclerosis Society; Warwara Larsen's Foundation; Norwegian Research Council; South-East Regional Norwegian Health Authorities; Odd Fellow MS Society; Oslo MS Society	Lundbeck Foundation(Lundbeckfonden); Danish Multiple Sclerosis Society; Warwara Larsen's Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); South-East Regional Norwegian Health Authorities; Odd Fellow MS Society; Oslo MS Society	This work was supported by The Lundbeck Foundation, The Danish Multiple Sclerosis Society and Warwara Larsen's Foundation. The Norwegian Bone Marrow Registry is acknowledged for recruitment of the Norwegian control samples. The Norwegian part of the study was supported by grants from the Norwegian Research Council, South-East Regional Norwegian Health Authorities, Odd Fellow MS Society and Oslo MS Society to the Oslo MS Genetics group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; GARDNER MB, 1993, GENETICA, V91, P199, DOI 10.1007/BF01435998; Johnson R T, 1975, Adv Neurol, V13, P1; LASKA MJ, 2011, PATHOGENESIS M UNPUB; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; Pepin M, 1998, VET RES, V29, P341; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076	16	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26438	10.1371/journal.pone.0026438	http://dx.doi.org/10.1371/journal.pone.0026438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22039488	gold, Green Published, Green Submitted			2022-12-25	WOS:000296517000019
J	Fouks, B; Lattorff, HMG				Fouks, Bertrand; Lattorff, H. Michael G.			Recognition and Avoidance of Contaminated Flowers by Foraging Bumblebees (Bombus terrestris)	PLOS ONE			English	Article							HOST-PARASITE INTERACTIONS; EVOLUTIONARY ECOLOGY; GENETIC DIVERSITY; BEES; BEHAVIOR; INFORMATION; CONSTANCY; WORKERS; CONSEQUENCES; POLLINATORS	Bumblebee colonies are founded by a single-mated queen. Due to this life history trait, bumblebees are more susceptible to parasites and diseases than polyandrous and/or polygynous social insects. A greater resistance towards parasites is shown when the genetic variability within a colony is increased. The parasite resistance may be divided into different levels regarding the step of the parasite infection (e. g. parasite uptake, parasite intake, parasite's establishment in the nest, parasite transmission). We investigate the prophylactic behaviour of bumblebees. Bumblebees were observed during their foraging flights on two artificial flowers; one of these was contaminated by Crithidia bombi, a naturally occurring gut parasite of bumblebees (in a control experiment the non-specific pathogen Escherichia coli was used). For C. bombi, bumblebees were preferentially observed feeding on the non-contaminated flower. Whereas for E. coli, the number of visits between flowers was the same, bumblebees spent more time feeding on the non-contaminated flower. These results demonstrate the ability of bumblebees to recognise the contamination of food sources. In addition, bumblebees have a stronger preference for the non-contaminated flower when C. bombi is present in the other flower than with E. coli which might be explained as an adaptive behaviour of bumblebees towards this specific gut parasite. It seems that the more specific the parasite is, the more it reduces the reward of the flower.	[Fouks, Bertrand; Lattorff, H. Michael G.] Univ Halle Wittenberg, Inst Biol, Halle, Germany	Martin Luther University Halle Wittenberg	Fouks, B (corresponding author), Univ Halle Wittenberg, Inst Biol, Halle, Germany.	bertrand.fouks@zoologie.uni-halle.de	Fouks, Bertrand/AAG-2921-2022; Lattorff, Michael/F-6287-2010; Fouks, Bertrand/AFK-4155-2022	Fouks, Bertrand/0000-0002-3675-3499; Lattorff, Michael/0000-0002-8603-6332; Fouks, Bertrand/0000-0002-3675-3499	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) [FKZ: 0315126]	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	Bundesministerium fur Bildung und Forschung grant (Federal Ministry of Education and Research) (FKZ: 0315126 to HMGL) URL: http://www.bmbf.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2006, CAN J ZOOL, V84, P1240, DOI 10.1139/Z06-117; Alford DV, 1975, BUMBLEBEES; Alghamdi A, 2008, BIOL LETTERS, V4, P479, DOI 10.1098/rsbl.2008.0331; Anfora G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018903; Baer B, 2001, EVOLUTION, V55, P1639, DOI 10.1111/j.0014-3820.2001.tb00683.x; Baer B, 1999, NATURE, V397, P151, DOI 10.1038/16451; Baer B, 2003, ECOL LETT, V6, P106, DOI 10.1046/j.1461-0248.2003.00411.x; Bar-Shai N, 2011, BEHAV ECOL, V22, P317, DOI 10.1093/beheco/arq206; Bates D., 2008, LME4 LINEAR MIXED EF; Bell G., 1982, MASTERPIECE NATURE E; Biernaskie JM, 2007, P ROY SOC B-BIOL SCI, V274, P2595, DOI 10.1098/rspb.2007.0705; Biernaskie JM, 2009, AM NAT, V174, P413, DOI 10.1086/603629; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Birmingham AL, 2004, CAN J ZOOL, V82, P1843, DOI 10.1139/Z04-181; Blarer A, 2002, ETHOLOGY, V108, P341, DOI 10.1046/j.1439-0310.2002.00778.x; Bonsall MB, 2004, PHYSIOL ENTOMOL, V29, P223, DOI 10.1111/j.0307-6962.2004.00389.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Christe P, 1996, ANIM BEHAV, V52, P1087, DOI 10.1006/anbe.1996.0256; Crawley MJ, 2005, STAT INTRO USING R; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Dornhaus A, 2005, BEHAV ECOL, V16, P661, DOI 10.1093/beheco/ari040; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Durisko Z, 2011, ETHOLOGY, V117, P49, DOI 10.1111/j.1439-0310.2010.01842.x; Durrer Stephan, 1994, Proceedings of the Royal Society of London Series B Biological Sciences, V258, P299, DOI 10.1098/rspb.1994.0176; Ebert Dieter, 1996, Trends in Ecology and Evolution, V11, P79, DOI 10.1016/0169-5347(96)81047-0; Erler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018126; Fankhauser R, 2008, EUR J WILDLIFE RES, V54, P88, DOI 10.1007/s10344-007-0115-1; Goulson D, 2000, J CHEM ECOL, V26, P2897, DOI 10.1023/A:1026406330348; Goulson D, 2001, J INSECT BEHAV, V14, P669, DOI 10.1023/A:1012231419067; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Ings TC, 2005, OECOLOGIA, V144, P508, DOI 10.1007/s00442-005-0081-9; Jordan CY, 2006, AM NAT, V167, P496, DOI 10.1086/501142; Kawaguchi LG, 2006, FUNCT ECOL, V20, P239, DOI 10.1111/j.1365-2435.2006.01086.x; Keasar T, 1997, ISRAEL J PLANT SCI, V45, P223, DOI 10.1080/07929978.1997.10676686; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; Leadbeater E, 2009, BIOL LETTERS, V5, P310, DOI 10.1098/rsbl.2008.0692; Lefebvre D, 2007, BEHAV ECOL SOCIOBIOL, V61, P1707, DOI 10.1007/s00265-007-0402-6; Liersch S, 1998, P ROY SOC B-BIOL SCI, V265, P221, DOI 10.1098/rspb.1998.0285; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; Lopez-Vaamonde C, 2004, NATURE, V430, P557, DOI 10.1038/nature02769; Otterstatter MC, 2005, BEHAV ECOL SOCIOBIOL, V58, P383, DOI 10.1007/s00265-005-0945-3; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Popp M, 2011, J EUKARYOT MICROBIOL, V58, P7, DOI 10.1111/j.1550-7408.2010.00514.x; R Team Core Development, 2008, R LANG ENV STAT COMP; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Raine NE, 2007, ENTOMOL GEN, V29, P179; Renner MA, 2008, INSECT SOC, V55, P417, DOI 10.1007/s00040-008-1021-6; Riddell C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007621; Riveros AJ, 2009, NATURWISSENSCHAFTEN, V96, P851, DOI 10.1007/s00114-009-0532-y; Salathe M, 2008, EVOLUTION, V62, P295, DOI 10.1111/j.1558-5646.2007.00265.x; Saleh N, 2007, ARTHROPOD-PLANT INTE, V1, P119, DOI 10.1007/s11829-007-9011-6; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; SCHMIDHEMPEL P, 1998, PARASITES SOCIAL INS; SHYKOFF JA, 1991, P ROY SOC B-BIOL SCI, V243, P55; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368	65	42	42	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26328	10.1371/journal.pone.0026328	http://dx.doi.org/10.1371/journal.pone.0026328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039462	Green Submitted, gold, Green Published			2022-12-25	WOS:000296515200011
J	Sibley, CR; Wood, MJA				Sibley, Christopher R.; Wood, Matthew J. A.			Identification of Allele-Specific RNAi Effectors Targeting Genetic Forms of Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN MUTATIONS; SECONDARY STRUCTURE; IN-VIVO; TRANSGENIC MICE; LRRK2; SIRNA; DEGRADATION; DYSFUNCTION; TOXICITY; STRATEGY	Parkinson's disease (PD) is a progressive neurological disorder affecting an estimated 5-10 million people worldwide. Recent evidence has implicated several genes that directly cause or increase susceptibility to PD. As well as advancing understanding of the genetic aetiology of PD these findings suggest new ways to modify the disease course, in some cases through genetic manipulation. Here we generated a 'walk-through' series of RNA Pol III-expressed shRNAs targeting both the alpha-synuclein A30P and LRRK2 G2019S PD-associated mutations. Allele-specific discrimination of the alpha-synuclein A30P mutation was achieved with alignments at position 10, 13 and 14 in two model systems, including a heterozygous model mimicking the disease setting, whilst 5'RACE was used to confirm stated alignments. Discrimination of the most common PD-linked LRRK2 G2019S mutation was assessed in hemizygous dual-luciferase assays and showed that alignment of the mutation opposite position 4 of the antisense species produced robust discrimination of alleles at all time points studied. Discrimination at this position was subsequently confirmed using siRNAs, where up to 10-fold discrimination was seen. The results suggest that RNAi-mediated silencing of PD-associated autosomal dominant genes could be a novel therapeutic approach for the treatment of the relevant clinical cases of PD in future.	[Sibley, Christopher R.; Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Sibley, Christopher R.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Oxford; MRC Laboratory Molecular Biology	Sibley, CR (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	matthew.wood@dpag.ox.ac.uk	Wood, Matthew/HDN-1469-2022	Wood, Matthew/0000-0002-5436-6011; Sibley, Christopher/0000-0002-8286-4683	Medical Research Council; Parkinson's UK; MRC [G0900887, MC_U105185858] Funding Source: UKRI; Medical Research Council [MC_U105185858, G0900887] Funding Source: researchfish; Parkinson&quot;s UK [G-0503, G-0904] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	Funding: This work was supported a Medical Research Council Studentship (CRS). This work was supported by a research grants from Parkinson's UK to MJAW. A free gift of an siRNA was provided by Novartis Pharmaceuticals with nothing in exchange. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Giasson BI, 2008, NEUROSIGNALS, V16, P99, DOI 10.1159/000109764; Gomez-Isla T, 2003, NEUROBIOL AGING, V24, P245, DOI 10.1016/S0197-4580(02)00091-X; Gorbatyuk OS, 2010, MOL THER, V18, P1450, DOI 10.1038/mt.2010.115; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Heale BSE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni026; Hickerson RP, 2008, J INVEST DERMATOL, V128, P594, DOI 10.1038/sj.jid.5701060; Holen T, 2005, NUCLEIC ACIDS RES, V33, P4704, DOI 10.1093/nar/gki785; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kanda S, 2000, NEUROSCIENCE, V97, P279, DOI 10.1016/S0306-4522(00)00077-4; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubodera T, 2005, OLIGONUCLEOTIDES, V15, P298, DOI 10.1089/oli.2005.15.298; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Nonaka T, 2009, BIOCHEMISTRY-US, V48, P8014, DOI 10.1021/bi900619j; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Pandey N, 2006, EXP NEUROL, V197, P515, DOI 10.1016/j.expneurol.2005.10.019; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rathke-Hartlieb S, 2001, J NEUROCHEM, V77, P1181, DOI 10.1046/j.1471-4159.2001.00366.x; Sapru MK, 2006, EXP NEUROL, V198, P382, DOI 10.1016/j.expneurol.2005.12.024; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Scholefield J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007232; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Strazewski P, 1999, RNA, V5, P1490, DOI 10.1017/S1355838299991586; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; WANG JJ, 2011, NEUROSCI LETT, DOI DOI 10.1016/J.NEULET.2011.04.064; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Yue ZY, 2009, FEBS J, V276, P6445, DOI 10.1111/j.1742-4658.2009.07343.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S9	46	14	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26194	10.1371/journal.pone.0026194	http://dx.doi.org/10.1371/journal.pone.0026194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031823	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200010
J	Antonioni, A; Tomassini, M				Antonioni, Alberto; Tomassini, Marco			Network Fluctuations Hinder Cooperation in Evolutionary Games	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; EMPIRICAL-ANALYSIS; SOCIAL DILEMMAS; EMERGENCE; DYNAMICS	In this paper we study the influence of random network fluctuations on the behavior of evolutionary games on Barabasi-Albert networks. This network class has been shown to promote cooperation on social dilemmas such as the Prisoner's Dilemma and the Snowdrift games when the population network is fixed. Here we introduce exogenous random fluctuations of the network links through several noise models, and we investigate the evolutionary dynamics comparing them with the known static network case. The results we obtain show that even a moderate amount of random noise on the network links causes a significant loss of cooperation, to the point that cooperation vanishes altogether in the Prisoner's Dilemma when the noise rate is the same as the agents' strategy revision rate. The results appear to be robust since they are essentially the same whatever the type of the exogenous noise. Besides, it turns out that random network noise is more important than strategy noise in suppressing cooperation. Thus, even in the more favorable situation of accumulated payoff in which links have no cost, the mere presence of random external network fluctuations act as a powerful limitation to the attainment of high levels of cooperation.	[Antonioni, Alberto; Tomassini, Marco] Univ Lausanne, Dept Informat Syst, Fac Business & Econ, Lausanne, Switzerland	University of Lausanne	Antonioni, A (corresponding author), Univ Lausanne, Dept Informat Syst, Fac Business & Econ, Lausanne, Switzerland.	alberto.antonioni@unil.ch	Antonioni, Alberto/U-6497-2018; Tomassini, Marco/D-6312-2013; Antonioni, Alberto/B-9686-2014	Antonioni, Alberto/0000-0002-5788-3348; Antonioni, Alberto/0000-0002-5788-3348	Swiss National Scientific Foundation [200021-132802/1]; University of Lausanne	Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF)); University of Lausanne	Project partially funded by the Swiss National Scientific Foundation under grant n. 200021-132802/1 (http://www.snf.ch/F/Pages/default.aspx). The rest of the salary of A. Antonioni is paid by the University of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; [Anonymous], 1995, EVOLUTIONARY GAME TH; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Leskovec J., 2007, ACM T KNOWLEDGE DISC, V1; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Luthi L, 2008, PHYSICA A, V387, P955, DOI 10.1016/j.physa.2007.09.046; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pestelacci Enea, 2008, Biological Theory, V3, P139, DOI 10.1162/biot.2008.3.2.139; Poncela J, 2010, INT J BIFURCAT CHAOS, V20, P849, DOI 10.1142/S0218127410026137; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Roca CP, 2009, EUR PHYS J B, V71, P587, DOI 10.1140/epjb/e2009-00189-0; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Tomassini M, 2007, PHYSICA A, V385, P750, DOI 10.1016/j.physa.2007.07.028; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	32	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25555	10.1371/journal.pone.0025555	http://dx.doi.org/10.1371/journal.pone.0025555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039416	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500014
J	Bailey, JR; Probert, CSJ; Cogan, TA				Bailey, Jennifer R.; Probert, Christopher S. J.; Cogan, Tristan A.			Identification and Characterisation of an Iron-Responsive Candidate Probiotic	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; LACTIC-ACID BACTERIA; INFLAMMATORY-BOWEL-DISEASE; STRAIN NISSLE 1917; ESCHERICHIA-COLI; ULCERATIVE-COLITIS; T-CELLS; EPITHELIAL-CELLS; ATOPIC DISEASE; DOUBLE-BLIND	Background: Iron is an essential cofactor in almost all biological systems. The lactic acid bacteria (LAB), frequently employed as probiotics, are unusual in having little or no requirement for iron. Iron in the human body is sequestered by transferrins and lactoferrin, limiting bacterial growth. An increase in the availability of iron in the intestine by bleeding, surgery, or under stress leads to an increase in the growth and virulence of many pathogens. Under these high iron conditions, LAB are rapidly out-competed; for the levels of probiotic bacteria to be maintained under high iron conditions they must be able to respond by increasing growth rate to compete with the normal flora. Despite this, iron-responsive genera are poorly characterised as probiotics. Methodology/Principal Findings: Here, we show that a panel of probiotics are not able to respond to increased iron availability, and identify an isolate of Streptococcus thermophilus that can increase growth rate in response to increased iron availability. The isolate of S. thermophilus selected was able to reduce epithelial cell death as well as NF-kappa B signalling and IL-8 production triggered by pathogens. It was capable of crossing an epithelial cell barrier in conjunction with E. coli and downregulating Th1 and Th17 responses in primary human intestinal leukocytes. Conclusions/Significance: We propose that an inability to compete with potential pathogens under conditions of high iron availability such as stress and trauma may contribute to the lack of efficacy of many LAB-based probiotics in treating disease. Therefore, we offer an alternative paradigm which considers that probiotics should be able to be competitive during periods of intestinal bleeding, trauma or stress.	[Bailey, Jennifer R.; Cogan, Tristan A.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Probert, Christopher S. J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Bailey, JR (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	tristan.cogan@bristol.ac.uk	Bailey, Jennifer/H-5856-2013	Probert, Christopher/0000-0003-4550-0239				Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Anukam KC, 2008, J CLIN GASTROENTEROL, V42, P239, DOI 10.1097/MCG.0b013e31802c7465; ARCHIBALD F, 1986, CRC CR REV MICROBIOL, V13, P63, DOI 10.3109/10408418609108735; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; BRUYNEEL B, 1989, BIOTECHNOL LETT, V11, P401, DOI 10.1007/BF01089472; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; Food and Agriculture Organization of the United Nations World Health Organization, 2001, REP JOINT FAO WHO EX; Freestone PP, 2002, SHOCK, V18, P465, DOI 10.1097/00024382-200211000-00014; Freestone PPE, 1999, FEMS MICROBIOL LETT, V172, P53, DOI 10.1111/j.1574-6968.1999.tb13449.x; Furet JP, 2004, INT J FOOD MICROBIOL, V97, P197, DOI 10.1016/j.ijfoodmicro.2004.04.020; Gronbach K, 2010, INFECT IMMUN, V78, P3036, DOI 10.1128/IAI.00218-10; Hafez M, 2010, INFECT IMMUN, V78, P2153, DOI 10.1128/IAI.01406-09; Haller D, 2010, J NUTR, V140, p690S, DOI 10.3945/jn.109.113746; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; Hoffmann M, 2008, J NUTR, V138, P1684, DOI 10.1093/jn/138.9.1684; Imbert M, 1998, CURR MICROBIOL, V37, P64, DOI 10.1007/s002849900339; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Ivory K, 2008, CLIN EXP ALLERGY, V38, P1282, DOI 10.1111/j.1365-2222.2008.03025.x; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Majamaa H, 1997, J ALLERGY CLIN IMMUN, V99, P179, DOI 10.1016/S0091-6749(97)70093-9; McFarland Lynne V, 2007, Travel Med Infect Dis, V5, P97, DOI 10.1016/j.tmaid.2005.10.003; Metchnikoff E., 1907, PROLONGATION LIFE OP; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; PANDEY A, 1994, APPL MICROBIOL BIOT, V40, P735, DOI [10.1007/BF00173337, 10.1007/s002530050058]; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Rodriguez C, 2010, WORLD J GASTROENTERO, V16, P1622, DOI 10.3748/wjg.v16.i13.1622; Roselli M, 2009, INFLAMM BOWEL DIS, V15, P1526, DOI 10.1002/ibd.20961; Sandrini SM, 2010, J BACTERIOL, V192, P587, DOI 10.1128/JB.01028-09; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stallmach A, 2001, EUR J IMMUNOL, V31, P1228, DOI 10.1002/1521-4141(200104)31:4<1228::AID-IMMU1228>3.0.CO;2-K; Sturm A, 2004, J IMMUNOL, V173, P3889, DOI 10.4049/jimmunol.173.6.3889; Subramanian S, 2008, INFLAMM BOWEL DIS, V14, P162, DOI 10.1002/ibd.20296; Szajewska H, 2007, ALIMENT PHARM THER, V25, P871, DOI 10.1111/j.1365-2036.2007.03282.x; Tursi A, 2004, MED SCI MONITOR, V10, pPI126; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Venturi A, 1999, ALIMENT PHARM THER, V13, P1103; West CE, 2009, PEDIATR ALLERGY IMMU, V20, P430, DOI 10.1111/j.1399-3038.2009.00745.x; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W	44	20	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26507	10.1371/journal.pone.0026507	http://dx.doi.org/10.1371/journal.pone.0026507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039501	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500079
J	Bian, YN; Zhou, W; Zhao, YC; Li, XP; Geng, W; Hao, RX; Yang, Q; Huang, WD				Bian, Yingnan; Zhou, Wei; Zhao, Yingchun; Li, Xiaoping; Geng, Wei; Hao, Ruixin; Yang, Qing; Huang, Weida			High-Dose siRNAs Upregulate Mouse Eri-1 at both Transcription and Posttranscription Levels	PLOS ONE			English	Article							GENE-EXPRESSION; HISTONE DEACETYLASE; PROMOTER ACTIVITY; SIGNAL TRANSDUCER; INTERFERING RNAS; MESSENGER-RNA; DNA-BINDING; IN-VIVO; C-JUN; EPITHELIAL-CELLS	The eri-1 gene encodes a 3' exonuclease that can negatively regulate RNA interference via siRNase activity. High-dose siRNAs (hd-siRNAs) can enhance Eri-1 expression, which in return degrade siRNAs and greatly reduces RNAi efficiency. Here we report that hd-siRNAs induce mouse Eri-1 (meri-1) expression through the recruitment of Sp1, Ets-1, and STAT3 to the meri-1 promoter and the formation of an Sp1-Ets-1-STAT3 complex. In addition, hd-siRNAs also abolish the 3' untranslated region (UTR) mediated posttranscriptional repression of meri-1. Our findings demonstrate the molecular mechanism underlying the upregulation of meri-1 by hd-siRNA.	[Bian, Yingnan; Zhou, Wei; Zhao, Yingchun; Li, Xiaoping; Geng, Wei; Hao, Ruixin; Yang, Qing; Huang, Weida] Fudan Univ, Sch Life Sci, Dept Biochem, Shanghai 200433, Peoples R China; [Huang, Weida] Chinese Acad Sci, Shanghai Adv Res Inst, Lab Synthet Biol, Ctr Nanomed, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Bian, YN (corresponding author), Fudan Univ, Sch Life Sci, Dept Biochem, Shanghai 200433, Peoples R China.	whuang@fudan.edu.cn		Zhou, Wei/0000-0003-3742-2592	Shanghai Leading Academic Discipline Project [B111]; NSF of China [50533010]	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NSF of China(National Natural Science Foundation of China (NSFC))	This study was supported by Shanghai Leading Academic Discipline Project (Project Number: B111, http://www.shmec.gov.cn/) and NSF of China (No. 50533010, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Burgyan Jozsef, 2008, V451, P69, DOI 10.1007/978-1-59745-102-4_5; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P3063, DOI 10.1093/nar/gkg435; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen BK, 2000, P NATL ACAD SCI USA, V97, P10406, DOI 10.1073/pnas.180321497; Diamond DA, 1999, J BIOL CHEM, V274, P16959, DOI 10.1074/jbc.274.24.16959; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DYER RB, 1995, NUCLEIC ACIDS RES, V23, P3345; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fischer SEJ, 2008, NATURE, V455, P491, DOI 10.1038/nature07274; Fujimoto E, 2005, ONCOGENE, V24, P3684, DOI 10.1038/sj.onc.1208430; Gess B, 2008, J NEUROSCI RES, V86, P797, DOI 10.1002/jnr.21528; Greenwel P, 1997, J BIOL CHEM, V272, P19738, DOI 10.1074/jbc.272.32.19738; Hong J, 2005, BIOCHEM J, V390, P675, DOI 10.1042/BJ20050647; Hong J, 2007, BIOCHEM BIOPH RES CO, V361, P373, DOI 10.1016/j.bbrc.2007.07.003; Hong J, 2006, BIOCHEM BIOPH RES CO, V348, P600, DOI 10.1016/j.bbrc.2006.07.107; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim KR, 2000, ONCOGENE, V19, P1764, DOI 10.1038/sj.onc.1203502; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Krainc D, 1998, J BIOL CHEM, V273, P26218, DOI 10.1074/jbc.273.40.26218; KUMAR P, 2010, J BIOL CHEM; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; LZEL MH, 2010, J BIOL CHEM, V285, P6364; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Petersohn D, 1996, EUR J BIOCHEM, V239, P827, DOI 10.1111/j.1432-1033.1996.0827u.x; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pushparaj PN, 2008, J DENT RES, V87, P992, DOI 10.1177/154405910808701109; Pushparaj PN, 2008, INT J BIOCHEM CELL B, V40, P1817, DOI 10.1016/j.biocel.2008.01.015; Qian ZK, 2005, WORLD J GASTROENTERO, V11, P1297, DOI 10.3748/wjg.v11.i9.1297; Ray S, 2008, NUCLEIC ACIDS RES, V36, P4510, DOI 10.1093/nar/gkn419; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryu H, 2003, J NEUROSCI, V23, P3597; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; Schnur N, 2007, BBA-MOL CELL BIOL L, V1771, P1271, DOI 10.1016/j.bbalip.2007.08.003; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shimizu R, 2010, LEUKEMIA, V24, P1760, DOI 10.1038/leu.2010.157; SIOUD M, 2006, J BIOMED BIOTECHNOL, V2, P4; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sliva K, 2006, VIROLOGY, V351, P218, DOI 10.1016/j.virol.2006.03.014; Sternson SM, 2001, ORG LETT, V3, P4239, DOI 10.1021/ol016915f; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P4295, DOI 10.1167/iovs.06-0412; Torigoe T, 2005, J BIOL CHEM, V280, P1179, DOI 10.1074/jbc.M410499200; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Xuan BQ, 2005, MOL BIOTECHNOL, V31, P203, DOI 10.1385/MB:31:3:203; Yan GZ, 1997, J NEUROSCI, V17, P6122; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200; Zheng ZM, 2005, ANN NY ACAD SCI, V1058, P105, DOI 10.1196/annals.1359.019	94	7	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26466	10.1371/journal.pone.0026466	http://dx.doi.org/10.1371/journal.pone.0026466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039495	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500073
J	El-Osta, H; Falchook, G; Tsimberidou, A; Hong, D; Naing, A; Kim, K; Wen, SJ; Janku, F; Kurzrock, R				El-Osta, Hazem; Falchook, Gerald; Tsimberidou, Apostolia; Hong, David; Naing, Aung; Kim, Kevin; Wen, Sijin; Janku, Filip; Kurzrock, Razelle			BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes	PLOS ONE			English	Article							COLORECTAL-CANCER; MELANOMA PATIENTS; KRAS; VALIDATION	Background: Oncogenic BRAF mutations have been found in diverse malignancies and activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the clinical characteristics and outcomes of patients with mutant (mut) BRAF advanced cancer referred to phase 1 clinic. Methods: We reviewed the records of 80 consecutive patients with mutBRAF advanced malignancies and 149 with wild-type (wt) BRAF (matched by tumor type) referred to the Clinical Center for Targeted Therapy and analyzed their outcome. Results: Of 80 patients with mutBRAF advanced cancer, 56 had melanoma, 10 colorectal, 11 papillary thyroid, 2 ovarian and 1 esophageal cancer. Mutations in codon 600 were found in 77 patients (62, V600E; 13, V600K; 1, V600R; 1, unreported). Multivariate analysis showed less soft tissue (Odds ratio (OR) = 0.39, 95%CI: 0.20-0.77, P = 0.007), lung (OR = 0.38, 95%CI: 0.19-0.73, p = 0.004) and retroperitoneal metastases (OR = 0.34, 95%CI: 0.13-0.86, p = 0.024) and more brain metastases (OR = 2.05, 95%CI: 1.02-4.11, P = 0.043) in patients with mutBRAF versus wtBRAF. Comparing to the corresponding wtBRAF, mutBRAF melanoma patients had insignificant trend to longer median survival from diagnosis (131 vs. 78 months, p = 0.14), while mutBRAF colorectal cancer patients had an insignificant trend to shorter median survival from diagnosis (48 vs. 53 months, p = 0.22). In melanoma, V600K mutations in comparison to other BRAF mutations were associated with more frequent brain (75% vs. 36.3%, p = 0.02) and lung metastases (91.6% vs. 47.7%, p = 0.007), and shorter time from diagnosis to metastasis and to death (19 vs. 53 months, p = 0.046 and 78 vs. 322 months, p = 0.024 respectively). Treatment with RAF/MEK targeting agents (Hazard ratio (HR) = 0.16, 95%CI: 0.03-0.89, p = 0.037) and any decrease in tumor size after referral (HR = 0.07, 95%CI: 0.015-0.35, p = 0.001) correlated with longer survival in mutBRAF patients. Conclusions: BRAF appears to be a druggable mutation that also defines subgroups of patients with phenotypic overlap, albeit with differences that correlate with histology or site of mutation.	[El-Osta, Hazem; Falchook, Gerald; Tsimberidou, Apostolia; Hong, David; Naing, Aung; Janku, Filip; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA; [Kim, Kevin] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Wen, Sijin] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	El-Osta, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA.	rkurzroc@mdanderson.org	Janku, Filip/ABB-9136-2020; Kurzrock, Razelle/AAU-9782-2020	Tsimberidou, Apostolia M./0000-0003-2713-233X; Wen, Sijin/0000-0002-6955-2917; Naing, Aung/0000-0002-4803-8513	National Center for Research Resources, National Institutes of Health Roadmap for Medical Research [RR024148]; GlaxoSmithKline; AstraZeneca; Genentech; Bayer; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Genentech(Roche HoldingGenentech); Bayer(Bayer AG); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by Grant Number RR024148 from the National Center for Research Resources, a component of the National Institutes of Health Roadmap for Medical Research. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; Dr Razelle Kurzrock received commercial research grants from GlaxoSmithKline, AstraZeneca, Genentech and Bayer. Dr Gerald Falchook received commercial research grant from GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arkenau HT, 2009, J CLIN ONCOL, V27, P2692, DOI 10.1200/JCO.2008.19.5081; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Chang David Z, 2004, J Transl Med, V2, P46, DOI 10.1186/1479-5876-2-46; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Flaherty KT, 2010, CANCER-AM CANCER SOC, V116, P4902, DOI 10.1002/cncr.25261; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fugazzola L, 2006, ENDOCR-RELAT CANCER, V13, P455, DOI 10.1677/erc.1.01086; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; INFANTE JR, 2010, J CLIN ONCOL S, V28, pS15; JOSEPH RW, 2010, J CLIN ONCOL S, V28, pS15; Jovanovic B, 2010, J INVEST DERMATOL, V130, P618, DOI 10.1038/jid.2009.287; Kefford RF, 2010, J CLIN ONCOL S, V28, p15s; Kumar R, 2003, CLIN CANCER RES, V9, P3362; LINOT B, 2010, 2010 GASTR CANC S; Long GV, 2010, J CLIN ONCOL, V28, p15s; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Sakr RA, 2010, APPL IMMUNOHISTO M M, V18, P371, DOI 10.1097/PAI.0b013e3181d50bd5; Scoggins CR, 2006, ANN SURG, V243, P693, DOI 10.1097/01.sla.0000216771.81362.6b; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; SOUGKLAKOS I, 2010, 2010 GASTR CANC S; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Tran B, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3592; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042; Zuo Z, 2009, MODERN PATHOL, V22, P1023, DOI 10.1038/modpathol.2009.59	36	67	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25806	10.1371/journal.pone.0025806	http://dx.doi.org/10.1371/journal.pone.0025806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039425	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500023
J	Gruendler, TOJ; Ullsperger, M; Huster, RJ				Gruendler, Theo O. J.; Ullsperger, Markus; Huster, Rene J.			Event-Related Potential Correlates of Performance-Monitoring in a Lateralized Time-Estimation Task	PLOS ONE			English	Article							ERROR-RELATED NEGATIVITY; ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; OBSESSIVE-COMPULSIVE DISORDER; ENHANCED COGNITIVE CONTROL; STOP-SIGNAL PARADIGM; RESPONSE-INHIBITION; TOURETTE-SYNDROME; BRAIN POTENTIALS; EXTERNAL INFORMATION	Performance-monitoring as a key function of cognitive control covers a wide range of diverse processes to enable goal directed behavior and to avoid maladjustments. Several event-related brain potentials (ERP) are associated with performance-monitoring, but their conceptual background differs. For example, the feedback-related negativity (FRN) is associated with unexpected performance feedback and might serve as a teaching signal for adaptational processes, whereas the error-related negativity (ERN) is associated with error commission and subsequent behavioral adaptation. The N2 is visible in the EEG when the participant successfully inhibits a response following a cue and thereby adapts to a given stop-signal. Here, we present an innovative paradigm to concurrently study these different performance-monitoring-related ERPs. In 24 participants a tactile time-estimation task interspersed with infrequent stop-signal trials reliably elicited all three ERPs. Sensory input and motor output were completely lateralized, in order to estimate any hemispheric processing preferences for the different aspects of performance monitoring associated with these ERPs. In accordance with the literature our data suggest augmented inhibitory capabilities in the right hemisphere given that stop-trial performance was significantly better with left-as compared to right-hand stop-signals. In line with this, the N2 scalp distribution was generally shifted to the right in addition to an ipsilateral shift in relation to the response hand. Other than that, task lateralization affected neither behavior related to error and feedback processing nor ERN or FRN. Comparing the ERP topographies using the Global Map Dissimilarity index, a large topographic overlap was found between all considered components. With an evenly distributed set of trials and a split-half reliability for all ERP components >=.85 the task is well suited to efficiently study N2, ERN, and FRN concurrently which might prove useful for group comparisons, especially in clinical populations.	[Gruendler, Theo O. J.; Ullsperger, Markus] Max Planck Inst Neurol Res, Cologne, Germany; [Ullsperger, Markus] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Huster, Rene J.] Carl von Ossietzky Univ Oldenburg, Inst Psychol, Expt Psychol Lab, D-2900 Oldenburg, Germany	Max Planck Society; Radboud University Nijmegen; Carl von Ossietzky Universitat Oldenburg	Gruendler, TOJ (corresponding author), Max Planck Inst Neurol Res, Cologne, Germany.	theo@gruendler.de	Ullsperger, Markus/E-2797-2010; Gruendler, Theo OJ/H-4486-2012; Ullsperger, Markus/I-4760-2019	Ullsperger, Markus/0000-0003-3970-1982; Gruendler, Theo OJ/0000-0002-5631-7352; Ullsperger, Markus/0000-0003-3970-1982				Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Baker TE, 2011, BIOL PSYCHOL, V87, P25, DOI 10.1016/j.biopsycho.2011.01.010; Baym CL, 2008, BRAIN, V131, P165, DOI 10.1093/brain/awm278; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cavanagh JF, 2010, NEUROPSYCHOLOGIA, V48, P2098, DOI 10.1016/j.neuropsychologia.2010.03.031; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DEHAENE S, 1994, PSYCHOL SCI; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eichele H, 2010, CHILD NEUROPSYCHOL, V16, P162, DOI 10.1080/09297040903150182; Endrass T, 2008, NEUROPSYCHOLOGIA, V46, P1877, DOI 10.1016/j.neuropsychologia.2007.12.001; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; FISSENI HJ, 1997, LEHRBUCH PSYCHOL; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fornito A, 2004, CEREB CORTEX, V14, P424, DOI 10.1093/cercor/bhh004; Fornito A, 2006, SCHIZOPHR RES, V88, P192, DOI 10.1016/j.schres.2006.06.034; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gentsch A, 2009, NEUROIMAGE, V47, P2023, DOI 10.1016/j.neuroimage.2009.05.064; Grundler TOJ, 2009, NEUROPSYCHOLOGIA, V47, P1978, DOI 10.1016/j.neuropsychologia.2009.03.010; Heldmann M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-33; HELMSTADTER GC, 1964, PRINCIPLES PSYCHOL M, P248; Hochman EY, 2009, LATERALITY, V14, P618, DOI 10.1080/13576500902823463; Hochman EY, 2004, BRAIN COGNITION, V55, P314, DOI 10.1016/j.bandc.2004.02.030; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Holroyd CB, 2008, CORTEX, V44, P548, DOI 10.1016/j.cortex.2007.08.013; Holroyd CB, 2007, PSYCHOPHYSIOLOGY, V44, P913, DOI 10.1111/j.1469-8986.2007.00561.x; Hugdahl K, 2000, ACTA PSYCHOL, V105, P211, DOI 10.1016/S0001-6918(00)00062-7; Huster RJ, 2011, NEUROIMAGE, V56, P1588, DOI 10.1016/j.neuroimage.2011.03.039; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; Huster RJ, 2011, BRAIN STRUCT FUNCT, V215, P225, DOI 10.1007/s00429-010-0289-2; Huster RJ, 2009, HUM BRAIN MAPP, V30, P1279, DOI 10.1002/hbm.20594; Jackson GM, 2007, EXP BRAIN RES, V182, P357, DOI 10.1007/s00221-007-0999-8; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Kline RB, 2004, SIGNIFICANCE TESTING, P325; Koenig T, 2009, ELECT NEUROIMAGING, P25, DOI DOI 10.1017/CBO9780511596889; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Liotti M, 2005, CORTEX, V41, P377, DOI 10.1016/S0010-9452(08)70274-0; Lutcke H, 2008, CEREB CORTEX, V18, P508, DOI 10.1093/cercor/bhm090; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Masaki H, 2001, NEUROREPORT, V12, P1851, DOI 10.1097/00001756-200107030-00018; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Mueller SC, 2006, CURR BIOL, V16, P570, DOI 10.1016/j.cub.2006.01.064; Muller SV, 2005, CLIN NEUROPHYSIOL, V116, P63, DOI 10.1016/j.clinph.2004.07.009; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Ocklenburg S, 2011, NEUROIMAGE, V55, P1771, DOI 10.1016/j.neuroimage.2011.01.035; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Olvet DM, 2009, BRAIN RES, V1284, P89, DOI 10.1016/j.brainres.2009.05.079; PERRIN F, 1990, J CLIN NEUROPHYSIOL, V7, P498, DOI 10.1097/00004691-199010000-00005; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peterson BS, 1998, ARCH GEN PSYCHIAT, V55, P326, DOI 10.1001/archpsyc.55.4.326; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Ramautar JR, 2006, BIOL PSYCHOL, V72, P96, DOI 10.1016/j.biopsycho.2005.08.001; Ramautar JR, 2004, BRAIN COGNITION, V56, P234, DOI 10.1016/j.bandc.2004.07.002; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riesel A, 2011, AM J PSYCHIAT, V168, P317, DOI 10.1176/appi.ajp.2010.10030416; Rosenthal R, 1994, HDB RES SYNTHESIS, P231; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Ullsperger M, 2006, INT J PSYCHOPHYSIOL, V59, P59, DOI 10.1016/j.ijpsycho.2005.06.010; van Gaal S, 2011, J COGNITIVE NEUROSCI, V23, P91, DOI 10.1162/jocn.2010.21431; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Van 't Ent D, 1999, CLIN NEUROPHYSIOL, V110, P1058, DOI 10.1016/S1388-2457(98)00036-4; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; WAGNER M, 2007, INT C SER, P185; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040; ZAIDEL E, 1990, NEUROBIOLOGY HIGHER	83	55	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25591	10.1371/journal.pone.0025591	http://dx.doi.org/10.1371/journal.pone.0025591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039418	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500016
J	Pascoe, S; Wilcox, C; Donlan, CJ				Pascoe, Sean; Wilcox, Chris; Donlan, C. Josh			Biodiversity Offsets: A Cost-Effective Interim Solution to Seabird Bycatch in Fisheries?	PLOS ONE			English	Article							FLESH-FOOTED SHEARWATERS; COMPENSATORY MITIGATION; MARINE BYCATCH; LONGLINE FISHERIES; ECONOMIC-BENEFITS; CONSERVATION; MANAGEMENT; AUSTRALIA; DISCOUNT; ISLANDS	The concept of biodiversity offsets is well established as an approach to environmental management. The concept has been suggested for environmental management in fisheries, particularly in relation to the substantial numbers of non-target species-seabirds in particular-caught and killed as incidental bycatch during fishing activities. Substantial areas of fisheries are being closed to protect these species at great cost to the fishing industry. However, other actions may be taken to offset the impact of fishing on these populations at lower cost to the fishing industry. This idea, however, has attracted severe criticism largely as it does not address the underlying externality problems created by the fishing sector, namely seabird fishing mortality. In this paper, we re-examine the potential role of compensatory mitigation as a fisheries management tool, although from the perspective of being an interim management measure while more long-lasting solutions to the problem are found. We re-model an example previously examined by both proponents and opponents of the approach, namely the cost effectiveness of rodent control relative to fishery area closures for the conservation of a seabird population adversely affected by an Australian tuna fishery. We find that, in the example being examined, invasive rodent eradication is at least 10 times more cost effective than area closures. We conclude that, while this does not solve the actual bycatch problem, it may provide breathing space for both the seabird species and the industry to find longer term means of reducing bycatch.	[Pascoe, Sean] CSIRO Marine & Atmospher Res, Brisbane, Qld, Australia; [Wilcox, Chris] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Donlan, C. Josh] Adv Conservat Strategies, Midway, UT USA; [Donlan, C. Josh] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Cornell University	Pascoe, S (corresponding author), CSIRO Marine & Atmospher Res, Brisbane, Qld, Australia.	sean.pascoe@csiro.au	Wilcox, Chris/A-3585-2010; Pascoe, Sean/D-9710-2011	Wilcox, Chris/0000-0002-5983-657X; Pascoe, Sean/0000-0001-6581-2649	National Center for Ecological Analysis and Synthesis; NSF [DEB-0553768]; University of California Santa Barbara; State of California; Australian Government	National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California Santa Barbara(University of California System); State of California; Australian Government(Australian GovernmentCGIAR)	This work was conducted as a part of the 'Exploring Compensatory Mitigation and Markets as Mechanisms for Resolving Fisheries Bycatch and Biodiversity Conservation Conflicts' Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant #DEB-0553768), the University of California Santa Barbara, and the State of California. Support for SP and CW has been provided through the Commonwealth Environment Research Facilities (CERF) program, an Australian Government initiative supporting world class, public good research. The CERF Marine Biodiversity Hub is a collaborative partnership between the University of Tasmania, CSIRO Wealth from Oceans Flagship, Geoscience Australia, Australian Institute of Marine Science and Museum Victoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2010, AUSTR FISH STAT 2009; *AFMA, 2008, AUSTR TUN BILLF LONG; Asche F, 2001, ENVIRON RESOUR ECON, V19, P403, DOI 10.1023/A:1011631714874; ATKINSON IAE, 1985, CONSERVATION ISLAND, P35; Baker GB, 2005, BIOL CONSERV, V126, P306, DOI 10.1016/j.biocon.2005.06.001; Baker GB, 2002, EMU, V102, P71, DOI 10.1071/MU01036; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; Brothers NP, 1999, FAO FISHERIES CIRCUL; CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; Cox TA, 2007, CONSERV BIOL, V21, P1155, DOI 10.1111/j.1523-1739.2007.00772.x; Cullen R, 2005, ECOL ECON, V53, P311, DOI 10.1016/j.ecolecon.2004.09.014; Dasgupta P, 2008, J RISK UNCERTAINTY, V37, P141, DOI 10.1007/s11166-008-9049-6; *DEP ENV CLIM CHAN, 2009, MONT ISL SEAB HAB RE; Doak D, 2007, FRONT ECOL ENVIRON, V5, P350, DOI 10.1890/1540-9295(2007)5[350:CMFMBW]2.0.CO;2; Donlan CJ, 2008, BIOL INVASIONS, V10, P1053, DOI 10.1007/s10530-007-9183-0; Eiswerth ME, 2009, ECOL ECON, V68, P2129, DOI 10.1016/j.ecolecon.2009.02.009; *ENV AUSTR, 1998, THREAT AB PLAN INC C; FAO, 2004, STAT WORLD FISH AQ 2; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; FISHER AC, 1975, Q J ECON, V89, P358, DOI 10.2307/1885257; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Groombridge B., 1992, GLOBAL BIODIVERSITY; Haraden J, 2004, ENVIRON RESOUR ECON, V28, P451, DOI 10.1023/B:EARE.0000036773.77566.3d; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Horowitz JK, 2002, ENVIRON RESOUR ECON, V21, P241, DOI 10.1023/A:1014592629514; Huang H, 2007, J ENVIRON MANAGE, V84, P523, DOI 10.1016/j.jenvman.2006.07.008; Hughey KFD, 2003, CONSERV BIOL, V17, P93, DOI 10.1046/j.1523-1739.2003.01317.x; Igual JM, 2006, ANIM CONSERV, V9, P59, DOI 10.1111/j.1469-1795.2005.00005.x; LANE N, 2005, DOMINION POST   0507; Lavers JL, 2010, BIOL INVASIONS, V12, P3839, DOI 10.1007/s10530-010-9776-x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Long JL, 2003, INTRO MAMMALS WORLD; Loomis JB, 1996, ECOL ECON, V18, P197, DOI 10.1016/0921-8009(96)00029-8; Lucchetti A, 2010, REV FISH BIOL FISHER, V20, P141, DOI 10.1007/s11160-009-9126-1; MacPhee R.D.E., 1999, P333; Igual JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004826; MARTIN G, 2005, SAN FRANCISCO C 0805; Martins TLF, 2006, ANIM CONSERV, V9, P439, DOI 10.1111/j.1469-1795.2006.00058.x; MONTGOMERY CA, 1994, J ENVIRON ECON MANAG, V26, P111, DOI 10.1006/jeem.1994.1007; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; Norton DA, 2009, ENVIRON MANAGE, V43, P698, DOI 10.1007/s00267-008-9192-5; PARKES J, 2004, LC030464 LANDC RES; Pascoe S, 2010, INT REV ENVIRON RESO, V4, P123, DOI 10.1561/101.00000032; Priddel D, 2006, BIOL CONSERV, V128, P412, DOI 10.1016/j.biocon.2005.10.007; Priddel D, 2007, FRONT ECOL ENVIRON, V5, P407, DOI 10.1890/i1540-9295-5-8-407.1; Punt AE, 2011, FISH RES, V109, P201, DOI 10.1016/j.fishres.2011.02.006; Schippers P, 2009, POPUL ECOL, V51, P459, DOI 10.1007/s10144-009-0159-z; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Stapp P, 2002, J APPL ECOL, V39, P831, DOI 10.1046/j.1365-2664.2002.00754.x; ten Kate K., 2004, BIODIVERSITY OFFSETS; Thalmann SJ, 2009, J WILDLIFE MANAGE, V73, P399, DOI 10.2193/2007-461; Vieira S., 2010, IMPACT STRUCTURAL AD; Watzold F, 2005, BIOL CONSERV, V123, P327, DOI 10.1016/j.biocon.2004.12.001; Weitzman ML, 1998, J ENVIRON ECON MANAG, V36, P201, DOI 10.1006/jeem.1998.1052; WEITZMAN ML, 1994, J ENVIRON ECON MANAG, V26, P200, DOI 10.1006/jeem.1994.1012; WILCOX C, 2010, PREDICTING IMPACT HO; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2; Zydelis R, 2009, CONSERV BIOL, V23, P608, DOI 10.1111/j.1523-1739.2009.01172.x; 2006, FEDERAL AGENCY CUTS	61	20	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25762	10.1371/journal.pone.0025762	http://dx.doi.org/10.1371/journal.pone.0025762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039422	Green Published, gold			2022-12-25	WOS:000296507500019
J	Aguirre, J; Buldu, JM; Stich, M; Manrubia, SC				Aguirre, Jacobo; Buldu, Javier M.; Stich, Michael; Manrubia, Susanna C.			Topological Structure of the Space of Phenotypes: The Case of RNA Neutral Networks	PLOS ONE			English	Article							SEQUENCE STRUCTURE MAPS; SMALL-WORLD; EXHAUSTIVE ENUMERATION; SECONDARY; ORGANIZATION; REPERTOIRE; PREDICTION; STABILITY; EVOLUTION; DYNAMICS	The evolution and adaptation of molecular populations is constrained by the diversity accessible through mutational processes. RNA is a paradigmatic example of biopolymer where genotype (sequence) and phenotype (approximated by the secondary structure fold) are identified in a single molecule. The extreme redundancy of the genotype-phenotype map leads to large ensembles of RNA sequences that fold into the same secondary structure and can be connected through single-point mutations. These ensembles define neutral networks of phenotypes in sequence space. Here we analyze the topological properties of neutral networks formed by 12-nucleotides RNA sequences, obtained through the exhaustive folding of sequence space. A total of 4 12 sequences fragments into 645 subnetworks that correspond to 57 different secondary structures. The topological analysis reveals that each subnetwork is far from being random: it has a degree distribution with a well-defined average and a small dispersion, a high clustering coefficient, and an average shortest path between nodes close to its minimum possible value, i.e. the Hamming distance between sequences. RNA neutral networks are assortative due to the correlation in the composition of neighboring sequences, a feature that together with the symmetries inherent to the folding process explains the existence of communities. Several topological relationships can be analytically derived attending to structural restrictions and generic properties of the folding process. The average degree of these phenotypic networks grows logarithmically with their size, such that abundant phenotypes have the additional advantage of being more robust to mutations. This property prevents fragmentation of neutral networks and thus enhances the navigability of sequence space. In summary, RNA neutral networks show unique topological properties, unknown to other networks previously described.	[Aguirre, Jacobo; Stich, Michael; Manrubia, Susanna C.] CSIC INTA, Ctr Astrobiol, Madrid, Spain; [Buldu, Javier M.] Univ Rey Juan Carlos, Complex Syst Grp, Madrid, Spain; [Buldu, Javier M.] UPM Campus Montegancedo, Ctr Biomed Technol, Lab Biol Networks, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Universidad Rey Juan Carlos; Universidad Politecnica de Madrid	Aguirre, J (corresponding author), CSIC INTA, Ctr Astrobiol, Madrid, Spain.	scmanrubia@cab.inta-csic.es	Manrubia, Susanna/K-4501-2014; Buldu, Javier Martin/R-8167-2018; Buldu, Javier/N-5422-2014; Aguirre, Jacobo/K-5855-2014	Manrubia, Susanna/0000-0003-0134-2785; Buldu, Javier/0000-0002-9345-599X; Aguirre, Jacobo/0000-0003-2196-5103	Spanish Ministry of Science and Innovation [FIS08-05273, FIS09-07072]; Comunidad de Madrid [MODELICO-CM S2009ESP-1691]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Spanish Ministry of Science and Innovation, grants FIS08-05273 and FIS09-07072; and Comunidad de Madrid, R&D Program of activities, grant MODELICO-CM S2009ESP-1691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066112; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B., 1985, RANDOM GRAPHS; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Casella DA, 2005, IEEE C EVOL COMPUTAT, P2499; Cowperthwaite MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000110; Diaz-Guilera A, 2009, INT J BIFURCAT CHAOS, V19, P687, DOI 10.1142/S0218127409023044; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FONTANA W, 1993, BIOPOLYMERS, V33, P1389, DOI 10.1002/bip.360330909; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gan HH, 2003, NUCLEIC ACIDS RES, V31, P2926, DOI 10.1093/nar/gkg365; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gruner W, 1996, MONATSH CHEM, V127, P355, DOI 10.1007/BF00810881; Gruner W, 1996, MONATSH CHEM, V127, P375, DOI 10.1007/BF00810882; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Gursoy A, 2008, BIOCHEM SOC T, V36, P1398, DOI 10.1042/BST0361398; Higgs PG, 1998, GENETICA, V102-3, P91, DOI 10.1023/A:1017059530664; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jorg T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-464; Kautz WH, 1958, IRE T ELECT COMPUTER, V7, P177, DOI DOI 10.1109/TEC.1958.5222529; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Penrose M., 2003, RANDOM GEOMETRIC GRA; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reidys C, 1997, B MATH BIOL, V59, P339, DOI 10.1016/S0092-8240(96)00089-4; Reidys C, 2001, B MATH BIOL, V63, P57, DOI 10.1006/bulm.2000.0206; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Schuster P, 2006, REP PROG PHYS, V69, P1419, DOI 10.1088/0034-4885/69/5/R04; Schuster Peter, 2003, P163; Stich M, 2008, J THEOR BIOL, V252, P750, DOI 10.1016/j.jtbi.2008.02.018; Stich M, 2011, J THEOR BIOL, V280, P117, DOI 10.1016/j.jtbi.2011.03.010; Tanaka R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.168101; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Wuchty Stefan, 2006, P165; Yook SH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.045105; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	60	52	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26324	10.1371/journal.pone.0026324	http://dx.doi.org/10.1371/journal.pone.0026324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028856	Green Published, Green Accepted, gold			2022-12-25	WOS:000296186900049
J	Kaeffer, B; Legrand, A; Moyon, T; Frondas-Chauty, A; Billard, H; Guzman-Quevedo, O; Darmaun, D; Roze, JC				Kaeffer, Bertrand; Legrand, Arnaud; Moyon, Thomas; Frondas-Chauty, Anne; Billard, Helene; Guzman-Quevedo, Omar; Darmaun, Dominique; Roze, Jean-Christophe			Non-Invasive Exploration of Neonatal Gastric Epithelium by Using Exfoliated Epithelial Cells	PLOS ONE			English	Article							PREMATURE-INFANTS; UP-REGULATION; STEM-CELLS; EXPRESSION; AUTOPHAGY; MECHANISMS; APOPTOSIS; STOMACH; DEFENSE; STOOL	Background & Aims: In preterm infants, exfoliated gastric epithelial cells can be retrieved from aspirates sampled through the naso-gastric feeding tube. Our aims were to determine (1) whether the recovery of exfoliated cells is feasible at any time from birth through the removal of the nasogastric tube, (2) whether they can be grown in culture in vitro, and (3) whether the physiological state of exfoliated cells expressing H+/K+-ATPases reflects that of their counterparts remaining in situ at the surface of the gastric epithelium in neonatal rat pups. Methods: In infants, gastric fluid aspirates were collected weekly after birth or every 3 hours over 24-h periods, and related to clinical parameters (Biocollection PROG/09/18). In rat pups submitted to a single fasting/refeeding cycle, we explored circadian exfoliation with the cellular counter-parts in the gland. All samples were analyzed by confocal imaging and Enzyme-Linked Immunosorbent Assay. Results: Epithelial cells were identified by microscopy using membrane-bound anti-H+/K+ ATPases antibody, assessed for nucleus integrity, and the expression of selected proteins (autophagy, circadian clock). On 34 infants, the H+/K+ -ATPase-positive cells were consistently found quiescent, regardless of gestational age and feeding schedule from day-5 of life to the day of removal of the naso-gastric tube. By logistic regression analysis, we did find a positive correlation between the intensity of exfoliation (cellular loss per sample) and the postnatal age (p, 0.001). The H+/K+ ATPase-positive cells established in culture retained the expression of a biomarker of progenitor status (Pouf5F1-Oct4). In rat pups, the expression pattern of Survivin in H+/K+ ATPase-positive exfoliated cells paralleled that observed in cells remaining at the surface of the gastric gland. Conclusions: Tracking parietal cells can improve clinical monitoring and understanding of the autophagic death via the phosphatidylinositol 3-kinase/Akt/survivin pathway.	[Kaeffer, Bertrand; Moyon, Thomas; Billard, Helene; Guzman-Quevedo, Omar; Darmaun, Dominique] INRA, UMR 1280, F-44026 Nantes, France; [Legrand, Arnaud; Frondas-Chauty, Anne; Darmaun, Dominique; Roze, Jean-Christophe] Univ Nantes, Hosp Mother & Child, Nantes, France	INRAE; Nantes Universite; CHU de Nantes	Kaeffer, B (corresponding author), INRA, UMR 1280, F-44026 Nantes, France.	Bertrand.Kaeffer@univ-nantes.fr	Quevedo, omar Guzman/AAG-6327-2020; Rozé, Jean-Christophe/AAS-1314-2021; Darmaun, Dominique/X-8453-2018; roze, jean christophe/B-5433-2012; Guzman Quevedo, Omar/ABU-5276-2022	Quevedo, omar Guzman/0000-0003-1358-1783; Darmaun, Dominique/0000-0002-0366-3227; Guzman Quevedo, Omar/0000-0003-1358-1783; Roze, Jean-Christophe/0000-0003-3367-512X; MOYON, Thomas/0000-0002-8308-8719; BILLARD, HELENE/0000-0002-1183-2959; Kaeffer, Bertrand/0000-0003-2459-5072	Departement Alimentation Humaine (Inra, France) [ANSSD-2008]; Region Pays de la Loire, France [PremaCol-2008]	Departement Alimentation Humaine (Inra, France); Region Pays de la Loire, France(Region Pays de la Loire)	The authors are grateful for receiving financial support from ANSSD-2008 Departement Alimentation Humaine (Inra, France); and PremaCol-2008 (Region Pays de la Loire, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama F, 2008, HISTOCHEM CELL BIOL, V129, P785, DOI 10.1007/s00418-008-0403-1; Bandaletova T, 2002, APMIS, V110, P239, DOI 10.1034/j.1600-0463.2002.100306.x; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010; Chen A, 2010, J MATERN-FETAL NEO M, V23, P1172, DOI 10.3109/14767051003677947; Chiou SK, 2003, BIOCHEM BIOPH RES CO, V305, P374, DOI 10.1016/S0006-291X(03)00724-1; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dimaline R, 2007, EXP PHYSIOL, V92, P591, DOI 10.1113/expphysiol.2006.036483; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Godlewski MM, 2007, J PHYSIOL PHARMACOL, V58, P97; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Kaeffer B, 2007, PEDIATR RES, V62, P564, DOI 10.1203/PDR.0b013e318155a402; Kitazawa H, 2004, J BIOL CHEM, V279, P42867, DOI 10.1074/jbc.M408047200; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Martinet W, 2006, AUTOPHAGY, V2, P55, DOI 10.4161/auto.2217; Nomura S, 1998, DEV BIOL, V204, P124, DOI 10.1006/dbio.1998.9055; Orozco-Solis R, 2011, INT J OBESITY, V35, P990, DOI 10.1038/ijo.2010.223; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Rivkees SA, 2004, PEDIATRICS, V113, P833, DOI 10.1542/peds.113.4.833; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Sachdeva UM, 2008, AUTOPHAGY, V4, P581, DOI 10.4161/auto.6141; Sawaguchi A, 2004, J HISTOCHEM CYTOCHEM, V52, P77, DOI 10.1177/002215540405200108; Tarnawski A, 2007, GASTROENTEROLOGY, V133, P1938, DOI 10.1053/j.gastro.2007.08.037; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25562	10.1371/journal.pone.0025562	http://dx.doi.org/10.1371/journal.pone.0025562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028779	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900008
J	Pham, LL; Garot, C; Brue, T; Brauner, R				Luu-Ly Pham; Garot, Christelle; Brue, Thierry; Brauner, Raja			Clinical, Biological and Genetic Analysis of 8 Cases of Congenital Isolated Adrenocorticotrophic Hormone (ACTH) Deficiency	PLOS ONE			English	Article							TPIT GENE; ADRENAL INSUFFICIENCY; EARLY-ONSET; MUTATIONS; OBESITY; DEATH	Background: Congenital isolated adrenocorticotrophic hormone (ACTH) deficiency may be rare, but it could be an underestimated cause of neonatal death. Our objective was to shorten the time between first symptoms and diagnosis. Methods: This single-centre retrospective case-cohort study was carried out on eight consecutive patients. Results: Two had the neonatal form and 6 the late onset form. Six were admitted to an intensive care unit at least once for seizures with hypoglycemia, major hypothermia, fever, and/or collapsus. The 2 neonatal cases presented with hypoglycemia and in a state of "apparent death" at birth or hypothermia (29 degrees C) at 6 days. All 6 late onset cases had also been admitted to an emergency department 1-3 times, but had left hospital incorrectly diagnosed. Their first symptoms were noted at 3-12.3 years, and they were diagnosed at 3.3-14.4 years. All had hypoglycemia, and 4 had had seizures. The presenting symptoms were vomiting and/or abdominal pain, asthenia, irritability, difficulty with physical activities, and anorexia. The school performance of 4 deteriorated. Two underwent psychotherapy and treatment for depression, which was stopped when Hydrocortisone (R) replacement therapy began. The plasma concentrations in spontaneous hypoglycemia were: ACTH<5 to 17.1 pg/mL, with concomitant cortisol <3.5 to 37 ng/mL. The plasma dehydroepiandrosterone sulfate (DHAS) concentrations were low in the 7 evaluated. The coding sequence of TPIT was normal in all. Conclusion: Several unexplained symptoms in a child, mainly gastro-intestinal symptoms and seizures due to hypoglycemia, may indicate ACTH deficiency. A low or normal basal plasma ACTH despite concomitant low cortisol at 8 a. m. and/or in spontaneous hypoglycemia, associated with low DHAS, in a patient not given corticosteroids is highly suggestive of ACTH deficiency. The isolated character of ACTH deficiency must be confirmed by determining the other hypothalamic-pituitary functions, and Hydrocortisone (R) replacement therapy initiated in emergency.	[Luu-Ly Pham; Garot, Christelle; Brauner, Raja] Univ Paris 05, Sorbonne Paris Cite, France; [Luu-Ly Pham; Garot, Christelle; Brauner, Raja] Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France; [Brue, Thierry] CHU Timone, AP HP, Ctr Reference Malad Rares Origine Hypophysaire, Marseille, France; [Brue, Thierry] Univ Aix Marseille 2, Marseille, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Pham, LL (corresponding author), Univ Paris 05, Sorbonne Paris Cite, France.	raja.brauner@wanadoo.fr	Brue, Thierry/AAI-2328-2019; Brue, Thierry/P-6571-2019	Brue, Thierry/0000-0001-8482-6691; Brue, Thierry/0000-0001-8482-6691				ADAN L, 1994, J CLIN ENDOCR METAB, V78, P478, DOI 10.1210/jc.78.2.478; Bremer AA, 2008, J PEDIATR ENDOCR MET, V21, P799; FOREST MG, 1992, FUNCTIONAL ENDOCRINO, P248; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Louvel M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-29; MCEACHERN R, 2011, J CLIN ENDOCRIN 0713; Metherell LA, 2004, EUR J ENDOCRINOL, V151, P463, DOI 10.1530/eje.0.1510463; Nasrallah MP, 2003, J CLIN ENDOCR METAB, V88, P5293, DOI 10.1210/jc.2003-030449; Nozue H, 2007, PEDIATR INT, V49, P522, DOI 10.1111/j.1442-200X.2007.02417.x; Shulman DI, 2007, PEDIATRICS, V119, pE484, DOI 10.1542/peds.2006-1612; STEINBERG A, 1954, J CLIN ENDOCR METAB, V14, P1519, DOI 10.1210/jcem-14-12-1519; Vallette-Kasic S, 2005, J CLIN ENDOCR METAB, V90, P1323, DOI 10.1210/jc.2004-1300; Vallette-Kasic S, 2007, J CLIN ENDOCR METAB, V92, P3991, DOI 10.1210/jc.2007-0284; Weintrob N, 2006, PEDIATRICS, V117, pE322, DOI 10.1542/peds.2005-1973	15	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26516	10.1371/journal.pone.0026516	http://dx.doi.org/10.1371/journal.pone.0026516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028893	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900071
J	Streicher, S; Boyles, JG; Oosthuizen, MK; Bennett, NC				Streicher, Sonja; Boyles, Justin G.; Oosthuizen, Maria K.; Bennett, Nigel C.			Body Temperature Patterns and Rhythmicity in Free-Ranging Subterranean Damaraland Mole-Rats, Fukomys damarensis	PLOS ONE			English	Article							CRYPTOMYS-DAMARENSIS; LOCOMOTOR-ACTIVITY; ENERGY AVAILABILITY; CIRCADIAN-RHYTHMS; TORPOR; ENERGETICS; RODENTIA; BATHYERGIDAE; SOLITARY; HETEROTHERMY	Body temperature (T-b) is an important physiological component that affects endotherms from the cellular to whole organism level, but measurements of T-b in the field have been noticeably skewed towards heterothermic species and seasonal comparisons are largely lacking. Thus, we investigated patterns of T-b patterns in a homeothermic, free-ranging small mammal, the Damaraland mole-rat (Fukomys damarensis) during both the summer and winter. Variation in T-b was significantly greater during winter than summer, and greater among males than females. Interestingly, body mass had only a small effect on variation in T-b and there was no consistent pattern relating ambient temperature to variation in T-b. Generally speaking, it appears that variation in T-b patterns varies between seasons in much the same way as in heterothermic species, just to a lesser degree. Both cosinor analysis and Fast Fourier Transform analysis revealed substantial individual variation in T-b rhythms, even within a single colony. Some individuals had no T-b rhythms, while others appeared to exhibit multiple rhythms. These data corroborate previous laboratory work showing multiplicity of rhythms in mole-rats and suggest the variation seen in the laboratory is a true indicator of the variation seen in the wild.	[Streicher, Sonja; Boyles, Justin G.; Oosthuizen, Maria K.; Bennett, Nigel C.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Bennett, Nigel C.] King Saud Univ, Dept Zool, Riyadh, Saudi Arabia	University of Pretoria; King Saud University	Streicher, S (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	jgboyles@zoology.up.ac.za	Oosthuizen, Maria/U-7276-2019; Boyles, Justin G/A-5152-2010; Oosthuizen, Maria Kathleen/K-7923-2012; Bennett, Nigel/E-4238-2010	Oosthuizen, Maria Kathleen/0000-0001-6305-8283; Bennett, Nigel/0000-0001-9748-2947	NRF; Claude Leon Postdoctoral Research Fellowship; DST-NRF	NRF; Claude Leon Postdoctoral Research Fellowship; DST-NRF(Department of Science & Technology (India))	SS was supported by a NRF Chair bursary during this research. JGB was supported by a Claude Leon Postdoctoral Research Fellowship. The research was supported by a core grant to NCB via the DST-NRF South African research Chair of Mammal Behavioural Ecology and Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; Angilletta MJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P197, DOI 10.1086/648567; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2006, SAS MIXED MODELS; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; ASCHOFF J, 1983, J THERM BIOL, V8, P143, DOI 10.1016/0306-4565(83)90094-3; Barclay RMR, 2001, CAN J ZOOL, V79, P1885, DOI 10.1139/cjz-79-10-1885; BENNETT NC, 1988, J MAMMAL, V69, P293, DOI 10.2307/1381379; Bennett NC, 1996, P ROY SOC B-BIOL SCI, V263, P1599, DOI 10.1098/rspb.1996.0234; BENNETT NC, 1990, J ZOOL, V220, P225, DOI 10.1111/j.1469-7998.1990.tb04305.x; BENNETT NC, 1994, OECOLOGIA, V97, P222, DOI 10.1007/BF00323153; BENNETT NC, 1988, S AFR J ZOOL, V23, P189; BENNETT NC, 1992, J ARID ENVIRON, V23, P189, DOI 10.1016/S0140-1963(18)30530-5; Bennett NC, 2009, AFR ZOOL, V44, P263, DOI 10.3377/004.044.0214; Boyles JG, J EXP ZOO A IN PRESS; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Brown CM, 1996, J THERM BIOL, V21, P227, DOI 10.1016/0306-4565(96)00006-X; BUFFENSTEIN R, 1991, J THERM BIOL, V16, P227, DOI 10.1016/0306-4565(91)90030-6; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; FANNING FD, 1980, AUST J ZOOL, V28, P229, DOI 10.1071/ZO9800229; Geiser F, 2007, J COMP PHYSIOL B, V177, P495, DOI 10.1007/s00360-007-0147-6; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; Hart L, 2004, PHYSIOL BEHAV, V82, P563, DOI 10.1016/j.physbeh.2004.05.008; Hetem RS, 2009, COMP BIOCHEM PHYS A, V152, P379, DOI 10.1016/j.cbpa.2008.11.011; Hilmer S, 2010, J THERM BIOL, V35, P270, DOI 10.1016/j.jtherbio.2010.06.002; HISLOP MS, 1994, J THERM BIOL, V19, P25, DOI 10.1016/0306-4565(94)90006-X; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; JACOBS DS, 1991, J ZOOL, V224, P553, DOI 10.1111/j.1469-7998.1991.tb03785.x; JARVIS JUM, 1993, BEHAV ECOL SOCIOBIOL, V33, P253, DOI 10.1007/BF02027122; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kotze J, 2008, PHYSIOL BEHAV, V93, P215, DOI 10.1016/j.physbeh.2007.08.016; LABYAK SE, 1995, PHYSIOL BEHAV, V58, P573, DOI 10.1016/0031-9384(95)00096-2; Landry-Cuerrier M, 2008, ECOLOGY, V89, P3306, DOI 10.1890/08-0121.1; LOVEGROVE BG, 1994, AUST J ZOOL, V42, P65, DOI 10.1071/ZO9940065; LOVEGROVE BG, 1986, OECOLOGIA, V69, P551, DOI 10.1007/BF00410361; Lovegrove BG, 1996, PHYSIOL BEHAV, V60, P991; Martinez GS, 2002, BRAIN RES, V955, P1, DOI 10.1016/S0006-8993(02)03264-X; McKechnie AE, 2007, J AVIAN BIOL, V38, P261, DOI 10.1111/j.2007.0908-8857.04116.x; MCNAB BK, 1979, ECOLOGY, V60, P1010, DOI 10.2307/1936869; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P272; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; Pereira ME, 2002, J MAMMAL, V83, P467, DOI 10.1644/1545-1542(2002)083<0467:TOHIEG>2.0.CO;2; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01204.x; REFINETTI R, 1992, J EXP ZOOL, V263, P453, DOI 10.1002/jez.1402630413; Refinetti R, 1999, J THERM BIOL, V24, P477, DOI 10.1016/S0306-4565(99)00077-7; Refinetti R, 1997, ANN NY ACAD SCI, V813, P63, DOI 10.1111/j.1749-6632.1997.tb51673.x; Roper TJ, 2001, J ZOOL, V254, P101, DOI 10.1017/S0952836901000590; Scantlebury M, 2006, NATURE, V440, P795, DOI 10.1038/nature04578; Schabenberger O, 2000, AM STAT, V54, P210, DOI 10.2307/2685592; SCHMIDTNIELSEN K, 1957, AM J PHYSIOL, V188, P103, DOI 10.1152/ajplegacy.1956.188.1.103; Signer C, 2011, FUNCT ECOL, V25, P537, DOI 10.1111/j.1365-2435.2010.01806.x; Smit B, J BIOL RHYT IN PRESS; Smit B, 2010, PHYSIOL BIOCHEM ZOOL, V83, P149, DOI 10.1086/605457; Stawski C, 2010, J EXP BIOL, V213, P393, DOI 10.1242/jeb.038224; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Warnecke L, 2007, J THERM BIOL, V32, P72, DOI 10.1016/j.jtherbio.2006.10.003; Willis CKR, 2007, PHYSIOL BIOCHEM ZOOL, V80, P643, DOI 10.1086/521085; Withers PC, 2000, AUST J ZOOL, V48, P241, DOI 10.1071/ZO99073; Wooden KM, 2004, J EXP BIOL, V207, P41, DOI 10.1242/jeb.00717; Zelova J, 2007, COMP BIOCHEM PHYS A, V147, P412, DOI 10.1016/j.cbpa.2007.01.002	62	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26346	10.1371/journal.pone.0026346	http://dx.doi.org/10.1371/journal.pone.0026346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028861	gold, Green Published			2022-12-25	WOS:000296186900052
J	Abramov, AY; Gegg, M; Grunewald, A; Wood, NW; Klein, C; Schapira, AHV				Abramov, Andrey Yurevich; Gegg, Matthew; Grunewald, Anne; Wood, Nicholas William; Klein, Christine; Schapira, Anthony Henry Vernon			Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; PINK1/PARKIN PATHWAY; OXIDATIVE STRESS; NEURODEGENERATION; MITOPHAGY; MORPHOLOGY; MITOFUSIN; DEFECTS; CALCIUM; DNA	Background: Mutations of the gene for PTEN-induced kinase 1 (PINK1) are a cause of familial Parkinson's disease (PD). PINK1 protein has been localised to mitochondria and PINK1 gene knockout models exhibit abnormal mitochondrial function. The purpose of this study was to determine whether cells derived from PD patients with a range of PINK1 mutations demonstrate similar defects of mitochondrial function, whether the nature and severity of the abnormalities vary between mutations and correlate with clinical features. Methodology: We investigated mitochondrial bioenergetics in live fibroblasts from PINK1 mutation patients using single cell techniques. We found that fibroblasts from PINK1 mutation patients had significant defects of bioenergetics including reduced mitochondrial membrane potential, altered redox state, a respiratory deficiency that was determined by substrate availability, and enhanced sensitivity to calcium stimulation and associated mitochondrial permeability pore opening. There was an increase in the basal rate of free radical production in the mutant cells. The pattern and severity of abnormality varied between different mutations, and the less severe defects in these cells were associated with later age of onset of PD. Conclusions: The results provide insight into the molecular pathology of PINK1 mutations in PD and also confirm the critical role of substrate availability in determining the biochemical phenotype - thereby offering the potential for novel therapeutic strategies to circumvent these abnormalities.	[Abramov, Andrey Yurevich; Wood, Nicholas William] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Gegg, Matthew; Schapira, Anthony Henry Vernon] UCL Inst Neurol, Dept Clin Neurosci, London, England; [Grunewald, Anne; Klein, Christine] Univ Lubeck, Dept Neurol, Lubeck, Germany	University of London; University College London; University of London; University College London; University of Lubeck	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London, England.	a.abramov@ucl.ac.uk; a.schapira@ucl.ac.uk	Schapira, Anthony H V/A-1245-2010; Abramov, Andrey Y/H-9053-2012; Gegg, Matthew E/B-4826-2011; Klein, Christine/AGK-8003-2022; Grünewald, Anne/ABD-1255-2021; Wood, Nicholas W/C-2505-2009; Abramov, Andrey/AAC-6712-2019	Schapira, Anthony H V/0000-0002-3018-3966; Abramov, Andrey Y/0000-0002-7646-7235; Gegg, Matthew E/0000-0001-8093-0723; Grünewald, Anne/0000-0002-4179-2994; Wood, Nicholas W/0000-0002-9500-3348; Abramov, Andrey/0000-0002-7646-7235; Klein, Christine/0000-0003-2102-3431	Wellcome Trust/MRC [WT089698]; Kattan Trust; Medical Research Council [MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [F-0806, K-0803, G-0612] Funding Source: researchfish; MRC [MC_G1000735] Funding Source: UKRI	Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Kattan Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC), and by Kattan Trust. Dr. Abramov is a Parkinson's UK Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Hedrich K, 2006, ARCH NEUROL-CHICAGO, V63, P833, DOI 10.1001/archneur.63.6.833; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com; Tan EK, 2006, MOVEMENT DISORD, V21, P789, DOI 10.1002/mds.20810; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	29	74	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25622	10.1371/journal.pone.0025622	http://dx.doi.org/10.1371/journal.pone.0025622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043288	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400015
J	Muller, GA; Hansen, U; Xu, Z; Griswold, B; Talan, MI; McDonnell, NB; Briest, W				Mueller, Gerd A.; Hansen, Uwe; Xu, Zhi; Griswold, Benjamin; Talan, Mark I.; McDonnell, Nazli B.; Briest, Wilfried			Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts	FASEB JOURNAL			English	Article						extracellular matrix; collagen; RNA interference	SYNDROME TYPE-IV; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MARFAN-SYNDROME; RNAI; HAPLOINSUFFICIENCY; DISCRIMINATION; BIOGENESIS; DEATH; MODEL	The vascular type of the Ehlers-Danlos syndrome (vEDS) is caused by dominant-negative mutations in the procollagen type III (COL3A1) gene. Patients with this autosomal dominant disorder have a shortened life expectancy due to complications from ruptured vessels or hollow organs. We tested the effectiveness of allele-specific RNA interference (RNAi) to reduce the mutated phenotype in fibroblasts. Small-interfering RNAs (siRNAs) discriminating between wild-type and mutant COL3A1 allele were identified by a luciferase reporter gene assay and in primary fibroblasts from a normal donor and a patient with vEDS. The best discriminative siRNA with the mutation at position 10 resulted in >90% silencing of the mutant allele without affecting the wild-type allele. Transmission and immunogold electron microscopy of extracted extracellular matrices from untreated fibroblasts of the patient with vEDS revealed structurally abnormal fibrils. After siRNA treatment, collagen fibrils became similar to fibrils from fibroblasts of normal and COL3A1 haploinsufficient donors. In addition, it was shown that expression of mutated COL3A1 activates the unfolded protein response and that reduction of the amount of mutated protein by siRNA reduces cellular stress. Taken together, the results provide evidence that allele-specific siRNAs are able to reduce negative effects of mutated COL3A1 proteins. Thus, the application of allele-specific RNAi may be a promising direction for future personalized therapies to reduce the severity of vEDS.-Muller, G. A., Hansen, U., Xu, Z., Griswold, B., Talan, M. I., McDonnell, N. B., Briest, W. Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts. FASEB J. 26, 668-677 (2012). www.fasebj.org	[Mueller, Gerd A.; Talan, Mark I.; Briest, Wilfried] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Xu, Zhi; Griswold, Benjamin; McDonnell, Nazli B.] NIA, Clin Invest Lab, Baltimore, MD 21224 USA; [Hansen, Uwe] Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, Munster, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Munster	Briest, W (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.	wilfried.briest@arcor.de	Müller, Gerd Armin/AAO-6714-2021; Briest, Wilfried/AAE-5820-2019; Müller, Gerd Armin/GYU-9447-2022; Xu, Zhi/I-2546-2012	Müller, Gerd Armin/0000-0002-4967-2487; Briest, Wilfried/0000-0003-4556-4849; Müller, Gerd Armin/0000-0002-4967-2487; 	U.S. National Institutes of Health, National Institute on Aging (NIA; Bethesda, MD, USA); NATIONAL INSTITUTE ON AGING [ZIAAG000865, ZIAAG000666] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging (NIA; Bethesda, MD, USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was fully funded by the Intramural Research Program of the U.S. National Institutes of Health, National Institute on Aging (NIA; Bethesda, MD, USA). The authors are indebted to Shannon Marshall (NIA), Gerburg Hoelscher (University Hospital of Munster), and Barbara Schedding (University Hospital of Munster) for expert technical assistance. The authors owe special thanks to Kenneth R. Boheler (NIA) for helpful discussions.	Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Briest W, 2011, J PHARMACOL EXP THER, V337, P621, DOI 10.1124/jpet.110.177782; Callewaert B, 2008, BEST PRACT RES CL RH, V22, P165, DOI 10.1016/j.berh.2007.12.005; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384; Germain DP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-32; HAUSSER I, 1994, HUM GENET, V93, P394; Hickerson RP, 2008, J INVEST DERMATOL, V128, P594, DOI 10.1038/sj.jid.5701060; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Khalique Z, 2009, EUR J VASC ENDOVASC, V38, P608, DOI 10.1016/j.ejvs.2009.07.009; Klootwijk RD, 2008, FASEB J, V22, P3846, DOI 10.1096/fj.08-110890; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Leistritz DF, 2011, GENET MED, V13, P717, DOI 10.1097/GIM.0b013e3182180c89; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Millington-Ward S, 2004, EUR J HUM GENET, V12, P864, DOI 10.1038/sj.ejhg.5201230; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Ong KT, 2010, LANCET, V376, P1476, DOI 10.1016/S0140-6736(10)60960-9; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Plancke A, 2009, EUR J HUM GENET, V17, P1411, DOI 10.1038/ejhg.2009.76; Pyeritz RE, 2000, NEW ENGL J MED, V342, P730, DOI 10.1056/NEJM200003093421009; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Stenson P. D, 2009, HUMAN GENE MUTATION, V2010; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Than Naing B., 2010, 60 ANN M AM SOC HUM; Watanabe Atsushi, 2008, Journal of Nippon Medical School, V75, P254, DOI 10.1272/jnms.75.254; Whiteman P, 2007, HUM MOL GENET, V16, P907, DOI 10.1093/hmg/ddm035; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	37	15	17	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					668	677		10.1096/fj.11-182162	http://dx.doi.org/10.1096/fj.11-182162			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22038052	Green Published			2022-12-25	WOS:000300485700019
J	Wildling, L; Rankl, C; Haselgrubler, T; Gruber, HJ; Holy, M; Newman, AH; Zou, MF; Zhu, R; Freissmuth, M; Sitte, HH; Hinterdorfer, P				Wildling, Linda; Rankl, Christian; Haselgruebler, Thomas; Gruber, Hermann J.; Holy, Marion; Newman, Amy Hauck; Zou, Mu-Fa; Zhu, Rong; Freissmuth, Michael; Sitte, Harald H.; Hinterdorfer, Peter			Probing Binding Pocket of Serotonin Transporter by Single Molecular Force Spectroscopy on Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; MONOAMINE TRANSPORTERS; BACTERIAL HOMOLOG; MICROSCOPE TIPS; AMPHETAMINES; LEUT; RECOGNITION; RECEPTORS; ATTACHMENT	The serotonin transporter (SERT) terminates neurotransmission by removing serotonin from the synaptic cleft. In addition, it is the site of action of antidepressants (which block the transporter) and of amphetamines (which induce substrate efflux). The interaction energies involved in binding of such compounds to the transporter are unknown. Here, we used atomic force microscopy (AFM) to probe single molecular interactions between the serotonin transporter and MFZ2-12 (a potent cocaine analog) in living CHOK1 cells. For the AFM measurements, MFZ2-12 was immobilized on AFM tips by using a heterobifunctional cross-linker. By varying the pulling velocity in force distance cycles drug-transporter complexes were ruptured at different force loadings allowing for mapping of the interaction energy landscape. We derived chemical rate constants from these recordings and compared them with those inferred from inhibition of transport and ligand binding: k(off) values were in good agreement with those derived from uptake experiments; in contrast, the k(on) values were scaled down when determined by AFM. Our observations generated new insights into the energy landscape of the interaction between SERT and inhibitors. They thus provide a useful framework for molecular dynamics simulations by exploring the range of forces and energies that operate during the binding reaction.	[Wildling, Linda; Gruber, Hermann J.; Zhu, Rong; Hinterdorfer, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Rankl, Christian] Austria GmbH, Agilent Technol, A-4040 Linz, Austria; [Haselgruebler, Thomas; Hinterdorfer, Peter] Ctr Adv Bioanal, A-4020 Linz, Austria; [Holy, Marion; Freissmuth, Michael; Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Newman, Amy Hauck; Zou, Mu-Fa] Natl Inst Drug Abuse, Med Chem Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program, Baltimore, MD 21224 USA	Johannes Kepler University Linz; Agilent Technologies; Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Hinterdorfer, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	peter.hinterdorfer@jku.at	Sitte, Harald/O-7025-2019; Hinterdorfer, Peter/C-4235-2013; Sitte, Harald/N-2681-2013; Gruber, Hermann J./C-4234-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Freissmuth, Michael/0000-0001-9398-1765; Hinterdorfer, Peter/0000-0003-2583-1305; Rankl, Christian/0000-0002-7354-7651	Austrian Science Fund [F35]; National Institute on Drug Abuse-NIH; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3503] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); National Institute on Drug Abuse-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Grant F35 and the National Institute on Drug Abuse-Intramural Research Program, NIH (to A. H. N. and M.-F. Z.).	Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Binning T, 1986, Clin Podiatr Med Surg, V3, P769; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Ebner A., 2008, FUNCTIONALIZATION PR, P29; Ebner A, 2007, ULTRAMICROSCOPY, V107, P922, DOI 10.1016/j.ultramic.2007.02.035; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Izrailev S, 1997, BIOPHYS J, V72, P1568, DOI 10.1016/S0006-3495(97)78804-0; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kamruzzahan ASM, 2006, BIOCONJUGATE CHEM, V17, P1473, DOI 10.1021/bc060252a; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kuhar MJ, 1999, DRUG ALCOHOL DEPEN, V56, P9, DOI 10.1016/S0376-8716(99)00005-8; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Newman AH, 2001, BIOORG MED CHEM LETT, V11, P1659, DOI 10.1016/S0960-894X(01)00271-2; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Rankl C, 2007, JPN J APPL PHYS 1, V46, P5536, DOI 10.1143/JJAP.46.5536; Rankl C, 2011, METHODS MOL BIOL, V736, P197, DOI 10.1007/978-1-61779-105-5_13; Rankl C, 2008, P NATL ACAD SCI USA, V105, P17778, DOI 10.1073/pnas.0806451105; Riener CK, 2003, ANAL CHIM ACTA, V497, P101, DOI 10.1016/j.aca.2003.08.041; Riener CK, 2003, ANAL CHIM ACTA, V479, P59, DOI 10.1016/S0003-2670(02)01373-9; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Schmitt KC, 2010, J NEUROCHEM, V112, P1605, DOI 10.1111/j.1471-4159.2010.06583.x; Scholze P, 2000, J PHARMACOL EXP THER, V293, P870; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	49	55	57	3	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					105	113		10.1074/jbc.M111.304873	http://dx.doi.org/10.1074/jbc.M111.304873			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22033932	Green Published, hybrid			2022-12-25	WOS:000298682400013
J	van der Ploeg, R; Barnett, JP; Vasisht, N; Goosens, VJ; Pother, DC; Robinson, C; van Dijl, JM				van der Ploeg, Rene; Barnett, James P.; Vasisht, Nishi; Goosens, Vivianne J.; Pother, Dierk C.; Robinson, Colin; van Dijl, Jan Maarten			Salt Sensitivity of Minimal Twin Arginine Translocases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN TRANSLOCATION; SIGNAL PEPTIDE; TRANSPORT-SYSTEM; TATA COMPONENT; EXPORT SYSTEM; PATHWAY; SECRETION; COMPLEX; MEMBRANE; SUBUNITS	Bacterial twin arginine translocation (Tat) pathways have evolved to facilitate transport of folded proteins across membranes. Gram-negative bacteria contain a TatABC translocase composed of three subunits named TatA, TatB, and TatC. In contrast, the Tat translocases of most Gram-positive bacteria consist of only TatA and TatC subunits. In these minimal TatAC translocases, a bifunctional TatA subunit fulfils the roles of both TatA and TatB. Here we have probed the importance of conserved residues in the bifunctional TatAy subunit of Bacillus subtilis by site-specific mutagenesis. A set of engineered TatAy proteins with mutations in the cytoplasmic hinge and amphipathic helix regions were found to be inactive in protein translocation under standard growth conditions for B. subtilis or when heterologously expressed in Escherichia coli. Nevertheless, these mutated TatAy proteins did assemble into TatAy and TatAyCy complexes, and they facilitated membrane association of twin arginine precursor proteins in E. coli. Interestingly, most of the mutated TatAyCy translocases were salt-sensitive in B. subtilis. Similarly, the TatAC translocases of Bacillus cereus and Staphylococcus aureus were salt-sensitive when expressed in B. subtilis. Taken together, our present observations imply that salt-sensitive electrostatic interactions have critical roles in the preprotein translocation activity of certain TatAC type translocases from Gram-positive bacteria.	[van Dijl, Jan Maarten] Univ Med Ctr Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands; [van Dijl, Jan Maarten] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Barnett, James P.; Vasisht, Nishi; Robinson, Colin] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Groningen; University of Groningen; University of Warwick	van Dijl, JM (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.	J.M.van.Dijl@med.umcg.nl	Pöther, Dierk-Christoph/A-4568-2017; van Dijl, Jan Maarten/G-1205-2013	Pöther, Dierk-Christoph/0000-0001-7000-3520; Barnett, James/0000-0003-1827-036X; van der Ploeg, Rene/0000-0003-2490-9262; Goosens, Vivianne/0000-0002-7808-5185	Commission of the European Union [LSHM-CT-2006-019064, LSHG-CT-2006-037469, 244093]; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research [04-EScope 01-011]; Biotechnology and Biological Sciences Research council;  [LSHG-CT-2004-005257];  [PITN-GA-2008-215524]	Commission of the European Union(European Commission); Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; 	Supported in part by Projects LSHG-CT-2004-005257 and PITN-GA-2008-215524.; Supported in part by Commission of the European Union Projects LSHM-CT-2006-019064, LSHG-CT-2006-037469, and 244093, a transnational SysMO initiative through projects BACELL SysMO 1 and 2, and Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research Grant 04-EScope 01-011.; Supported by a Biotechnology and Biological Sciences Research council grant.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Aldridge C, 2009, FEBS J, V276, P1177, DOI 10.1111/j.1742-4658.2009.06875.x; Barnett JP, 2008, J BIOL CHEM, V283, P2534, DOI 10.1074/jbc.M708134200; Barnett JP, 2011, ARCH MICROBIOL, V193, P583, DOI 10.1007/s00203-011-0699-4; Barnett JP, 2009, FEBS J, V276, P232, DOI 10.1111/j.1742-4658.2008.06776.x; Barrett CML, 2007, J BIOL CHEM, V282, P36206, DOI 10.1074/jbc.M704127200; Barrett CML, 2005, FEBS J, V272, P2261, DOI 10.1111/j.1742-4658.2005.04654.x; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Barrett CML, 2003, FEBS LETT, V537, P42, DOI 10.1016/S0014-5793(03)00068-1; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; CLINE K, 1992, J BIOL CHEM, V267, P2688; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; CLINE K, 2007, SEC TAT PROTEIN TRAN; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; De Keersmaeker S, 2006, ARCH MICROBIOL, V186, P507, DOI 10.1007/s00203-006-0161-1; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Eijlander RT, 2009, MICROBIOL-SGM, V155, P1776, DOI 10.1099/mic.0.027987-0; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hicks MG, 2003, FEBS LETT, V539, P61, DOI 10.1016/S0014-5793(03)00198-4; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lange C, 2007, BBA-BIOMEMBRANES, V1768, P2627, DOI 10.1016/j.bbamem.2007.06.021; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Muller SD, 2007, BBA-BIOMEMBRANES, V1768, P3071, DOI 10.1016/j.bbamem.2007.09.008; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; ROBINSON C, 1993, FEBS LETT, V325, P67, DOI 10.1016/0014-5793(93)81415-V; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wexler M, 1998, FEBS LETT, V431, P339, DOI 10.1016/S0014-5793(98)00790-X; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	63	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43759	43770		10.1074/jbc.M111.243824	http://dx.doi.org/10.1074/jbc.M111.243824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22041895	Green Published, hybrid			2022-12-25	WOS:000298402300019
J	Kokabu, Y; Murayama, Y; Kuwabara, N; Oroguchi, T; Hashimoto, H; Tsutsui, Y; Nozaki, N; Akashi, S; Unzai, S; Shimizu, T; Iwasaki, H; Sato, M; Ikeguchi, M				Kokabu, Yuichi; Murayama, Yasuto; Kuwabara, Naoyuki; Oroguchi, Tomotaka; Hashimoto, Hiroshi; Tsutsui, Yasuhiro; Nozaki, Naohito; Akashi, Satoko; Unzai, Satoru; Shimizu, Toshiyuki; Iwasaki, Hiroshi; Sato, Mamoru; Ikeguchi, Mitsunori			Fission Yeast Swi5-Sfr1 Protein Complex, an Activator of Rad51 Recombinase, Forms an Extremely Elongated Dogleg-shaped Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; DNA STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; REPAIR; RECA; MECHANISM; FILAMENT; MEDIATOR; SWI5; RPA	In eukaryotes, DNA strand exchange is the central reaction of homologous recombination, which is promoted by Rad51 recombinases forming a right-handed nucleoprotein filament on single-stranded DNA, also known as a presynaptic filament. Accessory proteins known as recombination mediators are required for the formation of the active presynaptic filament. One such mediator in the fission yeast Schizosaccharomyces pombe is the Swi5-Sfr1 complex, which has been identified as an activator of Rad51 that assists in presynaptic filament formation and stimulates its strand exchange reaction. Here, we determined the 1: 1 binding stoichiometry between the two subunits of the Swi5-Sfr1 complex using analytical ultracentrifugation and electrospray ionization mass spectrometry. Small-angle x-ray scattering experiments revealed that the Swi5-Sfr1 complex displays an extremely elongated dogleg-shaped structure in solution, which is consistent with its exceptionally high frictional ratio (f/f(0)) of 2.0 +/- 0.2 obtained by analytical ultracentrifugation. Furthermore, we determined a rough topology of the complex by comparing the small-angle x-ray scattering-based structures of the Swi5-Sfr1 complex and four Swi5-Sfr1-Fab complexes, in which the Fab fragments of monoclonal antibodies were specifically bound to experimentally determined sites of Sfr1. We propose a model for how the Swi5-Sfr1 complex binds to the Rad51 filament, in which the Swi5-Sfr1 complex fits into the groove of the Rad51 filament, leading to an active and stable presynaptic filament.	[Kokabu, Yuichi; Oroguchi, Tomotaka; Hashimoto, Hiroshi; Akashi, Satoko; Unzai, Satoru; Sato, Mamoru; Ikeguchi, Mitsunori] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Murayama, Yasuto; Tsutsui, Yasuhiro; Iwasaki, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nozaki, Naohito] Tokyo Inst Technol, Biofrontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Kuwabara, Naoyuki; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Yokohama City University; Tokyo Institute of Technology; Tokyo Institute of Technology; University of Tokyo	Ikeguchi, M (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ike@tsurumi.yokohama-cu.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873; Kuwabara, Naoyuki/0000-0002-1659-323X; Akashi, Satoko/0000-0002-8978-6358; Hashimoto, Hiroshi/0000-0003-1503-6789	Ministry of Education, Culture, Sports, Science, and Technology of Japan MEXT; Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation; Grants-in-Aid for Scientific Research [21113003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aids for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT; to S.A., T.S., H.I., M.S., and M.I.) and for scientific research A to H.I.) and B (to M.I.)); by the Grand Challenges in Next-Generation Integrated Simulation of Living Matter, part of the Development and Use of the Next-Generation Supercomputer Project of MEXT (to M.I.); by the Japan Society for the Promotion of Science (JSPS); and by research grants for bioscience from the Takeda Science Foundation (to H.I.).	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Akamatsu Y, 2007, EMBO J, V26, P1352, DOI 10.1038/sj.emboj.7601582; Akamatsu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001160; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Chen J, 2010, NUCLEIC ACIDS RES, V38, P4889, DOI 10.1093/nar/gkq209; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Glatter O., 1982, SMALL ANGLE X RAY SC; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Kuwabara N, 2010, ACTA CRYSTALLOGR F, V66, P1124, DOI 10.1107/S1744309110032239; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Xing X, 2004, BIOCHEMISTRY-US, V43, P16142, DOI 10.1021/bi048165y; Yuan JS, 2011, J BIOL CHEM, V286, P9888, DOI 10.1074/jbc.M110.207290	39	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43569	43576		10.1074/jbc.M111.303339	http://dx.doi.org/10.1074/jbc.M111.303339			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033972	Green Published, hybrid			2022-12-25	WOS:000298351300076
J	Rauen, T; Hedrich, CM; Juang, YT; Tenbrock, K; Tsokos, GC				Rauen, Thomas; Hedrich, Christian M.; Juang, Yuang-Taung; Tenbrock, Klaus; Tsokos, George C.			cAMP-responsive Element Modulator (CREM)alpha Protein Induces Interleukin 17A Expression and Mediates Epigenetic Alterations at the Interleukin-17A Gene Locus in Patients with Systemic Lupus Erythematosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; TCR ZETA-CHAIN; TRANSCRIPTIONAL REGULATION; DNA DEMETHYLATION; IL-2 PRODUCTION; HOST-DEFENSE; DIFFERENTIATION; ALPHA; CREM; AUTOIMMUNITY	IL-17A is a proinflammatory cytokine that is produced by specialized T helper cells and contributes to the development of several autoimmune diseases such as systemic lupus erythematosus (SLE). Transcription factor cAMP-responsive element modulator (CREM)alpha displays increased expression levels in T cells from SLE patients and has been described to account for aberrant T cell function in SLE pathogenesis. In this report, we provide evidence that CREM alpha physically binds to a cAMP-responsive element, CRE (-111/-104), within the proximal human IL17A promoter and increases its activity. Chromatin immunoprecipitation assays reveal that activated naive CD4(+) T cells as well as T cells from SLE patients display increased CREM alpha binding to this site compared with T cells from healthy controls. The histone H3 modification pattern at the CRE site (-111/-104) and neighboring conserved noncoding sequences within the human IL17A gene locus suggests an accessible chromatin structure (H3K27 hypomethylation/H3K18 hyperacetylation) in activated naive CD4(+) T cells and SLE T cells. H3K27 hypomethylation is accompanied by decreased cytosine phosphate guanosine (CpG)-DNA methylation in these regions in SLE T cells. Decreased recruitment of histone deacetylase (HDAC) 1 and DNA methyltransferase (DNMT)3a to the CRE site (-111/-104) probably accounts for the observed epigenetic alterations. Reporter studies confirmed that DNA methylation of the IL17A promoter indeed abrogates its inducibility. Our findings demonstrate an extended role for CREM alpha in the immunopathogenesis of SLE because it contributes to increased expression of IL-17A.	[Rauen, Thomas; Hedrich, Christian M.; Juang, Yuang-Taung; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany; [Tenbrock, Klaus] Rhein Westfal TH Aachen, Dept Pediat, Div Allergol & Immunol, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University; RWTH Aachen University	Rauen, T (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, CLS 937,330 Brookline Ave, Boston, MA 02115 USA.	trauen@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020	tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [R01 AI42269, R01 AI49954, R01 AI85567]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269, R01AI049954, R01AI085567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T. R.).	Ahlmann M, 2009, J IMMUNOL, V182, P4167, DOI 10.4049/jimmunol.0802976; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Bailey J, 2005, J MOL ENDOCRINOL, V34, P1, DOI 10.1677/jme.1.01594; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bird A, 2003, NAT IMMUNOL, V4, P208, DOI 10.1038/ni0303-208; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Foulkes NS, 1996, NATURE, V381, P83, DOI 10.1038/381083a0; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; HEDRICH CM, 2011, TRENDS MOL IN PRESS; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HUNDORFEAN G, 2011, INFLAMM BOWEL D 0304, DOI DOI 10.1002/IBD.21677; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Nambiar MP, 2002, J CELL BIOCHEM, V85, P459, DOI 10.1002/jcb.10160; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Patel DR, 2010, CURR OPIN RHEUMATOL, V22, P478, DOI 10.1097/BOR.0b013e32833ae915; Rauen T, 2011, J BIOL CHEM, V286, P32366, DOI 10.1074/jbc.M111.245811; Renaudineau Yves, 2011, Keio Journal of Medicine, V60, P10; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Strickland FM, 2008, AUTOIMMUNITY, V41, P278, DOI 10.1080/08916930802024616; Sunahori K, 2011, J IMMUNOL, V186, P4508, DOI 10.4049/jimmunol.1000340; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; TSOKOS GC, 2011, N ENGL J ME IN PRESS; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	44	93	95	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43437	43446		10.1074/jbc.M111.299313	http://dx.doi.org/10.1074/jbc.M111.299313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025620	hybrid, Green Published			2022-12-25	WOS:000298351300063
J	Przybycien-Szymanska, MM; Mott, NN; Pak, TR				Przybycien-Szymanska, Magdalena M.; Mott, Natasha N.; Pak, Toni R.			Alcohol Dysregulates Corticotropin-Releasing-Hormone (CRH) Promoter Activity by Interfering with the Negative Glucocorticoid Response Element (nGRE)	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; INTRACELLULAR CAMP LEVELS; GENE-EXPRESSION; ADRENOCORTICAL AXIS; HYPOTHALAMIC CELLS; GENDER-DIFFERENCE; BETA-ENDORPHIN; ETHANOL; INCREASES; STRESS	EtOH exposure in male rats increases corticotropin-releasing hormone (CRH) mRNA in the paraventricular nucleus of the hypothalamus (PVN), a brain region responsible for coordinating stress and anxiety responses. In this study we identified the molecular mechanisms involved in mediating these effects by examining the direct effects of EtOH on CRH promoter activity in a neuronal cell line derived from the PVN (IVB). In addition, we investigated the potential interactions of EtOH and glucocorticoids on the CRH promoter by concomitantly treating cells with EtOH and the glucocorticoid receptor (GR) antagonist RU486, and by sequentially deleting GR binding sites within glucocorticoid response element (GRE) on the CRH promoter. Cells were transiently transfected with a firefly luciferase reporter construct containing 2.5 kb of the rat wild type (WT) or mutated CRH promoter. Our results showed that EtOH treatment induced a biphasic response in CRH promoter activity. EtOH exposure for 0.5 h significantly decreased promoter activity compared to vehicle treated controls, whereas promoter activity was significantly increased after 2.0 h of EtOH exposure. Treatment with RU486, or deletion of the GR binding sites 1 and 2 within the GRE, abolished the EtOH-induced increase in the promoter activity, however did not affect EtOH-induced decrease in CRH promoter activity at an earlier time point. Overall, our data suggest that alcohol exposure directly regulates CRH promoter activity by interfering with the normal feedback mechanisms of glucocorticoids mediated by GR signaling at the GRE site of the CRH promoter.	[Przybycien-Szymanska, Magdalena M.; Mott, Natasha N.; Pak, Toni R.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA	Loyola University Chicago	Przybycien-Szymanska, MM (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA.	tpak@lumc.edu			National Institutes of Health (NIH) [R21 AA018398, T32 AA013527]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527, R21AA018398] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health (NIH) R21 AA018398 and NIH T32 AA013527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blevins T, 1997, J NEUROCHEM, V69, P2345; Boyadjieva N, 1999, BRAIN RES, V824, P112, DOI 10.1016/S0006-8993(99)01170-1; Boyadjieva NI, 1997, ALCOHOL CLIN EXP RES, V21, P1005, DOI 10.1111/j.1530-0277.1997.tb04245.x; Druse MJ, 2006, BRAIN RES, V1092, P79, DOI 10.1016/j.brainres.2006.02.065; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; Goujon E, 1997, PSYCHONEUROENDOCRINO, V22, pS75, DOI 10.1016/S0306-4530(97)00009-7; King BR, 2002, MOL CELL ENDOCRINOL, V194, P19, DOI 10.1016/S0303-7207(02)00218-6; Lee JH, 2009, BRAIN RES, V1249, P54, DOI 10.1016/j.brainres.2008.10.013; Li ZQ, 2005, MOL CELL NEUROSCI, V29, P345, DOI 10.1016/j.mcn.2005.04.002; Little HJ, 2008, NEUROSCIENCE, V156, P1017, DOI 10.1016/j.neuroscience.2008.08.029; McAlhany RE, 1999, ALCOHOL CLIN EXP RES, V23, P1691, DOI 10.1111/j.1530-0277.1999.tb04062.x; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Ogilvie KM, 1997, BRAIN RES, V744, P83, DOI 10.1016/S0006-8993(96)01082-7; Ogilvie KM, 1996, ALCOHOL CLIN EXP RES, V20, P255, DOI 10.1111/j.1530-0277.1996.tb01637.x; Ogilvie KM, 1997, BRAIN RES, V766, P19, DOI 10.1016/S0006-8993(97)00525-8; Ostrander MM, 2006, ENDOCRINOLOGY, V147, P2008, DOI 10.1210/en.2005-1041; Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184; PICKERING C, BASIC CLIN PHARM TOX, V106, P472; Przybycien-Szymanska MM, 2009, AM J PHYSL ENDOCRINO; RIVIER C, 1993, ALCOHOL CLIN EXP RES, V17, P854, DOI 10.1111/j.1530-0277.1993.tb00853.x; Roy A, 2002, J PHARMACOL EXP THER, V301, P774, DOI 10.1124/jpet.301.2.774; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schulkin J, 1998, PSYCHONEUROENDOCRINO, V23, P219, DOI 10.1016/S0306-4530(97)00099-1; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632	24	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26647	10.1371/journal.pone.0026647	http://dx.doi.org/10.1371/journal.pone.0026647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039522	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200036
J	Carvalho, SM; Kloosterman, TG; Kuipers, OP; Neves, AR				Carvalho, Sandra M.; Kloosterman, Tomas G.; Kuipers, Oscar P.; Neves, Ana Rute			CcpA Ensures Optimal Metabolic Fitness of Streptococcus pneumoniae	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; VIRULENCE GENE-EXPRESSION; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; GLYCOLYTIC FLUX; SUBSP CREMORIS; PROTEIN CCPA; SYSTEM	In Gram-positive bacteria, the transcriptional regulator CcpA is at the core of catabolite control mechanisms. In the human pathogen Streptococcus pneumoniae, links between CcpA and virulence have been established, but its role as a master regulator in different nutritional environments remains to be elucidated. Thus, we performed whole-transcriptome and metabolic analyses of S. pneumoniae D39 and its isogenic ccpA mutant during growth on glucose or galactose, rapidly and slowly metabolized carbohydrates presumably encountered by the bacterium in different host niches. CcpA affected the expression of up to 19% of the genome covering multiple cellular processes, including virulence, regulatory networks and central metabolism. Its prevalent function as a repressor was observed on glucose, but unexpectedly also on galactose. Carbohydrate-dependent CcpA regulation was also observed, as for the tagatose 6-phosphate pathway genes, which were activated by galactose and repressed by glucose. Metabolite analyses revealed that two pathways for galactose catabolism are functionally active, despite repression of the Leloir genes by CcpA. Surprisingly, galactose-induced mixed-acid fermentation apparently required CcpA, since genes involved in this type of metabolism were mostly under CcpA-repression. These findings indicate that the role of CcpA extends beyond transcriptional regulation, which seemingly is overlaid by other regulatory mechanisms. In agreement, CcpA influenced the level of many intracellular metabolites potentially involved in metabolic regulation. Our data strengthen the view that a true understanding of cell physiology demands thorough analyses at different cellular levels. Moreover, integration of transcriptional and metabolic data uncovered a link between CcpA and the association of surface molecules ( e. g. capsule) to the cell wall. Hence, CcpA may play a key role in mediating the interaction of S. pneumoniae with its host. Overall, our results support the hypothesis that S. pneumoniae optimizes basic metabolic processes, likely enhancing in vivo fitness, in a CcpA-mediated manner.	[Carvalho, Sandra M.; Neves, Ana Rute] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Kloosterman, Tomas G.; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Universidade Nova de Lisboa; University of Groningen	Carvalho, SM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	arn@itqb.unl.pt	Neves, Ana/B-9476-2008; Kuipers, Oscar/B-6752-2009	Neves, Ana/0000-0003-4896-9585; Kuipers, Oscar/0000-0001-5596-7735; Carvalho, Sandra/0000-0002-3144-411X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/35947/2007]; EU [HEALTH-F3-2009-222983]; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FEDER [PTDC/BIA-MIC/099963/2008, PTDC/SAU-MII/100964/2008, PEst-OE/EQB/LA0004/2011]; Programa Operacional Ciencia e Inovacao (POCTI); FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); EU(European Commission); Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); Programa Operacional Ciencia e Inovacao (POCTI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	S. M. Carvalho was supported by a Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. grant (SFRH/BD/35947/2007). T. G. Kloosterman is supported by the EU-funded Pneumopath project HEALTH-F3-2009-222983. This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and FEDER, projects PTDC/BIA-MIC/099963/2008 and PTDC/SAU-MII/100964/2008 and through grant PEst-OE/EQB/LA0004/2011. The NMR spectrometers are part of the National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010'' and FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Andersen HW, 2001, J BACTERIOL, V183, P3458, DOI 10.1128/JB.183.11.3458-3467.2001; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Garrigues C, 1997, J BACTERIOL, V179, P5282, DOI 10.1128/jb.179.17.5282-5287.1997; GASSON MJ, 1983, A VAN LEEUW J MICROB, V49, P275, DOI 10.1007/BF00399503; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Hendriksen WT, 2007, J BACTERIOL, V189, P1382, DOI 10.1128/JB.01144-06; Holo H, 1995, Methods Mol Biol, V47, P195; IWAMI Y, 1985, INFECT IMMUN, V50, P378, DOI 10.1128/IAI.50.2.378-381.1985; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; JOHANSEN E, 1992, PLASMID, V27, P200, DOI 10.1016/0147-619X(92)90022-3; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaufman GE, 2007, J BACTERIOL, V189, P5183, DOI 10.1128/JB.00449-07; Kietzman CC, 2010, INFECT IMMUN, V78, P241, DOI 10.1128/IAI.00746-09; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Neves AR, 2010, APPL ENVIRON MICROB, V76, P7048, DOI 10.1128/AEM.01195-10; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; Ramos A, 2001, APPL ENVIRON MICROB, V67, P33, DOI 10.1128/AEM.67.1.33-41.2001; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Song JH, 2005, MOL CELLS, V19, P365; Standish AJ, 2007, J BACTERIOL, V189, P5591, DOI 10.1128/JB.00335-07; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; YAMADA T, 1975, J BACTERIOL, V124, P55, DOI 10.1128/JB.124.1.55-61.1975; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Yesilkaya H, 2008, FEMS MICROBIOL LETT, V278, P231, DOI 10.1111/j.1574-6968.2007.01003.x; Yesilkaya H, 2009, INFECT IMMUN, V77, P5418, DOI 10.1128/IAI.00178-09; Zeng L, 2010, MOL MICROBIOL, V75, P1145, DOI 10.1111/j.1365-2958.2009.07029.x; Zheng LY, 2011, APPL ENVIRON MICROB, V77, P4318, DOI 10.1128/AEM.00309-11; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	61	95	97	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26707	10.1371/journal.pone.0026707	http://dx.doi.org/10.1371/journal.pone.0026707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039538	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200046
J	Lai, Y; Adhikarakunnathu, S; Bhardwaj, K; Ranjith-Kumar, CT; Wen, YH; Jordan, JL; Wu, LH; Dragnea, B; Mateo, LS; Kao, CC				Lai, Yvonne; Adhikarakunnathu, Sreedevi; Bhardwaj, Kanchan; Ranjith-Kumar, C. T.; Wen, Yahong; Jordan, Jarrat L.; Wu, Linda H.; Dragnea, Bogdan; Mateo, Lani San; Kao, C. Cheng			LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; RESPIRATORY EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; NF-KAPPA-B; ANTIMICROBIAL PEPTIDES; RIG-I; CATHELICIDIN LL-37; DENDRITIC CELLS; HOST-DEFENSE; VITAMIN-D	Background: Toll-like Receptor 3 (TLR3) detects viral dsRNA during viral infection. However, most natural viral dsRNAs are poor activators of TLR3 in cell-based systems, leading us to hypothesize that TLR3 needs additional factors to be activated by viral dsRNAs. The anti-microbial peptide LL37 is the only known human member of the cathelicidin family of antimicrobial peptides. LL37 complexes with bacterial lipopolysaccharide (LPS) to prevent activation of TLR4, binds to ssDNA to modulate TLR9 and ssRNA to modulate TLR7 and 8. It synergizes with TLR2/1, TLR3 and TLR5 agonists to increase IL8 and IL6 production. This work seeks to determine whether LL37 enhances viral dsRNA recognition by TLR3. Methodology/Principal Findings: Using a human bronchial epithelial cell line (BEAS2B) and human embryonic kidney cells (HEK 293T) transiently transfected with TLR3, we found that LL37 enhanced poly(I:C)-induced TLR3 signaling and enabled the recognition of viral dsRNAs by TLR3. The presence of LL37 also increased the cytokine response to rhinovirus infection in BEAS2B cells and in activated human peripheral blood mononuclear cells. Confocal microscopy determined that LL37 could co-localize with TLR3. Electron microscopy showed that LL37 and poly(I:C) individually formed globular structures, but a complex of the two formed filamentous structures. To separate the effects of LL37 on TLR3 and TLR4, other peptides that bind RNA and transport the complex into cells were tested and found to activate TLR3 signaling in response to dsRNAs, but had no effect on TLR4 signaling. This is the first demonstration that LL37 and other RNA-binding peptides with cell penetrating motifs can activate TLR3 signaling and facilitate the recognition of viral ligands. Conclusions/Significance: LL37 and several cell-penetrating peptides can enhance signaling by TLR3 and enable TLR3 to respond to viral dsRNA.	[Lai, Yvonne; Bhardwaj, Kanchan; Ranjith-Kumar, C. T.; Wen, Yahong; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Dragnea, Bogdan] Indiana Univ, Dept Chem, Bloomington, IN USA; [Adhikarakunnathu, Sreedevi; Jordan, Jarrat L.; Wu, Linda H.; Mateo, Lani San] Centocor Res & Dev Inc, Discovery Res, Radnor, PA USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Johnson & Johnson; Johnson & Johnson USA	Lai, Y (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	yylai@indiana.edu	Mackie, Ken/E-3384-2013; Bhardwaj, Kanchan/CAH-2291-2022; Kumar CT, Ranjith/J-5701-2016	Bhardwaj, Kanchan/0000-0002-7331-7717; Jordan, Jarrat/0000-0002-0699-3774	Centocor Inc.; National Institutes of Health [RAI075015A]; Centocor; Division Of Chemistry [0832651] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075015] Funding Source: NIH RePORTER	Centocor Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centocor; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant to C. K. by Centocor Inc. Students in the laboratory are partially supported by National Institutes of Health grant RAI075015A to study protein-RNA interaction. No patent is involved in this project. While authors S. A., J.J., L. W., L. M. are employees of Centocor Research and Development, funding from Centocor had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Duffy KE, 2007, CELL IMMUNOL, V248, P103, DOI 10.1016/j.cellimm.2007.10.002; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Filewod NCJ, 2009, FEMS IMMUNOL MED MIC, V56, P233, DOI 10.1111/j.1574-695X.2009.00571.x; Futaki S, 2003, J MOL RECOGNIT, V16, P260, DOI 10.1002/jmr.635; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Golec M, 2009, ANN AGR ENV MED, V16, P289; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kato A, 2004, J IMMUNOL, V172, P6185, DOI 10.4049/jimmunol.172.10.6185; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Kuznetsov YG, 2005, J MOL BIOL, V347, P41, DOI 10.1016/j.jmb.2005.01.006; LAI Y, 2011, PLOS ONE IN PRESS; Lancaster GI, 2005, J PHYSIOL-LONDON, V563, P945, DOI 10.1113/jphysiol.2004.081224; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Mendez-Samperio P, 2010, PEPTIDES, V31, P1791, DOI 10.1016/j.peptides.2010.06.016; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; Murray LA, 2008, AM J RESP CRIT CARE, V178, P1227, DOI 10.1164/rccm.200807-1020OC; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pistolic J, 2009, J INNATE IMMUN, V1, P254, DOI 10.1159/000171533; Potena Alfredo, 2007, Int J Chron Obstruct Pulmon Dis, V2, P477; Qi XP, 2011, MOL PLANT MICROBE IN, V24, P25, DOI 10.1094/MPMI-07-10-0147; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012878; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Starner TD, 2005, J IMMUNOL, V174, P1608, DOI 10.4049/jimmunol.174.3.1608; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Teng F, 2010, CELL IMMUNOL, V260, P98, DOI 10.1016/j.cellimm.2009.09.008; Tjabringa GS, 2005, PULM PHARMACOL THER, V18, P321, DOI 10.1016/j.pupt.2005.01.001; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	66	80	83	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26632	10.1371/journal.pone.0026632	http://dx.doi.org/10.1371/journal.pone.0026632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039520	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200034
J	Negrete, R; Hervera, A; Leanez, S; Martin-Campos, JM; Pol, O				Negrete, Roger; Hervera, Arnau; Leanez, Sergi; Martin-Campos, Jesus M.; Pol, Olga			The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids	PLOS ONE			English	Article							MECHANICALLY-EVOKED-RESPONSES; SENSITIVE GUANYLYL CYCLASE; CB2 RECEPTORS SUPPRESSES; NEUROPATHIC PAIN; PERIPHERAL ANTINOCICEPTION; ANALGESIC ACTIVITY; DORSAL-HORN; AGONIST; INHIBITION; EXPRESSION	Background: Cannabinoid 2 receptor (CB2R) agonists attenuate inflammatory pain but the precise mechanism implicated in these effects is not completely elucidated. We investigated if the peripheral nitric oxide-cGMP-protein kinase G (PKG)-ATPsensitive K(+) (KATP) channels signaling pathway triggered by the neuronal nitric oxide synthase (NOS1) and modulated by opioids, participates in the local antinociceptive effects produced by a CB2R agonist (JWH-015) during chronic inflammatory pain. Methodology/Principal Findings: In wild type (WT) and NOS1 knockout (NOS1-KO) mice, at 10 days after the subplantar administration of complete Freund's adjuvant (CFA), we evaluated the antiallodynic (von Frey filaments) and antihyperalgesic (plantar test) effects produced by the subplantar administration of JWH-015 and the reversion of their effects by the local co-administration with CB2R (AM630), peripheral opioid receptor (naloxone methiodide, NX-ME) or CB1R (AM251) antagonists. Expression of CB2R and NOS1 as well as the antinociceptive effects produced by a high dose of JWH-015 combined with different doses of selective L-guanylate cyclase (ODQ) or PKG (Rp-8-pCPT-cGMPs) inhibitors or a KATP channel blocker (glibenclamide), were also assessed. Results show that the local administration of JWH-015 dose-dependently inhibited the mechanical and thermal hypersensitivity induced by CFA which effects were completely reversed by the local co-administration of AM630 or NX-ME, but not AM251. Inflammatory pain increased the paw expression of CB2R and the dorsal root ganglia transcription of NOS1. Moreover, the antinociceptive effects of JWH-015 were absent in NOS1-KO mice and diminished by their co-administration with ODQ, Rp-8-pCPT-cGMPs or glibenclamide. Conclusions/Significance: These data indicate that the peripheral antinociceptive effects of JWH-015 during chronic inflammatory pain are mainly produced by the local activation of the nitric oxide-cGMP-PKG-KATP signaling pathway, triggered by NOS1 and mediated by endogenous opioids. These findings suggest that the activation of this pathway might be an interesting therapeutic target for the treatment of chronic inflammatory pain with cannabinoids.	[Negrete, Roger; Hervera, Arnau; Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Grp Neurofarmacol Mol, Inst Recerca, Hosp Sta Creu & St Pau, E-08193 Barcelona, Spain; [Negrete, Roger; Hervera, Arnau; Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Martin-Campos, Jesus M.] Hosp Sta Creu & St Pau, Inst Recerca, Grp Bioquim, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Negrete, R (corresponding author), Univ Autonoma Barcelona, Grp Neurofarmacol Mol, Inst Recerca, Hosp Sta Creu & St Pau, E-08193 Barcelona, Spain.	opol@santpau.es	Pol, Olga/C-9194-2011; Martín-Campos, Jesús M./AAQ-5478-2021; Pol, Olga/O-2146-2019; abad, Arnau Hervera/V-5435-2017; Martín-Campos, Jesús Maria/AGJ-2586-2022	Pol, Olga/0000-0002-4621-8457; abad, Arnau Hervera/0000-0001-8362-369X; Martín-Campos, Jesús Maria/0000-0003-0414-037X	Fondo de Investigacion Sanitaria, Madrid [PS0900968]; Fundacio La Marato de TV3 Barcelona, Spain [070810]	Fondo de Investigacion Sanitaria, Madrid; Fundacio La Marato de TV3 Barcelona, Spain	This work was supported by Fondo de Investigacion Sanitaria, Madrid (http://www.isciii.es/htdocs/investigacion/Fondo_lineas.jsp) [Grant: PS0900968] and the Fundacio La Marato de TV3 Barcelona (http://www.fundaciomaratotv3.cat/) [Grant: 070810], Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chu YC, 2005, PAIN, V119, P113, DOI 10.1016/j.pain.2005.09.024; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Curto-Reyes V, 2010, BRIT J PHARMACOL, V160, P561, DOI 10.1111/j.1476-5381.2009.00629.x; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; FERREIRA SH, 1991, EUR J PHARMACOL, V201, P121, DOI 10.1016/0014-2999(91)90333-L; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Gutierrez T, 2007, BRIT J PHARMACOL, V150, P153, DOI 10.1038/sj.bjp.0706984; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hervera A, 2010, J PHARMACOL EXP THER, V334, P887, DOI 10.1124/jpet.110.167585; Hervera A, 2009, N-S ARCH PHARMACOL, V380, P345, DOI 10.1007/s00210-009-0436-6; Hsieh GC, 2011, BRIT J PHARMACOL, V162, P428, DOI 10.1111/j.1476-5381.2010.01046.x; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Infante C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2208; Jones JD, 2008, NEUROPHARMACOLOGY, V54, P23, DOI 10.1016/j.neuropharm.2007.06.027; LARSON AA, 1986, PHARMACOL BIOCHEM BE, V24, P49, DOI 10.1016/0091-3057(86)90043-2; Leanez S, 2009, EUR J PHARMACOL, V602, P41, DOI 10.1016/j.ejphar.2008.11.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Reis GML, 2009, LIFE SCI, V85, P351, DOI 10.1016/j.lfs.2009.06.012; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Menendez L, 2007, NEUROPHARMACOLOGY, V53, P71, DOI 10.1016/j.neuropharm.2007.04.011; Nackley AG, 2004, J NEUROPHYSIOL, V92, P3562, DOI 10.1152/jn.00886.2003; Pacheco DF, 2005, EUR J PHARMACOL, V512, P23, DOI 10.1016/j.ejphar.2005.02.018; Pol O, 2007, CURR MED CHEM, V14, P1945; Quartilho A, 2003, ANESTHESIOLOGY, V99, P955, DOI 10.1097/00000542-200310000-00031; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Sokal DM, 2003, NEUROPHARMACOLOGY, V45, P404, DOI 10.1016/S0028-3908(03)00195-3; WESTON AH, 1991, Z KARDIOL, V80, P1; Yao BB, 2008, BRIT J PHARMACOL, V153, P390, DOI 10.1038/sj.bjp.0707568	31	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26688	10.1371/journal.pone.0026688	http://dx.doi.org/10.1371/journal.pone.0026688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031841	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200042
J	Strecker, JK; Minnerup, J; Gess, B; Ringelstein, EB; Schabitz, WR; Schilling, M				Strecker, Jan-Kolja; Minnerup, Jens; Gess, Burkhard; Ringelstein, E. Bernd; Schaebitz, Wolf-Ruediger; Schilling, Matthias			Monocyte Chemoattractant Protein-1-Deficiency Impairs the Expression of IL-6, IL-1 beta and G-CSF after Transient Focal Ischemia in Mice	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; COLONY-STIMULATING FACTOR; BRAIN-DAMAGE; STROKE; PROTEIN-1; RECRUITMENT; ACTIVATION; RECEPTOR; MODEL; INTERLEUKIN-1-BETA	Monocyte chemoattractant protein-1 (MCP-1), a chemokine secreted by neurons and astrocytes following stroke is known to aggravate ischemia-related damage. Previous studies revealed that MCP-1-deficient mice develop smaller infarcts and have an improved neurological outcome, whereas mice overexpressing MCP-1 show worsened brain damage and impaired neurological function. The aim of the present study was to elucidate the molecular background of the enhanced recovery in MCP-1-deficient mice after stroke. For this purpose, we (1) performed expression analyses on crucial post-stroke related inflammatory genes in MCP-1-deficient mice compared to wildtype controls, (2) analyzed a possible impact of MCP-1 on astrocyte activation (3) investigated the cellular origin of respective inflammatory cytokines and (4) analyzed the impact of MCP-1 secretion on the migration of both neutrophil granulocytes and T-cells. Here we report that MCP-1-deficiency leads to a shift towards a less inflammatory state following experimental occlusion of the middle cerebral artery including an impaired induction of interleukin-6, interleukin-1 beta and granulocyte-colony stimulating factor expression as well as a subsequent diminished influx of hematogenous cells. Additionally, MCP-1-deficient mice developed smaller infarcts 36 hours after experimental stroke. Investigations revealed no differences in transcription of tumor necrosis factor-a and astrogliosis 12 and 36 hours after onset of ischemia. These novel results help to understand post ischemic, inflammatory mechanisms and might give further arguments towards therapeutical interventions by modulation of MCP-1 expression in post stroke inflammation.	[Strecker, Jan-Kolja; Minnerup, Jens; Gess, Burkhard; Ringelstein, E. Bernd; Schaebitz, Wolf-Ruediger; Schilling, Matthias] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Schaebitz, Wolf-Ruediger] Evangel Krankenhaus, Dept Neurol, Bielefeld, Germany	University of Munster	Strecker, JK (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	strecker.jan@gmx.de			Innovative Medical Research of the University of Munster Medical School [SC 520 501]	Innovative Medical Research of the University of Munster Medical School	Funding: This work was supported by the Innovative Medical Research of the University of Munster Medical School (IMF grant nr: SC 520 501, http://campus.unimuenster.de/3856.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acalovschi D, 2003, STROKE, V34, P1864, DOI 10.1161/01.STR.0000079815.38626.44; Bowen KK, 2006, NEUROCHEM INT, V49, P127, DOI 10.1016/j.neuint.2006.02.011; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.490128; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Clark WM, 2000, STROKE, V31, P1715, DOI 10.1161/01.STR.31.7.1715; Deng YY, 2009, GLIA, V57, P604, DOI 10.1002/glia.20790; Gautier S, 2009, BRIT J PHARMACOL, V156, P673, DOI 10.1111/j.1476-5381.2009.00068.x; Gee JM, 2007, STROKE, V38, P783, DOI 10.1161/01.STR.0000248425.59176.7b; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Gibson CL, 2005, J NEUROPATH EXP NEUR, V64, P763, DOI 10.1097/01.jnen.0000179196.10032.dd; Gibson CL, 2010, J CEREBR BLOOD F MET, V30, P739, DOI 10.1038/jcbfm.2010.12; Haile WB, 2010, J CEREBR BLOOD F MET, V30, P1147, DOI 10.1038/jcbfm.2009.280; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Kriz J, 2009, ACTA NEUROPATHOL, V117, P497, DOI 10.1007/s00401-009-0496-1; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lin N, 2009, NEUROSURGERY, V65, pN13, DOI 10.1227/01.NEU.0000345343.04287.23; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Montaner J, 2003, J CEREBR BLOOD F MET, V23, P1403, DOI 10.1097/01.WCB.0000100044.07481.97; Murikinati S, 2010, FASEB J, V24, P788, DOI 10.1096/fj.09-141275; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Schilling M, 2009, NEUROSCIENCE, V161, P806, DOI 10.1016/j.neuroscience.2009.04.025; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sevimli S, 2009, EXP NEUROL, V217, P328, DOI 10.1016/j.expneurol.2009.03.018; Shin JA, 2009, J NEUROIMMUNOL, V217, P14, DOI 10.1016/j.jneuroim.2009.06.001; Touzani O, 2002, J NEUROSCI, V22, P38, DOI 10.1523/JNEUROSCI.22-01-00038.2002; Watanabe S, 2004, AM J NEPHROL, V24, P387, DOI 10.1159/000079706; Yamashita T, 2005, J NEUROCHEM, V94, P459, DOI 10.1111/j.1471-4159.2005.03227.x; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046	39	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25863	10.1371/journal.pone.0025863	http://dx.doi.org/10.1371/journal.pone.0025863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031820	Green Submitted, Green Published, gold			2022-12-25	WOS:000296513200007
J	Wang, P; Chen, SD; Guo, Y; Xiong, ZZ; Hu, FP; Zhu, DM; Zhang, YY				Wang, Peng; Chen, Shudan; Guo, Yan; Xiong, Zizhong; Hu, Fupin; Zhu, Demei; Zhang, Yingyuan			Occurrence of False Positive Results for the Detection of Carbapenemases in Carbapenemase-Negative Escherichia coli and Klebsiella pneumoniae Isolates	PLOS ONE			English	Article							BETA-LACTAMASE; ACID	Adequate detection of the production of carbapenemase in Enterobacteriaceae isolates is crucial for infection control measures and the appropriate choice of antimicrobial therapy. In this study, we investigated the frequency of false positive results for the detection of carbapenemases in carbapenemase-negative Escherichia coli and Klebsiella pneumoniae clinical isolates by the modified Hodge test (MHT). Three hundred and one E. coli and K. pneumoniae clinical isolates were investigated. All produced extended spectrum beta-lactamases (ESBLs) but were susceptible to carbapenems. Antimicrobial susceptibility testing was performed by the disk diffusion and agar dilution methods. The MHT was performed using the standard inoculum of test organisms recommended by the CLSI. Genes that encoded ESBLs and carbapenemases were identified by PCR and DNA sequencing. Among the 301 clinical isolates, none of the isolates conformed to the criteria for carbapenemase screening recommended by the CLSI. The susceptibility rates for imipenem, meropenem, and ertapenem all were 100.0%, 100.0%, and 100.0%, respectively. Of the 301 E. coli and K. pneumoniae isolates, none produced carbapenemase. The MHT gave a positive result for 3.3% (10/301) of the isolates. False positive results can occur when the MHT is used to detect carbapenemase in ESBL-producing isolates and clinical laboratories must be aware of this fact.	[Wang, Peng; Chen, Shudan; Guo, Yan; Hu, Fupin; Zhu, Demei; Zhang, Yingyuan] Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200433, Peoples R China; [Chen, Shudan] Fudan Univ, State Key Lab Genet Engn, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China; [Xiong, Zizhong] Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Hefei, Peoples R China	Fudan University; Fudan University; Anhui Medical University	Wang, P (corresponding author), Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200433, Peoples R China.	hufupin@163.com	Hu, Fupin/AAR-8314-2020		Shanghai Municipal Natural Science Foundation [11ZR1404700]	Shanghai Municipal Natural Science Foundation	Funding: This work was supported by Shanghai Municipal Natural Science Foundation (No. 11ZR1404700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KF, 2007, J CLIN MICROBIOL, V45, P2723, DOI 10.1128/JCM.00015-07; [Anonymous], 2010, M100S20 CLIN LAB STA; Bell JM, 2007, J CLIN MICROBIOL, V45, P1478, DOI 10.1128/JCM.02470-06; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Chen SD, 2011, ANTIMICROB AGENTS CH, V55, P2493, DOI 10.1128/AAC.00047-11; Girlich D, 2008, J ANTIMICROB CHEMOTH, V62, P1155, DOI 10.1093/jac/dkn317; Giske CG, 2011, CLIN MICROBIOL INFEC, V17, P552, DOI 10.1111/j.1469-0691.2010.03294.x; Hirsch EB, 2010, J ANTIMICROB CHEMOTH, V65, P1119, DOI 10.1093/jac/dkq108; HOSAKA M, 1995, ANTIMICROB AGENTS CH, V39, P1731, DOI 10.1128/AAC.39.8.1731; Landman D, 2005, J CLIN MICROBIOL, V43, P5639, DOI 10.1128/JCM.43.11.5639-5641.2005; Lee K, 2003, J CLIN MICROBIOL, V41, P4623, DOI 10.1128/JCM.41.10.4623-4629.2003; Lledo W, 2009, JAMA-J AM MED ASSOC, V301, P1979; Munoz-Price LS, 2009, CLIN INFECT DIS, V49, P1739, DOI 10.1086/648078; Pasteran F, 2009, J CLIN MICROBIOL, V47, P1631, DOI 10.1128/JCM.00130-09; Patrick RM, 2007, MANUAL CLIN MICROBIO, P1250; Stuart JC, 2010, INT J ANTIMICROB AG, V36, P205, DOI 10.1016/j.ijantimicag.2010.05.014; Tsakris A, 2008, J ANTIMICROB CHEMOTH, V62, P1257, DOI 10.1093/jac/dkn364; Tsakris A, 2009, J CLIN MICROBIOL, V47, P3420, DOI 10.1128/JCM.01314-09; Tsakris A, 2009, J CLIN MICROBIOL, V47, P362, DOI 10.1128/JCM.01922-08; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	21	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26356	10.1371/journal.pone.0026356	http://dx.doi.org/10.1371/journal.pone.0026356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031829	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200018
J	Brown, PH; Balbo, A; Zhao, HY; Ebel, C; Schuck, P				Brown, Patrick H.; Balbo, Andrea; Zhao, Huaying; Ebel, Christine; Schuck, Peter			Density Contrast Sedimentation Velocity for the Determination of Protein Partial-Specific Volumes	PLOS ONE			English	Article							HEAVY-OXYGEN WATER; ANALYTICAL ULTRACENTRIFUGATION; MEMBRANE-PROTEINS; DIFFERENTIAL SEDIMENTATION; SOLVENT INTERACTIONS; PHYSICAL PROPERTIES; NEUTRON-SCATTERING; DETERGENT BINDING; MACROMOLECULES; EQUILIBRIUM	The partial-specific volume of proteins is an important thermodynamic parameter required for the interpretation of data in several biophysical disciplines. Building on recent advances in the use of density variation sedimentation velocity analytical ultracentrifugation for the determination of macromolecular partial-specific volumes, we have explored a direct global modeling approach describing the sedimentation boundaries in different solvents with a joint differential sedimentation coefficient distribution. This takes full advantage of the influence of different macromolecular buoyancy on both the spread and the velocity of the sedimentation boundary. It should lend itself well to the study of interacting macromolecules and/or heterogeneous samples in microgram quantities. Model applications to three protein samples studied in either H2O, or isotopically enriched H-2 O-18 mixtures, indicate that partial-specific volumes can be determined with a statistical precision of better than 0.5%, provided signal/noise ratios of 50-100 can be achieved in the measurement of the macromolecular sedimentation velocity profiles. The approach is implemented in the global modeling software SEDPHAT.	[Brown, Patrick H.; Zhao, Huaying; Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA; [Ebel, Christine] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Ebel, Christine] CNRS, Grenoble, France; [Ebel, Christine] Commisariat Energie Atom, Grenoble, France	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CEA	Brown, PH (corresponding author), Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA.	schuckp@mail.nih.gov	Zhao, Huaying/F-5716-2012; Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966; Ebel, Christine/0000-0002-6912-500X	NIBIB, National Institutes of Health, Bethesda, Maryland, U.S.A; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000051] Funding Source: NIH RePORTER	NIBIB, National Institutes of Health, Bethesda, Maryland, U.S.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by the intramural research program of the NIBIB, National Institutes of Health, Bethesda, Maryland, U.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon S, 2011, METHODS; ARAKAWA T, 1986, J BIOCHEM-TOKYO, V100, P1471, DOI 10.1093/oxfordjournals.jbchem.a121853; Arnold MS, 2008, ACS NANO, V2, P2291, DOI 10.1021/nn800512t; Bevington PR., 2002, DATA REDUCTION ERROR; Brown PH, 2008, COMPUT PHYS COMMUN, V178, P105, DOI 10.1016/j.cpc.2007.08.012; Brown PH, 2009, EUR BIOPHYS J BIOPHY, V38, P1079, DOI 10.1007/s00249-009-0514-1; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; CASASSA EF, 1964, ADV PROTEIN CHEM, V19, P287, DOI 10.1016/S0065-3233(08)60191-6; Center RJ, 2001, P NATL ACAD SCI USA, V98, P14877, DOI 10.1073/pnas.261573898; CHENG PY, 1955, J POLYM SCI, V16, P19, DOI 10.1002/pol.1955.120168102; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Correia JJ, 2000, METHOD ENZYMOL, V321, P81; Dam J, 2004, METHOD ENZYMOL, V384, P185; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; Ebel C, 2002, BIOCHEMISTRY-US, V41, P13234, DOI 10.1021/bi0258290; Ebel C, 2000, BIOPHYS J, V78, P385, DOI 10.1016/S0006-3495(00)76601-X; Ebel C, 2011, METHODS; EBEL C, 2007, PROTEIN INTERACTIONS, P255; EDELSTEIN SJ, 1967, J BIOL CHEM, V242, P306; Eisenberg H, 2003, PROTEIN SCI, V12, P2647, DOI 10.1110/ps.0235803; EISENBERG H, 1981, J MOL BIOL, V150, P537, DOI 10.1016/0022-2836(81)90379-X; Eisenberg H, 1992, Biochem Soc Symp, V58, P113; Eisenberg H, 2000, BIOPHYS CHEM, V88, P1, DOI 10.1016/S0301-4622(00)00205-2; EISENBERG H, 1981, Q REV BIOPHYS, V14, P142, DOI 10.1017/S0033583500002237; Eisenberg H, 1990, NUMERICAL DATA FUNCT; Eisenberg H, 1976, BIOL MACROMOLECULES; Elder J P, 1979, Methods Enzymol, V61, P12; Errington N, 2003, EUR BIOPHYS J BIOPHY, V32, P511, DOI 10.1007/s00249-003-0315-x; GAGEN WL, 1966, BIOCHEMISTRY-US, V5, P2553, DOI 10.1021/bi00872a010; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Gohon Y, 2004, ANAL BIOCHEM, V334, P318, DOI 10.1016/j.ab.2004.07.033; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hellman LM, 2010, EUR BIOPHYS J BIOPHY, V39, P389, DOI 10.1007/s00249-009-0411-7; HENDERSO.RF, 1970, J BIOL CHEM, V245, P3733; Heredia KL, 2007, ORG BIOMOL CHEM, V5, P45, DOI 10.1039/b612355d; Howlett G.J., 1992, ANAL ULTRACENTRIFUGA, P470; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Hunter M J, 1978, Methods Enzymol, V48, P23; INOUE H, 1968, J AM CHEM SOC, V90, P1890, DOI 10.1021/ja01009a037; Jones G, 1936, J CHEM PHYS, V4, P30, DOI 10.1063/1.1749743; JOSSANG T, 1988, J PROTEIN CHEM, V7, P165, DOI 10.1007/BF01025246; Kratky O, 1973, Methods Enzymol, V27, P98; KUDISH AI, 1972, J CHEM SOC FARAD T 1, V68, P2041, DOI 10.1039/f19726802041; Kudish AI, 1973, JCS F1, V68, P1504; Lamm O., 1929, ARK MAT ASTR FYS, V21B, P1; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lebowitz J, 2003, PROTEIN SCI, V12, P2649; Lee J C, 1979, Methods Enzymol, V61, P26; LUSTIG A, 1991, BIOCHIM BIOPHYS ACTA, V1115, P89, DOI 10.1016/0304-4165(91)90016-A; MARTIN WG, 1956, CAN J CHEM, V34, P809, DOI 10.1139/v56-104; MARTIN WG, 1959, CAN J CHEM, V37, P1662, DOI 10.1139/v59-241; MATSUNAGA N, 1983, J PHYS CHEM REF DATA, V12, P933, DOI 10.1063/1.555694; Mayer G, 1999, PROG COLL POL SCI S, V113, P176; MCMEEKIN TL, 1952, SCIENCE, V116, P142, DOI 10.1126/science.116.3006.142; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Noy D, 2003, ANAL BIOCHEM, V320, P185, DOI 10.1016/S0003-2697(03)00347-6; Nury H, 2008, BIOCHEMISTRY-US, V47, P12319, DOI 10.1021/bi801053m; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Page M, 2002, PROTEIN PROTOCOLS HD, P987; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PHILLIPS DL, 1962, J ACM, V9, P84, DOI 10.1145/321105.321114; REYNOLDS JA, 1976, P NATL ACAD SCI USA, V73, P4467, DOI 10.1073/pnas.73.12.4467; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; SCHACHMAN HK, 1949, J AM CHEM SOC, V71, P536, DOI 10.1021/ja01170a047; Schilling K, 1999, PROG COLL POL SCI S, V113, P50; SCHUBERT D, 1991, PROG COLL POL SCI S, V86, P12, DOI 10.1007/BFb0115002; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2004, BIOPHYS CHEM, V108, P187, DOI 10.1016/j.bpc.2003.10.016; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2009, EUR BIOPHYS J; Schuck P, 2010, BIOPHYS J, V98, P2741, DOI 10.1016/j.bpj.2010.03.004; Schuck P, 2010, ANAL BIOCHEM, V401, P280, DOI 10.1016/j.ab.2010.02.037; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Shu JY, 2008, BIOMACROMOLECULES, V9, P2111, DOI 10.1021/bm800113g; STECKEL F, 1963, T FARADAY SOC, V59, P331, DOI 10.1039/tf9635900331; STOTHART PH, 1984, BIOCHEM J, V219, P1049, DOI 10.1042/bj2191049; Svedberg T, 1940, ULTRAZENTRIFUGE; Svedberg T, 1940, THE ULTRACENTRIFUGE; TARDIEU A, 1981, BIOCHEMISTRY-US, V20, P4399, DOI 10.1021/bi00518a026; TEWARI UJ, 1975, IMMUNOCHEMISTRY, V12, P925, DOI 10.1016/0019-2791(75)90254-2; TZIATZIOS C, 1994, Z NATURFORSCH C, V49, P220; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wandrey C, 2010, METHODS; ZACCAI G, 1983, ANNU REV BIOPHYS BIO, V12, P139, DOI 10.1146/annurev.bb.12.060183.001035; Zhao H, 2011, BIOPHYS J IN PRESS; Zhao H, 2011, METHODS	88	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26221	10.1371/journal.pone.0026221	http://dx.doi.org/10.1371/journal.pone.0026221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028836	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800027
J	Moorwood, C; Lozynska, O; Suri, N; Napper, AD; Diamond, SL; Khurana, TS				Moorwood, Catherine; Lozynska, Olga; Suri, Neha; Napper, Andrew D.; Diamond, Scott L.; Khurana, Tejvir S.			Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening	PLOS ONE			English	Article							CELL-BASED ASSAY; SKELETAL-MUSCLE; MDX MICE; RHEUMATOID-ARTHRITIS; PROTEIN; EXPRESSION; GENE; TRANSCRIPTION; ACCUMULATION; MECHANISM	Background: Duchenne muscular dystrophy (DMD) is a devastating muscle wasting disease caused by mutations in dystrophin, a muscle cytoskeletal protein. Utrophin is a homologue of dystrophin that can functionally compensate for its absence when expressed at increased levels in the myofibre, as shown by studies in dystrophin-deficient mice. Utrophin upregulation is therefore a promising therapeutic approach for DMD. The use of a small, drug-like molecule to achieve utrophin upregulation offers obvious advantages in terms of delivery and bioavailability. Furthermore, much of the time and expense involved in the development of a new drug can be eliminated by screening molecules that are already approved for clinical use. Methodology/Principal Findings: We developed and validated a cell-based, high-throughput screening assay for utrophin promoter activation, and used it to screen the Prestwick Chemical Library of marketed drugs and natural compounds. Initial screening produced 20 hit molecules, 14 of which exhibited dose-dependent activation of the utrophin promoter and were confirmed as hits. Independent validation demonstrated that one of these compounds, nabumetone, is able to upregulate endogenous utrophin mRNA and protein, in C2C12 muscle cells. Conclusions/Significance: We have developed a cell-based, high-throughput screening utrophin promoter assay. Using this assay, we identified and validated a utrophin promoter-activating drug, nabumetone, for which pharmacokinetics and safety in humans are already well described, and which represents a lead compound for utrophin upregulation as a therapy for DMD.	[Moorwood, Catherine; Suri, Neha; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Moorwood, Catherine; Suri, Neha; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Lozynska, Olga; Napper, Andrew D.; Diamond, Scott L.] Univ Penn, Penn Ctr Mol Discovery, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Moorwood, C (corresponding author), Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA.	tsk@mail.med.upenn.edu		Moorwood, Catherine/0000-0002-0589-861X	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [5R01AR048871-07]; Charley's Fund; Penn Medicine Institute for Translational Medicine and Therapeutics; University of Pennsylvania; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048871] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Charley's Fund; Penn Medicine Institute for Translational Medicine and Therapeutics; University of Pennsylvania; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by grants to TSK from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (Grant number 5R01AR048871-07), Charley's Fund and Penn Medicine Institute for Translational Medicine and Therapeutics and to SLD from the Chemical Biology In Translation Program in Translational Medicine and Therapeutics (University of Pennsylvania). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2009, THEORETIC APPLICABIL, P293; Amenta AR, BIGLYCAN RECRUITS UT, P762; ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Baby SM, 2010, DIFFERENTIAL EXPRESS, P323; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, CARDIOVASCULAR EVENT, P1092; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Chaubourt E, 1999, NEUROBIOL DIS, V6, P499, DOI 10.1006/nbdi.1999.0256; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Di L, 2003, CURR OPIN CHEM BIOL, V7, P402, DOI 10.1016/S1367-5931(03)00055-3; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Emery AEH, 2003, DUCHENNE MUSCULAR DY; Engel A., 2004, MYOLOGY BASIC CLIN; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Hedner T, 2004, DRUGS, V64, P2315, DOI 10.2165/00003495-200464200-00004; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2007, SKIPPING PERSONALIZE, P2719; Ji DB, 2008, BIOL PHARM BULL, V31, P2255, DOI 10.1248/bpb.31.2255; Jiang N, 2005, ACTA PHARMACOL SIN, V26, P1181, DOI 10.1111/j.1745-7254.2005.00199.x; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kohler M, 2009, J NEUROL NEUROSUR PS, V80, P320, DOI 10.1136/jnnp.2007.141721; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; Lu YF, 2008, J BIOL CHEM, V283, P34720, DOI 10.1074/jbc.M804518200; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MCDOUALL RM, 1990, J NEUROL SCI, V99, P199, DOI 10.1016/0022-510X(90)90156-H; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Nguyen T M, 1991, J Cell Biol, V115, P1695, DOI 10.1083/jcb.115.6.1695; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Reichert JM, 2003, NAT REV DRUG DISCOV, V2, P695, DOI 10.1038/nrd1178; Rodova M, 2004, NEUROSCI LETT, V363, P163, DOI 10.1016/j.neulet.2004.04.001; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Schulman SP, 2006, L ARGININE THERAPY A, P58; Solomon SD, 2005, CARDIOVASCULAR RISK, P1071; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; U. S. National Library of Medicine NIoH, 2010, DRUGS SUPPL L ARG; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; WROGEMANN K, 1976, LANCET, V1, P672; Xu ZL, 2004, ACTA PHARMACOL SIN, V25, P1165; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	63	50	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26169	10.1371/journal.pone.0026169	http://dx.doi.org/10.1371/journal.pone.0026169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028826	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800023
J	Reilly, JE; Hanson, HH; Fernandez-Monreal, M; Wearne, SL; Hof, PR; Phillips, GR				Reilly, James E.; Hanson, Hugo H.; Fernandez-Monreal, Monica; Wearne, Susan L.; Hof, Patrick R.; Phillips, Greg R.			Characterization of MSB Synapses in Dissociated Hippocampal Culture with Simultaneous Pre- and Postsynaptic Live Microscopy	PLOS ONE			English	Article							NEOCORTEX IN-VIVO; DENDRITIC SPINES; ADULT-RATS; 3-DIMENSIONAL STRUCTURE; PRESYNAPTIC TERMINALS; GAMMA-PROTOCADHERINS; MULTIPLE SYNAPSES; PYRAMIDAL CELLS; DENTATE GYRUS; NEURONS	Multisynaptic boutons (MSBs) are presynaptic boutons in contact with multiple postsynaptic partners. Although MSB synapses have been studied with static imaging techniques such as electron microscopy (EM), the dynamics of individual MSB synapses have not been directly evaluated. It is known that the number of MSB synapses increases with synaptogenesis and plasticity but the formation, behavior, and fate of individual MSB synapses remains largely unknown. To address this, we developed a means of live imaging MSB synapses to observe them directly over time. With time lapse confocal microscopy of GFP-filled dendrites in contact with VAMP2-DsRed-labeled boutons, we recorded both MSBs and their contacting spines hourly over 15 or more hours. Our live microscopy showed that, compared to spines contacting single synaptic boutons (SSBs), MSB-contacting spines exhibit elevated dynamic behavior. These results are consistent with the idea that MSBs serve as intermediates in synaptic development and plasticity.	[Reilly, James E.; Hanson, Hugo H.; Fernandez-Monreal, Monica; Wearne, Susan L.; Hof, Patrick R.; Phillips, Greg R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Wearne, Susan L.; Hof, Patrick R.] Mt Sinai Sch Med, Computat Neurobiol & Imaging Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Reilly, JE (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	greg.phillips@mssm.edu	Monreal, Monica Fernandez/P-6685-2019; Fernandez-Monreal, Mónica/I-7954-2012	Monreal, Monica Fernandez/0000-0001-7278-448X; Fernandez-Monreal, Mónica/0000-0001-7278-448X	National Institutes of Health [NS051238, MH071818]; Irma T. Hirschl Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS051238 and an Irma T. Hirschl Award, both to GRP. PRH was supported by NIH MH071818. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Federmeier KD, 2002, NEUROSCI LETT, V332, P180, DOI 10.1016/S0304-3940(02)00759-0; Fernandez-Monreal M, 2010, EUR J NEUROSCI, V32, P921, DOI 10.1111/j.1460-9568.2010.07386.x; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIELD PM, 1980, BRAIN RES, V189, P103, DOI 10.1016/0006-8993(80)90010-4; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Hanson HH, 2010, MICROSC MICROANAL, V16, P747, DOI 10.1017/S1431927610094092; Hanson HH, 2010, J BIOL CHEM, V285, P20982, DOI 10.1074/jbc.M109.092031; HARRIS KM, 1995, TRENDS NEUROSCI, V18, P365, DOI 10.1016/0166-2236(95)93930-V; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Jones TA, 1999, J COMP NEUROL, V414, P57; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Kirov SA, 1999, J NEUROSCI, V19, P2876; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Konur S, 2004, MOL CELL NEUROSCI, V27, P427, DOI 10.1016/j.mcn.2004.07.005; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; MATTHEWS DA, 1976, BRAIN RES, V115, P23, DOI 10.1016/0006-8993(76)90820-9; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nicholson DA, 2009, J COMP NEUROL, V512, P399, DOI 10.1002/cne.21896; RAISMAN G, 1973, BRAIN RES, V50, P241, DOI 10.1016/0006-8993(73)90729-4; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sorra KE, 1998, J COMP NEUROL, V398, P225; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEWARD O, 1988, J COMP NEUROL, V267, P203, DOI 10.1002/cne.902670205; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Woolley CS, 1996, J COMP NEUROL, V373, P108; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26478	10.1371/journal.pone.0026478	http://dx.doi.org/10.1371/journal.pone.0026478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028887	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800045
J	Zhao, LD; Guo, WW; Lin, C; Li, LX; Sun, JH; Wu, N; Ren, LL; Li, XX; Liu, HZ; Young, WY; Gao, WQ; Yang, SM				Zhao, Li-Dong; Guo, Wei-Wei; Lin, Chang; Li, Li-Xian; Sun, Jian-He; Wu, Nan; Ren, Li-Li; Li, Xin-Xin; Liu, Hui-Zhan; Young, Wie-Yen; Gao, Wei-Qiang; Yang, Shi-Ming			Effects of DAPT and Atoh1 Overexpression on Hair Cell Production and Hair Bundle Orientation in Cultured Organ of Corti from Neonatal Rats	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; PROSENSORY PATCHES; REGENERATION; COCHLEA; CHICK; REPLACEMENT; INHIBITION; MATH1; DIFFERENTIATION; EXPRESSION	Background: In mammals, hair cells do not undergo spontaneous regeneration when they are damaged and result in permanent hearing loss. Previous studies in cultured Organ of Corti dissected from neonatal animals have shown that both DAPT (r-secretase inhibitor in the Notch signal pathway) treatment and Atoh1 overexpression can induce supernumerary hair cells. The effects of simultaneous DAPT treatment and Atoh1 over expression in the cells of cultured Organ of Corti from neonatal rats are still obscure. Principal Findings: In this study, we set out to investigate the interaction of DAPT treatment and Atoh1 overexpression as well as culture time and the location of basilar fragment isolated form neonatal rat inner ear. Our results showed that DAPT treatment induced more hair cells in the apical turn, while Atoh1 overexpression induced more extra hair cells in the middle turn of the cultured Organ of Corti. When used together, their effects are additive but not synergistic. In addition, the induction of supernumerary hair cells by both DAPT and Atoh1 overexpression is dependent on the treatment time and the location of the cochlear tissue. Moreover, DAPT treatment causes dramatic changes in the orientation of the stereociliary bundles of hair cells, whereas Atoh1 overexpression didn't induce drastic change of the polarity of stereociliary bundles. Conclusions/Significance: Taken together, these results suggest that DAPT treatment are much more potent in inducing supernumerary hair cells than Atoh1 overexpression and that the new hair cells mainly come from the trans-differentiation of supporting cells around hair cells. The orientation change of stereociliary bundle of hair cells may be attributed to the insertion of the newly formed hair cells. The immature hair bundles on the newly formed hair cells may also contribute to the overall chaos of the stereociliary bundle of the sensory epithelia.	[Zhao, Li-Dong; Guo, Wei-Wei; Li, Li-Xian; Sun, Jian-He; Wu, Nan; Ren, Li-Li; Li, Xin-Xin; Liu, Hui-Zhan; Young, Wie-Yen; Yang, Shi-Ming] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing, Peoples R China; [Lin, Chang; Li, Li-Xian] Fujian Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Fuzhou, Peoples R China; [Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Med, Renji MedX Clin Stem Cell Res Ctr, Renji Hosp, Shanghai 200030, Peoples R China; [Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Med Res Inst X, Shanghai 200030, Peoples R China; [Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, Renji Hosp, Shanghai 200030, Peoples R China	Chinese People's Liberation Army General Hospital; Fujian Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, LD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing, Peoples R China.	weiqgao@yahoo.com; yangsm301@263.net	Gao, Wei/GXH-0380-2022; , sunjhe/S-5843-2019	Zhao, Lidong/0000-0002-0810-0941	Major State Basic Research Development Program of China (973) [2011CBA01000]; National Hi-Tech Research and Development Program of China (863) [2007AA02Z150]; National Natural Science Foundation of China [30871398, 30730040, 30628030]; National Basic Research Program of China [2012CB966800]; K. C. Wong endowment fund	Major State Basic Research Development Program of China (973)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); K. C. Wong endowment fund	This work was supported by grants from the Major State Basic Research Development Program of China (973) (#2011CBA01000), National Hi-Tech Research and Development Program of China (863) (#2007AA02Z150) to S-MY, and the National Natural Science Foundation of China (#30871398, 30730040, 30628030) to S-MY. National Basic Research Program of China (Grant No. 2012CB966800) to W-QG and K. C. Wong endowment fund (to W-QG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URL of the funder's website is as following: http://www.nsfc.gov.cn/Portal0/default124.htm.	ABDOUH A, 1994, BRAIN RES, V660, P181, DOI 10.1016/0006-8993(94)91288-2; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; CORWIN JT, 1991, ANNU REV NEUROSCI, V14, P301, DOI 10.1146/annurev.neuro.14.1.301; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Gale JE, 2002, J NEUROBIOL, V50, P81, DOI 10.1002/neu.10002; Hartman BH, 2009, JARO-J ASSOC RES OTO, V10, P321, DOI 10.1007/s10162-009-0162-2; Hori R, 2007, NEUROREPORT, V18, P1911, DOI 10.1097/WNR.0b013e3282f213e0; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jones JE, 1996, J NEUROSCI, V16, P649; KELLEY MW, 1995, J NEUROSCI, V15, P3013; Kelly M, 2007, INT J DEV BIOL, P13; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; LEWIS J, 1991, CIBA F SYMP, V160, P25, DOI 10.4171/RMI/104; RAPHAEL Y, 1991, CELL MOTIL CYTOSKEL, V18, P215, DOI 10.1002/cm.970180307; RAPHAEL Y, 1992, J NEUROCYTOL, V21, P663, DOI 10.1007/BF01191727; Sobkowicz HM, 1997, INT J DEV NEUROSCI, V15, P463, DOI 10.1016/S0736-5748(96)00104-9; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Stone JS, 1999, J NEUROCYTOL, V28, P863, DOI 10.1023/A:1007022205821; STONE JS, 1994, J COMP NEUROL, V341, P50, DOI 10.1002/cne.903410106; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Taylor RR, 2008, JARO-J ASSOC RES OTO, V9, P44, DOI 10.1007/s10162-007-0105-8; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wu WJ, 2001, HEARING RES, V158, P165, DOI 10.1016/S0378-5955(01)00303-3; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 1999, J NEUROSCI, V19, P2161; Zine A, 2000, DEVELOPMENT, V127, P3373	33	25	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e23729	10.1371/journal.pone.0023729	http://dx.doi.org/10.1371/journal.pone.0023729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028767	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800002
J	Bharatham, N; Chi, SW; Yoon, HS				Bharatham, Nagakumar; Chi, Seung-Wook; Yoon, Ho Sup			Molecular Basis of Bcl-X-L-p53 Interaction: Insights from Molecular Dynamics Simulations	PLOS ONE			English	Article							BCL-2 PROTEIN FAMILY; IN-VIVO; INDUCE APOPTOSIS; X-L; BH3-ONLY PROTEINS; NUCLEIC-ACIDS; CELL-SURVIVAL; P53; MDM2; COMPLEX	Bcl-X-L, an antiapoptotic Bcl-2 family protein, plays a central role in the regulation of the apoptotic pathway. Heterodimerization of the antiapoptotic Bcl-2 family proteins with the proapoptotic family members such as Bad, Bak, Bim and Bid is a crucial step in the apoptotic regulation. In addition to these conventional binding partners, recent evidences reveal that the Bcl-2 family proteins also interact with noncanonical binding partners such as p53. Our previous NMR studies showed that Bcl-X-L: BH3 peptide and Bcl-X-L: SN15 peptide (a peptide derived from residues S15-N29 of p53) complex structures share similar modes of bindings. To further elucidate the molecular basis of the interactions, here we have employed molecular dynamics simulations coupled with MM/PBSA approach. Bcl-XL and other Bcl-2 family proteins have 4 hydrophobic pockets (p1-p4), which are occupied by four systematically spaced hydrophobic residues (h1-h4) of the proapoptotic Bad and Bak BH3 peptides. We observed that three conserved hydrophobic residues (F19, W23 and L26) of p53 (SN15) peptide anchor into three hydrophobic pockets (p2-p4) of Bcl-X-L in a similar manner as BH3 peptide. Our results provide insights into the novel molecular recognition by Bcl-X-L with p53.	[Bharatham, Nagakumar; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore, Singapore; [Chi, Seung-Wook] KRIBB, Med Prote Res Ctr, Taejon, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Bharatham, N (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore, Singapore.	hsyoon@ntu.edu.sg	Yoon, Ho Sup/A-2193-2011	Yoon, Ho Sup/0000-0002-8243-3904	Ministry of Education Singapore [AcRF Tier 2 ARC 4/04]; Nanyang Technological University [RG161/06]; Ministry of Health Singapore [NMRC/1177/2008]	Ministry of Education Singapore(Ministry of Education, Singapore); Nanyang Technological University(Nanyang Technological University); Ministry of Health Singapore(Ministry of Health-Singapore)	This study was supported by Ministry of Education Singapore Grant AcRF Tier 2 ARC 4/04, Nanyang Technological University Grant RG161/06, and Ministry of Health Singapore Grant NMRC/1177/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; CASE DA, 2004, AMBER9; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Ha JH, 2011, J AM CHEM SOC, V133, P1244, DOI 10.1021/ja109521f; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; JOSEPH TL, 2010, CELL CYCLE, V9; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Kutzki O, 2002, J AM CHEM SOC, V124, P11838, DOI 10.1021/ja026861k; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; Lee HJ, 2007, CELL CYCLE, V6, P2604, DOI 10.4161/cc.6.21.4923; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Minn AJ, 1998, ADV IMMUNOL, V70, P245, DOI 10.1016/S0065-2776(08)60388-0; Moroy G, 2009, J BIOL CHEM, V284, P17499, DOI 10.1074/jbc.M805542200; Naski N, 2009, CELL CYCLE, V8, P31, DOI 10.4161/cc.8.1.7326; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Skommer J, 2007, LEUKEMIA RES, V31, P277, DOI 10.1016/j.leukres.2006.06.027; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; van der Spoel D., 2005, GROMACS USER MANUAL; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wahl GM, 2006, CELL DEATH DIFFER, V13, P973, DOI 10.1038/sj.cdd.4401911; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Xu HB, 2006, BIOCHEM BIOPH RES CO, V341, P938, DOI 10.1016/j.bbrc.2005.12.227; Xu HB, 2009, BIOCHEMISTRY-US, V48, P12159, DOI 10.1021/bi901188s; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	67	28	28	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26014	10.1371/journal.pone.0026014	http://dx.doi.org/10.1371/journal.pone.0026014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039431	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500027
J	Li, M; Song, Y; Cho, N; Chang, JM; Koo, HR; Yi, A; Kim, H; Park, S; Moon, WK				Li, Mulan; Song, Yonghyun; Cho, Nariya; Chang, Jung Min; Koo, Hye Ryoung; Yi, Ann; Kim, Hyeonjin; Park, Sunghyouk; Moon, Woo Kyung			An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; NMR-SPECTROSCOPY; CANCER TISSUE; IDENTIFICATION; METABOLISM; DIAGNOSIS; DISEASE; CLASSIFICATION; PREDICTION; BIOFLUIDS	Background: Much research has been devoted to the development of new breast cancer diagnostic measures, including those involving high-resolution magic angle spinning (HR-MAS) magnetic resonance (MR) spectroscopic techniques. Previous HR-MAS MR results have been obtained from post-surgery samples, which limits their direct clinical applicability. Methodology/Principal Findings: In the present study, we performed HR-MAS MR spectroscopic studies on 31 breast tissue samples (13 cancer and 18 non-cancer) obtained by percutaneous core needle biopsy. We showed that cancer and non-cancer samples can be discriminated very well with Orthogonal Projections to Latent Structure-Discriminant Analysis (OPLS-DA) multivariate model on the MR spectra. A subsequent blind test showed 69% sensitivity and 94% specificity in the prediction of the cancer status. A spectral analysis showed that in cancer cells, taurine-and choline-containing compounds are elevated. Our approach, additionally, could predict the progesterone receptor statuses of the cancer patients. Conclusions/Significance: HR-MAS MR metabolomics on intact breast tissues obtained by core needle biopsy may have a potential to be used as a complement to the current diagnostic and prognostic measures for breast cancers.	[Li, Mulan; Cho, Nariya; Chang, Jung Min; Koo, Hye Ryoung; Yi, Ann; Kim, Hyeonjin; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Song, Yonghyun; Park, Sunghyouk] Inha Univ, Dept Biochem, Coll Med, Inchon, South Korea; [Song, Yonghyun; Park, Sunghyouk] Inha Univ, Ctr Adv Med Educ, Coll Med, Inchon, South Korea	Seoul National University (SNU); Inha University; Inha University	Li, M (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	spark@inha.ac.kr; moonwk@snu.ac.kr	Kim, Hyeonjin/J-2751-2012; Moon, Woo Kyung/J-2755-2012; Kim, Hyeonjin/M-3761-2019; Cho, Nariya/J-5663-2012	Chang, Jung Min/0000-0001-5726-9797	NRF; Ministry Of Education, Science and Technology [20090080219, 2010-0005189]; Ministry of Health & Welfare, Republic of Korea [A01185]; Innovative Research Institute for Cell Therapy, Republic of Korea [A062260]; National Research Foundation of Korea (NRF); Ministry for Health & Welfare, Republic of Korea [A092006]	NRF; Ministry Of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Innovative Research Institute for Cell Therapy, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Mid-career Researcher Program through NRF grant funded by the Ministry Of Education, Science and Technology (No. 20090080219), by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (A01185), and by a grant (A062260) from the Innovative Research Institute for Cell Therapy, Republic of Korea. This research was also supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0005189), and a grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A092006) to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Beckonert O, 2003, NMR BIOMED, V16, P1, DOI 10.1002/nbm.797; Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Burns MA, 2004, TECHNOL CANCER RES T, V3, P591, DOI 10.1177/153303460400300609; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cecil KM, 2001, BREAST CANCER RES TR, V68, P45, DOI 10.1023/A:1017911211090; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Cheng LL, 1998, J MAGN RESON, V135, P194, DOI 10.1006/jmre.1998.1578; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Defeo EM, 2010, TECHNOL CANCER RES T, V9, P381, DOI 10.1177/153303461000900407; Giskeodegard GF, 2010, J PROTEOME RES, V9, P972, DOI 10.1021/pr9008783; Gribbestad IS, 1999, ANTICANCER RES, V19, P1737; Holmes E, 2006, J PROTEOME RES, V5, P1313, DOI 10.1021/pr050399w; Kang J, 2008, J AGR FOOD CHEM, V56, P11589, DOI 10.1021/jf802088a; Katz-Brull R, 2002, CANCER RES, V62, P1966; Kwon HN, 2011, KIDNEY INT, V79, P529, DOI 10.1038/ki.2010.440; Larsen TO, 2005, NAT PROD REP, V22, P672, DOI 10.1039/b404943h; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Martinez-Granados B, 2011, INT J MOL MED, V27, P111, DOI 10.3892/ijmm.2010.563; Mountford CE, 2001, BRIT J SURG, V88, P1234, DOI 10.1046/j.0007-1323.2001.01864.x; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; Rocha CM, 2010, J PROTEOME RES, V9, P319, DOI 10.1021/pr9006574; Roebuck JR, 1998, RADIOLOGY, V209, P269, DOI 10.1148/radiology.209.1.9769842; Sands CJ, 2009, ANAL CHEM, V81, P6458, DOI 10.1021/ac900828p; SINGER S, 1995, CANCER RES, V55, P5140; Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sitter B, 2010, NMR BIOMED, V23, P424, DOI 10.1002/nbm.1478; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Thomas MA, 2009, NMR BIOMED, V22, P77, DOI 10.1002/nbm.1310; Ting YLT, 1996, ANTICANCER RES, V16, P1381; Wen H, 2010, J HEPATOL, V52, P228, DOI 10.1016/j.jhep.2009.11.002; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510	36	55	57	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25563	10.1371/journal.pone.0025563	http://dx.doi.org/10.1371/journal.pone.0025563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028780	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900009
J	Zhang, Y; Thomas, GL; Swat, M; Shirinifard, A; Glazier, JA				Zhang, Ying; Thomas, Gilberto L.; Swat, Maciej; Shirinifard, Abbas; Glazier, James A.			Computer Simulations of Cell Sorting Due to Differential Adhesion	PLOS ONE			English	Article							HOMOPHILIC CADHERIN ADHESION; N-CADHERIN; ACTIN CYTOSKELETON; FORCE MEASUREMENTS; MEDIATED ADHESION; STRUCTURAL BASIS; WOUND CLOSURE; CHICK LIMB; MORPHOGENESIS; SPECIFICITY	The actions of cell adhesion molecules, in particular, cadherins during embryonic development and morphogenesis more generally, regulate many aspects of cellular interactions, regulation and signaling. Often, a gradient of cadherin expression levels drives collective and relative cell motions generating macroscopic cell sorting. Computer simulations of cell sorting have focused on the interactions of cells with only a few discrete adhesion levels between cells, ignoring biologically observed continuous variations in expression levels and possible nonlinearities in molecular binding. In this paper, we present three models relating the surface density of cadherins to the net intercellular adhesion and interfacial tension for both discrete and continuous levels of cadherin expression. We then use then the Glazier-Graner-Hogeweg (GGH) model to investigate how variations in the distribution of the number of cadherins per cell and in the choice of binding model affect cell sorting. We find that an aggregate with a continuous variation in the level of a single type of cadherin molecule sorts more slowly than one with two levels. The rate of sorting increases strongly with the interfacial tension, which depends both on the maximum difference in number of cadherins per cell and on the binding model. Our approach helps connect signaling at the molecular level to tissue-level morphogenesis.	[Zhang, Ying] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Thomas, Gilberto L.] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [Swat, Maciej; Shirinifard, Abbas; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN USA; [Swat, Maciej; Shirinifard, Abbas; Glazier, James A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal do Rio Grande do Sul; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, Y (corresponding author), NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA.	zhangy14@mail.nih.gov	Thomas, Gilberto L/H-8944-2012; Zhang, Ying/Q-6956-2016; Thomas, Gilberto L/AAW-4072-2020	Zhang, Ying/0000-0002-8045-3821; Thomas, Gilberto L/0000-0003-0317-6186; Glazier, James Alexander/0000-0003-3634-190X	Indiana University; Biocomplexity Institute at Indiana University; National Institutes of Health [NIGMS R01-GM76692, R01-GM077138]; EPA; Brazilian agencies Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [PRONEX-10/0008-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	Indiana University; Biocomplexity Institute at Indiana University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA(United States Environmental Protection Agency); Brazilian agencies Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from Indiana University and The Biocomplexity Institute at Indiana University and National Institutes of Health grants NIGMS R01-GM76692 and R01-GM077138 and The EPA grant "Texas-Indiana Virtual STAR Center.'' GLT acknowledges support from the Brazilian agencies Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) under the grant PRONEX-10/0008-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; ARMSTRONG PB, 1971, ROUX ARCH DEV BIOL, V168, P125, DOI 10.1007/BF00581804; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; BITZUR S, 1994, DEV DYNAM, V201, P121, DOI 10.1002/aja.1002010204; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Dan D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041909; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Frenkel J., 1945, J PHYS, V9, P385; FRIEDLANDER DR, 1989, P NATL ACAD SCI USA, V86, P7043, DOI 10.1073/pnas.86.18.7043; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Glazier JA, SINGLE CELL BASED MO, P79; Glazier JA, 2008, CURR TOP DEV BIOL, V81, P205, DOI 10.1016/S0070-2153(07)81007-6; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; Linask KK, 1998, DEV BIOL, V202, P85, DOI 10.1006/dbio.1998.9025; Lorger M, 2006, J CELL SCI, V119, P3385, DOI 10.1242/jcs.03027; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mombach JCM, 1996, PHYS REV LETT, V76, P3032, DOI 10.1103/PhysRevLett.76.3032; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Omi M, 2002, DEV BIOL, V250, P292, DOI 10.1006/dbio.2002.0804; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Poplawski NJ, 2007, PHYSICA A, V373, P521, DOI 10.1016/j.physa.2006.05.028; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Rieu JP, 2000, BIOPHYS J, V79, P1903, DOI 10.1016/S0006-3495(00)76440-X; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STEINBERG MS, 1972, J CELL BIOL, V55, P606, DOI 10.1083/jcb.55.3.606; Steinhaus H., 1957, B ACAD POL SCI, V4, P801; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P7467, DOI 10.1073/pnas.0902859106; Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047; Yajima H, 1999, DEV DYNAM, V216, P274, DOI 10.1002/(SICI)1097-0177(199911)216:3<274::AID-DVDY6>3.3.CO;2-J; Zajac M, 2000, PHYS REV LETT, V85, P2022, DOI 10.1103/PhysRevLett.85.2022; Zeng W, 2004, PHYSICA A, V341, P482, DOI 10.1016/j.physa.2004.03.089; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	55	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e24999	10.1371/journal.pone.0024999	http://dx.doi.org/10.1371/journal.pone.0024999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028771	Green Published, gold			2022-12-25	WOS:000296186900004
J	Brulc, JM; Yeoman, CJ; Wilson, MK; Miller, MEB; Jeraldo, P; Jindou, S; Goldenfeld, N; Flint, HJ; Lamed, R; Borovok, I; Vodovnik, M; Nelson, KE; Bayer, EA; White, BA				Brulc, Jennifer M.; Yeoman, Carl J.; Wilson, Melissa K.; Miller, Margret E. Berg; Jeraldo, Patricio; Jindou, Sadanari; Goldenfeld, Nigel; Flint, Harry J.; Lamed, Raphael; Borovok, Ilya; Vodovnik, Masa; Nelson, Karen E.; Bayer, Edward A.; White, Bryan A.			Cellulosomics, a Gene-Centric Approach to Investigating the Intraspecific Diversity and Adaptation of Ruminococcus flavefaciens within the Rumen	PLOS ONE			English	Article							COENZYME-M REDUCTASE; 16S RIBOSOMAL-RNA; BOVINE RUMEN; MICROBIAL COMMUNITIES; PHYLOGENETIC ANALYSIS; BACTERIA; CONSERVATION; DEGRADATION; POPULATIONS; SEQUENCES	Background: The bovine rumen maintains a diverse microbial community that serves to break down indigestible plant substrates. However, those bacteria specifically adapted to degrade cellulose, the major structural component of plant biomass, represent a fraction of the rumen microbiome. Previously, we proposed scaC as a candidate for phylotyping Ruminococcus flavefaciens, one of three major cellulolytic bacterial species isolated from the rumen. In the present report we examine the dynamics and diversity of scaC-types both within and between cattle temporally, following a dietary switch from corn-silage to grass-legume hay. These results were placed in the context of the overall bacterial population dynamics measured using the 16S rRNA. Principal Findings: As many as 117 scaC-types were estimated, although just nineteen were detected in each of three rumens tested, and these collectively accounted for the majority of all types present. Variation in scaC populations was observed between cattle, between planktonic and fiber-associated fractions and temporally over the six-week survey, and appeared related to scaC phylogeny. However, by the sixth week no significant separation of scaC populations was seen between animals, suggesting enrichment of a constrained set of scaC-types. Comparing the amino-acid translation of each scaC-type revealed sequence variation within part of the predicted dockerin module but strong conservation in the N-terminus, where the cohesin module is located. Conclusions: The R. flavefaciens species comprises a multiplicity of scaC-types in-vivo. Enrichment of particular scaC-types temporally, following a dietary switch, and between fractions along with the phylogenetic congruence suggests that functional differences exist between types. Observed differences in dockerin modules suggest at least part of the functional heterogeneity may be conferred by scaC. The polymorphic nature of scaC enables the relative distribution of R. flavefaciens strains to be examined and represents a gene-centric approach to investigating the intraspecific adaptation of an important specialist population.	[Brulc, Jennifer M.; Wilson, Melissa K.; Miller, Margret E. Berg; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Brulc, Jennifer M.; Yeoman, Carl J.; Miller, Margret E. Berg; Jeraldo, Patricio; Goldenfeld, Nigel; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Jeraldo, Patricio; Goldenfeld, Nigel] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Jindou, Sadanari] Meijo Univ, Dept Culture Educ, Fac Sci, Aichi, Japan; [Flint, Harry J.; Vodovnik, Masa] Univ Aberdeen, Microbial Ecol Grp, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Lamed, Raphael; Borovok, Ilya] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Vodovnik, Masa] Univ Ljubljana, Chair Microbiol & Microbial Biotechnol, Biotech Fac, Ljubljana, Slovenia; [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Meijo University; University of Aberdeen; Tel Aviv University; University of Ljubljana; J. Craig Venter Institute; Weizmann Institute of Science	Brulc, JM (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	bwhite44@illinois.edu	Vodovnik, Masa/U-4580-2019; BOROVOK, ILYA/ABB-7370-2022; Yeoman, Carl/ABA-1906-2021; Jeraldo, Patricio/H-8178-2019	Yeoman, Carl/0000-0002-8775-7879; Jeraldo, Patricio/0000-0003-0282-4217; Vodovnik, Masa/0000-0002-1189-2417; BOROVOK, ILYA/0000-0003-1602-4499; Berg, Margret/0000-0002-0411-1619	National Research Initiative from the USDA Cooperative State Research, Education, and Extension Service [2006-35206-16652]; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel - BSF; Israel Science Foundation [966/09, 159/07, 291/08]; Scottish Government Rural and Environmental Science and Analysis Service; BSF	National Research Initiative from the USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel - BSF(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Scottish Government Rural and Environmental Science and Analysis Service; BSF(US-Israel Binational Science Foundation)	This project was supported by National Research Initiative Competitive Grant no. 2006-35206-16652 from the USDA Cooperative State Research, Education, and Extension Service (http://www.csrees.usda.gov/), and in part by grants from the United States-Israel Binational Science Foundation (BSF; http://www.bsf.org.il), Jerusalem, Israel - BSF Energy Research grant to E. A. B. and B. A. W and Regular BSF Research grants to E. A. B. and B. A. W. and to R. L. and B. A. W. and by the Israel Science Foundation (grant nos 966/09, 159/07 and 291/08; http://www.isf.org.il). H.J.F. was supported by the Scottish Government Rural and Environmental Science and Analysis Service. E. A. B. holds The Maynard I. and Elaine Wishner Chair of Bio-organic Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cook KL, 2008, ANAEROBE, V14, P172, DOI 10.1016/j.anaerobe.2008.03.003; DEHORITY BA, 1967, J DAIRY SCI, V50, P1136, DOI 10.3168/jds.S0022-0302(67)87579-9; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hespell Robert B., 1997, P59; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; KARKHOFFSCHWEIZER RR, 1995, APPL ENVIRON MICROB, V61, P290, DOI 10.1128/AEM.61.1.290-296.1995; Kent AD, 2003, APPL ENVIRON MICROB, V69, P6768, DOI 10.1128/AEM.69.11.6768-6776.2003; Krause DO, 1999, J APPL MICROBIOL, V86, P487, DOI 10.1046/j.1365-2672.1999.00688.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lamed R, 1983, BIOTECHNOL BIOENG S, V13, P163; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Legendre P, 1998, NUMERICAL ECOLOGY; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Matsui H, 2010, CURR MICROBIOL, V60, P112, DOI 10.1007/s00284-009-9513-9; National Research Council, 2001, NUTR REQ DAIR CATTL, DOI DOI 10.17226/9825; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Robert C, 2003, FEMS MICROBIOL ECOL, V46, P81, DOI 10.1016/S0168-6496(03)00207-1; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tatsuoka N, 2004, LETT APPL MICROBIOL, V39, P257, DOI 10.1111/j.1472-765X.2004.01566.x; Warwick R. M., 2001, PRIMER E; Weimer PJ, 1999, J DAIRY SCI, V82, P122, DOI 10.3168/jds.S0022-0302(99)75216-1; Yeoman CJ, 2011, ENTROPY-SWITZ, V13, P570, DOI 10.3390/e13030570; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Yu ZT, 2006, ENVIRON MICROBIOL, V8, P603, DOI 10.1111/j.1462-2920.2005.00933.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	41	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25329	10.1371/journal.pone.0025329	http://dx.doi.org/10.1371/journal.pone.0025329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043282	Green Published, Green Submitted, gold			2022-12-25	WOS:000295984400009
J	Guarnieri, MT; Nag, A; Smolinski, SL; Darzins, A; Seibert, M; Pienkos, PT				Guarnieri, Michael T.; Nag, Ambarish; Smolinski, Sharon L.; Darzins, Al; Seibert, Michael; Pienkos, Philip T.			Examination of Triacylglycerol Biosynthetic Pathways via De Novo Transcriptomic and Proteomic Analyses in an Unsequenced Microalga	PLOS ONE			English	Article							CHLOROPLAST GENE-EXPRESSION; CHLAMYDOMONAS-REINHARDTII; CHLORELLA-VULGARIS; DIRECT TRANSESTERIFICATION; TRANSLATIONAL REGULATION; BIOFUEL PRODUCTION; CELL-WALL; STRESS; RNA; CHLOROPHYCEAE	Biofuels derived from algal lipids represent an opportunity to dramatically impact the global energy demand for transportation fuels. Systems biology analyses of oleaginous algae could greatly accelerate the commercialization of algal-derived biofuels by elucidating the key components involved in lipid productivity and leading to the initiation of hypothesis-driven strain-improvement strategies. However, higher-level systems biology analyses, such as transcriptomics and proteomics, are highly dependent upon available genomic sequence data, and the lack of these data has hindered the pursuit of such analyses for many oleaginous microalgae. In order to examine the triacylglycerol biosynthetic pathway in the unsequenced oleaginous microalga, Chlorella vulgaris, we have established a strategy with which to bypass the necessity for genomic sequence information by using the transcriptome as a guide. Our results indicate an upregulation of both fatty acid and triacylglycerol biosynthetic machinery under oil-accumulating conditions, and demonstrate the utility of a de novo assembled transcriptome as a search model for proteomic analysis of an unsequenced microalga.	[Guarnieri, Michael T.; Darzins, Al; Pienkos, Philip T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO USA; [Nag, Ambarish] Natl Renewable Energy Lab, Computat Sci Ctr, Golden, CO USA; [Smolinski, Sharon L.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Seibert, Michael] Natl Renewable Energy Lab, Energy Sci Directorate, Golden, CO USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Guarnieri, MT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO USA.	michael.guarnieri@nrel.gov		Guarnieri, Michael/0000-0003-1403-9689; Nag, Ambarish/0000-0001-5174-4673	Air Force Office of Scientific Research [WFC31000]; National Renewable Energy Laboratory (NREL) [06510901]; Alliance for Sustainable Energy, LLC [DE-AC36-08GO28308]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Renewable Energy Laboratory (NREL); Alliance for Sustainable Energy, LLC	This work was supported by Air Force Office of Scientific Research funding, grant WFC31000, for A. D., M. S., P. T. P., and M. T. G., and by the Laboratory Directed Research and Development (LDRD) Program at the National Renewable Energy Laboratory (NREL), LDRD # 06510901 for P. T. P, S. S., M. T. G., and A. N.. NREL is a national laboratory of the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy operated by the Alliance for Sustainable Energy, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by the Alliance for Sustainable Energy, LLC. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; Employees of the Alliance for Sustainable Energy, LLC, under Contract No. DE-AC36-08GO28308 with the U.S. Dept. of Energy have authored this work. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this work, or allow others to do so, for United States Government purposes.	Aizzat O, 2010, ADV MED SCI-POLAND, V55, P281, DOI 10.2478/v10039-010-0046-z; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Chow KC, 1999, PLANT CELL REP, V18, P778, DOI 10.1007/s002990050660; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dickey LA, 2002, N AM J AQUACULT, V64, P158, DOI 10.1577/1548-8454(2002)064&lt;0158:COADTM&gt;2.0.CO;2; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P252, DOI 10.1128/AEM.72.1.252-260.2006; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Feng YJ, 2011, BIORESOURCE TECHNOL, V102, P101, DOI 10.1016/j.biortech.2010.06.016; Ferreira VD, 2007, GENE, V389, P136, DOI 10.1016/j.gene.2006.10.023; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; GILLHAM NW, 1994, ANNU REV GENET, V28, P71, DOI 10.1146/annurev.ge.28.120194.000443; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; GRUISSEM W, 1993, CRIT REV PLANT SCI, V12, P19, DOI 10.1080/07352689309382355; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Jamers A, 2009, AQUAT TOXICOL, V92, P114, DOI 10.1016/j.aquatox.2009.02.012; JARVIS EE, 1991, CURR GENET, V19, P317, DOI 10.1007/BF00355062; Kim YK, 2005, ECOTOXICOLOGY, V14, P589, DOI 10.1007/s10646-005-0009-5; KIRK MM, 1985, CELL, V41, P419, DOI 10.1016/S0092-8674(85)80015-5; LEPAGE G, 1986, J LIPID RES, V27, P114; MAYFIELD SP, 1995, ANNU REV PLANT PHYS, V46, P147, DOI 10.1146/annurev.pp.46.060195.001051; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Ramos AL, 2010, NUTR CANCER, V62, P1170, DOI 10.1080/01635581.2010.513801; Ratledge C, 1988, OVERVIEW MICROBIAL L; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Rochaix JD, 1996, PLANT MOL BIOL, V32, P327, DOI 10.1007/BF00039389; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; ROESSLER PG, 1994, ANN NY ACAD SCI, V721, P250, DOI 10.1111/j.1749-6632.1994.tb47398.x; SCHULZ M, 2010, OASES DE NOVO TRANSC; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Sheehan J, 1998, DOE AQUATIC SPECIES; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Stephenson AL, 2010, BIOFUELS-UK, V1, P47, DOI 10.4155/BFS.09.1; TAKEDA H, 1991, J PHYCOL, V27, P224, DOI 10.1111/j.0022-3646.1991.00224.x; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Wang SB, 2004, PROTEOMICS, V4, P692, DOI 10.1002/pmic.200300634; Ward AJ, 2010, BIORESOURCE TECHNOL, V101, P2210, DOI 10.1016/j.biortech.2009.11.053; Wienkoop S, 2010, MOL BIOSYST, V6, P1018, DOI 10.1039/b920913a; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Work VH, 2010, EUKARYOT CELL, V9, P1251, DOI 10.1128/EC.00075-10; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	53	166	175	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25851	10.1371/journal.pone.0025851	http://dx.doi.org/10.1371/journal.pone.0025851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043295	Green Published, Green Submitted, gold			2022-12-25	WOS:000295984400023
J	Blache, D; Gautier, T; Tietge, UJF; Lagrost, L				Blache, Denis; Gautier, Thomas; Tietge, Uwe J. F.; Lagrost, Laurent			Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism	FASEB JOURNAL			English	Article						thrombosis; oxidative stress	INTIMA-MEDIA THICKNESS; GROUP-II; GROUP-V; SECRETORY PHOSPHOLIPASE-A2; CHOLESTEROL ACCUMULATION; POTENTIAL INVOLVEMENT; OXIDATIVE STRESS; APOLIPOPROTEIN-E; CORONARY EVENTS; LIPID PEROXIDES	Plasma activity of secretory phospholipase A2 (sPLA2) increases in patients with cardiovascular disease. The present study investigated whether platelet-released sPLA2 induces low-density lipoprotein (LDL) and high-density lipoprotein (HDL) modifications that translate into changes in lipoprotein function. Activated but not resting platelets induced oxidative modifications of human native LDLs and HDLs, which render these particles dysfunctional. Platelet-incubated LDLs stimulated the incorporation of cholesterol oleate into macrophages, and modified HDLs lost their cholesterol efflux capacity and antioxidant properties. In vitro and ex vivo experiments showed that lysophophatidylcholine accumulated in the platelet-modified LDLs and HDLs of mice expressing sPLA2 (Balb/c and transgenic C57Bl/6 mice expressing human sPLA2) but not in the lipoproteins of naturally sPLA2-deficient mice (C57Bl/6). Unlike C57Bl/6 mice, Balb/c mice injected with leptin (67 mu g/mouse, i.p.) as an in vivo prothrombotic agent displayed increased plasma sPLA2 activity, reduced clotting time, higher plasma levels of oxidation products, increased production of nonesterified fatty acids, and more substantial platelet-mediated modification of lipoproteins. These effects were blocked completely by injection of the platelet inhibitor ticlopidine (5 mg/kg, i.p.) or by a sPLA2 inhibitor (LY311727, 3 mg/kg, i.p.). These results demonstrate that stimulated platelets are major contributors to plasma sPLA2 activity in vivo and account to a large extent for the adverse modification of circulating lipoproteins.-Blache, D., Gautier, T., Tietge, U.J.F., Lagrost, L. Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism. FASEB J. 26, 927-937 (2012). www.fasebj.org	[Blache, Denis] Univ Bourgogne, INSERM, Res Ctr, Fac Med,UMR 866, F-21079 Dijon, France; [Tietge, Uwe J. F.] Univ Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of Groningen	Blache, D (corresponding author), Univ Bourgogne, INSERM, Res Ctr, Fac Med,UMR 866, 7 Blvd Jeanne Arc,BP 87900, F-21079 Dijon, France.	dblache@u-bourgogne.fr	Gautier, Thomas/Q-5371-2018	Gautier, Thomas/0000-0003-1119-7382	Institut National de la Sante et de la Recherche Medicale (INSERM); Conseil Regional de Bourgogne; Universite de Bourgogne; Netherlands Organization for Scientific Research [917-56-358]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Universite de Bourgogne; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The authors thank Benoit Larnaudie for helpful initial studies and Philip Bastable for manuscript editing. This work was supported in part by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Conseil Regional de Bourgogne, the Universite de Bourgogne, and by a grant from the Netherlands Organization for Scientific Research (VIDI grant 917-56-358 to U.J.F.T).	Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Arbibe L, 1998, J CLIN INVEST, V102, P1152, DOI 10.1172/JCI3236; AVIRAM M, 1990, ARTERIOSCLEROSIS, V10, P559, DOI 10.1161/01.ATV.10.4.559; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BERLINER JA, 1992, DIABETES, V41, P74, DOI 10.2337/diab.41.2.S74; Blache D, 1998, J AM OIL CHEM SOC, V75, P107, DOI 10.1007/s11746-998-0019-6; Blache D, 2002, FREE RADICAL BIO MED, V33, P1670, DOI 10.1016/S0891-5849(02)01139-5; BLACHE D, 1995, FEBS LETT, V357, P135, DOI 10.1016/0014-5793(94)01348-5; BLACHE D, 1995, AM J PHYSIOL-HEART C, V268, pH679, DOI 10.1152/ajpheart.1995.268.2.H679; Blache D, 2006, FREE RADICAL BIO MED, V41, P277, DOI 10.1016/j.freeradbiomed.2006.04.008; Bodary PF, 2005, ARTERIOSCL THROM VAS, V25, P119, DOI 10.1161/01.ATV.0000173306.47722.ec; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Carnevale R, 2007, FASEB J, V21, P927, DOI 10.1096/fj.06-6908com; Corsonello A, 2004, INT J OBESITY, V28, P979, DOI 10.1038/sj.ijo.0802722; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; ELSAADANI M, 1989, J LIPID RES, V30, P627; FOGELMAN AM, 1980, P NATL ACAD SCI-BIOL, V77, P2214, DOI 10.1073/pnas.77.4.2214; Garces F, 2010, OBESITY, V18, P2023, DOI 10.1038/oby.2010.9; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gesquiere L, 1999, FREE RADICAL BIO MED, V27, P134, DOI 10.1016/S0891-5849(99)00055-6; Gesquiere L, 2000, FREE RADICAL BIO MED, V29, P181, DOI 10.1016/S0891-5849(00)00337-3; Gesquiere L, 2002, BIOCHEMISTRY-US, V41, P4911, DOI 10.1021/bi015757x; Gesquiere L, 1997, FREE RADICAL BIO MED, V23, P541, DOI 10.1016/S0891-5849(97)00114-7; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Hatch F T, 1968, Adv Lipid Res, V6, P1; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; HurtCamejo E, 1997, ATHEROSCLEROSIS, V132, P1, DOI 10.1016/S0021-9150(97)00085-3; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P300, DOI 10.1161/01.ATV.17.2.300; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jaross W, 2002, EUR J CLIN INVEST, V32, P383, DOI 10.1046/j.1365-2362.2002.01000.x; Jawien J, 2007, EUR J PHARMACOL, V556, P129, DOI 10.1016/j.ejphar.2006.11.028; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Koenig W, 2009, EUR HEART J, V30, P2742, DOI 10.1093/eurheartj/ehp302; Korotaeva AA, 2010, PROSTAG OTH LIPID M, V91, P38, DOI 10.1016/j.prostaglandins.2009.12.004; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Kugiyama K, 2000, AM J CARDIOL, V86, P718, DOI 10.1016/S0002-9149(00)01069-9; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Leinonen ES, 2004, J INTERN MED, V256, P119, DOI 10.1111/j.1365-2796.2004.01350.x; Leite JO, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-7; Leitinger N, 1999, ARTERIOSCL THROM VAS, V19, P1291, DOI 10.1161/01.ATV.19.5.1291; Magrioti V, 2010, EXPERT OPIN THER PAT, V20, P1, DOI 10.1517/13543770903463905; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Mattsson N, 2010, ARTERIOSCL THROM VAS, V30, P1861, DOI 10.1161/ATVBAHA.110.204669; MOUNIER C, 1994, BBA-LIPID LIPID MET, V1214, P88, DOI 10.1016/0005-2760(94)90013-2; Oorni K, 2009, CURR OPIN LIPIDOL, V20, P421, DOI 10.1097/MOL.0b013e32832fa14d; POLETTE A, 1992, ATHEROSCLEROSIS, V96, P171, DOI 10.1016/0021-9150(92)90063-M; Porela P, 2000, BASIC RES CARDIOL, V95, P413, DOI 10.1007/s003950070041; Rauch U, 2001, ANN INTERN MED, V134, P224, DOI 10.7326/0003-4819-134-3-200102060-00014; Rosenblat M, 1999, J BIOL CHEM, V274, P13790, DOI 10.1074/jbc.274.20.13790; Rosengren B, 2006, ARTERIOSCL THROM VAS, V26, P1579, DOI 10.1161/01.ATV.0000221231.56617.67; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; STEINBRECHER UP, 1987, ARTERIOSCLEROSIS, V7, P135, DOI 10.1161/01.ATV.7.2.135; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tietge UJF, 2003, AM J PHYSIOL-ENDOC M, V285, pE403, DOI 10.1152/ajpendo.00576.2002; van der Giet M, 2010, J MOL MED, V88, P75, DOI 10.1007/s00109-009-0543-3; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Zusman RM, 1999, CLIN CARDIOL, V22, P559, DOI 10.1002/clc.4960220905	63	18	22	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					927	937		10.1096/fj.11-191593	http://dx.doi.org/10.1096/fj.11-191593			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22042222				2022-12-25	WOS:000300485700042
J	Messaed, C; Akoury, E; Djuric, U; Zeng, JB; Saleh, M; Gilbert, L; Seoud, M; Qureshi, S; Slim, R				Messaed, Christiane; Akoury, Elie; Djuric, Ugljesa; Zeng, Jibin; Saleh, Maya; Gilbert, Lucy; Seoud, Muhieddine; Qureshi, Salman; Slim, Rima			NLRP7, a Nucleotide Oligomerization Domain-like Receptor Protein, Is Required for Normal Cytokine Secretion and Co-localizes with Golgi and the Microtubule-organizing Center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECURRENT HYDATIDIFORM MOLE; MATERNAL EFFECT GENE; TROPHOBLASTIC NEOPLASIA; REPRODUCTIVE WASTAGE; AUTOINFLAMMATORY DISORDER; MUTATIONS; NALP7; INFLAMMATION; SPECTRUM; PYPAF3	A hydatidiform mole (HM) is a human pregnancy with hyperproliferative placenta and abnormal embryonic development. Mutations in NLRP7, a member of the nucleotide oligomerization domain-like receptor family of proteins with roles in inflammation and apoptosis, are responsible for recurrent HMs. However, little is known about the functional role of NLRP7. Here, we demonstrate that peripheral blood mononuclear cells from patients with NLRP7 mutations and rare variants secrete low levels of IL-1 beta and TNF in response to LPS. We show that the cells from patients, carrying mutations or rare variants, have variable levels of increased intracellular pro-IL-1 beta indicating that normal NLRP7 down-regulates pro-IL-1 beta synthesis in response to LPS. Using transient transfections, we confirm the role of normal NLRP7 in inhibiting pro-IL-1 beta and demonstrate that this inhibitory function is abolished by protein-truncating mutations after the Pyrin domain. Within peripheral blood mononuclear cells, NLRP7 co-localizes with the Golgi and the microtubule-organizing center and is associated with microtubules. This suggests that NLRP7 mutations may affect cytokine secretion by interfering, directly or indirectly, with their trafficking. We propose that the impaired cytokine trafficking and secretion caused by NLRP7 defects makes the patients tolerant to the growth of these earlier arrested conceptions with no fetal vessels and that the retention of these conceptions until the end of the first trimester contribute to the molar phenotype. Our data will impact our understanding of postmolar choriocarcinomas, the only allograft non-self tumors that are able to invade maternal tissues.	[Messaed, Christiane; Akoury, Elie; Djuric, Ugljesa; Zeng, Jibin; Slim, Rima] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; [Messaed, Christiane; Akoury, Elie; Djuric, Ugljesa; Zeng, Jibin; Gilbert, Lucy; Slim, Rima] McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H3G 1A4, Canada; [Saleh, Maya; Qureshi, Salman] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3G 1A4, Canada; [Saleh, Maya; Qureshi, Salman] McGill Univ, Ctr Hlth, Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; [Seoud, Muhieddine] Amer Univ Beirut, Dept Obstet & Gynecol, Beirut, Lebanon	McGill University; McGill University; McGill University; McGill University; American University of Beirut	Slim, R (corresponding author), Montreal Gen Hosp, Res Inst, L3-121,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	rima.slim@muhc.mcgill.ca	Slim, Rima/J-4104-2019; Gilbert, Lucy/M-6879-2019	Slim, Rima/0000-0002-4060-2159; Gilbert, Lucy/0000-0001-8605-5472; Djuric, Ugljesa/0000-0003-0027-3079; Saleh, Maya/0000-0003-1538-9146	Canadian Institutes of Health Research [MOP 86546, MOP 102469]; Centre for the Study of Reproduction; Hugh & Helen McPherson Memorial Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for the Study of Reproduction; Hugh & Helen McPherson Memorial Award	This work was supported by Canadian Institutes of Health Research Grants MOP 86546 and MOP 102469.; Supported in part by a trainee award from the Centre for the Study of Reproduction.; Supported by a Hugh & Helen McPherson Memorial Award. To whom correspondence should be addressed: Montreal General Hospital Research Institute, L3-121, 1650 Cedar Ave., Montreal, Quebec H3G 1A4, Canada. Tel.: 514-934-1934(ext. 44550); Fax: 514-934-8261; E-mail: rima. slim@muhc.mcgill.ca.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Altieri A, 2003, LANCET ONCOL, V4, P670, DOI 10.1016/S1470-2045(03)01245-2; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Deveault C, 2009, HUM MOL GENET, V18, P888, DOI 10.1093/hmg/ddn418; EDWARDS R, 1990, LANCET, V335, P1030, DOI 10.1016/0140-6736(90)91089-S; Hayward BE, 2009, HUM MUTAT, V30, pE629, DOI 10.1002/humu.20993; Helwani MN, 1999, HUM GENET, V105, P112, DOI 10.1007/s004390051071; HO PC, 1980, J REPROD IMMUNOL, V1, P307, DOI 10.1016/0165-0378(80)90004-2; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Jeru I, 2010, ARTHRITIS RHEUM-US, V62, P1176, DOI 10.1002/art.27326; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; KHANNA A, 1985, J SURG ONCOL, V28, P4, DOI 10.1002/jso.2930280103; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Loock J, 2010, J ALLERGY CLIN IMMUN, V125, P500, DOI 10.1016/j.jaci.2009.10.066; Messaed C, 2011, J MED GENET, V48, P540, DOI 10.1136/jmg.2011.089144; Milhavet F, 2008, HUM MUTAT, V29, P803, DOI 10.1002/humu.20720; Muhlstein J, 2011, EUR J OBSTET GYN R B, V157, P197, DOI 10.1016/j.ejogrb.2011.02.019; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Ohno S, 2008, ANTICANCER RES, V28, P2493; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; Puechberty J, 2009, CLIN GENET, V75, P298, DOI 10.1111/j.1399-0004.2008.01098.x; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Seckl MJ, 2010, LANCET, V376, P717, DOI 10.1016/S0140-6736(10)60280-2; Slim R, 2011, PLACENTA, V32, P409, DOI 10.1016/j.placenta.2011.02.001; TOMODA Y, 1976, AM J OBSTET GYNECOL, V126, P661, DOI 10.1016/0002-9378(76)90515-9; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	30	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43313	43323		10.1074/jbc.M111.306191	http://dx.doi.org/10.1074/jbc.M111.306191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025618	hybrid, Green Published			2022-12-25	WOS:000298351300051
J	Gowen, BB; Ennis, J; Russell, A; Sefing, EJ; Wong, MH; Turner, J				Gowen, Brian B.; Ennis, Jane; Russell, Andrew; Sefing, Eric J.; Wong, Min-Hui; Turner, Jeffrey			Use of Recombinant Adenovirus Vectored Consensus IFN-alpha to Avert Severe Arenavirus Infection	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; EQUINE ENCEPHALITIS-VIRUS; I INTERFERON INDUCTION; LASSA FEVER; POSTEXPOSURE PROPHYLAXIS; RIBAVIRIN; THERAPY; INHIBITION; RESPONSES; HAMSTERS	Several arenaviruses can cause viral hemorrhagic fever, a severe disease with case-fatality rates in hospitalized individuals ranging from 15-30%. Because of limited prophylaxis and treatment options, new medical countermeasures are needed for these viruses classified by the National Institutes of Allergy and Infectious Diseases (NIAID) as top priority biodefense Category A pathogens. Recombinant consensus interferon alpha (cIFN-alpha) is a licensed protein with broad clinical appeal. However, while cIFN-alpha has great therapeutic value, its utility for biodefense applications is hindered by its short in vivo half-life, mode and frequency of administration, and costly production. To address these limitations, we describe the use of DEF201, a replication-deficient adenovirus vector that drives the expression of cIFN-alpha, for pre- and post-exposure prophylaxis of acute arenaviral infection modeled in hamsters. Intranasal administration of DEF201 24 h prior to challenge with Pichinde virus (PICV) was highly effective at protecting animals from mortality and preventing viral replication and liver-associated disease. A significant protective effect was still observed with a single dosing of DEF201 given two weeks prior to PICV challenge. DEF201 was also efficacious when administered as a treatment 24 to 48 h post-virus exposure. The protective effect of DEF201 was largely attributed to the expression of cIFN-alpha, as dosing with a control empty vector adenovirus did not protect hamsters from lethal PICV challenge. Effective countermeasures that are highly stable, easily administered, and elicit long lasting protective immunity are much needed for arena and other viral infections. The DEF201 technology has the potential to address all of these issues and may serve as a broad-spectrum antiviral to enhance host defense against a number of viral pathogens.	[Gowen, Brian B.; Russell, Andrew; Sefing, Eric J.; Wong, Min-Hui] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA; [Gowen, Brian B.; Russell, Andrew; Sefing, Eric J.; Wong, Min-Hui] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Ennis, Jane; Turner, Jeffrey] Defyrus Inc, Toronto, ON, Canada	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gowen, BB (corresponding author), Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA.	brian.gowen@usu.edu			National Institutes of Health [AI30063, HHSN272201000039I, AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063, U54AI065357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institutes of Health (AI30063, HHSN272201000039I, and AI065357). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Baize S, 2009, J VIROL, V83, P5890, DOI 10.1128/JVI.01948-08; BARRY M, 1995, NEW ENGL J MED, V333, P294, DOI 10.1056/NEJM199508033330505; Bausch DG, 2010, CLIN INFECT DIS, V51, P1435, DOI 10.1086/657315; Bell SJ, 2008, BIOCONJUGATE CHEM, V19, P299, DOI 10.1021/bc070131q; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Buchmeier MJ, 2001, FIELDS VIROLOGY, P1635; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; de Manzione N, 1998, CLIN INFECT DIS, V26, P308, DOI 10.1086/516299; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gowen BB, 2005, ANTIMICROB AGENTS CH, V49, P2378, DOI 10.1128/AAC.49.6.2378-2386.2005; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Gowen Brian B., 2006, Antiviral Chemistry & Chemotherapy, V17, P175; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Hadi CM, 2010, EMERG INFECT DIS, V16, P2009, DOI 10.3201/eid1612.100994; Julander JG, 2011, ANTIMICROB AGENTS CH, V55, P2067, DOI 10.1128/AAC.01635-10; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kilgore PE, 1997, CLIN INFECT DIS, V24, P718, DOI 10.1093/clind/24.4.718; Kumaki Y, 2011, ANTIVIR RES, V89, P75, DOI 10.1016/j.antiviral.2010.11.007; MAIZTEGUI JI, 1979, LANCET, V2, P1216; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; *NIAID, 2002, COUNT BIOT RES AG NA; O'Brien L, 2009, J GEN VIROL, V90, P874, DOI 10.1099/vir.0.006833-0; Pannetier D, 2004, J VIROL, V78, P10516, DOI 10.1128/JVI.78.19.10516-10524.2004; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shayakhmetov DM, 2010, MOL THER, V18, P1422, DOI 10.1038/mt.2010.124; Wu JQH, 2007, VIROLOGY, V369, P206, DOI 10.1016/j.virol.2007.07.024	33	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26072	10.1371/journal.pone.0026072	http://dx.doi.org/10.1371/journal.pone.0026072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039436	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200006
J	Stavrum, R; Stavrum, AK; Valvatne, H; Riley, LW; Ulvestad, E; Jonassen, I; Assmus, J; Doherty, TM; Grewal, HMS				Stavrum, Ruth; Stavrum, Anne-Kristin; Valvatne, Havard; Riley, Lee W.; Ulvestad, Elling; Jonassen, Inge; Assmus, Joerg; Doherty, T. Mark; Grewal, Harleen M. S.			Modulation of Transcriptional and Inflammatory Responses in Murine Macrophages by the Mycobacterium tuberculosis Mammalian Cell Entry (Mce) 1 Complex	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; GENE-EXPRESSION; DENDRITIC CELLS; MICROARRAY DATA; ACTIVATION; SYSTEM; INDUCTION; INFECTION; VIRULENCE; BACTERIAL	The outcome of many infections depends on the initial interactions between agent and host. Aiming at elucidating the effect of the M. tuberculosis Mce1 protein complex on host transcriptional and immunological responses to infection with M. tuberculosis, RNA from murine macrophages at 15, 30, 60 min, 4 and 10 hrs post-infection with M. tuberculosis H37Rv or Delta-mce1 H37Rv was analyzed by whole-genome microarrays and RT-QPCR. Immunological responses were measured using a 23-plex cytokine assay. Compared to uninfected controls, 524 versus 64 genes were up-regulated by 15 min post H37Rv- and Delta-mce1 H37Rv-infection, respectively. By 15 min post-H37Rv infection, a decline of 17 cytokines combined with up-regulation of Ccl24 (26.5-fold), Clec4a2 (23.2-fold) and Pparc (10.5-fold) indicated an anti-inflammatory response initiated by IL-13. Down-regulation of Il13ra1 combined with up-regulation of Il12b (30.2-fold), suggested switch to a pro-inflammatory response by 4 hrs post H37Rv-infection. Whereas no significant change in cytokine concentration or transcription was observed during the first hour post Delta-mce1 H37Rv-infection, a significant decline of IL-1b, IL-9, IL-13, Eotaxin and GM-CSF combined with increased transcription of Il12b (25.1-fold) and Inb1 (17.9-fold) by 4 hrs, indicated a pro-inflammatory response. The balance between pro-and anti-inflammatory responses during the early stages of infection may have significant bearing on outcome.	[Stavrum, Ruth; Valvatne, Havard; Ulvestad, Elling; Grewal, Harleen M. S.] Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway; [Stavrum, Anne-Kristin] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Stavrum, Anne-Kristin; Jonassen, Inge] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Ulvestad, Elling; Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Jonassen, Inge] Uni Res AS, Uni Comp, Computat Biol Unit, Bergen, Norway; [Assmus, Joerg] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Doherty, T. Mark] Statens Serum Inst, DK-2300 Copenhagen, Denmark	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of California System; University of California Berkeley; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Statens Serum Institut	Stavrum, R (corresponding author), Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway.	Ruth.Stavrum@Gades.uib.no	Grewal, Harleen/ABC-5831-2020; Jonassen, Inge/AAC-7035-2020	Jonassen, Inge/0000-0003-4110-0748	Western Regional Health Authority; Norwegian Research Council; University of Bergen	Western Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Bergen	This study was funded by the Western Regional Health Authority, the Norwegian Research Council and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Bo TH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh026; Bouchonnet F, 2002, INFECT IMMUN, V70, P3020, DOI 10.1128/IAI.70.6.3020-3025.2002; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cantrell SA, 2005, STRUCTURAL FUNCTIONA; Casali N, 2006, J BACTERIOL, V188, P441, DOI 10.1128/JB.188.2.441-449.2006; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Falcone V, 1994, FEMS IMMUNOLOGY MED, V8, P7; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Freeman S, 2006, J INTERF CYTOK RES, V26, P27, DOI 10.1089/jir.2006.26.27; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Garcia-Perez BE, 2003, MICROB PATHOGENESIS, V35, P49, DOI 10.1016/S0882-4010(03)00089-5; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103; Korf JE, 2006, AM J RESP CRIT CARE, V174, P152, DOI 10.1164/rccm.200507-1175OC; Mah N, 2010, MICROBIOL-SGM, V156, P2506, DOI 10.1099/mic.0.040089-0; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Pajon R, 2006, TUBERCULOSIS, V86, P290, DOI 10.1016/j.tube.2006.01.005; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHWAB JH, 1975, BACTERIOL REV, V39, P121, DOI 10.1128/MMBR.39.2.121-143.1975; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Simmons DP, 2010, J IMMUNOL, V185, P2405, DOI 10.4049/jimmunol.0904005; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Wassie L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001522; Wright K, 1997, J BIOL CHEM, V272, P12626, DOI 10.1074/jbc.272.19.12626; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198	48	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26295	10.1371/journal.pone.0026295	http://dx.doi.org/10.1371/journal.pone.0026295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039457	Green Published, gold			2022-12-25	WOS:000296515200010
J	Maan, S; Maan, NS; Nomikou, K; Veronesi, E; Bachanek-Bankowska, K; Belaganahalli, MN; Attoui, H; Mertens, PPC				Maan, Sushila; Maan, Narender S.; Nomikou, Kyriaki; Veronesi, Eva; Bachanek-Bankowska, Katarzyna; Belaganahalli, Manjunatha N.; Attoui, Houssam; Mertens, Peter P. C.			Complete Genome Characterisation of a Novel 26th Bluetongue Virus Serotype from Kuwait	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; AFRICAN HORSE SICKNESS; RT-PCR ASSAY; PHYLOGENETIC ANALYSIS; PURIFYING SELECTION; POSITIVE SELECTION; MULTIPLE ALIGNMENT; FAMILY REOVIRIDAE; ANALYSIS TOOLS; ORBIVIRUS	Bluetongue virus is the "type'' species of the genus Orbivirus, family Reoviridae. Twenty four distinct bluetongue virus (BTV) serotypes have been recognized for decades, any of which is thought to be capable of causing "bluetongue'' (BT), an insect-borne disease of ruminants. However, two further BTV serotypes, BTV-25 (Toggenburg orbivirus, from Switzerland) and BTV-26 (from Kuwait) have recently been identified in goats and sheep, respectively. The BTV genome is composed of ten segments of linear dsRNA, encoding 7 virus-structural proteins (VP1 to VP7) and four distinct non-structural (NS) proteins (NS1 to NS4). We report the entire BTV-26 genome sequence (isolate KUW2010/02) and comparisons to other orbiviruses. Highest identity levels were consistently detected with other BTV strains, identifying KUW2010/02 as BTV. The outer-core protein and major BTV serogroup-specific antigen "VP7'' showed 98% aa sequence identity with BTV-25, indicating a common ancestry. However, higher level of variation in the nucleotide sequence of Seg-7 (81.2% identity) suggests strong conservation pressures on the protein of these two strains, and that they diverged a long time ago. Comparisons of Seg-2, encoding major outer-capsid component and cell-attachment protein "VP2'' identified KUW2010/02 as 26th BTV, within a 12th Seg-2 nucleotype [nucleotype L]. Comparisons of Seg-6, encoding the smaller outer capsid protein VP5, also showed levels of nt/aa variation consistent with identification of KUW2010/02 as BTV-26 (within a 9th Seg-6 nucleotype - nucleotype I). Sequence data for Seg-2 of KUW2010/02 were used to design four sets of oligonucleotide primers for use in BTV-26, type-specific RT-PCR assays. Analyses of other more conserved genome segments placed KUW2010/02 and BTV-25/SWI2008/01 closer to each other than to other "eastern'' or "western'' BTV strains, but as representatives of two novel and distinct geographic groups (topotypes). Our analyses indicate that all of the BTV genome segments have evolved under strong purifying selection.	[Maan, Sushila; Maan, Narender S.; Nomikou, Kyriaki; Veronesi, Eva; Bachanek-Bankowska, Katarzyna; Belaganahalli, Manjunatha N.; Attoui, Houssam; Mertens, Peter P. C.] Inst Anim Hlth, Vector Borne Dis Programme, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Maan, S (corresponding author), Inst Anim Hlth, Vector Borne Dis Programme, Woking, Surrey, England.	peter.mertens@iah.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019; Nomikou, Kyriaki/P-1840-2018; Nomikou, Kyriaki/Q-5555-2016	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Attoui, Houssam/0000-0001-9639-9981; Mertens, Peter/0000-0002-3438-3738; Veronesi, Eva/0000-0003-3411-7891	Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Wellcome BTV Programme; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; Commonwealth Scholarship Commission; Institute for Animal Health (IAH)	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome BTV Programme; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); Commonwealth Scholarship Commission; Institute for Animal Health (IAH)	Funding: This work was partly funded by the Department for Environment, Food and Rural Affairs (Defra)(SE2617) awarded to SM and EV; KN was involved in this study and is funded by Wellcome BTV Programme grant (http://www.wellcome.ac.uk/). NSM, PCM and HA were part of this work, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the European Union (EU) (SANCO/940/2002) and Defra. For part of this work, MB was funded by Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/), and KB was funded by an Institute for Animal Health (IAH) studentship (http://www.bbsrc.ac.uk/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, AM J TROP MED HYG, V51, P568, DOI 10.4269/ajtmh.1994.51.568; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anthony S, 2007, J VIROL METHODS, V141, P188, DOI 10.1016/j.jviromet.2006.12.013; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2006, J GEN VIROL, V87, P1375, DOI 10.1099/vir.0.81584-0; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Balasuriya UBR, 2008, VET MICROBIOL, V126, P91, DOI 10.1016/j.vetmic.2007.07.006; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Carpi G, 2010, J MOL EVOL, V70, P583, DOI 10.1007/s00239-010-9354-y; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Gibbs A., 1995, MOL BASIS VIRUS EVOL, P76; GOULD AR, 1987, VIRUS RES, V7, P169, DOI 10.1016/0168-1702(87)90078-5; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOWERTH EW, 1988, AM J VET RES, V49, P1906; Huismans H, 2004, Vet Ital, V40, P417; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; HUISMANS H, 1987, J VIROL, V61, P3589, DOI 10.1128/JVI.61.11.3589-3595.1987; HUISMANS H, 1979, VIROLOGY, V92, P397, DOI 10.1016/0042-6822(79)90144-2; Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0; Johnson DJ, 2007, P ANN C AM ASS VET L; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lee F, 2011, VET MICROBIOL, V148, P140, DOI 10.1016/j.vetmic.2010.08.016; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; MACLACHLAN NJ, 1994, COMP IMMUNOL MICROB, V17, P197, DOI 10.1016/0147-9571(94)90043-4; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1989, VIROLOGY, V170, P561, DOI 10.1016/0042-6822(89)90447-9; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Mertens PPC, 2011, RNAS PROTEINS DSRNA; Meyer G, 2009, EMERG INFECT DIS, V15, P608, DOI 10.3201/eid1504.081514; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; Orru G, 2006, J VIROL METHODS, V137, P34, DOI 10.1016/j.jviromet.2006.05.028; Planzer J, 2011, RES VET SCI; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Quan M, 2008, J GEN VIROL, V89, P1159, DOI 10.1099/vir.0.83502-0; ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051; ROY P, 1989, VIRUS RES, V13, P179, DOI 10.1016/0168-1702(89)90015-4; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tamura K, 2011, MOL BIOL EVOL; Thevasagayam JA, 1996, J VIROL METHODS, V56, P49, DOI 10.1016/0166-0934(95)01910-3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059	64	131	151	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26147	10.1371/journal.pone.0026147	http://dx.doi.org/10.1371/journal.pone.0026147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031822	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000296513200009
J	Thuesen, PA; Ebner, BC; Larson, H; Keith, P; Silcock, RM; Prince, J; Russell, DJ				Thuesen, Paul A.; Ebner, Brendan C.; Larson, Helen; Keith, Philippe; Silcock, Rebecca M.; Prince, Jason; Russell, David J.			Amphidromy Links a Newly Documented Fish Community of Continental Australian Streams, to Oceanic Islands of the West Pacific	PLOS ONE			English	Article							FRESH-WATER FISH; REPRODUCTIVE-BIOLOGY; ASSEMBLAGE STRUCTURE; GOBIIDAE; MANAGEMENT; GOBY; SICYDIINAE; STARVATION; DISPERSAL; ECOLOGY	Background: Indo-Pacific high island streams experience extreme hydrological variation, and are characterised by freshwater fish species with an amphidromous life history. Amphidromy is a likely adaptation for colonisation of island streams following stochastic events that lead to local extirpation. In the Wet Tropics of north-eastern Australia, steep coastal mountain streams share similar physical characteristics to island systems. These streams are poorly surveyed, but may provide suitable habitat for amphidromous species. However, due to their ephemeral nature, common non-diadromous freshwater species of continental Australia are unlikely to persist. Consequently, we hypothesise that coastal Wet Tropics streams are faunally more similar, to distant Pacific island communities, than to nearby faunas of large continental rivers. Methods/Principal Findings: Surveys of coastal Wet Tropics streams recorded 26 species, 10 of which are first records for Australia, with three species undescribed. This fish community is unique in an Australian context in that it contains mostly amphidromous species, including sicydiine gobies of the genera Sicyopterus, Sicyopus, Smilosicyopus and Stiphodon. Species presence/absence data of coastal Wet Tropics streams were compared to both Wet Tropics river networks and Pacific island faunas. ANOSIM indicated the fish fauna of north-eastern Australian coastal streams were more similar to distant Pacific islands (R = 0.76), than to nearby continental rivers (R = 0.98). Main Conclusions/Significance: Coastal Wet Tropics streams are faunally more similar to distant Pacific islands (79% of species shared), than to nearby continental fauna due to two factors. First, coastal Wet Tropics streams lack many non-diadromous freshwater fish which are common in nearby large rivers. Second, many amphidromous species found in coastal Wet Tropics streams and Indo-Pacific islands remain absent from large rivers of the Wet Tropics. The evolutionary and conservation significance of this newly discovered Australian fauna requires clarification in the context of the wider amphidromous fish community of the Pacific.	[Thuesen, Paul A.; Silcock, Rebecca M.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Thuesen, Paul A.; Russell, David J.] Dept Employment Econ Dev & Innovat, Cairns, Qld, Australia; [Ebner, Brendan C.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Larson, Helen] Museum & Art Gallery No Terr, Darwin, NT, Australia; [Keith, Philippe] Museum Natl Hist Nat, Lab Ichtyol, F-75231 Paris, France; [Prince, Jason] The Patch, Melbourne, Vic, Australia	James Cook University; Griffith University; Northern Territory Government; Museum National d'Histoire Naturelle (MNHN)	Thuesen, PA (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia.	paul.thuesen@gmail.com	Ebner, Brendan C/J-3759-2014	Ebner, Brendan C/0000-0001-8808-4998	W.V. Scott Charitable Trust	W.V. Scott Charitable Trust	This research was partially funded through a grant to B.C. Ebner via the W.V. Scott Charitable Trust. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Remaining expenses were covered by Thuesen and Ebner. As authors of this study, these funders played role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; Allen G.R., 2008, FRESHWATER FISHES FL; Amarasinghe U.S., 2006, FAUNA SRI LANKA STAT, P113; [Anonymous], 2007, FISH ATL N AUSTR; Barbee NC, 2002, INT VER THEOR ANGEW, V28, P739; Bell K.N.I., 1999, Naga, V22, P30; Blob RW, 2007, J ZOOL, V273, P200, DOI 10.1111/j.1469-7998.2007.00315.x; Boseto David, 2007, South Pacific Journal of Natural Science, V25, P16, DOI 10.1071/SP07003; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Clarke KR, 2001, PRIMER USER MANUAL T; COATES D, 1993, ENVIRON BIOL FISH, V38, P345, DOI 10.1007/BF00007528; Cook BD, 2008, MOL ECOL, V17, P1066, DOI 10.1111/j.1365-294X.2007.03637.x; Cook BD, 2009, J N AM BENTHOL SOC, V28, P709, DOI 10.1899/09-008.1; Cook BD, 2010, J BIOGEOGR, V37, P270, DOI 10.1111/j.1365-2699.2009.02215.x; Craig DA, 2003, BIOSCIENCE, V53, P1079, DOI 10.1641/0006-3568(2003)053[1079:GDORWH]2.0.CO;2; Crandall ED, 2010, HEREDITY, V104, P563, DOI 10.1038/hdy.2009.138; Ebner B, 2010, AUST J ZOOL, V58, P1; Fitzsimons JM, 2002, ENVIRON BIOL FISH, V65, P123; Harrison Ian J., 1993, Ichthyological Exploration of Freshwaters, V4, P201; Hoareau TB, 2007, MAR ECOL PROG SER, V333, P303, DOI 10.3354/meps333303; Hope Geoff, 1996, P165; Iguchi K, 1999, J FISH BIOL, V54, P705, DOI 10.1111/j.1095-8649.1999.tb02027.x; IWATA A., 1997, CIRCUMSTANCES ENDANG, P155; Jenkins AP, 2010, AQUAT CONSERV, V20, P224, DOI 10.1002/aqc.1086; Jenkins AP, 2007, FRESHWATER FISHES TE, P1; Johnson TB, 2005, J GREAT LAKES RES, V31, P78, DOI 10.1016/S0380-1330(05)70239-2; Keith P, 2008, MAR FRESHWATER RES, V59, P876, DOI 10.1071/MF08116; Keith P, 2011, MAR BIOL, V158, P311, DOI 10.1007/s00227-010-1560-z; Keith P, 2003, J FISH BIOL, V63, P831, DOI 10.1046/j.1095-8649.2003.00197.x; Kottelat M., 1996, World Bank Technical Paper; Lindstrom D. P., 1998, THESIS U MICHIGAN AN; Lord C, 2010, ECOL FRESHW FISH, V19, P26, DOI 10.1111/j.1600-0633.2009.00386.x; Lord C, 2008, ENVIRON BIOL FISH, V83, P169, DOI 10.1007/s10641-007-9311-9; MACIOLEK JA, 1980, PROG FISH CULT, V42, P57, DOI 10.1577/1548-8659(1980)42[57:EITIS]2.0.CO;2; March JG, 2003, BIOSCIENCE, V53, P1069, DOI 10.1641/0006-3568(2003)053[1069:DTISPS]2.0.CO;2; Marquet G., 2003, ATLAS POISSONS CRUST; McDowall RM, 2007, FISH FISH, V8, P1, DOI 10.1111/j.1467-2979.2007.00232.x; McDowall R. M., 1997, Micronesica, V30, P3; McDowall RM, 2010, REV FISH BIOL FISHER, V20, P87, DOI 10.1007/s11160-009-9125-2; McDowall RM, 2009, REV FISH BIOL FISHER, V19, P1, DOI 10.1007/s11160-008-9085-y; McDowall RM, 2003, J BIOGEOGR, V30, P703, DOI 10.1046/j.1365-2699.2003.00851.x; Moriyama A, 1998, ENVIRON BIOL FISH, V52, P321, DOI 10.1023/A:1007333302864; Nip Tony H.M., 2010, Journal of Threatened Taxa, V2, P1237; PARENTI L R, 1991, Australian Systematic Botany, V4, P137, DOI 10.1071/SB9910137; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; Pusey BJ, 1996, MAR FRESHWATER RES, V47, P563, DOI 10.1071/MF9960563; Rayner TS, 2008, MAR FRESHWATER RES, V59, P97, DOI 10.1071/MF07129; Reynolds James B., 1996, P221; Russell DJ, 2003, MAR FRESHWATER RES, V54, P813, DOI 10.1071/MF02046; Russell DJ, 1996, QI96008 QUEENSL DEP; Russell DJ, 1993, QI93056 QUEENSL DEP, P1; RYAN PA, 1991, NEW ZEAL J ZOOL, V18, P25, DOI 10.1080/03014223.1991.10757944; THUESEN P., 2004, ANGFA NEWS, V19, P4; Thuesen PA, 2011, MAR FRESHWATER RES, V62, P110, DOI 10.1071/MF10057; Thuesen PA, 2004, THESIS J COOK U CAIR; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Valade P, 2001, THESIS U LA REUNION; Way CM, 1998, ENVIRON BIOL FISH, V51, P53, DOI 10.1023/A:1007305917443; Williams MAJ, 1984, ARID AUSTR, P59; Woolfe KJ, 1998, GEOLOGY, V26, P75, DOI 10.1130/0091-7613(1998)026<0075:LRNNIT>2.3.CO;2; Yamasaki N, 2006, ICHTHYOL RES, V53, P13, DOI 10.1007/s10228-005-0307-1; Yokoi Ken-ichi, 2005, Japanese Journal of Ichthyology, V52, P31	64	47	50	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26685	10.1371/journal.pone.0026685	http://dx.doi.org/10.1371/journal.pone.0026685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039530	gold, Green Published, Green Accepted			2022-12-25	WOS:000296513200040
J	Knubel, CP; Martinez, FF; Rodriguez, EVA; Altamirano, A; Rivarola, HW; Lujan, CD; Fretes, RE; Cervi, L; Motran, CC				Knubel, Carolina P.; Martinez, Fernando F.; Acosta Rodriguez, Eva V.; Altamirano, Andres; Rivarola, Hector W.; Diaz Lujan, Cintia; Fretes, Ricardo E.; Cervi, Laura; Motran, Claudia C.			3-Hydroxy Kynurenine Treatment Controls T. cruzi Replication and the Inflammatory Pathology Preventing the Clinical Symptoms of Chronic Chagas Disease	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ARYL-HYDROCARBON RECEPTOR; RIBOSOMAL P PROTEINS; C-TERMINAL REGION; TRYPANOSOMA-CRUZI; IMMUNE-RESPONSE; TGF-BETA; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; PARASITE PERSISTENCE	Background: 3-Hydroxy Kynurenine (3-HK) administration during the acute phase of Trypanosoma. cruzi infection decreases the parasitemia of lethally infected mice and improves their survival. However, due to the fact that the treatment with 3-HK is unable to eradicate the parasite, together with the known proapoptotic and immunoregulatory properties of 3-HK and their downstream catabolites, it is possible that the 3-HK treatment is effective during the acute phase of the infection by controlling the parasite replication, but at the same time suppressed the protective T cell response before pathogen clearance worsening the chronic phase of the infection. Therefore, in the present study, we investigated the effect of 3-HK treatment on the development of chronic Chagas' disease. Principal Findings: In the present study, we treated mice infected with T. cruzi with 3-HK at day five post infection during 5 consecutive days and investigated the effect of this treatment on the development of chronic Chagas disease. Cardiac functional (electrocardiogram) and histopathological studies were done at 60 dpi. 3-HK treatment markedly reduced the incidence and the severity of the electrocardiogram alterations and the inflammatory infiltrates and fibrosis in heart and skeletal muscle. 3-HK treatment modulated the immune response at the acute phase of the infection impairing the Th1- and Th2-type specific response and inducing TGF-beta-secreting cells promoting the emergence of regulatory T cells and long-term specific IFN-gamma secreting cells. 3-HK in vitro induced regulatory phenotype in T cells from T. cruzi acutely infected mice. Conclusions: Our results show that the early 3-HK treatment was effective in reducing the cardiac lesions as well as altering the pattern of the immune response in experimental Chagas' disease. Thus, we propose 3-HK as a novel therapeutic treatment able to control both the parasite replication and the inflammatory response.	[Knubel, Carolina P.; Martinez, Fernando F.; Acosta Rodriguez, Eva V.; Altamirano, Andres; Cervi, Laura; Motran, Claudia C.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina; [Rivarola, Hector W.] Univ Nacl Cordoba, Fac Ciencias Med, Catedra Fis Biomed, RA-5000 Cordoba, Argentina; [Diaz Lujan, Cintia; Fretes, Ricardo E.] Univ Nacl Cordoba, Fac Med, Inst Biol Celular, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; National University of Cordoba	Knubel, CP (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, Ciudad Univ, RA-5000 Cordoba, Argentina.	cmotran@fcq.unc.edu.ar	Oliveira, Claudia DL/G-8618-2011; Motran, Claudia/U-9106-2019	Motran, Claudia/0000-0002-8088-3901; Acosta Rodriguez, Eva/0000-0001-5871-2391	Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnica [PICT 25511]; Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba; Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba; CONICET (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina (CONICET), Agencia Nacional de Promocion Cientifica y Tecnica (PICT 25511), Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba and Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba (grants to CCM). The work of CPK and FFM was supported by CONICET fellowships (Argentina). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE S G, 1987, Memorias do Instituto Oswaldo Cruz, V82, P59, DOI 10.1590/S0074-02761987000100010; Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001; BURLEIGH BA, 1995, ANNU REV MICROBIOL, V49, P175, DOI 10.1146/annurev.mi.49.100195.001135; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Cazorla SI, 2008, INFECT IMMUN, V76, P324, DOI 10.1128/IAI.01163-07; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Ecco G, 2009, GENE, V448, P1, DOI 10.1016/j.gene.2009.08.007; Elizari MV, 1999, MEDICINA-BUENOS AIRE, V59, P25; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; GEA S, 1992, REV I MED TROP, V34, P389, DOI 10.1590/S0036-46651992000500003; Giordanengo L, 2000, MUSCLE NERVE, V23, P1407, DOI 10.1002/1097-4598(200009)23:9<1407::AID-MUS12>3.3.CO;2-V; Giordanengo L, 2000, EUR J IMMUNOL, V30, P3181, DOI 10.1002/1521-4141(200011)30:11&lt;3181::AID-IMMU3181&gt;3.0.CO;2-A; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Guerri-Guttenberg RA, 2008, EUR HEART J, V29, P2587, DOI 10.1093/eurheartj/ehn424; Guinazu N, 2004, MICROBES INFECT, V6, P1250, DOI 10.1016/j.micinf.2004.07.010; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; HOFT DF, 1993, J IMMUNOL, V151, P7038; Hoft DF, 2000, INFECT IMMUN, V68, P197, DOI 10.1128/IAI.68.1.197-204.2000; Huss DJ, 2010, J IMMUNOL, V184, P5628, DOI 10.4049/jimmunol.1000288; Kaplan D, 1997, P NATL ACAD SCI USA, V94, P10301, DOI 10.1073/pnas.94.19.10301; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kierszenbaum F, 2005, TRENDS PARASITOL, V21, P513, DOI 10.1016/j.pt.2005.08.013; Kotner J, 2007, INFECT IMMUN, V75, P861, DOI 10.1128/IAI.01500-06; KROWCZYNSKA AM, 1989, NUCLEIC ACIDS RES, V17, P6408, DOI 10.1093/nar/17.15.6408; LAGUENS RP, 1981, MEDICINA-BUENOS AIRE, V41, P35; LEVIN MJ, 1990, MEM I OSWALDO CRUZ, V85, P539, DOI 10.1590/S0074-02761990000400028; Mariano FS, 2008, MICROBES INFECT, V10, P825, DOI 10.1016/j.micinf.2008.04.009; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Millar AE, 1999, J IMMUNOL, V162, P6092; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Motran CC, 1999, CLIN IMMUNOL, V91, P17, DOI 10.1006/clim.1998.4678; Motran CC, 1998, EXP PARASITOL, V88, P223, DOI 10.1006/expr.1998.4255; Motran CC, 2000, CLIN IMMUNOL, V97, P89, DOI 10.1006/clim.2000.4919; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Knubel CP, 2010, FASEB J, V24, P2689, DOI 10.1096/fj.09-150920; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x; ROSENBAUM MB, 1964, PROG CARDIOVASC DIS, V7, P199, DOI 10.1016/S0033-0620(64)80020-7; SADIGURSKY M, 1986, BRAZ J MED BIOL RES, V19, P379; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Sales-Junior PA, 2008, MICROBES INFECT, V10, P680, DOI 10.1016/j.micinf.2008.03.008; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; VAZQUEZ MP, 1992, NUCLEIC ACIDS RES, V20, P2599, DOI 10.1093/nar/20.10.2599; Viotti R, 2007, EXPERT REV ANTI-INFE, V5, P717, DOI 10.1586/14787210.5.4.717; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Waghabi MC, 2007, ANTIMICROB AGENTS CH, V51, P2905, DOI 10.1128/AAC.00022-07; Wehrens XHT, 2000, CARDIOVASC RES, V45, P231, DOI 10.1016/S0008-6363(99)00335-1; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26550	10.1371/journal.pone.0026550	http://dx.doi.org/10.1371/journal.pone.0026550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028903	gold, Green Submitted, Green Published			2022-12-25	WOS:000296507500087
J	Poritz, MA; Blaschke, AJ; Byington, CL; Meyers, L; Nilsson, K; Jones, DE; Thatcher, SA; Robbins, T; Lingenfelter, B; Amiott, E; Herbener, A; Daly, J; Dobrowolski, SF; David, HFT; Ririe, KM				Poritz, Mark A.; Blaschke, Anne J.; Byington, Carrie L.; Meyers, Lindsay; Nilsson, Kody; Jones, David E.; Thatcher, Stephanie A.; Robbins, Thomas; Lingenfelter, Beth; Amiott, Elizabeth; Herbener, Amy; Daly, Judy; Dobrowolski, Steven F.; David, H. -F. Teng; Ririe, Kirk M.			FilmArray, an Automated Nested Multiplex PCR System for Multi-Pathogen Detection: Development and Application to Respiratory Tract Infection	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; ANTIBIOTIC-RESISTANCE GENES; ACID AMPLIFICATION TESTS; CLINICAL MICROBIOLOGY; CHLAMYDOPHILA-PNEUMONIAE; MYCOPLASMA-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; BORDETELLA-PERTUSSIS; MOLECULAR DIAGNOSIS	The ideal clinical diagnostic system should deliver rapid, sensitive, specific and reproducible results while minimizing the requirements for specialized laboratory facilities and skilled technicians. We describe an integrated diagnostic platform, the "FilmArray'', which fully automates the detection and identification of multiple organisms from a single sample in about one hour. An unprocessed biologic/clinical sample is subjected to nucleic acid purification, reverse transcription, a high-order nested multiplex polymerase chain reaction and amplicon melt curve analysis. Biochemical reactions are enclosed in a disposable pouch, minimizing the PCR contamination risk. FilmArray has the potential to detect greater than 100 different nucleic acid targets at one time. These features make the system well-suited for molecular detection of infectious agents. Validation of the FilmArray technology was achieved through development of a panel of assays capable of identifying 21 common viral and bacterial respiratory pathogens. Initial testing of the system using both cultured organisms and clinical nasal aspirates obtained from children demonstrated an analytical and clinical sensitivity and specificity comparable to existing diagnostic platforms. We demonstrate that automated identification of pathogens from their corresponding target amplicon(s) can be accomplished by analysis of the DNA melting curve of the amplicon.	[Poritz, Mark A.; Meyers, Lindsay; Nilsson, Kody; Jones, David E.; Thatcher, Stephanie A.; Robbins, Thomas; Lingenfelter, Beth; Amiott, Elizabeth; Dobrowolski, Steven F.; David, H. -F. Teng; Ririe, Kirk M.] Idaho Technol Inc, Salt Lake City, UT USA; [Blaschke, Anne J.; Byington, Carrie L.; Herbener, Amy] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Daly, Judy] Univ Utah, Primary Childrens Med Ctr, Salt Lake City, UT USA; [Daly, Judy] Univ Utah, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Poritz, MA (corresponding author), Idaho Technol Inc, Salt Lake City, UT USA.	mark_poritz@idahotech.com	Poritz, Mark/AAH-4426-2021; Blaschke, Anne/GOJ-7946-2022	Poritz, Mark/0000-0002-5060-0560; Byington, Carrie/0000-0002-7350-9495	National Institutes of Health: National Institute of Allergy and Infectious Diseases [1R43 AI063695-01, U01 AI061611, U01 AI074419, 1K23-AI079401-01A1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K24HD047249]; Edna Benning Society; United States Air Force Surgeon General; Idaho Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD047249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074419, R43AI063695, K23AI079401, U01AI061611] Funding Source: NIH RePORTER	National Institutes of Health: National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Edna Benning Society; United States Air Force Surgeon General; Idaho Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health: National Institute of Allergy and Infectious Diseases: 1R43 AI063695-01 (SFD), U01 AI061611 (MAP, AJB, CLB), U01 AI074419 (SFD and CLB), 1K23-AI079401-01A1 (AJB) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development: K24HD047249 (CLB); the H. A. and Edna Benning Society (CLB); the United States Air Force Surgeon General; and by funds from Idaho Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archimbaud C, 2009, J MED VIROL, V81, P42, DOI 10.1002/jmv.21330; Auroux PA, 2004, LAB CHIP, V4, P534, DOI 10.1039/b408850f; BALDINO F, 1989, METHOD ENZYMOL, V168, P761; Barenfanger J, 2000, J CLIN MICROBIOL, V38, P2824, DOI 10.1128/JCM.38.8.2824-2828.2000; Belak S, 2001, Expert Rev Mol Diagn, V1, P434; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byington CL, 2002, ARCH PEDIAT ADOL MED, V156, P1230, DOI 10.1001/archpedi.156.12.1230; Byington CL, 2002, PEDIATR INFECT DIS J, V21, P996, DOI 10.1097/00006454-200211000-00004; Charles PGP, 2008, CURR OPIN PULM MED, V14, P176, DOI 10.1097/MCP.0b013e3282f7642f; Chen L, 2007, LAB CHIP, V7, P1413, DOI 10.1039/b708362a; Chia JH, 2005, J CLIN MICROBIOL, V43, P4486, DOI 10.1128/JCM.43.9.4486-4491.2005; Choi SM, 2003, J KOREAN MED SCI, V18, P631, DOI 10.3346/jkms.2003.18.5.631; Cockerill FR, 2003, ARCH PATHOL LAB MED, V127, P1112; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; DEAR P, 2004, PCR TECHNOLOGY CURRE, P245; Dundas NE, 2011, J MOL DIAGN, V13, P175, DOI 10.1016/j.jmoldx.2010.09.003; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Endimiani A, 2011, CLIN INFECT DIS, V52, pS373, DOI 10.1093/cid/cir054; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Falsey AR, 2007, ARCH INTERN MED, V167, P354, DOI 10.1001/archinte.167.4.ioi60207; Forbes BA, 2003, ARCH PATHOL LAB MED, V127, P1106; Fox JD, 2007, J CLIN VIROL, V40, pS15, DOI 10.1016/S1386-6532(07)70005-7; Fox JD, 2007, J CLIN VIROL, V40, pS24, DOI 10.1016/S1386-6532(07)70006-9; Ginevra C, 2005, J CLIN MICROBIOL, V43, P3247, DOI 10.1128/JCM.43.7.3247-3254.2005; Hatchette TF, 2009, CAN J PUBLIC HEALTH, V100, P204, DOI 10.1007/BF03405541; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS6, DOI 10.1097/01.inf.0000108187.63151.ea; Kang JH, 2008, LAB CHIP, V8, P176, DOI 10.1039/b712672g; Kehl SC, 2001, J CLIN MICROBIOL, V39, P1696, DOI 10.1128/JCM.39.5.1696-1701.2001; Khanna M, 2005, J CLIN MICROBIOL, V43, P565, DOI 10.1128/JCM.43.2.565-571.2005; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; KORGENSKI EK, 2007, EPIDEMIOLOGY CLIN FI; Kosters K, 2002, J CLIN MICROBIOL, V40, P1719, DOI 10.1128/JCM.40.5.1719-1722.2002; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; LASSAUNIERE R, 2010, J VIROL METHODS; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; Lessa FC, 2009, J INFECT DIS, V200, P1759, DOI 10.1086/647987; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; Lieberman D, 2002, DIAGN MICR INFEC DIS, V42, P21, DOI 10.1016/S0732-8893(01)00324-8; Lopez MM, 2003, INT MICROBIOL, V6, P233, DOI 10.1007/s10123-003-0143-y; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; MAHONY JB, 2009, J CLIN MICROBIOL; Marshall DJ, 2007, J CLIN MICROBIOL, V45, P3875, DOI 10.1128/JCM.00838-07; Martineau F, 2000, J ANTIMICROB CHEMOTH, V46, P527, DOI 10.1093/jac/46.4.527; MCCABE KM, 1995, PEDIATRICS, V95, P165; Meury S, 2004, EUR J PEDIATR, V163, P359, DOI 10.1007/s00431-004-1445-6; Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKAMURA S, 1993, VIRUS GENES, V7, P325, DOI 10.1007/BF01703389; Narayanan S, 1996, ADV CLIN CHEM, V32, P1, DOI 10.1016/S0065-2423(08)60424-2; Nolte FS, 2008, CLIN INFECT DIS, V47, pS123, DOI 10.1086/591392; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Nolte FS, 2011, J CLIN MICROBIOL, V49, P528, DOI 10.1128/JCM.01570-10; O'Shea MK, 2004, J VIROL METHODS, V118, P101, DOI 10.1016/j.jviromet.2004.01.022; Oh KW, 2005, LAB CHIP, V5, P845, DOI 10.1039/b503437j; Palka-Santini M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-1; Pepe M. S., 2003, STAT EVALUATION MED; Perez-Roth E, 2001, J CLIN MICROBIOL, V39, P4037, DOI 10.1128/JCM.39.11.4037-4041.2001; PERSING DH, 2010, MOL MICROBIOLOGY DIA; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Ramers C, 2000, JAMA-J AM MED ASSOC, V283, P2680, DOI 10.1001/jama.283.20.2680; Rand KH, 2011, J CLIN MICROBIOL, V49, P2449, DOI 10.1128/JCM.02582-10; Ratcliff RM, 2007, CURR ISSUES MOL BIOL, V9, P87; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Robinson CC, 2002, PEDIATR INFECT DIS J, V21, P283, DOI 10.1097/00006454-200204000-00005; Rocholl C, 2004, PEDIATRICS, V113, pE51, DOI 10.1542/peds.113.1.e51; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Stellrecht KA, 2002, J CLIN VIROL, V25, pS19, DOI 10.1016/S1386-6532(02)00030-6; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Sung RYT, 2009, J MED VIROL, V81, P153, DOI 10.1002/jmv.21364; Van Eldere J, 2005, CLIN MICROBIOL INFEC, V11, P15, DOI 10.1111/j.1469-0691.2005.01084.x; Versalovic J, 2002, TRENDS MICROBIOL, V10, pS15, DOI 10.1016/S0966-842X(02)02438-1; Weitzel T, 2007, CLIN MICROBIOL INFEC, V13, P665, DOI 10.1111/j.1469-0691.2007.01739.x; Whiley DM, 2008, CRIT REV MICROBIOL, V34, P71, DOI 10.1080/10408410801960913 ; Whiley DM, 2005, PATHOLOGY, V37, P364, DOI 10.1080/00313020500254552; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; Wu WJ, 2009, CLIN LAB MED, V29, P673, DOI 10.1016/j.cll.2009.07.005; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004; Zhang ZW, 2005, METH MOLEC MED, V114, P59	91	262	281	9	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26047	10.1371/journal.pone.0026047	http://dx.doi.org/10.1371/journal.pone.0026047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039434	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500029
J	Almeida, S; Zhou, LJ; Gao, FB				Almeida, Sandra; Zhou, Lijuan; Gao, Fen-Biao			Progranulin, a Glycoprotein Deficient in Frontotemporal Dementia, Is a Novel Substrate of Several Protein Disulfide Isomerase Family Proteins	PLOS ONE			English	Article							DEPENDENT REDUCTASE ERP57; LOBAR DEGENERATION; EPITHELIN PRECURSOR; BRAIN; MUTATIONS; SORTILIN; DELETION; DISEASE; ERP72; GENE	The reduced production or activity of the cysteine-rich glycoprotein progranulin is responsible for about 20% of cases of familial frontotemporal dementia. However, little is known about the molecular mechanisms that govern the level and secretion of progranulin. Here we show that progranulin is expressed in mouse cortical neurons and more prominently in mouse microglia in culture and is abundant in the endoplasmic reticulum (ER) and Golgi. Using chemical crosslinking, immunoprecipitation, and mass spectrometry, we found that progranulin is bound to a network of ER Ca(2+)-binding chaperones including BiP, calreticulin, GRP94, and four members of the protein disulfide isomerase (PDI) family. Loss of ERp57 inhibits progranulin secretion. Thus, progranulin is a novel substrate of several PDI family proteins and modulation of the ER chaperone network may be a therapeutic target for controlling progranulin secretion.	[Almeida, Sandra; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Zhou, Lijuan] Gladstone Inst Neurol Dis, San Francisco, CA USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; The J David Gladstone Institutes	Almeida, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	fen-biao.gao@umassmed.edu	Zhou, Li/GSE-4531-2022		Consortium for Frontotemporal Dementia Research; National Institutes of Health [RO1 NS057553]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057553] Funding Source: NIH RePORTER	Consortium for Frontotemporal Dementia Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the Consortium for Frontotemporal Dementia Research and RO1 NS057553 from the National Institutes of Health (F.-B.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BOXER AL, 2005, ALZ DIS ASSOC DIS S1, V19, pS36; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Gijselinck I, 2008, HUM MUTAT, V29, P53, DOI 10.1002/humu.20651; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Kozlov G, 2010, J MOL BIOL, V401, P618, DOI 10.1016/j.jmb.2010.06.045; Kozlov G, 2009, STRUCTURE, V17, P651, DOI 10.1016/j.str.2009.02.016; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rovelet-Lecrux A, 2008, NEUROBIOL DIS, V31, P41, DOI 10.1016/j.nbd.2008.03.004; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Songsrirote K, 2010, J PROTEOMICS, V73, P1479, DOI 10.1016/j.jprot.2010.02.013; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; Vossel KA, 2008, CURR OPIN NEUROL, V21, P708, DOI 10.1097/WCO.0b013e328318444d; Wang J, 2010, J NEUROCHEM, V112, P1305, DOI 10.1111/j.1471-4159.2009.06546.x; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202	29	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26454	10.1371/journal.pone.0026454	http://dx.doi.org/10.1371/journal.pone.0026454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028881	Green Submitted, gold, Green Published			2022-12-25	WOS:000296186900065
J	Ferreira, JP; Leitao, I; Santos-Reis, M; Revilla, E				Ferreira, Joaquim P.; Leitao, Ines; Santos-Reis, Margarida; Revilla, Eloy			Human-Related Factors Regulate the Spatial Ecology of Domestic Cats in Sensitive Areas for Conservation	PLOS ONE			English	Article							WILDCATS FELIS-SILVESTRIS; DOGS CANIS-FAMILIARIS; FERAL CATS; HABITAT USE; HYBRIDIZATION; DIET; INTROGRESSION; POPULATIONS; CARNIVORES; THREATS	Background: Domestic cats ranging freely in natural areas are a conservation concern due to competition, predation, disease transmission or hybridization with wildcats. In order to improve our ability to design effective control policies, we investigate the factors affecting their numbers and space use in natural areas of continental Europe. Methodology/Principal Findings: We describe the patterns of cat presence, abundance and space use and analyse the associated environmental and human constraints in a well-preserved Mediterranean natural area with small scattered local farms. We failed in detecting cats in areas away from human settlements (trapping effort above 4000 trap-nights), while we captured 30 individuals near inhabited farms. We identified 130 cats, all of them in farms still in use by people (30% of 128 farms). All cats were free-ranging and very wary of people. The main factor explaining the presence of cats was the presence of people, while the number of cats per farm was mostly affected by the occasional food provisioning with human refuse and the presence of people. The home ranges of eight radio tagged cats were centred at inhabited farms. Males went furthest away from the farms during the mating season (3.8 km on average, maximum 6.3 km), using inhabited farms as stepping-stones in their mating displacements (2.2 km of maximum inter-farm distance moved). In their daily movements, cats notably avoided entering in areas with high fox density. Conclusions: The presence, abundance and space use of cats were heavily dependent on human settlements. Any strategy aiming at reducing their impact in areas of conservation concern should aim at the presence of settlements and their spatial spread and avoid any access to human refuse. The movements of domestic cats would be limited in areas with large patches of natural vegetation providing good conditions for other carnivore mammals such as red foxes.	[Ferreira, Joaquim P.; Leitao, Ines; Santos-Reis, Margarida] Univ Lisbon, Ctr Biol Ambiental, Fac Ciencias Lisboa, Dept Biol Anim, P-1699 Lisbon, Portugal; [Ferreira, Joaquim P.; Revilla, Eloy] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Ferreira, Joaquim P.] Univ Aveiro Campus Univ Santiago, Ctr Environm & Marine Studies CESAM, Aveiro, Portugal; [Ferreira, Joaquim P.] Univ Aveiro Campus Univ Santiago, Dept Biol, Aveiro, Portugal	Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Aveiro; Universidade de Aveiro	Ferreira, JP (corresponding author), Univ Lisbon, Ctr Biol Ambiental, Fac Ciencias Lisboa, Dept Biol Anim, P-1699 Lisbon, Portugal.	joaquimpedro.ferreira@gmail.com	Revilla, Eloy/B-5100-2008; Santos-Reis, Margarida/H-4064-2011	Revilla, Eloy/0000-0001-5534-5581; Santos-Reis, Margarida/0000-0002-0337-963X; Ferreira, Joaquim/0000-0002-0469-1529	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/10600/2004, SFRH/BPD/72193/2010]; Spanish Ministerio de Ciencia e Innovacion [CGL2009-07301]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	JPF was supported by grants SFRH/BD/10600/2004 and SFRH/BPD/72193/2010 from the Fundacao para a Ciencia e Tecnologia (FCT). ER was supported by project CGL2009-07301 from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; ARTOIS M, 1994, VET REC, V134, P651, DOI 10.1136/vr.134.25.651; Barratt DG, 1997, ECOGRAPHY, V20, P271, DOI 10.1111/j.1600-0587.1997.tb00371.x; Bates D, 2006, LME4 LINEAR MIXED EF; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Biro Z, 2004, MAMM BIOL, V69, P302, DOI 10.1078/1616-5047-00149; Bradshaw JWS, 1999, APPL ANIM BEHAV SCI, V65, P273, DOI 10.1016/S0168-1591(99)00086-6; Butler JRA, 2002, ANIM CONSERV, V5, P29, DOI 10.1017/S136794300200104X; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Calenge C, 2006, ECOLOGY, V87, P2349, DOI 10.1890/0012-9658(2006)87[2349:EOSRFA]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Daniels MJ, 1999, J WILDLIFE DIS, V35, P121, DOI 10.7589/0090-3558-35.1.121; Daniels MJ, 2001, J APPL ECOL, V38, P146, DOI 10.1046/j.1365-2664.2001.00580.x; Faulquier L, 2009, WATERBIRDS, V32, P330, DOI 10.1675/063.032.0213; Fuchs F, 1972, ORISCHES MUSEUM STAD, V74, P119; Germain E, 2008, J ZOOL, V276, P195, DOI 10.1111/j.1469-7998.2008.00479.x; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Grimm D, 2009, SCIENCE, V325, P1490, DOI 10.1126/science.325_1490; Hertwig ST, 2009, J ZOOL SYST EVOL RES, V47, P283, DOI 10.1111/j.1439-0469.2009.00536.x; HUBBARD AL, 1992, BIOL CONSERV, V61, P203, DOI 10.1016/0006-3207(92)91117-B; Kerby G., 1988, P67; KIRKPATRICK RD, 1986, BIOTROPICA, V18, P72, DOI 10.2307/2388365; LIBERG O, 1984, J MAMMAL, V65, P424, DOI 10.2307/1381089; Liberg O., 2000, DOMESTIC CAT BIOL IT, P83; Martin GR, 1996, WILDLIFE RES, V23, P475, DOI 10.1071/WR9960475; Matias R, 2008, POLAR BIOL, V31, P609, DOI 10.1007/s00300-007-0396-6; Mechl D, 1983, HDB ANIMAL RADIO TRA; Meli ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004744; Millan J, 2009, VET J, V182, P114, DOI 10.1016/j.tvjl.2008.04.005; Ministerio do Ambiente Ordenamento e do Territorio (MAOT), 2008, DIAR REP, V87, P2017; Mladenoff DJ, 1999, ECOL APPL, V9, P37, DOI 10.1890/1051-0761(1999)009[0037:PGWLRL]2.0.CO;2; Molsher RL, 1999, THESIS U SYDNEY SYDN; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; O'Brien J, 2009, BIODIVERS CONSERV, V18, P2351, DOI 10.1007/s10531-009-9592-8; Oliveira R, 2008, PHILOS T R SOC B, V363, P2953, DOI 10.1098/rstb.2008.0052; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; Phillips RB, 2007, J MAMMAL, V88, P173, DOI 10.1644/06-MAMM-A-015R2.1; Pierpaoli M, 2003, MOL ECOL, V12, P2585, DOI 10.1046/j.1365-294X.2003.01939.x; Pires AE, 2003, CONSERV GENET, V4, P525, DOI 10.1023/A:1024762013876; RANDI E, 1991, J MAMMAL, V72, P79, DOI 10.2307/1381981; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Risbey DA, 1999, WILDLIFE RES, V26, P621; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Roland K, 2004, ANIMAL CONSERVATION, V7, P1; Say L, 2004, ANIM BEHAV, V68, P175, DOI 10.1016/j.anbehav.2003.11.008; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; VANRENSBURG PJJ, 1988, S AFR J ZOOL, V23, P301; Yamane A, 1996, J ETHOL, V14, P35, DOI 10.1007/BF02350090	54	48	50	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25970	10.1371/journal.pone.0025970	http://dx.doi.org/10.1371/journal.pone.0025970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043298	Green Submitted, gold, Green Published			2022-12-25	WOS:000295984400026
J	Reynier, F; Petit, F; Paye, M; Turrel-Davin, F; Imbert, PE; Hot, A; Mougin, B; Miossec, P				Reynier, Frederic; Petit, Fabien; Paye, Malick; Turrel-Davin, Fanny; Imbert, Pierre-Emmanuel; Hot, Arnaud; Mougin, Bruno; Miossec, Pierre			Importance of Correlation between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD CELLS; TRANSCRIPTIONAL ACTIVITY; REVISED CRITERIA; MESSENGER-RNA; MICROARRAY; ALPHA; DERMATOMYOSITIS; CLASSIFICATION; NORMALIZATION	Background: The analysis of gene expression data shows that many genes display similarity in their expression profiles suggesting some co-regulation. Here, we investigated the co-expression patterns in gene expression data and proposed a correlation-based research method to stratify individuals. Methodology/Principal Findings: Using blood from rheumatoid arthritis (RA) patients, we investigated the gene expression profiles from whole blood using Affymetrix microarray technology. Co-expressed genes were analyzed by a biclustering method, followed by gene ontology analysis of the relevant biclusters. Taking the type I interferon (IFN) pathway as an example, a classification algorithm was developed from the 102 RA patients and extended to 10 systemic lupus erythematosus (SLE) patients and 100 healthy volunteers to further characterize individuals. We developed a correlation-based algorithm referred to as Classification Algorithm Based on a Biological Signature (CABS), an alternative to other approaches focused specifically on the expression levels. This algorithm applied to the expression of 35 IFN-related genes showed that the IFN signature presented a heterogeneous expression between RA, SLE and healthy controls which could reflect the level of global IFN signature activation. Moreover, the monitoring of the IFN-related genes during the anti-TNF treatment identified changes in type I IFN gene activity induced in RA patients. Conclusions: In conclusion, we have proposed an original method to analyze genes sharing an expression pattern and a biological function showing that the activation levels of a biological signature could be characterized by its overall state of correlation.	[Reynier, Frederic; Petit, Fabien; Paye, Malick; Turrel-Davin, Fanny; Imbert, Pierre-Emmanuel; Hot, Arnaud; Mougin, Bruno; Miossec, Pierre] Hop Edouard Herriot, Joint Unit Hosp Civils Lyon BioMerieux, Lyon, France; [Miossec, Pierre] Univ Lyon, Hop Edouard Herriot, Dept Clin Immunol & Rheumatol, Lyon, France; [Miossec, Pierre] Univ Lyon, Hop Edouard Herriot, Immunogenom & Inflammat Res Unit EA 4130, Lyon, France	bioMerieux; CHU Lyon; CHU Lyon; CHU Lyon	Reynier, F (corresponding author), Hop Edouard Herriot, Joint Unit Hosp Civils Lyon BioMerieux, Lyon, France.	pierre.miossec@univ-lyon1.fr			bioMerieux; Hospices Civils de Lyon	bioMerieux; Hospices Civils de Lyon	There are no current external funding sources for this study. This work was supported by both bioMerieux and Hospices Civils de Lyon, with a 50/50 shared contribution. This support goes to a mixed research unit of which Professor Miossec is the director. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 2008, LUPUS, V17, P568, DOI 10.1177/0961203308089340; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2007, MOL MED, V13, P59, DOI 10.2119/2006-00085.Baechler; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Chou JW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-427; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Gugliesi F, 2005, J LEUKOCYTE BIOL, V77, P820, DOI 10.1189/jlb.0904507; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kerr MK, 2003, BIOMETRICS, V59, P822; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Malarstig A, 2008, ARTERIOSCL THROM VAS, V28, P975, DOI 10.1161/ATVBAHA.108.163733; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pisetsky DS, 2000, ARTHRITIS RHEUM, V43, P2381, DOI 10.1002/1529-0131(200011)43:11<2381::AID-ANR1>3.0.CO;2-M; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Rainen L, 2002, CLIN CHEM, V48, P1883; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tan FK, 2006, RHEUMATOLOGY, V45, P694, DOI 10.1093/rheumatology/kei244; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; van der Pouw Kraan TCTM, 2003, GENES IMMUN, V4, P187, DOI 10.1038/sj.gene.6363975; Wheelan SJ, 2008, MOL BIOSYST, V4, P726, DOI 10.1039/b706237k	37	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e24828	10.1371/journal.pone.0024828	http://dx.doi.org/10.1371/journal.pone.0024828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043277	Green Submitted, gold, Green Published			2022-12-25	WOS:000295984400004
J	Loubet, D; Dakowski, C; Pietri, M; Pradines, E; Bernard, S; Callebert, J; Ardila-Osorio, H; Mouillet-Richard, S; Launay, JM; Kellermann, O; Schneider, B				Loubet, Damien; Dakowski, Caroline; Pietri, Mathea; Pradines, Elodie; Bernard, Sophie; Callebert, Jacques; Ardila-Osorio, Hector; Mouillet-Richard, Sophie; Launay, Jean-Marie; Kellermann, Odile; Schneider, Benoit			Neuritogenesis: the prion protein controls beta 1 integrin signaling activity	FASEB JOURNAL			English	Article						Rho kinase; focal adhesions; actin cytoskeleton; neurite sprouting; neuronal differentiation	FOCAL ADHESION KINASE; NEURITE OUTGROWTH; LIPID RAFTS; TYROSINE PHOSPHORYLATION; NEURONAL POLARIZATION; ACTIN CYTOSKELETON; GENE-EXPRESSION; STRESS FIBERS; RHO FAMILY; DIFFERENTIATION	Cytoskeleton modifications are required for neuronal stem cells to acquire neuronal polarization. Little is known, however, about mechanisms that orchestrate cytoskeleton remodeling along neuritogenesis. Here, we show that the silencing of the cellular prion protein (PrPC) impairs the initial sprouting of neurites upon induction of differentiation of the 1C11 neuroectodermal cell line, indicating that PrPC is necessary to neuritogenesis. Such PrPC function relies on its capacity to negatively regulate the clustering, activation, and signaling activity of beta 1 integrins at the plasma membrane. beta 1 Integrin aggregation caused by PrPC depletion triggers overactivation of the RhoA-Rho kinase-LIMK-cofilin pathway, which, in turn, alters the turnover of focal adhesions, increases the stability of actin microfilaments, and in fine impairs neurite formation. Inhibition of Rho kinases is sufficient to compensate for the lack of PrPC and to restore neurite sprouting. We also observe an increased secretion of fibronectin in the surrounding milieu of PrPC-depleted 1C11 cells, which likely self-sustains beta 1 integrin signaling overactivation and contributes to neuritogenesis defect. Our overall data reveal that PrPC contributes to the acquisition of neuronal polarization by modulating beta 1 integrin activity, cell interaction with fibronectin, and cytoskeleton dynamics.-Loubet, D., Dakowski, C., Pietri, M., Pradines, E., Bernard, S., Callebert, J., Ardila-Osorio, H., Mouillet-Richard, S., Launay, J. M., Kellermann, O., Schneider, B. Neuritogenesis: the prion protein controls beta 1 integrin signaling activity. FASEB J. 26, 678-690 (2012). www.fasebj.org	[Schneider, Benoit] Univ Paris 05, INSERM, UMR S 747, F-75006 Paris, France; [Loubet, Damien; Dakowski, Caroline; Pietri, Mathea; Pradines, Elodie; Ardila-Osorio, Hector; Mouillet-Richard, Sophie; Kellermann, Odile; Schneider, Benoit] INSERM, Unite Mixte Rech Sante UMR S 747, Paris, France; [Bernard, Sophie] CNRS, Unite Mixte Rech UMR 8194, Paris, France; [Bernard, Sophie] Univ Paris 05, UMR 8194, F-75006 Paris, France; [Callebert, Jacques; Launay, Jean-Marie] Hop Lariboisiere, Assistance Publ Hop Paris, Serv Biochim, F-75475 Paris, France; [Launay, Jean-Marie] F Hoffmann La Roche, Pharma Res Dept, Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Roche Holding	Schneider, B (corresponding author), Univ Paris 05, INSERM, UMR S 747, 45 Rue St Peres, F-75006 Paris, France.	benoit.schneider@parisdescartes.fr	Mouillet, Sophie/E-4960-2017; callebert, jacques/L-4569-2017; Schneider, Benoit/AAF-3850-2019	Mouillet, Sophie/0000-0002-8950-1949; PIETRI, Mathea/0000-0002-1819-2878; ARDILA OSORIO, Hector/0000-0002-1198-6843; Schneider, Benoit/0000-0002-1377-2670	Agence Nationale pour la Recherche; INSERM; La Ligue Nationale Contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	The authors thank J.-M. Petit (Plateforme d'Imagerie des Saints-Peres, Paris, France) for fluorescence image acquisition and processing. The authors acknowledge M. Briley and S. Blanquet for critical reading of the manuscript. This work was supported by Agence Nationale pour la Recherche and INSERM. D. L. was funded by La Ligue Nationale Contre le Cancer.	Alenghat FJ, 2009, J CELL BIOCHEM, V106, P529, DOI 10.1002/jcb.22001; Andressen C, 2005, EUR J CELL BIOL, V84, P973, DOI 10.1016/j.ejcb.2005.09.017; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; BOWLUS CL, 1991, J BIOL CHEM, V266, P1122; Chadi S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-448; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Endo M, 2003, J NEUROSCI, V23, P2527; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hajj GNM, 2009, J COMP NEUROL, V517, P371, DOI 10.1002/cne.22157; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynds DL, 2001, J NEUROSCI RES, V66, P630, DOI 10.1002/jnr.10020; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/cne.21520; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 1999, MICROBES INFECT, V1, P969, DOI 10.1016/S1286-4579(99)80514-0; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Murakami H, 1999, ONCOGENE, V18, P1975, DOI 10.1038/sj.onc.1202514; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; Panetti TS, 2002, FRONT BIOSCI-LANDMRK, V7, pD143, DOI 10.2741/panetti; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Park JH, 2011, J CELL PHYSIOL, V226, P267, DOI 10.1002/jcp.22338; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Roman J, 2005, AM J PHYSIOL-LUNG C, V288, pL975, DOI 10.1152/ajplung.00003.2004; Sakudo A, 2007, MICROBIOL IMMUNOL, V51, P1, DOI 10.1111/j.1574-695X.2007.00284.x; Salani B, 2009, BIOCHEM BIOPH RES CO, V380, P489, DOI 10.1016/j.bbrc.2009.01.102; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Seidenfaden R, 2006, NEUROCHEM INT, V49, P1, DOI 10.1016/j.neuint.2005.12.011; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.mcn.2004.05.001; Thoumine O, 2008, CELL ADHES MIGR, V2, P263, DOI 10.4161/cam.2.4.7274; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	64	78	79	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2012	26	2					678	690		10.1096/fj.11-185579	http://dx.doi.org/10.1096/fj.11-185579			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22038049				2022-12-25	WOS:000300485700020
J	Lim, JH; Liu, Y; Reineke, E; Kao, HY				Lim, Jun Hee; Liu, Yu; Reineke, Erin; Kao, Hung-Ying			Mitogen-activated Protein Kinase Extracellular Signal-regulated Kinase 2 Phosphorylates and Promotes Pin1 Protein-dependent Promyelocytic Leukemia Protein Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-BODY FORMATION; TUMOR-SUPPRESSOR PML; RAR-ALPHA; BODIES; DEGRADATION; PATHWAY; GROWTH; CELLS; ERK; TRANSLOCATION	The promyelocytic leukemia (PML) protein is a tumor suppressor that has an important role in several cellular processes, including apoptosis, viral infection, DNA damage repair, cell cycle regulation, and senescence. PML is an essential component of sub-nuclear structures called PML nuclear bodies (NBs). Our laboratory has previously demonstrated that the peptidyl-prolyl cis-trans isomerase, Pin1, binds and targets PML for degradation in a phosphorylation-dependent manner. To further elucidate the mechanisms underlying Pin1-mediated PML degradation, we aimed to identify one or more factors that promote PML phosphorylation. Here we show that treatment with U0126, an inhibitor of the ERK2 upstream kinases MEK1/2, leads to an increase in PML protein accumulation and an inhibition of the interaction between Pin1 and PML in MDA-MB-231 breast cancer cells. Consistent with this observation, phosphorylated ERK2 partially co-localized with PML NBs. Although U0126 up-regulated exogenous wild-type PML levels, it did not have an effect on the steady-state level of a mutant form of PML that is defective in binding Pin1. In addition, exogenous wildtype, but not Pin1 binding-defective PML protein expression levels were decreased by overexpression of ERK2. In contrast, knockdown of ERK2 by siRNA resulted in an increase in PML protein levels and an increase in the formation of PML NBs. Using phospho-specific antibodies, we identified Ser-403 and Ser-505 as the ERK2 targets that promote Pin1-mediated PML degradation. Finally, we demonstrated that EGF induced activation of ERK and interaction between PML and phosphorylated ERK resulting in a decrease in PML protein levels. Taken together, our results support a model in which Pin1 promotes PML degradation in an ERK2-dependent manner.	[Lim, Jun Hee; Liu, Yu; Reineke, Erin; Kao, Hung-Ying] Case Western Reserve Univ CWRU, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] CWRU, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Univ Hosp, Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu			National Institutes of Health [R01 DK078965, HL093269]; Pardee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078965 and HL093269 (to H.-Y. K.). This work was also supported by the Pardee Foundation (to H.-Y. K.).	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dror N, 2007, J BIOL CHEM, V282, P5633, DOI 10.1074/jbc.M607825200; El Mchichi B, 2010, J VIROL, V84, P11634, DOI 10.1128/JVI.01321-10; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; LAVAU C, 1995, ONCOGENE, V11, P871; Ling PD, 2008, J VIROL, V82, P8000, DOI 10.1128/JVI.02752-07; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Reineke Erin L, 2009, Cancer Ther, V7, P219; Reineke EL, 2010, J BIOL CHEM, V285, P9485, DOI 10.1074/jbc.M109.063362; Reineke EL, 2009, INT J BIOL SCI, V5, P366; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Stadler M, 1995, ONCOGENE, V11, P2565; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	42	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44403	44411		10.1074/jbc.M111.289512	http://dx.doi.org/10.1074/jbc.M111.289512			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22033920	Green Published, hybrid			2022-12-25	WOS:000298645500012
J	Zhou, C; Lu, L; Tan, SY; Jiang, SB; Chen, YH				Zhou, Chang; Lu, Lu; Tan, Suiyi; Jiang, Shibo; Chen, Ying-Hua			HIV-1 Glycoprotein 41 Ectodomain Induces Activation of the CD74 Protein-mediated Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway to Enhance Viral Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MIGRATION INHIBITORY FACTOR; CC-CHEMOKINE RANTES; HTLV-III; ENVELOPE GLYCOPROTEIN; CELL-PROLIFERATION; IMMUNE-RESPONSE; TARGET-CELLS; FACTOR MIF; GP41 CORE	Besides mediating the viral entry process, the human immunodeficiency virus (HIV-1) envelope protein gp41 can bind to many host cell components and regulate cell functions. Using a yeast two-hybrid system, we screened a human bone marrow cDNA library and identified a novel gp41-binding protein, CD74 (the MHC class II-associated invariant chain). Here, we report possible biological effects mediated by interaction between gp41 and CD74. We found that HIV-1 gp41 could bind directly to host CD74 in HIV-1-infected cells, and the peptide 6358 derived from gp41 loop region (aa 597-611) could effectively block the gp41-CD74 interaction. As a result of this binding, recombinant soluble gp41 and gp41 peptide 6358 activated the CD74-mediated ERK/MAPK pathway and significantly enhanced HIV-1 infection in vitro. Conversely, the enhancing effect could be suppressed by the recombinant CD74 extracellular domain. These results reveal a novel mechanism underlying gp41 mediation of HIV-1 infection and replication.	[Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Minist Hlth Key Lab Med Mol Virol,Minist Educ, Shanghai 200032, Peoples R China; [Zhou, Chang; Chen, Ying-Hua] Tsinghua Univ, Beijing Key Lab Prot Therapeut, Sch Life Sci, Prot Sci Lab,Lab Immunol,Minist Educ, Beijing 100084, Peoples R China; [Lu, Lu; Tan, Suiyi; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Viral Immunol, New York, NY 10065 USA	Fudan University; Tsinghua University; New York Blood Center	Jiang, SB (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Minist Hlth Key Lab Med Mol Virol,Minist Educ, Shanghai 200032, Peoples R China.	shibojiang@fudan.edu.cn; chenyh@mail.tsinghua.edu.cn	chen, ying/HHS-8254-2022; lu, lu/HII-7530-2022; Jiang, Shibo/L-4500-2014; Zhou, Chang/C-8999-2013; lu, lu/HGA-0894-2022; Lu, Lu/K-7070-2014	Jiang, Shibo/0000-0001-8283-7135; Zhou, Chang/0000-0002-6990-0395; Lu, Lu/0000-0002-2255-0391	National Natural Science Foundation of China [81171548, 81173098, 81102476]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81171548 (to Y.-H.C.), 81173098 (to S.J.), and 81102476 (to L. L.).	BENKIRANE M, 1994, EMBO J, V13, P5559, DOI 10.1002/j.1460-2075.1994.tb06893.x; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Beswick EJ, 2005, INFECT IMMUN, V73, P2736, DOI 10.1128/IAI.73.5.2736-2743.2005; Briant L, 1998, J VIROL, V72, P6207, DOI 10.1128/JVI.72.7.6207-6214.1998; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; CHEN BYH, 1994, INT ARCH ALLERGY IMM, V104, P227, DOI 10.1159/000236670; CHEN YH, 1993, IMMUNOL LETT, V37, P41, DOI 10.1016/0165-2478(93)90130-T; Chen YH, 1995, IMMUNOL LETT, V48, P39, DOI 10.1016/0165-2478(95)02439-5; CHEN YH, 1993, IMMUNOBIOLOGY, V188, P323, DOI 10.1016/S0171-2985(11)80216-0; CHEN YH, 1992, AIDS, V6, P533, DOI 10.1097/00002030-199206000-00002; CHEN YH, 1993, MOL IMMUNOL, V30, P1583, DOI 10.1016/0161-5890(93)90449-L; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENNER J, 1994, AIDS, V8, P1063, DOI 10.1097/00002030-199408000-00005; Dunn SJ, 2004, VIROLOGY, V321, P260, DOI 10.1016/j.virol.2004.01.010; Grainger DJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-23; HENDERSON LA, 1993, J BIOL CHEM, V268, P15291; HENNE C, 1995, IMMUNOLOGY, V84, P177; Hovanessian AG, 2004, IMMUNITY, V21, P617, DOI 10.1016/j.immuni.2004.08.015; Huang JH, 2008, J BIOL CHEM, V283, P14994, DOI 10.1074/jbc.M800525200; Huang JH, 2007, J BIOL CHEM, V282, P6143, DOI 10.1074/jbc.M607701200; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Marozsan AJ, 2001, J VIROL, V75, P8624, DOI 10.1128/JVI.75.18.8624-8638.2001; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; POPOVIC M, 1984, LANCET, V2, P1472; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; QURESHI NM, 1990, AIDS, V4, P553, DOI 10.1097/00002030-199006000-00009; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; STRUBIN M, 1986, CELL, V47, P619, DOI 10.1016/0092-8674(86)90626-4; Swanson CM, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.005; Trkola A, 1999, J VIROL, V73, P6370, DOI 10.1128/JVI.73.8.6370-6379.1999; Ueda H, 1998, J CLIN INVEST, V102, P804, DOI 10.1172/JCI3273; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036	51	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44869	44877		10.1074/jbc.M111.267393	http://dx.doi.org/10.1074/jbc.M111.267393			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039051	hybrid, Green Published			2022-12-25	WOS:000298645500055
J	Soon, CPW; Donnelly, PS; Turner, BJ; Hung, LW; Crouch, PJ; Sherratt, NA; Tan, JL; Lim, NKH; Lam, L; Bica, L; Lim, S; Hickey, JL; Morizzi, J; Powell, A; Finkelstein, DI; Culvenor, JG; Masters, CL; Duce, J; White, AR; Barnham, KJ; Li, QX				Soon, Cynthia P. W.; Donnelly, Paul S.; Turner, Bradley J.; Hung, Lin W.; Crouch, Peter J.; Sherratt, Nicki A.; Tan, Jiang-Li; Lim, Nastasia K. -H.; Lam, Linh; Bica, Laura; Lim, SinChun; Hickey, James L.; Morizzi, Julia; Powell, Andrew; Finkelstein, David I.; Culvenor, Janetta G.; Masters, Colin L.; Duce, James; White, Anthony R.; Barnham, Kevin J.; Li, Qiao-Xin			Diacetylbis(N(4)-methylthiosemicarbazonato) Copper(II) (Cu-II(atsm)) Protects against Peroxynitrite-induced Nitrosative Damage and Prolongs Survival in Amyotrophic Lateral Sclerosis Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DEGENERATION; SOD1 TRANSGENIC MICE; SUPEROXIDE-DISMUTASE; SPINAL-CORD; OXIDATIVE STRESS; TDP-43; ALS; DISEASE; AGGREGATION	Amyotrophic lateral sclerosis (ALS) is a progressive paralyzing disease characterized by tissue oxidative damage and motor neuron degeneration. This study investigated the in vivo effect of diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (Cu-II(atsm)), which is an orally bioavailable, blood-brain barrier-permeable complex. In vitro the compound inhibits the action of peroxynitrite on Cu,Zn-superoxide dismutase (SOD1) and subsequent nitration of cellular proteins. Oral treatment of transgenic SOD1(G93A) mice with Cu-II(atsm) at presymptomatic and symptomatic ages was performed. The mice were examined for improvement in lifespan and motor function, as well as histological and biochemical changes to key disease markers. Systemic treatment of SOD1(G93A) mice significantly delayed onset of paralysis and prolonged lifespan, even when administered to symptomatic animals. Consistent with the properties of this compound, treated mice had reduced protein nitration and carbonylation, as well as increased antioxidant activity in spinal cord. Treatment also significantly preserved motor neurons and attenuated astrocyte and microglial activation in mice. Furthermore, Cu-II(atsm) prevented the accumulation of abnormally phosphorylated and fragmented TAR DNA-binding protein-43 (TDP-43) in spinal cord, a protein pivotal to the development of ALS. Cu-II(atsm) therefore represents a potential new class of neuroprotective agents targeting multiple major disease pathways of motor neurons with therapeutic potential for ALS.	[Soon, Cynthia P. W.; Hung, Lin W.; Crouch, Peter J.; Sherratt, Nicki A.; Tan, Jiang-Li; Lim, Nastasia K. -H.; Bica, Laura; Culvenor, Janetta G.; White, Anthony R.; Barnham, Kevin J.; Li, Qiao-Xin] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Soon, Cynthia P. W.; Hung, Lin W.; Crouch, Peter J.; Sherratt, Nicki A.; Lim, Nastasia K. -H.; Lam, Linh; Finkelstein, David I.; Masters, Colin L.; Duce, James; White, Anthony R.; Barnham, Kevin J.; Li, Qiao-Xin] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia; [Donnelly, Paul S.; Lim, SinChun; Hickey, James L.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Donnelly, Paul S.; Hung, Lin W.; Sherratt, Nicki A.; Lim, SinChun; Hickey, James L.; Barnham, Kevin J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Turner, Bradley J.; Crouch, Peter J.; Lim, Nastasia K. -H.; Culvenor, Janetta G.; White, Anthony R.; Li, Qiao-Xin] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Turner, Bradley J.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3010, Australia; [Morizzi, Julia; Powell, Andrew] Monash Univ, Monash Inst Pharmaceut Sci, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Barnham, KJ (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.	kbarnham@unimelb.edu.au; q.li@unimelb.edu.au	Finkelstein, David/B-9617-2009; Powell, Andrew K/G-7886-2011; White, Anthony/P-5596-2016	Finkelstein, David/0000-0002-8167-4917; Duce, James/0000-0002-8762-2245; Lim, Nastasia/0000-0003-4245-3692; Powell, Andrew/0000-0002-9779-1122; Crouch, Peter/0000-0002-7777-4747; White, Anthony/0000-0003-1802-9891; Turner, Bradley/0000-0001-6580-7655	Australian National Health and Medical Research Council (NHMRC); C. J. Martin Fellowship [359269]; Bethlehem Griffiths Research Foundation; Motor Neurone Disease Research Institute of Australia; Australian Research Council	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); C. J. Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Bethlehem Griffiths Research Foundation; Motor Neurone Disease Research Institute of Australia; Australian Research Council(Australian Research Council)	This work was supported by the Australian National Health and Medical Research Council (NHMRC), C. J. Martin Fellowship 359269 (to B. J. T.), the Bethlehem Griffiths Research Foundation, the Motor Neurone Disease Research Institute of Australia, and the Australian Research Council.	Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; Blower PJ, 2003, DALTON T, P4416, DOI 10.1039/b307499d; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cozzolino M, 2008, ANTIOXID REDOX SIGN, V10, P405, DOI 10.1089/ars.2007.1760; Crow JP, 2006, EXPERT OPIN INV DRUG, V15, P1383, DOI 10.1517/13543784.15.11.1383; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Feeney SJ, 2001, MUSCLE NERVE, V24, P1510, DOI 10.1002/mus.1176; Fodero-Tavoletti MT, 2010, J ALZHEIMERS DIS, V20, P49, DOI 10.3233/JAD-2010-1359; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; GINGRAS BA, 1962, CAN J CHEM, V40, P1053, DOI 10.1139/v62-161; GRAHAM JM, 1997, SUBCELLULAR FRACTION, P71; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lewis JS, 2008, J NUCL MED, V49, P1177, DOI 10.2967/jnumed.108.051326; Li QX, 2006, AGING CELL, V5, P153, DOI 10.1111/j.1474-9726.2006.00200.x; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Peluffo H, 2004, J NEUROCHEM, V89, P602, DOI 10.1046/j.1471-4159.2004.02363.x; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shan XY, 2009, NEUROSCI LETT, V458, P70, DOI 10.1016/j.neulet.2009.04.031; Soon CPW, 2010, NEUROMUSCULAR DISORD, V20, P260, DOI 10.1016/j.nmd.2009.11.015; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sumi H, 2009, J NEUROPATH EXP NEUR, V68, P37, DOI 10.1097/NEN.0b013e3181919cb5; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Turner BJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-104; WADA K, 1994, ARCH BIOCHEM BIOPHYS, V310, P1, DOI 10.1006/abbi.1994.1132; WADA K, 1994, BIOL PHARM BULL, V17, P701; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	49	98	98	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44035	44044		10.1074/jbc.M111.274407	http://dx.doi.org/10.1074/jbc.M111.274407			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033929	Green Published, hybrid			2022-12-25	WOS:000298402300044
J	Dange, T; Smith, D; Noy, T; Rommel, PC; Jurzitza, L; Cordero, RJB; Legendre, A; Finley, D; Goldberg, AL; Schmidt, M				Dange, Thomas; Smith, David; Noy, Tahel; Rommel, Philipp C.; Jurzitza, Lukas; Cordero, Radames J. B.; Legendre, Anne; Finley, Daniel; Goldberg, Alfred L.; Schmidt, Marion			Blm10 Protein Promotes Proteasomal Substrate Turnover by an Active Gating Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20 S-PROTEASOMES; SACCHAROMYCES-CEREVISIAE; PROTEOLYTIC MACHINE; REGULATORY PARTICLE; GENE DISRUPTION; 26S PROTEASOME; CORE PARTICLE; C-TERMINI; ATPASES; COMPLEX	Background: Association of the proteasome core with activators regulates proteasome activity. Results: Blm10 association increases proteasome activity toward peptides and the unstructured proteasome substrate tau-441. This process is mediated by the C terminus of Blm10. Conclusion: C-terminal docking-mediated proteasome activation by Blm10 facilitates the turnover of peptide and protein substrates. Significance: Blm10 contributes to the regulation of proteasome activity.	[Dange, Thomas; Noy, Tahel; Rommel, Philipp C.; Jurzitza, Lukas; Cordero, Radames J. B.; Schmidt, Marion] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Smith, David; Legendre, Anne; Finley, Daniel; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard Medical School	Schmidt, M (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	marion.schmidt@einstein.yu.edu	Rommel, Philipp C/AAP-1813-2020; Cordero, Radamés JB/F-6912-2011; Smith, David/AAL-7662-2020	Rommel, Philipp C/0000-0002-9790-4086; Cordero, Radamés JB/0000-0002-3026-7094; Smith, David/0000-0002-1502-676X; Noy, Tahel/0000-0002-8492-8505	National Institutes of Health [NIH-NIGMS-084228, NIH-NIGMS-043601, NIH-NIGMS 5R01GM51923]; Multiple Myeloma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923, R37GM043601, R01GM084228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH-NIGMS-084228 (to M. S.), NIH-NIGMS-043601 (to D. F.), and NIH-NIGMS 5R01GM51923 (to A. L. G.). This work was also supported by the Multiple Myeloma Research Foundation.	Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Brachmann CB, 1998, YEAST, V14, P115; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dohmen RJ, 2007, BBA-MOL CELL RES, V1773, P1599, DOI 10.1016/j.bbamcr.2007.05.015; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Kajava AV, 2004, J STRUCT BIOL, V146, P425, DOI 10.1016/j.jsb.2004.01.013; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Kopp F, 2001, J MOL BIOL, V313, P465, DOI 10.1006/jmbi.2001.5063; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Lehmann A, 2008, EMBO REP, V9, P1237, DOI 10.1038/embor.2008.190; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Yao Y, 1999, J BIOL CHEM, V274, P33921, DOI 10.1074/jbc.274.48.33921; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	52	57	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42830	42839		10.1074/jbc.M111.300178	http://dx.doi.org/10.1074/jbc.M111.300178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025621	Green Published, hybrid			2022-12-25	WOS:000298351300004
J	Chene, A; Nylen, S; Donati, D; Bejarano, MT; Kironde, F; Wahlgren, M; Falk, KI				Chene, Arnaud; Nylen, Susanne; Donati, Daria; Bejarano, Maria Teresa; Kironde, Fred; Wahlgren, Mats; Falk, Kerstin I.			Effect of Acute Plasmodium falciparum Malaria on Reactivation and Shedding of the Eight Human Herpes Viruses	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CENTRAL-NERVOUS-SYSTEM; KAPOSIS-SARCOMA; INFECTION; DNA; CHILDREN; CYTOMEGALOVIRUS; ZOSTER; EPIDEMIOLOGY; SEROPREVALENCE	Human herpes viruses (HHVs) are widely distributed pathogens. In immuno-competent individuals their clinical outcomes are generally benign but in immuno-compromised hosts, primary infection or extensive viral reactivation can lead to critical diseases. Plasmodium falciparum malaria profoundly affects the host immune system. In this retrospective study, we evaluated the direct effect of acute P. falciparum infection on reactivation and shedding of all known human herpes viruses (HSV-1, HSV-2, VZV, EBV, CMV, HHV-6, HHV-7, HHV-8). We monitored their presence by real time PCR in plasma and saliva of Ugandan children with malaria at the day of admission to the hospital (day-0) and 14 days later (after treatment), or in children with mild infections unrelated to malaria. For each child screened in this study, at least one type of HHV was detected in the saliva. HHV-7 and HHV-6 were detected in more than 70% of the samples and CMV in approximately half. HSV-1, HSV-2, VZV and HHV-8 were detected at lower frequency. During salivary shedding the highest mean viral load was observed for HSV-1 followed by EBV, HHV-7, HHV-6, CMV and HHV-8. After anti-malarial treatment the salivary HSV-1 levels were profoundly diminished or totally cleared. Similarly, four children with malaria had high levels of circulating EBV at day-0, levels that were cleared after anti-malarial treatment confirming the association between P. falciparum infection and EBV reactivation. This study shows that acute P. falciparum infection can contribute to EBV reactivation in the blood and HSV-1 reactivation in the oral cavity. Taken together our results call for further studies investigating the potential clinical implications of HHVs reactivation in children suffering from malaria.	[Chene, Arnaud; Nylen, Susanne; Bejarano, Maria Teresa; Wahlgren, Mats; Falk, Kerstin I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Donati, Daria; Bejarano, Maria Teresa] Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden; [Kironde, Fred] Makerere Univ, Fac Med, Dept Biochem, Kampala, Uganda; [Falk, Kerstin I.] Swedish Inst Communicable Dis, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Makerere University; Swedish Institute for Infectious Disease Control	Chene, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se	Chene, Arnaud/O-4397-2017	Chene, Arnaud/0000-0002-6551-4382; Kironde, Fred/0000-0003-4981-6417; Nylen, Susanne/0000-0002-3875-3353	SIDA/SAREC; Swedish Research Council; EviMalaR	SIDA/SAREC; Swedish Research Council(Swedish Research CouncilEuropean Commission); EviMalaR	This work was supported by grants from SIDA/SAREC (www.sida.se), the Swedish Research Council (www.vr.se) and EviMalaR (www.evimalar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYTTING M, 1992, J CLIN MICROBIOL, V30, P1937, DOI 10.1128/JCM.30.8.1937-1941.1992; Carbone A, 2008, BRIT J HAEMATOL, V140, P13, DOI 10.1111/j.1365-2141.2007.06879.x; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; Chene A, 2009, SEMIN CANCER BIOL, V19, P411, DOI 10.1016/j.semcancer.2009.10.002; Coluzzi M, 2003, MED VET ENTOMOL, V17, P461, DOI 10.1111/j.1365-2915.2003.00465.x; COOK IF, 1985, J TROP MED HYG, V88, P261; DOBBINS JG, 1994, PEDIATRICS, V94, P1016; Donati D, 2006, J INFECT DIS, V193, P971, DOI 10.1086/500839; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; Gabutti G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-372; Holden SR, 2007, J CLIN VIROL, V40, P245, DOI 10.1016/j.jcv.2007.08.011; Huang LM, 1997, ACTA PAEDIATR, V86, P604, DOI 10.1111/j.1651-2227.1997.tb08942.x; Hudnall SD, 2008, TRANSFUSION, V48, P1180, DOI 10.1111/j.1537-2995.2008.01685.x; Katsafanas GC, 1996, P NATL ACAD SCI USA, V93, P9788, DOI 10.1073/pnas.93.18.9788; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; Lademann M, 2005, AM J TROP MED HYG, V72, P478, DOI 10.4269/ajtmh.2005.72.478; Lundberg R, 2006, ANTICANCER RES, V26, P3627; Malvy D, 2007, J EUR ACAD DERMATOL, V21, P1398, DOI 10.1111/j.1468-3083.2007.02302.x; Miller CS, 2005, J CLIN MICROBIOL, V43, P2173, DOI 10.1128/JCM.43.5.2173-2180.2005; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Ndungu FM, 2005, PARASITE IMMUNOL, V27, P373, DOI 10.1111/j.1365-3024.2005.00771.x; Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x; Regunath Hariharan, 2008, Journal of Vector Borne Diseases, V45, P251; Serraino D, 2003, INFECTION, V31, P47, DOI 10.1007/s15010-002-3107-9; Sowunmi A, 2008, ACTA TROP, V106, P68, DOI 10.1016/j.actatropica.2007.03.005; SPECTOR SA, 1992, J CLIN MICROBIOL, V30, P2359, DOI 10.1128/JCM.30.9.2359-2365.1992; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; SUGA S, 1993, ANN NEUROL, V33, P597, DOI 10.1002/ana.410330607; Tanaka N, 2000, BONE MARROW TRANSPL, V26, P1193, DOI 10.1038/sj.bmt.1702710; Taplitz Randy A, 2002, Semin Respir Infect, V17, P121, DOI 10.1053/srin.2002.33447; Taylor GS, CANC LETT, V305, P263; Tedeschi R, 2006, J MED VIROL, V78, P372, DOI 10.1002/jmv.20549; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Torigoe S, 1996, J PEDIATR-US, V129, P301, DOI 10.1016/S0022-3476(96)70259-7; Tyler K. L., 2004, HERPES J IHMF, V11, P57; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Wahlgren M, 1995, SCAND J IMMUNOL, V42, P626, DOI 10.1111/j.1365-3083.1995.tb03705.x; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; YAMAMOTO M, 1995, J CLIN MICROBIOL, V33, P1765, DOI 10.1128/JCM.33.7.1765-1768.1995; Yoshikawa T, 2000, ARCH DIS CHILD, V83, P170, DOI 10.1136/adc.83.2.170; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	41	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26266	10.1371/journal.pone.0026266	http://dx.doi.org/10.1371/journal.pone.0026266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039454	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200008
J	Lim, PY; Keating, JA; Hoover, S; Striker, R; Bernard, KA				Lim, Pei-Yin; Keating, Julie A.; Hoover, Spencer; Striker, Rob; Bernard, Kristen A.			A Thiopurine Drug Inhibits West Nile Virus Production in Cell Culture, but Not in Mice	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASES; HEPATITIS-C VIRUS; 6-METHYLMERCAPTOPURINE RIBOSIDE; LIVER-TRANSPLANTATION; MYCOPHENOLIC-ACID; CHAIN-TERMINATORS; CRYSTAL-STRUCTURE; VIRAL LOAD; CDNA-CLONE; RIBAVIRIN	Many viruses within the Flavivirus genus cause significant disease in humans; however, effective antivirals against these viruses are not currently available. We have previously shown that a thiopurine drug, 6-methylmercaptopurine riboside (6MMPr), inhibits replication of distantly related viruses within the Flaviviridae family in cell culture, including bovine viral diarrhea virus and hepatitis C virus replicon. Here we further examined the potential antiviral effect of 6MMPr on several diverse flaviviruses. In cell culture, 6MMPr inhibited virus production of yellow fever virus, dengue virus-2 (DENV-2) and West Nile virus (WNV) in a dose-dependent manner, and DENV-2 was significantly more sensitive to 6MMPr treatment than WNV. We then explored the use of 6MMPr as an antiviral against WNV in an immunocompetent mouse model. Once a day treatment of mice with 0.5 mg 6MMPr was just below the toxic dose in our mouse model, and this dose was used in subsequent studies. Mice were treated with 6MMPr immediately after subcutaneous inoculation with WNV for eight consecutive days. Treatment with 6MMPr exacerbated weight loss in WNV-inoculated mice and did not significantly affect mortality. We hypothesized that 6MMPr has low bioavailability in the central nervous system (CNS) and examined the effect of pre-treatment with 6MMPr on viral loads in the periphery and CNS. Pre-treatment with 6MMPr had no significant effect on viremia or viral titers in the periphery, but resulted in significantly higher viral loads in the brain, suggesting that the effect of 6MMPr is tissue-dependent. In conclusion, despite being a potent inhibitor of flaviviruses in cell culture, 6MMPr was not effective against West Nile disease in mice; however, further studies are warranted to reduce the toxicity and/or improve the bioavailability of this potential antiviral drug.	[Lim, Pei-Yin; Bernard, Kristen A.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Lim, Pei-Yin; Bernard, Kristen A.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Striker, Rob] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Keating, Julie A.; Hoover, Spencer; Striker, Rob] Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; State University of New York (SUNY) System; Wadsworth Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison	Lim, PY (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	kbernard@vetmed.wisc.edu		Striker, Rob/0000-0002-0454-895X; Lim, Pei-Yin/0000-0003-4401-1265	National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH) [1U01-AI061193, 2T32AI007414]; Northeast Biodefence Center [U54-AI057158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007414, U01AI061193, U54AI057158] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefence Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by federal funds from the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health (NIH) under 1U01-AI061193. The BSL-3 animal core, which is funded in part by the Northeast Biodefence Center (U54-AI057158), was used for the animal studies conducted at the Wadsworth Center. JAK was supported by the NIH-funded Cellular and Molecular Parasitology Training Program (2T32AI007414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobbala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-102; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; D'Abramo CM, 2004, J MOL BIOL, V337, P1, DOI 10.1016/j.jmb.2004.01.030; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; ERIKSSON B, 1977, ANTIMICROB AGENTS CH, V11, P946, DOI 10.1128/AAC.11.6.946; Hageboutros A, 1997, INVEST NEW DRUG, V15, P139, DOI 10.1023/A:1005812923473; HEWLETT JS, 1979, CANCER TREAT REP, V63, P156; Hoover S, 2008, J GEN VIROL, V89, P1000, DOI 10.1099/vir.0.83381-0; HUNT DE, 1968, CANCER RES, V28, P1095; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Koh YH, 2005, J MED CHEM, V48, P2867, DOI 10.1021/jm049029u; Lipsky JJ, 1996, LANCET, V348, P1357, DOI 10.1016/S0140-6736(96)10310-X; MAGEE WC, 2011, ANTIMICROB AGENTS CH; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; MELVIN JB, 1984, CANCER RES, V44, P2794; Morrey JD, 2002, ANTIVIR RES, V55, P107, DOI 10.1016/S0166-3542(02)00013-X; Morrey John D., 2004, Antiviral Chemistry & Chemotherapy, V15, P101; Neyts J, 1996, ANTIVIR RES, V30, P125, DOI 10.1016/0166-3542(96)89697-5; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; REDEI I, 1994, INVEST NEW DRUG, V12, P319, DOI 10.1007/BF00873047; Rossi SL, 2005, VIROLOGY, V331, P457, DOI 10.1016/j.virol.2004.10.046; Samonakis DN, 2005, LIVER TRANSPLANT, V11, P386, DOI 10.1002/lt.20344; SCHEIDEL LM, 1991, VIROLOGY, V181, P490, DOI 10.1016/0042-6822(91)90881-B; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; Shackel NA, 2009, LIVER TRANSPLANT, V15, P709, DOI 10.1002/lt.21747; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Stangl JR, 2004, TRANSPLANTATION, V77, P562, DOI 10.1097/01.TP.0000114610.40412.C6; VANSCOIK KG, 1985, DRUG METAB REV, V16, P157, DOI 10.3109/03602538508991433; WHO, 2011, IMP DENG; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zekry A, 2004, LIVER TRANSPLANT, V10, P52, DOI 10.1002/lt.20000	34	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26697	10.1371/journal.pone.0026697	http://dx.doi.org/10.1371/journal.pone.0026697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039536	gold, Green Submitted, Green Published			2022-12-25	WOS:000296515200043
J	Matsumoto, M; Hikosaka, O				Matsumoto, Masayuki; Hikosaka, Okihide			Electrical Stimulation of the Primate Lateral Habenula Suppresses Saccadic Eye Movement through a Learning Mechanism	PLOS ONE			English	Article							ROSTROMEDIAL TEGMENTAL NUCLEUS; MIDBRAIN DOPAMINE NEURONS; NEGATIVE REWARD SIGNALS; DORSAL RAPHE NUCLEUS; SUBSTANTIA-NIGRA; BASAL GANGLIA; SEEKING BEHAVIOR; COMPLEX; RATS; AREA	The lateral habenula (LHb) is a brain structure which represents negative motivational value. Neurons in the LHb are excited by unpleasant events such as reward omission and aversive stimuli, and transmit these signals to midbrain dopamine neurons which are involved in learning and motivation. However, it remains unclear whether these phasic changes in LHb neuronal activity actually influence animal behavior. To answer this question, we artificially activated the LHb by electrical stimulation while monkeys were performing a visually guided saccade task. In one block of trials, saccades to one fixed direction (e.g., right direction) were followed by electrical stimulation of the LHb while saccades to the other direction (e. g., left direction) were not. The direction-stimulation contingency was reversed in the next block. We found that the post-saccadic stimulation of the LHb increased the latencies of saccades in subsequent trials. Notably, the increase of the latency occurred gradually as the saccade was repeatedly followed by the stimulation, suggesting that the effect of the post-saccadic stimulation was accumulated across trials. LHb stimulation starting before saccades, on the other hand, had no effect on saccade latency. Together with previous studies showing LHb activation by reward omission and aversive stimuli, the present stimulation experiment suggests that LHb activity contributes to learning to suppress actions which lead to unpleasant events.	[Matsumoto, Masayuki; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; [Matsumoto, Masayuki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Kyoto University	Matsumoto, M (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	mmatsumoto@pri.kyoto-u.ac.jp			National Institutes of Health, National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Intramural Research Program at the National Institutes of Health, National Eye Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; Brinschwitz K, 2010, NEUROSCIENCE, V168, P463, DOI 10.1016/j.neuroscience.2010.03.050; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; CORODIMAS KP, 1992, BEHAV NEUROSCI, V106, P853, DOI 10.1037/0735-7044.106.5.853; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Lecourtier L, 2004, EUR J NEUROSCI, V19, P2551, DOI 10.1111/j.0953-816X.2004.03356.x; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Murphy CA, 1996, BEHAV BRAIN RES, V81, P43, DOI 10.1016/S0166-4328(96)00041-1; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; THORNTON EW, 1991, PHYSIOL BEHAV, V49, P819, DOI 10.1016/0031-9384(91)90324-H; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; WANG RY, 1977, SCIENCE, V197, P89, DOI 10.1126/science.194312; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	39	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26701	10.1371/journal.pone.0026701	http://dx.doi.org/10.1371/journal.pone.0026701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039537	gold, Green Submitted, Green Published			2022-12-25	WOS:000296515200044
J	Mongrain, V; La Spada, F; Curie, T; Franken, P				Mongrain, Valerie; La Spada, Francesco; Curie, Thomas; Franken, Paul			Sleep Loss Reduces the DNA-Binding of BMAL1, CLOCK, and NPAS2 to Specific Clock Genes in the Mouse Cerebral Cortex	PLOS ONE			English	Article							E-BOX BINDING; CIRCADIAN-CLOCK; PERIPHERAL-TISSUES; MESSENGER-RNA; MOLECULAR CHARACTERIZATION; OVERLAPPING ROLES; EXPRESSION; TRANSCRIPTION; DEPRIVATION; RHYTHM	We have previously demonstrated that clock genes contribute to the homeostatic aspect of sleep regulation. Indeed, mutations in some clock genes modify the markers of sleep homeostasis and an increase in homeostatic sleep drive alters clock gene expression in the forebrain. Here, we investigate a possible mechanism by which sleep deprivation (SD) could alter clock gene expression by quantifying DNA-binding of the core-clock transcription factors CLOCK, NPAS2, and BMAL1 to the cis-regulatory sequences of target clock genes in mice. Using chromatin immunoprecipitation (ChIP), we first showed that, as reported for the liver, DNA-binding of CLOCK and BMAL1 to target clock genes changes in function of time-of-day in the cerebral cortex. Tissue extracts were collected at ZT0 (light onset), -6, -12, and -18, and DNA enrichment of E-box or E'-box containing sequences was measured by qPCR. CLOCK and BMAL1 binding to Cry1, Dbp, Per1, and Per2 depended on time-of-day, with maximum values reached at around ZT6. We then observed that SD, performed between ZT0 and -6, significantly decreased DNA-binding of CLOCK and BMAL1 to Dbp, consistent with the observed decrease in Dbp mRNA levels after SD. The DNA-binding of NPAS2 and BMAL1 to Per2 was also decreased by SD, although SD is known to increase Per2 expression in the cortex. DNA-binding to Per1 and Cry1 was not affected by SD. Our results show that the sleep-wake history can affect the clock molecular machinery directly at the level of chromatin binding thereby altering the cortical expression of Dbp and Per2 and likely other targets. Although the precise dynamics of the relationship between DNA-binding and mRNA expression, especially for Per2, remains elusive, the results also suggest that part of the reported circadian changes in DNA-binding of core clock components in tissues peripheral to the suprachiasmatic nuclei could, in fact, be sleep-wake driven.	[Mongrain, Valerie; La Spada, Francesco; Curie, Thomas; Franken, Paul] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Mongrain, Valerie] Univ Montreal, Dept Psychiat, Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, Montreal, PQ H3C 3J7, Canada	University of Lausanne; Universite de Montreal	Mongrain, V (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	valerie.mongrain@umontreal.ca; paul.franken@unil.ch	Mongrain, Valérie/A-3931-2012; Franken, Paul/A-9633-2018	Franken, Paul/0000-0002-2500-2921	University of Lausanne, Canton de Vaud (Switzerland); Swiss National Science Foundation [130825, 111974]; National Sciences and Engineering Research Council of Canada; Marie Curie Intra-European program fellowship [221254]	University of Lausanne, Canton de Vaud (Switzerland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Marie Curie Intra-European program fellowship	This work was supported by the University of Lausanne, Canton de Vaud (Switzerland), by grants from the Swiss National Science Foundation to PF (130825 and 111974), a fellowship from the National Sciences and Engineering Research Council of Canada to VM, and a Marie Curie Intra-European program fellowship to TC (IEF-FP7-Project Number: 221254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Baracchi F, 2008, BRAIN BEHAV IMMUN, V22, P982, DOI 10.1016/j.bbi.2008.02.001; Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Borbely A A, 1982, Hum Neurobiol, V1, P195; Cai W, 2008, MOL CELL BIOL, V28, P784, DOI 10.1128/MCB.00233-07; Curie T, GENES DEV UNPUB; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000; Franken P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-87; Fustin JM, 2009, J BIOL RHYTHM, V24, P16, DOI 10.1177/0748730408329267; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Graves LA, 2003, J NEUROPHYSIOL, V90, P1152, DOI 10.1152/jn.00882.2002; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hao HP, 2008, J NEUROSCI METH, V172, P38, DOI 10.1016/j.jneumeth.2008.04.002; Haque R, 2010, J NEUROCHEM, V113, P1296, DOI 10.1111/j.1471-4159.2010.06698.x; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hu J, 2003, BRAIN BEHAV IMMUN, V17, P498, DOI 10.1016/j.bbi.2003.03.001; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratov RV, 2006, CELL CYCLE, V5, P890, DOI 10.4161/cc.5.8.2684; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu S, 2007, CHRONOBIOL INT, V24, P793, DOI 10.1080/07420520701672556; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Naylor E, 2000, J NEUROSCI, V20, P8138; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Shirai H, 2007, BIOCHEM BIOPH RES CO, V357, P679, DOI 10.1016/j.bbrc.2007.04.002; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Takahashi S, 1996, NEUROREPORT, V7, P642, DOI 10.1097/00001756-199601310-00063; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07; Thompson CL, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00165; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Wisor JP, 2008, J NEUROSCI, V28, P7193, DOI 10.1523/JNEUROSCI.1150-08.2008; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yan LL, 2000, J NEUROSCI RES, V59, P291, DOI 10.1002/(SICI)1097-4547(20000115)59:2<291::AID-JNR16>3.0.CO;2-O; Yang SZ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r247; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	75	71	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26622	10.1371/journal.pone.0026622	http://dx.doi.org/10.1371/journal.pone.0026622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039518	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200034
J	Welsh-Bacic, D; Nowik, M; Kaissling, B; Wagner, CA				Welsh-Bacic, Desa; Nowik, Marta; Kaissling, Brigitte; Wagner, Carsten A.			Proliferation of Acid-Secretory Cells in the Kidney during Adaptive Remodelling of the Collecting Duct	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; INTERCALATED CELLS; TERMINAL DIFFERENTIATION; RAT-KIDNEY; METABOLIC-ACIDOSIS; EPITHELIAL-CELLS; H+-ATPASE; TRANSCRIPTION FACTOR; TRANSPORT PATHWAYS; ANION-EXCHANGER	The renal collecting duct adapts to changes in acid-base metabolism by remodelling and altering the relative number of acid or alkali secreting cells, a phenomenon termed plasticity. Acid secretory A intercalated cells (A-IC) express apical H+-ATPases and basolateral bicarbonate exchanger AE1 whereas bicarbonate secretory B intercalated cells (B-IC) express basolateral (and apical) H+-ATPases and the apical bicarbonate exchanger pendrin. Intercalated cells were thought to be terminally differentiated and unable to proliferate. However, a recent report in mouse kidney suggested that intercalated cells may proliferate and that this process is in part dependent on GDF-15. Here we extend these observations to rat kidney and provide a detailed analysis of regional differences and demonstrate that differentiated A-IC proliferate massively during adaptation to systemic acidosis. We used markers of proliferation (PCNA, Ki67, BrdU incorporation) and cell-specific markers for A-IC (AE1) and B-IC (pendrin). Induction of remodelling in rats with metabolic acidosis (with NH4Cl for 12 hrs, 4 and 7 days) or treatment with acetazolamide for 10 days resulted in a larger fraction of AE1 positive cells in the cortical collecting duct. A large number of AE1 expressing A-IC was labelled with proliferative markers in the cortical and outer medullary collecting duct whereas no labeling was found in B-IC. In addition, chronic acidosis also increased the rate of proliferation of principal collecting duct cells. The fact that both NH4Cl as well as acetazolamide stimulated proliferation suggests that systemic but not urinary pH triggers this response. Thus, during chronic acidosis proliferation of AE1 containing acid-secretory cells occurs and may contribute to the remodelling of the collecting duct or replace A-IC due to a shortened life span under these conditions.	[Welsh-Bacic, Desa; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Welsh-Bacic, Desa; Kaissling, Brigitte] Univ Zurich, Inst Anat, Zurich, Switzerland; [Welsh-Bacic, Desa; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Welsh-Bacic, D (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	Wagnerca@access.unizh.ch			Swiss National Science Foundation [3100A0-122217]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation to CAW(3100A0-122217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2003, J AM SOC NEPHROL, V14, pS16, DOI 10.1097/01.ASN.0000067633.19426.DD; Al-Awqati Q, 2003, ANNU REV PHYSIOL, V65, P567, DOI 10.1146/annurev.physiol.65.092101.142645; Al-Awqati Q, 2011, ANNU REV PHYSIOL, V73, P401, DOI 10.1146/annurev-physiol-012110-142253; AlAwqati Q, 1996, AM J PHYSIOL-CELL PH, V270, pC1571, DOI 10.1152/ajpcell.1996.270.6.C1571; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Ambuhl PM, 1996, AM J PHYSIOL-RENAL, V271, pF917, DOI 10.1152/ajprenal.1996.271.4.F917; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; BASTANI B, 1991, J CLIN INVEST, V88, P126, DOI 10.1172/JCI115268; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Breton S, 1995, AM J PHYSIOL-RENAL, V269, pF761, DOI 10.1152/ajprenal.1995.269.6.F761; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; CAPASSO G, 1994, J CLIN INVEST, V94, P830, DOI 10.1172/JCI117403; CHAN JCM, 1972, CLIN BIOCHEM, V5, P94, DOI 10.1016/S0009-9120(72)80014-6; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; Christensen BM, 2004, AM J PHYSIOL-CELL PH, V286, pC952, DOI 10.1152/ajpcell.00266.2003; DAWSON TP, 1989, J HISTOCHEM CYTOCHEM, V37, P39, DOI 10.1177/37.1.2535703; DIETRICH DR, 1993, CRIT REV TOXICOL, V23, P77, DOI 10.3109/10408449309104075; Gao X, 2010, P NATL ACAD SCI US; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Kim J, 1996, AM J PHYSIOL-RENAL, V270, pF575, DOI 10.1152/ajprenal.1996.270.4.F575; Kim J, 1999, J AM SOC NEPHROL, V10, P1; KIM J, 1992, AM J PHYSIOL, V262, pF288, DOI 10.1152/ajprenal.1992.262.2.F288; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Loffing J, 1996, KIDNEY INT, V50, P1180, DOI 10.1038/ki.1996.426; Loffing J, 2003, AM J PHYSIOL-RENAL, V284, pF628, DOI 10.1152/ajprenal.00217.2002; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; LOFFING J, 1995, KIDNEY INT, V47, P1615, DOI 10.1038/ki.1995.225; MADSEN KM, 1984, LAB INVEST, V51, P268; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Purkerson JM, 2010, KIDNEY INT, V78, P993, DOI 10.1038/ki.2010.195; Quentin F, 2004, AM J PHYSIOL-RENAL, V287, pF1179, DOI 10.1152/ajprenal.00211.2004; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Sabolic I, 1997, KIDNEY INT, V51, P125, DOI 10.1038/ki.1997.16; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwartz GJ, 2002, J CLIN INVEST, V109, P89, DOI 10.1172/JCI13292; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; SEATON B, 1984, MED LAB SCI, V41, P327; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Song HK, 2007, J AM SOC NEPHROL, V18, P2672, DOI 10.1681/ASN.2006101076; Stehberger PA, 2003, J AM SOC NEPHROL, V14, P3027, DOI 10.1097/01.ASN.0000099375.74789.AB; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; Takito J, 1996, J CLIN INVEST, V98, P2324, DOI 10.1172/JCI119044; TengUmnuay P, 1996, J AM SOC NEPHROL, V7, P260; Vallet M, 2006, J AM SOC NEPHROL, V17, P2153, DOI 10.1681/ASN.2005101054; Van Huyen JPD, 2008, J AM SOC NEPHROL, V19, P1965, DOI 10.1681/ASN.2007070781; VERLANDER JW, 1994, AM J PHYSIOL, V266, pF633, DOI 10.1152/ajprenal.1994.266.4.F633; Verlander JW, 1996, KIDNEY INT, V50, pS137; Vijayakumar S, 1999, J CELL BIOL, V144, P1057, DOI 10.1083/jcb.144.5.1057; Vogetseder A, 2005, HISTOCHEM CELL BIOL, V124, P97, DOI 10.1007/s00418-005-0023-y; Vogetseder A, 2008, AM J PHYSIOL-CELL PH, V294, pC22, DOI 10.1152/ajpcell.00227.2007; Vogetseder A, 2007, AM J PHYSIOL-CELL PH, V292, pC807, DOI 10.1152/ajpcell.00301.2006; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wehrli P, 2007, HISTOCHEM CELL BIOL, V127, P389, DOI 10.1007/s00418-006-0261-7; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144	61	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e25240	10.1371/journal.pone.0025240	http://dx.doi.org/10.1371/journal.pone.0025240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039408	Green Accepted, Green Published, gold			2022-12-25	WOS:000296515200001
J	Nassl, AM; Rubio-Aliaga, I; Sailer, M; Daniel, H				Naessl, Anna-Maria; Rubio-Aliaga, Isabel; Sailer, Manuela; Daniel, Hannelore			The Intestinal Peptide Transporter PEPT1 Is Involved in Food Intake Regulation in Mice Fed a High-Protein Diet	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CONDITIONED TASTE-AVERSION; AMINO-ACIDS; LEUCINE SUPPLEMENTATION; HIGH-CARBOHYDRATE; INDUCED OBESITY; CALORIC-INTAKE; PLASMA LEPTIN; L-ARGININE; RATS	High-protein diets are effective in achieving weight loss which is mainly explained by increased satiety and thermogenic effects. Recent studies suggest that the effects of protein-rich diets on satiety could be mediated by amino acids like leucine or arginine. Although high-protein diets require increased intestinal amino acid absorption, amino acid and peptide absorption has not yet been considered to contribute to satiety effects. We here demonstrate a novel finding that links intestinal peptide transport processes to food intake, but only when a protein-rich diet is provided. When mice lacking the intestinal peptide transporter PEPT1 were fed diets containing 8 or 21 energy% of protein, no differences in food intake and weight gain were observed. However, upon feeding a high-protein (45 energy%) diet, Pept1(-/-) mice reduced food intake much more pronounced than control animals. Although there was a regain in food consumption after a few days, no weight gain was observed which was associated with a reduced intestinal energy assimilation and increased fecal energy losses. Pept1(-/-) mice on high-protein diet displayed markedly reduced plasma leptin levels during the period of very low food intake, suggesting a failure of leptin signaling to increase energy intake. This together with an almost two-fold elevated plasma arginine level in Pept1(-/-) but not wildtype mice, suggests that a cross-talk of arginine with leptin signaling in brain, as described previously, could cause these striking effects on food intake.	[Naessl, Anna-Maria; Rubio-Aliaga, Isabel; Sailer, Manuela; Daniel, Hannelore] Tech Univ Munich, Biochem Abt, ZIEL Res Ctr Nutr & Food Sci, D-8050 Freising Weihenstephan, Germany	Technical University of Munich	Nassl, AM (corresponding author), Tech Univ Munich, Biochem Abt, ZIEL Res Ctr Nutr & Food Sci, D-8050 Freising Weihenstephan, Germany.	daniel@wzw.tum.de	Daniel, Hannelore/B-8982-2009	Rubio-Aliaga, Isabel/0000-0003-1051-9511	Deutsche Forschungsgemeinschaft (DFG) [DA 190/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding: This work was supported by a grant (DA 190/8-1) from the Deutsche Forschungsgemeinschaft (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Balage M, 2010, CURR OPIN CLIN NUTR, V13, P265, DOI 10.1097/MCO.0b013e328336f6b8; Bensaid A, 2003, PHYSIOL BEHAV, V78, P311, DOI 10.1016/S0031-9384(02)00977-0; Bensaid A, 2002, PHYSIOL BEHAV, V75, P577, DOI 10.1016/S0031-9384(02)00646-7; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Buchmann I, 1996, PHARMACOLOGY, V53, P133, DOI 10.1159/000139424; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Calapi G, 1999, J CLIN INVEST, V104, P975, DOI 10.1172/JCI5867; CHEN M, 2010, AM J PHYSL GASTROINT; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Denbow DM, 2000, PHYSIOL BEHAV, V69, P359, DOI 10.1016/S0031-9384(99)00258-9; Eastwood C, 1998, NEUROSCI LETT, V254, P145, DOI 10.1016/S0304-3940(98)00666-1; ERICKSON RH, 1995, BIOCHEM BIOPH RES CO, V216, P249, DOI 10.1006/bbrc.1995.2617; Faipoux R, 2008, J NUTR, V138, P1172, DOI 10.1093/jn/138.6.1172; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; Hindlet P, 2007, J PHARMACOL EXP THER, V323, P192, DOI 10.1124/jpet.107.125799; Hindlet P, 2009, J BIOL CHEM, V284, P6801, DOI 10.1074/jbc.M805564200; Hiroshige K, 2001, NEPHROL DIAL TRANSPL, V16, P1856, DOI 10.1093/ndt/16.9.1856; Hu YG, 2008, MOL PHARMACEUT, V5, P1122, DOI 10.1021/mp8001655; Jean C, 2002, PHYSIOL BEHAV, V76, P65, DOI 10.1016/S0031-9384(02)00676-5; KRAUSS RM, 1965, AM J PHYSIOL, V209, P479, DOI 10.1152/ajplegacy.1965.209.3.479; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; Latner JD, 1999, APPETITE, V33, P119, DOI 10.1006/appe.1999.0237; LeBricon T, 1996, CLIN NUTR, V15, P337, DOI 10.1016/S0261-5614(96)80011-2; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Martin G, 2007, BIOCHEM J, V401, P465, DOI 10.1042/BJ20061148; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Mithieux G, 2009, NUTRITION, V25, P881, DOI 10.1016/j.nut.2009.06.010; Mithieux G, 2009, CURR OPIN CLIN NUTR, V12, P419, DOI 10.1097/MCO.0b013e32832c4d6a; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; MORLEY JE, 1991, LIFE SCI, V49, P707, DOI 10.1016/0024-3205(91)90102-H; Nairizi A, 2009, J NUTR, V139, P715, DOI 10.3945/jn.108.100081; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; NASSL A, 2011, AM J PHYSL GASTROINT; Noatsch A, 2011, EUR J NUTR, V50, P479, DOI 10.1007/s00394-010-0155-2; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; PETERS JC, 1985, J NUTR, V115, P382, DOI 10.1093/jn/115.3.382; Phillips RJ, 1996, AM J PHYSIOL-REG I, V271, pR766, DOI 10.1152/ajpregu.1996.271.3.R766; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; REMESY C, 1978, BIOCHEM J, V170, P321, DOI 10.1042/bj1700321; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Smeets AJ, 2008, J NUTR, V138, P698, DOI 10.1093/jn/138.4.698; SQUADRITO F, 1993, EUR J PHARMACOL, V230, P125, DOI 10.1016/0014-2999(93)90422-E; SQUADRITO F, 1994, EUR J PHARMACOL, V255, P51, DOI 10.1016/0014-2999(94)90081-7; SQUADRITO F, 1994, NEUROPHARMACOLOGY, V33, P83, DOI 10.1016/0028-3908(94)90100-7; Team RDC, 2009, R LANG ENV STAT COMP; Terada T, 2007, BIOCHEM PHARMACOL, V73, P440, DOI 10.1016/j.bcp.2006.10.010; Tome D, 2004, BRIT J NUTR, V92, pS27, DOI 10.1079/BJN20041138; Tome D, 2009, AM J CLIN NUTR, V90, p838S, DOI 10.3945/ajcn.2009.27462W; van't Hof RJ, 2004, ENDOCRINOLOGY, V145, P5068, DOI 10.1210/en.2004-0205; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Yang SJ, 2007, PHYSIOL BEHAV, V92, P651, DOI 10.1016/j.physbeh.2007.05.009; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	58	33	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26407	10.1371/journal.pone.0026407	http://dx.doi.org/10.1371/journal.pone.0026407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031831	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200020
J	Fuka, G; Kauer, M; Kofler, R; Haas, OA; Panzer-Grumayer, R				Fuka, Gerhard; Kauer, Maximilian; Kofler, Reinhard; Haas, Oskar A.; Panzer-Gruemayer, Renate			The Leukemia-Specific Fusion Gene ETV6/RUNX1 Perturbs Distinct Key Biological Functions Primarily by Gene Repression	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPRESSION PATTERNS; SET ENRICHMENT; CELLS; CANCER; CD133; CLASSIFICATION; TRANSLOCATIONS; REVEALS; STRESS	Background: ETV6/RUNX1 (E/R) (also known as TEL/AML1) is the most frequent gene fusion in childhood acute lymphoblastic leukemia (ALL) and also most likely the crucial factor for disease initiation; its role in leukemia propagation and maintenance, however, remains largely elusive. To address this issue we performed a shRNA-mediated knock-down (KD) of the E/R fusion gene and investigated the ensuing consequences on genome-wide gene expression patterns and deducible regulatory functions in two E/R-positive leukemic cell lines. Findings: Microarray analyses identified 777 genes whose expression was substantially altered. Although approximately equal proportions were either up-(KD-UP) or down-regulated (KD-DOWN), the effects on biological processes and pathways differed considerably. The E/R KD-UP set was significantly enriched for genes included in the "cell activation", "immune response", "apoptosis", "signal transduction" and "development and differentiation" categories, whereas in the E/R KD-DOWN set only the "PI3K/AKT/mTOR signaling" and "hematopoietic stem cells" categories became evident. Comparable expression signatures obtained from primary E/R-positive ALL samples underline the relevance of these pathways and molecular functions. We also validated six differentially expressed genes representing the categories "stem cell properties", "B-cell differentiation", "immune response", "cell adhesion" and "DNA damage" with RT-qPCR. Conclusion: Our analyses provide the first preliminary evidence that the continuous expression of the E/R fusion gene interferes with key regulatory functions that shape the biology of this leukemia subtype. E/R may thus indeed constitute the essential driving force for the propagation and maintenance of the leukemic process irrespective of potential consequences of associated secondary changes. Finally, these findings may also provide a valuable source of potentially attractive therapeutic targets.	[Fuka, Gerhard; Kauer, Maximilian; Panzer-Gruemayer, Renate] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Kofler, Reinhard] Innsbruck Med Univ, Div Mol Pathophysiol, Tyrolean Canc Res Inst, Innsbruck, Austria; [Kofler, Reinhard] Innsbruck Med Univ, Bioctr, Innsbruck, Austria; [Haas, Oskar A.; Panzer-Gruemayer, Renate] St Anna Childrens Hosp, Vienna, Austria	Saint Anna Children's Hospital; Medical University of Innsbruck; Medical University of Innsbruck; Saint Anna Children's Hospital	Fuka, G (corresponding author), St Anna Childrens Hosp, Childrens Canc Res Inst, Kinderspitalgasse 6, A-1090 Vienna, Austria.	renate.panzer@ccri.at	Haas, Oskar/AAM-5794-2020		Austrian National Bank ONB [12213, 13466]; St. Anna Kinderkrebsforschung; GENAU-CHILD Projekt [GZ200.136/1 -VI/1/2005]; ONCOTYROL; Austrian Research Promotion Agency; Tiroler Zukunftsstiftung; Styrian Business Promotion Agency	Austrian National Bank ONB; St. Anna Kinderkrebsforschung; GENAU-CHILD Projekt; ONCOTYROL; Austrian Research Promotion Agency; Tiroler Zukunftsstiftung; Styrian Business Promotion Agency	This work was supported by the Austrian National Bank ONB (12213 and 13466), the St. Anna Kinderkrebsforschung and GENAU-CHILD Projekt (GZ200.136/1 -VI/1/2005) to RP-G and by ONCOTYROL (a COMET Center funded by the Austrian Research Promotion Agency, the Tiroler Zukunftsstiftung and the Styrian Business Promotion Agency) to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Nabi AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012464; Akers SM, 2010, EXP HEMATOL, V38, P733, DOI 10.1016/j.exphem.2010.05.001; Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Baal N, 2004, THROMB HAEMOSTASIS, V92, P767, DOI 10.1160/TH04-02-0079; Bomken S, 2010, BRIT J CANCER, V103, P439, DOI 10.1038/sj.bjc.6605821; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Cox CV, 2009, BLOOD, V113, P3287, DOI 10.1182/blood-2008-04-154187; De Zen L, 2000, LEUKEMIA, V14, P1225, DOI 10.1038/sj.leu.2401824; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diakos C, 2007, BLOOD, V109, P2607, DOI 10.1182/blood-2006-04-019612; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Fine BM, 2004, BLOOD, V103, P1043, DOI 10.1182/blood-2003-05-1518; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Gandemer V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Inthal A, 2008, CLIN CANCER RES, V14, P7196, DOI 10.1158/1078-0432.CCR-07-5051; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kuster L, 2011, BLOOD, V117, P2658, DOI 10.1182/blood-2010-03-275347; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Rossetti S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-38; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wotton S, 2008, ONCOGENE, V27, P5856, DOI 10.1038/onc.2008.195; Yang G, 2007, ONCOGENE, V26, P594, DOI 10.1038/sj.onc.1209807; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	48	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26348	10.1371/journal.pone.0026348	http://dx.doi.org/10.1371/journal.pone.0026348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028862	Green Submitted, Green Published, gold			2022-12-25	WOS:000296510800037
J	Siltanen, S; Wahlfors, T; Schindler, M; Saramaki, OR; Mpindi, JP; Latonen, L; Vessella, RL; Tammela, TLJ; Kallioniemi, O; Visakorpi, T; Schleutker, J				Siltanen, Sanna; Wahlfors, Tiina; Schindler, Martin; Saramaki, Outi R.; Mpindi, John Patrick; Latonen, Leena; Vessella, Robert L.; Tammela, Teuvo L. J.; Kallioniemi, Olli; Visakorpi, Tapio; Schleutker, Johanna			Contribution of ARLTS1 Cys148Arg (T442C) Variant with Prostate Cancer Risk and ARLTS1 Function in Prostate Cancer Cells	PLOS ONE			English	Article							PROLIFERATIVE INFLAMMATORY ATROPHY; COLORECTAL-CANCER; ALLELIC IMBALANCE; FAMILIAL CANCER; GENE; EXPRESSION; CARCINOGENESIS; BREAST; TUMORS; ASSOCIATION	ARLTS1 is a recently characterized tumor suppressor gene at 13q14.3, a region frequently deleted in both sporadic and hereditary prostate cancer (PCa). ARLTS1 variants, especially Cys148Arg (T442C), increase susceptibility to different cancers, including PCa. In this study the role of Cys148Arg substitution was investigated as a risk factor for PCa using both genetic and functional analysis. Cys148Arg genotypes and expression of the ARLTS1 were explored in a large set of familial and unselected PCa cases, clinical tumor samples, xenografts, prostate cancer cell lines and benign prostatic hyperplasia (BPH) samples. The frequency of the variant genotype CC was significantly higher in familial (OR = 1.67, 95% CI = 1.08-2.56, P = 0.019) and unselected patients (OR = 1.52, 95% CI = 1.18-1.97, P = 0.001) and the overall risk was increased (OR = 1.54, 95% CI = 1.20-1.98, P = 0.0007). Additional analysis with clinicopathological data revealed an association with an aggressive disease (OR = 1.28, 95% CI = 1.05-infinity, P = 0.02). The CC genotype of the Cys148Arg variant was also contributing to the lowered ARLTS1 expression status in lymphoblastoid cells from familial patients. In addition significantly lowered ARLTS1 expression was observed in clinical tumor samples compared to BPH samples (P = 0.01). The ARLTS1 co-expression signature based on previously published microarray data was generated from 1587 cancer samples confirming the low expression of ARLTS1 in PCa and showed that ARLTS1 expression was strongly associated with immune processes. This study provides strong confirmation of the important role of ARLTS1 Cys148Arg variant as a contributor in PCa predisposition and a potential marker for aggressive disease outcome.	[Siltanen, Sanna; Wahlfors, Tiina; Schindler, Martin; Saramaki, Outi R.; Latonen, Leena; Visakorpi, Tapio] Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland; [Siltanen, Sanna; Wahlfors, Tiina; Schindler, Martin; Saramaki, Outi R.; Latonen, Leena; Visakorpi, Tapio] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Mpindi, John Patrick; Kallioniemi, Olli] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Vessella, Robert L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Vessella, Robert L.] Puget Sound VA Med Syst, Seattle, WA USA; [Tammela, Teuvo L. J.] Univ Tampere, Dept Urol, FIN-33101 Tampere, Finland; [Schleutker, Johanna] Univ Turku, Dept Med Biochem & Genet, Turku, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Washington; University of Washington Seattle; Tampere University; University of Turku	Siltanen, S (corresponding author), Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland.	Johanna.Schleutker@utu.fi	Latonen, Leena/C-8787-2016; Kallioniemi, Olli P/H-5111-2011; Wahlfors, Tiina/U-7635-2018	Latonen, Leena/0000-0003-4502-2193; Kallioniemi, Olli P/0000-0002-3231-0332; Visakorpi, Tapio/0000-0002-5004-0364; Schindler, Martin/0000-0002-6002-6953; Wahlfors, Tiina/0000-0002-3910-796X; Saramaki, Outi/0000-0001-7051-7855; Schleutker, Johanna/0000-0002-1863-0305	Pirkanmaa Hospital District [9L091]; Reino Lahtikari Foundation; Finnish Cancer Organisations; Sigrid Juselius Foundation; Academy of Finland [126714, 116437]	Pirkanmaa Hospital District; Reino Lahtikari Foundation; Finnish Cancer Organisations; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by The Competitive Research Funding of the Pirkanmaa Hospital District (grant number 9L091), Reino Lahtikari Foundation, Finnish Cancer Organisations, Sigrid Juselius Foundation and Academy of Finland [grant number 126714 to T.W. and 116437 to J.S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bieche I, 1999, CANCER RES, V59, P2759; Brookman-Amissah N, 2007, CANCER GENET CYTOGEN, V179, P118, DOI 10.1016/j.cancergencyto.2007.08.017; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; CASTELLVIBEL S, 2007, CARCINOGENESIS; De Brakeleer S, 2005, NEW ENGL J MED, V353, P313; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Frank B, 2006, INT J CANCER, V118, P2505, DOI 10.1002/ijc.21687; Frank B, 2006, CANCER LETT, V244, P172, DOI 10.1016/j.canlet.2005.12.006; Frank B, 2006, INT J CANCER, V119, P1736, DOI 10.1002/ijc.22008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishkanian AS, 2009, PROSTATE, V69, P1091, DOI 10.1002/pros.20959; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; KAHN RA, 1992, FASEB J, V6, P2512, DOI 10.1096/fasebj.6.8.1592203; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Laitinen S, 2002, GENE CHROMOSOME CANC, V35, P66, DOI 10.1002/gcc.10097; Latil A, 2003, PROSTATE, V57, P39, DOI 10.1002/pros.10272; Linja MJ, 2001, CANCER RES, V61, P3550; Nakano M, 2008, PATHOL INT, V58, P415, DOI 10.1111/j.1440-1827.2008.02246.x; Petrocca F, 2006, CANCER RES, V66, P10287, DOI 10.1158/0008-5472.CAN-06-2289; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Saramaki OR, 2006, GENE CHROMOSOME CANC, V45, P639, DOI 10.1002/gcc.20327; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schleutker J, 2000, CLIN CANCER RES, V6, P4810; Sellick GS, 2006, LEUKEMIA RES, V30, P1573, DOI 10.1016/j.leukres.2006.02.021; Siltanen S, 2008, EUR J HUM GENET, V16, P983, DOI 10.1038/ejhg.2008.43; Valeri A, 2005, UROL ONCOL-SEMIN ORI, V23, P87, DOI 10.1016/j.urolonc.2004.08.015; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; Yendamuri S, 2007, CANCER RES, V67, P7738, DOI 10.1158/0008-5472.CAN-07-1481	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26595	10.1371/journal.pone.0026595	http://dx.doi.org/10.1371/journal.pone.0026595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028916	gold, Green Published, Green Submitted			2022-12-25	WOS:000296510800058
J	Sugiyama, H; Kashimoto, T; Ueno, S; Ehara, H; Kodama, T; Iida, T; Susa, N				Sugiyama, Hiroyuki; Kashimoto, Takashige; Ueno, Shunji; Ehara, Hayato; Kodama, Toshio; Iida, Tetsuya; Susa, Nobuyuki			Relationship between Localization on Cellular Membranes and Cytotoxicity of Vibrio vulnificus Hemolysin	PLOS ONE			English	Article							PORE-FORMING TOXIN; LIPID RAFTS; ANCHORED PROTEIN; CHOLESTEROL; CYTOLYSIN; DETERGENT; REORGANIZATION; PURIFICATION; PATHOGENESIS; MECHANISM	Vibrio vulnificus secretes a hemolysin/cytolysin (VVH) that induces cytolysis in target cells. A detergent resistant membrane domain (DRM) fraction of the cells after sucrose gradient centrifugation includes cholesterol-rich membrane microdomains which have been called "lipid rafts". It was reported that some pore-forming toxins require association with DRM and/or lipid rafts to exert their cytotoxicity. It has also been thought that cellular cholesterol is involved in VVH cytotoxicity because VVH cytotoxicity was inhibited by pre-incubation with cholesterol. However, both cellular localization and mode of action of VVH cytotoxicity remain unclear. In this study, we investigated the relationship between VVH localization on the cellular membrane and its cytotoxicity. Oligomers of VVH were detected from DRM fractions by sucrose gradient ultracentrifugation but all of these oligomers shifted from DRM fractions to non-DRM fractions after treatment with methyl-beta-cyclodextrin (M beta CD), a cholesterol sequestering agent. On the other hand, immunofluorescence analysis showed that VVH did not co-localize with major lipid raft markers on cellular membrane of CHO cells. These data suggested that VVH localized at membrane regions which are relatively abundant in cholesterol but which are not identical with lipid rafts. To determine the linkage between localization and cytotoxicity of VVH, cytotoxicity was evaluated in M beta CD-treated CHO cells. The cytotoxicity of VVH was not decreased by the M beta CD treatment. In addition, the amount of VVH oligomer did not decrease in M beta CD-treated CHO cells. Thus, we found that the amount of oligomer on cellular membrane is important for induction of cytotoxicity, whereas localization to lipid rafts on the cellular membrane was not essential to cytotoxicity.	[Sugiyama, Hiroyuki; Kashimoto, Takashige; Ueno, Shunji; Ehara, Hayato; Susa, Nobuyuki] Kitasato Univ, Lab Vet Publ Hlth, Sch Vet Med, Aomori, Japan; [Kodama, Toshio] Osaka Univ, Dept Bacterial Infect, Microbial Dis Res Inst, Osaka, Japan; [Iida, Tetsuya] Osaka Univ, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan	Kitasato University; Osaka University; Osaka University	Sugiyama, H (corresponding author), Kitasato Univ, Lab Vet Publ Hlth, Sch Vet Med, Aomori, Japan.	kashimot@vmas.kitasato-u.ac.jp		Kodama, Toshio/0000-0002-6511-7301	School of Veterinary medicine, Kitasato University [S1004]; Grants-in-Aid for Scientific Research [23790474] Funding Source: KAKEN	School of Veterinary medicine, Kitasato University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a grant from the School of Veterinary medicine, Kitasato University (No. S1004). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; GEOFFROY C, 1982, TOXICON, V20, P239, DOI 10.1016/0041-0101(82)90208-2; GRAY LD, 1985, INFECT IMMUN, V48, P62, DOI 10.1128/IAI.48.1.62-72.1985; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Kim BS, 2002, EXP MOL MED, V34, P239, DOI 10.1038/emm.2002.33; KIM HR, 1993, LIFE SCI, V53, P571, DOI 10.1016/0024-3205(93)90714-E; Kim YR, 2010, BIOCHEM BIOPH RES CO, V399, P607, DOI 10.1016/j.bbrc.2010.07.122; KOENIG KL, 1991, WESTERN J MED, V155, P400; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Matsuda S, 2010, INFECT IMMUN, V78, P603, DOI 10.1128/IAI.00946-09; MIYOSHI S, 1993, J TOXICOL-TOXIN REV, V12, P253, DOI 10.3109/15569549309014409; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Nelson KL, 2000, J BIOL CHEM, V275, P19839, DOI 10.1074/jbc.M002785200; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; OH EG, 1993, MICROBIOL IMMUNOL, V37, P975, DOI 10.1111/j.1348-0421.1993.tb01732.x; Shogomori H, 2008, BBA-GEN SUBJECTS, V1780, P612, DOI 10.1016/j.bbagen.2007.09.001; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; YAMANAKA H, 1987, J GEN MICROBIOL, V133, P2859; Yu HN, 2007, ARCH MICROBIOL, V187, P467, DOI 10.1007/s00203-007-0214-0	29	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26018	10.1371/journal.pone.0026018	http://dx.doi.org/10.1371/journal.pone.0026018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028805	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800015
J	Woyke, T; Sczyrba, A; Lee, J; Rinke, C; Tighe, D; Clingenpeel, S; Malmstrom, R; Stepanauskas, R; Cheng, JF				Woyke, Tanja; Sczyrba, Alexander; Lee, Janey; Rinke, Christian; Tighe, Damon; Clingenpeel, Scott; Malmstrom, Rex; Stepanauskas, Ramunas; Cheng, Jan-Fang			Decontamination of MDA Reagents for Single Cell Whole Genome Amplification	PLOS ONE			English	Article							DAMAGE	Single cell genomics is a powerful and increasingly popular tool for studying the genetic make-up of uncultured microbes. A key challenge for successful single cell sequencing and analysis is the removal of exogenous DNA from whole genome amplification reagents. We found that UV irradiation of the multiple displacement amplification (MDA) reagents, including the Phi29 polymerase and random hexamer primers, effectively eliminates the amplification of contaminating DNA. The methodology is quick, simple, and highly effective, thus significantly improving whole genome amplification from single cells.	[Woyke, Tanja; Sczyrba, Alexander; Lee, Janey; Rinke, Christian; Tighe, Damon; Clingenpeel, Scott; Malmstrom, Rex; Cheng, Jan-Fang] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, Boothbay Harbor, ME 04575 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Bigelow Laboratory for Ocean Sciences	Woyke, T (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	jfcheng@lbl.gov	t, lf/AAJ-4924-2020; Rinke, Christian/AAE-8100-2019; Malmstrom, Rex/K-7339-2012; Rinke, Christian/ABA-3139-2021	Rinke, Christian/0000-0003-4632-1187; Cheng, Jan-Fang/0000-0001-7315-7613; Malmstrom, Rex/0000-0002-4758-7369; Sczyrba, Alexander/0000-0002-4405-3847; Clingenpeel, Scott/0000-0002-6619-6320; Stepanauskas, Ramunas/0000-0003-4458-3108	U.S. Department of Energy Joint Genome Institute; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation (NSF) [EF-0633142, MCB-738232, EF-826924]	U.S. Department of Energy Joint Genome Institute(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was conducted by the U.S. Department of Energy Joint Genome Institute and supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Dr. Stepanauskas was supported by National Science Foundation (NSF) grants EF-0633142, MCB-738232 and EF-826924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; BRASH DE, 1982, NATURE, V298, P189, DOI 10.1038/298189a0; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; CADET J, 1986, BIOCHIMIE, V68, P813, DOI 10.1016/S0300-9084(86)80097-9; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; OU CY, 1991, BIOTECHNIQUES, V10, P442; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; VARGHESE AJ, 1969, NATURE, V223, P299, DOI 10.1038/223299a0; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	16	108	111	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26161	10.1371/journal.pone.0026161	http://dx.doi.org/10.1371/journal.pone.0026161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028825	Green Published, gold			2022-12-25	WOS:000296510800022
J	Ding, JR; Liao, W; Zhang, ZQ; Mantini, D; Xu, Q; Wu, GR; Lu, GM; Chen, HF				Ding, Ju-Rong; Liao, Wei; Zhang, Zhiqiang; Mantini, Dante; Xu, Qiang; Wu, Guo-Rong; Lu, Guangming; Chen, Huafu			Topological Fractionation of Resting-State Networks	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SCALE BRAIN NETWORKS; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; LOW-FREQUENCY; COMPLEX NETWORKS; IN-VIVO; FMRI; MRI	Exploring topological properties of human brain network has become an exciting topic in neuroscience research. Large-scale structural and functional brain networks both exhibit a small-world topology, which is evidence for global and local parallel information processing. Meanwhile, resting state networks (RSNs) underlying specific biological functions have provided insights into how intrinsic functional architecture influences cognitive and perceptual information processing. However, topological properties of single RSNs remain poorly understood. Here, we have two hypotheses: i) each RSN also has optimized small-world architecture; ii) topological properties of RSNs related to perceptual and higher cognitive processes are different. To test these hypotheses, we investigated the topological properties of the default-mode, dorsal attention, central-executive, somato-motor, visual and auditory networks derived from resting-state functional magnetic resonance imaging (fMRI). We found small-world topology in each RSN. Furthermore, small-world properties of cognitive networks were higher than those of perceptual networks. Our findings are the first to demonstrate a topological fractionation between perceptual and higher cognitive networks. Our approach may be useful for clinical research, especially for diseases that show selective abnormal connectivity in specific brain networks.	[Ding, Ju-Rong; Liao, Wei; Xu, Qiang; Wu, Guo-Rong; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China; [Zhang, Zhiqiang; Lu, Guangming] Nanjing Univ, Coll Med, Nanjing Jinling Hosp, Dept Med Imaging,Clin Sch, Nanjing 210008, Peoples R China; [Mantini, Dante] KU Leuven Med Sch, Lab Neuropsychophysiol, Louvain, Belgium	University of Electronic Science & Technology of China; Nanjing University; KU Leuven	Ding, JR (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China.	cjr.luguangming@vip.163.com; chenhf@uestc.edu.cn	Mantini, Dante/D-6989-2014; Mantini, Dante/H-3061-2011; Håkansson, Gustaf/F-5409-2011	Mantini, Dante/0000-0001-6485-5559; Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [61035006, 90820006]; Changjiang Scholars and Innovative Research Team in University; Natural Science Foundation of China [30800264, 81020108022]; Research Foundation Flanders [A4/5-SDS15387]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation Flanders(FWO)	J-RD, WL, HC, QX and G-RW were supported by the Natural Scientific Foundation of China [Grant Nos. 61035006, 90820006] and Changjiang Scholars and Innovative Research Team in University. ZZ and GL were supported by the Natural Science Foundation of China [Grant No. 30800264, 81020108022]. DM is a post-doc fellow of the Research Foundation Flanders [Grant no. A4/5-SDS15387 to DM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carhart-Harris RL, 2010, BRAIN, V133, P1265, DOI 10.1093/brain/awq010; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathias N, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021117; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer W, 2011, CEREB CORTEX; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O., 2010, NETWORKS BRAIN; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stevens MC, 2007, HUM BRAIN MAPP, V28, P394, DOI 10.1002/hbm.20285; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; ZHANG Z, 2011, ALTERED FUNCTIONAL S, DOI DOI 10.1093/BRAIN/AWR1223; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	72	35	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26596	10.1371/journal.pone.0026596	http://dx.doi.org/10.1371/journal.pone.0026596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028917	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500093
J	Hamalukic, M; Huelsenbeck, J; Schad, A; Wirtz, S; Kaina, B; Fritz, G				Hamalukic, Melanie; Huelsenbeck, Johannes; Schad, Arno; Wirtz, Stefan; Kaina, Bernd; Fritz, Gerhard			Rac1-Regulated Endothelial Radiation Response Stimulates Extravasation and Metastasis That Can Be Blocked by HMG-CoA Reductase Inhibitors	PLOS ONE			English	Article							NF-KAPPA-B; CELL-ADHESION MOLECULES; COLON-CANCER CELLS; IONIZING-RADIATION; E-SELECTIN; BREAST-CANCER; SIALYL-LEWIS; VASCULAR ENDOTHELIUM; INDUCED APOPTOSIS; GROWTH-FACTOR	Radiotherapy (RT) plays a key role in cancer treatment. Although the benefit of ionizing radiation (IR) is well established, some findings raise the possibility that irradiation of the primary tumor not only triggers a killing response but also increases the metastatic potential of surviving tumor cells. Here we addressed the question of whether irradiation of normal cells outside of the primary tumor augments metastasis by stimulating the extravasation of circulating tumor cells. We show that IR exposure of human endothelial cells (EC), tumor cells (TC) or both increases TC-EC adhesion in vitro. IR-stimulated TC-EC adhesion was blocked by the HMG-CoA reductase inhibitor lovastatin. Glycyrrhizic acid from liquorice root, which acts as a Sialyl-Lewis X mimetic drug, and the Rac1 inhibitor NSC23766 also reduced TC-EC adhesion. To examine the in vivo relevance of these findings, tumorigenic cells were injected into the tail vein of immunodeficient mice followed by total body irradiation (TBI). The data obtained show that TBI dramatically enhances tumor cell extravasation and lung metastasis. This pro-metastatic radiation effect was blocked by pre-treating mice with lovastatin, glycyrrhizic acid or NSC23766. TBI of mice prior to tumor cell transplantation also stimulated metastasis, which was again blocked by lovastatin. The data point to a pro-metastatic trans-effect of RT, which likely rests on the endothelial radiation response promoting the extravasation of circulating tumor cells. Administration of the widely used lipid-lowering drug lovastatin prior to irradiation counteracts this process, likely by suppressing Rac1-regulated E-selectin expression following irradiation. The data support the concern that radiation exposure might increase the extravasation of circulating tumor cells and recommend co-administration of lipid-lowering drugs to avoid this adverse effect of ionizing radiation.	[Hamalukic, Melanie; Huelsenbeck, Johannes; Kaina, Bernd; Fritz, Gerhard] Johannes Gutenberg Univ Mainz, Inst Toxicol, Univ Med Ctr, D-6500 Mainz, Germany; [Schad, Arno] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, D-6500 Mainz, Germany; [Wirtz, Stefan] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, D-6500 Mainz, Germany; [Fritz, Gerhard] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf	Hamalukic, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Toxicol, Univ Med Ctr, D-6500 Mainz, Germany.	fritz@uni-duesseldorf.de	Kaina, Bernd/AAE-4692-2020	Wirtz, Stefan/0000-0001-6936-7431	Wilhelm Sander-Stiftung [2005.120.1]	Wilhelm Sander-Stiftung	This work was supported by the Wilhelm Sander-Stiftung (2005.120.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agemy L, 2008, PROSTATE, V68, P530, DOI 10.1002/pros.20702; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Baluna RG, 2006, RADIAT RES, V166, P819, DOI 10.1667/RR0380.1; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; Brown PD, 2008, INT J RADIAT ONCOL, V70, P1305, DOI 10.1016/j.ijrobp.2007.11.047; Camphausen K, 2001, CANCER RES, V61, P2207; Chung YL, 2006, CLIN CANCER RES, V12, P2706, DOI 10.1158/1078-0432.CCR-05-2721; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; DELAMONTE SM, 1988, CANCER, V61, P2176; Fritz G, 2003, INT J RADIAT BIOL, V79, P601, DOI 10.1080/09553000310001609233; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerhard R, 2005, J BIOL CHEM, V280, P1499, DOI 10.1074/jbc.M406014200; Haase O, 2004, RADIOTHER ONCOL, V73, pS144, DOI 10.1016/S0167-8140(04)80037-9; Hallahan D, 1996, CANCER RES, V56, P5150; Hallahan D. E., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P605; Hallahan DE, 1997, CANCER RES, V57, P2096; Hallahan DE, 1998, CANCER RES, V58, P5484; Hallahan DE, 1997, RADIAT RES, V147, P41, DOI 10.2307/3579441; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Haydont V, 2007, CLIN CANCER RES, V13, P5331, DOI 10.1158/1078-0432.CCR-07-0625; Huang F, 2009, INT J RADIAT ONCOL, V73, P752, DOI 10.1016/j.ijrobp.2008.05.031; Imaizumi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011084; ITO H, 1984, CLIN EXP METASTAS, V2, P235, DOI 10.1007/BF00132930; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kaliski A, 2005, MOL CANCER THER, V4, P1717, DOI 10.1158/1535-7163.MCT-05-0179; Kikkawa H, 2002, CLIN EXP METASTAS, V19, P717, DOI 10.1023/A:1021356019563; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Krause T, 1999, CLIN EXP METASTAS, V17, P183, DOI 10.1023/A:1006626500852; Lee M, 2010, INT J RADIAT ONCOL, V76, P1528, DOI 10.1016/j.ijrobp.2009.11.022; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Monceau V, 2010, CURR DRUG TARGETS, V11, P1395, DOI 10.2174/1389450111009011395; Nakayama T, 2007, RADIAT RES, V168, P433, DOI 10.1667/RR0869.1; Nubel T, 2004, FASEB J, V18, P140, DOI 10.1096/fj.03-0261fje; Nubel T, 2004, CARCINOGENESIS, V25, P1335, DOI 10.1093/carcin/bgh133; OSTRAU C, 2009, RADIOTHER ONCOL; Ostrau C, 2009, RADIOTHER ONCOL, V92, P492, DOI 10.1016/j.radonc.2009.06.020; Paquette B, 2007, BRIT J CANCER, V97, P1505, DOI 10.1038/sj.bjc.6604072; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; RAO BNN, 1994, J BIOL CHEM, V269, P19663; Sauer KA, 2008, J IMMUNOL, V181, P6148, DOI 10.4049/jimmunol.181.9.6148; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Tomlinson J, 2000, INT J ONCOL, V16, P347; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang J, 2007, INT J RADIAT ONCOL, V68, P1483, DOI 10.1016/j.ijrobp.2007.03.036; Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9; WITTIG BM, 1995, GASTROENTEROLOGY S; Yamada N, 1997, BRIT J CANCER, V76, P582, DOI 10.1038/bjc.1997.429; Zhao WL, 2009, CURR MED CHEM, V16, P130, DOI 10.2174/092986709787002790	56	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26413	10.1371/journal.pone.0026413	http://dx.doi.org/10.1371/journal.pone.0026413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039482	gold, Green Submitted, Green Published			2022-12-25	WOS:000296507500064
J	Rosenbluh, J; Nijhawan, D; Chen, Z; Wong, KK; Masutomi, K; Hahn, WC				Rosenbluh, Joseph; Nijhawan, Deepak; Chen, Zhao; Wong, Kwok-Kin; Masutomi, Kenkichi; Hahn, William C.			RMRP Is a Non-Coding RNA Essential for Early Murine Development	PLOS ONE			English	Article							CARTILAGE-HAIR HYPOPLASIA; MUTATIONS	RMRP is a non-coding RNA that is ubiquitously expressed in both humans and mice. RMRP mutations that lead to decreased RMRP levels are found in the pleiotropic syndrome Cartilage Hair Hypoplasia. To assess the effects of deleting RMRP, we engineered a targeting vector that contains loxP sequences flanking RMRP and created hemizygous mice harboring this engineered allele (RMRP conditional). We found that insertion of this cassette suppressed RMRP expression, and we failed to obtain viable mice homozygous for the RMRP conditional allele. Furthermore, we were unable to obtain viable homozygous RMRP null mice, indicating that RMRP is essential for early embryonic development.	[Rosenbluh, Joseph; Nijhawan, Deepak; Chen, Zhao; Wong, Kwok-Kin; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Chen, Zhao; Wong, Kwok-Kin; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Chen, Zhao; Wong, Kwok-Kin; Hahn, William C.] Harvard Univ, Sch Med, Boston, MA USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Hahn, William C.] Broad Inst Harvard & Massachusetts Inst Technol M, Cambridge, MA USA; [Masutomi, Kenkichi] Natl Canc Ctr, Res Inst, Div Canc Stem Cell, Tokyo 104, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Cancer Center - Japan	Rosenbluh, J (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	kmasutom@ncc.go.jp; William_Hahn@dfci.harvard.edu		Rosenbluh, Joseph/0000-0001-9815-8049; wong, kwok kin/0000-0001-6323-235X	US National Institutes of Health [F32GM090437-01, R01 AG23145]; NATIONAL CANCER INSTITUTE [R01CA122794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023145] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a US National Institutes of Health postdoctoral fellowship to J.R. F32GM090437-01, and R01 AG23145 (WCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hermanns P, 2006, AM J MED GENET A, V140A, P2121, DOI 10.1002/ajmg.a.31331; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Nakashima E, 2007, AM J MED GENET A, V143A, P2675, DOI 10.1002/ajmg.a.32053; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2	7	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26270	10.1371/journal.pone.0026270	http://dx.doi.org/10.1371/journal.pone.0026270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039455	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500047
J	Sharma, AM; Wang, JB; Duffy, S; Zhang, SM; Wong, MK; Rashed, A; Cooper, ML; Daane, KM; Almeida, RPP				Sharma, Abhineet M.; Wang, Jinbo; Duffy, Siobain; Zhang, Siming; Wong, Michelle K.; Rashed, Arash; Cooper, Monica L.; Daane, Kent M.; Almeida, Rodrigo P. P.			Occurrence of Grapevine Leafroll-Associated Virus Complex in Napa Valley	PLOS ONE			English	Article							SPATIAL-ANALYSIS; GRAPEVINE-LEAFROLL-ASSOCIATED-VIRUS-3; VARIABILITY; VINEYARDS; DISEASE; SPREAD; DIVERSITY; AUSTRALIA; MEALYBUG; ISOLATE	Grapevine leafroll disease (GLD) is caused by a complex of several virus species (grapevine leafroll-associated viruses, GLRaV) in the family Closteroviridae. Because of its increasing importance, it is critical to determine which species of GLRaV is predominant in each region where this disease is occurring. A structured sampling design, utilizing a combination of RT-PCR based testing and sequencing methods, was used to survey GLRaVs in Napa Valley (California, USA) vineyards (n = 36). Of the 216 samples tested for GLRaV-1, -2, -3, -4, -5, and -9, 62% (n = 134) were GLRaV positive. Of the positives, 81% (n = 109) were single infections with GLRaV-3, followed by GLRaV-2 (4%, n = 5), while the remaining samples (15%, n = 20) were mixed infections of GLRaV-3 with GLRaV-1, 2, 4, or 9. Additionally, 468 samples were tested for genetic variants of GLRaV-3, and of the 65% (n = 306) of samples positive for GLRaV-3, 22% were infected with multiple GLRaV-3 variants. Phylogenetic analysis utilizing sequence data from the single infection GLRaV-3 samples produced seven well-supported GLRaV-3 variants, of which three represented 71% of all GLRaV-3 positive samples in Napa Valley. Furthermore, two novel variants, which grouped with a divergent isolate from New Zealand (NZ-1), were identified, and these variants comprised 6% of all positive GLRaV-3 samples. Spatial analyses showed that GLRaV-3a, 3b, and 3c were not homogeneously distributed across Napa Valley. Overall, 86% of all blocks (n = 31) were positive for GLRaVs and 90% of positive blocks (n = 28) had two or more GLRaV-3 variants, suggesting complex disease dynamics that might include multiple insect-mediated introduction events.	[Sharma, Abhineet M.; Wang, Jinbo; Zhang, Siming; Wong, Michelle K.; Daane, Kent M.; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Duffy, Siobain] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Rashed, Arash] Texas A&M AgriLife Res, Amarillo, TX USA; [Cooper, Monica L.] Univ Calif, Napa, CA USA	University of California System; University of California Berkeley; Rutgers State University New Brunswick; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Sharma, AM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	rodrigoalmeida@berkeley.edu	Almeida, Rodrigo/GZH-0682-2022; Duffy, Siobain/A-9104-2009	Duffy, Siobain/0000-0003-0753-223X; Almeida, Rodrigo/0000-0003-2888-9617	Rutgers School of Environmental and Biological Sciences; New Jersey Agricultural Experiment Station; United States Department of Agriculture NIFA-SCRI [2009-51181-06027]; American Vineyard Foundation	Rutgers School of Environmental and Biological Sciences; New Jersey Agricultural Experiment Station; United States Department of Agriculture NIFA-SCRI; American Vineyard Foundation	SD acknowledges support from the Rutgers School of Environmental and Biological Sciences and the New Jersey Agricultural Experiment Station. This research was supported by an award from the United States Department of Agriculture NIFA-SCRI (award no. 2009-51181-06027), and a grant to MLC from the American Vineyard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas B, 2007, J PHYTOPATHOL, V155, P122, DOI 10.1111/j.1439-0434.2007.01206.x; Bertazzon N, 2010, EUR J PLANT PATHOL, V127, P185, DOI 10.1007/s10658-010-9583-3; Cabaleiro C, 2008, EUR J PLANT PATHOL, V121, P121, DOI 10.1007/s10658-007-9254-1; Charles JG, 2009, AUSTRALAS PLANT PATH, V38, P576, DOI 10.1071/AP09042; DELINDEN AJO, 1970, NZ J AGR RES, V13, P689; Engel EA, 2008, VIRUS GENES, V37, P110, DOI 10.1007/s11262-008-0241-1; Fajardo Thor V. M., 2007, Fitopatologia Brasileira, V32, P335, DOI 10.1590/S0100-41582007000400008; Fiore N, 2008, J PLANT PATHOL, V90, P125; Fuchs M, 2009, PHYTOPATHOLOGY, V99, P1177, DOI 10.1094/PHYTO-99-10-1177; Fuchs M, 2009, PLANT DIS, V93, P395, DOI 10.1094/PDIS-93-4-0395; Golino DA, 2008, CALIF AGR, V62, P156, DOI 10.3733/ca.v062n04p156; Gribaudo I, 2009, J PLANT PATHOL, V91, P741; Habili N, 1997, PLANT DIS, V81, P625, DOI 10.1094/PDIS.1997.81.6.625; HABILI N, 1995, PHYTOPATHOLOGY, V85, P1418, DOI 10.1094/Phyto-85-1418; HOEFERT LL, 1967, HILGARDIA, V38, P403, DOI 10.3733/hilg.v38n11p403; Jooste AEC, 2010, ARCH VIROL, V155, P1997, DOI 10.1007/s00705-010-0793-y; Mahfoudhi N, 2008, J PHYTOPATHOL, V156, P556, DOI 10.1111/j.1439-0434.2008.01414.x; Maliogka VI, 2008, VIRUS RES, V135, P125, DOI 10.1016/j.virusres.2008.02.015; Maree HJ, 2008, ARCH VIROL, V153, P755, DOI 10.1007/s00705-008-0040-y; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin RR, 2005, PLANT DIS, V89, P763, DOI 10.1094/PD-89-0763; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; Pietersen G, 2007, S AFR J SCI, V103, pII; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tsai CW, 2010, PHYTOPATHOLOGY, V100, P830, DOI 10.1094/PHYTO-100-8-0830; Turturo C, 2005, J GEN VIROL, V86, P217, DOI 10.1099/vir.0.80395-0; Wang JB, 2011, PHYTOPATHOLOGY, V101, P445, DOI 10.1094/PHYTO-07-10-0173	29	61	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26227	10.1371/journal.pone.0026227	http://dx.doi.org/10.1371/journal.pone.0026227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039446	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500040
J	Toth, Z; Griggio, M				Toth, Zoltan; Griggio, Matteo			Leaders Are More Attractive: Birds with Bigger Yellow Breast Patches Are Followed by More Group-Mates in Foraging Groups	PLOS ONE			English	Article							SPARROW PETRONIA-PETRONIA; ROCK SPARROW; FEMALE ORNAMENTATION; DECISION-MAKING; SOCIAL NETWORK; ZEBRA; EVOLUTION; DOMINANCE; BEHAVIOR; ORGANIZATION	Social network theory provides a perfect tool to better understand the population-level consequences of how individuals interact and make their decisions; however, this approach is generally overlooked among evolutionary biologists interested in social relationships. Here, we used social network analysis to examine the patterns of leader-follower interactions in relation to individual characteristics in foraging groups of free-living rock sparrows (Petronia petronia). We found that yellow feather ornamentation, a carotenoid-based trait, was the best predictor of leadership: birds with bigger ornaments exerted greater influence in the foraging groups and were followed by more group-mates than less elaborate individuals. An individual's tendency for eliciting followings was not influenced by sex, condition or the level of parental investment. None of the above individual characteristics had significant effect on the tendency of individuals to follow others. Our results indicate that a sexually selected trait can also play a significant role in group coordination and social organization of a species.	[Toth, Zoltan; Griggio, Matteo] Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria	University of Veterinary Medicine Vienna	Toth, Z (corresponding author), Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria.	matteo.griggio@vetmeduni.ac.at		Toth, Zoltan/0000-0002-2634-8393; Griggio, Matteo/0000-0002-3298-2905				Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Andersson Malte, 1994; Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; BIDDAU L, 1995, AVOCETTA, V19, P38; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; BRUSH AH, 1990, FASEB J, V4, P2969, DOI 10.1096/fasebj.4.12.2394316; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Conradt L, 2007, P ROY SOC B-BIOL SCI, V274, P2317, DOI 10.1098/rspb.2007.0186; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; CRAMP S, 1994, BIRDS W PALEARCTIC, V3; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Csardi N., 2006, INT J COMP SYST, V1695, P1; Edgington E. S., 1995, RANDOMIZATION TESTS; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Giraudoux P., 2006, PGIRMESS MISCELLANEO; GOTCEITAS V, 1991, BEHAV ECOL SOCIOBIOL, V29, P255, DOI 10.1007/BF00163982; Griggio M, 2003, ETHOLOGY, V109, P659, DOI 10.1046/j.1439-0310.2003.00909.x; Griggio M, 2003, ETHOL ECOL EVOL, V15, P389; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Griggio M, 2009, J EVOLUTION BIOL, V22, P2077, DOI 10.1111/j.1420-9101.2009.01823.x; Griggio M, 2007, ANIM BEHAV, V74, P779, DOI 10.1016/j.anbehav.2007.01.007; Griggio M, 2007, BEHAV ECOL SOCIOBIOL, V61, P423, DOI 10.1007/s00265-006-0270-5; Griggio M, 2010, J ETHOL, V28, P455, DOI 10.1007/s10164-010-0205-5; Griggio M, 2009, BEHAV ECOL, V20, P1072, DOI 10.1093/beheco/arp099; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Junker B. H., 2008, WILEY SERIES BIOINFO; Jurasinski G, 2007, SIMBA COLLECTION FUN; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King Andrew J., 2009, Communicative & Integrative Biology, V2, P147; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Krause J, 2002, LIVING GROUPS; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Mateos-Gonzalez F, 2011, BIOL LETTERS, V7, P668, DOI 10.1098/rsbl.2011.0163; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oh KP, 2010, AM NAT, V176, pE80, DOI 10.1086/655216; Opsahl T., 2009, THESIS U LONDON LOND, P104; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Pilastro A, 2003, ANIM BEHAV, V66, P265, DOI 10.1006/anbe.2003.2203; Pilastro A, 2001, J AVIAN BIOL, V32, P68, DOI 10.1034/j.1600-048X.2001.320109.x; R Core Team, 2021, R LANG ENV STAT COMP; Rands SA, 2004, P ROY SOC B-BIOL SCI, V271, P2613, DOI 10.1098/rspb.2004.2906; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2006, BEHAV ECOL SOCIOBIOL, V60, P572, DOI 10.1007/s00265-006-0202-4; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Senar Juan Carlos, 2002, Avian Science, V2, P19; Serra L, 2007, J EVOLUTION BIOL, V20, P2028, DOI 10.1111/j.1420-9101.2007.01360.x; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Surai PF, 1999, BIOL TRACE ELEM RES, V68, P63, DOI 10.1007/BF02784397; Szekely T., 2010, SOCIAL BEHAV GENES E; Tavecchia G, 2002, IBIS, V144, pE79, DOI 10.1046/j.1474-919X.2002.00059.x; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510; ZANETTE L, 1994, ANIM BEHAV, V48, P119, DOI 10.1006/anbe.1994.1218	71	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26605	10.1371/journal.pone.0026605	http://dx.doi.org/10.1371/journal.pone.0026605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028920	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500094
J	Hollants, J; Leroux, O; Leliaert, F; Decleyre, H; De Clerck, O; Willems, A				Hollants, Joke; Leroux, Olivier; Leliaert, Frederik; Decleyre, Helen; De Clerck, Olivier; Willems, Anne			Who Is in There? Exploration of Endophytic Bacteria within the Siphonous Green Seaweed Bryopsis (Bryopsidales, Chlorophyta)	PLOS ONE			English	Article							PHYLOGENETIC CHARACTERIZATION; EPIPHYTIC BACTERIA; MARINE MACROALGAE; ACID BACTERIA; SP-NOV.; DIVERSITY; ABALONE; IDENTIFICATION; ENDOSYMBIONTS; VARIABILITY	Associations between marine seaweeds and bacteria are widespread, with endobiotic bacterial-algal interactions being described for over 40 years. Also within the siphonous marine green alga Bryopsis, intracellular bacteria have been visualized by electron microscopy in the early '70s, but were up to now never molecularly analyzed. To study this partnership, we examined the presence and phylogenetic diversity of microbial communities within the cytoplasm of two Bryopsis species by combining fluorescence in situ hybridization (FISH), denaturing gradient gel electrophoresis (DGGE) and 16S rRNA gene clone libraries. Sequencing results revealed the presence of Arcobacter, Bacteroidetes, Flavobacteriaceae, Mycoplasma, Labrenzia, Phyllobacteriaceae and Xanthomonadaceae species. Although the total diversity of the endobiotic communities was unique to each Bryopsis culture, Bacteroidetes, Mycoplasma, Phyllobacteriaceae, and in particular Flavobacteriaceae bacteria, were detected in several Bryopsis samples collected hundreds of kilometres apart. This suggests that Bryopsis closely associates with well-defined endophytic bacterial communities of which some members possibly maintain an endosymbiotic relationship with the algal host.	[Hollants, Joke; Decleyre, Helen; Willems, Anne] Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Hollants, Joke; Leliaert, Frederik; De Clerck, Olivier] Univ Ghent, Phycol Res Grp, Dept Biol, B-9000 Ghent, Belgium; [Leroux, Olivier] Univ Ghent, Pteridol Res Grp, Dept Biol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Hollants, J (corresponding author), Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium.	Joke.Hollants@UGent.be	Leliaert, Frederik/A-9162-2009; De Clerck, Olivier/A-9083-2010; Willems, Anne/B-2872-2010; De Clerck, Olivier/AAU-4295-2020	Leliaert, Frederik/0000-0002-4627-7318; De Clerck, Olivier/0000-0002-3699-8402; Willems, Anne/0000-0002-8421-2881; Leroux, Olivier/0000-0001-9723-5604	'Fonds Wetenschappelijk Onderzoek' FWO-Flanders [G.0045.08]	'Fonds Wetenschappelijk Onderzoek' FWO-Flanders(FWO)	This research was funded by 'Fonds Wetenschappelijk Onderzoek' FWO-Flanders project G.0045.08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashen JB, 2000, APPL ENVIRON MICROB, V66, P3024, DOI 10.1128/AEM.66.7.3024-3030.2000; Bano N, 2007, ENVIRON MICROBIOL, V9, P2636, DOI 10.1111/j.1462-2920.2007.01381.x; Biebl H, 2007, INT J SYST EVOL MICR, V57, P1095, DOI 10.1099/ijs.0.64821-0; BURR F A, 1970, Phycologia, V9, P17, DOI 10.2216/i0031-8884-9-1-17.1; Chisholm JRM, 1996, NATURE, V381, P382, DOI 10.1038/381382a0; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; COLOMBO PM, 1978, PHYCOLOGIA, V17, P148, DOI 10.2216/i0031-8884-17-2-148.1; CORREA JA, 1993, J PHYCOL, V29, P853, DOI 10.1111/j.0022-3646.1993.00853.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; DAWES C J, 1978, Revue Algologique, V13, P309; De Meyer SE, 2011, SOIL BIOL BIOCHEM, V43, P2384, DOI 10.1016/j.soilbio.2011.08.005; De Vuyst L, 2008, INT J FOOD MICROBIOL, V125, P79, DOI 10.1016/j.ijfoodmicro.2007.02.030; Delbridge L, 2004, SYMBIOSIS, V37, P335; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eloe EA, 2011, ENV MICROBIOL REP, V3, P449, DOI 10.1111/j.1758-2229.2010.00223.x; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Green DH, 2004, FEMS MICROBIOL ECOL, V47, P345, DOI 10.1016/S0168-6496(03)00298-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Hanyuda T, 2000, J PLANT RES, V113, P403, DOI 10.1007/PL00013948; Hempel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-58; Hollants J, 2010, SYMBIOSIS, V51, P131, DOI 10.1007/s13199-010-0068-0; Horn M, 2004, J EUKARYOT MICROBIOL, V51, P509, DOI 10.1111/j.1550-7408.2004.tb00278.x; Huang ZB, 2010, AQUAC RES, V41, pe760, DOI 10.1111/j.1365-2109.2010.02577.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Kan Y, 1999, J NAT PROD, V62, P1169, DOI 10.1021/np990053y; Kikuchi Y, 2009, MICROBES ENVIRON, V24, P195, DOI 10.1264/jsme2.ME09140S; Kim HM, 2010, INT J SYST EVOL MICR, V60, P531, DOI 10.1099/ijs.0.007740-0; KUYKENDALL LD, 2005, BERGEYS MANUAL SYS C; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; MCBRIDE DL, 1974, PROTOPLASMA, V79, P249, DOI 10.1007/BF01276605; Meusnier I, 2001, MOL ECOL, V10, P931, DOI 10.1046/j.1365-294X.2001.01245.x; Naidoo K, 2006, J APPL PHYCOL, V18, P437, DOI 10.1007/s10811-006-9045-7; Noel GR, 2006, INT J SYST EVOL MICR, V56, P1697, DOI 10.1099/ijs.0.64234-0; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Penesyan A, 2009, FEMS MICROBIOL ECOL, V69, P113, DOI 10.1111/j.1574-6941.2009.00688.x; Pinhassi J, 2006, INT J SYST EVOL MICR, V56, P1489, DOI 10.1099/ijs.0.64232-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rao KV, 2008, J NAT PROD, V71, P772, DOI 10.1021/np070508g; Romero J, 2002, MICROBIAL ECOL, V44, P365, DOI 10.1007/s00248-002-1063-7; SADDLER GS, 2005, BERGEYS MANUAL SYS B; Seibold A, 2001, AQUAT MICROB ECOL, V25, P229, DOI 10.3354/ame025229; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka R, 2004, AQUACULTURE, V241, P453, DOI 10.1016/j.aquaculture.2004.08.032; Thamdrup B, 2000, APPL ENVIRON MICROB, V66, P2888, DOI 10.1128/AEM.66.7.2888-2897.2000; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Tujula NA, 2006, J MICROBIOL METH, V65, P604, DOI 10.1016/j.mimet.2005.09.006; Tujula NA, 2010, ISME J, V4, P301, DOI 10.1038/ismej.2009.107; TURNER JB, 1974, J PHYCOL, V10, P125; Van Hoorde K, 2008, FOOD MICROBIOL, V25, P929, DOI 10.1016/j.fm.2008.06.006; Weber CF, 2007, APPL ENVIRON MICROB, V73, P1266, DOI 10.1128/AEM.01724-06; West JA, 1999, HYDROBIOLOGIA, V399, P101; Wiese J, 2009, MAR BIOTECHNOL, V11, P287, DOI 10.1007/s10126-008-9143-4; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002	61	50	51	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26458	10.1371/journal.pone.0026458	http://dx.doi.org/10.1371/journal.pone.0026458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028882	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900066
J	Layana, C; Diambra, L				Layana, Carla; Diambra, Luis			Time-Course Analysis of Cyanobacterium Transcriptome: Detecting Oscillatory Genes	PLOS ONE			English	Article							EXPRESSION; CYCLE	The microarray technique allows the simultaneous measurements of the expression levels of thousands of mRNAs. By mining these data one can identify the dynamics of the gene expression time series. The detection of genes that are periodically expressed is an important step that allows us to study the regulatory mechanisms associated with the circadian cycle. The problem of finding periodicity in biological time series poses many challenges. Such challenge occurs due to the fact that the observed time series usually exhibit non-idealities, such as noise, short length, outliers and unevenly sampled time points. Consequently, the method for finding periodicity should preferably be robust against such anomalies in the data. In this paper, we propose a general and robust procedure for identifying genes with a periodic signature at a given significance level. This identification method is based on autoregressive models and the information theory. By using simulated data we show that the suggested method is capable of identifying rhythmic profiles even in the presence of noise and when the number of data points is small. By recourse of our analysis, we uncover the circadian rhythmic patterns underlying the gene expression profiles from Cyanobacterium Synechocystis.	[Layana, Carla; Diambra, Luis] Univ Nacl La Plata, CREG, Florencio Varela, Argentina	National University of La Plata	Layana, C (corresponding author), Univ Nacl La Plata, CREG, Florencio Varela, Argentina.	ldiambra@creg.org.ar	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; layana, carla/0000-0002-2313-2028	CONICET (Argentina)	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	CL thanks CONICET (Argentina) for financial support. LD is a researcher of CONICET (Argentina). The authors thank Ken-ichi Kucho for having provided the data, and Prof. Rolando Rivera-Pomar for valuable suggestions.	Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; [Anonymous], KEGG CATEGORIES; Chaudhuri P, 1996, J AM STAT ASSOC, V91, P862; de Hoon MJL, 2002, BIOINFORMATICS, V18, P1477, DOI 10.1093/bioinformatics/18.11.1477; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Diambra L, 2008, PHYSICA A, V387, P2187, DOI 10.1016/j.physa.2007.12.006; Diambra L, 1996, PHYS LETT A, V216, P278, DOI 10.1016/0375-9601(96)00290-3; Ditty JL, 2003, ANNU REV GENET, V37, P513, DOI 10.1146/annurev.genet.37.110801.142716; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Hogenesch John B, 2003, Novartis Found Symp, V253, P171; Hughes M, 2007, COLD SPRING HARB SYM, V72, P381, DOI 10.1101/sqb.2007.72.011; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Johnson CH, 1999, ANNU REV MICROBIOL, V53, P389, DOI 10.1146/annurev.micro.53.1.389; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Levine RD, 1978, MAXIMUM ENTROPY PRIN; Lu X, 2004, NUCLEIC ACIDS RES, V32, P447, DOI 10.1093/nar/gkh205; Luan Y, 2004, BIOINFORMATICS, V20, P332, DOI 10.1093/bioinformatics/btg413; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Muro-Pastor AM, 2001, J BACTERIOL, V183, P1090, DOI 10.1128/JB.183.3.1090-1095.2001; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Schmitt WA, 2004, GENOME RES, V14, P1654, DOI 10.1101/gr.2439804; Schmitt WA, 2003, BIOTECHNOL BIOENG, V84, P855, DOI 10.1002/bit.10843; Shannon C., 1964, MATH THEORY COMMUNIC; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26291	10.1371/journal.pone.0026291	http://dx.doi.org/10.1371/journal.pone.0026291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028849	Green Submitted, gold, Green Published			2022-12-25	WOS:000296186900043
J	Mizobata, T; Uemura, T; Isaji, K; Hirayama, T; Hongo, K; Kawata, Y				Mizobata, Tomohiro; Uemura, Tatsuya; Isaji, Kazuhiro; Hirayama, Takuma; Hongo, Kunihiro; Kawata, Yasushi			Probing the Functional Mechanism of Escherichia coli GroEL Using Circular Permutation	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; CHAPERONIN GROEL; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; APICAL DOMAIN; PROTEIN; POLYPEPTIDE; INTERMEDIATE; BINDING; CYCLE	Background: The Escherichia coli chaperonin GroEL subunit consists of three domains linked via two hinge regions, and each domain is responsible for a specific role in the functional mechanism. Here, we have used circular permutation to study the structural and functional characteristics of the GroEL subunit. Methodology/Principal Findings: Three soluble, partially active mutants with polypeptide ends relocated into various positions of the apical domain of GroEL were isolated and studied. The basic functional hallmarks of GroEL (ATPase and chaperoning activities) were retained in all three mutants. Certain functional characteristics, such as basal ATPase activity and ATPase inhibition by the cochaperonin GroES, differed in the mutants while at the same time, the ability to facilitate the refolding of rhodanese was roughly equal. Stopped-flow fluorescence experiments using a fluorescent variant of the circularly permuted GroEL CP376 revealed that a specific kinetic transition that reflects movements of the apical domain was missing in this mutant. This mutant also displayed several characteristics that suggested that the apical domains were behaving in an uncoordinated fashion. Conclusions/Significance: The loss of apical domain coordination and a concomitant decrease in functional ability highlights the importance of certain conformational signals that are relayed through domain interlinks in GroEL. We propose that circular permutation is a very versatile tool to probe chaperonin structure and function.	[Mizobata, Tomohiro; Isaji, Kazuhiro; Hongo, Kunihiro; Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 680, Japan; [Hirayama, Takuma] Tottori Univ, Fac Engn, Dept Biotechnol, Tottori 680, Japan; [Mizobata, Tomohiro; Uemura, Tatsuya; Hongo, Kunihiro; Kawata, Yasushi] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori 680, Japan	Tottori University; Tottori University; Tottori University	Mizobata, T (corresponding author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 680, Japan.	mizobata@bio.tottori-u.ac.jp	Mizobata, Tomohiro/V-6672-2019; Kawata, Yasushi/ABA-9608-2021	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Japan Society for the Promotion of Science (JSPS) of Japan [22570119]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22020025]; Faculty of Engineering, Tottori University; Venture Business Laboratory, Tottori University; Grants-in-Aid for Scientific Research [21570113] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Faculty of Engineering, Tottori University; Venture Business Laboratory, Tottori University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 22570119 to T. M.) from the Japan Society for the Promotion of Science (JSPS) of Japan, a Grant-in-Aid for Scientific Research on Priority Areas (No. 22020025 to Y. K.) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and also by grants to T. M. from the Faculty of Engineering, Tottori University and the Venture Business Laboratory, Tottori University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chatellier J, 1998, P NATL ACAD SCI USA, V95, P9861, DOI 10.1073/pnas.95.17.9861; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Graf R, 1996, P NATL ACAD SCI USA, V93, P11591, DOI 10.1073/pnas.93.21.11591; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Iwasa H, 2011, J BIOL CHEM, V286, P21796, DOI 10.1074/jbc.M111.228445; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; Kamireddi M, 1997, PROTEIN EXPRES PURIF, V11, P47, DOI 10.1006/prep.1997.0764; Kawata Y, 1999, BIOCHEMISTRY-US, V38, P15731, DOI 10.1021/bi9909750; KUBO T, 1993, J BIOL CHEM, V268, P19346; Li Y, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455101; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Machida K, 2009, BBA-PROTEINS PROTEOM, V1794, P1344, DOI 10.1016/j.bbapap.2008.12.003; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Miyazaki T, 2002, J BIOL CHEM, V277, P50621, DOI 10.1074/jbc.M209183200; Mizobata T, 2000, J BIOL CHEM, V275, P25600, DOI 10.1074/jbc.M000795200; MIZOBATA T, 1994, BBA-PROTEIN STRUCT M, V1209, P83, DOI 10.1016/0167-4838(94)90140-6; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Paavola CD, 2006, NANOTECHNOLOGY, V17, P1171, DOI 10.1088/0957-4484/17/5/001; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taniguchi M, 2004, J BIOL CHEM, V279, P16368, DOI 10.1074/jbc.M311806200; Tehver R, 2009, J MOL BIOL, V387, P390, DOI 10.1016/j.jmb.2008.12.032; Wang QH, 2000, J MOL BIOL, V304, P873, DOI 10.1006/jmbi.2000.4276; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; Yoshimi T, 2006, J BIOCHEM, V139, P407, DOI 10.1093/jb/mvj043	38	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26462	10.1371/journal.pone.0026462	http://dx.doi.org/10.1371/journal.pone.0026462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028884	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900067
J	Wu, ZQ; Xue, Y; Wang, B; Du, J; Jin, Q				Wu, Zhiqiang; Xue, Ying; Wang, Bei; Du, Jiang; Jin, Qi			Broad-Spectrum Antiviral Activity of RNA Interference against Four Genotypes of Japanese Encephalitis Virus Based on Single MicroRNA Polycistrons	PLOS ONE			English	Article							EXPRESSION VECTORS; MAMMALIAN-CELLS; REPLICATION; GENE; INHIBITION; SIRNAS; MIRNAS; CHINA	Japanese encephalitis virus (JEV), a neurotropic mosquito-borne flavivirus, causes acute viral encephalitis and neurologic disease with a high fatality rate in humans and a range of animals. Small interfering RNA (siRNA) is a powerful antiviral agent able to inhibit JEV replication. However, the high rate of genetic variability between JEV strains (of four confirmed genotypes, genotypes I, II, III and IV) hampers the broad-spectrum application of siRNAs, and mutations within the targeted sequences could facilitate JEV escape from RNA interference (RNAi)-mediated antiviral therapy. To improve the broad-spectrum application of siRNAs and prevent the generation of escape mutants, multiple siRNAs targeting conserved viral sequences need to be combined. In this study, using a siRNA expression vector based on the miR-155 backbone and promoted by RNA polymerase II, we initially identified nine siRNAs targeting highly conserved regions of seven JEV genes among strains of the four genotypes of JEV to effectively block the replication of the JEV vaccine strain SA14-14-2. Then, we constructed single microRNA-like polycistrons to simultaneously express these effective siRNAs under a single RNA polymerase II promoter. Finally, these single siRNAs or multiple siRNAs from the microRNA-like polycistrons showed effective anti-virus activity in genotype I and genotype III JEV wild type strains, which are the predominant genotypes of JEV in mainland China. The anti-JEV effect of these microRNA-like polycistrons was also predicted in other genotypes of JEV (genotypes II and IV), The inhibitory efficacy indicated that siRNAs69 could theoretically inhibit the replication of JEV genotypes II and IV.	[Wu, Zhiqiang] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, ZQ (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China.	zdsys@vip.sina.com	Jin, Qi/B-5379-2009		National ST Major Project [2009ZX10004-102, 2009ZX10004-216]	National ST Major Project	This work was supported by the National S&T Major Project "Prevention and Control for AIDS, Viral Hepatitis and Other Major Infectious Diseases" (Grant No. 2009ZX10004-102 and 2009ZX10004-216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2008, GENE THER, V15, P1536, DOI 10.1038/gt.2008.147; Amarzguioui M, 2005, FEBS LETT, V579, P5974, DOI 10.1016/j.febslet.2005.08.070; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen WZ, 2004, J VIROL, V78, P6900, DOI 10.1128/JVI.78.13.6900-6907.2004; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Du Q, 2004, BIOCHEM BIOPH RES CO, V325, P243, DOI 10.1016/j.bbrc.2004.09.222; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Gould EA, 2008, ANTIVIR RES, V78, P140, DOI 10.1016/j.antiviral.2007.10.005; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Huang JH, 2010, EMERG INFECT DIS, V16, P876, DOI 10.3201/eid1605.091055; Israsena N, 2009, ANTIVIR RES, V84, P76, DOI 10.1016/j.antiviral.2009.07.012; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lehto T, 2010, J CONTROL RELEASE, V141, P42, DOI 10.1016/j.jconrel.2009.08.028; Liu YP, 2008, NUCLEIC ACIDS RES, V36, P2811, DOI 10.1093/nar/gkn109; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Morita K, 2009, VACCINE, V27, P7131, DOI 10.1016/j.vaccine.2009.09.051; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murakami M, 2005, MICROBIOL IMMUNOL, V49, P1047, DOI 10.1111/j.1348-0421.2005.tb03701.x; Qi WB, 2008, VIRUS RES, V132, P145, DOI 10.1016/j.virusres.2007.11.014; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Watanabe T, 2007, ADV DRUG DELIVER REV, V59, P1263, DOI 10.1016/j.addr.2007.03.022; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]; Wu ZQ, 2008, ANTIVIR RES, V80, P295, DOI 10.1016/j.antiviral.2008.06.017; Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105; Yuan J, 2005, J VIROL, V79, P2151, DOI 10.1128/JVI.79.4.2151-2159.2005; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhiqiang W, 2010, ANTIVIR RES, V85, P559, DOI 10.1016/j.antiviral.2009.12.010; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	45	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26304	10.1371/journal.pone.0026304	http://dx.doi.org/10.1371/journal.pone.0026304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028851	gold, Green Submitted, Green Published			2022-12-25	WOS:000296186900045
J	Magnone, M; Sturla, L; Jacchetti, E; Scarfi, S; Bruzzone, S; Usai, C; Guida, L; Salis, A; Damonte, G; De Flora, A; Zocchi, E				Magnone, Mirko; Sturla, Laura; Jacchetti, Emanuela; Scarfi, Sonia; Bruzzone, Santina; Usai, Cesare; Guida, Lucrezia; Salis, Annalisa; Damonte, Gianluca; De Flora, Antonio; Zocchi, Elena			Autocrine abscisic acid plays a key role in quartz-induced macrophage activation	FASEB JOURNAL			English	Article						inflammation; NF kappa B; TNF alpha; PGE(2); LANCL2	NECROSIS-FACTOR-ALPHA; CYCLIC ADP-RIBOSE; MURINE MACROPHAGES; LIPID-PEROXIDATION; SCAVENGER RECEPTOR; IN-VITRO; KAPPA-B; EXPRESSION; SILICA; LUNG	Inhalation of quartz induces silicosis, a lung disease where alveolar macrophages release inflammatory mediators, including prostaglandin-E-2 (PGE(2)) and tumor necrosis factor alpha (TNF-alpha). Here we report the pivotal role of abscisic acid (ABA), a recently discovered human inflammatory hormone, in silica-induced activation of murine RAW264.7 macrophages and of rat alveolar macrophages (AMs). Stimulation of both RAW264.7 cells and AMs with quartz induced a significant increase of ABA release (5- and 10-fold, respectively), compared to untreated cells. In RAW264.7 cells, autocrine ABA released after quartz stimulation sequentially activates the plasma membrane receptor LANCL2 and NADPH oxidase, generating a Ca2+ influx resulting in NF kappa B nuclear translocation and PGE(2) and TNF-alpha release (3-, 2-, and 3.5-fold increase, respectively, compared to control, un-stimulated cells). Quartz-stimulated RAW264.7 cells silenced for LANCL2 or preincubated with a monoclonal antibody against ABA show an almost complete inhibition of NF kappa B nuclear translocation and PGE(2) and TNF-alpha release compared to controls electroporated with a scramble oligonucleotide or preincubated with an unrelated antibody. AMs showed similar early and late ABA-induced responses as RAW264.7 cells. These findings identify ABA and LANCL2 as key mediators in quartz-induced inflammation, providing possible new targets for antisilicotic therapy.-Magnone, M., Sturla, L., Jacchetti, E., Scarf, S., Bruzzone, S., Usai, C., Guida, L., Salis, A., Damonte, G., De Flora, A., Zocchi, E. Autocrine abscisic acid plays a key role in quartz-induced macrophage activation. FASEB J. 26, 1261-1271 (2012). www.fasebj.org	[Magnone, Mirko; Sturla, Laura; Scarfi, Sonia; Bruzzone, Santina; Guida, Lucrezia; Salis, Annalisa; Damonte, Gianluca; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med DIMES, I-16132 Genoa, Italy; [Magnone, Mirko; Sturla, Laura; Scarfi, Sonia; Bruzzone, Santina; Guida, Lucrezia; Salis, Annalisa; Damonte, Gianluca; De Flora, Antonio; Zocchi, Elena] Univ Genoa, CEBR, I-16132 Genoa, Italy; [Jacchetti, Emanuela; Usai, Cesare] CNR, Inst Biophys, Genoa, Italy; [Scarfi, Sonia; Zocchi, Elena] Adv Biotechnol Ctr CBA, Genoa, Italy	University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Magnone, M (corresponding author), Univ Genoa, Biochem Sect, DIMES, Viale Benedetto XV 1, I-16132 Genoa, Italy.	mirko.magnone@unige.it; ezocchi@unige.it	Bruzzone, Santina/A-4264-2015; Scarfi, Sonia/AAJ-2387-2020; JACCHETTI, Emanuela/AAP-2453-2021; Salis, Annalisa/R-9241-2018	Bruzzone, Santina/0000-0003-2034-3716; Scarfi, Sonia/0000-0002-7079-6919; JACCHETTI, Emanuela/0000-0001-5990-001X; Usai, Cesare/0000-0001-8863-7759; Salis, Annalisa/0000-0002-3082-2908	Italian Ministry of Education, University and Scientific Research; University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia; Compagnia di S. Paolo; European Community; Regione Liguria	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione Cassa di Risparmio di Genova e Imperia; Compagnia di S. Paolo(Compagnia di San Paolo); European Community(European Commission); Regione Liguria(Regione Liguria)	This work was supported in part by the Italian Ministry of Education, University and Scientific Research, by the University of Genova, by the Fondazione Cassa di Risparmio di Genova e Imperia, by the Compagnia di S. Paolo, by the European Community, and by Regione Liguria. The authors declare no conflicts of interest.	Aitken RJ, 2007, MOL HUM REPROD, V13, P203, DOI 10.1093/molehr/gal119; Albrecht C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-129; Albrecht C, 2004, AM J RESP CELL MOL, V31, P292, DOI 10.1165/rcmb.2003-0300OC; Bapat S, 2002, J AM SOC NEPHROL, V13, P2990, DOI 10.1097/01.ASN.0000036870.58561.81; Bodrato N, 2009, J BIOL CHEM, V284, P14777, DOI 10.1074/jbc.M802604200; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Campa VM, 2005, INFLAMM RES, V54, P328, DOI 10.1007/s00011-005-1359-4; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Cathcart MK, 2004, ARTERIOSCL THROM VAS, V24, P23, DOI 10.1161/01.ATV.0000097769.47306.12; Chen F., 2007, AM J PHYSIOL-LUNG C, V272, pL779; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; CLAUDIO E, 1995, AM J RESP CELL MOL, V13, P547, DOI 10.1165/ajrcmb.13.5.7576690; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; Ding M, 2002, INT IMMUNOPHARMACOL, V2, P173, DOI 10.1016/S1567-5769(01)00170-9; DRISCOLL KE, 1990, AM J RESP CELL MOL, V2, P381, DOI 10.1165/ajrcmb/2.4.381; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Finney-Hayward TK, 2010, AM J RESP CELL MOL, V43, P296, DOI 10.1165/rcmb.2008-0373OC; GABOR S, 1975, ARCH ENVIRON HEALTH, V30, P499, DOI 10.1080/00039896.1975.10666761; Garcia YJ, 2005, J NEUROSCI METH, V144, P127, DOI 10.1016/j.jneumeth.2004.10.018; Gozal E, 2002, AM J RESP CELL MOL, V27, P91, DOI 10.1165/ajrcmb.27.1.4790; Hannigan MO, 2004, CURR TOP MICROBIOL, V282, P165; KREYLING WG, 1992, ENVIRON HEALTH PERSP, V97, P121, DOI 10.2307/3431339; Lysko PG, 1999, J PHARMACOL EXP THER, V289, P1277; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; MIYAZAKI Y, 1995, J CLIN INVEST, V96, P250, DOI 10.1172/JCI118029; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; NYBERG P, 1991, ENVIRON RES, V55, P157, DOI 10.1016/S0013-9351(05)80172-0; Orfila C, 1998, HISTOCHEM J, V30, P857, DOI 10.1023/A:1003485312164; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; RASMUSSEN U, 1978, ACTA PHARM SUEC, V15, P133; Roca J, 2004, J ANDROL, V25, P397; RUOTSALAINEN M, 1995, TOXICOL LETT, V78, P195, DOI 10.1016/0378-4274(95)03255-J; Scarfi S, 2007, FEBS J, V274, P60, DOI 10.1111/j.1742-4658.2006.05564.x; Scarfi S, 2009, STEM CELLS, V27, P2469, DOI 10.1002/stem.173; Scarfi S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-25; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tarnok A, 1997, ANAL CELL PATHOL, V15, P61, DOI 10.1155/1997/539384; Vidyashankar S, 2010, MOL CELL BIOCHEM, V333, P41, DOI 10.1007/s11010-009-0202-6; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Warheit DB, 2007, TOXICOL SCI, V95, P270, DOI 10.1093/toxsci/kfl128; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Zeidler PC, 2003, J TOXICOL ENV HEAL A, V66, P995, DOI 10.1080/15287390306395; ZHANG Y, 1993, J IMMUNOL, V150, P4188; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	50	32	35	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1261	1271		10.1096/fj.11-187351	http://dx.doi.org/10.1096/fj.11-187351			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22042223				2022-12-25	WOS:000300949300028
J	Aslam, A; Chapel, H; Ogg, G				Aslam, Aamir; Chapel, Helen; Ogg, Graham			Direct Ex-Vivo Evaluation of Pneumococcal Specific T-Cells in Healthy Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE COLONIZATION; NASOPHARYNGEAL CARRIAGE; CD4+T CELLS; VIRUS; POLYSACCHARIDE; ACTIVATION; ANTIBODIES; INFECTION; RESPONSES; CHILDREN	Streptococcus pneumoniae is an encapsulated bacterium that causes significant global morbidity and mortality. The nasopharynxes of children are believed to be the natural reservoir of pneumococcus and by adulthood nasopharyngeal carriage is infrequent; such infrequency may be due to demonstrable pneumococcal specific T and B-cell responses. HLA Class 2 tetrameric complexes have been used to characterise antigen specific T-cell responses in a variety of models of infection. We therefore sought to determine the frequency and phenotype of pneumococcal specific T-cells, using a novel HLA-DRB1*1501 tetramer complex incorporating a recently defined T-cell epitope derived from the conserved pneumococcal serine/threonine kinase (StkP). We were able to detect direct ex-vivo StkP(446-60)-tetramer binding in HLA-DRB1*1501 adults. These StkP(446-60)-tetramer binding T-cells had increased CD38 expression and were enriched in CCR7-CD45RA+ expression indicating recent and on-going activation and differentiation. Furthermore, these StkP(446-60)-tetramer binding T-cells demonstrated rapid effector function by secreting interferon-gamma on stimulation with recombinant StkP. This is the first study to directly enumerate and characterise pneumococcal specific T-cells using HLA class 2 tetrameric complexes. We found that ex-vivo pneumococcal-specific T cells were detectable in healthy adults and that they were enriched with cell surface markers associated with recent antigen exposure and later stages of antigen-driven differentiation. It is likely that these activated pneumococcal specific T-cells reflect recent immunostimulatory pneumococcal exposure in the nasopharynx and it is possible that they may be preventing subsequent colonisation and disease.	[Aslam, Aamir; Ogg, Graham] Univ Oxford, Weatherall Inst Mol Med, Oxford NIHR Biomed Res Ctr, MRC Human Immunol Unit, Oxford, England; [Chapel, Helen] Univ Oxford, Nuffield Dept Med, Clin Immunol Unit, Oxford, England	University of Oxford; University of Oxford	Ogg, G (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford NIHR Biomed Res Ctr, MRC Human Immunol Unit, Oxford, England.	graham.ogg@ndm.ox.ac.uk		Ogg, Graham/0000-0002-3097-045X	Medical Research Council [HBRRYDT]; NIHR Biomedical Research Centre; Medical Research Council [G1000800h] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Medical Research Council grant code: HBRRYDT, http://www.mrc.ac.uk/index.htm; and supported by the NIHR Biomedical Research Centre Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Aslam A, 2010, FEMS IMMUNOL MED MIC, V60, P113, DOI 10.1111/j.1574-695X.2010.00724.x; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011028; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Centers for Disease Control and Prevention, 2010, ACT BACT COR SURV RE; Chan W, 1999, FMOC SOLID PHASE PEP, V222; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Flamaing J, 2010, J AM GERIATR SOC, V58, P396, DOI 10.1111/j.1532-5415.2009.02700.x; Gill CJ, 2008, J INFECT DIS, V197, P1000, DOI 10.1086/528806; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Im EJ, 2006, EUR J IMMUNOL, V36, P2574, DOI 10.1002/eji.200636482; Khan AQ, 2004, J IMMUNOL, V172, P532, DOI 10.4049/jimmunol.172.1.532; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lucas M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000649; Malavige GN, 2008, CLIN EXP IMMUNOL, V152, P522, DOI 10.1111/j.1365-2249.2008.03633.x; Malley R, 2007, J INFECT DIS, V196, P928, DOI 10.1086/520937; McCool TL, 2003, INFECT IMMUN, V71, P5402, DOI 10.1128/IAI.71.9.5402-5406.2003; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Scriba TJ, 2005, J IMMUNOL, V175, P6334, DOI 10.4049/jimmunol.175.10.6334; Soininen A, 2001, J INFECT DIS, V184, P569, DOI 10.1086/322794; Wei HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006905; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617; Zhang QB, 2006, INFECT IMMUN, V74, P4735, DOI 10.1128/IAI.00165-06	28	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e25367	10.1371/journal.pone.0025367	http://dx.doi.org/10.1371/journal.pone.0025367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039412	gold, Green Published, Green Submitted			2022-12-25	WOS:000296515200002
J	Castilho, A; Bohorova, N; Grass, J; Bohorov, O; Zeitlin, L; Whaley, K; Altmann, F; Steinkellner, H				Castilho, Alexandra; Bohorova, Natasha; Grass, Josephine; Bohorov, Ognian; Zeitlin, Larry; Whaley, Kevin; Altmann, Friedrich; Steinkellner, Herta			Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody	PLOS ONE			English	Article							RNA VIRUS; N-GLYCANS; GLYCOSYLATION; PLANTS; REPLICATION; EXPRESSION; GLYCOPROTEINS; LYMPHOMA; EPITOPES; RESIDUE	Background: Fc-glycosylation of monoclonal antibodies (mAbs) has profound implications on the Fc-mediated effector functions. Alteration of this glycosylation may affect the efficiency of an antibody. However, difficulties in the production of mAbs with homogeneous N-glycosylation profiles in sufficient amounts hamper investigations of the potential biological impact of different glycan residues. Methodology/Principal Findings: Here we set out to evaluate a transient plant viral based production system for the rapid generation of different glycoforms of a monoclonal antibody. Ebola virus mAb h-13F6 was generated using magnICON expression system in Nicotiana benthamiana, a plant species developed for commercial scale production of therapeutic proteins. h-13F6 was co-expressed with a series of modified mammalian enzymes involved in the processing of complex N-glycans. Using wild type (WT) plants and the glycosylation mutant Delta XTFT that synthesizes human like biantennary N-glycans with terminal N-acetylglucosamine on each branch (GnGn structures) as expression hosts we demonstrate the generation of h-13F6 complex N-glycans with (i) bisected structures, (ii) core alpha 1,6 fucosylation and (iii) beta 1,4 galactosylated oligosaccharides. In addition we emphasize the significance of precise sub Golgi localization of enzymes for engineering of IgG Fc-glycosylation. Conclusion: The method described here allows the efficient generation of a series of different human-like glycoforms at large homogeneity of virtually any antibody within one week after cDNA delivery to plants. This accelerates follow up functional studies and thus may contribute to study the biological role of N-glycan residues on Fcs and maximizing the clinical efficacy of therapeutic antibodies.	[Castilho, Alexandra; Steinkellner, Herta] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria; [Bohorova, Natasha; Bohorov, Ognian; Zeitlin, Larry; Whaley, Kevin] Mapp Biopharmaceut, San Diego, CA USA; [Grass, Josephine; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Castilho, A (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	herta.steinkellner@boku.ac.at	Steinkellner, Herta/N-4267-2016; Castilho, Alexandra/AAC-8927-2020	Steinkellner, Herta/0000-0003-4823-1505; Castilho, Alexandra/0000-0003-4114-7861; Altmann, Friedrich/0000-0002-0112-7877	NIAID [AI061270]; Laura Bassi Centres of Expertise [822757]; FWF [L575-B13]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061270] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laura Bassi Centres of Expertise; FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant Number AI061270 from NIAID, the Laura Bassi Centres of Expertise (Grant Number 822757), and the FWF (Grant Number L575-B13). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2005, VACCINE, V23, P1784, DOI 10.1016/j.vaccine.2004.11.005; Bakker H, 2006, P NATL ACAD SCI USA, V103, P7577, DOI 10.1073/pnas.0600879103; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Carette JE, 2002, J VIROL, V76, P6293, DOI 10.1128/JVI.76.12.6293-6301.2002; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Rouwendal GJA, 2007, GLYCOBIOLOGY, V17, P334, DOI 10.1093/glycob/cwl078; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Sainsbury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013976; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Schuster Manfred, 2007, Biotechnology Journal, V2, P700, DOI 10.1002/biot.200600255; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; ZEITLIN L, DESIGN TEST IN PRESS	31	48	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26040	10.1371/journal.pone.0026040	http://dx.doi.org/10.1371/journal.pone.0026040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039433	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200005
J	Frolov, RV; Ignatova, II; Singh, S				Frolov, Roman V.; Ignatova, Irina I.; Singh, Satpal			Inhibition of hERG Potassium Channels by Celecoxib and Its Mechanism	PLOS ONE			English	Article							LONG QT SYNDROME; TORSADES-DE-POINTES; CARDIAC-ARRHYTHMIAS; K+ CHANNEL; DRUG DEVELOPMENT; MUTATIONS; RECTIFIER; CURRENTS; KVLQT1; BLOCK	Background: Celecoxib (Celebrex), a widely prescribed selective inhibitor of cyclooxygenase-2, can modulate ion channels independently of cyclooxygenase inhibition. Clinically relevant concentrations of celecoxib can affect ionic currents and alter functioning of neurons and myocytes. In particular, inhibition of Kv2.1 channels by celecoxib leads to arrhythmic beating of Drosophila heart and of rat heart cells in culture. However, the spectrum of ion channels involved in human cardiac excitability differs from that in animal models, including mammalian models, making it difficult to evaluate the relevance of these observations to humans. Our aim was to examine the effects of celecoxib on hERG and other human channels critically involved in regulating human cardiac rhythm, and to explore the mechanisms of any observed effect on the hERG channels. Methods and Results: Celecoxib inhibited the hERG, SCN5A, KCNQ1 and KCNQ1/MinK channels expressed in HEK-293 cells with IC(50)s of 6.0 mu M, 7.5 mu M, 3.5 mu M and 3.7 mu M respectively, and the KCND3/KChiP2 channels expressed in CHO cells with an IC(50) of 10.6 mu M. Analysis of celecoxib's effects on hERG channels suggested gating modification as the mechanism of drug action. Conclusions: The above channels play a significant role in drug-induced long QT syndrome (LQTS) and short QT syndrome (SQTS). Regulatory guidelines require that all new drugs under development be tested for effects on the hERG channel prior to first administration in humans. Our observations raise the question of celecoxib's potential to induce cardiac arrhythmias or other channel related adverse effects, and make a case for examining such possibilities.	[Frolov, Roman V.; Ignatova, Irina I.; Singh, Satpal] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Frolov, Roman V.; Ignatova, Irina I.] Univ Oulu, Dept Phys Sci, Div Biophys, Oulu, Finland	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Oulu	Frolov, RV (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA.	singhs@buffalo.edu	Frolov, Roman/I-3889-2016; Frolov, Roman/H-8099-2012	Frolov, Roman/0000-0002-7431-5297; Ignatova, Irina/0000-0002-9861-2640	National Science Foundation, USA [MCB-0094477, MCB-0322461]	National Science Foundation, USA(National Science Foundation (NSF))	This work was supported by the National Science Foundation, USA, grant numbers MCB-0094477 and MCB-0322461 (http://nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias II O, 2011, CHANNELS AUSTIN, V5; Bellocq C, 2004, CIRCULATION, V109, P2394, DOI 10.1161/01.CIR.0000130409.72142.FE; Brueggemann LI, 2009, MOL PHARMACOL, V76, P1053, DOI 10.1124/mol.109.057844; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; FDA US Food and Drug Administration, 2010, PROP WITHDR RISK CAR; Frolov RV, 2008, NEUROSCIENCE, V154, P1525, DOI 10.1016/j.neuroscience.2008.05.004; Frolov RV, 2010, BRIT J PHARMACOL, V159, P405, DOI 10.1111/j.1476-5381.2009.00539.x; Frolov RV, 2008, J BIOL CHEM, V283, P1518, DOI 10.1074/jbc.M708100200; Frolov RV, 2010, BRAIN RES, V1359, P67, DOI 10.1016/j.brainres.2010.08.062; Gaborit N, 2009, EUR HEART J, V30, P487, DOI 10.1093/eurheartj/ehn520; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Kang JS, 2003, EUR J PHARMACOL, V458, P25, DOI 10.1016/S0014-2999(02)02700-0; Kuryshev YA, 2000, J PHARMACOL EXP THER, V295, P614; Liu Huajun, 2003, Am J Pharmacogenomics, V3, P173, DOI 10.2165/00129785-200303030-00003; Lupoglazoff JM, 2004, J AM COLL CARDIOL, V43, P826, DOI 10.1016/j.jacc.2003.09.049; Macias A, 2010, J MOL CELL CARDIOL, V49, P984, DOI 10.1016/j.yjmcc.2010.09.012; Milnes JT, 2003, FEBS LETT, V547, P20, DOI 10.1016/S0014-5793(03)00662-8; Park SY, 2007, BRAIN RES, V1148, P53, DOI 10.1016/j.brainres.2007.02.023; *PFIZ, 2009, PHYS PRESCR INF; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Raschi E, 2008, PHARMACOL RES, V57, P181, DOI 10.1016/j.phrs.2008.01.009; Refaat M, 2008, PACE, V31, P1246, DOI 10.1111/j.1540-8159.2008.01173.x; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Shah RR, 2004, ANN MED, V36, P47, DOI 10.1080/17431380410032445; Snyders DJ, 1996, MOL PHARMACOL, V49, P949; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Ten Tusscher KHWJ, 2007, CIRC RES, V100, pE87, DOI 10.1161/CIRCRESAHA.107.150730; The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2005, S7B NONCL EV POT DEL; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vik T, 2008, PHARMACOL THERAPEUT, V119, P210, DOI 10.1016/j.pharmthera.2008.05.006; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; Zhang Y, 2007, ACTA PHYS SIN-CH ED, V56, P56, DOI 10.7498/aps.56.56; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	42	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26344	10.1371/journal.pone.0026344	http://dx.doi.org/10.1371/journal.pone.0026344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039467	Green Submitted, Green Published, gold			2022-12-25	WOS:000296515200014
J	Laroni, A; Gandhi, R; Beynon, V; Weiner, HL				Laroni, Alice; Gandhi, Roopali; Beynon, Vanessa; Weiner, Howard L.			IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CD4(+) T-CELLS; MULTIPLE-SCLEROSIS; ADAPTIVE IMMUNITY; LYMPH-NODES; INNATE; INTERLEUKIN-27; CYTOKINES; RECEPTOR; IL-10	Interleukin-27 (IL-27) is a cytokine with multiple roles in regulating the immune response, but its effect on human CD56(bright) and CD56(dim) NK cell subsets is unknown. NK cell subsets interact with other components of the immune system, leading to cytotoxicity or immunoregulation depending on stimulating factors. We found that IL-27 treatment results in increased IL-10 and IFN-gamma expression, increased viability and decreased proliferation in both CD56(bright) and CD56(dim) NK cell subsets. More importantly, IL-27 treatment imparts regulatory activity to CD56(bright) NK cells, which mediates its suppressive function on T cells in a contact-dependent manner. There is growing evidence that CD56(bright) NK cell-mediated immunoregulation plays an important role in the control of autoimmunity. Thus, understanding the role of IL-27 in NK cell function has important implications for treatment of autoimmune disorders.	[Laroni, Alice; Gandhi, Roopali; Beynon, Vanessa; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Laroni, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu	Laroni, Alice/K-4714-2016	Laroni, Alice/0000-0001-5599-9788	National Multiple Sclerosis Society [RG4151-A-12]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	The study was funded by National Multiple Sclerosis Society (nationalmssociety.org) Grant RG4151-A-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; de Rham C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2336; Diveu C, 2008, CURR OPIN IMMUNOL, V20, P663, DOI 10.1016/j.coi.2008.09.003; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Feriazzo Guido, 2008, V415, P197, DOI 10.1007/978-1-59745-570-1_12; Flodstrom-Tullberg M, 2009, CURR OPIN IMMUNOL, V21, P634, DOI 10.1016/j.coi.2009.09.012; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matsui M, 2009, CANCER RES, V69, P2523, DOI 10.1158/0008-5472.CAN-08-2793; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8	24	41	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26173	10.1371/journal.pone.0026173	http://dx.doi.org/10.1371/journal.pone.0026173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039443	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500037
J	Lipps, DB; Galecki, AT; Ashton-Miller, JA				Lipps, David B.; Galecki, Andrzej T.; Ashton-Miller, James A.			On the Implications of a Sex Difference in the Reaction Times of Sprinters at the Beijing Olympics	PLOS ONE			English	Article							TWITCH CONTRACTILE PROPERTIES; WORLD-CLASS SPRINTERS; BRAIN-STEM RESPONSE; GENDER DIFFERENCES; POWER; MUSCLES; STARTS; AGE	Elite sprinters offer insights into the fastest whole body auditory reaction times. When, however, is a reaction so fast that it represents a false start? Currently, a false start is awarded if an athlete increases the force on their starting block above a given threshold before 100 ms has elapsed after the starting gun. To test the hypothesis that the fastest valid reaction times of sprinters really is 100 ms and that no sex difference exists in that time, we analyzed the fastest reaction times achieved by each of the 425 male and female sprinters who competed at the 2008 Beijing Olympics. After power transformation of the skewed data, a fixed effects ANOVA was used to analyze the effects of sex, race, round and lane position. The lower bounds of the 95, 99 and 99.9% confidence intervals were then calculated and back transformed. The mean fastest reaction time recorded by men was significantly faster than women (p<0.001). At the 99.9% confidence level, neither men nor women can react in 100 ms, but they can react in as little as 109 ms and 121 ms, respectively. However, that sex difference in reaction time is likely an artifact caused by using the same force threshold in women as men, and it permits a woman to false start by up to 21 ms without penalty. We estimate that female sprinters would have similar reaction times to male sprinters if the force threshold used at Beijing was lowered by 22% in order to account for their lesser muscle strength.	[Lipps, David B.; Ashton-Miller, James A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Galecki, Andrzej T.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Galecki, Andrzej T.; Ashton-Miller, James A.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lipps, DB (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	jaam@umich.edu	Lipps, David/A-7080-2013; Lipps, David/C-3964-2014	Lipps, David/0000-0003-1140-9891	National Defense Science and Engineering Graduate Fellowship; National Institutes of Health [P30 AG024824]; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Defense Science and Engineering Graduate Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge funding from a National Defense Science and Engineering Graduate Fellowship (DBL) and a National Institutes of Health grant (P30 AG024824) (ATG and JAAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MJL, 1989, CAN J SPORT SCI, V14, P148; BOVAY JP, 1985, Patent No. 4523204; Brown AM, 2008, MED SCI SPORT EXER, V40, P1142, DOI 10.1249/MSS.0b013e31816770e1; Collet C, 1999, PERCEPT MOTOR SKILL, V88, P65, DOI 10.2466/PMS.88.1.65-75; DERG, 2006, PSYCHOL AGING, V21, P62; DON M, 1993, J ACOUST SOC AM, V94, P2135, DOI 10.1121/1.407485; *IAAF, 2008, COMP RUL 2008; Janssen I, 2000, J APPL PHYSIOL, V89, P81; KOMI PV, 2009, IAAF NEW STUDIES ATH, V24, P37; Mero A, 2006, J SPORT SCI, V24, P165, DOI 10.1080/02640410500131753; MERO A, 1990, EUR J APPL PHYSIOL O, V61, P73, DOI 10.1007/BF00236697; Paasuke M, 1999, EUR J APPL PHYSIOL O, V80, P448, DOI 10.1007/s004210050616; Paasuke M, 2002, MED SPORT, V55, P279; Pain MTG, 2007, J SPORT SCI, V25, P79, DOI 10.1080/02640410600718004; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; TRUNE DR, 1988, HEARING RES, V32, P165, DOI 10.1016/0378-5955(88)90088-3; Uth N, 2005, J SPORT SCI MED, V4, P608; WIDDING E, 1999, Patent No. 6002336; Wunderlich RE, 2001, MED SCI SPORT EXER, V33, P605; ZEMPER ED, 2009, US TRACK FIELD START	20	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26141	10.1371/journal.pone.0026141	http://dx.doi.org/10.1371/journal.pone.0026141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039438	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500032
J	Deville, S; Viazzi, C; Leloup, J; Lasalle, A; Guizard, C; Maire, E; Adrien, J; Gremillard, L				Deville, Sylvain; Viazzi, Celine; Leloup, Jerome; Lasalle, Audrey; Guizard, Christian; Maire, Eric; Adrien, Jerome; Gremillard, Laurent			Ice Shaping Properties, Similar to That of Antifreeze Proteins, of a Zirconium Acetate Complex	PLOS ONE			English	Article							ADSORPTION	The control of the growth morphologies of ice crystals is a critical issue in fields as diverse as biomineralization, medicine, biology, civil or food engineering. Such control can be achieved through the ice-shaping properties of specific compounds. The development of synthetic ice-shaping compounds is inspired by the natural occurrence of such properties exhibited by antifreeze proteins. We reveal how a particular zirconium acetate complex is exhibiting ice-shaping properties very similar to that of antifreeze proteins, albeit being a radically different compound. We use these properties as a bioinspired approach to template unique faceted pores in cellular materials. These results suggest that ice-structuring properties are not exclusive to long organic molecules and should broaden the field of investigations and applications of such substances.	[Deville, Sylvain; Viazzi, Celine; Leloup, Jerome; Lasalle, Audrey; Guizard, Christian] UMR3080 CNRS St Gobain, Lab Synth & Fonctionnalisat Ceram, Cavaillon, France; [Maire, Eric; Adrien, Jerome; Gremillard, Laurent] Univ Lyon, INSA Lyon, MATEIS CNRS UMR5510, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Deville, S (corresponding author), UMR3080 CNRS St Gobain, Lab Synth & Fonctionnalisat Ceram, Cavaillon, France.	sylvain.deville@saint-gobain.com	Gremillard, Laurent/D-7813-2011; adrien, jerome/A-5912-2009; Deville, Sylvain/H-5515-2019	Gremillard, Laurent/0000-0001-7258-6483; adrien, jerome/0000-0003-0341-3559; Deville, Sylvain/0000-0002-3363-3184; , eric/0000-0003-1952-2602	National Research Agency (ANR) [BLAN07-2_192446]	National Research Agency (ANR)(French National Research Agency (ANR))	Financial support was provided for the development of the cooling cell for X-rays experiments by the National Research Agency (ANR), project NACRE in the non-thematic BLANC program, reference BLAN07-2_192446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley SL, 2009, MODERN BIOPOLYMER SCIENCE: BRIDGING THE DIVIDE BETWEEN FUNDAMENTAL TREATISE AND INDUSTRIAL APPLICATION, P93, DOI 10.1016/B978-0-12-374195-0.00003-3; Cheng CHC, 1998, CURR OPIN GENET DEV, V8, P715, DOI 10.1016/S0959-437X(98)80042-7; Clarke CJ, 2002, CRYOLETTERS, V23, P89; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270; Geiculescu AC, 1999, J SOL-GEL SCI TECHN, V16, P243, DOI 10.1023/A:1008769204022; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; KNIGHT CA, 1995, CRYOBIOLOGY, V32, P23, DOI 10.1006/cryo.1995.1002; MULLIN JW, 1998, CRYSTALLIZATION; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Sokolov O, 2002, J PHYS CHEM A, V106, P775, DOI 10.1021/jp013291m; XU MGH, 1998, CAN J MICROBIOL, V44, P64; Zepeda S, 2008, CRYST GROWTH DES, V8, P3666, DOI 10.1021/cg800269w; ZOU J, ACS NANO, V4, P7293	15	56	57	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26474	10.1371/journal.pone.0026474	http://dx.doi.org/10.1371/journal.pone.0026474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028886	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900069
J	Garcia, AE; Mada, SR; Rico, MC; Dela Cadena, RA; Kunapuli, SP				Garcia, Analia E.; Mada, Sripal R.; Rico, Mario C.; Dela Cadena, Raul A.; Kunapuli, Satya P.			Clopidogrel, a P2Y12 Receptor Antagonist, Potentiates the Inflammatory Response in a Rat Model of Peptidoglycan Polysaccharide-Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CELL-WALL; NEUTROPHIL ACTIVATION; CALCIUM MOBILIZATION; MOLECULAR-BASIS; ADP RECEPTORS; PLATELETS; BLOOD; CHEMOKINES; SYNOVITIS	The P2Y12 receptor plays a crucial role in the regulation of platelet activation by several agonists, which is irreversibly antagonized by the active metabolite of clopidogrel, a widely used anti-thrombotic drug. In this study, we investigated whether reduction of platelet reactivity leads to reduced inflammatory responses using a rat model of erosive arthritis. We evaluated the effect of clopidogrel on inflammation in Lewis rats in a peptidoglycan polysaccharide (PG-PS)-induced arthritis model with four groups of rats: 1) untreated, 2) clopidogrel-treated, 3) PG-PS-induced, and 4) PG-PS-induced and clopidogrel-treated. There were significant differences between the PG-PS+ clopidogrel group when compared to the PG-PS group including: increased joint diameter and clinical manifestations of inflammation, elevated plasma levels of proinflammatory cytokines (IL-1 beta, interferon (IFN) gamma, and IL-6), an elevated neutrophil blood count and an increased circulating platelet count. Plasma levels of IL-10 were significantly lower in the PG-PS+ clopidogrel group compared to the PG-PS group. Plasma levels of platelet factor 4 (PF4) were elevated in both the PG-PS and the PG-PS+ clopidogrel groups, however PF4 levels showed no difference upon clopidogrel treatment, suggesting that the pro-inflammatory effect of clopidogrel may be due to its action on cells other than platelets. Histology indicated an increase in leukocyte infiltration at the inflammatory area of the joint, increased pannus formation, blood vessel proliferation, subsynovial fibrosis and cartilage erosion upon treatment with clopidogrel in PG-PS-induced arthritis animals. In summary, animals treated with clopidogrel showed a pro-inflammatory effect in the PG-PS-induced arthritis animal model, which might not be mediated by platelets. Elucidation of the mechanism of clopidogrel-induced cell responses is important to understand the role of the P2Y12 receptor in inflammation.	[Garcia, Analia E.; Mada, Sripal R.; Rico, Mario C.; Dela Cadena, Raul A.; Kunapuli, Satya P.] Temple Univ, Sch Med, Temple Univ Hosp, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Garcia, Analia E.; Dela Cadena, Raul A.; Kunapuli, Satya P.] Temple Univ, Sch Med, Temple Univ Hosp, Dept Physiol, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Temple Univ Hosp, Dept Pharmacol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Garcia, AE (corresponding author), Temple Univ, Sch Med, Temple Univ Hosp, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA.	agarcia@temple.edu		Rico, Mario/0000-0002-1356-0416	National Heart, Lung and Blood Institute of the National Institutes of Health (NHLBI-NIH) [K01 HL092586, R01 HL60683, R25 HL096331, T32 HL07777, K01 HL103197]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL096331, K01HL092586, K01HL103197, R01HL060683, T32HL007777] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health (NHLBI-NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Research Grants of the National Heart, Lung and Blood Institute of the National Institutes of Health (NHLBI-NIH): K01 HL092586 (AG), R01 HL60683 (SPK), R25 HL096331 (RADC), and T32 HL07777, K01 HL103197 (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2006, DIABETES, V55, P780, DOI 10.2337/diabetes.55.03.06.db05-1394; Blauwet L, 2003, JCR-J CLIN RHEUMATOL, V9, P128, DOI 10.1097/01.RHU.0000062515.74319.4b; Bleich A, 2009, INFLAMM BOWEL DIS, V15, P1794, DOI 10.1002/ibd.21018; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boulman N, 2005, ISR MED ASSOC J, V7, P670; Burstein S A, 1996, Stem Cells, V14 Suppl 1, P154; Cattaneo Marco, 2007, Expert Rev Cardiovasc Ther, V5, P45, DOI 10.1586/14779072.5.1.45; Chen KK, 2003, INTERN MED J, V33, P618, DOI 10.1111/j.1445-5994.2003.00496.x; COWEN DS, 1989, J CLIN INVEST, V83, P1651, DOI 10.1172/JCI114064; CROMARTIE WJ, 1977, J EXP MED, V146, P1585, DOI 10.1084/jem.146.6.1585; Dangelmaier C, 2001, THROMB HAEMOSTASIS, V85, P341, DOI 10.1055/s-0037-1615690; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; DELACADENA RA, 1991, AM J PHYSIOL, V260, pG213, DOI 10.1152/ajpgi.1991.260.2.G213; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Espinola RG, 2004, AM J PATHOL, V165, P969, DOI 10.1016/S0002-9440(10)63358-5; Fuseler JW, 1997, INFLAMMATION, V21, P113, DOI 10.1023/A:1027351111240; Garg A, 2000, BRIT MED J, V320, P483; GREENBLATT J, 1978, INFECT IMMUN, V19, P296, DOI 10.1128/IAI.19.1.296-303.1978; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kannan Krishnaswamy, 2005, Pathophysiology, V12, P167, DOI 10.1016/j.pathophys.2005.07.011; Kawashiri SY, 2009, RHEUMATOL INT; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623; Koizumi F, 1999, PATHOL INT, V49, P298, DOI 10.1046/j.1440-1827.1999.00863.x; Kowalska MA, 2000, BLOOD, V96, P50, DOI 10.1182/blood.V96.1.50.013k40_50_57; Kunapuli SP, 1998, BIOCHEM J, V336, P513, DOI 10.1042/bj3360513; Leon C, 2004, BLOOD, V103, P594, DOI 10.1182/blood-2003-05-1385; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Rico MC, 2008, TRANSL RES, V152, P95, DOI 10.1016/j.trsl.2008.06.002; Rico MC, 2007, J CELL PHYSIOL, V211, P504, DOI 10.1002/jcp.20958; ROONEY M, 1988, ARTHRITIS RHEUM, V31, P956, DOI 10.1002/art.1780310803; RUF A, 1995, BRIT J HAEMATOL, V90, P791, DOI 10.1111/j.1365-2141.1995.tb05197.x; SAVI P, 1992, BIOCHEM PHARMACOL, V44, P527, DOI 10.1016/0006-2952(92)90445-O; Savi P, 2005, SEMIN THROMB HEMOST, V31, P174, DOI 10.1055/s-2005-869523; Schrijver IA, 2001, CLIN EXP IMMUNOL, V123, P140, DOI 10.1046/j.1365-2249.2001.01419.x; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Swennen ELR, 2005, EUR J IMMUNOL, V35, P852, DOI 10.1002/eji.200425423; Swennen ELR, 2006, BIOCHEM BIOPH RES CO, V348, P1194, DOI 10.1016/j.bbrc.2006.07.177; Tayyareci Y, 2008, JCR-J CLIN RHEUMATOL, V14, P254, DOI 10.1097/RHU.0b013e31818272a6; Telfer JF, 2004, MED SCI MONITOR, V10, pBR91; van Gestel MA, 2003, ARTERIOSCL THROM VAS, V23, P518, DOI 10.1161/01.ATV.0000057809.32354.22; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; YAN ZQ, 1994, BLOOD, V84, P2329	46	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26035	10.1371/journal.pone.0026035	http://dx.doi.org/10.1371/journal.pone.0026035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028806	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900025
J	Liu, BR; Fu, YG; Wang, ZF; Zhou, SS; Sun, Y; Wu, YP; Xu, AL				Liu, Benrong; Fu, Yonggui; Wang, Zhifen; Zhou, Sisi; Sun, Yu; Wu, Yuping; Xu, Anlong			HLA-DRB1 May Be Antagonistically Regulated by the Coordinately Evolved Promoter and 3 '-UTR under Stabilizing Selection	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II GENES; HLA-DRB GENES; 3-DIMENSIONAL STRUCTURE; NATURAL-SELECTION; POLYMORPHISM; EXPRESSION; MHC; REGION; ASSOCIATION	HLA-DRB1 is the most polymorphic MHC (major histocompatibility complex) class II gene in human, and plays a crucial role in the development and function of the immune system. Extensive polymorphisms exist in the promoter and 3'-UTR of HLA-DRB1, especially a LTR (Long terminal repeat) element in the promoter, which may be involved in the expression regulation. However, it remains unknown how the polymorphisms in the whole promoter region and 3'-UTR to regulate the gene expression. In this study, we investigated the extensive polymorphisms in the HLA-DRB1 promoter and 3'-UTR, and how these polymorphisms affect the gene expression in both independent and jointly manners. It was observed that most of the haplotypes in the DRB1 promoter and 3'-UTR were clustered into 4 conserved lineages (H1, H2, H3 and H4), and showed high linkage disequilibrium. Compared with H1 and H2 lineage, a LTR element in the promoter of H3 and H4 lineage significantly suppressed the promoter activity, whereas the activity of the linked 3'-UTR increased, leading to no apparent difference in the final expression product between H1/H2 and H3/H4 lineage. Nevertheless, compared with the plasmid with a promoter and 3'-UTR from the same lineage, the recombinant plasmid with a promoter from H2 and a 3'-UTR from H3 showed about double fold increased luciferase activity, Conversely, the recombinant plasmid with a promoter from H3 and a 3'-UTR from H2 resulted in about 2-fold decreased luciferase activity. These results indicate that the promoter and 3'-UTR of HLA-DRB1 may antagonistically regulate the gene expression, which may be subjected to stabilizing selection. These findings may provide a novel insight into the mechanisms of the diseases associated with HLA-DRB1 genes.	[Liu, Benrong; Fu, Yonggui; Wang, Zhifen; Zhou, Sisi; Sun, Yu; Wu, Yuping; Xu, Anlong] Sun Yat Sen Zhongshan Univ, State Key Lab Biocontrol, Guangdong Prov Key Lab Pharmaceut Funct Genes, Dept Biochem,Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, BR (corresponding author), Sun Yat Sen Zhongshan Univ, State Key Lab Biocontrol, Guangdong Prov Key Lab Pharmaceut Funct Genes, Dept Biochem,Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	Sun, Yu/D-4237-2016		National Natural Science Foundation of China [30730089]; National Basic Research Program (973) [2007CB815800]; State High-Tech Development Project (863) [2006AA09Z433, 2008AA092603]; Ministry of Science and Technology of China [2007DFA30840]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973)(National Basic Research Program of China); State High-Tech Development Project (863)(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Key Project (No 30730089) from National Natural Science Foundation of China (http://www.nsfc.gov.cn), Project 2007CB815800 of the National Basic Research Program (973), projects 2006AA09Z433 and 2008AA092603 of the State High-Tech Development Project (863), project 2007DFA30840 of International S&T Cooperation Program from the Ministry of Science and Technology of China (http://www.most.gov.cn). Dr. Xu is the recipent of "Outstanding Young Scientist Award'' from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaez C, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-79; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; Baker CS, 2006, IMMUNOGENETICS, V58, P283, DOI 10.1007/s00251-006-0080-y; BERDOZ J, 1987, J IMMUNOL, V139, P1336; Bergstrom TF, 1999, IMMUNOL REV, V167, P351, DOI 10.1111/j.1600-065X.1999.tb01404.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Dharam P, 1995, IMMUNOGENETICS, V43, P50; Doherty P C, 1975, Nature, V256, P50; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Garamszegi LZ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-73; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kadota Y, 2000, CLIN EXP IMMUNOL, V121, P59, DOI 10.1046/j.1365-2249.2000.01256.x; Kotsch K, 1999, TISSUE ANTIGENS, V53, P486, DOI 10.1034/j.1399-0039.1999.530505.x; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Lemos B, 2005, EVOLUTION, V59, P126; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Liu B, 2011, TISSUE ANTIGENS, V77, P159, DOI 10.1111/j.1399-0039.2010.01593.x; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Liu XY, 2006, AM J HUM GENET, V78, P393, DOI 10.1086/500593; Loisel DA, 2006, P NATL ACAD SCI USA, V103, P16331, DOI 10.1073/pnas.0607662103; LOUIS P, 1994, J IMMUNOL, V153, P5059; LOUIS P, 1994, CR ACAD SCI III-VIE, V317, P161; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Marsh SGE, 1998, TISSUE ANTIGENS, V51, P582, DOI 10.1111/j.1399-0039.1998.tb02998.x; Mueller-Hilke B, 2006, CURR PHARM DESIGN, V12, P3743; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; QIU X, 1995, TRANSPLANT P, V27, P682; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Ridgway WM, 1998, J EXP MED, V188, P2267, DOI 10.1084/jem.188.12.2267; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shankarkumar U, 2009, JAIDS-J ACQ IMM DEF, V51, P640, DOI 10.1097/QAI.0b013e3181add600; SINGAL DP, 1994, MOL IMMUNOL, V31, P1117, DOI 10.1016/0161-5890(94)90107-4; Singal DP, 1996, IMMUNOGENETICS, V43, P50; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; STUNZ LL, 1989, J IMMUNOL, V143, P3081; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; TAKAHATA N, 1992, GENETICS, V130, P925; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari J L, 1981, Prog Clin Biol Res, V58, P151; Tomilin NV, 2008, BIOESSAYS, V30, P338, DOI 10.1002/bies.20741; Viret C, 1999, Rev Immunogenet, V1, P91; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	56	0	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25794	10.1371/journal.pone.0025794	http://dx.doi.org/10.1371/journal.pone.0025794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028790	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900018
J	Mauda-Havakuk, M; Litichever, N; Chernichovski, E; Nakar, O; Winkler, E; Mazkereth, R; Orenstein, A; Bar-Meir, E; Ravassard, P; Meivar-Levy, I; Ferber, S				Mauda-Havakuk, Michal; Litichever, Naomi; Chernichovski, Ellad; Nakar, Odelia; Winkler, Eyal; Mazkereth, Ram; Orenstein, Arie; Bar-Meir, Eran; Ravassard, Philippe; Meivar-Levy, Irit; Ferber, Sarah			Ectopic PDX-1 Expression Directly Reprograms Human Keratinocytes along Pancreatic Insulin-Producing Cells Fate	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; PLURIPOTENT STEM-CELLS; BETA-CELLS; PROGENITOR CELLS; GENE-EXPRESSION; DIRECT CONVERSION; LIVER; TRANSDIFFERENTIATION; DIFFERENTIATION; HYPERGLYCEMIA	Background: Cellular differentiation and lineage commitment have previously been considered irreversible processes. However, recent studies have indicated that differentiated adult cells can be reprogrammed to pluripotency and, in some cases, directly into alternate committed lineages. However, although pluripotent cells can be induced in numerous somatic cell sources, it was thought that inducing alternate committed lineages is primarily only possible in cells of developmentally related tissues. Here, we challenge this view and analyze whether direct adult cell reprogramming to alternate committed lineages can cross the boundaries of distinct developmental germ layers. Methodology/Principal Findings: We ectopically expressed non-integrating pancreatic differentiation factors in ectoderm-derived human keratinocytes to determine whether these factors could directly induce endoderm-derived pancreatic lineage and beta-cell-like function. We found that PDX-1 and to a lesser extent other pancreatic transcription factors, could rapidly and specifically activate pancreatic lineage and beta-cell-like functional characteristics in ectoderm-derived human keratinocytes. Human keratinocytes transdifferentiated along the beta cell lineage produced processed and secreted insulin in response to elevated glucose concentrations. Using irreversible lineage tracing for KRT-5 promoter activity, we present supporting evidence that insulin-positive cells induced by ectopic PDX-1 expression are generated in ectoderm derived keratinocytes. Conclusions/Significance: These findings constitute the first demonstration of human ectoderm cells to endoderm derived pancreatic cells transdifferentiation. The study represents a proof of concept which suggests that transcription factors induced reprogramming is wider and more general developmental process than initially considered. These results expanded the arsenal of adult cells that can be used as a cell source for generating functional endocrine pancreatic cells. Directly reprogramming somatic cells into alternate desired tissues has important implications in developing patient-specific, regenerative medicine approaches.	[Mauda-Havakuk, Michal; Litichever, Naomi; Chernichovski, Ellad; Nakar, Odelia; Meivar-Levy, Irit; Ferber, Sarah] Sheba Med Ctr, Sheba Regenerat Med Stem Cells & Tissue Engn Ctr, Tel Hashomer, Israel; [Mauda-Havakuk, Michal; Litichever, Naomi; Chernichovski, Ellad; Nakar, Odelia; Ferber, Sarah] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; [Winkler, Eyal; Orenstein, Arie; Bar-Meir, Eran] Sheba Med Ctr, Dept Plast & Reconstruct, Tel Hashomer, Israel; [Mazkereth, Ram] Sheba Med Ctr, Albert Katz Dept Neonatol, Tel Hashomer, Israel; [Ravassard, Philippe] Univ Paris 06, Biotechnol & Biotherapy Grp,Ctr Recj, Inst Cerveau & Moelle, CNRS UMR7225,INSERM UMRS795, Paris, France	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Mauda-Havakuk, M (corresponding author), Sheba Med Ctr, Sheba Regenerat Med Stem Cells & Tissue Engn Ctr, Tel Hashomer, Israel.	sferber@sheba.health.gov.il		ravassard, philippe/0000-0002-0393-9262; Ferber, Sarah/0000-0003-2764-2786	Friends of Sheba in LA	Friends of Sheba in LA	The work was supported, in part, by the Friends of Sheba in LA (to S. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Aviv V, 2009, J BIOL CHEM, V284, P33509, DOI 10.1074/jbc.M109.017608; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Deutsch G, 2001, DEVELOPMENT, V128, P871; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; Endo M, 2008, MOL THER, V16, P131, DOI 10.1038/sj.mt.6300332; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Ferber S, 2000, ISR MED ASSOC J, V2, P32; Gefen-Halevi S, 2010, CELL REPROGRAM, V12, P655, DOI 10.1089/cell.2010.0030; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; Gershengorn MC, 2005, CELL CYCLE, V4, P380, DOI 10.4161/cc.4.3.1538; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Green H, 1977, Prog Clin Biol Res, V17, P493; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kahn A, 2000, NAT MED, V6, P505, DOI 10.1038/74980; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Koizumi M, 2004, SURGERY, V136, P449, DOI 10.1016/j.surg.2004.05.024; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Meivar-Levy I, 2007, HEPATOLOGY, V46, P898, DOI 10.1002/hep.21766; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nakajima-Nagata N, 2004, BIOCHEM BIOPH RES CO, V318, P625, DOI 10.1016/j.bbrc.2004.04.059; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; PANG ZP, 2011, NATURE, P26; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Seijffers R, 1999, ENDOCRINOLOGY, V140, P3311, DOI 10.1210/en.140.7.3311; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang DQ, 2006, LAB INVEST, V86, P829, DOI 10.1038/labinvest.3700434; Tang DQ, 2006, LAB INVEST, V86, P83, DOI 10.1038/labinvest.3700368; Theise ND, 2002, CR BIOL, V325, P1039, DOI 10.1016/S1631-0691(02)01525-1; Theise ND, 2010, EXP HEMATOL, V38, P529, DOI 10.1016/j.exphem.2010.04.013; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vorburger SA, 2002, ONCOLOGIST, V7, P46, DOI 10.1634/theoncologist.7-1-46; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100; ZHAO T, 2011, NATURE, P13; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	53	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26298	10.1371/journal.pone.0026298	http://dx.doi.org/10.1371/journal.pone.0026298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028850	Green Submitted, gold, Green Published			2022-12-25	WOS:000296186900044
J	Wang, TC; Chiu, H; Chang, YJ; Hsu, TY; Chiu, IM; Chen, LY				Wang, Tien-Cheng; Chiu, Hsun; Chang, Yu-Jung; Hsu, Tai-Yu; Chiu, Ing-Ming; Chen, Linyi			The Adaptor Protein SH2B3 (Lnk) Negatively Regulates Neurite Outgrowth of PC12 Cells and Cortical Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; GLUCOSE-HOMEOSTASIS; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; SELF-RENEWAL; SH2-B; DIFFERENTIATION; APS; ACTIVATION; RECEPTOR	SH2B adaptor protein family members (SH2B1-3) regulate various physiological responses through affecting signaling, gene expression, and cell adhesion. SH2B1 and SH2B2 were reported to enhance nerve growth factor (NGF)-induced neuronal differentiation in PC12 cells, a well-established neuronal model system. In contrast, SH2B3 was reported to inhibit cell proliferation during the development of immune system. No study so far addresses the role of SH2B3 in the nervous system. In this study, we provide evidence suggesting that SH2B3 is expressed in the cortex of embryonic rat brain. Overexpression of SH2B3 not only inhibits NGF-induced differentiation of PC12 cells but also reduces neurite outgrowth of primary cortical neurons. SH2B3 does so by repressing NGF-induced activation of PLC gamma, MEK-ERK1/2 and PI3K-AKT pathways and the expression of Egr-1. SH2B3 is capable of binding to phosphorylated NGF receptor, TrkA, as well as SH2B1 beta. Our data further demonstrate that overexpression of SH2B3 reduces the interaction between SH2B1 beta and TrkA. Consistent with this finding, overexpressing the SH2 domain of SH2B3 is sufficient to inhibit NGF-induced neurite outgrowth. Together, our data demonstrate that SH2B3, unlike the other two family members, inhibits neuronal differentiation of PC12 cells and primary cortical neurons. Its inhibitory mechanism is likely through the competition of TrkA binding with the positive-acting SH2B1 and SH2B2.	[Wang, Tien-Cheng; Chang, Yu-Jung; Hsu, Tai-Yu; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Chiu, Hsun] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Chiu, Ing-Ming] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan	Wang, TC (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan.	lchen@life.nthu.edu.tw	Chiu, Ing-Ming/B-1534-2008; Chen, Linyi/AAV-2632-2020	Chen, Linyi/0000-0001-7258-8817; Chang, Yu-Jung/0000-0002-4781-0946	National Science Council [NSC97-2311-B-007-007-MY3]; National Health Research Institutes of Taiwan [NHRI-EX100-NC9719]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This work is funded by National Science Council (http://web1.nsc.gov.tw/)(NSC97-2311-B-007-007-MY3) and National Health Research Institutes of Taiwan (http://english.nhri.org.tw/)(NHRI-EX100-NC9719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2001, BIOCHEM SOC T, V29, P529, DOI 10.1042/BST0290529; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Gery S, 2007, BLOOD, V110, P3360, DOI 10.1182/blood-2007-05-089326; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; Gueller S, 2011, EXP HEMATOL, V39, P591, DOI 10.1016/j.exphem.2011.02.001; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hu JJ, 2005, J BIOL CHEM, V280, P18943, DOI 10.1074/jbc.M414157200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iseki M, 2005, BIOCHEM BIOPH RES CO, V330, P1005, DOI 10.1016/j.bbrc.2005.03.073; Jantas D, 2009, APOPTOSIS, V14, P900, DOI 10.1007/s10495-009-0370-6; Kovalenko D, 2003, J BIOL CHEM, V278, P14087, DOI 10.1074/jbc.C200606200; Li M, 2006, ENDOCRINOLOGY, V147, P2163, DOI 10.1210/en.2005-1313; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Minowada G, 1999, DEVELOPMENT, V126, P4465; Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200; Nishi M, 2005, MOL CELL BIOL, V25, P2607, DOI 10.1128/MCB.25.7.2607-2621.2005; O'Brien KB, 2002, J BIOL CHEM, V277, P8673, DOI 10.1074/jbc.M109165200; Qian XZ, 2001, MOL CELL BIOL, V21, P1613, DOI 10.1128/MCB.21.5.1613-1620.2001; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; REN D, 2005, CELL METAB, V2, DOI DOI 10.1016/J.CMET.2005.1007.1004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Rui LY, 1999, J BIOL CHEM, V274, P26485, DOI 10.1074/jbc.274.37.26485; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Simon C, 2008, BLOOD, V112, P1039, DOI 10.1182/blood-2008-05-154849; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Tong W, 2004, J EXP MED, V200, P569, DOI 10.1084/jem.20040762; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Xiong SQ, 2003, J BIOL CHEM, V278, P50273, DOI 10.1074/jbc.M306936200; Yamada M, 2001, J NEUROCHEM, V78, P940, DOI 10.1046/j.1471-4159.2001.00497.x; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Yokouchi M, 1999, ONCOGENE, V18, P759, DOI 10.1038/sj.onc.1202326	40	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26433	10.1371/journal.pone.0026433	http://dx.doi.org/10.1371/journal.pone.0026433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028877	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900062
J	Schmitt, KC; Reith, MEA				Schmitt, Kyle C.; Reith, Maarten E. A.			The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors	PLOS ONE			English	Article							BACTERIAL HOMOLOG; IN-VIVO; NOREPINEPHRINE TRANSPORTER; DISCRIMINATIVE STIMULUS; MONOAMINE TRANSPORTERS; CONFORMATIONAL-CHANGES; REINFORCING STRENGTH; SODIUM SYMPORTER; BINDING-SITES; NEUROTRANSMITTER	Modafinil is a mild psychostimulant with pro-cognitive and antidepressant effects. Unlike many conventional stimulants, modafinil has little appreciable potential for abuse, making it a promising therapeutic agent for cocaine addiction. The chief molecular target of modafinil is the dopamine transporter (DAT); however, the mechanistic details underlying modafinil's unique effects remain unknown. Recent studies suggest that the conformational effects of a given DAT ligand influence the magnitude of the ligand's reinforcing properties. For example, the atypical DAT inhibitors benztropine and GBR12909 do not share cocaine's notorious addictive liability, despite having greater binding affinity. Here, we show that the binding mechanism of modafinil is different than cocaine and similar to other atypical inhibitors. We previously established two mutations (W84L and D313N) that increase the likelihood that the DAT will adopt an outward-facing conformational state-these mutations increase the affinity of cocaine-like inhibitors considerably, but have little or opposite effect on atypical inhibitor binding. Thus, a compound's WT/mutant affinity ratio can indicate whether the compound preferentially interacts with a more outward-or inward-facing conformational state. Modafinil displayed affinity ratios similar to those of benztropine, GBR12909 and bupropion (which lack cocaine-like effects in humans), but far different than those of cocaine, beta-CFT or methylphenidate. Whereas treatment with zinc (known to stabilize an outward-facing transporter state) increased the affinity of cocaine and methylphenidate two-fold, it had little or no effect on the binding of modafinil, benztropine, bupropion or GBR12909. Additionally, computational modeling of inhibitor binding indicated that while b-CFT and methylphenidate stabilize an "open-to-out'' conformation, binding of either modafinil or bupropion gives rise to a more closed conformation. Our findings highlight a mechanistic difference between modafinil and cocaine-like stimulants and further demonstrate that the conformational effects of a given DAT inhibitor influence its phenomenological effects.	[Schmitt, Kyle C.; Reith, Maarten E. A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Reith, Maarten E. A.] NYU, Sch Med, Dept Psychiat, New York, NY USA	New York University; New York University	Schmitt, KC (corresponding author), NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA.	maarten.reith@nyumc.org	Reith, Maarten E./AAD-2303-2019	Reith, Maarten E./0000-0002-1900-842X; Schmitt, Kyle/0000-0002-8456-422X	United States National Institutes of Health (NIH) [DA013261, DA019676]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019676, R01DA013261] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Project supported by United States National Institutes of Health (NIH) Grants DA013261 and DA019676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballon JS, 2006, J CLIN PSYCHIAT, V67, P554, DOI 10.4088/JCP.v67n0406; Batman AM, 2010, EUR J PHARMACOL, V648, P127, DOI 10.1016/j.ejphar.2010.08.051; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Campbell VC, 2005, J PHARMACOL EXP THER, V315, P631, DOI 10.1124/jpet.105.090829; Cao JJ, 2011, ACS MED CHEM LETT, V2, P48, DOI 10.1021/ml1002025; Chen NH, 2004, J NEUROCHEM, V89, P853, DOI 10.1111/j.1471-4159.2004.02386.x; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Chen NH, 2003, J NEUROCHEM, V86, P678, DOI 10.1046/j.1471-4159.2003.01889.x; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Czoty PW, 2010, PHARMACOL BIOCHEM BE, V96, P274, DOI 10.1016/j.pbb.2010.05.017; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; Damaj MI, 2004, MOL PHARMACOL, V66, P675, DOI 10.1124/mol.104.001313; Deroche-Gamonet V, 2002, PSYCHOPHARMACOLOGY, V161, P387, DOI 10.1007/s00213-002-1080-8; Desai RI, 2005, J PHARMACOL EXP THER, V315, P397, DOI 10.1124/jpet.105.091231; Desai RI, 2005, J NEUROSCI, V25, P1889, DOI 10.1523/JNEUROSCI.4778-04.2005; Donovan JL, 2003, THER DRUG MONIT, V25, P197, DOI 10.1097/00007691-200304000-00009; ECKERMAN DA, 1991, PHARMACOL BIOCHEM BE, V40, P875, DOI 10.1016/0091-3057(91)90100-G; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gedeon PC, 2010, PROTEINS, V78, P797, DOI 10.1002/prot.22601; GLENNON RA, 1995, PHARMACOL BIOCHEM BE, V50, P601, DOI 10.1016/0091-3057(94)00348-3; Gold LH, 1996, PSYCHOPHARMACOLOGY, V126, P286, DOI 10.1007/BF02247379; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P761, DOI 10.1038/sj.npp.1301472; Herin DV, 2010, ANN NY ACAD SCI, V1187, P76, DOI 10.1111/j.1749-6632.2009.05145.x; Hill ER, 2011, NEUROPHARMACOLOGY, V61, P112, DOI 10.1016/j.neuropharm.2011.03.014; Hiranita T, 2009, J PHARMACOL EXP THER, V329, P677, DOI 10.1124/jpet.108.145813; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Huang XQ, 2009, J PHYS CHEM B, V113, P15057, DOI 10.1021/jp900963n; Jasinski DR, 2000, J PSYCHOPHARMACOL, V14, P53, DOI 10.1177/026988110001400107; Kimmel HL, 2008, PHARMACOL BIOCHEM BE, V90, P453, DOI 10.1016/j.pbb.2008.03.032; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kopajtic TA, 2010, J PHARMACOL EXP THER, V335, P703, DOI 10.1124/jpet.110.171629; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lam JY, 2007, ANN PHARMACOTHER, V41, P1005, DOI 10.1345/aph.1H526; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SM, 2005, J PHARMACOL EXP THER, V313, P1223, DOI 10.1124/jpet.105.084541; Li SM, 2011, J PHARMACOL EXP THER, V336, P575, DOI 10.1124/jpet.110.173260; Liang YJ, 2009, J NEUROCHEM, V109, P981, DOI 10.1111/j.1471-4159.2009.06034.x; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Marchant NL, 2009, PSYCHOPHARMACOLOGY, V202, P487, DOI 10.1007/s00213-008-1395-1; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Newman JL, 2010, EXP CLIN PSYCHOPHARM, V18, P395, DOI 10.1037/a0021042; Ninan PT, 2004, J CLIN PSYCHIAT, V65, P414; Paterson NE, 2010, PHARMACOL BIOCHEM BE, V95, P449, DOI 10.1016/j.pbb.2010.03.006; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rasetti R, 2010, NEUROPSYCHOPHARMACOL, V35, P2101, DOI 10.1038/npp.2010.83; Regenthal R, 2009, PSYCHOPHARMACOLOGY, V204, P627, DOI 10.1007/s00213-009-1493-8; Reith MEA, 2001, J BIOL CHEM, V276, P29012, DOI 10.1074/jbc.M011785200; Ridenour TA, 2005, DRUG ALCOHOL DEPEN, V80, P1, DOI 10.1016/j.drugalcdep.2005.02.005; Rothman RB, 2003, J PHARMACOL EXP THER, V307, P138, DOI 10.1124/jpet.103.053975; Rothman RB, 2008, BIOCHEM PHARMACOL, V75, P2, DOI 10.1016/j.bcp.2007.08.007; Schmitt KC, 2008, J NEUROCHEM, V107, P928, DOI 10.1111/j.1471-4159.2008.05667.x; Schmitt KC, 2010, J NEUROCHEM, V112, P1605, DOI 10.1111/j.1471-4159.2010.06583.x; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SOGAARD U, 1990, INT CLIN PSYCHOPHARM, V5, P237, DOI 10.1097/00004850-199010000-00001; Tahsili-Fahadan P, 2010, NEUROPSYCHOPHARMACOL, V35, P2203, DOI 10.1038/npp.2010.94; Tanda G, 2009, J PHARMACOL EXP THER, V330, P802, DOI 10.1124/jpet.109.154302; Tella SR, 1997, J PHARMACOL EXP THER, V281, P508; Tsanov M, 2010, NEUROPHARMACOLOGY, V59, P9, DOI 10.1016/j.neuropharm.2010.03.010; Tsuang MT, 1999, BEHAV GENET, V29, P473, DOI 10.1023/A:1021635223370; Turner DC, 2004, BIOL PSYCHIAT, V55, P1031, DOI 10.1016/j.biopsych.2004.02.008; Velazquez-Sanchez C, 2009, NEUROPSYCHOPHARMACOL, V34, P2497, DOI 10.1038/npp.2009.78; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Volz TJ, 2004, SYNAPSE, V52, P272, DOI 10.1002/syn.20021; Vosburg SK, 2010, DRUG ALCOHOL DEPEN, V106, P233, DOI 10.1016/j.drugalcdep.2009.09.002; Wee S, 2006, NEUROPSYCHOPHARMACOL, V31, P351, DOI 10.1038/sj.npp.1300795; Whiting E, 2008, BRAIN LANG, V104, P254, DOI 10.1016/j.bandl.2007.03.003; Williard RL, 2007, BEHAV PHARMACOL, V18, P39, DOI 10.1097/FBP.0b013e3280143226; Woolverton WL, 2004, EUR J PHARMACOL, V486, P251, DOI 10.1016/j.ejphar.2004.01.003; Wuo-Silva R, 2011, ADDICT BIOL, V16, P565, DOI 10.1111/j.1369-1600.2011.00341.x; Xu TX, 2010, J NEUROCHEM, V115, P1643, DOI 10.1111/j.1471-4159.2010.07073.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zeeuws I, 2010, HUM PSYCHOPHARM CLIN, V25, P326, DOI 10.1002/hup.1120; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zolkowska D, 2009, J PHARMACOL EXP THER, V329, P738, DOI 10.1124/jpet.108.146142; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	91	88	89	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25790	10.1371/journal.pone.0025790	http://dx.doi.org/10.1371/journal.pone.0025790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043293	gold, Green Submitted, Green Published			2022-12-25	WOS:000295984400021
J	Arnold, LH; Butt, LE; Prior, SH; Read, CM; Fields, GB; Pickford, AR				Arnold, Laurence H.; Butt, Louise E.; Prior, Stephen H.; Read, Christopher M.; Fields, Gregg B.; Pickford, Andrew R.			The Interface between Catalytic and Hemopexin Domains in Matrix Metalloproteinase-1 Conceals a Collagen Binding Exosite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; SCATTERING DATA-ANALYSIS; EHLERS-DANLOS-SYNDROME; FIBROBLAST COLLAGENASE; I COLLAGEN; SUBSTRATE-SPECIFICITY; MAMMALIAN COLLAGENASES; EXTRACELLULAR-MATRIX; OSTEO-SARCOMA; CELL-SURFACE	Matrix metalloproteinase-1 (MMP-1) is an instigator of collagenolysis, the catabolism of triple helical collagen. Previous studies have implicated its hemopexin (HPX) domain in binding and possibly destabilizing the collagen substrate in preparation for hydrolysis of the polypeptide backbone by the catalytic (CAT) domain. Here, we use biophysical methods to study the complex formed between the MMP-1 HPX domain and a synthetic triple helical peptide (THP) that encompasses theMMP-1 cleavage site of the collagen alpha 1(I) chain. The two components interact with 1: 1 stoichiometry and micromolar affinity via a binding site within blades 1 and 2 of the four-bladed HPX domain propeller. Subsequent site-directed mutagenesis and assay implicates blade 1 residues Phe(301), Val(319), and Asp(338) in collagen binding. Intriguingly, Phe(301) is partially masked by the CAT domain in the crystal structure of full-length MMP-1 implying that transient separation of the domains is important in collagen recognition. However, mutation of this residue in the intact enzyme disrupts the CAT-HPX interface resulting in a drastic decrease in binding activity. Thus, a balanced equilibrium between these compact and dislocated states may be an essential feature of MMP-1 collagenase activity.	[Butt, Louise E.; Prior, Stephen H.; Read, Christopher M.; Pickford, Andrew R.] Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DY, Hants, England; [Arnold, Laurence H.] MRC Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	University of Portsmouth; MRC National Institute for Medical Research; Torrey Pines Institute for Molecular Studies, Florida	Pickford, AR (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DY, Hants, England.	andy.pickford@port.ac.uk	Pickford, Andy/AGB-6901-2022	Prior, Steve/0000-0002-6133-0607; Butt, Louise/0000-0003-2422-1046; Arnold, Laurence/0000-0001-6785-1035; Pickford, Andy/0000-0002-7237-0030	National Institutes of Health [CA098799]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/F004532/1]; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; BBSRC [BB/F004532/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant CA098799 (to G. B. F.).; Supported by the Royal Society and Biotechnology and Biological Sciences Research Council Grant BB/F004532/1.; We are extremely grateful to Hideaki Nagase and Robert Visse for providing the original pET-3a plasmid constructs for expressing pro-MMP-1* and HPX-1. We thank Tom Frenkiel, Geoff Kelly, and Alain Oregioni for help at the MRC Biomedical NMR Centre, Mill Hill, UK. We are also indebted to Helen Vincent, Anastasia Callaghan, and Marc Malfois for help in the acquisition and processing of SAXS data at the Diamond Light Source. Funding for the University of Portsmouth NMR facility was provided by the Wellcome Trust.	ALLAN JA, 1991, J CELL SCI, V99, P789; ASOKAN R, 1993, MOL CELL BIOCHEM, V121, P99, DOI 10.1007/BF00925968; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; CHERVENKA CH, 1970, ANAL BIOCHEM, V34, P24, DOI 10.1016/0003-2697(70)90082-5; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EHRLICH HP, 1982, BIOCHEM MED METAB B, V28, P273, DOI 10.1016/0006-2944(82)90080-1; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GLATTER O, 1979, J APPL CRYSTALLOGR, V12, P166, DOI 10.1107/S0021889879012139; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; JIMENEZ SA, 1977, BIOCHEM BIOPH RES CO, V78, P1354, DOI 10.1016/0006-291X(77)91441-3; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Knauper V, 2001, EUR J BIOCHEM, V268, P1888, DOI 10.1046/j.1432-1033.2001.02062.x; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Malfait F, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038224; MORO L, 1977, ARCH BIOCHEM BIOPHYS, V182, P33, DOI 10.1016/0003-9861(77)90280-6; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; NARAYANAN AS, 1980, BIOCHEMISTRY-US, V19, P5037, DOI 10.1021/bi00563a016; O'Farrell TJ, 2006, BIOCHEMISTRY-US, V45, P15411, DOI 10.1021/bi060849d; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Schwarze U, 2004, AM J HUM GENET, V74, P917, DOI 10.1086/420794; SHAPIRO FD, 1982, J NATL CANCER I, V69, P1009; Sober H. A, 1968, HDB BIOCH SELECTED D; STRICKLIN GP, 1983, BIOCHEMISTRY-US, V22, P61, DOI 10.1021/bi00270a009; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Tsukada H, 2002, J BIOL CHEM, V277, P27378, DOI 10.1074/jbc.M201367200; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WELGUS HG, 1985, COLLAGEN REL RES, V5, P167; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; YAMAGATA S, 1984, J BIOCHEM-TOKYO, V96, P17, DOI 10.1093/oxfordjournals.jbchem.a134809	63	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45073	45082		10.1074/jbc.M111.285213	http://dx.doi.org/10.1074/jbc.M111.285213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22030392	Green Published, hybrid			2022-12-25	WOS:000298645500074
J	Kwakman, PHS; Krijgsveld, J; de Boer, L; Nguyen, LT; Boszhard, L; Vreede, J; Dekker, HL; Speijer, D; Drijfhout, JW; Velde, AAT; Crielaard, W; Vogel, HJ; Vandenbroucke-Grauls, CMJE; Zaat, SAJ				Kwakman, Paulus H. S.; Krijgsveld, Jeroen; de Boer, Leonie; Nguyen, Leonard T.; Boszhard, Laura; Vreede, Jocelyne; Dekker, Henk L.; Speijer, Dave; Drijfhout, Jan W.; Velde, Anje A. Te; Crielaard, Wim; Vogel, Hans J.; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.			Native Thrombocidin-1 and Unfolded Thrombocidin-1 Exert Antimicrobial Activity via Distinct Structural Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING PEPTIDE-III; BETA-DEFENSIN 3; PROTEOLYTIC ACTIVATION; HUMAN BETA-DEFENSIN-3; BACTERICIDAL ACTIVITY; CXC CHEMOKINES; ANTIBACTERIAL; PROTEIN; CCL20/MIP-3-ALPHA; PURIFICATION	Chemokines (chemotactic cytokines) can have direct antimicrobial activity, which is apparently related to the presence of a distinct positively charged patch on the surface. However, chemokines can retain antimicrobial activity upon linearization despite the loss of their positive patch, thus questioning the importance of this patch for activity. Thrombocidin-1 (TC-1) is a microbicidal protein isolated from human blood platelets. TC-1 only differs from the chemokine NAP-2/CXCL7 by a two-amino acid C-terminal deletion, but this truncation is crucial for antimicrobial activity. We assessed the structure-activity relationship for antimicrobial activity of TC-1. Reduction of the charge of the TC-1-positive patch by replacing lysine 17 with alanine reduced the activity against bacteria and almost abolished activity against the yeast Candida albicans. Conversely, augmentation of the positive patch by increasing charge density or size resulted in a 2-3-fold increased activity against Staphylococcus aureus, Escherichia coli, and Bacillus subtilis but did not substantially affect activity against C. albicans. Reduction of TC-1 resulted in loss of the folded conformation, but this disruption of the positive patch did not affect antimicrobial activity. Using overlapping 15-mer synthetic peptides, we demonstrate peptides corresponding to the N-terminal part of TC-1 to have similar antimicrobial activity as intact TC-1. Although we demonstrate that the positive patch is essential for activity of folded TC-1, unfolded TC-1 retained antimicrobial activity despite the absence of a positive patch. This activity is probably exerted by a linear peptide stretch in the N-terminal part of the molecule. We conclude that intact TC-1 and unfolded TC-1 exert antimicrobial activity via distinct structural elements.	[Kwakman, Paulus H. S.; de Boer, Leonie; Boszhard, Laura; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Velde, Anje A. Te] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Vreede, Jocelyne] Univ Amsterdam, Acad Ctr Dent Amsterdam, Van tHoff Inst Mol Sci, NL-1098 XH Amsterdam, Netherlands; [Dekker, Henk L.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [Crielaard, Wim] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Cariol Endodontol & Pedodontol, NL-1098 XH Amsterdam, Netherlands; [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Dis, NL-1081 BT Amsterdam, Netherlands; [Drijfhout, Jan W.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 AA Leiden, Netherlands; [Krijgsveld, Jeroen] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Nguyen, Leonard T.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; European Molecular Biology Laboratory (EMBL); University of Calgary	Zaat, SAJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	s.a.zaat@amc.uva.nl	Speijer, Dave/AAE-4613-2019; Drijfhout, Jan Wouter/ABA-6318-2021; Krijgsveld, Jeroen/F-5974-2011; Vandenbroucke-Grauls, Christina/AAO-7953-2020	Speijer, Dave/0000-0002-2340-2753; Drijfhout, Jan Wouter/0000-0003-4808-5296; Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Krijgsveld, Jeroen/0000-0001-7549-9326				Antcheva N, 2004, ANTIMICROB AGENTS CH, V48, P685, DOI 10.1128/AAC.48.2.685-688.2004; Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Bjorstad A, 2005, ANTIMICROB AGENTS CH, V49, P3889, DOI 10.1128/AAC.49.9.3889-3895.2005; BRANDT E, 1991, CYTOKINE, V3, P311, DOI 10.1016/1043-4666(91)90499-4; Callihan D, 1996, J MAGN RESON SER B, V112, P82, DOI 10.1006/jmrb.1996.0114; Chan DI, 2008, ANTIMICROB AGENTS CH, V52, P883, DOI 10.1128/AAC.00805-07; Chandrababu KB, 2009, BIOCHEMISTRY-US, V48, P6052, DOI 10.1021/bi900154f; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Dankert J, 2001, J INFECT DIS, V184, P597, DOI 10.1086/322802; DEKOSTER HS, 1995, J IMMUNOL METHODS, V187, P179, DOI 10.1016/0022-1759(95)00182-A; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; GOODSELL DS, 2005, CURR PROTOC BIOINFOR, P23, DOI DOI 10.1002/0471250953.BI0504S11; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; HARWIG SSL, 1994, METHOD ENZYMOL, V236, P160; Hasan L, 2006, J IMMUNOL, V176, P6512, DOI 10.4049/jimmunol.176.11.6512; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749; Kobayashi S, 2000, BIOCHEMISTRY-US, V39, P8648, DOI 10.1021/bi0004549; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; KRIJGSVELD J, 1999, THESIS U AMSTERDAM A; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Liu B, 2010, EUR J IMMUNOL, V40, P186, DOI 10.1002/eji.200939819; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; MALKOWSKI MG, 1995, J BIOL CHEM, V270, P7077, DOI 10.1074/jbc.270.13.7077; Mandal M, 2002, PEPTIDES, V23, P413, DOI 10.1016/S0196-9781(01)00628-3; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nguyen LT, 2011, ANTIMICROB AGENTS CH, V55, P2074, DOI 10.1128/AAC.01351-10; Nguyen LT, 2010, BBA-BIOMEMBRANES, V1798, P1062, DOI 10.1016/j.bbamem.2009.11.021; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Perez-Canadillas JM, 2001, J BIOL CHEM, V276, P28372, DOI 10.1074/jbc.M103121200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reynolds NL, 2010, ANTIMICROB AGENTS CH, V54, P1922, DOI 10.1128/AAC.01568-09; Richter R, 2005, J IMMUNOL, V175, P1599, DOI 10.4049/jimmunol.175.3.1599; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Semple CAM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r31; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; WALZ A, 1990, J EXP MED, V171, P449, DOI 10.1084/jem.171.2.449; WENGER RH, 1989, BLOOD, V73, P1498; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	52	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43506	43514		10.1074/jbc.M111.248641	http://dx.doi.org/10.1074/jbc.M111.248641			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025617	Green Published, hybrid			2022-12-25	WOS:000298351300070
J	Cerutti, A; Maillard, P; Minisini, R; Vidalain, PO; Roohvand, F; Pecheur, EI; Pirisi, M; Budkowska, A				Cerutti, Andrea; Maillard, Patrick; Minisini, Rosalba; Vidalain, Pierre-Olivier; Roohvand, Farzin; Pecheur, Eve-Isabelle; Pirisi, Mario; Budkowska, Agata			Identification of a Functional, CRM-1-Dependent Nuclear Export Signal in Hepatitis C Virus Core Protein	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; DENGUE VIRUS; NUCLEOCYTOPLASMIC TRANSPORT; LIPID DROPLETS; HEPATOCELLULAR-CARCINOMA; INTRACELLULAR-LOCALIZATION; INTRAMEMBRANE PROTEOLYSIS; STRUCTURAL PROTEINS; VIRAL REPLICATION; INFECTED PATIENTS	Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. HCV core protein is involved in nucleocapsid formation, but it also interacts with multiple cytoplasmic and nuclear molecules and plays a crucial role in the development of liver disease and hepatocarcinogenesis. The core protein is found mostly in the cytoplasm during HCV infection, but also in the nucleus in patients with hepatocarcinoma and in core-transgenic mice. HCV core contains nuclear localization signals (NLS), but no nuclear export signal (NES) has yet been identified. We show here that the aa(109-133) region directs the translocation of core from the nucleus to the cytoplasm by the CRM-1-mediated nuclear export pathway. Mutagenesis of the three hydrophobic residues (L119, I123 and L126) in the identified NES or in the sequence encoding the mature core aa(1-173) significantly enhanced the nuclear localisation of the corresponding proteins in transfected Huh7 cells. Both the NES and the adjacent hydrophobic sequence in domain II of core were required to maintain the core protein or its fragments in the cytoplasmic compartment. Electron microscopy studies of the JFH1 replication model demonstrated that core was translocated into the nucleus a few minutes after the virus entered the cell. The blockade of nucleocytoplasmic export by leptomycin B treatment early in infection led to the detection of core protein in the nucleus by confocal microscopy and coincided with a decrease in virus replication. Our data suggest that the functional NLS and NES direct HCV core protein shuttling between the cytoplasmic and nuclear compartments, with at least some core protein transported to the nucleus. These new properties of HCV core may be essential for virus multiplication and interaction with nuclear molecules, influence cell signaling and the pathogenesis of HCV infection.	[Cerutti, Andrea; Maillard, Patrick; Roohvand, Farzin; Budkowska, Agata] Inst Pasteur, Dept Virol, Unite Hepacivirus & Immunite Innee, Paris, France; [Cerutti, Andrea; Minisini, Rosalba; Pirisi, Mario] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Med Clin & Sperimentale, Novara, Italy; [Cerutti, Andrea; Maillard, Patrick; Vidalain, Pierre-Olivier; Roohvand, Farzin; Budkowska, Agata] CNRS, URA3015, Paris, France; [Vidalain, Pierre-Olivier] Inst Pasteur, Dept Virol, Unite Genom Virale & Vaccinat, Paris, France; [Roohvand, Farzin] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran, Iran; [Pecheur, Eve-Isabelle] Univ Lyon 1, F-69365 Lyon, France; [Pecheur, Eve-Isabelle] CNRS, UMR5086, Lyon, France; [Pecheur, Eve-Isabelle] Bases Mol & Struct Syst Infect, IBCP, Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Eastern Piedmont Amedeo Avogadro; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS)	Cerutti, A (corresponding author), Inst Pasteur, Dept Virol, Unite Hepacivirus & Immunite Innee, Paris, France.	agata.budkowska@pasteur.fr	Minisini, Rosalba/ABF-9724-2021; Pirisi, Mario/ABF-2102-2020; Vidalain, Pierre-Olivier/F-9778-2019; Roohvand, Farzin/K-8931-2018	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Roohvand, Farzin/0000-0002-9597-3555; Pirisi, Mario/0000-0001-9740-0155; Cerutti, Andrea/0000-0003-3026-4704; Pecheur, Eve/0000-0002-8613-862X	Agence Nationale de Recherche sur le Sida (ANRS); Italian Ministry for Education, University and Research; Ricerca Sanitaria Finalizzata Program, Regione Piemonte, Italy	Agence Nationale de Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Ricerca Sanitaria Finalizzata Program, Regione Piemonte, Italy(Regione Piemonte)	The work was funded by a grant from Agence Nationale de Recherche sur le Sida (ANRS); AC was granted a fellowship from the Italian Ministry for Education, University and Research and was partially supported by a grant from Ricerca Sanitaria Finalizzata Program, Regione Piemonte, Italy; FR was supported by a fellowship grant from ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09; Anzola Monica, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006926; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Balsano Clara, 2007, Dig Liver Dis, V39 Suppl 1, pS46, DOI 10.1016/S1590-8658(07)80010-7; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Duvignaud JB, 2009, BIOCHEM BIOPH RES CO, V378, P27, DOI 10.1016/j.bbrc.2008.10.141; Falcon V, 2005, BIOCHEM BIOPH RES CO, V329, P1320, DOI 10.1016/j.bbrc.2005.02.107; Falcon V, 2003, BIOCHEM BIOPH RES CO, V310, P54, DOI 10.1016/j.bbrc.2003.08.118; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GONZALEZPERALTA RP, 1994, J HEPATOL, V21, P255, DOI 10.1016/S0168-8278(05)80405-2; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gowans EJ, 2000, SEMIN LIVER DIS, V20, P85, DOI 10.1055/s-2000-9503; Hakata Y, 1998, J VIROL, V72, P6602, DOI 10.1128/JVI.72.8.6602-6607.1998; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Horie C, 1996, BIOCHEM BIOPH RES CO, V218, P674, DOI 10.1006/bbrc.1996.0121; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jin DY, 2000, EMBO J, V19, P729, DOI 10.1093/emboj/19.4.729; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Kanwal C, 2002, AAPS PHARMSCI, V4; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kasprzak A, 2005, LIVER INT, V25, P896, DOI 10.1111/j.1478-3231.2005.01109.x; Kasprzak A, 2008, HEPATOL RES, V38, P1, DOI 10.1111/j.1872-034X.2007.00261.x; Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lee SK, 2007, BIOCHEM BIOPH RES CO, V352, P756, DOI 10.1016/j.bbrc.2006.11.098; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Liu QY, 1997, J VIROL, V71, P657, DOI 10.1128/JVI.71.1.657-662.1997; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417; MATSUURA Y, 1994, INTERVIROLOGY, V37, P114, DOI 10.1159/000150365; Matto M, 2004, J VIROL, V78, P12047, DOI 10.1128/JVI.78.21.12047-12053.2004; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Moriishi K, 2010, HEPATOLOGY, V52, P411, DOI 10.1002/hep.23680; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Oka K, 2003, MICROBIOL IMMUNOL, V47, P429, DOI 10.1111/j.1348-0421.2003.tb03380.x; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Polyak S. J., 2006, HEPATITIS C VIRUSES; Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200; Roingeard P, 2008, J VIRAL HEPATITIS, V15, P157, DOI 10.1111/j.1365-2893.2007.00953.x; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Rowland RRR, 2003, VIRUS RES, V95, P23, DOI 10.1016/S0168-1702(03)00161-8; Ruggieri A, 2004, ARCH VIROL, V149, P61, DOI 10.1007/s00705-003-0202-x; Ruster B, 1996, BIOCHEM BIOPH RES CO, V219, P911, DOI 10.1006/bbrc.1996.0340; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Sansonno D, 2004, J VIRAL HEPATITIS, V11, P27, DOI 10.1046/j.1365-2893.2003.00474.x; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005; SUZUKI R, 1995, J GEN VIROL, V76, P53, DOI 10.1099/0022-1317-76-1-53; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tanaka N, 2008, INT J CANCER, V122, P124, DOI 10.1002/ijc.23056; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walker FM, 1998, J HISTOCHEM CYTOCHEM, V46, P653, DOI 10.1177/002215549804600510; Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Yamaguchi R, 2004, INT J MOL MED, V14, P1097; Yamanaka T, 2002, BIOCHEM BIOPH RES CO, V294, P528, DOI 10.1016/S0006-291X(02)00508-9; Yamanaka T, 2002, BIOCHEM BIOPH RES CO, V294, P521, DOI 10.1016/S0006-291X(02)00507-7; YAP SH, 1994, J HEPATOL, V20, P275, DOI 10.1016/S0168-8278(05)80069-8; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yeh CT, 1997, J GEN VIROL, V78, P2761, DOI 10.1099/0022-1317-78-11-2761; You LR, 1999, J VIROL, V73, P2841, DOI 10.1128/JVI.73.4.2841-2853.1999	91	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e25854	10.1371/journal.pone.0025854	http://dx.doi.org/10.1371/journal.pone.0025854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039426	Green Submitted, Green Published, gold			2022-12-25	WOS:000296515200003
J	Waki, ML; Onoue, K; Takahashi, T; Goto, K; Saito, Y; Inami, K; Makita, I; Angata, Y; Suzuki, T; Yamashita, M; Sato, N; Nakamura, S; Yuki, D; Sugiura, Y; Zaima, N; Goto-Inoue, N; Hayasaka, T; Shimomura, Y; Setou, M				Waki, Michihiko Luca; Onoue, Kenji; Takahashi, Tsukasa; Goto, Kensuke; Saito, Yusuke; Inami, Katsuaki; Makita, Ippei; Angata, Yurika; Suzuki, Tomomi; Yamashita, Mihi; Sato, Narumi; Nakamura, Saki; Yuki, Dai; Sugiura, Yuki; Zaima, Nobuhiro; Goto-Inoue, Naoko; Hayasaka, Takahiro; Shimomura, Yutaka; Setou, Mitsutoshi			Investigation by Imaging Mass Spectrometry of Biomarker Candidates for Aging in the Hair Cortex	PLOS ONE			English	Article							FOLLICLE; SECTIONS; AGE	Background: Human hair is one of the essential components that define appearance and is a useful source of samples for non-invasive biomonitoring. We describe a novel application of imaging mass spectrometry (IMS) of hair biomolecules for advanced molecular characterization and a better understanding of hair aging. As a cosmetic and biomedical application, molecules whose levels in hair altered with aging were comprehensively investigated. Methods: Human hair was collected from 15 young (20 +/- 65 years old) and 15 older (50 +/- 65 years old) volunteers. Matrix-free laser desorption/ionization IMS was used to visualize molecular distribution in the hair sections. Hair-specific ions displaying a significant difference in the intensities between the 2 age groups were extracted as candidate markers for aging. Tissue localization of the molecules and alterations in their levels in the cortex and medulla in the young and old groups were determined. Results: Among the 31 molecules detected specifically in hair sections, 2-one at m/z 153.00, tentatively assigned to be dihydrouracil, and the other at m/z 207.04, identified to be 3,4-dihydroxymandelic acid (DHMA)-exhibited a higher signal intensity in the young group than in the old, and 1 molecule at m/z 164.00, presumed to be O-phosphoethanolamine, displayed a higher intensity in the old group. Among the 3, putative O-phosphoethanolamine showed a cortex-specific distribution. The 3 molecules in cortex presented the same pattern of alteration in signal intensity with aging, whereas those in medulla did not exhibit significant alteration. Conclusion: Three molecules whose levels in hair altered with age were extracted. While they are all possible markers for aging, putative dihydrouracil and DHMA, are also suspected to play a role in maintaining hair properties and could be targets for cosmetic supplementation. Mapping of ion localization in hair by IMS is a powerful method to extract biomolecules in specified regions and determine their tissue distribution.	[Waki, Michihiko Luca; Onoue, Kenji; Takahashi, Tsukasa; Goto, Kensuke; Saito, Yusuke; Inami, Katsuaki; Makita, Ippei; Angata, Yurika; Suzuki, Tomomi; Yamashita, Mihi; Sato, Narumi; Nakamura, Saki; Yuki, Dai; Sugiura, Yuki; Zaima, Nobuhiro; Goto-Inoue, Naoko; Hayasaka, Takahiro; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan; [Shimomura, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Lab Genet Skin Dis, Niigata, Japan	Hamamatsu University School of Medicine; Niigata University	Waki, ML (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan.	setou@hama-med.ac.jp	Onoue, Kenji/GRJ-6704-2022	Waki, Michihiko/0000-0002-3754-9780; Sugiura, Yuki/0000-0002-6983-8958	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This research was supported by grants-in-aid for the scientific research project "Machinery of bioactive lipids in homeostatis and diseases" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and for the project "Development of Systems and Technology for Advanced Measurement and Analysis" by Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Balikova Marie, 2005, Biomedical Papers (Olomouc), V149, P199; BARTONE NA, 1991, J PROTEIN CHEM, V10, P603, DOI 10.1007/BF01025712; Bryson WG, 2009, J STRUCT BIOL, V166, P46, DOI 10.1016/j.jsb.2008.12.006; Chen N, 2005, J MICROSC-OXFORD, V220, P96, DOI 10.1111/j.1365-2818.2005.01517.x; Deedrick D. W., 2000, FORENSIC SCI COMMUN, V2; DEEMING SB, 1978, AM J CLIN NUTR, V31, P1175, DOI 10.1093/ajcn/31.7.1175; Gamez-Garcia M, 2009, J COSMET SCI, V60, P85; GERACE E, 2011, FORENSIC SCI INT; Goto-Inoue N, 2010, J AM SOC MASS SPECTR, V21, P1940, DOI 10.1016/j.jasms.2010.08.002; Goto-Inoue N, 2010, METHOD ENZYMOL, V478, P287, DOI 10.1016/S0076-6879(10)78014-9; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Haake HM, 2009, J COSMET SCI, V60, P143; Hagan NA, 2008, INT J MASS SPECTROM, V278, P158, DOI 10.1016/j.ijms.2008.04.009; Hallegot P, 2004, J INVEST DERMATOL, V122, P381, DOI 10.1046/j.0022-202X.2004.22217.x; HALLEGOT P, 1993, J MICROSC-OXFORD, V172, P131, DOI 10.1111/j.1365-2818.1993.tb03404.x; Harada T, 2009, ANAL CHEM, V81, P9153, DOI 10.1021/ac901872n; Hayasaka T, 2010, J AM SOC MASS SPECTR, V21, P1446, DOI 10.1016/j.jasms.2010.04.005; Jiang H, 2004, BRIT J PHARMACOL, V141, P616, DOI 10.1038/sj.bjp.0705651; Keis K, 2007, J COSMET SCI, V58, P135; Kempson IM, 2005, SCI TOTAL ENVIRON, V338, P213, DOI 10.1016/j.scitotenv.2004.07.017; KOPIN IJ, 1985, PHARMACOL REV, V37, P333; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192; Le Stunff H, 2002, BBA-MOL CELL BIOL L, V1582, P8, DOI 10.1016/S1388-1981(02)00132-4; Lee Won-Soo, 2009, Int J Trichology, V1, P94, DOI 10.4103/0974-7753.58551; LV J, 2011, BIOL TRACE ELEM RES; Mathur BN, 2009, CEREB CORTEX, V19, P2372, DOI 10.1093/cercor/bhn253; McMullen R, 2003, J COSMET SCI, V54, P335; Nagase S, 2009, J COSMET SCI, V60, P637; Petzke KJ, 2010, CURR OPIN CLIN NUTR, V13, P532, DOI 10.1097/MCO.0b013e32833c3c84; POLITI L, 2010, J PHARM BIOMED ANAL, V54, P1192; Porta T, 2011, ANAL CHEM, V83, P4266, DOI 10.1021/ac200610c; ROGERS GE, 1959, ANN NY ACAD SCI, V83, P378; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Setou M, 2011, J ELECTRON MICROSC, V60, P47, DOI 10.1093/jmicro/dfq079; Setou M, 2010, MED MOL MORPHOL, V43, P1, DOI 10.1007/s00795-009-0489-0; Shimomura Y, 2005, J INVEST DERM SYMP P, V10, P230, DOI 10.1111/j.1087-0024.2005.10112.x; Shrivas K, 2010, ANAL CHEM; STEPIEN KB, 1982, BIOCHEM PHARMACOL, V31, P3359, DOI 10.1016/0006-2952(82)90612-8; Sugiura Y, 2009, RAPID COMMUN MASS SP, V23, P3269, DOI 10.1002/rcm.4242; Tobin D. J., 2008, International Journal of Cosmetic Science, V30, P233, DOI 10.1111/j.1468-2494.2008.00456.x; TODD MK, 1994, J APPL PHYSIOL, V76, P1548, DOI 10.1152/jappl.1994.76.4.1548; Tsutsui H, 2011, CLIN CHIM ACTA, V412, P861, DOI 10.1016/j.cca.2010.12.023; Washam C, 2006, ENVIRON HEALTH PERSP, V114, pA636, DOI 10.1289/ehp.114-a636; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zouboulis CC, 2011, CLIN DERMATOL, V29, P3, DOI 10.1016/j.clindermatol.2010.07.001; SPECIALCHEM4COSMETIC	50	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26721	10.1371/journal.pone.0026721	http://dx.doi.org/10.1371/journal.pone.0026721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039541	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200046
J	Goudevenou, K; Martin, P; Yeh, YJ; Jones, P; Sablitzky, F				Goudevenou, Katerina; Martin, Paul; Yeh, Yu-Jung; Jones, Peter; Sablitzky, Fred			Def6 Is Required for Convergent Extension Movements during Zebrafish Gastrulation Downstream of Wnt5b Signaling	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; VERTEBRATE GASTRULATION; RHO-GTPASES; CELL MOVEMENTS; EMBRYONIC-DEVELOPMENT; TAIL FORMATION; DANIO-RERIO; NO TAIL; POLARITY; MECHANISMS	During gastrulation, convergent extension (CE) cell movements are regulated through the non-canonical Wnt signaling pathway. Wnt signaling results in downstream activation of Rho GTPases that in turn regulate actin cytoskeleton rearrangements essential for co-ordinated CE cell movement. Rho GTPases are bi-molecular switches that are inactive in their GDP-bound stage but can be activated to bind GTP through guanine nucleotide exchange factors (GEFs). Here we show that def6, a novel GEF, regulates CE cell movement during zebrafish gastrulation. Def6 morphants exhibit broadened and shortened body axis with normal cell fate specification, reminiscent of the zebrafish mutants silberblick and pipetail that lack Wnt11 or Wnt5b, respectively. Indeed, def6 morphants phenocopy Wnt5b mutants and ectopic overexpression of def6 essentially rescues Wnt5b morphants, indicating a novel role for def6 as a central GEF downstream of Wnt5b signaling. In addition, by knocking down both def6 and Wnt11, we show that def6 synergises with the Wnt11 signaling pathway.	[Goudevenou, Katerina; Martin, Paul; Yeh, Yu-Jung; Sablitzky, Fred] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Sch Biol, Nottingham NG7 2RD, England; [Jones, Peter] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Goudevenou, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, London, England.	fred.sablitzky@nottingham.ac.uk	Sablitzky, Fred/A-2276-2011	Sablitzky, Fred/0000-0001-9718-1546	University of Nottingham	University of Nottingham	This work was supported by The University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Daggett DF, 2004, CURR BIOL, V14, P1632, DOI 10.1016/j.cub.2004.08.024; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Djiane A, 2000, DEVELOPMENT, V127, P3091; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Mavrakis KJ, 2004, EXP CELL RES, V294, P335, DOI 10.1016/j.yexcr.2003.12.004; Miyakoshi A, 2004, DIFFERENTIATION, V72, P48, DOI 10.1111/j.1432-0436.2004.07201004.x; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; Schier AF, 1997, DEVELOPMENT, V124, P327; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Sepich DS, 2005, DEV DYNAM, V234, P279, DOI 10.1002/dvdy.20507; Solnica-Krezel L, 2003, DEVELOPMENT, V130, P4229, DOI 10.1242/dev.00693; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sumanas S, 2001, GENESIS, V30, P114, DOI 10.1002/gene.1043; Tada M, 2009, ZEBRAFISH, V6, P29, DOI 10.1089/zeb.2008.0566; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; WARGA RM, 1990, DEVELOPMENT, V108, P569; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	46	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26548	10.1371/journal.pone.0026548	http://dx.doi.org/10.1371/journal.pone.0026548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039507	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200029
J	Dhasarathy, A; Phadke, D; Mav, D; Shah, RR; Wade, PA				Dhasarathy, Archana; Phadke, Dhiral; Mav, Deepak; Shah, Ruchir R.; Wade, Paul A.			The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA-PAR6 POLARITY PATHWAY; REPRESSES E-CADHERIN; GENE-EXPRESSION; TGF-BETA; CLAUDIN-LOW; PROTEIN; SUPERFAMILY; FIBROBLASTS; OVARIAN	The transcriptional repressors Snail and Slug are situated at the core of several signaling pathways proposed to mediate epithelial to mesenchymal transition or EMT, which has been implicated in tumor metastasis. EMT involves an alteration from an organized, epithelial cell structure to a mesenchymal, invasive and migratory phenotype. In order to obtain a global view of the impact of Snail and Slug expression, we performed a microarray experiment using the MCF-7 breast cancer cell line, which does not express detectable levels of Snail or Slug. MCF-7 cells were infected with Snail, Slug or control adenovirus, and RNA samples isolated at various time points were analyzed across all transcripts. Our analyses indicated that Snail and Slug regulate many genes in common, but also have distinct sets of gene targets. Gene set enrichment analyses indicated that Snail and Slug directed the transcriptome of MCF-7 cells from a luminal towards a more complex pattern that includes many features of the claudin-low breast cancer signature. Of particular interest, genes involved in the TGF-beta signaling pathway are upregulated, while genes responsible for a differentiated morphology are downregulated following Snail or Slug expression. Further we noticed increased histone acetylation at the promoter region of the transforming growth factor beta-receptor II (TGFBR2) gene following Snail or Slug expression. Inhibition of the TGF-beta signaling pathway using selective small-molecule inhibitors following Snail or Slug addition resulted in decreased cell migration with no impact on the repression of cell junction molecules by Snail and Slug. We propose that there are two regulatory modules embedded within EMT: one that involves repression of cell junction molecules, and the other involving cell migration via TGF-beta and/or other pathways.	[Dhasarathy, Archana; Wade, Paul A.] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; [Phadke, Dhiral; Mav, Deepak; Shah, Ruchir R.] SRA Int Inc, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); SRA International	Dhasarathy, A (corresponding author), NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA.	wadep2@niehs.nih.gov	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X	NIEHS, NIH [Z01ES101965]; National Institute of Environmental Health Sciences, National Institute of Health, Department of Health and Human Services [HHSN291200555547C]; GSA Contract [GS-00F-003L]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, Z01ES101965, ZIAES101965] Funding Source: NIH RePORTER	NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences, National Institute of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); GSA Contract; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by the Intramural Research Program, NIEHS, NIH (Project number Z01ES101965 to P. A. W.). D. P., D. M. and R. R. S. were supported in whole or in part with federal funds from the National Institute of Environmental Health Sciences, National Institute of Health, Department of Health and Human Services, Delivery Order HHSN291200555547C, GSA Contract GS-00F-003L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P2708, DOI 10.1167/iovs.06-0639; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Elloul S, 2006, VIRCHOWS ARCH, V449, P520, DOI 10.1007/s00428-006-0274-6; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hajra KM, 2002, CANCER RES, V62, P1613; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kuphal S, 2005, MELANOMA RES, V15, P305, DOI 10.1097/00008390-200508000-00012; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Moses H, 2011, COLD SPRING HARB PER, V3; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strumane K, 2004, HANDB EXP PHARM, V165, P69, DOI 10.1007/978-3-540-68170-0_4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Viloria-Petit AM, 2010, CELL CYCLE, V9, P623, DOI 10.4161/cc.9.4.10779; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; WRANA JL, 1991, EUR J BIOCHEM, V197, P519, DOI 10.1111/j.1432-1033.1991.tb15940.x; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	56	117	122	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26514	10.1371/journal.pone.0026514	http://dx.doi.org/10.1371/journal.pone.0026514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028892	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800049
J	Mishima, T; Miner, JH; Morizane, M; Stahl, A; Sadovsky, Y				Mishima, Takuya; Miner, Jeffrey H.; Morizane, Mayumi; Stahl, Andreas; Sadovsky, Yoel			The Expression and Function of Fatty Acid Transport Protein-2 and-4 in the Murine Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; LIPID DROPLETS; TROPHOBLAST CELLS; ANIMAL-MODELS; WRINKLE-FREE; MOUSE; GENE; METABOLISM; TRIGLYCERIDE; PERILIPIN	Background: The uptake and trans-placental trafficking of fatty acids from the maternal blood into the fetal circulation are essential for embryonic development, and involve several families of proteins. Fatty acid transport proteins (FATPs) uniquely transport fatty acids into cells. We surmised that placental FATPs are germane for fetal growth, and are regulated during hypoxic stress, which is associated with reduced fat supply to the fetus. Methodology/Principal Findings: Using cultured primary term human trophoblasts we found that FATP2, FATP4 and FATP6 were highly expressed in trophoblasts. Hypoxia enhanced the expression of trophoblastic FATP2 and reduced the expression of FATP4, with no change in FATP6. We also found that Fatp2 and Fatp4 are expressed in the mouse amnion and placenta, respectively. Mice deficient in Fatp2 or Fatp4 did not deviate from normal Mendelian distribution, with both embryos and placentas exhibiting normal weight and morphology, triglyceride content, and expression of genes related to fatty acid mobilization. Conclusions/Significance: We conclude that even though hypoxia regulates the expression of FATP2 and FATP4 in human trophoblasts, mouse Fatp2 and Fatp4 are not essential for intrauterine fetal growth.	[Mishima, Takuya; Morizane, Mayumi; Sadovsky, Yoel] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Miner, Jeffrey H.] Washington Univ, Dept Internal Med, St Louis, MO USA; [Miner, Jeffrey H.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA; [Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Sadovsky, Yoel] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mishima, T (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	ysadovsky@mwri.magee.edu	Mishima, Takuya/G-1671-2011	Sadovsky, Yoel/0000-0003-2969-6737	Kobe University; National Institutes of Health [R01AR049269, R01ES011597]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011597] Funding Source: NIH RePORTER	Kobe University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project was supported by the Kobe University Overseas Visiting Program for Young Researchers (to MM), National Institutes of Health R01AR049269 (to JHM), and National Institutes of Health R01ES011597 (to YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Araya J, 1995, Rev Med Chil, V122, P503; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Biron-Shental T, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.066; BONET B, 1992, METABOLISM, V41, P596, DOI 10.1016/0026-0495(92)90051-B; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Cetin I, 2002, PEDIATR RES, V52, P750, DOI 10.1203/00006450-200211000-00023; Cetin I, 2009, PLACENTA, V30, pS77, DOI 10.1016/j.placenta.2008.12.006; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; Daoud G, 2005, BBA-MOL CELL BIOL L, V1687, P181, DOI 10.1016/j.bbalip.2004.11.017; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Dutta-Roy AK, 2000, CELL MOL LIFE SCI, V57, P1360, DOI 10.1007/PL00000621; Dutta-Roy AK, 2000, AM J CLIN NUTR, V71, p315S, DOI 10.1093/ajcn/71.1.315s; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOX H, 1970, AM J OBSTET GYNECOL, V107, P1058, DOI 10.1016/0002-9378(70)90629-0; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Gheorghe CP, 2007, REPROD SCI, V14, P223, DOI 10.1177/1933719107302860; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Haggarty P, 2002, PLACENTA, V23, pS28, DOI 10.1053/plac.2002.0791; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; HANLEY T, 1991, BIOTECHNIQUES, V10, P56; Heinzer AK, 2003, ADV EXP MED BIOL, V544, P75; Heinzer AK, 2003, HUM MOL GENET, V12, P1145, DOI 10.1093/hmg/ddg126; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Herrmann T, 2005, J INVEST DERMATOL, V125, P1228, DOI 10.1111/j.0022-202X.2005.23972.x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; HORNSTRA G, 1995, EUR J OBSTET GYN R B, V61, P57, DOI 10.1016/0028-2243(95)02153-J; Johnson ACM, 2005, KIDNEY INT, V67, P2196, DOI 10.1111/j.1523-1755.2005.00325.x; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Knipp GT, 2000, PLACENTA, V21, P367, DOI 10.1053/plac.1999.0484; Knipp GT, 1999, ADV DRUG DELIVER REV, V38, P41, DOI 10.1016/S0169-409X(99)00005-8; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Larque E, 2002, ANN NY ACAD SCI, V967, P299; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnusson AL, 2004, J CLIN ENDOCR METAB, V89, P4607, DOI 10.1210/jc.2003-032234; Magnusson-Olsson AL, 2007, AM J PHYSIOL-ENDOC M, V293, pE24, DOI 10.1152/ajpendo.00571.2006; Maity A, 2000, EXP CELL RES, V255, P250, DOI 10.1006/excr.1999.4804; Mando C, 2011, PLACENTA, V32, P44, DOI 10.1016/j.placenta.2010.10.009; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Mohanty S, 2010, J REPROD IMMUNOL, V84, P133, DOI 10.1016/j.jri.2009.10.008; Morice-Picard F, 2010, AM J MED GENET A, V152A, P2664, DOI 10.1002/ajmg.a.33648; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; Peltier MR, 2011, AM J REPROD IMMUNOL; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Roh CR, 2005, PLACENTA, V26, P319, DOI 10.1016/j.placenta.2004.06.013; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; Schaiff WT, 2005, J CLIN ENDOCR METAB, V90, P4267, DOI 10.1210/jc.2004-2265; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Takizawa T, 2005, J IMMUNOL, V175, P2331, DOI 10.4049/jimmunol.175.4.2331; UAUY R, 1989, SEMIN PERINATOL, V13, P118; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545	72	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25865	10.1371/journal.pone.0025865	http://dx.doi.org/10.1371/journal.pone.0025865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028793	Green Accepted, Green Published, gold			2022-12-25	WOS:000296510800009
J	Lacroix, B; Citovsky, V				Lacroix, Benoit; Citovsky, Vitaly			Extracellular VirB5 Enhances T-DNA Transfer from Agrobacterium to the Host Plant	PLOS ONE			English	Article							IV SECRETION SYSTEMS; INCN PLASMID PKM101; GENETIC-TRANSFORMATION; MEDIATED TRANSFORMATION; TUMEFACIENS; PROTEIN; EXPRESSION; ASSOCIATION; ACTIVATION; MEMBRANES	VirB5 is a type 4 secretion system protein of Agrobacterium located on the surface of the bacterial cell. This localization pattern suggests a function for VirB5 which is beyond its known role in biogenesis and/or stabilization of the T-pilus and which may involve early interactions between Agrobacterium and the host cell. Here, we identify VirB5 as the first Agrobacterium virulence protein that can enhance infectivity extracellularly. Specifically, we show that elevating the amounts of the extracellular VirB5-by exogenous addition of the purified protein, its overexpression in the bacterium, or transgenic expression in and secretion out of the host cell-enhances the efficiency the Agrobacterium-mediated T-DNA transfer, as measured by transient expression of genes contained on the transferred T-DNA molecule. Importantly, the exogenous VirB5 enhanced transient T-DNA expression in sugar beet, a major crop recalcitrant to genetic manipulation. Increasing the pool of the extracellular VirB5 did not complement an Agrobacterium virB5 mutant, suggesting a dual function for VirB5: in the bacterium and at the bacterium-host cell interface. Consistent with this idea, VirB5 expressed in the host cell, but not secreted, had no effect on the transformation efficiency. That the increase in T-DNA expression promoted by the exogenous VirB5 was not due to its effects on bacterial growth, virulence gene induction, bacterial attachment to plant tissue, or host cell defense response suggests that VirB5 participates in the early steps of the T-DNA transfer to the plant cell.	[Lacroix, Benoit; Citovsky, Vitaly] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lacroix, B (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	blacroix@notes.cc.sunysb.edu	Lacroix, Benoit/AAG-8607-2021	Lacroix, Benoit/0000-0002-3463-0452; Citovsky, Vitaly/0000-0003-2024-6844	National Science Foundation; United States Department of Agriculture National Institute of Food and Agriculture; National Institutes of Health; United States-Israel Binational Agricultural Research and Development Fund (BARD)	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation)	The work in our laboratory is supported by grants from the National Science Foundation, the United States Department of Agriculture National Institute of Food and Agriculture, the National Institutes of Health, and the United States-Israel Binational Agricultural Research and Development Fund (BARD) to VC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; Aly KA, 2008, J BACTERIOL, V190, P1595, DOI 10.1128/JB.01718-07; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Bundock P, 1996, P NATL ACAD SCI USA, V93, P15272, DOI 10.1073/pnas.93.26.15272; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; CITOVSKY V, 1989, P NATL ACAD SCI USA, V86, P1193, DOI 10.1073/pnas.86.4.1193; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; De Caroli M, 2011, PLANT J, V65, P295, DOI 10.1111/j.1365-313X.2010.04421.x; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; JACQ B, 1993, PLANT CELL REP, V12, P621, DOI 10.1007/BF00232811; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lacroix B, 2005, EMBO J, V24, P428, DOI 10.1038/sj.emboj.7600524; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Lacroix B, 2008, P NATL ACAD SCI USA, V105, P15429, DOI 10.1073/pnas.0805641105; Matthysse AG, 2005, MOL PLANT MICROBE IN, V18, P1002, DOI 10.1094/MPMI-18-1002; Miller J.H., 1972, EXPT MOL GENETICS; Nam J, 1999, MOL GEN GENET, V261, P429, DOI 10.1007/s004380050985; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Piers KL, 1996, P NATL ACAD SCI USA, V93, P1613, DOI 10.1073/pnas.93.4.1613; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; STACHEL SE, 1986, EMBO J, V5, P1445, DOI 10.1002/j.1460-2075.1986.tb04381.x; STACHEL SE, 1985, EMBO J, V4, P891, DOI 10.1002/j.1460-2075.1985.tb03715.x; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; WINANS SC, 1985, J BACTERIOL, V161, P402, DOI 10.1128/JB.161.1.402-410.1985; Wozniak CA, 1999, APPLIED PLANT BIOTECHNOLOGY, P301; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yeo HJ, 2003, P NATL ACAD SCI USA, V100, P15947, DOI 10.1073/pnas.2535211100; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhou AF, 2005, J BIOL CHEM, V280, P35554, DOI 10.1074/jbc.M503299200	44	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25578	10.1371/journal.pone.0025578	http://dx.doi.org/10.1371/journal.pone.0025578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028781	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900010
J	Rimbaud, S; Ruiz, M; Piquereau, J; Mateo, P; Fortin, D; Veksler, V; Garnier, A; Ventura-Clapier, R				Rimbaud, Stephanie; Ruiz, Matthieu; Piquereau, Jerome; Mateo, Philippe; Fortin, Dominique; Veksler, Vladimir; Garnier, Anne; Ventura-Clapier, Renee			Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; INDUCED CARDIAC-HYPERTROPHY; KINASE-DEFICIENT MICE; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; TRANS-RESVERATROL; PROTEIN-KINASE; EXPRESSION; PREVENTS; FIBROSIS	Heart failure (HF) is characterized by contractile dysfunction associated with altered energy metabolism. This study was aimed at determining whether resveratrol, a polyphenol known to activate energy metabolism, could be beneficial as a metabolic therapy of HF. Survival, ventricular and vascular function as well as cardiac and skeletal muscle energy metabolism were assessed in a hypertensive model of HF, the Dahl salt-sensitive rat fed with a high-salt diet (HS-NT). Resveratrol (18 mg/kg/day; HS-RSV) was given for 8 weeks after hypertension and cardiac hypertrophy were established (which occurred 3 weeks after salt addition). Resveratrol treatment improved survival (64% in HS-RSV versus 15% in HS-NT, p < 0.001), and prevented the 25% reduction in body weight in HS-NT (P < 0.001). Moreover, RSV counteracted the development of cardiac dysfunction (fractional shortening -34% in HS-NT) as evaluated by echocardiography, which occurred without regression of hypertension or hypertrophy. Moreover, aortic endothelial dysfunction present in HS-NT was prevented in resveratrol-treated rats. Resveratrol treatment tended to preserve mitochondrial mass and biogenesis and completely protected mitochondrial fatty acid oxidation and PPAR alpha (peroxisome proliferator-activated receptor alpha) expression. We conclude that resveratrol treatment exerts beneficial protective effects on survival, endothelium-dependent smooth muscle relaxation and cardiac contractile and mitochondrial function, suggesting that resveratrol or metabolic activators could be a relevant therapy in hypertension-induced HF.	[Rimbaud, Stephanie; Ruiz, Matthieu; Piquereau, Jerome; Mateo, Philippe; Fortin, Dominique; Veksler, Vladimir; Garnier, Anne; Ventura-Clapier, Renee] Univ Paris 11, INSERM, UMR S 769, Chatenay Malabry, France; [Rimbaud, Stephanie; Ruiz, Matthieu; Piquereau, Jerome; Mateo, Philippe; Fortin, Dominique; Veksler, Vladimir; Garnier, Anne; Ventura-Clapier, Renee] Univ Paris 11, IFR 141, Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Rimbaud, S (corresponding author), Univ Paris 11, INSERM, UMR S 769, Chatenay Malabry, France.	renee.ventura@u-psud.fr		Ventura-Clapier, Renee/0000-0002-7488-4123; Piquereau, Jerome/0000-0002-6019-8683; Garnier, Anne/0000-0002-6241-4554; Veksler, Vladimir/0000-0002-8869-9594	Fondation de France [FDF_R08111LL]; European Union [LSHM-CT-2005-018833/EUGeneHeart]; Bonus Qualite Recherche Universite Paris-Sud	Fondation de France(Fondation de France); European Union(European Commission); Bonus Qualite Recherche Universite Paris-Sud	This work was supported by grants from Fondation de France (FDF_R08111LL), the European Union contract (LSHM-CT-2005-018833/EUGeneHeart) and Bonus Qualite Recherche Universite Paris-Sud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Renee Ventura-Clapier is senior scientist at Centre National de la Recherche Scientifique.	Agouni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005557; Bahi L, 2005, J CELL PHYSIOL, V203, P589, DOI 10.1002/jcp.20273; Biala A, 2010, BLOOD PRESSURE, V19, P196, DOI 10.3109/08037051.2010.481808; Bledsoe G, 2006, HUM GENE THER, V17, P545, DOI 10.1089/hum.2006.17.545; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; De Sousa E, 1999, CIRC RES, V85, P68; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Duncan JG, 2008, PPAR RES, V2008, DOI 10.1155/2008/253817; Edwards JA, 2011, ANN NY ACAD SCI, V1215, P131, DOI 10.1111/j.1749-6632.2010.05855.x; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; Joubert F, 2008, J PHYSIOL-LONDON, V586, P5181, DOI 10.1113/jphysiol.2008.157677; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; Liang B, 2007, BRIT J PHARMACOL, V152, P903, DOI 10.1038/sj.bjp.0707472; Lin JF, 2008, LIFE SCI, V83, P313, DOI 10.1016/j.lfs.2008.06.016; Liu ZP, 2005, CLIN EXP PHARMACOL P, V32, P1049, DOI 10.1111/j.1440-1681.2005.04303.x; Manger WM, 2009, J HYPERTENS, V27, P587, DOI 10.1097/HJH.0b013e32831ffec7; Mettauer B, 2006, PFLUG ARCH EUR J PHY, V452, P653, DOI 10.1007/s00424-006-0072-7; Miyazaki R, 2008, ARTERIOSCL THROM VAS, V28, P1263, DOI 10.1161/ATVBAHA.108.166991; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Prunier F, 2002, AM J PHYSIOL-HEART C, V283, pH346, DOI 10.1152/ajpheart.01050.2001; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Seymour EM, 2008, J GERONTOL A-BIOL, V63, P1034, DOI 10.1093/gerona/63.10.1034; Seymour EM, 2010, HYPERTENSION, V55, P1179, DOI 10.1161/HYPERTENSIONAHA.109.149393; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Taegtmeyer H, 2004, CIRCULATION, V110, P894, DOI 10.1161/01.CIR.0000139340.88769.D5; Takeda Y, 2007, AM J HYPERTENS, V20, P1119, DOI 10.1016/j.amjhyper.2007.05.008; Thandapilly SJ, 2010, AM J HYPERTENS, V23, P192, DOI 10.1038/ajh.2009.228; Tian Q, 2006, CURR HYPERTENS REP, V8, P465, DOI 10.1007/s11906-006-0024-9; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006; VEKSLER VI, 1995, J BIOL CHEM, V270, P19921, DOI 10.1074/jbc.270.34.19921; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Ventura-Clapier R, 2002, NEWS PHYSIOL SCI, V17, P191, DOI 10.1152/nips.01392.2002; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; von Haehling S, 2009, PHARMACOL THERAPEUT, V121, P227, DOI 10.1016/j.pharmthera.2008.09.009; Wojciechowski P, 2010, J NUTR, V140, P962, DOI 10.3945/jn.109.115006; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61	54	98	101	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26391	10.1371/journal.pone.0026391	http://dx.doi.org/10.1371/journal.pone.0026391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028869	Green Submitted, gold, Green Published			2022-12-25	WOS:000296186900057
J	Tan, KY; Eminli, S; Hettmer, S; Hochedlinger, K; Wagers, AJ				Tan, Kah Yong; Eminli, Sarah; Hettmer, Simone; Hochedlinger, Konrad; Wagers, Amy J.			Efficient Generation of iPS Cells from Skeletal Muscle Stem Cells	PLOS ONE			English	Article							BETA-CELLS; DIFFERENTIATION; PROGENITORS; SYSTEM; MOUSE; FAT	Reprogramming of somatic cells into inducible pluripotent stem cells generally occurs at low efficiency, although what limits reprogramming of particular cell types is poorly understood. Recent data suggest that the differentiation status of the cell targeted for reprogramming may influence its susceptibility to reprogramming as well as the differentiation potential of the induced pluripotent stem (iPS) cells that are derived from it. To assess directly the influence of lineage commitment on iPS cell derivation and differentiation, we evaluated reprogramming in adult stem cell and mature cell populations residing in skeletal muscle. Our data using clonal assays and a second-generation inducible reprogramming system indicate that stem cells found in mouse muscle, including resident satellite cells and mesenchymal progenitors, reprogram with significantly greater efficiency than their more differentiated daughters (myoblasts and fibroblasts). However, in contrast to previous reports, we find no evidence of biased differentiation potential among iPS cells derived from myogenically committed cells. These data support the notion that adult stem cells reprogram more efficiently than terminally differentiated cells, and argue against the suggestion that "epigenetic memory" significantly influences the differentiation potential of iPS cells derived from distinct somatic cell lineages in skeletal muscle.	[Tan, Kah Yong; Hettmer, Simone; Wagers, Amy J.] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Tan, Kah Yong; Eminli, Sarah; Hettmer, Simone; Hochedlinger, Konrad; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tan, Kah Yong; Eminli, Sarah; Hettmer, Simone; Hochedlinger, Konrad; Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA USA; [Tan, Kah Yong] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Eminli, Sarah; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Eminli, Sarah; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA USA; [Eminli, Sarah] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Hettmer, Simone] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hettmer, Simone] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Hochedlinger, Konrad; Wagers, Amy J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Free University of Berlin; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Tan, KY (corresponding author), Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA.	amy.wagers@joslin.harvard.edu		Hettmer, Simone/0000-0003-1709-4448; Tan, Kah Yong/0000-0002-6825-2752	Beckman Foundation; Joslin Diabetes Center; NIH [1DP2OD003266-01]; Harvard Stem Cell Institute [DP-0003-07-03, CF-0003-08-00]; Hope Street Kids; Alex's Lemonade Stand Foundation; Bear Necessities; NIDDK [P30DK036836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Beckman Foundation; Joslin Diabetes Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Hope Street Kids; Alex's Lemonade Stand Foundation; Bear Necessities; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge support for this project from the Beckman Foundation (http://www.beckman-foundation.com), and Joslin Diabetes Center (www.joslinresearch.org) (to AW, no Award Number), NIH Innovator Award (to KH, Award Number 1DP2OD003266-01), the Harvard Stem Cell Institute (www.hsci.harvard.edu, to AW and KH, Award number DP-0003-07-03), and by Hope Street Kids (www.hopestreetkids.org), P. A. L. S. Bermuda/St. Baldrick's (www.stbaldricks.org), Alex's Lemonade Stand Foundation (www.alexlemonade.org) and Bear Necessities (www.bearnecessities.org) (to SH). Flow cytometry facilities were supported in by grants from the Harvard Stem Cell Institute (Award Number CF-0003-08-00) and NIDDK (Award Number P30DK036836). KY is a fellow of the Agency of Science, Technology and Research, Singapore (www.a-star.edu.sg). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding agencies that supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Jang YC, 2011, COLD SPRING HARB S Q; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quattrocelli M, 2011, J PATHOL, V223, P593, DOI 10.1002/path.2845; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Young AP, 2010, J CELL SCI, V123, P2632, DOI 10.1242/jcs.061606	22	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26406	10.1371/journal.pone.0026406	http://dx.doi.org/10.1371/journal.pone.0026406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028872	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900059
J	Vitulo, N; Albiero, A; Forcato, C; Campagna, D; Dal Pero, F; Bagnaresi, P; Colaiacovo, M; Faccioli, P; Lamontanara, A; Simkova, H; Kubalakova, M; Perrotta, G; Facella, P; Lopez, L; Pietrella, M; Gianese, G; Dolezel, J; Giuliano, G; Cattivelli, L; Valle, G; Stanca, AM				Vitulo, Nicola; Albiero, Alessandro; Forcato, Claudio; Campagna, Davide; Dal Pero, Francesca; Bagnaresi, Paolo; Colaiacovo, Moreno; Faccioli, Primetta; Lamontanara, Antonella; Simkova, Hana; Kubalakova, Marie; Perrotta, Gaetano; Facella, Paolo; Lopez, Loredana; Pietrella, Marco; Gianese, Giulio; Dolezel, Jaroslav; Giuliano, Giovanni; Cattivelli, Luigi; Valle, Giorgio; Stanca, A. Michele			First Survey of the Wheat Chromosome 5A Composition through a Next Generation Sequencing Approach	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; TRANSPOSABLE ELEMENTS; MOLECULAR CHARACTERIZATION; GENOME EVOLUTION; PLANT MICRORNAS; HEXAPLOID WHEAT; BREAD WHEAT; SMALL RNAS; GENE; RICE	Wheat is one of the world's most important crops and is characterized by a large polyploid genome. One way to reduce genome complexity is to isolate single chromosomes using flow cytometry. Low coverage DNA sequencing can provide a snapshot of individual chromosomes, allowing a fast characterization of their main features and comparison with other genomes. We used massively parallel 454 pyrosequencing to obtain a 2x coverage of wheat chromosome 5A. The resulting sequence assembly was used to identify TEs, genes and miRNAs, as well as to infer a virtual gene order based on the synteny with other grass genomes. Repetitive elements account for more than 75% of the genome. Gene content was estimated considering non-redundant reads showing at least one match to ESTs or proteins. The results indicate that the coding fraction represents 1.08% and 1.3% of the short and long arm respectively, projecting the number of genes of the whole chromosome to approximately 5,000. 195 candidate miRNA precursors belonging to 16 miRNA families were identified. The 5A genes were used to search for syntenic relationships between grass genomes. The short arm is closely related to Brachypodium chromosome 4, sorghum chromosome 8 and rice chromosome 12; the long arm to regions of Brachypodium chromosomes 4 and 1, sorghum chromosomes 1 and 2 and rice chromosomes 9 and 3. From these similarities it was possible to infer the virtual gene order of 392 (5AS) and 1,480 (5AL) genes of chromosome 5A, which was compared to, and found to be largely congruent with the available physical map of this chromosome.	[Vitulo, Nicola; Albiero, Alessandro; Forcato, Claudio; Campagna, Davide; Valle, Giorgio] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Albiero, Alessandro; Dal Pero, Francesca] Bmr Genom Srl, Padua, Italy; [Bagnaresi, Paolo; Colaiacovo, Moreno; Faccioli, Primetta; Lamontanara, Antonella; Cattivelli, Luigi; Stanca, A. Michele] CRA Genom Res Ctr, Fiorenzuola Darda, Italy; [Simkova, Hana; Kubalakova, Marie; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Perrotta, Gaetano; Facella, Paolo; Lopez, Loredana] TRISAIA Res Ctr, ENEA, Rotondella, Italy; [Pietrella, Marco; Giuliano, Giovanni] CASACCIA Res Ctr, ENEA, Rome, Italy; [Gianese, Giulio] Ylichron Srl, Rome, Italy	University of Padua; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Italian National Agency New Technical Energy & Sustainable Economics Development; Italian National Agency New Technical Energy & Sustainable Economics Development	Vitulo, N (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy.	luigi.cattivelli@entecra.it	Pietrella, Marco/ABE-3613-2020; Facella, Paolo/HHC-1895-2022; Giuliano, Giovanni/A-2701-2012; Dolezel, Jaroslav/B-7716-2008; cattivelli, luigi/AAE-7046-2020; Simkova, Hana/F-7734-2014; Kubaláková, Marie/F-8269-2014; Vitulo, Nicola/GVT-2319-2022	Facella, Paolo/0000-0001-9076-3754; Giuliano, Giovanni/0000-0002-2486-0510; Dolezel, Jaroslav/0000-0002-6263-0492; cattivelli, luigi/0000-0002-6067-4600; Simkova, Hana/0000-0003-4159-7619; Vitulo, Nicola/0000-0002-9571-0747; Pietrella, Marco/0000-0002-8789-6860; VALLE, GIORGIO/0000-0003-4377-5685; Perrotta, Gaetano/0000-0003-2037-1063; Bagnaresi, Paolo/0000-0001-8466-4805; Lamontanara, Antonella/0000-0003-3420-1524	Italian Ministry of Agriculture; Ministry of Education, Youth and Sports of the Czech Republic; European Regional Development Fund [CZ.1.05/2.1.00/01.0007]	Italian Ministry of Agriculture; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission)	This work was supported by the Italian Ministry of Agriculture "Progetto MAPPA 5A" and by the Ministry of Education, Youth and Sports of the Czech Republic and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. CZ.1.05/2.1.00/01.0007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Cattivelli L, 2002, PLANT MOL BIOL, V48, P649, DOI 10.1023/A:1014824404623; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han YS, 2009, SCI CHINA SER C, V52, P1091, DOI 10.1007/s11427-009-0144-y; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kadri S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S35; Kubalakova M, 2003, GENOME, V46, P893, DOI [10.1139/g03-054, 10.1139/G03-054]; Kubalakova M, 2002, THEOR APPL GENET, V104, P1362, DOI 10.1007/s00122-002-0888-2; Linkiewicz AM, 2004, GENETICS, V168, P665, DOI 10.1534/genetics.104.034835; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; NAGAKI K, 1995, GENOME, V38, P479, DOI 10.1139/g95-063; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Sarma RN, 2000, GENOME, V43, P191, DOI 10.1139/gen-43-1-191; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SEARS ER, 1954, MO EXP STA RES B, V572, P1; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vrana J, 2000, GENETICS, V156, P2033; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Wicker T, 2009, PLANT PHYSIOL, V149, P258, DOI 10.1104/pp.108.129734; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	49	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26421	10.1371/journal.pone.0026421	http://dx.doi.org/10.1371/journal.pone.0026421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028874	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900060
J	Duc, C; Nentwig, W; Lindfeld, A				Duc, Caroline; Nentwig, Wolfgang; Lindfeld, Andreas			No Adverse Effect of Genetically Modified Antifungal Wheat on Decomposition Dynamics and the Soil Fauna Community - A Field Study	PLOS ONE			English	Article							MILDEW RESISTANCE GENES; TRANSGENIC BT MAIZE; CROPPING SYSTEMS; ORIBATID MITE; SILVER BIRCH; LITTER; MICROARTHROPODS; POPULATIONS; PATTERNS; FOREST	The cultivation of genetically modified (GM) plants has raised several environmental concerns. One of these concerns regards non-target soil fauna organisms, which play an important role in the decomposition of organic matter and hence are largely exposed to GM plant residues. Soil fauna may be directly affected by transgene products or indirectly by pleiotropic effects such as a modified plant metabolism. Thus, ecosystem services and functioning might be affected negatively. In a litterbag experiment in the field we analysed the decomposition process and the soil fauna community involved. Therefore, we used four experimental GM wheat varieties, two with a race-specific antifungal resistance against powdery mildew (Pm3b) and two with an unspecific antifungal resistance based on the expression of chitinase and glucanase. We compared them with two non-GM isolines and six conventional cereal varieties. To elucidate the mechanisms that cause differences in plant decomposition, structural plant components (i.e. C:N ratio, lignin, cellulose, hemicellulose) were examined and soil properties, temperature and precipitation were monitored. The most frequent taxa extracted from decaying plant material were mites (Cryptostigmata, Gamasina and Uropodina), springtails (Isotomidae), annelids (Enchytraeidae) and Diptera (Cecidomyiidae larvae). Despite a single significant transgenic/month interaction for Cecidomyiidae larvae, which is probably random, we detected no impact of the GM wheat on the soil fauna community. However, soil fauna differences among conventional cereal varieties were more pronounced than between GM and non-GM wheat. While leaf residue decomposition in GM and non-GM wheat was similar, differences among conventional cereals were evident. Furthermore, sampling date and location were found to greatly influence soil fauna community and decomposition processes. The results give no indication of ecologically relevant adverse effects of antifungal GM wheat on the composition and the activity of the soil fauna community.	[Duc, Caroline; Nentwig, Wolfgang; Lindfeld, Andreas] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	University of Bern	Duc, C (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	andreas.lindfeld@iee.unibe.ch	Nentwig, Wolfgang/A-6624-2011		Swiss National Science Foundation [405940-115604]; wheat consortium, a subunit of the National Research Programme [NRP 59]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); wheat consortium, a subunit of the National Research Programme	This project was funded by the Swiss National Science Foundation (http://www.snf.ch; SNF Grant 405940-115604) and is part of the wheat consortium, a subunit of the National Research Programme NRP 59 "Benefits and risks of the deliberate release of genetically modified plants'' (www.NRP59.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Bieri S, 2003, MOL BREEDING, V11, P37, DOI 10.1023/A:1022145915983; Bigler I, 2012, J APPL ENTOMOL, V136, P51, DOI 10.1111/j.1439-0418.2011.01622.x; Bliffeld M, 1999, THEOR APPL GENET, V98, P1079, DOI 10.1007/s001220051170; Chen YH, 2009, MOL BREEDING, V24, P141, DOI 10.1007/s11032-009-9279-6; Cortet J, 2007, PEDOBIOLOGIA, V51, P207, DOI 10.1016/j.pedobi.2007.04.001; Devevre OC, 2000, SOIL BIOL BIOCHEM, V32, P1773, DOI 10.1016/S0038-0717(00)00096-1; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Doane JF, 2008, CROP PROT, V27, P951, DOI 10.1016/j.cropro.2007.11.016; Donegan KK, 1997, J APPL ECOL, V34, P767, DOI 10.2307/2404921; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Griffiths BS, 2007, PEDOBIOLOGIA, V51, P195, DOI 10.1016/j.pedobi.2007.04.002; Grime JP, 1996, OIKOS, V77, P489, DOI 10.2307/3545938; Hedlund K, 2000, OIKOS, V88, P585, DOI 10.1034/j.1600-0706.2000.880315.x; Honemann L, 2008, APPL SOIL ECOL, V40, P203, DOI 10.1016/j.apsoil.2008.04.006; Honemann L, 2009, EUR J SOIL BIOL, V45, P351, DOI 10.1016/j.ejsobi.2009.03.001; Huhta V, 1998, APPL SOIL ECOL, V9, P53, DOI 10.1016/S0929-1393(98)00053-5; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Illig J, 2005, J TROP ECOL, V21, P589, DOI 10.1017/S0266467405002646; Ioset JR, 2007, PLANT MOL BIOL, V65, P645, DOI 10.1007/s11103-007-9229-9; Jacobs W, 1988, BIOL OKOLOGIE INSEKT; Kotilainen T, 2004, EUR J SOIL BIOL, V40, P155, DOI 10.1016/j.ejsobi.2005.03.001; LAGERLOF J, 1989, J APPL ECOL, V26, P183, DOI 10.2307/2403660; Lindfeld A, 2011, APPL SOIL ECOL, V47, P51, DOI 10.1016/j.apsoil.2010.10.012; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Manu Minodora, 2010, Acta Entomologica Serbica, V15, P129; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2003, SOIL BIOL BIOCHEM, V35, P1387, DOI 10.1016/S0038-0717(03)00218-9; O'Callaghan M, 2001, N Z PLANT PROTECT-SE, V54, P105, DOI 10.30843/nzpp.2001.54.3725; Peschel K, 2006, SOIL BIOL BIOCHEM, V38, P2985, DOI 10.1016/j.soilbio.2006.04.035; Peter M, 2010, PEDOBIOLOGIA, V53, P271, DOI 10.1016/j.pedobi.2009.12.006; Poerschmann J, 2005, J ENVIRON QUAL, V34, P1508, DOI 10.2134/jeq2005.0070; Prasifka JR, 2007, J APPL ENTOMOL, V131, P115, DOI 10.1111/j.1439-0418.2006.01141.x; R Development Core Team, 2009, R FDN STAT COMP; Romeis J, 2003, PEDOBIOLOGIA, V47, P141, DOI 10.1078/0031-4056-00177; Rottmann N, 2010, EUR J SOIL BIOL, V46, P27, DOI 10.1016/j.ejsobi.2009.09.004; SANTOS PF, 1981, ECOLOGY, V62, P654, DOI 10.2307/1937733; Sanvido O, 2007, J VERBRAUCH LEBENSM, V2, P37, DOI 10.1007/s00003-007-0292-6; Saxena D, 2002, SOIL BIOL BIOCHEM, V34, P133, DOI 10.1016/S0038-0717(01)00161-4; Saxena D, 2001, AM J BOT, V88, P1704, DOI 10.2307/3558416; Schadler M, 2003, OIKOS, V103, P121, DOI 10.1034/j.1600-0706.2003.12659.x; SIEPEL H, 1994, BIOL FERT SOILS, V18, P263, DOI 10.1007/BF00570628; Srichumpa P, 2005, PLANT PHYSIOL, V139, P885, DOI 10.1104/pp.105.062406; Tan FX, 2010, PLANT SOIL, V329, P349, DOI 10.1007/s11104-009-0163-2; Vauramo S, 2006, APPL SOIL ECOL, V32, P338, DOI 10.1016/j.apsoil.2005.07.007; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Wu WX, 2009, J SOIL SEDIMENT, V9, P457, DOI 10.1007/s11368-009-0106-9; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Zeilinger AR, 2010, SOIL BIOL BIOCHEM, V42, P1284, DOI 10.1016/j.soilbio.2010.04.004; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; Zheng DW, 1997, AM NAT, V149, P125, DOI 10.1086/285982; Zurbrugg C, 2010, TRANSGENIC RES, V19, P257, DOI 10.1007/s11248-009-9304-x; Zwahlen C, 2007, PLANT SOIL, V300, P245, DOI 10.1007/s11104-007-9410-6	54	12	12	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25014	10.1371/journal.pone.0025014	http://dx.doi.org/10.1371/journal.pone.0025014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043279	Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400006
J	Ghosh, AK; Rossi, ML; Singh, DK; Dunn, C; Ramamoorthy, M; Croteau, DL; Liu, Y; Bohr, VA				Ghosh, Avik K.; Rossi, Marie L.; Singh, Dharmendra Kumar; Dunn, Christopher; Ramamoorthy, Mahesh; Croteau, Deborah L.; Liu, Yie; Bohr, Vilhelm A.			RECQL4, the Protein Mutated in Rothmund-Thomson Syndrome, Functions in Telomere Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; MAMMALIAN TELOMERES; HOMOLOGOUS RECOMBINATION; CANCER PREDISPOSITION; SYNDROME HELICASE; GENOTOXIC AGENTS; BLM HELICASE; REPLICATION; TRF1; INITIATION	Telomeres are structures at the ends of chromosomes and are composed of long tracks of short tandem repeat DNA sequences bound by a unique set of proteins (shelterin). Telomeric DNA is believed to form G-quadruplex and D-loop structures, which presents a challenge to the DNA replication and repair machinery. Although the RecQ helicases WRN and BLM are implicated in the resolution of telomeric secondary structures, very little is known about RECQL4, the RecQ helicase mutated in Rothmund-Thomson syndrome (RTS). Here, we report that RTS patient cells have elevated levels of fragile telomeric ends and that RECQL4-depleted human cells accumulate fragile sites, sister chromosome exchanges, and double strand breaks at telomeric sites. Further, RECQL4 localizes to telomeres and associates with shelterin proteins TRF1 and TRF2. Using recombinant proteins we showed that RECQL4 resolves telomeric D-loop structures with the help of shelterin proteins TRF1, TRF2, and POT1. We also found a novel functional synergistic interaction of this protein with WRN during D-loop unwinding. These data implicate RECQL4 in telomere maintenance.	[Ghosh, Avik K.; Rossi, Marie L.; Singh, Dharmendra Kumar; Dunn, Christopher; Ramamoorthy, Mahesh; Croteau, Deborah L.; Liu, Yie; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	vbohr@nih.gov	Liu, Yie/AAO-2092-2020; Croteau, Deb/AAP-5933-2020; Bohr, Vilhelm/AAP-5931-2020	Dunn, Christopher/0000-0001-7899-0110; Croteau, Deborah/0000-0002-6094-4084; Ramamoorthy, Mahesh/0000-0002-2359-5647	National Institutes of Health NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000754, ZIAAG000749, ZIAAG000726, ZIAAG000744] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health NIA Intramural Program.	Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2000, NUCLEIC ACIDS RES, V28, P2420, DOI 10.1093/nar/28.12.2420; Cabral REC, 2008, MUTAT RES-FUND MOL M, V643, P41, DOI 10.1016/j.mrfmmm.2008.06.002; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Ghosh A, 2009, J BIOL CHEM, V284, P31074, DOI 10.1074/jbc.M109.027532; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hagelstrom RT, 2010, P NATL ACAD SCI USA, V107, P15768, DOI 10.1073/pnas.1006338107; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Jin WD, 2008, HUM GENET, V123, P643, DOI 10.1007/s00439-008-0518-4; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Larizza L, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-2; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011152; Liu YL, 2010, DNA REPAIR, V9, P325, DOI 10.1016/j.dnarep.2010.01.006; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Mohaghegh P, 2001, HUM MOL GENET, V10, P741, DOI 10.1093/hmg/10.7.741; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Rossi ML, 2010, DNA REPAIR, V9, P796, DOI 10.1016/j.dnarep.2010.04.003; Saharia A, 2010, J BIOL CHEM, V285, P27057, DOI 10.1074/jbc.M110.112276; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schurman SH, 2009, HUM MOL GENET, V18, P3470, DOI 10.1093/hmg/ddp291; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Siitonen HA, 2009, EUR J HUM GENET, V17, P151, DOI 10.1038/ejhg.2008.154; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Singh DK, 2010, AGING CELL, V9, P358, DOI 10.1111/j.1474-9726.2010.00562.x; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stinco G, 2008, J DERMATOL, V35, P154, DOI 10.1111/j.1346-8138.2008.00436.x; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Tripathi V, 2007, J CELL BIOL, V178, P9, DOI 10.1083/jcb.200610051; VENNOS EM, 1992, J AM ACAD DERMATOL, V27, P750, DOI 10.1016/0190-9622(92)70249-F; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Walne AJ, 2010, HUM MOL GENET, V19, P4453, DOI 10.1093/hmg/ddq371; Walpita D, 1999, P NATL ACAD SCI USA, V96, P5622, DOI 10.1073/pnas.96.10.5622; Wang LL, 2001, AM J MED GENET, V102, P11, DOI 10.1002/1096-8628(20010722)102:1<11::AID-AJMG1413>3.0.CO;2-A; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	62	76	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					196	209		10.1074/jbc.M111.295063	http://dx.doi.org/10.1074/jbc.M111.295063			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22039056	Green Published, hybrid			2022-12-25	WOS:000298682400021
J	Kumar, R; Chadha, S; Saraswat, D; Bajwa, JS; Li, RA; Conti, HR; Edgerton, M				Kumar, Rohitashw; Chadha, Sonia; Saraswat, Darpan; Bajwa, Jashanjot Singh; Li, Rui A.; Conti, Heather R.; Edgerton, Mira			Histatin 5 Uptake by Candida albicans Utilizes Polyamine Transporters Dur3 and Dur31 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; YEAST ABC PROTEINS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; ANTIMICROBIAL PEPTIDES; NONAQUEOUS SOLUTIONS; CATIONIC PEPTIDES; H+-ATPASE; TRANSLOCATION; SPERMIDINE	Histatin 5 (Hst 5) is a salivary gland-secreted cationic peptide with potent fungicidal activity against Candida albicans. Hst 5 kills fungal cells following intracellular translocation, although its selective transport mechanism is unknown. C. albicans cells grown in the presence of polyamines were resistant to Hst 5 due to reduced intracellular uptake, suggesting that this cationic peptide may enter candidal cells through native yeast polyamine transporters. Based upon homology to known Saccharomyces cerevisiae polyamine permeases, we identified six C. albicans Dur polyamine transporter family members and propose a new nomenclature. Gene deletion mutants were constructed for C. albicans polyamine transporters Dur3, Dur31, Dur33, Dur34, and were tested for Hst 5 sensitivity and uptake of spermidine. We found spermidine uptake and Hst 5 mediated killing were decreased significantly in Delta dur3, Delta dur31, and Delta dur3/Delta dur31 strains; whereas a DUR3 overexpression strain increased Hst 5 sensitivity and higher spermidine uptake. Treatment of cells with a spermidine synthase inhibitor increased spermidine uptake and Hst 5 killing, whereas protonophores and cold treatment reduced spermidine uptake. Inhibition assays showed that Hst 5 is a competitive analog of spermidine for uptake into C. albicans cells, and that Hst 5 K-i values were increased by 80-fold in Delta dur3/Delta dur31 cells. Thus, Dur3p and Dur31p are preferential spermidine transporters used by Hst 5 for its entry into candidal cells. Understanding of polyamine transporter-mediated internalization of Hst 5 provides new insights into the uptake mechanism for C. albicans toxicity, and further suggests design for targeted fungal therapeutic agents.	[Kumar, Rohitashw; Chadha, Sonia; Saraswat, Darpan; Bajwa, Jashanjot Singh; Li, Rui A.; Conti, Heather R.; Edgerton, Mira] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA; [Chadha, Sonia] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Bhabha Atomic Research Center (BARC)	Edgerton, M (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Oral Biol, 310 Foster Hall,3435 Main St, Buffalo, NY 14214 USA.	edgerto@buffalo.edu	Kumar, Rohitashw/D-1968-2014; Chadha, Sonia/AAJ-2483-2020	Kumar, Rohitashw/0000-0001-8695-3555; CHADHA, SONIA/0000-0003-2831-6907; Saraswat, Darpan/0000-0002-3226-8656	National Institutes of Health from the NIDCR [DE10641]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE010641] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE10641 from the NIDCR (to M. E.).	Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Baev D, 2004, J BIOL CHEM, V279, P55060, DOI 10.1074/jbc.M411031200; Baev D, 2001, MICROBIOL-SGM, V147, P3323, DOI 10.1099/00221287-147-12-3323; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Brewer D, 1998, BIOCHEM CELL BIOL, V76, P247, DOI 10.1139/bcb-76-2-3-247; Chattopadhyay MK, 2009, YEAST, V26, P531, DOI 10.1002/yea.1703; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; den Hertog AL, 2004, BIOCHEM J, V379, P665, DOI 10.1042/BJ20031785; FERREIRAPEREIRA A, 1994, J BIOL CHEM, V269, P12074; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FONZI WA, 1993, GENETICS, V134, P717; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Jang WS, 2008, ANTIMICROB AGENTS CH, V52, P497, DOI 10.1128/AAC.01199-07; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Kaouass M, 1998, J BIOL CHEM, V273, P2109, DOI 10.1074/jbc.273.4.2109; Koshlukova SE, 1999, J BIOL CHEM, V274, P18872, DOI 10.1074/jbc.274.27.18872; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Li XWS, 2006, J BIOL CHEM, V281, P22453, DOI 10.1074/jbc.M604064200; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Navarathna DHMLP, 2011, MICROBIOL-SGM, V157, P270, DOI 10.1099/mic.0.045005-0; Nozaki T, 1996, BIOCHEM BIOPH RES CO, V228, P452, DOI 10.1006/bbrc.1996.1681; Oliver D, 2000, EUR J BIOCHEM, V267, P5824, DOI 10.1046/j.1432-1327.2000.01669.x; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; Raj PA, 1998, BIOPOLYMERS, V45, P51, DOI 10.1002/(SICI)1097-0282(199801)45:1<51::AID-BIP5>3.0.CO;2-Y; Rothstein DM, 2001, ANTIMICROB AGENTS CH, V45, P1367, DOI 10.1128/AAC.45.5.1367-1373.2001; Ruissen ALA, 2001, BIOCHEM J, V356, P361, DOI 10.1042/0264-6021:3560361; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Shah P, 2009, EXP BIOL MED, V234, P403, DOI 10.3181/0809-RM-269; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Situ H, 2000, BBA-GEN SUBJECTS, V1475, P377, DOI 10.1016/S0304-4165(00)00096-9; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tomitori H, 2001, BIOCHEM J, V353, P681, DOI 10.1042/0264-6021:3530681; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Veerman ECI, 2007, J BIOL CHEM, V282, P18831, DOI 10.1074/jbc.M610555200; Vylkova S, 2007, PURINERG SIGNAL, V3, P91, DOI 10.1007/s11302-006-9040-0; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; Xu YY, 1999, ANTIMICROB AGENTS CH, V43, P2256, DOI 10.1128/AAC.43.9.2256	55	48	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43748	43758		10.1074/jbc.M111.311175	http://dx.doi.org/10.1074/jbc.M111.311175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033918	Green Published, hybrid			2022-12-25	WOS:000298402300018
J	Tokuoka, H; Muramatsu, S; Sumi-Ichinose, C; Sakane, H; Kojima, M; Aso, Y; Nomura, T; Metzger, D; Ichinose, H				Tokuoka, Hirofumi; Muramatsu, Shin-ichi; Sumi-Ichinose, Chiho; Sakane, Hiroaki; Kojima, Masayo; Aso, Yoshinori; Nomura, Takahide; Metzger, Daniel; Ichinose, Hiroshi			Compensatory Regulation of Dopamine after Ablation of the Tyrosine Hydroxylase Gene in the Nigrostriatal Projection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED DISRUPTION; PARKINSONS-DISEASE; DEFICIENT MICE; NEURONS; RAT; TRANSPORT; RELEASE; PHOSPHORYLATION; NORADRENALINE; MECHANISMS	The tyrosine hydroxylase (TH; EC 1.14.16.2) is a rate-limiting enzyme in the dopamine synthesis and important for the central dopaminergic system, which controls voluntary movements and reward-dependent behaviors. Here, to further explore the regulatory mechanism of dopamine levels by TH in adult mouse brains, we employed a genetic method to inactivate the Th gene in the nigrostriatal projection using the Cre-loxP system. Stereotaxic injection of adeno-associated virus expressing Cre recombinase (AAV-Cre) into the substantia nigra pars compacta (SNc), where dopaminergic cell bodies locate, specifically inactivated the Th gene. Whereas the number of TH-expressing cells decreased to less than 40% in the SNc 2 weeks after the AAV-Cre injection, the striatal TH protein level decreased to 75%, 50%, and 39% at 2, 4, and 8 weeks, respectively, after the injection. Thus, unexpectedly, the reduction of TH protein in the striatum, where SNc dopaminergic axons innervate densely, was slower than in the SNc. Moreover, despite the essential requirement of TH for dopamine synthesis, the striatal dopamine contents were only moderately decreased, to 70% even 8 weeks after AAV-Cre injection. Concurrently, in vivo synthesis activity of L-dihydroxyphenylalanine, the dopamine precursor, per TH protein level was augmented, suggesting up-regulation of dopamine synthesis activity in the intact nigrostriatal axons. Collectively, our conditional Th gene targeting method demonstrates two regulatory mechanisms of TH in axon terminals for dopamine homeostasis in vivo: local regulation of TH protein amount independent of soma and trans-axonal regulation of apparent L-dihydroxyphenylalanine synthesis activity per TH protein.	[Tokuoka, Hirofumi; Sakane, Hiroaki; Kojima, Masayo; Aso, Yoshinori; Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Dept Med, Div Neurol, Shimotsuke, Tochigi 3290498, Japan; [Sumi-Ichinose, Chiho; Nomura, Takahide] Fujita Hlth Univ, Sch Med, Dept Pharmacol, Toyoake, Aichi 4701192, Japan; [Metzger, Daniel] Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; [Metzger, Daniel] CNRS, Illkirch Graffenstaden, France; [Metzger, Daniel] Univ Strasbourg, F-67000 Strasbourg, France	Tokyo Institute of Technology; Jichi Medical University; Fujita Health University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tokuoka, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Midori Ku, 4259 B-7 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	htokuoka@bio.titech.ac.jp; hichinos@bio.titech.ac.jp	Aso, Yoshinori/ACJ-9439-2022; Ichinose, Hiroshi/D-8986-2015; Muramatsu, Shinichi/ABC-6093-2021; Muramatsu, Shin-ichi/K-9420-2013	Ichinose, Hiroshi/0000-0001-6008-6860; Muramatsu, Shinichi/0000-0002-3185-7790; Muramatsu, Shin-ichi/0000-0002-3185-7790; Metzger, Daniel/0000-0002-5555-046X; Sumi-Ichinose, Chiho/0000-0001-5261-0853	Ministry of Health, Labor and Welfare of Japan [18A-2]; MEXT; Nakajima Foundation; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST); Grants-in-Aid for Scientific Research [21500305] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakajima Foundation; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Human Frontier Science Program; by Research Grant 18A-2 for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare of Japan; by KAKENHI from MEXT; by the Nakajima Foundation; and by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST).	BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; CUBEDDU LX, 1982, J PHARMACOL EXP THER, V223, P497; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Fernandez E, 1999, J NEUROCHEM, V73, P169, DOI 10.1046/j.1471-4159.1999.0730169.x; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Gordon SL, 2008, J NEUROCHEM, V106, P1614, DOI 10.1111/j.1471-4159.2008.05509.x; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graybiel AM, 2000, TRENDS NEUROSCI, V23, pS71, DOI 10.1016/S1471-1931(00)00027-6; Hakansson K, 2004, EUR J NEUROSCI, V20, P1108, DOI 10.1111/j.1460-9568.2004.03547.x; HEFTI F, 1985, NEUROPHARMACOLOGY, V24, P19, DOI 10.1016/0028-3908(85)90090-5; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; JARROTT B, 1972, P NATL ACAD SCI USA, V69, P3440, DOI 10.1073/pnas.69.11.3440; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Lane EL, 2005, J PHARMACOL EXP THER, V312, P1124, DOI 10.1124/jpet.104.076554; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; McCallum SE, 2006, J NEUROCHEM, V96, P960, DOI 10.1111/j.1471-4159.2005.03610.x; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Pifl C, 2006, NEUROCHEM INT, V49, P519, DOI 10.1016/j.neuint.2006.03.013; Pothos EN, 1998, J NEUROSCI, V18, P4106; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; TANK AW, 1986, MOL PHARMACOL, V30, P497; Terada S, 2003, NEUROSCI RES, V47, P367, DOI 10.1016/j.neures.2003.08.005; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; ZIGMOND MJ, 1984, ARCH NEUROL-CHICAGO, V41, P856, DOI 10.1001/archneur.1984.04050190062015	43	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43549	43558		10.1074/jbc.M111.284729	http://dx.doi.org/10.1074/jbc.M111.284729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027820	Green Published, hybrid			2022-12-25	WOS:000298351300074
J	DiAngi, YT; Panozzo, CA; Ramogola-Masire, D; Steenhoff, AP; Brewer, NT				DiAngi, Yumi Taylor; Panozzo, Catherine A.; Ramogola-Masire, Doreen; Steenhoff, Andrew P.; Brewer, Noel T.			A Cross-Sectional Study of HPV Vaccine Acceptability in Gaborone, Botswana	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; ADOLESCENT GIRLS; KEY CHALLENGES; WOMEN; IMMUNIZATION; ATTITUDES; BARRIERS; AREA	Background: Cervical cancer is the most common cancer among women in Botswana and elsewhere in Sub-Saharan Africa. We sought to examine whether HPV vaccine is acceptable among parents in Botswana, which recently licensed the vaccine to prevent cervical cancer. Methods and Findings: We conducted a cross-sectional survey in 2009, around the time the vaccine was first licensed, with adults recruited in general medicine and HIV clinics in Gaborone, the capital of Botswana. Although only 9% (32/376) of respondents had heard of HPV vaccine prior to the survey, 88% (329/376) said they definitely will have their adolescent daughters receive HPV vaccine. Most respondents would get the vaccine for their daughters at a public or community clinic (42%) or a gynecology or obstetrician's office (39%), and 74% would get it for a daughter if it were available at her school. Respondents were more likely to say that they definitely will get HPV vaccine for their daughters if they had less education (OR = 0.20, 95% CI = 0.07-0.58) or lived more than 30 kilometers from the capital, Gaborone (OR = 2.29, 95% CI = 1.06-4.93). Other correlates of acceptability were expecting to be involved in the decision to get HPV vaccine, thinking the vaccine would be hard to obtain, and perceiving greater severity of HPV-related diseases. Conclusions: HPV vaccination of adolescent girls would be highly acceptable if the vaccine became widely available to the daughters of healthcare seeking parents in Gaborone, Botswana. Potential HPV vaccination campaigns should provide more information about HPV and the vaccine as well as work to minimize barriers.	[DiAngi, Yumi Taylor; Ramogola-Masire, Doreen] Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA; [DiAngi, Yumi Taylor; Ramogola-Masire, Doreen; Steenhoff, Andrew P.] Botswana Univ Penn Partnership, Gaborone, Botswana; [Panozzo, Catherine A.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Ramogola-Masire, Doreen] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Ramogola-Masire, Doreen] Univ Botswana, Dept Internal Med, Gaborone, Botswana; [Ramogola-Masire, Doreen] Univ Botswana, Dept Obstet & Gynecol, Gaborone, Botswana; [Steenhoff, Andrew P.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Brewer, Noel T.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Brewer, Noel T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Botswana; University of Botswana; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	DiAngi, YT (corresponding author), Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA.	ydiangi@gmail.com; ntb1@unc.edu	Brewer, Noel T/C-4375-2008; Ramogola-Masire, Doreen/AAP-2754-2020	Brewer, Noel T/0000-0003-2241-7002; Ramogola-Masire, Doreen/0000-0001-9624-8366	Penn Center for AIDS Research (CFAR), a National Institutes of Health (NIH) [P30 AI 045008]; American Cancer Society [MSRG-06-259-01-CPPB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	Penn Center for AIDS Research (CFAR), a National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible through core services and support from the Penn Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program (P30 AI 045008). Additional support for publication of the findings was provided by a grant from the American Cancer Society (MSRG-06-259-01-CPPB). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; *BEDIA, 2010, BOTSW STAT; Black LL, 2009, VACCINE, V27, P1668, DOI 10.1016/j.vaccine.2009.01.035; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Breitkopf CR, 2009, VACCINE, V27, P2367, DOI 10.1016/j.vaccine.2009.02.021; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Brewer NT, 2011, SEX TRANSM DIS, V38, P197, DOI 10.1097/OLQ.0b013e3181f12dbf; Fazekas KI, 2008, J WOMENS HEALTH, V17, P539, DOI 10.1089/jwh.2007.0489; Harries J, 2009, VACCINE, V27, P38, DOI 10.1016/j.vaccine.2008.10.033; Katahoire R A, 2008, Afr J Reprod Health, V12, P159; Keating KM, 2008, J ADOLESCENT HEALTH, V43, pS61, DOI 10.1016/j.jadohealth.2008.06.015; Kwan TTC, 2008, SEX TRANSM INFECT, V84, P227, DOI 10.1136/sti.2007.029363; Li J, 2009, VACCINE, V27, P1210, DOI 10.1016/j.vaccine.2008.12.020; Madhivanan P, 2009, VACCINE, V27, P5203, DOI 10.1016/j.vaccine.2009.06.073; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; McFarland D M, 2003, Int Nurs Rev, V50, P167, DOI 10.1046/j.1466-7657.2003.00195.x; McRee AL, 2010, SEX TRANSM DIS, V37, P234, DOI 10.1097/OLQ.0b013e3181c37e15; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Reeve C, 2008, COMMUN DIS INTELL, V32, P94; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Sam IC, 2009, J ADOLESCENT HEALTH, V44, P610, DOI 10.1016/j.jadohealth.2008.11.014; UNAIDS WHO, 2010, 2008 REP GLOB AIDS E; *UNICEF, 2010, BOTSW STAT; *WHO, 2010, HPV REL CANC BOTSW; *WHO, 2010, HPV REL CANC AFR; Winkler JL, 2008, VACCINE, V26, pL73, DOI 10.1016/j.vaccine.2008.05.027; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591	28	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25481	10.1371/journal.pone.0025481	http://dx.doi.org/10.1371/journal.pone.0025481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22039413	Green Published, Green Submitted, gold			2022-12-25	WOS:000296517000005
J	Bedolla, DE; Torre, V				Bedolla, Diana E.; Torre, Vincent			A Component of Retinal Light Adaptation Mediated by the Thyroid Hormone Cascade	PLOS ONE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; PHOTORECEPTOR GUANYLYL CYCLASE; BROWN ADIPOSE-TISSUE; OTX2 HOMEOBOX GENE; CONE PHOTORECEPTORS; PINEAL-GLAND; PIGMENT GENES; MOUSE RETINA; DARK CYCLE; RAT RETINA	Analysis with DNA-microrrays and real time PCR show that several genes involved in the thyroid hormone cascade, such as deiodinase 2 and 3 (Dio2 and Dio3) are differentially regulated by the circadian clock and by changes of the ambient light. The expression level of Dio2 in adult rats (2-3 months of age) kept continuously in darkness is modulated by the circadian clock and is up-regulated by 2 fold at midday. When the diurnal ambient light was on, the expression level of Dio2 increased by 4-8 fold and a consequent increase of the related protein was detected around the nuclei of retinal photoreceptors and of neurons in inner and outer nuclear layers. The expression level of Dio3 had a different temporal pattern and was down-regulated by diurnal light. Our results suggest that DIO2 and DIO3 have a role not only in the developing retina but also in the adult retina and are powerfully regulated by light. As the thyroid hormone is a ligand-inducible transcription factor controlling the expression of several target genes, the transcriptional activation of Dio2 could be a novel genomic component of light adaptation.	[Bedolla, Diana E.; Torre, Vincent] Int Sch Adv Studies SISSA, Neurobiol Sect, I-34014 Trieste, Italy; [Torre, Vincent] Italian Inst Technol, SISSA Unit, Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Bedolla, DE (corresponding author), Int Sch Adv Studies SISSA, Neurobiol Sect, I-34014 Trieste, Italy.	torre@sissa.it		Bedolla Orozco, Diana Eva/0000-0003-1902-1517	Fondo per gli Investimenti della Ricerca di Base (FIRB), Italian Government [RBLA03AF28_007]	Fondo per gli Investimenti della Ricerca di Base (FIRB), Italian Government	The present study was funded by the Fondo per gli Investimenti della Ricerca di Base (FIRB) grant #RBLA03AF28_007, from the Italian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia RR, 2011, J BIOL CHEM, V286, P23799, DOI 10.1074/jbc.M111.246389; Bai L, 2008, BRAIN RES, V1203, P89, DOI 10.1016/j.brainres.2008.01.073; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barrera-Hernandez G, 1999, ENDOCRINOLOGY, V140, P5267, DOI 10.1210/en.140.11.5267; Bassett JHD, 2008, BONE, V43, P418, DOI 10.1016/j.bone.2008.05.007; BIANCO AC, 1987, J CLIN INVEST, V79, P295, DOI 10.1172/JCI112798; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; CARVALHO SD, 1991, ENDOCRINOLOGY, V128, P2149, DOI 10.1210/endo-128-4-2149; CERVETTO L, 1977, J PHYSIOL-LONDON, V267, P17, DOI 10.1113/jphysiol.1977.sp011799; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Codega P, 2009, J PHYSIOL-LONDON, V587, P2457, DOI 10.1113/jphysiol.2009.168609; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Deeb SS, 2006, VISUAL NEUROSCI, V23, P371, DOI 10.1017/S0952523806233030; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Elias R, 2004, MOL VIS, V10, P672; Fain G L, 2001, Prog Brain Res, V131, P383; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Fischer AJ, 2011, NEUROSCIENCE, V178, P250, DOI 10.1016/j.neuroscience.2011.01.022; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; IMAKI J, 1995, MOL BRAIN RES, V30, P48, DOI 10.1016/0169-328X(94)00270-O; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Kramer RH, 2001, J EXP BIOL, V204, P2921; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOLLEY RN, 1992, NEUROCHEM RES, V17, P81, DOI 10.1007/BF00966868; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; Martins RAP, 2006, EUR J NEUROSCI, V24, P969, DOI 10.1111/j.1460-9568.2006.04966.x; Morgan R, 2006, TRENDS GENET, V22, P67, DOI 10.1016/j.tig.2005.11.004; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; NGO JT, 1990, GENOMICS, V7, P84, DOI 10.1016/0888-7543(90)90521-U; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Opitz R, 2010, GEN COMP ENDOCR, V168, P199, DOI 10.1016/j.ygcen.2010.04.013; Osawa S, 2008, J NEUROCHEM, V107, P1314, DOI 10.1111/j.1471-4159.2008.05691.x; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Politi LE, 2001, INVEST OPHTH VIS SCI, V42, P3008; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; QIAN HH, 1993, NATURE, V361, P162, DOI 10.1038/361162a0; Qian J, 2005, NUCLEIC ACIDS RES, V33, P3479, DOI 10.1093/nar/gki658; Rath MF, 2009, J NEUROCHEM, V108, P285, DOI 10.1111/j.1471-4159.2008.05765.x; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Reidel B, 2006, VISION RES, V46, P4464, DOI 10.1016/j.visres.2006.07.019; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Roomets E, 2008, INVEST OPHTH VIS SCI, V49, P1660, DOI 10.1167/iovs.07-1094; Scheetz TE, 2006, P NATL ACAD SCI USA, V103, P14429, DOI 10.1073/pnas.0602562103; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; SCHREMSER JL, 1995, EXP EYE RES, V61, P25, DOI 10.1016/S0014-4835(95)80055-7; Shaaban SA, 1998, INVEST OPHTH VIS SCI, V39, P885; SharanjeetKaur, 1997, OPHTHAL PHYSL OPT, V17, P232, DOI 10.1111/j.1475-1313.1997.tb00050.x; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; Trimarchi JM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-101; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WILLIAMS GR, LOCAL CONTROL THYROI; Wu YF, 2000, TRENDS ENDOCRIN MET, V11, P207, DOI 10.1016/S1043-2760(00)00263-0; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003	80	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26334	10.1371/journal.pone.0026334	http://dx.doi.org/10.1371/journal.pone.0026334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039463	Green Published, gold, Green Submitted			2022-12-25	WOS:000296515200012
J	Kentrup, D; Reuter, S; Schnockel, U; Grabner, A; Edemir, B; Pavenstadt, H; Schober, O; Schafers, M; Schlatter, E; Bussemaker, E				Kentrup, Dominik; Reuter, Stefan; Schnoeckel, Uta; Grabner, Alexander; Edemir, Bayram; Pavenstaedt, Hermann; Schober, Otmar; Schaefers, Michael; Schlatter, Eberhard; Buessemaker, Eckhart			Hydroxyfasudil-Mediated Inhibition of ROCK1 and ROCK2 Improves Kidney Function in Rat Renal Acute Ischemia-Reperfusion Injury	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; RHO-KINASE INHIBITOR; BINDING PROTEIN RHO; SMALL-ANIMAL PET; TRANSENDOTHELIAL MIGRATION; ALLOGRAFT-REJECTION; MATRIX METALLOPROTEINASES; SERINE/THREONINE KINASE; LEUKOCYTE RECRUITMENT; BLOOD-FLOW	Renal ischemia-reperfusion (IR) injury (IRI) is a common and important trigger of acute renal injury (AKI). It is inevitably linked to transplantation. Involving both, the innate and the adaptive immune response, IRI causes subsequent sterile inflammation. Attraction to and transmigration of immune cells into the interstitium is associated with increased vascular permeability and loss of endothelial and tubular epithelial cell integrity. Considering the important role of cytoskeletal reorganization, mainly regulated by RhoGTPases, in the development of IRI we hypothesized that a preventive, selective inhibition of the Rho effector Rho-associated coiled coil containing protein kinase (ROCK) by hydroxyfasudil may improve renal IRI outcome. Using an IRI-based animal model of AKI in male Sprague Dawley rats, animals treated with hydroxyfasudil showed reduced proteinuria and polyuria as well as increased urine osmolarity when compared with sham-treated animals. In addition, renal perfusion (as assessed by (18)F-fluoride Positron Emission Tomography (PET)), creatinine-and urea-clearances improved significantly. Moreover, endothelial leakage and renal inflammation was significantly reduced as determined by histology, (18)F-fluordesoxyglucose-microautoradiography, Evans Blue, and real-time PCR analysis. We conclude from our study that ROCK-inhibition by hydroxyfasudil significantly improves kidney function in a rat model of acute renal IRI and is therefore a potential new therapeutic option in humans.	[Kentrup, Dominik; Reuter, Stefan; Grabner, Alexander; Edemir, Bayram; Pavenstaedt, Hermann; Schlatter, Eberhard; Buessemaker, Eckhart] Univ Munster, Dept Internal Med D, Munster, Germany; [Schnoeckel, Uta; Schober, Otmar] Univ Munster, Dept Nucl Med, Munster, Germany; [Schaefers, Michael] Univ Munster, European Inst Mol Imaging, Munster, Germany; [Buessemaker, Eckhart] Dialysis Unit Hamm, Hamm, Germany	University of Munster; University of Munster; University of Munster	Kentrup, D (corresponding author), Univ Munster, Dept Internal Med D, Munster, Germany.	buessema@hotmail.com	Edemir, Bayram/AAF-6845-2020	Kentrup, Dominik/0000-0003-3887-4304	Innovative Medical Research (IMF) [I-BU 9844000]; Interdisciplinary Centre for Clinicial Research (IZKF, Core Unit SmAP) of the Medical Faculty Munster, Germany; German Research Foundation (DFG) [SFB656C7]; University of Muenster	Innovative Medical Research (IMF); Interdisciplinary Centre for Clinicial Research (IZKF, Core Unit SmAP) of the Medical Faculty Munster, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Muenster	Funding: This study was supported by the Innovative Medical Research (IMF, Project I-BU 9844000) and the Interdisciplinary Centre for Clinicial Research (IZKF, Core Unit SmAP) of the Medical Faculty Munster, Germany, and the German Research Foundation (DFG, SFB656C7). The authors acknowledge support by Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Bolisetty S, 2009, KIDNEY INT, V75, P674, DOI 10.1038/ki.2008.689; Carbajal JM, 2000, AM J PHYSIOL-CELL PH, V279, pC195; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; De Greef KE, 2001, KIDNEY INT, V60, P1415, DOI 10.1046/j.1523-1755.2001.0600041415.x; Di Marco GS, 2011, EUR HEART J, V32, P1935, DOI 10.1093/eurheartj/ehq436; Ermolli M, 2003, TRANSPL IMMUNOL, V11, P137, DOI 10.1016/S0966-3274(02)00150-8; Gavard J, 2008, J BIOL CHEM, V283, P29888, DOI 10.1074/jbc.M803880200; HILSON AJW, 1978, J NUCL MED, V19, P994; Honing H, 2004, J LEUKOCYTE BIOL, V75, P523, DOI 10.1189/jlb.0203054; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kaim AH, 2002, RADIOLOGY, V223, P446, DOI 10.1148/radiol.2232010914; Kanda T, 2003, KIDNEY INT, V64, P2009, DOI 10.1046/j.1523-1755.2003.00300.x; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Komers R, 2011, KIDNEY INT, V79, P432, DOI 10.1038/ki.2010.428; Kramer S, 2009, AM J PHYSIOL-RENAL, V297, pF218, DOI 10.1152/ajprenal.90617.2008; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Letourneau I, 2002, NEPHRON, V90, P408, DOI 10.1159/000054728; Leung T, 1996, MOL CELL BIOL, V16, P5313; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Nagatoya K, 2002, KIDNEY INT, V61, P1684, DOI 10.1046/j.1523-1755.2002.00328.x; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nishikimi T, 2004, J HYPERTENS, V22, P1787, DOI 10.1097/00004872-200409000-00024; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; PALLER MS, 1989, J LAB CLIN MED, V113, P379; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Prakash J, 2008, J AM SOC NEPHROL; Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x; Rao RM, 2005, MICROCIRCULATION, V12, P83, DOI 10.1080/10739680590896018; Reuter S, 2010, J NUCL MED, V51, P1644, DOI 10.2967/jnumed.110.078550; Reuter S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005296; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ronco P, 2008, KIDNEY INT, V74, P873, DOI 10.1038/ki.2008.349; Samaniego R, 2007, J CELL SCI, V120, P3534, DOI 10.1242/jcs.006296; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; Satoh S, 2002, EUR J PHARMACOL, V455, P169, DOI 10.1016/S0014-2999(02)02619-5; Schafers KP, 2005, J NUCL MED, V46, P996; Schnockel U, 2008, EUR J NUCL MED MOL I, V35, P2267, DOI 10.1007/s00259-008-0878-y; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Si J, 2010, LAB INVEST, V90, P448, DOI 10.1038/labinvest.2009.142; Takada M, 1997, J CLIN INVEST, V100, P1199, DOI 10.1172/JCI119632; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Teraishi K, 2004, EUR J PHARMACOL, V505, P205, DOI 10.1016/j.ejphar.2004.10.040; THORNTON MA, 1989, AM J PATHOL, V135, P509; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Versteilen AMG, 2006, AM J PHYSIOL-RENAL, V291, pF606, DOI 10.1152/ajprenal.00434.2005; Versteilen AMG, 2011, NEPHRON EXP NEPHROL, V118, pE79, DOI 10.1159/000322605; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Ysebaert DK, 2000, NEPHROL DIAL TRANSPL, V15, P1562, DOI 10.1093/ndt/15.10.1562; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502	63	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26419	10.1371/journal.pone.0026419	http://dx.doi.org/10.1371/journal.pone.0026419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031832	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200021
J	Schreiber, S; Bueche, CZ; Garz, C; Kropf, S; Kuester, D; Amann, K; Heinze, HJ; Goertler, M; Reymann, KG; Braun, H				Schreiber, Stefanie; Bueche, Celine Z.; Garz, Cornelia; Kropf, Siegfried; Kuester, Doerthe; Amann, Kerstin; Heinze, Hans-Jochen; Goertler, Michael; Reymann, Klaus G.; Braun, Holger			Kidney Pathology Precedes and Predicts the Pathological Cascade of Cerebrovascular Lesions in Stroke Prone Rats	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; SPONTANEOUSLY HYPERTENSIVE RAT; BRAIN; PROTEINURIA; EXPRESSION; FAILURE; INJURY; ATTACK; RENIN	Introduction: Human cerebral small vessel disease (CSVD) has been hypothesized to be an age-dependent disease accompanied by similar vascular changes in other organs. SHRSP feature numerous vascular risk factors and may be a valid model of some aspects of human CSVD. Here we compare renal histopathological changes with the brain pathology of spontaneously hypertensive stroke-prone rats (SHRSP). Material and Methods: We histologically investigated the brains and kidneys of 61 SHRSP at different stages of age (12 to 44 weeks). The brain pathology (aggregated erythrocytes in capillaries and arterioles, microbleeds, microthromboses) and the kidney pathology (aggregated erythrocytes within peritubular capillaries, tubular protein cylinders, glomerulosclerosis) were quantified separately. The prediction of the brain pathology by the kidney pathology was assessed by creating ROC-curves integrating the degree of kidney pathology and age of SHRSP. Results: Both, brain and kidney pathology, show an age-dependency and proceed in definite stages whereas an aggregation of erythrocytes in capillaries and arterioles, we parsimoniously interpreted as stases, represent the initial finding in both organs. Thus, early renal tubulointerstitial damage characterized by rather few intravasal erythrocyte aggregations and tubular protein cylinders predicts the initial step of SHRSPs' cerebral vascular pathology marked by accumulated erythrocytes. The combined increase of intravasal erythrocyte aggregations and protein cylinders accompanied by glomerulosclerosis and thrombotic renal microangiopathy in kidneys of older SHRSP predicts the final stages of SHRSPs' cerebrovascular lesions marked by microbleeds and thrombotic infarcts. Conclusion: Our results illustrate a close association between structural brain and kidney pathology and support the concept of small vessel disease to be an age-dependent systemic pathology. Further, an improved joined nephrologic and neurologic diagnostic may help to identify patients with CSVD at an early stage.	[Schreiber, Stefanie; Bueche, Celine Z.; Garz, Cornelia; Heinze, Hans-Jochen; Goertler, Michael] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Kropf, Siegfried] Otto Von Guericke Univ, Inst Biometry & Med Informat, Magdeburg, Germany; [Kuester, Doerthe] Otto Von Guericke Univ, Inst Pathol, Magdeburg, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany; [Heinze, Hans-Jochen; Reymann, Klaus G.; Braun, Holger] Deutsch Zentrum Neurodegenerat Erkrankungen, Magdeburg, Germany; [Heinze, Hans-Jochen; Reymann, Klaus G.] Leibniz Inst Neurobiol, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; University of Erlangen Nuremberg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz Institut fur Neurobiologie (LIN)	Schreiber, S (corresponding author), Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany.	stefanie.schreiber@med.ovgu.de	Reymann, Klaus G/J-8507-2013; Jechorek, Doerthe/J-4716-2014; Schreiber, Stefanie/S-3223-2019	Jechorek, Doerthe/0000-0002-1480-5200; Schreiber, Stefanie/0000-0003-4439-4374	Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany; Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany	Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany; Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany	Funding: This work was funded by the Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany, and the Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 2009, CEREBROVASC DIS, V27, P493, DOI 10.1159/000210432; Anderson W P, 1994, Blood Press Suppl, V5, P57; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127; FELD LG, 1977, KIDNEY INT, V12, P332, DOI 10.1038/ki.1977.120; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; GATTONE VH, 1983, HYPERTENSION, V5, P8, DOI 10.1161/01.HYP.5.1.8; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Hayashi K, 1996, J HYPERTENS, V14, P1387, DOI 10.1097/00004872-199612000-00002; Hill GS, 2008, CURR OPIN NEPHROL HY, V17, P266, DOI 10.1097/MNH.0b013e3282f88a1f; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; INAGAMI T, 1991, BLOOD VESSELS, V28, P217; Johnson RJ, 2002, J HYPERTENS, V20, pS1; Khatri M, 2007, STROKE, V38, P3121, DOI 10.1161/STROKEAHA.107.493593; Lammie GA, 1997, STROKE, V28, P2222, DOI 10.1161/01.STR.28.11.2222; LARAGH JH, 1991, AM J HYPERTENS, V4, pS2, DOI 10.1093/ajh/4.1.2S; MCGIFF JC, 1981, CIRC RES, V48, P455, DOI 10.1161/01.RES.48.4.455; Meyrier A, 1998, KIDNEY INT, V54, P2, DOI 10.1046/j.1523-1755.1998.00968.x; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Obata J, 2000, J HYPERTENS, V18, P1247, DOI 10.1097/00004872-200018090-00011; Ovbiagele B, 2010, ARCH NEUROL-CHICAGO, V67, P45, DOI 10.1001/archneurol.2009.310; Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003; Schreiber S, 2011, J CEREB BLO IN PRESS; Thompson CS, 2009, STROKE, V40, pE322, DOI 10.1161/STROKEAHA.108.542266	26	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26287	10.1371/journal.pone.0026287	http://dx.doi.org/10.1371/journal.pone.0026287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031827	Green Published, Green Submitted, gold			2022-12-25	WOS:000296513200014
J	Zheng, ZL; Andersson, AF; Ye, WM; Nyren, O; Normark, S; Engstrand, L				Zheng, Zongli; Andersson, Anders F.; Ye, Weimin; Nyren, Olof; Normark, Staffan; Engstrand, Lars			A Method for Metagenomics of Helicobacter pylori from Archived Formalin-Fixed Gastric Biopsies Permitting Longitudinal Studies of Carcinogenic Risk	PLOS ONE			English	Article							GENETIC DIVERSITY	The human microbiota has come into focus in the search for component causes of chronic diseases, such as gastrointestinal cancers. Presumably long induction periods and altered local environments after disease onset call for the development of methods for characterization of microorganisms colonizing the host decades before disease onset. Sequencing of microbial genomes in old formalin-fixed and paraffin-embedded (FFPE) gastrointestinal biopsies provides a means for such studies but is still challenging. Here we report a method based on laser capture micro-dissection and modified Roche 454 high-throughput pyrosequencing to obtain metagenomic profiles of Helicobacter pylori. We applied this method to two 15 year old FFPE biopsies from two patients. Frozen homogenized biopsies from the same gastroscopy sessions were also available for comparison after re-culture of H. pylori. For both patients, H. pylori DNA dissected from FFPE sections had similar to 96.4% identity with culture DNA from the same patients, while only similar to 92.5% identity with GenBank reference genomes, and with culture DNA from the other patient. About 82% and 60% of the predicted genes in the two genomes were captured by at least a single sequencing read. Along with sequences displaying high similarity to known H. pylori genes, novel and highly variant H. pylori sequences were identified in the FFPE sections by our physical enrichment approach, which would likely not have been detected by a sequence capture approach. The study demonstrates the feasibility of longitudinal metagenomic studies of H. pylori using decade-preserved FFPE biopsies.	[Zheng, Zongli; Ye, Weimin; Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Zheng, Zongli; Normark, Staffan; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Andersson, Anders F.] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Normark, Staffan; Engstrand, Lars] Swedish Inst Communicable Dis Control, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology; Swedish Institute for Infectious Disease Control	Zheng, ZL (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	lars.engstrand@ki.se	zheng, zongli/B-2917-2011; Andersson, Anders/J-9310-2019; zheng, zongli/C-7309-2008	zheng, zongli/0000-0003-4849-4903; Andersson, Anders/0000-0002-3627-6899; 	European Union [LSHC-CT-2005-018704]; Swedish Cancer Society [4925-B06-03XCC]; Karolinska Institutet (KID)	European Union(European Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet (KID)	Funding: This work was supported by the Sixth Research Framework Program of the European Union, project INCA (LSHC-CT-2005-018704) to ON, SN and LE, and the Swedish Cancer Society (4925-B06-03XCC) to ON, WY and LE. ZZ was also supported by a scholarship from the Karolinska Institutet (KID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LP, 2009, FEMS IMMUNOL MED MIC, V56, P112, DOI 10.1111/j.1574-695X.2009.00556.x; Enroth H, 1999, HELICOBACTER, V4, P7, DOI 10.1046/j.1523-5378.1999.09034.x; Enroth H, 2000, CANCER EPIDEM BIOMAR, V9, P981; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Quach Nancy, 2004, BMC Clin Pathol, V4, P1, DOI 10.1186/1472-6890-4-1; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Wang Y, 2010, APPL MICROBIOL BIOTE; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369; Zheng ZL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq332	12	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26442	10.1371/journal.pone.0026442	http://dx.doi.org/10.1371/journal.pone.0026442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031833	Green Submitted, Green Published, gold			2022-12-25	WOS:000296513200022
J	Huang, YJA; Pereira, E; Roper, SD				Huang, Yijen A.; Pereira, Elizabeth; Roper, Stephen D.			Acid Stimulation (Sour Taste) Elicits GABA and Serotonin Release from Mouse Taste Cells	PLOS ONE			English	Article							BUDS; CALCIUM; ATP; EXPRESSION; NEUROTRANSMISSION; COMMUNICATION; HEMICHANNELS; ACTIVATION; RECEPTORS; INCREASES	Several transmitter candidates including serotonin (5-HT), ATP, and norepinephrine (NE) have been identified in taste buds. Recently, gamma-aminobutyric acid (GABA) as well as the associated synthetic enzymes and receptors have also been identified in taste cells. GABA reduces taste-evoked ATP secretion from Receptor cells and is considered to be an inhibitory transmitter in taste buds. However, to date, the identity of GABAergic taste cells and the specific stimulus for GABA release are not well understood. In the present study, we used genetically-engineered Chinese hamster ovary (CHO) cells stably co-expressing GABA(B) receptors and G alpha qo5 proteins to measure GABA release from isolated taste buds. We recorded robust responses from GABA biosensors when they were positioned against taste buds isolated from mouse circumvallate papillae and the buds were depolarized with KCl or a stimulated with an acid (sour) taste. In contrast, a mixture of sweet and bitter taste stimuli did not trigger GABA release. KCl- or acid-evoked GABA secretion from taste buds was Ca2+-dependent; removing Ca2+ from the bathing medium eliminated GABA secretion. Finally, we isolated individual taste cells to identify the origin of GABA secretion. GABA was released only from Presynaptic (Type III) cells and not from Receptor (Type II) cells. Previously, we reported that 5-HT released from Presynaptic cells inhibits taste-evoked ATP secretion. Combined with the recent findings that GABA depresses taste-evoked ATP secretion [1], the present results indicate that GABA and 5-HT are inhibitory transmitters in mouse taste buds and both likely play an important role in modulating taste responses.	[Huang, Yijen A.; Pereira, Elizabeth; Roper, Stephen D.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Roper, Stephen D.] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA	University of Miami; University of Miami	Huang, YJA (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA.	SRoper@med.miami.edu		Roper, Stephen/0000-0001-6049-8320; Tilahin, Shimelis/0000-0001-8975-8026	National Institutes of Health [2R01DC007630, 5R01DC000374]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000374, R01DC007630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by National Institutes of Health grants to SDR, 2R01DC007630 and 5R01DC000374. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baryshnikov SG, 2003, J NEUROPHYSIOL, V90, P3283, DOI 10.1152/jn.00312.2003; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dvoryanchikov G, 2011, J NEUROSCI, V31, P5782, DOI 10.1523/JNEUROSCI.5559-10.2011; Eguchi K, 2008, CHEM SENSES, V33, P47, DOI 10.1093/chemse/bjm065; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Franek M, 1999, NEUROPHARMACOLOGY, V38, P1657, DOI 10.1016/S0028-3908(99)00135-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hacker K, 2008, J NEUROPHYSIOL, V100, P2177, DOI 10.1152/jn.90534.2008; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YA, 2010, J PHYSIOL-LONDON, V588, P2343, DOI 10.1113/jphysiol.2010.191106; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YA, 2008, J NEUROSCI, V28, P13088, DOI 10.1523/JNEUROSCI.4187-08.2008; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; IREDALE PA, 1993, BRIT J PHARMACOL, V110, P1305, DOI 10.1111/j.1476-5381.1993.tb13960.x; Nagai T, 1998, J COMP NEUROL, V392, P199, DOI 10.1002/(SICI)1096-9861(19980309)392:2<199::AID-CNE4>3.0.CO;2-Y; Obata H, 1997, MOL BRAIN RES, V49, P29, DOI 10.1016/S0169-328X(97)00118-6; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 2002, J NEUROPHYSIOL, V87, P3152, DOI 10.1152/jn.2002.87.6.3152; Pagano A, 2001, J NEUROSCI, V21, P1189; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Starostik MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013639; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2010, J NEUROSCI, V30, P14695, DOI 10.1523/JNEUROSCI.1570-10.2010; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	31	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25471	10.1371/journal.pone.0025471	http://dx.doi.org/10.1371/journal.pone.0025471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028776	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800006
J	van den Berg, S; van Wamel, WJB; Snijders, SV; Ouwerling, B; de Vogel, CP; Boelens, HA; Willems, RJL; Huijsdens, XW; Verreck, FAW; Kondova, I; Heidt, PJ; Verbrugh, HA; van Belkum, A				van den Berg, Sanne; van Wamel, Willem J. B.; Snijders, Susan V.; Ouwerling, Boudewijn; de Vogel, Corne P.; Boelens, Helene A.; Willems, Rob J. L.; Huijsdens, Xander W.; Verreck, Frank A. W.; Kondova, Ivanela; Heidt, Peter J.; Verbrugh, Henri A.; van Belkum, Alex			Rhesus Macaques (Macaca mulatta) Are Natural Hosts of Specific Staphylococcus aureus Lineages	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; MUPIROCIN NASAL OINTMENT; HUMORAL IMMUNE-RESPONSE; METHICILLIN-RESISTANT; ANTIBODY-RESPONSES; MODEL HOST; CARRIAGE; CARRIERS; STRAINS; GENES	Currently, there is no animal model known that mimics natural nasal colonization by Staphylococcus aureus in humans. We investigated whether rhesus macaques are natural nasal carriers of S. aureus. Nasal swabs were taken from 731 macaques. S. aureus isolates were typed by pulsed-field gel electrophoresis (PFGE), spa repeat sequencing and multi-locus sequence typing (MLST), and compared with human strains. Furthermore, the isolates were characterized by several PCRs. Thirty-nine percent of 731 macaques were positive for S. aureus. In general, the macaque S. aureus isolates differed from human strains as they formed separate PFGE clusters, 50% of the isolates were untypeable by agr genotyping, 17 new spa types were identified, which all belonged to new sequence types (STs). Furthermore, 66% of macaque isolates were negative for all superantigen genes. To determine S. aureus nasal colonization, three nasal swabs from 48 duo-housed macaques were taken during a 5 month period. In addition, sera were analyzed for immunoglobulin G and A levels directed against 40 staphylococcal proteins using a bead-based flow cytometry technique. Nineteen percent of the animals were negative for S. aureus, and 17% were three times positive. S. aureus strains were easily exchanged between macaques. The antibody response was less pronounced in macaques compared to humans, and nasal carrier status was not associated with differences in serum anti-staphylococcal antibody levels. In conclusion, rhesus macaques are natural hosts of S. aureus, carrying host-specific lineages. Our data indicate that rhesus macaques are useful as an autologous model for studying S. aureus nasal colonization and infection prevention.	[van den Berg, Sanne; van Wamel, Willem J. B.; Snijders, Susan V.; de Vogel, Corne P.; Boelens, Helene A.; Verbrugh, Henri A.; van Belkum, Alex] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Ouwerling, Boudewijn; Kondova, Ivanela; Heidt, Peter J.] Biomed Primate Res Ctr, Dept Anim Sci, Rijswijk, Netherlands; [Willems, Rob J. L.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Huijsdens, Xander W.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Verreck, Frank A. W.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	van den Berg, S (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.vandenberg@erasmusmc.nl	Willems, Rob JL/E-3681-2010; Heidt, Peter/GQQ-8459-2022	Willems, Rob JL/0000-0002-7370-0812; van den Berg, Sanne/0000-0001-9209-0178; van Wamel, Willem/0000-0001-9145-9121	Top Institute Pharma [T4-213]; EUPRIM-NET2 [262443]	Top Institute Pharma; EUPRIM-NET2	S.v.d.B. and A.v.B. were in part supported financially by the Top Institute Pharma project T4-213. B.O. and I.K. were in part supported financially by EUPRIM-NET2, grant agreement no. 262443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Collery MM, 2008, J MED MICROBIOL, V57, P348, DOI 10.1099/jmm.0.47734-0; Collins LV, 2006, GRAM POSITIVE PATHOG, P535; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; HU L, 1995, J MED MICROBIOL, V42, P127, DOI 10.1099/00222615-42-2-127; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kalmeijer MD, 2002, CLIN INFECT DIS, V35, P353, DOI 10.1086/341025; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koning S, 2003, J CLIN MICROBIOL, V41, P3017, DOI 10.1128/JCM.41.7.3017-3021.2003; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; LeClaire RD, 2002, INFECT IMMUN, V70, P2278, DOI 10.1128/IAI.70.5.2278-2281.2002; LEIGH DA, 1993, J ANTIMICROB CHEMOTH, V31, P909, DOI 10.1093/jac/31.6.909; Lu QJ, 2003, TOXICOL PATHOL, V31, P14, DOI 10.1080/01926230309741; Martins TB, 2006, J IMMUNOL METHODS, V316, P97, DOI 10.1016/j.jim.2006.08.007; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Mertz D, 2007, CLIN INFECT DIS, V45, P475, DOI 10.1086/520016; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; NOBLE WC, 1964, J CLIN PATHOL, V17, P79, DOI 10.1136/jcp.17.1.79; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Tarkowski A, 2001, TRENDS MICROBIOL, V9, P321, DOI 10.1016/S0966-842X(01)02078-9; Thomas Damien, 2007, Chem Immunol Allergy, V93, P24, DOI 10.1159/000100856; Tristan A, 2003, J CLIN MICROBIOL, V41, P4465, DOI 10.1128/JCM.41.9.4465-4467.2003; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Verkaik NJ, 2010, EUR J CLIN MICROBIOL, V29, P509, DOI 10.1007/s10096-010-0888-0; Verkaik N, 2008, J IMMUNOL METHODS, V335, P121, DOI 10.1016/j.jim.2008.02.022; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; WATANAKUNAKORN C, 1995, AM J INFECT CONTROL, V23, P306, DOI 10.1016/0196-6553(95)90061-6; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2005, ANTIMICROB AGENTS CH, V49, P1465, DOI 10.1128/AAC.49.4.1465-1467.2005; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Wulf M, 2008, CLIN MICROBIOL INFEC, V14, P519, DOI 10.1111/j.1469-0691.2008.01970.x	48	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26170	10.1371/journal.pone.0026170	http://dx.doi.org/10.1371/journal.pone.0026170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028827	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800024
J	Gray, LJ; Yates, T; Davies, MJ; Brady, E; Webb, DR; Sattar, N; Khunti, K				Gray, Laura J.; Yates, Thomas; Davies, Melanie J.; Brady, Emer; Webb, David R.; Sattar, Naveed; Khunti, Kamlesh			Defining Obesity Cut-Off Points for Migrant South Asians	PLOS ONE			English	Article							BODY-MASS INDEX; DIABETES PREVENTION PROGRAM; IMPAIRED GLUCOSE-TOLERANCE; WAIST CIRCUMFERENCE; MULTIETHNIC POPULATION; METABOLIC SYNDROME; ABDOMINAL OBESITY; RISK-FACTORS; PREVALENCE; ADIPOSITY	Background: Body mass index (BMI) and waist circumference (WC) are used to define cardiovascular and type 2 diabetes risk. We aimed to derive appropriate BMI and WC obesity cut-off points in a migrant South Asian population. Methods: 4688 White Europeans and 1333 South Asians resident in the UK aged 40-75 years inclusive were screened for type 2 diabetes. Principal components analysis was used to derive a glycaemia, lipid, and a blood pressure factor. Regression models for each factor, adjusted for age and stratified by sex, were used to identify BMI and WC cut-off points in South Asians that correspond to those defined for White Europeans. Findings: For South Asian males, derived BMI obesity cut-off points equivalent to 30.0 kg/m(2) in White Europeans were 22.6 kg/m(2) (95% Confidence Interval (95% CI) 20.7 kg/m(2) to 24.5 kg/m(2)) for the glycaemia factor, 26.0 kg/m(2) (95% CI 24.7 kg/m(2) to 27.3 kg/m(2)) for the lipid factor, and 28.4 kg/m(2) (95% CI 26.5 kg/m(2) to 30.4 kg/m(2)) for the blood pressure factor. For WC, derived cut-off points for South Asian males equivalent to 102 cm in White Europeans were 83.8 cm (95% CI 79.3 cm to 88.2 cm) for the glycaemia factor, 91.4 cm (95% CI 86.9 cm to 95.8 cm) for the lipid factor, and 99.3 cm (95% CI 93.3 cm to 105.2 cm) for the blood pressure factor. Lower ethnicity cut-off points were seen for females for both BMI and WC. Conclusions: Substantially lower obesity cut-off points are needed in South Asians to detect an equivalent level of dysglycemia and dyslipidemia as observed in White Europeans. South Asian ethnicity could be considered as a similar level of risk as obesity (in White Europeans) for the development of type 2 diabetes.	[Gray, Laura J.; Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Yates, Thomas; Davies, Melanie J.; Webb, David R.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Brady, Emer] Univ Hosp Leicester, Dept Diabet Res, Leicester, Leics, England; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Glasgow	Gray, LJ (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Webb, David/0000-0002-3932-3339; Khunti, Kamlesh/0000-0003-2343-7099; Gray, Laura/0000-0002-9284-9321; Davies, Melanie/0000-0002-9987-9371	NHS Department of Health; NIHR Biomedical Research Centre; NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC)	NHS Department of Health; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC)	The project was funded for support and treatment costs by NHS Department of Health Support for Science and project grants. The sponsors of the study had no role in the study design, data collection, data analysis, interpretation or writing of the paper.; Departments of Health Sciences and Cardiovascular Sciences, University of Leicester are grateful for support from the NIHR Biomedical Research Centre and the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC). The study was hosted by the University Hospitals of Leicester, UK and was registered with an internationally recognized trials registry (Clinicaltrial.gov NCT00318032).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aujla N., 2010, DIABETIC MED S1, V27, P371; Cameron AJ, 2010, OBESITY, V18, P2039, DOI 10.1038/oby.2009.455; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Gholap N, 2011, PRIM CARE DIABETES, V5, P45, DOI 10.1016/j.pcd.2010.08.002; He MZ, 2010, CAN FAM PHYSICIAN, V56, pE174; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Hojgaard B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002619; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kumar S, 2011, INT J CLIN PRACT, V65, P378, DOI 10.1111/j.1742-1241.2010.02548.x; Kumar S., 2009, POSITION STATEMENT D; Lear SA, 2003, METABOLISM, V52, P1295, DOI 10.1016/S0026-0495(03)00196-3; Likhari T, 2010, J CLIN PATHOL, V63, P278, DOI 10.1136/jcp.2009.065821; MATHER HM, 1985, BRIT MED J, V291, P1081, DOI 10.1136/bmj.291.6502.1081; Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111; Misra A, 2005, DIABETES CARE, V28, P398, DOI 10.2337/diacare.28.2.398; Misra A, 2009, J Assoc Physicians India, V57, P163; Mohan V, 2007, METABOLISM, V56, P961, DOI 10.1016/j.metabol.2007.02.009; Organization WH, 1998, WELLB MEAS PRIM HLTH; Oza-Frank R, 2009, DIABETES CARE, V32, P1644, DOI 10.2337/dc09-0573; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; SRINIVASAN BT, 2009, DIABETES S1, V58; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Tuan NT, 2009, AM J CLIN NUTR, V89, P1905, DOI 10.3945/ajcn.2008.26809; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2010, DIABETOLOGIA, V53, P890, DOI 10.1007/s00125-010-1670-7; Webb DR, 2011, DIABETOLOGIA, V54, P2237, DOI 10.1007/s00125-011-2189-2; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; WHO, 2004, LANCET, V363, P902	32	66	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26464	10.1371/journal.pone.0026464	http://dx.doi.org/10.1371/journal.pone.0026464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039493	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000296507500071
J	Jia, SZ; Peng, JC; Gao, B; Chen, ZB; Zhou, Y; Fu, QX; Wang, HP; Zhan, LS				Jia, Shuaizheng; Peng, Jianchun; Gao, Bo; Chen, Zhongbin; Zhou, Yong; Fu, Qiuxia; Wang, Haiping; Zhan, Linsheng			Relative Quantification of Protein-Protein Interactions Using a Dual Luciferase Reporter Pull-Down Assay System	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MAMMALIAN-CELLS; IN-VIVO; BIOTINYLATION; INNATE; CARDIF; MAVS	The identification and quantitative analysis of protein-protein interactions are essential to the functional characterization of proteins in the post-proteomics era. The methods currently available are generally time-consuming, technically complicated, insensitive and/or semi-quantitative. The lack of simple, sensitive approaches to precisely quantify protein-protein interactions still prevents our understanding of the functions of many proteins. Here, we develop a novel dual luciferase reporter pull-down assay by combining a biotinylated Firefly luciferase pull-down assay with a dual luciferase reporter assay. The biotinylated Firefly luciferase-tagged protein enables rapid and efficient isolation of a putative Renilla luciferase-tagged binding protein from a relatively small amount of sample. Both of these proteins can be quantitatively detected using the dual luciferase reporter assay system. Protein-protein interactions, including Fos-Jun located in the nucleus; MAVS-TRAF3 in cytoplasm; inducible IRF3 dimerization; viral protein-regulated interactions, such as MAVS-MAVS and MAVS-TRAF3; IRF3 dimerization; and protein interaction domain mapping, are studied using this novel assay system. Herein, we demonstrate that this dual luciferase reporter pull-down assay enables the quantification of the relative amounts of interacting proteins that bind to streptavidin-coupled beads for protein purification. This study provides a simple, rapid, sensitive, and efficient approach to identify and quantify relative protein-protein interactions. Importantly, the dual luciferase reporter pull-down method will facilitate the functional determination of proteins.	[Jia, Shuaizheng; Peng, Jianchun; Gao, Bo; Zhou, Yong; Fu, Qiuxia; Zhan, Linsheng] Beijing Inst Transfus Med, Beijing, Peoples R China; [Chen, Zhongbin] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wang, Haiping] Hosp 307 Chinese Peoples Liberat Army, Dept Blood Transfus, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Jia, SZ (corresponding author), Beijing Inst Transfus Med, Beijing, Peoples R China.	lszhan91@yahoo.com	ZHANG, LIN/GYD-9123-2022; Zhan, Linsheng/AAR-5687-2021; zhan, lin/AAP-5149-2020					Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sherf BA., 1996, PROMEGA NOTES, V57, P2; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Viens A, 2004, ANAL BIOCHEM, V325, P68, DOI 10.1016/j.ab.2003.10.015; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; Pinto MGV, 2009, PROTEOMICS, V9, P5303, DOI 10.1002/pmic.200900298	19	7	8	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26414	10.1371/journal.pone.0026414	http://dx.doi.org/10.1371/journal.pone.0026414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039483	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500065
J	McKinley, AC; Dafforn, KA; Taylor, MD; Johnston, EL				McKinley, Andrew C.; Dafforn, Katherine A.; Taylor, Matthew D.; Johnston, Emma L.			High Levels of Sediment Contamination Have Little Influence on Estuarine Beach Fish Communities	PLOS ONE			English	Article							AUSTRALIAN ESTUARIES; SEWAGE-SLUDGE; MARINE; INVERTEBRATES; EXPOSURE; METAANALYSIS; ASSEMBLAGES; RECRUITMENT; RICHNESS; IMPACTS	While contaminants are predicted to have measurable impacts on fish assemblages, studies have rarely assessed this potential in the context of natural variability in physico-chemical conditions within and between estuaries. We investigated links between the distribution of sediment contamination (metals and PAHs), physico-chemical variables (pH, salinity, temperature, turbidity) and beach fish assemblages in estuarine environments. Fish communities were sampled using a beach seine within the inner and outer zones of six estuaries that were either heavily modified or relatively unmodified by urbanization and industrial activity. All sampling was replicated over two years with two periods sampled each year. Shannon diversity, biomass and abundance were all significantly higher in the inner zone of estuaries while fish were larger on average in the outer zone. Strong differences in community composition were also detected between the inner and outer zones. Few differences were detected between fish assemblages in heavily modified versus relatively unmodified estuaries despite high concentrations of sediment contaminants in the inner zones of modified estuaries that exceeded recognized sediment quality guidelines. Trends in species distributions, community composition, abundance, Shannon diversity, and average fish weight were strongly correlated to physico-chemical variables and showed a weaker relationship to sediment metal contamination. Sediment PAH concentrations were not significantly related to the fish assemblage. These findings suggest that variation in some physico-chemical factors (salinity, temperature, pH) or variables that co-vary with these factors (e. g., wave activity or grain size) have a much greater influence on this fish assemblage than anthropogenic stressors such as contamination.	[McKinley, Andrew C.; Dafforn, Katherine A.; Taylor, Matthew D.; Johnston, Emma L.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	McKinley, AC (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	andrew.mckinley@hotmail.com	Johnston, Emma L/B-7210-2009; Johnston, Emma/AAC-2878-2022; Taylor, Matthew/C-4833-2008; Dafforn, Katherine A/J-9647-2013	Johnston, Emma L/0000-0002-2117-366X; Johnston, Emma/0000-0002-2117-366X; Dafforn, Katherine A/0000-0001-8848-377X	Australian Research Council; Canadian National Sciences and Engineering Research Council; Animal Care and Ethics Committee of the University of New South Wales [09/110A]; New South Wales Department of Primary Industries [P09/0072-1.0]	Australian Research Council(Australian Research Council); Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Animal Care and Ethics Committee of the University of New South Wales; New South Wales Department of Primary Industries	This research was primarily supported by the Australian Research Council through an Australian Research Fellowship awarded to ELJ and a Linkage Grant awarded to ELJ. The writing of this manuscript was also supported through the Canadian National Sciences and Engineering Research Council through an award given to ACM. http://www.arc.gov.au/. http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Cian Foster-Thorpe, Shinjiro Ushiama, David Day, Valeriya Komyakova, and Anthousa Harris for their assistance in the field. We would also like to thank the Bluescope Steel Company for their generous support of this research and Marine Parks NSW for their help and advice. This study was approved and carried out in strict accordance with the recommendations of the Animal Care and Ethics Committee of the University of New South Wales (Project No. 09/110A) and the New South Wales Department of Primary Industries (Permit No. P09/0072-1.0).	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON MJ, 2003, PCO PRINCIPAL COORDI; *ANRA, 2009, LAND US CLYD RIV JER; ANZECC (Australian and New Zealand Environment and Conservation Council), 2000, GUID FRESH MAR WAT Q; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Burton GA, 2010, ENVIRON TOXICOL CHEM, V29, P2625, DOI 10.1002/etc.332; CASTILLA JC, 1983, MAR POLLUT BULL, V14, P459, DOI 10.1016/0025-326X(83)90046-2; Clark BM, 1997, ESTUAR COAST SHELF S, V44, P659, DOI 10.1006/ecss.1996.0151; COSTELLO MJ, 1994, MAR ENVIRON RES, V37, P23, DOI 10.1016/0141-1136(94)90061-2; DALLINGER R, 1987, OECOLOGIA, V73, P91, DOI 10.1007/BF00376982; Deegan LA, 2002, ESTUARIES, V25, P727, DOI 10.1007/BF02804902; DSEWPC, 2011, INT BIOG REG AUSTR; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P107, DOI 10.1016/0022-0981(95)00085-2; Element C., 2007, FRESEN J ANAL CHEM, V111, P362; Elliott M, 2007, FISH FISH, V8, P241, DOI 10.1111/j.1467-2679.2007.00253.x; Froese R., 2014, FISHBASE; Gomon M.F., 2008, FISHES AUSTRALIAS SO; Hall BD, 1997, WATER AIR SOIL POLL, V100, P13; IVERSON RL, 1990, LIMNOL OCEANOGR, V35, P1593, DOI 10.4319/lo.1990.35.7.1593; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Kingsford MJ, 1996, MAR POLLUT BULL, V33, P201, DOI 10.1016/S0025-326X(96)00166-X; Knott NA, 2009, J APPL ECOL, V46, P770, DOI 10.1111/j.1365-2664.2009.01679.x; Long ER, 2006, ENVIRON SCI TECHNOL, V40, P1726, DOI 10.1021/es058012d; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MAHER WA, 1992, SCI TOTAL ENVIRON, V112, P143, DOI 10.1016/0048-9697(92)90184-T; MASSELINK G, 1993, J COASTAL RES, V9, P785; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MCKINLEY AC, J APPL ECOL IN PRESS; McKinley A, 2010, MAR ECOL PROG SER, V420, P175, DOI 10.3354/meps08856; McKinley AC, 2011, ENVIRON POLLUT, V159, P1499, DOI 10.1016/j.envpol.2011.03.008; Miskiewicz A.G., 1998, LARVAE TEMPERATE AUS, P54; MISKIEWICZ AG, 1994, ENVIRON POLLUT, V84, P269, DOI 10.1016/0269-7491(94)90138-4; *NSWDNR, 2010, EST NEW S WAL; PAULY D, 2005, PHILOS T ROYAL SOC B, V360; Potter IC, 1999, AUST J ECOL, V24, P395, DOI 10.1046/j.1442-9993.1999.00980.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAKOCINSKI CF, 1992, MAR ECOL PROG SER, V80, P135, DOI 10.3354/meps080135; Reopanichkul P, 2009, MAR POLLUT BULL, V58, P1356, DOI 10.1016/j.marpolbul.2009.04.024; Rice CA, 2006, ESTUARIES COASTS, V29, P63, DOI 10.1007/BF02784699; Robinet TT, 2002, ECOTOXICOLOGY, V11, P265, DOI 10.1023/A:1016352305382; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Scanes P, 2010, NSW ESTUARINE CATCHM; Taylor MD, 2006, MAR ECOL PROG SER, V328, P237, DOI 10.3354/meps328237; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Waring CP, 1996, ENVIRON POLLUT, V93, P17, DOI 10.1016/0269-7491(96)00019-X	48	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26353	10.1371/journal.pone.0026353	http://dx.doi.org/10.1371/journal.pone.0026353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039470	gold, Green Submitted, Green Published			2022-12-25	WOS:000296507500055
J	Suarez, R; Fernandez-Aburto, P; Manger, PR; Mpodozis, J				Suarez, Rodrigo; Fernandez-Aburto, Pedro; Manger, Paul R.; Mpodozis, Jorge			Deterioration of the G alpha o Vomeronasal Pathway in Sexually Dimorphic Mammals	PLOS ONE			English	Article							ACCESSORY OLFACTORY-BULB; PUTATIVE PHEROMONE RECEPTORS; CALIFORNIA GROUND-SQUIRRELS; SENSORY NEURONS; G-PROTEINS; DIFFERENTIAL LOCALIZATION; AFRICAN ELEPHANT; MULTIGENE FAMILY; SYSTEM; TRANSDUCTION	In mammals, social and sexual behaviours are largely mediated by the vomeronasal system (VNS). The accessory olfactory bulb (AOB) is the first synaptic locus of the VNS and ranges from very large in Caviomorph rodents, small in carnivores and ungulates, to its complete absence in apes, elephants, most bats and aquatic species. Two pathways have been described in the VNS of mammals. In mice, vomeronasal neurons expressing G alpha i2 protein project to the rostral portion of the AOB and respond mostly to small volatile molecules, whereas neurons expressing G alpha o project to the caudal AOB and respond mostly to large non-volatile molecules. However, the G alpha o-expressing pathway is absent in several species (horses, dogs, musk shrews, goats and marmosets) but no hypotheses have been proposed to date to explain the loss of that pathway. We noted that the species that lost the G alpha o pathway belong to Laurasiatheria and Primates lineages, both clades with ubiquitous sexual dimorphisms across species. To assess whether similar events of G alpha o pathway loss could have occurred convergently in dimorphic species we studied G-protein expression in the AOB of two species that independently evolved sexually dimorphic traits: the California ground squirrel Spermophilus beecheyi (Rodentia; Sciurognathi) and the cape hyrax Procavia capensis (Afrotheria; Hyracoidea). We found that both species show uniform expression of G alpha i2-protein throughout AOB glomeruli, while G alpha o expression is restricted to main olfactory glomeruli only. Our results suggest that the degeneration of the G alpha o-expressing vomeronasal pathway has occurred independently at least four times in Eutheria, possibly related to the emergence of sexual dimorphisms and the ability of detecting the gender of conspecifics at distance.	[Suarez, Rodrigo; Fernandez-Aburto, Pedro; Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Lab Neurobiol & Biol Conocer, Santiago, Chile; [Manger, Paul R.] Univ Witwatersrand, Fac Hlth Sci, Sch Anat Sci, Johannesburg, South Africa	Universidad de Chile; University of Witwatersrand	Suarez, R (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	rsuarezsaa@gmail.com	mpodozis, jorge/A-1992-2013; Suarez, Rodrigo/N-9437-2016; Suarez, Rodrigo/J-1529-2014	Suarez, Rodrigo/0000-0001-5153-5652; Suarez, Rodrigo/0000-0001-5153-5652	Mecesup [UCH 0306]; Conicyt; Fondecyt [1080094]	Mecesup; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The authors acknowledge financial support from Mecesup UCH 0306, Conicyt (Termino de tesis doctoral) and Fondecyt (1080094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, WALKERS MAMMALS WORL; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Barry RE, 1998, AFR J ECOL, V36, P221, DOI 10.1046/j.1365-2028.1998.00145.x; Berghard A, 1996, J NEUROSCI, V16, P909; Bursten SN, 2000, J COMP PSYCHOL, V114, P281, DOI 10.1037//0735-7036.114.3.281; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Darwin G., 1871, P423; De Blieux DD, 2006, J VERTEBR PALEONTOL, V26, P160, DOI 10.1671/0272-4634(2006)26[160:SDOTIM]2.0.CO;2; De Blieux DD, 2002, J VERTEBR PALEONTOL, V22, P122, DOI 10.1671/0272-4634(2002)022[0122:CADAOA]2.0.CO;2; Dudley CA, 1999, NEUROSCIENCE, V91, P1549, DOI 10.1016/S0306-4522(98)00711-8; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Enomoto T, 2011, J NEUROSCI, V31, P10159, DOI 10.1523/JNEUROSCI.1245-11.2011; FREDES F, 2009, VIA TECTOFUGAL AVES; Gravett N, 2009, J CHEM NEUROANAT, V38, P57, DOI 10.1016/j.jchemneu.2009.02.005; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; Halpern M, 1998, MICROSC RES TECHNIQ, V41, P519, DOI 10.1002/(SICI)1097-0029(19980615)41:6<519::AID-JEMT7>3.3.CO;2-C; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HENDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; IMAMURA K, 1985, BRAIN RES, V328, P362, DOI 10.1016/0006-8993(85)91050-9; Inamura K, 1999, EUR J NEUROSCI, V11, P2254, DOI 10.1046/j.1460-9568.1999.00646.x; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; KOREN L, 2006, THESIS TEL AVIV U TE; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; LANDE R, 1980, EVOLUTION, V34, P292, DOI 10.1111/j.1558-5646.1980.tb04817.x; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; LOUGHRY WJ, 1988, ANIM BEHAV, V36, P1533, DOI 10.1016/S0003-3472(88)80224-0; MANN G, 1961, J COMP NEUROL, V116, P135, DOI 10.1002/cne.901160204; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Matsuoka M, 1999, NEUROSCI RES, V35, P189, DOI 10.1016/S0168-0102(99)00082-6; Meisami E, 1998, MICROSC RES TECHNIQ, V43, P476, DOI 10.1002/(SICI)1097-0029(19981215)43:6<476::AID-JEMT2>3.3.CO;2-M; MIYASATO L, 2006, ASSESSMENT ALARM CAL; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Ngwenya A, 2011, BRAIN STRUCT FUNCT, V216, P403, DOI 10.1007/s00429-011-0316-y; RALLS K, 1977, AM NAT, V111, P917, DOI 10.1086/283223; ROSE KD, 2006, BEGINNING AGE MAMMAL; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Schulte-Hostedde Albrecht I., 2007, P115; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SHINOHARA H, 1992, J NEUROSCI, V12, P1275; Shrader AM, 2006, J ZOOL, V270, P40, DOI 10.1111/j.1469-7998.2006.00108.x; SUAREZ R, 2009, 39 ANN M SOC NEUR CH; Suarez R, 2011, J ANAT, V218, P558, DOI 10.1111/j.1469-7580.2011.01357.x; Suarez R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008005; Suarez R, 2009, BEHAV BRAIN RES, V198, P306, DOI 10.1016/j.bbr.2008.11.009; Sugai T, 1997, NEUROSCIENCE, V79, P871, DOI 10.1016/S0306-4522(96)00690-2; Sugai T, 2006, NEUROREPORT, V17, P1663, DOI 10.1097/01.wnr.0000239950.14954.59; Takigami S, 2000, CHEM SENSES, V25, P387, DOI 10.1093/chemse/25.4.387; Takigami S, 2004, CHEM SENSES, V29, P301, DOI 10.1093/chemse/bjh032; Thomas O., 1892, Proceedings of the Zoological Society, P50; Todd NE, 2010, ANAT REC, V293, P62, DOI 10.1002/ar.21011; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zhao HB, 2011, MOL BIOL EVOL, V28, P7, DOI 10.1093/molbev/msq207; [No title captured], DOI DOI 10.1007/BF00299371	64	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26436	10.1371/journal.pone.0026436	http://dx.doi.org/10.1371/journal.pone.0026436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039487	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500069
J	Cortese, R; Lewin, J; Backdahl, L; Krispin, M; Wasserkort, R; Eckhardt, F; Beck, S				Cortese, Rene; Lewin, Joern; Baeckdahl, Liselotte; Krispin, Manuel; Wasserkort, Reinhold; Eckhardt, Florian; Beck, Stephan			Genome-Wide Screen for Differential DNA Methylation Associated with Neural Cell Differentiation in Mouse	PLOS ONE			English	Article							EPIGENETIC CONTROL; GENE-EXPRESSION; PLURIPOTENT; PROFILE	Cellular differentiation involves widespread epigenetic reprogramming, including modulation of DNA methylation patterns. Using Differential Methylation Hybridization (DMH) in combination with a custom DMH array containing 51,243 features covering more than 16,000 murine genes, we carried out a genome-wide screen for cell- and tissue-specific differentially methylated regions (tDMRs) in undifferentiated embryonic stem cells (ESCs), in in-vitro induced neural stem cells (NSCs) and 8 differentiated embryonic and adult tissues. Unsupervised clustering of the generated data showed distinct cell- and tissue-specific DNA methylation profiles, revealing 202 significant tDMRs (p<0.005) between ESCs and NSCs and a further 380 tDMRs (p<0.05) between NSCs/ESCs and embryonic brain tissue. We validated these tDMRs using direct bisulfite sequencing (DBS) and methylated DNA immunoprecipitation on chip (MeDIP-chip). Gene ontology (GO) analysis of the genes associated with these tDMRs showed significant (absolute Z score>1.96) enrichment for genes involved in neural differentiation, including, for example, Jag1 and Tcf4. Our results provide robust evidence for the relevance of DNA methylation in early neural development and identify novel marker candidates for neural cell differentiation.	[Cortese, Rene; Lewin, Joern; Krispin, Manuel; Wasserkort, Reinhold; Eckhardt, Florian] Epigenomics AG, Berlin, Germany; [Baeckdahl, Liselotte; Beck, Stephan] UCL, Univ Coll London UCL Canc Inst, London, England	University of London; University College London	Cortese, R (corresponding author), Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, Toronto, ON, Canada.	Rene_Cortese@camh.net		Cortese, Rene/0000-0001-9262-7828	European Union [LSHG-CT-2005-018883]; High-throughput Epigenetic Regulatory Organisation in Chromatin (HEROIC) [018883]; Wellcome Trust [084071]; Royal Society	European Union(European Commission); High-throughput Epigenetic Regulatory Organisation in Chromatin (HEROIC)(European Commission); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was partially supported by the European Union-sponsored project, High-throughput Epigenetic Regulatory Organisation in Chromatin (HEROIC), contract number 018883. LS was supported by a HEROIC grant, LSHG-CT-2005-018883, from the European Union under the Sixth Framework Programme to SB. SB was supported by the Wellcome Trust (084071) and a Royal Society Wolfson Research Merit Award. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altun G, 2010, J CELL BIOCHEM, V109, P1, DOI 10.1002/jcb.22374; Backdahl L, 2009, EPIGENETICS-US, V4, P248; Beck S, 2010, NAT BIOTECHNOL, V28, P1026, DOI 10.1038/nbt1010-1026; Biswas A, 2007, STEM CELLS DEV, V16, P213, DOI 10.1089/scd.2006.0081; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Fassbender A, 2010, METHODS MOL BIOL, V576, P155, DOI 10.1007/978-1-59745-545-9_9; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Ghosh S, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12228; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kulikov AV, 2010, ILAR J, V51, pE11, DOI 10.1093/ilar.51.2.E11; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Lewin J, 2007, INT J BIOCHEM CELL B, V39, P1539, DOI 10.1016/j.biocel.2007.03.006; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McNamara RK, 2009, LIPIDS, V44, P1, DOI 10.1007/s11745-008-3244-8; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato S, 2010, GENES CELLS, V15, P607, DOI 10.1111/j.1365-2443.2010.01404.x; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	33	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26002	10.1371/journal.pone.0026002	http://dx.doi.org/10.1371/journal.pone.0026002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028803	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900024
J	Scott, A; Weldon, S; Buchanan, PJ; Schock, B; Ernst, RK; McAuley, DF; Tunney, MM; Irwin, CR; Elborn, JS; Taggart, CC				Scott, Aaron; Weldon, Sinead; Buchanan, Paul J.; Schock, Bettina; Ernst, Robert K.; McAuley, Danny F.; Tunney, Michael M.; Irwin, Chris R.; Elborn, J. Stuart; Taggart, Clifford C.			Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo	PLOS ONE			English	Article							CYSTIC-FIBROSIS LUNG; CATHELICIDIN ANTIMICROBIAL PEPTIDE; SECRETORY LEUCOPROTEASE INHIBITOR; AIRWAY SURFACE FLUID; PSEUDOMONAS-AERUGINOSA; HOST-DEFENSE; ANTIBACTERIAL ACTIVITY; EPITHELIAL-CELLS; BINDING PROTEIN; INNATE IMMUNITY	Background: Human cathelicidin LL-37 is a cationic antimicrobial peptide (AMP) which possesses a variety of activities including the ability to neutralise endotoxin. In this study, we investigated the role of LPS neutralisation in mediating LL-37's ability to inhibit Pseudomonas aeruginosa LPS signalling in human monocytic cells. Methodology/Principal Findings: Pre-treatment of monocytes with LL-37 significantly inhibited LPS-induced IL-8 production and the signalling pathway of associated transcription factors such as NF-kappa B. However, upon removal of LL-37 from the media prior to LPS stimulation, these inhibitory effects were abolished. These findings suggest that the ability of LL-37 to inhibit LPS signalling is largely dependent on extracellular LPS neutralisation. In addition, LL-37 potently inhibited cytokine production induced by LPS extracted from P. aeruginosa isolated from the lungs of cystic fibrosis (CF) patients. In the CF lung, polyanionic molecules such as glycosaminoglycans (GAGs) and DNA bind LL-37 and impact negatively on its antibacterial activity. In order to determine whether such interactions interfere with the LPS neutralising ability of LL-37, the status of LL-37 and its ability to bind LPS in CF sputum were investigated. Overall our findings suggest that in the CF lung, the ability of LL-37 to bind LPS and inhibit LPS-induced IL-8 production is attenuated as a result of binding to DNA and GAGs. However, LL-37 levels and its concomitant LPS-binding activity can be increased with a combination of DNase and GAG lyase (heparinase II) treatment. Conclusions/Significance: Overall, these findings suggest that a deficiency in available LL-37 in the CF lung may contribute to greater LPS-induced inflammation during CF lung disease.	[Scott, Aaron; Weldon, Sinead; Buchanan, Paul J.; Schock, Bettina; McAuley, Danny F.; Elborn, J. Stuart; Taggart, Clifford C.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Tunney, Michael M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Irwin, Chris R.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Dent Educ, Belfast, Antrim, North Ireland	Queens University Belfast; University System of Maryland; University of Maryland Baltimore; Queens University Belfast; Queens University Belfast	Scott, A (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland.	s.weldon@qub.ac.uk	Taggart, Clifford C/G-4492-2014; Weldon, Sinead/J-5451-2014; Scott, Aaron/AAB-5203-2019	Weldon, Sinead/0000-0001-5628-6624; Scott, Aaron/0000-0001-9325-5026; Taggart, Clifford/0000-0002-9930-2978; Ernst, Robert/0000-0001-5016-8694; Buchanan, Paul/0000-0002-9055-2794; McAuley, Daniel/0000-0002-3283-1947; elborn, joseph/0000-0002-2323-442X; TUNNEY, MICHAEL/0000-0002-7433-7074	Department for Employment and Learning; Public Health Agency [COM/4275/10, CDV/3650/07] Funding Source: researchfish	Department for Employment and Learning; Public Health Agency	The study was funded by the Department for Employment and Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 1999, J CLIN INVEST, V103, P303, DOI 10.1172/JCI6277; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Bals R, 2001, AM J RESP CELL MOL, V25, P21, DOI 10.1165/ajrcmb.25.1.4436; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; BAUGH RF, 1992, ANESTH ANALG, V74, P201, DOI 10.1213/00000539-199202000-00005; Benincasa M, 2009, J PEPT SCI, V15, P595, DOI 10.1002/psc.1142; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bhaskar KR, 1998, HEPATOLOGY, V27, P7, DOI 10.1002/hep.510270103; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176; Burton MF, 2009, NAT PROD REP, V26, P1572, DOI 10.1039/b912533g; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chakraborty K, 2009, J BIOL CHEM, V284, P21810, DOI 10.1074/jbc.M109.001180; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; CHEN CP, 1995, FEBS LETT, V370, P46, DOI 10.1016/0014-5793(95)00792-8; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Dooring G, 2009, CELL MICROBIOL, V11, P208, DOI 10.1111/j.1462-5822.2008.01271.x; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ernst RK, 2003, J ENDOTOXIN RES, V9, P395, DOI 10.1179/096805103225002764; Ernst RK, 2007, J INFECT DIS, V196, P1088, DOI 10.1086/521367; Felgentreff K, 2006, PEPTIDES, V27, P3100, DOI 10.1016/j.peptides.2006.07.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Herasimenka Y, 2005, PEPTIDES, V26, P1127, DOI 10.1016/j.peptides.2005.01.020; Hiemstra PS, 2007, EXP LUNG RES, V33, P537, DOI 10.1080/01902140701756687; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; LETHEM MI, 1990, EUR RESPIR J, V3, P19; Meyer KC, 1997, AM J RESP CRIT CARE, V156, P1536, DOI 10.1164/ajrccm.156.5.9701098; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Papakonstantinou E, 2009, BRIT J PHARMACOL, V157, P1111, DOI 10.1111/j.1476-5381.2009.00279.x; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; RAHMOUNE H, 1991, AM J RESP CELL MOL, V5, P315, DOI 10.1165/ajrcmb/5.4.315; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Shriver Z, 1998, J BIOL CHEM, V273, P22904, DOI 10.1074/jbc.273.36.22904; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Solic N, 2005, AM J RESP CRIT CARE, V172, P892, DOI 10.1164/rccm.200409-1207OC; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; Weldon S, 2009, J IMMUNOL, V183, P8148, DOI 10.4049/jimmunol.0901716; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316	57	74	77	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26525	10.1371/journal.pone.0026525	http://dx.doi.org/10.1371/journal.pone.0026525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028895	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900072
J	Naka, T; Maeda, S; Niki, M; Ohara, N; Yamamoto, S; Yano, I; Maeyama, J; Ogura, H; Kobayashi, K; Fujiwara, N				Naka, Takashi; Maeda, Shinji; Niki, Mamiko; Ohara, Naoya; Yamamoto, Saburo; Yano, Ikuya; Maeyama, Jun-ichi; Ogura, Hisashi; Kobayashi, Kazuo; Fujiwara, Nagatoshi			Lipid Phenotype of Two Distinct Subpopulations of Mycobacterium bovis Bacillus Calmette-Guerin Tokyo 172 Substrain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCG VACCINE STRAINS; IMMUNE-RESPONSE; GENOME SEQUENCE; MULTIPLEX PCR; TUBERCULOSIS; IDENTIFICATION; INTRACELLULARE; GENE; DIACYLGLYCEROL; DERIVATIZATION	Bacillus Calmette-Guerin (BCG) Tokyo 172 is a predominant World Health Organization Reference Reagent for the BCG vaccine. Recently, the BCG Tokyo 172 substrain was reported to consist of two subpopulations with different colony morphologies, smooth and rough. Smooth colonies had a characteristic 22-bp deletion in Rv3405c of the region of difference (RD) 16 (type I), and rough colonies were complete in this region (type II). We hypothesized that the morphological difference is related to lipid phenotype and affects their antigenicity. We determined the lipid compositions and biosynthesis of types I and II. Scanning electron microscopy showed that type I was 1.5 times longer than type II. Phenolic glycolipid (PGL) and phthiocerol dimycocerosate (PDIM) were found only in type I. Although it has been reported that the RD16 is involved in the expression of PGL, type II did not possess PGL/PDIM. We examined the ppsA-E gene responsible for PGL/PDIM biosynthesis and found that the existence of PGL/PDIM in types I and II is caused by a ppsA gene mutation not regulated by the RD16. PGL suppressed the host recognition of total lipids via Toll-like receptor 2, and this suggests that PGL is antigenic and involved in host responses, acting as a cell wall component. This is the first report to show the difference between lipid phenotypes of types I and II. It is important to clarify the heterogeneity of BCG vaccine substrains to discuss and evaluate the quality, safety, and efficacy of the BCG vaccine.	[Fujiwara, Nagatoshi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, Osaka 5458585, Japan; [Ogura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Virol, Osaka 5458585, Japan; [Naka, Takashi] MBR Co Ltd, Osaka 5608552, Japan; [Maeda, Shinji] Japan AntiTB Assoc, Res Inst TB, Mol Epidemiol Div, Mycobacterium Reference Ctr, Tokyo 2048533, Japan; [Ohara, Naoya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Okayama 7008558, Japan; [Yamamoto, Saburo; Yano, Ikuya] Japan BCG Lab, Tokyo 2040022, Japan; [Maeyama, Jun-ichi] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo 2080011, Japan; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Tokyo 2080011, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Okayama University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Fujiwara, N (corresponding author), Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	fujiwara@med.osaka-cu.ac.jp	OHARA, Naoya/B-2481-2011		Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Health Sciences Foundation, Ministry of Health, Labour and Welfare in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation, Ministry of Health, Labour and Welfare in Japan	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan; and the Japan Health Sciences Foundation (Research on Publicly Essential Drugs and Medical Devices), the Ministry of Health, Labour and Welfare in Japan.	[Anonymous], 2011, GLOB TUB CONTR 2010; BARROW WW, 1982, J BACTERIOL, V150, P381, DOI 10.1128/JB.150.1.381-384.1982; Bedwell J, 2001, VACCINE, V19, P2146, DOI 10.1016/S0264-410X(00)00369-8; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brosch R, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P155; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chen JM, 2007, VACCINE, V25, P8114, DOI 10.1016/j.vaccine.2007.09.041; Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0; FUJIWARA N, 2008, GLYCOLIPIDS NEW RES, P99; Fujiwara N, 2008, J BACTERIOL, V190, P3613, DOI 10.1128/JB.01850-07; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; GILBART J, 1987, EUR J CLIN MICROBIOL, V6, P715, DOI 10.1007/BF02013084; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gomes LHF, 2011, J BACTERIOL, V193, P5600, DOI 10.1128/JB.05827-11; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Guilhot C, 2008, MYCOBACTERIAL CELL ENVELOPE, P273; Hayashi D, 2009, FEMS IMMUNOL MED MIC, V56, P116, DOI 10.1111/j.1574-695X.2009.00559.x; Ho MM, 2008, VACCINE, V26, P4754, DOI 10.1016/j.vaccine.2008.06.026; Ho MM, 2011, VACCINE, V29, P512, DOI 10.1016/j.vaccine.2010.10.066; Honda I, 2006, VACCINE, V24, P4969, DOI 10.1016/j.vaccine.2006.03.055; Knezevic I, 2006, VACCINE, V24, P3874, DOI 10.1016/j.vaccine.2006.03.014; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413; Markey K, 2010, VACCINE, V28, P6964, DOI [10.1016/j.vaccine.2010.08.045, 10.1016/j.vaccine.2010.07.086]; Martinez A, 1999, J BACTERIOL, V181, P7331; MILLER LT, 1982, J CLIN MICROBIOL, V16, P584, DOI 10.1128/JCM.16.3.584-586.1982; Naka T, 2011, J BACTERIOL, V193, P5766, DOI 10.1128/JB.05412-11; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Scherman H, 2009, J BACTERIOL, V191, P6769, DOI 10.1128/JB.00431-09; Seki M, 2009, VACCINE, V27, P1710, DOI 10.1016/j.vaccine.2009.01.034; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	40	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44153	44161		10.1074/jbc.M111.310037	http://dx.doi.org/10.1074/jbc.M111.310037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22030395	Green Published, hybrid			2022-12-25	WOS:000298402300056
J	Needham, PG; Mikoluk, K; Dhakarwal, P; Khadem, S; Snyder, AC; Subramanya, AR; Brodsky, JL				Needham, Patrick G.; Mikoluk, Kasia; Dhakarwal, Pradeep; Khadem, Shaheen; Snyder, Avin C.; Subramanya, Arohan R.; Brodsky, Jeffrey L.			The Thiazide-sensitive NaCl Cotransporter Is Targeted for Chaperone-dependent Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ER-ASSOCIATED DEGRADATION; CL-COTRANSPORTER; UBIQUITIN-LIGASE; FUNCTIONAL EXPRESSION; PROTEIN TRANSLOCATION; INTRACELLULAR TRAFFICKING; MOLECULAR CHAPERONES; MEMBRANE-PROTEINS; DISTINCT ROLES	The thiazide-sensitive NaCl cotransporter (NCC, SLC12A3) mediates salt reabsorption in the distal nephron of the kidney and is the target of thiazide diuretics, which are commonly prescribed to treat hypertension. Mutations in NCC also give rise to Gitelman syndrome, a hereditary salt-wasting disorder thought in most cases to arise from impaired NCC biogenesis through enhanced endoplasmic reticulum-associated degradation (ERAD). Because the machinery that mediates NCC quality control is completely undefined, we employed yeast as a model heterologous expression system to identify factors involved in NCC degradation. We confirmed that NCC was a bona fide ERAD substrate in yeast, as the majority of NCC polypeptide was integrated into ER membranes, and its turnover rate was sensitive to proteasome inhibition. NCC degradation was primarily dependent on the ER membrane-associated E3 ubiquitin ligase Hrd1. Whereas several ER luminal chaperones were dispensable for NCC ERAD, NCC ubiquitination and degradation required the activity of Ssa1, a cytoplasmic Hsp70 chaperone. Compatible findings were observed when NCC was expressed in mammalian kidney cells, as the cotransporter was polyubiquitinated and degraded by the proteasome, and mammalian cytoplasmic Hsp70 (Hsp72) coexpression stimulated the degradation of newly synthesized NCC. Hsp70 also preferentially associated with the ER-localized NCC glycosylated species, indicating that cytoplasmic Hsp70 plays a critical role in selecting immature forms of NCC for ERAD. Together, these results provide the first survey of components involved in the ERAD of a mammalian SLC12 cation chloride cotransporter and provide a framework for future studies on NCC ER quality control.	[Needham, Patrick G.; Mikoluk, Kasia; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Dhakarwal, Pradeep; Khadem, Shaheen; Snyder, Avin C.; Subramanya, Arohan R.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Khadem, Shaheen; Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Needham, PG (corresponding author), 3550 Terrace St,S832 Scaife Hall, Pittsburgh, PA 15261 USA.	ars129@pitt.edu	Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643	National Institutes of Health [DK79307, GM75061, DK84566]; United States Department of Veterans Affairs; American Heart Association [10BGIA3890010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R21DK084566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK79307 (to the Pittsburgh Center for Kidney Research-Model Organisms Core), GM75061 (to J. L. B.), and DK84566 (to A. R. S.). This work was also supported by a Mid-Level Career Development Award from the United States Department of Veterans Affairs (to A. R. S.) and James A. Shaver Fund of the American Heart Association Grant 10BGIA3890010 (to A. R. S.).	Ahner A, 2005, ARCH BIOCHEM BIOPHYS, V435, P32, DOI 10.1016/j.abb.2004.11.005; Ahner A, 2007, MOL BIOL CELL, V18; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Bostonjoglo M, 1998, J AM SOC NEPHROL, V9, P1347; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; DAVIDSON HW, 1993, J BIOL CHEM, V268, P4216; De Jong JC, 2003, J AM SOC NEPHROL, V14, P2428, DOI 10.1097/01.ASN.0000089832.52063.F5; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Devuyst O, 2008, NAT GENET, V40, P495, DOI 10.1038/ng0508-495; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gaczynska M, 2005, METHOD ENZYMOL, V398, P425, DOI 10.1016/S0076-6879(05)98035-X; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; JONES EW, 1982, GENETICS, V102, P665; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Knoers NVAM, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-22; Kolb AR, 2011, AM J PHYSIOL-RENAL, V301, pF1, DOI 10.1152/ajprenal.00141.2011; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Ong DST, 2011, CURR OPIN CELL BIOL, V23, P231, DOI 10.1016/j.ceb.2010.11.002; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Shmueli A, 2009, BIOCHEM BIOPH RES CO, V390, P758, DOI 10.1016/j.bbrc.2009.10.045; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Singh OV, 2006, J PROTEOME RES, V5, P562, DOI 10.1021/pr050319o; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Subramanya AR, 2011, AM J PHYSIOL-RENAL, V300, pF838, DOI 10.1152/ajprenal.00078.2011; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vargas-Poussou R, 2011, J AM SOC NEPHROL, V22, P693, DOI 10.1681/ASN.2010090907; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	64	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43611	43621		10.1074/jbc.M111.288928	http://dx.doi.org/10.1074/jbc.M111.288928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027832	Green Published, hybrid			2022-12-25	WOS:000298402300004
J	Nomme, J; Fanning, AS; Caffrey, M; Lye, MF; Anderson, JM; Lavie, A				Nomme, Julian; Fanning, Alan S.; Caffrey, Michael; Lye, Ming F.; Anderson, James M.; Lavie, Arnon			The Src Homology 3 Domain Is Required for Junctional Adhesion Molecule Binding to the Third PDZ Domain of the Scaffolding Protein ZO-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANYLATE KINASE DOMAINS; TIGHT-JUNCTION; INTRAMOLECULAR INTERACTION; LIGAND-BINDING; CELL POLARITY; LOCALIZATION; MEMBRANE; PSD-95; SITES; DIMERIZATION	Tight junctions are cell-cell contacts that regulate the paracellular flux of solutes and prevent pathogen entry across cell layers. The assembly and permeability of this barrier are dependent on the zonula occludens (ZO) membrane-associated guanylate kinase (MAGUK) proteins ZO-1, -2, and -3. MAGUK proteins are characterized by a core motif of protein-binding domains that include a PDZ domain, a Src homology 3 (SH3) domain, and a region of homology to guanylate kinase (GUK); the structure of this core motif has never been determined for any MAGUK. To better understand how ZO proteins organize the assembly of protein complexes we have crystallized the entire PDZ3-SH3-GUK core motif of ZO-1. We have also crystallized this core motif in complex with the cytoplasmic tail of the ZO-1 PDZ3 ligand, junctional adhesion molecule A (JAM-A) to determine how the activity of different domains is coordinated. Our study shows a new feature for PDZ class II ligand binding that implicates the two highly conserved Phe(-2) and Ser(-3) residues of JAM. Our x-ray structures and NMR experiments also show for the first time a role for adjacent domains in the binding of ligands to PDZ domains in the MAGUK proteins family.	[Nomme, Julian; Caffrey, Michael; Lye, Ming F.; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Fanning, Alan S.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Anderson, James M.] NHLBI, NIH, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,Mol Biol Res Bldg,Rm 1108, Chicago, IL 60607 USA.	lavie@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722; Anderson, James/0000-0003-2765-7996	National Institutes of Health [DK61397]; University of North Carolina; University of Illinois; National Institutes of Health Division of Intramural Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061397, R01DK061397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina; University of Illinois; National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by National Institutes of Health Grant DK61397 (to A. S. F. and A. L.). This work was also supported by the National Institutes of Health Division of Intramural Research and the Universities of North Carolina and Illinois.	Brenman JE, 1998, J NEUROSCI, V18, P8805; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Harris BZ, 2001, J CELL SCI, V114, P3219; Hoskins R, 1996, DEVELOPMENT, V122, P97; Javier RT, 2008, ONCOGENE, V27, P7031, DOI 10.1038/onc.2008.352; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kausalya PJ, 2004, MOL BIOL CELL, V15, P5503, DOI 10.1091/mbc.E04-04-0350; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Sasaki H, 2003, P NATL ACAD SCI USA, V100, P3971, DOI 10.1073/pnas.0630649100; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595	36	55	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43352	43360		10.1074/jbc.M111.304089	http://dx.doi.org/10.1074/jbc.M111.304089			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22030391	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000298351300055
J	Wedeken, L; Singh, P; Klempnauer, KH				Wedeken, Lena; Singh, Priyanka; Klempnauer, Karl-Heinz			Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; INITIATION-FACTOR 4A; DNA-DAMAGE; EUKARYOTIC TRANSLATION; COLORECTAL-CANCER; STRUCTURAL BASIS; GENE-EXPRESSION; BINDING-PROTEIN; TRANSFORMATION; MA-3	Background: Pdcd4 is a tumor suppressor involved in translational regulation. Results: Pdcd4 interacts with p53 mRNA and inhibits its translation via the 5'-UTR. Under stress conditions, the expression of Pdcd4 decreases. Conclusion: Translation of p53 mRNA is suppressed by Pdcd4 under normal growth conditions. Significance: Pdcd4 is a new translational regulator of p53.	[Wedeken, Lena; Singh, Priyanka; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de	Xie, Huangming/B-2260-2012	Singh, Priyanka/0000-0002-5928-6280; Wedeken, Lena/0000-0003-1061-9459	Deutsche Krebshilfe; Wilhelm-Sander-Stiftung; Deutsche Forschungsgemeinschaft; Graduate School of Chemistry, University of Munster	Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of Chemistry, University of Munster	This work was supported in part by grants from the Deutsche Krebshilfe, the Wilhelm-Sander-Stiftung, and the Deutsche Forschungsgemeinschaft.; Supported by fellowships from the Graduate School of Chemistry, University of Munster.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Singh P, 2011, ONCOGENE, V30, P4864, DOI 10.1038/onc.2011.202; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters LC, 2011, J BIOL CHEM, V286, P17270, DOI 10.1074/jbc.M110.166157; Wedeken Lena, 2010, Genes Cancer, V1, P293, DOI 10.1177/1947601910364227; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Xiong L, 2007, J CELL BIOL, V178, P995, DOI 10.1083/jcb.200703044; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002	46	58	64	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42855	42862		10.1074/jbc.M111.269456	http://dx.doi.org/10.1074/jbc.M111.269456			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033922	Green Published, hybrid			2022-12-25	WOS:000298351300007
J	Bohnekamp, J; Schoneberg, T				Bohnekamp, Jens; Schoeneberg, Torsten			Cell Adhesion Receptor GPR133 Couples to G(s) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; V2 VASOPRESSIN RECEPTOR; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE DOMAIN; ANGIOGENESIS; FAMILY; GPCRS; ACTIVATION; MUTATIONS; MIGRATION	Adhesion G protein-coupled receptors (GPCR), with their very large and complex N termini, are thought to participate in cell-cell and cell-matrix interactions and appear to be highly relevant in several developmental processes. Their intracellular signaling is still poorly understood. Here we demonstrate that GPR133, a member of the adhesion GPCR subfamily, activates the Gs protein/adenylyl cyclase pathway. The presence of the N terminus and the cleavage at the GPCR proteolysis site are not required for G protein signaling. Gs protein coupling was verified by G alpha(s) knockdown with siRNA, overexpression of G alpha(s), co-expression of the chimeric Gq(s4) protein that routes GPR133 activity to the phospholipase C/inositol phosphate pathway, and missense mutation within the transmembrane domain that abolished receptor activity without changing cell surface expression. It is likely that not only GPR133 but also other adhesion GPCR signal via classical receptor/G protein-interaction.	[Bohnekamp, Jens; Schoeneberg, Torsten] Univ Leipzig, Fac Med, Inst Biochem, Sect Mol Biochem, D-04103 Leipzig, Germany	Leipzig University	Schoneberg, T (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Sect Mol Biochem, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de			Deutsche Forschungsgemeinschaft [Sfb 610]; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (Integriertes Forschungs- und Behandlungszentrum AdipositasDiseases Leipzig)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (Integriertes Forschungs- und Behandlungszentrum AdipositasDiseases Leipzig)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Grant Sfb 610) and the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (Integriertes Forschungs- und Behandlungszentrum AdipositasDiseases Leipzig).	BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Boselt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005573; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Feldman RD, 2007, LIFE SCI, V81, P267, DOI 10.1016/j.lfs.2007.05.015; Hsiao CC, 2011, FEBS LETT, V585, P313, DOI 10.1016/j.febslet.2010.12.005; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Jeong BC, 2006, FEBS LETT, V580, P669, DOI 10.1016/j.febslet.2005.12.086; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Krasnoperov V, 2009, BIOCHEMISTRY-US, V48, P3230, DOI 10.1021/bi802163p; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Kwakkenbos MJ, 2004, IMMUNOGENETICS, V55, P655, DOI 10.1007/s00251-003-0625-2; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; LEFKOWITZ RJ, 1993, NATURE, V365, P603, DOI 10.1038/365603a0; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Preuss H, 2007, J PHARMACOL EXP THER, V321, P983, DOI 10.1124/jpet.107.120014; Rompler H, 2006, GENOMICS, V87, P724, DOI 10.1016/j.ygeno.2006.02.009; Rompler M, 2005, J BIOL CHEM, V280, P31068, DOI 10.1074/jbc.M503586200; Sanchez-Mas J, 2004, PIGM CELL RES, V17, P386, DOI 10.1111/j.1600-0749.2004.00160.x; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schmidt C, 2003, J BIOL CHEM, V278, P30248, DOI 10.1074/jbc.M304991200; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Silva JP, 2009, J BIOL CHEM, V284, P6495, DOI 10.1074/jbc.M806979200; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Vanti WB, 2003, BIOCHEM BIOPH RES CO, V305, P67, DOI 10.1016/S0006-291X(03)00709-5; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yona S, 2008, FASEB J, V22, P741, DOI 10.1096/fj.07-9435com; Zhang ML, 2005, J BIOL CHEM, V280, P26169, DOI 10.1074/jbc.M502102200	49	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41912	41916		10.1074/jbc.C111.265934	http://dx.doi.org/10.1074/jbc.C111.265934			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22025619	hybrid, Green Published			2022-12-25	WOS:000298180900002
J	Mbantenkhu, M; Wang, XW; Nardozzi, JD; Wilkens, S; Hoffman, E; Patel, A; Cosgrove, MS; Chen, XJ				Mbantenkhu, MacMillan; Wang, Xiaowen; Nardozzi, Jonathan D.; Wilkens, Stephan; Hoffman, Elizabeth; Patel, Anamika; Cosgrove, Michael S.; Chen, Xin Jie			Mgm101 Is a Rad52-related Protein Required for Mitochondrial DNA Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; BINDING-PROTEIN; STRAND EXCHANGE; INVERTED-REPEAT; RAD52 PROTEIN; ORGANIZATION; REPLICATION; MAINTENANCE; GENOME	Homologous recombination is a conserved molecular process that has primarily evolved for the repair of double-stranded DNA breaks and stalled replication forks. However, the recombination machinery in mitochondria is poorly understood. Here, we show that the yeast mitochondrial nucleoid protein, Mgm101, is related to the Rad52-type recombination proteins that are widespread in organisms from bacteriophage to humans. Mgm101 is required for repeat-mediated recombination and suppression of mtDNA fragmentation in vivo. It preferentially binds to single-stranded DNA and catalyzes the annealing of ssDNA precomplexed with the mitochondrial ssDNA-binding protein, Rim1. Transmission electron microscopy showed that Mgm101 forms large oligomeric rings of similar to 14-fold symmetry and highly compressed helical filaments. Specific mutations affecting ring formation reduce protein stability in vitro. The data suggest that the ring structure may provide a scaffold for stabilization of Mgm101 by preventing the aggregation of the otherwise unstable monomeric conformation. Upon binding to ssDNA, Mgm101 is remobilized from the rings to form distinct nucleoprotein filaments. These studies reveal a recombination protein of likely bacteriophage origin in mitochondria and support the notion that recombination is indispensable for mtDNA integrity.	[Mbantenkhu, MacMillan; Wang, Xiaowen; Nardozzi, Jonathan D.; Wilkens, Stephan; Hoffman, Elizabeth; Chen, Xin Jie] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Patel, Anamika; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University	Chen, XJ (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	chenx@upstate.edu		Nardozzi, Jonathan/0000-0002-6655-4765	National Institutes of Health [R01AG023731, R01GM058600, R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG023731, R01GM058600, and R01CA140522 (to X. J. C., S. W., and M. S. C.).	Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Bogenhagen DF, 2010, EXP GERONTOL, V45, P473, DOI 10.1016/j.exger.2009.12.002; Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; CHEN XJ, 1993, NUCLEIC ACIDS RES, V21, P3473, DOI 10.1093/nar/21.15.3473; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Davis AP, 2001, GENETICS, V159, P515; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Howell N, 1996, AM J HUM GENET, V59, P749; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LING F, 1995, EMBO J, V14, P4090, DOI 10.1002/j.1460-2075.1995.tb00081.x; Ling F, 2002, EMBO J, V21, P4730, DOI 10.1093/emboj/cdf466; Ling F, 2000, NUCLEIC ACIDS RES, V28, P4956, DOI 10.1093/nar/28.24.4956; Ling F, 2009, J BIOL CHEM, V284, P9341, DOI 10.1074/jbc.M900023200; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luria SE, 1943, GENETICS, V28, P491; Masuda T, 2010, FEBS J, V277, P1440, DOI 10.1111/j.1742-4658.2010.07574.x; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Mortensen UH, 2002, GENETICS, V161, P549; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Mott C, 2011, DNA REPAIR, V10, P408, DOI 10.1016/j.dnarep.2011.01.007; Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; Ploquin M, 2008, CURR BIOL, V18, P1142, DOI 10.1016/j.cub.2008.06.071; Pohjoismaki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137; Pohjoismaki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; POTEETE AR, 1983, J MOL BIOL, V171, P401, DOI 10.1016/0022-2836(83)90037-2; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Zuo XM, 2007, FEMS YEAST RES, V7, P131, DOI 10.1111/j.1567-1364.2006.00141.x; Zuo XM, 2002, GENETICS, V160, P1389	68	33	34	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42360	42370		10.1074/jbc.M111.307512	http://dx.doi.org/10.1074/jbc.M111.307512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22027892	hybrid, Green Published			2022-12-25	WOS:000298180900045
J	Kim, SH; Sehrawat, A; Sakao, K; Hahm, ER; Singh, SV				Kim, Su-Hyeong; Sehrawat, Anuradha; Sakao, Kozue; Hahm, Eun-Ryeong; Singh, Shivendra V.			Notch Activation by Phenethyl Isothiocyanate Attenuates Its Inhibitory Effect on Prostate Cancer Cell Migration	PLOS ONE			English	Article							DOWN-REGULATION; CRUCIFEROUS VEGETABLES; CHEMOPREVENTIVE AGENT; DIALLYL TRISULFIDE; ANDROGEN RECEPTOR; INDUCED APOPTOSIS; GENE-EXPRESSION; IN-VITRO; ARREST; GROWTH	Phenethyl isothiocyanate (PEITC) is a promising cancer chemopreventive component of edible cruciferous vegetables with in vivo efficacy against prostate cancer in experimental rodents. Cancer chemopreventive response to PEITC is characterized by its ability to inhibit multiple oncogenic signaling pathways, including nuclear factor-kappa B, Akt, and androgen receptor. The present study demonstrates, for the first time, that PEITC treatment activates Notch signaling in malignant as well as normal human prostate cells. Exposure of human prostate cancer cells (LNCaP, PC-3, and DU145) and a normal human prostate epithelial cell line (PrEC) to PEITC resulted in cleavage (active form) of Notch1 and Notch2, and increased transcriptional activity of Notch. In PC-3 and LNCaP cells, PEITC treatment caused induction of Notch ligands Jagged1 and Jagged2 (PC-3), overexpression of c-secretase complex components Presenilin1 and Nicastrin (PC-3), nuclear enrichment of cleaved Notch2, and/or up-regulation of Notch1, Notch2, Jagged1, and/or Jagged2 mRNA. PEITC-induced apoptosis in LNCaP and PC-3 cells was significantly attenuated by RNA interference of Notch2, but not by pharmacological inhibition of Notch1. Inhibition of PC-3 and LNCaP cell migration resulting from PEITC exposure was significantly augmented by knockdown of Notch2 protein as well as pharmacological inhibition of Notch1 activation. Nuclear expression of cleaved Notch2 protein was significantly higher in PC-3 xenografts from PEITC-treated mice and dorsolateral prostates from PEITC-fed TRAMP mice compared with respective control. Because Notch signaling is implicated in epithelial-mesenchymal transition and metastasis, the present study suggests that anti-metastatic effect of PEITC may be augmented by a combination regimen involving a Notch inhibitor.	[Kim, Su-Hyeong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, SH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	singhs@upmc.edu			National Cancer Institute [RO1 CA101753-08]; NATIONAL CANCER INSTITUTE [R01CA101753] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by the National Cancer Institute grant RO1 CA101753-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2007, NEOPLASIA, V9, P427, DOI 10.1593/neo.07211; Barve A, 2008, PHARM RES-DORDR, V25, P2181, DOI 10.1007/s11095-008-9574-7; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Chiao JW, 2004, CARCINOGENESIS, V25, P1403, DOI 10.1093/carcin/bgh136; Clementz AG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2900; Gong AY, 2009, MOL NUTR FOOD RES, V53, P878, DOI 10.1002/mnfr.200800253; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji Y, 2005, PHARM RES-DORDR, V22, P1658, DOI 10.1007/s11095-005-7097-z; Khor TO, 2008, MOL CARCINOGEN, V47, P321, DOI 10.1002/mc.20390; Kim YA, 2007, MOL CANCER THER, V6, P1599, DOI 10.1158/1535-7163.MCT-06-0754; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kolonel LN, 2000, CANCER EPIDEM BIOMAR, V9, P795; Konsue N, 2010, MOL NUTR FOOD RES, V54, P426, DOI 10.1002/mnfr.200900090; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Powolny AA, 2011, JNCI-J NATL CANCER I, V103, P571, DOI 10.1093/jnci/djr029; Powolny AA, 2010, PHARM RES-DORDR, V27, P2766, DOI 10.1007/s11095-010-0278-4; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Scorey N, 2006, PROSTATE CANCER P D, V9, P399, DOI 10.1038/sj.pcan.4500894; Shou JY, 2001, CANCER RES, V61, P7291; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; STONER GD, 1991, CANCER RES, V51, P2063; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395, DOI 10.1093/jnci/58.2.395; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2005, CLIN CANCER RES, V11, P2670, DOI 10.1158/1078-0432.CCR-04-1545; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao D, 2004, MOL CANCER THER, V3, P567; Xiao D, 2007, CANCER RES, V67, P2239, DOI 10.1158/0008-5472.CAN-06-3645; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Xiao D, 2010, PHARM RES-DORDR, V27, P722, DOI 10.1007/s11095-010-0079-9; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Zhang YX, 2006, INT J CANCER, V119, P2071, DOI 10.1002/ijc.22077	45	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26615	10.1371/journal.pone.0026615	http://dx.doi.org/10.1371/journal.pone.0026615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039516	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000296515200031
J	Giritharan, G; Ilic, D; Gormley, M; Krtolica, A				Giritharan, Gnanaratnam; Ilic, Dusko; Gormley, Matthew; Krtolica, Ana			Human Embryonic Stem Cells Derived from Embryos at Different Stages of Development Share Similar Transcription Profiles	PLOS ONE			English	Article							TERMINAL DOMAIN; GENE; EXPRESSION; FAMILY; PROTEIN; 4-CELL; BLASTOMERES; GALECTINS	We have derived hESC from biopsied blastomeres of cleavage stage embryos under virtually the same conditions we used for the derivation of hESC lines from inner cell mass of blastocyst stage embryos. Blastomere-derived hESC lines exhibited all the standard characteristics of hESC including undifferentiated proliferation, genomic stability, expression of pluripotency markers and the ability to differentiate into the cells of all three germ layers both in vitro and in vivo. To examine whether hESC lines derived from two developmental stages of the embryo differ in gene expression, we have subjected three blastomere-derived hESC lines and two ICM-derived hESC lines grown under identical culture conditions to transcriptome analysis using gene expression arrays. Unlike previously reported comparisons of hESC lines which demonstrated, apart from core hESC-associated pluripotency signature, significant variations in gene expression profiles of different lines, our data show that hESC lines derived and grown under well-controlled defined culture conditions adopt nearly identical gene expression profiles. Moreover, blastomere-derived and ICM-derived hESC exhibited very similar transcriptional profiles independent of the developmental stage of the embryo from which they originated. Furthermore, this profile was evident in very early passages of the cells and did not appear to be affected by extensive passaging. These results suggest that during derivation process cells which give rise to hESC acquire virtually identical stable phenotype and are not affected by the developmental stage of the starting cell population.	[Giritharan, Gnanaratnam; Ilic, Dusko; Krtolica, Ana] StemLifeLine Inc, SLL Sci, San Carlos, CA USA; [Gormley, Matthew] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Giritharan, G (corresponding author), StemLifeLine Inc, SLL Sci, San Carlos, CA USA.	akrtolica@sllsciences.com		ILIC, DUSKO/0000-0003-1647-0026	StemLifeLine, Inc.	StemLifeLine, Inc.	This work was supported by StemLifeLine, Inc. through the employment of Gnanaratnam Giritharan, Dusko Ilic and Ana Krtolica. StemLifeLine conceived, designed and performed the experiments and analyzed the data.	Abedin MJ, 2003, J LEUKOCYTE BIOL, V73, P650, DOI 10.1189/jlb.0402163; Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; Albrecht DE, 2004, J BIOL CHEM, V279, P7014, DOI 10.1074/jbc.M312205200; Ballow DJ, 2006, GENE EXPR PATTERNS, V6, P1014, DOI 10.1016/j.modgep.2006.04.007; Becker R, 2008, J BIOL CHEM, V283, P22659, DOI 10.1074/jbc.M803540200; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Bresson-Mazet C, 2008, CELL PROLIFERAT, V41, P726, DOI 10.1111/j.1365-2184.2008.00554.x; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cole MF, 2008, COLD SH Q B, V73, P183, DOI 10.1101/sqb.2008.73.027; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Geens M, 2009, HUM REPROD, V24, P2709, DOI 10.1093/humrep/dep262; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong TWL, 2003, GENOMICS, V82, P143, DOI 10.1016/S0888-7543(03)00111-3; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guy J, 2003, GENOME RES, V13, P159, DOI 10.1101/gr.644503; Ilic D, 2009, STEM CELLS DEV, V18, P1343, DOI 10.1089/scd.2008.0416; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Kruger M, 2000, P NATL ACAD SCI USA, V97, P8566, DOI 10.1073/pnas.97.15.8566; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Mao M, 1996, P NATL ACAD SCI USA, V93, P5910, DOI 10.1073/pnas.93.12.5910; O'Toole JF, 2010, J CLIN INVEST, V120, P791, DOI 10.1172/JCI40076; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Petit MMR, 1999, GENOMICS, V57, P438, DOI 10.1006/geno.1999.5778; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Than NG, 2009, P NATL ACAD SCI USA, V106, P9731, DOI 10.1073/pnas.0903568106; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turner S, 2010, MOL HUM REPROD, V16, P685, DOI 10.1093/molehr/gaq048; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Van de Velde H, 2008, HUM REPROD, V23, P1742, DOI 10.1093/humrep/den190; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844	43	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26570	10.1371/journal.pone.0026570	http://dx.doi.org/10.1371/journal.pone.0026570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039509	Green Published, Green Submitted			2022-12-25	WOS:000296513200030
J	Kapoor, A; Shandilya, M; Kundu, S				Kapoor, Abhijeet; Shandilya, Manish; Kundu, Suman			Structural Insight of Dopamine beta-Hydroxylase, a Drug Target for Complex Traits, and Functional Significance of Exonic Single Nucleotide Polymorphisms	PLOS ONE			English	Article							FAST INTERACTION REFINEMENT; STRUCTURE PREDICTION; STRUCTURE VALIDATION; CHROMAFFIN GRANULES; PARKINSONS-DISEASE; MONONUCLEAR COPPER; MOLECULAR DOCKING; SULFUR LIGAND; WEB SERVER; DBH GENE	Background: Human dopamine beta-hydroxylase (DBH) is an important therapeutic target for complex traits. Several single nucleotide polymorphisms (SNPs) have also been identified in DBH with potential adverse physiological effect. However, difficulty in obtaining diffractable crystals and lack of a suitable template for modeling the protein has ensured that neither crystallographic three-dimensional structure nor computational model for the enzyme is available to aid rational drug design, prediction of functional significance of SNPs or analytical protein engineering. Principal Findings: Adequate biochemical information regarding human DBH, structural coordinates for peptidylglycine alpha-hydroxylating monooxygenase and computational data from a partial model of rat DBH were used along with logical manual intervention in a novel way to build an in silico model of human DBH. The model provides structural insight into the active site, metal coordination, subunit interface, substrate recognition and inhibitor binding. It reveals that DOMON domain potentially promotes tetramerization, while substrate dopamine and a potential therapeutic inhibitor nepicastat are stabilized in the active site through multiple hydrogen bonding. Functional significance of several exonic SNPs could be described from a structural analysis of the model. The model confirms that SNP resulting in Ala318Ser or Leu317Pro mutation may not influence enzyme activity, while Gly482Arg might actually do so being in the proximity of the active site. Arg549Cys may cause abnormal oligomerization through non-native disulfide bond formation. Other SNPs like Glu181, Glu250, Lys239 and Asp290 could potentially inhibit tetramerization thus affecting function. Conclusions: The first three-dimensional model of full-length human DBH protein was obtained in a novel manner with a set of experimental data as guideline for consistency of in silico prediction. Preliminary physicochemical tests validated the model. The model confirms, rationalizes and provides structural basis for several biochemical data and claims testable hypotheses regarding function. It provides a reasonable template for drug design as well.	[Kapoor, Abhijeet; Shandilya, Manish; Kundu, Suman] Univ Delhi S Campus, Dept Biochem, New Delhi, India	University of Delhi	Kapoor, A (corresponding author), Univ Delhi S Campus, Dept Biochem, New Delhi, India.	sumankundu7@gmail.com	Shandilya, Manish/AAU-7961-2020; Kapoor, Abhijeet/V-3284-2019	Shandilya, Manish/0000-0003-2983-7958; Kapoor, Abhijeet/0000-0002-3606-3463	Department of Biotechnology (DBT), Government of India [BT/01/COE/07/UDSC]; University of Delhi University; University Grants Commission, Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); University of Delhi University; University Grants Commission, Government of India(University Grants Commission, India)	Financial assistance from Department of Biotechnology (DBT,http://dbtindia.nic.in/index.asp#), Government of India in the form of research grant to SK (BT/01/COE/07/UDSC) is especially acknowledged. Research and Development funding by University of Delhi (www.du.ac.in) University are also duly acknowledged. Financial assistance to MS in the form of research fellowship by University Grants Commission (www.ugc.ac.in), Government of India is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P524, DOI 10.1016/S0968-0004(01)01924-7; ASH DE, 1984, J BIOL CHEM, V259, P3395; Bhaduri N, 2003, INT ARCH BIOSCI, P1122; Bhaduri N, 2008, CELL MOL NEUROBIOL, V28, P343, DOI 10.1007/s10571-007-9256-8; BLACKBURN NJ, 1991, J BIOL CHEM, V266, P23120; BLACKBURN NJ, 1988, BIOCHEMISTRY-US, V27, P6001, DOI 10.1021/bi00416a026; BLACKBURN NJ, 1990, J BIOL CHEM, V265, P15383; BRENNER MC, 1989, BIOCHEMISTRY-US, V28, P4656, DOI 10.1021/bi00437a022; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Champloy F, 1998, INORG CHEM, V37, P3910, DOI 10.1021/ic9709281; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comings DE, 1996, AM J MED GENET, V67, P264, DOI 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N; Cubells JF, 1997, AM J MED GENET, V74, P374, DOI 10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P; DUONG LT, 1985, J BIOL CHEM, V260, P2393; Fernandez F, 2009, NEUROGENETICS, V10, P199, DOI 10.1007/s10048-009-0176-2; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GOLDSTEIN M, 1964, LIFE SCI, V3, P763, DOI 10.1016/0024-3205(64)90031-1; GOLDSTEIN M, 1964, BIOCHEM PHARMACOL, V13, P1103, DOI 10.1016/0006-2952(64)90109-1; Grimmelikhuijzen CJP, 1994, BIOSYNTHESIS NEUROPE, P97; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHII A, 1991, NEUROSCI LETT, V125, P25, DOI 10.1016/0304-3940(91)90121-9; Iyer LM, 2007, BIOINFORMATICS, V23, P2660, DOI 10.1093/bioinformatics/btm411; Kamachi T, 2005, INORG CHEM, V44, P4226, DOI 10.1021/ic048477p; Karshikoff A, 2007, METHODS PROTEIN STRU, P71; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kieling C, 2008, AM J MED GENET B, V147B, P485, DOI 10.1002/ajmg.b.30636; KLINMAN JP, 1984, J BIOL CHEM, V259, P3399; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; Li B, 1996, BIOCHEM J, V313, P57, DOI 10.1042/bj3130057; LIEBERMAN AN, 1972, LANCET, V1, P153; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; MCCRACKEN J, 1988, BIOCHEMISTRY-US, V27, P4133, DOI 10.1021/bi00411a034; Narita M, 1996, FEBS LETT, V396, P208, DOI 10.1016/0014-5793(96)01091-5; Nunes T, 2010, HLTH SUBJECTS DRUGS, V10, P225; OBATA A, 1987, BIOCHEMISTRY-US, V26, P4962, DOI 10.1021/bi00390a012; OCONNOR DT, 1979, MOL PHARMACOL, V16, P529; PETTINGILL TM, 1991, J BIOL CHEM, V266, P16996; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Prigge ST, 2004, SCIENCE, V304, P864, DOI 10.1126/science.1094583; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; REEDY BJ, 1994, J AM CHEM SOC, V116, P1924, DOI 10.1021/ja00084a037; ROBERTSON JG, 1994, BIOCHEMISTRY-US, V33, P11563, DOI 10.1021/bi00204a019; Ross OA, 2008, PARKINSONISM RELAT D, V14, P544, DOI 10.1016/j.parkreldis.2008.07.002; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Santra BK, 2002, INORG CHEM, V41, P1328, DOI 10.1021/ic010926n; SAXENA A, 1985, J BIOL CHEM, V260, P3386; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Stanley W.C., 1998, HEART FAIL REV, V2, P195, DOI [10.1023/A:1009721100943, DOI 10.1023/A:1009721100943]; Stanley WC, 1997, BRIT J PHARMACOL, V121, P1803, DOI 10.1038/sj.bjp.0701315; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; Tang Y, 2007, EUR J HUM GENET, V15, P878, DOI 10.1038/sj.ejhg.5201838; Tang YL, 2006, BIOL PSYCHIAT, V60, P1034, DOI 10.1016/j.biopsych.2006.02.017; Thakurta PG, 2004, BIOCHEMISTRY-US, V43, P1532, DOI 10.1021/bi0357659; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Togsverd M, 2008, J AFFECT DISORDERS, V106, P169, DOI 10.1016/j.jad.2007.06.010; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Zabetian CP, 2001, AM J HUM GENET, V68, P515, DOI 10.1086/318198; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	69	22	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26509	10.1371/journal.pone.0026509	http://dx.doi.org/10.1371/journal.pone.0026509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028891	gold, Green Published			2022-12-25	WOS:000296510800048
J	Patrick, SC; Browning, LE				Patrick, Samantha C.; Browning, Lucy E.			Exploration Behaviour Is Not Associated with Chick Provisioning in Great Tits	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; AVIAN PERSONALITIES; PARTNER CONTRIBUTION; PARENTAL EFFORT; OFFSPRING CARE; PARUS-MAJOR; TRADE-OFFS; EVOLUTION; POPULATIONS; QUALITY	In biparental systems, members of the same pair can vary substantially in the amount of parental care they provide to offspring. The extent of this asymmetry should depend on the relative costs and benefits of care. Individual variation in personality is likely to influence this trade-off, and hence is a promising candidate to explain differences in care. In addition, plasticity in parental care may also be associated with personality differences. Using exploration behaviour (EB) as a measure of personality, we investigated these possibilities using both natural and experimental data from a wild population of great tits (Parus major). Contrary to predictions, we found no association between EB and natural variation in provisioning behaviour. Nor was EB linked to responsiveness to experimentally increased brood demand. These results are initially surprising given substantial data from other studies suggesting personality should influence investment in parental care. However, they are consistent with a recent study showing selection on EB is weak and highly context-specific in the focal population. This emphasises the difficulty faced by personality studies attempting to make predictions based on previous work, given that personalities often vary among populations of the same species.	[Patrick, Samantha C.] Univ Oxford, Edward Grey Inst, Oxford, England; [Patrick, Samantha C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Browning, Lucy E.] Univ New S Wales, Arid Zone Res Stn, Sydney, NSW, Australia	University of Oxford; University of Plymouth; University of New South Wales Sydney	Patrick, SC (corresponding author), Univ Oxford, Edward Grey Inst, Oxford, England.	samantha.patrick@plymouth.ac.uk	Browning, Lucy/B-6030-2011		NERC (Natural Environment Research Council); BBSRC (Biotechnology and Biological Sciences Research Council)	NERC (Natural Environment Research Council)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Samantha C. Patrick was funded by a NERC (Natural Environment Research Council) studentship, and Lucy E. Browning was funded by a BBSRC (Biotechnology and Biological Sciences Research Council) studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Benus RF, 1996, ANIM BEHAV, V51, P67, DOI 10.1006/anbe.1996.0006; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Boon AK, 2007, ECOL LETT, V10, P1094, DOI 10.1111/j.1461-0248.2007.01106.x; Both C, 2005, J ANIM ECOL, V74, P667, DOI 10.1111/j.1365-2656.2005.00962.x; Brydges NM, 2008, J ANIM ECOL, V77, P229, DOI 10.1111/j.1365-2656.2007.01343.x; Budaev SV, 1999, PERS INDIV DIFFER, V26, P801, DOI 10.1016/S0191-8869(98)00179-2; Burley NT, 2002, PHILOS T R SOC B, V357, P241, DOI 10.1098/rstb.2001.0923; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cote J, 2007, P R SOC B, V274, P383, DOI 10.1098/rspb.2006.3734; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Drent P.J., 1999, P 22 INT ORNITHOLOGI, P896; Garcia-Navas V, 2011, IBIS, V153, P59, DOI 10.1111/j.1474-919X.2010.01077.x; Gosler A, 1993, GREAT TIT; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Hinde CA, 2006, BEHAV ECOL, V17, P6, DOI 10.1093/beheco/ari092; Hinde CA, 2007, P ROY SOC B-BIOL SCI, V274, P53, DOI 10.1098/rspb.2006.3692; Hollander FA, 2008, ETHOLOGY, V114, P405, DOI 10.1111/j.1439-0310.2008.01488.x; Houston AI, 1985, ECOLOGICAL CONSEQUEN, P471; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Lack D., 1968, pvii; Macleod R, 2005, J ANIM ECOL, V74, P956, DOI 10.1111/j.1365-2656.2005.00993.x; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; MINOT EO, 1986, J ANIM ECOL, V55, P331, DOI 10.2307/4712; Quinn JL, 2009, J ANIM ECOL, V78, P1203, DOI 10.1111/j.1365-2656.2009.01585.x; Roulin A, 2010, ETHOLOGY, V116, P787, DOI 10.1111/j.1439-0310.2010.01793.x; Sanz JJ, 2000, J ANIM ECOL, V69, P74, DOI 10.1046/j.1365-2656.2000.00373.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P622, DOI 10.1016/j.tree.2004.09.018; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; SLAGSVOLD T, 1994, BEHAVIOUR, V131, P115, DOI 10.1163/156853994X00244; Smiseth PT, 2003, P ROY SOC B-BIOL SCI, V270, P1773, DOI 10.1098/rspb.2003.2444; SMITH HG, 1988, BEHAV ECOL SOCIOBIOL, V22, P447, DOI 10.1007/BF00294983; Stauss MJ, 2005, J AVIAN BIOL, V36, P47, DOI 10.1111/j.0908-8857.2005.02855.x; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Thorogood R, 2011, P ROYAL SOC B; Tinbergen JM, 2000, J ANIM ECOL, V69, P323, DOI 10.1046/j.1365-2656.2000.00395.x; TRIVERS RL, 1972, AM ZOOL, V12, P648; van Oers K, 2005, BEHAVIOUR, V142, P1185, DOI 10.1163/156853905774539364; van Overveld T, 2011, BEHAV ECOL, V22, P899, DOI 10.1093/beheco/arr063; van Overveld T, 2010, BIOL LETTERS, V6, P187, DOI 10.1098/rsbl.2009.0764; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Webb TJ, 2010, METHODS ECOL EVOL, V1, P221, DOI 10.1111/j.2041-210X.2010.00027.x; Wilkin TA, 2009, J AVIAN BIOL, V40, P135, DOI 10.1111/j.1600-048X.2009.04362.x; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Woon-Kee Paek, 1996, Acta Ornithologica (Warsaw), V31, P155; Wright J, 1998, J ANIM ECOL, V67, P620, DOI 10.1046/j.1365-2656.1998.00221.x; Wright J, 1990, BEHAV ECOL, V1, P116, DOI 10.1093/beheco/1.2.116	54	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26383	10.1371/journal.pone.0026383	http://dx.doi.org/10.1371/journal.pone.0026383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028867	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800039
J	Sormani, MP; Calabrese, M; Signori, A; Giorgio, A; Gallo, P; De Stefano, N				Sormani, Maria Pia; Calabrese, Massimiliano; Signori, Alessio; Giorgio, Antonio; Gallo, Paolo; De Stefano, Nicola			Modeling the Distribution of New MRI Cortical Lesions in Multiple Sclerosis Longitudinal Studies	PLOS ONE			English	Article							PATHOLOGY; COUNTS	Objective: Recent studies have shown the relevance of the cerebral grey matter involvement in multiple sclerosis (MS). The number of new cortical lesions (CLs), detected by specific MRI sequences, has the potential to become a new research outcome in longitudinal MS studies. Aim of this study is to define the statistical model better describing the distribution of new CLs developed over 12 and 24 months in patients with relapsing-remitting (RR) MS. Methods: Four different models were tested (the Poisson, the Negative Binomial, the zero-inflated Poisson and the zero-inflated Negative Binomial) on a group of 191 RRMS patients untreated or treated with 3 different disease modifying therapies. Sample size for clinical trials based on this new outcome measure were estimated by a bootstrap resampling technique. Results: The zero-inflated Poisson model gave the best fit, according to the Akaike criterion to the observed distribution of new CLs developed over 12 and 24 months both in each treatment group and in the whole RRMS patients group adjusting for treatment effect. Conclusions: The sample size calculations based on the zero-inflated Poisson model indicate that randomized clinical trials using this new MRI marker as an outcome are feasible.	[Sormani, Maria Pia; Signori, Alessio] Univ Genoa, Biostat Unit, Dept Hlth Sci, Genoa, Italy; [Calabrese, Massimiliano; Gallo, Paolo] Univ Hosp Padua, Dept Neurosci, Multiple Sclerosis Ctr, Padua, Italy; [Giorgio, Antonio; De Stefano, Nicola] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy	University of Genoa; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Siena	Sormani, MP (corresponding author), Univ Genoa, Biostat Unit, Dept Hlth Sci, Genoa, Italy.	mariapia.sormani@unige.it	Sormani, Maria Pia/ABH-8756-2020; Calabrese, Massimiliano/AAB-7082-2022; Calabrese, Massimiliano/I-6195-2012; Signori, Alessio/L-3081-2016	Calabrese, Massimiliano/0000-0002-3362-7403; Signori, Alessio/0000-0001-6289-9144; De Stefano, Nicola/0000-0003-4930-7639; SORMANI, MARIA PIA/0000-0001-6892-104X	Biogen IDEC; Merck Serono; Actelion; Synthon; Teva; Sanofi Aventis	Biogen IDEC(Biogen); Merck Serono(Merck & Company); Actelion; Synthon; Teva(Teva Pharmaceutical Industries); Sanofi Aventis(Sanofi-Aventis)	Maria Pia Sormani has received consulting fee or honoraria from Biogen IDEC, Merck Serono, Actelion, Synthon. Alessio Signori and Antonio Giorgio have no conflict of interest. Nicola De Stefano has received consulting fee or honoraria and support for travel to meetings by Merck Serono, Teva, Biogen Idec, Sanofi Aventis. Massimiliano Calabrese and Paolo Gallo have received consulting fee or honoraria and support for travel to meetings by Merck Serono, Biogen Idec, Sanofi Aventis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/760254; Calabrese M, 2010, NAT REV NEUROL, V6, P438, DOI 10.1038/nrneurol.2010.93; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Sormani M, 2011, MULT SCLER; Sormani MP, 1999, J NEUROL SCI, V163, P74, DOI 10.1016/S0022-510X(99)00015-5; Stadelmann C, 2008, CURR OPIN NEUROL, V21, P229, DOI 10.1097/01.wco.0000318863.65635.9a; van den Elskamp IJ, 2009, MULT SCLER, V15, P42, DOI 10.1177/1352458508096683	9	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26712	10.1371/journal.pone.0026712	http://dx.doi.org/10.1371/journal.pone.0026712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028937	gold, Green Published, Green Submitted			2022-12-25	WOS:000296510800066
J	Kutiyanawalla, A; Terry, AV; Pillai, A				Kutiyanawalla, Ammar; Terry, Alvin V., Jr.; Pillai, Anilkumar			Cysteamine Attenuates the Decreases in TrkB Protein Levels and the Anxiety/Depression-Like Behaviors in Mice Induced by Corticosterone Treatment	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; DENDRITIC GROWTH; FRONTAL-CORTEX; BRAIN; DEPRESSION; STRESS; BDNF; SCHIZOPHRENIA; EXPRESSION; ANXIETY	Objective: Stress and glucocorticoid hormones, which are released into the circulation following stressful experiences, have been shown to contribute significantly to the manifestation of anxiety-like behaviors observed in many neuropsychiatric disorders. Brain-derived neurotrophic factor (BDNF) signaling through its receptor TrkB plays an important role in stress-mediated changes in structural as well as functional neuroplasticity. Studies designed to elucidate the mechanisms whereby TrkB signaling is regulated in chronic stress might provide valuable information for the development of new therapeutic strategies for several stress-related psychiatric disorders. Materials and Methods: We examined the potential of cysteamine, a neuroprotective compound to attenuate anxiety and depression like behaviors in a mouse model of anxiety/depression induced by chronic corticosterone exposure. Results: Cysteamine administration (150 mg/kg/day, through drinking water) for 21 days significantly ameliorated chronic corticosterone-induced decreases in TrkB protein levels in frontal cortex and hippocampus. Furthermore, cysteamine treatment reversed the anxiety and depression like behavioral abnormalities induced by chronic corticosterone treatment. Finally, mice deficient in TrkB, showed a reduced response to cysteamine in behavioral tests, suggesting that TrkB signaling plays an important role in the antidepressant effects of cysteamine. Conclusions: The animal studies described here highlight the potential use of cysteamine as a novel therapeutic strategy for glucocorticoid-related symptoms of psychiatric disorders.	[Kutiyanawalla, Ammar; Pillai, Anilkumar] Georgia Hlth Sci Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA; [Terry, Alvin V., Jr.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Kutiyanawalla, Ammar; Pillai, Anilkumar] Charlie Norwood Vet Affairs Med Ctr, Med Res Serv, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kutiyanawalla, A (corresponding author), Georgia Hlth Sci Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA.	apillai@georgiahealth.edu	PILLAI, ANILKUMAR/N-4809-2017	Terry, Alvin/0000-0003-2071-4767				Ao MRB, 2008, AUST NZ J PSYCHIAT, V42, P995, DOI 10.1080/00048670802512073; Ardayfio P, 2006, BEHAV NEUROSCI, V120, P249, DOI 10.1037/0735-7044.120.2.249; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Borrell-Pages M, 2006, J CLIN INVEST, V116, P1410, DOI 10.1172/JCI27607; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Calabrese F, 2007, NEUROPSYCHOPHARMACOL, V32, P2351, DOI 10.1038/sj.npp.1301360; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dwivedi Y, 2010, ANN MED, V42, P87, DOI 10.3109/07853890903485730; Ernst C, 2011, BIOL PSYCHIAT, V69, P604, DOI 10.1016/j.biopsych.2010.10.008; Holmes A, 2001, BEHAV BRAIN RES, V122, P159, DOI 10.1016/S0166-4328(01)00184-X; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Howell KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020198; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Kessler A, 2008, METAB BRAIN DIS, V23, P81, DOI 10.1007/s11011-007-9078-x; KUTIYANAWALLA A, 2011, INT J NEUROPSYCHOPH, V22, P1; Leitch MM, 2003, NEUROPSYCHOPHARMACOL, V28, P119, DOI 10.1038/sj.npp.1300016; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Pandey GN, 2008, INT J NEUROPSYCHOPH, V11, P1047, DOI 10.1017/S1461145708009000; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pillai A, 2008, J NEUROCHEM, V107, P941, DOI 10.1111/j.1471-4159.2008.05665.x; Pillai A, 2008, NEUROSIGNALS, V16, P183, DOI 10.1159/000111562; Pillai A, 2008, SCHIZOPHR RES, V100, P325, DOI 10.1016/j.schres.2007.11.030; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P22; Rohrer B, 2004, VISUAL NEUROSCI, V21, P703, DOI 10.1017/S095252380421505X; Shieh CH, 2008, PROG NEURO-PSYCHOPH, V32, P1590, DOI 10.1016/j.pnpbp.2008.06.003; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Weickert CS, 2005, MOL PSYCHIATR, V10, P637, DOI 10.1038/sj.mp.4001678; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; YOUNG EA, 1995, J NEUROENDOCRINOL, V7, P37, DOI 10.1111/j.1365-2826.1995.tb00665.x	36	42	44	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26153	10.1371/journal.pone.0026153	http://dx.doi.org/10.1371/journal.pone.0026153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039440	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500034
J	Li, RQ; Zou, QH; Chen, LJ; Zhang, HR; Wang, YM				Li, Renqing; Zou, Qinghua; Chen, Lijuan; Zhang, Herun; Wang, Yumei			Molecular Analysis of Virulent Determinants of Enterovirus 71	PLOS ONE			English	Article							MOUTH-DISEASE; STRUCTURE PREDICTION; SECONDARY STRUCTURE; RNA; POLIOVIRUS; HAND; FOOT; STRAINS; NEUROVIRULENCE; ATTENUATION	Enterovirus 71 (EV71) is the most important causative agent of hand, foot and mouth disease (HFMD) in children. In most cases, it is a self-limiting illness. However some EV71 infectious cases can develop severe clinical outcomes, such as encephalitis, meningitis, poliomyelitis like paralysis, and even death. To identify the determinants of virulence, the deduced amino acid sequence of polyprotein and nucleotide sequence of 5'-NTR and 3'-NTR in 25 SC-EV71 strains (strains from severe cases) and 31 MC-EV71 strains (strains from mild cases) were analyzed. Results showed four amino acids on two positions (Gly(P710)/Gln(P710)/Arg(P710) and Glu(P729)) on the DE and EF loop of VP1, one (Lys(P930)) on the surface of protease 2A and four nucleotides on three positions (G(P272), U-P488 and A(P700)/U-P700) in the 5'-NTR region are associated with EV71 virulent phenotype. Predicted secondary structure of RNA using the consensus sequence of 5'-NTR by RNAStructure showed the mutation of nucleotide at position 488 in strain BJ08-Z004-3 (position 491 in prototype strain BrCr) can result in the discrepancy of an additional pair of nucleotides and thus change the stability of the second structure of IRES. Fragment base content analysis showed that in the region 696 to 714 bp at the 5'-NTR, where the A(P700)/U-P700 was located, the nucleotide constitution ratios differed significantly between SC-EV71 and MC-EV71 strains. In conclusion, comparative genomic analysis showed that virulence of EV71 strains are mainly determined by the amino acids on two positions of VP1, one position of protease 2A and the nucleotides on three positions in 5'-NTR.	[Li, Renqing; Chen, Lijuan; Zhang, Herun; Wang, Yumei] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zou, Qinghua] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China	Peking University	Li, RQ (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China.	lirenqingz@sina.com			Chinese government	Chinese government	This work was funded by the funds for enterovirus surveillance from Chinese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; CHRISTODOULOU C, 1990, J VIROL, V64, P4922, DOI 10.1128/JVI.64.10.4922-4929.1990; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gromeier M, 1996, P NATL ACAD SCI USA, V93, P2370, DOI 10.1073/pnas.93.6.2370; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; HAGIWARA A, 1984, ARCH VIROL, V79, P273, DOI 10.1007/BF01310816; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Melchers WJG, 1997, J VIROL, V71, P686, DOI 10.1128/JVI.71.1.686-696.1997; MELNICK JL, 1984, REV INFECT DIS, V6, pS387; Merkle I, 2002, J VIROL, V76, P9900, DOI 10.1128/JVI.76.19.9900-9909.2002; Singh S, 2002, MICROBIOL IMMUNOL, V46, P801, DOI 10.1111/j.1348-0421.2002.tb02767.x; SKINNER MA, 1989, J MOL BIOL, V207, P379, DOI 10.1016/0022-2836(89)90261-1; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632	26	47	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26237	10.1371/journal.pone.0026237	http://dx.doi.org/10.1371/journal.pone.0026237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039449	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500043
J	Ajjawi, I; Coku, A; Froehlich, JE; Yang, Y; Osteryoung, KW; Benning, C; Last, RL				Ajjawi, Imad; Coku, Ardian; Froehlich, John E.; Yang, Yue; Osteryoung, Katherine W.; Benning, Christoph; Last, Robert L.			A J-Like Protein Influences Fatty Acid Composition of Chloroplast Lipids in Arabidopsis	PLOS ONE			English	Article							J-DOMAIN; MOLECULAR CHAPERONE; PLASTID DIVISION; IMPORT MOTOR; INTERMEMBRANE SPACE; FUNCTIONAL-ANALYSIS; ENVELOPE MEMBRANES; MUTANT DEFICIENT; LEAF LIPIDS; THALIANA	A comprehensive understanding of the lipid and fatty acid metabolic machinery is needed for optimizing production of oils and fatty acids for fuel, industrial feedstocks and nutritional improvement in plants. T-DNA mutants in the poorly annotated Arabidopsis thaliana gene At1g08640 were identified as containing moderately high levels (50-100%) of 16:1 Delta 7 and 18:1 Delta 9 leaf fatty acids and subtle decreases (5-30%) of 16:3 and 18:3 (http://www.plastid.msu.edu/). TLC separation of fatty acids in the leaf polar lipids revealed that the chloroplastic galactolipids monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG) were the main lipid types affected by this mutation. Analysis of the inferred amino acid sequence of At1g08640 predicted the presence of a transit peptide, three transmembrane domains and an N-terminal J-like domain, and the gene was named CJD1 for Chloroplast J-like Domain 1. GFP reporter experiments and in vitro chloroplast import assays demonstrated CJD1 is a chloroplast membrane protein. Screening of an Arabidopsis cDNA library by yeast-2-hybrid (Y2H) using the J-like domain of CJD1 as bait identified a plastidial inner envelope protein (Accumulation and Replication of Chloroplasts 6, ARC6) as the primary interacting partner in the Y2H assay. ARC6 plays a central role in chloroplast division and binds CJD1 via its own J-like domain along with an adjacent conserved region whose function is not fully known. These results provide a starting point for future investigations of how mutations in CJD1 affect lipid composition.	[Ajjawi, Imad; Coku, Ardian; Froehlich, John E.; Benning, Christoph; Last, Robert L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Froehlich, John E.] Michigan State Univ, Dept Engn DOE Plant Res Labs, E Lansing, MI 48824 USA; [Yang, Yue; Osteryoung, Katherine W.; Last, Robert L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Michigan State University	Ajjawi, I (corresponding author), Synthet Genom Inc, La Jolla, CA USA.	lastr@msu.edu	Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667; Coku, Ardian/0000-0001-7154-9162; Last, Robert/0000-0001-6974-9587	National Science Foundation [MCB-0519740]; Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (DOE) [DE-FG02-91ER20021]; United States DOE, Office of Basic Energy Sciences [DE-FG02-10ER15808]	National Science Foundation(National Science Foundation (NSF)); Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (DOE)(United States Department of Energy (DOE)); United States DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The Chloroplast 2010 Project was funded by National Science Foundation Arabidopsis 2010 Program grant number MCB-0519740 awarded to CB, KWO, RLL and others. JEF was funded by the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (DOE), through grant DE-FG02-91ER20021 awarded to KK (Michigan State University (MSU)-DOE Plant Research Laboratory, East Lansing, Michigan). YY was funded by the United States DOE, Office of Basic Energy Sciences through Grant DE-FG02-10ER15808 awarded to KWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjawi I, 2010, PLANT PHYSIOL, V152, P529, DOI 10.1104/pp.109.148494; Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bonaventure G, 2002, PLANT PHYSIOL, V128, P223, DOI 10.1104/pp.010397; Bowen AJ, 2010, J MOL BIOL, V395, P937, DOI 10.1016/j.jmb.2009.11.065; Brautigam A, 2008, J BIOTECHNOL, V136, P44, DOI 10.1016/j.jbiotec.2008.02.007; Branen JK, 2003, PLANT PHYSIOL, V132, P748, DOI 10.1104/pp.102.018622; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; BROWSE J, 1986, PLANT PHYSIOL, V81, P859, DOI 10.1104/pp.81.3.859; BROWSE J, 1985, SCIENCE, V227, P763, DOI 10.1126/science.227.4688.763; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FALCONE DL, 1994, PLANT PHYSIOL, V106, P1453, DOI 10.1104/pp.106.4.1453; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; GAO J, 2010, PLANT J, V152, P529; Gebauer M, 1997, FEBS LETT, V417, P109, DOI 10.1016/S0014-5793(97)01267-2; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Glynn JM, 2008, PLANT CELL, V20, P2460, DOI 10.1105/tpc.108.061440; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HLOUSEKRADOJCIC A, 1992, PLANT PHYSIOL, V98, P206, DOI 10.1104/pp.98.1.206; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kubis Sybille E., 2008, V425, P171, DOI 10.1007/978-1-60327-210-0_16; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; KUNST L, 1989, PLANT PHYSIOL, V90, P943, DOI 10.1104/pp.90.3.943; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; LIBEISSON Y, 2010, ACYL LIPID METABOLIS, DOI DOI 10.1199/TAB.0133; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Lu Y, 2008, PLANT PHYSIOL, V146, P1482, DOI 10.1104/pp.107.115220; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; Madera M, 2008, BIOINFORMATICS, V24, P2630, DOI 10.1093/bioinformatics/btn504; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Miernyk JA, 2001, CELL STRESS CHAPERON, V6, P209, DOI 10.1379/1466-1268(2001)006<0209:TJDPOA>2.0.CO;2; Moellering ER, 2010, PLANT PHYSIOL, V152, P1951, DOI 10.1104/pp.110.153262; Mokranjac D, 2005, J BIOL CHEM, V280, P31608, DOI 10.1074/jbc.M502397200; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Napier JA, 2010, CURR OPIN PLANT BIOL, V13, P330, DOI 10.1016/j.pbi.2010.01.008; Nicoll WS, 2006, PROTEIN EXPRES PURIF, V46, P1, DOI 10.1016/j.pep.2005.08.005; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Noiriel A, 2007, PLANT J, V51, P378, DOI 10.1111/j.1365-313X.2007.03143.x; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; Sambrook J., 2002, MOL CLONING LAB MANU; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Su PH, 2008, PLANT PHYSIOL, V146, P1231, DOI 10.1104/pp.107.114496; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Viana AAB, 2010, J BIOL CHEM, V285, P12948, DOI 10.1074/jbc.M110.109744; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Xu CC, 2008, PLANT CELL, V20, P2190, DOI 10.1105/tpc.108.061176; Yang Y, 2008, CURR OPIN PLANT BIOL, V11, P577, DOI 10.1016/j.pbi.2008.10.001; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	69	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25368	10.1371/journal.pone.0025368	http://dx.doi.org/10.1371/journal.pone.0025368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028775	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900006
J	Hegde, P; Maddur, MS; Friboulet, A; Bayry, J; Kaveri, SV				Hegde, Pushpa; Maddur, Mohan S.; Friboulet, Alain; Bayry, Jagadeesh; Kaveri, Srini V.			Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC HEPATITIS-C; QUALITY-OF-LIFE; EUROPEAN MISTLETOE; COX-2 EXPRESSION; CANCER-PATIENTS; NITRIC-OXIDE; IN-VIVO; THERAPEUTIC-IMPLICATIONS; ANTICANCER ACTIVITIES	Viscum album (VA) preparations are extensively used as complementary therapy in cancer and are shown to exert antitumor activities which involve the cytotoxic properties, induction of apoptosis, inhibition of angiogenesis and several other immunomodulatory mechanisms. In addition to their application in cancer therapy, VA preparations have also been successfully utilized in the treatment of several inflammatory pathologies. Owing to the intricate association of inflammation and cancer and in view of the fact that several anti-tumor phytotherapeutics also exert a potent anti-inflammatory effect, we hypothesized that VA exerts an anti-inflammatory effect that is responsible for its therapeutic benefit. Since, inflammatory cytokine-induced cyclo-oxygenase-2 (COX-2) and prostaglandin E2 (PGE2) play a critical role in the pathogenesis of inflammatory diseases, we investigated the anti-inflammatory effect of VA on regulation of cyclooxygenase expression and PGE2 biosynthesis by using human lung adenocarcinoma cells (A549 cells) as a model. A549 cells were stimulated with IL-1 beta and treated with VA preparation (VA Qu Spez) for 18 hours. PGE2 was analysed in the culture supernatants by enzyme immunoassay. Expression of COX-2 and COX-1 proteins was analyzed by immunoblotting and the expression of COX-2 mRNA was assessed by semi-quantitative RT-PCR. We found that VA Qu Spez inhibit the secretion of IL-1 beta-induced PGE2 in a dose-dependent manner. Further, we also show that this inhibitory action was associated with a reduced expression of COX-2 without modulating the COX-1 expression. Together these results demonstrate a novel anti-inflammatory mechanism of action of VA preparations wherein VA exerts an anti-inflammatory effect by inhibiting cytokine-induced PGE2 via selective inhibition of COX-2.	[Hegde, Pushpa; Maddur, Mohan S.; Bayry, Jagadeesh; Kaveri, Srini V.] Inst Natl Sante & Rech Med, Unite 872, Paris, France; [Friboulet, Alain] Univ Technol Compiegne, UMR CNRS 6022, F-60206 Compiegne, France; [Maddur, Mohan S.; Bayry, Jagadeesh; Kaveri, Srini V.] Univ Paris 06, Equipe Immunopathol & Therapeut Immunointervent 1, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Maddur, Mohan S.; Bayry, Jagadeesh; Kaveri, Srini V.] Univ Paris 05, UMR S 872, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Technologie de Compiegne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hegde, P (corresponding author), Inst Natl Sante & Rech Med, Unite 872, Paris, France.	srini.kaveri@crc.jussieu.fr	Maddur, Mohan/E-4763-2015; Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Hegde, Pushpa/0000-0002-2376-8659; Kaveri, Srini/0000-0002-0837-4053; Maddur, Mohan/0000-0002-7085-1762	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universite Pierre et Marie Curie; Universite Paris Descartes; Weleda AG, Switzerland	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie; Universite Paris Descartes; Weleda AG, Switzerland	This work is Supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite Pierre et Marie Curie and Universite Paris Descartes, regional program Bio-Asie 2011 and Weleda AG, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achoui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015105; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Augustin M, 2005, ARZNEIMITTELFORSCH, V55, P38; Bayry J, 2007, DRUG DISCOV TODAY, V12, P548, DOI 10.1016/j.drudis.2007.05.002; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bayry J, 2009, NAT REV RHEUMATOL, V5, P244, DOI 10.1038/nrrheum.2009.77; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Bock PR, 2004, ARZNEIMITTELFORSCH, V54, P456; Bussing A, 1999, ANTICANCER RES, V19, P23; Bussing A, 2005, ANTICANCER RES, V25, P4753; Carey MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011610; Cerella C, 2010, BIOCHEM PHARMACOL, V80, P1801, DOI 10.1016/j.bcp.2010.06.050; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Christen-Clottu O, 2010, J VET INTERN MED, V24, P1483, DOI 10.1111/j.1939-1676.2010.0597.x; Chrubasik S, 2001, RHEUMATOLOGY, V40, P1388, DOI 10.1093/rheumatology/40.12.1388; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Cravotto G, 2010, J CLIN PHARM THER, V35, P11, DOI 10.1111/j.1365-2710.2009.01096.x; Elluru SR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-161; Frank U, 2003, EUR J CLIN MICROBIOL, V22, P501, DOI 10.1007/s10096-003-0964-9; FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481; Gardin NE, 2009, PHYTOTHER RES, V23, P407, DOI 10.1002/ptr.2643; GOLDYNE ME, 1973, PROSTAG OTH LIPID M, V4, P737, DOI 10.1016/S0090-6980(73)80058-9; Habib SHM, 2008, CLINICS, V63, P807, DOI 10.1590/S1807-59322008000600017; Hamsa TP, 2011, INFLAMMATION, V34, P171, DOI 10.1007/s10753-010-9221-4; Hegeman MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015653; Heinzerling L, 2006, J CLIN IMMUNOL, V26, P347, DOI 10.1007/s10875-006-9023-5; Hong JG, 2006, CARCINOGENESIS, V27, P278, DOI 10.1093/carcin/bgi208; Hostanska K, 1995, NAT IMMUN, V14, P295; Hwang YP, 2011, FOOD CHEM TOXICOL, V49, P93, DOI 10.1016/j.fct.2010.10.002; Jin M, 2010, FOOD CHEM TOXICOL, V48, P3073, DOI 10.1016/j.fct.2010.07.048; Kaegi E, 1998, CAN MED ASSOC J, V158, P1157; Kale A, 2008, PHYTOTHER RES, V22, P567, DOI 10.1002/ptr.2283; Karagoz A, 2003, PHYTOTHER RES, V17, P560, DOI 10.1002/ptr.1163; KARMALI RA, 1983, BRIT J CANCER, V48, P689, DOI 10.1038/bjc.1983.251; Kaveri SV, 2010, NEW ENGL J MED, V363, P1080, DOI 10.1056/NEJMcibr1006936; KHWAJA TA, 1986, ONCOLOGY, V43, P42, DOI 10.1159/000226419; Kienle GS, 2010, INTEGR CANCER THER, V9, P142, DOI 10.1177/1534735410369673; Klopp R, 2005, ANTICANCER RES, V25, P601; Kunnumakkara AB, 2009, INT J CANCER, V125, P2187, DOI 10.1002/ijc.24593; Lavastre V, 2004, CLIN EXP IMMUNOL, V137, P272, DOI 10.1111/j.1365-2249.2004.02545.x; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Maddur MS, 2010, TRENDS IMMUNOL, V31, P45, DOI 10.1016/j.it.2009.12.004; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meyer-Kirchrath J, 2000, CURR MED CHEM, V7, P1121, DOI 10.2174/0929867003374219; Min KJ, 2011, INT IMMUNOPHARMACOL, V11, P1137, DOI 10.1016/j.intimp.2011.02.029; OLSNES S, 1982, J BIOL CHEM, V257, P13263; Orhan DD, 2006, Z NATURFORSCH C, V61, P26; Pairet M, 1996, FUND CLIN PHARMACOL, V10, P1, DOI 10.1111/j.1472-8206.1996.tb00144.x; PASSWELL J, 1983, CLIN EXP IMMUNOL, V51, P61; Pozzi A, 2009, WIRES SYST BIOL MED, V1, P254, DOI 10.1002/wsbm.7; Radenkovic M, 2006, PHYTOTHER RES, V20, P374, DOI 10.1002/ptr.1865; Redondo S, 2011, DIABETOLOGIA, V54, P190, DOI 10.1007/s00125-010-1947-x; Rosenkranz HS, 2003, ONCOL RES, V13, P529, DOI 10.3727/000000003108748054; Salazar AT, 2011, INT J CLIN PHARM TH, V49, P93, DOI 10.5414/CPP49093; Sharma C, 2006, TOXICOLOGY, V228, P1, DOI 10.1016/j.tox.2006.07.027; Stein GM, 2000, ANTICANCER RES, V20, P2987; Stein GM, 2000, ANTICANCER RES, V20, P1673; Stein GM, 2002, ANTICANCER RES, V22, P4215; Tenorio FA, 2005, FITOTERAPIA, V76, P204, DOI 10.1016/j.fitote.2004.12.013; Tetsuka T, 1996, J BIOL CHEM, V271, P11689, DOI 10.1074/jbc.271.20.11689; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; Tusenius KJ, 2005, ARZNEIMITTELFORSCH, V55, P749; Tusenius KJ, 2001, COMPLEMENT THER MED, V9, P12, DOI 10.1054/ctim.2000.0408; Urech K, 2006, ARZNEIMITTEL-FORSCH, V56, P428; Van Huyen JPD, 2006, CANCER LETT, V243, P32, DOI 10.1016/j.canlet.2005.11.016; Van Huyen JPD, 2003, CHEMOTHERAPY, V49, P298, DOI 10.1159/000074530; Van Huyen JPD, 2002, MOL MED, V8, P600, DOI 10.1007/BF03402170; Van Huyen JPD, 2001, CHEMOTHERAPY, V47, P366, DOI 10.1159/000048545; Vane JR, 1996, SCAND J RHEUMATOL, P9; Yoon TJ, 2001, INT IMMUNOPHARMACOL, V1, P881, DOI 10.1016/S1567-5769(01)00024-8; Zhou HY, 2008, EUR J PHARMACOL, V586, P340, DOI 10.1016/j.ejphar.2008.02.044	75	38	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26312	10.1371/journal.pone.0026312	http://dx.doi.org/10.1371/journal.pone.0026312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028854	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900047
J	Kurzawa, L; Pellerano, M; Coppolani, JB; Morris, MC				Kurzawa, Laetitia; Pellerano, Morgan; Coppolani, J. B.; Morris, May C.			Peptide Biosensor for Probing the Relative Abundance of Cyclin-Dependent Kinases in Living Cells	PLOS ONE			English	Article							FLUORESCENT BIOSENSORS; RECOGNITION PROPERTIES; RECRUITMENT PEPTIDES; PENETRATING PEPTIDES; MAMMALIAN-CELLS; CANCER; ACTIVATION; MECHANISM; SUBSTRATE; DELIVERY	Cyclin-dependant kinases play a central role in coordinating cell growth and division, and in sustaining proliferation of cancer cells, thereby constituting attractive pharmacological targets. However, there are no direct means of assessing their relative abundance in living cells, current approaches being limited to antigenic and proteomic analysis of fixed cells. In order to probe the relative abundance of these kinases directly in living cells, we have developed a fluorescent peptide biosensor with biligand affinity for CDKs and cyclins in vitro, that retains endogenous CDK/cyclin complexes from cell extracts, and that bears an environmentally-sensitive probe, whose fluorescence increases in a sensitive fashion upon recognition of its targets. CDKSENS was introduced into living cells, through complexation with the cell-penetrating carrier CADY2 and applied to assess the relative abundance of CDK/Cyclins through fluorescence imaging and ratiometric quantification. This peptide biosensor technology affords direct and sensitive readout of CDK/cyclin complex levels, and reports on differences in complex formation when tampering with a single CDK or cyclin. CDKSENS further allows for detection of differences between different healthy and cancer cell lines, thereby enabling to distinguish cells that express high levels of these heterodimeric kinases, from cells that present decreased or defective assemblies. This fluorescent biosensor technology provides information on the overall status of CDK/Cyclin complexes which cannot be obtained through antigenic detection of individual subunits, in a non-invasive fashion which does not require cell fixation or extraction procedures. As such it provides promising perspectives for monitoring the response to therapeutics that affect CDK/Cyclin abundance, for cell-based drug discovery strategies and fluorescence-based cancer diagnostics.	[Kurzawa, Laetitia; Pellerano, Morgan; Coppolani, J. B.; Morris, May C.] Univ Montpellier, CRBM, CNRS, Dept Mol Biophys & Therapeut,UMR 5237, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Kurzawa, L (corresponding author), Univ Montpellier, CRBM, CNRS, Dept Mol Biophys & Therapeut,UMR 5237, F-34059 Montpellier, France.	may.morris@crbm.cnrs.fr	MORRIS, May/ABB-2629-2021; Pellerano, Morgan/AAF-9057-2019; MORRIS, May C/J-5940-2016	MORRIS, May/0000-0001-8106-9728; Pellerano, Morgan/0000-0001-6951-2344; MORRIS, May C/0000-0001-8106-9728	CNRS (Centre National de la Recherche Scientifique); Association de Recherche contre le Cancer (ARC); Region Languedoc-Roussillon; Fondation pour la Recherche Medicale (FRM)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Association de Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Region Languedoc-Roussillon(Region Ile-de-FranceRegion Occitanie); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the CNRS (Centre National de la Recherche Scientifique) and grants from the Association de Recherche contre le Cancer (ARC) and the Region Languedoc-Roussillon (Subvention "Chercheuse d'Avenir") to MCM. LK is recipient of a fellowship from the Region Languedoc-Roussillon and the CNRS. MP is funded by a grant from the the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown NR, 2007, CELL CYCLE, V6, P1350, DOI 10.4161/cc.6.11.4278; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Crombez L, 2009, NUCLEIC ACIDS RES, V37, P4559, DOI 10.1093/nar/gkp451; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Ekberg J, 2005, EUR J HAEMATOL, V75, P106, DOI 10.1111/j.1600-0609.2005.00473.x; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Harwell RM, 2004, J BIOL CHEM, V279, P12695, DOI 10.1074/jbc.M313407200; Heitz F, 1997, BIOCHEMISTRY-US, V36, P4995, DOI 10.1021/bi962349y; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Husdal A, 2006, CELL ONCOL, V28, P107; Ionov Y, 2010, ONCOTARGET, V1, P148, DOI 10.18632/oncotarget.118; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kurzawa L, 2010, BBA-BIOMEMBRANES, V1798, P2274, DOI 10.1016/j.bbamem.2010.02.027; Kurzawa L, 2010, CHEMBIOCHEM, V11, P1037, DOI 10.1002/cbic.200900729; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lolli G, 2010, CELL CYCLE, V9, P1551, DOI 10.4161/cc.9.8.11195; Loving GS, 2010, TRENDS BIOTECHNOL, V28, P73, DOI 10.1016/j.tibtech.2009.11.002; Lowe ED, 2002, BIOCHEMISTRY-US, V41, P15625, DOI 10.1021/bi0268910; Lukovic E, 2009, ANGEW CHEM INT EDIT, V48, P6828, DOI 10.1002/anie.200902374; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Merrick KA, 2010, CELL CYCLE, V9, P706, DOI 10.4161/cc.9.4.10732; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris MC, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm053; Morris MC, 2010, CELL BIOCHEM BIOPHYS, V56, P19, DOI 10.1007/s12013-009-9070-7; Morris MC, 2002, J BIOL CHEM, V277, P23847, DOI 10.1074/jbc.M107890200; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Shanna V, 2008, BBA-PROTEINS PROTEOM, V1784, P94, DOI 10.1016/j.bbapap.2007.07.016; Suzuki T, 2007, CANCER SCI, V98, P644, DOI 10.1111/j.1349-7006.2007.00444.x; Wang HX, 2009, CHEMBIOCHEM, V10, P2560, DOI 10.1002/cbic.200900249	42	18	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26555	10.1371/journal.pone.0026555	http://dx.doi.org/10.1371/journal.pone.0026555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028905	Green Published, gold			2022-12-25	WOS:000296186900073
J	Michallet, AS; Mondiere, P; Taillardet, M; Leverrier, Y; Genestier, L; Defrance, T				Michallet, Anne-Sophie; Mondiere, Paul; Taillardet, Morgan; Leverrier, Yann; Genestier, Laurent; Defrance, Thierry			Compromising the Unfolded Protein Response Induces Autophagy-Mediated Cell Death in Multiple Myeloma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; MESSENGER-RNA; APOPTOSIS; SURVIVAL; PERK; ACTIVATION; INHIBITION; BORTEZOMIB	Objective: To determine whether the Unfolded Protein Response (UPR) sensors (PERK, ATF6 and IRE-1) can be targeted to promote death of Multiple Myeloma (MM) cells. Methods: We have knocked-down separately each UPR stress sensor in human MM cell lines using RNA interference and followed MM cell death by monitoring the membrane, mitochondrial and nuclear alterations. Involvement of caspases in MM cell death consecutive to UPR sensor knock-down was analyzed by western blotting, measurement of their enzymatic activity using fluorigenic substrates and susceptibility to a pan-caspase inhibitor. Activation of the autophagic process was measured directly by detection of autophagosomes (electronic microscopy), monodansylcadaverine staining, production of the cleaved form of the microtubule-associated protein 1A/1B light chain 3 (LC3) and indirectly by analyzing the impact of pharmacological inhibitors of autophagy such as 3MA and bafilomycin A1. Results: We show that extinction of a single UPR stress sensor (PERK) induces a non-apoptotic form of cell death in MM cells that requires autophagy for its execution. We also show that this cytotoxic autophagic process represses the apoptosis program by reducing the cytosolic release of the apoptogenic factors Smac/DIABLO and cytochrome c. Interpretation: Altogether our findings suggest that autophagy can contribute to execution of death in mammalian cells that are exposed to mild ER stress. They also suggest that the autophagic process can regulate the intrinsic apoptotic pathway by inhibiting production of death effectors by the mitochondria, thus preventing formation of a functional apoptosome. Altogether these findings give credit to the idea that UPR sensors can be envisaged as therapeutic targets for the treatment of MM.	[Michallet, Anne-Sophie; Mondiere, Paul; Taillardet, Morgan; Leverrier, Yann; Genestier, Laurent; Defrance, Thierry] INSERM, F-69008 Lyon, France; [Michallet, Anne-Sophie; Mondiere, Paul; Taillardet, Morgan; Leverrier, Yann; Genestier, Laurent; Defrance, Thierry] Univ Lyon, Lyon, France; [Michallet, Anne-Sophie] Ctr Hosp Lyon Sud, Hosp Civils Lyon, F-69310 Pierre Benite, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Michallet, AS (corresponding author), INSERM, F-69008 Lyon, France.	thierry.defrance@inserm.fr	LEVERRIER, Yann/M-3767-2014; MICHALLET, Anne-Sophie/M-6505-2014; Genestier, Laurent/H-6443-2016; DEFRANCE, Thierry/G-1460-2013; Taillardet, Morgan/M-1749-2014	LEVERRIER, Yann/0000-0002-4227-5446; Genestier, Laurent/0000-0002-0527-4583; DEFRANCE, Thierry/0000-0002-6943-358X	Association pour le Recherche Contre le Cancer; National and Regional Committees of la Ligue Contre le Cancer; la Fondation de France	Association pour le Recherche Contre le Cancer; National and Regional Committees of la Ligue Contre le Cancer; la Fondation de France(Fondation de France)	This work was supported by grants from the Association pour le Recherche Contre le Cancer, the National and Regional Committees of la Ligue Contre le Cancer, and la Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Elgendy M, 2011, MOL CELL; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fernandez Y, 2006, J BIOL CHEM, V281, P1107, DOI 10.1074/jbc.M511607200; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Han J, 2008, J BIOL CHEM; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lai WL, 2008, EXP CELL RES, V314, P1667, DOI 10.1016/j.yexcr.2008.02.002; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lerena C, 2008, CURR MOL MED, V8, P92; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Meister S, 2010, NEOPLASIA, V12, P550, DOI 10.1593/neo.10228; Molinari A, 2005, CURR TOP MICROBIOL, V300, P1; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Palumbo A, 2007, J CLIN ONCOL, V25, P4459, DOI 10.1200/JCO.2007.12.3463; Pelletier N, 2006, J IMMUNOL, V176, P1340, DOI 10.4049/jimmunol.176.3.1340; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richardson PG, 2007, BRIT J HAEMATOL, V137, P429, DOI 10.1111/j.1365-2141.2007.06585.x; Rieder SE, 2001, CURR PROTOC CELL BIO; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Waterhouse NJ, 2002, BIOCHIMIE, V84, P113, DOI 10.1016/S0300-9084(02)01379-2; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zismanov V, 2009, BRIT J CANCER, V101, P1402, DOI 10.1038/sj.bjc.6605291	51	37	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25820	10.1371/journal.pone.0025820	http://dx.doi.org/10.1371/journal.pone.0025820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028791	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900019
J	Allsopp, RC; Evans, RJ				Allsopp, Rebecca C.; Evans, Richard J.			The Intracellular Amino Terminus Plays a Dominant Role in Desensitization of ATP-gated P2X Receptor Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIRST TRANSMEMBRANE DOMAIN; SMOOTH-MUSCLE; CATION CHANNELS; ACTIVATION; CELLS; PORE; IDENTIFICATION; MUTAGENESIS; EXPRESSION; RESPONSES	P2X receptors show marked variations in the time-course of response to ATP application from rapidly desensitizing P2X1 receptors to relatively sustained P2X2 receptors. In this study we have used chimeras between human P2X1 and P2X2 receptors in combination with mutagenesis to address the contribution of the extracellular ligand binding loop, the transmembrane channel, and the intracellular regions to receptor time-course. Swapping either the extracellular loop or both transmembrane domains (TM1 and -2) between the P2X1 and P2X2 receptors had no effect on the time-course of ATP currents in the recipient receptor. These results suggest that the agonist binding and channel-forming portions of the receptor do not play a major role in the control of the time-course. In contrast replacing the amino terminus of the P2X1 receptor with that from the non-desensitizing P2X2 receptor (P2X1-2N) slowed desensitization, and the mirror chimera induced rapid desensitization in the P2X2-1N chimera. These reciprocal effects on time-course can be replicated by changing four variant amino acids just before the first transmembrane (TM1) segment. These pre-TM1 residues also had a dominant effect on chimeras where both TMs had been transferred; mutating the variant amino acids 21-23 to those found in the P2X2 receptor removed desensitization from the P2X1-2TM1/-2 chimera, and the reciprocal mutants induced rapid desensitization in the non-desensitizing P2X2-1TM1/-2 chimera. These results suggest that the intracellular amino terminus, in particular the region just before TM1, plays a dominant role in the regulation of the time-course of ATP evoked P2X receptor currents.	[Allsopp, Rebecca C.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Bavan S, 2011, MOL PHARMACOL, V79, P776, DOI 10.1124/mol.110.070037; BENHAM CD, 1989, J PHYSIOL-LONDON, V419, P689, DOI 10.1113/jphysiol.1989.sp017893; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Brandle U, 1997, FEBS LETT, V404, P294, DOI 10.1016/S0014-5793(97)00128-2; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1996, J NEUROSCI, V16, P2495; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, BIOCHEM BIOPH RES CO, V291, P611, DOI 10.1006/bbrc.2002.6488; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fountain SJ, 2006, J BIOL CHEM, V281, P15044, DOI 10.1074/jbc.M600442200; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Lalo U, 2008, J NEUROSCI, V28, P5473, DOI 10.1523/JNEUROSCI.1149-08.2008; Lalo U, 2010, J NEUROCHEM, V113, P1177, DOI 10.1111/j.1471-4159.2010.06730.x; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lewis CJ, 2000, BRIT J PHARMACOL, V131, P1659, DOI 10.1038/sj.bjp.0703744; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Liu GJ, 2003, AUTON NEUROSCI-BASIC, V108, P12, DOI 10.1016/S1566-0702(03)00154-1; Mahaut-Smith MP, 2011, PURINERG SIGNAL, V7, P341, DOI 10.1007/s11302-011-9224-0; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; NAKAZAWA K, 1994, J NEUROSCI, V14, P740; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oury C, 2003, BLOOD, V101, P3969, DOI 10.1182/blood-2002-10-3215; Pankratov Y, 2009, NEUROSCIENCE, V158, P137, DOI 10.1016/j.neuroscience.2008.03.076; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Robertson SJ, 2001, CURR OPIN NEUROBIOL, V11, P378, DOI 10.1016/S0959-4388(00)00222-1; Simon J, 1997, MOL PHARMACOL, V52, P237, DOI 10.1124/mol.52.2.237; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; SURPRENANT A, 1995, TRENDS NEUROSCI, V18, P224, DOI 10.1016/0166-2236(95)93907-F; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Vial C, 2002, MOL PHARMACOL, V62, P1438, DOI 10.1124/mol.62.6.1438; Vulchanova L, 1996, P NATL ACAD SCI USA, V93, P8063, DOI 10.1073/pnas.93.15.8063; Wen HR, 2009, J NEUROCHEM, V108, P331, DOI 10.1111/j.1471-4159.2008.05761.x; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Zemkova H, 2004, J NEUROSCI, V24, P6968, DOI 10.1523/JNEUROSCI.1471-04.2004	55	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44691	44701		10.1074/jbc.M111.303917	http://dx.doi.org/10.1074/jbc.M111.303917			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22027824	hybrid, Green Published			2022-12-25	WOS:000298645500039
J	Alam, S; Li, HL; Margariti, A; Martin, D; Zampetaki, A; Habi, O; Cockerill, G; Hu, YH; Xu, QB; Zeng, LF				Alam, Saydul; Li, Hongling; Margariti, Andriana; Martin, Daniel; Zampetaki, Anna; Habi, Ouassila; Cockerill, Gillian; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang			Galectin-9 Protein Expression in Endothelial Cells Is Positively Regulated by Histone Deacetylase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; KAPPA-B; T-CELL; TIM-3; MICE; ACETYLATION; INHIBITORS; MONOCYTES; PROLONGS; IMMUNITY	Galectin-9 expression in endothelial cells can be induced in response to inflammation. However, the mechanism of its expression remains unclear. In this study, we found that interferon-gamma (IFN-gamma) induced galectin-9 expression in human endothelial cells in a time-dependent manner, which coincided with the activation of histone deacetylase (HDAC). When endothelial cells were treated with the HDAC3 inhibitor, apicidin, or shRNA-HDAC3 knockdown, IFN-gamma-induced galectin-9 expression was abolished. Overexpression of HDAC3 induced the interaction between phosphoinositol 3-kinase (PI3K) and IFN response factor 3 (IRF3), leading to IRF3 phosphorylation, nuclear translocation, and galectin-9 expression. HDAC3 functioned as a scaffold protein for PI3K/IRF3 interaction. In addition to galectin-9 expression, IFN-gamma also induced galectin-9 location onto plasma membrane, which was HDAC3-independent. Importantly, HDAC3 was essential for the constitutive transcription of PI3K and IRF3, which might be responsible for the basal level of galectin-9 expression. The phosphorylation of IRF3 was essential for galectin-9 expression. This study provides new evidence that HDAC3 regulates galectin-9 expression in endothelial cells via interaction with PI3K-IRF3 signal pathway.	[Alam, Saydul; Li, Hongling; Margariti, Andriana; Martin, Daniel; Zampetaki, Anna; Habi, Ouassila; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang] Kings Coll London, Div Cardiovasc, British Heart Founcat Ctr, London SE5 9NU, England; [Cockerill, Gillian] St Georges Univ London, Dept Cardiovasc Sci, London SW17 0RE, England	University of London; King's College London; St Georges University London	Zeng, LF (corresponding author), Kings Coll London, Div Cardiovasc, British Heart Founcat Ctr, 125 Cold Harbour La, London SE5 9NU, England.	lingfang.zeng@kcl.ac.uk	Margariti, Andriana/AAH-5318-2019	Zampetaki, Anna/0000-0002-7257-8624; Zeng, Lingfang/0000-0002-0390-4561	British Heart Foundation; Oak Foundation	British Heart Foundation(British Heart Foundation); Oak Foundation	This work was supported by grants from British Heart Foundation and Oak Foundation.	Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Chagan-Yasutan Haorile, 2010, Clin Mol Allergy, V8, P12, DOI 10.1186/1476-7961-8-12; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; He WT, 2009, TRANSPLANTATION, V88, P782, DOI 10.1097/TP.0b013e3181b47f25; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Imaizumi T, 2003, INT ARCH ALLERGY IMM, V131, P57, DOI 10.1159/000070436; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Imaizumi T, 2007, GLYCOBIOLOGY, V17, p12C, DOI 10.1093/glycob/cwm045; Inoue K, 2006, ARTERIOSCL THROM VAS, V26, P2652, DOI 10.1161/01.ATV.0000247247.89787.e7; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Jung SB, 2010, CIRC RES, V107, P877, DOI 10.1161/CIRCRESAHA.110.222968; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsuura A, 2009, GENES CELLS, V14, P511, DOI 10.1111/j.1365-2443.2009.01287.x; Matteucci E, 2007, MOL CANCER RES, V5, P833, DOI 10.1158/1541-7786.MCR-07-0054; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512; Ozaki T, 2009, BIOCHEM BIOPH RES CO, V386, P207, DOI 10.1016/j.bbrc.2009.06.035; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Strobl JS, 2007, J PARASITOL, V93, P694, DOI 10.1645/GE-1043R.1; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wang F, 2007, CELL IMMUNOL, V250, P68, DOI 10.1016/j.cellimm.2008.01.006; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Wang JG, 2007, J BIOL CHEM, V282, P28408, DOI 10.1074/jbc.M703586200; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Xu HG, 2010, MOL BIOL REP, V37, P3073, DOI 10.1007/s11033-009-9880-0; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Zampetaki A, 2010, CIRCULATION, V121, P132, DOI 10.1161/CIRCULATIONAHA.109.890491; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang MX, 2008, MOL BIOL CELL, V19, P3997, DOI 10.1091/mbc.E07-11-1186; Zhao Y, 2006, GLIA, V54, P775, DOI 10.1002/glia.20418; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	41	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44211	44217		10.1074/jbc.M111.242289	http://dx.doi.org/10.1074/jbc.M111.242289			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027828	hybrid, Green Published			2022-12-25	WOS:000298402300061
J	Lohman, GJS; Chen, LX; Evans, TC				Lohman, Gregory J. S.; Chen, Lixin; Evans, Thomas C., Jr.			Kinetic Characterization of Single Strand Break Ligation in Duplex DNA by T4 DNA Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-PAIRED ENDS; DEOXYRIBONUCLEIC ACID; ENZYMATIC BREAKAGE; POLYNUCLEOTIDE LIGASE; MUTATIONAL ANALYSIS; NICK RECOGNITION; ADENYLATE INTERMEDIATE; RNA LIGASES; MECHANISM; BACTERIOPHAGE	T4 DNA ligase catalyzes phosphodiester bond formation between juxtaposed 5'-phosphate and 3'-hydroxyl termini in duplex DNA in three steps: 1) enzyme-adenylylate formation by reaction with ATP; 2) adenylyl transfer to a 5'-phosphorylated polynucleotide to generate adenylylated DNA; and 3) phosphodiester bond formation with release of AMP. This investigation used synthetic, nicked DNA substrates possessing either a 5'-phosphate or a 5'-adenylyl phosphate. Steady state experiments with a nicked substrate containing juxtaposed dC and 5'-phosphorylated dT deoxynucleotides (substrate 1) yielded k(cat) and k(cat)/K-m values of 0.4 +/- 0.1 s(-1) and 150 +/- 50 mu M-1 s(-1), respectively. Under identical reaction conditions, turnover of an adenylylated version of this substrate (substrate 1A) yielded k(cat) and k(cat)/K-m values of 0.64 +/- 0.08 s(-1) and 240 +/- 40 mu M-1 s(-1). Single turnover experiments utilizing substrate 1 gave fits for the forward rates of Step 2 (k(2)) and Step 3 (k(3)) of 5.3 and 38 s(-1), respectively, with the slowest step similar to 10-fold faster than the rate of turnover seen under steady state conditions. Single turnover experiments with substrate 1A produced a Step 3 forward rate constant of 4.3 s(-1), also faster than the turnover rate of 1A. Enzyme self-adenylylation was confirmed to also occur on a fast time scale (similar to 6 s(-1)), indicating that the rate-limiting step for T4 DNA ligase nick sealing is not a chemical step but rather is most likely product release. Pre-steady state reactions displayed a clear burst phase, consistent with this conclusion.	[Lohman, Gregory J. S.; Chen, Lixin; Evans, Thomas C., Jr.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Evans, TC (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	evanst@neb.com		Lohman, Gregory/0000-0002-0638-7555				Cherepanov A, 2001, J BIOCHEM-TOKYO, V129, P61, DOI 10.1093/oxfordjournals.jbchem.a002837; Cherepanov AV, 2008, P NATL ACAD SCI USA, V105, P8563, DOI 10.1073/pnas.0709140105; Cherepanov AV, 2003, EUR J BIOCHEM, V270, P4315, DOI 10.1046/j.1432-1033.2003.03824.x; Cherepanov AV, 2002, J BIOL CHEM, V277, P1695, DOI 10.1074/jbc.M109616200; Cherepanov AV, 2001, BIOPHYS J, V81, P3545, DOI 10.1016/S0006-3495(01)75985-1; Chiuman W, 2002, BIOORG CHEM, V30, P332, DOI 10.1016/S0045-2068(02)00018-4; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Crut A, 2008, P NATL ACAD SCI USA, V105, P6894, DOI 10.1073/pnas.0800113105; DEUGAU KV, 1978, BIOCHEMISTRY-US, V17, P723, DOI 10.1021/bi00597a026; HARVEY CL, 1971, J BIOL CHEM, V246, P4523; HAYASHI KI, 1985, NUCLEIC ACIDS RES, V13, P7979, DOI 10.1093/nar/13.22.7979; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Lohman G. J. S., 2011, CURR PROTOC MOL BIOL; MONTECUCCO A, 1988, NUCLEIC ACIDS RES, V16, P7369, DOI 10.1093/nar/16.15.7369; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Odell M, 2003, NUCLEIC ACIDS RES, V31, P5090, DOI 10.1093/nar/gkg665; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2008, CURR OPIN STRUC BIOL, V18, P96, DOI 10.1016/j.sbi.2007.12.008; Patel MP, 2008, BIOORG CHEM, V36, P46, DOI 10.1016/j.bioorg.2007.10.001; Rossi R, 1997, NUCLEIC ACIDS RES, V25, P2106, DOI 10.1093/nar/25.11.2106; Samai P, 2011, J BIOL CHEM, V286, P22642, DOI 10.1074/jbc.M111.245399; Sannai P, 2011, J BIOL CHEM, V286, P13314, DOI 10.1074/jbc.M111.226191; SGARAMELLA V, 1972, FARMACO-ED SCI, V27, P809; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Sogaramella V, 1972, J Mol Biol, V72, P493; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Sriskanda V, 2002, NUCLEIC ACIDS RES, V30, P903, DOI 10.1093/nar/30.4.903; Taylor MR, 2011, J BIOL CHEM, V286, P23054, DOI 10.1074/jbc.M111.248831; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Vollmer M, 2009, METHODS MOL BIOL, V544, P3, DOI 10.1007/978-1-59745-483-4_1; Wang Y, 2007, BIOCHEMISTRY-US, V46, P4962, DOI 10.1021/bi0621516; WEISS B, 1968, J BIOL CHEM, V243, P4543; WEISS B, 1967, J BIOL CHEM, V242, P4270; WEISS B, 1967, P NATL ACAD SCI USA, V57, P1021, DOI 10.1073/pnas.57.4.1021; WU DY, 1989, GENE, V76, P245, DOI 10.1016/0378-1119(89)90165-0; Yuan CL, 2007, NUCLEIC ACIDS RES, V35, P5294, DOI 10.1093/nar/gkm582; Zhelkovsky AM, 2011, NUCLEIC ACIDS RES, V39, pE117, DOI 10.1093/nar/gkr544	43	28	31	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44187	44196		10.1074/jbc.M111.284992	http://dx.doi.org/10.1074/jbc.M111.284992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027837	Green Published, hybrid			2022-12-25	WOS:000298402300059
J	Fukumoto, Y; Kurita, S; Takai, Y; Ogita, H				Fukumoto, Yuri; Kurita, Souichi; Takai, Yoshimi; Ogita, Hisakazu			Role of Scaffold Protein Afadin Dilute Domain-interacting Protein (ADIP) in Platelet-derived Growth Factor-induced Cell Movement by Activating Rac Protein through Vav2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOVING NIH3T3 CELLS; ADHERENS JUNCTIONS; LEADING EDGES; PDGF RECEPTOR; NECL-5/POLIOVIRUS RECEPTOR; EPITHELIAL-CELLS; BINDING PROTEIN; SRC FAMILY; E-CADHERIN; MIGRATION	Cell movement is an important cellular function not only in physiological but also in pathological conditions. Although numerous studies have been conducted to reveal the mechanism of cell movement, the full picture has yet to be depicted, likely due to the complex features of cell movement. We show here that the scaffold protein afadin dilute domain-interacting protein (ADIP), an afadin-binding protein, is involved in the regulation of cell movement. ADIP localized at the leading edge of moving cells in response to platelet-derived growth factor (PDGF) and was required for the formation of the leading edge and the promotion of cell movement. Impaired cell movement observed in ADIP knockdown cells was not rescued by expression of an ADIP mutant that is incapable of binding to afadin, leading to the notion that the function of ADIP in moving cells depends on its interaction with afadin. Knockdown of ADIP as well as knockdown of afadin inhibited the activation of the small G protein Rac, which is important for the formation of the leading edge and the promotion of cell movement. Furthermore, ADIP interacted with Vav2, a GDP/GTP exchange factor for Rac, in a Src phosphorylation-dependent manner, suggesting that ADIP mediates the activation of Rac through Vav2. These results indicate that ADIP plays an essential role in PDGF-induced cell movement by interacting with afadin and Vav2 and regulating the activation of Rac.	[Ogita, Hisakazu] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Otsu, Shiga 5202192, Japan; [Fukumoto, Yuri; Kurita, Souichi; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan	Shiga University of Medical Science; Kobe University	Ogita, H (corresponding author), Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	hogita@belle.shiga-med.ac.jp	Ogita, Hisakazu/AAE-4416-2020	Ogita, Hisakazu/0000-0001-6750-1668	Ministry of Education, Culture, Sports, Science, and Technology, Japan; The Uehara Memorial Foundation; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [23590335] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research and by the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2010 and 2011); The Uehara Memorial Foundation; and the Japan Foundation for Applied Enzymology.	ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Asada M, 2003, J BIOL CHEM, V278, P4103, DOI 10.1074/jbc.M209832200; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; de Bruijn DRH, 2002, GENE CHROMOSOME CANC, V34, P285, DOI 10.1002/gcc.10073; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Guinn B, 2005, BIOCHEM BIOPH RES CO, V335, P1293, DOI 10.1016/j.bbrc.2005.08.024; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Miyata M, 2009, J BIOL CHEM, V284, P24595, DOI 10.1074/jbc.M109.016436; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Tureci O, 1996, CANCER RES, V56, P4766; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Woodard AS, 1998, J CELL SCI, V111, P469; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	48	17	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43537	43548		10.1074/jbc.M111.308858	http://dx.doi.org/10.1074/jbc.M111.308858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027834	hybrid, Green Published			2022-12-25	WOS:000298351300073
J	Kweider, N; Fragoulis, A; Rosen, C; Pecks, U; Rath, W; Pufe, T; Wruck, CJ				Kweider, Nisreen; Fragoulis, Athanassios; Rosen, Christian; Pecks, Ulrich; Rath, Werner; Pufe, Thomas; Wruck, Christoph Jan			Interplay between Vascular Endothelial Growth Factor (VEGF) and Nuclear Factor Erythroid 2-related Factor-2 (Nrf2) IMPLICATIONS FOR PREECLAMPSIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; MEDIATED DAMAGE; ACTIVATION; CELLS; ANTIOXIDANTS; PREGNANCY; PLACENTA; RECEPTOR	Background: Several studies have suggested that decreasing VEGF levels might result in placental oxidative stress in preeclampsia. Results: VEGF activates Nrf2 in an ERK1/2-dependent manner, protecting against oxidative stress, and, in turn, up-regulates VEGF expression. Conclusion: Reduced VEGF bioavailability may lead to aggregation of oxidative stress and result in preeclampsia. Significance: Nrf2 activation might be considered as an adjunct therapeutic strategy to combat preeclampsia.	[Kweider, Nisreen; Fragoulis, Athanassios; Rosen, Christian; Pufe, Thomas; Wruck, Christoph Jan] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Fac Med, D-52074 Aachen, Germany; [Pecks, Ulrich; Rath, Werner] Univ Hosp RWTH, Dept Obstet & Gynecol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital	Wruck, CJ (corresponding author), Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Fac Med, Wendlingweg 2, D-52074 Aachen, Germany.	cwruck@ukaachen.de	Fragoulis, Athanassios/O-1191-2019; Pecks, Ulrich/D-1190-2012; Fragoulis, Athanassios/K-9623-2015	Fragoulis, Athanassios/0000-0002-6973-3080; Pecks, Ulrich/0000-0002-0784-1262; 	Deutsche Forschungsgemeinschaft [Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, SFB617]; START Program of the Faculty of Medicine; RWTH Aachen University; Department of Histology, Faculty of Medicine, Damascus University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START Program of the Faculty of Medicine; RWTH Aachen University; Department of Histology, Faculty of Medicine, Damascus University	This work was supported by Deutsche Forschungsgemeinschaft Grants Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, and SFB617; the START Program of the Faculty of Medicine, RWTH Aachen University; and the Department of Histology, Faculty of Medicine, Damascus University.	AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Ahmed A, 2009, BIOCHEM SOC T, V37, P1237, DOI 10.1042/BST0371237; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Bainbridge SA, 2005, FREE RADICAL BIO MED, V38, P979, DOI 10.1016/j.freeradbiomed.2004.11.002; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Bridges JP, 2009, AM J HYPERTENS, V22, P564, DOI 10.1038/ajh.2009.24; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Faleo G, 2008, TRANSPLANTATION, V85, P1833, DOI 10.1097/TP.0b013e31817c6f63; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kulkarni AV, 2010, HYPERTENS RES, V33, P561, DOI 10.1038/hr.2010.31; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Mann Giovanni E., 2007, Shengli Xuebao, V59, P117; Maraldi T, 2010, INT J ONCOL, V36, P1581, DOI 10.3892/ijo_00000645; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mistry HD, 2010, PLACENTA, V31, P401, DOI 10.1016/j.placenta.2010.02.011; Moll SJ, 2007, APOPTOSIS, V12, P1611, DOI 10.1007/s10495-007-0092-6; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Perkins AV, 2006, AUST NZ J OBSTET GYN, V46, P77, DOI 10.1111/j.1479-828X.2006.00532.x; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Sahlin L, 2000, PLACENTA, V21, P603, DOI 10.1053/plac.2000.0554; SHARKEY AM, 1993, J REPROD FERTIL, V99, P609; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; SUZUKI Y, 1980, J CLIN INVEST, V66, P1409, DOI 10.1172/JCI109994; Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489; Watson AL, 1998, J CLIN ENDOCR METAB, V83, P1697, DOI 10.1210/jc.83.5.1697; *WHO, 2003, WHO SURV; *WHO, 2005, MAK MOTH CHILD COUNT; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Wruck CJ, 2008, MOL PHARMACOL, V73, P1785, DOI 10.1124/mol.107.042499; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Wruck CJ, 2009, HISTOPATHOLOGY, V55, P102, DOI 10.1111/j.1365-2559.2009.03339.x; Yoshida Y, 2003, FREE RADICAL RES, V37, P861, DOI 10.1080/1071576031000148736; Zhao H, 2009, PLACENTA, V30, P861, DOI 10.1016/j.placenta.2009.07.012	50	72	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42863	42872		10.1074/jbc.M111.286880	http://dx.doi.org/10.1074/jbc.M111.286880			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033923	Green Published, hybrid			2022-12-25	WOS:000298351300008
J	Yamada, K; Kanai, M; Osakabe, Y; Ohiraki, H; Shinozaki, K; Yamaguchi-Shinozaki, K				Yamada, Kohji; Kanai, Motoki; Osakabe, Yuriko; Ohiraki, Haruka; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Monosaccharide Absorption Activity of Arabidopsis Roots Depends on Expression Profiles of Transporter Genes under High Salinity Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSIOLOGICAL CHARACTERIZATION; SUGAR TRANSPORTERS; HEXOSE TRANSPORTER; GLUCOSE-UPTAKE; ORGANIC-ACIDS; THALIANA; IDENTIFICATION; RHIZOSPHERE; BACTERIA; ROLES	Plant roots are able to absorb sugars from the rhizosphere but also release sugars and other metabolites that are critical for growth and environmental signaling. Reabsorption of released sugar molecules could help reduce the loss of photosynthetically fixed carbon through the roots. Although biochemical analyses have revealed monosaccharide uptake mechanisms in roots, the transporters that are involved in this process have not yet been fully characterized. In the present study we demonstrate that Arabidopsis STP1 and STP13 play important roles in roots during the absorption of monosaccharides from the rhizosphere. Among 14 STP transporter genes, we found that STP1 had the highest transcript level and that STP1 was a major contributor for monosaccharide uptake under normal conditions. In contrast, STP13 was found to be induced by abiotic stress, with low expression under normal conditions. We analyzed the role of STP13 in roots under high salinity conditions where membranes of the epidermal cells were damaged, and we detected an increase in the amount of STP13-dependent glucose uptake. Furthermore, the amount of glucose efflux from stp13 mutants was higher than that from wild type plants under high salinity conditions. These results indicate that STP13 can reabsorb the monosaccharides that are released by damaged cells under high salinity conditions. Overall, our data indicate that sugar uptake capacity in Arabidopsis roots changes in response to environmental stresses and that this activity is dependent on the expression pattern of sugar transporters.	[Yamada, Kohji; Kanai, Motoki; Osakabe, Yuriko; Ohiraki, Haruka; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Tokyo 1138657, Japan; [Yamada, Kohji; Kanai, Motoki; Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Biol Resources & Post Harvest Div, Ibaraki 3058686, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Kanagawa 2030045, Japan	University of Tokyo; Japan International Research Center for Agricultural Sciences; RIKEN	Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Shinozaki, Kazuo/AAB-4945-2019; Yamada, Kohji/O-6731-2015; Osakabe, Yuriko/GRI-9818-2022; Osakabe, Yuriko/Y-2507-2019; Shinozaki, Kazuo/G-4202-2013; Yamaguchi-Shinozaki, Kazuko/K-9004-2015	Shinozaki, Kazuo/0000-0002-6317-9867; Yamada, Kohji/0000-0001-7779-9656; Osakabe, Yuriko/0000-0001-5503-1427; Osakabe, Yuriko/0000-0001-5503-1427; Shinozaki, Kazuo/0000-0002-6317-9867; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency/Japan International Cooperation Agency; Program for the Promotion of Basic Research Activities for Innovative Biosciences of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency/Japan International Cooperation Agency(Japan Science & Technology Agency (JST)); Program for the Promotion of Basic Research Activities for Innovative Biosciences of Japan	This work was supported by grants-in-aid for Scientific Research in Priority Areas (to K.Y.-S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Science and Technology Research Partnership for Sustainable Development of the Japan Science and Technology Agency/Japan International Cooperation Agency, and the Program for the Promotion of Basic Research Activities for Innovative Biosciences of Japan (to K.Y.-S.).	Aluri S, 2007, P NATL ACAD SCI USA, V104, P2537, DOI 10.1073/pnas.0610278104; Bacilio-Jimenez M, 2003, PLANT SOIL, V249, P271, DOI 10.1023/A:1022888900465; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Etxeberria E, 2005, J EXP BOT, V56, P1905, DOI 10.1093/jxb/eri185; Farrar JF, 2000, NEW PHYTOL, V147, P43, DOI 10.1046/j.1469-8137.2000.00688.x; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P1121, DOI 10.1094/MPMI-19-1121; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P851, DOI 10.1016/j.soilbio.2005.07.012; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; LIN W, 1984, PLANT PHYSIOL, V76, P894, DOI 10.1104/pp.76.4.894; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Norholm MHH, 2006, FEBS LETT, V580, P2381, DOI 10.1016/j.febslet.2006.03.064; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Pego JV, 1999, PLANT PHYSIOL, V119, P1017, DOI 10.1104/pp.119.3.1017; Poschet G, 2010, PLANT CELL PHYSIOL, V51, P1571, DOI 10.1093/pcp/pcq100; Reinders A, 2005, J BIOL CHEM, V280, P1594, DOI 10.1074/jbc.M410831200; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Sacchi GA, 2000, PLANT SOIL, V220, P1, DOI 10.1023/A:1004701912815; SAUER N, 1990, EMBO J, V9, P3045, DOI 10.1002/j.1460-2075.1990.tb07500.x; Schneider S, 2008, PLANT CELL, V20, P1073, DOI 10.1105/tpc.107.055632; Schneidereit A, 2003, PLANT PHYSIOL, V133, P182, DOI 10.1104/pp.103.026674; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Sherson SM, 2000, PLANT J, V24, P849, DOI 10.1046/j.1365-313x.2000.00935.x; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Stadler R, 2003, PLANT PHYSIOL, V133, P528, DOI 10.1104/pp.103.024240; Takahashi H, 2000, PLANT J, V23, P171, DOI 10.1046/j.1365-313x.2000.00768.x; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Truernit E, 1996, PLANT CELL, V8, P2169, DOI 10.1105/tpc.8.12.2169; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; Williams LE, 2000, TRENDS PLANT SCI, V5, P283, DOI 10.1016/S1360-1385(00)01681-2; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290; Yamada K, 2010, J BIOL CHEM, V285, P1138, DOI 10.1074/jbc.M109.054288	35	59	61	6	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43577	43586		10.1074/jbc.M111.269712	http://dx.doi.org/10.1074/jbc.M111.269712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22041897	Green Published, hybrid			2022-12-25	WOS:000298351300077
J	Sharma, A; Jenkins, KR; Heroux, A; Bowman, GD				Sharma, Amit; Jenkins, Katherine R.; Heroux, Annie; Bowman, Gregory D.			Crystal Structure of the Chromodomain Helicase DNA-binding Protein 1 (Chd1) DNA-binding Domain in Complex with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN; MECHANISM; CONTAINS; CLEAVAGE; ENZYME; SANT	Chromatin remodelers are ATP-dependent machines that dynamically alter the chromatin packaging of eukaryotic genomes by assembling, sliding, and displacing nucleosomes. The Chd1 chromatin remodeler possesses a C-terminal DNA-binding domain that is required for efficient nucleosome sliding and believed to be essential for sensing the length of DNA flanking the nucleosome core. The structure of the Chd1 DNA-binding domain was recently shown to consist of a SANT and SLIDE domain, analogous to the DNA-binding domain of the ISWI family, yet the details of how Chd1 recognized DNA were not known. Here we present the crystal structure of the Saccharomyces cerevisiae Chd1 DNA-binding domain in complex with a DNA duplex. The bound DNA duplex is straight, consistent with the preference exhibited by the Chd1 DNA-binding domain for extranucleosomal DNA. Comparison of this structure with the recently solved ISW1a DNA-binding domain bound to DNA reveals that DNA lays across each protein at a distinct angle, yet contacts similar surfaces on the SANT and SLIDE domains. In contrast to the minor groove binding seen for Isw1 and predicted for Chd1, the SLIDE domain of the Chd1 DNA-binding domain contacts the DNA major groove. The majority of direct contacts with the phosphate backbone occur only on one DNA strand, suggesting that Chd1 may not strongly discriminate between major and minor grooves.	[Sharma, Amit; Jenkins, Katherine R.; Bowman, Gregory D.] Johns Hopkins Univ, Thomas C Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Johns Hopkins University; United States Department of Energy (DOE); Brookhaven National Laboratory	Bowman, GD (corresponding author), Johns Hopkins Univ, Thomas C Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	gdbowman@jhu.edu			National Institutes of Health [R01 GM084192]; National Center for Research Resources (NCRR), National Institutes of Health [P41RR012408]; Office of Biological and Environmental Research; Office of Basic Energy Sciences of the United States Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084192) (to G. D. B.).; We thank T. Owen-Hughes and D. Ryan for providing us with the coordinates for the uncomplexed Chd1 DNA-binding domain prior to publication (2XB0) and Chd1-DNA models. We greatly appreciate G. Hauk for help with data collection and I. Nodelman for critical comments on the manuscript. Support for beamlines X25 and X29 of the National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy and from the National Center for Research Resources (NCRR), National Institutes of Health (Grant P41RR012408).	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen CY, 2011, BIOPHYS J, V101, P1139, DOI 10.1016/j.bpj.2011.07.016; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; Doudeva LG, 2006, PROTEIN SCI, V15, P269, DOI 10.1110/ps.051903406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li CL, 2003, EMBO J, V22, P4014, DOI 10.1093/emboj/cdg377; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Walfridsson J, 2007, EMBO J, V26, P2868, DOI 10.1038/sj.emboj.7601728; Wang YT, 2007, NUCLEIC ACIDS RES, V35, P584, DOI 10.1093/nar/gkl621; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; YUAN H, 1992, BIOCHEMISTRY-US, V31, P8009, DOI 10.1021/bi00149a035	31	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42099	42104		10.1074/jbc.C111.294462	http://dx.doi.org/10.1074/jbc.C111.294462			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22033927	hybrid, Green Published			2022-12-25	WOS:000298180900020
J	Egginger, JG; Parmentier, C; Garrel, G; Cohen-Tannoudji, J; Camus, A; Calas, A; Hardin-Pouzet, H; Grange-Messent, V				Egginger, Johann-Guenther; Parmentier, Caroline; Garrel, Ghislaine; Cohen-Tannoudji, Joelle; Camus, Alain; Calas, Andre; Hardin-Pouzet, Helene; Grange-Messent, Valerie			Direct Evidence for the Co-Expression of URP and GnRH in a Sub-Population of Rat Hypothalamic Neurones: Anatomical and Functional Correlation	PLOS ONE			English	Article							II-RELATED PEPTIDE; GONADOTROPIN-RELEASING-HORMONE; UROTENSIN-II; MESSENGER-RNA; GALANIN; RECEPTOR; REPRODUCTION; EXPRESSION; PITUITARY; PUBERTY	Urotensin-II-related peptide (URP) is an eight amino-acid neuropeptide recently isolated from rat brain and considered as the endogenous ligand for the GPR14 receptor. Using single and double immunohistochemical labelling, in situ hybridization and ultrastructural immunocytochemistry, we explored the cellular and subcellular localization of URP in the male rat brain. URP peptide was detected in numerous varicose fibres of the median eminence (ME) and organum vasculosum laminae terminalis (OVLT) as well as in neuronal cell bodies of the medial septal nucleus and diagonal band of Broca where corresponding mRNA were also detected. Combining in situ hybridization with immunohistochemistry, we showed that cell bodies of the rat anterior hypothalamus contained both URP mRNA and GnRH peptide. In addition, double ultrastructural immunodetection of URP and GnRH peptides clearly revealed, in the median eminence, the co-localization of both peptides in the same neuronal processes in the vicinity of fenestrated portal vessels. This remarkable cellular and subcellular distribution led us to test the effect of URP on the GnRH-induced gonadotrophins release in the anterior pituitary, and to discuss its putative role at the level of the median eminence.	[Egginger, Johann-Guenther] Univ Paris 06, CNRS, UMR 7101, Lab Neurobiol Signaux Intercellulaires, Paris, France; [Parmentier, Caroline; Hardin-Pouzet, Helene; Grange-Messent, Valerie] Univ Paris 06, CNRS, UMR 7224,INSERM, Lab Physiopathol Malad Syst Nerveux Cent,U952, Paris, France; [Garrel, Ghislaine; Cohen-Tannoudji, Joelle] Univ Paris 07, CNRS, EAC 4413, Unit Biol Fonct & Adaptat, Paris, France; [Camus, Alain] Univ Paris 06, CNRS, UMR 7101, Lab Neurobiol Signaux Intercellulaires, Paris, France; [Calas, Andre] Univ Bordeaux Segalen, CNRS, UMR 5297, Interdisciplinary Inst Neurosci IINS, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Egginger, JG (corresponding author), Univ Artois, Fac Sci Jean Perrin, Lab Physiopathol Barriere Hemato Encephalique, Univ Lille Nord France, Lens, France.	valerie.messent@snv.jussieu.fr	Parmentier, Caroline/B-3341-2014; GARREL, Ghislaine/L-2654-2017	GARREL, Ghislaine/0000-0001-8547-1191; Messent, Valerie/0000-0001-7038-1302; Hardin-Pouzet, Helene/0000-0001-9401-2456				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; Ciofi P, 2000, NEUROSCIENCE, V99, P133, DOI 10.1016/S0306-4522(00)00186-X; de Lecea L, 2008, PEPTIDES, V29, P845, DOI 10.1016/j.peptides.2008.02.009; do Rego JC, 2008, PEPTIDES, V29, P838, DOI 10.1016/j.peptides.2007.12.016; Dubessy C, 2008, J NEUROCHEM, V107, P361, DOI 10.1111/j.1471-4159.2008.05624.x; Dudas B, 2006, J NEUROENDOCRINOL, V18, P79, DOI 10.1111/j.1365-2826.2005.01398.x; Egginger JG, 2005, CR BIOL, V328, P724, DOI 10.1016/j.crvi.2005.06.002; Esclapez M, 1996, HIPPOCAMPUS, V6, P225; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; Jegou S, 2006, J COMP NEUROL, V495, P21, DOI 10.1002/cne.20845; Leprince J, 2008, PEPTIDES, V29, P658, DOI 10.1016/j.peptides.2007.08.014; MERCHENTHALER I, 1990, P NATL ACAD SCI USA, V87, P6326, DOI 10.1073/pnas.87.16.6326; MERCHENTHALER I, 1993, P NATL ACAD SCI USA, V90, P10479, DOI 10.1073/pnas.90.22.10479; MOHR E, 1995, P NATL ACAD SCI USA, V92, P4377, DOI 10.1073/pnas.92.10.4377; Mori M, 2004, PEPTIDES, V25, P1815, DOI 10.1016/j.peptides.2004.06.025; Ojeda S.R., 2001, CURR OPIN ENDOCRINOL, V8, P154; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Peters EEM, 2009, NEUROENDOCRINOLOGY, V89, P18, DOI 10.1159/000151446; Prevot V, 2010, FRONT NEUROENDOCRIN, V31, P241, DOI 10.1016/j.yfrne.2010.05.003; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; ROSSMANITH WG, 1994, ENDOCRINOLOGY, V135, P1401, DOI 10.1210/en.135.4.1401; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; STARZEC A, 1989, MOL ENDOCRINOL, V3, P618, DOI 10.1210/mend-3-4-618; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Sugo T, 2008, PEPTIDES, V29, P809, DOI 10.1016/j.peptides.2007.06.005; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; TREMBLEAU A, 1994, J NEUROSCI, V14, P39; Vaudry H, 2008, PEPTIDES, V29, P647, DOI 10.1016/j.peptides.2008.01.010	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26611	10.1371/journal.pone.0026611	http://dx.doi.org/10.1371/journal.pone.0026611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039515	Green Submitted, Green Published, gold			2022-12-25	WOS:000296515200030
J	Humphries, WH; Szymanski, CJ; Payne, CK				Humphries, William H.; Szymanski, Craig J.; Payne, Christine K.			Endo-Lysosomal Vesicles Positive for Rab7 and LAMP1 Are Terminal Vesicles for the Transport of Dextran	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; ENDOCYTIC PATHWAY; LATE ENDOSOMES; MEMBRANE-PROTEINS; LIVING CELLS; RAT-LIVER; BIOGENESIS; ENZYMES; TRAFFICKING; FUSION	The endo-lysosomal pathway is essential for intracellular transport and the degradation of extracellular cargo. The relationship between three populations of endo-lysosomal vesicles-Rab7-positive, LAMP1-positive, and both Rab7- and LAMP1-postive-was probed with fluorescence microscopy and single particle tracking. Of specific interest was determining if these vesicles were intermediate or terminal vesicles in the transport of extracellular cargo. We find that the major organelle in the endo-lysosomal pathway, both in terms of population and cargo transport, is positive for Rab7 and LAMP1. Dextran, a fluid phase cargo, shifts from localization within all three populations of vesicles at 30 minutes and 1 hour to primarily LAMP1- and Rab7/LAMP1-vesicles at longer times. This demonstrates that LAMP1- and Rab7/LAMP1-vesicles are terminal vesicles in the endo-lysosomal pathway. We tested two possible mechanisms for this distribution of cargo, delivery to mannose 6-phosphate receptor (M6PR)-negative vesicles and the fusion dynamics of individual vesicles. We find no correlation with M6PR but do find that Rab7-vesicles undergo significantly fewer fusion events than LAMP1- or Rab7/LAMP1-vesicles suggesting that the distribution of fluid phase cargo is driven by vesicle dynamics.	[Humphries, William H.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Humphries, WH (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	christine.payne@chemistry.gatech.edu	Payne, Christine K./E-5954-2010		National Institutes of Health (NIH) [R01-GM086195, 1DP2OD006470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086195] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006470] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health (NIH) grant R01-GM086195 and an NIH Director's New Innovator Award 1DP2OD006470 (to CKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BOWSER R, 1990, J CELL PHYSIOL, V143, P110, DOI 10.1002/jcp.1041430115; Bright NA, 1997, J CELL SCI, V110, P2027; BROWN WJ, 1986, J CELL BIOL, V103, P1235, DOI 10.1083/jcb.103.4.1235; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; Cho YW, 2003, J PHARM PHARMACOL, V55, P721, DOI 10.1211/002235703765951311; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; Duan HW, 2007, J AM CHEM SOC, V129, P3333, DOI 10.1021/ja068158s; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; GEUZE HJ, 1985, J CELL BIOL, V101, P2253, DOI 10.1083/jcb.101.6.2253; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hacker U, 1997, J CELL SCI, V110, P105; Humphries WH, 2010, INTEGR BIOL-UK, V2, P536, DOI 10.1039/c0ib00035c; Kang JX, 1998, P NATL ACAD SCI USA, V95, P13687, DOI 10.1073/pnas.95.23.13687; KJEKEN R, 1995, EXP CELL RES, V216, P290, DOI 10.1006/excr.1995.1037; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; LUDWIG T, 1991, J CELL BIOL, V115, P1561, DOI 10.1083/jcb.115.6.1561; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MERESSE S, 1995, J CELL SCI, V108, P3349; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; REGGIO H, 1984, J CELL BIOL, V99, P1511, DOI 10.1083/jcb.99.4.1511; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; RUNQUIST EA, 1991, J BIOL CHEM, V266, P22557; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; SAHAGIAN GG, 1983, J BIOL CHEM, V258, P7121; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; SOLDATI T, 1995, J BIOL CHEM, V270, P25541, DOI 10.1074/jbc.270.43.25541; Szymanski CJ, 2011, ANALYST, V136, P3527, DOI 10.1039/c0an00855a; THILO L, 1995, J CELL SCI, V108, P1791; Tjelle TE, 1996, J CELL SCI, V109, P2905; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391	45	65	65	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26626	10.1371/journal.pone.0026626	http://dx.doi.org/10.1371/journal.pone.0026626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039519	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200035
J	Paweletz, CP; Andersen, JN; Pollock, R; Nagashima, K; Hayashi, ML; Yu, SU; Guo, HB; Bobkova, EV; Xu, ZW; Northrup, A; Blume-Jensen, P; Hendrickson, RC; Chi, A				Paweletz, Cloud P.; Andersen, Jannik N.; Pollock, Roy; Nagashima, Kumiko; Hayashi, Mansuo L.; Yu, Shangshuan U.; Guo, Hongbo; Bobkova, Ekaterina V.; Xu, Zangwei; Northrup, Alan; Blume-Jensen, Peter; Hendrickson, Ronald C.; Chi, An			Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics	PLOS ONE			English	Article							EARLY CLINICAL-TRIALS; PROTEIN; AUTOPHOSPHORYLATION; PROTEOMICS; DISCOVERY; CANCER; VERIFICATION; ENRICHMENT; INHIBITORS; MECHANISM	Pharmacodynamic (PD) biomarkers are an increasingly valuable tool for decision-making and prioritization of lead compounds during preclinical and clinical studies as they link drug-target inhibition in cells with biological activity. They are of particular importance for novel, first-in-class mechanisms, where the ability of a targeted therapeutic to impact disease outcome is often unknown. By definition, proximal PD biomarkers aim to measure the interaction of a drug with its biological target. For kinase drug discovery, protein substrate phosphorylation sites represent candidate PD biomarkers. However, substrate phosphorylation is often controlled by input from multiple converging pathways complicating assessment of how potently a small molecule drug hits its target based on substrate phoshorylation measurements alone. Here, we report the use of quantitative, differential mass-spectrometry to identify and monitor novel drug-regulated phosphorylation sites on target kinases. Autophosphorylation sites constitute clinically validated biomarkers for select protein tyrosine kinase inhibitors. The present study extends this principle to phosphorylation sites in serine/threonine kinases looking beyond the T-loop autophosphorylation site. Specifically, for the 3'-phosphoinositide-dependent protein kinase 1 (PDK1), two phospho-residues p-PDK1(Ser410) and p-PDK1(Thr513) are modulated by small-molecule PDK1 inhibitors, and their degree of dephosphorylation correlates with inhibitor potency. We note that classical, ATP-competitive PDK1 inhibitors do not modulate PDK1 T-loop phosphorylation (p-PDK1(Ser241)), highlighting the value of an unbiased approach to identify drug target-regulated phosphorylation sites as these are complementary to pathway PD biomarkers. Finally, we extend our analysis to another protein Ser/Thr kinase, highlighting a broader utility of our approach for identification of kinase drug-target engagement biomarkers.	[Paweletz, Cloud P.; Andersen, Jannik N.; Pollock, Roy; Nagashima, Kumiko; Hayashi, Mansuo L.; Yu, Shangshuan U.; Guo, Hongbo; Bobkova, Ekaterina V.; Xu, Zangwei; Northrup, Alan; Chi, An] Merck & Co Inc, Boston, MA USA; [Hayashi, Mansuo L.] Merck & Co Inc, West Point, PA USA; [Blume-Jensen, Peter] Metamark Genet Inc, Cambridge, MA USA; [Hendrickson, Ronald C.] Merck & Co Inc, Rahway, NJ 07065 USA	Merck & Company; Merck & Company; Merck & Company	Paweletz, CP (corresponding author), Merck & Co Inc, Boston, MA USA.	pblumejensen@metamarkgenetics.com; an_chi@merck.com		Andersen, Jannik/0000-0003-4528-2120	Merck Company	Merck Company(Merck & Company)	This work was funded by Merck & Company who had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Addona TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/nbt.1899; Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Baselga J, 2001, EUR J CANCER, V37, pS16; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bobkova EV, 2010, J BIOL CHEM, V285, P18838, DOI 10.1074/jbc.M109.089946; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Dancey JE, 2010, CLIN CANCER RES, V16, P1745, DOI 10.1158/1078-0432.CCR-09-2167; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ellwood-Yen K, 2011, CANCER RES, V71, P3052, DOI 10.1158/0008-5472.CAN-10-2282; Gao XX, 2006, BIOORG CHEM, V34, P200, DOI 10.1016/j.bioorg.2006.05.002; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuhn E, 2009, CLIN CHEM, V55, P1108, DOI 10.1373/clinchem.2009.123935; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nagashima K, 2011, J BIOL CHEM, V286, P6433, DOI 10.1074/jbc.M110.156463; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Phillips KA, 2006, NAT REV DRUG DISCOV, V5, P463, DOI 10.1038/nrd2033; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sarker D, 2007, BIOMARK MED, V1, P399, DOI 10.2217/17520363.1.3.399; Sequist LV, 2011, CANCER DISCOV, V1, P14, DOI 10.1158/2159-8274.CD-11-0044; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tan DSW, 2009, CANCER J, V15, P406, DOI 10.1097/PPO.0b013e3181bd0445; Wagner JA, 2007, CLIN PHARMACOL THER, V81, P104, DOI 10.1038/sj.clpt.6100017; Wagner JA, 2008, ANNU REV PHARMACOL, V48, P631, DOI 10.1146/annurev.pharmtox.48.113006.094611; Wang J, 2011, J BIOL CHEM, V286, P2689, DOI 10.1074/jbc.M110.156505; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Xu ZW, 2009, J BIOMOL SCREEN, V14, P1257, DOI 10.1177/1087057109349356	42	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26459	10.1371/journal.pone.0026459	http://dx.doi.org/10.1371/journal.pone.0026459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039492	gold, Green Published, Green Submitted			2022-12-25	WOS:000296515200021
J	Yusuf, E; Bijsterbosch, J; Slagboom, PE; Kroon, HM; Rosendaal, FR; Huizinga, TWJ; Kloppenburg, M				Yusuf, Erlangga; Bijsterbosch, Jessica; Slagboom, P. Eline; Kroon, Herman M.; Rosendaal, Frits R.; Huizinga, Tom W. J.; Kloppenburg, Margreet			Association between Several Clinical and Radiological Determinants with Long-Term Clinical Progression and Good Prognosis of Lower Limb Osteoarthritis	PLOS ONE			English	Article							RADIOGRAPHIC KNEE OSTEOARTHRITIS; HIP OSTEOARTHRITIS; HEALTH SURVEY; RISK-FACTORS; COMMUNITY; INDEX; CLASSIFICATION; ARTHRITIS; CRITERIA; OUTCOMES	Objective: To investigate the factors associated with clinical progression and good prognosis in patients with lower limb osteoarthritis (OA). Methods: Cohort study of 145 patients with OA in either knee, hip or both. Progression was defined as 1) new joint prosthesis or 2) increase in WOMAC pain or function score during 6-years follow-up above pre-defined thresholds. Patients without progression with decrease in WOMAC pain or function score lower than pre-defined thresholds were categorized as good prognosis. Relative risks (RRs) for progression and good prognosis with 95% confidence interval (95% CI) were calculated by comparing the highest tertile or category to the lowest tertile, for baseline determinants (age, sex, BMI, WOMAC pain and function scores, pain on physical examination, total range of motion (tROM), osteophytes and joint space narrowing (JSN) scores), and for worsening in WOMAC pain and function score in 1-year. Adjustments were performed for age, sex, and BMI. Results: Follow-up was completed by 117 patients (81%, median age 60 years, 84% female); 62 (53%) and 31 patients (26%) showed progression and good prognosis, respectively. These following determinants were associated with progression: pain on physical examination (RR 1.2 (1.0 to 1.5)); tROM (1.4 (1.1 to 1.6); worsening in WOMAC pain (1.9 (1.2 to 2.3)); worsening in WOMAC function (2.4 (1.7 to 2.6)); osteophytes 1.5 (1.0 to 1.8); and JSN scores (2.3 (1.5 to 2.7)). Worsening in WOMAC pain (0.1 (0.1 to 0.8)) and function score (0.1 (0.1 to 0.7)), were negatively associated with good prognosis. Conclusion: Worsening of self-reported pain and function in one year, limited tROM and higher osteophytes and JSN scores were associated with clinical progression. Worsening in WOMAC pain and function score in 1-year were associated with lower risk to have good prognosis. These findings help to inform patients with regard to their OA prognosis.	[Yusuf, Erlangga; Bijsterbosch, Jessica; Huizinga, Tom W. J.; Kloppenburg, Margreet] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Kroon, Herman M.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Rosendaal, Frits R.; Kloppenburg, Margreet] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Yusuf, E (corresponding author), Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands.	angga.yusuf@gmail.com	Slagboom, P. Eline/R-4790-2016; Yusuf, Erlangga/H-5166-2019; Rosendaal, Frits/Q-3842-2017	Slagboom, P. Eline/0000-0002-2875-4723; Yusuf, Erlangga/0000-0003-4779-2191; Rosendaal, Frits/0000-0003-2558-7496	Pfizer (Groton, CT, USA); Dutch Arthritis Association; TI-Pharma	Pfizer (Groton, CT, USA)(Pfizer); Dutch Arthritis Association; TI-Pharma	Funding: This study was financially supported by Pfizer (Groton, CT, USA), the Dutch Arthritis Association, and TI-Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Belo JN, 2007, ARTHRIT RHEUM-ARTHR, V57, P13, DOI 10.1002/art.22475; Bijsterbosch J, 2010, OSTEOARTHR CARTILAGE, V18, P1046, DOI 10.1016/j.joca.2010.05.009; Bykerk V, 2009, J RHEUMATOL, V36, P1565, DOI 10.3899/jrheum.090673; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Dieppe P, 2000, OSTEOARTHR CARTILAGE, V8, P63, DOI 10.1053/joca.1999.0272; DOYLE DV, 1981, ANN RHEUM DIS, V40, P75, DOI 10.1136/ard.40.1.75; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; Felson DT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2531; Lacey RJ, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-82; Lane NE, 2004, ARTHRITIS RHEUM-US, V50, P1477, DOI 10.1002/art.20213; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Nilsdotter AK, 2009, ACTA ORTHOP, V80, P55, DOI 10.1080/17453670902805007; O'Reilly SC, 2000, OSTEOARTHR CARTILAGE, V8, P78, DOI 10.1053/joca.1999.0274; Riyazi N, 2005, ANN RHEUM DIS, V64, P438, DOI 10.1136/ard.2004.024661; Roos EM, 2008, ANN RHEUM DIS, V67, P505, DOI 10.1136/ard.2007.074088; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wright AA, 2009, ARTHRIT RHEUM-ARTHR, V61, P925, DOI 10.1002/art.24641; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang W, 2010, ANN RHEUM DIS, V69, P483, DOI 10.1136/ard.2009.113100; Zhang YQ, 2010, ARTHRIT CARE RES, V62, P1527, DOI 10.1002/acr.20287	25	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25426	10.1371/journal.pone.0025426	http://dx.doi.org/10.1371/journal.pone.0025426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031816	Green Published, gold, Green Submitted			2022-12-25	WOS:000296513200003
J	Schaaf, S; Shibamiya, A; Mewe, M; Eder, A; Stohr, A; Hirt, MN; Rau, T; Zimmermann, WH; Conradi, L; Eschenhagen, T; Hansen, A				Schaaf, Sebastian; Shibamiya, Aya; Mewe, Marco; Eder, Alexandra; Stoehr, Andrea; Hirt, Marc N.; Rau, Thomas; Zimmermann, Wolfram-Hubertus; Conradi, Lenard; Eschenhagen, Thomas; Hansen, Arne			Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INFARCTED RAT HEARTS; CARDIAC-MUSCLE; CARDIOMYOCYTES; DIFFERENTIATION; POPULATION; COCULTURE; MYOCYTES; GROWTH	Human embryonic stem cell (hESC) progenies hold great promise as surrogates for human primary cells, particularly if the latter are not available as in the case of cardiomyocytes. However, high content experimental platforms are lacking that allow the function of hESC-derived cardiomyocytes to be studied under relatively physiological and standardized conditions. Here we describe a simple and robust protocol for the generation of fibrin-based human engineered heart tissue (hEHT) in a 24-well format using an unselected population of differentiated human embryonic stem cells containing 30-40% alpha-actinin-positive cardiac myocytes. Human EHTs started to show coherent contractions 5-10 days after casting, reached regular (mean 0.5 Hz) and strong (mean 100 mu N) contractions for up to 8 weeks. They displayed a dense network of longitudinally oriented, interconnected and cross-striated cardiomyocytes. Spontaneous hEHT contractions were analyzed by automated video-optical recording and showed chronotropic responses to calcium and the beta-adrenergic agonist isoprenaline. The proarrhythmic compounds E-4031, quinidine, procainamide, cisapride, and sertindole exerted robust, concentration-dependent and reversible decreases in relaxation velocity and irregular beating at concentrations that recapitulate findings in hERG channel assays. In conclusion this study establishes hEHT as a simple in vitro model for heart research.	[Schaaf, Sebastian; Shibamiya, Aya; Eder, Alexandra; Stoehr, Andrea; Hirt, Marc N.; Rau, Thomas; Zimmermann, Wolfram-Hubertus; Eschenhagen, Thomas; Hansen, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, Hamburg, Germany; [Mewe, Marco] Univ Med Ctr Hamburg Eppendorf, Dept Pharmacol Pharmacists, Cardiovasc Res Ctr, Hamburg, Germany; [Conradi, Lenard] Univ Med Ctr Hamburg Eppendorf, Dept Cardiovasc Surg, Cardiovasc Res Ctr, Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schaaf, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, Hamburg, Germany.	ar.hansen@uke.de	Zimmermann, Wolfram-Hubertus H/I-6838-2012; Stoehr, Andrea/F-7452-2018; Conradi, Lenard/AAQ-7476-2021	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; Stoehr, Andrea/0000-0003-3573-1818; Conradi, Lenard/0000-0003-2237-9050	Deutsche Forschungsgemeinschaft [HA 3423/3-1, ZI 708/7-1, 8-1]; Deutsche Herzstiftung [F/13/10]; European Union; Novartis-Stiftung; Bundesministerium fur Bildung und Forschung [DLR FKZ: 01GN0520]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung; European Union(European Commission); Novartis-Stiftung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This study was supported by funds from the Deutsche Forschungsgemeinschaft (HA 3423/3-1, ZI 708/7-1, 8-1), Deutsche Herzstiftung (F/13/10), European Union (FP6 EUGene Heart, FP7 Angioscaff), Novartis-Stiftung and Bundesministerium fur Bildung und Forschung (DLR FKZ: 01GN0520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P371, DOI 10.1016/j.yjmcc.2007.05.021; EMA, 2005, NONCL EV POT DEL VEN; Eschenhagen T, 1997, FASEB J, V11, P683, DOI 10.1096/fasebj.11.8.9240969; EVERETT AW, 1986, J MOL CELL CARDIOL, V18, P607, DOI 10.1016/S0022-2828(86)80968-3; FDA, 2005, GUID IND S7B NONCL E; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	29	240	256	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26397	10.1371/journal.pone.0026397	http://dx.doi.org/10.1371/journal.pone.0026397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028871	Green Published, gold, Green Submitted			2022-12-25	WOS:000296510800040
J	Lee, AW				Lee, Angel W.			The Role of Atypical Protein Kinase C in CSF-1-Dependent Erk Activation and Proliferation in Myeloid Progenitors and Macrophages	PLOS ONE			English	Article							STIMULATING FACTOR-I; NF-KAPPA-B; CSF-1 RECEPTOR; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIAL EXPRESSION; BINDING-SITE; PI 3-KINASE; PKC-ZETA; SPECIFICITY	Colony stimulating factor-1 (CSF-1 or M-CSF) is the major physiological regulator of the proliferation, differentiation and survival of cells of the mononuclear phagocyte lineage. CSF-1 binds to a receptor tyrosine kinase, the CSF-1 receptor (CSF-1R). Multiple pathways are activated downstream of the CSF-1R; however, it is not clear which pathways regulate proliferation and survival. Here, we investigated the role of atypical protein kinase Cs (PKCf) in a myeloid progenitor cell line that expressed CSF-1R (32D. R) and in primary murine bone marrow derived macrophages (BMMs). In 32D. R cells, CSF-1 induced the phosphorylation of PKCf and increased its kinase activity. PKC inhibitors and transfections with mutant PKCs showed that optimal CSF-1-dependent Erk activation and proliferation depended on the activity of PKCf. We previously reported that CSF-1 activated the Erk pathway through an A-Raf-dependent and an A-Raf independent pathway (Lee and States, Mol. Cell. Biol. 18, 6779). PKC inhibitors did not affect CSF-1 induced Ras and A-Raf activity but markedly reduced MEK and Erk activity, implying that PKCf regulated the CSF-1-Erk pathway at the level of MEK. PKCf has been implicated in activating the NF-kappa B pathway. However, CSF-1 promoted proliferation in an NF-kB independent manner. We established stable 32D. R cell lines that overexpressed PKCf. Overexpression of PKCf increased the intensity and duration of CSF-1 induced Erk activity and rendered cells more responsive to CSF-1 mediated proliferation. In contrast to 32D. R cells, PKCf inhibition in BMMs had only a modest effect on proliferation. Moreover, PKCf-specific and pan-PKC inhibitors induced a paradoxical increase in MEK-Erk phosphorylation suggesting that PKCs targeted a common negative regulatory step upstream of MEK. Our results demonstrated that CSF-1 dependent Erk activation and proliferation are regulated differentially in progenitors and differentiated cells.	[Lee, Angel W.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Lee, Angel W.] Univ Texas Hlth Sci Ctr, Ctr Prote & Syst Biol, Inst Mol Med, Houston, TX USA; [Lee, Angel W.] OncProTech, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston	Lee, AW (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	awmlee@angelleelab.org			Public Health Service, National Cancer Institute [RO1-CA85368]; NATIONAL CANCER INSTITUTE [R01CA085368] Funding Source: NIH RePORTER	Public Health Service, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The initial phase of the work was supported by Public Health Service grant RO1-CA85368 from the National Cancer Institute (to AWL). No additional external funding was received for this study. There is no financial conflict of interest to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cohen EEW, 2006, CANCER RES, V66, P6296, DOI 10.1158/0008-5472.CAN-05-3139; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DEBRUIJN MFTR, 1994, EUR J IMMUNOL, V24, P2279, DOI 10.1002/eji.1830241003; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Garcia-Paramio P, 1998, BIOCHEM J, V333, P631, DOI 10.1042/bj3330631; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guo H, 2009, J LEUKOCYTE BIOL, V85, P911, DOI 10.1189/jlb.0708429; Hamdorf M, 2011, STEM CELLS, V29, P297, DOI 10.1002/stem.564; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hunter M, 2009, FRONT BIOSCI-LANDMRK, V14, P4079, DOI 10.2741/3514; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Junttila I, 2003, J LEUKOCYTE BIOL, V73, P281, DOI 10.1189/jlb.0702359; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee AWM, 2006, CELL DEATH DIFFER, V13, P1900, DOI 10.1038/sj.cdd.4401884; Lee AW, 1999, BLOOD, V93, P537, DOI 10.1182/blood.V93.2.537.402k30_537_553; LEE AW, 1990, P NATL ACAD SCI USA, V87, P7270, DOI 10.1073/pnas.87.18.7270; Lee AWM, 2000, MOL CELL BIOL, V20, P6779, DOI 10.1128/MCB.20.18.6779-6798.2000; Lee MC, 2008, J LEUKOCYTE BIOL, V84, P835, DOI 10.1189/jlb.1007691; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mancini A, 1997, ONCOGENE, V15, P1565, DOI 10.1038/sj.onc.1201518; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Moscat J, 2011, NAT IMMUNOL, V12, P12, DOI 10.1038/ni0111-12; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; OHTSUKA M, 1990, MOL CELL BIOL, V10, P1664, DOI 10.1128/MCB.10.4.1664; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; Roberts NA, 2004, BIOCHEM PHARMACOL, V68, P1923, DOI 10.1016/j.bcp.2004.07.040; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Valledor AF, 1999, J IMMUNOL, V163, P2452; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; vanDijk MCM, 1997, BIOCHEM J, V323, P693, DOI 10.1042/bj3230693; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wilhelmsen K, 2002, ONCOGENE, V21, P1079, DOI 10.1038/sj.onc.1205166; WOOTEN MW, 1994, CELL GROWTH DIFFER, V5, P395; Xiong Y, 2011, J BIOL CHEM, V286, P952, DOI 10.1074/jbc.M110.166702; Xu D, 2010, BLOOD, V116, P3611, DOI 10.1182/blood-2010-01-265652	56	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25580	10.1371/journal.pone.0025580	http://dx.doi.org/10.1371/journal.pone.0025580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028782	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900011
J	Zhang, HY; Zhang, L; Myerson, J; Bibee, K; Scott, M; Allen, J; Sicard, G; Lanza, G; Wickline, S				Zhang, Huiying; Zhang, Lei; Myerson, Jacob; Bibee, Kristin; Scott, Michael; Allen, John; Sicard, Gregorio; Lanza, Gregory; Wickline, Samuel			Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents	PLOS ONE			English	Article							RISK-ASSESSMENT STRATEGIES; ENDOTHELIAL SENESCENCE; CORONARY-THROMBOSIS; VULNERABLE PATIENT; NITRIC-OXIDE; PLAQUE; ANGIOGENESIS; PERMEABILITY; NANOTECHNOLOGY; IDENTIFICATION	Rationale: Acute atherothrombotic occlusion in heart attack and stroke implies disruption of the vascular endothelial barrier that exposes a highly procoagulant intimal milieu. However, the evolution, severity, and pathophysiological consequences of vascular barrier damage in atherosclerotic plaque remain unknown, in part because quantifiable methods and experimental models are lacking for its in vivo assessment. Objective: To develop quantitative nondestructive methodologies and models for detecting vascular barrier disruption in advanced plaques. Methods and Results: Sustained hypercholesterolemia in New Zealand White (NZW) rabbits for >7-14 months engendered endothelial barrier disruption that was evident from massive and rapid passive penetration and intimal trapping of perfluorocarbon-core nanoparticles (PFC-NP: similar to 250 nm diameter) after in vivo circulation for as little as 1 hour. Only older plaques (>7 mo), but not younger plaques (<3 mo) demonstrated the marked enhancement of endothelial permeability to these particles. Electron microscopy revealed a complex of subintimal spongiform channels associated with endothelial apoptosis, superficial erosions, and surface-penetrating cholesterol crystals. Fluorine (F-19) magnetic resonance imaging and spectroscopy (MRI/MRS) enabled absolute quantification (in nanoMolar) of the passive permeation of PFC-NP into the disrupted vascular lesions by sensing the unique spectral signatures from the fluorine core of plaque-bound PFC-NP. Conclusions: The application of semipermeant nanoparticles reveals the presence of profound barrier disruption in later stage plaques and focuses attention on the disrupted endothelium as a potential contributor to plaque vulnerability. The response to sustained high cholesterol levels yields a progressive deterioration of the vascular barrier that can be quantified with fluorine MRI/MRS of passively permeable nanostructures. The possibility of plaque classification based on the metric of endothelial permeability to nanoparticles is suggested.	[Zhang, Huiying; Zhang, Lei; Myerson, Jacob; Bibee, Kristin; Scott, Michael; Allen, John; Lanza, Gregory; Wickline, Samuel] Washington Univ, Dept Med, St Louis, MO 63130 USA; [Myerson, Jacob; Lanza, Gregory; Wickline, Samuel] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Bibee, Kristin; Wickline, Samuel] Washington Univ, Dept Cellular Biol, St Louis, MO USA; [Sicard, Gregorio] Washington Univ, Dept Surg, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhang, HY (corresponding author), Washington Univ, Dept Med, St Louis, MO 63130 USA.	wicklines@wuphys.wustl.edu	Zhang, Lei/K-4587-2019		NIH [R01 HL 73646, R01 NS059302]; Edith and Allan Wolff Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edith and Allan Wolff Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 HL 73646, R01 NS059302, and the Edith and Allan Wolff Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Amerongen GPV, 2000, CIRCULATION, V102, P2803; Arora R, 2008, AM J THER; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Brix G, 2010, EUR J NUCL MED MOL I, V37, pS30, DOI 10.1007/s00259-010-1448-7; Calcagno C, 2010, ANGIOGENESIS, V13, P87, DOI 10.1007/s10456-010-9172-2; Chen YL, 1997, ATHEROSCLEROSIS, V133, P7, DOI 10.1016/S0021-9150(97)06111-X; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; DAVIES MJ, 1985, BRIT HEART J, V53, P363; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; FLAIM SF, 1994, ARTIF CELL BLOOD SUB, V22, P1043, DOI 10.3109/10731199409138801; Frank PG, 2009, CELL TISSUE RES, V335, P41, DOI 10.1007/s00441-008-0659-8; Gates PE, 2009, EXP PHYSIOL, V94, P311, DOI 10.1113/expphysiol.2008.043349; Hayashi T, 2010, GERIATR GERONTOL INT, V10, P115, DOI 10.1111/j.1447-0594.2009.00581.x; Jaffer FA, 2007, CIRCULATION, V116, P1052, DOI 10.1161/CIRCULATIONAHA.106.647164; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Lee K, 2005, CIRC RES, V97, P450, DOI 10.1161/01.RES.0000181026.94390.c9; Lee K, 2008, AM J PHYSIOL-HEART C, V295, pH2273, DOI 10.1152/ajpheart.00242.2008; Liu YW, 2000, THERMOCHIM ACTA, V351, P51; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Mun GI, 2010, AM J PHYSIOL-HEART C, V298, pH2102, DOI 10.1152/ajpheart.00835.2009; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Op den Buijs J, 2004, AM J PHYSIOL-HEART C, V287, pH2651, DOI 10.1152/ajpheart.00332.2004; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Pedersen SF, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-10; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Sadeghi MM, 2010, J NUCL MED, V51, p51S, DOI 10.2967/jnumed.109.068163; Schapira K, 2007, CURR PHARM DESIGN, V13, P1013, DOI 10.2174/138161207780487575; Schwartz RS, 2009, J AM COLL CARDIOL, V54, P2167, DOI 10.1016/j.jacc.2009.07.042; Shaish A, 2001, PATHOBIOLOGY, V69, P225, DOI 10.1159/000055947; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Simionescu M, 2007, ARTERIOSCL THROM VAS, V27, P266, DOI 10.1161/01.ATV.0000253884.13901.e4; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Underhill HR, 2010, NAT REV CARDIOL, V7, P165, DOI 10.1038/nrcardio.2009.246; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Waters EA, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-43; Wickline SA, 2006, ARTERIOSCL THROM VAS, V26, P435, DOI 10.1161/01.ATV.0000201069.47550.8b; Wickline SA, 2003, CIRCULATION, V107, P1092, DOI 10.1161/01.CIR.0000059651.17045.77; Wickline SA, 2010, MOL IMAGING PRINCIPL, P542; Wickline SA, 2007, J MAGN RESON IMAGING, V25, P667, DOI 10.1002/jmri.20866; Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95; Yeh HI, 2003, ARTERIOSCL THROM VAS, V23, P1391, DOI 10.1161/01.ATV.0000083508.21989.15; Yuan C, 2001, RADIOLOGY, V221, P285, DOI 10.1148/radiol.2212001612; Yuan C, 2002, J MAGN RESON IMAGING, V15, P62, DOI 10.1002/jmri.10030	51	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26385	10.1371/journal.pone.0026385	http://dx.doi.org/10.1371/journal.pone.0026385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028868	gold, Green Submitted, Green Published			2022-12-25	WOS:000296186900056
J	Sacho, EJ; Maizels, N				Sacho, Elizabeth J.; Maizels, Nancy			DNA Repair Factor MRE11/RAD50 Cleaves 3 '-Phosphotyrosyl Bonds and Resects DNA to Repair Damage Caused by Topoisomerase 1 Poisons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE KINASE-ACTIVITY; STRAND BREAK REPAIR; COVALENT COMPLEXES; MRE11; RAD50; NUCLEASE; TDP1; GENE; PATHWAYS; FURIOSUS	MRE11-RAD50 is a highly conserved multifunctional DNA repair factor. Here, we show that MRE11-RAD50 cleaves the covalent 3'-phosphotyrosyl-DNA bonds that join topoisomerase 1 (Top1) to the DNA backbone and that are the hallmark of damage caused by Top1 poisons such as camptothecin. Cleavage generates a 3'-phosphate DNA end that MRE11-RAD50 can resect in an ATP-regulated reaction, to produce a 3'-hydroxyl that can prime repair synthesis. The 3'-phosphotyrosyl cleavage activity maps to the MRE11 active site. These results define a new activity of MRE11 and distinguish MRE11-RAD50 functions in repair of Top1-DNA complexes and double-strand breaks.	[Sacho, Elizabeth J.; Maizels, Nancy] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maizels, N (corresponding author), Univ Washington, Sch Med, Dept Immunol, Box 357650,1959 NE Pacific St, Seattle, WA 98195 USA.	maizels@u.washington.edu		Sacho, Elizabeth/0000-0002-4499-5869	National Institutes of Health [P01 CA77852, T32 AI007411]; NCI [R01 GM41712]; NIAID; American Cancer Society [PF-10-083-01]; Hillcrest Committee of Southern Oregon; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Cancer Society(American Cancer Society); Hillcrest Committee of Southern Oregon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant P01 CA77852 from NCI and Grant R01 GM41712 (to N. M.). This work was also supported by National Institutes of Health Grant T32 AI007411 from NIAID and by American Cancer Society Postdoctoral Fellowship Award PF-10-083-01 from the Hillcrest Committee of Southern Oregon (to E. J. S.).	Attwooll CL, 2009, MOL CELL BIOL, V29, P5540, DOI 10.1128/MCB.00479-09; Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bressan DA, 1998, GENETICS, V150, P591; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; de Jager M, 2002, NUCLEIC ACIDS RES, V30, P4425, DOI 10.1093/nar/gkf574; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Hamilton NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015387; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lammens A, 2010, J MOL BIOL, V401, P265, DOI 10.1016/j.jmb.2010.06.029; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Liu CY, 2004, DNA REPAIR, V3, P593, DOI 10.1016/j.dnarep.2004.03.030; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Malik M, 2004, EUKARYOT CELL, V3, P82, DOI 10.1128/EC.3.1.82-90.2004; Marra G, 2005, ADV EXP MED BIOL, V570, P83; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Stracker TH, 2008, CELL CYCLE, V7, P3618, DOI 10.4161/cc.7.23.7064; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	41	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44945	44951		10.1074/jbc.M111.299347	http://dx.doi.org/10.1074/jbc.M111.299347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039049	hybrid, Green Published			2022-12-25	WOS:000298645500063
J	Du, F; Hui, Y; Zhang, M; Linton, MF; Fazio, S; Fan, DP				Du, Fen; Hui, Yvonne; Zhang, Michelle; Linton, MacRae F.; Fazio, Sergio; Fan, Daping			Novel Domain Interaction Regulates Secretion of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PLASMA LDL-CHOLESTEROL; C-TERMINAL DOMAIN; NONHUMAN-PRIMATES; CRYSTAL-STRUCTURE; SERUM LDL; MUTATIONS; DEGRADATION; GENE	PCSK9 (proprotein convertase subtilisin/kexin type 9) has emerged as a novel therapeutic target for hypercholesterolemia due to its LDL receptor (LDLR)-reducing activity. Although its structure has been solved, the lack of a detailed understanding of the structure-function relation hinders efforts to develop small molecule inhibitors. In this study, we used mutagenesis and transfection approaches to investigate the roles of the prodomain (PD) and the C-terminal domain (CD) and its modules (CM1-3) in the secretion and function of PCSK9. Deletion of PD residues 31-40, 41-50, or 51-60 did not affect the self-cleavage, secretion, or LDLR-degrading activity of PCSK9, whereas deletion of residues 61-70 abolished all of these functions. Deletion of the entire CD protein did not impair PCSK9 self-cleavage or secretion but completely abolished LDLR-degrading activity. Deletion of any one or two of the CD modules did not affect self-cleavage but influenced secretion and LDLR-reducing activity. Furthermore, in cotransfection experiments, a secretion-defective PD deletion mutant (Delta PD) was efficiently secreted in the presence of CD deletion mutants. This was due to the transfer of PD from the cotransfected CD mutants to the Delta PD mutant. Finally, we found that a discrete CD protein fragment competed with full-length PCSK9 for binding to LDLR in vitro and attenuated PCSK9-mediated hypercholesterolemia in mice. These results show a previously unrecognized domain interaction as a critical determinant in PCSK9 secretion and function. This knowledge should fuel efforts to develop novel approaches to PCSK9 inhibition.	[Linton, MacRae F.; Fazio, Sergio] Vanderbilt Univ, Med Ctr, Atherosclerosis Res Unit, Div Cardiol,Dept Med, Nashville, TN 37232 USA; [Du, Fen; Hui, Yvonne; Zhang, Michelle; Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29209 USA; [Linton, MacRae F.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Fazio, Sergio] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Vanderbilt University; Vanderbilt University	Fazio, S (corresponding author), Vanderbilt Univ, Med Ctr, Atherosclerosis Res Unit, Div Cardiol,Dept Med, PRB318,2220 Pierce Ave, Nashville, TN 37232 USA.	sergio.fazio@vanderbilt.edu; daping.fan@uscmed.sc.edu			National Institutes of Health [HL106845, HL106325]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106325, R01HL106845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL106845 (to S. F.) and HL106325 (to D. F.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Alborn WE, 2007, CLIN CHEM, V53, P1814, DOI 10.1373/clinchem.2007.091280; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Betzel C, 2001, BIOCHEMISTRY-US, V40, P3080, DOI 10.1021/bi002538n; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Duff CJ, 2009, BIOCHEM J, V419, P577, DOI 10.1042/BJ20082407; Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359; Fazio S, 2007, CURR OPIN LIPIDOL, V18, P387, DOI 10.1097/MOL.0b013e3282a0794d; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holla OL, 2011, BIOCHEM BIOPH RES CO, V406, P234, DOI 10.1016/j.bbrc.2011.02.023; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lilly SM, 2007, CURR OPIN LIPIDOL, V18, P650, DOI 10.1097/MOL.0b013e3282f169c6; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; Miyake Y, 2008, ATHEROSCLEROSIS, V196, P29, DOI 10.1016/j.atherosclerosis.2006.12.035; Mousavi SA, 2009, J INTERN MED, V266, P507, DOI 10.1111/j.1365-2796.2009.02167.x; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	43	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43054	43061		10.1074/jbc.M111.273474	http://dx.doi.org/10.1074/jbc.M111.273474			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027821	Green Published, hybrid			2022-12-25	WOS:000298351300026
J	Gunn, A; Bennardo, N; Cheng, A; Stark, JM				Gunn, Amanda; Bennardo, Nicole; Cheng, Anita; Stark, Jeremy M.			Correct End Use during End Joining of Multiple Chromosomal Double Strand Breaks Is Influenced by Repair Protein RAD50, DNA-dependent Protein Kinase DNA-PKcs, and Transcription Context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC INSTABILITY; V(D)J RECOMBINATION; HISTONE H2AX; HOMOLOGOUS RECOMBINATION; MRE11/RAD50 COMPLEXES; MAMMALIAN-CELLS; MURINE CELLS; ATM; TRANSLOCATIONS; PATHWAYS	During repair of multiple chromosomal double strand breaks (DSBs), matching the correct DSB ends is essential to limit rearrangements. To investigate the maintenance of correct end use, we examined repair of two tandem noncohesive DSBs generated by endonuclease I-SceI and the 3' nonprocessive exonuclease Trex2, which can be expressed as an I-SceI-Trex2 fusion. We examined end joining (EJ) repair that maintains correct ends (proximal-EJ) versus using incorrect ends (distal-EJ), which provides a relative measure of incorrect end use (distal end use). Previous studies showed that ATM is important to limit distal end use. Here we show that DNA-PKcs kinase activity and RAD50 are also important to limit distal end use, but that H2AX is dispensable. In contrast, we find that ATM, DNA-PKcs, and RAD50 have distinct effects on repair events requiring end processing. Furthermore, we developed reporters to examine the effects of the transcription context on DSB repair, using an inducible promoter. We find that a DSB downstream from an active promoter shows a higher frequency of distal end use, and a greater reliance on ATM for limiting incorrect end use. Conversely, DSB transcription context does not affect end processing during EJ, the frequency of homology-directed repair, or the role of RAD50 and DNA-PKcs in limiting distal end use. We suggest that RAD50, DNA-PKcs kinase activity, and transcription context are each important to limit incorrect end use during EJ repair of multiple DSBs, but that these factors and conditions have distinct roles during repair events requiring end processing.	[Gunn, Amanda; Bennardo, Nicole; Cheng, Anita; Stark, Jeremy M.] Beckman Res Inst,City Hope, Dept Canc Biol, Duarte, CA 91010 USA; [Gunn, Amanda; Bennardo, Nicole; Stark, Jeremy M.] Beckman Res Inst City Hope, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Bennardo, N (corresponding author), 1500 E Duarte Rd, Duarte, CA 91010 USA.	jstark@coh.org		Gunn, Amanda Lyn/0000-0002-9450-4976	National Cancer Institute of the NIH [RO1CA120954]; NATIONAL CANCER INSTITUTE [R01CA120954] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant RO1CA120954 from the National Cancer Institute of the NIH (to J. M. S.).	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Allen C, 2003, MOL CANCER RES, V1, P913; Allen C, 2003, DNA REPAIR, V2, P1147, DOI 10.1016/S1568-7864(03)00139-3; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bennardo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001194; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bredemeyer AL, 2008, J IMMUNOL, V181, P2620, DOI 10.4049/jimmunol.181.4.2620; Chen MJ, 2007, NUCLEIC ACIDS RES, V35, P2682, DOI 10.1093/nar/gkm151; Davis AJ, 2010, CELL CYCLE, V9, P2529, DOI 10.4161/cc.9.13.12148; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Gapud EJ, 2011, CELL CYCLE, V10, P1928, DOI 10.4161/cc.10.12.16011; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Helmink BA, 2011, NATURE, V469, P245, DOI 10.1038/nature09585; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mathas S, 2009, CELL, V139, P1047, DOI 10.1016/j.cell.2009.11.037; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nakai W, 2011, DNA REPAIR, V10, P102, DOI 10.1016/j.dnarep.2010.10.004; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Palli SR, 2003, EUR J BIOCHEM, V270, P1308, DOI 10.1046/j.1432-1033.2003.03501.x; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rahal EA, 2010, CELL CYCLE, V9, P2866, DOI 10.4161/cc.9.14.12408; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stark JM, 2003, MOL CELL BIOL, V23, P733, DOI 10.1128/MCB.23.2.733-743.2003; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; Veuger SJ, 2003, CANCER RES, V63, P6008; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Weterings E, 2003, NUCLEIC ACIDS RES, V31, P7238, DOI 10.1093/nar/gkg889; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105	73	81	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42470	42482		10.1074/jbc.M111.309252	http://dx.doi.org/10.1074/jbc.M111.309252			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22027841	Green Published, hybrid			2022-12-25	WOS:000298180900055
J	Leggat, W; Seneca, F; Wasmund, K; Ukani, L; Yellowlees, D; Ainsworth, TD				Leggat, William; Seneca, Francois; Wasmund, Kenneth; Ukani, Lubna; Yellowlees, David; Ainsworth, Tracy D.			Differential Responses of the Coral Host and Their Algal Symbiont to Thermal Stress	PLOS ONE			English	Article							REEF-BUILDING CORALS; GENE-EXPRESSION; HEAT-STRESS; MICROARRAY ANALYSIS; INVERTEBRATE SYMBIOSIS; ACROPORA-MILLEPORA; REGULATED GENES; DINOFLAGELLATE; TEMPERATURE; SYMBIODINIUM	The success of any symbiosis under stress conditions is dependent upon the responses of both partners to that stress. The coral symbiosis is particularly susceptible to small increases of temperature above the long term summer maxima, which leads to the phenomenon known as coral bleaching, where the intracellular dinoflagellate symbionts are expelled. Here we for the first time used quantitative PCR to simultaneously examine the gene expression response of orthologs of the coral Acropora aspera and their dinoflagellate symbiont Symbiodinium. During an experimental bleaching event significant up-regulation of genes involved in stress response (HSP90 and HSP70) and carbon metabolism (glyceraldehyde-3-phosphate dehydrogenase, alpha-ketoglutarate dehydrogenase, glycogen synthase and glycogen phosphorylase) from the coral host were observed. In contrast in the symbiont, HSP90 expression decreased, while HSP70 levels were increased on only one day, and only the alpha-ketoglutarate dehydrogenase expression levels were found to increase. In addition the changes seen in expression patterns of the coral host were much larger, up to 10.5 fold, compared to the symbiont response, which in all cases was less than 2-fold. This targeted study of the expression of key metabolic and stress genes demonstrates that the response of the coral and their symbiont vary significantly, also a response in the host transcriptome was observed prior to what has previously been thought to be the temperatures at which thermal stress events occur.	[Leggat, William; Seneca, Francois; Wasmund, Kenneth; Ukani, Lubna] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Leggat, William; Yellowlees, David; Ainsworth, Tracy D.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Leggat, W (corresponding author), James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia.	bill.leggat@jcu.edu.au	Seneca, Francois/F-9040-2010; Wasmund, Kenneth/A-2265-2016; Leggat, William/C-4532-2012; Yellowlees, David/A-5379-2013; Ainsworth, Tracy D/L-7309-2016; Leggat, Bill/AAJ-8929-2020	Seneca, Francois/0000-0002-8908-1227; Wasmund, Kenneth/0000-0001-6706-7291; Ainsworth, Tracy D/0000-0001-6476-9263; Leggat, Bill/0000-0003-4148-2555	Australian Research Council Centre of Excellence for Coral Reef Studies [CE0561435]; Australian Research Council [DP0877226]	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Research Council(Australian Research Council)	This project was supported by funding from the Australian Research Council Centre of Excellence for Coral Reef Studies (CE0561435, http://www.coralcoe.org.au/) and an Australian Research Council funded discovery project to TA (DP0877226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; Boldt L, 2010, P 11 ICRS FT LAUD FL, P118; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Diaz-Almeyda E, 2011, CORAL REEFS, V30, P217, DOI 10.1007/s00338-010-0691-5; Dove S, 2004, MAR ECOL PROG SER, V272, P99, DOI 10.3354/meps272099; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Edmunds PJ, 2005, MAR BIOL, V146, P655, DOI 10.1007/s00227-004-1485-5; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Gordon BR, 2010, MAR DRUGS, V8, P2546, DOI 10.3390/md8102546; Hoegh-Guldberg O, 2004, CORAL REEFS, V23, P444, DOI 10.1007/s00338-004-0401-2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Leggat W, 2003, PLANT CELL ENVIRON, V26, P1951, DOI 10.1046/j.0016-8025.2003.01111.x; LEGGAT W, 2011, J EXPT MARI IN PRESS; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Miller DJ, 2011, J EXP MAR BIOL ECOL, V408, P114, DOI 10.1016/j.jembe.2011.07.031; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; OHTAKA C, 1991, SYMBIOSIS, V11, P19; Okamoto OK, 2003, GENE, V321, P73, DOI 10.1016/j.gene.2003.07.003; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Okamoto OK, 2001, J BIOL CHEM, V276, P19989, DOI 10.1074/jbc.M101169200; Papina M, 2007, COMP BIOCHEM PHYS B, V147, P583, DOI 10.1016/j.cbpb.2007.02.011; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Robbart ML, 2004, MAR ECOL PROG SER, V283, P151, DOI 10.3354/meps283151; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; ROSIC N, 2010, MARINE BIOTECHNOLOGY, P1; ROSIC N, 2010, CELL STRESS CHAPERON, P1; SENECA F, 2010, MARINE BIOTECHNOLOGY, P1; SHARP VA, 1994, J EXP MAR BIOL ECOL, V179, P179, DOI 10.1016/0022-0981(94)90113-9; Sharp VA, 1997, J THERM BIOL, V22, P11, DOI 10.1016/S0306-4565(96)00029-0; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Van Dolah FM, 2007, J PHYCOL, V43, P741, DOI 10.1111/j.1529-8817.2007.00354.x; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Voolstra CR, 2009, COMP BIOCHEM PHYS D, V4, P67, DOI 10.1016/j.cbd.2008.11.001; Wang JT, 1998, J EXP BIOL, V201, P2445; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilcox JL, 2003, MOL MICROBIOL, V48, P1491, DOI 10.1046/j.1365-2958.2003.03522.x; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	60	100	100	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26687	10.1371/journal.pone.0026687	http://dx.doi.org/10.1371/journal.pone.0026687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039532	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000296515200041
J	Osan, R; Su, E; Shinbrot, T				Osan, Remus; Su, Emily; Shinbrot, Troy			The Interplay between Branching and Pruning on Neuronal Target Search during Developmental Growth: Functional Role and Implications	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; PYRAMIDAL NEURONS; SENSORY NEURONS; MAP DEVELOPMENT; INTERNEURONS; PLASTICITY; ARBORS; CELLS; AXONS; OPTIMIZATION	Regenerative strategies that facilitate the regrowth and reconnection of neurons are some of the most promising methods in spinal cord injury research. An essential part of these strategies is an increased understanding of the mechanisms by which growing neurites seek out and synapse with viable targets. In this paper, we use computational and theoretical tools to examine the targeting efficiency of growing neurites subject to limited resources, such as maximum total neural tree length. We find that in order to efficiently reach a particular target, growing neurites must achieve balance between pruning and branching: rapidly growing neurites that do not prune will exhaust their resources, and frequently pruning neurites will fail to explore space effectively. We also find that the optimal branching/pruning balance must shift as the target distance changes: different strategies are called for to reach nearby vs. distant targets. This suggests the existence of a currently unidentified higher-level regulatory factor to control arborization dynamics. We propose that these findings may be useful in future therapies seeking to improve targeting rates through manipulation of arborization behaviors.	[Osan, Remus] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Osan, Remus] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Su, Emily; Shinbrot, Troy] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	University System of Georgia; Georgia State University; Boston University; Rutgers State University New Brunswick	Osan, R (corresponding author), Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA.	rosan@gsu.edu			Center for Neuroscience, Boston University; New Jersey Commission on Spinal Cord Research [06-3055-SCR-E-0, 07-2932-SCR-E-0]	Center for Neuroscience, Boston University; New Jersey Commission on Spinal Cord Research	R.O. has received funding from the Center for Neuroscience, Boston University (internal grant). E.S. and T.S. have received funding from the New Jersey Commission on Spinal Cord Research (06-3055-SCR-E-0 and 07-2932-SCR-E-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2001, ANAT EMBRYOL, V204, P283, DOI 10.1007/s004290100201; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; BURKE RE, 1992, J NEUROSCI, V12, P2403; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; CHERNIAK C, 1992, BIOL CYBERN, V66, P503, DOI 10.1007/BF00204115; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; Chklovskii DB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-18; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Faulkner RL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-21; Friedrich BM, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026007; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Godfrey KB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000600; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Kandel E., 2000, PRINCIPLES NEURAL SC; KATER SB, 1994, PROG BRAIN RES, V102, P49; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; LETOURNEAU PC, 1994, PROG BRAIN RES, V102, P35; Lindsay KA, 2007, MATH BIOSCI, V205, P271, DOI 10.1016/j.mbs.2006.08.005; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; Maskery SM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-22; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; O'Leary DDM, 1900, COLD SPRING HARB SYM, V55, P453; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Sang Q, 2002, MOL CELL NEUROSCI, V21, P250, DOI 10.1006/mcne.2002.1156; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schierwagen A, 2008, NEUROPHYSIOLOGY+, V40, P310, DOI 10.1007/s11062-009-9054-7; Sheasby BW, 1999, J NEUROPHYSIOL, V81, P1685, DOI 10.1152/jn.1999.81.4.1685; Shefi O, 2004, NEUROCOMPUTING, V58, P487, DOI [10.1016/j.neucom.2004.01.85, 10.1016/j.neucom.2004.01.085]; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; TOLBERT DL, 1987, DEV BRAIN RES, V33, P11, DOI 10.1016/0165-3806(87)90171-4; Uylings HBM, 2002, NETWORK-COMP NEURAL, V13, P397, DOI 10.1088/0954-898X/13/3/309; van Ooyen A, 2002, NETWORK-COMP NEURAL, V13, P311, DOI 10.1088/0954-898X/13/3/304; Van Pelt J., 2005, MODELING NEUROSCIENC, P89, DOI DOI 10.1201/9780203390979.CH5; Washington SD, 2000, NEUROCOMPUTING, V32, P261, DOI 10.1016/S0925-2312(00)00173-9; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25135	10.1371/journal.pone.0025135	http://dx.doi.org/10.1371/journal.pone.0025135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028773	gold, Green Submitted, Green Published			2022-12-25	WOS:000296510800004
J	Maier, S; Schleberger, P; Lu, W; Wacker, T; Pfluger, T; Litz, C; Andrade, SLA				Maier, Sarah; Schleberger, Paula; Lu, Wei; Wacker, Tobias; Pflueger, Tobias; Litz, Claudia; Andrade, Susana L. A.			Mechanism of Disruption of the Amt-GlnK Complex by P-II-Mediated Sensing of 2-Oxoglutarate	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PROTEIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GLUTAMINE-SYNTHETASE; AMMONIA TRANSPORT; NITROGEN; PII; REVEALS; ARABIDOPSIS; CYANOBACTERIA	GlnK proteins regulate the active uptake of ammonium by Amt transport proteins by inserting their regulatory T-loops into the transport channels of the Amt trimer and physically blocking substrate passage. They sense the cellular nitrogen status through 2-oxoglutarate, and the energy level of the cell by binding both ATP and ADP with different affinities. The hyperthermophilic euryarchaeon Archaeoglobus fulgidus possesses three Amt proteins, each encoded in an operon with a GlnK ortholog. One of these proteins, GlnK2 was recently found to be incapable of binding 2-OG, and in order to understand the implications of this finding we conducted a detailed structural and functional analysis of a second GlnK protein from A. fulgidus, GlnK3. Contrary to Af-GlnK2 this protein was able to bind both ATP/2-OG and ADP to yield inactive and functional states, respectively. Due to the thermostable nature of the protein we could observe the exact positioning of the notoriously flexible T-loops and explain the binding behavior of GlnK proteins to their interaction partner, the Amt proteins. A thermodynamic analysis of these binding events using microcalorimetry evaluated by microstate modeling revealed significant differences in binding cooperativity compared to other characterized P-II proteins, underlining the diversity and adaptability of this class of regulatory signaling proteins.	[Maier, Sarah; Schleberger, Paula; Lu, Wei; Wacker, Tobias; Pflueger, Tobias; Litz, Claudia; Andrade, Susana L. A.] Univ Freiburg, Inst Organ Chem & Biochem, D-7800 Freiburg, Germany	University of Freiburg	Maier, S (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-7800 Freiburg, Germany.	andrade@bio.chemie.uni-freiburg.de	Andrade, Susana L. A./D-5119-2012	Andrade, Susana L. A./0000-0003-2267-8499; Litz, Claudia/0000-0002-7527-0633	Deutsche Forschungsgemeinschaft [AN 676/1, IRTG 1478]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de), grants AN 676/1 and IRTG 1478. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Atkinson MR, 1998, MOL MICROBIOL, V29, P431, DOI 10.1046/j.1365-2958.1998.00932.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Blauwkamp TA, 2002, MOL MICROBIOL, V46, P203, DOI 10.1046/j.1365-2958.2002.03153.x; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; Fokina O, 2010, J MOL BIOL, V399, P410, DOI 10.1016/j.jmb.2010.04.018; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Forchhammer K, 1997, EUR J BIOCHEM, V244, P869, DOI 10.1111/j.1432-1033.1997.00869.x; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Heinrich A, 2006, J BIOL CHEM, V281, P34909, DOI 10.1074/jbc.M607582200; Helfmann S, 2010, J MOL BIOL, V402, P165, DOI 10.1016/j.jmb.2010.07.020; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; HURWITZ C, 1967, J BIOL CHEM, V242, P3719; Jaggi R, 1996, FEBS LETT, V391, P223, DOI 10.1016/0014-5793(96)00737-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Litz C, 2011, ACTA CRYSTALLOGR F, V67, P178, DOI 10.1107/S1744309110047482; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Mizuno Y, 2007, BIOCHEMISTRY-US, V46, P1477, DOI 10.1021/bi062149e; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Radchenko MV, 2010, J BIOL CHEM, V285, P31037, DOI 10.1074/jbc.M110.153908; Smith CS, 2003, PLANT J, V33, P353, DOI 10.1046/j.1365-313X.2003.01634.x; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; TEMPEST DW, 1970, BIOCHEM J, V117, P405, DOI 10.1042/bj1170405; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Uhrig RG, 2009, TRENDS PLANT SCI, V14, P505, DOI 10.1016/j.tplants.2009.07.003; vanHeeswijk WC, 1996, MOL MICROBIOL, V21, P133, DOI 10.1046/j.1365-2958.1996.6281349.x; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	45	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26327	10.1371/journal.pone.0026327	http://dx.doi.org/10.1371/journal.pone.0026327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039461	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500050
J	Rosidi, NL; Zhou, J; Pattanaik, S; Wang, P; Jin, WY; Brophy, M; Olbricht, WL; Nishimura, N; Schaffer, CB				Rosidi, Nathanael L.; Zhou, Joan; Pattanaik, Sanket; Wang, Peng; Jin, Weiyang; Brophy, Morgan; Olbricht, William L.; Nishimura, Nozomi; Schaffer, Chris B.			Cortical Microhemorrhages Cause Local Inflammation but Do Not Trigger Widespread Dendrite Degeneration	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; BETA-AMYLOID DEPOSITION; IN-VIVO; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; FRACTALKINE-RECEPTOR; MICROGLIAL CELLS; EDEMA FORMATION; CRANIAL WINDOW	Microhemorrhages are common in the aging brain, and their incidence is correlated with increased risk of neurodegenerative disease. Past work has shown that occlusion of individual cortical microvessels as well as large-scale hemorrhages can lead to degeneration of neurons and increased inflammation. Using two-photon excited fluorescence microscopy in anesthetized mice, we characterized the acute and chronic dynamics of vessel bleeding, tissue compression, blood flow change, neural degeneration, and inflammation following a microhemorrhage caused by rupturing a single penetrating arteriole with tightly-focused femtosecond laser pulses. We quantified the extravasation of red blood cells (RBCs) and blood plasma into the brain and determined that the bleeding was limited by clotting. The vascular bleeding formed a RBC-filled core that compressed the surrounding parenchymal tissue, but this compression was not sufficient to crush nearby brain capillaries, although blood flow speeds in these vessels was reduced by 20%. Imaging of cortical dendrites revealed no degeneration of the large-scale structure of the dendritic arbor up to 14 days after the microhemorrhage. Dendrites close to the RBC core were displaced by extravasating RBCs but began to relax back one day after the lesion. Finally, we observed a rapid inflammatory response characterized by morphology changes in microglia/macrophages up to 200 mu m from the microhemorrhage as well as extension of cellular processes into the RBC core. This inflammation persisted over seven days. Taken together, our data suggest that a cortical microhemorrhage does not directly cause significant neural pathology but does trigger a sustained, local inflammatory response.	[Rosidi, Nathanael L.; Zhou, Joan; Pattanaik, Sanket; Jin, Weiyang; Brophy, Morgan; Olbricht, William L.; Nishimura, Nozomi; Schaffer, Chris B.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Wang, Peng; Olbricht, William L.] Cornell Univ, Dept Chem & Biomol Engn, Ithaca, NY USA	Cornell University; Cornell University	Rosidi, NL (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	cs385@cornell.edu	Schaffer, Chris B./A-7409-2008; Nishimura, Nozomi/P-8908-2015; Nishimura, Nozomi/AAV-2425-2020	Schaffer, Chris B./0000-0002-7800-9596; Nishimura, Nozomi/0000-0003-4342-9416; Nishimura, Nozomi/0000-0003-4342-9416	American Heart Association [0735644T]; Ellison Medical Foundation [AG-NS-0330-86]; National Institutes of Health [1F32AG031620-01A2]; L'Oreal USA Fellowship for Women in Science; National Science Foundation [0841291]; NATIONAL INSTITUTE ON AGING [F32AG031620] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L'Oreal USA Fellowship for Women in Science; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the American Heart Association (0735644T to CBS) and the Ellison Medical Foundation (AG-NS-0330-86 to CBS), by a National Institutes of Health post-doctoral fellowship (1F32AG031620-01A2 to NN), a L'Oreal USA Fellowship for Women in Science fellowship (NN), and a National Science Foundation GK-12 fellowship (0841291 to NLR). We would also like to thank IMRA America, Inc. for the loan of laser equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NN received a L'Oreal USA Fellowship for Women in Science. The authors received a loan of laser equipment (mu Jewel FCPA) that was used in these experiments from IMRA America, Inc. This support does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BASSER PJ, 1992, MICROVASC RES, V44, P143, DOI 10.1016/0026-2862(92)90077-3; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Biber K, 2008, J NEUROIMMUNOL, V198, P69, DOI 10.1016/j.jneuroim.2008.04.012; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flaherty ML, 2008, NEUROLOGY, V71, P1084, DOI 10.1212/01.wnl.0000326895.58992.27; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Fujimoto S, 2008, J CEREBR BLOOD F MET, V28, P506, DOI 10.1038/sj.jcbfm.9600547; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; LAUER A, 2011, CIRCULATION; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966; MacLellan CL, 2010, STROKE, V41, pS95, DOI 10.1161/STROKEAHA.110.594457; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mendelow A D, 1984, Neurol Res, V6, P189; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Mostany R, 2011, J NEUROSCI, V31, P1734, DOI 10.1523/JNEUROSCI.4386-10.2011; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nishino Hitoo, 1994, Neurobiology (Budapest), V2, P223; PETITO CK, 1984, J NEUROPATH EXP NEUR, V43, P141, DOI 10.1097/00005072-198403000-00004; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Tanaka R, 2003, NEUROSCIENCE, V117, P531, DOI 10.1016/S0306-4522(02)00954-5; Terai K, 2003, NEUROCHEM RES, V28, P779, DOI 10.1023/A:1022826220469; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	52	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26612	10.1371/journal.pone.0026612	http://dx.doi.org/10.1371/journal.pone.0026612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028924	Green Published, gold, Green Submitted			2022-12-25	WOS:000296507500098
J	Bogaert, S; De Vos, M; Olievier, K; Peeters, H; Elewaut, D; Lambrecht, B; Pouliot, P; Laukens, D				Bogaert, Sara; De Vos, Martine; Olievier, Kim; Peeters, Harald; Elewaut, Dirk; Lambrecht, Bart; Pouliot, Philippe; Laukens, Debby			Involvement of Endoplasmic Reticulum Stress in Inflammatory Bowel Disease: A Different Implication for Colonic and Ileal Disease?	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; XBP1 MESSENGER-RNA; ER STRESS; ATF6; EXPRESSION; IRE1; TRANSLATION; INHIBITION; CLEAVAGE; KINASE	Background: Endoplasmic reticulum (ER) stress has been suggested to play a role in inflammatory bowel disease (IBD). The three branches (ATF6, IRE1 and PERK) of the unfolded protein response (UPR) have different roles and are not necessarily activated simultaneously. Methodology/Principal Findings: Expression of UPR-related genes was investigated in colonic and ileal biopsies of 23 controls, 15 ulcerative colitis (UC) and 54 Crohn's disease (CD) patients. This expression was confirmed at protein level in colonic and ileal samples of five controls, UC and CD patients. HSPA5, PDIA4 and XBP1s were significantly increased in colonic IBD at mRNA and/or protein levels, indicating activation of the ATF6 and IRE1 branch. Colonic IBD was associated with increased phosphorylation of EIF2A suggesting the activation of the PERK branch, but subsequent induction of GADD34 was not observed. In ileal CD, no differential expression of the UPR-related genes was observed, but our data suggested a higher basal activation of the UPR in the ileal mucosa of controls. This was confirmed by the increased expression of 16 UPR-related genes as 12 of them were significantly more expressed in ileal controls compared to colonic controls. Tunicamycin stimulation of colonic and ileal samples of healthy individuals revealed that although the ileal mucosa is exhibiting this higher basal UPR activation, it is still responsive to ER stress, even more than colonic mucosa. Conclusions/Significance: Activation of the three UPR-related arms is seen in colonic IBD-associated inflammation. However, despite EIF2A activation, inflamed colonic tissue did not increase GADD34 expression, which is usually involved in re-establishment of ER homeostasis. This study also implies the presence of a constitutive UPR activation in healthy ileal mucosa, with no further activation during inflammation. Therefore, engagement of the UPR differs between colon and ileum and this could be a factor in the development of ileal or colonic disease.	[Bogaert, Sara; De Vos, Martine; Olievier, Kim; Peeters, Harald; Laukens, Debby] Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium; [Elewaut, Dirk] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium; [Lambrecht, Bart; Pouliot, Philippe] Univ Ghent, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Bogaert, S (corresponding author), Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium.	martine.devos@ugent.be	Lambrecht, Bart N/K-2484-2014; Elewaut, Dirk/K-6831-2014	Lambrecht, Bart N/0000-0003-4376-6834; Laukens, Debby/0000-0002-1984-5850; Elewaut, Dirk/0000-0002-7468-974X	Ghent University [GOA2001/12051501]; MSD; Abott; Ghent University (GROUP-ID-MRP)	Ghent University(Ghent University); MSD; Abott; Ghent University (GROUP-ID-MRP)(Ghent University)	This study is supported by a concerted action grant GOA2001/12051501 of Ghent University, a grant of MSD and a grant of Abott. MSD and Abott had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Lambrecht, Dr. Elewaut and Dr. Pouliot are supported by a MRP grant of Ghent University (GROUP-ID-MRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P15, DOI 10.1097/00054725-200401000-00002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Boden G, 2010, J CLIN ENDOCR METAB, V95, P349, DOI 10.1210/jc.2009-1815; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Daig R, 1996, GUT, V38, P216, DOI 10.1136/gut.38.2.216; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Ishiguro Y, 1999, J GASTROENTEROL, V34, P66, DOI 10.1007/s005350050218; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeire S, 2004, GUT, V53, P980, DOI 10.1136/gut.2003.034033; Vermeulen Joelle, 2009, BMC Res Notes, V2, P235, DOI 10.1186/1756-0500-2-235; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	43	53	55	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25589	10.1371/journal.pone.0025589	http://dx.doi.org/10.1371/journal.pone.0025589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028783	Green Published, Green Submitted, gold			2022-12-25	WOS:000296186900012
J	Galsworthy, SJ; ten Bosch, QA; Hoye, BJ; Heesterbeek, JAP; Klaassen, M; Klinkenberg, D				Galsworthy, Stephen J.; ten Bosch, Quirine A.; Hoye, Bethany J.; Heesterbeek, Johan A. P.; Klaassen, Marcel; Klinkenberg, Don			Effects of Infection-Induced Migration Delays on the Epidemiology of Avian Influenza in Wild Mallard Populations	PLOS ONE			English	Article							A VIRUS; ANAS-PLATYRHYNCHOS; ENVIRONMENTAL TRANSMISSION; SATELLITE TELEMETRY; NORTHERN EUROPE; H5N1 VIRUS; BIRDS; SPREAD; DUCKS; SURVEILLANCE	Wild waterfowl populations form a natural reservoir of Avian Influenza (AI) virus, and fears exist that these birds may contribute to an AI pandemic by spreading the virus along their migratory flyways. Observational studies suggest that individuals infected with AI virus may delay departure from migratory staging sites. Here, we explore the epidemiological dynamics of avian influenza virus in a migrating mallard (Anas platyrhynchos) population with a specific view to understanding the role of infection-induced migration delays on the spread of virus strains of differing transmissibility. We develop a host-pathogen model that combines the transmission dynamics of influenza with the migration, reproduction and mortality of the host bird species. Our modeling predicts that delayed migration of individuals influences both the timing and size of outbreaks of AI virus. We find that (1) delayed migration leads to a lower total number of cases of infection each year than in the absence of migration delay, (2) when the transmission rate of a strain is high, the outbreak starts at the staging sites at which birds arrive in the early part of the fall migration, (3) when the transmission rate is low, infection predominantly occurs later in the season, which is further delayed when there is a migration delay. As such, the rise of more virulent AI strains in waterfowl could lead to a higher prevalence of infection later in the year, which could change the exposure risk for farmed poultry. A sensitivity analysis shows the importance of generation time and loss of immunity for the effect of migration delays. Thus, we demonstrate, in contrast to many current transmission risk models solely using empirical information on bird movements to assess the potential for transmission, that a consideration of infection-induced delays is critical to understanding the dynamics of AI infection along the entire flyway.	[Galsworthy, Stephen J.; ten Bosch, Quirine A.; Heesterbeek, Johan A. P.; Klinkenberg, Don] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [ten Bosch, Quirine A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Hoye, Bethany J.; Klaassen, Marcel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrat Ecol, Geelong, Vic 3217, Australia	Utrecht University; University of Notre Dame; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Galsworthy, SJ (corresponding author), Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.	d.klinkenberg@uu.nl	Hoye, Bethany J/A-4486-2010; Bosch, Quirine ten/H-6734-2019; Klaassen, Marcel/B-4325-2008	Hoye, Bethany J/0000-0001-9502-5582; Bosch, Quirine ten/0000-0002-5227-1406; Klaassen, Marcel/0000-0003-3907-9599; Klinkenberg, Don/0000-0002-9449-6873; Heesterbeek, Hans/0000-0001-8537-6418	Research Council for Earth and Life Sciences (ALW); Netherlands Organization for Scientific Research (NWO) [851.40.073, 851.40.074]; National Institutes of Health [NIAIDNIH HHSN266200700010C]	Research Council for Earth and Life Sciences (ALW)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Research Council for Earth and Life Sciences (ALW) and through the Bird Health programme within the International Polar Year, by the Netherlands Organization for Scientific Research (NWO), grants 851.40.073 and 851.40.074. Further support was received from the Intramural Research Programme of the National Institutes of Health, contract NIAIDNIH HHSN266200700010C. This is publication 5110 of the NIOO-KNAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Bourouiba L, 2010, J R SOC INTERFACE, V7, P1627, DOI 10.1098/rsif.2010.0126; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brochet AL, 2009, ECOHEALTH, V6, P449, DOI 10.1007/s10393-010-0275-4; Capua I, 2007, INFLUENZA OTHER RESP, V1, P11, DOI 10.1111/j.1750-2659.2006.00004.x; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Cumming GS, 2008, ECOL SOC, V13; Delany S, 2006, WATERBIRD POPULATION; Domanska-Blicharz K, 2010, AVIAN DIS, V54, P734, DOI 10.1637/8786-040109-ResNote.1; Feare CJ, 2010, AVIAN DIS, V54, P201, DOI 10.1637/8766-033109-ResNote.1; Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henaux V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010997; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; Hirschfeld Axel, 2005, Berichte zum Vogelschutz, V42, P47; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Schekkerman H, 2008, POPULATION DYNAMICS; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; van der Goot JA, 2008, VIROLOGY, V382, P91, DOI 10.1016/j.virol.2008.08.037; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; van Roomen M., 2007, WATERVOGELS NEDERLAN; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yamaguchi N, 2008, ZOOL SCI, V25, P875, DOI 10.2108/zsj.25.875	41	23	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26118	10.1371/journal.pone.0026118	http://dx.doi.org/10.1371/journal.pone.0026118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028812	Green Published, gold			2022-12-25	WOS:000296186900027
J	Stockl, D; Meisinger, C; Peters, A; Thorand, B; Huth, C; Heier, M; Rathmann, W; Kowall, B; Stockl, H; Doring, A				Stoeckl, Doris; Meisinger, Christa; Peters, Annette; Thorand, Barbara; Huth, Cornelia; Heier, Margit; Rathmann, Wolfgang; Kowall, Bernd; Stoeckl, Heidi; Doering, Angela			Age at Menarche and Its Association with the Metabolic Syndrome and Its Components: Results from the KORA F4 Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; POSTMENOPAUSAL WOMEN; CHILDHOOD PREDICTORS; REPRODUCTIVE HISTORY; ADULTHOOD; OBESITY; DEFINITIONS; POPULATION; MENOPAUSE; HEALTH	Objective: The metabolic syndrome is a major public health challenge and identifies persons at risk for diabetes and cardiovascular disease. The aim of this study was to examine the association between age at menarche and the metabolic syndrome (IDF and NCEP ATP III classification) and its components. Design: 1536 women aged 32 to 81 years of the German population based KORA F4 study were investigated. Data was collected by standardized interviews, physical examinations, and whole blood and serum measurements. Results: Young age at menarche was significantly associated with elevated body mass index (BMI), greater waist circumference, higher fasting glucose levels, and 2 hour glucose (oral glucose tolerance test), even after adjusting for the difference between current BMI and BMI at age 25. The significant effect on elevated triglycerides and systolic blood pressure was attenuated after adjustment for the BMI change. Age at menarche was inversely associated with the metabolic syndrome adjusting for age (p-values: <0.001 IDF, 0.003 NCEP classification) and additional potential confounders including lifestyle and reproductive history factors (p-values: 0.001, 0.005). Associations remain significant when additionally controlling for recollected BMI at age 25 (p-values: 0.008, 0.033) or the BMI change since age 25 (p-values: 0.005, 0.022). Conclusion: Young age at menarche might play a role in the development of the metabolic syndrome. This association is only partially mediated by weight gain and increased BMI. A history of early menarche may help to identify women at risk for the metabolic syndrome.	[Stoeckl, Doris; Meisinger, Christa; Peters, Annette; Thorand, Barbara; Huth, Cornelia; Heier, Margit] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Stoeckl, Doris] Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Rathmann, Wolfgang; Kowall, Bernd] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Stoeckl, Heidi] London Sch Hyg & Trop Med, Social & Math Epidemiol Grp, London WC1, England; [Doering, Angela] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of London; London School of Hygiene & Tropical Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stockl, D (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany.	doris.stoeckl@helmholtz-muenchen.de	Stöckl, Doris/B-5352-2014; Thorand, Barbara/B-5349-2014; Peters, Annette/A-6117-2011; Meisinger, Christine/B-5358-2014; Heier, Margit/AAT-5280-2020; Huth, Cornelia/B-5350-2014	Thorand, Barbara/0000-0002-8416-6440; Peters, Annette/0000-0001-6645-0985; Huth, Cornelia/0000-0003-2421-433X; Stockl, Heidi/0000-0002-0907-8483; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research; MRC [G0802699] Funding Source: UKRI; Medical Research Council [G0802699] Funding Source: researchfish	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria and Cornelia Huth was supported by a grant from the German Federal Ministry of Education and Research to the German Center for Diabetes Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Boronat M, 2009, NUTR METAB CARDIOVAS, V19, P417, DOI 10.1016/j.numecd.2008.07.010; Bosetti C, 2001, J CLIN EPIDEMIOL, V54, P902, DOI 10.1016/S0895-4356(01)00362-6; Boudreau DM, 2009, METAB SYNDR RELAT D, V7, P305, DOI 10.1089/met.2008.0070; Cho GJ, 2009, MENOPAUSE, V16, P998, DOI 10.1097/gme.0b013e3181a03807; Cui R, 2006, J EPIDEMIOL, V16, P177, DOI 10.2188/jea.16.177; Day Caroline, 2007, Diab Vasc Dis Res, V4, P32, DOI 10.3132/dvdr.2007.003; de Kleijn MJJ, 1999, MATURITAS, V33, P7, DOI 10.1016/S0378-5122(99)00038-9; Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19; Elks CE., 2010, NAT GENET, V42, P1077; Feng Y, 2008, ATHEROSCLEROSIS, V196, P590, DOI 10.1016/j.atherosclerosis.2007.06.016; Freedman David S, 2003, BMC Pediatr, V3, P3, DOI 10.1186/1471-2431-3-3; Frontini MG, 2003, INT J OBESITY, V27, P1398, DOI 10.1038/sj.ijo.0802422; GARN SM, 1986, AM J CLIN NUTR, V43, P879, DOI 10.1093/ajcn/43.6.879; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gunderson EP, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.031; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Heys M, 2007, EPIDEMIOLOGY, V18, P740, DOI 10.1097/EDE.0b013e3181567faf; Kivimaki M, 2008, AM J CLIN NUTR, V87, P1876, DOI 10.1093/ajcn/87.6.1876; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lao XQ, 2006, CLIN ENDOCRINOL, V65, P460, DOI 10.1111/j.1365-2265.2006.02615.x; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; Mousavi E, 2009, METAB SYNDR RELAT D, V7, P519, DOI 10.1089/met.2008.0076; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; Rathmann W, 2006, DIABETES CARE, V29, P461, DOI 10.2337/diacare.29.02.06.dc05-1885; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Remsberg KE, 2005, J CLIN ENDOCR METAB, V90, P2718, DOI 10.1210/jc.2004-1991; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; vanLenthe FJ, 1996, AM J CLIN NUTR, V64, P18, DOI 10.1093/ajcn/64.1.18	35	77	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26076	10.1371/journal.pone.0026076	http://dx.doi.org/10.1371/journal.pone.0026076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028807	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900026
J	Tori, K; Perler, FB				Tori, Kazuo; Perler, Francine B.			The Arthrobacter Species FB24 Arth_1007 (DnaB) Intein Is a Pseudogene	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; MECHANISM	An Arthrobacter species FB24 gene (locus tag Arth_1007) was previously annotated as a putative intein-containing DnaB helicase of phage origin (Arsp-FB24 DnaB intein). However, it is not a helicase gene because the sequence similarity is limited to inteins. In fact, the flanking exteins total only 66 amino acids. Therefore, the intein should be referred to as the Arsp-FB24 Arth_1007 intein. The Arsp-FB24 Arth_1007 intein failed to splice in its native precursor and in a model precursor. We previously noted that the Arsp-FB24 Arth_1007 intein is the only putative Class 3 intein that is missing the catalytically essential Cys at position 4 of intein Motif F, which is one of the three defining signature residues of this class. Additionally, a catalytically essential His in position 10 of intein Motif B is also absent; this His is the most conserved residue amongst all inteins. Splicing activity was not rescued when these two catalytically important positions were 'reverted' back to their consensus residues. This study restores the unity of the Class 3 intein signature sequence in active inteins by demonstrating that the Arsp-FB24 Arth_1007 intein is an inactive pseudogene.	[Tori, Kazuo; Perler, Francine B.] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Tori, K (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	perler@neb.com			New England Biolabs	New England Biolabs	We thank Manoj Cheriyan (New England Biolabs) for helpful discussions, Lise Raleigh for reading of the manuscript (New England Biolabs) and Don Comb (New England Biolabs) for support and encouragement.	Brace LE, 2010, PROTEIN SCI, V19, P1525, DOI 10.1002/pro.431; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mills KV, 2005, PROTEIN PEPTIDE LETT, V12, P751, DOI 10.2174/0929866054864337; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Paulus H, 1998, CHEM SOC REV, V27, P375, DOI 10.1039/a827375z; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Tori K, 2011, J BACTERIOL, V193, P2035, DOI 10.1128/JB.01407-10; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567	16	6	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26361	10.1371/journal.pone.0026361	http://dx.doi.org/10.1371/journal.pone.0026361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028863	Green Published, gold, Green Submitted			2022-12-25	WOS:000296186900053
J	Persons, WS; Currie, PJ				Persons, W. Scott; Currie, Philip J.			Dinosaur Speed Demon: The Caudal Musculature of Carnotaurus sastrei and Implications for the Evolution of South American Abelisaurids	PLOS ONE			English	Article							CARNIVOROUS DINOSAUR; ROTATIONAL INERTIA; ALLIGATOR; THEROPODA; TAIL	In the South American abelisaurids Carnotaurus sastrei, Aucasaurus garridoi, and, to a lesser extent Skorpiovenator bustingorryi, the anterior caudal ribs project at a high dorsolateral inclination and have interlocking lateral tips. This unique morphology facilitated the expansion of the caudal hypaxial musculature at the expense of the epaxial musculature. Distinct ridges on the ventrolateral surfaces of the caudal ribs of Aucasaurus garridoi are interpreted as attachment scars from the intra caudofemoralis/ilio-ischiocaudalis septa, and confirm that the M. caudofemoralis of advanced South American abelisaurids originated from a portion of the caudal ribs. Digital muscle models indicate that, relative to its overall body size, Carnotaurus sastrei had a substantially larger M. caudofemoralis than any other theropod yet studied. In most non-avian theropods, as in many extant sauropsids, the M. caudofemoralis served as the primary femoral retractor muscle during the locomotive power stroke. This large investment in the M. caudofemoralis suggests that Carnotaurus sastrei had the potential for great cursorial abilities, particularly short-burst sprinting. However, the tightly interlocking morphology of the anterior caudal vertebrae implies a reduced ability to make tight turns. Examination of these vertebral traits in evolutionary context reveals a progressive sequence of increasing caudofemoral mass and tail rigidity among the Abelisauridae of South America.	[Persons, W. Scott; Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Persons, WS (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	persons@ualberta.ca	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161	Dinosaur Research Institute	Dinosaur Research Institute	This work was made possible by the financial support of the Dinosaur Research Institute (http://www.dinosaurresearch.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Arbour VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006738; Bates KT, 2010, J VERTEBR PALEONTOL, V30, P458, DOI 10.1080/02724630903409329; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Brochu CA, 2002, SOC VERTEBRATE PALEO, V7, P1, DOI DOI 10.2307/3889334; Calvo JO, 2004, AMEGHINIANA, V41, P555; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2007, J VERTEBR PALEONTOL, V27, P163, DOI 10.1671/0272-4634(2007)27[163:TASOMC]2.0.CO;2; Carrano Matthew T., 2011, Smithsonian Contributions to Paleobiology, P1; Carrier DR, 2001, J EXP BIOL, V204, P3917; Cong L., 1998, GROSS ANATOMY ALLIGA; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Coria Rodolfo A., 2000, Gaia (Lisboa), V15, P89; Coria Rodolfo A., 2007, P229; Ernelinnov SW., 1937, ZOOLOGISCHE JB AOT, V62, P173; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Gatesy SM, 1997, J MORPHOL, V234, P197, DOI 10.1002/(SICI)1097-4687(199711)234:2<197::AID-JMOR6>3.0.CO;2-9; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS57, DOI 10.1098/rsbl.2003.0097; Higgins GM, 1923, AM J ANAT, V31, P373, DOI 10.1002/aja.1000310405; Juarez Valieri RD, 2010, PALEONTOLOGIA DINOSA, P161; Mallison H, 2011, PALAEONTOL ELECTRON, V14; Manning P., 2008, GRAVE SECRETS DINOSA; Mazzatta Gerardo V., 2000, Gaia (Lisboa), V15, P185; McNeel Robert & Associates, 2007, RHIN NURBS MOD WIND; Novas Fernando E., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P67; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; Paul GS, 2010, DINOSAUR MASS ESTIMA; Persons WS, 2011, ANAT REC, V294, P119, DOI 10.1002/ar.21290; RIEPPEL O, 1993, ZOOL J LINN SOC-LOND, V109, P301, DOI 10.1111/j.1096-3642.1993.tb02537.x; Romer A, 1956, OSTEOLOGY REPTILES; ROMER ALFRED S., 1927, ACTA ZOOL [STOCKHOLM], V8, P225; Romer AS, 1923, B AM MUS NAT HIST, V48, P605; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Sereno P.C., 1998, NEUES JB GEOLOGIE PA, V210, P41, DOI DOI 10.1127/NJGPA/210/1998/41; SNYDER RC, 1962, AM ZOOL, V2, P191; Wilhite R., 2003, THESIS LOUISIANA STA; Wilson Jeffrey A., 2003, Contributions from the Museum of Paleontology University of Michigan, V31, P1	39	36	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25763	10.1371/journal.pone.0025763	http://dx.doi.org/10.1371/journal.pone.0025763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043292	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400020
J	Salani, B; Maffioli, S; Hamoudane, M; Parodi, A; Ravera, S; Passalacqua, M; Alama, A; Nhiri, M; Cordera, R; Maggi, D				Salani, Barbara; Maffioli, Sara; Hamoudane, Meriem; Parodi, Alessia; Ravera, Silvia; Passalacqua, Mario; Alama, Angela; Nhiri, Mohamed; Cordera, Renzo; Maggi, Davide			Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells	FASEB JOURNAL			English	Article						NSCLC; AKT; FOXO3a; OCT1	ACTIVATED PROTEIN-KINASE; IN-VITRO; TRANSCRIPTION FACTORS; DIABETES-MELLITUS; GROWTH; INSULIN; RECEPTOR; EXPRESSION; THERAPY; PATHWAY	Metformin causes an AMP/ATP ratio increase and AMP-activated protein kinase (AMPK) activation. Since caveolin-1 (Cav-1) plays a role in AMPK activation and energy balance, we investigated whether Cav-1 could participate in metformin's inhibitory effect on IGF1 signaling. The effect of metformin was studied in two non-small-cell lung cancer (NSCLC) cell lines, Calu-1 and Calu-6, expressing higher and lower amounts of Cav-1, respectively. In Calu-1, but not in Calu-6 cells, metformin reduced phosphorylation of type 1 insulin-like growth factor receptor (IGF-IR) substrates Akt and Forkhead transcription factor 3a (FOXO3a), inhibited IGF1-dependent FOXO3a nuclear exit, and decreased IGF1-dependent cell proliferation. Here, we show that sensitivity of NSCLC cells to metformin was dependent on Cav-1 expression and that metformin required Cav-1 to induce AMPK phosphorylation and AMP/ATP ratio increase. Cav-1 silencing in Calu-1 and overexpression in Calu-6 reduced and improved, respectively, the inhibitory effect of metformin on IGF1-dependent Akt phosphorylation. Prolonged metformin treatment in Calu-6 cells induced a dose-dependent expression increase of Cav-1 and OCT1, a metformin transporter. Cav-1 and OCT1 expression was associated with the antiproliferative effect of metformin in Calu-6 cells (IC50 = 18 mM). In summary, these data suggest that Cav-1 is required for metformin action in NSCLC cells.-Salani, B., Maffioli, S., Hamoudane, M., Parodi, A., Ravera, S., Passalacqua, M., Alama, A., Nhiri, M., Cordera, R., Maggi, D. Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells. FASEB J. 26, 788-798 (2012). www.fasebj.org	[Salani, Barbara; Maffioli, Sara; Hamoudane, Meriem; Cordera, Renzo; Maggi, Davide] Univ Genoa, Dept Endocrinol & Med, I-16132 Genoa, Italy; [Parodi, Alessia] Univ Genoa, Dept Internal Med & Med Specialties, I-16132 Genoa, Italy; [Ravera, Silvia] Univ Genoa, Dept Biol, I-16132 Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Italian Inst Biostruct & Biosyst, I-16132 Genoa, Italy; [Hamoudane, Meriem; Nhiri, Mohamed] Univ Abdelmalek Essaadi, Fac Sci & Tech Tangier, Tangier, Morocco; [Alama, Angela] Natl Inst Canc Res, Lung Canc Unit, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; University of Genoa; Abdelmalek Essaadi University of Tetouan; University of Genoa; IRCCS AOU San Martino IST	Maggi, D (corresponding author), Univ Genoa, Dept Endocrinol & Med, Viale Benedetto 15-6, I-16132 Genoa, Italy.	davide.maggi@unige.it	Alama, Angela/AAE-7203-2019; Passalacqua, Mario/W-1973-2019; Ravera, Silvia/AAA-7982-2019; Cordera, Renzo/I-7229-2017; maggi, davide/AAL-4687-2020	Alama, Angela/0000-0002-9726-201X; Passalacqua, Mario/0000-0003-2779-6259; Ravera, Silvia/0000-0002-0803-1042; Cordera, Renzo/0000-0002-5280-9691; MAGGI, DAVIDE CARLO/0000-0003-3928-1295	Programma di Ricerca di Rilevante Interesse Nazionale; Fondazione Carige; University of Genoa	Programma di Ricerca di Rilevante Interesse Nazionale; Fondazione Carige(Fondazione Carige); University of Genoa	The authors thank Maria Rosa Dagnino for her skillful administrative assistance. This work was supported by grants from Programma di Ricerca di Rilevante Interesse Nazionale, Fondazione Carige, and the University of Genoa.	Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; BARZU O, 1983, FEBS LETT, V153, P280, DOI 10.1016/0014-5793(83)80624-3; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodt P, 2000, BIOCHEM PHARMACOL, V60, P1101, DOI 10.1016/S0006-2952(00)00422-6; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fang LA, 2011, TOXICOL APPL PHARM, V251, P8, DOI 10.1016/j.taap.2010.11.007; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gualberto A, 2010, CLIN CANCER RES, V16, P4654, DOI 10.1158/1078-0432.CCR-10-0089; Hartog H, 2007, EUR J CANCER, V43, P1895, DOI 10.1016/j.ejca.2007.05.021; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Iwasa T, 2009, CLIN CANCER RES, V15, P5117, DOI 10.1158/1078-0432.CCR-09-0478; Kikuchi R, 2012, ANN SURG ONCOL, V19, pS412, DOI 10.1245/s10434-011-1878-x; KORNBERG A, 1951, J BIOL CHEM, V193, P481; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li D, 2011, J DIABETES, V10, P649; Linnerth NM, 2009, NEOPLASIA, V11, P672, DOI 10.1593/neo.09310; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Moreno-Navarrete JM, 2011, DIABETES, V60, P168, DOI 10.2337/db10-0805; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Onozato R, 2007, CANCER SCI, V98, P1747, DOI 10.1111/j.1349-7006.2007.00585.x; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Pal SK, 2010, MOL CANCER THER, V9, P1931, DOI 10.1158/1535-7163.MCT-10-0239; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Raposio E, 2008, CELL PROLIFERAT, V41, P739, DOI 10.1111/j.1365-2184.2008.00547.x; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Razani B, 2001, J BIOL CHEM, V276, P38121; Reitman ML, 2007, J CLIN INVEST, V117, P1226, DOI 10.1172/JCI32133; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Roussel E, 2004, ANTI-CANCER DRUG, V15, P961, DOI 10.1097/00001813-200411000-00005; Salani B, 2008, ENDOCRINOLOGY, V149, P461, DOI 10.1210/en.2007-0312; Salani B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014157; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shukla S, 2009, INT J ONCOL, V34, P1613, DOI 10.3892/ijo_00000291; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; van den Heuvel APJ, 2005, BIOCHEM J, V385, P795, DOI 10.1042/BJ20041449; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18	57	54	58	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2012	26	2					788	798		10.1096/fj.11-192088	http://dx.doi.org/10.1096/fj.11-192088			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	895HA	22038047				2022-12-25	WOS:000300485700030
J	Patel, A; McKnight, JN; Genzor, P; Bowman, GD				Patel, Ashok; McKnight, Jeffrey N.; Genzor, Pavol; Bowman, Gregory D.			Identification of Residues in Chromodomain Helicase DNA-Binding Protein 1 (Chd1) Required for Coupling ATP Hydrolysis to Nucleosome Sliding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; RNA HELICASE; TRANSLOCATION; SWI2/SNF2; DOMAIN; TRIPHOSPHATASE; TRANSCRIPTION; MECHANISMS; CONTAINS; DYNAMICS	Chromatin remodelers are ATP-dependent machines responsible for directionally shifting nucleosomes along DNA. We are interested in defining which elements of the chromodomain helicase DNA-binding protein 1 (Chd1) remodeler are necessary and sufficient for sliding nucleosomes. This work focuses on the polypeptide segment that joins the ATPase motor to the C-terminal DNA-binding domain. We identify amino acid positions outside the ATPase motor that, when altered, dramatically reduce nucleosome sliding ability and yet have only similar to 3-fold reduction in ATPase stimulation by nucleosomes. These residues therefore appear to play a role in functionally coupling ATP hydrolysis to nucleosome sliding, and suggest that the ATPase motor requires cooperation with external elements to slide DNA past the histone core.	[Patel, Ashok; McKnight, Jeffrey N.; Genzor, Pavol; Bowman, Gregory D.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Bowman, GD (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	gdbowman@jhu.edu	Genzor, Pavol/ABA-7935-2021	Genzor, Pavol/0000-0002-3316-5659; McKnight, Jeffrey/0000-0002-1066-1879	National Institutes of Health [R01 GM084192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084192.	Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; Eberharter A, 2004, METHOD ENZYMOL, V377, P344; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Flaus A, 2011, FEBS J, V278, P3579, DOI 10.1111/j.1742-4658.2011.08281.x; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Glatt S, 2011, CURR OPIN STRUC BIOL, V21, P335, DOI 10.1016/j.sbi.2011.02.003; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Heilek GM, 1997, J VIROL, V71, P6264, DOI 10.1128/JVI.71.8.6264-6266.1997; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Schwer B, 2000, EMBO J, V19, P6582, DOI 10.1093/emboj/19.23.6582; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Zhang L, 2009, BIOCHEM CELL BIOL, V87, P265, DOI 10.1139/O08-101; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	39	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43984	43993		10.1074/jbc.M111.282970	http://dx.doi.org/10.1074/jbc.M111.282970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039057	Green Published, hybrid			2022-12-25	WOS:000298402300039
J	Mohammad, S; Ramos, LS; Buck, J; Levin, LR; Rubino, F; McGraw, TE				Mohammad, Sameer; Ramos, Lavoisier S.; Buck, Jochen; Levin, Lonny R.; Rubino, Francesco; McGraw, Timothy E.			Gastric Inhibitory Peptide Controls Adipose Insulin Sensitivity via Activation of cAMP-response Element-binding Protein and p110 beta Isoform of Phosphatidylinositol 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-TRANSPORT; AKT/PROTEIN KINASE-B; BETA-GAMMA-SUBUNITS; PHOSPHOINOSITIDE 3-KINASE; PLASMA-MEMBRANE; CELL-SURVIVAL; POLYPEPTIDE RECEPTOR; SELECTIVE INHIBITOR; SIGNAL-TRANSDUCTION; LIPOPROTEIN-LIPASE	Gastric inhibitory peptide (GIP) is an incretin hormone secreted in response to food intake. The best known function of GIP is to enhance glucose-dependent insulin secretion from pancreatic beta-cells. Extra-pancreatic effects of GIP primarily occur in adipose tissues. Here, we demonstrate that GIP increases insulin-dependent translocation of the Glut4 glucose transporter to the plasma membrane and exclusion of FoxO1 transcription factor from the nucleus in adipocytes, establishing that GIP has a general effect on insulin action in adipocytes. Stimulation of adipocytes with GIP alone has no effect on these processes. Using pharmacologic and molecular genetic approaches, we show that the effect of GIP on adipocyte insulin sensitivity requires activation of both the cAMP/protein kinase A/CREB signaling module and p110 beta phosphoinositol-3' kinase, establishing a novel signal transduction pathway modulating insulin action in adipocytes. This insulin-sensitizing effect is specific for GIP because isoproterenol, which elevates adipocyte cAMP and activates PKA/CREB signaling, does not affect adipocyte insulin sensitivity. The insulin-sensitizing activity points to a more central role for GIP in intestinal regulation of peripheral tissue metabolism, an emerging feature of inter-organ communication in the control of metabolism.	[Mohammad, Sameer; McGraw, Timothy E.] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10065 USA; [Ramos, Lavoisier S.; Buck, Jochen; Levin, Lonny R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Rubino, Francesco] Cornell Univ, Weill Med Coll, Dept Surg, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	McGraw, TE (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10065 USA.	temcgraw@med.cornell.edu	Mohammad, Sameer/GWV-2875-2022	Mohammad, Sameer/0000-0002-1129-7685; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [DK52852, DK69982]; Weill Cornell Medical College; Qatar Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052852, R56DK052852, R01DK096925, R56DK069982, R01DK069982, R56DK096925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Medical College; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52852 and DK69982 (to T. E. M.). This work was also supported by the Biomedical Research Program funds at Weill Cornell Medical College, a program funded by Qatar Foundation.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Asmar M, 2010, AM J PHYSIOL-ENDOC M, V298, pE614, DOI 10.1152/ajpendo.00639.2009; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang E, 2009, MOL CELL ENDOCRINOL, V307, P77, DOI 10.1016/j.mce.2009.03.024; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; ELKS ML, 1985, ENDOCRINOLOGY, V116, P2119, DOI 10.1210/endo-116-5-2119; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; GIBBS EM, 1988, BIOCHEMISTRY-US, V27, P6681, DOI 10.1021/bi00418a006; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Harber MP, 2005, AM J PHYSIOL-ENDOC M, V289, pE306, DOI 10.1152/ajpendo.00069.2005; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; JOOST HG, 1987, MOL PHARMACOL, V31, P279; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Kim SJ, 2007, J BIOL CHEM, V282, P34139, DOI 10.1074/jbc.M704896200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Kim SJ, 2010, J LIPID RES, V51, P3145, DOI 10.1194/jlr.M006841; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KURODA M, 1987, J BIOL CHEM, V262, P245; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Lampson MA, 2000, J CELL SCI, V113, P4065; LU M, 1993, ENDOCRINOLOGY, V132, P94, DOI 10.1210/en.132.1.94; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; RAHN T, 1994, FEBS LETT, V350, P314, DOI 10.1016/0014-5793(94)00797-7; REGEN DM, 1964, J BIOL CHEM, V239, P381; Rhoads JM, 2000, GASTROENTEROLOGY, V118, P90, DOI 10.1016/S0016-5085(00)70417-3; ROSS SA, 1978, DIABETES, V27, P327, DOI 10.2337/diabetes.27.3.327; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; SHANAHAN MF, 1986, BIOCHIM BIOPHYS ACTA, V887, P121, DOI 10.1016/0167-4889(86)90132-1; Smith FD, 2006, EUR J CELL BIOL, V85, P585, DOI 10.1016/j.ejcb.2006.01.011; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; STARICH GH, 1985, AM J PHYSIOL, V249, pE603, DOI 10.1152/ajpendo.1985.249.6.E603; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Welsh GL, 2005, BIOCHEM SOC T, V33, P346, DOI 10.1042/BST0330346; Widenmaier SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009590; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yip RGC, 1999, LIFE SCI, V66, P91, DOI 10.1016/S0024-3205(99)00314-8; YOUNG DA, 1985, AM J PHYSIOL, V248, pC406, DOI 10.1152/ajpcell.1985.248.5.C406; ZAWALICH WS, 1990, MOL CELL ENDOCRINOL, V70, P119, DOI 10.1016/0303-7207(90)90152-X; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	75	35	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43062	43070		10.1074/jbc.M111.289009	http://dx.doi.org/10.1074/jbc.M111.289009			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027830	hybrid, Green Published			2022-12-25	WOS:000298351300027
J	Sasaki, M; Honmou, O; Radtke, C; Kocsis, JD				Sasaki, Masanori; Honmou, Osamu; Radtke, Christine; Kocsis, Jeffery D.			Development of a Middle Cerebral Artery Occlusion Model in the Nonhuman Primate and a Safety Study of IV Infusion of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; PROMOTE FUNCTIONAL RECOVERY; AUTOLOGOUS BONE-MARROW; SPINAL-CORD-INJURY; ISCHEMIC-STROKE; ADULT-RAT; THERAPEUTIC BENEFITS; FOLLOW-UP; TRANSPLANTATION; BRAIN	Background: Most experimental stroke research is carried out in rodents, but given differences between rodents and human, nonhuman primate (NHP) models may provide a valuable tool to study therapeutic interventions. The authors developed a surgical method for transient occlusion of the M1 branch of middle cerebral artery (MCA) in the African green monkey to evaluate safety aspects of intravenous infusion of mesenchymal stem cells (hMSCs) derived from human bone marrow. Methods: The left Sylvian fissure was exposed by a small fronto-temporal craniotomy. The M1 branch of the MCA was exposed by microsurgical dissection and clipped for 2 to 4 hours. Neurological examinations and magnetic resonance imaging (MRI) were carried out at regular post-operative course. hMSCs were infused 1 hour after reperfusion (clip release) in the 3-hour occlusion model. Results: During M1 occlusion, two patterns of changes were observed in the lateral hemisphere surface. One pattern (Pattern 1) was darkening of venous blood, small vessel collapse, and blood pooling with no venous return in cortical veins. Animals with these three features had severe and lasting hemiplegia and MRI demonstrated extensive MCA territory infarction. Animals in the second pattern (Pattern 2) displayed darkening of venous blood, small vessel collapse, and reduced but incompletely occluded venous flow and the functional deficit was much less severe and MRI indicated smaller infarction areas in brain. The severe group (Pattern 1) likely had less extensive collateral circulation than the less severe group (Pattern 2) where venous pooling of blood was not observed. The hMSC infused animals showed a trend for greater functional improvement that was not statistically significant in the acute phase and no additive negative effects. Conclusions: These results indicate inter-animal variability of collateral circulation after complete M1 occlusion and that hMSC infusion is safe in the developed NHP stroke model.	[Sasaki, Masanori; Honmou, Osamu; Radtke, Christine; Kocsis, Jeffery D.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Sasaki, Masanori; Honmou, Osamu; Radtke, Christine; Kocsis, Jeffery D.] Vet Affairs Connecticut Healthcare Syst, Ctr Neurosci & Regenerat Res, West Haven, CT USA; [Sasaki, Masanori] Sapporo Med Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Honmou, Osamu] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Neural Regenerat Med, Sapporo, Hokkaido, Japan; [Radtke, Christine] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Sapporo Medical University; Sapporo Medical University; Hannover Medical School	Sasaki, M (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	Jeffery.Kocsis@yale.edu	Radtke, Christine/M-2927-2013; Sasaki, Masanori/B-3246-2008; Radtke, Christine/B-8491-2018	Sasaki, Masanori/0000-0001-7961-9698; honmou, Osamu/0000-0001-8697-7530; Radtke, Christine/0000-0001-6877-5038	Medical and Rehabilitation and Development Research Services of Department of Veterans Affairs (VA); VA Spinal Cord Injury Translational Collaborative Consortium for Regenerative Medicine; National Institutes of Health [NS43432]; National Multiple Sclerosis Society [RG2135, CA1009A10]; Paralyzed Veterans of America Research Foundation [2469]; Japanese Ministry of Education, Science, Sports and Culture [19591691, 20390388, 20591717]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043432] Funding Source: NIH RePORTER	Medical and Rehabilitation and Development Research Services of Department of Veterans Affairs (VA)(US Department of Veterans Affairs); VA Spinal Cord Injury Translational Collaborative Consortium for Regenerative Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Paralyzed Veterans of America Research Foundation; Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Medical and Rehabilitation and Development Research Services of Department of Veterans Affairs (VA); the VA Spinal Cord Injury Translational Collaborative Consortium for Regenerative Medicine; the National Institutes of Health [NS43432 to J.D.K.]; the National Multiple Sclerosis Society [RG2135, CA1009A10 to J.D.K.]; the Paralyzed Veterans of America Research Foundation [2469 to M. S.]; and the Japanese Ministry of Education, Science, Sports and Culture [19591691; 20390388; 20591717 to O.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; de Crespigny Alex J, 2005, J Stroke Cerebrovasc Dis, V14, P80, DOI 10.1016/j.jstrokecerebrovasdis.2004.12.005; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fukuda S, 2003, ILAR J, V44, P96, DOI 10.1093/ilar.44.2.96; Furuichi Y, 2003, J CEREBR BLOOD F MET, V23, P1183, DOI 10.1097/01.WCB.0000088761.02615.EB; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Imai H, 2006, J NEUROSURG, V104, P123, DOI 10.3171/ped.2006.104.2.123; Isakova IA, 2007, STEM CELLS, V25, P3261, DOI 10.1634/stemcells.2007-0543; Isakova LA, 2006, MOL THER, V13, P1173, DOI 10.1016/j.ymthe.2005.12.014; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; Kobune M, 2003, EXP HEMATOL, V31, P715, DOI 10.1016/S0301-472X(03)00177-2; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Liu ZW, 2010, J CEREBR BLOOD F MET, V30, P1288, DOI 10.1038/jcbfm.2010.8; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Miki Y, 2007, NEUROSURGERY, V61, P586, DOI 10.1227/01.NEU.0000290907.30814.42; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pavlichenko N, 2008, BRAIN RES, V1233, P203, DOI 10.1016/j.brainres.2008.06.123; Radtke C, 2003, FASEB J, V17, P335, DOI 10.1096/fj.03-0214fje; Rasmussen PA, 2009, J NEUROIMAGING, V19, p30S, DOI 10.1111/j.1552-6569.2009.00420.x; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; Roitberg BZ, 2006, J NEUROSURG, V105, P96, DOI 10.3171/jns.2006.105.1.96; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sasaki Masanori, 2009, V549, P187, DOI 10.1007/978-1-60327-931-4_13; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Virley D, 2004, J CEREBR BLOOD F MET, V24, P24, DOI 10.1097/01.WCB.0000095801.98378.4A; West GA, 2009, J CEREBR BLOOD F MET, V29, P1175, DOI 10.1038/jcbfm.2009.43; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zhang J, 2009, J CEREBR BLOOD F MET, V29, P1166, DOI 10.1038/jcbfm.2009.41	54	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26577	10.1371/journal.pone.0026577	http://dx.doi.org/10.1371/journal.pone.0026577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039510	Green Published, Green Submitted, gold			2022-12-25	WOS:000296515200027
J	Negin, J; van Lettow, M; Semba, M; Martiniuk, A; Chan, A; Cumming, RG				Negin, Joel; van Lettow, Monique; Semba, Medson; Martiniuk, Alexandra; Chan, Adrienne; Cumming, Robert G.			Anti-Retroviral Treatment Outcomes among Older Adults in Zomba District, Malawi	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; FOLLOW-UP; PATIENTS LOST; THERAPY; MORTALITY; SURVIVAL; AIDS; AGE; DETERMINANTS	Background: There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are HIV-positive. Despite this, little is known about the characteristics of older adults who are on treatment and their treatment outcomes. Methods: A retrospective cohort analysis was performed using routinely collected data with Malawi Ministry of Health monitoring tools from facilities providing antiretroviral therapy services in Zomba district. Patients aged 25 years and older initiated on treatment from July 2005 to June 2010 were included. Differences in survival, by age group, were determined using Kaplan-Meier survival plots and Cox proportional hazards regression models. Results: There were 10,888 patients aged 25 and older. Patients aged 50 and older (N = 1419) were more likely to be male (P < 0.0001) and located in rural areas (P = 0.003) than those aged 25-49. Crude survival estimates among those aged 50-59 were not statistically different from those aged 25-49 (P = 0.925). However, survival among those aged 60 and older (N = 345) was worse (P = 0.019) than among those 25-59. In the proportional hazards model, after controlling for sex and stage at initiation, survival in those aged 50-59 did not differ significantly from those aged 25-49 (hazard ratio 1.00 (95% CI: 0.79 to 1.27; P = 0.998) but the hazard ratio was 1.46 (95% CI: 1.03 to 2.06; P = 0.032) for those aged 60 and older compared to those aged 25-49. Conclusions: Treatment outcomes of those aged 50-59 are similar to those aged 25-49. A better understanding of how older adults present for and respond to treatment is critical to improving HIV services.	[Negin, Joel; Cumming, Robert G.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [van Lettow, Monique; Chan, Adrienne] Dignitas Int, Zomba, Malawi; [van Lettow, Monique; Martiniuk, Alexandra; Chan, Adrienne] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Semba, Medson] Minist Hlth, Zomba, Malawi; [Martiniuk, Alexandra] George Inst Global Hlth, Sydney, NSW, Australia; [Martiniuk, Alexandra] Univ Toronto, Sunnybrook Hlth Sci Res Inst, Toronto, ON, Canada; [Chan, Adrienne] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada	University of Sydney; University of Toronto; George Institute for Global Health; University of Sydney; University of Toronto; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Negin, J (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	joel.negin@sydney.edu.au	Martiniuk, Alexandra/K-2600-2019; Cumming, Robert G/R-1548-2016	Martiniuk, Alexandra/0000-0003-1368-8206; Cumming, Robert G/0000-0002-0261-6103	Dignitas International Data Management Team	Dignitas International Data Management Team	We are grateful to the ART providers at Zomba Central Hospital and in Zomba District for their dedication to patient care. We are grateful to the Zomba Central Hospital, Zomba District Health Office Management and the MOH of Malawi for the collaboration and encouragement in trying to implement HIV-related activities. We would also like to thank the Dignitas International Data Management Team for their meticulous work with data collection and support.	[Anonymous], 2010, WORLD POP PROSP 2010; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, 2008, AIDS, V22, P1463, DOI 10.1097/QAD.0b013e3282f88d02; Darby SC, 1996, LANCET, V347, P1573, DOI 10.1016/S0140-6736(96)91073-9; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Ettenhofer ML, 2009, AM J GERIAT PSYCHIAT, V17, P281, DOI 10.1097/JGP.0b013e31819431bd; Gebo KA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1460; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Goetz MB, 2001, AIDS, V15, P1576, DOI 10.1097/00002030-200108170-00017; Grimes RM, 2002, CLIN INFECT DIS, V34, P1530, DOI 10.1086/340404; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, MON DECL COMM HIV AI; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kasunda A, 2010, NATION SUNDAY   1106; Kimokoti RW, 2008, NUTR REV, V66, P611, DOI 10.1111/j.1753-4887.2008.00113.x; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Knobel H, 2001, AIDS, V15, P1591, DOI 10.1097/00002030-200108170-00025; Lacerda HR, 2008, INT J STD AIDS, V19, P450, DOI 10.1258/ijsa.2008.007317; Manfredi R, 2000, AIDS, V14, P1475, DOI 10.1097/00002030-200007070-00034; Martin CP, 2008, AM J MED, V121, P1032, DOI 10.1016/j.amjmed.2008.08.009; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mills EJ, 2010, LANCET, V377, P1131; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Negin J, 2011, AIDS BEHAV      0708; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; UNAIDS, 2010, REP GLOB AIDS EP; United Nations, 2010, MILL DEV GOALS REP 2; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Wellons MF, 2002, J AM GERIATR SOC, V50, P603, DOI 10.1046/j.1532-5415.2002.50152.x; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	43	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26546	10.1371/journal.pone.0026546	http://dx.doi.org/10.1371/journal.pone.0026546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031839	gold, Green Published, Green Submitted			2022-12-25	WOS:000296513200028
J	Totino, PRR; Daniel-Ribeiro, CT; Ferreira-da-Cruz, MD				Rivas Totino, Paulo Renato; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima			Refractoriness of Eryptotic Red Blood Cells to Plasmodium falciparum Infection: A Putative Host Defense Mechanism Limiting Parasitaemia	PLOS ONE			English	Article							ERYTHROCYTE PHOSPHATIDYLSERINE; MALARIA; APOPTOSIS; PATHOGENESIS; EXPOSURE; SPECTRIN; DISEASE; ACTIN; DEATH	Recently, we have described that apoptosis-like process of red blood cells (RBC) - eryptosis - in malaria is not restricted to parasitized cells, occurring also in non-parasitized RBC (nRBC). Besides to pathogenic proprieties, apoptosis also participates in the innate defense trough restriction of intracellular pathogens propagation. In the present study, we investigated the capacity of P. falciparum parasites to infect eryptotic RBC. Schizont parasitized RBC concentrated by magnetic separation were cultured with eryptotic RBC obtained by ionomycin treatment and, then, parasite growth was evaluated in Giemsa-stained thin blood smears. While parasites infected and developed normally in control non-eryptotic RBC, cultures performed with eryptotic RBC had a marked decrease in parasitaemia. It was noteworthy a great number of free merozoites in eryptotic RBC cultures, indicating that these cells were not susceptible to invasion. We suggest that although eryptosis could be involved in malaria pathogenesis, it could also acting protectively by controlling parasite propagation.	[Rivas Totino, Paulo Renato; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Malaria Res Lab, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Totino, PRR (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Malaria Res Lab, BR-21045900 Rio De Janeiro, Brazil.	mffcruz@ioc.fiocruz.br	Daniel-Ribeiro, Cláudio Tadeu/G-2216-2015; Totino, Paulo/GLV-4516-2022	Totino, Paulo/0000-0002-4790-3317	Instituto Oswaldo Cruz-Fiocruz; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)	Instituto Oswaldo Cruz-Fiocruz; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Instituto Oswaldo Cruz-Fiocruz and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesutan I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-118; Basu S, 2008, BRIT J HAEMATOL, V141, P92, DOI 10.1111/j.1365-2141.2008.06995.x; Bienvenu AL, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-106; Bobbala D, 2010, ACTA TROP, V116, P39, DOI 10.1016/j.actatropica.2010.05.005; Brown SB, 1997, BIOCHEM J, V323, P233, DOI 10.1042/bj3230233; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Dockrell DH, 2001, J INFECTION, V42, P227, DOI 10.1053/jinf.2001.0836; Eda S, 2002, CELL PHYSIOL BIOCHEM, V12, P373, DOI 10.1159/000067908; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koka S, 2008, CELL PHYSIOL BIOCHEM, V22, P261, DOI 10.1159/000149804; Komba AN, 2009, CLIN INFECT DIS, V49, P216, DOI 10.1086/599834; Lang F, 2004, PFLUG ARCH EUR J PHY, V448, P319, DOI 10.1007/s00424-004-1254-9; Lang F, 2008, CELL PHYSIOL BIOCHEM, V22, P373, DOI 10.1159/000185448; Lang PA, 2009, CELL PHYSIOL BIOCHEM, V24, P415, DOI 10.1159/000257529; Ljungstr?m I., 2004, METHODS MALARIA RES; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Setty BNY, 2002, BLOOD, V99, P1564, DOI 10.1182/blood.V99.5.1564; SHEAR HL, 1991, BRIT J HAEMATOL, V78, P555, DOI 10.1111/j.1365-2141.1991.tb04488.x; Totino PRR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-350; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Williams G T, 1994, Trends Microbiol, V2, P463, DOI 10.1016/0966-842X(94)90648-3; Wood BL, 1996, BLOOD, V88, P1873	27	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26575	10.1371/journal.pone.0026575	http://dx.doi.org/10.1371/journal.pone.0026575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031840	Green Published, Green Submitted, gold			2022-12-25	WOS:000296513200031
J	Simbaqueba, J; Sanchez, P; Sanchez, E; Zarantes, VMN; Chacon, MI; Barrero, LS; Marino-Ramirez, L				Simbaqueba, Jaime; Sanchez, Pilar; Sanchez, Erika; Nunez Zarantes, Victor Manuel; Isabel Chacon, Maria; Stella Barrero, Luz; Marino-Ramirez, Leonardo			Development and Characterization of Microsatellite Markers for the Cape Gooseberry Physalis peruviana	PLOS ONE			English	Article							EST-SSRS; ANTIINFLAMMATORY ACTIVITY; IN-VITRO; EXTRACTS; PLANTS; WHEAT; DNA; L.	Physalis peruviana, commonly known as Cape gooseberry, is an Andean Solanaceae fruit with high nutritional value and interesting medicinal properties. In the present study we report the development and characterization of microsatellite loci from a P. peruviana commercial Colombian genotype. We identified 932 imperfect and 201 perfect Simple Sequence Repeats (SSR) loci in untranslated regions (UTRs) and 304 imperfect and 83 perfect SSR loci in coding regions from the assembled Physalis peruviana leaf transcriptome. The UTR SSR loci were used for the development of 162 primers for amplification. The efficiency of these primers was tested via PCR in a panel of seven P. peruviana accessions including Colombia, Kenya and Ecuador ecotypes and one closely related species Physalis floridana. We obtained an amplification rate of 83% and a polymorphic rate of 22%. Here we report the first P. peruviana specific microsatellite set, a valuable tool for a wide variety of applications, including functional diversity, conservation and improvement of the species.	[Simbaqueba, Jaime; Sanchez, Erika; Nunez Zarantes, Victor Manuel; Stella Barrero, Luz; Marino-Ramirez, Leonardo] Colombian Corp Agr Res CORPOICA, CBB, Plant Mol Genet Lab, Bogota, Colombia; [Sanchez, Pilar; Isabel Chacon, Maria] Univ Nacl Colombia, Fac Agron, Bogota, Colombia; [Stella Barrero, Luz; Marino-Ramirez, Leonardo] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia; [Marino-Ramirez, Leonardo] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Universidad Nacional de Colombia; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Simbaqueba, J (corresponding author), Colombian Corp Agr Res CORPOICA, CBB, Plant Mol Genet Lab, Bogota, Colombia.	marino@ncbi.nlm.nih.gov	Mariño-Ramírez, Leonardo/I-5759-2013; Mariño-Ramírez, Leonardo/N-5395-2019	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Sanchez-Betancourt, Erika/0000-0002-3024-3180; simbaqueba, jaime/0000-0003-4389-9418	Colombian Ministry of Agriculture [054/08072-2008L4787-3281, 054/08190-2008L7922-3322]; National Institutes of Health; National Library of Medicine; National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE [ZIALM082713] Funding Source: NIH RePORTER	Colombian Ministry of Agriculture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support for this research was provided by a grant from the Colombian Ministry of Agriculture Contract Nos. 054/08072-2008L4787-3281 to LSB and 054/08190-2008L7922-3322 to VMNZ. This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine, and National Center for Biotechnology Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Bonilla M, 2009, AGENDA PROSPECTIVA I; Bozhko M, 2003, MOL ECOL, V12, P3147, DOI 10.1046/j.1365-294X.2003.01983.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Franco LA, 2007, BIOMEDICA, V27, P110, DOI 10.7705/biomedica.v27i1.237; Fujimori S, 2003, FEBS LETT, V554, P17, DOI 10.1016/S0014-5793(03)01041-X; Goldstein D, 1999, MICROSATELLITES EVOL; Gonzalez OT, 2008, REV BRAS FRUTIC, V30, P708, DOI 10.1590/S0100-29452008000300025; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Lagos-Burbano TC, 2003, FITOTEC COLOMB, V3, P1; LIGARRETO G., 2005, AVANCES CULTIVO POSC, P9; Lu FH, 2011, MOL BIOL REP; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Martinez W, 2010, IMMUNOPHARM IMMUNOT, V32, P63, DOI 10.1080/08923970903143957; MAYER C, 2008, PHOBOS TANDEM REPEAT; MENZEL M. Y., 1951, Proceedings of the American Philosophical Society, V95, P132; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Munoz Florez J. E., 2008, Acta Agronomica, Universidad Nacional de Colombia, V57, P219; Pinto MD, 2009, J MED FOOD, V12, P278, DOI 10.1089/jmf.2008.0113; Popenoe H, 1990, LOST CROPS INCAS LIT, P241; Ramadan MF, 2003, J AGR FOOD CHEM, V51, P969, DOI 10.1021/jf020778z; Rodriguez C. N. C., 2006, Acta Biologica Colombiana, V11, P75; Rozen S, 2000, Methods Mol Biol, V132, P365; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Wu SJ, 2009, FOOD CHEM TOXICOL; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94	33	20	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26719	10.1371/journal.pone.0026719	http://dx.doi.org/10.1371/journal.pone.0026719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039540	Green Submitted, gold, Green Published			2022-12-25	WOS:000296513200047
J	Allali, S; Muller, JB; Brauner, R; Lourenco, D; Boudjenah, R; Karageorgou, V; Trivin, C; Lottmann, H; Lortat-Jacob, S; Nihoul-Fekete, C; De Dreuzy, O; McElreavey, K; Bashamboo, A				Allali, Slimane; Muller, Jean-Baptiste; Brauner, Raja; Lourenco, Diana; Boudjenah, Radia; Karageorgou, Vasiliki; Trivin, Christine; Lottmann, Henri; Lortat-Jacob, Stephen; Nihoul-Fekete, Claire; De Dreuzy, Olivier; McElreavey, Ken; Bashamboo, Anu			Mutation Analysis of NR5A1 Encoding Steroidogenic Factor 1 in 77 Patients with 46, XY Disorders of Sex Development (DSD) Including Hypospadias	PLOS ONE			English	Article							INHIBIN B; ADRENAL INSUFFICIENCY; GONADAL DEVELOPMENT; HORMONE; GENE; BOYS; TRANSCRIPTION; REVERSAL; AD4BP; SF-1	Background: Mutations of the NR5A1 gene encoding steroidogenic factor-1 have been reported in association with a wide spectrum of 46, XY DSD (Disorder of Sex Development) phenotypes including severe forms of hypospadias. Methodology/Principal Findings: We evaluated the frequency of NR5A1 gene mutations in a large series of patients presenting with 46, XY DSD and hypospadias. Based on their clinical presentation 77 patients were classified either as complete or partial gonadal dysgenesis (uterus seen at genitography and/or surgery, n = 11), ambiguous external genitalia without uterus (n = 33) or hypospadias (n = 33). We identified heterozygous NR5A1 mutations in 4 cases of ambiguous external genitalia without uterus (12.1%; p. Trp279Arg, pArg39Pro, c.390delG, c140_141insCACG) and a de novo missense mutation in one case with distal hypospadias (3%; p.Arg313Cys). Mutant proteins showed reduced transactivation activity and mutants p.Arg39Pro and p.Arg313Cys did not synergize with the GATA4 cofactor to stimulate reporter gene activity, although they retained their ability to physically interact with the GATA4 protein. Conclusions/Significance: Mutations in NR5A1 were observed in 5/77 (6.5%) cases of 46, XY DSD including hypospadias. Excluding the cases of 46, XY gonadal dysgenesis the incidence of NR5A1 mutations was 5/66 (7.6%). An individual with isolated distal hypopadias carried a de novo heterozygous missense mutation, thus extending the range of phenotypes associated with NR5A1 mutations and suggesting that this group of patients should be screened for NR5A1 mutations.	[Allali, Slimane; Muller, Jean-Baptiste; Brauner, Raja] Univ Paris 05, Fac Med, Le Kremlin Bicetre, France; [Allali, Slimane; Muller, Jean-Baptiste; Brauner, Raja] Hop Bicetre, AP HP, Unite Endocrinol, Le Kremlin Bicetre, France; [Lourenco, Diana; Boudjenah, Radia; Karageorgou, Vasiliki; McElreavey, Ken; Bashamboo, Anu] Inst Pasteur, Paris, France; [Trivin, Christine] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France; [Lottmann, Henri; Lortat-Jacob, Stephen] Hop Necker Enfants Malad, AP HP, Serv Chirurg Viscerale Pediat, Paris, France; [Nihoul-Fekete, Claire] Univ Paris 05, Paris, France; [De Dreuzy, Olivier] Hop Bicetre, AP HP, Serv Chirurg Pediat, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Allali, S (corresponding author), Univ Paris 05, Fac Med, Le Kremlin Bicetre, France.	kenmce@pasteur.fr; anu.bashamboo@pasteur.fr	Allali, Slimane/AGW-0037-2022	Allali, Slimane/0000-0001-7068-4530	Agence Nationale de la Recherche-GIS Institut des Maladies Rares; March of Dimes Foundation [1-FY07-490]; EuroDSD in the European Community [201444]; Portuguese Foundation for Science and Technology	Agence Nationale de la Recherche-GIS Institut des Maladies Rares(French National Research Agency (ANR)); March of Dimes Foundation(March of Dimes); EuroDSD in the European Community; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by research grants rewarded to KM from the Agence Nationale de la Recherche-GIS Institut des Maladies Rares and a grant (1-FY07-490) from the March of Dimes Foundation. Authors KM and AB received support from the EuroDSD in the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 201444 (www.euroDSD.eu). Author DL was supported by a research grant from the Portuguese Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bashamboo A, 2010, AM J HUM GENET, V87, P505, DOI 10.1016/j.ajhg.2010.09.009; Baskin LS, 2006, J PEDIATR SURG, V41, P463, DOI 10.1016/j.jpedsurg.2005.11.059; Beleza-Meireles A, 2007, EUR J HUM GENET, V15, P405, DOI 10.1038/sj.ejhg.5201777; Chen YG, 2010, EUR J MED GENET, V53, P122, DOI 10.1016/j.ejmg.2010.03.005; Correa RV, 2004, J CLIN ENDOCR METAB, V89, P1767, DOI 10.1210/jc.2003-031240; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; FLATAU E, 1975, J PEDIATR-US, V87, P663, DOI 10.1016/S0022-3476(75)80877-8; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1136/adc.2006.098319, 10.1016/j.jpurol.2006.03.004]; Ito M, 2000, J BIOL CHEM, V275, P31708, DOI 10.1074/jbc.M002892200; Kohler B, 2009, EUR J ENDOCRINOL, V161, P237, DOI 10.1530/EJE-09-0067; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003; MOROHASHI K, 1994, MOL ENDOCRINOL, V8, P643, DOI 10.1210/me.8.5.643; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Philibert P, 2007, HUM REPROD, V22, P3255, DOI 10.1093/humrep/dem278; Rey RA, 1999, J CLIN ENDOCR METAB, V84, P627, DOI 10.1210/jc.84.2.627; Schnack TH, 2008, AM J EPIDEMIOL, V167, P251, DOI 10.1093/aje/kwm317; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Seminara SB, 1996, J CLIN ENDOCR METAB, V81, P3692, DOI 10.1210/jc.81.10.3692; Tremblay JJ, 2003, J BIOL CHEM, V278, P42637, DOI 10.1074/jbc.M305485200; Tremblay JJ, 2001, MOL ENDOCRINOL, V15, P1636, DOI 10.1210/me.15.9.1636; van der Zanden LFM, 2010, J CLIN ENDOCR METAB, V95, P2384, DOI 10.1210/jc.2009-2101; Wang MH, 2008, J ANDROL, V29, P499, DOI 10.2164/jandrol.108.004945	33	61	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e24117	10.1371/journal.pone.0024117	http://dx.doi.org/10.1371/journal.pone.0024117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028768	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800003
J	Li, S; Xiong, RY; Wang, XF; Zhou, YJ				Li, Shuo; Xiong, Ruyi; Wang, Xifeng; Zhou, Yijun			Five Proteins of Laodelphax striatellus Are Potentially Involved in the Interactions between Rice Stripe Virus and Vector	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; KINASE-C; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; MOLECULAR-BIOLOGY; GENE-EXPRESSION; MYZUS-PERSICAE; INSECT VECTOR; MOSAIC-VIRUS; BINDING	Rice stripe virus (RSV) is the type member of the genus Tenuivirus, which relies on the small brown planthopper (Laodelphax striatellus Fallen) for its transmission in a persistent, circulative-propagative manner. To be transmitted, virus must cross the midgut and salivary glands epithelial barriers in a transcytosis mechanism where vector receptors interact with virions, and as propagative virus, RSV need utilize host components to complete viral propagation in vector cells. At present, these mechanisms remain unknown. In this paper, we screened L. striatellus proteins, separated by two-dimensional electrophoresis (2-DE), as potential RSV binding molecules using a virus overlay assay of protein blots. The results, five L. striatellus proteins that bound to purified RSV particles in vitro were resolved and identified using mass spectrometry. The virus-binding capacities of five proteins were further elucidated in yeast two-hybrid screen (YTHS) and virus-binding experiments of expressed proteins. Among five proteins, the receptor for activated protein kinase C (RACK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH3) did not interact with RSV nucleocapsid protein (NCP) in YTHS and in far-Western blot, and three ribosomal proteins (RPL5, RPL7a and RPL8) had specific interactions with RSV. In dot immunobinding assay (DIBA), all five proteins were able to bind to RSV particles. The five proteins' potential contributions to the interactions between RSV and L. striatellus were discussed. We proposed that RACK and GAPDH3 might be involved in the epithelial transcytosis of virus particles, and three ribosomal proteins probably played potential crucial roles in the infection and propagation of RSV in vector cells.	[Li, Shuo; Zhou, Yijun] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect,Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Peoples R China; [Li, Shuo; Xiong, Ruyi; Zhou, Yijun] Jiangsu Acad Agr Sci, Inst Plant Protect, Jiangsu Tech Serv Ctr Diag & Detect Plant Virus D, Nanjing, Peoples R China; [Wang, Xifeng] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Li, S (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect,Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Peoples R China.	yjzhou@jaas.ac.cn	Wang, Xifeng/A-6476-2016	Wang, Xifeng/0000-0002-4982-8947	National Key Basic Research and Development Program (973 Program) of China [2010CB126203]; National Natural Science Foundation of China [30970132]; Special Fund for Agro-scientific Research in the Public Interest of China [201003031]; Natural Science Foundation of Jiangsu Province [BK2010018]	National Key Basic Research and Development Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the National Key Basic Research and Development Program (973 Program) of China (grant no. 2010CB126203), the National Natural Science Foundation of China (grant no. 30970132), the Special Fund for Agro-scientific Research in the Public Interest of China (grant no. 201003031) and the Natural Science Foundation of Jiangsu Province (grant no. BK2010018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson B, 1999, VIRUS RES, V64, P125, DOI 10.1016/S0168-1702(99)00087-8; Bandla MD, 1998, PHYTOPATHOLOGY, V88, P98, DOI 10.1094/PHYTO.1998.88.2.98; Bee A, 2006, CLIN CANCER RES, V12, P2061, DOI 10.1158/1078-0432.CCR-05-2445; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bureau M, 2004, J GEN VIROL, V85, P3765, DOI 10.1099/vir.0.80242-0; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Choi DS, 2003, MOL PHARMACOL, V64, P1541, DOI 10.1124/mol.64.6.1541; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Delgado ML, 2001, MICROBIOL-SGM, V147, P411, DOI 10.1099/00221287-147-2-411; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; GOUDOTCROZEL V, 1989, J EXP MED, V170, P2065, DOI 10.1084/jem.170.6.2065; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Kikkert M, 1998, PHYTOPATHOLOGY, V88, P63, DOI 10.1094/PHYTO.1998.88.1.63; KOGANEZAWA H, 1975, Annals of the Phytopathological Society of Japan, V41, P148, DOI 10.3186/jjphytopath.41.148; Li CY, 2001, VIROLOGY, V286, P125, DOI 10.1006/viro.2001.0929; Liang DL, 2005, VIRUS GENES, V31, P211, DOI 10.1007/s11262-005-1798-6; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Nguyen TTA, 2007, J INSECT PHYSIOL, V53, P601, DOI [10.1016/j.jinphys.2007.02.018, 10.1016/j.jinsphys.2007.02.018]; PEDERSEN KJ, 1991, ACTA ZOOL-STOCKHOLM, V72, P181, DOI 10.1111/j.1463-6395.1991.tb01196.x; RAMIREZ BC, 1994, J GEN VIROL, V75, P467, DOI 10.1099/0022-1317-75-3-467; Rocha CS, 2008, VIROLOGY, V380, P165, DOI 10.1016/j.virol.2008.08.005; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Seddas P, 2004, VIROLOGY, V325, P399, DOI 10.1016/j.virol.2004.05.014; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Suzuki Yoshihiko, 1992, Annals of the Phytopathological Society of Japan, V58, P480, DOI 10.3186/jjphytopath.58.480; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; TORIYAMA S, 1983, CMI ABB DESCRIPTION, V269, P15; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; VandenHeuvel JFJM, 1997, J VIROL, V71, P7258, DOI 10.1128/JVI.71.10.7258-7265.1997; VOLKER KW, 1995, COMP BIOCHEM PHYS B, V112, P503, DOI 10.1016/0305-0491(95)00096-8; Wang GuiZhen, 2004, Acta Phytopathologica Sinica, V34, P302; Wang W, 2002, INT J BIOCHEM CELL B, V34, P93, DOI 10.1016/S1357-2725(01)00094-2; Xie L. H., 1991, Journal of Fujian Agricultural College, V20, P144; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yang CL, 2009, VIROLOGY, V390, P163, DOI 10.1016/j.virol.2009.05.018; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhou GY, 1999, ANN APPL BIOL, V135, P573, DOI 10.1111/j.1744-7348.1999.tb00888.x	52	28	39	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26585	10.1371/journal.pone.0026585	http://dx.doi.org/10.1371/journal.pone.0026585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028913	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800057
J	Barazzoni, R; Zanetti, M; Semolic, A; Cattin, MR; Pirulli, A; Cattin, L; Guarnieri, G				Barazzoni, Rocco; Zanetti, Michela; Semolic, Annamaria; Cattin, Maria Rosa; Pirulli, Alessia; Cattin, Luigi; Guarnieri, Gianfranco			High-Fat Diet with Acyl-Ghrelin Treatment Leads to Weight Gain with Low Inflammation, High Oxidative Capacity and Normal Triglycerides in Rat Muscle	PLOS ONE			English	Article							SKELETAL-MUSCLE; LIPID-PEROXIDATION; INSULIN-RESISTANCE; IN-VIVO; EXPRESSION; ACTIVATION; EXERCISE; STRESS; LIVER	Obesity is associated with muscle lipid accumulation. Experimental models suggest that inflammatory cytokines, low mitochondrial oxidative capacity and paradoxically high insulin signaling activation favor this alteration. The gastric orexigenic hormone acylated ghrelin (A-Ghr) has antiinflammatory effects in vitro and it lowers muscle triglycerides while modulating mitochondrial oxidative capacity in lean rodents. We tested the hypothesis that A-Ghr treatment in high-fat feeding results in a model of weight gain characterized by low muscle inflammation and triglycerides with high muscle mitochondrial oxidative capacity. A-Ghr at a non-orexigenic dose (HFG: twice-daily 200-mu g s.c.) or saline (HF) were administered for 4 days to rats fed a high-fat diet for one month. Compared to lean control (C) HF had higher body weight and plasma free fatty acids (FFA), and HFG partially prevented FFA elevation (P<0.05). HFG also had the lowest muscle inflammation (nuclear NFkB, tissue TNF-alpha) with mitochondrial enzyme activities higher than C (P<0.05 vs C, P = NS vs HF). Under these conditions HFG prevented the HF-associated muscle triglyceride accumulation (P<0.05). The above effects were independent of changes in redox state (total-oxidized glutathione, glutathione peroxidase activity) and were not associated with changes in phosphorylation of AKT and selected AKT targets. Ghrelin administration following high-fat feeding results in a novel model of weight gain with low inflammation, high mitochondrial enzyme activities and normalized triglycerides in skeletal muscle. These effects are independent of changes in tissue redox state and insulin signaling, and they suggest a potential positive metabolic impact of ghrelin in fat-induced obesity.	[Barazzoni, Rocco; Zanetti, Michela; Semolic, Annamaria; Cattin, Maria Rosa; Pirulli, Alessia; Cattin, Luigi; Guarnieri, Gianfranco] Univ Trieste, Dept Med Surg & Hlth Sci, Med Clin, Trieste, Italy	University of Trieste	Barazzoni, R (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Med Clin, Trieste, Italy.	barazzon@units.it		ZANETTI, MICHELA/0000-0002-2634-6363				Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Barazzoni R, 2007, OBESITY, V15, P2614, DOI 10.1038/oby.2007.313; Barazzoni R, 2010, KIDNEY INT, V77, P23, DOI 10.1038/ki.2009.411; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Choi KC, 2003, ENDOCRINOLOGY, V144, P754, DOI 10.1210/en.2002-220783; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Greathouse KL, 2005, EUR J NUTR, V44, P429, DOI 10.1007/s00394-005-0548-9; Kheradmand A, 2010, REGUL PEPTIDES, V162, P84, DOI 10.1016/j.regpep.2010.02.008; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Liu L, 2010, EXP NEUROL, V222, P25, DOI 10.1016/j.expneurol.2009.11.009; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Yokota T, 2009, AM J PHYSIOL-HEART C, V297, pH1069, DOI 10.1152/ajpheart.00267.2009	18	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26224	10.1371/journal.pone.0026224	http://dx.doi.org/10.1371/journal.pone.0026224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039445	gold, Green Published, Green Submitted			2022-12-25	WOS:000296507500039
J	Ge, C; Beauchamp, G; Li, ZQ				Ge, Chen; Beauchamp, Guy; Li, Zhongqiu			Coordination and Synchronisation of Anti-Predation Vigilance in Two Crane Species	PLOS ONE			English	Article							GROUP-SIZE; COLLECTIVE DETECTION; SOCIAL INFORMATION; BEHAVIOR; FLOCKS; INDIVIDUALS; HABITAT; WINTER; COSTS; BIRDS	Much of the previous research on anti-predation vigilance in groups has assumed independent scanning for threats among group members. Alternative patterns that are based on monitoring the vigilance levels of companions can also be adaptive. Coordination of vigilance, in which foragers avoid scanning at the same time as others, should decrease the odds that no group member is alert. Synchronisation of vigilance implies that individuals are more likely to be vigilant when companions are already vigilant. While synchronisation will increase the odds that no one is vigilant, it may allow a better assessment of potential threats. We investigated temporal sequences of vigilance in family flocks consisting of two parents and at most two juveniles in two species of cranes in coastal China. We established whether the observed probability that at least one parent is alert was greater (coordination) or lower (synchronisation) than that predicted under the null hypothesis of independent vigilance. We documented coordination of vigilance in common cranes (Grus grus) foraging in an area with high potential for disturbance by people. We documented synchronisation of vigilance in red-crowned cranes (Grus japonensis) in the less but not in the more disturbed area. Coordination in small flocks leads to high collective vigilance but low foraging rates that may not be suitable in areas with low disturbance. We also argue that synchronisation should break down in areas with high disturbance because periods with low vigilance are riskier. Results highlight the view that temporal patterns of vigilance can take many forms depending on ecological factors.	[Ge, Chen; Li, Zhongqiu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Beauchamp, Guy] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada	Nanjing University; Universite de Montreal	Ge, C (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	lizq0314@gmail.com	Li, Zhong-qiu/A-1748-2011	Li, Zhong-qiu/0000-0003-2004-293X	Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period [2008BAC39B03]; Nanjing University	Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period; Nanjing University(Nanjing University)	We thank the Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period (2008BAC39B03) and Nanjing University Funds for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JA, 1993, AUK, V110, P78; ARTISS T, 1995, ANIM BEHAV, V49, P1249, DOI 10.1006/anbe.1995.0157; Aviles JM, 2007, J AVIAN BIOL, V38, P690, DOI 10.1111/j.2007.0908-8857.04002.x; Beauchamp G, 2009, BIOL LETTERS, V5, P9, DOI 10.1098/rsbl.2008.0490; Bednekoff PA, 1998, TRENDS ECOL EVOL, V13, P284, DOI 10.1016/S0169-5347(98)01327-5; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; Caro T., 2005, ANTIPREDATOR DEFENCE; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Conover MR, 2000, AM NAT, V156, P193, DOI 10.1086/303377; Ebensperger LA, 2006, ETHOLOGY, V112, P879, DOI 10.1111/j.1439-0310.2006.01242.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P898, DOI 10.1093/beheco/arh092; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Jackson AL, 2006, BEHAV ECOL, V17, P532, DOI 10.1093/beheco/arj060; Jonsson JE, 2008, WILSON J ORNITHOL, V120, P725, DOI 10.1676/07-124.1; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Ma ZJ, 1999, IBIS, V141, P135, DOI 10.1111/j.1474-919X.1999.tb04272.x; MA ZJ, 2000, CONSERVATION RED CRO; MCGOWAN KJ, 1989, ANIM BEHAV, V37, P1000, DOI 10.1016/0003-3472(89)90144-9; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Ost M, 2011, BEHAV ECOL, V22, P378, DOI 10.1093/beheco/arq223; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2007, ANIM BEHAV, V73, P595, DOI 10.1016/j.anbehav.2006.06.007; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; PULLIAM HR, 1982, J THEOR BIOL, V95, P89, DOI 10.1016/0022-5193(82)90289-2; Radford AN, 2007, BIOLOGY LETT, V3, P249, DOI 10.1098/rsbl.2007.0110; Radford AN, 2009, P ROY SOC B-BIOL SCI, V276, P2437, DOI 10.1098/rspb.2009.0187; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; RASA OAE, 1986, ETHOLOGY, V71, P340, DOI 10.1111/j.1439-0310.1986.tb00598.x; Rodriguez-Girones MA, 2002, P ROY SOC B-BIOL SCI, V269, P1803, DOI 10.1098/rspb.2002.2043; Ruxton GD, 1999, ANIM BEHAV, V57, P493, DOI 10.1006/anbe.1998.0965; SAINO N, 1995, IBIS, V137, P227, DOI 10.1111/j.1474-919X.1995.tb03243.x; Sirot E, 2006, ANIM BEHAV, V72, P373, DOI 10.1016/j.anbehav.2005.10.028; Sirot E, 2009, AM NAT, V173, P47, DOI 10.1086/593358; Stillman RA, 2002, J ANIM ECOL, V71, P874, DOI 10.1046/j.1365-2656.2002.00652.x; TACHA TC, 1988, WILDL MONOGR; Wang Z, 2011, BIOL CONSERV, V144, P101, DOI 10.1016/j.biocon.2010.06.025; WARD PI, 1985, J THEOR BIOL, V114, P383, DOI 10.1016/S0022-5193(85)80173-9	42	26	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26447	10.1371/journal.pone.0026447	http://dx.doi.org/10.1371/journal.pone.0026447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028880	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500070
J	Schnell, C; Fresemann, J; Hulsmann, S				Schnell, Christian; Fresemann, Jens; Huelsmann, Swen			Determinants of Functional Coupling between Astrocytes and Respiratory Neurons in the Pre-Botzinger Complex	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; HIPPOCAMPAL SYNAPSES; FLUORESCENT PROTEINS; MEDULLARY SLICES; NETWORK ACTIVITY; TRANSGENIC MICE; CALCIUM; RHYTHM	Respiratory neuronal network activity is thought to require efficient functioning of astrocytes. Here, we analyzed neuronastrocyte communication in the pre-Botzinger Complex (preBotC) of rhythmic slice preparations from neonatal mice. In astrocytes that exhibited rhythmic potassium fluxes and glutamate transporter currents, we did not find a translation of respiratory neuronal activity into phase-locked astroglial calcium signals. In up to 20% of astrocytes, 2-photon calcium imaging revealed spontaneous calcium fluctuations, although with no correlation to neuronal activity. Calcium signals could be elicited in preBotC astrocytes by metabotropic glutamate receptor activation or after inhibition of glial glutamate uptake. In the latter case, astrocyte calcium elevation preceded a surge of respiratory neuron discharge activity followed by network failure. We conclude that astrocytes do not exhibit respiratory-rhythmic calcium fluctuations when they are able to prevent synaptic glutamate accumulation. Calcium signaling is, however, observed when glutamate transport processes in astrocytes are suppressed or neuronal discharge activity is excessive.	[Schnell, Christian; Fresemann, Jens; Huelsmann, Swen] Univ Gottingen, Zentrum Physiol & Pathophysiol, Abt Neuro & Sinnesphysiol, Gottingen, Germany; [Schnell, Christian; Fresemann, Jens; Huelsmann, Swen] DFG Ctr Mol Physiol Brain CMPB, Gottingen, Germany	University of Gottingen	Schnell, C (corresponding author), Univ Gottingen, Zentrum Physiol & Pathophysiol, Abt Neuro & Sinnesphysiol, Gottingen, Germany.	shuelsm2@uni-goettingen.de	Schnell, Christian/E-3140-2014; Hülsmann, Swen/F-7169-2010	Schnell, Christian/0000-0002-3499-9217; Hülsmann, Swen/0000-0001-5042-8724	Deutsche Forschungsgemeinschaft [CMPB, SPP1172]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by The Deutsche Forschungsgemeinschaft (grants to S.H.; CMPB and SPP1172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; BROCKHAUS J, 1993, J PHYSIOL-LONDON, V462, P421, DOI 10.1113/jphysiol.1993.sp019562; Drobizhev M, 2009, J PHYS CHEM B, V113, P855, DOI 10.1021/jp8087379; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; FUNK GD, 1995, J NEUROSCI, V15, P4046; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grass D, 2004, J NEUROSCI, V24, P1358, DOI 10.1523/JNEUROSCI.4022-03.2004; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; Haak LL, 1997, J NEUROSCI, V17, P1825; Hartel K, 2007, CELL CALCIUM, V42, P271, DOI 10.1016/j.ceca.2006.12.004; Hartel K, 2009, GLIA, V57, P815, DOI 10.1002/glia.20808; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Hulsmann S, 2000, EUR J NEUROSCI, V12, P856, DOI 10.1046/j.1460-9568.2000.00973.x; Hulsmann S, 2000, EUR J NEUROSCI, V12, P239, DOI 10.1046/j.1460-9568.2000.00902.x; Huxtable AG, 2010, J NEUROSCI, V30, P3947, DOI 10.1523/JNEUROSCI.6027-09.2010; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Nolte C, 2001, GLIA, V33, P72; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; RICHTER DW, 1982, J EXP BIOL, V100, P93; Richter DW, 1999, J PHYSIOL-LONDON, V514, P567, DOI 10.1111/j.1469-7793.1999.567ae.x; RICHTER DW, 1978, PFLUG ARCH EUR J PHY, V376, P139, DOI 10.1007/BF00581577; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Shimamoto K, 2004, MOL PHARMACOL, V65, P1008, DOI 10.1124/mol.65.4.1008; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Somjen GG, 2008, J COMPUT NEUROSCI, V25, P349, DOI 10.1007/s10827-008-0083-9; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Winter SM, 2009, PFLUG ARCH EUR J PHY, V458, P459, DOI 10.1007/s00424-009-0647-1; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	38	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26309	10.1371/journal.pone.0026309	http://dx.doi.org/10.1371/journal.pone.0026309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039458	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000296507500048
J	Yoon, JS; Lee, HJ; Choi, SH; Chang, EJ; Lee, SY; Lee, EJ				Yoon, Jin Sook; Lee, Hyun Jung; Choi, Soo Hyun; Chang, Eun-Ju; Lee, Sang Yeul; Lee, Eun Jig			Quercetin Inhibits IL-1 beta-Induced Inflammation, Hyaluronan Production and Adipogenesis in Orbital Fibroblasts from Graves' Orbitopathy	PLOS ONE			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; 3T3-L1 ADIPOCYTES; EYE DISEASE; EXPRESSION; DIFFERENTIATION; PATHOGENESIS; RESVERATROL; MECHANISMS; CELLS; PROLIFERATION	Management of Graves' orbitopathy (GO) is challenging, as no reliable, specific, and safe medical therapeutic agents have yet been developed. We investigated the effect of quercetin in primary cultured orbital fibroblasts from GO, targeting pathways of inflammation, aberrant accumulation of extracellular matrix macromolecules, and adipose tissue expansion. Quercetin significantly attenuated intercellular adhesion molecule-1 (ICAM-1), interleukin (IL) -6, IL-8, and cyclooxygenase (COX) -2 mRNA expression, and inhibited IL-1 beta-induced increases in ICAM-1, IL-6, and IL-8 mRNA. Increased hyaluronan production induced by IL-1 beta or tumor necrosis factor-alpha was suppressed by quercetin in a dose-and time-dependent manner. Treatment with noncytotoxic doses of quercetin inhibited accumulation of intracytoplasmic lipid droplets and resulted in a dose-dependent decrease in expression of peroxisome proliferator-activated receptor gamma, CCAAT/enhancer-binding protein (C/EBP) alpha, and C/EBP beta proteins. In conclusion, inhibition of inflammation, hyaluronan production, and adipogenesis by the natural plant product quercetin in vitro provides the basis for further study of its potential use in the treatment of GO.	[Yoon, Jin Sook; Choi, Soo Hyun; Lee, Sang Yeul] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea; [Chang, Eun-Ju] Univ Ulsan, Coll Med, Dept Anat & Cell Biol, Cellular Dysfunct Res Ctr, Seoul, South Korea; [Lee, Hyun Jung; Lee, Eun Jig] Inst Endocrine Res, Brain Korea Project Med Sci 21, Seoul, South Korea; [Lee, Hyun Jung; Lee, Eun Jig] Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea	Yonsei University; Yonsei University Health System; University of Ulsan	Yoon, JS (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea.	sylee@yuhs.ac; EJLEE423@yuhs.ac		Lee, Eun Jig/0000-0002-9876-8370; Yoon, Jin Sook/0000-0002-8751-9467	National Research Foundation of Korea [2009-0067080]; Ministry for Health, Welfare Family Affairs [A085136]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry for Health, Welfare Family Affairs	This work was supported by the National Research Foundation of Korea Grant (grant numbers: 2009-0067080 [to JSY]) (URL: http://www.nrf.re.kr/html/en/) and by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs (grant numbers : A085136 [to EJL]) (URL: http://eng.khidi.or.kr/index.jsp). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Burnstine MA, 1998, BRIT J OPHTHALMOL, V82, P318, DOI 10.1136/bjo.82.3.318; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; Cawood TJ, 2007, J CLIN ENDOCR METAB, V92, P59, DOI 10.1210/jc.2006-1824; Cawood TJ, 2006, EUR J ENDOCRINOL, V155, P395, DOI 10.1530/eje.1.02242; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Crisp M, 2000, INVEST OPHTH VIS SCI, V41, P3249; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; Garrity JA, 2006, AM J OPHTHALMOL, V142, P147, DOI 10.1016/j.ajo.2006.02.047; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HEUFELDER AE, 1992, EUR J CLIN INVEST, V22, P529, DOI 10.1111/j.1365-2362.1992.tb01501.x; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Hwang CJ, 2009, INVEST OPHTH VIS SCI, V50, P2262, DOI 10.1167/iovs.08-2328; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; Kawada N, 1998, HEPATOLOGY, V27, P1265, DOI 10.1002/hep.510270512; KUPPUSAMY UR, 1994, BIOCHEM PHARMACOL, V47, P521, DOI 10.1016/0006-2952(94)90184-8; Kuriyan AE, 2008, CURR OPIN OPHTHALMOL, V19, P499, DOI 10.1097/ICU.0b013e3283131557; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; Lisi S, 2011, J ENDOCRINOL INVEST, V34, P521, DOI 10.3275/7321; Mertens-Talcott SU, 2003, J NUTR, V133, P2669, DOI 10.1093/jn/133.8.2669; Ong CS, 2004, ONCOL REP, V11, P727; Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077; Pritchard J, 2002, J IMMUNOL, V168, P942, DOI 10.4049/jimmunol.168.2.942; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; SMITH TJ, 1995, AM J PHYSIOL-CELL PH, V268, pC382, DOI 10.1152/ajpcell.1995.268.2.C382; Sorisky A, 1996, J CLIN ENDOCR METAB, V81, P3428, DOI 10.1210/jc.81.9.3428; Visentin V, 2003, EUR J PHARMACOL, V466, P235, DOI 10.1016/S0014-2999(03)01562-0; Wakelkamp IMMJ, 2003, CLIN ENDOCRINOL, V58, P280, DOI 10.1046/j.1365-2265.2003.01708.x; Ying BW, 2009, MOL BIOL REP, V36, P1825, DOI 10.1007/s11033-008-9386-1; Zhao LQ, 2010, INVEST OPHTH VIS SCI, V51, P4652, DOI 10.1167/iovs.09-3789; Zieleniak A, 2008, ARCH IMMUNOL THER EX, V56, P331, DOI 10.1007/s00005-008-0037-y	35	53	56	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26261	10.1371/journal.pone.0026261	http://dx.doi.org/10.1371/journal.pone.0026261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039452	Green Published, Green Submitted, gold			2022-12-25	WOS:000296507500045
J	Egger, B; Klaefiger, Y; Theis, A; Salzburger, W				Egger, Bernd; Klaefiger, Yuri; Theis, Anya; Salzburger, Walter			A Sensory Bias Has Triggered the Evolution of Egg-Spots in Cichlid Fishes	PLOS ONE			English	Article							ALGAL-FORAGING ABILITY; MUTUAL MATE CHOICE; SEXUAL SELECTION; RECEIVER BIASES; COLORATION; PREFERENCE; SPECIATION; AFRICAN; DUMMIES; TRAITS	Although, generally, the origin of sex-limited traits remains elusive, the sensory exploitation hypothesis provides an explanation for the evolution of male sexual signals. Anal fin egg-spots are such a male sexual signal and a key characteristic of the most species-rich group of cichlid fishes, the haplochromines. Males of about 1500 mouth-brooding species utilize these conspicuous egg-dummies during courtship - apparently to attract females and to maximize fertilization success. Here we test the hypothesis that the evolution of haplochromine egg-spots was triggered by a pre-existing bias for eggs or egg-like coloration. To this end, we performed mate-choice experiments in the basal haplochromine Pseudocrenilabrus multicolor, which manifests the plesiomorphic character-state of an egg-spot-less anal fin. Experiments using computer-animated photographs of males indeed revealed that females prefer images of males with virtual ('in-silico') egg-spots over images showing unaltered males. In addition, we tested for color preferences (outside a mating context) in a phylogenetically representative set of East African cichlids. We uncovered a strong preference for yellow, orange or reddish spots in all haplochromines tested and, importantly, also in most other species representing more basal lines. This preexisting female sensory bias points towards high-quality (carotenoids-enriched) food suggesting that it is adaptive.	[Egger, Bernd; Klaefiger, Yuri; Theis, Anya; Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland	University of Basel	Egger, B (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	walter.salzburger@unibas.ch	Salzburger, Walter/G-1598-2011	Salzburger, Walter/0000-0002-9988-1674	European Research Council (ERC); Austrian Science Foundation (FWF); Department of Fisheries	European Research Council (ERC)(European Research Council (ERC)European Commission); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Department of Fisheries	This work has been supported by the European Research Council (ERC; Starting Grant 'INTERGENADAPT') and the Austrian Science Foundation (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Ministry of Agriculture, Food and Fisheries, Republic of Zambia, for permissions to conduct this research. We are very grateful to T. Veall, without whom the experiments in Africa would not have been possible, and to L. Makasa from the Department of Fisheries for support. We thank our field assistants L. Baldo, S. Rutschmann, L. Schild, L. Walther; and A. Indermaur for assistance with fish keeping. We would like to thank V. Amrhein, D. Berner and M. Kolliker for advice on statistical analyses; V. Amrhein, M. Dittmann, M. Kolliker, and the members of the SalzburgerLab for valuable comments on the manuscript.	Arnqvist G, 2006, PHILOS T R SOC B, V361, P375, DOI 10.1098/rstb.2005.1790; Arnqvist G, 2010, J EVOLUTION BIOL, V23, P1907, DOI 10.1111/j.1420-9101.2010.02055.x; Baldauf SA, 2009, J FISH BIOL, V75, P738, DOI 10.1111/j.1095-8649.2009.02347.x; Baldauf SA, 2011, BEHAV ECOL, V22, P478, DOI 10.1093/beheco/arq226; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1988, ANNU REV ECOL SYST, V19, P395, DOI 10.1146/annurev.es.19.110188.002143; Fryer G., 1972, CICHLID FISHES GREAT; Fuller RC, 2009, EVOLUTION, V63, P1697, DOI 10.1111/j.1558-5646.2009.00659.x; Grether GF, 2005, P ROY SOC B-BIOL SCI, V272, P2181, DOI 10.1098/rspb.2005.3197; Grether GF, 2001, P ROY SOC B-BIOL SCI, V268, P1245, DOI 10.1098/rspb.2001.1624; HERT E, 1989, ANIM BEHAV, V37, P726, DOI 10.1016/0003-3472(89)90058-4; HERT E, 1991, J FISH BIOL, V38, P951, DOI 10.1111/j.1095-8649.1991.tb03634.x; Karino K, 2005, BEHAV ECOL SOCIOBIOL, V59, P1, DOI 10.1007/s00265-005-0001-3; Karino K, 2007, ZOOL SCI, V24, P571, DOI 10.2108/zsj.24.571; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; MADDISON WP, 2005, MESQUITE MODULAR SYS; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Salzburger W, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-51; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Tobler Michael, 2006, Zeitschrift fuer Fischkunde, V8, P39; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; Wickler W., 1962, Zeitschrift fuer Tierpsychologie, V19, P129; WICKLER W, 1962, NATURE, V194, P1092, DOI 10.1038/1941092a0	36	28	28	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25601	10.1371/journal.pone.0025601	http://dx.doi.org/10.1371/journal.pone.0025601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028784	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900013
J	Klinge, A; Beutelmann, R; Klump, GM				Klinge, Astrid; Beutelmann, Rainer; Klump, Georg M.			Effect of Harmonicity on the Detection of a Signal in a Complex Masker and on Spatial Release from Masking	PLOS ONE			English	Article							NONSPEECH AUDITORY PATTERNS; INFORMATIONAL MASKING; LEVEL DIFFERENCES; FREE-FIELD; MULTICOMPONENT MASKERS; SPEECH-INTELLIGIBILITY; FREQUENCY; MODEL; IDENTIFICATION; SEGREGATION	The amount of masking of sounds from one source (signals) by sounds from a competing source (maskers) heavily depends on the sound characteristics of the masker and the signal and on their relative spatial location. Numerous studies investigated the ability to detect a signal in a speech or a noise masker or the effect of spatial separation of signal and masker on the amount of masking, but there is a lack of studies investigating the combined effects of many cues on the masking as is typical for natural listening situations. The current study using free-field listening systematically evaluates the combined effects of harmonicity and inharmonicity cues in multi-tone maskers and cues resulting from spatial separation of target signal and masker on the detection of a pure tone in a multi-tone or a noise masker. A linear binaural processing model was implemented to predict the masked thresholds in order to estimate whether the observed thresholds can be accounted for by energetic masking in the auditory periphery or whether other effects are involved. Thresholds were determined for combinations of two target frequencies (1 and 8 kHz), two spatial configurations (masker and target either co-located or spatially separated by 90 degrees azimuth), and five different masker types (four complex multi-tone stimuli, one noise masker). A spatial separation of target and masker resulted in a release from masking for all masker types. The amount of masking significantly depended on the masker type and frequency range. The various harmonic and inharmonic relations between target and masker or between components of the masker resulted in a complex pattern of increased or decreased masked thresholds in comparison to the predicted energetic masking. The results indicate that harmonicity cues affect the detectability of a tonal target in a complex masker.	[Klinge, Astrid; Beutelmann, Rainer; Klump, Georg M.] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Anim Physiol & Behav Grp, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Klinge, A (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Anim Physiol & Behav Grp, D-2900 Oldenburg, Germany.	astrid.klinge@uni-oldenburg.de		Beutelmann, Rainer/0000-0001-9708-4113	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich SFB/TRR31]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft within the Sonderforschungsbereich SFB/TRR31 "The Active Auditory System". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Best V, 2005, J ACOUST SOC AM, V118, P3766, DOI 10.1121/1.2130949; Beutelmann R, 2010, J ACOUST SOC AM, V127, P2479, DOI 10.1121/1.3295575; Breebaart J, 2001, J ACOUST SOC AM, V110, P1074, DOI 10.1121/1.1383297; Bronkhorst AW, 2000, ACUSTICA, V86, P117; BUUS S, 1997, AUDITORY MASKING, P1427; CARHART R, 1969, J ACOUST SOC AM, V45, P694, DOI 10.1121/1.1911445; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; COHEN MF, 1991, J ACOUST SOC AM, V89, P3007, DOI 10.1121/1.400739; Du Y, 2011, CEREB CORTEX, V21, P698, DOI 10.1093/cercor/bhq136; Durlach NI, 2003, J ACOUST SOC AM, V113, P2984, DOI 10.1121/1.1570435; DURLACH NI, 1963, J ACOUST SOC AM, V35, P1206, DOI 10.1121/1.1918675; Epp B, 2009, J COMPUT NEUROSCI, V26, P393, DOI 10.1007/s10827-008-0118-2; Freyman RL, 2001, J ACOUST SOC AM, V109, P2112, DOI 10.1121/1.1354984; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Gilkey RH, 1995, HUM FACTORS, V37, P835, DOI 10.1518/001872095778995580; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Green D. M., 1966, SIGNAL DETECTION THE, V1; HAFTER ER, 1971, J ACOUST SOC AM, V50, P1116, DOI 10.1121/1.1912743; HARTMANN WM, 1988, PITCH PERCEPTION SEG, P623; Hohmann V, 2002, ACTA ACUST UNITED AC, V88, P433; Kidd G, 2002, J ACOUST SOC AM, V111, P1367, DOI 10.1121/1.1448342; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Kidd G, 1998, J ACOUST SOC AM, V104, P422, DOI 10.1121/1.423246; Klinge A, 2010, J ACOUST SOC AM, V128, P280, DOI 10.1121/1.3436552; Leung AWS, 2011, J EXP PSYCHOL HUMAN, V37, P727, DOI 10.1037/a0021932; LUTFI RA, 1990, J ACOUST SOC AM, V88, P2607, DOI 10.1121/1.399980; MARIN M, 1994, J PHYS IV, V4, P233, DOI 10.1051/jp4:1994546; McDonald KL, 2005, J ACOUST SOC AM, V118, P1593, DOI 10.1121/1.2000747; Moore BCJ, 2003, J ACOUST SOC AM, V114, P408, DOI 10.1121/1.1577552; MOORE BCJ, 1985, J ACOUST SOC AM, V77, P1861, DOI 10.1121/1.391937; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1351, DOI 10.1121/1.398695; NEFF DL, 1995, J ACOUST SOC AM, V98, P125, DOI 10.1121/1.413748; NEFF DL, 1987, PERCEPT PSYCHOPHYS, V41, P409, DOI 10.3758/BF03203033; Oh EL, 2000, J ACOUST SOC AM, V108, P706, DOI 10.1121/1.429603; Roberts B, 2001, J ACOUST SOC AM, V110, P2479, DOI 10.1121/1.1410965; SABERI K, 1991, J ACOUST SOC AM, V90, P1355, DOI 10.1121/1.401927; Shinn-Cunningham BG, 2005, ACTA ACUST UNITED AC, V91, P967; van de Par S, 1999, J ACOUST SOC AM, V106, P1940, DOI 10.1121/1.427942; Warusfel O., LISTEN HRTF DATABASE; ZUREK PM, 1993, BINAURAL ADVANTAGES, P255	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26124	10.1371/journal.pone.0026124	http://dx.doi.org/10.1371/journal.pone.0026124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028814	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900028
J	Liu, JX; Qin, W; Yuan, K; Li, J; Wang, W; Li, Q; Wang, YR; Sun, JB; von Deneen, KM; Liu, YJ; Tian, J				Liu, Jixin; Qin, Wei; Yuan, Kai; Li, Jing; Wang, Wei; Li, Qiang; Wang, Yarong; Sun, Jinbo; von Deneen, Karen M.; Liu, Yijun; Tian, Jie			Interaction between Dysfunctional Connectivity at Rest and Heroin Cues-Induced Brain Responses in Male Abstinent Heroin-Dependent Individuals	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; SMALL-WORLD; INTRINSIC CONNECTIVITY; NEUROIMAGING EVIDENCE; PREFRONTAL CORTEX; NETWORKS; PATTERNS; STRESS; USERS; PERFORMANCE	Background: The majority of previous heroin cue-reactivity functional magnetic resonance imaging (fMRI) studies focused on local function impairments, such as inhibitory control, decision-making and stress regulation. Our previous studies have demonstrated that these brain circuits also presented dysfunctional connectivity during the resting state. Yet few studies considered the relevance of resting state dysfunctional connectivity to task-related neural activity in the same chronic heroin user (CHU). Methodology/Principal Findings: We employed the method of graph theory analysis, which detected the abnormality of brain regions and dysregulation of brain connections at rest between 16 male abstinent chronic heroin users (CHUs) and 16 non-drug users (NDUs). Using a cue-reactivity task, we assessed the relationship between drug-related cue-induced craving activity and the abnormal topological properties of the CHUs' resting networks. Comparing NDUs' brain activity to that of CHUs, the intensity of functional connectivity of the medial frontal gyrus (meFG) in patients' resting state networks was prominently greater and positively correlated with the same region's neural activity in the heroin-related task; decreased functional connectivity intensity of the anterior cingulate cortex (ACC) in CHUs at rest was associated with more drug-related cue-induced craving activities. Conclusions: These results may indicate that there exist two brain systems interacting simultaneously in the heroin-addicted brain with regards to a cue-reactivity task. The current study may shed further light on the neural architecture that supports craving responses in heroin dependence.	[Liu, Jixin; Qin, Wei; Yuan, Kai; Li, Jing; Sun, Jinbo; von Deneen, Karen M.; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Wang, Wei; Li, Qiang; Wang, Yarong] Fourth Mil Med Univ, Xian 710032, Shaanxi, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, JX (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	qinwei@life.xidian.edu.cn; tian@ieee.org	Yuan, Kai/M-9403-2013; Yuan, Kai/I-4150-2016; tian, jie/M-6336-2013; Tian, Jie/H-1190-2011; JinBo, Sun/GLT-2082-2022; Life, PAM/M-9552-2013; 秦, 伟/J-9770-2016	Yuan, Kai/0000-0002-3098-1124; Tian, Jie/0000-0003-0498-0432; 秦, 伟/0000-0003-4583-0406	Chinese Academy of Sciences [KGCX2-YW-129]; National Natural Science Foundation of China [81000641, 81000640, 30970774, 60901064, 30873462, 30870685, 81071142]; National Key Basic Research and Development Program (973) [2006CB705700]; 863 program [2008AA01Z411]; Fundamental Research Funds for the Central Universities	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by CAS Hundred Talents Program, the National Natural Science Foundation of China under Grant Nos. 81000641, 81000640, 30970774, 60901064, 30873462, 30870685, 30870685,81071142; the Knowledge Innovation Program of the Chinese Academy of Sciences under grant No. KGCX2-YW-129; the Project for the National Key Basic Research and Development Program (973) under Grant No. 2006CB705700; and 863 program under Grant No. 2008AA01Z411, the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Dyer KR, 1997, ADDICTION, V92, P1445, DOI 10.1111/j.1360-0443.1997.tb02866.x; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Forman SD, 2004, BIOL PSYCHIAT, V55, P531, DOI 10.1016/j.biopsych.2003.09.011; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kreek MJ, 2000, ANN NY ACAD SCI, V909, P186; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lee TM, 2002, BRAIN INJURY, V16, P885, DOI 10.1080/02699050210128915; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Liu JX, 2011, J MAGN RESON IMAGING, V33, P33, DOI 10.1002/jmri.22393; Liu JX, 2010, NEUROSCI LETT, V468, P353, DOI 10.1016/j.neulet.2009.11.031; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Upadhyay J, 2010, BRAIN, V133, P2098, DOI 10.1093/brain/awq138; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Xiao ZW, 2006, DRUG ALCOHOL DEPEN, V83, P157, DOI 10.1016/j.drugalcdep.2005.11.012; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Yuan K, 2010, NEUROSCI LETT, V475, P20, DOI 10.1016/j.neulet.2010.03.033; Zhang XC, 2011, NEUROIMAGE, V54, P131, DOI 10.1016/j.neuroimage.2010.07.063	51	84	89	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e23098	10.1371/journal.pone.0023098	http://dx.doi.org/10.1371/journal.pone.0023098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028765	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900001
J	Palanisamy, GS; Kirk, NM; Ackart, DF; Shanley, CA; Orme, IM; Basaraba, RJ				Palanisamy, Gopinath S.; Kirk, Natalie M.; Ackart, David F.; Shanley, Crystal A.; Orme, Ian M.; Basaraba, Randall J.			Evidence for Oxidative Stress and Defective Antioxidant Response in Guinea Pigs with Tuberculosis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; CELLULAR IMMUNE-RESPONSE; SUBUNIT GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; LIGHT SUBUNIT; INFECTION; CELLS; MODEL; LUNG	The development of granulomatous inflammation with caseous necrosis is an important but poorly understood manifestation of tuberculosis in humans and some animal models. In this study we measured the byproducts of oxidative stress in granulomatous lesions as well as the systemic antioxidant capacity of BCG vaccinated and non-vaccinated guinea pigs experimentally infected with Mycobacterium tuberculosis. In non-vaccinated guinea pigs, oxidative stress was evident within 2 weeks of infection as measured by a decrease in the serum total antioxidant capacity and blood glutathione levels accompanied by an increase in malondialdehyde, a byproduct of lipid peroxidation, within lesions. Despite a decrease in total and reduced blood glutathione concentrations, there was an increase in lesion glutathione by immunohistochemistry in response to localized oxidative stress. In addition there was an increase in the expression of the host transcription factor nuclear erythroid 2 p45-related factor 2 (Nrf2), which regulates several protein and non-proteins antioxidants, including glutathione. Despite the increase in cytoplasmic expression of Nrf2, immunohistochemical staining revealed a defect in Nrf2 nuclear translocation within granulomatous lesions as well as a decrease in the expression of the Nrf2-regulated antioxidant protein NQO1. Treating M. tuberculosis-infected guinea pigs with the antioxidant drug N-acetyl cysteine (NAC) partially restored blood glutathione concentrations and the serum total antioxidant capacity. Treatment with NAC also decreased spleen bacterial counts, as well as decreased the lung and spleen lesion burden and the severity of lesion necrosis. These data suggest that the progressive oxidative stress during experimental tuberculosis in guinea pigs is due in part to a defect in host antioxidant defenses, which, we show here, can be partially restored with antioxidant treatment. These data suggest that the therapeutic strategies that reduce oxidant-mediated tissue damage may be beneficial as an adjunct therapy in the treatment and prevention of tuberculosis in humans.	[Palanisamy, Gopinath S.; Kirk, Natalie M.; Ackart, David F.; Shanley, Crystal A.; Orme, Ian M.; Basaraba, Randall J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Palanisamy, GS (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Randall.Basaraba@colostate.edu			National Institutes of Health at Colorado State University [AI070456, AI083856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070456, R21AI083856] Funding Source: NIH RePORTER	National Institutes of Health at Colorado State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health grants AI070456 (RJB) and AI083856 (IMO) at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Basaraba RJ, 2007, TUBERCULOSIS EDINB; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Cai JX, 1997, BIOCHEM J, V326, P167, DOI 10.1042/bj3260167; Canetti G., 1955, TUBERCLE BACILLUS PU; Castandet J, 2005, RES MICROBIOL, V156, P1005, DOI 10.1016/j.resmic.2005.05.013; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chen C, 2004, FREE RADICAL BIO MED, V37, P1578, DOI 10.1016/j.freeradbiomed.2004.07.021; Espinal MA, 2003, TUBERCULOSIS, P33; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Galloway DC, 1998, BIOCHEM J, V336, P535, DOI 10.1042/bj3360535; JACK CIA, 1994, TUBERCLE LUNG DIS, V75, P132, DOI 10.1016/0962-8479(94)90042-6; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kwiatkowska S, 1999, RESP MED, V93, P272, DOI 10.1016/S0954-6111(99)90024-0; Larnsal Madhab, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P695; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Madebo T, 2003, AM J CLIN NUTR, V78, P117, DOI 10.1093/ajcn/78.1.117; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; McMurray DN, 1994, GUINEA PIG MODEL TUB, P135; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; Mithen R, 2003, THEOR APPL GENET, V106, P727, DOI 10.1007/s00122-002-1123-x; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Qian Y, 2003, J BIOL CHEM, V278, P16189, DOI 10.1074/jbc.M207517200; SCHORAH CJ, 1992, P NUTR SOC, V51, P189, DOI 10.1079/PNS19920029; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Vijayamalini A, 2004, CELL BIOCHEM FUNCT, V22, P19, DOI [10.1002/cbf.1039, 10.1027/cbf.1039]; Walubo A, 1998, METHOD FIND EXP CLIN, V20, P649, DOI 10.1358/mf.1998.20.8.487491; WHO, 2010, GLOB TB CONTR REP 20; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108	37	79	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26254	10.1371/journal.pone.0026254	http://dx.doi.org/10.1371/journal.pone.0026254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028843	Green Submitted, Green Published, gold			2022-12-25	WOS:000296186900039
J	Laxman, S; Tu, BP				Laxman, Sunil; Tu, Benjamin P.			Multiple TORC1-Associated Proteins Regulate Nitrogen Starvation-Dependent Cellular Differentiation in Saccharomyces cerevisiae	PLOS ONE			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; HAPLOID INVASIVE GROWTH; PSEUDOHYPHAL DIFFERENTIATION; FILAMENTOUS GROWTH; KINASE-A; TOR KINASES; MAP KINASE; GENE; EXPRESSION; DISTINCT	Background: The budding yeast Saccharomyces cerevisiae undergoes differentiation into filamentous-like forms and invades the growth medium as a foraging response to nutrient and environmental stresses. These developmental responses are under the downstream control of effectors regulated by the cAMP/PKA and MAPK pathways. However, the upstream sensors and signals that induce filamentous growth through these signaling pathways are not fully understood. Herein, through a biochemical purification of the yeast TORC1 (Target of Rapamycin Complex 1), we identify several proteins implicated in yeast filamentous growth that directly associate with the TORC1 and investigate their roles in nitrogen starvation-dependent or independent differentiation in yeast. Methodology: We isolated the endogenous TORC1 by purifying tagged, endogenous Kog1p, and identified associated proteins by mass spectrometry. We established invasive and pseudohyphal growth conditions in two S. cerevisiae genetic backgrounds (Sigma 1278b and CEN.PK). Using wild type and mutant strains from these genetic backgrounds, we investigated the roles of TORC1 and associated proteins in nitrogen starvation-dependent diploid pseudohyphal growth as well as nitrogen starvation-independent haploid invasive growth. Conclusions: We show that several proteins identified as associated with the TORC1 are important for nitrogen starvation-dependent diploid pseudohyphal growth. In contrast, invasive growth due to other nutritional stresses was generally not affected in mutant strains of these TORC1-associated proteins. Our studies suggest a role for TORC1 in yeast differentiation upon nitrogen starvation. Our studies also suggest the CEN. PK strain background of S. cerevisiae may be particularly useful for investigations of nitrogen starvation-induced diploid pseudohyphal growth.	[Laxman, Sunil; Tu, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Laxman, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	sunil.laxman@utsouthwestern.edu; benjamin.tu@utsouthwestern.edu	Laxman, Sunil/F-9886-2018	Laxman, Sunil/0000-0002-0861-5080	University of Texas; Burroughs Wellcome Fund Career Award in Biomedical Sciences; Welch Foundation [I-1697]; American Cancer Society/Simmons Cancer Center [ACS-IRG-02-196]; National Institute of General Medical Sciences [R01GM094314]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094314] Funding Source: NIH RePORTER	University of Texas; Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); Welch Foundation(The Welch Foundation); American Cancer Society/Simmons Cancer Center(American Cancer Society); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Texas Southwestern Endowed Scholars Program, a Burroughs Wellcome Fund Career Award in Biomedical Sciences, a Welch Foundation Research Grant I-1697, an American Cancer Society/Simmons Cancer Center Institutional Research Grant (ACS-IRG-02-196), and award R01GM094314 from the National Institute of General Medical Sciences (B. P. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharucha N, 2008, MOL BIOL CELL, V19, P2708, DOI 10.1091/mbc.E07-11-1199; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Dumortier F, 2000, INT J FOOD MICROBIOL, V55, P103, DOI 10.1016/S0168-1605(00)00184-7; Duvel K, 2003, CURR TOP MICROBIOL, V279, P19; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Edskes HK, 1999, GENETICS, V153, P585; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Kuchin S, 2002, MOL CELL BIOL, V22, P3994, DOI 10.1128/MCB.22.12.3994-4000.2002; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenz MC, 2000, GENETICS, V154, P609; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Orlova M, 2006, EUKARYOT CELL, V5, P1831, DOI 10.1128/EC.00110-06; Orlova M, 2010, EUKARYOT CELL, V9, P208, DOI 10.1128/EC.00216-09; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Strudwick N, 2010, MOL CELL BIOL, V30, P5514, DOI 10.1128/MCB.00390-10; Sydorskyy Y, 2003, MOL CELL BIOL, V23, P2042, DOI 10.1128/MCB.23.6.2042-2054.2003; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; Tu BP, 2010, METHOD ENZYMOL, V470, P857, DOI 10.1016/S0076-6879(10)70035-5; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Van de Velde S, 2008, EUKARYOT CELL, V7, P286, DOI 10.1128/EC.00276-07; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005	57	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26081	10.1371/journal.pone.0026081	http://dx.doi.org/10.1371/journal.pone.0026081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043304	Green Submitted, gold, Green Published			2022-12-25	WOS:000295984400032
J	Malessy, MJA; Pondaag, W; Yang, LJS; Hofstede-Buitenhuis, SM; le Cessie, S; van Dijk, JG				Malessy, Martijn J. A.; Pondaag, Willem; Yang, Lynda J. -S.; Hofstede-Buitenhuis, Sonja M.; le Cessie, Saskia; van Dijk, J. Gert			Severe Obstetric Brachial Plexus Palsies Can Be Identified at One Month of Age	PLOS ONE			English	Article							BIRTH PALSY; NATURAL-HISTORY; SURGICAL-TREATMENT; LESIONS; RECONSTRUCTION; MANAGEMENT; PROGNOSIS; INJURIES	Objective: To establish whether severe obstetric brachial plexus palsy (OBPP) can be identified reliably at or before three months of age. Methods: Severe OBPP was defined as neurotmesis or avulsion of spinal nerves C5 and C6 irrespective of additional C7-T1 lesions, assessed during surgery and confirmed by histopathological examination. We first prospectively studied a derivation group of 48 infants with OBPP with a minimal follow-up of two years. Ten dichotomous items concerning active clinical joint movement and needle electromyography of the deltoid, biceps and triceps muscles were gathered at one week, one month and three months of age. Predictors for a severe lesion were identified using a two-step forward logistic regression analysis. The results were validated in two independent cohorts of OBPP infants of 60 and 13 infants. Results: Prediction of severe OBPP at one month of age was better than at one week and at three months. The presence of elbow extension, elbow flexion and of motor unit potentials in the biceps muscle correctly predicted whether lesions were mild or severe in 93.6% of infants in the derivation group (sensitivity 1.0, specificity 0.88), in 88.3% in the first validation group (sensitivity 0.97, specificity 0.76) and in 84.6% in the second group (sensitivity of 1.0, specificity 0.66). Interpretation: Infants with OBPP with severe lesions can be identified at one month of age by testing elbow extension, elbow flexion and recording motor unit potentials (MUPs) in the biceps muscle. The decision rule implies that children without active elbow extension at one month should be referred to a specialized center, while children with active elbow extension as well as active flexion should not. When there is active elbow extension, but no active elbow flexion an EMG is needed; absence of MUPs in the biceps muscle is an indication for referral.	[Malessy, Martijn J. A.; Pondaag, Willem; Hofstede-Buitenhuis, Sonja M.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Yang, Lynda J. -S.] Univ Michigan Hosp, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Hofstede-Buitenhuis, Sonja M.] Leiden Univ, Med Ctr, Dept Neurosurg Phys Therapy, Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Med Ctr, Dept Neurosurg Med Stat, Leiden, Netherlands; [van Dijk, J. Gert] Leiden Univ, Med Ctr, Dept Neurosurg Neurol & Clin Neurophysiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Michigan System; University of Michigan; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Malessy, MJA (corresponding author), Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands.	malessy@lumc.nl	Malessy, Martijn/AAZ-9996-2021; le+Cessie, Saskia/HGC-8966-2022	Malessy, Martijn/0000-0003-1936-3664; le Cessie, Saskia/0000-0003-2154-4923	ZON-MW, the Netherlands Organization for Health Research and Development	ZON-MW, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	Martijn J. A. Malessy was supported by ZON-MW (http://www.zonmw.nl), the Netherlands Organization for Health Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bager B, 1997, ACTA PAEDIATR, V86, P1214, DOI 10.1111/j.1651-2227.1997.tb14849.x; Bellew M, 2003, J HAND SURG-BRIT EUR, V28B, P339, DOI 10.1016/S0266-7681(03)00081-0; Bisinella GL, 2003, J HAND SURG-BRIT EUR, V28B, P148, DOI 10.1016/S0266-7681(02)00281-4; BORRERO JL, 2005, OBSTET BRACHIAL PLEX; Clark LP, 1905, AM J MED SCI, V130, P670, DOI 10.1097/00000441-190510000-00013; Dawodu A, 1997, ANN TROP PAEDIATR, V17, P195, DOI 10.1080/02724936.1997.11747886; Evans-Jones G, 2003, ARCH DIS CHILD-FETAL, V88, P185, DOI 10.1136/fn.88.3.F185; GILBERT A, 1991, CLIN ORTHOP RELAT R, P39; KAWABATA H, 1987, CLIN ORTHOP RELAT R, P233; Kay SPJ, 1998, BRIT J PLAST SURG, V51, P43, DOI 10.1054/bjps.1997.0166; Malessy MJA, 2009, NEUROSURGERY, V65, pA153, DOI 10.1227/01.NEU.0000338429.66249.7D; Malessy MJA, 2009, NEUROSURG CLIN N AM, V20, P1, DOI 10.1016/j.nec.2008.07.024; Marcus JR, 2003, CLIN PLAST SURG, V30, P289, DOI 10.1016/S0094-1298(02)00100-1; METAIZEAU JP, 1979, CHIR PEDIATR, V20, P159; MICHELOW BJ, 1994, PLAST RECONSTR SURG, V93, P675, DOI 10.1097/00006534-199404000-00001; Pondaag W, 2005, NEUROSURGERY, V57, P530, DOI 10.1227/01.NEU.0000170557.13788.D2; Pondaag W, 2004, DEV MED CHILD NEUROL, V46, P138; Smith NC, 2004, J BONE JOINT SURG AM, V86A, P2163, DOI 10.2106/00004623-200410000-00006; Steens SCA, 2011, RADIOLOGY, V259, P508, DOI 10.1148/radiol.10101417; Sunderland S, 1991, NERVE INJURIES THEIR; Tassin J. L., 1983, THESIS U PARIS; van Dijk JG, 2001, MUSCLE NERVE, V24, P1451, DOI 10.1002/mus.1168; Waters PM, 2005, J PEDIATR ORTHOP B, V14, P233, DOI 10.1097/01202412-200507000-00001; Waters PM, 1999, J BONE JOINT SURG AM, V81A, P649, DOI 10.2106/00004623-199905000-00006	24	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26193	10.1371/journal.pone.0026193	http://dx.doi.org/10.1371/journal.pone.0026193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043309	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400037
J	Zhang, ZF; Zhang, J; Hui, YN; Zheng, MH; Liu, XP; Kador, PF; Wang, YS; Yao, LB; Zhou, J				Zhang, Zi-Feng; Zhang, Jian; Hui, Yan-Nian; Zheng, Min-Hua; Liu, Xin-Ping; Kador, Peter F.; Wang, Yu-Sheng; Yao, Li-Bo; Zhou, Jian			Up-Regulation of NDRG2 in Senescent Lens Epithelial Cells Contributes to Age-Related Cataract in Human	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; HUMAN-DIPLOID FIBROBLASTS; N-MYC; CELLULAR SENESCENCE; NEURITE OUTGROWTH; BREAST-CANCER; GENE FAMILY; DNA-DAMAGE; PC12 CELLS; EXPRESSION	Background: Human N-Myc downstream regulated gene2 (NDRG2), a novel gene has been cloned and shown to be related to a number of cellular processes, including proliferation, differentiation, stress, and apoptosis. NDRG2 has also been linked to age-related Alzheimer's disease. Since the role of this gene in senescence is limited, we have investigated the potential role of NDRG2 in human lens epithelial cells (HLECs), a paradigm implicated in age-related cataract. Methodology/Principal Findings: Cultured HLECs (SRA01/04) were subjected to prolonged exposure to low dose of H2O2 to simulate senescence. After being exposed to 50 mu M H2O2 for 2 weeks, HLECs senescent-morphological changes appeared, cell viability decreased dramatically, cell proliferation reduced from 37.4% to 16.1%, and senescence-associated beta-galactosidase activity increased from 0 to 90.3%. Ndrg2 protein expression was also significantly increased in these senescent cells. To induce overexpression of NDRG2, SRA01/04 cells were infected with the adenoviral vector of NDRG2. In these cells, overexpression of NDRG2 resulted in a fibroblast-like appearance and the cell viability decreased about 20%. In addition, the NDRG2-overexpression cells demonstrated 20% lower viability when exposed to 50-200 mu M H2O2 for acute oxidative stress. Furthermore, the expression of NDRG2 from age-related cataracts was up-regulated 2-fold at both mRNA and protein levels compared with the clear lenses. Conclusions/Significance: NDRG2 is up regulated not only in the ageing process of HLECs in vitro but also in the cells from human age-related cortical cataract in vivo. Up-regulation of NDRG2 induces cell morphological changes, reduces cell viability, and especially lowers cellular resistance to oxidative stress. NDRG2-mediated affects in HLECs may associate with age-related cataract formation.	[Zhang, Zi-Feng; Hui, Yan-Nian; Wang, Yu-Sheng; Zhou, Jian] Fourth Mil Med Univ, Xi Jing Hosp, Eye Inst Chinese PLA, Dept Ophthalmol, Xian 710032, Peoples R China; [Zhang, Jian; Liu, Xin-Ping; Yao, Li-Bo] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Zheng, Min-Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Kador, Peter F.] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Coll Pharm, Omaha, NE USA; [Kador, Peter F.] Univ Nebraska, Sch Med, Med Ctr, Dept Ophthalmol, Omaha, NE 68198 USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Zhang, ZF (corresponding author), Fourth Mil Med Univ, Xi Jing Hosp, Eye Inst Chinese PLA, Dept Ophthalmol, Xian 710032, Peoples R China.	bioyao@fmmu.edu.cn; zhoujian@fmmu.edu.cn			National Natural Science Foundation of China (NSFC) [30000185, 30672292, 30801275]; Program for New Century Excellent Talents in University (NCET) [NCET-06-0932]; University funds for PhD thesis [2004012]; Alexander von Humboldt Foundation in Germany [V-8151/02085]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET)); University funds for PhD thesis; Alexander von Humboldt Foundation in Germany(Alexander von Humboldt Foundation)	This study was supported by the grants from National Natural Science Foundation of China (NSFC) to J. Zhou (No. 30000185 and No. 30672292) and Z.-F. Zhang (No. 30801275), Program for New Century Excellent Talents in University (NCET) to J. Zhou (No. NCET-06-0932), and the University funds for PhD thesis to Z.-F. Zhang (No. 2004012). The study was also sponsored partly by the equipment donation from the Alexander von Humboldt Foundation in Germany to Y.-S. Wang (V-8151/02085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbell PA, 2005, LANCET, V365, P599; Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Chen Jian-Hua, 2007, Methods Mol Biol, V371, P179; Choi SC, 2003, FEBS LETT, V553, P413, DOI 10.1016/S0014-5793(03)01030-5; Choi SC, 2007, EXP MOL MED, V39, P705, DOI 10.1038/emm.2007.77; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duan HM, 2005, INT J BIOCHEM CELL B, V37, P1407, DOI 10.1016/j.biocel.2005.01.010; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Furuta H, 2010, BIOCHEM BIOPH RES CO, V391, P1785, DOI 10.1016/j.bbrc.2009.12.156; Hou WG, 2009, CELL TISSUE RES, V337, P257, DOI 10.1007/s00441-009-0814-x; Hu XL, 2006, CELL TISSUE RES, V325, P67, DOI 10.1007/s00441-005-0137-5; Hu XL, 2004, WORLD J GASTROENTERO, V10, P3518; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Kim YJ, 2009, INT J CANCER, V124, P7, DOI 10.1002/ijc.23945; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kurdistani SK, 1998, CANCER RES, V58, P4439; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Liu N, 2007, BIOCHEM BIOPH RES CO, V358, P164, DOI 10.1016/j.bbrc.2007.04.089; Liu XP, 2009, APPL BIOCHEM BIOTECH, V152, P306, DOI 10.1007/s12010-008-8267-3; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Lorentzen A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-14; Lusis EA, 2005, CANCER RES, V65, P7121, DOI 10.1158/0008-5472.CAN-05-0043; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Ohki T, 2002, DEV BRAIN RES, V135, P55; Okuda T, 1999, BIOCHEM BIOPH RES CO, V266, P208, DOI 10.1006/bbrc.1999.1780; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Takahashi K, 2005, NEUROSCI LETT, V388, P157, DOI 10.1016/j.neulet.2005.06.055; vanBelzen N, 1997, LAB INVEST, V77, P85; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wu Guo-Qiang, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P357; Yang JD, 2010, WOUND REPAIR REGEN, V18, P524, DOI 10.1111/j.1524-475X.2010.00614.x; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zhang J, 2006, J BIOL CHEM, V281, P39159, DOI 10.1074/jbc.M605820200; Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303; Zhao W, 2001, BBA-GENE STRUCT EXPR, V1519, P134, DOI 10.1016/S0167-4781(01)00210-X; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	46	16	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26102	10.1371/journal.pone.0026102	http://dx.doi.org/10.1371/journal.pone.0026102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043305	Green Submitted, Green Published, gold			2022-12-25	WOS:000295984400033
J	Hondares, E; Rosell, M; Diaz-Delfin, J; Olmos, Y; Monsalve, M; Iglesias, R; Villarroya, F; Giralt, M				Hondares, Elayne; Rosell, Meritxell; Diaz-Delfin, Julieta; Olmos, Yolanda; Monsalve, Maria; Iglesias, Roser; Villarroya, Francesc; Giralt, Marta			Peroxisome Proliferator-activated Receptor alpha (PPAR alpha) Induces PPAR gamma Coactivator 1 alpha (PGC-1 alpha) Gene Expression and Contributes to Thermogenic Activation of Brown Fat INVOLVEMENT OF PRDM16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN-1 GENE; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL CONTROL; CELLULAR PLASTICITY; WHITE FAT; ADIPOCYTES; INDUCTION; MICE; COMPETENT	Peroxisome proliferator activated receptor alpha (PPAR alpha) is a distinctive marker of the brown fat phenotype that has been proposed to coordinate the transcriptional activation of genes for lipid oxidation and for thermogenic uncoupling protein 1 in brown adipose tissue. Here, we investigated the involvement of PPAR alpha in the transcriptional control of the PPAR alpha coactivator (PGC)-1 alpha gene. Treatment with PPAR alpha agonists induced PGC-1 alpha mRNA expression in brown fat in vivo and in primary brown adipocytes. This enhancement of PGC-1 alpha transcription was mediated by PPAR alpha binding to a PPAR-responsive element in the distal PGC-1 alpha gene promoter. PGC-1 alpha gene expression was decreased in PPAR alpha-null brown fat, both under basal conditions and in response to thermogenic activation. Moreover, PPAR alpha- and cAMP-mediated pathways interacted to control PGC-1 alpha transcription. PRDM16 (PRD1-BF1-RIZ1 homologous domain-containing 16) promoted PPAR alpha induction of PGC-1 alpha gene transcription, especially under conditions in which protein kinase A pathways were activated. This enhancement was associated with the interaction of PRDM16 with the PGC-1 alpha promoter at the PPAR alpha-binding site. In addition, PPAR alpha promoted the expression of the PRDM16 gene in brown adipocytes, and activation of PPAR alpha in human white adipocytes led to the appearance of a brown adipocyte pattern of gene expression, including induction of PGC-1 alpha and PRDM16. Collectively, these results suggest that PPAR alpha acts as a key component of brown fat thermogenesis by coordinately regulating lipid catabolism and thermogenic gene expression via induction of PGC-1 alpha and PRDM16.	[Hondares, Elayne; Rosell, Meritxell; Diaz-Delfin, Julieta; Iglesias, Roser; Villarroya, Francesc; Giralt, Marta] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Catalonia, Spain; [Hondares, Elayne; Rosell, Meritxell; Diaz-Delfin, Julieta; Iglesias, Roser; Villarroya, Francesc; Giralt, Marta] Univ Barcelona, Inst Biomed IBUB, Barcelona, Catalonia, Spain; [Hondares, Elayne; Rosell, Meritxell; Diaz-Delfin, Julieta; Iglesias, Roser; Villarroya, Francesc; Giralt, Marta] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Barcelona, Catalonia, Spain; [Olmos, Yolanda; Monsalve, Maria] Inst Salud Carlos III, Ctr Nacl Invest Cardiovasc, Madrid, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Instituto de Salud Carlos III	Giralt, M (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Avda Diagonal 643, E-08028 Barcelona, Catalunya, Spain.	mgiralt@ub.edu	Giralt, Marta/A-4756-2013; Olmos, Yolanda/AAX-6661-2021; Villarroya, Francesc/K-4357-2014; Iglesias, Roser/C-5561-2017; Monsalve, Maria/K-4416-2014	Giralt, Marta/0000-0001-7968-4190; Olmos, Yolanda/0000-0002-5952-1607; Iglesias, Roser/0000-0002-7107-8097; Monsalve, Maria/0000-0003-2796-1453; Villarroya, Francesc/0000-0003-1266-9142	Instituto de Salud Carlos III [PI081715]; Ministerio de Ciencia e Innovacion, Spain [SAF2008-01896, SAF2009-07599, CSD 2007-00020]; Spanish Ministry of Science and Innovation; Pro-CNIC Foundation	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pro-CNIC Foundation	This research was supported by Instituto de Salud Carlos III Grant PI081715 and Ministerio de Ciencia e Innovacion Grants SAF2008-01896, SAF2009-07599, and CSD 2007-00020), Spain. The CNIC is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. CIBER Fisiopatologia de la Obesidad y Nutricion is an initiative of the Instituto de Salud Carlos III, Spain.	Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Barbier O, 2003, J BIOL CHEM, V278, P13975, DOI 10.1074/jbc.M300749200; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Carmona MC, 2002, J BIOL CHEM, V277, P21489, DOI 10.1074/jbc.M201710200; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Komatsu M, 2010, GENES CELLS, V15, P91, DOI 10.1111/j.1365-2443.2009.01368.x; Larsen TM, 2002, AM J CLIN NUTR, V76, P780, DOI 10.1093/ajcn/76.4.780; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MacLaren R, 2008, J LIPID RES, V49, P308, DOI 10.1194/jlr.M700199-JLR200; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MURAMATSU MA, 1989, MOL CELL BIOL, V9, P831, DOI 10.1128/MCB.9.2.831; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ribet C, 2010, ENDOCRINOLOGY, V151, P123, DOI 10.1210/en.2009-0726; Rim JS, 2004, J BIOL CHEM, V279, P25916, DOI 10.1074/jbc.M402102200; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tong YH, 2005, BIOCHEM BIOPH RES CO, V336, P76, DOI 10.1016/j.bbrc.2005.08.041; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valmaseda A, 1999, MOL CELL ENDOCRINOL, V154, P101, DOI 10.1016/S0303-7207(99)00081-7; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Yubero P, 1998, MOL ENDOCRINOL, V12, P1023, DOI 10.1210/me.12.7.1023; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V198, P653, DOI 10.1006/bbrc.1994.1095	52	214	231	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43112	43122		10.1074/jbc.M111.252775	http://dx.doi.org/10.1074/jbc.M111.252775			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033933	hybrid, Green Published			2022-12-25	WOS:000298351300032
J	Margalida, A; Oro, D; Cortes-Avizanda, A; Heredia, R; Donazar, JA				Margalida, Antoni; Oro, Daniel; Cortes-Avizanda, Ainara; Heredia, Rafael; Donazar, Jose A.			Misleading Population Estimates: Biases and Consistency of Visual Surveys and Matrix Modelling in the Endangered Bearded Vulture	PLOS ONE			English	Article							GYPAETUS-BARBATUS; CONSERVATION; BIRD; AGE; DYNAMICS; LIMITATION; MORTALITY; VIABILITY; RECOVERY; SURVIVAL	Conservation strategies for long-lived vertebrates require accurate estimates of parameters relative to the populations' size, numbers of non-breeding individuals (the "cryptic" fraction of the population) and the age structure. Frequently, visual survey techniques are used to make these estimates but the accuracy of these approaches is questionable, mainly because of the existence of numerous potential biases. Here we compare data on population trends and age structure in a bearded vulture (Gypaetus barbatus) population from visual surveys performed at supplementary feeding stations with data derived from population matrix-modelling approximations. Our results suggest that visual surveys overestimate the number of immature (<2 years old) birds, whereas subadults (3-5 y.o.) and adults (>6 y.o.) were underestimated in comparison with the predictions of a population model using a stable-age distribution. In addition, we found that visual surveys did not provide conclusive information on true variations in the size of the focal population. Our results suggest that although long-term studies (i.e. population matrix modelling based on capture-recapture procedures) are a more time-consuming method, they provide more reliable and robust estimates of population parameters needed in designing and applying conservation strategies. The findings shown here are likely transferable to the management and conservation of other long-lived vertebrate populations that share similar life-history traits and ecological requirements.	[Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain; [Margalida, Antoni] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Oro, Daniel] CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Esporles, Spain; [Cortes-Avizanda, Ainara; Donazar, Jose A.] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Helmholtz Ctr Environm Res UFZ, Leipzig, Germany; [Cortes-Avizanda, Ainara] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain	Fundacion para la Conservacion del Quebranthuesos (FCQ); University of Bern; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Margalida, A (corresponding author), Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain.	antoni.margalida@iee.unibe.ch	Margalida, Antoni/AAG-5337-2020; Cortés-Avizanda, Ainara/C-6634-2013; Oro, Daniel/H-4208-2012; Margalida, Antoni/A-2723-2011; CORTES-AVIZANDA, AINARA/O-3248-2019; Margalida, Antoni/A-2723-2011	Cortés-Avizanda, Ainara/0000-0002-9674-6434; Oro, Daniel/0000-0003-4782-3007; Margalida, Antoni/0000-0002-0576-3993; CORTES-AVIZANDA, AINARA/0000-0002-9674-6434; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212; Donazar, Jose Antonio/0000-0002-9433-9755	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministerio de Medio Ambiente	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministerio de Medio Ambiente	AM was supported by the Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministerio de Medio Ambiente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison MD, 2003, MAR MAMMAL SCI, V19, P764, DOI 10.1111/j.1748-7692.2003.tb01129.x; Antor RJ, 2007, ACTA ORNITHOL, V42, P114, DOI 10.3161/068.042.0106; Bibby C., 1993, BIRD CENSUS TECHNIQU; Blanco G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014163; Brown CJ, 1997, AFR J ECOL, V35, P53, DOI 10.1111/j.1365-2028.1997.048-89048.x; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Chaudhary A, BIRD CONSER IN PRESS; CLARKE R, 1990, BIRD STUDY, V37, P84, DOI 10.1080/00063659009477044; Cortes-Avizanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021016; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; Donazar J.A., 2009, MUNIBE S, V29; Donazar JA., 1996, BIOLOG A CONSERVACI, P189; FRANKLIN AB, 1992, WILDLIFE 2001 : POPULATIONS, P815; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Grande JM, 2009, OIKOS, V118, P580, DOI 10.1111/j.1600-0706.2009.17218.x; Green RE, 2008, P ROY SOC B-BIOL SCI, V275, P2381, DOI 10.1098/rspb.2008.0473; Heredia Rafael, 1991, P101; Hernandez M, 2009, ENVIRON RES, V109, P837, DOI 10.1016/j.envres.2009.05.001; Holt KR, 2008, CAN J FISH AQUAT SCI, V65, P212, DOI 10.1139/F07-160; Huot M, 2006, ANN ZOOL FENN, V43, P131; Kasprzykowski Z, 2011, ORNIS FENNICA, V88, P98; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; KLOMP NI, 1992, J APPL ECOL, V29, P341, DOI 10.2307/2404503; Lebreton J.-D., 1991, BIRD POPULATION STUD, P105; Margalida A, 2003, J RAPTOR RES, V37, P157; Margalida A, 2003, IBIS, V145, P244, DOI 10.1046/j.1474-919X.2003.00148.x; Margalida A, 2000, IBIS, V142, P225, DOI 10.1111/j.1474-919X.2000.tb04862.x; Margalida A, 2005, BIOL CONSERVACION QU; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Margalida A, 2009, IBIS, V151, P235; McCullagh P., 2000, GEN LINEAR MIXED MOD; McGowan CP, 2009, J FIELD ORNITHOL, V80, P79, DOI 10.1111/j.1557-9263.2009.00207.x; MMA, 2001, ESTR CONS QUEBR GYP; Mundy P., 1992, VULTURES AFRICA; NEWTON I, 1992, BIOL REV, V67, P129, DOI 10.1111/j.1469-185X.1992.tb01017.x; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Penteriani V, 2005, P ROY SOC LOND B BIO, V18, P58; PIENKOWSKI MW, 1991, IBIS, V133, P62, DOI 10.1111/j.1474-919X.1991.tb07670.x; Rohner C, 1996, J ANIM ECOL, V65, P359, DOI 10.2307/5882; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P2069, DOI 10.1098/rspb.2006.3507; Sarasola JH, 2008, DIVERS DISTRIB, V14, P686, DOI 10.1111/j.1472-4642.2008.00475.x; SAS Institute Inc, 2009, SAS STAT 9 2 LANG RE; Schaub M, 2011, J OMITH, V152, pS227; Schaub M, 2009, J APPL ECOL, V46, P92, DOI 10.1111/j.1365-2664.2008.01585.x; Sergio F, 2011, BASIC APPL ECOL, V12, P107, DOI 10.1016/j.baae.2010.11.004; Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x; Sese JA, 2005, BIOL CONSERVACION QU, P279; Sternberg H, 2002, ARDEA, V90, P461; Taylor SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003047; Thomas L, 1996, ECOLOGY, V77, P49, DOI 10.2307/2265653; Van Beest F, 2008, BIRD CONSERV INT, V18, P102, DOI 10.1017/S0959270908000129; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; Whitfield DP, 2004, BIOL CONSERV, V119, P319, DOI 10.1016/j.biocon.2003.11.015; Williams AK, 2004, J WILDLIFE MANAGE, V68, P418, DOI 10.2193/0022-541X(2004)068[0418:RFAISD]2.0.CO;2; WUNDERLE JM, 1991, CURR ORNITHOL, V8, P273	62	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26784	10.1371/journal.pone.0026784	http://dx.doi.org/10.1371/journal.pone.0026784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039550	gold, Green Published			2022-12-25	WOS:000296513200053
J	Muhlhans, J; Brandstatter, JH; Giessl, A				Muehlhans, Johanna; Brandstaetter, Johann Helmut; Giessl, Andreas			The Centrosomal Protein Pericentrin Identified at the Basal Body Complex of the Connecting Cilium in Mouse Photoreceptors	PLOS ONE			English	Article							MICROTUBULE ORGANIZATION; VERTEBRATE PHOTORECEPTOR; SPINDLE ORGANIZATION; PRIMORDIAL DWARFISM; VESICLE TRANSPORT; CG-NAP; CELLS; KENDRIN; GENE; TRANSLOCATION	Background: Pericentrin (Pcnt), a conserved protein of the pericentriolar material, serves as a multifunctional scaffold for numerous proteins and plays an important role in microtubule organization. Recent studies indicate that Pcnt mutations are associated with a range of diseases including primordial dwarfism and ciliopathies. To date, three Pcnt splice variants from orthologous genes in mice and humans are known. Principal Findings: We generated a specific Pcnt antiserum detecting all known Pcnt splice variants and examined the cellular and subcellular distribution of Pcnt in ciliated tissues of the mouse, the olfactory epithelium and the retina. For the first time, we identified Pcnt and its centrosomal interaction partners at the basal body complex of mouse retinal photoreceptors. Photoreceptors are morphologically and functionally subdivided into the light sensitive outer segment and the inner segment comprising the metabolic function of the cell. The two compartments are linked via a modified, specialized, non-motile cilium, the connecting cilium. Here, Pcnt colocalized with the whole protein machinery responsible for transport processes between the two compartments. Surprisingly, photoreceptors expressed a small Pcnt splice transcript - most likely a modified variant of Pcnt S - which was not present in receptor neurons of the olfactory epithelium. Conclusions: Our findings suggest distinct functional roles of several Pcnt variants in different ciliated tissues and sensory neurons, like the olfactory epithelium and the retina of the mouse. The individual patchwork of different Pcnt splice transcripts seems to reflect the complexity of Pcnt function, an assumption corroborated by the heterogeneous clinical manifestations associated with mutations in the Pcnt gene.	[Muehlhans, Johanna; Brandstaetter, Johann Helmut; Giessl, Andreas] Univ Erlangen Nurnberg, Dept Biol, Erlangen, Germany	University of Erlangen Nuremberg	Giessl, A (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Erlangen, Germany.	agiessl@biologie.uni-erlangen.de		Giessl, Andreas/0000-0002-9768-2049	Deutsche Forschungsgemeinschaft [GI 770/1-1]; Dr. Hertha und Helmut Schmauser-Stiftung (Erlangen, Germany); Universitatsbund Erlangen-Nurnberg e.V. (Erlangen, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dr. Hertha und Helmut Schmauser-Stiftung (Erlangen, Germany); Universitatsbund Erlangen-Nurnberg e.V. (Erlangen, Germany)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (GI 770/1-1), the funds of the Dr. Hertha und Helmut Schmauser-Stiftung (Erlangen, Germany) and the Universitatsbund Erlangen-Nurnberg e.V. (Erlangen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Endoh-Yamagami S, 2010, DEV BIOL, V340, P41, DOI 10.1016/j.ydbio.2010.01.017; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; GieBl A, 2010, E NEUROFORUM, DOI [10.1007/s13295-13010-10007-13299, DOI 10.1007/S13295-13010-10007-13299]; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; GIESSL A, 2004, CELL BIOL RELATED DI, P122; Giessl A, 2006, VISION RES, V46, P4502, DOI 10.1016/j.visres.2006.07.029; Gillingham AK, 2000, EMBO REP, V1, P524; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jenkins PM, 2009, CHEM SENSES, V34, P451, DOI 10.1093/chemse/bjp020; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Karcher C, 2005, DIFFERENTIATION, V73, P425, DOI 10.1111/j.1432-0436.2005.00048.x; Kawaguchi S, 2004, MOL BIOL CELL, V15, P37, DOI 10.1091/mbc.E03-03-0191; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kersten FFJ, 2010, INVEST OPHTH VIS SCI, V51, P2338, DOI 10.1167/iovs.09-4650; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Liu QQ, 2001, J CELL SCI, V114, P797; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2006, BIOCHEM BIOPH RES CO, V351, P745, DOI 10.1016/j.bbrc.2006.10.101; Miyoshi K, 2006, DEV GENES EVOL, V216, P537, DOI 10.1007/s00427-006-0065-8; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Piane M, 2009, AM J MED GENET A, V149A, P2452, DOI 10.1002/ajmg.a.33035; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Reidel B, 2008, CELL MOTIL CYTOSKEL, V65, P785, DOI 10.1002/cm.20300; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Sedmak T, 2009, METHOD CELL BIOL, V94, P259, DOI 10.1016/S0091-679X(08)94013-9; Shimizu S, 2008, BIOCHEM BIOPH RES CO, V377, P1051, DOI 10.1016/j.bbrc.2008.10.100; Shu X, 2005, HUM MOL GENET, V14, P1183, DOI 10.1093/hmg/ddi129; Sung CH, 2000, INT REV CYTOL, V195, P215; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	53	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26496	10.1371/journal.pone.0026496	http://dx.doi.org/10.1371/journal.pone.0026496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031837	Green Published, Green Submitted, gold			2022-12-25	WOS:000296513200026
J	Huang, KY; Chen, GD; Cheng, CH; Liao, KY; Hung, CC; Chang, GD; Hwang, PP; Lin, SY; Tsai, MC; Khoo, KH; Lee, MT; Huang, CJ				Huang, Kai-Yun; Chen, Gen-Der; Cheng, Chia-Hsiung; Liao, Kuan-Ya; Hung, Chin-Chun; Chang, Geen-Dong; Hwang, Pung-Pung; Lin, Shu-Yu; Tsai, Ming-Chieh; Khoo, Kay-Hooi; Lee, Ming-Ting; Huang, Chang-Jen			Phosphorylation of the Zebrafish M6Ab at Serine 263 Contributes to Filopodium Formation in PC12 Cells and Neurite Outgrowth in Zebrafish Embryos	PLOS ONE			English	Article							PROTEIN-KINASE-II; CENTRAL-NERVOUS-SYSTEM; PROTEOLIPID PROTEIN; PHOSPHOPROTEOMIC ANALYSIS; DENDRITIC FILOPODIA; SYNAPSE FORMATION; GENOME EVOLUTION; SPINE FORMATION; HOX CLUSTERS; GENE FAMILY	Background: Mammalian M6A, a member of the proteolipid protein (PLP/DM20) family expressed in neurons, was first isolated by expression cloning with a monoclonal antibody. Overexpression of M6A was shown to induce filopodium formation in neuronal cells; however, the underlying mechanism of is largely unknown. Possibly due to gene duplication, there are two M6A paralogs, M6Aa and M6Ab, in the zebrafish genome. In the present study, we used the zebrafish as a model system to investigate the role of zebrafish M6Ab in filopodium formation in PC12 cells and neurite outgrowth in zebrafish embryos. Methodology/Principal Findings: We demonstrated that zebrafish M6Ab promoted extensive filopodium formation in NGF-treated PC12 cells, which is similar to the function of mammalian M6A. Phosphorylation at serine 263 of zebrafish M6Ab contributed to this induction. Transfection of the S263A mutant protein greatly reduced filopodium formation in PC12 cells. In zebrafish embryos, only S263D could induce neurite outgrowth. Conclusions/Significance: Our results reveal that the phosphorylation status of zebrafish M6Ab at serine 263 is critical for its role in regulating filopodium formation and neurite outgrowth.	[Huang, Kai-Yun; Chang, Geen-Dong; Khoo, Kay-Hooi; Lee, Ming-Ting; Huang, Chang-Jen] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Huang, Kai-Yun; Chen, Gen-Der; Cheng, Chia-Hsiung; Liao, Kuan-Ya; Hung, Chin-Chun; Khoo, Kay-Hooi; Lee, Ming-Ting; Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lin, Shu-Yu] Acad Sinica, Inst Biol Chem, Common Mass Spectrometry Facil, Taipei, Taiwan; [Tsai, Ming-Chieh] Acad Sinica, Inst Biol Chem, NRPGM, Core Facil Prote & Glycomcis, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Huang, KY (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	mtlee@gate.sinica.edu.tw; cjibc@gate.sinica.edu.tw	Khoo, Kay-Hooi/E-1989-2019; Hwang, Pung-Pung/AAH-1538-2022; Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011; lin, shuyu/GRF-5383-2022; Cheng, Chia-Hsiung/A-6044-2019; Hung, Chin-Chun/G-8879-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Cheng, Chia-Hsiung/0000-0003-0307-9650; Hung, Chin-Chun/0000-0003-4769-7194	Academia Sinica, Taipei, Taiwan [AS-99-TP-B08]	Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	This study was supported by a grant (AS-99-TP-B08) from Academia Sinica, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2004, GENOME RES, V14, P1, DOI 10.1101/gr.1717804; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brocco MA, 2010, EUR J NEUROSCI, V31, P195, DOI 10.1111/j.1460-9568.2009.07064.x; Chang MH, 2004, BIOCHEM BIOPH RES CO, V321, P502, DOI 10.1016/j.bbrc.2004.06.172; Chen GD, 2006, BIOCHEM BIOPH RES CO, V344, P272, DOI 10.1016/j.bbrc.2006.03.136; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; DeGiorgis JA, 2005, J PROTEOME RES, V4, P306, DOI 10.1021/pr0498436; Douard V, 2008, J PHYSIOL-LONDON, V586, P3657, DOI 10.1113/jphysiol.2008.155226; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fuchsova B, 2009, J BIOL CHEM, V284, P32075, DOI 10.1074/jbc.M109.012377; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Hering H, 2003, J NEUROSCI, V23, P11759; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Rothschild SC, 2007, DEV DYNAM, V236, P295, DOI 10.1002/dvdy.21005; Schweitzer M, 2006, MOL CELL NEUROSCI, V31, P161, DOI 10.1016/j.mcn.2005.10.007; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Westerfield M, 2007, ZEBRAFISH BOOK; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	39	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26461	10.1371/journal.pone.0026461	http://dx.doi.org/10.1371/journal.pone.0026461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028883	Green Published, Green Submitted, gold			2022-12-25	WOS:000296510800044
J	Wang, JN; Gerretsen, SC; Maki, JH; Jaarsma, C; Kooi, ME; Herzka, D; Chu, BC; Yarnykh, VL; Yuan, C; Leiner, T				Wang, Jinnan; Gerretsen, Suzanne C.; Maki, Jeffrey H.; Jaarsma, Caroline; Kooi, M. Eline; Herzka, Daniel; Chu, Baocheng; Yarnykh, Vasily L.; Yuan, Chun; Leiner, Tim			Time-Efficient Black Blood RCA Wall Imaging at 3T Using Improved Motion Sensitized Driven Equilibrium (iMSDE): Feasibility and Reproducibility	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; SPIN-ECHO TSE; CORONARY ATHEROSCLEROSIS; HEART-DISEASE; RISK; MRI; SEQUENCE	Background: The aim of this study was to explore the feasibility and reproducibility of a time-efficient coronary vessel wall measurement approach using an improved motion-sensitized driven equilibrium (iMSDE) pulse sequence. Methodology: In this study, the iMSDE pulse sequence was first optimized and then applied on a group of healthy volunteers (N = 10) to evaluate its feasibility of vessel wall visualization. The same technique was also applied on a separate group of volunteers (N = 19) for a reproducibility study by scanning the same subject in two separate sessions. The iMSDE sequence was found to provide good coronary vessel wall delineation. It was also found to provide reproducible coronary vessel wall diameter and thickness measurements in both proximal and middle segments of the right coronary artery. Conclusion: The feasibility and reproducibility of iMSDE based coronary vessel wall imaging were demonstrated for the first time, paving the way for further testing in a clinical environment for fast and accurate coronary artery disease detection.	[Wang, Jinnan; Maki, Jeffrey H.; Chu, Baocheng; Yarnykh, Vasily L.; Yuan, Chun; Leiner, Tim] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Wang, Jinnan] Philips Res N Amer, Clin Sites Res Program, Briarcliff Manor, NY USA; [Gerretsen, Suzanne C.; Jaarsma, Caroline; Kooi, M. Eline; Leiner, Tim] Maastricht Univ Med Ctr, Dept Radiol & Cardiol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Herzka, Daniel] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Leiner, Tim] Univ Utrecht, Med Ctr, Utrecht, Netherlands	University of Washington; University of Washington Seattle; Philips; Philips Research; Maastricht University; Maastricht University Medical Centre (MUMC); Johns Hopkins University; Utrecht University	Wang, JN (corresponding author), Univ Washington, Dept Radiol, Seattle, WA 98195 USA.	timleiner@gmail.com	Yarnykh, Vasiliy L./N-7635-2014; Yarnykh, Vasily L/G-8757-2016; Yarnykh, Vasily/ABF-7873-2021; Kooi, M. Eline/D-3848-2016	Yarnykh, Vasily L/0000-0002-1583-8979; Kooi, M. Eline/0000-0001-7562-5724; Herzka, Daniel/0000-0002-9400-7814	National Institutes of Health (NIH) [HL56874, NIH HL076378-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056874, R29HL056874, R01HL076378] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH HL56874 and NIH HL076378-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Austen W G, 1975, Circulation, V51, P5; Desai MY, 2005, EUR HEART J, V26, P2320, DOI 10.1093/eurheartj/ehi357; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; EDELMAN RR, 1991, RADIOLOGY, V181, P655, DOI 10.1148/radiology.181.3.1947077; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Fan ZY, 2010, J MAGN RESON IMAGING, V31, P645, DOI 10.1002/jmri.22058; Gerretsen SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012998; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Hazirolan T, 2005, J CARDIOVASC MAGN R, V7, P409, DOI 10.1081/JCMR-200053464; Henningsson M, 2011, J CARDIOVASC MAGN S1, V13, pP229; KANNEL WB, 1982, ANN NY ACAD SCI, V382, P3, DOI 10.1111/j.1749-6632.1982.tb55203.x; Katscher U, 2006, NMR BIOMED, V19, P393, DOI 10.1002/nbm.1049; Leiner T, 2005, J MAGN RESON IMAGING, V22, P577, DOI 10.1002/jmri.20399; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lloyd-Jones DM, 2006, ARCH INTERN MED, V166, P1342, DOI 10.1001/archinte.166.13.1342; Narula J, 2008, NAT CLIN PRACT CARD, V5, pS2, DOI 10.1038/ncpcardio1247; Scott AD, 2011, J MAGN RESON IMAGING, V33, P77, DOI 10.1002/jmri.22398; Tuzcu EM, 2001, CIRCULATION, V103, P2705; Vogl TJ, 2002, RADIOLOGY, V223, P212, DOI 10.1148/radiol.2231010515; Wang J, 2007, MAGN RESON MED, V58, P973, DOI 10.1002/mrm.21385; Wang JN, 2010, J MAGN RESON IMAGING, V31, P1256, DOI 10.1002/jmri.22149; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yang Q, 2009, J AM COLL CARDIOL, V54, P69, DOI 10.1016/j.jacc.2009.03.016	24	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26567	10.1371/journal.pone.0026567	http://dx.doi.org/10.1371/journal.pone.0026567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028910	Green Submitted, gold, Green Published			2022-12-25	WOS:000296510800055
J	Trimble, MJ; van Aarde, RJ; Ferreira, SM; Norgaard, CF; Fourie, J; Lee, PC; Moss, CJ				Trimble, Morgan J.; van Aarde, Rudi J.; Ferreira, Sam M.; Norgaard, Camilla F.; Fourie, Johan; Lee, Phyllis C.; Moss, Cynthia J.			Age Determination by Back Length for African Savanna Elephants: Extending Age Assessment Techniques for Aerial-Based Surveys	PLOS ONE			English	Article							LOXODONTA-AFRICANA; NATIONAL-PARK; POPULATION; SURVIVAL; DENSITY; GROWTH; KENYA; IVORY; TRADE; DNA	Determining the age of individuals in a population can lead to a better understanding of population dynamics through age structure analysis and estimation of age-specific fecundity and survival rates. Shoulder height has been used to accurately assign age to free-ranging African savanna elephants. However, back length may provide an analog measurable in aerial-based surveys. We assessed the relationship between back length and age for known-age elephants in Amboseli National Park, Kenya, and Addo Elephant National Park, South Africa. We also compared age-and sex-specific back lengths between these populations and compared adult female back lengths across 11 widely dispersed populations in five African countries. Sex-specific Von Bertalanffy growth curves provided a good fit to the back length data of known-age individuals. Based on back length, accurate ages could be assigned relatively precisely for females up to 23 years of age and males up to 17. The female back length curve allowed more precise age assignment to older females than the curve for shoulder height does, probably because of divergence between the respective growth curves. However, this did not appear to be the case for males, but the sample of known-age males was limited to <= 27 years. Age-and sex-specific back lengths were similar in Amboseli National Park and Addo Elephant National Park. Furthermore, while adult female back lengths in the three Zambian populations were generally shorter than in other populations, back lengths in the remaining eight populations did not differ significantly, in support of claims that growth patterns of African savanna elephants are similar over wide geographic regions. Thus, the growth curves presented here should allow researchers to use aerial-based surveys to assign ages to elephants with greater precision than previously possible and, therefore, to estimate population variables.	[Trimble, Morgan J.; van Aarde, Rudi J.; Ferreira, Sam M.; Norgaard, Camilla F.; Fourie, Johan] Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa; [Ferreira, Sam M.] S African Natl Pk, Sci Serv, Skukuza, South Africa; [Lee, Phyllis C.; Moss, Cynthia J.] Amboseli Trust Elephants, Nairobi, Kenya; [Lee, Phyllis C.] Univ Stirling, Sch Nat Sci, Behav & Evolut Res Grp, Stirling FK9 4LA, Scotland	University of Pretoria; University of Stirling	Trimble, MJ (corresponding author), Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa.	rjvaarde@zoology.up.ac.za	Trimble, Morgan J/B-1161-2010	Trimble, Morgan J/0000-0002-9914-0788; Lee, Phyllis/0000-0002-4296-3513	International Fund for Animal Welfare; Peace Parks Foundation; United States Fish & Wildlife Services; National Research Foundation; National Science Foundation	International Fund for Animal Welfare; Peace Parks Foundation; United States Fish & Wildlife Services; National Research Foundation; National Science Foundation(National Science Foundation (NSF))	Grants to R.J.v.A. from the International Fund for Animal Welfare, the Peace Parks Foundation, the United States Fish & Wildlife Services, and the National Research Foundation funded the project. M.J.T. is supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CROZE H, 1972, AFR J ECOL, V10, P91; Douglas-Hamilton I, 1972, THESIS OXFORD U OXFO; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Ferreira SM, 2008, J WILDLIFE MANAGE, V72, P822, DOI 10.2193/2007-151; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Hanks J., 1972, East African Wildlife Journal, V10, P251; Laws R. M., 1969, Journal of Reproduction and Fertility Suppl, VNo. 6, P495; LAWS RM, 1968, S ZOOL SOC LOND, V21, P319; LEE PC, 1995, J ZOOL, V236, P29, DOI 10.1111/j.1469-7998.1995.tb01782.x; Lee Phyllis C., 2011, P74; LEUTHOLD W, 1976, J APPL ECOL, V13, P435, DOI 10.2307/2401793; MICHOD RE, 1980, ECOLOGY, V61, P265, DOI 10.2307/1935184; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss Cynthia, 1996, P58; Shrader AM, 2006, J ZOOL, V270, P40, DOI 10.1111/j.1469-7998.2006.00108.x; Shrader AM, 2006, S AFR J WILDL RES, V36, P1; Shrader AM, 2010, BIODIVERS CONSERV, V19, P2235, DOI 10.1007/s10531-010-9836-7; Sibly RM, 1998, J ANIM ECOL, V67, P17, DOI 10.1046/j.1365-2656.1998.00178.x; Trimble MJ, 2009, J ZOOL, V279, P18, DOI 10.1111/j.1469-7998.2009.00560.x; Udevitz MS, 1998, J WILDLIFE MANAGE, V62, P779, DOI 10.2307/3802355; van aarde Rudi, 2008, P84; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; Whitehouse AM, 2000, ORYX, V34, P46, DOI 10.1046/j.1365-3008.2000.00093.x; Wolf P.R., 1974, ELEMENTS PHOTOGRAMME; Young KD, 2010, J ANIM ECOL, V79, P662, DOI 10.1111/j.1365-2656.2010.01667.x	27	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26614	10.1371/journal.pone.0026614	http://dx.doi.org/10.1371/journal.pone.0026614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028925	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500099
J	Daskin, JH; Alford, RA; Puschendorf, R				Daskin, Joshua H.; Alford, Ross A.; Puschendorf, Robert			Short-Term Exposure to Warm Microhabitats Could Explain Amphibian Persistence with Batrachochytrium dendrobatidis	PLOS ONE			English	Article							FOREST STREAM FROGS; EMERGING DISEASE; CHYTRIDIOMYCOSIS; DECLINES; POPULATION; PREVALENCE; EXTINCTION; INFECTION; AUSTRALIA; DEFENSES	Environmental conditions can alter the outcomes of symbiotic interactions. Many amphibian species have declined due to chytridiomycosis, caused by the pathogenic fungus Batrachochytrium dendrobatidis (Bd), but many others persist despite high Bd infection prevalence. This indicates that Bd's virulence is lower, or it may even be a commensal, in some hosts. In the Australian Wet Tropics, chytridiomycosis extirpated Litoria nannotis from high-elevation rain forests in the early 1990 s. Although the species is recolonizing many sites, no population has fully recovered. Litoria lorica disappeared from all known sites in the early 1990 s and was thought globally extinct, but a new population was discovered in 2008, in an upland dry forest habitat it shares with L. nannotis. All frogs of both species observed during three population censuses were apparently healthy, but most carried Bd. Frogs perch on sun-warmed rocks in dry forest streams, possibly keeping Bd infections below the lethal threshold attained in cooler rain forests. We tested whether short-term elevated temperatures can hamper Bd growth in vitro over one generation (four days). Simulating the temperatures available to frogs on strongly and moderately warmed rocks in dry forests, by incubating cultures at 33 degrees C for one hour daily, reduced Bd growth below that of Bd held at 15 degrees C constantly (representing rain forest habitats). Even small decreases in the exponential growth rate of Bd on hosts may contribute to the survival of frogs in dry forests.	[Daskin, Joshua H.; Alford, Ross A.; Puschendorf, Robert] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Daskin, JH (corresponding author), Archbold Biol Stat, Lake Placid, FL USA.	jhdaskin@gmail.com	Puschendorf, Robert/B-6280-2011; Alford, Ross A/H-1577-2011	Puschendorf, Robert/0000-0002-8105-171X; Alford, Ross A/0000-0002-3010-6768	Australian Research Council; Australian-American Fulbright Commission	Australian Research Council(Australian Research Council); Australian-American Fulbright Commission	Research funding was provided by the Australian Research Council (http://www.arc.gov.au/) Discovery Grant Understanding and managing resistance to the amphibian chytrid fungus Batrachochytrium dendrobatidis in Australian tropical rainforest frogs. JHD was supported by a U.S. Postgraduate Fulbright Scholarship from the Australian-American Fulbright Commission (http://www.fulbright.com.au) during this project. RP was supported by a Postdoctoral Research Fellowship of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Cunningham Michael, 2002, Memoirs of the Queensland Museum, V48, P93; Hero JM, 2004, IUCN 2010 IUCN RED L; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; McDonald K, 1999, DECLINES DISAPPEARAN, P14; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2009, ENV EFFECTS HOST PAT; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; RIBAS L, 2009, PLOS ONE, V4; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rollins-Smith LA, 2002, BIOCHEM BIOPH RES CO, V297, P361, DOI 10.1016/S0006-291X(02)02217-9; Rowley JJL, 2007, WILDLIFE RES, V34, P371, DOI 10.1071/WR07014; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	25	37	37	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26215	10.1371/journal.pone.0026215	http://dx.doi.org/10.1371/journal.pone.0026215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028834	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000296186900036
J	Liao, JY; Thakur, SA; Zalinger, ZB; Gerrish, KE; Imani, F				Liao, Jie-ying; Thakur, Sheetal A.; Zalinger, Zachary B.; Gerrish, Kevin E.; Imani, Farhad			Inosine-Containing RNA Is a Novel Innate Immune Recognition Element and Reduces RSV Infection	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; TOLL-LIKE RECEPTOR-3; PROTEIN-KINASE; ADENOSINE-DEAMINASE; VIRUS-REPLICATION; EPITHELIAL-CELLS; BIASED HYPERMUTATION; MESSENGER-RNA; RIG-I	During viral infections, single-and double-stranded RNA (ssRNA and dsRNA) are recognized by the host and induce innate immune responses. The cellular enzyme ADAR-1 (adenosine deaminase acting on RNA-1) activation in virally infected cells leads to presence of inosine-containing RNA (Ino-RNA). Here we report that ss-Ino-RNA is a novel viral recognition element. We synthesized unmodified ssRNA and ssRNA that had 6% to16% inosine residues. The results showed that in primary human cells, or in mice, 10% ss-Ino-RNA rapidly and potently induced a significant increase in inflammatory cytokines, such as interferon (IFN)-beta (35 fold), tumor necrosis factor (TNF)-alpha (9.7 fold), and interleukin (IL)-6 (11.3 fold) (p<0.01). Flow cytometry data revealed a corresponding 4-fold increase in influx of neutrophils into the lungs by ss-Ino-RNA treatment. In our in vitro experiments, treatment of epithelial cells with ss-Ino-RNA reduced replication of respiratory syncytial virus (RSV). Interestingly, RNA structural analysis showed that ss-Ino-RNA had increased formation of secondary structures. Our data further revealed that extracellular ss-Ino-RNA was taken up by scavenger receptor class-A (SR-A) which activated downstream MAP Kinase pathways through Toll-like receptor 3 (TLR3) and dsRNA-activated protein kinase (PKR). Our data suggests that ss-Ino-RNA is an as yet undescribed virus-associated innate immune stimulus.	[Liao, Jie-ying; Thakur, Sheetal A.; Zalinger, Zachary B.] NIEHS, Lab Resp Biol, NIH, Durham, NC USA; [Gerrish, Kevin E.] NIEHS, Gene Array Core Facil, NIH, Durham, NC USA; [Imani, Farhad] ViraSource Labs, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liao, JY (corresponding author), NIEHS, Lab Resp Biol, NIH, Durham, NC USA.	fimani@virasource.com			Intramural National Institute of Health (NIH)	Intramural National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was fully funded by Intramural National Institute of Health (NIH) funding, and the authors are NIH employees. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; DER SD, 1995, P NATL ACAD SCI USA, V92, P8841, DOI 10.1073/pnas.92.19.8841; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; DOUKAS J, 1994, AM J PATHOL, V145, P137; FELDER MP, 1994, J VIROL, V68, P4759, DOI 10.1128/JVI.68.8.4759-4767.1994; Gamper HB, 2004, BIOCHEMISTRY-US, V43, P10224, DOI 10.1021/bi049196w; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; HAJJAR AM, 1995, J VIROL, V69, P5878, DOI 10.1128/JVI.69.9.5878-5882.1995; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; IMANI F, 1988, P NATL ACAD SCI USA, V85, P7887, DOI 10.1073/pnas.85.21.7887; Jayan GC, 2002, J VIROL, V76, P3819, DOI 10.1128/JVI.76.8.3819-3827.2002; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; LEBLEU B, 1976, P NATL ACAD SCI USA, V73, P3107, DOI 10.1073/pnas.73.9.3107; LEE JY, 1994, VIROLOGY, V200, P307, DOI 10.1006/viro.1994.1192; Lei M, 1998, VIROLOGY, V245, P188, DOI 10.1006/viro.1998.9162; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Majde JA, 1998, ARCH VIROL, V143, P2371, DOI 10.1007/s007050050467; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MEROLLA R, 1995, AM J RESP CRIT CARE, V152, P1358, DOI 10.1164/ajrccm.152.4.7551395; Meusel TR, 2002, J IMMUNOL, V168, P6429, DOI 10.4049/jimmunol.168.12.6429; Minor RAC, 2010, J INTERF CYTOK RES, V30, P263, DOI 10.1089/jir.2009.0051; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; MURPHY DG, 1991, VIROLOGY, V181, P760, DOI 10.1016/0042-6822(91)90913-V; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; NISHIKURA K, 1991, EMBO J, V10, P3523, DOI 10.1002/j.1460-2075.1991.tb04916.x; OHARA PJ, 1984, CELL, V36, P915, DOI 10.1016/0092-8674(84)90041-2; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; RUEDA P, 1994, VIROLOGY, V198, P653, DOI 10.1006/viro.1994.1077; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Taylor DR, 2005, J VIROL, V79, P6291, DOI 10.1128/JVI.79.10.6291-6298.2005; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zahn RC, 2007, J VIROL, V81, P457, DOI 10.1128/JVI.00067-06	50	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26463	10.1371/journal.pone.0026463	http://dx.doi.org/10.1371/journal.pone.0026463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028885	gold, Green Published, Green Submitted			2022-12-25	WOS:000296186900068
J	Truttmann, MC; Guye, P; Dehio, C				Truttmann, Matthias C.; Guye, Patrick; Dehio, Christoph			BID-F1 and BID-F2 Domains of Bartonella henselae Effector Protein BepF Trigger Together with BepC the Formation of Invasome Structures	PLOS ONE			English	Article							RHO-PROTEINS; BACTERIAL; FAMILY; BINDING; GTPASES; GLUCOSYLATION; LAMELLIPODIA; CYTOSKELETON; PREDICTION; SEQUENCE	The gram-negative, zoonotic pathogen Bartonella henselae (Bhe) translocates seven distinct Bartonella effector proteins (Beps) via the VirB/VirD4 type IV secretion system (T4SS) into human cells, thereby interfering with host cell signaling [1,2]. In particular, the effector protein BepG alone or the combination of effector proteins BepC and BepF trigger massive F-actin rearrangements that lead to the establishment of invasome structures eventually resulting in the internalization of entire Bhe aggregates [2,3]. In this report, we investigate the molecular function of the effector protein BepF in the eukaryotic host cell. We show that the N-terminal [E/T]PLYAT tyrosine phosphorylation motifs of BepF get phosphorylated upon translocation but do not contribute to invasome-mediated Bhe uptake. In contrast, we found that two of the three BID domains of BepF are capable to trigger invasome formation together with BepC, while a mutation of the WxxxE motif of the BID-F1 domain inhibited its ability to contribute to the formation of invasome structures. Next, we show that BepF function during invasome formation can be replaced by the over-expression of constitutive-active Rho GTPases Rac1 or Cdc42. Finally we demonstrate that BID-F1 and BID-F2 domains promote the formation of filopodia-like extensions in NIH 3T3 and HeLa cells as well as membrane protrusions in HeLa cells, suggesting a role for BepF in Rac1 and Cdc42 activation during the process of invasome formation.	[Truttmann, Matthias C.; Guye, Patrick; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland; [Guye, Patrick] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Basel; Massachusetts Institute of Technology (MIT)	Truttmann, MC (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.	Christoph.dehio@unibas.ch	Dehio, Christoph/R-8277-2016; truttmann, matthias/ABC-2727-2021; Dehio, Christoph/AAD-5572-2019	Dehio, Christoph/0000-0001-7288-1052; truttmann, matthias/0000-0002-0536-7923; Dehio, Christoph/0000-0001-7288-1052	Swiss National Science Foundation [31003A-132979]; Howard Hughes Medical Institute; SystemsX.ch [51RT-0_126008]; Swiss Initiative for Systems Biology;  [5500550]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); SystemsX.ch; Swiss Initiative for Systems Biology; 	This work was supported by grant 31003A-132979 from the Swiss National Science Foundation, grant 5500550 and from the Howard Hughes Medical Institute and grant 51RT-0_126008 (InfectX) from SystemsX.ch, the Swiss Initiative for Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Arbeloa A, 2010, CELL MICROBIOL, V12, P654, DOI 10.1111/j.1462-5822.2009.01423.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09; Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997; Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700; Dehio C, 1997, J CELL SCI, V110, P2141; Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x; Fiorentini C, 1997, J BIOL CHEM, V272, P19532, DOI 10.1074/jbc.272.31.19532; Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897; Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Litvak Y, 2003, TRENDS BIOCHEM SCI, V28, P628, DOI 10.1016/j.tibs.2003.10.001; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018; Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmid MC, 2006, TRANSLOCATED BACTERI; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	33	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e25106	10.1371/journal.pone.0025106	http://dx.doi.org/10.1371/journal.pone.0025106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22043280	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000295984400007
J	Chen, H; Zhang, BC; Hicks, LM; Xiong, LM				Chen, Hao; Zhang, Baichen; Hicks, Leslie M.; Xiong, Liming			A Nucleotide Metabolite Controls Stress-Responsive Gene Expression and Plant Development	PLOS ONE			English	Article							3'-PHOSPHATE 5'-PHOSPHOSULFATE TRANSPORTER; INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; ACID SIGNAL-TRANSDUCTION; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; SALT TOLERANCE; 3(2),5-BISPHOSPHATE NUCLEOTIDASE; NEGATIVE REGULATOR; FREEZING TOLERANCE; SULFUR METABOLISM	Abiotic stress, such as drought and high salinity, activates a network of signaling cascades that lead to the expression of many stress-responsive genes in plants. The Arabidopsis FIERY1 (FRY1) protein is a negative regulator of stress and abscisic acid (ABA) signaling and exhibits both an inositol polyphosphatase and a 3',5'-bisphosphate nucleotidase activity in vitro. The FRY1 nucleotidase degrades the sulfation byproduct 3'-phosphoadenosine-5'-phosphate (PAP), yet its in vivo functions and particularly its roles in stress gene regulation remain unclear. Here we developed a LC-MS/MS method to quantitatively measure PAP levels in plants and investigated the roles of this nucleotidase activity in stress response and plant development. It was found that PAP level was tightly controlled in plants and did not accumulate to any significant level either under normal conditions or under NaCl, LiCl, cold, or ABA treatments. In contrast, high levels of PAP were detected in multiple mutant alleles of FRY1 but not in mutants of other FRY1 family members, indicating that FRY1 is the major enzyme that hydrolyzes PAP in vivo. By genetically reducing PAP levels in fry1 mutants either through overexpression of a yeast PAP nucleotidase or by generating a triple mutant of fry1 apk1 apk2 that is defective in the biosynthesis of the PAP precursor 3'-phosphoadenosine-5'-phosphosulfate (PAPS), we demonstrated that the developmental defects and superinduction of stress-responsive genes in fry1 mutants correlate with PAP accumulation in planta. We also found that the hypersensitive stress gene regulation in fry1 requires ABH1 but not ABI1, two other negative regulators in ABA signaling pathways. Unlike in yeast, however, FRY1 overexpression in Arabidopsis could not enhance salt tolerance. Taken together, our results demonstrate that PAP is critical for stress gene regulation and plant development, yet the FRY1 nucleotidase that catabolizes PAP may not be an in vivo salt toxicity target in Arabidopsis.	[Chen, Hao; Zhang, Baichen; Hicks, Leslie M.; Xiong, Liming] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Chen, Hao; Xiong, Liming] King Abdullah Univ Sci & Technol, Div Chem & Life Sci & Engn, Thuwal, Saudi Arabia	Donald Danforth Plant Science Center; King Abdullah University of Science & Technology	Chen, H (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	liming.xiong@kaust.edu.sa	Hicks, Leslie M/E-8015-2010; Chen, Hao/AAF-3704-2020	Hicks, Leslie M/0000-0002-8008-3998; Xiong, Liming/0000-0001-8099-0806	National Science Foundation [0446359]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation grant #0446359 (to L.X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown E, 2007, BIOCHEM CELL BIOL, V85, P444, DOI 10.1139/O07-059; Chen H, 2005, PLANT J, V44, P396, DOI 10.1111/j.1365-313X.2005.02538.x; Chen H, 2011, PLANT SIGNAL BEHAV, V6, P123, DOI 10.4161/psb.6.1.14231; Chen H, 2010, PLANT CELL ENVIRON, V33, P2180, DOI 10.1111/j.1365-3040.2010.02218.x; Chen H, 2010, J BIOL CHEM, V285, P24238, DOI 10.1074/jbc.M110.123661; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Davidian JC, 2010, MOL PLANT, V3, P314, DOI 10.1093/mp/ssq001; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gibon Y, 2002, PLANT J, V30, P221, DOI 10.1046/j.1365-313X.2001.01278.x; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Hirsch J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016724; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Kim BH, 2009, PLANT J, V58, P208, DOI 10.1111/j.1365-313X.2008.03770.x; Koiwa H, 2006, J EXP BOT, V57, P1119, DOI 10.1093/jxb/erj093; Lee H, 1999, PLANT J, V17, P301, DOI 10.1046/j.1365-313X.1999.00375.x; Lee S, 1998, BIOCHEM BIOPH RES CO, V247, P171, DOI 10.1006/bbrc.1998.8751; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; Leustek T, 1999, PLANT PHYSIOL, V120, P637, DOI 10.1104/pp.120.3.637; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lillig CH, 2001, ARCH BIOCHEM BIOPHYS, V392, P303, DOI 10.1006/abbi.2001.2453; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; LUNN JE, 1990, PLANT PHYSIOL, V94, P1345, DOI 10.1104/pp.94.3.1345; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; Mechold U, 2006, NUCLEIC ACIDS RES, V34, P2364, DOI 10.1093/nar/gkl247; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; MURGUIA JR, 1995, SCIENCE, V267, P232; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; RENOSTO F, 1993, ARCH BIOCHEM BIOPHYS, V307, P272, DOI 10.1006/abbi.1993.1590; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; SCHMIDT A, 1992, ANNU REV PLANT PHYS, V43, P325, DOI 10.1146/annurev.pp.43.060192.001545; STITT M, 1986, PLANT PHYSIOL, V81, P1115, DOI 10.1104/pp.81.4.1115; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; THOMAS D, 1992, J GEN MICROBIOL, V138, P2021, DOI 10.1099/00221287-138-10-2021; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; Verslues PE, 2006, PLANT J, V47, P776, DOI 10.1111/j.1365-313X.2006.02833.x; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Xiong LM, 2004, PLANT J, V40, P536, DOI 10.1111/j.1365-313X.2004.02225.x; Xiong LM, 2001, DEV CELL, V1, P771, DOI 10.1016/S1534-5807(01)00087-9; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; ZARUBA ME, 1988, BIOCHEM BIOPH RES CO, V155, P1271, DOI 10.1016/S0006-291X(88)81278-6; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	65	109	112	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26661	10.1371/journal.pone.0026661	http://dx.doi.org/10.1371/journal.pone.0026661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	21792361	Green Submitted, Green Published, gold			2022-12-25	WOS:000296507500105
J	Huang, QD; Zhong, GX; Zhang, Y; Ren, J; Fu, Y; Zhang, J; Zhu, W; Yu, XQ				Huang, Qing-Dong; Zhong, Guo-Xing; Zhang, Yang; Ren, Jiang; Fu, Yun; Zhang, Ji; Zhu, Wen; Yu, Xiao-Qi			Cyclen-Based Cationic Lipids for Highly Efficient Gene Delivery towards Tumor Cells	PLOS ONE			English	Article							DNA COMPLEXES; TRANSFECTION; VECTORS; THERAPY; LINKER; GROWTH	Background: Gene therapy has tremendous potential for both inherited and acquired diseases. However, delivery problems limited their clinical application, and new gene delivery vehicles with low cytotoxicity and high transfection efficiency are greatly required. Methods: In this report, we designed and synthesized three amphiphilic molecules (L1-L3) with the structures involving 1, 4, 7, 10-tetraazacyclododecane (cyclen), imidazolium and a hydrophobic dodecyl chain. Their interactions with plasmid DNA were studied via electrophoretic gel retardation assays, fluorescent quenching experiments, dynamic light scattering and transmission electron microscopy. The in vitro gene transfection assay and cytotoxicity assay were conducted in four cell lines. Results: Results indicated that L1 and L3-formed liposomes could effectively bind to DNA to form well-shaped nanoparticles. Combining with neutral lipid DOPE, L3 was found with high efficiency in gene transfer in three tumor cell lines including A549, HepG2 and H460. The optimized gene transfection efficacy of L3 was nearly 5.5 times more efficient than that of the popular commercially available gene delivery agent Lipofectamine 2000 (TM) in human lung carcinoma cells A549. In addition, since L1 and L3 had nearly no gene transfection performance in normal cells HEK293, these cationic lipids showed tumor cell-targeting property to a certain extent. No significant cytotoxicity was found for the lipoplexes formed by L1-L3, and their cytotoxicities were similar to or slightly lower than the lipoplexes prepared from Lipofectamine 2000 (TM). Conclusion: Novel cyclen-based cationic lipids for effective in vitro gene transfection were founded, and these studies here may extend the application areas of macrocyclic polyamines, especially for cyclen.	[Huang, Qing-Dong] Sichuan Univ, W China Hosp, Coll Chem, Key Lab Green Chem & Technol,Minist Educ, Chengdu 610064, Peoples R China; Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Huang, QD (corresponding author), Sichuan Univ, W China Hosp, Coll Chem, Key Lab Green Chem & Technol,Minist Educ, Chengdu 610064, Peoples R China.	jzhang@scu.edu.cn; zhuwen@scu.edu.cn; xqyu@scu.edu.cn	Yu, Xiao-Qi/AAF-2741-2020	YU, WEI/0000-0002-1777-5254	National Science Foundation of China [20972104, 20725206, 20732004, 20902062]; Program for Changjiang Scholars and Innovative Research Team in University; Chinese Ministry of Education in China; Scientific Fund of Sichuan Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education in China; Scientific Fund of Sichuan Province	This work was financially supported by the National Science Foundation of China (Nos. 20972104, 20725206, 20732004 and 20902062), the Program for Changjiang Scholars and Innovative Research Team in University, the Key Project of Chinese Ministry of Education in China and the Scientific Fund of Sichuan Province for Outstanding Young Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J GENE MED, V7, P739, DOI 10.1002/jgm.717; Aissaoui A, 2004, J MED CHEM, V47, P5210, DOI 10.1021/jm0408159; Anderson WF, 1998, NATURE, V392, P25; Bajaj A, 2008, J MED CHEM, V51, P2533, DOI 10.1021/jm7010436; Bajaj A, 2007, BIOCONJUGATE CHEM, V18, P1537, DOI 10.1021/bc070010q; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Boktov J, 2007, J GENE MED, V9, P884, DOI 10.1002/jgm.1079; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cheung JL, 1997, J ORG CHEM, V62, P62, DOI 10.1021/jo961254z; Dobbs W, 2009, J AM CHEM SOC, V131, P13338, DOI 10.1021/ja903028f; Ewert K, 2002, J MED CHEM, V45, P5023, DOI 10.1021/jm020233w; Ewert KK, 2006, J AM CHEM SOC, V128, P3998, DOI 10.1021/ja055907h; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fujiwara T, 2000, BBA-BIOMEMBRANES, V1468, P396, DOI 10.1016/S0005-2736(00)00278-9; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Huang QD, 2008, CHEM BIOL DRUG DES, V71, P224, DOI 10.1111/j.1747-0285.2008.00631.x; Kimura E, 1999, CHEM-EUR J, V5, P3113, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3113::AID-CHEM3113>3.0.CO;2-L; Lam AMI, 2000, BBA-BIOMEMBRANES, V1463, P279, DOI 10.1016/S0005-2736(99)00219-9; Li QL, 2006, BIOORGAN MED CHEM, V14, P4151, DOI 10.1016/j.bmc.2006.01.069; Liberska A, 2009, ORG BIOMOL CHEM, V7, P61, DOI 10.1039/b815733b; Martin B, 2005, CURR PHARM DESIGN, V11, P375, DOI 10.2174/1381612053382133; Miller AD, 2003, CURR MED CHEM, V10, P1195, DOI 10.2174/0929867033457485; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Petukhov IA, 2010, RUSS CHEM B+, V59, P260, DOI 10.1007/s11172-010-0071-x; Rajesh M, 2007, J AM CHEM SOC, V129, P11408, DOI 10.1021/ja0704683; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Xia CQ, 2006, BIOORGAN MED CHEM, V14, P5756, DOI 10.1016/j.bmc.2006.04.048; Xiang YZ, 2010, ORG BIOMOL CHEM, V8, P640, DOI 10.1039/b914877a; Yang XB, 2008, BIOORGAN MED CHEM, V16, P3871, DOI 10.1016/j.bmc.2008.01.037; Yi WJ, 2011, ORG BIOMOL CHEM, V9, P2413, DOI 10.1039/c0ob00879f; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X; Zhang SB, 2007, J CONTROL RELEASE, V123, P1, DOI 10.1016/j.jconrel.2007.07.016; Zhou LH, 2009, CHEM BIOL DRUG DES, V73, P216, DOI 10.1111/j.1747-0285.2008.00765.x	35	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23134					11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21887233				2022-12-25	WOS:000295454200045
J	Holodniy, M; Brown, ST; Cameron, DW; Kyriakides, TC; Angus, B; Babiker, A; Singer, J; Owens, DK; Anis, A; Goodall, R; Hudson, F; Piaseczny, M; Russo, J; Schechter, M; Deyton, L; Darbyshire, J				Holodniy, Mark; Brown, Sheldon T.; Cameron, D. William; Kyriakides, Tassos C.; Angus, Brian; Babiker, Abdel; Singer, Joel; Owens, Douglas K.; Anis, Aslam; Goodall, Ruth; Hudson, Fleur; Piaseczny, Mirek; Russo, John; Schechter, Martin; Deyton, Lawrence; Darbyshire, Janet		OPTIMA Team	Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial	PLOS ONE			English	Article							STRUCTURED TREATMENT INTERRUPTION; QUALITY-OF-LIFE; CROSS-RESISTANCE; CLINICAL PROGRESSION; VIROLOGICAL FAILURE; MEGA-HAART; COHORT; THERAPY; INHIBITORS; VIRUS	Background: Guidance is needed on best medical management for advanced HIV disease with multidrug resistance (MDR) and limited retreatment options. We assessed two novel antiretroviral (ARV) treatment approaches in this setting. Methods and Findings: We conducted a 262 factorial randomized open label controlled trial in patients with a CD4 count <= 300 cells/mu l who had ARV treatment (ART) failure requiring retreatment, to two options (a) re-treatment with either standard (<= 4 ARVs) or intensive (>= 5 ARVs) ART and b) either treatment starting immediately or after a 12-week monitored ART interruption. Primary outcome was time to developing a first AIDS-defining event (ADE) or death from any cause. Analysis was by intention to treat. From 2001 to 2006, 368 patients were randomized. At baseline, mean age was 48 years, 2% were women, median CD4 count was 106/mu l, mean viral load was 4.74 log(10) copies/ml, and 59% had a prior AIDS diagnosis. Median follow-up was 4.0 years in 1249 person-years of observation. There were no statistically significant differences in the primary composite outcome of ADE or death between re-treatment options of standard versus intensive ART (hazard ratio 1.17; CI 0.86-1.59), or between immediate retreatment initiation versus interruption before re-treatment (hazard ratio 0.93; CI 0.68-1.30), or in the rate of non-HIV associated serious adverse events between re-treatment options. Conclusions: We did not observe clinical benefit or harm assessed by the primary outcome in this largest and longest trial exploring both ART interruption and intensification in advanced MDR HIV infection with poor retreatment options.	[Holodniy, Mark; Owens, Douglas K.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Holodniy, Mark; Owens, Douglas K.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Brown, Sheldon T.] James J Peters VA Med Ctr, Bronx, NY USA; [Brown, Sheldon T.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Cameron, D. William] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Cameron, D. William; Singer, Joel; Anis, Aslam; Piaseczny, Mirek; Schechter, Martin] St Pauls Hosp, Canadian HIV Trials Network, Vancouver, BC V6Z 1Y6, Canada; [Kyriakides, Tassos C.; Russo, John] VA Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; [Angus, Brian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Babiker, Abdel; Goodall, Ruth; Hudson, Fleur; Darbyshire, Janet] MRC Clin Trials Unit, London, England; [Deyton, Lawrence] Off Publ Hlth & Environm Hazards, Dept Vet Affairs, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; University of Ottawa; Ottawa Hospital Research Institute; St. Paul's Hospital; University of Saskatchewan; University of Oxford; Medical Research Council Clinical Trials Unit	Holodniy, M (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	bcameron@ohri.ca	Kyriakides, Tassos/E-4980-2013; Angus, Brian/L-9246-2019; Cameron, Bill/E-9180-2010; Giongo, Adriana/P-8718-2015; Wasserfall, Clive/J-9078-2012	Kyriakides, Tassos/0000-0001-8913-108X; Angus, Brian/0000-0003-3598-7784; Cameron, Bill/0000-0002-0090-3539; Hyoty, Heikki/0000-0003-0370-4145; Kozal, Michael/0000-0002-3100-8254; Holodniy, Mark/0000-0002-6655-7982; Ilonen, Jorma/0000-0002-9973-2062; Knip, Mikael/0000-0003-0474-0033; Giongo, Adriana/0000-0002-1412-7040; Wasserfall, Clive/0000-0002-3522-8932; , Michael/0000-0002-7719-7396; Drew, Jennifer/0000-0002-4037-108X; Brown, Chris/0000-0002-7758-6447; Schechter, Martin/0000-0001-6063-2155; Goodall, Ruth/0000-0003-0622-5035	Ontario Ministry of Health/Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network, Canada; MRC [MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_U122886352] Funding Source: researchfish	Ontario Ministry of Health/Ontario HIV Treatment Network(Ministry of Health and Long-Term Care, Ontario); CIHR Canadian HIV Trials Network, Canada(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DWC is supported with a Career Scientist Award of the Ontario Ministry of Health/Ontario HIV Treatment Network. The study was supported in part in Canada through the CIHR Canadian HIV Trials Network. The study funders (MRC-UK, VACSP, CIHR) reviewed and approved the design and conduct of the trial, with external expert reviewers who were represented on the Trial Steering Committee. The OPTIMA Writing Committee and the OPTIMA team had full access to the statistical report and to the study data by request and the Writing Committee had final responsibility for the submitted manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis AH, 2009, JAIDS-J ACQ IMM DEF, V51, P631, DOI 10.1097/QAI.0b013e3181a4f00d; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Antinori A, 2002, AIDS RES HUM RETROV, V18, P835, DOI 10.1089/08892220260190308; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cozzi-Lepri A, 2008, AIDS, V22, P2187, DOI 10.1097/QAD.0b013e328310e04f; DARMINIO MA, 2005, ARCH INTERN MED, V0165; *DEP HLTH HUM SERV, PAN ANT GUID AD GUID; Hamers RL, 2008, ANTIVIR THER, V13, P625; Hughes A, 2008, J INFECTION, V57, P1, DOI 10.1016/j.jinf.2008.05.006; Joyce VR, 2009, JAIDS-J ACQ IMM DEF, V50, P27, DOI 10.1097/QAI.0b013e31818ce6f3; Katlama C, 2004, AIDS, V18, P217, DOI 10.1097/00002030-200401230-00011; KAUF TL, 2008, PREDICTIVE MODEL HLT; Kyriakides TC, 2003, CONTROL CLIN TRIALS, V24, P481, DOI 10.1016/S0197-2456(03)00029-1; Lawrence J, 2003, NEW ENGL J MED, V349, P837, DOI 10.1056/NEJMoa035103; LAWRENCE JKH, 2006, ANTIRETROVIRAL PHENO; Lawrence J, 2006, JAIDS-J ACQ IMM DEF, V43, P169, DOI 10.1097/01.qai.0000242450.74779.ee; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lo Re V, 2008, CLIN LIVER DIS, V12, P587, DOI 10.1016/j.cld.2008.03.009; Miller V, 2000, ANTIVIR THER, V5, P49; Miller V, 2001, ANTIVIR THER, V6, P25; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Montaner JSG, 2001, AIDS, V15, P61, DOI 10.1097/00002030-200101050-00010; Morse CG, 2006, JAMA-J AM MED ASSOC, V296, P844, DOI 10.1001/jama.296.7.844; Pai N. P., 2006, COCHRANE DB SYST REV, V3; Perno CF, 2008, J MED VIROL, V80, P565, DOI 10.1002/jmv.21034; Race E, 1999, AIDS, V13, P2061, DOI 10.1097/00002030-199910220-00008; Reynolds SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010307; Rottmann C, 1999, ANTIVIR THER, V4, P93; Zaccarelli M, 2005, AIDS, V19, P1081, DOI 10.1097/01.aids.0000174455.01369.ad	30	445	452	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2011	6	3							e14764	10.1371/journal.pone.0014764	http://dx.doi.org/10.1371/journal.pone.0014764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743YU	21483491	gold, Green Submitted, Green Published			2022-12-25	WOS:000289057200001
J	Kim, SH; Lu, HF; Alano, CC				Kim, Sun Hee; Lu, Hua Fei; Alano, Conrad C.			Neuronal Sirt3 Protects against Excitotoxic Injury in Mouse Cortical Neuron Culture	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; POLY(ADP-RIBOSE) PAR POLYMER; APOPTOSIS-INDUCING FACTOR; NMDA RECEPTOR ACTIVATION; CEREVISIAE LIFE-SPAN; INDUCED CELL-DEATH; NAD(+) DEPLETION; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; CEREBRAL-ISCHEMIA	Background: Sirtuins (Sirt), a family of nicotinamide adenine nucleotide (NAD) dependent deacetylases, are implicated in energy metabolism and life span. Among the known Sirt isoforms (Sirt1-7), Sirt3 was identified as a stress responsive deacetylase recently shown to play a role in protecting cells under stress conditions. Here, we demonstrated the presence of Sirt3 in neurons, and characterized the role of Sirt3 in neuron survival under NMDA-induced excitotoxicity. Methodology/Principal Findings: To induce excitotoxic injury, we exposed primary cultured mouse cortical neurons to NMDA (30 mu M). NMDA induced a rapid decrease of cytoplasmic NAD (but not mitochondrial NAD) in neurons through poly (ADP-ribose) polymerase-1 (PARP-1) activation. Mitochondrial Sirt3 was increased following PARP-1 mediated NAD depletion, which was reversed by either inhibition of PARP-1 or exogenous NAD. We found that massive reactive oxygen species (ROS) produced under this NAD depleted condition mediated the increase in mitochondrial Sirt3. By transfecting primary neurons with a Sirt3 overexpressing plasmid or Sirt3 siRNA, we showed that Sirt3 is required for neuroprotection against excitotoxicity. Conclusions: This study demonstrated for the first time that mitochondrial Sirt3 acts as a prosurvival factor playing an essential role to protect neurons under excitotoxic injury.	[Kim, Sun Hee; Lu, Hua Fei; Alano, Conrad C.] Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA; [Alano, Conrad C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Kim, SH (corresponding author), Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA.	conrad.alano@ucsf.edu	Kim, Sun/GSN-4867-2022; Gaquerel, Emmanuel/I-2503-2014	Gaquerel, Emmanuel/0000-0003-0796-6417; Baldwin, Ian/0000-0001-5371-2974; Yon, Felipe/0000-0002-5667-873X; Gulati, Jyotasana/0000-0003-0163-1296	Department of Veterans Affairs; American Heart Association	Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association)	This work was supported by the Department of Veterans Affairs (CCA) and the American Heart Association (CCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castilho RF, 1999, J NEUROCHEM, V72, P1394, DOI 10.1046/j.1471-4159.1999.721394.x; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Ciani E, 1996, BRAIN RES, V728, P1; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Goebel DJ, 2006, J NEUROCHEM, V98, P1732, DOI 10.1111/j.1471-4159.2006.04065.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Halmosi R, 2001, MOL PHARMACOL, V59, P1497, DOI 10.1124/mol.59.6.1497; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaundal RK, 2006, LIFE SCI, V79, P2293, DOI 10.1016/j.lfs.2006.07.034; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; TAO R, 2010, J CARDIOVASC PHARM; Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; YAN T, 2009, NEUROCHEM INT; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zeng JY, 2007, J CEREBR BLOOD F MET, V27, P304, DOI 10.1038/sj.jcbfm.9600335	71	166	176	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e14731	10.1371/journal.pone.0014731	http://dx.doi.org/10.1371/journal.pone.0014731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390294	Green Published, gold, Green Submitted			2022-12-25	WOS:000287932100001
J	Lee, DH; Steffes, MW; Sjodin, A; Jones, RS; Needham, LL; Jacobs, DR				Lee, Duk-Hee; Steffes, Michael W.; Sjoedin, Andreas; Jones, Richard S.; Needham, Larry L.; Jacobs, David R., Jr.			Low Dose Organochlorine Pesticides and Polychlorinated Biphenyls Predict Obesity, Dyslipidemia, and Insulin Resistance among People Free of Diabetes	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; ENDOCRINE-DISRUPTING CHEMICALS; SERUM CONCENTRATIONS; NONDIABETIC ADULTS; NATIONAL-HEALTH; ASSOCIATION; MECHANISMS	Background: There is emerging evidence that background exposure to persistent organic pollutants (POPs) are important in the development of conditions predisposing to diabetes as well as of type 2 diabetes itself. We recently reported that low dose POPs predicted incident type 2 diabetes in a nested case-control study. The current study examined if low dose POPs predicted future adiposity, dyslipidemia, and insulin resistance among controls without diabetes in that study. Methodology/Principal Findings: The 90 controls were diabetes-free during 20 years follow-up. They were a stratified random sample, enriched with overweight and obese persons. POPs measured in 1987-88 (year 2) sera included 8 organochlorine (OC) pesticides, 22 polychlorinated biphenyls (PCBs), and 1 polybrominated biphenyl (PBB). Body mass index (BMI), triglycerides, HDL-cholesterol, LDL-cholesterol, and homeostasis model assessment value for insulin resistance (HOMA-IR) were study outcomes at 2005-06 (year 20). The evolution of study outcomes during 18 years by categories of serum concentrations of POPs at year 2 was evaluated by adjusting for the baseline values of outcomes plus potential confounders. Parallel to prediction of type 2 diabetes, many statistically significant associations of POPs with dysmetabolic conditions appeared at low dose, forming inverted U-shaped dose-response relations. Among OC pesticides, p,p'-DDE most consistently predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 after adjusting for baseline values. Oxychlordane, trans-nonachlor, and hexachlorobenzene also significantly predicted higher triglycerides. Persistent PCBs with >= 7 chlorides predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 with similar dose-response curves. Conclusions/Significance: Simultaneous exposure to various POPs in the general population may contribute to development of obesity, dyslipidemia, and insulin resistance, common precursors of type 2 diabetes and cardiovascular diseases. Although obesity is a primary cause of these metabolic abnormalities, POPs exposure may contribute to excess adiposity and other features of dysmetabolism.	[Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea; [Steffes, Michael W.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Sjoedin, Andreas; Jones, Richard S.; Needham, Larry L.] Ctr Dis Control & Prevent, Organ Analyt Toxicol Branch OAT, DLS, NCEH, Atlanta, GA USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	Kyungpook National University; University of Minnesota System; University of Minnesota Twin Cities; Centers for Disease Control & Prevention - USA; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo	Lee, DH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea.	jacob004@umn.edu	Needham, Larry/E-4930-2011; Sjodin, Andreas/F-2464-2010	Jacobs, David/0000-0002-7232-0543; Palsson, Bernhard/0000-0003-2357-6785	National Heart, Lung, and Blood Institute (CARDIA field centers), (CARDIA Coordinating Center) [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095]; YALTA [R01-HL-53560]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048049, N01HC095095, N01HC048047, N01HC048050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL053560, R01HL048050, R01HL048049, R01HL048048] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (CARDIA field centers), (CARDIA Coordinating Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); YALTA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Heart, Lung, and Blood Institute contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 (CARDIA field centers), N01-HC-95095 (CARDIA Coordinating Center), and grant R01-HL-53560 (YALTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Daston GP, 2003, TOXICOL SCI, V74, P245, DOI 10.1093/toxsci/kfg105; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karmaus W, 2009, OCCUP ENVIRON MED, V66, P143, DOI 10.1136/oem.2008.041921; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; LEE DH, 2010, LOW DOSE PERSISTENT; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lopez MCC, 2003, ENVIRON INT, V28, P751, DOI 10.1016/S0160-4120(02)00120-4; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; OBANA H, 1987, ENVIRON RES, V42, P500, DOI 10.1016/S0013-9351(87)80217-7; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640; Sjodin A, 2004, ANAL CHEM, V76, P1921, DOI 10.1021/ac030381; Szapary PO, 2004, AM HEART J, V148, P211, DOI 10.1016/j.ahj.2004.03.037; Turyk M, 2009, ENVIRON HEALTH PERSP, V117, P1076, DOI 10.1289/ehp.0800281; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494	23	276	299	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15977	10.1371/journal.pone.0015977	http://dx.doi.org/10.1371/journal.pone.0015977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	22028828	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800014
J	Kumar, A; Gao, H; Xu, J; Reuben, J; Yu, DH; Mehta, K				Kumar, Anupam; Gao, Hui; Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil			Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; DRUG-RESISTANT; GLAND CELLS; BREAST; PROLIFERATION; MECHANISMS	Cancer stem cells (CSCs) or tumor initiating cells (TICs) make up only a small fraction of total tumor cell population, but recent evidence suggests that they are responsible for tumor initiation and the maintenance of tumor growth. Whether CSCs/TICs originate from normal stem cells or result from the dedifferentiation of terminally differentiated cells remains unknown. Here we provide evidence that sustained expression of the proinflammatory protein tissue transglutaminase (TG2) confers stem cell like properties in non-transformed and transformed mammary epithelial cells. Sustained expression of TG2 was associated with increase in CD44(high)/CD24(low/-) subpopulation, increased ability of cells to form mammospheres, and acquisition of self-renewal ability. Mammospheres derived from TG2-transfected mammary epithelial cells (MCF10A) differentiated into complex secondary structures when grown in Matrigel cultures. Cells in these secondary structures differentiated into Muc1-positive (luminal marker) and integrin alpha 6-positive (basal marker) cells in response to prolactin treatment. Highly aggressive MDA-231 and drug-resistant MCF-7/RT breast cancer cells, which express high basal levels of TG2, shared many traits with TG2-transfected MCF10A stem cells but unlike MCF10A-derived stem cells they failed to form the secondary structures and to differentiate into Muc1-positive luminal cells when grown in Matrigel culture. Downregulation of TG2 attenuated stem cell properties in both non-transformed and transformed mammary epithelial cells. Taken together, these results suggested a new function for TG2 and revealed a novel mechanism responsible for promoting the stem cell characteristics in adult mammary epithelial cells.	[Kumar, Anupam; Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Gao, Hui; Reuben, James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Xu, Jia; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kumar, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kmehta@mdanderson.org	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Susan G. Komen for the Cure Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from Susan G. Komen for the Cure Foundation (http://ww5.komen.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gamucci T, 2007, BRIT J CANCER, V97, P1040, DOI 10.1038/sj.bjc.6603982; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Lacerda L, 2010, DRUG RESIST UPDATE, V13, P99, DOI 10.1016/j.drup.2010.08.001; Lawson JC, 2009, BREAST CANCER RES TR, V118, P241, DOI 10.1007/s10549-009-0524-9; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; LU S, 1995, J BIOL CHEM, V270, P9748, DOI 10.1074/jbc.270.17.9748; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; SUTO N, 1993, J BIOL CHEM, V268, P7469; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716	31	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20701	10.1371/journal.pone.0020701	http://dx.doi.org/10.1371/journal.pone.0020701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21526230	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500037
J	Kumar, A; Bullard, RL; Patel, P; Paslay, LC; Singh, D; Bienkiewicz, EA; Morgan, SE; Rangachari, V				Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Paslay, Lea C.; Singh, Dipti; Bienkiewicz, Ewa A.; Morgan, Sarah E.; Rangachari, Vijayaraghavan			Non-Esterified Fatty Acids Generate Distinct Low-Molecular Weight Amyloid-beta (A beta 42) Oligomers along Pathway Different from Fibril Formation	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; ALPHA-SYNUCLEIN; IN-VITRO; CONTAINING MEMBRANES; APOLIPOPROTEIN-E; ENDOGENOUS SEED; LIPID-MEMBRANES; TRANSGENIC MICE	Amyloid-beta (A beta) peptide aggregation is known to play a central role in the etiology of Alzheimer's disease (AD). Among various aggregates, low-molecular weight soluble oligomers of A beta are increasingly believed to be the primary neurotoxic agents responsible for memory impairment. Anionic interfaces are known to influence the A beta aggregation process significantly. Here, we report the effects of interfaces formed by medium-chain (C9-C12), saturated non-esterified fatty acids (NEFAs) on A beta 42 aggregation. NEFAs uniquely affected A beta 42 aggregation rates that depended on both the ratio of A beta:NEFA as well the critical micelle concentration (CMC) of the NEFAs. More importantly, irrespective of the kind of NEFA used, we observed that two distinct oligomers, 12-18 mers and 4-5 mers were formed via different pathway of aggregation under specific experimental conditions: (i) 12-18 mers were generated near the CMC in which NEFAs augment the rate of A beta 42 aggregation towards fibril formation, and, (ii) 4-5 mers were formed above the CMC, where NEFAs inhibit fibril formation. The data indicated that both 12-18 mers and 4-5 mers are formed along an alternate pathway called 'off-pathway' that did not result in fibril formation and yet have subtle structural and morphological differences that distinguish their bulk molecular behavior. These observations, (i) reflect the possible mechanism of A beta aggregation in physiological lipid-rich environments, and (ii) reiterate the fact that all oligomeric forms of A beta need not be obligatory intermediates of the fibril formation pathway.	[Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Paslay, Lea C.; Singh, Dipti; Morgan, Sarah E.] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA; [Bienkiewicz, Ewa A.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	University of Southern Mississippi; University of Southern Mississippi; State University System of Florida; Florida State University	Kumar, A (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Alzheimer's Association [NIRG-09-132721]; American Heart Association [0535185N]; National Science Foundation [DMR-0213883]; National Center for Research Resources, National Institutes of Health [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by NIRG grant from Alzheimer's Association (NIRG-09-132721) (www.Alz.org) and an American Heart Association SDG award (0535185N) for VR (www.AHA.org). Partial support by the MRSEC program of the National Science Foundation (DMR-0213883) as well as Mississippi INBRE funded by the National Center for Research Resources, National Institutes of Health (award# P20RR016476) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Carpentier YA, 2006, PROSTAG LEUKOTR ESS, V75, P145, DOI 10.1016/j.plefa.2006.05.004; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fletcher TG, 1997, PROTEIN SCI, V6, P666; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Hagihara Y, 2002, BIOCHEMISTRY-US, V41, P1020, DOI 10.1021/bi015693q; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; LUZZATI V, 1966, ANN NY ACAD SCI, V137, P409, DOI 10.1111/j.1749-6632.1966.tb50172.x; Ma Z, 2002, MOL MED, V8, P863, DOI 10.1007/BF03402092; Mandal PK, 2004, NEUROCHEM RES, V29, P2273, DOI 10.1007/s11064-004-7036-0; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MAYES PA, 2000, LANGE MED BOOKS, P268; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MICHAEL R, 2005, BIOCHEMISTRY-US, V44, P165; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Perczel A., 1996, CIRCULAR DICHROISM C, P285; Pillot T, 1996, J BIOL CHEM, V271, P28757, DOI 10.1074/jbc.271.46.28757; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; REISSHUSSON F, 1966, J COLLOID INTERF SCI, V21, P534, DOI 10.1016/0095-8522(66)90051-1; Ross BP, 2004, MOL PHARMACEUT, V1, P233, DOI 10.1021/mp049964d; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Schlame M, 1996, J LIPID RES, V37, P2608; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; SOLFRIZZI V, 2009, AGEING RES REV; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Waiter MF, 1997, BIOCHEM BIOPH RES CO, V233, P760, DOI 10.1006/bbrc.1997.6547; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Wood SJ, 1996, J BIOL CHEM, V271, P4086; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Yamamoto N, 2004, FEBS LETT, V569, P135, DOI 10.1016/j.febslet.2004.05.037; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	71	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18759	10.1371/journal.pone.0018759	http://dx.doi.org/10.1371/journal.pone.0018759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526230	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100019
